PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Nelson, HD				Nelson, HD			Assessing benefits and harms of hormone replacement therapy - Clinical applications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							HEART; METAANALYSIS; DISEASE; CANCER; WOMEN; RISK	An estimated one third of postmenopausal women in the United States use hormone replacement therapy (HRT) to treat symptoms of menopause and prevent chronic conditions. In the context of this widespread use, evidence has been growing about the potential harms of HRT, particularly regarding long-term use. Physicians and patients are often confused about how to use results of studies in individual cases. This article applies the current state of evidence for the benefits and harms of HRT to management decisions in 4 clinical situations. Patient preferences, as well as evidence, are important for these decisions. Benefits and harms need to be readdressed periodically to apply newly published evidence and to reassess emerging risks, comorbidities, and needs of individuals.	Oregon Hlth Sci Univ, Div Med Informat & Outcomes Res, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Evidence Based Practice Ctr, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Dept Med, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Vet Affairs Med Ctr, Med Serv, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Nelson, HD (corresponding author), Oregon Hlth Sci Univ, Div Med Informat & Outcomes Res, Mail Code BICC 504,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.							Cauley JA, 2001, J CLIN ENDOCR METAB, V86, P5700, DOI 10.1210/jc.86.12.5700; CRANNEY A, 2000, NAT I HLTH CONS DEV; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; Grady D, 2002, JAMA-J AM MED ASSOC, V287, P2130, DOI 10.1001/jama.287.16.2130; Grady D, 2001, OBSTET GYNECOL, V97, P116, DOI 10.1016/S0029-7844(00)01115-7; Grodstein F, 1999, AM J MED, V106, P574, DOI 10.1016/S0002-9343(99)00063-7; GRODSTEIN F, 1994, OBSTET GYNECOL, V83, P5; Hlatky MA, 2002, JAMA-J AM MED ASSOC, V287, P591, DOI 10.1001/jama.287.5.591; Hulley S, 2002, JAMA-J AM MED ASSOC, V288, P58, DOI 10.1001/jama.288.1.58; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; HUMPHREY LL, IN PRESS ANN INTERN; Lacey JV, 2002, JAMA-J AM MED ASSOC, V288, P334, DOI 10.1001/jama.288.3.334; LeBlanc ES, 2001, JAMA-J AM MED ASSOC, V285, P1489, DOI 10.1001/jama.285.11.1489; Miller J, 2002, ANN INTERN MED, V136, P680, DOI 10.7326/0003-4819-136-9-200205070-00011; Mosca L, 2001, CIRCULATION, V104, P499, DOI 10.1161/hc2901.092200; National Cancer Institute, BREAST CANC RISK ASS; Nelson HD, 2002, JAMA-J AM MED ASSOC, V288, P872, DOI 10.1001/jama.288.7.872; NELSON HD, IN PRESS ARCH INTERN; Riman T, 2002, JNCI-J NATL CANCER I, V94, P497, DOI 10.1093/jnci/94.7.497; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sellers TA, 1997, ANN INTERN MED, V127, P973, DOI 10.7326/0003-4819-127-11-199712010-00004	21	21	23	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2002	288	7					882	884		10.1001/jama.288.7.882	http://dx.doi.org/10.1001/jama.288.7.882			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585FC	12186606	Bronze			2022-12-28	WOS:000177513100031
J	Miller, AD; Bezel, I; Gaffney, KJ; Garrett-Roe, S; Liu, SH; Szymanski, P; Harris, CB				Miller, AD; Bezel, I; Gaffney, KJ; Garrett-Roe, S; Liu, SH; Szymanski, P; Harris, CB			Electron solvation in two dimensions	SCIENCE			English	Article							PHOTOELECTRON-SPECTROSCOPY; FEMTOSECOND DYNAMICS; AU(100) SURFACE; INTERFACES; ACETONITRILE; ORIENTATION; STATES	Ultrafast two-photon photoemission has been used to study electron solvation at two-dimensional metal/polar-adsorbate interfaces. The molecular motion that causes the excess electron solvation is manifested as a dynamic shift in the electronic energy. Although the initially excited electron is delocalized in the plane of the interface, interactions with the adsorbate can lead to its localization. A method for determining the spatial extent of the localized electron in the plane of the interface has been developed. This spatial extent was measured to be on the order of a single adsorbate molecule.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Chem Sci, Berkeley, CA 94720 USA; Miller Inst Basic Res Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Harris, CB (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.		Garrett-Roe, Sean/C-6037-2011; Gaffney, Kelly J/N-1597-2017; Gaffney, Kelly/AAG-7136-2020	Garrett-Roe, Sean/0000-0001-6199-8773; Gaffney, Kelly J/0000-0002-0525-6465; 				Baldelli S, 2001, J PHYS CHEM B, V105, P654, DOI 10.1021/jp002546d; Benjamin I, 1996, CHEM REV, V96, P1449, DOI 10.1021/cr950230+; BUSCH DG, 1995, PHYS REV LETT, V75, P673, DOI 10.1103/PhysRevLett.75.673; ECHENIQUE PM, 1978, J PHYS C SOLID STATE, V11, P2065, DOI 10.1088/0022-3719/11/10/017; EMIN D, 1976, PHYS REV LETT, V36, P323, DOI 10.1103/PhysRevLett.36.323; FAUSTER T, 1995, PHOTONIC PROBES SURF, P347; Fleming GR, 1996, ANNU REV PHYS CHEM, V47, P109, DOI 10.1146/annurev.physchem.47.1.109; Harris CB, 1997, ANNU REV PHYS CHEM, V48, P711, DOI 10.1146/annurev.physchem.48.1.711; HASHEMI R, 1991, J PHYS CHEM-US, V95, P6402, DOI 10.1021/j100170a002; Hofer U, 1997, SCIENCE, V277, P1480, DOI 10.1126/science.277.5331.1480; HOLSTEIN T, 1959, ANN PHYS-NEW YORK, V8, P343, DOI 10.1016/0003-4916(59)90003-X; KABANOV VV, 1993, PHYS REV B, V47, P6060, DOI 10.1103/PhysRevB.47.6060; Kalosakas G, 1998, PHYS REV B, V58, P3094, DOI 10.1103/PhysRevB.58.3094; KEVAN SD, 1987, PHYS REV B, V36, P5809, DOI 10.1103/PhysRevB.36.5809; KEVAN SD, 1987, ANGLE RESOLVED PHOTO; Kloepfer JA, 1998, CHEM PHYS LETT, V298, P120, DOI 10.1016/S0009-2614(98)01210-X; Kugler T, 1999, ACCOUNTS CHEM RES, V32, P225, DOI 10.1021/ar980041o; LIDE DR, 2000, CRC HDB CHEM PHYSICS; Loughnane BJ, 2000, J PHYS CHEM B, V104, P5421, DOI 10.1021/jp000323h; Memmel N, 1998, SURF SCI REP, V32, P91, DOI 10.1016/S0167-5729(98)00006-5; Ogasawara M., 1991, EXC EL DIEL MED, P288; Petek H, 2000, SCIENCE, V288, P1402, DOI 10.1126/science.288.5470.1402; ROSSKY PJ, 1994, NATURE, V370, P263, DOI 10.1038/370263a0; SOLOMUN T, 1991, J ELECTROANAL CHEM, V309, P355, DOI 10.1016/0022-0728(91)87028-3; SOLOMUN T, 1989, J PHYS CHEM-US, V93, P7199, DOI 10.1021/j100357a035; STEVENS PA, 1989, J CHEM PHYS, V91, P4338, DOI 10.1063/1.456814; Stratt RM, 1996, J PHYS CHEM-US, V100, P12981, DOI 10.1021/jp9608483; SUMI H, 1994, J PHYS SOC JPN, V63, P637, DOI 10.1143/JPSJ.63.637; WALHOUT PK, 1995, CHEM PHYS LETT, V232, P135, DOI 10.1016/0009-2614(94)01314-L; WANDELT K, 1987, THIN METAL FILMS GAS, P280; Willard DM, 1998, J AM CHEM SOC, V120, P4151, DOI 10.1021/ja980086k; Zhong Q, 2002, SURF SCI, V496, P21, DOI 10.1016/S0039-6028(01)01502-3; Zimdars D, 1999, J PHYS CHEM A, V103, P10567, DOI 10.1021/jp992746t	33	114	114	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2002	297	5584					1163	1166		10.1126/science.1073571	http://dx.doi.org/10.1126/science.1073571			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183625				2022-12-28	WOS:000177447600044
J	Fisher, NC; Hanson, J; Phillips, A; Rao, JN; Swarbrick, ET				Fisher, NC; Hanson, J; Phillips, A; Rao, JN; Swarbrick, ET			Mortality from liver disease in the West Midlands, 1993-2000: observational study	BRITISH MEDICAL JOURNAL			English	Article									Russells Hall Hosp, Dudley Grp Hosp NHS Trust, Dept Gastroenterol, Dudley DY1 2HQ, W Midlands, England; Dudley Hlth Author, Dudley DY12 2DD, England; Wolverhampton Hlth Author, Wolverhampton WV13 0XE, England; Sandwell Hlth Author, Bromwich B70 9LD, England; Wolverhampton Univ, New Cross Hosp, Div Clin Sci, Wolverhampton WV10 0QP, England	Russells Hall Hospital; New Cross Hospital; University of Wolverhampton	Fisher, NC (corresponding author), Russells Hall Hosp, Dudley Grp Hosp NHS Trust, Dept Gastroenterol, Dudley DY1 2HQ, W Midlands, England.							Armitage P., 2001, STAT METHODS MED RES; Chick J, 1997, Health Bull (Edinb), V55, P134; *DEP HLTH, 1999, HLTH B DEP HLTH; NOBLE B, 1994, POPULATION TRENDS, V76, P1	4	23	23	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 10	2002	325	7359					312	313		10.1136/bmj.325.7359.312	http://dx.doi.org/10.1136/bmj.325.7359.312			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	584RQ	12169508	Bronze, Green Published			2022-12-28	WOS:000177482500019
J	Lynch, M				Lynch, M			Genomics - Gene duplication and evolution	SCIENCE			English	Editorial Material							SPECIATION; DROSOPHILA		Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Lynch, M (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.							Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bennetzen JL, 2002, PLANT MOL BIOL, V48, P821, DOI 10.1023/A:1014841515249; Coghlan A, 2002, GENOME RES, V12, P857, DOI 10.1101/gr.172702; Coyne JA, 1997, EVOLUTION, V51, P295, DOI [10.1111/j.1558-5646.1997.tb02412.x, 10.2307/2410984]; Force A, 1999, GENETICS, V151, P1531; Haldane JBS, 1933, AM NAT, V67, P5, DOI 10.1086/280465; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2001, GENETICS, V159, P1789; Lynch M, 2000, AM NAT, V156, P590, DOI 10.1086/316992; LYNCH M, IN PRESS GENOME EVOL; Mounsey A, 2002, GENOME RES, V12, P770, DOI 10.1101/gr208802. Article published online before print in April ; Ranz JM, 2001, GENOME RES, V11, P230, DOI 10.1101/gr.162901; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Samonte RV, 2002, NAT REV GENET, V3, P65, DOI 10.1038/nrg705; Semple C, 1999, J MOL EVOL, V48, P555, DOI 10.1007/PL00006498; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x	16	128	135	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2002	297	5583					945	947		10.1126/science.1075472	http://dx.doi.org/10.1126/science.1075472			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169715				2022-12-28	WOS:000177325400024
J	Prasanth, SG; Prasanth, KV; Stillman, B				Prasanth, SG; Prasanth, KV; Stillman, B			Orc6 involved in DNA replication, chromosome segregation, and cytokinesis	SCIENCE			English	Article							ORIGIN RECOGNITION COMPLEX; CENTROMERE PROTEIN INCENP; CYCLE; CHECKPOINTS; METAPHASE; MITOSIS; KINASES; CELLS	Origin recognition complex (ORC) proteins serve as a landing pad for the assembly of a multiprotein prereplicative complex, which is required to initiate DNA replication. During mitosis, the smallest subunit of human ORC, Orc6, localizes to kinetochores and to a reticular-like structure around the cell periphery. As chromosomes segregate during anaphase, the reticular structures align along the plane of cell division and some Orc6 localizes to the midbody before cells separate. Silencing of Orc6 expression by small interfering RNA (siRNA) resulted in cells with multipolar spindles, aberrant mitosis, formation of multinucleated cells, and decreased DNA replication. Prolonged periods of Orc6 depletion caused a decrease in cell proliferation and increased cell death. These results implicate Orc6 as an essential gene that coordinates chromosome replication and segregation with cytokinesis.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Stillman, B (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.			Stillman, Bruce/0000-0002-9453-4091	NCI NIH HHS [CA13106, P01 CA013106] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams RR, 2001, J CELL BIOL, V153, P865, DOI 10.1083/jcb.153.4.865; Bell SP, 2002, GENE DEV, V16, P659, DOI 10.1101/gad.969602; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Chesnokov I, 1999, GENE DEV, V13, P1289, DOI 10.1101/gad.13.10.1289; Chesnokov I, 2001, P NATL ACAD SCI USA, V98, P11997, DOI 10.1073/pnas.211342798; EARNSHAW WC, 1991, CHROMOSOMA, V100, P139, DOI 10.1007/BF00337241; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fortugno P, 2002, J CELL SCI, V115, P575; Gillespie PJ, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-15; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Harborth J, 2001, J CELL SCI, V114, P4557; Jablonski SA, 1998, CHROMOSOMA, V107, P386, DOI 10.1007/s004120050322; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Lee DG, 1997, MOL CELL BIOL, V17, P7159, DOI 10.1128/MCB.17.12.7159; Mendez J, 2002, MOL CELL, V9, P481, DOI 10.1016/S1097-2765(02)00467-7; MULLINS JM, 1982, J CELL BIOL, V94, P654, DOI 10.1083/jcb.94.3.654; Murakami H, 2000, BIOCHEM J, V349, P1, DOI 10.1042/0264-6021:3490001; Pflumm MF, 2001, DEVELOPMENT, V128, P1697; PRASANTH SG, UNPUB; Sibon OCM, 2000, NAT CELL BIOL, V2, P90, DOI 10.1038/35000041; Skoufias DA, 2001, P NATL ACAD SCI USA, V98, P4492, DOI 10.1073/pnas.081076898; Uren AG, 2000, CURR BIOL, V10, P1319, DOI 10.1016/S0960-9822(00)00769-7; Van Hooser AA, 1999, FASEB J, V13, pS216, DOI 10.1096/fasebj.13.9002.S216; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Weinreich M, 2001, P NATL ACAD SCI USA, V98, P11211, DOI 10.1073/pnas.201387198; Zeitlin SG, 2001, CURR BIOL, V11, pR514, DOI 10.1016/S0960-9822(01)00307-4	26	165	171	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2002	297	5583					1026	1031		10.1126/science.1072802	http://dx.doi.org/10.1126/science.1072802			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169736				2022-12-28	WOS:000177325400048
J	Molldrem, JJ; Leifer, E; Bahceci, E; Saunthararajah, Y; Rivera, M; Dunbar, C; Liu, J; Nakamura, R; Young, NS; Barrett, AJ				Molldrem, JJ; Leifer, E; Bahceci, E; Saunthararajah, Y; Rivera, M; Dunbar, C; Liu, J; Nakamura, R; Young, NS; Barrett, AJ			Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes	ANNALS OF INTERNAL MEDICINE			English	Article							MEDIATED INHIBITION; APLASTIC-ANEMIA; PATHOPHYSIOLOGY; THERAPY	Background: Almost half of the deaths that result from myelodysplastic syndromes are due to cytopenia associated with bone marrow failure. Treatment is mostly supportive care. Objective: To determine whether treatment with antithymocyte globulin improves cytopenia and reverses dependence on red blood cell transfusions in patients with myelodysplastic syndromes. Design: Single-treatment, prospective study. Setting: Tertiary referral center. Patients: 61 patients with myelodysplastic syndromes. Intervention: Antithymocyte globulin, 40 mg/kg of body weight, given daily for 4 days. Measurements: Evaluation of bone marrow, blood counts, transfusions, progression, and survival for a median of 30 months (range, 1 to 88 months). Results: Within 8 months of treatment, 21 of 61 patients (34%) no longer required red blood cell transfusions. This independence from transfusions was maintained in 17 responders (81%) for a median of 36 months (range, 3 to 72 months). Ten of 21 patients (47.5%) with severe thrombocytopenia had sustained platelet count increases, and 6 of 11 patients (55%) with severe neutropenia had sustained neutrophil counts of greater than 1 x 109 cells/L. Characteristics favorable for response were younger patient age (P = 0.005) and lower platelet counts (P = 0.038). One of the 21 responders (5%) and 22 of the 40 nonresponders (55%) died before the end of the study (P = 0.008). One of the 21 responders (5%) and 13 of the 40 nonresponders (33%) had disease progression (P = 0.086). Conclusions: Although this study was a nonrandomized, single-treatment study, 34% of patients treated with antithymocyte globulin became transfusion independent. Response was associated with a statistically significant longer survival and an almost significant decreased time to disease progression, Treatment with antithymocyte globulin did not seem to be detrimental because historical overall median survival times were similar to those of nonresponders.	NHLBI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Molldrem, JJ (corresponding author), Univ Texas, MD Anderson Canc Ctr, Transplantat Immunol Sect, Dept Blood & Marrow Transplantat, 1515 Holcombe Blvd,Box 448, Houston, TX 77030 USA.	jmolldre@mdanderson.org		Dunbar, Cynthia/0000-0002-7645-838X	NATIONAL CANCER INSTITUTE [R01CA085843] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002342, Z01HL002315, Z01HL002342, ZIAHL002315] Funding Source: NIH RePORTER; NCI NIH HHS [CA85843] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barrett J, 2000, SEMIN HEMATOL, V37, P15; BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x; Bennett JM, 1998, LEUKEMIA RES, V22, pS1, DOI 10.1016/S0145-2126(98)00033-2; Biesma DH, 1997, CANCER-AM CANCER SOC, V79, P1548, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1548::AID-CNCR16>3.0.CO;2-Y; COX DR, 1972, J R STAT SOC B, V34, P187; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Greenwood M., 1926, REPORTS PUBLIC HLTH, V33, P1; HOSMER DW, 1989, APPL LOGISTIC REGRES; Jonasova A, 1998, BRIT J HAEMATOL, V100, P304, DOI 10.1046/j.1365-2141.1998.00551.x; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; MANGI MH, 1992, BLOOD, V79, P198, DOI 10.1182/blood.V79.1.198.198; Molldrem JJ, 1998, BRIT J HAEMATOL, V102, P1314, DOI 10.1046/j.1365-2141.1998.00920.x; Molldrem JJ, 1997, BRIT J HAEMATOL, V99, P699, DOI 10.1046/j.1365-2141.1997.4423249.x; SMITH MA, 1991, LEUKEMIA RES, V15, P597, DOI 10.1016/0145-2126(91)90028-R; Stetler-Stevenson M, 2001, BLOOD, V98, P979, DOI 10.1182/blood.V98.4.979; SUGAWARA T, 1992, AM J HEMATOL, V41, P304, DOI 10.1002/ajh.2830410425; TICHELLI A, 1988, BRIT J HAEMATOL, V68, P139, DOI 10.1111/j.1365-2141.1988.tb04194.x; WILLIAMSON PJ, 1994, BRIT J HAEMATOL, V87, P743, DOI 10.1111/j.1365-2141.1994.tb06733.x; Young NS, 1997, NEW ENGL J MED, V336, P1365, DOI 10.1056/NEJM199705083361906	19	165	172	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 6	2002	137	3					156	163		10.7326/0003-4819-137-3-200208060-00007	http://dx.doi.org/10.7326/0003-4819-137-3-200208060-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580XP	12160363				2022-12-28	WOS:000177262300002
J	Garcia-Castro, MI; Marcelle, C; Bronner-Fraser, M				Garcia-Castro, MI; Marcelle, C; Bronner-Fraser, M			Ectodermal Wnt function as a neural crest inducer	SCIENCE			English	Article							BONE MORPHOGENETIC PROTEINS; WINGLESS PROTEIN; CELL PATTERN; INDUCTION; DORSAL; PLATE; EXPRESSION; TUBE; XENOPUS; FAMILY	Neural crest cells, which generate peripheral nervous system and facial skeleton, arise at the neural plate/ectodermal border via an inductive interaction between these tissues. Wnts and bone morphogenetic proteins (BMPs) play roles in neural crest induction in amphibians and zebrafish. Here, we show that, in avians, Wnt6 is localized in ectoderm and in vivo inhibition of Wnt signaling perturbs neural crest formation. Furthermore, Wnts induce neural crest from naive neural plates in vitro in a defined medium without added factors, whereas BMPs require additives. Our data suggest that Wnt molecules are necessary and sufficient to induce neural crest cells in avian embryos.	CALTECH, Div Biol 139 74, Pasadena, CA 91125 USA	California Institute of Technology	Garcia-Castro, MI (corresponding author), CALTECH, Div Biol 139 74, Wilson & Calif, Pasadena, CA 91125 USA.	mig1000@its.caltech.edu		Bronner, Marianne/0000-0003-4274-1862; Garcia-Castro, Martin I./0000-0001-5128-0004	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036585, R01NS036585] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bang AG, 1999, DEV BIOL, V212, P366, DOI 10.1006/dbio.1999.9319; Basch ML, 2000, DEV NEUROSCI-BASEL, V22, P217, DOI 10.1159/000017444; BASLER K, 1993, CELL, V73, P687, DOI 10.1016/0092-8674(93)90249-P; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Cauthen CA, 2001, MECH DEVELOP, V104, P133, DOI 10.1016/S0925-4773(01)00369-0; CHAKRABARTI A, 1992, DEVELOPMENT, V115, P355; Chang CB, 1998, DEV BIOL, V194, P129, DOI 10.1006/dbio.1997.8820; Connolly DJ, 1997, INT J DEV BIOL, V41, P389; Cook D, 1996, EMBO J, V15, P4526, DOI 10.1002/j.1460-2075.1996.tb00830.x; Dale TC, 1998, BIOCHEM J, V329, P209; Deardorff MA, 2001, DEVELOPMENT, V128, P3655; DICKINSON ME, 1995, DEVELOPMENT, V121, P2099; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hammerschmidt M, 1996, DEVELOPMENT, V123, P95; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; Hsieh JC, 1999, NATURE, V398, P431, DOI 10.1038/18899; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; LaBonne C, 1998, DEVELOPMENT, V125, P2403; Le Douarin NM, 1999, NEURAL CREST, V2; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; McGrew LL, 1997, MECH DEVELOP, V69, P105, DOI 10.1016/S0925-4773(97)00160-3; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Millar JBA, 2002, GENOME BIOL, V3; MonsoroBurq AH, 1996, DEVELOPMENT, V122, P3607; MOURY JD, 1989, DEV BIOL, V133, P44, DOI 10.1016/0012-1606(89)90295-9; Neave B, 1997, MECH DEVELOP, V62, P183, DOI 10.1016/S0925-4773(97)00659-X; Nguyen VH, 2000, DEVELOPMENT, V127, P1209; Nguyen VH, 1998, DEV BIOL, V199, P93, DOI 10.1006/dbio.1998.8927; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Pera E, 1999, DEVELOPMENT, V126, P63; RAMAKRISHNA NR, 1993, DEVELOPMENT, P95; ROLLHAUSERTERHORST J, 1979, ANAT EMBRYOL, V157, P113, DOI 10.1007/BF00315644; SaintJeannet JP, 1997, P NATL ACAD SCI USA, V94, P13713, DOI 10.1073/pnas.94.25.13713; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Selleck MAJ, 1998, DEVELOPMENT, V125, P4919; SELLECK MAJ, 1995, DEVELOPMENT, V121, P525; Streit A, 1998, DEVELOPMENT, V125, P507; Tan C, 2001, DEVELOPMENT, V128, P3665; TUCKER GC, 1984, CELL DIFFER DEV, V14, P223, DOI 10.1016/0045-6039(84)90049-6; VANLEEUWEN F, 1994, NATURE, V368, P342, DOI 10.1038/368342a0; Watanabe Y, 1996, MECH DEVELOP, V57, P69, DOI 10.1016/0925-4773(96)00534-5; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Xu QH, 1998, DEVELOPMENT, V125, P4767; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O	47	390	396	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2002	297	5582					848	851		10.1126/science.1070824	http://dx.doi.org/10.1126/science.1070824			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161657				2022-12-28	WOS:000177192800055
J	Levsky, JM; Shenoy, SM; Pezo, RC; Singer, RH				Levsky, JM; Shenoy, SM; Pezo, RC; Singer, RH			Single-cell gene expression profiling	SCIENCE			English	Article								A key goal of biology is to relate the expression of specific genes to a particular cellular phenotype. However, current assays for gene expression destroy the structural context. By combining advances in computational fluorescence microscopy with multiplex probe design, we devised technology in which the expression of many genes can be visualized simultaneously inside single cells with high spatial and temporal resolution. Analysis of 11 genes in serum-stimulated cultured cells revealed unique patterns of gene expression within individual cells. Using the nucleus as the substrate for parallel gene analysis, we provide a platform for the fusion of genomics and cell biology: "cellular genomics."	Yeshiva Univ Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Singer, RH (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Anat & Struct Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	rhsinger@aecom.yu.edu	shenoy, shailesh/AAD-4962-2020	Shenoy, Shailesh/0000-0002-5132-7236	NATIONAL CANCER INSTITUTE [R33CA083208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288, T32GM007491] Funding Source: NIH RePORTER; NCI NIH HHS [R33CA83208] Funding Source: Medline; NIGMS NIH HHS [T32GM07491, GM54887, T32GM07288] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alwine J C, 1979, Methods Enzymol, V68, P220; BROWN J, 2001, NAT MED, V7, P4; DENDUNNEN JT, 1992, HUM MOL GENET, V1, P19; ERBA HP, 1988, MOL CELL BIOL, V8, P1775, DOI 10.1128/MCB.8.4.1775; FEMINO AM, 1998, SCIENCE, V280, P5363; HABETS GG, 2001, METHODS ENZYMOL, V332; HERSCHMAN HR, 1991, ANN REV BIOCH, V60; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; KISLAUSKIS EH, 1993, J CELL BIOL, V123, P165, DOI 10.1083/jcb.123.1.165; LANAHAN A, 1992, MOL CELL BIOL, V12, P3919, DOI 10.1128/MCB.12.9.3919; LAWRENCE JB, 1989, CELL, V57, P493, DOI 10.1016/0092-8674(89)90924-0; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; LOCKHART DJ, 1996, NAT BIOTECHNOL, V14, P13; NEDERLOF PM, 1992, CYTOMETRY, V13, P8; NG SY, 1998, NUCLEIC ACIDS RES, V17, P2; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; SCHWACHTGEN JL, 2000, DNA SEQUENCE, V10, P6; SPEICHER MR, 1996, NAT GENET, V12, P4; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484	20	384	441	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2002	297	5582					836	840		10.1126/science.1072241	http://dx.doi.org/10.1126/science.1072241			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161654				2022-12-28	WOS:000177192800051
J	Ma, RLZ; Gao, JF; Meeker, ND; Fillmore, PD; Tung, HSK; Watanabe, T; Zachary, JF; Offner, H; Blankenhorn, EP; Teuscher, C				Ma, RLZ; Gao, JF; Meeker, ND; Fillmore, PD; Tung, HSK; Watanabe, T; Zachary, JF; Offner, H; Blankenhorn, EP; Teuscher, C			Identification of Bphs, an autoimmune disease locus, as histamine receptor H-1	SCIENCE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; DELAYED-TYPE HYPERSENSITIVITY; WEIBEL-PALADE BODIES; BORDETELLA-PERTUSSIS; T-CELL; ENDOTHELIAL-CELLS; GENETIC-LOCI; MICE; SUSCEPTIBILITY; BRAIN	Bphs controls Bordetella pertussis toxin (PTX) induced vasoactive amine sensitization elicited by histamine (VAASH) and has an established role in autoimmunity. We report that congenic mapping links Bphs to the histamine H-1 receptor gene (Hrh1/H1R) and that H1R differs at three amino acid residues in VAASH-susceptible and -resistant mice. Hrh1(-/-) mice are protected from VAASH, which can be restored by genetic complementation with a susceptible Bphs/Hrh1 allele, and experimental allergic encephalomyelitis and autoimmune orchitis due to immune deviation. Thus, natural alleles of Hrh1 control both the autoimmune T cell and vascular responses regulated by histamine after PTX sensitization.	Univ Vermont, Dept Med, Burlington, VT 05405 USA; Chinese Acad Sci, Inst Genet, Lab Anim Ctr, Beijing 100101, Peoples R China; Univ Illinois, Dept Vet Pathobiol, Urbana, IL 61802 USA; Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA; Kyushu Univ, Med Inst Bioregulat, Fukuoka 812, Japan; Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Vet Affairs Med Ctr, Portland, OR 97201 USA; MCPHU, Dept Microbiol & Immunol, Philadelphia, PA 19129 USA	University of Vermont; Chinese Academy of Sciences; University of Illinois System; University of Illinois Urbana-Champaign; University of Virginia; Kyushu University; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Drexel University	Teuscher, C (corresponding author), Univ Vermont, Dept Med, Burlington, VT 05405 USA.				NIAID NIH HHS [AI4515, AI42376, AI41747, AI41236] Funding Source: Medline; NIAMS NIH HHS [AR45222] Funding Source: Medline; NINDS NIH HHS [NS23444, NS36526] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042376, R01AI041747, R01AI041236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR045222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023444, R01NS036526] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Atkinson T, 1992, INFLAMMATION BASIC P, P193; Banu Y, 1999, J EXP MED, V189, P673, DOI 10.1084/jem.189.4.673; Blankenhorn EP, 2000, J IMMUNOL, V164, P3420, DOI 10.4049/jimmunol.164.6.3420; Bordet J., 1906, ANN LINSTITUT PASTEU, V20, P731; Butterfield RJ, 1998, J IMMUNOL, V161, P1860; Butterfield RJ, 2000, AM J PATHOL, V157, P637, DOI 10.1016/S0002-9440(10)64574-9; Dimitriadou V, 2000, INT J IMMUNOPHARMACO, V22, P673, DOI 10.1016/S0192-0561(00)00029-1; Fujimoto K, 1999, MOL PHARMACOL, V55, P735; HATTORI R, 1989, J BIOL CHEM, V264, P7768; Inoue I, 1996, P NATL ACAD SCI USA, V93, P13316, DOI 10.1073/pnas.93.23.13316; Jutel M, 2001, NATURE, V413, P420, DOI 10.1038/35096564; KASLOW HR, 1992, FASEB J, V6, P2684, DOI 10.1096/fasebj.6.9.1612292; Kobayashi T, 2000, J CLIN INVEST, V105, P1741, DOI 10.1172/JCI9441; LINTHICUM DS, 1982, CELL IMMUNOL, V73, P299, DOI 10.1016/0008-8749(82)90457-9; Matejuk A, 2002, J NEUROSCI RES, V67, P680, DOI 10.1002/jnr.10156; MUNOZ JJ, 1977, IMMUNOLOGY SERIES, V4; NEMETALLAH BR, 1985, ARCH ANDROLOGY, V15, P41, DOI 10.3109/01485018508986890; NEMETALLAH BR, 1985, ARCH ANDROLOGY, V15, P79, DOI 10.3109/01485018508986895; Offner H, 2000, J CLIN INVEST, V105, P1465, DOI 10.1172/JCI9213; ORR EL, 1989, J NEUROCHEM, V53, P111, DOI 10.1111/j.1471-4159.1989.tb07301.x; Pedotti R, 2001, NAT IMMUNOL, V2, P216, DOI 10.1038/85266; SEKURA RD, 1985, PERTUSSIS TOXIN; SEWELL WA, 1986, CELL IMMUNOL, V97, P238, DOI 10.1016/0008-8749(86)90394-1; SEWELL WA, 1983, J EXP MED, V157, P2087, DOI 10.1084/jem.157.6.2087; SEWELL WA, 1984, J IMMUNOL, V133, P1716; Smit MJ, 1999, CLIN EXP ALLERGY, V29, P19, DOI 10.1046/j.1365-2222.1999.00008.x; SUDWEEKS JD, 1993, P NATL ACAD SCI USA, V90, P3700, DOI 10.1073/pnas.90.8.3700; TEUSCHER C, 1985, IMMUNOGENETICS, V22, P417, DOI 10.1007/BF00418088; Teuscher C, 1998, J IMMUNOL, V160, P2751; Utgaard JO, 1998, J EXP MED, V188, P1751, DOI 10.1084/jem.188.9.1751; Vleeming W, 2000, BRIT J PHARMACOL, V129, P1801, DOI 10.1038/sj.bjp.0703263; WAXMAN FJ, 1984, CELL IMMUNOL, V85, P82, DOI 10.1016/0008-8749(84)90280-6; Wolff B, 1998, J EXP MED, V188, P1757, DOI 10.1084/jem.188.9.1757; [No title captured]	35	115	122	4	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2002	297	5581					620	623		10.1126/science.1072810	http://dx.doi.org/10.1126/science.1072810			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142541				2022-12-28	WOS:000177054200056
J	Zimmerman, SC; Wendland, MS; Rakow, NA; Zharov, I; Suslick, KS				Zimmerman, SC; Wendland, MS; Rakow, NA; Zharov, I; Suslick, KS			Synthetic hosts by monomolecular imprinting inside dendrimers	NATURE			English	Article							MOLECULAR RECOGNITION; CORED DENDRIMERS; POLYMERS; PORPHYRINS; ARCHITECTURE; METATHESIS; EVOLUTION; BINDING	Synthetic host systems capable of selectively binding guest molecules are of interest for applications ranging from separations and chemical or biological sensing to the development of biomedical materials. Such host systems can be efficiently prepared by 'imprinting' polymers or inorganic materials with template molecules, which, upon removal, leave behind spatially arranged functional groups that act as recognition sites(1-4). However, molecularly imprinted polymers have limitations, including incomplete template removal, broad guest affinities and selectivities, and slow mass transfer(5-8). An alternative strategy for moulding desired recognition sites uses combinatorial libraries of assemblies that are made of a relatively small number of molecules, interconverting in dynamic equilibrium; upon addition of a target molecule, the library equilibrium shifts towards the best hosts(9-11). Here we describe the dynamic imprinting of dendritic macromolecules with porphyrin templates to yield synthetic host molecules containing one binding site each. The process is based on our general strategy to prepare cored dendrimers(12,13), and involves covalent attachment of dendrons to a porphyrin core, cross-linking of the end-groups of the dendrons, and removal of the porphyrin template by hydrolysis. In contrast to more traditional polymer imprinting, our approach ensures nearly homogeneous binding sites and quantitative template removal. Moreover, the hosts are soluble in common organic solvents and amenable to the incorporation of other functional groups, which should facilitate further development of this system for novel applications.	Univ Illinois, Dept Chem, Urbana, IL 61801 USA; Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Zimmerman, SC (corresponding author), Univ Illinois, Dept Chem, 600 S Mathews Ave, Urbana, IL 61801 USA.		ZHAROV, ILYA/B-3166-2013; Suslick, Kenneth S/A-1841-2010; Zimmerman, Steven C. C/E-4244-2010	Suslick, Kenneth S/0000-0001-5422-0701; Zimmerman, Steven C. C/0000-0002-5333-3437; Wendland, Michael/0000-0002-3581-3349				ADLER AD, 1967, J ORG CHEM, V32, P476, DOI 10.1021/jo01288a053; ANDERSSON L, 1984, TETRAHEDRON LETT, V25, P5211, DOI 10.1016/S0040-4039(01)81566-5; Balzani V, 2001, COORDIN CHEM REV, V219, P545, DOI 10.1016/S0010-8545(01)00351-4; Bhyrappa P, 1996, J AM CHEM SOC, V118, P5708, DOI 10.1021/ja953474k; Coates GW, 1996, J AM CHEM SOC, V118, P229, DOI 10.1021/ja9532603; COLLMAN JP, 1978, J AM CHEM SOC, V100, P2761, DOI 10.1021/ja00477a031; Cousins GRL, 2000, CURR OPIN CHEM BIOL, V4, P270, DOI 10.1016/S1367-5931(00)00088-0; DANDLIKER PJ, 1996, ANGEW CHEM INT EDIT, V34, P2725; HAWKER CJ, 1990, J AM CHEM SOC, V112, P7638, DOI 10.1021/ja00177a027; Katz A, 1999, MACROMOLECULES, V32, P4113, DOI 10.1021/ma981445z; Katz A, 2000, NATURE, V403, P286, DOI 10.1038/35002032; Klekota B, 1999, TRENDS BIOTECHNOL, V17, P205, DOI 10.1016/S0167-7799(99)01305-0; Lehn JM, 2001, SCIENCE, V291, P2331, DOI 10.1126/science.1060066; Matsui J, 2000, J AM CHEM SOC, V122, P5218, DOI 10.1021/ja000064+; Newkome GR, 2001, DENDRIMERS DENDRONS; Ogoshi H, 1999, CURR OPIN CHEM BIOL, V3, P736, DOI 10.1016/S1367-5931(99)00033-2; Rakow NA, 2000, NATURE, V406, P710, DOI 10.1038/35021028; RHO TY, 1994, SYNTHETIC COMMUN, V24, P253, DOI 10.1080/00397919408013824; Sadamoto R, 1996, J AM CHEM SOC, V118, P3978, DOI 10.1021/ja952855v; SANDERS JKM, 1996, COMPREHENSIVE SUPRAM, V9, P131; Schultz LG, 2001, ANGEW CHEM INT EDIT, V40, P1962, DOI 10.1002/1521-3773(20010518)40:10<1962::AID-ANIE1962>3.0.CO;2-J; SELLERGREN B, 1993, J CHROMATOGR, V635, P39; SHEA KJ, 1994, TRENDS POLYM SCI, V2, P166; Trnka TM, 2001, ACCOUNTS CHEM RES, V34, P18, DOI 10.1021/ar000114f; VLATAKIS G, 1993, NATURE, V361, P645, DOI 10.1038/361645a0; Wendland MS, 1999, J AM CHEM SOC, V121, P1389, DOI 10.1021/ja983097m; WULFF G, 1972, ANGEW CHEM INT EDIT, V11, P341; WULFF G, 1995, ANGEW CHEM INT EDIT, V34, P1812, DOI 10.1002/anie.199518121	28	356	365	2	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2002	418	6896					399	403		10.1038/nature00877	http://dx.doi.org/10.1038/nature00877			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12140553				2022-12-28	WOS:000177009700033
J	Lin, J; Wu, H; Tarr, PT; Zhang, CY; Wu, ZD; Boss, O; Michael, LF; Puigserver, P; Isotani, E; Olson, EN; Lowell, BB; Bassel-Duby, R; Spiegelman, BM				Lin, J; Wu, H; Tarr, PT; Zhang, CY; Wu, ZD; Boss, O; Michael, LF; Puigserver, P; Isotani, E; Olson, EN; Lowell, BB; Bassel-Duby, R; Spiegelman, BM			Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres	NATURE			English	Article							SKELETAL-MUSCLE; FIBER-TYPE; MITOCHONDRIAL BIOGENESIS; COACTIVATOR PGC-1; CALCINEURIN; EXPRESSION; ELEMENTS; PATHWAY; MEF2; GENE	The biochemical basis for the regulation of fibre-type determination in skeletal muscle is not well understood. In addition to the expression of particular myofibrillar proteins, type I (slow-twitch) fibres are much higher in mitochondrial content and are more dependent on oxidative metabolism than type II (fast-twitch) fibres(1). We have previously identified a transcriptional co-activator, peroxisome-proliferator-activated receptor-gamma coactivator-1 (PGC-1alpha), which is expressed in several tissues including brown fat and skeletal muscle, and that activates mitochondrial biogenesis and oxidative metabolism(2-4).We show here that PGC-1alpha is expressed preferentially in muscle enriched in type I fibres. When PGC-1alpha is expressed at physiological levels in transgenic mice driven by a muscle creatine kinase (MCK) promoter, a fibre type conversion is observed: muscles normally rich in type II fibres are redder and activate genes of mitochondrial oxidative metabolism. Notably, putative type II muscles from PGC-1alpha transgenic mice also express proteins characteristic of type I fibres, such as troponin I (slow) and myoglobin, and show a much greater resistance to electrically stimulated fatigue. Using fibre-type-specific promoters, we show in cultured muscle cells that PGC-1alpha activates transcription in cooperation with Mef2 proteins and serves as a target for calcineurin signalling, which has been implicated in slow fibre gene expression. These data indicate that PGC-1alpha is a principal factor regulating muscle fibre type determination.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Endocrinol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.			Wu, Zhidan/0000-0001-7289-9420				Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Bigard X, 2000, J BIOL CHEM, V275, P19653, DOI 10.1074/jbc.M000430200; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; BOOTH FW, 1991, PHYSIOL REV, V71, P541, DOI 10.1152/physrev.1991.71.2.541; Calvo S, 1999, MOL CELL BIOL, V19, P515; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Delling U, 2000, MOL CELL BIOL, V20, P6600, DOI 10.1128/MCB.20.17.6600-6611.2000; Esterbauer H, 1999, GENOMICS, V62, P98, DOI 10.1006/geno.1999.5977; GOLLNICK PD, 1972, J APPL PHYSIOL, V33, P312, DOI 10.1152/jappl.1972.33.3.312; Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134; Grange RW, 2001, AM J PHYSIOL-CELL PH, V281, pC1487, DOI 10.1152/ajpcell.2001.281.5.C1487; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Jarvis JC, 1996, MUSCLE NERVE, V19, P1469, DOI 10.1002/(SICI)1097-4598(199611)19:11<1469::AID-MUS11>3.0.CO;2-O; JOHNSON JE, 1989, MOL CELL BIOL, V9, P3393, DOI 10.1128/MCB.9.8.3393; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Michael I, 1998, EUR MASS SPECTROM, V4, P1; Nakayama M, 1996, MOL CELL BIOL, V16, P2408; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; OGILVIE RW, 1990, STAIN TECHNOL, V65, P231, DOI 10.3109/10520299009105613; Olson EN, 2000, BIOESSAYS, V22, P510, DOI 10.1002/(SICI)1521-1878(200006)22:6<510::AID-BIES4>3.3.CO;2-T; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wu H, 2001, EMBO J, V20, P6414, DOI 10.1093/emboj/20.22.6414; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	27	1928	2026	1	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 15	2002	418	6899					797	801		10.1038/nature00904	http://dx.doi.org/10.1038/nature00904			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181572				2022-12-28	WOS:000177428000044
J	Snoke, D; Denev, S; Liu, Y; Pfeiffer, L; West, K				Snoke, D; Denev, S; Liu, Y; Pfeiffer, L; West, K			Long-range transport in excitonic dark states in coupled quantum wells	NATURE			English	Article								During the past ten years, coupled quantum wells have emerged as a promising system for experiments on Bose condensation of excitons, with numerous theoretical(1-6) and experimental(7-12) studies aimed at the demonstration of this effect. One of the issues driving these studies is the possibility of long-range coherent transport of excitons. Excitons in quantum wells typically diffuse only a few micrometres from the spot where they are generated by a laser pulse; their diffusion is limited by their lifetime (typically a few nanoseconds) and by scattering due to disorder in the well structure. Here we report photoluminescence measurements of InGaAs quantum wells and the observation of an effect by which luminescence from excitons appears hundreds of micrometres away from the laser excitation spot. This luminescence appears as a ring around the laser spot; almost none appears in the region between the laser spot and the ring. This implies that the excitons must travel in a dark state until they reach some critical distance, at which they collectively revert to luminescing states. It is unclear whether this effect is related to macroscopic coherence caused by Bose condensation of excitons.	Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA; Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Alcatel-Lucent; Lucent Technologies; AT&T	Snoke, D (corresponding author), Univ Pittsburgh, Dept Phys & Astron, 3941 Ohara St, Pittsburgh, PA 15260 USA.	snoke@pitt.edu	Denev, Stefan A./F-7398-2011	Denev, Stefan A./0000-0002-4849-8261				BAGAEV VS, 1976, SOV PHYS JETP, V70, P702; Butov LV, 1998, PHYS REV B, V58, P1980, DOI 10.1103/PhysRevB.58.1980; Butov LV, 2002, NATURE, V417, P47, DOI 10.1038/417047a; Dzyubenko AB, 1996, PHYS REV B, V53, P16355, DOI 10.1103/PhysRevB.53.16355; FernandezRossier J, 1997, PHYS REV LETT, V78, P4809, DOI 10.1103/PhysRevLett.78.4809; FOX AM, 1991, PHYS REV B, V44, P6231, DOI 10.1103/PhysRevB.44.6231; GREENSTEIN M, 1978, PHYS REV LETT, V41, P715, DOI 10.1103/PhysRevLett.41.715; HENSEL JC, 1977, PHYS REV LETT, V39, P969, DOI 10.1103/PhysRevLett.39.969; KATO Y, 1994, J APPL PHYS, V75, P7476, DOI 10.1063/1.356618; Krivolapchuk VV, 1999, SOLID STATE COMMUN, V111, P49, DOI 10.1016/S0038-1098(99)00162-3; Larionov AV, 2001, JETP LETT+, V73, P301, DOI 10.1134/1.1374266; Lida T, 1999, PHYS REV B, V60, P5802, DOI 10.1103/PhysRevB.60.5802; Lozovik YE, 1997, J EXP THEOR PHYS+, V84, P1027, DOI 10.1134/1.558220; Moskalenko S. A., 2000, BOSE EINSTEIN CONDEN; Negoita V, 1999, PHYS REV B, V60, P2661, DOI 10.1103/PhysRevB.60.2661; Negoita V, 2000, PHYS REV B, V61, P2779, DOI 10.1103/PhysRevB.61.2779; Negoita V, 2000, OPT LETT, V25, P572, DOI 10.1364/OL.25.000572; Negoita V, 1999, APPL PHYS LETT, V75, P2059, DOI 10.1063/1.124915; Snoke DW, 1997, PHYS REV B, V55, P13789, DOI 10.1103/PhysRevB.55.13789; Yudson VI, 1996, PHYS REV LETT, V77, P1564, DOI 10.1103/PhysRevLett.77.1564; ZHU XJ, 1995, PHYS REV LETT, V74, P1633, DOI 10.1103/PhysRevLett.74.1633	21	256	261	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2002	418	6899					754	757		10.1038/nature00940	http://dx.doi.org/10.1038/nature00940			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181560				2022-12-28	WOS:000177428000032
J	Bailey, JA; Gu, ZP; Clark, RA; Reinert, K; Samonte, RV; Schwartz, S; Adams, MD; Myers, EW; Li, PW; Eichler, EE				Bailey, JA; Gu, ZP; Clark, RA; Reinert, K; Samonte, RV; Schwartz, S; Adams, MD; Myers, EW; Li, PW; Eichler, EE			Recent segmental duplications in the human genome	SCIENCE			English	Article							LOW-COPY REPEATS; DELETION SYNDROME; SEQUENCE; REARRANGEMENTS; ORGANIZATION; DISORDERS; EVOLUTION; GENES; SITES; MAP	Primate-specific segmental duplications are considered important in human disease and evolution. The inability to distinguish between allelic and duplication sequence overlap has hampered their characterization as well as assembly and annotation of our genome. We developed a method whereby each public sequence is analyzed at the clone level for overrepresentation within a whole-genome shotgun sequence. This test has the ability to detect duplications larger than 15 kilobases irrespective of copy number, location, or high sequence similarity. We mapped 169 large regions flanked by highly similar duplications. Twenty-four of these hot spots of genomic instability have been associated with genetic disease. Our analysis indicates a highly nonrandom chromosomal and genic distribution of recent segmental duplications, with a likely role in expanding protein diversity.	Case Western Reserve Univ, Sch Med, Ctr Computat Genom, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Ctr Human Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Celera Genom, Rockville, MD 20850 USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Eichler, EE (corresponding author), Case Western Reserve Univ, Sch Med, Ctr Computat Genom, Dept Genet, Cleveland, OH 44106 USA.	eee@cwru.edu	Reinert, Knut/V-3327-2019	Reinert, Knut/0000-0003-3078-8129; Vallente, Rhea/0000-0002-1573-4782	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250, R01GM058815] Funding Source: NIH RePORTER; NCI NIH HHS [CA094816] Funding Source: Medline; NHGRI NIH HHS [HG002318] Funding Source: Medline; NIGMS NIH HHS [T32 GM007250, GM58815] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Apweiler R, 2000, BIOINFORMATICS, V16, P1145, DOI 10.1093/bioinformatics/16.12.1145; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey JA, 2002, AM J HUM GENET, V70, P83, DOI 10.1086/338458; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; Christian SL, 1999, HUM MOL GENET, V8, P1025, DOI 10.1093/hmg/8.6.1025; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; Eichler EE, 2001, TRENDS GENET, V17, P661, DOI 10.1016/S0168-9525(01)02492-1; Eichler EE, 2001, GENOME RES, V11, P653, DOI 10.1101/gr.188901; Guy J, 2000, HUM MOL GENET, V9, P2029, DOI 10.1093/hmg/9.13.2029; Jenne DE, 2001, AM J HUM GENET, V69, P516, DOI 10.1086/323043; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li W. H, 1997, MOL EVOLUTION; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Mazzarella R, 1998, GENOME RES, V8, P1007, DOI 10.1101/gr.8.10.1007; Mefford HC, 2002, NAT REV GENET, V3, P91, DOI 10.1038/nrg727; OHNO S, 1968, HEREDITAS-GENETISK A, V59, P169; Ohno S., 1970, EVOLUTION GENE DUPLI; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	25	969	1008	0	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 9	2002	297	5583					1003	1007		10.1126/science.1072047	http://dx.doi.org/10.1126/science.1072047			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169732				2022-12-28	WOS:000177325400042
J	Kivipelto, M; Helkala, EL; Laakso, MP; Hanninen, T; Hallikainen, M; Alhainen, K; Iivonen, S; Mannermaa, A; Tuomilehto, J; Nissinen, A; Soininen, H				Kivipelto, M; Helkala, EL; Laakso, MP; Hanninen, T; Hallikainen, M; Alhainen, K; Iivonen, S; Mannermaa, A; Tuomilehto, J; Nissinen, A; Soininen, H			Apolipoprotein E epsilon 4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease	ANNALS OF INTERNAL MEDICINE			English	Article							APOE GENOTYPE; COGNITIVE DECLINE; NORTH-KARELIA; DEMENTIA; POPULATION; ATHEROSCLEROSIS; ASSOCIATION; PREVALENCE; ROTTERDAM; AD	Background: Presence of the apolipoprotein E (apoE) epsilon4 allele, which is involved in cholesterol metabolism, is the most important genetic risk factor for Alzheimer disease. Elevated midlife values for total cholesterol level and blood pressure have been implicated recently as risk factors for Alzheimer disease. Objective: To study the relative importance and the putative relationship among the apoE epsilon4 allele, midlife total cholesterol level, and midlife blood pressure as risk factors for late-life Alzheimer disease. Design: Prospective population-based study. Setting: Kuopio and Joensuu, eastern Finland. Participants: Participants were derived from random population surveys from 1972, 1977, 1982, and 1987. A total of 1449 persons (73%), 65 to 79 years of age, participated in the reexamination in 1998 (mean follow-up, 21 years). Measurements: Midlife blood pressure and total cholesterol level, apoE genotype, and development of Alzheimer disease during follow-up. Results: The apoE epsilon4 allele was an independent risk factor for Alzheimer disease, even after adjustment for midlife vascular risk factors and other confounders (odds ratio, 2.1 [95% Cl, 1.1 to 4.1]). Similarly, elevated midlife values for serum total cholesterol level (odds ratio, 2.8 [Cl, 1.2 to 6.7]) and systolic blood pressure (odds ratio, 2.6 [Cl, 1.1 to 6.6]) were independent risk factors for Alzheimer disease, even after adjustment for apoE genotype and other confounding factors. Conclusions: The association between the apoE epsilon4 allele and Alzheimer disease does not seem to be mediated by vascular factors. The apoE epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for Alzheimer disease. The risk for Alzheimer disease from treatable factors-elevated total cholesterol level and blood pressure appears to be greater than that from the apoE epsilon4 allele.	Univ Kuopio, Dept Neurol & Neurosci, FIN-70211 Kuopio, Finland; Kuopio Univ Hosp, SF-70210 Kuopio, Finland; N Karelia Cent Hosp, Joensuu, Finland; Natl Publ Hlth Inst, Helsinki, Finland	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Finland National Institute for Health & Welfare	Kivipelto, M (corresponding author), Univ Kuopio, Dept Neurol & Neurosci, POB 1627, FIN-70211 Kuopio, Finland.	miia.kivipelto@uku.fi	Laakso, Mikko/AHB-7022-2022; Kivipelto, Miia/AAS-3557-2021	Laakso, Mikko/0000-0003-1250-3425; Kivipelto, Miia/0000-0003-0992-3875				ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Braak E, 1999, EUR ARCH PSY CLIN N, V249, P14; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Carmelli D, 1998, NEUROLOGY, V50, P1580, DOI 10.1212/WNL.50.6.1580; Coca A, 1998, J HYPERTENS, V16, pS45; Frikke-Schmidt R, 2001, NEUROLOGY, V56, P194, DOI 10.1212/WNL.56.2.194; Haan MN, 1999, JAMA-J AM MED ASSOC, V282, P40, DOI 10.1001/jama.282.1.40; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; JARVIK GP, 1995, NEUROLOGY, V45, P1092, DOI 10.1212/WNL.45.6.1092; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; Kivipelto M, 2001, NEUROLOGY, V56, P1683, DOI 10.1212/WNL.56.12.1683; Klungel OH, 2000, STROKE, V31, P420, DOI 10.1161/01.STR.31.2.420; Launer LJ, 2000, NEUROBIOL AGING, V21, P49, DOI 10.1016/S0197-4580(00)00096-8; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mitka W, 2001, JAMA-J AM MED ASSOC, V286, P2799; Notkola IL, 1998, NEUROEPIDEMIOLOGY, V17, P14, DOI 10.1159/000026149; PETERSEN RC, 1995, JAMA-J AM MED ASSOC, V273, P1274, DOI 10.1001/jama.273.16.1274; Prince M, 2000, NEUROLOGY, V54, P397, DOI 10.1212/WNL.54.2.397; PUSKA P, 1979, BRIT MED J, V2, P1173, DOI 10.1136/bmj.2.6199.1173; Romas SN, 1999, NEUROLOGY, V53, P517, DOI 10.1212/WNL.53.3.517; Skoog I, 1996, LANCET, V347, P1141, DOI 10.1016/S0140-6736(96)90608-X; Slooter AJC, 1999, NEUROLOGY, V53, P1593, DOI 10.1212/WNL.53.7.1593; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; TSUKAMOTO K, 1993, J LAB CLIN MED, V121, P598; VARTIAINEN E, 1994, INT J EPIDEMIOL, V23, P495, DOI 10.1093/ije/23.3.495; Wilson PWF, 1996, ARTERIOSCL THROM VAS, V16, P1250, DOI 10.1161/01.ATV.16.10.1250; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439	30	496	523	2	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 6	2002	137	3					149	155		10.7326/0003-4819-137-3-200208060-00006	http://dx.doi.org/10.7326/0003-4819-137-3-200208060-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580XP	12160362				2022-12-28	WOS:000177262300001
J	Johnstone, RA				Johnstone, RA			The evolution of inaccurate mimics	NATURE			English	Article							BATESIAN MIMICRY; MODEL; FREQUENCY	Instances of strikingly accurate Batesian mimicry (in which a palatable prey organism closely resembles an aversive model) are often cited to illustrate the power of natural selection(1). Less attention has been paid to those mimics, such as many hoverfly (Syrphidae) mimics of wasps or bees, that resemble their models only poorly(2-4). Attempts to provide an adaptive explanation for imperfect mimicry have suggested that what seems a crude resemblance to human observers may appear a close match to predators(2), or that inaccurate mimics may bear a general resemblance to several different model species(3,4). I show here, however, that truly inaccurate mimicry of a single model organism may be favoured over perfect resemblance, by kin selection. Signal detection theory predicts that predators will modify their level of discrimination adaptively in response to the relative frequencies and similarity of models and mimics(5-7). If models are rare and/or weakly aversive, greater local similarity of mimics can thus lead to greater attack rates. Where individual mimics are related to others in their vicinity, kin selection will then oppose the evolution of accurate mimicry.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Johnstone, RA (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.							BROWER JV, 1960, AM NAT, V94, P271, DOI 10.1086/282128; DITTRICH W, 1993, P ROY SOC B-BIOL SCI, V251, P195, DOI 10.1098/rspb.1993.0029; DUNCAN C. J., 1965, BEHAVIOUR, V24, P269, DOI 10.1163/156853965X00066; Edmunds M, 2000, BIOL J LINN SOC, V70, P459; Fisher R.A., 1930, GENETICAL THEORY NAT; Frank, 1998, FDN SOCIAL EVOLUTION; GETTY T, 1985, AM NAT, V125, P239, DOI 10.1086/284339; GITTLEMAN JL, 1980, NATURE, V286, P149, DOI 10.1038/286149a0; GOODALE MA, 1977, ANIM BEHAV, V25, P660, DOI 10.1016/0003-3472(77)90117-8; GREENWOOD JJD, 1986, AM NAT, V128, P294, DOI 10.1086/284561; Guilford T, 1988, AM NAT, V131, P7; HARVEY PH, 1981, OIKOS, V37, P391, DOI 10.2307/3544135; HETZ M, 1988, OECOLOGIA, V76, P570, DOI 10.1007/BF00397872; HOWSE PE, 1994, P ROY SOC B-BIOL SCI, V257, P111, DOI 10.1098/rspb.1994.0102; LEA RG, 1972, BEHAVIOUR, V42, P131, DOI 10.1163/156853972X00149; Lindstrom L, 1997, P ROY SOC B-BIOL SCI, V264, P149, DOI 10.1098/rspb.1997.0022; Mappes J, 1997, EVOLUTION, V51, P2050, DOI 10.1111/j.1558-5646.1997.tb05129.x; Pfennig DW, 2001, NATURE, V410, P323, DOI 10.1038/35066628; PILECKI C, 1971, EVOLUTION, V25, P365, DOI 10.1111/j.1558-5646.1971.tb01890.x; Rodriguez-Girones MA, 1999, AM NAT, V153, P633, DOI 10.1086/303198; Wickler W., 1968, MIMICRY PLANTS ANIMA	21	70	71	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2002	418	6897					524	526		10.1038/nature00845	http://dx.doi.org/10.1038/nature00845			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152077				2022-12-28	WOS:000177162800038
J	Mukherjee, S; Brieba, LG; Sousa, R				Mukherjee, S; Brieba, LG; Sousa, R			Structural transitions mediating transcription initiation by T7 RNA polymerase	CELL			English	Article							LAC UV5 PROMOTER; TERNARY COMPLEXES; THUMB SUBDOMAIN; BACTERIOPHAGE-T7; DNA; ELONGATION; TERMINATION; STABILITY; MECHANISM; LYSOZYME	During transcription initiation, RNA polymerases appear to retain promoter interactions while transcribing short RNAs that are frequently released from the complex. Upon transition to elongation, the polymerase releases promoter and forms a stable elongation complex. Little is known about the changes in polymerase conformation or polymerase:DNA interactions that occur during this process. To characterize the transitions that occur in the T7 RNA polyrnerase transcription complex during initiation, we prepared enzymes with Fe-BABE conjugated at 11 different positions. Addition of H2O2 to transcription complexes prepared with these enzymes led to nucleic acid strand scission near the conjugate. Changes in the cleavage sites revealed a series of conformational changes and rearrangements of protein:nucleic acid contacts that mediate progression through the initiation reaction.	Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Sousa, R (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Biochem, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.		Brieba, Luis/I-8447-2016; Meares, Claude F/A-8345-2011	Brieba, Luis/0000-0002-6073-5207; Sousa, Rui/0000-0003-4314-121X	NIGMS NIH HHS [GM52522, R01 GM052522] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; Brieba LG, 2001, BIOCHEMISTRY-US, V40, P3882, DOI 10.1021/bi002716c; Brieba LG, 2001, EMBO J, V20, P6826, DOI 10.1093/emboj/20.23.6826; Brieba LG, 2001, J BIOL CHEM, V276, P10306, DOI 10.1074/jbc.M009866200; CARPOUSIS AJ, 1980, BIOCHEMISTRY-US, V19, P3245, DOI 10.1021/bi00555a023; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Greiner DP, 1997, BIOCONJUGATE CHEM, V8, P44, DOI 10.1021/bc9600731; Gruber TM, 2001, MOL CELL, V8, P21, DOI 10.1016/S1097-2765(01)00292-1; HAN HY, 1994, P NATL ACAD SCI USA, V91, P4955, DOI 10.1073/pnas.91.11.4955; HANSEN UM, 1980, J BIOL CHEM, V255, P9564; Huang JB, 1999, J MOL BIOL, V293, P457, DOI 10.1006/jmbi.1999.3135; Huang JB, 2000, J MOL BIOL, V303, P347, DOI 10.1006/jmbi.2000.4150; IKEDA RA, 1986, P NATL ACAD SCI USA, V83, P3614, DOI 10.1073/pnas.83.11.3614; Jeruzalmi D, 1998, EMBO J, V17, P4101, DOI 10.1093/emboj/17.14.4101; Jia YP, 1997, BIOCHEMISTRY-US, V36, P4223, DOI 10.1021/bi9630467; KRUMMEL B, 1989, BIOCHEMISTRY-US, V28, P7829, DOI 10.1021/bi00445a045; Kuznedelov K, 2002, SCIENCE, V295, P855, DOI 10.1126/science.1066303; Landick R, 2001, CELL, V105, P567, DOI 10.1016/S0092-8674(01)00381-6; MACDONALD LE, 1993, J MOL BIOL, V232, P1030, DOI 10.1006/jmbi.1993.1458; MACDONALD LE, 1994, J MOL BIOL, V238, P145, DOI 10.1006/jmbi.1994.1277; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Mentesana PE, 2000, J MOL BIOL, V302, P1049, DOI 10.1006/jmbi.2000.4114; Mukhopadhyay J, 2001, CELL, V106, P453, DOI 10.1016/S0092-8674(01)00464-0; Nudler E, 1999, J MOL BIOL, V288, P1, DOI 10.1006/jmbi.1999.2641; Palangat M, 2001, J MOL BIOL, V311, P265, DOI 10.1006/jmbi.2001.4842; Place C, 1999, BIOCHEMISTRY-US, V38, P4948, DOI 10.1021/bi982689e; SOUSA R, 1992, J MOL BIOL, V224, P319, DOI 10.1016/0022-2836(92)90997-X; SOUSA R, 1993, NATURE, V364, P593, DOI 10.1038/364593a0; SOUSA R, 1994, J MOL BIOL, V244, P6, DOI 10.1006/jmbi.1994.1699; STRANEY DC, 1987, J MOL BIOL, V193, P267, DOI 10.1016/0022-2836(87)90218-X; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Temiakov D, 2000, P NATL ACAD SCI USA, V97, P14109, DOI 10.1073/pnas.250473197; Ujvari A, 2000, J MOL BIOL, V295, P1173, DOI 10.1006/jmbi.1999.3418; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Villemain J, 1998, J MOL BIOL, V281, P793, DOI 10.1006/jmbi.1998.1989; Villemain J, 1997, J MOL BIOL, V273, P958, DOI 10.1006/jmbi.1997.1358; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; Zhang X, 1997, J MOL BIOL, V269, P10, DOI 10.1006/jmbi.1997.1016	41	40	45	4	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 12	2002	110	1					81	91		10.1016/S0092-8674(02)00815-2	http://dx.doi.org/10.1016/S0092-8674(02)00815-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	573PU	12150999	Bronze			2022-12-28	WOS:000176840700009
J	Kuhlbrandt, W; Zeelen, J; Dietrich, J				Kuhlbrandt, W; Zeelen, J; Dietrich, J			Structure, mechanism, and regulation of the neurospora plasma membrane H+-ATPase	SCIENCE			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; SARCOPLASMIC-RETICULUM; CALCIUM-PUMP; BACTERIORHODOPSIN; RESOLUTION; DOMAINS; MAPS	Proton pumps in the plasma membrane of plants and yeasts maintain the intracellular pH and membrane potential. To gain insight into the molecular mechanisms of proton pumping, we built an atomic homology model of the proton pump based on the 2.6 angstrom x-ray structure of the related Ca2+ pump from rabbit sarcoplasmic reticulum. The model, when fitted to an 8 angstrom map of the Neurospora proton pump determined by electron microscopy, reveals the likely path of the proton through the membrane and shows that the nucleotide-binding domain rotates by similar to70degrees to deliver adenosine triphosphate (ATP) to the phosphorylation site. A synthetic peptide corresponding to the carboxyl-terminal regulatory domain stimulates ATPase activity, suggesting a mechanism for proton transport regulation.	Max Planck Inst Biophys, D-60528 Frankfurt, Germany	Max Planck Society	Kuhlbrandt, W (corresponding author), Max Planck Inst Biophys, Heinrich Hoffmann Str 7, D-60528 Frankfurt, Germany.			Kuhlbrandt, Werner/0000-0002-2013-4810				Auer M, 1998, NATURE, V392, P840, DOI 10.1038/33967; BIGELOW DJ, 1992, BIOCHIM BIOPHYS ACTA, V1113, P323, DOI 10.1016/0304-4157(92)90005-U; CYRKLAFF M, 1995, EMBO J, V14, P1854, DOI 10.1002/j.1460-2075.1995.tb07177.x; GOORMAGHTIGH E, 1994, J BIOL CHEM, V269, P27409; Goossens A, 2000, MOL CELL BIOL, V20, P7654, DOI 10.1128/MCB.20.20.7654-7661.2000; HENNESSEY JP, 1988, J BIOL CHEM, V263, P3123; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KUBLER O, 1978, ULTRAMICROSCOPY, V3, P161, DOI 10.1016/S0304-3991(78)80022-9; KUHLBRANDT W, UNPUB; Lancaster CRD, 1997, STRUCTURE, V5, P1339, DOI 10.1016/S0969-2126(97)00285-2; Luecke H, 2000, BBA-BIOENERGETICS, V1460, P133, DOI 10.1016/S0005-2728(00)00135-3; Lutsenko S, 1997, J BIOL CHEM, V272, P18939, DOI 10.1074/jbc.272.30.18939; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; Morsomme P, 2000, BBA-REV BIOMEMBRANES, V1469, P133, DOI 10.1016/S0304-4157(00)00015-0; Ponamarev MV, 1998, BIOCHEMISTRY-US, V37, P17199, DOI 10.1021/bi981814j; PORTILLO F, 1991, FEBS LETT, V287, P71, DOI 10.1016/0014-5793(91)80018-X; PORTILLO F, 1999, BIOCHIM BIOPHYS ACTA, V1469, P31; Rhee KH, 2002, EMBO J, V21, P3582, DOI 10.1093/emboj/cdf385; Roseman AM, 2000, ACTA CRYSTALLOGR D, V56, P1332, DOI 10.1107/S0907444900010908; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SERRANO R, 1992, ACTA PHYSIOL SCAND, V146, P131; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TITTOR J, 1995, BIOPHYS CHEM, V56, P153, DOI 10.1016/0301-4622(95)00027-U; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Xu C, 2002, J MOL BIOL, V316, P201, DOI 10.1006/jmbi.2001.5330; Zhang PJ, 1998, NATURE, V392, P835, DOI 10.1038/33959; Zscherp C, 1999, P NATL ACAD SCI USA, V96, P5498, DOI 10.1073/pnas.96.10.5498	28	86	90	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2002	297	5587					1692	1696		10.1126/science.1072574	http://dx.doi.org/10.1126/science.1072574			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12169656				2022-12-28	WOS:000177819100047
J	Gu, ZZ; Kaul, M; Yan, BX; Kridel, SJ; Cui, JK; Strongin, A; Smith, JW; Liddington, RC; Lipton, SA				Gu, ZZ; Kaul, M; Yan, BX; Kridel, SJ; Cui, JK; Strongin, A; Smith, JW; Liddington, RC; Lipton, SA			S-nitrosylation of matrix metalloproteinases: Signaling pathway to neuronal cell death	SCIENCE			English	Article							FOCAL CEREBRAL-ISCHEMIA; NITRIC-OXIDE PRODUCTION; MATRIX-METALLOPROTEINASE-9; ACTIVATION; EXPRESSION; MECHANISM; REPERFUSION; INHIBITION; DEFICIENT; INCREASES	Matrix metalloproteinases (MMPs) are implicated in the pathogenesis of neurodegenerative diseases and stroke. However, the mechanism of MMP activation remains unclear. We report that MMP activation involves S-nitrosylation. During cerebral ischemia in vivo, MMP-9 colocalized with neuronal nitric oxide synthase. S-Nitrosylation activated MMP-9 in vitro and induced neuronal apoptosis. Mass spectrometry identified the active derivative of MMP-9, both in vitro and in vivo, as a stable sulfonic or sulfonic acid, whose formation was triggered by S-nitrosylation. These findings suggest a potential extracellular proteolysis pathway to neuronal cell death in which S-nitrosylation activates MMPs, and further oxidation results in a stable posttranslational modification with pathological activity.	Burnham Inst, Ctr Neurosci Aging, La Jolla, CA 92037 USA; Burnham Inst, Program Cell Adhes & Extracellular Matrix Biol, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Lipton, SA (corresponding author), Burnham Inst, Ctr Neurosci Aging, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	slipton@burnham.org	Strongin, Alex/R-6609-2019; Kaul, Marcus/AAS-8955-2020	Strongin, Alex/0000-0003-3765-3016; Lipton, Stuart/0000-0002-3490-1259	NCI NIH HHS [R01 CA 69306] Funding Source: Medline; NEI NIH HHS [R01 EY09024, R01 EY05477] Funding Source: Medline; NIAMS NIH HHS [AR08505, R01 AR42750] Funding Source: Medline; NIA NIH HHS [T32 AG00252] Funding Source: Medline; NICHD NIH HHS [P01 HD29587] Funding Source: Medline; NINDS NIH HHS [R01 NS41207] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD029587] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA069306] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY005477, R01EY009024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000252] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681, DOI 10.1097/00004647-200012000-00007; Asensio VC, 1999, TRENDS NEUROSCI, V22, P504, DOI 10.1016/S0166-2236(99)01453-8; Becker K, 1998, NAT STRUCT BIOL, V5, P267, DOI 10.1038/nsb0498-267; Cardone MH, 1997, CELL, V90, P315, DOI 10.1016/S0092-8674(00)80339-6; Choi YB, 2000, NAT NEUROSCI, V3, P15, DOI 10.1038/71090; DAWSON TM, 1994, J NEUROSCI, V14, P5147; Eberhardt W, 2000, KIDNEY INT, V57, P59, DOI 10.1046/j.1523-1755.2000.00808.x; Gasche Y, 1999, J CEREBR BLOOD F MET, V19, P1020, DOI 10.1097/00004647-199909000-00010; GU ZH, UNPUB; Huang DY, 2000, FASEB J, V14, P407, DOI 10.1096/fasebj.14.2.407; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Kridel SJ, 2001, J BIOL CHEM, V276, P20572, DOI 10.1074/jbc.M100900200; KUMURA E, 1994, J CEREBR BLOOD F MET, V14, P487, DOI 10.1038/jcbfm.1994.60; LEI SZ, 1992, NEURON, V8, P1087, DOI 10.1016/0896-6273(92)90130-6; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Lukes A, 1999, MOL NEUROBIOL, V19, P267, DOI 10.1007/BF02821717; Matthews JR, 1996, NUCLEIC ACIDS RES, V24, P2236, DOI 10.1093/nar/24.12.2236; Melino G, 1997, NATURE, V388, P432, DOI 10.1038/41237; Montaner J, 2001, STROKE, V32, P1759, DOI 10.1161/01.STR.32.8.1759; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Okamoto T, 1997, ARCH BIOCHEM BIOPHYS, V342, P261, DOI 10.1006/abbi.1997.0127; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; SATO S, 1994, BRAIN RES, V647, P91, DOI 10.1016/0006-8993(94)91402-8; Stamler JS, 1998, NAT STRUCT BIOL, V5, P247, DOI 10.1038/nsb0498-247; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; Wink DA, 1999, METHOD ENZYMOL, V301, P201; Yan BX, 2000, J BIOL CHEM, V275, P39964, DOI 10.1074/jbc.M007041200; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Zhang JW, 1997, J NEUROSCI METH, V76, P15, DOI 10.1016/S0165-0270(97)00065-4	34	786	825	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2002	297	5584					1186	1190		10.1126/science.1073634	http://dx.doi.org/10.1126/science.1073634			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183632				2022-12-28	WOS:000177447600052
J	Eden, S; Rohatgi, R; Podtelejnikov, AV; Mann, M; Kirschner, MW				Eden, S; Rohatgi, R; Podtelejnikov, AV; Mann, M; Kirschner, MW			Mechanism of regulation of WAVE1-induced actin nucleation by Rac1 and Nck	NATURE			English	Article							ALDRICH-SYNDROME PROTEIN; WASP-RELATED PROTEIN; ARP2/3 COMPLEX; N-WASP; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; MOLECULAR-CLONING; MASS-SPECTROMETRY; ACTIVATION; CDC42; WAVE	Rac signalling to actin-a pathway that is thought to be mediated by the protein Scar/WAVE (WASP (Wiskott-Aldrich syndrome protein)-family verprolin homologous protein)-has a principal role in cell motility. In an analogous pathway, direct interaction of Cdc42 with the related protein N-WASP stimulates actin polymerization(1). For the Rac-WAVE pathway, no such direct interaction has been identified. Here we report a mechanism by which Rac and the adapter protein Nck activate actin nucleation through WAVE1. WAVE1 exists in a heterotetrameric complex that includes orthologues of human PIR121 (p53-inducible messenger RNA with a relative molecular mass (M-r)of 140,000), Nap125 (NCK-associated protein with an M-r of 125,000) and HSPC300. Whereas recombinant WAVE1 is constitutively active, the WAVE1 complex is inactive. We therefore propose that Rac1 and Nck cause dissociation of the WAVE1 complex, which releases active WAVE1-HSPC300 and leads to actin nucleation.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ So Denmark Odense, Prot Interact Lab, DK-5230 Odense M, Denmark	Harvard University; Harvard Medical School	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.		Mann, Matthias/A-3454-2013; Podtelejnikov, Alexandre/B-6120-2017	Mann, Matthias/0000-0003-1292-4799; Podtelejnikov, Alexandre/0000-0002-8124-6584				BAUMGARTNER S, 1995, J MOL BIOL, V251, P41, DOI 10.1006/jmbi.1995.0414; Bear JE, 1998, J CELL BIOL, V142, P1325, DOI 10.1083/jcb.142.5.1325; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Hahne P, 2001, FEBS LETT, V492, P215, DOI 10.1016/S0014-5793(01)02239-6; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Kitamura T, 1996, BIOCHEM BIOPH RES CO, V219, P509, DOI 10.1006/bbrc.1996.0264; Kitamura Y, 1997, BIOCHEM J, V322, P873, DOI 10.1042/bj3220873; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Ma L, 1998, P NATL ACAD SCI USA, V95, P15362, DOI 10.1073/pnas.95.26.15362; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Muller WA, 1996, TRENDS GENET, V12, P91, DOI 10.1016/0168-9525(96)81419-3; Nagase T, 1998, DNA Res, V5, P31, DOI 10.1093/dnares/5.1.31; Nagase T, 1996, DNA Res, V3, P17, DOI 10.1093/dnares/3.1.17; Nakagawa H, 2001, J CELL SCI, V114, P1555; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; Saller E, 1999, EMBO J, V18, P4424, DOI 10.1093/emboj/18.16.4424; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Suetsugu S, 1999, BIOCHEM BIOPH RES CO, V260, P296, DOI 10.1006/bbrc.1999.0894; Suzuki T, 2000, GENOMICS, V63, P246, DOI 10.1006/geno.1999.6053; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; [No title captured]	30	613	636	3	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 15	2002	418	6899					790	793		10.1038/nature00859	http://dx.doi.org/10.1038/nature00859			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181570				2022-12-28	WOS:000177428000042
J	Discher, DE; Eisenberg, A				Discher, DE; Eisenberg, A			Polymer vesicles	SCIENCE			English	Review							BLOCK-COPOLYMER VESICLES; TRIBLOCK COPOLYMER; PHASE-BEHAVIOR; LIPOSOMES; MEMBRANES; SYSTEMS; ENCAPSULATION; PROTEINS; DELIVERY; DIAGRAM	Vesicles are microscopic sacs that enclose a volume with a molecularly thin membrane. The membranes are generally self-directed assemblies of amphiphilic molecules with a dual hydrophilic-hydrophobic character. Biological amphiphiles form vesicles central to cell function and are principally lipids of molecular weight less than 1 kilodalton. Block copolymers that mimic lipid amphiphilicity can also self-assemble into vesicles in dilute solution, but polymer molecular weights can be orders of magnitude greater than those of lipids. Structural features of vesicles, as well as properties including stability, fluidity, and intermembrane dynamics, are greatly influenced by characteristics of the polymers. Future applications of polymer vesicles will rely on exploiting unique property-performance relations, but results to date already underscore the fact that biologically derived vesicles are but a small subset of what is physically and chemically possible.	Univ Penn, Sch Engn & Appl Sci, Philadelphia, PA 19104 USA; McGill Univ, Dept Chem, Montreal, PQ H3A 2K6, Canada	University of Pennsylvania; McGill University	Discher, DE (corresponding author), Univ Penn, Sch Engn & Appl Sci, Philadelphia, PA 19104 USA.	discher@seas.upenn.edu		discher, dennis/0000-0001-6163-2229				AHMED F, UNPUB; Aranda-Espinoza H, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.208301; BANGHAM AD, 1993, CHEM PHYS LIPIDS, V64, P275, DOI 10.1016/0009-3084(93)90071-A; Bates FS, 1999, PHYS TODAY, V52, P32, DOI 10.1063/1.882522; Batycky RP, 1997, J PHARM SCI, V86, P1464, DOI 10.1021/js9604117; BeduAddo FK, 1996, PHARMACEUT RES, V13, P710, DOI 10.1023/A:1016091314940; BERMUDEZ H, IN PRESS MACROMOLECU; BLOOM M, 1991, Q REV BIOPHYS, V24, P293, DOI 10.1017/S0033583500003735; Caruso F, 2000, LANGMUIR, V16, P1485, DOI 10.1021/la991161n; CHOUCAIR A, UNPUB; Cornelissen JJLM, 1998, SCIENCE, V280, P1427, DOI 10.1126/science.280.5368.1427; CORNET B, 1992, AIDS RES HUM RETROV, V8, P1823, DOI 10.1089/aid.1992.8.1823; DAN N, 1994, MACROMOLECULES, V27, P5766, DOI 10.1021/ma00098a034; Dimova R, 2002, EUR PHYS J E, V7, P241, DOI 10.1140/epje/i200101032; Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143; Discher BM, 2002, J PHYS CHEM B, V106, P2848, DOI 10.1021/jp011958z; Dobereiner HG, 1997, PHYS REV E, V55, P4458, DOI 10.1103/PhysRevE.55.4458; EGGENS I, 1983, BIOCHIM BIOPHYS ACTA, V751, P355, DOI 10.1016/0005-2760(83)90294-1; Evans E.A., 1980, MECH THERMODYNAMICS; Forster S, 1996, J CHEM PHYS, V104, P9956, DOI 10.1063/1.471723; Forster S, 2001, MACROMOLECULES, V34, P4610, DOI 10.1021/ma001923h; GEBICKI JM, 1973, NATURE, V243, P232, DOI 10.1038/243232a0; Graff A, 2002, P NATL ACAD SCI USA, V99, P5064, DOI 10.1073/pnas.062654499; Hagan SA, 1996, LANGMUIR, V12, P2153, DOI 10.1021/la950649v; Hajduk DA, 1998, J PHYS CHEM B, V102, P4269, DOI 10.1021/jp973323z; Hanley KJ, 2000, MACROMOLECULES, V33, P5918, DOI 10.1021/ma000318b; HELFAND E, 1982, DEV BLOCK COPOLYMERS, pCH4; HIGGINS CF, 1994, CELL, V79, P393, DOI 10.1016/0092-8674(94)90248-8; Israelachvili J.N., 1991, INTERMOLECULAR SURFA; Jenekhe SA, 1998, SCIENCE, V279, P1903, DOI 10.1126/science.279.5358.1903; Jung HT, 2001, P NATL ACAD SCI USA, V98, P1353, DOI 10.1073/pnas.041420998; Lambert O, 2000, P NATL ACAD SCI USA, V97, P7248, DOI 10.1073/pnas.130187297; Lasic DD, 1998, MED APPL LIPOSOMES; Lee JCM, 2002, MACROMOLECULES, V35, P323, DOI 10.1021/ma0112063; Lee JCM, 2001, BIOTECHNOL BIOENG, V73, P135, DOI 10.1002/bit.1045; Lipowsky R., 1995, P521; Liu SC, 2002, J AM CHEM SOC, V124, P6037, DOI 10.1021/ja0123507; Luo LB, 2002, ANGEW CHEM INT EDIT, V41, P1001, DOI 10.1002/1521-3773(20020315)41:6<1001::AID-ANIE1001>3.0.CO;2-Q; Luo LB, 2001, LANGMUIR, V17, P6804, DOI 10.1021/la0104370; Luo LB, 2001, J AM CHEM SOC, V123, P1012, DOI 10.1021/ja005824v; Mathur R, 1995, ACS SYM SER, V610, P219; MAXWELL IA, 1995, LANGMUIR, V11, P1987, DOI 10.1021/la00006a027; Meier W, 2000, ANGEW CHEM INT EDIT, V39, P4599, DOI 10.1002/1521-3773(20001215)39:24<4599::AID-ANIE4599>3.0.CO;2-Y; Napoli A, 2001, MACROMOLECULES, V34, P8913, DOI 10.1021/ma0108057; Nardin C, 2000, LANGMUIR, V16, P1035, DOI 10.1021/la990951u; PHOTOS PJ, UNPUB; Regenbrecht M, 1999, J PHYS CHEM B, V103, P6669, DOI 10.1021/jp990077d; RINGSDORF H, 1988, ANGEW CHEM INT EDIT, V27, P113, DOI 10.1002/anie.198801131; Schillen K, 1999, MACROMOLECULES, V32, P6885, DOI 10.1021/ma9908144; Semple SC, 1998, ADV DRUG DELIVER REV, V32, P3, DOI 10.1016/S0169-409X(97)00128-2; Shen HW, 1999, J PHYS CHEM B, V103, P9473, DOI 10.1021/jp991365c; Sommerdijk NAJM, 2000, MACROMOLECULES, V33, P8289, DOI 10.1021/ma0011385; Uchegbu IF, 2000, DRUG TARG D, V11, P115; VANHEST JCM, 1995, SCIENCE, V268, P1592, DOI 10.1126/science.268.5217.1592; Velonia K, 2002, J AM CHEM SOC, V124, P4224, DOI 10.1021/ja017809b; ZHANG LF, 1995, SCIENCE, V268, P1728, DOI 10.1126/science.268.5218.1728; Zhou SQ, 2001, SCIENCE, V291, P1944, DOI 10.1126/science.291.5510.1944	57	3107	3192	43	2143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 9	2002	297	5583					967	973		10.1126/science.1074972	http://dx.doi.org/10.1126/science.1074972			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169723				2022-12-28	WOS:000177325400032
J	Trewavas, A				Trewavas, A			Malthus foiled again and again	NATURE			English	Editorial Material									Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JH, Midlothian, Scotland	University of Edinburgh	Trewavas, A (corresponding author), Univ Edinburgh, Inst Cell & Mol Biol, Mayfield Rd, Edinburgh EH9 3JH, Midlothian, Scotland.							Chrispeels MJ, 1994, PLANTS GENES AGR; Dyson T, 1996, POPULATION FOOD GLOB; Evans L., 1998, FEEDING 10 BILLION P; Gregory PJ, 2002, AGR ECOSYST ENVIRON, V88, P279, DOI 10.1016/S0167-8809(01)00263-8; Smil V., 2000, FEEDING WORLD CHALLE; Trewavas AJ, 2001, PLANT PHYSIOL, V125, P174, DOI 10.1104/pp.125.1.174	6	82	91	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2002	418	6898					668	670		10.1038/nature01013	http://dx.doi.org/10.1038/nature01013			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167872				2022-12-28	WOS:000177305600052
J	Zrenner, A; Beham, E; Stufler, S; Findeis, F; Bichler, M; Abstreiter, G				Zrenner, A; Beham, E; Stufler, S; Findeis, F; Bichler, M; Abstreiter, G			Coherent properties of a two-level system based on a quantum-dot photodiode	NATURE			English	Article							ABSORPTION	Present-day information technology is based mainly on incoherent processes in conventional semiconductor devices(1). To realize concepts for future quantum information technologies, which are based on coherent phenomena, a new type of 'hardware' is required(2). Semiconductor quantum dots are promising candidates for the basic device units for quantum information processing. One approach is to exploit optical excitations (excitons) in quantum dots. It has already been demonstrated that coherent manipulation between two excitonic energy levels-via so-called Rabi oscillations-can be achieved in single quantum dots by applying electromagnetic fields(3-7). Here we make use of this effect by placing an InGaAs quantum dot in a photodiode, which essentially connects it to an electric circuit. We demonstrate that coherent optical excitations in the quantum-dot two-level system can be converted into deterministic photocurrents. For optical excitation with so-called p-pulses, which completely invert the two-level system, the current is given by I = fe, where f is the repetition frequency of the experiment and e is the elementary charge. We find that this device can function as an optically triggered single-electron turnstile.	Tech Univ Munich, Walter Schottky Inst, D-85748 Garching, Germany	Technical University of Munich	Zrenner, A (corresponding author), Tech Univ Munich, Walter Schottky Inst, D-85748 Garching, Germany.	zrenner@physik.upb.de						Alferov ZI, 2001, REV MOD PHYS, V73, P767, DOI 10.1103/RevModPhys.73.767; [Anonymous], 1975, OPTICAL RESONANCE 2; Bayer M, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.041308; Beham E, 2001, APPL PHYS LETT, V79, P2808, DOI 10.1063/1.1411987; Borri P, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.157401; BRUNNER K, 1994, PHYS REV LETT, V73, P1138, DOI 10.1103/PhysRevLett.73.1138; Findeis F, 2001, APPL PHYS LETT, V78, P2958, DOI 10.1063/1.1369148; Htoon H, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.087401; KAMADA H, 2001, PHYS REV LETT, V87; POTHIER H, 1992, EUROPHYS LETT, V17, P249, DOI 10.1209/0295-5075/17/3/011; Rabi II, 1937, PHYS REV, V51, P0652, DOI 10.1103/PhysRev.51.652; Stievater TH, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.133603; ZRENNER A, 2001, Patent No. 10006909; [No title captured]	14	707	721	0	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2002	418	6898					612	614		10.1038/nature00912	http://dx.doi.org/10.1038/nature00912			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167853				2022-12-28	WOS:000177305600034
J	Cook, DM				Cook, DM			Shouldn't adults with growth hormone deficiency be offered growth hormone replacement therapy?	ANNALS OF INTERNAL MEDICINE			English	Article							RECOMBINANT HUMAN GH; HYPOPITUITARY ADULTS; SERUM-LIPIDS; CANCER RISK; FACTOR-I; MORTALITY; MEN; LIPOPROTEINS; INCREASES; SEVERITY	Growth hormone as therapy for adults with growth hormone deficiency has not been universally accepted by endocrinologists who treat adult patients. The following are addressed in this commentary: the evidence on safety and efficacy in the literature supporting the idea that growth hormone should be offered as replacement therapy to adults who are growth hormone deficient; common concerns of the average prescribing endocrinologist, including the purported association between insulin-like growth factor-I and malignant neoplasms and quality-of-life issues with long-term therapy; and controversial subjects, such as differences in dosing for adults versus children and diagnostic issues. This analysis should encourage reluctant practitioners to at least consider growth hormone replacement therapy for patients with definite growth hormone deficiency-that is, patients with symptomatic panhypopituitarism.	Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Cook, DM (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,L607, Portland, OR 97201 USA.	cookd@ohsu.edu						Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379; Bates AS, 1996, J CLIN ENDOCR METAB, V81, P1169, DOI 10.1210/jc.81.3.1169; BATES AS, 1997, J ENDOCRINOL S, V152; BENGTSSON BA, 1993, J CLIN ENDOCR METAB, V76, P309, DOI 10.1210/jc.76.2.309; BENGTSSON BA, 1999, ENDO 1999 C CLIN OR; BESHYAH SA, 1995, J CLIN ENDOCR METAB, V80, P356, DOI 10.1210/jc.80.2.356; Bulow B, 1997, CLIN ENDOCRINOL, V46, P75, DOI 10.1046/j.1365-2265.1997.d01-1749.x; BURMAN P, 1995, J CLIN ENDOCR METAB, V80, P3585, DOI 10.1210/jc.80.12.3585; Capaldo B, 1997, J CLIN ENDOCR METAB, V82, P1378, DOI 10.1210/jc.82.5.1378; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; Colao A, 1999, J CLIN ENDOCR METAB, V84, P1919, DOI 10.1210/jc.84.6.1919; Cook DM, 1999, J CLIN ENDOCR METAB, V84, P3956, DOI 10.1210/jc.84.11.3956; CUNEO RC, 1993, METABOLISM, V42, P1519, DOI 10.1016/0026-0495(93)90145-E; Drake WM, 1998, J CLIN ENDOCR METAB, V83, P3913, DOI 10.1210/jc.83.11.3913; EDEN S, 1993, ARTERIOSCLER THROMB, V13, P296, DOI 10.1161/01.ATV.13.2.296; EDWARDS CK, 1991, P NATL ACAD SCI USA, V88, P2274, DOI 10.1073/pnas.88.6.2274; EDWARDS CK, 1988, SCIENCE, V239, P769, DOI 10.1126/science.2829357; Gibney J, 1999, J CLIN ENDOCR METAB, V84, P2596, DOI 10.1210/jc.84.8.2596; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Hansen TB, 1995, CLIN ENDOCRINOL, V43, P689, DOI 10.1111/j.1365-2265.1995.tb00536.x; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; HOLMES SJ, 1995, CLIN ENDOCRINOL, V43, P151, DOI 10.1111/j.1365-2265.1995.tb01909.x; HOLMES SJ, 1994, J CLIN ENDOCR METAB, V78, P669, DOI 10.1210/jc.78.3.669; Johannsson G, 1996, J CLIN ENDOCR METAB, V81, P2865, DOI 10.1210/jc.81.8.2865; Johannsson G, 1997, J CLIN ENDOCR METAB, V82, P2877, DOI 10.1210/jc.82.9.2877; Johannsson G, 1996, J CLIN ENDOCR METAB, V81, P1575, DOI 10.1210/jc.81.4.1575; Johannsson G, 1999, J CLIN ENDOCR METAB, V84, P4516, DOI 10.1210/jc.84.12.4516; JOHANSSON JO, 1995, NEUROENDOCRINOLOGY, V61, P57, DOI 10.1159/000126813; KIESS W, 1986, NEW ENGL J MED, V314, P321; Ma J, 1999, J NATL CANCER I, V91, P620, DOI 10.1093/jnci/91.7.620; MARKUSSIS V, 1992, LANCET, V340, P1188, DOI 10.1016/0140-6736(92)92892-J; NASS R, 1995, J CLIN ENDOCR METAB, V80, P552, DOI 10.1210/jc.80.2.552; Nishi Y, 1999, J CLIN ENDOCR METAB, V84, P1961, DOI 10.1210/jc.84.6.1961; Orme SM, 1998, J CLIN ENDOCR METAB, V83, P2730, DOI 10.1210/jc.83.8.2730; Pfeifer M, 1999, J CLIN ENDOCR METAB, V84, P453, DOI 10.1210/jc.84.2.453; Rosen T, 1997, EUR J ENDOCRINOL, V137, P240, DOI 10.1530/eje.0.1370240; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; Russell RGG, 1999, BONE, V25, P97, DOI 10.1016/S8756-3282(99)00116-7; RUSSELLJONES DL, 1994, CLIN ENDOCRINOL, V41, P345, DOI 10.1111/j.1365-2265.1994.tb02555.x; Serri O, 1999, J CLIN ENDOCR METAB, V84, P58, DOI 10.1210/jc.84.1.58; Sesmilo G, 2000, ANN INTERN MED, V133, P111, DOI 10.7326/0003-4819-133-2-200007180-00010; Takala J, 1999, NEW ENGL J MED, V341, P785, DOI 10.1056/NEJM199909093411102; Ter Maaten JC, 1999, J CLIN ENDOCR METAB, V84, P2373, DOI 10.1210/jc.84.7.2373; TOMLINSON JW, 2000, BRIT END SOC EUR FED; TOOGOOD AA, 1994, CLIN ENDOCRINOL, V41, P511, DOI 10.1111/j.1365-2265.1994.tb02583.x; Verhelst J, 1997, CLIN ENDOCRINOL, V47, P485, DOI 10.1046/j.1365-2265.1997.3041112.x	47	14	16	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 6	2002	137	3					197	201		10.7326/0003-4819-137-3-200208060-00012	http://dx.doi.org/10.7326/0003-4819-137-3-200208060-00012			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580XP	12160368				2022-12-28	WOS:000177262300007
J	Muranyi, W; Haas, J; Wagner, M; Krohne, G; Koszinowski, UH				Muranyi, W; Haas, J; Wagner, M; Krohne, G; Koszinowski, UH			Cytomegalovirus recruitment of cellular kinases to dissolve the nuclear lamina	SCIENCE			English	Article							PROTEIN; ENVELOPE; MEMBRANE; PHOSPHORYLATION; INFECTION; MITOSIS; VIRUS; AUTOINTEGRATION; PHASE; DNA	The passage of large-sized herpesviral capsids through the nuclear lamina and the inner nuclear membrane to leave the nucleus requires a dissolution of the nuclear lamina. Here, we report on the functions of M50/p35, a beta-herpesviral protein of murine cytomegalovirus. M50/p35 inserts into the inner nuclear membrane and is aggregated by a second viral protein, M53/p38, to form the capsid docking site. M50/p35 recruits the cellular protein kinase C for phosphorylation and dissolution of the nuclear lamina, suggesting that herpesviruses target a critical element of nuclear architecture.	Univ Munich, Genzentrum, D-80336 Munich, Germany; Univ Munich, Max Von Pettenkofer Inst, D-80336 Munich, Germany; Univ Wurzburg, Bioctr, Div Elect Microscopy, D-97074 Wurzburg, Germany	University of Munich; University of Munich; University of Wurzburg	Koszinowski, UH (corresponding author), Univ Munich, Genzentrum, D-80336 Munich, Germany.							Alcami A, 2000, IMMUNOL TODAY, V21, P447, DOI 10.1016/S0167-5699(00)01699-6; Buendia B, 2001, CELL MOL LIFE SCI, V58, P1781, DOI 10.1007/PL00000818; Chen HM, 1998, P NATL ACAD SCI USA, V95, P15270, DOI 10.1073/pnas.95.26.15270; CUDMORE S, 1995, NATURE, V378, P636, DOI 10.1038/378636a0; DELVAL M, 1989, CELL, V58, P305, DOI 10.1016/0092-8674(89)90845-3; DESSEV G, 1988, P NATL ACAD SCI USA, V85, P2994, DOI 10.1073/pnas.85.9.2994; FIELDS AP, 1988, J BIOL CHEM, V263, P8253; Furukawa K, 1999, J CELL SCI, V112, P2485; GERACE L, 1980, CELL, V19, P277, DOI 10.1016/0092-8674(80)90409-2; HOGER TH, 1991, EUR J CELL BIOL, V54, P150; JAULT FM, 1995, J VIROL, V69, P6697, DOI 10.1128/JVI.69.11.6697-6704.1995; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; Laguri C, 2001, STRUCTURE, V9, P503, DOI 10.1016/S0969-2126(01)00611-6; Lee MS, 1998, P NATL ACAD SCI USA, V95, P1528, DOI 10.1073/pnas.95.4.1528; Lu MS, 1996, J VIROL, V70, P8850, DOI 10.1128/JVI.70.12.8850-8857.1996; Mettenleiter TC, 2002, J VIROL, V76, P1537, DOI 10.1128/JVI.76.4.1537-1547.2002; Mocarski E, 1996, FIELDS VIROLOGY, P2447; OTTAVIANO Y, 1985, J BIOL CHEM, V260, P624; Otto H, 2001, EUR J BIOCHEM, V268, P420, DOI 10.1046/j.1432-1033.2001.01901.x; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; RADSAK KD, 1991, EUR J CELL BIOL, V54, P299; Rawlinson WD, 1996, J VIROL, V70, P8833, DOI 10.1128/JVI.70.12.8833-8849.1996; Roller RJ, 2000, J VIROL, V74, P117, DOI 10.1128/JVI.74.1.117-129.2000; Scott ES, 2001, J VIROL, V75, P8818, DOI 10.1128/JVI.75.18.8818-8830.2001; Ye GJ, 2000, J VIROL, V74, P1355, DOI 10.1128/JVI.74.3.1355-1363.2000	25	224	230	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2002	297	5582					854	857		10.1126/science.1071506	http://dx.doi.org/10.1126/science.1071506			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161659				2022-12-28	WOS:000177192800057
J	Poliakoff, M; Fitzpatrick, JM; Farren, TR; Anastas, PT				Poliakoff, M; Fitzpatrick, JM; Farren, TR; Anastas, PT			Green chemistry: Science and politics of change	SCIENCE			English	Article							SUPERCRITICAL FLUIDS	The chemical industry plays a key role in sustaining the world economy and underpinning future technologies, yet is under unprecedented pressure from the effects of globalization and change in many of its traditional markets. Against this background, what will be needed for the industry to embrace efforts to make it "greener"? We explore some of the issues raised by the development of green chemistry techniques and identify potential barriers to their implementation by industry.	Univ Nottingham, Sch Chem, Nottingham NG7 2RD, England; Rohm & Haas Co, Philadelphia, PA 19106 USA	University of Nottingham; Dow Chemical Company	Poliakoff, M (corresponding author), Univ Nottingham, Sch Chem, Nottingham NG7 2RD, England.		Anastas, Paul/L-3258-2013	Anastas, Paul/0000-0003-4777-5172				Adam D, 2000, NATURE, V407, P938, DOI 10.1038/35039717; Anastas P. T., 1998, GREEN CHEM THEORY PR; Cave GWV, 2001, CHEM COMMUN, P2159, DOI 10.1039/b106677n; Constable DJC, 2001, GREEN CHEM, V3, P7, DOI 10.1039/b007875l; Curzons AD, 2001, GREEN CHEM, V3, P1, DOI 10.1039/b007871i; Darr JA, 1999, CHEM REV, V99, P495, DOI 10.1021/cr970036i; DeSimone JM, 2002, SCIENCE, V297, P799, DOI 10.1126/science.1069622; Eissen M, 2002, ANGEW CHEM INT EDIT, V41, P414, DOI 10.1002/1521-3773(20020201)41:3<414::AID-ANIE414>3.0.CO;2-N; Freemantle M, 2001, CHEM ENG NEWS, V79, P30, DOI 10.1021/cen-v079n022.p030; Gray WK, 1999, J AM CHEM SOC, V121, P10711, DOI 10.1021/ja991562p; Gross RA, 2002, SCIENCE, V297, P803, DOI 10.1126/science.297.5582.803; HAMLEY PA, 2001, CHEM ENG, V72, P24; Hileman B, 2002, CHEM ENG NEWS, V80, P10; Hitzler MG, 1998, ORG PROCESS RES DEV, V2, P137, DOI 10.1021/op970056m; Hitzler MG, 1998, CHEM COMMUN, P359, DOI 10.1039/a707149c; Jessop PG, 1999, CHEM REV, V99, P475, DOI 10.1021/cr970037a; JESSOP PG, 1999, CHEM SYNTHESIS USING; Kazarian SG, 2000, CHEM COMMUN, P2047, DOI 10.1039/b005514j; MCGRAYNE SB, 2001, PROMETHEANS LAB CHEM; Oakes RS, 2001, J CHEM SOC PERK T 1, P917, DOI 10.1039/b101219n; Oakes RS, 1999, CHEM COMMUN, P247; Poliakoff M, 2001, NATURE, V413, P257, DOI 10.1038/35095133; Poliakoff M, 2001, NATURE, V412, P125, DOI 10.1038/35084292; Ritter SK, 2001, CHEM ENG NEWS, V79, P24, DOI 10.1021/cen-v079n027.p024; RITTER SK, 2001, CHEM ENG NEWS, V80, P26; Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736; SEDDON KR, 2002, GREEN CHEM, V4; Sheldon R. A., 1994, CHEMTECH, P38; SORRELL SR, REPORT BARRIERS PROJ; Talbot R. E., 1998, INT WATER C P, V59, P561; TAYLOR G, 2002, CHEM IND, V6, P12; WARHURST M, 2002, GREEN CHEM, V4, pG20; Watkins K, 2002, CHEM ENG NEWS, V80, P15, DOI 10.1021/cen-v080n016.p015; WILKINSON MP, 2002, GREEN CHEM, V4, pG34; WILLINGHAM GL, 1996, ACS SYM SER, V640, P226; WOODHOUSE EJ, 2003, CHEM STATES	36	686	702	10	273	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2002	297	5582					807	810		10.1126/science.297.5582.807	http://dx.doi.org/10.1126/science.297.5582.807			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161647				2022-12-28	WOS:000177192800041
J	Hopfner, KP; Craig, L; Moncalian, G; Zinkel, RA; Usui, T; Owen, BAL; Karcher, A; Henderson, B; Bodmer, JL; McMurray, CT; Carney, JP; Petrini, JHJ; Tainer, JA				Hopfner, KP; Craig, L; Moncalian, G; Zinkel, RA; Usui, T; Owen, BAL; Karcher, A; Henderson, B; Bodmer, JL; McMurray, CT; Carney, JP; Petrini, JHJ; Tainer, JA			The Rad50 zinc-hook is a structure joining Mre11 complexes in DNA recombination and repair	NATURE			English	Article							STRAND BREAK REPAIR; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; PROTEIN COMPLEX; NUCLEASE; MAINTENANCE; YEAST; REQUIREMENT; CELLS	The Mre11 complex (Mre11-Rad50-Nbs1) is central to chromosomal maintenance and functions in homologous recombination, telomere maintenance and sister chromatid association(1-7). These functions all imply that the linked binding of two DNA substrates occurs, although the molecular basis for this process remains unknown. Here we present a 2.2 Angstrom crystal structure of the Rad50 coiled-coil region that reveals an unexpected dimer interface at the apex of the coiled coils in which pairs of conserved Cys-X-X-Cys motifs form interlocking hooks that bind one Zn2+ ion. Biochemical, X-ray and electron microscopy data indicate that these hooks can join oppositely protruding Rad50 coiled-coil domains to forma flexible bridge of up to 1,200 Angstrom. This suggests a function for the long insertion in the Rad50 ABC-ATPase domain(8). The Rad50 hook is functional, because mutations in this motif confer radiation sensitivity in yeast and disrupt binding at the distant Mre11 nuclease interface. These data support an architectural role for the Rad50 coiled coils in forming metal-mediated bridging complexes between two DNA-binding heads. The resulting assemblies have appropriate lengths and conformational properties to link sister chromatids in homologous recombination and DNA ends in non-homologous end-joining.	Scripps Res Inst, Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Univ Munich, Gene Ctr, D-81377 Munich, Germany; Univ Munich, Inst Biochem, D-81377 Munich, Germany; Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Mayo Clin & Mayo Fdn, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; Univ Maryland, Sch Med, Radiat Oncol Res Lab, Baltimore, MD 21201 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	Scripps Research Institute; Scripps Research Institute; University of Munich; University of Munich; University of Wisconsin System; University of Wisconsin Madison; Memorial Sloan Kettering Cancer Center; Mayo Clinic; University System of Maryland; University of Maryland Baltimore; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Tainer, JA (corresponding author), Scripps Res Inst, Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA.		Tainer, John/GWQ-4878-2022; Hopfner, Karl-Peter/B-6864-2014; Moncalian, Gabriel/K-3493-2014; Owen, Barbara/AAD-2322-2021	Tainer, John/0000-0003-1659-2429; Hopfner, Karl-Peter/0000-0002-4528-8357; Moncalian, Gabriel/0000-0002-3007-6490; Craig, Lisa/0000-0001-8515-9915; Petrini, John/0000-0001-5102-5679				Anderson DE, 2001, J BIOL CHEM, V276, P37027, DOI 10.1074/jbc.M106179200; Bressan DA, 1998, GENETICS, V150, P591; Bressan DA, 1999, MOL CELL BIOL, V19, P7681; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; Connelly JC, 1999, NUCLEIC ACIDS RES, V27, P1039, DOI 10.1093/nar/27.4.1039; Connelly JC, 1998, P NATL ACAD SCI USA, V95, P7969, DOI 10.1073/pnas.95.14.7969; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; Hartsuiker E, 2001, EMBO J, V20, P6660, DOI 10.1093/emboj/20.23.6660; Hirano T, 1999, GENE DEV, V13, P11, DOI 10.1101/gad.13.1.11; Hopfner KP, 2000, J BACTERIOL, V182, P6036, DOI 10.1128/JB.182.21.6036-6041.2000; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Huang JR, 2002, NUCLEIC ACIDS RES, V30, P667, DOI 10.1093/nar/30.3.667; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; Merino ST, 2000, P NATL ACAD SCI USA, V97, P10477, DOI 10.1073/pnas.190346097; Moreau S, 1999, MOL CELL BIOL, V19, P556; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Petrini JHJ, 2000, CURR OPIN CELL BIOL, V12, P293, DOI 10.1016/S0955-0674(00)00091-0; SHARPLES GJ, 1995, MOL MICROBIOL, V17, P1215, DOI 10.1111/j.1365-2958.1995.mmi_17061215_1.x; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Tsukamoto Y, 2001, CURR BIOL, V11, P1328, DOI 10.1016/S0960-9822(01)00372-4; Usui T, 2001, MOL CELL, V7, P1255, DOI 10.1016/S1097-2765(01)00270-2; Wu XL, 2001, J BIOL CHEM, V276, P1735, DOI 10.1074/jbc.M006727200; Xiao YH, 1997, NUCLEIC ACIDS RES, V25, P2985, DOI 10.1093/nar/25.15.2985; Yamaguchi-Iwai Y, 1999, EMBO J, V18, P6619, DOI 10.1093/emboj/18.23.6619; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7	30	409	418	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2002	418	6897					562	566		10.1038/nature00922	http://dx.doi.org/10.1038/nature00922			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152085				2022-12-28	WOS:000177162800047
J	Olschewski, H; Simonneau, G; Galie, N; Higenbottam, T; Naeije, R; Rubin, LJ; Nikkho, S; Speich, R; Hoeper, MM; Behr, J; Winkler, J; Sitbon, O; Popov, W; Ghofrani, HA; Manes, A; Kiely, DG; Ewert, R; Siedentop, H; Seeger, W				Olschewski, H; Simonneau, G; Galie, N; Higenbottam, T; Naeije, R; Rubin, LJ; Nikkho, S; Speich, R; Hoeper, MM; Behr, J; Winkler, J; Sitbon, O; Popov, W; Ghofrani, HA; Manes, A; Kiely, DG; Ewert, R; Siedentop, H; Seeger, W			Inhaled iloprost for severe pulmonary hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONTINUOUS INTRAVENOUS EPOPROSTENOL; AEROSOLIZED PROSTACYCLIN; NITRIC-OXIDE; ARTERIAL-HYPERTENSION; EXERCISE CAPACITY; DOUBLE-BLIND; THERAPY; ANALOG	Background Uncontrolled studies suggested that aerosolized iloprost, a stable analogue of prostacyclin, causes selective pulmonary vasodilatation and improves hemodynamics and exercise capacity in patients with pulmonary hypertension. Methods We compared repeated daily inhalations of 2.5 or 5.0 mug of iloprost (six or nine times per day; median inhaled dose, 30 mug per day) with inhalation of placebo. A total of 203 patients with selected forms of severe pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (New York Heart Association [NYHA] functional class III or IV) were included. The primary end point was met if, after week 12, the NYHA class and distance walked in six minutes were improved by at least one class and at least 10 percent, respectively, in the absence of clinical deterioration according to predefined criteria and death. Results The combined clinical end point was met by 16.8 percent of the patients receiving iloprost, as compared with 4.9 percent of the patients receiving placebo (P = 0.007). There were increases in the distance walked in six minutes of 36.4 m in the iloprost group as a whole (P = 0.004) and of 58.8 m in the subgroup of patients with primary pulmonary hypertension. Overall, 4.0 percent of patients in the iloprost group (including one who died) and 13.7 percent of those in the placebo group (including four who died) did not complete the study (P = 0.024); the most common reason for withdrawal was clinical deterioration. As compared with base-line values, hemodynamic values were significantly improved at 12 weeks when measured after iloprost inhalation (P < 0.001), were largely unchanged when measured before iloprost inhalation, and were significantly worse in the placebo group. Further significant beneficial effects of iloprost treatment included an improvement in the NYHA class (P = 0.03), dyspnea (P = 0.015), and quality of life (P = 0.026). Syncope occurred with similar frequency in the two groups but was more frequently rated as serious in the iloprost group, although this adverse effect was not associated with clinical deterioration. Conclusions Inhaled iloprost is an effective therapy for patients with severe pulmonary hypertension.	Univ Clin, Dept Internal Med 2, D-35392 Giessen, Germany; Hop Antoine Beclere, Serv Pneumol, Clamart, France; Univ Bologna, Ist Cardiol, Bologna, Italy; Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England; Erasme Univ Hosp, Dept Cardiol, B-1070 Brussels, Belgium; Univ Calif San Diego, Med Ctr, La Jolla, CA 92093 USA; Schering, Berlin, Germany; Univ Hosp, Dept Internal Med, Zurich, Switzerland; Hannover Med Sch, Dept Pneumol, D-3000 Hannover, Germany; Univ Munich Grosshadern, Div Pulm Dis, Munich, Germany; Univ Clin, Dept Pneumol, Leipzig, Germany; Ernst Moritz Arndt Univ Greifswald, Dept Pneumol & Infect Dis, Greisswald, Germany; Univ Hamburg, Klinikum Eppendorf, Bereich Pneumol, Med Kerklin & Poliklin, Hamburg, Germany; Freeman Rd Hosp, Newcastle Upon Tyne, Tyne & Wear, England; Gasthuisberg Univ Clin, Dept Pneumol, Louvain, Belgium; Hosp 12 Octubre, Pulm Hypertens Unit, E-28041 Madrid, Spain	University of Duisburg Essen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; University of Bologna; University of Sheffield; Universite Libre de Bruxelles; University of California System; University of California San Diego; University of Zurich; University Zurich Hospital; Hannover Medical School; University of Munich; Leipzig University; Ernst Moritz Arndt Universitat Greifswald; University of Hamburg; Newcastle Freeman Hospital; Newcastle University - UK; Hospital Universitario 12 de Octubre	Seeger, W (corresponding author), Univ Clin, Dept Internal Med 2, Klin Str 36, D-35392 Giessen, Germany.	werner.seeger@innere.med.uni-giessen.de	Ghofrani, Hossein Ardeschir/AAD-2856-2022; Ghofrani, Ardeschir/AAD-5293-2020; Galie, Nazzareno/F-7004-2014; Hoeper, Marius C/Z-1546-2019; Sitbon, Olivier/I-3623-2019; Olschewski, Horst/L-3547-2019	Ghofrani, Ardeschir/0000-0002-2029-4419; Galie, Nazzareno/0000-0003-4271-8670; Hoeper, Marius C/0000-0001-9086-2293; Sitbon, Olivier/0000-0002-1942-1951; Olschewski, Horst/0000-0002-2834-7466; Seeger, Werner/0000-0003-1946-0894				Badesch DB, 2000, ANN INTERN MED, V132, P425, DOI 10.7326/0003-4819-132-6-200003210-00002; Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504; BARST RJ, 1994, ANN INTERN MED, V121, P409, DOI 10.7326/0003-4819-121-6-199409150-00003; Beghetti M, 2001, Heart, V86, pE10, DOI 10.1136/heart.86.3.e10; Cueto E, 1997, ACTA PAEDIATR, V86, P1337, DOI 10.1111/j.1651-2227.1997.tb14909.x; Fitscha P, 1987, Adv Prostaglandin Thromboxane Leukot Res, V17A, P450; Galie N, 2002, J AM COLL CARDIOL, V39, P1496, DOI 10.1016/S0735-1097(02)01786-2; Gessler T, 2001, EUR RESPIR J, V17, P14, DOI 10.1183/09031936.01.17100140; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; Hoeper MM, 2000, J AM COLL CARDIOL, V35, P176, DOI 10.1016/S0735-1097(99)00494-5; Hoeper MM, 2000, NEW ENGL J MED, V342, P1866, DOI 10.1056/NEJM200006223422503; MAHLER DA, 1984, CHEST, V85, P751, DOI 10.1378/chest.85.6.751; MANTEL N, 1959, J NATL CANCER I, V22, P719; McLaughlin VV, 1998, NEW ENGL J MED, V338, P273, DOI 10.1056/NEJM199801293380501; MILLER OI, 1995, LANCET, V346, P51, DOI 10.1016/S0140-6736(95)92681-X; Olschewski H, 2000, ANN INTERN MED, V132, P435, DOI 10.7326/0003-4819-132-6-200003210-00003; Olschewski H, 1999, AM J RESP CRIT CARE, V160, P600, DOI 10.1164/ajrccm.160.2.9810008; Olschewski H, 1998, INTENS CARE MED, V24, P631, DOI 10.1007/s001340050628; Olschewski H, 1996, ANN INTERN MED, V124, P820, DOI 10.7326/0003-4819-124-9-199605010-00006; Olschewski Horst, 2000, Chest, V118, p136S; Rich S, 1998, PRIMARY PULMONARY HY; ROTH C, 1999, J AEROSOL MED, V12, P98; Rubin LJ, 2002, NEW ENGL J MED, V346, P1258; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Simonneau G, 2002, AM J RESP CRIT CARE, V165, P800, DOI 10.1164/ajrccm.165.6.2106079; Stricker H, 1999, SCHWEIZ MED WSCHR, V129, P923; Walmrath D, 1996, AM J RESP CRIT CARE, V153, P991, DOI 10.1164/ajrccm.153.3.8630585; WALMRATH D, 1995, AM J RESP CRIT CARE, V151, P724; WALMRATH D, 1993, LANCET, V342, P961, DOI 10.1016/0140-6736(93)92004-D; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Warren JB, 1996, LANCET, V348, P629, DOI 10.1016/S0140-6736(05)65068-4; Wensel R, 2000, CIRCULATION, V101, P2388, DOI 10.1161/01.CIR.101.20.2388; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Zwissler B, 1996, AM J RESP CRIT CARE, V154, P1671, DOI 10.1164/ajrccm.154.6.8970353	34	1238	1322	0	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2002	347	5					322	329		10.1056/NEJMoa020204	http://dx.doi.org/10.1056/NEJMoa020204			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587WC	12151469	Green Published			2022-12-28	WOS:000177665900004
J	Gray, JA; Roth, BL				Gray, JA; Roth, BL			Cell biology - A last GASP for GPCRs?	SCIENCE			English	Editorial Material							RECEPTOR; UBIQUITINATION		Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University	Gray, JA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.		Roth, Bryan/ABE-7032-2020; Roth, Bryan L/F-3928-2010	Roth, Bryan/0000-0002-0561-6520; 				Cong M, 2001, J BIOL CHEM, V276, P45145, DOI 10.1074/jbc.M106087200; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Kurten RC, 1996, SCIENCE, V272, P1008, DOI 10.1126/science.272.5264.1008; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Roth BL, 1998, DRUG ALCOHOL DEPEN, V51, P73, DOI 10.1016/S0376-8716(98)00067-2; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216; Wang YJ, 2002, MOL BIOL CELL, V13, P1965, DOI 10.1091/mbc.E01-11-0131; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308	10	25	25	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2002	297	5581					529	531		10.1126/science.1075453	http://dx.doi.org/10.1126/science.1075453			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142517				2022-12-28	WOS:000177054200029
J	Hammond, EM; Giaccia, AJ				Hammond, EM; Giaccia, AJ			Antiangiogenic therapy and p53	SCIENCE			English	Editorial Material							ANGIOGENESIS; CELLS		Stanford Univ, Dept Radiat Oncol, Ctr Clin Sci Res, Stanford, CA 94303 USA	Stanford University	Hammond, EM (corresponding author), Stanford Univ, Dept Radiat Oncol, Ctr Clin Sci Res, Stanford, CA 94303 USA.			Hammond, Ester/0000-0002-2335-3146				Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Denko NC, 2000, EXP CELL RES, V258, P82, DOI 10.1006/excr.2000.4928; Folkman J, 2001, SEMIN ONCOL, V28, P536, DOI 10.1053/sonc.2001.29543; Kerbel RS, 2001, CANCER METAST REV, V20, P79, DOI 10.1023/A:1013172910858; Ravi R, 2000, GENE DEV, V14, P34; Yu JL, 2002, SCIENCE, V295, P1526, DOI 10.1126/science.1068327	6	6	6	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2002	297	5581												1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142499				2022-12-28	WOS:000177054200001
J	Kolodner, RD; Putnam, CD; Myung, K				Kolodner, RD; Putnam, CD; Myung, K			Maintenance of genome stability in Saccharomyces cerevisiae	SCIENCE			English	Review							DOUBLE-STRAND-BREAK; DNA MISMATCH REPAIR; TELOMERE ELONGATION; CHROMOSOMAL REARRANGEMENTS; HOMOLOGOUS RECOMBINATION; REPLICATION CHECKPOINT; DAMAGE CHECKPOINTS; POLYMERASE-DELTA; PROTEIN COMPLEX; BUDDING YEAST	Most human cancer cells show signs of genome instability, ranging from elevated mutation rates to gross chromosomal rearrangements and alterations in chromosome number. Little is known about the molecular mechanisms that generate this instability or how it is suppressed in normal cells. Recent studies of the yeast Saccharomyces cerevisiae have begun to uncover the extensive and redundant pathways that keep the rate of genome rearrangements at very low levels. These studies, which we review here, have implicated more than 50 genes in the suppression of genome instability, including genes that function in S-phase checkpoints, recombination pathways, and telomere maintenance. Human homologs of several of these genes have well-established roles as tumor suppressors, consistent with the hypothesis that the mechanisms preserving genome stability in yeast are the same mechanisms that go awry in cancer.	Univ Calif San Diego, Sch Med, Ctr Canc, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Kolodner, RD (corresponding author), Univ Calif San Diego, Sch Med, Ctr Canc, Ludwig Inst Canc Res, CMME3058,9500 Gilman Dr, La Jolla, CA 92093 USA.			Putnam, Christopher/0000-0002-6145-1265				Abdel-Rahman WM, 2001, P NATL ACAD SCI USA, V98, P2538, DOI 10.1073/pnas.041603298; Bashkirov VI, 2000, MOL CELL BIOL, V20, P4393, DOI 10.1128/MCB.20.12.4393-4404.2000; Bayani J, 2001, CLIN GENET, V59, P65, DOI 10.1034/j.1399-0004.2001.590201.x; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Bosco G, 1998, GENETICS, V150, P1037; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Bressan DA, 1999, MOL CELL BIOL, V19, P7681; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chen C, 1998, MOL CELL, V2, P9, DOI 10.1016/S1097-2765(00)80109-4; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Chen QJ, 2001, MOL CELL BIOL, V21, P1819, DOI 10.1128/MCB.21.5.1819-1827.2001; Cromie GA, 2001, MOL CELL, V8, P1163, DOI 10.1016/S1097-2765(01)00419-1; Datta A, 1996, MOL CELL BIOL, V16, P1085; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Foiani M, 2000, MUTAT RES-FUND MOL M, V451, P187, DOI 10.1016/S0027-5107(00)00049-X; Frei C, 2000, GENE DEV, V14, P81; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; Gardner RD, 2000, TRENDS CELL BIOL, V10, P154, DOI 10.1016/S0962-8924(00)01727-X; Hackett JA, 2001, CELL, V106, P275, DOI 10.1016/S0092-8674(01)00457-3; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Hiraoka M, 2000, GENETICS, V156, P1531; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Huang ME, 2002, GENETICS, V160, P1409; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; JINKSROBERTSON S, 1986, GENETICS, V114, P731; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; KEIL RL, 1993, GENETICS, V135, P711; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Klein HL, 2001, GENETICS, V159, P1501; Kokoska RJ, 1998, MOL CELL BIOL, V18, P2779, DOI 10.1128/MCB.18.5.2779; Kolodner R, 1996, GENE DEV, V10, P1433, DOI 10.1101/gad.10.12.1433; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kraus E, 2001, P NATL ACAD SCI USA, V98, P8255, DOI 10.1073/pnas.151008198; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Le S, 1999, GENETICS, V152, P143; LEACH DRF, 1983, NATURE, V305, P448, DOI 10.1038/305448a0; Lee SK, 1999, SCIENCE, V286, P2339, DOI 10.1126/science.286.5448.2339; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; Lingner J, 1998, CURR OPIN GENET DEV, V8, P226, DOI 10.1016/S0959-437X(98)80145-7; Lobachev KS, 2000, EMBO J, V19, P3822, DOI 10.1093/emboj/19.14.3822; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Lopes J, 2002, EMBO J, V21, P3201, DOI 10.1093/emboj/cdf310; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lowndes NF, 2000, CURR OPIN GENET DEV, V10, P17, DOI 10.1016/S0959-437X(99)00050-7; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; MALLORY J, UNPUB; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Marians KJ, 2000, CURR OPIN GENET DEV, V10, P151, DOI 10.1016/S0959-437X(00)00059-9; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; McClintock B, 1939, P NATL ACAD SCI USA, V25, P405, DOI 10.1073/pnas.25.8.405; Merker RJ, 2002, MOL CELL BIOL, V22, P421, DOI 10.1128/MCB.22.2.421-429.2002; Michel B, 2000, TRENDS BIOCHEM SCI, V25, P173, DOI 10.1016/S0968-0004(00)01560-7; MIKUS MD, 1982, GENETICS, V101, P369; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Myung K, 2002, P NATL ACAD SCI USA, V99, P4500, DOI 10.1073/pnas.062702199; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Padilla-Nash HM, 1999, GENE CHROMOSOME CANC, V25, P53, DOI 10.1002/(SICI)1098-2264(199905)25:1<53::AID-GCC8>3.0.CO;2-T; Paulovich AG, 1997, CELL, V88, P315, DOI 10.1016/S0092-8674(00)81870-X; Paulovich AG, 1997, GENETICS, V145, P45; Rizki A, 2001, NATURE, V411, P713, DOI 10.1038/35079641; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Sattler M, 2001, INT J HEMATOL, V73, P278, DOI 10.1007/BF02981952; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; SHOEMAKER AC, UNPUB; Shore D, 1998, SCIENCE, V281, P1818, DOI 10.1126/science.281.5384.1818; Sia EA, 1997, MOL CELL BIOL, V17, P2851, DOI 10.1128/MCB.17.5.2851; Sidorova JM, 1997, GENE DEV, V11, P3032, DOI 10.1101/gad.11.22.3032; Signon L, 2001, MOL CELL BIOL, V21, P2048, DOI 10.1128/MCB.21.6.2048-2056.2001; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Stenger JE, 2001, GENOME RES, V11, P12, DOI 10.1101/gr.158801; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; SUGAWARA N, 1983, P NATL ACAD SCI-BIOL, V80, P5675, DOI 10.1073/pnas.80.18.5675; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; Teng SC, 1999, MOL CELL BIOL, V19, P8083; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; Tran HT, 1996, GENETICS, V143, P1579; Umezu K, 2002, GENETICS, V160, P97; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Vessey CJ, 2000, PROG NUCLEIC ACID RE, V63, P189, DOI 10.1016/S0079-6603(08)60723-0; Watanabe K, 2002, EUKARYOT CELL, V1, P200, DOI 10.1128/EC.1.2.200-212.2002; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; YU EE, 1996, SCIENCE, V272, P258; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhou JQ, 2000, SCIENCE, V289, P771, DOI 10.1126/science.289.5480.771; Zou H, 1997, CELL, V90, P87, DOI 10.1016/S0092-8674(00)80316-5	97	378	386	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2002	297	5581					552	557		10.1126/science.1075277	http://dx.doi.org/10.1126/science.1075277			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142524				2022-12-28	WOS:000177054200037
J	Mazzola, CA; Albright, AL; Sutton, LN; Tuite, GF; Hamilton, RL; Pollack, IF				Mazzola, CA; Albright, AL; Sutton, LN; Tuite, GF; Hamilton, RL; Pollack, IF			Dermoid inclusion cysts and early spinal cord tethering after fetal surgery for myelomeningocele	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IN-UTERO; REPAIR; BIFIDA		Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Neurosurg, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA; Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; Univ S Florida, Dept Neurosurg, St Petersburg, FL 33701 USA; Univ S Florida, All Childrens Hosp, St Petersburg, FL 33701 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Pollack, IF (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Neurosurg, 3705 5th Ave,Suite 3705,3rd Fl, Pittsburgh, PA 15213 USA.							Adzick NS, 1998, LANCET, V352, P1675, DOI 10.1016/S0140-6736(98)00070-1; Adzick NS, 1999, LANCET, V353, P407, DOI 10.1016/S0140-6736(05)74978-3; Adzick NS, 2000, NEW ENGL J MED, V342, P1726, DOI 10.1056/NEJM200006083422307; Bruner J. P., 1999, American Journal of Obstetrics and Gynecology, V180, pS31; Bruner JP, 1999, JAMA-J AM MED ASSOC, V282, P1819, DOI 10.1001/jama.282.19.1819; Bruner JP, 1999, AM J OBSTET GYNECOL, V180, P153, DOI 10.1016/S0002-9378(99)70167-5; COPP AJ, 1993, TRENDS NEUROSCI, V16, P381, DOI 10.1016/0166-2236(93)90001-3; Farmer Diana, 2001, American Journal of Obstetrics and Gynecology, V184, pS140; HERMAN JM, 1993, PEDIATR NEUROSURG, V19, P243, DOI 10.1159/000120739; Iskandar BJ, 1999, PRINCIPLES AND PRACTICE OF PEDIATRIC NEUROSURGERY, P165; Lary J M, 1996, MMWR CDC Surveill Summ, V45, P15; LORBER J, 1961, ARCH DIS CHILD, V36, P381, DOI 10.1136/adc.36.188.381; McLone D, 1985, CONCEPTS PEDIATR NEU, P97; MEULI M, 1995, NAT MED, V1, P342, DOI 10.1038/nm0495-342; Paek BW, 2000, AM J OBSTET GYNECOL, V183, P1119, DOI 10.1067/mob.2000.108867; SCOTT RM, 1986, J NEUROSURG, V65, P779, DOI 10.3171/jns.1986.65.6.0779; STEINBOK P, 1992, CHILD NERV SYST, V8, P92, DOI 10.1007/BF00298448; Sutton LN, 1999, JAMA-J AM MED ASSOC, V282, P1826, DOI 10.1001/jama.282.19.1826; Sutton LN, 2001, NEUROSURGERY, V48, P124; Tulipan N, 1998, PEDIATR NEUROSURG, V28, P177, DOI 10.1159/000028645	20	42	43	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 25	2002	347	4					256	259		10.1056/NEJMoa013325	http://dx.doi.org/10.1056/NEJMoa013325			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587WB	12140301	Bronze			2022-12-28	WOS:000177665800005
J	Aparicio, S; Chapman, J; Stupka, E; Putnam, N; Chia, J; Dehal, P; Christoffels, A; Rash, S; Hoon, S; Smit, A; Gelpke, MDS; Roach, J; Oh, T; Ho, IY; Wong, M; Detter, C; Verhoef, F; Predki, P; Tay, A; Lucas, S; Richardson, P; Smith, SF; Clark, MS; Edwards, YJK; Doggett, N; Zharkikh, A; Tavtigian, SV; Pruss, D; Barnstead, M; Evans, C; Baden, H; Powell, J; Glusman, G; Rowen, L; Hood, L; Tan, YH; Elgar, G; Hawkins, T; Venkatesh, B; Rokhsar, D; Brenner, S				Aparicio, S; Chapman, J; Stupka, E; Putnam, N; Chia, J; Dehal, P; Christoffels, A; Rash, S; Hoon, S; Smit, A; Gelpke, MDS; Roach, J; Oh, T; Ho, IY; Wong, M; Detter, C; Verhoef, F; Predki, P; Tay, A; Lucas, S; Richardson, P; Smith, SF; Clark, MS; Edwards, YJK; Doggett, N; Zharkikh, A; Tavtigian, SV; Pruss, D; Barnstead, M; Evans, C; Baden, H; Powell, J; Glusman, G; Rowen, L; Hood, L; Tan, YH; Elgar, G; Hawkins, T; Venkatesh, B; Rokhsar, D; Brenner, S			Whole-genome shotgun assembly and analysis of the genome of Fugu rubripes	SCIENCE			English	Article							RNA-BINDING PROTEIN; JAPANESE PUFFERFISH; VERTEBRATE GENOME; SEQUENCE-ANALYSIS; IMMUNOGLOBULIN SUPERFAMILY; REGULATORY SEQUENCE; COMPACT GENOME; HOX CLUSTERS; GENE; DNA	The compact genome of Fugu rubripes has been sequenced to over 95% coverage, and more than 80% of the assembly is in multigene-sized scaffolds. In this 365-megabase vertebrate genome, repetitive DNA accounts for less than one-sixth of the sequence, and gene loci occupy about one-third of the genome. As with the human genome, gene loci are not evenly distributed, but are clustered into sparse and dense regions. Some giant genes were observed that had average coding sequence sizes but were spread over genomic lengths significantly larger than those of their human orthologs. Although three-quarters of predicted human proteins have a strong match to Fugu, approximately a quarter of the human proteins had highly diverged from or had no pufferfish homologs, highlighting the extent of protein evolution in the 450 million years since teleosts and mammals diverged. Conserved linkages between Fugu and human genes indicate the preservation of chromosomal segments from the common vertebrate ancestor, but with considerable scrambling of gene order.	Univ Cambridge, Dept Oncol, Hutchison MRC Res Ctr, Cambridge CB2 2XZ, England; Inst Mol & Cell Biol, Singapore 117609, Singapore; US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; Inst Syst Biol, Seattle, WA 98103 USA; MRC UK HGMP Resource Ctr, Cambridge CB10 1SB, England; Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Myriad Genet Inc, Salt Lake City, UT 84108 USA; Celera Genom, Rockville, MD 20850 USA; Paradigm Therapeut Ltd, Physiol Lab, Cambridge CB2 3EG, England; Salk Inst Biol Studies, La Jolla, CA 92037 USA	University of Cambridge; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Institute for Systems Biology (ISB); United States Department of Energy (DOE); Los Alamos National Laboratory; Myriad Genetics, Inc; University of Cambridge; Salk Institute	Aparicio, S (corresponding author), Univ Cambridge, Dept Oncol, Hutchison MRC Res Ctr, Cambridge CB2 2XZ, England.	saa1000@cam.ac.uk; elia@fugu-sg.org; gelgar@hgmp.mrc.ac.uk; trevor.hawkins@am.amershambiosciences.com; mcbbv@imcb.nus.edu.sg; dsrokhsar@lbl.gov; sbrenner@salk.edu	Stupka, Elia/J-6279-2012; Hoon, Shawn/Q-2472-2016; Chia, Jer-Ming/C-9992-2012; Putnam, Nicholas/B-9968-2008; Christoffels, Alan/C-3269-2014; Clark, Melody S/D-7371-2014	Stupka, Elia/0000-0003-3154-4011; Hoon, Shawn/0000-0002-3892-3332; Putnam, Nicholas/0000-0002-1315-782X; Christoffels, Alan/0000-0002-0420-2916; Clark, Melody S/0000-0002-3442-3824; Edwards, Yvonne/0000-0001-8505-3168; Rokhsar, Daniel/0000-0002-8704-2224; Glusman, Gustavo/0000-0001-8060-5955; Wong-Erasmus, Marie/0000-0003-0066-6606; Aparicio, Samuel/0000-0002-0487-9599; Venkatesh, Byrappa/0000-0003-3620-0277; Elgar, Greg/0000-0001-7323-1596				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Aparicio S, 1998, NAT GENET, V18, P301, DOI 10.1038/ng0198-301; Aparicio S, 1997, NAT GENET, V16, P79, DOI 10.1038/ng0597-79; APARICIO S, 1995, P NATL ACAD SCI USA, V92, P1684, DOI 10.1073/pnas.92.5.1684; Attwood TK, 2000, NUCLEIC ACIDS RES, V28, P225, DOI 10.1093/nar/28.1.225; Bagheri-Fam S, 2001, GENOMICS, V78, P73, DOI 10.1006/geno.2001.6648; Bailey JA, 2002, AM J HUM GENET, V70, P83, DOI 10.1086/338458; Barton LM, 2001, P NATL ACAD SCI USA, V98, P6747, DOI 10.1073/pnas.101532998; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bateman A, 1996, PROTEIN SCI, V5, P1939, DOI 10.1002/pro.5560050923; BAXENDALE S, 1995, NAT GENET, V10, P67, DOI 10.1038/ng0595-67; Bernardi G, 2000, GENE, V241, P3, DOI 10.1016/S0378-1119(99)00485-0; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; BRENNER S, 1993, NATURE, V366, P265, DOI 10.1038/366265a0; Brenner S, 2002, P NATL ACAD SCI USA, V99, P2936, DOI 10.1073/pnas.032680599; Carvalho AB, 1999, NATURE, V401, P344, DOI 10.1038/43827; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Coutelle O, 1998, GENE, V208, P7, DOI 10.1016/S0378-1119(97)00614-8; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edwards YJK, 1998, J MOL BIOL, V278, P843, DOI 10.1006/jmbi.1998.1752; Elgar G, 1999, GENOME RES, V9, P960, DOI 10.1101/gr.9.10.960; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Fischer C, 2000, CYTOGENET CELL GENET, V88, P50, DOI 10.1159/000015484; Flint J, 2001, HUM MOL GENET, V10, P371, DOI 10.1093/hmg/10.4.371; Gellner K, 1999, GENOME RES, V9, P251; Glusman G, 2000, MAMM GENOME, V11, P1016, DOI 10.1007/s003350010196; GRONDEL JL, 1984, IMMUNOLOGY, V52, P477; Guigo R, 2000, GENOME RES, V10, P1631, DOI 10.1101/gr.122800; Hawke NA, 1999, IMMUNOGENETICS, V50, P124, DOI 10.1007/s002510050588; HINEGARD.R, 1968, AM NAT, V102, P517, DOI 10.1086/282564; Hirota Y, 1999, MECH DEVELOP, V87, P93, DOI 10.1016/S0925-4773(99)00143-4; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Kammandel B, 1999, DEV BIOL, V205, P79, DOI 10.1006/dbio.1998.9128; Kapitonov VV, 2001, P NATL ACAD SCI USA, V98, P8714, DOI 10.1073/pnas.151269298; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Kawasaki K, 1997, GENOME RES, V7, P250, DOI 10.1101/gr.7.3.250; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee EY, 2001, GENE, V274, P237, DOI 10.1016/S0378-1119(01)00600-X; Lefranc MP, 2001, NUCLEIC ACIDS RES, V29, P207, DOI 10.1093/nar/29.1.207; Lehane DB, 1999, GEN COMP ENDOCR, V114, P80, DOI 10.1006/gcen.1998.7237; LUNDIN LG, 1993, GENOMICS, V16, P1, DOI 10.1006/geno.1993.1133; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MARSHALL H, 1994, NATURE, V370, P567, DOI 10.1038/370567a0; Miller N, 1998, IMMUNOL REV, V166, P187, DOI 10.1111/j.1600-065X.1998.tb01263.x; Myers EW, 2002, P NATL ACAD SCI USA, V99, P4145, DOI 10.1073/pnas.092136699; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nadeau JH, 1998, MAMM GENOME, V9, P491, DOI 10.1007/s003359900806; NADEAU JH, 1984, P NATL ACAD SCI-BIOL, V81, P814, DOI 10.1073/pnas.81.3.814; Najakshin AM, 1999, EUR J IMMUNOL, V29, P375, DOI 10.1002/(SICI)1521-4141(199902)29:02<375::AID-IMMU375>3.3.CO;2-Y; NAKAMURA M, 1994, NEURON, V13, P67, DOI 10.1016/0896-6273(94)90460-X; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nonchev S, 1996, P NATL ACAD SCI USA, V93, P9339, DOI 10.1073/pnas.93.18.9339; Okabe M, 1997, DEV NEUROSCI-BASEL, V19, P9, DOI 10.1159/000111178; Okabe M, 2001, NATURE, V411, P94, DOI 10.1038/35075094; Peixoto BR, 2000, IMMUNOGENETICS, V51, P443, DOI 10.1007/s002510050643; Pfeffer PL, 2002, DEVELOPMENT, V129, P307; POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; ROACH JC, 1995, GENOMICS, V26, P345, DOI 10.1016/0888-7543(95)80219-C; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; Roest Crollius H, 2000, GENOME RES, V10, P939, DOI 10.1101/gr.10.7.939; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Rowitch DH, 1998, DEVELOPMENT, V125, P2735; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Sakakibara S, 1997, J NEUROSCI, V17, P8300; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Scordis P, 1999, BIOINFORMATICS, V15, P799, DOI 10.1093/bioinformatics/15.10.799; Shimoda N, 1996, BIOCHEM BIOPH RES CO, V220, P226, DOI 10.1006/bbrc.1996.0385; Shpaer EG, 1996, GENOMICS, V38, P179, DOI 10.1006/geno.1996.0614; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Smit AFA, 1996, P NATL ACAD SCI USA, V93, P1443, DOI 10.1073/pnas.93.4.1443; Smith SF, 2002, GENOME RES, V12, P776, DOI 10.1101/gr.221802; Stenvik J, 2000, IMMUNOGENETICS, V51, P452, DOI 10.1007/s002510050644; Teichmann SA, 2000, J MOL BIOL, V296, P1367, DOI 10.1006/jmbi.1999.3497; Trower MK, 1996, P NATL ACAD SCI USA, V93, P1366, DOI 10.1073/pnas.93.4.1366; Venkatesh B, 1999, P NATL ACAD SCI USA, V96, P10267, DOI 10.1073/pnas.96.18.10267; Venkatesh B, 1997, GENE, V187, P211, DOI 10.1016/S0378-1119(96)00750-0; Venkatesh B, 1997, P NATL ACAD SCI USA, V94, P12462, DOI 10.1073/pnas.94.23.12462; Venkatesh B, 1998, GENE, V211, P169, DOI 10.1016/S0378-1119(98)00096-1; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Volff JN, 1999, MOL BIOL EVOL, V16, P1427, DOI 10.1093/oxfordjournals.molbev.a026055; Volff JN, 2000, MOL BIOL EVOL, V17, P1673, DOI 10.1093/oxfordjournals.molbev.a026266; Wang K, 2001, IMMUNOGENETICS, V53, P31, DOI 10.1007/s002510100298; Wang W, 2000, MOL BIOL EVOL, V17, P1294, DOI 10.1093/oxfordjournals.molbev.a026413; WATERSTON RH, 2002, P NATL ACAD SCI USA, V5, P5; Weber JL, 1997, GENOME RES, V7, P401, DOI 10.1101/gr.7.5.401; Wentworth JM, 1999, GENE, V236, P315, DOI 10.1016/S0378-1119(99)00265-6; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wootton JC, 1996, METHOD ENZYMOL, V266, P554; Yoda A, 2000, GENES CELLS, V5, P885, DOI 10.1046/j.1365-2443.2000.00378.x; Yu WP, 2001, ONCOGENE, V20, P5554, DOI 10.1038/sj.onc.1204679	96	1199	1255	7	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2002	297	5585					1301	1310		10.1126/science.1072104	http://dx.doi.org/10.1126/science.1072104			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12142439				2022-12-28	WOS:000177573900034
J	Merritt, D; Ekers, RD				Merritt, D; Ekers, RD			Tracing black hole mergers through radio lobe morphology	SCIENCE			English	Article							GALAXY	Binary supermassive black holes are produced by galactic mergers as the black holes from the two galaxies fall to the center of the merged system and form a bound pair. The two black holes will eventually coalesce in an enormous burst of gravitational radiation. Here we show that the orientation of a black hole's spin axis would change dramatically even in a minor merger, leading to a sudden flip in the direction of any associated jet. We identify the winged or X-type radio sources with galaxies in which this has occurred. The inferred coalescence rate is similar to the overall galaxy merger rate, implying that of the order of one merger event per year could be detected by gravitational wave interferometers.	Rutgers State Univ, Dept Phys & Astron, New Brunswick, NJ 08903 USA; CSIRO, Australia Telescope Natl Facil, Epping, NSW 2121, Australia; Univ Calif Berkeley, Radio Astron Lab, Berkeley, CA 94720 USA	Rutgers State University New Brunswick; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of California System; University of California Berkeley	Merritt, D (corresponding author), Rutgers State Univ, Dept Phys & Astron, New Brunswick, NJ 08903 USA.	merritt@physics.rutgers.edu	Ekers, Ron/AAY-6012-2020	Ekers, Ron/0000-0002-3532-9928				AURIEMMA C, 1977, ASTRON ASTROPHYS, V57, P41; BAKER J, ASTROPH0202469; BARDEEN JM, 1970, NATURE, V226, P64, DOI 10.1038/226064a0; BARDEEN JM, 1975, ASTROPHYS J, V195, pL65, DOI 10.1086/181711; BEGELMAN MC, 1984, REV MOD PHYS, V56, P255, DOI 10.1103/RevModPhys.56.255; Bender PL, 2001, STUD HI ENER PHY COS, P115; Carlberg RG, 2000, ASTROPHYS J, V532, pL1, DOI 10.1086/312560; Dennett-Thorpe J, 1999, MON NOT R ASTRON SOC, V304, P271, DOI 10.1046/j.1365-8711.1999.02234.x; Dennett-Thorpe J, 2002, MON NOT R ASTRON SOC, V330, P609, DOI 10.1046/j.1365-8711.2002.05106.x; EKERS RD, 1978, NATURE, V276, P588, DOI 10.1038/276588a0; FANAROFF BL, 1974, MON NOT R ASTRON SOC, V167, pP31, DOI 10.1093/mnras/167.1.31P; Flanagan EE, 1998, PHYS REV D, V57, P4535, DOI 10.1103/PhysRevD.57.4535; Haehnelt MG, 1998, AIP CONF PROC, V456, P45, DOI 10.1063/1.57420; HECKMAN TM, 1986, ASTROPHYS J, V311, P526, DOI 10.1086/164793; KIDDER LE, 1993, PHYS REV D, V47, P3281, DOI 10.1103/PhysRevD.47.3281; KLEIN U, 1995, ASTRON ASTROPHYS, V303, P427; LEAHY JP, 1984, MON NOT R ASTRON SOC, V210, P929, DOI 10.1093/mnras/210.4.929; LEAHY JP, 1992, EXTRAGALACTIC RADIO SOURCES - FROM BEAMS TO JETS, P307; Merritt D, 2000, ASTR SOC P, V197, P221; Merritt D, 2001, ASTROPHYS J, V551, pL41, DOI 10.1086/319845; Merritt D, 2001, MON NOT R ASTRON SOC, V320, pL30, DOI 10.1046/j.1365-8711.2001.04165.x; Milosavljevic M, 2001, ASTROPHYS J, V563, P34, DOI 10.1086/323830; Murgia M, 2001, ASTRON ASTROPHYS, V380, P102, DOI 10.1051/0004-6361:20011436; MURGIA M, 2000, THESIS U BOLOGNA; ODEA CP, 1985, ASTRON J, V90, P954, DOI 10.1086/113802; Pringle JE, 1996, MON NOT R ASTRON SOC, V281, P357, DOI 10.1093/mnras/281.1.357; REES MJ, 1978, NATURE, V275, P516, DOI 10.1038/275516a0; WILSON AS, 1995, ASTROPHYS J, V438, P62, DOI 10.1086/175054	28	221	222	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2002	297	5585					1310	1313		10.1126/science.1074688	http://dx.doi.org/10.1126/science.1074688			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12154199	Green Submitted			2022-12-28	WOS:000177573900035
J	Crump, JA; Sulka, AC; Langer, AJ; Schaben, C; Crielly, AS; Gage, R; Baysinger, M; Moll, M; Withers, G; Toney, DM; Hunter, SB; Hoekstra, RM; Wong, SK; Griffin, PM; Van Gilder, TJ				Crump, JA; Sulka, AC; Langer, AJ; Schaben, C; Crielly, AS; Gage, R; Baysinger, M; Moll, M; Withers, G; Toney, DM; Hunter, SB; Hoekstra, RM; Wong, SK; Griffin, PM; Van Gilder, TJ			An outbreak of Escherichia coli O157 : H7 infections among visitors to a dairy farm	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEMOLYTIC-UREMIC SYNDROME; UNITED-STATES; CATTLE; ENVIRONMENT; FAMILIES	Background Outbreaks of Escherichia coli O157: H7 infections have involved direct transmission from animals and their environment to humans. We describe an outbreak among visitors to a Pennsylvania dairy and petting farm that provides public access to animals. Methods We conducted both a case-control study among visitors to a farm to identify risk factors for infection and a household survey to determine the rates of diarrheal illness among these visitors. We performed an extensive environmental study to identify sources of E. coli O157:117 on the farm. Results Fifty-one patients with confirmed or suspected E. coli O157:H7 infection were enrolled in the case-control study. The median age of the patients was four years, and the hemolytic-uremic syndrome developed in eight. Contact with calves and their environment was associated with an increased risk of infection, whereas hand washing was protective. The household survey indicated that visitors to the farm during the outbreak had higher than expected rates of diarrhea. Environmental studies showed that 28 of the 216 cattle on the farm (13 percent) were colonized with E. coli O157:H7 that had the same distinct pattern on pulsed-field gel electrophoresis that was found in isolates from the patients. This organism was also recovered from surfaces that were accessible to the public. Conclusions In a large outbreak of E. coli O157:H7 infections among visitors to a dairy farm, predominantly children, high rates of carriage of E. coli O157: H7 among calves and young cattle most likely resulted in contamination of both the animals' hides and the environment.	CDCP, Foodborne & Diarrheal Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; CDCP, Epidem Intelligence Serv, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA 30333 USA; CDCP, Biostat & Informat Management Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Montgomery Cty Hlth Dept, Norristown, PA USA; Penn Dept Hlth, Harrisburg, PA 17108 USA; Penn Dept Hlth, Bur Labs, Lionville, PA USA; Virginia Dept Consolidated Lab Serv, Richmond, VA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Crump, JA (corresponding author), CDCP, Foodborne & Diarrheal Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, MS A-38,1600 Clifton Rd, Atlanta, GA 30333 USA.		Crump, John A./AAZ-6412-2020; Langer, Adam Justin/P-1188-2019	Crump, John A./0000-0002-4529-102X; Langer, Adam Justin/0000-0001-5980-3359; Hoekstra, Robert Michael/0000-0002-0340-8015				BOYCE TG, 1995, NEW ENGL J MED, V333, P364, DOI 10.1056/NEJM199508103330608; *CDCP, 2000, STAND MOL SUBT FOODB; *CDCP, 1997, FOODB DIS ACT SURV N; *CDCP, 1999, FOODB DIS ACT SURV N; Chapman PA, 1997, EPIDEMIOL INFECT, V119, P245, DOI 10.1017/S0950268897007826; Hancock D., 1998, ESCHERICHIA COLI, V157, P85, DOI [10.3168/jds.S0022-0302(05)73131-3., DOI 10.3168/JDS.S0022-0302(05)73131-3]; Hancock DD, 1998, PREV VET MED, V35, P11, DOI 10.1016/S0167-5877(98)00050-6; Hancock DD, 1997, J FOOD PROTECT, V60, P462, DOI 10.4315/0362-028X-60.5.462; Hancock DD, 1997, EPIDEMIOL INFECT, V118, P193, DOI 10.1017/S0950268896007212; KASSENBORG H, 1998, INT C EM INF DIS ATL; Kernland KH, 1997, SCHWEIZ MED WSCHR, V127, P1229; MARTIN ML, 1986, LANCET, V2, P1043; Maule A, 2000, J APPL MICROBIOL, V88, p71S, DOI 10.1111/j.1365-2672.2000.tb05334.x; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Milne L M, 1999, Commun Dis Public Health, V2, P22; O'Brien SJ, 2001, EMERG INFECT DIS, V7, P1049, DOI 10.3201/eid0706.010626; OLSVIK O, 1991, MOL CELL PROBE, V5, P429, DOI 10.1016/S0890-8508(05)80014-3; PARRY SM, 1995, LANCET, V346, P572, DOI 10.1016/S0140-6736(95)91407-2; Rahn K, 1997, EPIDEMIOL INFECT, V119, P251, DOI 10.1017/S0950268897007929; Rahn K, 1998, J INFECT DIS, V177, P1139, DOI 10.1086/517394; Randall L P, 1999, Vet Rec, V145, P500; Reymond D, 1996, J CLIN MICROBIOL, V34, P2053, DOI 10.1128/JCM.34.9.2053-2057.1996; Shukla R, 1995, Commun Dis Rep CDR Rev, V5, pR86; Swaminathan B, 2001, EMERG INFECT DIS, V7, P382; Trevena W B, 1999, Commun Dis Public Health, V2, P263; Warshawsky Bryna, 2002, Can J Infect Dis, V13, P175; Wilson JB, 1996, J INFECT DIS, V174, P1021, DOI 10.1093/infdis/174.5.1021; 2001, MMWR MORB MORTAL WKL, V50, P293	28	123	139	0	7	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 22	2002	347	8					555	560		10.1056/NEJMoa020524	http://dx.doi.org/10.1056/NEJMoa020524			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587ZR	12192014				2022-12-28	WOS:000177675400003
J	Williams, BAP; Hirt, RP; Lucocq, JM; Embley, TM				Williams, BAP; Hirt, RP; Lucocq, JM; Embley, TM			A mitochondrial remnant in the microsporidian Trachipleistophora hominis	NATURE			English	Article							PARASITE ENTAMOEBA-HISTOLYTICA; MOLECULAR EVIDENCE; NOSEMA-LOCUSTAE; GENE; EUKARYOTES; EVOLUTION; SEQUENCE; GENOME; HSP70; FUNGI	Microsporidia are obligate intracellular parasites of several eukaryotes. They have a highly complex and unique infection apparatus but otherwise appear structurally simple(1). Microsporidia are thought to lack typical eukaryotic organelles, such as mitochondria and peroxisomes. This has been interpreted as support for the hypothesis that these peculiar eukaryotes diverged before the mitochondrial endosymbiosis, which would make them one of the earliest offshoots in eukaryotic evolution(2,3). But microsporidial nuclear genes that encode orthologues of typical mitochondrial heatshock Hsp70 proteins have been detected, which provides evidence for secondary loss of the organelle or endosymbiont(4-6). In addition, gene trees and more sophisticated phylogenetic analyses have recovered microsporidia as the relatives of fungi, rather than as basal eukaryotes(7-9). Here we show that a highly specific antibody raised against a Trachipleistophora hominis Hsp70 protein detects the presence, under light and electron microscopy, of numerous tiny (similar to50 x 90 nm) organelles with double membranes in this human microsporidial parasite. The finding of relictual mitochondria in microsporidia provides further evidence of the reluctance of eukaryotes to lose the mitochondrial organelle, even when its canonical function of aerobic respiration has been apparently lost.	Nat Hist Museum, Dept Zool, London SW7 5BD, England; Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland	Natural History Museum London; University of Dundee	Embley, TM (corresponding author), Nat Hist Museum, Dept Zool, Cromwell Rd, London SW7 5BD, England.		Hirt, Robert/R-5429-2017	Hirt, Robert/0000-0002-3760-9958; Embley, Thomas Martin/0000-0002-1484-340X; lucocq, john/0000-0002-5191-0093; Williams, Bryony/0000-0003-1123-2176				Akhmanova A, 1998, NATURE, V396, P527, DOI 10.1038/25023; Arisue N, 2002, PARASITOL INT, V51, P9, DOI 10.1016/S1383-5769(01)00093-9; BUCHBERGER A, 1997, GUIDEBOOK MOL CHAPER, P22; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Canning E.U., 1990, P53; CAVALIERSMITH T, 1987, NATURE, V326, P332, DOI 10.1038/326332a0; Cheney SA, 2001, PARASITE, V8, P91, DOI 10.1051/parasite/2001082091; Dyall SD, 2000, CURR OPIN MICROBIOL, V3, P404, DOI 10.1016/S1369-5274(00)00112-0; Fast NM, 2001, MOL BIOCHEM PARASIT, V117, P201, DOI 10.1016/S0166-6851(01)00356-5; Germot A, 1997, MOL BIOCHEM PARASIT, V87, P159, DOI 10.1016/S0166-6851(97)00064-9; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; Hirt RP, 1997, CURR BIOL, V7, P995, DOI 10.1016/S0960-9822(06)00420-9; Hollister WS, 1996, PARASITOLOGY, V112, P143, DOI 10.1017/S0031182000065185; Huynen MA, 2001, HUM MOL GENET, V10, P2463, DOI 10.1093/hmg/10.21.2463; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Keeling PJ, 2000, MOL BIOL EVOL, V17, P23, DOI 10.1093/oxfordjournals.molbev.a026235; Lill R, 2000, TRENDS BIOCHEM SCI, V25, P352, DOI 10.1016/S0968-0004(00)01589-9; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; Mai ZM, 1999, MOL CELL BIOL, V19, P2198; Peyretaillade E, 1998, MOL BIOL EVOL, V15, P683, DOI 10.1093/oxfordjournals.molbev.a025971; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Roger AJ, 1998, P NATL ACAD SCI USA, V95, P229, DOI 10.1073/pnas.95.1.229; Tovar J, 1999, MOL MICROBIOL, V32, P1013, DOI 10.1046/j.1365-2958.1999.01414.x; Van de Peer Y, 2000, GENE, V246, P1, DOI 10.1016/S0378-1119(00)00063-9; van der Giezen M, 2002, EMBO J, V21, P572, DOI 10.1093/emboj/21.4.572; Vavra Jiri, 1999, P7; VOSSBRINCK CR, 1987, NATURE, V326, P411, DOI 10.1038/326411a0; WILBANKS S, 1997, GUIDEBOOK MOL CHAPER, P13; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	29	295	325	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2002	418	6900					865	869		10.1038/nature00949	http://dx.doi.org/10.1038/nature00949			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192407				2022-12-28	WOS:000177555600035
J	Annane, D; Sebille, V; Charpentier, C; Bollaert, PE; Francois, B; Korach, JM; Capellier, G; Cohen, Y; Azoulay, E; Troche, G; Chaumet-Riffaut, P; Bellissant, E				Annane, D; Sebille, V; Charpentier, C; Bollaert, PE; Francois, B; Korach, JM; Capellier, G; Cohen, Y; Azoulay, E; Troche, G; Chaumet-Riffaut, P; Bellissant, E			Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORTISOL RESPONSE; ACUTE PHYSIOLOGY; SEVERE SEPSIS; DOUBLE-BLIND; METHYLPREDNISOLONE; CLASSIFICATION; SENSITIVITY; ENDOTOXIN; THERAPY	Context Septic shock maybe associated with relative adrenal insufficiency. Thus, a replacement therapy of low doses of corticosteroids has been proposed to treat septic shock. Objective To assess whether low doses of corticosteroids improve 28-day survival in patients with septic shock and relative adrenal insufficiency. Design and Setting Placebo-controlled, randomized, double-blind, parallel-group trial performed in 19 intensive care units in France from October 9, 1995, to February 23, 1999. Patients Three hundred adult patients who fulfilled usual criteria for septic shock were enrolled after undergoing a short corticotropin test. Intervention Patients were randomly assigned to receive either hydrocortisone (50-mg intravenous bolus every 6 hours) and fludrocortisone (50-mug tablet once daily) (n=151) or matching placebos (n=149) for 7 days. Main Outcome Measure Twenty-eight-day survival distribution in patients with relative adrenal insufficiency (nonresponders to the corticotropin test). Results One patient from the corticosteroid group was excluded from analyses because of consent withdrawal. There Were 229 nonresponders to the corticotropin test (placebo, 115; corticosteroids, 114) and 70 responders to the corticotropin test (placebo, 34; corticosteroids, 36). In nonresponders, there were 73 deaths (63%) in the placebo group and 60 deaths (53%) in the corticosteroid group (hazard ratio, 0.67; 95% confidence interval, 0.47-0.95; P=.02). Vasopressor therapy was withdrawn within 28 days in 46 patients (40%) in the placebo group and in 65 patients (57%) in the corticosteroid group (hazard ratio, 1.91; 95% confidence interval, 1.29-2.84; P=.001). There was no significant difference between groups in responders. Adverse events rates were similar in the 2 groups. Conclusion In our trial, a 7-day treatment with low doses of hydrocortisone and fludrocortisone significantly reduced the risk of death in patients with septic shock and relative adrenal insufficiency without increasing adverse events.	Univ Paris 05, Fac Med Paris Ouest, Hop Raymond Poincare, Serv Reanimat Med, F-92380 Garches, France; Univ Rennes 1, Hop Pontchaillou, Unite Pharmacol Clin, Serv Pharmacol, Rennes, France; Hop Cent, Serv Reanimat Chirurg, Nancy, France; Hop Cent, Serv Reanimat Med, Nancy, France; Hop Dupuytren, Serv Reanimat Polyvalente, Limoges, France; Ctr Hosp, Serv Reanimat Polyvalente, Chalons Sur Marne, France; Hop Jean Minjoz, Serv Reanimat Med, F-25030 Besancon, France; Hop Avicenne, Serv Reanimat Medicochirurg, F-93009 Bobigny, France; Hop St Louis, Serv Reanimat Med, Paris, France; Hop St Louis, Assistance Publ Hop Paris, Delegat Rech Clin, Paris, France; Hop Antoine Beclere, Serv Reanimat Chirurg, Clamart, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Rennes; Universite de Rennes; CHU de Nancy; CHU de Nancy; CHU Limoges; Universite de Franche-Comte; CHU Besancon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP	Annane, D (corresponding author), Univ Paris 05, Fac Med Paris Ouest, Hop Raymond Poincare, Serv Reanimat Med, 104 Blvd Raymond Poincare, F-92380 Garches, France.	djillali.annane@rpc.ap-hop-paris-fr	Sebille, Veronique/I-3309-2015; Annane, Djillali/R-7947-2019; François, Bruno/O-8404-2016	François, Bruno/0000-0002-2531-1652; Sebille, Veronique/0000-0002-0780-7742; Troche, Gilles/0000-0002-8150-6630				Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 1998, BRIT J CLIN PHARMACO, V46, P589; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; BARBER AE, 1993, J IMMUNOL, V150, P1999; Bellissant E, 2000, CLIN PHARMACOL THER, V68, P293, DOI 10.1067/mcp.2000.109354; Bhagat K, 1996, CIRCULATION, V94, P490, DOI 10.1161/01.CIR.94.3.490; Bollaert PE, 1998, CRIT CARE MED, V26, P645, DOI 10.1097/00003246-199804000-00010; BONE RC, 1987, NEW ENGL J MED, V317, P653, DOI 10.1056/NEJM198709103171101; BRIEGEL J, 1994, CLIN INVESTIGATOR, V72, P782; Briegel J, 1999, CRIT CARE MED, V27, P723, DOI 10.1097/00003246-199904000-00025; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; COX DR, 1972, J R STAT SOC B, V34, P187; CRONIN L, 1995, CRIT CARE MED, V23, P1430, DOI 10.1097/00003246-199508000-00019; FINDLING JW, 1987, J CLIN ENDOCR METAB, V64, P592, DOI 10.1210/jcem-64-3-592; KEH D, 1999, CRIT CARE, V3, P51; KLASTERSKY J, 1971, NEW ENGL J MED, V284, P1248, DOI 10.1056/NEJM197106032842206; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; Lamberts SWJ, 1997, NEW ENGL J MED, V337, P1285, DOI 10.1056/NEJM199710303371807; LEFERING R, 1995, CRIT CARE MED, V23, P1294, DOI 10.1097/00003246-199507000-00021; LeGall JR, 1996, JAMA-J AM MED ASSOC, V276, P802, DOI 10.1001/jama.276.10.802; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LUCAS CE, 1984, ARCH SURG-CHICAGO, V119, P537; LUCE JM, 1988, AM REV RESPIR DIS, V138, P62, DOI 10.1164/ajrccm/138.1.62; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; MCKEE JI, 1983, LANCET, V1, P484; MEDURI GU, 1999, SEPSIS, V3, P21, DOI DOI 10.1023/A:1009870524359; MOLIJN GJ, 1995, J CLIN ENDOCR METAB, V80, P1799, DOI 10.1210/jc.80.6.1799; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Oelkers W, 1996, NEW ENGL J MED, V335, P1206, DOI 10.1056/NEJM199610173351607; PEDUZZI P, 1987, NEW ENGL J MED, V317, P659; Quinkler M, 2001, EUR J ENDOCRINOL, V144, P87, DOI 10.1530/eje.0.1440087; ROTHWELL PM, 1991, LANCET, V337, P582, DOI 10.1016/0140-6736(91)91641-7; Sapin R, 1998, CLIN CHEM LAB MED, V36, P855, DOI 10.1515/CCLM.1998.150; SPRUNG CL, 1984, NEW ENGL J MED, V311, P1137, DOI 10.1056/NEJM198411013111801; Wheeler AP, 1999, NEW ENGL J MED, V340, P207, DOI 10.1056/NEJM199901213400307; Zeni F, 1997, CRIT CARE MED, V25, P1095, DOI 10.1097/00003246-199707000-00001; ZIPSER RD, 1981, J CLIN ENDOCR METAB, V53, P867, DOI 10.1210/jcem-53-4-867	38	2008	2145	3	53	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2002	288	7					862	871		10.1001/jama.288.7.862	http://dx.doi.org/10.1001/jama.288.7.862			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585FC	12186604	Bronze			2022-12-28	WOS:000177513100029
J	Ahlert, J; Shepard, E; Lomovskaya, N; Zazopoulos, E; Staffa, A; Bachmann, BO; Huang, KX; Fonstein, L; Czisny, A; Whitwam, RE; Farnet, CM; Thorson, JS				Ahlert, J; Shepard, E; Lomovskaya, N; Zazopoulos, E; Staffa, A; Bachmann, BO; Huang, KX; Fonstein, L; Czisny, A; Whitwam, RE; Farnet, CM; Thorson, JS			The calicheamicin gene cluster and its iterative type I enediyne PKS	SCIENCE			English	Article							FATTY-ACIDS; BIOSYNTHESIS; DNA; CHEMISTRY; CLONING	The enediynes exemplify nature's ingenuity. We have cloned and characterized the biosynthetic locus coding for perhaps the most notorious member of the nonchromoprotein enediyne family, calicheamicin. This gene cluster contains an unusual polyketide synthase (PKS) that is demonstrated to be essential for enediyne biosynthesis. Comparison of the calicheamicin locus with the locus encoding the chromoprotein enediyne C-1027 reveals that the enediyne PKS is highly conserved among these distinct enediyne families. Contrary to previous hypotheses, this suggests that the chromoprotein and nonchromoprotein enediynes are generated by similar biosynthetic pathways.	Ecopia Biosci Inc, Montreal, PQ H4S 2A1, Canada; Univ Wisconsin, Sch Pharm, Pharmaceut Sci Div, Lab Biosynthet Chem, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Farnet, CM (corresponding author), Ecopia Biosci Inc, 7290 Frederick Banting, Montreal, PQ H4S 2A1, Canada.	farnet@ecopiabio.com; jthorson@pharmacy.wisc.edu	Farnet, Chris/ABE-5463-2021; Thorson, Jon S/L-3696-2013	Thorson, Jon S/0000-0002-7148-0721; Bachmann, Brian/0000-0001-5815-1176; Farnet, Chris/0000-0003-4927-198X	NCI NIH HHS [CA08748, CA84374] Funding Source: Medline; NIGMS NIH HHS [GM58196] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA084374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058196] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHLERT J, UNPUB; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Biggins JB, 2000, P NATL ACAD SCI USA, V97, P13537, DOI 10.1073/pnas.240460997; BIGGINS JB, UNPUB; Danishefsky SJ, 1996, J ORG CHEM, V61, P16, DOI 10.1021/jo951560x; Decker H, 1996, FEMS MICROBIOL LETT, V141, P195, DOI 10.1016/0378-1097(96)00221-2; DEVOSS JJ, 1990, J AM CHEM SOC, V112, P4554, DOI 10.1021/ja00167a069; FANTINI AA, 1995, ENEDIYNE ANTIBIOTICS, P39; GREENSTEIN M, 1986, ANTIMICROB AGENTS CH, V29, P861, DOI 10.1128/AAC.29.5.861; HENSENS OD, 1989, J AM CHEM SOC, V111, P3295, DOI 10.1021/ja00191a028; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; LAM KS, 1993, J AM CHEM SOC, V115, P12340, DOI 10.1021/ja00079a014; Liu W, 2002, SCIENCE, V297, P1170, DOI 10.1126/science.1072110; LOVE SF, 1992, APPL ENVIRON MICROB, V58, P1376, DOI 10.1128/AEM.58.4.1376-1378.1992; Metz JG, 2001, SCIENCE, V293, P290, DOI 10.1126/science.1059593; Morita N, 2000, BIOCHEM SOC T, V28, P943, DOI 10.1042/BST0280943; MYERS AG, 1994, J AM CHEM SOC, V116, P1255, DOI 10.1021/ja00083a012; Sievers EL, 2001, CURR OPIN ONCOL, V13, P522, DOI 10.1097/00001622-200111000-00016; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Takeyama H, 1997, MICROBIOL-UK, V143, P2725, DOI 10.1099/00221287-143-8-2725; Thorson JS, 2000, CURR PHARM DESIGN, V6, P1841, DOI 10.2174/1381612003398564; Watanabe CMH, 2002, CHEM BIOL, V9, P245, DOI 10.1016/S1074-5521(02)00103-5; Weitnauer G, 2001, CHEM BIOL, V8, P569, DOI 10.1016/S1074-5521(01)00040-0; Whitwam RE, 2000, J AM CHEM SOC, V122, P1556, DOI 10.1021/ja993612w; ZEIN N, 1988, SCIENCE, V240, P1198, DOI 10.1126/science.3240341	25	233	251	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2002	297	5584					1173	1176		10.1126/science.1072105	http://dx.doi.org/10.1126/science.1072105			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183629				2022-12-28	WOS:000177447600048
J	Park, JO; Tsuru, T; Kodaira, S; Cummins, PR; Kaneda, Y				Park, JO; Tsuru, T; Kodaira, S; Cummins, PR; Kaneda, Y			Splay fault branching along the Nankai subduction zone	SCIENCE			English	Article							SOUTHWEST JAPAN; EARTHQUAKE; THRUST; SLIP; PALEOSEISMICITY; TECTONICS; MIGRATION; TROUGH	Seismic reflection profiles reveal steeply landward dipping splay faults in the rupture area of the magnitude ( M) 8.1 Tonankai earthquake in the Nankai subduction zone. These splay faults branch upward from the plate-boundary interface ( that is, the subduction zone) at a depth of similar to10 kilometers, similar to50 to 55 kilometers landward of the trough axis, breaking through the upper crustal plate. Slip on the active splay fault may be an important mechanism that accommodates the elastic strain caused by relative plate motion.	Japan Marine Sci & Technol Ctr, Inst Frontier Res Earth Evolut, Yokosuka, Kanagawa 2370061, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Park, JO (corresponding author), Japan Marine Sci & Technol Ctr, Inst Frontier Res Earth Evolut, Yokosuka, Kanagawa 2370061, Japan.	jopark@jamstec.go.jp	Tsuru, Tetsuro/K-4382-2016; Kodaira, Shuichi/G-8746-2016	Kodaira, Shuichi/0000-0002-5774-2561; Cummins, Phil/0000-0001-8826-3021				ANDO M, 1975, TECTONOPHYSICS, V27, P119, DOI 10.1016/0040-1951(75)90102-X; ASADA A, 1998, P JPN SOC MARINE SUR, V10, P15; ASHI J, 2001, ESO S, V82; BERRYMAN KR, 1989, TECTONOPHYSICS, V163, P185, DOI 10.1016/0040-1951(89)90256-4; CLARKE SH, 1992, SCIENCE, V255, P188, DOI 10.1126/science.255.5041.188; Cummins PR, 2001, EARTH PLANETS SPACE, V53, P243, DOI 10.1186/BF03352381; FUKAO Y, 1979, J GEOPHYS RES, V84, P2303, DOI 10.1029/JB084iB05p02303; Hattori M., 2002, JAMSTEC J DEEP SEA R, V20, P37; HYNDMAN RD, 1995, J GEOPHYS RES-SOL EA, V100, P15373, DOI 10.1029/95JB00153; IGARASHI G, 1995, SCIENCE, V269, P60, DOI 10.1126/science.269.5220.60; KATO T, 1983, TECTONOPHYSICS, V96, P31, DOI 10.1016/0040-1951(83)90242-1; KIKUCHI M, 2001, SEISMO, V7, P6; LIU ZY, 1995, GEOPHYSICS, V60, P142, DOI 10.1190/1.1443741; Moore G., 1993, P OCEAN DRILLING PRO, P73; Moore JC, 2001, GEOLOGY, V29, P183, DOI 10.1130/0091-7613(2001)029<0183:ULOTSZ>2.0.CO;2; NAKANISHI A, 2002, J GEOPHYS RES, V107; Park JO, 2000, GEOPHYS RES LETT, V27, P1033, DOI 10.1029/1999GL008443; PLAFKER G, 1972, J GEOPHYS RES, V77, P901, DOI 10.1029/JB077i005p00901; SENO T, 1993, J GEOPHYS RES-SOL EA, V98, P17941, DOI 10.1029/93JB00782; SHIPLEY TH, 1994, GEOLOGY, V22, P411, DOI 10.1130/0091-7613(1994)022<0411:SIDDNB>2.3.CO;2; SUGIYAMA Y, 1994, GEOFIS INT, V33, P53; Tanioka Y, 2001, GEOPHYS RES LETT, V28, P1075, DOI 10.1029/2000GL012284; TICHELAAR BW, 1993, J GEOPHYS RES-SOL EA, V98, P2017, DOI 10.1029/92JB02045; VROLIJK P, 1990, GEOLOGY, V18, P703, DOI 10.1130/0091-7613(1990)018<0703:OTMROS>2.3.CO;2	24	406	414	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2002	297	5584					1157	1160		10.1126/science.1074111	http://dx.doi.org/10.1126/science.1074111			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183623				2022-12-28	WOS:000177447600042
J	Jellinek, AM; Manga, M				Jellinek, AM; Manga, M			The influence of a chemical boundary layer on the fixity, spacing and lifetime of mantle plumes	NATURE			English	Article							THERMAL-CONVECTION; BASE; HOTSPOTS; D''	Seismological observations provide evidence that the lowermost mantle contains superposed thermal and compositional boundary layers(1) that are laterally heterogeneous(2,3). Whereas the thermal boundary layer forms as a consequence of the heat flux from the Earth's outer core, the origin of an (intrinsically dense) chemical boundary layer remains uncertain(4). Observed zones of 'ultra-low' seismic velocity(5) suggest that this dense layer may contain metals(6,7) or partial melt(8,) and thus it is reasonable to expect the dense layer to have a relatively low viscosity. Also, it is thought that instabilities in the thermal boundary layer could lead to the intermittent formation and rise of mantle plumes. Flow into ascending plumes can deform the dense layer, leading, in turn, to its gradual entrainment(9-14). Here we use analogue experiments to show that the presence of a dense layer at the bottom of the mantle induces lateral variations in temperature and viscosity that, in turn, determine the location and dynamics of mantle plumes. A dense layer causes mantle plumes to become spatially fixed, and the entrainment of low-viscosity fluid enables plumes to persist within the Earth for hundreds of millions of years.	Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Jellinek, AM (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.		Manga, Michael/D-3847-2013	Manga, Michael/0000-0003-3286-4682				Brandon AD, 1998, SCIENCE, V280, P1570, DOI 10.1126/science.280.5369.1570; Castle JC, 2000, J GEOPHYS RES-SOL EA, V105, P21543, DOI 10.1029/2000JB900193; Davaille A, 1999, NATURE, V402, P756, DOI 10.1038/45461; Davaille A, 1999, J FLUID MECH, V379, P223, DOI 10.1017/S0022112098003322; Farnetani CG, 1997, GEOPHYS RES LETT, V24, P1583, DOI 10.1029/97GL01548; Garnero EJ, 2000, ANNU REV EARTH PL SC, V28, P509, DOI 10.1146/annurev.earth.28.1.509; GONNERMANN HM, 2002, GEOPHYS RES LETT, V29, DOI DOI 10.1029/2002GL014851; GURNIS M, 1998, MONOGRAPH AM GEOPHYS, V28; Jellinek A.M., 2002, GEOPHYS RES LETT, V29; KNITTLE E, 1991, SCIENCE, V251, P1438, DOI 10.1126/science.251.5000.1438; Lay T, 1998, NATURE, V392, P461, DOI 10.1038/33083; LISTER JR, 1989, J FLUID MECH, V202, P577, DOI 10.1017/S0022112089001308; Manga M, 1999, PHYS FLUIDS, V11, P2969, DOI 10.1063/1.870156; MARTIN D, 1988, J GEOPHYS RES-SOLID, V93, P7974, DOI 10.1029/JB093iB07p07974; Montague NL, 2000, J GEOPHYS RES-SOL EA, V105, P11101, DOI 10.1029/1999JB900450; NATAF HC, 1991, TECTONOPHYSICS, V187, P361, DOI 10.1016/0040-1951(91)90475-8; NEAVEL KE, 1991, TECTONOPHYSICS, V200, P1, DOI 10.1016/0040-1951(91)90002-A; OLSON P, 1993, J GEOPHYS RES-SOL EA, V98, P6829, DOI 10.1029/92JB01013; OLSON P, 1991, J GEOPHYS RES-SOLID, V96, P4347, DOI 10.1029/90JB02530; Schaeffer N, 2001, GEOPHYS RES LETT, V28, P455, DOI 10.1029/2000GL012215; SLEEP NH, 1988, GEOPHYS J INT, V95, P437, DOI 10.1111/j.1365-246X.1988.tb06695.x; SLEEP NH, 1992, J GEOPHYS RES-SOL EA, V97, P20007, DOI 10.1029/92JB01468; SPARROW EM, 1970, J FLUID MECH, V41, P793, DOI 10.1017/S0022112070000927; Steinberger B, 1998, GEOPHYS J INT, V132, P412, DOI 10.1046/j.1365-246x.1998.00447.x; TACKLEY PJ, 2002, GEOCHEM GEOPHY GEOSY, V3, pU1; Turner J. S., 1973, BUOYANCY EFFECTS FLU; vanKeken PE, 1997, J GEOPHYS RES-SOL EA, V102, P22477, DOI 10.1029/97JB01353; Williams Q, 1996, SCIENCE, V273, P1528, DOI 10.1126/science.273.5281.1528; Wysession ME, 1996, NATURE, V382, P244, DOI 10.1038/382244a0	29	127	128	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 15	2002	418	6899					760	763		10.1038/nature00979	http://dx.doi.org/10.1038/nature00979			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181562				2022-12-28	WOS:000177428000034
J	Lindskog, M; Svenningsson, P; Pozzi, L; Kim, Y; Fienberg, AA; Bibb, JA; Fredholm, BB; Nairn, AC; Greengard, P; Fisone, G				Lindskog, M; Svenningsson, P; Pozzi, L; Kim, Y; Fienberg, AA; Bibb, JA; Fredholm, BB; Nairn, AC; Greengard, P; Fisone, G			Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine	NATURE			English	Article							ADENOSINE A(2A) RECEPTORS; RAT STRIATUM; REGULATED PHOSPHOPROTEIN; GENE-EXPRESSION; DOPAMINE; NEURONS; CLONING; BRAIN; MICE	Caffeine has been imbibed since ancient times in tea and coffee, and more recently in colas. Caffeine owes its psychostimulant action to a blockade of adenosine A(2A) receptors(1), but little is known about its intracellular mechanism of action. Here we show that the stimulatory effect of caffeine on motor activity in mice was greatly reduced following genetic deletion of DARPP-32 (dopamine- and cyclic AMP-regulated phosphoprotein of relative molecular mass 32,000)(2). Results virtually identical to those seen with caffeine were obtained with the selective A(2A) antagonist SCH 58261. The depressant effect of the A(2A) receptor agonist, CGS 21680, on motor activity was also greatly attenuated in DARPP-32 knockout mice. In support of a role for DARPP-32 in the action of caffeine, we found that, in striata of intact mice, caffeine increased the state of phosphorylation of DARPP-32 at Thr 75. Caffeine increased Thr 75 phosphorylation through inhibition of PP-2A-catalysed dephosphorylation, rather than through stimulation of cyclin-dependent kinase 5 (Cdk5)-catalysed phosphorylation, of this residue. Together, these studies demonstrate the involvement of DARPP-32 and its phosphorylation/dephosphorylation in the stimulant action of caffeine.	Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden	Karolinska Institutet; Rockefeller University; Karolinska Institutet	Fisone, G (corresponding author), Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden.	gilberto.fisone@neuro.ki.se	Lindskog, Maria/F-1729-2011; Svenningsson, Per JL/K-5210-2014; Pozzi, Laura/F-8687-2011	Lindskog, Maria/0000-0002-4178-2825; Pozzi, Laura/0000-0001-7662-2904; Kim, Yong/0000-0002-1387-2962; Fisone, Gilberto/0000-0002-0719-8000; Nairn, Angus/0000-0002-7075-0195	NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER; NIDA NIH HHS [P01 DA010044] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; EHRLICH ME, 1990, J MOL NEUROSCI, V2, P1, DOI 10.1007/BF02896920; El Yacoubi M, 2000, BRIT J PHARMACOL, V129, P1465, DOI 10.1038/sj.bjp.0703170; Fienberg AA, 1998, SCIENCE, V281, P838, DOI 10.1126/science.281.5378.838; FINK JS, 1992, MOL BRAIN RES, V14, P186, DOI 10.1016/0169-328X(92)90173-9; Fredholm BB, 1999, PHARMACOL REV, V51, P83; FREDHOLM BB, 1977, MED BIOL, V55, P262; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; HEMMINGS HC, 1986, J NEUROSCI, V6, P1469; Kafka SH, 1996, EUR J PHARMACOL, V295, P147, DOI 10.1016/0014-2999(95)00668-0; Kull B, 2000, MOL PHARMACOL, V58, P771, DOI 10.1124/mol.58.4.771; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; LEMOINE C, 1995, J COMP NEUROL, V355, P418, DOI 10.1002/cne.903550308; Liu L, 1998, J IRON STEEL RES INT, V5, P1; Nishi A, 2000, P NATL ACAD SCI USA, V97, P12840, DOI 10.1073/pnas.220410397; Nishi A, 1999, J NEUROCHEM, V72, P2015, DOI 10.1046/j.1471-4159.1999.0722015.x; OGREN SO, 1979, DOPAMINERGIC ERGOT D, P225; Ongini E, 1997, DRUG DEVELOP RES, V42, P63; Ouimet CC, 1998, BRAIN RES, V808, P8, DOI 10.1016/S0006-8993(98)00724-0; Rimondini R, 1998, EUR J PHARMACOL, V347, P153, DOI 10.1016/S0014-2999(98)00107-1; SCHIFFMANN SN, 1993, J NEUROSCI, V13, P1080; SNYDER SH, 1981, P NATL ACAD SCI-BIOL, V78, P3260, DOI 10.1073/pnas.78.5.3260; Svenningsson P, 2000, P NATL ACAD SCI USA, V97, P1856, DOI 10.1073/pnas.97.4.1856; Svenningsson P, 2000, J NEUROCHEM, V75, P248, DOI 10.1046/j.1471-4159.2000.0750248.x; WALAAS SI, 1983, NATURE, V301, P69	25	131	135	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2002	418	6899					774	778		10.1038/nature00817	http://dx.doi.org/10.1038/nature00817			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181566				2022-12-28	WOS:000177428000038
J	Schofield, L; Hewitt, MC; Evans, K; Siomos, MA; Seeberger, PH				Schofield, L; Hewitt, MC; Evans, K; Siomos, MA; Seeberger, PH			Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria	NATURE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; VASCULAR ENDOTHELIAL-CELLS; TUMOR-NECROSIS-FACTOR; PROTEIN-KINASE-C; GLYCOSYLPHOSPHATIDYLINOSITOL TOXIN; PLASMODIUM-FALCIPARUM; INTRAERYTHROCYTIC STAGE; MONOCLONAL-ANTIBODY; SIGNAL-TRANSDUCTION; CEREBRAL MALARIA	The malaria parasite Plasmodium falciparum infects 5-10% of the world's population and kills two million people annually(1). Fatalities are thought to result in part from pathological reactions initiated by a malarial toxin. Glycosylphosphatidylinositol (GPI) originating from the parasite has the properties predicted of a toxin(2-6); however, a requirement for toxins in general and GPI in particular in malarial pathogenesis and fatality remains unproven. As anti-toxic vaccines can be highly effective public health tools, we sought to determine whether anti-GPI vaccination could prevent pathology and fatalities in the Plasmodium berghei/rodent model of severe malaria. The P. falciparum GPI glycan of the sequence NH2-CH2-CH2-PO4-( Manalpha1-2) 6Manalpha1-2Manalpha1-6Manalpha1-4GlcNH(2)alpha1-6myo-inositol- 1,2-cyclic-phosphate was chemically synthesized, conjugated to carriers, and used to immunize mice. Recipients were substantially protected against malarial acidosis, pulmonary oedema, cerebral syndrome and fatality. Anti-GPI antibodies neutralized pro-inflammatory activity by P. falciparum in vitro. Thus, we show that GPI is a significant pro-inflammatory endotoxin of parasitic origin, and that several disease parameters in malarious mice are toxin-dependent. GPI may contribute to pathogenesis and fatalities in humans. Synthetic GPI is therefore a prototype carbohydrate anti-toxic vaccine against malaria.	Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; MIT, Dept Chem, Cambridge, MA 02139 USA	Royal Melbourne Hospital; Walter & Eliza Hall Institute; Massachusetts Institute of Technology (MIT)	Schofield, L (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	schofield@wehi.edu.au; seeberg@mit.edu						Almeida IC, 2000, EMBO J, V19, P1476, DOI 10.1093/emboj/19.7.1476; Berhe S, 1999, MOL BIOCHEM PARASIT, V103, P273, DOI 10.1016/S0166-6851(99)00125-5; Chang WL, 2001, INFECT IMMUN, V69, P7341, DOI 10.1128/IAI.69.12.7341-7348.2001; CHRISTOPHERS S. R., 1924, Indian Journal of Medical Research, V12, P273; de Souza JB, 2002, MICROBES INFECT, V4, P291, DOI 10.1016/S1286-4579(02)01541-1; DIECKMANNSCHUPPERT A, 1992, EUR J BIOCHEM, V205, P815, DOI 10.1111/j.1432-1033.1992.tb16846.x; DIECKMANNSCHUPPERT A, 1993, EUR J BIOCHEM, V216, P779, DOI 10.1111/j.1432-1033.1993.tb18198.x; GEROLD P, 1994, J BIOL CHEM, V269, P2597; Golgi C, 1886, ARCHIVO SCI MEDICHE, V10, P109; Gowda DC, 1997, J BIOL CHEM, V272, P6428, DOI 10.1074/jbc.272.10.6428; GRAU GE, 1991, EUR J IMMUNOL, V21, P2265, DOI 10.1002/eji.1830210939; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; GRAU GE, 1989, P NATL ACAD SCI USA, V86, P5572, DOI 10.1073/pnas.86.14.5572; GRAU GE, 1987, SCIENCE, V237, P1210, DOI 10.1126/science.3306918; Jennings VM, 1997, INFECT IMMUN, V65, P4883, DOI 10.1128/IAI.65.11.4883-4887.1997; Magez S, 1998, J IMMUNOL, V160, P1949; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; MCGREGOR IA, 1956, BRIT MED J, V2, P686, DOI 10.1136/bmj.2.4994.686; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Naik RS, 2000, J EXP MED, V192, P1563, DOI 10.1084/jem.192.11.1563; SCHOFIELD F, 1986, REV INFECT DIS, V8, P144; Schofield L, 1996, J IMMUNOL, V156, P1886; SCHOFIELD L, 1993, J EXP MED, V177, P145, DOI 10.1084/jem.177.1.145; SINTON J. A., 1939, JOUR MALARIA INST INDIA, V2, P71; TACHADO SD, 1994, BIOCHEM BIOPH RES CO, V205, P984, DOI 10.1006/bbrc.1994.2763; Tachado SD, 1996, J IMMUNOL, V156, P1897; Tachado SD, 1997, P NATL ACAD SCI USA, V94, P4022, DOI 10.1073/pnas.94.8.4022; TURNER GDH, 1994, AM J PATHOL, V145, P1057; WHITE NJ, 1992, ADV PARASIT, V31, P83, DOI 10.1016/S0065-308X(08)60021-4; *WHO, 1992, WORLD HLTH STAT Q, V45, P257	30	377	400	0	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2002	418	6899					785	789		10.1038/nature00937	http://dx.doi.org/10.1038/nature00937			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181569				2022-12-28	WOS:000177428000041
J	Zhu, M; Yu, XB				Zhu, M; Yu, XB			A primitive fish close to the common ancestor of tetrapods and lungfish	NATURE			English	Article							PSAROLEPIS; AUSTRALIA	The relationship of the three living groups of sarcopterygians or lobe-finned fish (tetrapods, lungfish and coelacanths) has been a matter of debate(1-5). Although opinions still differ, most recent phylogenies suggest that tetrapods are more closely related to lungfish than to coelacanths(6-10). However, no previously known fossil taxon exhibits a concrete character combination approximating the condition expected in the last common ancestor of tetrapods and lungfish-and it is still poorly understood how early sarcopterygians diverged into the tetrapod lineage (Tetrapodomorpha)(7) and the lungfish lineage (Dipnomorpha)(7). Here we describe a fossil sarcopterygian fish, Styloichthys changae gen. et sp. nov., that possesses an eyestalk and which exhibits the character combination expected in a stem group close to the last common ancestor of tetrapods and lungfish. Styloichthys from the Lower Devonian of China bridges the morphological gap between stem-group sarcopterygians (Psarolepis and Achoania)(10) and basal tetrapodomorphs/basal dipnomorphs. It provides information that will help in the study of the relationship of early sarcopterygians, and which will also help to resolve the tetrapod-lungfish divergence into a documented sequence of character acquisition.	Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Kean Univ, Dept Biol Sci, Union, NJ 07083 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Zhu, M (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.	zhumin@ht.rol.cn.net	Zhu, Min/E-8728-2012; Yu, Xiaobo/G-7160-2011; min, zhu/AAL-6712-2021	Zhu, Min/0000-0002-4786-0898; Yu, Xiaobo/0000-0001-9600-7888; 				Ahlberg PE, 1998, NATURE, V395, P792, DOI 10.1038/27421; AHLBERG PE, 1991, ZOOL J LINN SOC-LOND, V103, P241, DOI 10.1111/j.1096-3642.1991.tb00905.x; Basden AM, 2000, NATURE, V403, P185, DOI 10.1038/35003183; Basden AM, 2001, J VERTEBR PALEONTOL, V21, P754, DOI 10.1671/0272-4634(2001)021[0754:APANFT]2.0.CO;2; CHAN V, 1993, PEDIATR PULM, V15, P183, DOI 10.1002/ppul.1950150310; Chang M.-M., 1982, THESIS STOCKHOLM U; Chang Mee-Mann, 1997, American Museum Novitates, V3189, P1; CHANG MM, 1991, VERTEBRATES RELATED, P355; Cloutier Richard, 1996, P227; Husken T.-C., 1997, Acta Universitatis Carolinae Geologica, V40, P445, DOI 10.1016/B978-012670950-6/50018-7; Forey P.L., 1998, HIST COELACANTH FISH; Fox Richard C., 1995, Memoirs of the Queensland Museum, V38, P97; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; Janvier P., 1996, EARLY VERTEBRATES; JESSEN H L, 1980, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V167, P180; Johanson Z, 1998, NATURE, V394, P569, DOI 10.1038/29058; Long J.A., 1989, Journal of Vertebrate Paleontology, V9, P1; Long JA, 2001, J VERTEBR PALEONTOL, V21, P815, DOI 10.1671/0272-4634(2001)021[0815:OTROPA]2.0.CO;2; MAISEY J G, 1986, Cladistics, V2, P201, DOI 10.1111/j.1096-0031.1986.tb00462.x; MEYER A, 1995, TRENDS ECOL EVOL, V35, P93; ROSEN D E, 1981, Bulletin of the American Museum of Natural History, V167, P159; SCHULTZE HP, 1994, SYST BIOL, V43, P155, DOI 10.2307/2413459; SCHULTZE HP, 1987, J MORPH S, V1, P39; Swofford D., 1998, PAUP PHYLOGENETIC AN; Yu XB, 1998, J VERTEBR PALEONTOL, V18, P261, DOI 10.1080/02724634.1998.10011055; Zardoya R, 1998, MOL BIOL EVOL, V15, P506, DOI 10.1093/oxfordjournals.molbev.a025950; Zhu M, 2001, SYST ASSOC SPEC VOL, V61, P289; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594; Zhu M, 2001, NATURE, V410, P81, DOI 10.1038/35065078; [No title captured]	30	96	110	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2002	418	6899					767	770		10.1038/nature00871	http://dx.doi.org/10.1038/nature00871			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181564				2022-12-28	WOS:000177428000036
J	Crawford, LM				Crawford, LM			Proposed reporting guidance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Crawford, LM (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2002	288	6					688	688		10.1001/jama.288.6.688	http://dx.doi.org/10.1001/jama.288.6.688			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	583KY	12169049				2022-12-28	WOS:000177408100007
J	Roter, DL; Hall, JA; Aoki, Y				Roter, DL; Hall, JA; Aoki, Y			Physician gender effects in medical communication - A meta-analytic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEX-DIFFERENCES; HEALTH-CARE; PSYCHOSOCIAL PERFORMANCE; PATIENT COMMUNICATION; BEHAVIOR; STYLE; CONSULTATIONS; INTERVIEW; VISITS; WOMEN	Context Physician gender has been viewed as a possible source of variation in the interpersonal aspects of medical practice, with speculation that female physicians facilitate more open and equal exchange and a different therapeutic milieu from that of male physicians. However, studies in this area are generally based on small samples, with conflicting results. Objective To systematically review and quantify the effect of physician gender on communication during medical visits. Data Sources On line database searches of English-language abstracts for the years 1967 to 2001 (MEDLINE, AIDSLINE, PsycINFO, and Bioethics); a hand search was conducted of reprint files and the reference sections of review articles and other publications. Study Selection Studies using a communication data source, such as audiotape, videotape, or direct observation, and large national or regional studies in which physician report was used to establish length of visit, were identified through bibliographic and computerized searches. Twenty-three observational studies and 3 large physician-report studies reported in 29 publications met inclusion criteria and were rated. Data Extraction The Cohen d was computed based on 2 reviewers' (J.A.H. and Y.A.) independent extraction of quantitative information from the publications. Study heterogeneity was tested using Q statistics and pooled effect sizes were computed using the appropriate effects model. The characteristics of the study populations were also extracted. Data Synthesis Female physicians engage in significantly more active partnership behaviors, positive talk, psychosocial counseling, psychosocial question asking, and emotionally focused talk. There were no gender differences evident in the amount, quality, or manner of biomedical information giving or social conversation. Medical visits with female physicians are, on average, 2 minutes (10%) longer than those with male physicians. Obstetrics and gynecology may present a different pattern than that of primary care, with male physicians demonstrating higher levels of emotionally focused talk than their female colleagues. Conclusions Female primary care physicians engage in more communication that can be considered patient centered and have longer visits than their male colleagues. Limited studies exist outside of primary care, and gender-related practice patterns in some subspecialties may differ from those evident in primary care.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; Northeastern Univ, Dept Psychol, Boston, MA 02115 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Northeastern University	Roter, DL (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 624 N Broadway, Baltimore, MD 21205 USA.	droter@jhsph.edu	Roter, Debra L/N-8830-2014					Aries E, 1996, MEN WOMEN INTERACTIO; BENSING JM, 1993, MED CARE, V31, P219, DOI 10.1097/00005650-199303000-00004; Bernzweig J, 1997, ARCH PEDIAT ADOL MED, V151, P586, DOI 10.1001/archpedi.1997.02170430052011; BERTAKIS KD, 1995, MED CARE, V33, P407, DOI 10.1097/00005650-199504000-00007; Carr-Hill R, 1998, J Health Serv Res Policy, V3, P207; CHARON R, 1994, EMPATHIC PRACTITIONE, P205; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; COLLIVER JA, 1993, ACAD MED, V68, P153, DOI 10.1097/00001888-199302000-00013; CYPRESS BK, 1980, VITAL HLTH STAT 13, V13, P12; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; DINDIA K, 1992, PSYCHOL BULL, V112, P106, DOI 10.1037/0033-2909.112.1.106; EAGLY AH, 1990, PSYCHOL BULL, V108, P233, DOI 10.1037/0033-2909.108.2.233; ELSTAD JI, 1994, WOMEN HEALTH, V21, P1, DOI 10.1300/J013v21n04_01; Hall J A, 1998, J Gend Specif Med, V1, P39; Hall J. A., 1984, NONVERBAL SEX DIFFER; HALL JA, 1988, MED CARE, V26, P657, DOI 10.1097/00005650-198807000-00002; HALL JA, 1994, HEALTH PSYCHOL, V13, P384, DOI 10.1037/0278-6133.13.5.384; Hall JA, 1995, EVAL HEALTH PROF, V18, P393, DOI 10.1177/016327879501800404; HALL JA, IN PRESS PATIENT ED; HARRIGAN JA, 1989, SOC SCI MED, V28, P87, DOI 10.1016/0277-9536(89)90310-9; Henderson JT, 2001, MED CARE, V39, P1281, DOI 10.1097/00005650-200112000-00004; Huston S, 2001, J WOMEN HEALTH GEN-B, V10, P279, DOI 10.1089/152460901300140031; IRISH JT, 1995, SOC SCI MED, V41, P873, DOI 10.1016/0277-9536(94)00399-E; JARSKI RW, 1985, J MED EDUC, V60, P545; JONAS H S, 1988, Journal of the American Medical Association, V260, P1063, DOI 10.1001/jama.260.8.1063; Klass Perri, 1987, NOT ENTIRELY BENIGN; KURTZ RA, 1991, SOCIOLOGY MED ILLNES; Labov W., 1977, STUDY NONSTANDARD EN; LAW SAT, 1995, BRIT J GEN PRACT, V45, P520; LIPKIN M, 1984, ANN INTERN MED, V100, P277, DOI 10.7326/0003-4819-100-2-277; LIPSEY MW, 1993, AM PSYCHOL, V48, P1181, DOI 10.1037/0003-066X.48.12.1181; Lurie N, 1997, J GEN INTERN MED, V12, P34; MARTEAU TM, 1991, MED EDUC, V25, P127, DOI 10.1111/j.1365-2923.1991.tb00038.x; Marvel MK, 1999, JAMA-J AM MED ASSOC, V281, P283, DOI 10.1001/jama.281.3.283; Mechanic D, 1996, MILBANK Q, V74, P171, DOI 10.2307/3350245; Mechanic D, 2001, NEW ENGL J MED, V344, P198, DOI 10.1056/NEJM200101183440307; Mechanic D., 1978, MED SOCIOLOGY; MEEUWESEN L, 1991, SOC SCI MED, V32, P1143, DOI 10.1016/0277-9536(91)90091-P; MENDEZ A, 1986, MED EDUC, V20, P437, DOI 10.1111/j.1365-2923.1986.tb01190.x; MEULEMAN JR, 1992, ARCH INTERN MED, V152, P1677, DOI 10.1001/archinte.152.8.1677; Meyer GJ, 2001, AM PSYCHOL, V56, P128, DOI 10.1037//0003-066X.56.2.128; Office of the Surgeon General, 2019, SURG GEN ADV MAR US; Pearse W H, 1994, Womens Health Issues, V4, P38, DOI 10.1016/S1049-3867(05)80108-2; Rosenthal R, 1991, METAANALYTIC PROCEDU; ROTER D, 1991, MED CARE, V29, P1083; Roter D, 2000, PATIENT EDUC COUNS, V39, P5, DOI 10.1016/S0738-3991(99)00086-5; Roter DL, 1999, OBSTET GYNECOL, V93, P635, DOI 10.1016/S0029-7844(98)00542-0; Roter DL, 1998, J WOMENS HEALTH, V7, P1093, DOI 10.1089/jwh.1998.7.1093; ROTER DL, 1988, PATIENT EDUC COUNS, V12, P99, DOI 10.1016/0738-3991(88)90057-2; Roter DL, 2001, MAYO CLIN PROC, V76, P673, DOI 10.4065/76.7.673; ROTER DL, 1995, ARCH INTERN MED, V155, P1877, DOI 10.1001/archinte.155.17.1877; SAUNDERS DG, 1993, J GEN INTERN MED, V8, P606, DOI 10.1007/BF02599714; SHAPIRO J, 1991, FAM PRACT, V8, P10, DOI 10.1093/fampra/8.1.10; SHAPIRO J, 1990, SOC SCI MED, V31, P1035, DOI 10.1016/0277-9536(90)90116-A; SHARP S, 1998, STAT TECHNICAL B REP, V7, P106; Skelton JR, 1999, BRIT MED J, V318, P576, DOI 10.1136/bmj.318.7183.576; Smith RC, 2000, PATIENT EDUC COUNS, V39, P27, DOI 10.1016/S0738-3991(99)00088-9; Stafford RS, 1999, ARCH FAM MED, V8, P26, DOI 10.1001/archfami.8.1.26; *STATA CORP, 1999, STATA STAT SOFTW; STEINGART RM, 1991, NEW ENGL J MED, V325, P226, DOI 10.1056/NEJM199107253250402; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; van den Brink-Muinen A, 1998, MED CARE, V36, P100, DOI 10.1097/00005650-199801000-00012; van Dulmen AM, 2000, WOMEN HEALTH, V30, P49, DOI 10.1300/J013v30n03_04; VANDENBRINKMUIN.A, 1996, GENDER HLTH HLTH CAR; VANDENBRINKMUINEN A, 1994, BRIT J GEN PRACT, V44, P205; VERBRUGGE LM, 1981, MED CARE, V19, P609, DOI 10.1097/00005650-198106000-00005; WASSERMAN RC, 1984, PEDIATRICS, V74, P1047; WEISMAN CS, 1989, PATIENT EDUC COUNS, V13, P183, DOI 10.1016/0738-3991(89)90060-8; WEST C, 1984, ROUTINE COMPLICATION, P51	69	767	777	2	54	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2002	288	6					756	764		10.1001/jama.288.6.756	http://dx.doi.org/10.1001/jama.288.6.756			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	583KY	12169083	Bronze			2022-12-28	WOS:000177408100040
J	Rappuoli, R; Miller, HI; Falkow, S				Rappuoli, R; Miller, HI; Falkow, S			Medicine - The intangible value of vaccination	SCIENCE			English	Editorial Material									Chiron SpA, IRIS, I-53100 Siena, Italy; Stanford Univ, Hoover Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Novartis; Stanford University; Stanford University	Rappuoli, R (corresponding author), Chiron SpA, IRIS, Via Fiorentina 1, I-53100 Siena, Italy.	rino_rappuoli@chiron.it						BARKSRUGGLES E, 2002, SAN FRANCISCO C 0106, pD6; Bloom DE, 2000, SCIENCE, V287, P1207, DOI 10.1126/science.287.5456.1207; Brugha R, 2002, LANCET, V359, P435, DOI 10.1016/S0140-6736(02)07607-9; *CDC, 2002, MMWR-MORBID MORTAL W, V51, P190; *CDC, 2002, MMWR-MORBID MORTAL W, V50, P1159; *CDC, 1999, OUNC PREV WHAT AR RE; *CDC, 2000, CALL SHOTS IMM FIN P, P1; CDC, 1999, MMWR MORB MORTAL WKL, V48, P243; *CDC, 2001, MMWR-MORBID MORTAL W, V50, P1144; *CDC, 2002, MMWR-MORBID MORTAL W, V51, P234; Fenner F., 1988, HIST INT PUBLIC HLTH; Greco M, 2001, VACCINE, V20, pS101, DOI 10.1016/S0264-410X(01)00293-6; Hotez PJ, 2001, EMBO REP, V2, P862, DOI 10.1093/embo-reports/kve215; Hull HF, 1997, SCIENCE, V275, P40, DOI 10.1126/science.275.5296.40; ORENSTEIN WA, 1999, VACCINES, P1024; SACHS J, 2002, SAN FRANCISCO C 0106, pD6; Stratton KR, 2000, VACC 21 CENT TOOL DE, P460; VISCUSI WK, 1996, ADV MED INNOVATION H	18	105	111	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 9	2002	297	5583					937	+		10.1126/science.1075173	http://dx.doi.org/10.1126/science.1075173			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169712				2022-12-28	WOS:000177325400018
J	Jackson, RB; Banner, JL; Jobbagy, EG; Pockman, WT; Wall, DH				Jackson, RB; Banner, JL; Jobbagy, EG; Pockman, WT; Wall, DH			Ecosystem carbon loss with woody plant invasion of grasslands	NATURE			English	Article							SOIL ORGANIC-CARBON; VEGETATION CHANGE; CLIMATE; RESPONSES; BUDGET	The invasion of woody vegetation into deserts, grasslands and savannas is generally thought to lead to an increase in the amount of carbon stored in those ecosystems. For this reason, shrub and forest expansion (for example, into grasslands) is also suggested to be a substantial, if uncertain, component of the terrestrial carbon sink(1-14). Here we investigate woody plant invasion along a precipitation gradient (200 to 1,100 mm yr(-1)) by comparing carbon and nitrogen budgets and soil delta(13)C profiles between six pairs of adjacent grasslands, in which one of each pair was invaded by woody species 30 to 100 years ago. We found a clear negative relationship between precipitation and changes in soil organic carbon and nitrogen content when grasslands were invaded by woody vegetation, with drier sites gaining, and wetter sites losing, soil organic carbon. Losses of soil organic carbon at the wetter sites were substantial enough to offset increases in plant biomass carbon, suggesting that current land-based assessments may overestimate carbon sinks. Assessments relying on carbon stored from woody plant invasions to balance emissions may therefore be incorrect.	Duke Univ, Dept Biol, Durham, NC 27708 USA; Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA; Univ Texas, Dept Geol Sci, Austin, TX 78712 USA; Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA	Duke University; Duke University; University of Texas System; University of Texas Austin; Colorado State University	Jackson, RB (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	jackson@duke.edu	Banner, Jay L/C-8676-2011; Wall, Diana H/F-5491-2011; Pockman, William T/D-4086-2014; Jobbágy, Esteban Gabriel/A-6293-2010	Pockman, William T/0000-0002-3286-0457; Jobbágy, Esteban Gabriel/0000-0002-4214-6011; Jackson, Robert/0000-0001-8846-7147				Allen CD, 1998, P NATL ACAD SCI USA, V95, P14839, DOI 10.1073/pnas.95.25.14839; Amundson R, 2001, ANNU REV EARTH PL SC, V29, P535, DOI 10.1146/annurev.earth.29.1.535; Archer S., 2001, GLOBAL BIOGEOCHEM CY, P115; Batjes NH, 2014, EUR J SOIL SCI, V65, P10, DOI 10.1111/ejss.12114_2; Boutton TW, 1998, GEODERMA, V82, P5, DOI 10.1016/S0016-7061(97)00095-5; Brown JH, 1997, P NATL ACAD SCI USA, V94, P9729, DOI 10.1073/pnas.94.18.9729; BURKE IC, 1989, SOIL SCI SOC AM J, V53, P800, DOI 10.2136/sssaj1989.03615995005300030029x; Casper BB, 1997, ANNU REV ECOL SYST, V28, P545, DOI 10.1146/annurev.ecolsys.28.1.545; Conant RT, 2001, ECOL APPL, V11, P343, DOI 10.1890/1051-0761(2001)011[0343:GMACIG]2.0.CO;2; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Gill RA, 2002, NATURE, V417, P279, DOI 10.1038/417279a; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Jackson RB, 2000, ECOL APPL, V10, P470, DOI 10.1890/1051-0761(2000)010[0470:BCOVCA]2.0.CO;2; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Neill C, 2000, ADV SOIL SCI-SER, P197; NEPSTAD DC, 1994, NATURE, V372, P666, DOI 10.1038/372666a0; Pacala SW, 2001, SCIENCE, V292, P2316, DOI 10.1126/science.1057320; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Tilman D, 2000, ECOLOGY, V81, P2680, DOI 10.1890/0012-9658(2000)081[2680:FSAECS]2.0.CO;2; Trumbore SE, 1997, P NATL ACAD SCI USA, V94, P8284, DOI 10.1073/pnas.94.16.8284; TUCKER CJ, 1991, SCIENCE, V253, P299, DOI 10.1126/science.253.5017.299; Turner B., 1990, EARTH TRANSFORMED HU; Van Auken OW, 2000, ANNU REV ECOL SYST, V31, P197, DOI 10.1146/annurev.ecolsys.31.1.197; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Vitousek PM, 1999, OECOLOGIA, V121, P255, DOI 10.1007/s004420050927; Wall DH, 2001, ECOL STU AN, V152, P47	30	727	794	12	415	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2002	418	6898					623	626		10.1038/nature00910	http://dx.doi.org/10.1038/nature00910			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167857				2022-12-28	WOS:000177305600038
J	Schnadt, J; Bruhwiler, PA; Patthey, L; O'Shea, JN; Sodergren, S; Odelius, M; Ahuja, R; Karis, O; Bassler, M; Persson, P; Siegbahn, H; Lunell, S; Martensson, N				Schnadt, J; Bruhwiler, PA; Patthey, L; O'Shea, JN; Sodergren, S; Odelius, M; Ahuja, R; Karis, O; Bassler, M; Persson, P; Siegbahn, H; Lunell, S; Martensson, N			Experimental evidence for sub-3-fs charge transfer from an aromatic adsorbate to a semiconductor	NATURE			English	Article							BI-ISONICOTINIC ACID; ELECTRON INJECTION; TRANSFER DYNAMICS; EXCITED-STATE; SURFACE; BINDING; DONOR; LIGHT; TIME	The ultrafast timescale of electron transfer processes is crucial to their role in many biological systems and technological devices. In dye-sensitized solar cells(1-4), the electron transfer from photoexcited dye molecules to nanostructured semiconductor substrates needs to be sufficiently fast to compete effectively against loss processes and thus achieve high solar energy conversion efficiencies(4). Time-resolved laser techniques indicate an upper limit of 20 to 100 femtoseconds(5-9) for the time needed to inject an electron from a dye into a semiconductor, which corresponds to the timescale on which competing processes such as charge redistribution(10,11) and intramolecular thermalization of excited states(12-14) occur. Here we use resonant photoemission spectroscopy, which has previously been used to monitor electron transfer in simple systems with an order-of-magnitude improvement in time resolution(15,16), to show that electron transfer from an aromatic adsorbate to a TiO2 semiconductor surface can occur in less than 3 fs. These results directly confirm that electronic coupling of the aromatic molecule to its substrate is sufficiently strong to suppress competing processes(17).	Uppsala Univ, Dept Phys, S-75121 Uppsala, Sweden; Uppsala Univ, Dept Chem Phys, S-75121 Uppsala, Sweden; Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; Lund Univ, MAX Lab, S-22100 Lund, Sweden	Uppsala University; Uppsala University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Lund University	Bruhwiler, PA (corresponding author), Uppsala Univ, Dept Phys, Box 530, S-75121 Uppsala, Sweden.	paul.bruhwiler@fysik.uu.se	O'Shea, James/B-5881-2016; Odelius, Michael/J-6142-2019; Odelius, Michael/A-7628-2014; Patthey, Luc/G-6130-2018; Persson, Petter/B-5135-2016	O'Shea, James/0000-0003-4687-7257; Odelius, Michael/0000-0002-7023-2486; Patthey, Luc/0000-0001-6101-8069; Persson, Petter/0000-0001-7600-3230; Karis, Olof/0000-0001-6406-217X; Ahuja, Rajeev/0000-0003-1231-9994; Schnadt, Joachim/0000-0001-9375-831X				Asbury JB, 2001, J PHYS CHEM B, V105, P4545, DOI 10.1021/jp003485m; Benko G, 2002, J AM CHEM SOC, V124, P489, DOI 10.1021/ja016561n; Blanchet V, 1999, NATURE, V401, P52, DOI 10.1038/43410; Bruhwiler PA, 2002, REV MOD PHYS, V74, P703, DOI 10.1103/RevModPhys.74.703; Chang EK, 2000, PHYS REV LETT, V85, P2613, DOI 10.1103/PhysRevLett.85.2613; CRONEMEYER DC, 1952, PHYS REV, V87, P876, DOI 10.1103/PhysRev.87.876; Damrauer NH, 1997, SCIENCE, V275, P54, DOI 10.1126/science.275.5296.54; Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607; Hagfeldt A, 2000, ACCOUNTS CHEM RES, V33, P269, DOI 10.1021/ar980112j; Hannappel T, 1997, J PHYS CHEM B, V101, P6799, DOI 10.1021/jp971581q; Haque SA, 2000, J PHYS CHEM B, V104, P538, DOI 10.1021/jp991085x; Heimer TA, 2000, J PHYS CHEM A, V104, P4256, DOI 10.1021/jp993438y; LANZAFAME JM, 1994, J PHYS CHEM-US, V98, P11020, DOI 10.1021/j100094a008; LU H, 1993, J AM CHEM SOC, V115, P4927, DOI 10.1021/ja00064a079; Miller R. J. D., 1995, SURFACE ELECT TRANSF; NAZEERUDDIN MK, 1993, J AM CHEM SOC, V115, P6382, DOI 10.1021/ja00067a063; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Patthey L, 1999, J CHEM PHYS, V110, P5913, DOI 10.1063/1.478491; Persson P, 2000, SOL ENERG MAT SOL C, V63, P139, DOI 10.1016/S0927-0248(99)00169-5; Persson P, 2000, J CHEM PHYS, V112, P3945, DOI 10.1063/1.480945; Petersson A, 2000, J PHYS CHEM B, V104, P8498, DOI 10.1021/jp001085t; Ramakrishna S, 2000, J PHYS CHEM B, V104, P68, DOI 10.1021/jp991428r; Rensmo H, 1999, J CHEM PHYS, V111, P2744, DOI 10.1063/1.479551; Sandell A, 1997, PHYS REV LETT, V78, P4994, DOI 10.1103/PhysRevLett.78.4994; Tachibana Y, 1996, J PHYS CHEM-US, V100, P20056, DOI 10.1021/jp962227f; Vlcek A, 2000, COORDIN CHEM REV, V200, P933, DOI 10.1016/S0010-8545(00)00308-8; Willig F, 2000, ELECTROCHIM ACTA, V45, P4565, DOI 10.1016/S0013-4686(00)00608-3; Wurth W, 2000, CHEM PHYS, V251, P141, DOI 10.1016/S0301-0104(99)00305-5; Yeh AT, 2000, SCIENCE, V289, P935, DOI 10.1126/science.289.5481.935	29	328	328	1	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2002	418	6898					620	623		10.1038/nature00952	http://dx.doi.org/10.1038/nature00952			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167856				2022-12-28	WOS:000177305600037
J	Butt, YM; Torres, DF; Romero, GE; Dame, TM; Combi, JA				Butt, YM; Torres, DF; Romero, GE; Dame, TM; Combi, JA			Astrophysics - Supernova-remnant origin of cosmic rays?	NATURE			English	Article									Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; Inst Argentino Radioastron, RA-1894 Buenos Aires, DF, Argentina	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Princeton University; Instituto Argentino de Radioastronomia	Butt, YM (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.		Torres, Diego F/ABD-7940-2020; Torres, Diego F./AAF-7931-2019; Torres, Diego F./O-9422-2016	Torres, Diego F./0000-0002-1522-9065; Torres, Diego F./0000-0002-1522-9065; Combi, Jorge Ariel/0000-0002-2565-5025				Butt YM, 2001, ASTROPHYS J, V562, pL167, DOI 10.1086/324592; Drury LO, 2001, SPACE SCI REV, V99, P329, DOI 10.1023/A:1013825905795; Enomoto R, 2002, NATURE, V416, P823, DOI 10.1038/416823a; Hartman RC, 1999, ASTROPHYS J SUPPL S, V123, P79, DOI 10.1086/313231; KOYAMA K, 1995, NATURE, V378, P255, DOI 10.1038/378255a0; POHL M, 1996, ASTRON ASTROPHYS, V307, P57; REIMER O, 2002, IN PRESS ASTRON ASTR; SHKLOVSKII IS, 1953, DOKL AKAD NAUK SSSR+, V91, P475; Slane P, 1999, ASTROPHYS J, V525, P357, DOI 10.1086/307893	9	36	36	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2002	418	6897					499	499		10.1038/418499a	http://dx.doi.org/10.1038/418499a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152068	Green Submitted, Bronze			2022-12-28	WOS:000177162800029
J	Ho, DD; Huang, YX				Ho, DD; Huang, YX			The HIV-1 vaccine race	CELL			English	Review							VIRAL DYNAMICS; INFECTION	There is an urgent need to come up with a vaccine that will curtail the spread of HIV-1. To be successful, the scientific community must work in concert to develop sound strategies based on a deeper understanding of the virus. Significant technological advances are also required to overcome the unique obstacles posed by HIV-1. Some of the challenges we face in this endeavor are discussed here.	Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA	Rockefeller University	Ho, DD (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 455 1st Ave, New York, NY 10016 USA.							Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Little SJ, 1999, J EXP MED, V190, P841, DOI 10.1084/jem.190.6.841; McMichael A, 2002, NAT REV IMMUNOL, V2, P283, DOI 10.1038/nri779; Nowak MA, 1997, J VIROL, V71, P7518, DOI 10.1128/JVI.71.10.7518-7525.1997; Poignard P, 2001, ANNU REV IMMUNOL, V19, P253, DOI 10.1146/annurev.immunol.19.1.253; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Stafford MA, 2000, J THEOR BIOL, V203, P285, DOI 10.1006/jtbi.2000.1076; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884	11	50	53	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 26	2002	110	2					135	138		10.1016/S0092-8674(02)00832-2	http://dx.doi.org/10.1016/S0092-8674(02)00832-2			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	578EV	12150921	Bronze			2022-12-28	WOS:000177105200001
J	Baek, SH; Ohgi, KA; Rose, DW; Koo, EH; Glass, CK; Rosenfeld, MG				Baek, SH; Ohgi, KA; Rose, DW; Koo, EH; Glass, CK; Rosenfeld, MG			Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappa B and beta-amyloid precursor protein	CELL			English	Article							NUCLEAR RECEPTOR-COREPRESSOR; SIGNAL-TRANSDUCTION PATHWAY; INTRACELLULAR DOMAIN; HISTONE DEACETYLASE; METASTASIS SUPPRESSOR; ALZHEIMER-DISEASE; TAK1 MAPKKK; REPRESSION; RELEASE; GAMMA	Defining the molecular mechanisms that integrate diverse signaling pathways at the level of gene transcription remains a central issue in biology. Here, we demonstrate that interleukin-1beta (IL-1beta) causes nuclear export of a specific N-CoR corepressor complex, resulting in derepression of a specific subset of NF-kappaB-regulated genes, exemplified by the tetraspanin KA/1 that regulates membrane receptor function. Nuclear export of the N-CoR/TAB2/HDAC3 complex by IL-1beta is temporally linked to selective recruitment of a Tip60 coactivator complex. Surprisingly, KA/1 is also directly activated by a ternary complex, dependent on the acetyltransferase activity of Tip60, consisting of the presenilin-dependent C-terminal cleavage product of the amyloid beta precursor protein (APP), Fe65, and Tip60, identifying a specific in vivo gene target of an APP-dependent transcription complex in the brain.	Univ Calif San Diego, Howard Hughes Med Inst, Dept Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, Sch Med, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592				Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dechend R, 1999, ONCOGENE, V18, P3316, DOI 10.1038/sj.onc.1202717; DONG JT, 1995, SCIENCE, V268, P884, DOI 10.1126/science.7754374; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Glass CK, 2000, GENE DEV, V14, P121; Guenther MG, 2000, GENE DEV, V14, P1048; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Li J, 2001, J BIOL CHEM, V276, P18579, DOI 10.1074/jbc.M100846200; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; McKay LI, 1999, ENDOCR REV, V20, P435, DOI 10.1210/er.20.4.435; Mrak RE, 2000, J NEUROPATH EXP NEUR, V59, P471, DOI 10.1093/jnen/59.6.471; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Odintsova E, 2000, CURR BIOL, V10, P1009, DOI 10.1016/S0960-9822(00)00652-7; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Pinnix I, 2001, J BIOL CHEM, V276, P481, DOI 10.1074/jbc.M005968200; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Smith CL, 1997, MOL ENDOCRINOL, V11, P657, DOI 10.1210/me.11.6.657; Steiner H, 2001, J MOL NEUROSCI, V17, P193, DOI 10.1385/JMN:17:2:193; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Wyss-Coray T, 2000, NAT MED, V6, P973, DOI 10.1038/79661; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9	45	471	504	1	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 12	2002	110	1					55	67		10.1016/S0092-8674(02)00809-7	http://dx.doi.org/10.1016/S0092-8674(02)00809-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	573PU	12150997	Bronze			2022-12-28	WOS:000176840700007
J	Sharpless, NE; DePinho, RA				Sharpless, NE; DePinho, RA			p53: Good cop/bad cop	CELL			English	Review							STRESS-RESPONSE; LIFE-SPAN; CANCER; SIR2; MICE; TELOMERASE; DEFICIENT; NAD; DNA	Activation of the p53 transcription factor in response to a variety of cellular stresses, including DNA damage and oncogene activation, initiates a program of gene expression that blocks the proliferative expansion of damaged cells. While the beneficial impact of the anticancer function of p53 is well established, several recent papers suggest that p53 activation may in some circumstances act in a manner detrimental to the long-term homeostasis of the organism. Here, we discuss the significant participation of p53 in three non-mutually exclusive theories of human aging involving DNA damage, telomere shortening, and oxidative stress. These "good cop/bad cop" functions of p53 appear to place it at the nexus of two opposing forces, cancer and aging. By extension, this relationship implies that therapies aimed to reduce cancer and postpone aging, and thereby increase longevity, will necessarily work either upstream or downstream, but not on the level of, p53.	Harvard Univ, Dept Adult Oncol, Dana Farber Canc Inst, Dept Med & Genet,Sch Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	DePinho, RA (corresponding author), Harvard Univ, Dept Adult Oncol, Dana Farber Canc Inst, Dept Med & Genet,Sch Med, Boston, MA 02115 USA.	ron_depinho@dfci.harvard.edu		DePinho, Ronald/0000-0002-5625-577X; Sharpless, Norman/0000-0001-7078-9455				Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Guarente L, 2001, TRENDS GENET, V17, P391, DOI 10.1016/S0168-9525(01)02339-3; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Mori H, 2002, P NATL ACAD SCI USA, V99, P8242, DOI 10.1073/pnas.112218799; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Trinei M, 2002, ONCOGENE, V21, P3872, DOI 10.1038/sj.onc.1205513; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585	20	216	226	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 12	2002	110	1					9	12		10.1016/S0092-8674(02)00818-8	http://dx.doi.org/10.1016/S0092-8674(02)00818-8			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	573PU	12150992	Bronze			2022-12-28	WOS:000176840700003
J	Starr, DA; Han, M				Starr, DA; Han, M			Role of ANC-1 in tethering nuclei to the actin cytoskeleton	SCIENCE			English	Article							PROTEIN; MIGRATION; NEMATODE; MEMBRANE; ENVELOPE; UNC-84; FAMILY; CELLS; GENE	Mutations in anc-1 (nuclear anchorage defective) disrupt the positioning of nuclei and mitochondria in Caenorhabditis elegans. ANC-1 is shown to consist of mostly coiled regions with a nuclear envelope localization domain (called the KASH domain) and an actin-binding domain; this structure was conserved with the Drosophila protein Msp-300 and the mammalian Syne proteins. Antibodies against ANC-1 localized cytoplasmically and were enriched at the nuclear periphery in an UNC-84 dependent manner. Overexpression of the KASH domain or the actin-binding domain caused a dominant negative anchorage defect. Thus, ANC-1 may connect nuclei to the cytoskeleton by interacting with UNC-84 at the nuclear envelope and with actin in the cytoplasm.	Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Han, M (corresponding author), Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.	mhan@colorado.edu		Starr, Daniel/0000-0001-7339-6606	NIGMS NIH HHS [F32 GM020127] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM020127] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Apel ED, 2000, J BIOL CHEM, V275, P31986, DOI 10.1074/jbc.M004775200; Burton EA, 2002, CELL, V108, P5, DOI 10.1016/S0092-8674(01)00626-2; Chytilova E, 2000, MOL BIOL CELL, V11, P2733, DOI 10.1091/mbc.11.8.2733; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Guild GM, 1997, J CELL BIOL, V138, P783, DOI 10.1083/jcb.138.4.783; HEDGECOCK EM, 1982, CELL, V30, P321, DOI 10.1016/0092-8674(82)90038-1; HORVITZ HR, 1980, GENETICS, V96, P435; Lee KK, 2002, MOL BIOL CELL, V13, P892, DOI 10.1091/mbc.01-06-0294; Malone CJ, 1999, DEVELOPMENT, V126, P3171; Mislow JMK, 2002, J CELL SCI, V115, P61; Morris NR, 2000, J CELL BIOL, V148, P1097, DOI 10.1083/jcb.148.6.1097; Mosley-Bishop KL, 1999, CURR BIOL, V9, P1211, DOI 10.1016/S0960-9822(99)80501-6; Ono S, 1999, J CELL BIOL, V145, P491, DOI 10.1083/jcb.145.3.491; Reinsch S, 1998, J CELL SCI, V111, P2283; RosenbergHasson Y, 1996, MECH DEVELOP, V60, P83, DOI 10.1016/S0925-4773(96)00602-8; Starr DA, 2001, DEVELOPMENT, V128, P5039; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; VOLK T, 1992, DEVELOPMENT, V116, P721; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; YAN Y, 1993, SCIENCE, V262, P2027, DOI 10.1126/science.8266097; Zhang QP, 2001, J CELL SCI, V114, P4485; Zhen YY, 2002, J CELL SCI, V115, P3207	23	302	317	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2002	298	5592					406	409		10.1126/science.1075119	http://dx.doi.org/10.1126/science.1075119			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	602NB	12169658				2022-12-28	WOS:000178510400046
J	Pradhan, AD; Manson, JE; Rossouw, JE; Siscovick, DS; Mouton, CP; Rifai, N; Wallace, RB; Jackson, RD; Pettinger, MB; Ridker, PM				Pradhan, AD; Manson, JE; Rossouw, JE; Siscovick, DS; Mouton, CP; Rifai, N; Wallace, RB; Jackson, RD; Pettinger, MB; Ridker, PM			Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease - Prospective analysis from the Women's Health Initiative observational study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; POSTMENOPAUSAL WOMEN; PLASMA-CONCENTRATION; UNSTABLE ANGINA; INSULIN-RESISTANCE; ADIPOSE-TISSUE; RISK; INTERLEUKIN-6; OBESITY	Context Postmenopausal hormone replacement therapy (HRT) has been shown to elevate C-reactive protein (CRP) levels. Several inflammatory biomarkers, including CRP, are associated with increased cardiovascular risk. However, whether the,effect of HRT on CRP represents a clinical hazard is unknown. Objectives To assess the association between baseline levels of CRP and interleukin 6 (IL-6) and incident coronary heart disease (CHD) and to examine the relationship between baseline use of HRT, CRP, and IL-6 levels as they relate to subsequent vascular risk. Design, Setting, and Participants Prospective, nested case-control study of postmenopausal women, forming part of the Women's Health Initiative, a large, nationwide, observational study. Among 75343 women with no history of cardiovascular disease or cancer, 304 women who developed incident CHD were defined as cases and matched by age, smoking status, ethnicity, and follow-up time with 304 study participants who remained event free during a median observation period of 2.9 years. Main Outcome Measure Incidence of first myocardial infarction or death from CHD. Results Median baseline levels of CRP (0.33 vs 0.25 mg/dL; interquartile range [IQR], 0.14-0.71 vs 0.10-0.47; P < 001) and IL-6 (1.81 vs 1.47 pg/mL; IQR, 1.30-2.75 vs 1.05-2.15; P < .001) were significantly higher among cases compared with controls. In matched analyses, the odds ratio (OR) for incident CHD in the highest vs lowest quartile was 2.3 for CRP (95% confidence interval [CI], 1.4-3.7; P for trend = .002) and 3.3 for IL-6 (95% 10, 2.0-5.5; P for trend <.001), After additional adjustment for lipid and nonlipid risk factors, both inflammatory markers were significantly associated with a 2-fold increase in odds for CHD events. As anticipated, current use of HRT was associated with significantly elevated median CRP levels. However, there was no association between HRT and IL-6. In analyses comparing individuals with comparable baseline levels of either CRP or IL-6, those taking or not taking HRT had similar CHD ORs. In analyses stratified by HRT, we observed a positively graded relationship between plasma CRP levels and the OR for CHD among both users and nonusers of HRT across the full spectrum of baseline CRP. Conclusions These prospective findings indicate that CRP and IL-6 independently predict vascular events among apparently healthy postmenopausal women and that HRT increases CRP. However, use or nonuse of HRT had less importance as a predictor of cardiovascular risk than did baseline levels of either CRP or IL-6.	Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Div Prevent Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Div Cardiol, Boston, MA 02215 USA; Brigham & Womens Hosp, Leducq Ctr Mol & Genet Epidemiol Cardiovasc Disor, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; NHLBI, Bethesda, MD 20892 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA USA; Univ Texas, Hlth Sci Ctr, Dept Family & Community Med, Div Community Geriatr, San Antonio, TX USA; Childrens Hosp, Med Ctr, Dept Pathol, Boston, MA 02115 USA; Univ Iowa, Coll Med, Dept Epidemiol, Iowa City, IA USA; Ohio State Univ, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA; Fred Hutchinson Canc Res Ctr, Womens Hlth Initiat Clin Coordinating Ctr, Seattle, WA 98104 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Health San Antonio; Harvard University; Boston Children's Hospital; University of Iowa; University System of Ohio; Ohio State University; Fred Hutchinson Cancer Center	Ridker, PM (corresponding author), Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Div Prevent Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063293] Funding Source: NIH RePORTER; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH032109] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 63293, HL 07575] Funding Source: Medline; WHI NIH HHS [N01-WH-3-2109] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); WHI NIH HHS		Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Barinas-Mitchell E, 2001, AM J EPIDEMIOL, V153, P1094, DOI 10.1093/aje/153.11.1094; Biasucci LM, 1999, CIRCULATION, V99, P855, DOI 10.1161/01.CIR.99.7.855; Cushman M, 1999, ARTERIOSCL THROM VAS, V19, P893, DOI 10.1161/01.ATV.19.4.893; Cushman M, 1999, CIRCULATION, V100, P717, DOI 10.1161/01.CIR.100.7.717; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Hak AE, 1999, ARTERIOSCL THROM VAS, V19, P1986, DOI 10.1161/01.ATV.19.8.1986; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Haverkate F, 1997, LANCET, V349, P462, DOI 10.1016/S0140-6736(96)07591-5; Hemminki E, 1997, BRIT MED J, V315, P149, DOI 10.1136/bmj.315.7101.149; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963; Lindahl B, 2000, NEW ENGL J MED, V343, P1139, DOI 10.1056/NEJM200010193431602; LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701; Lowe GDO, 2001, THROMB HAEMOSTASIS, V86, P550; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Morrow DA, 1998, J AM COLL CARDIOL, V31, P1460, DOI 10.1016/S0735-1097(98)00136-3; Nakagomi A, 2000, CIRCULATION, V101, P1785, DOI 10.1161/01.CIR.101.15.1785; Ockene IS, 2001, CLIN CHEM, V47, P444; Rexrode KM, 1996, CURR OPIN CARDIOL, V11, P490, DOI 10.1097/00001573-199609000-00007; Ridker PM, 1999, CIRCULATION, V100, P713, DOI 10.1161/01.CIR.100.7.713; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Ridker PM, 1999, CIRCULATION, V100, P230, DOI 10.1161/01.CIR.100.3.230; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2001, JAMA-J AM MED ASSOC, V285, P2481, DOI 10.1001/jama.285.19.2481; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sattar N, 1999, LANCET, V354, P487, DOI 10.1016/S0140-6736(99)02079-6; Straub RH, 2000, J CLIN ENDOCR METAB, V85, P1340, DOI 10.1210/jc.85.3.1340; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P1121, DOI 10.1161/01.ATV.17.6.1121; van Baal WM, 1999, THROMB HAEMOSTASIS, V81, P925, DOI 10.1055/s-0037-1614600; Walsh BW, 2000, J CLIN ENDOCR METAB, V85, P214, DOI 10.1210/jc.85.1.214; Weinhold B, 1997, BIOCHEM J, V327, P425, DOI 10.1042/bj3270425; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972	38	525	536	1	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2002	288	8					980	987		10.1001/jama.288.8.980	http://dx.doi.org/10.1001/jama.288.8.980			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587RM	12190368	Bronze			2022-12-28	WOS:000177656400023
J	Ono, K; Austing, DG; Tokura, Y; Tarucha, S				Ono, K; Austing, DG; Tokura, Y; Tarucha, S			Current rectification by Pauli exclusion in a weakly coupled double quantum dot system	SCIENCE			English	Article							SINGLE; BLOCKADE; COULOMB; STATES	We observe spin blockade due to Pauli exclusion in the tunneling characteristics of a coupled quantum dot system when two same-spin electrons occupy the lowest energy state in each dot. Spin blockade only occurs in one bias direction when there is asymmetry in the electron population of the two dots, leading to current recti cation. We induce the collapse of the spin blockade by applying a magnetic field to open up a new spin-triplet current-carrying channel.	Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; NTT Corp, Nippon Telegraph & Tel Basic Res Labs, Atsugi, Kanagawa 2430198, Japan; Natl Res Council Canada, Inst Microstruct Sci M23A, Ottawa, ON K1A 0R6, Canada; Japan Sci & Technol, Exploratory Res Adv Technol Mesoscop Correlat Pro, Atsugi, Kanagawa 2430198, Japan	University of Tokyo; Nippon Telegraph & Telephone Corporation; National Research Council Canada; Japan Science & Technology Agency (JST)	Tarucha, S (corresponding author), Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan.		Tokura, Yasuhiro/A-5550-2011; Ono, Keiji/A-2989-2013; TARUCHA, SEIGO/I-7030-2012	Tokura, Yasuhiro/0000-0001-6656-4237; 				Amaha S, 2001, SOLID STATE COMMUN, V119, P183, DOI 10.1016/S0038-1098(01)00176-4; Austing DG, 1996, SEMICOND SCI TECH, V11, P388, DOI 10.1088/0268-1242/11/3/018; Austing DG, 1998, PHYSICA B, V249, P206, DOI 10.1016/S0921-4526(98)00099-4; AVERIN DV, 1992, COULOMB BLOCKADE PHE, P217; Ciorga M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.256804; Ciorga M, 2000, PHYS REV B, V61, P16315, DOI 10.1103/PhysRevB.61.R16315; FUJISAWA T, IN PRESS NATURE; Imamura H, 1998, PHYS REV B, V57, pR4257, DOI 10.1103/PhysRevB.57.R4257; Joachim C, 2000, NATURE, V408, P541, DOI 10.1038/35046000; Kouwenhoven L. P., 1997, MESOSCOPIC ELECT T E, V345; Kouwenhoven LP, 1997, SCIENCE, V278, P1788, DOI 10.1126/science.278.5344.1788; Kumar A, 1996, PHYS REV LETT, V76, P2778, DOI 10.1103/PhysRevLett.76.2778; Liu RC, 1998, NATURE, V391, P263, DOI 10.1038/34611; Livermore C, 1996, SCIENCE, V274, P1332, DOI 10.1126/science.274.5291.1332; ONO K, UNPUB; Pi M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.066801; Schmidt T, 1997, PHYS REV LETT, V78, P1544, DOI 10.1103/PhysRevLett.78.1544; Stopa M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.146802; TANAKA Y, 1996, PHYS REV B, V53, P3091; Tarucha S, 2000, PHYS REV LETT, V84, P2485, DOI 10.1103/PhysRevLett.84.2485; Tokura Y, 1999, J PHYS-CONDENS MAT, V11, P6023, DOI 10.1088/0953-8984/11/31/310; WEIMANN D, 1995, PHYS REV LETT, V74, P984	23	652	653	3	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2002	297	5585					1313	1317		10.1126/science.1070958	http://dx.doi.org/10.1126/science.1070958			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12142438				2022-12-28	WOS:000177573900036
J	Nelson, HD; Humphrey, LL; Nygren, P; Teutsch, SM; Allan, JD				Nelson, HD; Humphrey, LL; Nygren, P; Teutsch, SM; Allan, JD			Postmenopausal hormone replacement therapy - Scientific review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CORONARY-HEART-DISEASE; NON-CONTRACEPTIVE ESTROGENS; ACUTE MYOCARDIAL-INFARCTION; WOMEN RECEIVING ESTROGEN; TERM-FOLLOW-UP; BREAST-CANCER; ALZHEIMERS-DISEASE; VENOUS THROMBOEMBOLISM; HIP FRACTURE; RISK-FACTORS	Context Although postmenopausal hormone replacement therapy (HRT) is widely used in the United States, new evidence about its benefits and harms requires reconsideration of its use for the primary prevention of chronic conditions. Objective To assess the benefits and harms of HRT for the primary prevention of cardiovascular disease, thromboembolism, osteoporosis, cancer, dementia, and cholecystitis by reviewing the literature, conducting meta-analyses, and calculating outcome rates. Data Sources All relevant English-language studies were identified in MEDLINE (19662001), HealthSTAR (1975-2001), Cochrane Library databases, and reference lists of key articles. Recent results of the Women's Health Initiative (WHI) and the Heart and Estrogen/progestin Replacement Study (HERS) are included for reported outcomes. Study Selection and Data Extraction We used all published studies of HRT if they contained a comparison group of HRT nonusers and reported data relating to HRT use and clinical outcomes of interest. Studies were excluded if the population was selected according to prior events or presence of conditions associated with higher risks for targeted outcomes. Data Synthesis Meta-analyses of observational studies indicated summary relative risks (RRs) for coronary heart disease (CHD) incidence and mortality that were significantly reduced among current HRT users only, although risk for incidence was not reduced when only studies that controlled for socioeconomic status were included. The WHI reported increased CHD events (hazard ratio [HR], 1.29; 95% confidence interval [CI], 1.02-1.63). Stroke incidence but not mortality was significantly increased among HRT users in the meta-analysis and the WHI. The meta-analysis indicated that risk was significantly elevated for thromboembolic stroke (RR, 1.20; 95% CI, 1.01-1.40) but not subarachnoid or intracerebral stroke. Risk of venous thromboembolism among current HRT users was increased overall (RR, 2.14; 95% CI, 1.64-2.81) and was highest during the first year of use (RR, 3.49; 95% CI, 2.33-5.59) according to a meta-analysis of 12 studies. Protection against osteoporotic fractures is supported by a meta-analysis of 22 estrogen trials, cohort studies, results of the WHI, and trials with bone density outcomes. Current estrogen users have an increased risk of breast cancer that increases with duration of use. Endometrial cancer incidence, but not mortality, is increased with unopposed estrogen use but not with estrogen with progestin. A meta-analysis of 18 observational studies showed a 20% reduction in colon cancer incidence among women who had ever used HRT (RR, 0.80; 95% CI, 0.74-0.86), a finding supported by the WHI. Women symptomatic from menopause had improvement in certain aspects of cognition. Current studies of estrogen and dementia are not definitive. In a cohort study, current HRT users had an age-adjusted RR for cholecystitis of 1.8 (95% CI, 1.6-2.0), increasing to 2.5 (95% CI, 2.0-2.9) after 5 years of use. Conclusions Benefits of HRT include prevention of osteoporotic fractures and colorectal cancer, while prevention of dementia is uncertain. Harms include CHD, stroke, thromboembolic events, breast cancer with 5 or more years of use, and cholecystitis.	Oregon Hlth & Sci Univ, Div Med Informat & Outcomes Res, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Evidence Based Practice Ctr, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Med Serv, Portland, OR 97201 USA; Merck & Co Inc, West Point, PA USA; Univ Texas, Hlth Sci Ctr, Sch Nursing, San Antonio, TX USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Merck & Company; University of Texas System; University of Texas Health San Antonio	Nelson, HD (corresponding author), Oregon Hlth & Sci Univ, Div Med Informat & Outcomes Res, Mail Code BICC 504,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	nelsonh@ohsu.edu			PHS HHS [290-97-0018] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AMADUCCI LA, 1986, NEUROLOGY, V36, P922, DOI 10.1212/WNL.36.7.922; ARMSTRONG BK, 1988, MED J AUSTRALIA, V148, P213, DOI 10.5694/j.1326-5377.1988.tb99424.x; Barrett-Connor E, 1998, ANNU REV PUBL HEALTH, V19, P55, DOI 10.1146/annurev.publhealth.19.1.55; BARRETTCONNOR E, 1994, FERTIL STERIL, V62, pS127; BEARD CM, 1989, MAYO CLIN PROC, V64, P1471, DOI 10.1016/S0025-6196(12)65702-4; BRENNER DE, 1994, AM J EPIDEMIOL, V140, P262, DOI 10.1093/oxfordjournals.aje.a117245; BROE GA, 1990, NEUROLOGY, V40, P1698, DOI 10.1212/WNL.40.11.1698; BUSH TL, 1987, CIRCULATION, V75, P1102, DOI 10.1161/01.CIR.75.6.1102; CAULEY JA, 1995, ANN INTERN MED, V122, P9, DOI 10.7326/0003-4819-122-1-199501010-00002; Cauley JA, 2001, AM J MED, V110, P442, DOI 10.1016/S0002-9343(01)00647-7; Cauley JA, 1997, ARCH INTERN MED, V157, P2181, DOI 10.1001/archinte.157.19.2181; COLDITZ GA, 1993, AM J OBSTET GYNECOL, V168, P1473, DOI 10.1016/S0002-9378(11)90784-4; COLDITZ GA, 1995, NEW ENGL J MED, V332, P1589, DOI 10.1056/NEJM199506153322401; *COLL DRUG SURV PR, 1974, NEW ENGL J MED, V290, P15; Coronary Drug Project Research Group, 1977, N Engl J Med, V296, P1185; CRANNEY A, 2000, NAT I HLTH CONS DEV; CRIQUI MH, 1988, AM J EPIDEMIOL, V128, P606, DOI 10.1093/oxfordjournals.aje.a115008; CROFT P, 1989, BRIT MED J, V298, P165, DOI 10.1136/bmj.298.6667.165; Daly E, 1996, LANCET, V348, P1027, DOI 10.1016/S0140-6736(96)24041-3; Daly E, 1996, LANCET, V348, P977, DOI 10.1016/S0140-6736(96)07113-9; DERBY CA, 1995, AM J OBSTET GYNECOL, V173, P544, DOI 10.1016/0002-9378(95)90280-5; DEVOR M, 1992, AM J MED, V92, P275, DOI 10.1016/0002-9343(92)90077-O; DIEHL AK, 1980, SOUTHERN MED J, V73, P438, DOI 10.1097/00007611-198004000-00012; DITKOFF EC, 1991, OBSTET GYNECOL, V78, P991; DUPONT WD, 1991, ARCH INTERN MED, V151, P67, DOI 10.1001/archinte.151.1.67; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ettinger B, 1996, OBSTET GYNECOL, V87, P6, DOI 10.1016/0029-7844(95)00358-4; EVERSON RB, 1982, GASTROENTEROLOGY, V82, P4; FARMER ME, 1984, AM J PUBLIC HEALTH, V74, P1374, DOI 10.2105/AJPH.74.12.1374; Fedor-Freybergh P, 1977, Acta Obstet Gynecol Scand Suppl, V64, P1; FINUCANE FF, 1993, ARCH INTERN MED, V153, P73, DOI 10.1001/archinte.153.1.73; FOLSOM AR, 1995, AM J PUBLIC HEALTH, V85, P1128, DOI 10.2105/AJPH.85.8_Pt_1.1128; Fung MM, 1999, J WOMENS HEALTH, V8, P359, DOI 10.1089/jwh.1999.8.359; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; GRADY D, 1995, OBSTET GYNECOL, V85, P304, DOI 10.1016/0029-7844(94)00383-O; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; GRAVES AB, 1990, ANN NEUROL, V28, P766, DOI 10.1002/ana.410280607; Grodstein F, 1999, EPIDEMIOLOGY, V10, P476, DOI 10.1097/00001648-199909000-00003; Grodstein F, 1999, AM J MED, V106, P574, DOI 10.1016/S0002-9343(99)00063-7; GRODSTEIN F, 1994, OBSTET GYNECOL, V83, P5; Grodstein F, 1996, NEW ENGL J MED, V335, P453, DOI 10.1056/NEJM199608153350701; Grodstein F, 1996, LANCET, V348, P983, DOI 10.1016/S0140-6736(96)07308-4; Grodstein F, 1997, NEW ENGL J MED, V336, P1769, DOI 10.1056/NEJM199706193362501; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; Gutthann SP, 1997, BMJ-BRIT MED J, V314, P796, DOI 10.1136/bmj.314.7083.796; Hackman B W, 1976, Curr Med Res Opin, V4, P303, DOI 10.1185/03007997609109322; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Harwood DG, 1999, NEUROLOGY, V52, P551, DOI 10.1212/WNL.52.3.551; Heckbert SR, 1997, ARCH INTERN MED, V157, P1330, DOI 10.1001/archinte.157.12.1330; Hemminki E, 1997, BRIT MED J, V315, P149, DOI 10.1136/bmj.315.7101.149; HENDERSON VW, 1994, ARCH NEUROL-CHICAGO, V51, P896, DOI 10.1001/archneur.1994.00540210068014; HERNANDEZ AM, 1990, EPIDEMIOLOGY, V1, P128; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; HEYMAN A, 1984, ANN NEUROL, V15, P335, DOI 10.1002/ana.410150406; Hoidrup S, 1999, AM J EPIDEMIOL, V149, P993; Holbraaten E, 1999, THROMB HAEMOSTASIS, V82, P1218; HONORE LH, 1980, J REPROD MED, V25, P187; HORWITZ RI, 1990, LANCET, V336, P542, DOI 10.1016/0140-6736(90)92095-Y; Hulley S, 2002, JAMA-J AM MED ASSOC, V288, P58, DOI 10.1001/jama.288.1.58; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Humphrey LL, 2002, HORMONE REPLACEMENT; HUMPHREY LL, 2002, POSTMENOPAUSAL HORMO; HUMPHREY LL, IN PRESS ANN INTERN; Janowsky JS, 2000, J COGNITIVE NEUROSCI, V12, P407, DOI 10.1162/089892900562228; Jick H, 1996, LANCET, V348, P981, DOI 10.1016/S0140-6736(96)07114-0; JORGENSEN T, 1988, GUT, V29, P433, DOI 10.1136/gut.29.4.433; KAKAR F, 1988, AM J PUBLIC HEALTH, V78, P564, DOI 10.2105/AJPH.78.5.564; Kawas C, 1997, NEUROLOGY, V48, P1517, DOI 10.1212/WNL.48.6.1517; Keating NL, 1999, ANN INTERN MED, V130, P545, DOI 10.7326/0003-4819-130-7-199904060-00002; Keefover RW, 1996, NEUROL CLIN, V14, P337, DOI 10.1016/S0733-8619(05)70260-7; KIEL DP, 1987, NEW ENGL J MED, V317, P1169, DOI 10.1056/NEJM198711053171901; Komulainen MH, 1998, MATURITAS, V31, P45, DOI 10.1016/S0378-5122(98)00085-1; Lacey JV, 2002, JAMA-J AM MED ASSOC, V288, P334, DOI 10.1001/jama.288.3.334; LAVECCHIA C, 1992, J EPIDEMIOL COMMUN H, V46, P234, DOI 10.1136/jech.46.3.234; LeBlanc ES, 2001, JAMA-J AM MED ASSOC, V285, P1489, DOI 10.1001/jama.285.11.1489; LONGSTRETH WT, 1994, ANN INTERN MED, V121, P168, DOI 10.7326/0003-4819-121-3-199408010-00002; Mamdani MM, 2000, CAN MED ASSOC J, V162, P1421; MANN RD, 1994, J CLIN EPIDEMIOL, V47, P307, DOI 10.1016/0895-4356(94)90014-0; Matthews KA, 1996, AM J EPIDEMIOL, V143, P971; MAXIM P, 1995, OSTEOPOROSIS INT, V5, P23, DOI 10.1007/BF01623654; Melton LJ, 1998, OSTEOPOROSIS INT, V8, P341, DOI 10.1007/s001980050073; MELTON LJ, 1989, AM J EPIDEMIOL, V129, P1000, DOI 10.1093/oxfordjournals.aje.a115204; Miller J, 2002, ANN INTERN MED, V136, P680, DOI 10.7326/0003-4819-136-9-200205070-00011; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; MORTEL KF, 1995, J NEUROPSYCH CLIN N, V7, P334; Mosekilde L, 2000, MATURITAS, V36, P181, DOI 10.1016/S0378-5122(00)00158-4; NACHTIGALL LE, 1979, OBSTET GYNECOL, V54, P74, DOI 10.1097/00006250-197907000-00017; NAESSEN T, 1990, ANN INTERN MED, V113, P95, DOI 10.7326/0003-4819-113-2-95; NELSON HD, 2001, HORMONE REPLACEMENT; PaganiniHill A, 1996, ARCH INTERN MED, V156, P2213, DOI 10.1001/archinte.156.19.2213; Pedersen AT, 1997, LANCET, V350, P1277, DOI 10.1016/S0140-6736(97)06005-4; PEPI Trial, 1995, JAMA-J AM MED ASSOC, V274, P1676; Persson I, 1997, J CLIN EPIDEMIOL, V50, P611, DOI 10.1016/S0895-4356(97)00004-8; Persson I, 1996, INT J CANCER, V67, P327, DOI 10.1002/(SICI)1097-0215(19960729)67:3<327::AID-IJC4>3.0.CO;2-T; PETITTI DB, 1979, JAMA-J AM MED ASSOC, V242, P1150, DOI 10.1001/jama.242.11.1150; Petitti DB, 1998, STROKE, V29, P23, DOI 10.1161/01.STR.29.1.23; PETITTI DB, 1988, GASTROENTEROLOGY, V94, P91, DOI 10.1016/0016-5085(88)90614-2; PETITTI DB, 1987, OBSTET GYNECOL, V70, P289; PFEFFER RI, 1978, AM J EPIDEMIOL, V107, P479, DOI 10.1093/oxfordjournals.aje.a112567; PFEFFER RI, 1978, J CHRON DIS, V31, P389, DOI 10.1016/0021-9681(78)90003-6; PHILLIPS SM, 1992, PSYCHONEUROENDOCRINO, V17, P485, DOI 10.1016/0306-4530(92)90007-T; Polo-Kantola P, 1998, OBSTET GYNECOL, V91, P459, DOI 10.1016/S0029-7844(97)00700-X; Poulter NR, 1997, LANCET, V349, P1202, DOI 10.1016/S0140-6736(97)02358-1; Ries L. A. G., 1999, SEER CANC STAT REV 1; Riman T, 2002, JNCI-J NATL CANCER I, V94, P497, DOI 10.1093/jnci/94.7.497; Rodriguez C, 2001, AM J EPIDEMIOL, V153, P145, DOI 10.1093/aje/153.2.145; ROSENBERG L, 1993, AM J EPIDEMIOL, V137, P54, DOI 10.1093/oxfordjournals.aje.a116602; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schairer C, 1999, J NATL CANCER I, V91, P264, DOI 10.1093/jnci/91.3.264; SCRAGG RKR, 1984, BRIT MED J, V288, P1795, DOI 10.1136/bmj.288.6433.1795; Sellers TA, 1997, ANN INTERN MED, V127, P973, DOI 10.7326/0003-4819-127-11-199712010-00004; Shaywitz SE, 1999, JAMA-J AM MED ASSOC, V281, P1197, DOI 10.1001/jama.281.13.1197; SHERWIN BB, 1988, PSYCHONEUROENDOCRINO, V13, P345, DOI 10.1016/0306-4530(88)90060-1; Sidney S, 1997, ANN INTERN MED, V127, P501, DOI 10.7326/0003-4819-127-7-199710010-00001; SILLEROARENAS M, 1992, OBSTET GYNECOL, V79, P286; Slavin Robert E., 1986, EDUC RESEARCHER, V15, P5, DOI [10.3102/0013189X015009005, DOI 10.3102/0013189X015009005]; Sourander L, 1998, LANCET, V352, P1965, DOI 10.1016/S0140-6736(98)05066-1; Spiegelhalter DJ, 1999, WINBUGS VERSION 1 2; STAMPFER MJ, 1991, PREV MED, V20, P47, DOI 10.1016/0091-7435(91)90006-P; STEINBERG KK, 1994, EPIDEMIOLOGY, V5, P415, DOI 10.1097/00001648-199407000-00007; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Sutton AJAK, 2000, METHODS METAANALYSIS; Tang MX, 1996, LANCET, V348, P429, DOI 10.1016/S0140-6736(96)03356-9; THOMPSON SG, 1989, J EPIDEMIOL COMMUN H, V43, P173, DOI 10.1136/jech.43.2.173; Thrift AG, 1996, STROKE, V27, P2020, DOI 10.1161/01.STR.27.11.2020; Torgerson DJ, 2001, JAMA-J AM MED ASSOC, V285, P2891, DOI 10.1001/jama.285.22.2891; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; VANHULLE G, 1976, CONSENSUS MENOPAUSE; Varas-Lorenzo C, 2000, CIRCULATION, V101, P2572, DOI 10.1161/01.CIR.101.22.2572; Varas-Lorenzo C, 1998, AM J EPIDEMIOL, V147, P387; Waring SC, 1999, NEUROLOGY, V52, P965, DOI 10.1212/WNL.52.5.965; Willis DB, 1996, CANCER CAUSE CONTROL, V7, P449, DOI 10.1007/BF00052671; WILSON PWF, 1985, NEW ENGL J MED, V313, P1038, DOI 10.1056/NEJM198510243131702; WOLF PH, 1991, AM J OBSTET GYNECOL, V164, P489, DOI 10.1016/S0002-9378(11)80006-2	135	729	775	0	57	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2002	288	7					872	881		10.1001/jama.288.7.872	http://dx.doi.org/10.1001/jama.288.7.872			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585FC	12186605	Bronze			2022-12-28	WOS:000177513100030
J	Wilder-Smith, A; Barkham, TMS; Earnest, A; Paton, NI				Wilder-Smith, A; Barkham, TMS; Earnest, A; Paton, NI			Acquisition of W135 meningococcal carriage in Hajj pilgrims and transmission to household contacts: prospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Tan Tock Seng Hosp, Travellers Hlth & Vaccinat Ctr, Singapore 308433, Singapore; Tan Tock Seng Hosp, Dept Pathol & Lab Med, Singapore 308433, Singapore; Tan Tock Seng Hosp, Clin Epidemiol Unit, Singapore 308433, Singapore; Tan Tock Seng Hosp, Dept Infect Dis, Singapore 308433, Singapore	Tan Tock Seng Hospital; Tan Tock Seng Hospital; Tan Tock Seng Hospital; Tan Tock Seng Hospital	Wilder-Smith, A (corresponding author), Tan Tock Seng Hosp, Travellers Hlth & Vaccinat Ctr, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	epvws@pacific.net.sg	Earnest, Arul/L-4747-2013; Wilder-Smith, Annelies/F-8751-2015	Earnest, Arul/0000-0003-2693-5034; Wilder-Smith, Annelies/0000-0003-0362-5375				[Anonymous], 2001, Wkly Epidemiol Rec, V76, P141; Popovic T, 2000, EMERG INFECT DIS, V6, P428, DOI 10.3201/eid0604.000423; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Taha MK, 2000, LANCET, V356, P2159, DOI 10.1016/S0140-6736(00)03502-9	4	48	50	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 17	2002	325	7360					365	366		10.1136/bmj.325.7360.365	http://dx.doi.org/10.1136/bmj.325.7360.365			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587DV	12183308	Green Published, Bronze			2022-12-28	WOS:000177626000019
J	Yan, H; Yuan, WS; Velculescu, VE; Vogelstein, B; Kinzler, KW				Yan, H; Yuan, WS; Velculescu, VE; Vogelstein, B; Kinzler, KW			Allelic variation in human gene expression	SCIENCE			English	Article									Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; Johns Hopkins Med Inst, Howard Hughes Med Inst, Baltimore, MD 21231 USA; Johns Hopkins Univ, Dept Math Sci, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Kinzler, KW (corresponding author), Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA.		Velculescu, Victor/ABF-4846-2020	Velculescu, Victor/0000-0003-1195-438X; Edsall, Lee Elizabeth/0000-0002-0326-2829	NCI NIH HHS [CA57345, CA43460, CA 62924] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA057345, R37CA043460, R37CA057345, P50CA062924, R01CA043460] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Johnson NA, 2000, J THEOR BIOL, V205, P527, DOI 10.1006/jtbi.2000.2070; Levine M, 2002, NATURE, V415, P848, DOI 10.1038/415848a; Matyas G, 2002, HUM MUTAT, V19, P58, DOI 10.1002/humu.10013; Yan H, 2002, NAT GENET, V30, P25, DOI 10.1038/ng799	4	587	610	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2002	297	5584					1143	1143		10.1126/science.1072545	http://dx.doi.org/10.1126/science.1072545			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183620				2022-12-28	WOS:000177447600037
J	Dobson, CM				Dobson, CM			Protein-misfolding diseases: Getting out of shape	NATURE			English	Editorial Material									Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge	Dobson, CM (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.							BLIS RJ, 2002, NATURE, V416, P483; Dobson CM, 2001, PHILOS T ROY SOC B, V356, P129, DOI 10.1098/rstb.2000.0757; Ferguson NM, 2002, NATURE, V415, P420, DOI 10.1038/nature709; Iversen L, 2002, NATURE, V417, P231, DOI 10.1038/417231a; OSERMELY P, 2001, TRENDS GENOM, V17, P701; SOLOMON B, 2001, CONFORMATIONAL DIS C	6	284	293	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2002	418	6899					729	730		10.1038/418729a	http://dx.doi.org/10.1038/418729a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181546				2022-12-28	WOS:000177428000018
J	Fairhurst, TM; Pegues, DA				Fairhurst, TM; Pegues, DA			Pulmonary cryptococcal granulomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Fairhurst, TM (corresponding author), Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90095 USA.								0	2	4	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 15	2002	347	7					497	497						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587ZM	12181404				2022-12-28	WOS:000177674400006
J	Callegari, A; Theule, P; Muenter, JS; Tolchenov, RN; Zobov, NF; Polyansky, OL; Tennyson, J; Rizzo, TR				Callegari, A; Theule, P; Muenter, JS; Tolchenov, RN; Zobov, NF; Polyansky, OL; Tennyson, J; Rizzo, TR			Dipole moments of highly vibrationally excited water	SCIENCE			English	Article							POTENTIAL-ENERGY SURFACE; AB-INITIO; SOLAR-ENERGY; ABSORPTION; VAPOR; CONVERGENCE; SPECTRUM; CLOUDS; CM(-1); STATES	The intensity of water absorption in the region of the solar spectrum plays a dominant role in atmospheric energy balance and hence strongly influences climate. Significant controversy exists over how to model this absorption accurately. We report dipole moment measurements of highly vibrationally excited water, which provide stringent tests of intensities determined by other means. Our measurements and accompanying calculations suggest that the best currently available potential and dipole surfaces do not accurately model intensities in the optical spectrum of water.	Ecole Polytech Fed Lausanne, LCPM, CH-1015 Lausanne, Switzerland; Univ Rochester, Dept Chem, Rochester, NY 14627 USA; UCL, Dept Phys Astron, London WC1E 6BT, England; Russian Acad Sci, Inst Phys Appl, Nizhnii Novgorod 603950, Russia	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Rochester; University of London; University College London; Russian Academy of Sciences	Rizzo, TR (corresponding author), Ecole Polytech Fed Lausanne, LCPM, CH-1015 Lausanne, Switzerland.	thomas.rizzo@epfl.ch	Rizzo, Thomas R/D-1554-2011; Tennyson, Jonathan/I-2222-2012; Nikolay, Zobov/U-1709-2019	Rizzo, Thomas R/0000-0003-2796-905X; Tennyson, Jonathan/0000-0002-4994-5238; 				Allard F, 1997, ANNU REV ASTRON ASTR, V35, P137, DOI 10.1146/annurev.astro.35.1.137; Arking A, 1999, GEOPHYS RES LETT, V26, P2729, DOI 10.1029/1999GL900544; Arking A, 1996, SCIENCE, V273, P779, DOI 10.1126/science.273.5276.779; Barnes RJ, 1997, J CHEM PHYS, V106, P1284, DOI 10.1063/1.473179; Belmiloud D, 2000, GEOPHYS RES LETT, V27, P3703, DOI 10.1029/2000GL011899; BITTO H, 1990, OPT COMMUN, V80, P184, DOI 10.1016/0030-4018(90)90382-4; CESS RD, 1995, SCIENCE, V267, P496, DOI 10.1126/science.267.5197.496; CHILD MS, 1982, CHEM PHYS LETT, V87, P217, DOI 10.1016/0009-2614(82)83128-X; Chou MD, 1999, TERR ATMOS OCEAN SCI, V10, P511, DOI 10.3319/TAO.1999.10.3.511(A); de Oliveira G, 1999, THEOR CHEM ACC, V101, P435, DOI 10.1007/s002140050461; DYKE TR, 1973, J CHEM PHYS, V59, P3125, DOI 10.1063/1.1680453; Halkier A, 1999, J CHEM PHYS, V111, P4424, DOI 10.1063/1.480036; KHUNDKAR LR, 1990, ANNU REV PHYS CHEM, V41, P15; Kjaergaard HG, 1999, MOL PHYS, V96, P1125, DOI 10.1080/00268979909483055; LEHMANN KK, 1991, J CHEM PHYS, V95, P2361, DOI 10.1063/1.460942; LEHMANN KK, 1990, J CHEM PHYS, V93, P6140, DOI 10.1063/1.458985; Li ZQ, 1997, B AM METEOROL SOC, V78, P53, DOI 10.1175/1520-0477(1997)078<0053:OSEDAP>2.0.CO;2; Lubin D, 2000, J GEOPHYS RES-ATMOS, V105, P22445, DOI 10.1029/2000JD900317; MENGEL M, 1995, J MOL SPECTROSC, V169, P73, DOI 10.1006/jmsp.1995.1007; Mlawer EJ, 2000, GEOPHYS RES LETT, V27, P2653, DOI 10.1029/2000GL011498; *NAT ADV GROUP AER, 1993, TERM ASS METH SOL PR; Partridge H, 1997, J CHEM PHYS, V106, P4618, DOI 10.1063/1.473987; Polyansky OL, 1997, SCIENCE, V277, P346, DOI 10.1126/science.277.5324.346; Polyansky OL, 1996, J CHEM PHYS, V105, P6490, DOI 10.1063/1.472501; POLYANSKY OL, UNPUB; Schermaul R, 2001, J MOL SPECTROSC, V208, P43, DOI 10.1006/jmsp.2001.8374; Schwenke DW, 2000, J CHEM PHYS, V113, P6592, DOI 10.1063/1.1311392; Schwenke DW, 2001, J PHYS CHEM A, V105, P2352, DOI 10.1021/jp0032513; SHIRIN SV, UNPUB; SHOSTAK SL, 1991, J CHEM PHYS, V94, P5875, DOI 10.1063/1.460471; SHOSTAK SL, 1991, J CHEM PHYS, V94, P5883, DOI 10.1063/1.460472; SMITH AM, 1991, J CHEM PHYS, V94, P5040, DOI 10.1063/1.460539; TENNYSON J, 1995, COMPUT PHYS COMMUN, V86, P175, DOI 10.1016/0010-4655(94)00139-S; Tennyson J, 2001, J PHYS CHEM REF DATA, V30, P735, DOI 10.1063/1.1364517; Townes CH., 1955, MICROWAVE SPECTROSCO, V1; VANDERWAL RL, 1991, J CHEM PHYS, V94, P1859, DOI 10.1063/1.460694; Zhong WY, 2001, Q J ROY METEOR SOC, V127, P1615, DOI 10.1002/qj.49712757508	37	32	32	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 9	2002	297	5583					993	995		10.1126/science.1073731	http://dx.doi.org/10.1126/science.1073731			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169729				2022-12-28	WOS:000177325400039
J	Miller, MG; Johnson, AD				Miller, MG; Johnson, AD			White-opaque switching in Candida albicans is controlled by mating-type locus homeodomain proteins and allows efficient mating	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; SIGNAL-TRANSDUCTION; GENE; TRANSITION; PHASE; PHENOTYPE; MISEXPRESSION; CONSTRUCTION; VIRULENCE; HOMOLOG	Discovered over a decade ago, white-opaque switching in the human fungal pathogen Candida albicans is an alternation between two quasistable, heritable transcriptional states. Here, we show that white-opaque switching and sexual mating are both controlled by mating type locus homeodomain proteins and that opaque cells mate approximately 10(6) times more efficiently than do white cells. These results show that opaque cells are a mating-competent form of C. albicans and that this pathogen undergoes a white-to-opaque switch as a critical step in the mating process. As white cells are generally more robust in a mammalian host than are opaque cells, this strategy allows the organism to survive the rigors of life within a mammalian host, yet generate mating-competent cells.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Johnson, AD (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.				NIAID NIH HHS [R01 AI49187] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049187] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON J, 1989, INFECT IMMUN, V57, P458, DOI 10.1128/IAI.57.2.458-467.1989; ANDERSON J, 1990, J BACTERIOL, V172, P224, DOI 10.1128/JB.172.1.224-235.1990; ANDERSON JM, 1987, J BACTERIOL, V169, P5579, DOI 10.1128/jb.169.12.5579-5588.1987; Casselton LA, 1998, MICROBIOL MOL BIOL R, V62, P55, DOI 10.1128/MMBR.62.1.55-70.1998; CHU WS, 1992, J BACTERIOL, V174, P2951, DOI 10.1128/JB.174.9.2951-2957.1992; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COLLART MA, 1993, CURRENT PROTOCOL S23, V2; Coppin E, 1997, MICROBIOL MOL BIOL R, V61, P411, DOI 10.1128/.61.4.411-428.1997; Diener AC, 1996, GENETICS, V143, P769; Edmond MB, 1999, CLIN INFECT DIS, V29, P239, DOI 10.1086/520192; FONZI WA, 1993, GENETICS, V134, P717; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; HERSKOWITZ I, 1981, MOL BIOL YEAST SACCH, P181; HERSKOWITZ I, 1992, MOL CELLULAR BIOL YE, V2, P583; Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9; Hull CM, 2000, SCIENCE, V289, P307, DOI 10.1126/science.289.5477.307; Hull CM, 1999, SCIENCE, V285, P1271, DOI 10.1126/science.285.5431.1271; Janbon G, 1999, GENETICS, V153, P653; Janbon G, 1998, P NATL ACAD SCI USA, V95, P5150, DOI 10.1073/pnas.95.9.5150; JOHNSON AD, 1995, CURR OPIN GENET DEV, V5, P552, DOI 10.1016/0959-437X(95)80022-0; Klar AJS, 2001, GENETICS, V158, P919; KOLOTILA MP, 1990, INFECT IMMUN, V58, P1174, DOI 10.1128/IAI.58.5.1174-1179.1990; Kronstad JW, 1997, ANNU REV GENET, V31, P245, DOI 10.1146/annurev.genet.31.1.245; Kvaal C, 1999, INFECT IMMUN, V67, P6652; Kvaal CA, 1997, INFECT IMMUN, V65, P4468, DOI 10.1128/IAI.65.11.4468-4475.1997; Leberer E, 1996, P NATL ACAD SCI USA, V93, P13217, DOI 10.1073/pnas.93.23.13217; Mackay Vivian L., 1993, P273; Magee BB, 2000, SCIENCE, V289, P310, DOI 10.1126/science.289.5477.310; MORROW B, 1989, J GEN MICROBIOL, V135, P1201; MORROW B, 1992, MOL CELL BIOL, V12, P2997, DOI 10.1128/MCB.12.7.2997; MORROW B, 1993, INFECT IMMUN, V61, P1823, DOI 10.1128/IAI.61.5.1823-1828.1993; Raymond M, 1998, MOL MICROBIOL, V27, P587, DOI 10.1046/j.1365-2958.1998.00704.x; RUSTCHENKOBULGAC EP, 1991, J BACTERIOL, V173, P6586, DOI 10.1128/jb.173.20.6586-6596.1991; SADHU C, 1992, MOL CELL BIOL, V12, P1977, DOI 10.1128/MCB.12.5.1977; SLUTSKY B, 1987, J BACTERIOL, V169, P189, DOI 10.1128/JB.169.1.189-197.1987; SOLL DR, 1993, TRENDS GENET, V9, P61, DOI 10.1016/0168-9525(93)90189-O; Soll DR, 1997, MICROBIOL-UK, V143, P279, DOI 10.1099/00221287-143-2-279; Sonneborn A, 1999, INFECT IMMUN, V67, P4655, DOI 10.1128/IAI.67.9.4655-4660.1999; SPRAGUE G F JR, 1991, P77; Srikantha T, 2000, J BACTERIOL, V182, P1580, DOI 10.1128/JB.182.6.1580-1591.2000; Srikantha T, 2001, J BACTERIOL, V183, P4614, DOI 10.1128/JB.183.15.4614-4625.2001; SRIKANTHA T, 1993, GENE, V131, P53, DOI 10.1016/0378-1119(93)90668-S; Tibayrenc M, 1997, TRENDS MICROBIOL, V5, P253, DOI 10.1016/S0966-842X(97)01068-8; TSUBOI R, 1994, J MED VET MYCOL, V32, P91; Tzung KW, 2001, P NATL ACAD SCI USA, V98, P3249, DOI 10.1073/pnas.061628798; Vilgalys R, 1997, TRENDS MICROBIOL, V5, P254, DOI 10.1016/S0966-842X(97)01076-7; WHITE TC, 1993, J BACTERIOL, V175, P6126, DOI 10.1128/JB.175.19.6126-6133.1993; Yesland K, 2000, MICROBIOL-SGM, V146, P2097, DOI 10.1099/00221287-146-9-2097	48	404	433	0	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 9	2002	110	3					293	302		10.1016/S0092-8674(02)00837-1	http://dx.doi.org/10.1016/S0092-8674(02)00837-1			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	583MN	12176317	Bronze			2022-12-28	WOS:000177411800006
J	Kumar, R; Wang, RA; Mazumdar, A; Talukder, AH; Mandal, M; Yang, ZB; Bagheri-Yarmand, R; Sahin, A; Hortobagyi, G; Adam, L; Barnes, CJ; Vadlamudi, RK				Kumar, R; Wang, RA; Mazumdar, A; Talukder, AH; Mandal, M; Yang, ZB; Bagheri-Yarmand, R; Sahin, A; Hortobagyi, G; Adam, L; Barnes, CJ; Vadlamudi, RK			A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm	NATURE			English	Article							ESTROGEN-RECEPTOR; BREAST-CANCER; MCF-7 CELLS; GENE; SEQUENCE; EXPRESSION; GROWTH	Oestrogen receptor (ER) is a good prognostic marker for the treatment of breast cancers. Upregulation of metastatic tumour antigen 1 (MTA1) is associated with the invasiveness and metastatic potential of several human cancers(1,2) and acts as a corepressor of nuclear ER-alpha(3). Here we identify a naturally occurring short form of MTA1 (MTA1s) that contains a previously unknown sequence of 33 amino acids with an ER-binding motif, Leu-Arg-Ile-Leu-Leu (LRILL). MTA1s localizes in the cytoplasm, sequesters ER in the cytoplasm, and enhances non-genomic responses of ER. Deleting the LRILL motif in MTA1s abolishes its co-repressor function and its interaction with ER, and restores nuclear localization of ER. Dysregulation of human epidermal growth factor receptor-2 in breast cancer cells enhances the expression of MTA1s and the cytoplasmic sequestration of ER. Expression of MTA1s in breast cancer cells prevents ligand-induced nuclear translocation of ER and stimulates malignant phenotypes. MTA1s expression is increased in human breast tumours with no or low nuclear ER. The regulation of the cellular localization of ER by MTA1s represents a mechanism for redirecting nuclear receptor signalling by nuclear exclusion.	Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Kumar, R (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.		Mandal, Mahitosh/GMW-6195-2022; Wang, Brian/HGA-9535-2022	Mandal, Mahitosh/0000-0003-3861-3323; Wang, Rui-An/0000-0003-2320-1211; Bagheri-Yarmand, Rozita/0000-0001-5139-6381				BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; BERRY M, 1989, P NATL ACAD SCI USA, V86, P1218, DOI 10.1073/pnas.86.4.1218; CATORIA G, 1999, EMBO J, V18, P2500; Crawford J, 1999, GENOMICS, V56, P90, DOI 10.1006/geno.1998.5676; Henttu PMA, 1997, MOL CELL BIOL, V17, P1832, DOI 10.1128/MCB.17.4.1832; Kumar R, 1996, CLIN CANCER RES, V2, P1215; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; Mandal M, 2001, J BIOL CHEM, V276, P9699, DOI 10.1074/jbc.M008514200; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; Migliaccio A, 1996, EMBO J, V15, P1292, DOI 10.1002/j.1460-2075.1996.tb00471.x; Nawa A, 2000, J CELL BIOCHEM, V79, P202, DOI 10.1002/1097-4644(20001101)79:2<202::AID-JCB40>3.0.CO;2-L; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Song RXD, 2002, MOL ENDOCRINOL, V16, P116, DOI 10.1210/me.16.1.116; TOH Y, 1994, J BIOL CHEM, V269, P229; Vadlamudi RK, 2001, J BIOL CHEM, V276, P38272	15	189	199	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2002	418	6898					654	657		10.1038/nature00889	http://dx.doi.org/10.1038/nature00889			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167865				2022-12-28	WOS:000177305600046
J	Fulop, N; Protopsaltis, G; Hutchings, A; King, A; Allen, P; Normand, C; Walters, R				Fulop, N; Protopsaltis, G; Hutchings, A; King, A; Allen, P; Normand, C; Walters, R			Process and impact of mergers of NHS trusts: multicentre case study and management cost analysis	BRITISH MEDICAL JOURNAL			English	Article							CARE; BIGGER	Objective To study the processes involved in and impact of mergers between NHS trusts, including the effect on management costs. Design Cross sectional study involving in depth interviews and documentary analysis; case study to compare savings in management costs between case trusts and control trusts. Setting Nine trusts (cross sectional study) and four trusts (case study) in London. Participants 96 interviews with trust board members, other senior managers, clinicians, service managers, and representatives of health authorities, regional office, community health councils, local authorities, other trusts in the area, and primary care groups and trusts. Main outcome measures Stated and unstated drivers, and impact of merger on delivery and development of services, management structures, and staff recruitment, retention, and morale. Effects of difference in trust size before and after the merger. Savings in management costs two years after merger. Results Some important drivers for merger are not publicly stated. Mergers had a negative effect on delivery of services because of a loss of managerial focus on services. Planned developments in services were delayed by at least 18 months. Trusts' larger sizes after mergers had unintended negative consequences, as well as predicted advantages. The tendency for one trust's management team to dominate over the other resulted in tension. No improvement in recruitment or retention of clinical and managerial staff was reported. Perceived differences in organisational culture were an important barrier to bringing together two or more organisations. Two years after merger, merged trusts had not achieved the objective of saving pound500 000 a year in management costs. Conclusions Important unintended consequences need to be accounted for when mergers are planned. Mergers can cause considerable disruptions to services, and require greater management support than previously acknowledged. Other organisations undergoing restructuring, such as primary care groups developing into primary care trusts and health authorities merging into strategic health authorities, should take these findings into account	Univ London London Sch Hyg & Trop Med, Hlth Serv Res Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Fulop, N (corresponding author), Univ London London Sch Hyg & Trop Med, Hlth Serv Res Unit, Keppel St, London WC1E 7HT, England.			Allen, Pauline/0000-0001-5598-1684; Fulop, Naomi/0000-0001-5306-6140; Hutchings, Andrew/0000-0003-0215-9923; Normand, Charles/0000-0002-0885-5754				Argyris C., 1996, ORG LEARNING; Bojke C, 2001, BRIT MED J, V322, P599, DOI 10.1136/bmj.322.7286.599; Bowling A., 1997, RES METHODS HLTH; Bryman A., 1994, ANAL QUALITATIVE DAT; Burgess R. G, 1984, FIELD INTRO FIELD RE; Davies HTO, 2000, QUAL HEALTH CARE, V9, P111, DOI 10.1136/qhc.9.2.111; *DEP HLTH, 1997, STRAT REV LOND HLTH; *DEP HLTH, 1998, REV LOND HLTH SERV G; Department of Health, 2001, SHIFT BAL POW NHS SE; DOWIE R, 1997, CONCENTRATION CHOICE, P51; Ferguson B, 1997, CONCENTRATION CHOICE, P67; FERGUSON B, 1997, CONCENTRATION CHOICE, P1; Garside P, 1999, BRIT MED J, V318, P345, DOI 10.1136/bmj.318.7180.345; Goddard M., 1997, MERGERS NHS MADE HEA; Gulland A, 2001, BRIT MED J, V322, P1443, DOI 10.1136/bmj.322.7300.1443; McClenahan J., 1999, HLTH CARE UK 1999 20, P94; MILES MB, 1979, ADMIN SCI QUART, V24, P590, DOI 10.2307/2392365; *NHS, 2000, NHS PLAN PLAN INV PL; *NHS CTR REV DISS, 1997, 8 CRD NHS CTR REV 1; *NHS PLAN, 2000, PLAN INV PLAN REF; Posnett J, 1999, BRIT MED J, V319, P1063, DOI 10.1136/bmj.319.7216.1063; Smith R, 2001, BRIT MED J, V323, P245, DOI 10.1136/bmj.323.7307.245; Weil T P, 2000, Health Serv Manage Res, V13, P137; 1996, EFFECTIVE HLTH CARE, V2	24	91	91	1	16	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 3	2002	325	7358					246	249		10.1136/bmj.325.7358.246	http://dx.doi.org/10.1136/bmj.325.7358.246			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582FL	12153920	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000177339000017
J	Vogt, BA				Vogt, BA			Knocking out the dream to study pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									SUNY Upstate Med Univ, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Vogt, BA (corresponding author), SUNY Upstate Med Univ, Syracuse, NY 13210 USA.		Vogt, Brent A/C-4038-2015	Vogt, Brent A/0000-0003-1228-4410	NINDS NIH HHS [NS38485] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038485] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Cheng HYM, 2002, CELL, V108, P31, DOI 10.1016/S0092-8674(01)00629-8; Jasmin L, 2002, P NATL ACAD SCI USA, V99, P1029, DOI 10.1073/pnas.012598599; Laughlin TM, 2001, J PHARMACOL EXP THER, V299, P6; Ledo F, 2000, MOL CELL BIOL, V20, P9120, DOI 10.1128/MCB.20.24.9120-9126.2000; Meuli-Simmen C, 1999, HUM GENE THER, V10, P2689, DOI 10.1089/10430349950016735	6	12	12	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2002	347	5					362	364		10.1056/NEJMcibr021152	http://dx.doi.org/10.1056/NEJMcibr021152			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587WC	12151476				2022-12-28	WOS:000177665900012
J	Stoodley, N				Stoodley, N			Non-accidental head injury in children: gathering the evidence	LANCET			English	Editorial Material							TRAUMATIC BRAIN INJURY; YOUNG-CHILDREN; IMAGING FINDINGS; INFANTS; NEUROPATHOLOGY; ABUSE		Univ Wales Hosp, Cardiff CF14 4XW, S Glam, Wales	Cardiff University	Stoodley, N (corresponding author), Univ Wales Hosp, Heath Pk, Cardiff CF14 4XW, S Glam, Wales.							Barlow KM, 1999, ACTA PAEDIATR, V88, P734; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Biousse V, 2002, AM J OPHTHALMOL, V133, P249, DOI 10.1016/S0002-9394(01)01366-6; Chabrol B, 1999, CHILD ABUSE NEGLECT, V23, P217, DOI 10.1016/S0145-2134(98)00128-8; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Haviland J, 1997, ARCH DIS CHILD, V77, P504, DOI 10.1136/adc.77.6.504; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Kemp AM, 2002, ARCH DIS CHILD, V86, P98, DOI 10.1136/adc.86.2.98; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; Sane SM, 2000, PEDIATRICS, V105, P1345; SATO Y, 1989, RADIOLOGY, V173, P653, DOI 10.1148/radiology.173.3.2813768; Suh DY, 2001, NEUROSURGERY, V49, P309, DOI 10.1097/00006123-200108000-00011	17	13	13	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 27	2002	360	9329					271	272		10.1016/S0140-6736(02)09563-6	http://dx.doi.org/10.1016/S0140-6736(02)09563-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578DT	12147367				2022-12-28	WOS:000177102700005
J	Browder, T; Folkman, J; Hahnfeldt, P; Heymach, J; Hlatky, L; Kieran, M; Rogers, MS				Browder, T; Folkman, J; Hahnfeldt, P; Heymach, J; Hlatky, L; Kieran, M; Rogers, MS			Antiangiogenic therapy and p53	SCIENCE			English	Editorial Material							GROWTH-FACTOR; ANGIOGENESIS; EXPRESSION		Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Browder, T (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA.	judah.folkman@tch.harvard.edu	Rogers, Michael S/A-9814-2009; Rogers, Michael/AAE-2217-2019	Rogers, Michael S/0000-0002-5250-8434; Rogers, Michael/0000-0002-5250-8434; Kieran, Mark/0000-0003-2184-7692				Bergers G, 1999, SCIENCE, V284, P808, DOI 10.1126/science.284.5415.808; CHU E, 2001, CANC PRINCIPLES PRAC, P290; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; Darnell G, 1999, BLOOD, V94, P781, DOI 10.1182/blood.V94.2.781.414k32_781_792; Furuwatari C, 1998, AM J CLIN PATHOL, V110, P368, DOI 10.1093/ajcp/110.3.368; KERBEL RS, 1991, BIOESSAYS, V13, P31, DOI 10.1002/bies.950130106; Kisker O, 2001, CANCER RES, V61, P7669; Klement G, 2000, J CLIN INVEST, V105, pR15, DOI 10.1172/JCI8829; Ravi R, 2000, GENE DEV, V14, P34; Relf M, 1997, CANCER RES, V57, P963; Sherif ZA, 2001, CANCER GENE THER, V8, P771, DOI 10.1038/sj.cgt.7700361; Yu JL, 2002, SCIENCE, V295, P1526, DOI 10.1126/science.1068327; Zhang LL, 2000, CANCER RES, V60, P3655	13	10	10	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2002	297	5581												2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12143876				2022-12-28	WOS:000177054200002
J	Carr, AM				Carr, AM			Checking that replication breakdown is not terminal	SCIENCE			English	Editorial Material							DAMAGE TOLERANCE; DNA-DAMAGE; CHECKPOINTS; HOMOLOG; REPAIR		Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	University of Sussex	Carr, AM (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.			Carr, Antony Michael/0000-0002-2028-2389				Bashkirov VI, 2000, MOL CELL BIOL, V20, P4393, DOI 10.1128/MCB.20.12.4393-4404.2000; Boddy MN, 2000, MOL CELL BIOL, V20, P8758, DOI 10.1128/MCB.20.23.8758-8766.2000; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Cox MM, 2001, P NATL ACAD SCI USA, V98, P8173, DOI 10.1073/pnas.131004998; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8227, DOI 10.1073/pnas.111008698; Michel B, 1997, EMBO J, V16, P430, DOI 10.1093/emboj/16.2.430; Muris DFR, 1996, J CELL SCI, V109, P73; Murray JM, 1997, MOL CELL BIOL, V17, P6868, DOI 10.1128/MCB.17.12.6868; Rhind N, 2000, CURR BIOL, V10, pR908, DOI 10.1016/S0960-9822(00)00849-6; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Zhao XL, 2001, EMBO J, V20, P3544, DOI 10.1093/emboj/20.13.3544	13	25	30	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2002	297	5581					557	558		10.1126/science.1075456	http://dx.doi.org/10.1126/science.1075456			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142525				2022-12-28	WOS:000177054200038
J	Choi, YH; Gehring, M; Johnson, L; Hannon, M; Harada, JJ; Goldberg, RB; Jacobsen, SE; Fischer, RL				Choi, YH; Gehring, M; Johnson, L; Hannon, M; Harada, JJ; Goldberg, RB; Jacobsen, SE; Fischer, RL			DEMETER, a DNA glycosylase domain protein, is required for endosperm gene imprinting and seed viability in Arabidopsis	CELL			English	Article							POLYCOMB GROUP GENE; MEDEA; FIE; FERTILIZATION; MUTATIONS; PLANTS; ORIGIN; MECHANISMS; EXPRESSION; THALIANA	We isolated mutations in Arabidopsis to understand how the female gametophyte controls embryo and endosperm development. For the DEMETER (DME) gene, seed viability depends only on the maternal allele. DME encodes a large protein with DNA glycosylase and nuclear localization domains. DME is expressed primarily in the central cell of the female gametophyte, the progenitor of the endosperm. DME is required for maternal allele expression of the imprinted MEDEA (MEA) Polycomb gene in the central cell and endosperm. Ectopic DME expression in endosperm activates expression of the normally silenced paternal MEA allele. In leaf, ectopic DME expression induces MEA and nicks the MEA promoter. Thus, a DNA glycosylase activates maternal expression of an imprinted gene in the central cell.	Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Davis, Plant Biol Sect, Div Biol Sci, Davis, CA 95616 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Berkeley; University of California System; University of California Los Angeles; University of California System; University of California Davis; University of California System; University of California Los Angeles	Fischer, RL (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.		Choi, Yeonhee/AAF-5906-2020		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060398, R37GM060398] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 60398] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Birve A, 2001, DEVELOPMENT, V128, P3371; BOWMAN JL, 1994, ARABIDOPSIS ATLAS MO, P135; Brown RC, 1999, SEX PLANT REPROD, V12, P32, DOI 10.1007/s004970050169; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; CAVROIS M, 1995, RES VIROLOGY, V146, P179, DOI 10.1016/0923-2516(96)80578-4; Drews GN, 1998, PLANT CELL, V10, P5, DOI 10.1105/tpc.10.1.5; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; Garcia-Ortiz MV, 2001, PLANT MOL BIOL, V47, P795, DOI 10.1023/A:1013644026132; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; Holding DR, 2002, PLANTA, V214, P373, DOI 10.1007/s00425-001-0686-0; IRISH VF, 1992, DEVELOPMENT, V115, P745; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jiricny J, 2002, NATURE, V415, P593, DOI 10.1038/415593a; Jost JP, 2001, NUCLEIC ACIDS RES, V29, P4452, DOI 10.1093/nar/29.21.4452; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; Kasinsky HE, 2001, FASEB J, V15, P34, DOI 10.1096/fj.00-0237rev; Kinoshita T, 1999, PLANT CELL, V11, P1945, DOI 10.1105/tpc.11.10.1945; Kiyosue T, 1999, P NATL ACAD SCI USA, V96, P4186, DOI 10.1073/pnas.96.7.4186; Krokan HE, 1997, BIOCHEM J, V325, P1; Langst G, 2001, MOL CELL, V8, P1085, DOI 10.1016/S1097-2765(01)00397-5; Luo M, 2000, P NATL ACAD SCI USA, V97, P10637, DOI 10.1073/pnas.170292997; Luo M, 1999, P NATL ACAD SCI USA, V96, P296, DOI 10.1073/pnas.96.1.296; MEYEROWITZ EM, 1994, ARABIDOPSIS, P435; Niwa Y, 1999, PLANT J, V18, P455, DOI 10.1046/j.1365-313X.1999.00464.x; Ohad N, 1999, PLANT CELL, V11, P407, DOI 10.1105/tpc.11.3.407; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; ROGERS SG, 1987, METHOD ENZYMOL, V153, P253; Scharer OD, 2001, BIOESSAYS, V23, P270, DOI 10.1002/1521-1878(200103)23:3<270::AID-BIES1037>3.0.CO;2-J; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Vielle-Calzada JP, 1999, GENE DEV, V13, P2971, DOI 10.1101/gad.13.22.2971; Vinkenoog R, 2000, PLANT CELL, V12, P2271, DOI 10.1105/tpc.12.11.2271; Yadegari R, 2000, PLANT CELL, V12, P2367, DOI 10.1105/tpc.12.12.2367	34	555	601	9	79	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 12	2002	110	1					33	42		10.1016/S0092-8674(02)00807-3	http://dx.doi.org/10.1016/S0092-8674(02)00807-3			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	573PU	12150995	Bronze			2022-12-28	WOS:000176840700005
J	Isberg, RR; Barnes, P				Isberg, RR; Barnes, P			Dancing with the host: Flow-dependent bacterial adhesion	CELL			English	Review							SELECTIN; BINDING; SHEAR; KINETICS; CELLS	Most bacteria that colonize eukaryotes must bind directly to host cells to establish a replicative niche. In enteric bacteria, adhesion to host cells is often promoted by a lectin found on surface-localized pili. Some pili promote efficient adhesion only when they are subjected to shear stress, as found during the flow of blood over endothelium or mucous over the surface of the epithelium.	Tufts Univ, Howard Hughes Med Inst, Sch Med, Boston, MA 02111 USA; Tufts Univ, Dept Mol Biol & Microbiol, Sch Med, Boston, MA 02111 USA	Howard Hughes Medical Institute; Tufts University; Tufts University	Isberg, RR (corresponding author), Tufts Univ, Howard Hughes Med Inst, Sch Med, 136 Harrison Ave, Boston, MA 02111 USA.							Alon R, 1997, J CELL BIOL, V138, P1169, DOI 10.1083/jcb.138.5.1169; BROOKS DE, 1983, J GEN MICROBIOL, V129, P3661; Chang KC, 1999, BIOPHYS J, V76, P1280, DOI 10.1016/S0006-3495(99)77291-7; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; DICKINSON RB, 1995, INFECT IMMUN, V63, P3143, DOI 10.1128/IAI.63.8.3143-3150.1995; Finger EB, 1996, NATURE, V379, P266, DOI 10.1038/379266a0; HASLAM DB, 1994, MOL MICROBIOL, V14, P399, DOI 10.1111/j.1365-2958.1994.tb02175.x; Hung CS, 2002, MOL MICROBIOL, V44, P903, DOI 10.1046/j.1365-2958.2002.02915.x; Janeway CA, 2001, P NATL ACAD SCI USA, V98, P7461, DOI 10.1073/pnas.131202998; Joh D, 1999, MATRIX BIOL, V18, P211, DOI 10.1016/S0945-053X(99)00025-6; Kirn TJ, 2000, MOL MICROBIOL, V35, P896, DOI 10.1046/j.1365-2958.2000.01764.x; Lawrence MB, 1997, J CELL BIOL, V136, P717, DOI 10.1083/jcb.136.3.717; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; Nassif X, 2002, TRENDS MICROBIOL, V10, P227, DOI 10.1016/S0966-842X(02)02349-1; RINGER M, 1980, AM J CARDIOL, V45, P383, DOI 10.1016/0002-9149(80)90663-3; Sokurenko EV, 1997, J BIOL CHEM, V272, P17880, DOI 10.1074/jbc.272.28.17880; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1	17	66	68	2	25	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 12	2002	110	1					1	4		10.1016/S0092-8674(02)00821-8	http://dx.doi.org/10.1016/S0092-8674(02)00821-8			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	573PU	12150990	Bronze			2022-12-28	WOS:000176840700001
J	Polishchuk, LV				Polishchuk, LV			Ecology: Conservation priorities for Russian mammals	SCIENCE			English	Editorial Material							BIODIVERSITY		Moscow MV Lomonosov State Univ, Dept Gen Ecol, Moscow 119899, Russia; Netherlands Inst Ecol, Dept Food Web Studies, Ctr Limnol, NL-3631 AC Nieuwersluis, Netherlands	Lomonosov Moscow State University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Polishchuk, LV (corresponding author), Moscow MV Lomonosov State Univ, Dept Gen Ecol, Moscow 119899, Russia.	LV@Polishchuk.msk.ru	Polishchuk, Leonard/I-9342-2012					BANNIKOV AG, 1984, RED BOOK USSR RARE 1, V1; Brook BW, 2000, NATURE, V404, P385, DOI 10.1038/35006050; Coulson T, 2001, TRENDS ECOL EVOL, V16, P219, DOI 10.1016/S0169-5347(01)02137-1; *MIN NAT RES RUSS, 2001, EC NAT RES RUSS 2002; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Pimm SL, 1991, BALANCE NATURE ECOLO; Polishchuk LV, 2001, ZH OBSHCH BIOL, V62, P3; *RUSS CONS MON CTR, 1997, 1 RUSS CONS MON CTR; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Southwood T.R.E., 1976, P26	11	14	14	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2002	297	5584					1123	1123		10.1126/science.1072836	http://dx.doi.org/10.1126/science.1072836			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183611				2022-12-28	WOS:000177447600024
J	Lindsay, ME; Plafker, K; Smith, AE; Clurman, BE; Macara, IG				Lindsay, ME; Plafker, K; Smith, AE; Clurman, BE; Macara, IG			Npap60/Nup50 is a tri-stable switch that stimulates importin-alpha :beta-mediated nuclear protein import	CELL			English	Article							PORE COMPLEX; LOCALIZATION SEQUENCES; YEAST NUCLEOPORIN; STRUCTURAL BASIS; EXPORT; TRANSPORT; NUP2P; BINDING; IDENTIFICATION; RANGTP	Many nuclear-targeted proteins are transported through the nuclear pore complex (NPC) by the importin-alpha:beta receptor. We now show that Npap60 (also called Nup50), a protein previously believed to be a structural component of the NPC, is a Ran binding protein and a cofactor for importin-alpha:beta-mediated import. Npap60 is a tri-stable switch that alternates between binding modes. The C terminus binds importin-P through RanGTP. The N terminus binds the C terminus of importin-alpha, while a central domain binds importin-beta. Npap60:importin-alpha:beta binds cargo and can stimulate nuclear import. Endogenous Npap60 can shuttle and is accessible from the cytoplasmic side of the nuclear envelope. These results identify Npap60 as a cofactor for importin-alpha:beta nuclear import and as a previously unidentified subunit of the importin complex.	Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	University of Virginia; University of Virginia; University of Virginia; Fred Hutchinson Cancer Center	Macara, IG (corresponding author), Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA.		Clurman, Bruce/AAV-3854-2021		NATIONAL CANCER INSTITUTE [R01CA084069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050526] Funding Source: NIH RePORTER; NCI NIH HHS [CA84069] Funding Source: Medline; NIGMS NIH HHS [GM50526] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAM SA, 1991, CELL, V66, P837, DOI 10.1016/0092-8674(91)90431-W; Aitchison JD, 1996, SCIENCE, V274, P624, DOI 10.1126/science.274.5287.624; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166; BELANGER KD, 1994, J CELL BIOL, V126, P619, DOI 10.1083/jcb.126.3.619; Bischoff FR, 1997, FEBS LETT, V419, P249, DOI 10.1016/S0014-5793(97)01467-1; Black BE, 1999, MOL CELL BIOL, V19, P8616; Booth JW, 1999, J BIOL CHEM, V274, P32360, DOI 10.1074/jbc.274.45.32360; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Denning D, 2001, J CELL BIOL, V154, P937, DOI 10.1083/jcb.200101007; Dilworth DJ, 2001, J CELL BIOL, V153, P1465, DOI 10.1083/jcb.153.7.1465; Englmeier L, 2001, EMBO REP, V2, P926, DOI 10.1093/embo-reports/kve200; Fan F, 1997, GENOMICS, V40, P444, DOI 10.1006/geno.1996.4557; Floer M, 1997, J BIOL CHEM, V272, P19538, DOI 10.1074/jbc.272.31.19538; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; GORLICH D, 1995, NATURE, V377, P246, DOI 10.1038/377246a0; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Guan TL, 2000, MOL CELL BIOL, V20, P5619, DOI 10.1128/MCB.20.15.5619-5630.2000; Herold A, 1998, J CELL BIOL, V143, P309, DOI 10.1083/jcb.143.2.309; Hood JK, 2000, J CELL SCI, V113, P1471; IMAMOTO N, 1995, EMBO J, V14, P3617, DOI 10.1002/j.1460-2075.1995.tb00031.x; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Lindsay ME, 2001, J CELL BIOL, V153, P1391, DOI 10.1083/jcb.153.7.1391; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Pemberton LF, 1998, CURR OPIN CELL BIOL, V10, P392, DOI 10.1016/S0955-0674(98)80016-1; Plafker K, 2000, MOL CELL BIOL, V20, P3510, DOI 10.1128/MCB.20.10.3510-3521.2000; Plafker SM, 2000, EMBO J, V19, P5502, DOI 10.1093/emboj/19.20.5502; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; Ryan KJ, 2000, CURR OPIN CELL BIOL, V12, P361, DOI 10.1016/S0955-0674(00)00101-0; Smitherman M, 2000, MOL CELL BIOL, V20, P5631, DOI 10.1128/MCB.20.15.5631-5642.2000; Solsbacher J, 2000, MOL CELL BIOL, V20, P8468, DOI 10.1128/MCB.20.22.8468-8479.2000; Taura T, 1998, P NATL ACAD SCI USA, V95, P7427, DOI 10.1073/pnas.95.13.7427; WEIS K, 1995, SCIENCE, V268, P1049, DOI 10.1126/science.7754385; Welch K, 1999, MOL CELL BIOL, V19, P8400	39	92	94	1	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 9	2002	110	3					349	360		10.1016/S0092-8674(02)00836-X	http://dx.doi.org/10.1016/S0092-8674(02)00836-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	583MN	12176322	Bronze			2022-12-28	WOS:000177411800011
J	Little, SJ; Holte, S; Routy, JP; Daar, ES; Markowitz, M; Collier, AC; Koup, RA; Mellors, JW; Connick, E; Conway, B; Kilby, M; Wang, L; Whitcomb, JM; Hellmann, NS; Richman, DD				Little, SJ; Holte, S; Routy, JP; Daar, ES; Markowitz, M; Collier, AC; Koup, RA; Mellors, JW; Connick, E; Conway, B; Kilby, M; Wang, L; Whitcomb, JM; Hellmann, NS; Richman, DD			Antiretroviral-drug resistance among patients recently infected with HIV	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SOCIETY-USA PANEL; ZIDOVUDINE-RESISTANCE; REVERSE-TRANSCRIPTASE; VERTICAL TRANSMISSION; GENOTYPIC RESISTANCE; THERAPY; MUTATIONS; AIDS; SUSCEPTIBILITY	Background Among persons in North America who are newly infected With the human immunodeficiency virus (HIV), the prevalence of transmitted resistance to antiretroviral drugs has been estimated at 1 to 11 percent. Methods We performed a retrospective analysis of susceptibility to antiretroviral drugs before treatment and drug-resistance mutations in HIV in plasma samples from 377 subjects with primary HIV infection who had not yet received treatment and who were identified between May 1995 and June 2000 in 10 North American cities. Responses to treatment could be evaluated in 202 subjects. Results Over the five-year period, the frequency of transmitted drug resistance increased significantly. The frequency of high-level resistance to one or more drugs (indicated by a value of more than 10 for the ratio of the 50 percent inhibitory concentration [IC50] for the subject's virus to the IC50 for a drug-sensitive reference virus) increased from 3.4 percent during the period from 1995 to 1998 to 12.4 percent during the period from 1999 to 2000 (P = 0.002), and the frequency of multidrug resistance increased from 1.1 percent to 6.2 percent (P = 0.01). The frequency of resistance mutations detected by sequence analysis increased from 8.0 percent to 22.7 percent (P < 0.001), and the frequency of multidrug resistance detected by sequence analysis increased from 3.8 percent to 10.2 percent (P = 0.05). Among subjects infected with drug-resistant virus, the time to viral suppression after the initiation of antiretroviral therapy was longer (P = 0.05), and the time to virologic failure was shorter (P = 0.05). Conclusions The proportion of new HIV infections that involve drug-resistant virus is increasing in North America. Initial antiretroviral therapy is more likely to fail in patients who are infected with drug-resistant virus. Testing for resistance to drugs before therapy begins is now indicated even for recently infected patients.	Univ Calif San Diego, Antiviral Res Ctr, Dept Med, San Diego, CA 92103 USA; Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA; Univ Washington, Dept Med, Seattle, WA USA; McGill Univ, Dept Med, Ctr Hlth, Montreal, PQ, Canada; Univ Calif Los Angeles, Harbor Med Ctr, Dept Med, Torrance, CA 90509 USA; Aaron Diamond AIDS Res Ctr, New York, NY USA; NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA; Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA; Univ British Columbia, Dept Pharmacol & Med Therapeut, Vancouver, BC V5Z 1M9, Canada; Univ Alabama, Dept Med, Birmingham, AL 35294 USA; Virologic, San Francisco, CA USA; Vet Affairs San Diego Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; McGill University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; National Institutes of Health (NIH) - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of British Columbia; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Little, SJ (corresponding author), Univ Calif San Diego, Antiviral Res Ctr, Dept Med, 150 W Washington St,Ste 100, San Diego, CA 92103 USA.		FRCPI, Mark D Kilby MB BS DSc MD FRCOG/AAW-9704-2020; Little, Susan/AAA-6116-2019	FRCPI, Mark D Kilby MB BS DSc MD FRCOG/0000-0001-9987-4223; 	NCRR NIH HHS [M01-RR0002, M01-RR00425, M01-RR00102] Funding Source: Medline; NIAID NIH HHS [AI 36214, AI 38858, AI 41532, AI 43638, AI 47033, AI 29164, AI 43271-01, AI 41536, AI 41535, AI 467376-03, AI 27670] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425, M01RR000102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI041535, P30AI036214, ZIAAI005014, R37AI029164, R01AI029164, R01AI047033, U01AI041532, Z01AI005014, U01AI027670, U01AI038858, U01AI043638, R01AI043271, U01AI041536] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 1999, MMWR MORB MORTAL WKL, V48, P45; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Balotta C, 2000, ANTIVIR THER, V5, P7; Boden D, 1999, JAMA-J AM MED ASSOC, V282, P1135, DOI 10.1001/jama.282.12.1135; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; Brodine SK, 1999, ANN INTERN MED, V131, P502, DOI 10.7326/0003-4819-131-7-199910050-00004; Brown AJL, 2000, J VIROL, V74, P10269, DOI 10.1128/JVI.74.22.10269-10273.2000; BROWN AJL, 2002, 9 C RETR OPP INF SEA; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; Colgrove RC, 1998, AIDS, V12, P2281, DOI 10.1097/00002030-199817000-00009; CONLON CP, 1994, J INFECT DIS, V169, P411, DOI 10.1093/infdis/169.2.411; Conway B, 1999, CLIN INFECT DIS, V28, P910, DOI 10.1086/515225; DAQUILA RT, 1995, ANN INTERN MED, V122, P401, DOI 10.7326/0003-4819-122-6-199503150-00001; deRonde A, 1996, AIDS, V10, P231, DOI 10.1097/00002030-199602000-00017; ERICE A, 1993, NEW ENGL J MED, V328, P1163, DOI 10.1056/NEJM199304223281605; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; FITZGIBBON JE, 1993, NEW ENGL J MED, V329, P1835, DOI 10.1056/NEJM199312163292502; Garcia-Lerma JG, 2001, P NATL ACAD SCI USA, V98, P13907, DOI 10.1073/pnas.241300698; Hecht FM, 1998, NEW ENGL J MED, V339, P307, DOI 10.1056/NEJM199807303390504; Hirsch MS, 2000, JAMA-J AM MED ASSOC, V283, P2417, DOI 10.1001/jama.283.18.2417; Imrie A, 1997, J INFECT DIS, V175, P1502, DOI 10.1086/516487; Jacobson M A, 1998, AIDS, V12 Suppl A, pS157; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Janssen RS, 1999, JAMA-J AM MED ASSOC, V281, P1893; Johnson VA, 2001, J INFECT DIS, V183, P1688, DOI 10.1086/320697; Kamkamidze G, 2001, J CLIN VIROL, V22, P143, DOI 10.1016/S1386-6532(01)00178-0; Kellogg T, 1999, AIDS, V13, P2303, DOI 10.1097/00002030-199911120-00013; Lederman MM, 1998, J INFECT DIS, V178, P70, DOI 10.1086/515591; Little SJ, 1999, JAMA-J AM MED ASSOC, V282, P1142, DOI 10.1001/jama.282.12.1142; LITTLE SJ, 2002, 9 C RETR OPP INF SEA; LITTLE SJ, 2001, ANTIVIR THER S, V6, P21; Lorenzi P, 1999, AIDS, V13, pF17, DOI 10.1097/00002030-199902040-00001; Masquelier B, 2001, J ACQ IMMUN DEF SYND, V27, P99, DOI 10.1097/00126334-200106010-00001; MAYERS DL, 1995, AIDS RES HUM RETROV, V11, pS162; Murphy EL, 2001, ANN INTERN MED, V135, P17, DOI 10.7326/0003-4819-135-1-200107030-00005; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Petropoulos CJ, 2000, ANTIMICROB AGENTS CH, V44, P920, DOI 10.1128/AAC.44.4.920-928.2000; Porter K, 2001, BRIT MED J, V322, P1087, DOI 10.1136/bmj.322.7294.1087; Quigg M, 1997, AIDS, V11, P835; RICHMAN DD, 2001, 41 INT C ANT AG CHEM; Rubio A, 1997, AIDS, V11, P1184, DOI 10.1097/00002030-199709000-00016; Salomon H, 2000, AIDS, V14, pF17, DOI 10.1097/00002030-200001280-00003; *STAT CTR HIV AIDS, 2002, AC HIV INF EARL DIS; VEENSTRA J, 1995, CLIN INFECT DIS, V21, P556, DOI 10.1093/clinids/21.3.556; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yerly S, 2001, AIDS, V15, P2287, DOI 10.1097/00002030-200111230-00010; Yerly S, 1999, LANCET, V354, P729, DOI 10.1016/S0140-6736(98)12262-6; Zolopa AR, 1999, ANN INTERN MED, V131, P813, DOI 10.7326/0003-4819-131-11-199912070-00003; 2001, MMWR MORB MORTAL WKL, V50, P117; 2001, MMWR MORB MORTAL WKL, V50, P440	50	925	987	2	52	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 8	2002	347	6					385	394		10.1056/NEJMoa013552	http://dx.doi.org/10.1056/NEJMoa013552			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587YR	12167680				2022-12-28	WOS:000177672400002
J	Buchholz, U; Mermin, J; Rios, R; Casagrande, TL; Galey, F; Lee, M; Quattrone, A; Farrar, J; Nagelkerke, N; Werner, SB				Buchholz, U; Mermin, J; Rios, R; Casagrande, TL; Galey, F; Lee, M; Quattrone, A; Farrar, J; Nagelkerke, N; Werner, SB			An outbreak of food-borne illness associated with methomyl-contaminated salt	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context On January 5, 1999, the California Department of Health Services was notified of the repeated occurrence (December 21, 1998, and January 2, 1999) of gastrointestinal tract illness among patrons at a Thai restaurant in central California. Objective To identify the source of the outbreak. Design Case-control study; microbiological and toxicological laboratory testing of samples of food, stool, and vomitus. Setting Thai food restaurant in central California. Participants Patrons of the restaurant. A case (n=107) was defined as dizziness, nausea, or vomiting occurring in a person who ate at the restaurant between December 20, 1998, and January 2, 1999, with onset of symptoms within 2 hours of eating. A control (n = 169) was a person who ate at the restaurant during the same period but reported no symptoms. Main Outcome Measures Odds ratios (ORs) of illness associated with food exposures; ORs of shifts during which illness occurred associated with certain cooks; laboratory results. Results The median latency period was 40 minutes from beginning eating to first symptom and was 2 hours to onset of diarrhea. The median duration of symptoms was 6 hours. Twenty-six persons (24%) visited the emergency department or were treated by a physician; no person required hospitalization. Patients reported nausea (95%), dizziness (72%), abdominal cramps (58%), headache (52%), vomiting (51%), chills (48%), and diarrhea (46%). Fifty-one cases (48%) included dizziness, lightheadedness, or a feeling of disequilibrium as the initial symptom. Illness was statistically associated with several foods and ingredients, but no single dish or ingredient explained a substantial number of cases. The analysis of food exposures included salt added by cooks, as estimated by using the amount of salt in the recipe for each dish and the amount of each dish eaten by respondents. This association was stronger with increasing levels of salt: ORs for illness among persons who consumed more than 0.42 to 0.84, more than 0.84 to 1.25, and more than 1.25 tsp of salt added to foods in the kitchen were 1.9 (95% confidence interval [CI], 0.6-5.7), 3.0 (95% Cl, 1.0-8.8), and 4.0 (95% Cl, 1.3-13.5) compared with persons who consumed less than 0.42 tsp (P value for trend=.004). Methomyl, a highly toxic carbamate pesticide, was identified in a sample of vomitus (20 ppm) and in salt taken from containers in the storeroom (mean, 5600 ppm) and the stovetop (mean, 1425 ppm). The oral toxic dose causing illness in 50% of those exposed to methomyl was estimated to be 0.15 mg/kg of body weight (estimated range, 0.09-0.31 mg/kg of body weight). The presence of cook A was associated with shifts during which cases of illness occurred (OR, 10.4; 95% Cl, 1.2-157.4). Conclusion This outbreak of gastrointestinal illness was associated with the consumption of food seasoned with methomyl-contaminated salt. To allow rapid assessment for further investigational and control measures by health officials, physicians should report suspected outbreaks of illness to public health departments, however trivial the symptoms or cause may seem.	Ctr Dis Control & Prevent, Epidem Intelligence Serv, Epidemiol Program Off, Atlanta, GA USA; Fresno Cty Dept Community Hlth, Fresno, CA USA; Univ Calif Davis, Davis, CA 95616 USA; Calif Dept Food & Agr, Sacramento, CA 95814 USA; Calif Dept Hlth Serv, Berkeley, CA USA; Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Centers for Disease Control & Prevention - USA; University of California System; University of California Davis; California Department of Food & Agriculture; California Department of Health Care Services; Netherlands National Institute for Public Health & the Environment	Buchholz, U (corresponding author), Robert Koch Inst, Zentrum Infekt Epidemiol, Seestr 10, D-13353 Berlin, Germany.		Mermin, Jonathan/J-9847-2012; QUATTRONE, Aldo/A-6734-2016	QUATTRONE, Aldo/0000-0003-2001-957X				KIDD H, 1991, AGROCHEMICALS HDB, V3, P11; LIDDLE JA, 1979, CLIN TOXICOL, V15, P159, DOI 10.3109/15563657908989861; SWADDIWUDHIPONG W, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P125	3	19	20	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	2002	288	5					604	610		10.1001/jama.288.5.604	http://dx.doi.org/10.1001/jama.288.5.604			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	581FJ	12150672				2022-12-28	WOS:000177280200019
J	Chambers, SA; Droubay, T; Jennison, DR; Mattsson, TR				Chambers, SA; Droubay, T; Jennison, DR; Mattsson, TR			Laminar growth of ultrathin metal films on metal oxides: Co on hydroxylated alpha-Al2O3(0001)	SCIENCE			English	Article							EPITAXIAL-GROWTH; SURFACE; ADSORPTION; DYNAMICS; ENERGIES; ALUMINA; RHODIUM; AL2O3; ATOMS; WATER	Metals deposited in vacuum on metal oxides such as alumina normally grow as three-dimensional clusters because of weak adatom-substrate interactions. This tendency hinders our ability to form interfaces of ultrathin, laminar metal films on oxides for use in microelectronics and other technologies where nanostructural control is desired. We present experimental and theoretical results showing that room temperature Co deposition on fully hydroxylated clean sapphire (alpha-Al2O3) produces a surface chemical reaction that leads to laminar growth, despite a large mismatch in lattice constants. This process should be applicable to a wide range of metals and metal oxides.	Pacific NW Natl Lab, Richland, WA 99352 USA; Sandia Natl Labs, Albuquerque, NM 87185 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Sandia National Laboratories	Chambers, SA (corresponding author), Pacific NW Natl Lab, POB 999,MSK8-93, Richland, WA 99352 USA.	sa.chambers@pnl.gov	Mattsson, Thomas/B-6057-2009; Droubay, Tim/D-5395-2016	Droubay, Tim/0000-0002-8821-0322				Baumer M, 1999, PROG SURF SCI, V61, P127, DOI 10.1016/S0079-6816(99)00012-X; Bogicevic A, 1999, SURF SCI, V437, pL741, DOI 10.1016/S0039-6028(99)00746-3; Bogicevic A, 1999, PHYS REV LETT, V82, P4050, DOI 10.1103/PhysRevLett.82.4050; Chambers SA, 2002, J MAGN MAGN MATER, V246, P124, DOI 10.1016/S0304-8853(02)00039-2; Chambers SA, 2000, SURF SCI REP, V39, P105, DOI 10.1016/S0167-5729(00)00005-4; CURTISS LA, 1991, J CHEM PHYS, V94, P7221, DOI 10.1063/1.460205; Eng PJ, 2000, SCIENCE, V288, P1029, DOI 10.1126/science.288.5468.1029; Ertl G, 1999, PHYS TODAY, V52, P32, DOI 10.1063/1.882569; Guenard P, 1998, SURF REV LETT, V5, P321, DOI 10.1142/S0218625X98000591; Hansen KH, 1999, PHYS REV LETT, V83, P4120, DOI 10.1103/PhysRevLett.83.4120; Hass KC, 2000, J PHYS CHEM B, V104, P5527, DOI 10.1021/jp000040p; Heemeier M, 2000, CATAL LETT, V68, P19, DOI 10.1023/A:1019058714724; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; HUNTAROSSO JL, 1996, GEOCHIM COSCOCHIM AC, V60, P305; JAEGER RM, 1991, SURF SCI, V259, P235, DOI 10.1016/0039-6028(91)90555-7; Jennison DR, 2000, SURF SCI, V464, P108, DOI 10.1016/S0039-6028(00)00578-1; Kendelewicz T, 2000, SURF SCI, V453, P32, DOI 10.1016/S0039-6028(00)00305-8; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Libuda J, 1997, SURF SCI, V384, P106, DOI 10.1016/S0039-6028(97)00170-2; Mattsson A. E., UNPUB; MILLS G, 1995, SURF SCI, V324, P305, DOI 10.1016/0039-6028(94)00731-4; Moulder J. F., 1992, HDB XRAY PHOTOELECTR, P261; Niu C, 2000, SURF SCI, V465, P163, DOI 10.1016/S0039-6028(00)00728-7; PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671; PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048; Persson M, 1999, J CHEM PHYS, V110, P2240, DOI 10.1063/1.477836; Rosenhahn A, 1999, APPL SURF SCI, V142, P169, DOI 10.1016/S0169-4332(98)00669-2; STONEHAM AM, 1983, APPL SURF SC, V14, P249, DOI 10.1016/0378-5963(83)90040-5; Stromquist J, 1998, SURF SCI, V397, P382, DOI 10.1016/S0039-6028(97)00759-0; TANUMA S, 1988, SURF INTERFACE ANAL, V11, P577, DOI 10.1002/sia.740111107; Tehrani S, 2000, IEEE T MAGN, V36, P2752, DOI 10.1109/20.908581; THORNTON G, 2000, FARADAY DISCUSS CHEM, V114; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; Verdozzi C, 1999, PHYS REV LETT, V82, P799, DOI 10.1103/PhysRevLett.82.799	35	122	123	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2002	297	5582					827	831		10.1126/science.1073404	http://dx.doi.org/10.1126/science.1073404			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161651				2022-12-28	WOS:000177192800048
J	Dulloo, AG				Dulloo, AG			Biomedicine: A sympathetic defense against obesity	SCIENCE			English	Editorial Material							THERMOGENESIS; GLUTTONY		Univ Fribourg, Dept Med, Div Physiol, CH-1700 Fribourg, Switzerland	University of Fribourg	Dulloo, AG (corresponding author), Univ Fribourg, Dept Med, Div Physiol, CH-1700 Fribourg, Switzerland.	abdul.dulloo@unifr.ch		DULLOO, Abdul/0000-0003-3877-6149				Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; Dulloo AG, 1999, INT J OBESITY, V23, P1118, DOI 10.1038/sj.ijo.0801110; Dulloo AG, 2002, INT J OBESITY, V26, pS46, DOI 10.1038/sj.ijo.0802127; DULLOO AG, 1987, WORLD REV NUTR DIET, V50, P9; Harper ME, 2001, BBA-BIOENERGETICS, V1504, P159, DOI 10.1016/S0005-2728(00)00244-9; KURPAD AV, 1994, AM J PHYSIOL, V266, pE877, DOI 10.1152/ajpendo.1994.266.6.E877; LANDSBERG L, 1984, AM J PHYSIOL, V247, pE181, DOI 10.1152/ajpendo.1984.247.2.E181; MILLER DS, 1967, AM J CLIN NUTR, V20, P1223, DOI 10.1093/ajcn/20.11.1223; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; Stock MJ, 1999, INT J OBESITY, V23, P1105, DOI 10.1038/sj.ijo.0801108; Tataranni PA, 1997, OBES RES, V5, P341, DOI 10.1002/j.1550-8528.1997.tb00562.x	12	51	53	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2002	297	5582					780	781		10.1126/science.1074923	http://dx.doi.org/10.1126/science.1074923			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161638				2022-12-28	WOS:000177192800031
J	Rashed, R				Rashed, R			Portraits of science: A polymath in the 10th century	SCIENCE			English	Article									Ctr Hist Sci & Philosophies Arabes & Medievales, CNRS, UMR 7062, F-94801 Villejuif, France	Centre National de la Recherche Scientifique (CNRS)	Rashed, R (corresponding author), Ctr Hist Sci & Philosophies Arabes & Medievales, CNRS, UMR 7062, 7 Rue Guy Moquet, F-94801 Villejuif, France.							Nazif M, 1942, AL HASAN IBN AL HAYT; Rashed R., 1996, ENCY HIST ARABIC SCI; Sabra A. I., 1989, OPTICS IBN AL HAYTHA; [No title captured]	4	7	7	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2002	297	5582					773	773		10.1126/science.1074591	http://dx.doi.org/10.1126/science.1074591			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161634				2022-12-28	WOS:000177192800025
J	McCracken, JT; McGough, J; Shah, B; Cronin, P; Hong, D; Aman, MG; Arnold, E; Lindsay, R; Nash, P; Hollway, J; McDougle, CJ; Posey, D; Swiezy, N; Kohn, A; Scahill, L; Martin, A; Koenig, K; Volkmar, F; Carroll, D; Lancor, A; Tierney, E; Ghuman, J; Gonzalez, NM; Grados, M; Vitiello, B; Ritz, L; Davies, M; Robinson, J; McMahon, D				McCracken, JT; McGough, J; Shah, B; Cronin, P; Hong, D; Aman, MG; Arnold, E; Lindsay, R; Nash, P; Hollway, J; McDougle, CJ; Posey, D; Swiezy, N; Kohn, A; Scahill, L; Martin, A; Koenig, K; Volkmar, F; Carroll, D; Lancor, A; Tierney, E; Ghuman, J; Gonzalez, NM; Grados, M; Vitiello, B; Ritz, L; Davies, M; Robinson, J; McMahon, D		Res Units Pediat Psychopharmacolog	Risperidone in children with autism and serious behavioral problems	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERVASIVE DEVELOPMENTAL DISORDERS; ATYPICAL ANTIPSYCHOTICS; INFANTILE-AUTISM; HALOPERIDOL; ADOLESCENTS; SYMPTOMS; NETWORK; NORMS	Background Atypical antipsychotic agents, which block postsynaptic dopamine and serotonin receptors, have advantages over traditional antipsychotic medications in the treatment of adults with schizophrenia and may be beneficial in children with autistic disorder who have serious behavioral disturbances. However, data on the safety and efficacy of atypical antipsychotic agents in children are limited. Methods We conducted a multisite, randomized, double-blind trial of risperidone as compared with placebo for the treatment of autistic disorder accompanied by severe tantrums, aggression, or self-injurious behavior in children 5 to 17 years old. The primary outcome measures were the score on the Irritability subscale of the Aberrant Behavior Checklist and the rating on the Clinical Global Impressions - Improvement (CGI-I) scale at eight weeks. Results A total of 101 children (82 boys and 19 girls; mean [+/-SD] age, 8.8 +/- 2.7 years) were randomly assigned to receive risperidone (49 children) or placebo (52). Treatment with risperidone for eight weeks (dose range, 0.5 to 3.5 mg per day) resulted in a 56.9 percent reduction in the Irritability score, as compared with a 14.1 percent decrease in the placebo group (P < 0.001). The rate of a positive response, defined as at least a 25 percent decrease in the Irritability score and a rating of much improved or very much improved on the CGI-I scale, was 69 percent in the risperidone group (34 of 49 children had a positive response) and 12 percent in the placebo group (6 of 52, P < 0.001). Risperidone therapy was associated with an average weight gain of 2.7 +/- 2.9 kg, as compared with 0.8 +/- 2.2 kg with placebo (P < 0.001). Increased appetite, fatigue, drowsiness, dizziness, and drooling were more common in the risperidone group than in the placebo group (P < 0.05 for each comparison). In two thirds of the children with a positive response to risperidone at eight weeks (23 of 34), the benefit was maintained at six months. Conclusions Risperidone was effective and well tolerated for the treatment of tantrums, aggression, or self-injurious behavior in children with autistic disorder. The short period of this trial limits inferences about adverse effects such as tardive dyskinesia.	Yale Univ, Ctr Child Study, New Haven, CT 06520 USA; Univ Calif Los Angeles, Los Angeles, CA 90024 USA; Ohio State Univ, Columbus, OH 43210 USA; Indiana Univ, Indianapolis, IN 46204 USA; Yale Univ, New Haven, CT USA; Kennedy Krieger Inst, Baltimore, MD USA; NIMH, Bethesda, MD 20892 USA; Columbia Univ, New York, NY USA; Nathan S Kline Inst Psychiat Res, Orangeburg, NY USA	Yale University; University of California System; University of California Los Angeles; University System of Ohio; Ohio State University; Indiana University System; Indiana University-Purdue University Indianapolis; Yale University; Kennedy Krieger Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Columbia University; Nathan Kline Institute for Psychiatric Research	Scahill, L (corresponding author), Yale Univ, Ctr Child Study, POB 207900, New Haven, CT 06520 USA.		Vitiello, Benedetto/AAC-1758-2022; Habibi, Nastaran/H-1222-2015; Volkmar, Fred/AEB-0666-2022; Dodangi, Nasrin/H-5753-2017; astaneh, ali nazeri/P-4905-2017; Swiezy, Naomi/AAZ-5697-2021	Grados, Marco/0000-0002-6189-6264; Scahill, Lawrence/0000-0001-5073-1707	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000750, M01RR000052, M01RR000034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [N01MH070001, N01MH080011, N01MH070010, N01MH070009, K23MH001883] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00052, M01 RR00034, M01 RR00750] Funding Source: Medline; NIMH NIH HHS [K23 MH001883-02, N01MH70001, N01MH70010, N01MH80011, N01MH70009] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aman MG, 1999, MENT RETARD DEV D R, V5, P253, DOI 10.1002/(SICI)1098-2779(1999)5:4<253::AID-MRDD2>3.0.CO;2-R; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; ANDERSON LT, 1984, AM J PSYCHIAT, V141, P1195; ANDERSON LT, 1989, J AUTISM DEV DISORD, V19, P227, DOI 10.1007/BF02211843; Arnold LE, 2000, J AUTISM DEV DISORD, V30, P99, DOI 10.1023/A:1005451304303; Brown EC, 2002, RES DEV DISABIL, V23, P45, DOI 10.1016/S0891-4222(01)00091-9; Buitelaar JK, 2001, J CLIN PSYCHIAT, V62, P239, DOI 10.4088/JCP.v62n0405; Campbell M, 1997, J AM ACAD CHILD PSY, V36, P835, DOI 10.1097/00004583-199706000-00022; Carter AS, 1998, J AUTISM DEV DISORD, V28, P287, DOI 10.1023/A:1026056518470; Chakrabarti S, 2001, JAMA-J AM MED ASSOC, V285, P3093, DOI 10.1001/jama.285.24.3093; Fisman S, 1996, J CHILD ADOL PSYCHOP, V6, P177, DOI 10.1089/cap.1996.6.177; FOMBONNE E, 1992, SOC PSYCH PSYCH EPID, V27, P203, DOI 10.1007/BF00789007; GIBBONS RD, 1993, ARCH GEN PSYCHIAT, V50, P739; Glick ID, 2001, J PSYCHIATR RES, V35, P187, DOI 10.1016/S0022-3956(01)00020-6; Guy W., 1976, DHEW PUBLICATION ADM, V76-338; Kapur S, 2001, AM J PSYCHIAT, V158, P360, DOI 10.1176/appi.ajp.158.3.360; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Lord C, 1997, J AUTISM DEV DISORD, V27, P501, DOI 10.1023/A:1025873925661; MARSHBURN EC, 1992, J AUTISM DEV DISORD, V22, P357, DOI 10.1007/BF01048240; McDougle CJ, 2000, CHILD ADOL PSYCH CL, V9, P201; McDougle CJ, 1998, ARCH GEN PSYCHIAT, V55, P633, DOI 10.1001/archpsyc.55.7.633; McDougle CJ, 1997, J AM ACAD CHILD PSY, V36, P685, DOI 10.1097/00004583-199705000-00020; Scahill L, 2001, J CHILD ADOL PSYCHOP, V11, P377, DOI 10.1089/104454601317261555; Schreibman L, 2000, J AUTISM DEV DISORD, V30, P373, DOI 10.1023/A:1005535120023; Simpson G M, 1970, Acta Psychiatr Scand Suppl, V212, P11	25	1004	1060	5	99	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2002	347	5					314	321		10.1056/NEJMoa013171	http://dx.doi.org/10.1056/NEJMoa013171			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	587WC	12151468	Bronze			2022-12-28	WOS:000177665900003
J	Obata, Y; Kono, T; Hatada, I				Obata, Y; Kono, T; Hatada, I			Oogenesis: Maturation of mouse fetal germ cells in vitro - Even immature oocytes can eventually be fertilized after some skilful manipulation.	NATURE			English	Article							EPIGENETIC MODIFICATIONS; IN-VITRO; GROWTH; EXPRESSION; MICE; FOLLICLES		Gunma Univ, Ctr Gene Res, Maebashi, Gumma 3718511, Japan; Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo 1568502, Japan	Gunma University; Tokyo University of Agriculture	Obata, Y (corresponding author), Gunma Univ, Ctr Gene Res, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.	ihatada@showa.gunma-u.ac.jp						Bao SQ, 2000, BIOL REPROD, V62, P616, DOI 10.1095/biolreprod62.3.616; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; BUEHR M, 1985, GAMETE RES, V11, P271, DOI 10.1002/mrd.1120110306; Cortvrindt R, 1996, HUM REPROD, V11, P2656; Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197; Kono T, 1996, NAT GENET, V13, P91, DOI 10.1038/ng0596-91; Lucifero D, 2002, GENOMICS, V79, P530, DOI 10.1006/geno.2002.6732; Obata Y, 2002, J BIOL CHEM, V277, P5285, DOI 10.1074/jbc.M108586200; Obata Y, 1998, DEVELOPMENT, V125, P1553; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631	11	77	79	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2002	418	6897					497	498		10.1038/418497a	http://dx.doi.org/10.1038/418497a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152066	Bronze			2022-12-28	WOS:000177162800027
J	Crawford, SC; Davis, JA; Siddiqui, NA; de Caestecker, L; Gillis, CR; Hole, D				Crawford, SC; Davis, JA; Siddiqui, NA; de Caestecker, L; Gillis, CR; Hole, D			The waiting time paradox: population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland	BRITISH MEDICAL JOURNAL			English	Article							CARCINOMA		Stobhill Gen Hosp, Dept Gynaecol Oncol, Glasgow G21 3UW, Lanark, Scotland; Greater Glasgow Hlth Board, Dept Publ Hlth, Glasgow G3 8YT, Lanark, Scotland; Univ Glasgow, Dept Publ Hlth, W Scotland Canc Surveillance Unit, Glasgow G12 8RZ, Lanark, Scotland; Aberdeen Matern Hosp, Scottish Programme Clin Effectiveness Reprod Hlth, Aberdeen, Scotland	University of Glasgow; University of Aberdeen	Crawford, SC (corresponding author), Stobhill Gen Hosp, Dept Gynaecol Oncol, Glasgow G21 3UW, Lanark, Scotland.							Creutzberg CL, 2000, LANCET, V355, P1404, DOI 10.1016/S0140-6736(00)02139-5; Fruchter R G, 1981, Cancer Detect Prev, V4, P481; MENCZER J, 1995, AM J OBSTET GYNECOL, V173, P774, DOI 10.1016/0002-9378(95)90340-2; *NHS EX, 1999, GUID COMM CANC SERV, P25; SHEPHERD JH, 1989, BRIT J OBSTET GYNAEC, V96, P889, DOI 10.1111/j.1471-0528.1989.tb03341.x	5	78	79	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 27	2002	325	7357					196	196		10.1136/bmj.325.7357.196	http://dx.doi.org/10.1136/bmj.325.7357.196			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580PX	12142308	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000177243900021
J	Robertson, DW; Bedell, R; Lavery, JV; Upshur, R				Robertson, DW; Bedell, R; Lavery, JV; Upshur, R			What kind of evidence do we need to justify humanitarian medical aid?	LANCET			English	Editorial Material							REFUGEE CAMP; DIARRHEA; HEALTH		Univ Toronto, Joint Ctr Bioeth, Dept Family & Community, Toronto, ON M4N 3M5, Canada; Univ Toronto, Joint Ctr Bioeth, Dept Publ Hlth Sci, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Psychiat, Toronto, ON, Canada; Queens Univ, Queens Hlth Policy Res Unit, Kingston, ON, Canada	University of Toronto; University of Toronto; University of Toronto; Queens University - Canada	Upshur, R (corresponding author), Univ Toronto, Joint Ctr Bioeth, Dept Family & Community, Toronto, ON M4N 3M5, Canada.	rupshur@idirect.com	Lavery, James/E-5254-2012; Bedell, Richard/AAC-2595-2020	Bedell, Richard/0000-0002-5687-8053; Upshur, Ross/0000-0003-1128-0557				Banatvala N, 2000, BMJ-BRIT MED J, V321, P101, DOI 10.1136/bmj.321.7253.101; *BRIT MED ASS, 2001, MED PROF HUM RIGHTS; Donabedian A, 1980, EXPLORATIONS QUALITY, V1; Feinstein AR, 1997, AM J MED, V103, P529, DOI 10.1016/S0002-9343(97)00244-1; FORD N, 1999, INTENTIONS CONSEQUEN; Fox RC, 1995, SOC SCI MED, V41, P1607, DOI 10.1016/0277-9536(95)00144-V; GLOVER J, 1999, HUMANITY MORAL HIST, P411; GOODMAN SN, 1988, AM J PUBLIC HEALTH, V78, P1568, DOI 10.2105/AJPH.78.12.1568; Griekspoor A, 2001, BRIT MED J, V323, P740, DOI 10.1136/bmj.323.7315.740; Haelterman E, 1996, TROP MED INT HEALTH, V1, P385, DOI 10.1046/j.1365-3156.1996.d01-49.x; KERRIDGE I, 1998, BRIT MED J, P1151; KHAN MU, 1982, T ROY SOC TROP MED H, V76, P373, DOI 10.1016/0035-9203(82)90194-8; KLEINMAN A, 1988, ILLNESS NARRATIVES, P28; LAVERY JV, 1992, JESUIT J         JUL, P13; *MSF INT, 1995, FIN DOC CHANT M; Naficy A, 1998, JAMA-J AM MED ASSOC, V279, P521, DOI 10.1001/jama.279.7.521; *OMB PROJ WORK GRO, 2000, HUM ACC PROJ WORK HU; Peterson EA, 1998, INT J EPIDEMIOL, V27, P520, DOI 10.1093/ije/27.3.520; Ramsay S, 2001, LANCET, V358, P41, DOI 10.1016/S0140-6736(01)05302-8; Reed BA, 1998, LANCET, V351, P128, DOI 10.1016/S0140-6736(97)06329-0; SCHWEITZER A, 1965, TEACHING REVERENCE L, P9; SHEARS P, 1987, BMJ-BRIT MED J, V295, P314, DOI 10.1136/bmj.295.6593.314; Taylor Charles., 1990, PHILOS HUMAN SCI PHI; TAYLOR WR, 1983, INT J EPIDEMIOL, V12, P433, DOI 10.1093/ije/12.4.433; VESPA J, 1995, BRIT MED J, V311, P652, DOI 10.1136/bmj.311.7006.652; YIP R, 1993, JAMA-J AM MED ASSOC, V270, P587, DOI 10.1001/jama.270.5.587	26	28	28	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 27	2002	360	9329					330	333		10.1016/S0140-6736(02)09558-2	http://dx.doi.org/10.1016/S0140-6736(02)09558-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578DT	12147390				2022-12-28	WOS:000177102700028
J	Cha, RS; Kleckner, N				Cha, RS; Kleckner, N			ATR homolog Mec1 promotes fork progression, thus averting breaks in replication slow zones	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE CHROMOSOME; MEIOTIC DNA-REPLICATION; SITES; PAUSE; MAP; LOCALIZATION; COMPLETION; COHESION; ORIGINS; GROWTH	Budding yeast Mec1, homolog of mammalian ATR, is an essential protein that mediates S-phase checkpoint responses and meiotic recombination. Elimination of Mec1 function leads to genomewide fork stalling followed by chromosome breakage. Breaks do not result from stochastic collapse of stalled forks or other incidental lesions; instead, they occur in specific regions of the genome during a G(2) chromosomal transition. Break regions are found to be genetically encoded replication slow zones (RSZs), a newly discovered yeast chromosomal determinant. Thus, Mec1 has important functions in normal S phase and the genome instability of mec1 (and, analogously, ATR(-/-)) mutants stems from defects in these basic roles.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Kleckner, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	kleckner@fas.harvard.edu		Cha, Rita/0000-0001-8223-1520	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025326, R01GM025326] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM25326, R01 GM025326] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; BAKER BS, 1972, GENETICS, V71, P255; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Borde V, 1999, MOL CELL BIOL, V19, P4832; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; Brown EJ, 2000, GENE DEV, V14, P397; Cha RS, 2000, GENE DEV, V14, P493; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; Dujon B, 1996, TRENDS GENET, V12, P263, DOI 10.1016/0168-9525(96)10027-5; GREENFEDER SA, 1992, MOL CELL BIOL, V12, P4056, DOI 10.1128/MCB.12.9.4056; GREENFEDER SA, 1992, MOL BIOL CELL, V3, P999, DOI 10.1091/mbc.3.9.999; Grushcow JM, 1999, GENETICS, V153, P607; GUTHRIE C, 1991, GUIDE YEAST GENET MO, V194; HENNESSY KM, 1991, GENE DEV, V5, P958, DOI 10.1101/gad.5.6.958; HILL TM, 1996, ESCHERICHIA COLI SAL, P1602; LAIRD CD, 1993, COLD SPRING HARB SYM, V58, P633, DOI 10.1101/SQB.1993.058.01.070; Le SY, 1997, YEAST, V13, P1029, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1029::AID-YEA160>3.0.CO;2-1; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; MATHEWS CK, 1993, PROG NUCLEIC ACID RE, V44, P167, DOI 10.1016/S0079-6603(08)60220-2; NEWLON CS, 1991, GENETICS, V129, P343; NGHIEM P, 2001, P NATL ACAD SCI USA, P9029; Poloumienko A, 2001, MOL BIOL CELL, V12, P3317, DOI 10.1091/mbc.12.11.3317; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; REDDY GPV, 1983, NATURE, V304, P658; SCHLEGEL R, 1986, SCIENCE, V232, P1264, DOI 10.1126/science.2422760; SHARP PM, 1993, NUCLEIC ACIDS RES, V21, P179, DOI 10.1093/nar/21.2.179; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Sutherland G, 1985, FRAGILE SITES HUMAN; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; THEIS J, 2001, MOL CELL BIOL, V21, P2970; Thrower DA, 2001, MOL BIOL CELL, V12, P2800, DOI 10.1091/mbc.12.9.2800; Wang YZ, 2001, MOL CELL BIOL, V21, P4938, DOI 10.1128/MCB.21.15.4938-4948.2001; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; Yang DQ, 2000, NAT CELL BIOL, V2, P893, DOI 10.1038/35046542; Zhao XL, 2001, EMBO J, V20, P3544, DOI 10.1093/emboj/20.13.3544; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; ZHU JG, 1992, MOL CELL BIOL, V12, P4733, DOI 10.1128/MCB.12.10.4733	44	366	378	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2002	297	5581					602	606		10.1126/science.1071398	http://dx.doi.org/10.1126/science.1071398			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142538				2022-12-28	WOS:000177054200051
J	Mahdavi, J; Sonden, B; Hurtig, M; Olfat, FO; Forsberg, L; Roche, N; Angstrom, J; Larsson, T; Teneberg, S; Karlsson, KA; Altraia, S; Wadstrom, T; Kersulyte, D; Berg, DE; Dubois, A; Petersson, C; Magnusson, KE; Norberg, T; Lindh, F; Lundskog, BB; Arnqvist, A; Hammarstrom, L; Boren, T				Mahdavi, J; Sonden, B; Hurtig, M; Olfat, FO; Forsberg, L; Roche, N; Angstrom, J; Larsson, T; Teneberg, S; Karlsson, KA; Altraia, S; Wadstrom, T; Kersulyte, D; Berg, DE; Dubois, A; Petersson, C; Magnusson, KE; Norberg, T; Lindh, F; Lundskog, BB; Arnqvist, A; Hammarstrom, L; Boren, T			Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation	SCIENCE			English	Article							BLOOD-GROUP ANTIGENS; HUMAN GASTRIC EPITHELIUM; SIALYL-LEWIS-A; PATHOGENICITY ISLAND; MONOCLONAL-ANTIBODY; CELL LINEAGE; CARCINOMA; EXPRESSION; GLYCOSYLATION; SPECIFICITY	Helicobacter pylori adherence in the human gastric mucosa involves specific bacterial adhesins and cognate host receptors. Here, we identify sialyl-dimeric-Lewis x glycosphingolipid as a receptor for H. pylori and show that H. pylori infection induced formation of sialyl-Lewis x antigens in gastric epithelium in humans and in a Rhesus monkey. The corresponding sialic acid binding adhesin (SabA) was isolated with the retagging method, and the underlying sabA gene (JHP662/HP0725) was identified. The ability of many H. pylori strains to adhere to sialylated glycoconjugates expressed during chronic inflammation might thus contribute to virulence and the extraordinary chronicity of H. pylori infection.	Umea Univ, Dept Odontol Oral Microbiol, SE-90187 Umea, Sweden; Swedish Inst Infect Dis Control, SE-17182 Solna, Sweden; Univ Gothenburg, Inst Med Biochem, SE-40530 Gothenburg, Sweden; Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; Lund Univ, Dept Infect Dis & Med Microbiol, SE-22362 Lund, Sweden; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Uniformed Serv Univ Hlth Sci, Dept Med, Gastrointestinal & Liver Studies Lab, Bethesda, MD 20814 USA; Linkoping Univ, Dept Mol & Clin Med, Div Med Microbiol, SE-58185 Linkoping, Sweden; Swedish Univ Agr Sci, Dept Chem, SE-75007 Uppsala, Sweden; IsoSep AB, SE-14636 Tullinge, Sweden; Umea Univ, Dept Med Biosci Clin Cytol, SE-90187 Umea, Sweden; Umea Univ, Dept Biol Mol, SE-90187 Umea, Sweden; Karolinska Inst, Novum, Ctr Biotechnol, SE-14157 Huddinge, Sweden	Umea University; Swedish Institute for Infectious Disease Control; University of Gothenburg; University of Tartu; Lund University; Washington University (WUSTL); Uniformed Services University of the Health Sciences - USA; Linkoping University; Swedish University of Agricultural Sciences; Umea University; Umea University; Karolinska Institutet	Boren, T (corresponding author), Umea Univ, Dept Odontol Oral Microbiol, SE-90187 Umea, Sweden.	Thomas.Boren@odont.umu.se	Aspholm, Marina/ABB-5298-2020	Aspholm, Marina/0000-0003-3175-6022; Magnusson, Karl-Eric/0000-0002-7809-8437	NATIONAL CANCER INSTITUTE [R01CA082312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038166, R03AI049161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, R01DK053727] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA082312, R01 CA082312-08] Funding Source: Medline; NIAID NIH HHS [R03 AI49161, R01 AI38166] Funding Source: Medline; NIDDK NIH HHS [P30 DK052574, R01 DK53727, P30 DK52574] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akopyants NS, 1998, MOL MICROBIOL, V28, P37, DOI 10.1046/j.1365-2958.1998.00770.x; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Alper J, 2001, SCIENCE, V291, P2338, DOI 10.1126/science.291.5512.2338; Amado M, 1998, GASTROENTEROLOGY, V114, P462, DOI 10.1016/S0016-5085(98)70529-3; Angstrom J, 1998, GLYCOBIOLOGY, V8, P297, DOI 10.1093/glycob/8.4.297; ARNQVIST A, UNPUB; Barstrom M, 2000, CARBOHYD RES, V328, P525, DOI 10.1016/S0008-6215(00)00128-2; BLASZCZYKTHURIN M, 1987, J BIOL CHEM, V262, P372; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; BOREN T, 1994, SCIENCE, V264, P1387, DOI 10.1126/science.264.5164.1387; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; CLAUSEN H, 1989, VOX SANG, V56, P1, DOI 10.1111/j.1423-0410.1989.tb03040.x; Cover T. L., 2001, PRINCIPLES BACTERIAL, P509; Dubois A, 1999, GASTROENTEROLOGY, V116, P90, DOI 10.1016/S0016-5085(99)70232-5; FALK P, 1993, P NATL ACAD SCI USA, V90, P2035, DOI 10.1073/pnas.90.5.2035; FALK PG, 1995, P NATL ACAD SCI USA, V92, P1515, DOI 10.1073/pnas.92.5.1515; Gerhard M, 1999, P NATL ACAD SCI USA, V96, P12778, DOI 10.1073/pnas.96.22.12778; GERHARD M, 2001, MOL CELL BIOL, pCH12; Guruge JL, 1998, P NATL ACAD SCI USA, V95, P3925, DOI 10.1073/pnas.95.7.3925; HAKOMORI S, 1989, GANGLIOSIDES CANCER, P58; HAKOMORI SI, 1989, ADV CANCER RES, V52, P257; Herron MJ, 2000, SCIENCE, V288, P1653, DOI 10.1126/science.288.5471.1653; HURTIG M, UNPUB; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; KARLSSON KA, 1987, METHOD ENZYMOL, V138, P212; Karlsson KA, 1998, MOL MICROBIOL, V29, P1, DOI 10.1046/j.1365-2958.1998.00854.x; Larsson T, 2000, FEBS LETT, V469, P155, DOI 10.1016/S0014-5793(00)01270-9; LEVERY SB, 1986, CARBOHYD RES, V151, P311, DOI 10.1016/S0008-6215(00)90351-3; MADRID JF, 1990, HISTOCHEMISTRY, V95, P179; MAGNANI JL, 1981, SCIENCE, V212, P55, DOI 10.1126/science.7209516; NORREGAARDJENSEN O, 1999, METHODS MOLEC BIOL, P571; Ota H, 1998, VIRCHOWS ARCH, V433, P419, DOI 10.1007/s004280050269; SAKAMOTO J, 1989, CANCER RES, V49, P745; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; SIPPONEN P, 1986, ACTA PATH MICRO IM A, V94, P305; SIPPONEN P, 1989, SCAND J GASTROENTERO, V24, P581, DOI 10.3109/00365528909093093; SUERBAUM S, 1993, J BACTERIOL, V175, P3278, DOI 10.1128/jb.175.11.3278-3288.1993; Syder AJ, 1999, MOL CELL, V3, P263, DOI 10.1016/S1097-2765(00)80454-2; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483	40	639	691	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2002	297	5581					573	578		10.1126/science.1069076	http://dx.doi.org/10.1126/science.1069076			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142529	Green Submitted, Green Accepted			2022-12-28	WOS:000177054200042
J	Jobe, AH				Jobe, AH			Fetal surgery for myelomeningocele	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Childrens Hosp, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Jobe, AH (corresponding author), Childrens Hosp, Cincinnati, OH 45229 USA.								0	5	5	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 25	2002	347	4					230	231		10.1056/NEJMp020073	http://dx.doi.org/10.1056/NEJMp020073			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587WB	12140297				2022-12-28	WOS:000177665800001
J	Hobbs, NK; Bondareva, AA; Barnett, S; Capecchi, MR; Schmidt, EE				Hobbs, NK; Bondareva, AA; Barnett, S; Capecchi, MR; Schmidt, EE			Removing the vertebrate-specific TBP N terminus disrupts placental beta 2m-dependent interactions with the maternal immune system	CELL			English	Article							TATA-BINDING PROTEIN; MHC CLASS-I; TFIID-TAU; T-CELLS; MOUSE; MICE; GENE; TRANSCRIPTION; PREGNANCY; IMPLANTATION	Mammalian TBP consists of a 180 amino acid core that is common to all eukaryotes, fused to a vertebrate-specific N-terminal domain. We generated mice having a modified tbp allele, tbp(DeltaN), that produces a version of TBP lacking 111 of the 135 vertebrate-specific amino acids. Most tbp(DeltaN/DeltaN) fetuses (>90%) died in mid-gestation from an apparent defect in the placenta. tbp(DeltaN/DeltaN) fetuses could be rescued by supplying them with a wild-type tetraploid placenta. Mutants also could be rescued by rearing them in immunocompromised mothers. In immune-competent mothers, survival of tbp(DeltaN/DeltaN) fetuses increased when fetal/placental beta2m expression was genetically disrupted. These results suggest that the TBP N terminus functions in transcriptional regulation of a placental beta2m-dependent process that favors maternal immunotolerance of pregnancy.	Montana State Univ, Vet Mol Biol Marsh Labs, Bozeman, MT 59717 USA; Univ Utah, Howard Hughes Med Inst, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA	Montana State University System; Montana State University Bozeman; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Schmidt, EE (corresponding author), Montana State Univ, Vet Mol Biol Marsh Labs, Bozeman, MT 59717 USA.	eschmidt@montana.edu			NICHD NIH HHS [R03 HD035824-02, R03 HD039242-01, R03 HD039242-02] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD039242, R03HD035824] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Auchinloss H.J, 1999, FUNDAMENTAL IMMUNOLO, P1175; CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020; Dang Y, 2001, J IMMUNOL, V166, P3641, DOI 10.4049/jimmunol.166.6.3641; Du Pasquier L., 1999, FUNDAMENTAL IMMUNOLO, P605; DYNLACHT BD, 1991, CELL, V66, P563, DOI 10.1016/0092-8674(81)90019-2; Erlebacher A, 2001, CURR OPIN IMMUNOL, V13, P590, DOI 10.1016/S0952-7915(00)00264-8; Freiman RN, 2001, SCIENCE, V293, P2084, DOI 10.1126/science.1061935; Fuzzi B, 2002, EUR J IMMUNOL, V32, P311, DOI 10.1002/1521-4141(200202)32:2<311::AID-IMMU311>3.3.CO;2-#; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; HALLAK M, 1994, J SOC GYNECOL INVEST, V1, P25, DOI 10.1177/107155769400100106; HASHIMOTO S, 1992, NUCLEIC ACIDS RES, V20, P3788, DOI 10.1093/nar/20.14.3788; Hausner W, 2001, J BACTERIOL, V183, P3025, DOI 10.1128/JB.183.10.3025-3031.2001; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; Hiller MA, 2001, GENE DEV, V15, P1021, DOI 10.1101/gad.869101; Hogan B, 1994, MANIPULATING MOUSE E; HUNZIKER RD, 1986, CRC CR REV IMMUNOL, V6, P245; Hutter H, 1998, Dev Immunol, V6, P197, DOI 10.1155/1998/65065; JAFFE L, 1992, P NATL ACAD SCI USA, V89, P5927, DOI 10.1073/pnas.89.13.5927; JAFFE L, 1991, J IMMUNOL, V147, P2740; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Kraut N, 1998, EMBO J, V17, P6276, DOI 10.1093/emboj/17.21.6276; LI XP, 1993, TRANSPLANTATION, V55, P940, DOI 10.1097/00007890-199304000-00046; Littlefield O, 1999, P NATL ACAD SCI USA, V96, P13668, DOI 10.1073/pnas.96.24.13668; Loke YW, 2000, J REPROD FERTIL, P83; MARGULIES DH, 1999, FUNDAMENTAL IMMUNOLO, P263; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; NAGY A, 1990, DEVELOPMENT, V110, P815; Ohbayashi T, 1996, BIOCHEM BIOPH RES CO, V225, P275, DOI 10.1006/bbrc.1996.1166; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Pfeiffer KA, 2001, MOL HUM REPROD, V7, P373, DOI 10.1093/molehr/7.4.373; Qureshi SA, 1997, EMBO J, V16, P2927, DOI 10.1093/emboj/16.10.2927; Rinkenberger JL, 1997, DEV GENET, V21, P6, DOI 10.1002/(SICI)1520-6408(1997)21:1&lt;6::AID-DVG2&gt;3.0.CO;2-B; Riteau B, 2001, TRANSPLANT P, V33, P2360, DOI 10.1016/S0041-1345(01)02021-8; ROSSANT J, 1998, MECH DEVELOP, V73, P133; Schmidt EE, 1997, J BIOL CHEM, V272, P5326, DOI 10.1074/jbc.272.8.5326; SCHREIBER H, 1999, FUNDAMENTAL IMMUNOLO, P1237; SHEVACH EM, 1999, FUNDAMENTAL IMMUNOLO, P1089; SUMITA K, 1993, NUCLEIC ACIDS RES, V21, P2769, DOI 10.1093/nar/21.11.2769; TAFURI A, 1995, SCIENCE, V270, P630, DOI 10.1126/science.270.5236.630; TAKADA R, 1992, P NATL ACAD SCI USA, V89, P11809, DOI 10.1073/pnas.89.24.11809; Tanaka M, 1997, DEV BIOL, V190, P55, DOI 10.1006/dbio.1997.8685; van Kampen CA, 2001, HUM IMMUNOL, V62, P201, DOI 10.1016/S0198-8859(01)00209-9; VANVLASSELAER P, 1984, CELL IMMUNOL, V83, P422, DOI 10.1016/0008-8749(84)90322-8; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x; WEGMANN TG, 1980, CAN MED ASSOC J, V123, P991; WEGMANN TG, 1979, P NATL ACAD SCI USA, V76, P2410, DOI 10.1073/pnas.76.5.2410; Xu CG, 2000, SCIENCE, V287, P498, DOI 10.1126/science.287.5452.498; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; Yamasaki M, 2001, J IMMUNOL, V166, P7244, DOI 10.4049/jimmunol.166.12.7244; Zhang D, 2001, SCIENCE, V292, P1153, DOI 10.1126/science.1059188	54	32	36	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 12	2002	110	1					43	54		10.1016/S0092-8674(02)00806-1	http://dx.doi.org/10.1016/S0092-8674(02)00806-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	573PU	12150996	Green Accepted, Bronze			2022-12-28	WOS:000176840700006
J	Brochard, L				Brochard, L			Noninvasive ventilation for acute respiratory failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POSITIVE AIRWAY PRESSURE; OBSTRUCTIVE PULMONARY-DISEASE; RANDOMIZED CONTROLLED TRIAL; CONVENTIONAL MECHANICAL VENTILATION; FACE MASK; SUPPORT VENTILATION; ACUTE EXACERBATIONS; EDEMA; THERAPY; INSUFFICIENCY		Univ Paris 11, Assistance Publ Hop Paris, Hop Henri Mondor, Med Intens Care Unit, Creteil, France; INSERM, U492, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm)	Brochard, L (corresponding author), Hop Henri Mondor, Serv Reanimat Med, F-94010 Creteil, France.							AbouShala N, 1996, CRIT CARE MED, V24, P705, DOI 10.1097/00003246-199604000-00025; Aguilo R, 1997, CHEST, V112, P117, DOI 10.1378/chest.112.1.117; Antonelli M, 1998, NEW ENGL J MED, V339, P429, DOI 10.1056/NEJM199808133390703; Antonelli M, 2000, JAMA-J AM MED ASSOC, V283, P235, DOI 10.1001/jama.283.2.235; Auriant I, 2001, AM J RESP CRIT CARE, V164, P1231, DOI 10.1164/ajrccm.164.7.2101089; Azoulay E, 2001, CRIT CARE MED, V29, P519, DOI 10.1097/00003246-200103000-00009; Barbe F, 1996, EUR RESPIR J, V9, P1240, DOI 10.1183/09031936.96.09061240; BERSTEN AD, 1991, NEW ENGL J MED, V325, P1825, DOI 10.1056/NEJM199112263252601; BOTT J, 1993, LANCET, V341, P1555, DOI 10.1016/0140-6736(93)90696-E; BROCHARD L, 1995, NEW ENGL J MED, V333, P817, DOI 10.1056/NEJM199509283331301; BROCHARD L, 1990, NEW ENGL J MED, V323, P1523, DOI 10.1056/NEJM199011293232204; BROCHARD L, 1999, CURR OPIN CRIT CARE, V5, P28; Calderini E, 1999, INTENS CARE MED, V25, P662, DOI 10.1007/s001340050927; Carlucci A, 2001, AM J RESP CRIT CARE, V163, P874, DOI 10.1164/ajrccm.163.4.2006027; CARREY Z, 1990, CHEST, V97, P150, DOI 10.1378/chest.97.1.150; Confalonieri M, 1999, AM J RESP CRIT CARE, V160, P1585, DOI 10.1164/ajrccm.160.5.9903015; Corrado A, 1996, EUR RESPIR J, V9, P1531, DOI 10.1183/09031936.96.09071531; Delclaux C, 2000, JAMA-J AM MED ASSOC, V284, P2352, DOI 10.1001/jama.284.18.2352; Evans T W, 2001, Intensive Care Med, V27, P166, DOI 10.1007/s001340000721; Girault C, 1999, AM J RESP CRIT CARE, V160, P86, DOI 10.1164/ajrccm.160.1.9802120; Girou E, 2000, JAMA-J AM MED ASSOC, V284, P2361, DOI 10.1001/jama.284.18.2361; Hilbert G, 1998, EUR RESPIR J, V11, P1349, DOI 10.1183/09031936.98.11061349; Hilbert G, 2001, NEW ENGL J MED, V344, P481, DOI 10.1056/NEJM200102153440703; Keenan SP, 2002, JAMA-J AM MED ASSOC, V287, P3238, DOI 10.1001/jama.287.24.3238; KRAMER N, 1995, AM J RESP CRIT CARE, V151, P1799, DOI 10.1164/ajrccm.151.6.7767523; Lenique F, 1997, AM J RESP CRIT CARE, V155, P500, DOI 10.1164/ajrccm.155.2.9032185; LIN M, 1995, CHEST, V107, P1379, DOI 10.1378/chest.107.5.1379; MAKI DG, 1989, ARCH INTERN MED, V149, P30, DOI 10.1001/archinte.149.1.30; Martin TJ, 2000, AM J RESP CRIT CARE, V161, P807, DOI 10.1164/ajrccm.161.3.9808143; Masip J, 2000, LANCET, V356, P2126, DOI 10.1016/S0140-6736(00)03492-9; MEDURI GU, 1994, CRIT CARE MED, V22, P1584; Mehta S, 1997, CRIT CARE MED, V25, P620, DOI 10.1097/00003246-199704000-00011; Mehta S, 2001, AM J RESP CRIT CARE, V163, P540, DOI 10.1164/ajrccm.163.2.9906116; Nava S, 1997, CHEST, V111, P1631, DOI 10.1378/chest.111.6.1631; Nava S, 1998, ANN INTERN MED, V128, P721, DOI 10.7326/0003-4819-128-9-199805010-00004; Navalesi P, 2000, CRIT CARE MED, V28, P1785, DOI 10.1097/00003246-200006000-00015; Plant PK, 2000, LANCET, V355, P1931, DOI 10.1016/S0140-6736(00)02323-0; Richards GN, 1996, AM J RESP CRIT CARE, V154, P182, DOI 10.1164/ajrccm.154.1.8680678; Sharon A, 2000, J AM COLL CARDIOL, V36, P832, DOI 10.1016/S0735-1097(00)00785-3; Thorens JB, 1997, EUR RESPIR J, V10, P2553, DOI 10.1183/09031936.97.10112553; Wood KA, 1998, CHEST, V113, P1339, DOI 10.1378/chest.113.5.1339; WYSOCKI M, 1995, CHEST, V107, P761, DOI 10.1378/chest.107.3.761	42	63	67	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2002	288	8					932	935		10.1001/jama.288.8.932	http://dx.doi.org/10.1001/jama.288.8.932			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587RM	12190351				2022-12-28	WOS:000177656400002
J	Sadler, JE				Sadler, JE			Biomedicine: Contact - How platelets touch von Willebrand factor	SCIENCE			English	Editorial Material							GLYCOPROTEIN-IB-ALPHA; VONWILLEBRAND DISEASE; BINDING; MUTATION; DOMAIN		St Louis Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; St Louis Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; St Louis Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Saint Louis University; Saint Louis University; Howard Hughes Medical Institute; Saint Louis University	Sadler, JE (corresponding author), St Louis Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.		Sadler, Evan/D-8556-2011	Sadler, J. Evan/0000-0001-5705-469X				Celikel R, 2000, NAT STRUCT BIOL, V7, P881; Doggett TA, 2002, BIOPHYS J, V83, P194, DOI 10.1016/S0006-3495(02)75161-8; Dong JF, 2001, J BIOL CHEM, V276, P16690, DOI 10.1074/jbc.M101035200; Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; MARCHESE P, 1995, J BIOL CHEM, V270, P9571, DOI 10.1074/jbc.270.16.9571; Matsushita T, 2000, J BIOL CHEM, V275, P11044, DOI 10.1074/jbc.275.15.11044; MILLER JL, 1991, P NATL ACAD SCI USA, V88, P4761, DOI 10.1073/pnas.88.11.4761; RUSSELL SD, 1993, BLOOD, V81, P1787; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; Shen Y, 2000, BLOOD, V95, P903, DOI 10.1182/blood.V95.3.903.003k37_903_910; SUGIMOTO M, 1993, J BIOL CHEM, V268, P12185; UFF S, 2002, J BIOL CHEM    0626	14	35	36	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2002	297	5584					1128	1129		10.1126/science.1075452	http://dx.doi.org/10.1126/science.1075452			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183613				2022-12-28	WOS:000177447600030
J	Choi, HJ; Roundy, D; Sun, H; Cohen, ML; Louie, SG				Choi, HJ; Roundy, D; Sun, H; Cohen, ML; Louie, SG			The origin of the anomalous superconducting properties of MgB2	NATURE			English	Article							ENERGY	Magnesium diboride(1) differs from ordinary metallic superconductors in several important ways, including the failure of conventional models(2) to predict accurately its unusually high transition temperature, the effects of isotope substitution on the critical transition temperature, and its anomalous specific heat(3-5). A detailed examination of the energy associated with the formation of charge-carrying pairs, referred to as the 'superconducting energy gap', should clarify why MgB2 is different. Some early experimental studies have indicated that MgB2 has multiple gaps(3-9), but past theoretical studies(10-16) have not explained from first principles the origin of these gaps and their effects. Here we report an ab initio calculation of the superconducting gaps in MgB2 and their effects on measurable quantities. An important feature is that the electronic states dominated by orbitals in the boron plane couple strongly to specific phonon modes, making pair formation favourable. This explains the high transition temperature, the anomalous structure in the specific heat, and the existence of multiple gaps in this material. Our analysis suggests comparable or higher transition temperatures may result in layered materials based on B, C and N with partially filled planar orbitals.	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Louie, SG (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	sglouie@uclink.berkeley.edu	Choi, Hyoung Joon/N-8933-2015; Roundy, David/AAG-2356-2019; Sun, Hong/O-1206-2015	Choi, Hyoung Joon/0000-0001-8565-8597; Roundy, David/0000-0001-5287-5472; 				ALLEN PB, 1982, SOLID STATE PHYS, V37, P1; An JM, 2001, PHYS REV LETT, V86, P4366, DOI 10.1103/PhysRevLett.86.4366; BARDEEN J, 1964, PHYS REV A-GEN PHYS, V136, P1485, DOI 10.1103/PhysRev.136.A1485; Bohnen KP, 2001, PHYS REV LETT, V86, P5771, DOI 10.1103/PhysRevLett.86.5771; Bouquet F, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.047001; Buzea C, 2001, SUPERCOND SCI TECH, V14, pR115, DOI 10.1088/0953-2048/14/11/201; CARBOTTE JP, 1990, REV MOD PHYS, V62, P1027, DOI 10.1103/RevModPhys.62.1027; Chen XB, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.012001; Choi HJ, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.020513; Eliashberg G M, 1960, ZH EKSP TEOR FIZ, V11, P696; ELIASHBERG GM, 1960, SOV PHYS JETP-USSR, V11, P696; Giubileo F, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.177008; Hinks DG, 2001, NATURE, V411, P457, DOI 10.1038/35078037; Karapetrov G, 2001, PHYS REV LETT, V86, P4374, DOI 10.1103/PhysRevLett.86.4374; Kong Y, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.020501; Kortus J, 2001, PHYS REV LETT, V86, P4656, DOI 10.1103/PhysRevLett.86.4656; Liu AY, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.087005; MARSIGLIO F, 1988, PHYS REV B, V37, P4965, DOI 10.1103/PhysRevB.37.4965; Nagamatsu J, 2001, NATURE, V410, P63, DOI 10.1038/35065039; Rubio-Bollinger G, 2001, PHYS REV LETT, V86, P5582, DOI 10.1103/PhysRevLett.86.5582; Schmidt H, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.220504; Sharoni A, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.220508; SUHL H, 1959, PHYS REV LETT, V3, P552, DOI 10.1103/PhysRevLett.3.552; Takahashi T, 2001, PHYS REV LETT, V86, P4915, DOI 10.1103/PhysRevLett.86.4915; Tsuda S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.177006; Wang YX, 2001, PHYSICA C, V355, P179, DOI 10.1016/S0921-4534(01)00617-7; Yang HD, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.167003; Yildirim T, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.037001	29	777	795	8	230	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2002	418	6899					758	760		10.1038/nature00898	http://dx.doi.org/10.1038/nature00898			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181561				2022-12-28	WOS:000177428000033
J	Hirsch, HH; Knowles, W; Dickenmann, M; Passweg, J; Klimkait, T; Mihatsch, MJ; Steiger, J				Hirsch, HH; Knowles, W; Dickenmann, M; Passweg, J; Klimkait, T; Mihatsch, MJ; Steiger, J			Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERSTITIAL NEPHRITIS; ALLOGRAFT RECIPIENTS; VIRUS NEPHROPATHY; DIAGNOSIS; INFECTION; REJECTION; DISEASE; KIDNEY; LOAD; DNA	Background Nephropathy associated with the polyomavirus type BK (BKV) nephropathy has emerged as a cause of allograft failure linked to immunosuppressive regimens containing tacrolimus or mycophenolate mofetil. The presence of viral inclusions, known as "decoy cells," in urine and the presence of BKV DNA in plasma have been proposed as markers for the replication of BKV and associated nephropathy, but data from prospective studies have been lacking. Methods In a prospective, single-center study, we followed 78 renal-transplant recipients who were receiving immunosuppressive therapy that included tacrolimus (37 patients) or mycophenolate mofetil (41 patients). Urine was tested for the presence of decoy cells at routine visits. BKV DNA was measured 3, 6, and 12 months after transplantation and whenever decoy cells were detected. The! viral load in plasma was quantified with the use of a real-time polymerase-chain-reaction method. Renal biopsy was performed if allograft function deteriorated. Results Twenty-three patients had decoy-cell shedding a median of 16 weeks after transplantation (range, 2 to 69), 10 patients had BKV viremia at a median of 23 weeks (range, 4 to 73),,and 5 had BKV nephropathy at a median of 28 weeks (range, 8 to 86). Kaplan-Meier estimates of the probability of decoy-cell shedding, viremia, and nephropathy were 30 percent (95 percent confidence interval, 20 to 40 percent), 13 percent (95 percent confidence interval, 5 to 21 percent), and 8 percent (95 percent confidence interval, 1 to 15 percent), respectively. Antirejection treatment, particularly with corticosteroids, was associated with BKV replication and nephropathy. The viral load in plasma was higher in patients with BKV nephropathy than in those without nephropathy (P < 0.001 by the Mann-Whitney test). BKV antibodies were detected in 77 percent of the 78 patients, before transplantation, including 4 of 5 with BKV nephropathy. Conclusions BKV nephropathy in renal-transplant recipients represents a secondary infection associated with rejection and its treatment in most cases and could be monitored by measuring the viral load in plasma.	Univ Basel, Div Infect Dis, Basel, Switzerland; Univ Basel, Inst Med Microbiol, Basel, Switzerland; Univ Basel, Div Nephrol & Transplantat Immunol, Basel, Switzerland; Univ Basel, Div Hematol, Basel, Switzerland; Univ Basel, Inst Pathol, Basel, Switzerland; Cent Publ Hlth Lab, Neurol Virus Lab, London NW9 5HT, England	University of Basel; University of Basel; University of Basel; University of Basel; University of Basel; Public Health England	Hirsch, HH (corresponding author), Univ Basel Hosp, Dept Internal Med, Div Infect Dis, Petersgraben 4, CH-4031 Basel, Switzerland.		Klimkait, Thomas/A-1057-2008; passweg, jakob/AAG-3911-2020; Dickenmann, Michael/A-7813-2011	Klimkait, Thomas/0000-0003-4945-6511; Hirsch, Hans H./0000-0003-0883-0423; Passweg, Jakob R/0000-0001-7092-3351				Binet I, 1999, TRANSPLANTATION, V67, P918, DOI 10.1097/00007890-199903270-00022; CHESTERS PM, 1983, J INFECT DIS, V147, P676, DOI 10.1093/infdis/147.4.676; Colvin RB, 2001, TRANSPLANT P, V33, P1778, DOI 10.1016/S0041-1345(00)02676-2; Colvin RB, 1997, J AM SOC NEPHROL, V8, P1930; de Ligny BH, 2000, TRANSPL P, V32, P2760, DOI 10.1016/S0041-1345(00)01869-8; Drachenberg CB, 1999, HUM PATHOL, V30, P970, DOI 10.1016/S0046-8177(99)90252-6; Hirsch HH, 2002, AM J TRANSPLANT, V2, P25, DOI 10.1034/j.1600-6143.2002.020106.x; Hirsch HH, 2001, J INFECT DIS, V184, P1494, DOI 10.1086/324425; Howell DN, 1999, TRANSPLANTATION, V68, P1279, DOI 10.1097/00007890-199911150-00011; IMPERIALE MJ, 2001, HUMAN POLYOMAVIRUSES, V53, P71; Knowles WA, 1999, J MED VIROL, V59, P474, DOI 10.1002/(SICI)1096-9071(199912)59:4&lt;474::AID-JMV9&gt;3.0.CO;2-W; Limaye AP, 2001, J INFECT DIS, V183, P1669, DOI 10.1086/320711; Mathur VS, 1997, AM J KIDNEY DIS, V29, P754; Mayr M, 2001, AM J KIDNEY DIS, V38, part. no., DOI 10.1053/ajkd.2001.26917; Nickeleit V, 2000, NEW ENGL J MED, V342, P1309, DOI 10.1056/NEJM200005043421802; Nickeleit V, 1999, J AM SOC NEPHROL, V10, P1080; Nickeleit V, 2000, NEPHROL DIAL TRANSPL, V15, P324, DOI 10.1093/ndt/15.3.324; PURIGHALLA R, 1995, AM J KIDNEY DIS, V26, P671, DOI 10.1016/0272-6386(95)90608-8; Randhawa PS, 2000, NEW ENGL J MED, V342, P1361, DOI 10.1056/NEJM200005043421809; Randhawa PS, 1999, TRANSPLANTATION, V67, P103, DOI 10.1097/00007890-199901150-00018; Shah KV, 2000, NEPHROL DIAL TRANSPL, V15, P754, DOI 10.1093/ndt/15.6.754; Stoner GL, 2001, HUMAN POLYOMAVIRUSES, P527, DOI DOI 10.1002/0471221945.CH19	22	878	935	1	27	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 15	2002	347	7					488	496		10.1056/NEJMoa020439	http://dx.doi.org/10.1056/NEJMoa020439			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587ZM	12181403				2022-12-28	WOS:000177674400005
J	Phillips, OL; Martinez, RV; Arroyo, L; Baker, TR; Killeen, T; Lewis, SL; Malhi, Y; Mendoza, AM; Neill, D; Vargas, PN; Alexiades, M; Ceron, C; Di Fiore, A; Erwin, T; Jardim, A; Palacios, W; Saldias, M; Vinceti, B				Phillips, OL; Martinez, RV; Arroyo, L; Baker, TR; Killeen, T; Lewis, SL; Malhi, Y; Mendoza, AM; Neill, D; Vargas, PN; Alexiades, M; Ceron, C; Di Fiore, A; Erwin, T; Jardim, A; Palacios, W; Saldias, M; Vinceti, B			Increasing dominance of large lianas in Amazonian forests	NATURE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; TROPICAL FORESTS; RAIN-FOREST; PATTERNS; BIOMASS; SINK	Ecological orthodoxy suggests that old-growth forests should be close to dynamic equilibrium, but this view has been challenged by recent findings that neotropical forests are accumulating carbon(1,2) and biomass(3,4), possibly in response to the increasing atmospheric concentrations of carbon dioxide(5,6). However, it is unclear whether the recent increase in tree biomass has been accompanied by a shift in community composition. Such changes could reduce or enhance the carbon storage potential of old-growth forests in the long term. Here we show that non-fragmented Amazon forests are experiencing a concerted increase in the density, basal area and mean size of woody climbing plants (lianas). Over the last two decades of the twentieth century the dominance of large lianas relative to trees has increased by 1.7-4.6% a year. Lianas enhance tree mortality and suppress tree growth(7), so their rapid increase implies that the tropical terrestrial carbon sink may shut down sooner than current models suggest(8-10). Predictions of future tropical carbon fluxes will need to account for the changing composition and dynamics of supposedly undisturbed forests.	Univ Leeds, Sch Geog, Ctr Biodivers & Conservat, Leeds LS2 9JT, W Yorkshire, England; Jardin Bot Missouri, Jaen, Peru; Missouri Bot Garden, St Louis, MO 63166 USA; Museo Hist Nat Moel Kempff Mercado, Santa Cruz, Bolivia; Conservat Int, Washington, DC 20036 USA; Univ Edinburgh, Sch Earth Environm & Geog Sci, Edinburgh EH9 3JU, Midlothian, Scotland; Univ San Antonio Abad Cusco, Herbario Vargas, Cuzco, Peru; Fdn Jatun Sacha, Quito, Ecuador; Univ Cent Ecuador, Escuela Biol, Herbario QAP, Quito, Ecuador; New York Bot Garden, Bronx, NY 10458 USA; NYU, Dept Anthropol, New York, NY 10003 USA; Smithsonian Inst, Museum Nat Hist, Washington, DC 20560 USA	University of Leeds; Missouri Botanical Gardens; Conservation International; University of Edinburgh; Universidad Nacional de San Antonio Abad del Cusco; Universidad Central del Ecuador; New York Botanical Garden; New York University; Smithsonian Institution; Smithsonian National Museum of Natural History	Phillips, OL (corresponding author), Univ Leeds, Sch Geog, Ctr Biodivers & Conservat, Leeds LS2 9JT, W Yorkshire, England.	o.phillips@geog.leeds.ac.uk	Phillips, Oliver/A-1523-2011	Phillips, Oliver/0000-0002-8993-6168; Neill, David Alan/0000-0002-5143-9430; Lewis, Simon/0000-0002-8066-6851				Brown S., 1997, FAO Forestry Paper; Chambers JQ, 2001, NATURE, V410, P429, DOI 10.1038/35068624; Condit R, 1996, J VEG SCI, V7, P405, DOI 10.2307/3236284; CONDON MA, 1992, FUNCT ECOL, V6, P680, DOI 10.2307/2389964; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Gentry A.H., 1991, BIOL VINES, P3; Gerwing JJ, 2000, J TROP ECOL, V16, P327, DOI 10.1017/S0266467400001437; GRACE J, 1995, SCIENCE, V270, P778, DOI 10.1126/science.270.5237.778; GRANADOS J, IN PRESS GLOB CHANGE; Hegarty E.E., 1991, BIOL VINES, P313; Korner C, 2000, ECOL APPL, V10, P1590, DOI 10.2307/2641226; Laurance WF, 2001, ECOLOGY, V82, P105, DOI 10.1890/0012-9658(2001)082[0105:RFFATS]2.0.CO;2; Malhi Y, 1998, J GEOPHYS RES-ATMOS, V103, P31593, DOI 10.1029/98JD02647; Malhi Y, 2000, TRENDS ECOL EVOL, V15, P332, DOI 10.1016/S0169-5347(00)01906-6; MALHI Y, IN PRESS J VEGN SCI; Perez-Salicrup DR, 2001, BIOTROPICA, V33, P34, DOI 10.1111/j.1744-7429.2001.tb00155.x; PHILLIPS O, 1993, ECON BOT, V47, P33, DOI 10.1007/BF02862204; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Phillips OL, 2002, ECOL APPL, V12, P576, DOI 10.1890/1051-0761(2002)012[0576:CIGOTF]2.0.CO;2; PHILLIPS OL, 1994, SCIENCE, V263, P954, DOI 10.1126/science.263.5149.954; Phillips OL, 1997, BIODIVERS CONSERV, V6, P291, DOI 10.1023/A:1018352405482; PHILLIPS OL, IN PRESS GLOBAL PATT; PRENTICE IC, 2001, IN PRESS CLIMATE CHA, pCH3; PUTZ FE, 1983, BIOTROPICA, V15, P185, DOI 10.2307/2387827; Retallack GJ, 2001, NATURE, V411, P287, DOI 10.1038/35077041; Schnitzer SA, 2002, TRENDS ECOL EVOL, V17, P223, DOI 10.1016/S0169-5347(02)02491-6; Sombroek W, 2001, AMBIO, V30, P388, DOI 10.1639/0044-7447(2001)030[0388:SATPOA]2.0.CO;2; van Reeuwijk L.P, 1995, PROCEDURES SOIL ANAL; White A, 2000, GLOBAL CHANGE BIOL, V6, P817, DOI 10.1046/j.1365-2486.2000.00358.x	29	405	442	3	106	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 15	2002	418	6899					770	774		10.1038/nature00926	http://dx.doi.org/10.1038/nature00926			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181565	Green Accepted			2022-12-28	WOS:000177428000037
J	Parienti, JJ; Thibon, P; Heller, R; Le Roux, Y; von Theobald, P; Bensadoun, H; Bouvet, A; Lemarchand, F; Le Coutour, X				Parienti, JJ; Thibon, P; Heller, R; Le Roux, Y; von Theobald, P; Bensadoun, H; Bouvet, A; Lemarchand, F; Le Coutour, X		Antisepsie Chirurgicale Mains Stud	Hand-rubbing with an aqueous alcoholic solution vs traditional surgical hand-scrubbing and 30-day surgical site infection rates - A randomized equivalence study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WOUND-INFECTION; NOSOCOMIAL INFECTIONS; DISINFECTION; SURVEILLANCE; OUTBREAK; EFFICACY; AGENTS	Context Surgical site infections prolong hospital stays, are among the leading nosocomial causes of morbidity, and a source of excess medical costs. Clinical studies comparing the risk of nosocomial infection after different hand antisepsis protocols are scarce. Objective To compare the effectiveness of hand-cleansing protocols in preventing surgical site infections during routine surgical practice. Design Randomized equivalence trial. Setting Six surgical services from teaching and nonteaching hospitals in France. Patients A total of 4387 consecutive patients who underwent clean and clean-contaminated surgery between January 1, 2000, and May 1, 2001. Interventions Surgical services used 2 hand-cleansing methods alternately every other month: a hand-rubbing protocol with 75% aqueous alcoholic solution containing propanol-1, propanol-2, and mecetronium etilsulfate; and a hand-scrubbing protocol with antiseptic preparation containing 4% povidone iodine or 4% chlorhexidine gluconate. Main Outcome Measures Thirty-day surgical site infection rates were the primary end point; operating department teams' tolerance of and compliance with hand antisepsis were secondary end points. Results The 2 protocols were comparable in regard to surgical site infection risk factors. Surgical site infection rates were 55 of 2252 (2.44%) in the hand-rubbing protocol and 53 of 2135 (2.48%) in the hand-scrubbing protocol, for a difference of 0.04% (95% confidence interval, -0.88% to 0.96%). Based on subsets of personnel, compliance with the recommended duration of hand antisepsis was better in the hand-rubbing protocol of the study compared with the hand-scrubbing protocol (44% vs 28%, respectively; P=.008), as was tolerance, with less skin dryness and less skin irritation after aqueous solution use. Conclusions Hand-rubbing with aqueous alcoholic solution, preceded by a 1-minute nonantiseptic hand wash before each surgeon's first procedure of the day and before any other procedure if the hands were soiled, was as effective as traditional hand-scrubbing with antiseptic soap in preventing surgical site infections. The hand-rubbing protocol was better tolerated by the surgical teams and improved compliance with hygiene guidelines. Hand-rubbing with liquid aqueous alcoholic solution can thus be safely used as an alternative to traditional surgical hand-scrubbing.	Cote Nacre Univ Hosp Ctr, Dept Infect Dis, F-14033 Caen, France; Cote Nacre Univ Hosp Ctr, Dept Hyg & Publ Hlth, Intens Care Unit, F-14033 Caen, France; Cote Nacre Univ Hosp Ctr, Dept Abdominal Surg, F-14033 Caen, France; Cote Nacre Univ Hosp Ctr, Dept Obstet & Gynaecol, F-14033 Caen, France; Cote Nacre Univ Hosp Ctr, Dept Urol, F-14033 Caen, France; Gen Hosp, Dept Hyg, Colmar, France; Francois Baclesse Oncol Ctr, Dept Anaesthesiol, Caen, France; Gen Hosp, Dept Gen Surg, Pont Audemer, France	CHU de Caen NORMANDIE; CHU de Caen NORMANDIE; CHU de Caen NORMANDIE; CHU de Caen NORMANDIE; CHU de Caen NORMANDIE; UNICANCER; Centre Francois Baclesse	Parienti, JJ (corresponding author), Cote Nacre Univ Hosp Ctr, Dept Infect Dis, F-14033 Caen, France.	parienti@u444.jussieu.fr	Parienti, Jean-Jacques/AAD-1701-2021	Parienti, Jean-Jacques/0000-0002-4774-5590				AMER FA, 2000, 40 INT C ANT AG CHEM; [Anonymous], MANUAL CONTROL INFEC; AYLIFFE GAJ, 1988, J HOSP INFECT, V11, P226, DOI 10.1016/0195-6701(88)90101-6; BOYCE JM, 1990, J INFECT DIS, V161, P493, DOI 10.1093/infdis/161.3.493; Boyce JM, 2000, INFECT CONT HOSP EP, V21, P442, DOI 10.1086/501785; COELLO R, 1993, J HOSP INFECT, V25, P239, DOI 10.1016/0195-6701(93)90110-L; Couto RC, 1998, INT J GYNECOL OBSTET, V61, P227, DOI 10.1016/S0020-7292(98)00047-2; DOEBBELING BN, 1992, NEW ENGL J MED, V327, P88, DOI 10.1056/NEJM199207093270205; Dunnett CW, 1996, STAT MED, V15, P1729; Girard R, 2001, J HOSP INFECT, V47, P131, DOI 10.1053/jhin.2000.0854; GIRARD R, 1996, HYGIENES, V12, P34; HALEY RW, 1981, AM J MED, V70, P51, DOI 10.1016/0002-9343(81)90411-3; HALEY RW, 1985, AM J EPIDEMIOL, V121, P206, DOI 10.1093/oxfordjournals.aje.a113991; Hobson DW, 1998, AM J INFECT CONTROL, V26, P507, DOI 10.1016/S0196-6553(98)70024-0; HORAN TC, 1992, AM J INFECT CONTROL, V20, P271, DOI 10.1016/S0196-6553(05)80201-9; Jones E, 1996, BMJ-BRIT MED J, V313, P36, DOI 10.1136/bmj.313.7048.36; LARSON EL, 1986, ANTIMICROB AGENTS CH, V30, P542, DOI 10.1128/AAC.30.4.542; LARSON EL, 1990, INFECT CONT HOSP EP, V11, P139; LEFRANCOIS C, 2001, ANN FR ANESTH S, V20, P2325; MAKUCH R, 1978, CANCER TREAT REP, V62, P1037; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; McNeil SA, 2001, CLIN INFECT DIS, V33, P317, DOI 10.1086/321890; MedinaCuadros M, 1996, AM J INFECT CONTROL, V24, P421, DOI 10.1016/S0196-6553(96)90035-8; OLSON MM, 1990, ARCH SURG-CHICAGO, V125, P794; Parienti JJ, 2002, J HOSP INFECT, V50, P162, DOI 10.1053/jhin.2001.1139; Pereira LJ, 1997, J HOSP INFECT, V36, P49, DOI 10.1016/S0195-6701(97)90090-6; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pittet D, 1999, ANN INTERN MED, V130, P126, DOI 10.7326/0003-4819-130-2-199901190-00006; REYBROUCK G, 1986, J HOSP INFECT, V8, P5, DOI 10.1016/0195-6701(86)90100-3; Sands K, 1996, J INFECT DIS, V173, P963, DOI 10.1093/infdis/173.4.963; THOMAS M, 1974, LANCET, V1, P1215; Wallenstein S, 1997, STAT MED, V16, P1329, DOI 10.1002/(SICI)1097-0258(19970630)16:12<1329::AID-SIM567>3.0.CO;2-I; WENZEL RP, 1995, J HOSP INFECT, V31, P79, DOI 10.1016/0195-6701(95)90162-0	33	176	179	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2002	288	6					722	727		10.1001/jama.288.6.722	http://dx.doi.org/10.1001/jama.288.6.722			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	583KY	12169076	Bronze			2022-12-28	WOS:000177408100033
J	Johnson, D; Whitworth, IH				Johnson, D; Whitworth, IH			Recent developments in plastic surgery	BMJ-BRITISH MEDICAL JOURNAL			English	Review							IMMEDIATE BREAST RECONSTRUCTION; FREE TISSUE TRANSFER; CUTANEOUS MELANOMA; NODE BIOPSY; EXPERIENCE; MANAGEMENT; MASTECTOMY; IMPLANTS; CANCER; NECK		Salisbury Dist Hosp, Dept Plast & Reconstruct Surg, Salisbury SP2 8JB, Wilts, England	Salisbury District Hospital	Johnson, D (corresponding author), Salisbury Dist Hosp, Dept Plast & Reconstruct Surg, Salisbury SP2 8JB, Wilts, England.	davidjohnson_plastic@lycos.co.uk						Banwell P E, 1999, J Wound Care, V8, P79; Bishop JAN, 2002, BRIT J PLAST SURG, V55, P46, DOI 10.1054/bjps.2001.3745; *BRIT ORTH ASS BRI, 1997, BR J PLAST SURG, V50, P570; Clary BM, 2001, ANN SURG, V233, P250, DOI 10.1097/00000658-200102000-00015; FOO ITH, 1993, J HAND SURG-BRIT EUR, V18B, P279, DOI 10.1016/0266-7681(93)90041-D; Francois CG, 2000, MICROSURG, V20, P360, DOI 10.1002/1098-2752(2000)20:8<360::AID-MICR4>3.3.CO;2-5; GEORGIADE GS, 1985, PLAST RECONSTR SURG, V76, P415, DOI 10.1097/00006534-198509000-00014; Gershenwald JE, 1999, J CLIN ONCOL, V17, P976, DOI 10.1200/JCO.1999.17.3.976; Gu YD, 1997, J RECONSTR MICROSURG, V13, P405, DOI 10.1055/s-2007-1006420; Hobby J, 2001, J HAND SURG-BRIT EUR, V26, P459, DOI 10.1054/jhsb.2001.0587; Khoo A, 1998, PLAST RECONSTR SURG, V101, P964, DOI 10.1097/00006534-199804040-00011; Kirkwood JM, 1996, J CLIN ONCOL, V14, P7, DOI 10.1200/JCO.1996.14.1.7; Mullner T, 1997, BRIT J PLAST SURG, V50, P194, DOI 10.1016/S0007-1226(97)91369-2; Musharafieh RS, 1999, INT SURG, V84, P129; OBRIEN W, 1993, AM J SURG, V166, P1, DOI 10.1016/S0002-9610(05)80572-0; PETIT JY, 1994, PLAST RECONSTR SURG, V94, P115, DOI 10.1097/00006534-199407000-00011; Pribaz JJ, 2001, CLIN PLAST SURG, V28, P261; Pribaz JJ, 1999, PLAST RECONSTR SURG, V103, P808, DOI 10.1097/00006534-199903000-00006; PRIBAZ JJ, 1999, OPERATIVE TECHNIQUES, V6, P240; STEVENS LA, 1984, PLAST RECONSTR SURG, V73, P619, DOI 10.1097/00006534-198404000-00018; TAN E, 1988, AUST NZ J SURG, V58, P369, DOI 10.1111/j.1445-2197.1988.tb01081.x; Taylor P, 2001, SPINAL CORD, V39, P156, DOI 10.1038/sj.sc.3101126; Thomas JM, 2000, BRIT MED J, V321, P3, DOI 10.1136/bmj.321.7252.3; Vandeweyer E, 2001, PLAST RECONSTR SURG, V107, P1409, DOI 10.1097/00006534-200105000-00013	24	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 10	2002	325	7359					319	322		10.1136/bmj.325.7359.319	http://dx.doi.org/10.1136/bmj.325.7359.319			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	584RQ	12169510	Green Published			2022-12-28	WOS:000177482500021
J	Roth, GS; Lane, MA; Ingram, DK; Mattison, JA; Elahi, D; Tobin, JD; Muller, D; Metter, EJ				Roth, GS; Lane, MA; Ingram, DK; Mattison, JA; Elahi, D; Tobin, JD; Muller, D; Metter, EJ			Biomarkers of caloric restriction may predict longevity in humans	SCIENCE			English	Article							RHESUS-MONKEYS		NIA, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Roth, GS (corresponding author), NIA, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.				NATIONAL INSTITUTE ON AGING [Z01AG000302, ZIAAG000302, ZIAAG000015, Z01AG000304, Z01AG000015] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		KALIMI M, 1999, DEHYDROEPIANDROSTERO; LANE MA, 1995, AM J PHYSIOL-ENDOC M, V268, pE941, DOI 10.1152/ajpendo.1995.268.5.E941; Lane MA, 1998, J ANTI-AGING MED, V1, P315, DOI DOI 10.1089/rej.1.1998.1.315; Roth GS, 2001, J CLIN ENDOCR METAB, V86, P3292, DOI 10.1210/jc.86.7.3292; Shock N.W., 1984, NORMAL HUMAN AGING B; WEINDRUCH R, 1988, RETARDATION AGING DI; Zainal TA, 2000, FASEB J, V14, P1825, DOI 10.1096/fj.99-0881com	7	292	301	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2002	297	5582					811	811		10.1126/science.1071851	http://dx.doi.org/10.1126/science.1071851			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161648				2022-12-28	WOS:000177192800042
J	Pelletier, L; Stern, CA; Pypaert, M; Sheff, D; Ngo, HM; Roper, N; He, CY; Hu, K; Toomre, D; Coppens, I; Roos, DS; Joiner, KA; Warren, G				Pelletier, L; Stern, CA; Pypaert, M; Sheff, D; Ngo, HM; Roper, N; He, CY; Hu, K; Toomre, D; Coppens, I; Roos, DS; Joiner, KA; Warren, G			Golgi biogenesis in Toxoplasma gondii	NATURE			English	Article							CELL-CYCLE; APPARATUS; COMPLEX; ER; MAINTENANCE; DYNAMICS; MITOSIS; STAGE; EXIT	Two models have been put forward to explain the growth of new Golgi during the cell cycle. The first suggests that a new Golgi grows out of the endoplasmic reticulum by de novo synthesis(1). The second suggests that a pre-existing Golgi is needed for the growth of a new one, that is, the Golgi is an autonomously replicating organelle(2). To resolve this issue, we have exploited the simplicity of the apicomplexan parasite Toxoplasma gondii(3), which has only a single Golgi stack(4). Here we show, by using video fluorescence microscopy and three-dimensional reconstructions of serial thin sections, that the Golgi grows by a process of lateral extension followed by medial fission. Further fission leads to the inheritance by each daughter of a pair of Golgi structures, which then coalesce to re-form a single Golgi. Our results indicate that new Golgi grow by autonomous duplication and raise the possibility that the Golgi is a paired structure that is analogous to centrioles(5).	Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Cell Biol, New Haven, CT 06520 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06520 USA; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	Ludwig Institute for Cancer Research; Yale University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Yale University; University of Pennsylvania	Warren, G (corresponding author), Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.		Sheff, David/A-1269-2007; Pelletier, Laurence/F-8858-2013; He, Cynthia/H-9789-2012; Joiner, Keith/AAH-1059-2021	Joiner, Keith/0000-0003-3062-823X; Roos, David Siker/0000-0001-6725-4089				Bracker CE, 1996, PROTOPLASMA, V194, P250, DOI 10.1007/BF01882032; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; Dubremetz JF, 1998, INT J PARASITOL, V28, P1007, DOI 10.1016/S0020-7519(98)00076-9; Field H, 2000, MOL BIOCHEM PARASIT, V107, P329, DOI 10.1016/S0166-6851(00)00224-3; Hager KM, 1999, J CELL SCI, V112, P2631; Hu K, 2002, MOL BIOL CELL, V13, P593, DOI 10.1091/mbc.01-06-0309; Joiner KA, 2002, J CELL BIOL, V157, P557, DOI 10.1083/jcb.200112144; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Lippincott-Schwartz J, 2000, HISTOCHEM CELL BIOL, V114, P93; LUJAN HD, 1995, J BIOL CHEM, V270, P4612, DOI 10.1074/jbc.270.9.4612; Marshall WF, 2001, CURR BIOL, V11, pR487, DOI 10.1016/S0960-9822(01)00289-5; ODENTHALSCHNITTLER M, 1993, BIOCHEM J, V291, P713, DOI 10.1042/bj2910713; Pelletier L, 2000, NAT CELL BIOL, V2, P840, DOI 10.1038/35041089; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Presley JF, 1998, MOL BIOL CELL, V9, P1617, DOI 10.1091/mbc.9.7.1617; PREUSS D, 1992, MOL BIOL CELL, V3, P789, DOI 10.1091/mbc.3.7.789; Radke JR, 2001, MOL BIOCHEM PARASIT, V115, P165, DOI 10.1016/S0166-6851(01)00284-5; Roos David S., 1999, Novartis Foundation Symposium, V226, P176; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Rossanese OW, 1999, J CELL BIOL, V145, P69, DOI 10.1083/jcb.145.1.69; Seemann J, 2000, NATURE, V407, P1022, DOI 10.1038/35039538; SHEFFIELD HG, 1968, J PARASITOL, V54, P209, DOI 10.2307/3276925; Shima DT, 1997, J CELL BIOL, V137, P1211, DOI 10.1083/jcb.137.6.1211; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; WARREN G, 1993, ANNU REV BIOCHEM, V62, P323, DOI 10.1146/annurev.bi.62.070193.001543; Whaley W.B., 1975, GOLGI APPARATUS; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Wooding S, 1998, MOL BIOL CELL, V9, P2667, DOI 10.1091/mbc.9.9.2667; Zaal KJM, 1999, CELL, V99, P589, DOI 10.1016/S0092-8674(00)81548-2	29	143	153	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2002	418	6897					548	552		10.1038/nature00946	http://dx.doi.org/10.1038/nature00946			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152082				2022-12-28	WOS:000177162800044
J	Chang, F; Peter, M				Chang, F; Peter, M			Cell biology - Formins set the record straight	SCIENCE			English	Editorial Material							ACTIN-POLYMERIZATION; ARP2/3 COMPLEX; PROTEINS		Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA; Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland; Inst Biochem, CH-8032 Zurich, Switzerland	Columbia University; Swiss Institute Experimental Cancer Research	Chang, F (corresponding author), Columbia Univ Coll Phys & Surg, Dept Microbiol, 701 W 168th St, New York, NY 10032 USA.							Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; Evangelista M, 2002, NAT CELL BIOL, V4, P32, DOI 10.1038/ncb718; Fradelizi J, 2001, NAT CELL BIOL, V3, P699, DOI 10.1038/35087009; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; PELHAM R, IN PRESS NATURE; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; SAGOT I, IN PRESS NATURE CELL; Wasserman S, 1998, TRENDS CELL BIOL, V8, P111, DOI 10.1016/S0962-8924(97)01217-8; Winter D, 1997, CURR BIOL, V7, P519, DOI 10.1016/S0960-9822(06)00223-5	10	12	12	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2002	297	5581					531	532		10.1126/science.1074649	http://dx.doi.org/10.1126/science.1074649			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142518				2022-12-28	WOS:000177054200030
J	Nam, KH; Li, JM				Nam, KH; Li, JM			BRI1/BAK1, a receptor kinase pair mediating brassinosteroid signaling	CELL			English	Article							LEUCINE-RICH REPEAT; CYTOPLASMIC DOMAINS; ARABIDOPSIS; GENE; GROWTH; ACTIVATION; BRI1; CYTOCHROME-P450; CLAVATA3; LIGAND	The Arabidopsis BAK1 (BRI1 Associated receptor Kinase 1) was identified by a yeast two-hybrid screen as a specific interactor for BRI1, a critical component of a membrane brassinosteroid (BR) receptor. In yeast, BAK1/BRI1 interaction activates their kinase activities through transphosphorylation. BAK1 and BRI1 share similar gene expression and subcellular localization patterns and physically associate with each other in plants. Overexpression of the BAK1 gene leads to a phenotype reminiscent of BRI1-overexpression transgenic plants and rescues a weak bri1 mutant. In contrast, a bak1 knockout mutation gives rise to a weak bri1-like phenotype and enhances a weak bri1 mutation. We propose that BAK1 and BRI1 function together to mediate plant steroid signaling.	Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Li, JM (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	jian@umich.edu	Li, Jianming/O-1772-2014	Li, Jianming/0000-0003-3231-0778	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060519] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM060519-02, R01 GM060519, GM60519] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bishop GJ, 2002, PLANT CELL, V14, pS97, DOI 10.1105/tpc.001461; CHEN RH, 1995, J BIOL CHEM, V270, P12235, DOI 10.1074/jbc.270.20.12235; Clark SE, 2001, NAT REV MOL CELL BIO, V2, P276, DOI 10.1038/35067079; CLIFFORD R, 1994, GENETICS, V137, P531; Clouse SD, 1996, PLANT PHYSIOL, V111, P671, DOI 10.1104/pp.111.3.671; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Fankhauser C, 1999, SCIENCE, V284, P1539, DOI 10.1126/science.284.5419.1539; Feng XH, 1996, J BIOL CHEM, V271, P13123, DOI 10.1074/jbc.271.22.13123; Friedrichsen D, 2001, BIOESSAYS, V23, P1028, DOI 10.1002/bies.1148; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Giranton JL, 2000, P NATL ACAD SCI USA, V97, P3759, DOI 10.1073/pnas.070025097; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Kauschmann A, 1996, PLANT J, V9, P701, DOI 10.1046/j.1365-313X.1996.9050701.x; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li J, 2001, P NATL ACAD SCI USA, V98, P5916, DOI 10.1073/pnas.091065998; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 2002, SCIENCE, V295, P1299; Li JM, 2001, PLANT PHYSIOL, V127, P14, DOI 10.1104/pp.127.1.14; Mathur J, 1998, PLANT J, V14, P593, DOI 10.1046/j.1365-313X.1998.00158.x; Noguchi T, 1999, PLANT PHYSIOL, V121, P743, DOI 10.1104/pp.121.3.743; Oh MH, 2000, PLANT PHYSIOL, V124, P751, DOI 10.1104/pp.124.2.751; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schmidt EDL, 1997, DEVELOPMENT, V124, P2049; Shah H, 2001, J MOL BIOL, V309, P641, DOI 10.1006/jmbi.2001.4706; Shah K, 2001, J BIOL CHEM, V276, P41263, DOI 10.1074/jbc.M102381200; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Simin K, 1998, GENETICS, V148, P801; Torii KU, 2000, CURR OPIN PLANT BIOL, V3, P361, DOI 10.1016/S1369-5266(00)00097-2; Trotochaud AE, 2000, SCIENCE, V289, P613, DOI 10.1126/science.289.5479.613; Trotochaud AE, 1999, PLANT CELL, V11, P393, DOI 10.1105/tpc.11.3.393; von Arnim AG, 1998, GENE, V221, P35, DOI 10.1016/S0378-1119(98)00433-8; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; WANG ZY, 2000, PLANT BIOL; Winkler RG, 1998, PLANT PHYSIOL, V118, P743, DOI 10.1104/pp.118.3.743; Yamamuro C, 2000, PLANT CELL, V12, P1591, DOI 10.1105/tpc.12.9.1591	39	817	885	12	161	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 26	2002	110	2					203	212		10.1016/S0092-8674(02)00814-0	http://dx.doi.org/10.1016/S0092-8674(02)00814-0			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	578EV	12150928	Bronze			2022-12-28	WOS:000177105200008
J	Docken, WP; Arena, JF; Mark, EJ; Ilkhanoff, L; Bloch, KJ; Colvin, RB				Docken, WP; Arena, JF; Mark, EJ; Ilkhanoff, L; Bloch, KJ; Colvin, RB			A 73-year-old man with leg pains, occipital headaches, and night sweats - Giant-cell arteritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TEMPORAL ARTERITIS; POLYMYALGIA-RHEUMATICA; DISEASE-ACTIVITY; CLINICAL-FEATURES; SERUM FERRITIN; BIOPSY; VASCULITIS; INTERLEUKIN-6; INFLAMMATION; INVOLVEMENT		Brigham & Womens Hosp, Div Rheumatol & Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Docken, WP (corresponding author), Brigham & Womens Hosp, Div Rheumatol & Immunol, 75 Francis St, Boston, MA 02115 USA.		Ilkhanoff, Leonard/AAQ-2523-2020					ACHKAR AA, 1994, ANN INTERN MED, V120, P987, DOI 10.7326/0003-4819-120-12-199406150-00003; Boyev LR, 1999, AM J OPHTHALMOL, V128, P211, DOI 10.1016/S0002-9394(99)00101-4; Brack A, 1999, ARTHRITIS RHEUM, V42, P311, DOI 10.1002/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F; CALAMIA KT, 1980, CLIN RHEUM DIS, V6, P389; CALAMIA KT, 1981, ARTHRITIS RHEUM, V24, P1414, DOI 10.1002/art.1780241113; CHURG J, 1989, MODERN PATHOL, V2, P144; Coll-Vinent B, 1999, ANN RHEUM DIS, V58, P189, DOI 10.1136/ard.58.3.189; Corcoran GM, 2001, AM J CLIN PATHOL, V115, P342; COSTELLO JM, 1990, CHEST, V98, P875, DOI 10.1378/chest.98.4.875; Font C, 1997, BRIT J RHEUMATOL, V36, P251; Gabay C, 1999, NEW ENGL J MED, V340, P1376; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; GABRIEL SE, 1995, J RHEUMATOL, V22, P93; Genereau T, 1999, ARTHRITIS RHEUM, V42, P2674, DOI 10.1002/1529-0131(199912)42:12<2674::AID-ANR25>3.0.CO;2-A; Genereau T, 2000, ARTHRITIS RHEUM-US, V43, P929; GLOVER MU, 1987, CHEST, V91, P924, DOI 10.1378/chest.91.6.924; Gonzalez-Gay MA, 1999, MEDICINE, V78, P292, DOI 10.1097/00005792-199909000-00002; GonzalezGay MA, 1997, J RHEUMATOL, V24, P2166; GONZALEZGAY MA, 2000, MEDICINE, V79, P282; GRAHAM JR, 1986, NEW ENGL J MED, V315, P631; HALL S, 1983, LANCET, V2, P1217; Hamrin B, 1972, Acta Med Scand Suppl, V533, P1; Heneghan MA, 1998, DIGEST DIS SCI, V43, P2164, DOI 10.1023/A:1018892122026; JONES JG, 1991, BAILLIERE CLIN RHEUM, V5, P413, DOI 10.1016/S0950-3579(05)80063-9; KLEIN RG, 1975, ANN INTERN MED, V83, P806, DOI 10.7326/0003-4819-83-6-806; KODURI PR, 1995, AM J HEMATOL, V49, P247, DOI 10.1002/ajh.2830490314; LEE MH, 1995, AM J MED, V98, P566, DOI 10.1016/S0002-9343(99)80015-1; NESHER G, 1994, J RHEUMATOL, V21, P1283; ROBBNICHOLSON C, 1988, J RHEUMATOL, V15, P1793; RodriguezValverde V, 1997, AM J MED, V102, P331, DOI 10.1016/S0002-9343(97)00117-4; Rogers JT, 1996, BLOOD, V87, P2525, DOI 10.1182/blood.V87.6.2525.bloodjournal8762525; SALVARANI C, 1994, ARTHRITIS RHEUM, V37, P1621, DOI 10.1002/art.1780371111; SALVARANI C, 1992, J RHEUMATOL, V19, P1100; Salvarani C, 2001, ARTHRIT RHEUM-ARTHR, V45, P140, DOI 10.1002/1529-0131(200104)45:2<140::AID-ANR166>3.0.CO;2-2; Schmidt WA, 1997, NEW ENGL J MED, V337, P1336, DOI 10.1056/NEJM199711063371902; SCHWARZEYWILL M, 1992, ANN RHEUM DIS, V51, P683, DOI 10.1136/ard.51.5.683; SMALL P, 1991, ARTHRITIS RHEUM, V34, P220, DOI 10.1002/art.1780340215; SMITH CA, 1983, ARTHRITIS RHEUM, V26, P1214, DOI 10.1002/art.1780261007; VIRMANI R, 1996, ATLAS CARDIOVASCULAR, P167; WEYAND CM, 1994, ARTHRITIS RHEUM, V37, P514, DOI 10.1002/art.1780370411; Weyand CM, 2000, ARTHRITIS RHEUM, V43, P1041, DOI 10.1002/1529-0131(200005)43:5<1041::AID-ANR12>3.0.CO;2-7; WILKINSON IM, 1972, ARCH NEUROL-CHICAGO, V27, P378, DOI 10.1001/archneur.1972.00490170010003	42	2	3	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 25	2002	347	4					272	278		10.1056/NEJMcpc020106	http://dx.doi.org/10.1056/NEJMcpc020106			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587WB	12140304				2022-12-28	WOS:000177665800008
J	Kiesel, H; Renz, A; Hasselbach, F				Kiesel, H; Renz, A; Hasselbach, F			Observation of Hanbury Brown-Twiss anticorrelations for free electrons	NATURE			English	Article							FEASIBILITY	Fluctuations in the counting rate of photons originating from uncorrelated point sources become, within the coherently illuminated area, slightly enhanced compared to a random sequence of classical particles. This phenomenon, known in astronomy as the Hanbury Brown-Twiss effect(1-5), is a consequence of quantum interference between two indistinguishable photons and Bose-Einstein statistics(6). The latter require that the composite bosonic wavefunction is a symmetric superposition of the two possible paths. For fermions, the corresponding two-particle wavefunction is antisymmetric: this excludes overlapping wave trains, which are forbidden by the Pauli exclusion principle. Here we use an electron field emitter to coherently illuminate two detectors, and find anticorrelations in the arrival times of the free electrons. The particle beam has low degeneracy (about 10(-4) electrons per cell in phase space); as such, our experiment represents the fermionic twin of the Hanbury Brown-Twiss effect for photons.	Univ Tubingen, Inst Angew Phys, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Hasselbach, F (corresponding author), Univ Tubingen, Inst Angew Phys, Morgenstelle 10, D-72076 Tubingen, Germany.							BRANNEN E, 1956, NATURE, V178, P481, DOI 10.1038/178481a0; BROWN RH, 1956, NATURE, V177, P27, DOI 10.1038/177027a0; BROWN RH, 1958, PROC R SOC LON SER-A, V243, P291, DOI 10.1098/rspa.1958.0001; BROWN RH, 1974, INTENSITY INTERFEROM, V7; GOLDBERGER ML, 1963, PHYS REV, V132, P2764, DOI 10.1103/PhysRev.132.2764; HANBURYBROWN R, 1954, PHILOS MAG, V45, P663; HANBURYBROWN R, 1956, NATURE, V178, P1046, DOI DOI 10.1038/1781046A0; HANBURYBROWN R, 1956, NATURE, V178, P1447; HASSELBACH F, 1988, Z PHYS B CON MAT, V71, P443, DOI 10.1007/BF01313930; Henny M, 1999, SCIENCE, V284, P296, DOI 10.1126/science.284.5412.296; Kodama T, 1998, PHYS REV A, V57, P2781, DOI 10.1103/PhysRevA.57.2781; Oliver WD, 1999, SCIENCE, V284, P299, DOI 10.1126/science.284.5412.299; Purcell E. M., 1956, NATURE, V178, P1449; SILVERMAN MP, 1986, PHYS LETT A, V118, P155, DOI 10.1016/0375-9601(86)90502-5; SILVERMAN MP, 1987, NUOVO CIMENTO B, V97, P200, DOI 10.1007/BF02888820; SILVERMAN MP, 1987, PHYS LETT A, V120, P442, DOI 10.1016/0375-9601(87)90106-X; SILVERMAN MP, 1988, OSA P PHOTON CORRELA, V1, P26; Twiss R. Q., 1959, AUST J PHYS, V12, P77; [No title captured]	19	146	146	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2002	418	6896					392	394		10.1038/nature00911	http://dx.doi.org/10.1038/nature00911			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12140550				2022-12-28	WOS:000177009700030
J	Pando, MP; Morse, D; Cermakian, N; Sassone-Corsi, P				Pando, MP; Morse, D; Cermakian, N; Sassone-Corsi, P			Phenotypic rescue of a peripheral clock genetic defect via SCN hierarchical dominance	CELL			English	Article							MAMMALIAN PERIOD GENES; SUPRACHIASMATIC NUCLEUS; CIRCADIAN CLOCK; MESSENGER-RNA; DIFFERENTIAL REGULATION; RHYTHMIC EXPRESSION; LOCOMOTOR-ACTIVITY; PHOTIC INDUCTION; LIGHT; TISSUES	The mammalian circadian system contains both central and peripheral oscillators. To understand the communication pathways between them, we have studied the rhythmic behavior of mouse embryo fibroblasts (MEFs) surgically implanted in mice of different genotypes. MEFs from Perl(-/-) mice have a much shorter period in culture than do tissues in the intact animal. When implanted back into mice, however, the Perl(-/-) MEF take on the rhythmic characteristics of the host. A functioning clock is required for oscillations in the target tissues, as arrhythmic clock(c/c) MEFs remain arrhythmic in implants. These results demonstrate that SON hierarchical dominance can compensate for severe intrinsic genetic defects in peripheral clocks, but cannot induce rhythmicity in clock-defective tissues.	ULP, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, F-67404 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sassone-Corsi, P (corresponding author), ULP, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, 1 Rue Laurent Fries, F-67404 Strasbourg, France.	paolosc@igbmc.u-strasbg.fr	Sassone-Corsi, Paolo/H-6182-2011	Morse, David/0000-0003-4131-4367; Cermakian, Nicolas/0000-0003-4517-9131				Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Abrahamson EE, 2001, NEUROREPORT, V12, P435, DOI 10.1097/00001756-200102120-00048; Allen G, 2001, J NEUROSCI, V21, P7937, DOI 10.1523/JNEUROSCI.21-20-07937.2001; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Brown SA, 1999, CURR OPIN GENET DEV, V9, P588, DOI 10.1016/S0959-437X(99)00009-X; Buijs RM, 2001, NAT REV NEUROSCI, V2, P521, DOI 10.1038/35081582; Cermakian N, 2000, P NATL ACAD SCI USA, V97, P4339, DOI 10.1073/pnas.97.8.4339; Cermakian N, 2001, EMBO J, V20, P3967, DOI 10.1093/emboj/20.15.3967; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Giebultowicz JM, 2000, CURR BIOL, V10, P107, DOI 10.1016/S0960-9822(00)00299-2; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; KRIEGER DT, 1977, SCIENCE, V197, P398, DOI 10.1126/science.877566; Krishnan B, 1999, NATURE, V400, P375, DOI 10.1038/22566; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; LeSauter J, 1998, CHRONOBIOL INT, V15, P535, DOI 10.3109/07420529808998706; Maywood ES, 1999, P NATL ACAD SCI USA, V96, P15211, DOI 10.1073/pnas.96.26.15211; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Mrosovsky N, 1996, BIOL REV, V71, P343, DOI 10.1111/j.1469-185X.1996.tb01278.x; Oishi K, 1998, BIOCHEM BIOPH RES CO, V253, P199, DOI 10.1006/bbrc.1998.9779; Oishi K, 2000, BIOCHEM BIOPH RES CO, V268, P164, DOI 10.1006/bbrc.1999.2054; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; PALMER TD, 1989, BLOOD, V73, P438; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Redlin U, 1999, J COMP PHYSIOL A, V184, P439, DOI 10.1007/s003590050343; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Ripperger JA, 2000, GENE DEV, V14, P679; Sakamoto K, 1998, J BIOL CHEM, V273, P27039, DOI 10.1074/jbc.273.42.27039; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shearman LP, 1999, NEUROREPORT, V10, P613, DOI 10.1097/00001756-199902250-00031; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; STLOUIS D, 1988, P NATL ACAD SCI USA, V85, P3150; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Ueyama T, 1999, NAT NEUROSCI, V2, P1051, DOI 10.1038/15973; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Whitmore D, 1998, NAT NEUROSCI, V1, P701, DOI 10.1038/3703; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; Yagita K, 2000, GENE DEV, V14, P1353; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	63	141	146	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 12	2002	110	1					107	117		10.1016/S0092-8674(02)00803-6	http://dx.doi.org/10.1016/S0092-8674(02)00803-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	573PU	12151001	Bronze			2022-12-28	WOS:000176840700011
J	Burns, RB; Hartman, EE				Burns, RB; Hartman, EE			A 47-year-old woman with tension-type headaches, 1 year later	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		Welch KMA, 2001, JAMA-J AM MED ASSOC, V286, P960, DOI 10.1001/jama.286.8.960	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2002	288	8					1011	1011		10.1001/jama.288.8.1011	http://dx.doi.org/10.1001/jama.288.8.1011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587RM	12190372				2022-12-28	WOS:000177656400027
J	D'Aunno, T; Pollack, HA				D'Aunno, T; Pollack, HA			Changes in methadone treatment practices - Results from a national panel study, 1988-2000	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUBSTANCE-ABUSE TREATMENT; DRUG-USERS; MANAGED CARE; HIV	Context Results from several studies conducted in the early 1990s showed that the majority of US methadone maintenance programs did not use treatment practices that met established standards for the care of heroin users. Effective treatment for heroin users is critical given the upsurge in heroin use and the continued role of injection drug use in the human immunodeficiency virus and hepatitis C epidemics. Objectives To examine the extent to which US methadone maintenance treatment programs have made changes in the past 12 years to provide adequate methadone doses and to identify factors associated with variation in program performance. Design, Setting, and Participants Program directors and clinical supervisors of nationally representative methadone treatment programs that varied by ownership (for-profit, public, or private not-for-profit) and setting (eg, free-standing, hospital-based) were surveyed in 1988 (n=172), 1990 (n=140), 1995 (n=116), and 2000 (n=150). Main Outcome Measures Percentage of patients in each treatment program receiving methadone dosages of less than 40, 60, and 80 mg/d. Results The percentage of patients receiving methadone dosage levels less than the recommended 60 mg/d has decreased from 79.5% in 1988 to 35.5% in 2000. Results also show that programs with a greater percentage of African American patients are especially likely to dispense low dosages, while programs with Joint Commission on Accreditation of Healthcare Organizations accreditation are more likely to provide adequate methadone doses. Conclusions Efforts to improve methadone treatment practices appear to be making progress, but many patients are still receiving substandard care.	Univ Chicago, Sch Social Serv Adm, Chicago, IL 60637 USA; Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; Univ Michigan, Sch Publ Hlth, Dept Hlth Policy & Management, Ann Arbor, MI 48109 USA	University of Chicago; University of Chicago; University of Michigan System; University of Michigan	D'Aunno, T (corresponding author), INSEAD, Blvd Constance, F-77305 Fontainebleau, France.		D'Aunno, Thomas/V-8107-2019; Pollack, Harold A/A-1166-2007; D'Aunno, Thomas/P-9320-2019		NATIONAL INSTITUTE ON DRUG ABUSE [R01DA003272] Funding Source: NIH RePORTER; NIDA NIH HHS [DA03272] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		[Anonymous], 1995, FEDERAL REGULATION M; Bach PB, 1999, AM J PUBLIC HEALTH, V89, P662, DOI 10.2105/AJPH.89.5.662; BALL JC, 1991, EFFECTIVENESS METHOD; BATTON HL, 1992, DRUG SERVICES RES SU; COOPER JR, 1992, JAMA-J AM MED ASSOC, V267, P281; CZECHOWICZ D, 1997, J MAINT ADDICT, V1, P11; D'Aunno T, 1999, AM J DRUG ALCOHOL AB, V25, P681, DOI 10.1081/ADA-100101886; DAUNNO T, 1992, JAMA-J AM MED ASSOC, V267, P253, DOI 10.1001/jama.267.2.253; DAUNNO T, 1995, TREATING DRUG ABUSE; Diggle PJ, 1994, ANAL LONGITUDINAL DA; *GEN ACC OFF, 1990, GAOHRD90104 GEN ACC; GROVES R, 1988, TELEPHONE SURVEY MET; Hagan H, 2000, MT SINAI J MED, V67, P423; Holmberg SD, 1996, AM J PUBLIC HEALTH, V86, P642, DOI 10.2105/AJPH.86.5.642; *I MED, 2000, NO TIM LOS MAK MOST; Joseph H, 2000, MT SINAI J MED, V67, P347; Leavitt SB, 2000, MT SINAI J MED, V67, P404; Lemak CH, 2001, J BEHAV HEALTH SER R, V28, P12, DOI 10.1007/BF02287231; Lemak CH, 2001, MED CARE RES REV, V58, P455, DOI 10.1177/107755870105800405; Little R. J. A., 1987, STAT ANAL MISSING DA; LITTLE RJA, 1995, J AM STAT ASSOC, V90, P1112, DOI 10.2307/2291350; MCCANN MJ, 1994, CSAT TECHNICAL ASSIS, V7; METZGER DS, 1993, J ACQ IMMUN DEF SYND, V6, P1049; *NIH CONS STAT 108, EFF MED TREATM OP AD; *OFF NAT DRUG CONT, 1988, WHAT AM US SPEND ILL; PARRINO MW, 1993, TREATMENT IMPROVEMEN; PLAUT JJ, 1998, HEROIN AGE CRACK COC, P160; Pollack HA, 2001, MED DECIS MAKING, V21, P357, DOI 10.1177/02729890122062659; SIMPSON DD, 1997, TREATING DRUG ABUSER, P41; Strain EC, 1999, JAMA-J AM MED ASSOC, V281, P1000, DOI 10.1001/jama.281.11.1000; *US DEP HHS OFF AP, DRUG ALC SERV INF; VAUGHN TE, 1993, THESIS U MICHIGAN AN; West SL, 2000, J SUBST ABUSE, V12, P405, DOI 10.1016/S0899-3289(01)00054-2; 1991, MONITORING FUTURE 20	34	106	106	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2002	288	7					850	856		10.1001/jama.288.7.850	http://dx.doi.org/10.1001/jama.288.7.850			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585FC	12186602	Bronze			2022-12-28	WOS:000177513100027
J	Girou, E; Loyeau, S; Legrand, P; Oppein, F; Brun-Buisson, C				Girou, E; Loyeau, S; Legrand, P; Oppein, F; Brun-Buisson, C			Efficacy of handrubbing with alcohol based solution versus standard handwashing with antiseptic soap: randomised clinical trial	BRITISH MEDICAL JOURNAL			English	Article							INTENSIVE-CARE UNIT; HAND-CLEANSING AGENTS; CONTAMINATED HANDS; PATIENT-CARE; DISINFECTION; INFECTION; PROGRAM; IMPACT; SETTINGS; HYGIENE	Objective To compare the efficacy of handrubbing with an alcohol based solution versus conventional handwashing With antiseptic soap in reducing hand contamination during routine patient care. Design Randomised controlled trial during daily nursing sessions of 2, to 3 hours. Setting Three intensive care units in a French university hospital. Participants 23 healthcare workers. Interventions Handrubbing with alcohol based solution (n = 12) or handwashing with antiseptic soap (n = 11) when hand hygiene was indicated before and after patient care. Imprints taken of fingertips and palm of dominant hand before and after hand hygiene procedure. Bacterial counts quantified blindly. Main outcome measures Bacterial reduction of hand contamination. Results With handrubbing the median percentage reduction in bacteria] contamination was significantly higher than with handwashing (83% v 58%, P=0.012), With a median difference in the percentage reduction of 26% (95% confidence interval 8% to 44%). The median duration of hand hygiene was 30 seconds in each group. Conclusions During routine patient care handrubbing with an alcohol based solution is significantly more efficient in reducing hand contamination than handwashing with antiseptic soap.	Assistance Publ Hop Paris, Hop Henri Mondor, Infect Control Unit, Creteil, France; Assistance Publ Hop Paris, Hop Henri Mondor, Microbiol Lab, Creteil, France; Assistance Publ Hop Paris, Hop Henri Mondor, Med Intens Care Unit, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Girou, E (corresponding author), Assistance Publ Hop Paris, Hop Henri Mondor, Infect Control Unit, Creteil, France.							Austin DJ, 1999, P NATL ACAD SCI USA, V96, P6908, DOI 10.1073/pnas.96.12.6908; AYLIFFE GAJ, 1988, J HOSP INFECT, V11, P226, DOI 10.1016/0195-6701(88)90101-6; BARTZOKAS CA, 1983, J HOSP INFECT, V4, P245, DOI 10.1016/0195-6701(83)90025-7; Bischoff WE, 2000, ARCH INTERN MED, V160, P1017, DOI 10.1001/archinte.160.7.1017; Cardoso CL, 1999, AM J INFECT CONTROL, V27, P327, DOI 10.1016/S0196-6553(99)70052-0; Coignard B, 1998, INFECT CONT HOSP EP, V19, P510; CONLY JM, 1989, AM J INFECT CONTROL, V17, P330, DOI 10.1016/0196-6553(89)90002-3; Girou E, 2001, J HOSP INFECT, V48, pS55, DOI 10.1016/S0195-6701(01)90015-5; GOULD D, 1994, J HOSP INFECT, V28, P15, DOI 10.1016/0195-6701(94)90149-X; Guilhermetti M, 2001, INFECT CONT HOSP EP, V22, P105, DOI 10.1086/501872; LARSON EL, 1995, AM J INFECT CONTROL, V23, P251, DOI 10.1016/0196-6553(95)90070-5; Larson EL, 2001, CRIT CARE MED, V29, P944, DOI 10.1097/00003246-200105000-00007; LUND S, 1994, AM J INFECT CONTROL, V22, P352, DOI 10.1016/0196-6553(94)90034-5; Maury E, 2000, AM J RESP CRIT CARE, V162, P324, DOI 10.1164/ajrccm.162.1.9908118; Paulson DS, 1999, AM J INFECT CONTROL, V27, P332, DOI 10.1016/S0196-6553(99)70053-2; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pittet D, 1999, ANN INTERN MED, V130, P126, DOI 10.7326/0003-4819-130-2-199901190-00006; Pittet D, 1999, ARCH INTERN MED, V159, P821, DOI 10.1001/archinte.159.8.821; PRESTON GA, 1981, AM J MED, V70, P641, DOI 10.1016/0002-9343(81)90588-X; Rotter ML, 1999, HOSP EPIDEMIOLOGY IN, P691; SIMMONS B, 1990, INFECT CONT HOSP EP, V11, P589; Voss A, 1997, INFECT CONT HOSP EP, V18, P205; WADE JJ, 1991, J HOSP INFECT, V18, P211, DOI 10.1016/0195-6701(91)90145-X; Zaragoza M, 1999, AM J INFECT CONTROL, V27, P258, DOI 10.1053/ic.1999.v27.a97622	24	197	198	1	49	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 17	2002	325	7360					362	365		10.1136/bmj.325.7360.362	http://dx.doi.org/10.1136/bmj.325.7360.362			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587DV	12183307	Bronze, Green Published			2022-12-28	WOS:000177626000018
J	Anbar, AD; Knoll, AH				Anbar, AD; Knoll, AH			Proterozoic ocean chemistry and evolution: A bioinorganic bridge?	SCIENCE			English	Review							BANDED IRON FORMATIONS; BLACK-SEA; ISOTOPIC COMPOSITION; ATMOSPHERIC OXYGEN; NITROGEN-FIXATION; SOUTH-AFRICA; SULFUR CYCLE; PRECAMBRIAN CARBONATES; SULFATE REDUCTION; TURUKHANSK UPLIFT	Recent data imply that for much of the Proterozoic Eon ( 2500 to 543 million years ago), Earth's oceans were moderately oxic at the surface and sulfidic at depth. Under these conditions, biologically important trace metals would have been scarce in most marine environments, potentially restricting the nitrogen cycle, affecting primary productivity, and limiting the ecological distribution of eukaryotic algae. Oceanic redox conditions and their bioinorganic consequences may thus help to explain observed patterns of Proterozoic evolution.	Univ Rochester, Dept Earth & Environm Sci, Rochester, NY 14627 USA; Univ Rochester, Dept Chem, Rochester, NY 14627 USA; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	University of Rochester; University of Rochester; Harvard University	Anbar, AD (corresponding author), Univ Rochester, Dept Earth & Environm Sci, 601 Elmwood Ave, Rochester, NY 14627 USA.	anbar@earth.rochester.edu						Antipova AN, 1998, FEBS LETT, V441, P257, DOI 10.1016/S0014-5793(98)01510-5; Barling J, 2001, EARTH PLANET SC LETT, V193, P447, DOI 10.1016/S0012-821X(01)00514-3; Bartley JK, 2001, PRECAMBRIAN RES, V111, P165, DOI 10.1016/S0301-9268(01)00160-7; Beaumont V, 1999, PRECAMBRIAN RES, V96, P63, DOI 10.1016/S0301-9268(99)00005-4; Bekker A, 2001, AM J SCI, V301, P261, DOI 10.2475/ajs.301.3.261; BEKKER A, 2002, 12 ANN VM GOLDSCHM C; BERTINE KK, 1973, GEOCHIM COSMOCHIM AC, V37, P1415, DOI 10.1016/0016-7037(73)90080-X; BEUKES NJ, 1990, ECON GEOL BULL SOC, V85, P663, DOI 10.2113/gsecongeo.85.4.663; Bjerrum CJ, 2002, NATURE, V417, P159, DOI 10.1038/417159a; Brandes JA, 1998, NATURE, V395, P365, DOI 10.1038/26450; Brasier MD, 1998, GEOLOGY, V26, P555, DOI 10.1130/0091-7613(1998)026<0555:ABYOES>2.3.CO;2; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; BUICK R, 1995, CHEM GEOL, V123, P153, DOI 10.1016/0009-2541(95)00049-R; Butterfield NJ, 2001, PRECAMBRIAN RES, V111, P235, DOI 10.1016/S0301-9268(01)00162-0; Butterfield NJ, 1997, PALEOBIOLOGY, V23, P247, DOI 10.1017/S009483730001681X; Calver CR, 2000, PRECAMBRIAN RES, V100, P121, DOI 10.1016/S0301-9268(99)00072-8; CAMERON EM, 1982, NATURE, V296, P145, DOI 10.1038/296145a0; Canfield DE, 1999, AM J SCI, V299, P697, DOI 10.2475/ajs.299.7-9.697; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; CANFIELD DE, 1994, SCIENCE, V266, P1973, DOI 10.1126/science.11540246; Canfield DE, 1996, NATURE, V382, P127, DOI 10.1038/382127a0; Canfield DE, 1996, AM J SCI, V296, P818, DOI 10.2475/ajs.296.7.818; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; Capone DG, 2001, CURR OPIN MICROBIOL, V4, P341, DOI 10.1016/S1369-5274(00)00215-0; CLAYPOOL GE, 1980, CHEM GEOL, V28, P199, DOI 10.1016/0009-2541(80)90047-9; CLOUD P, 1972, AM J SCI, V272, P537, DOI 10.2475/ajs.272.6.537; COLLIER RW, 1985, LIMNOL OCEANOGR, V30, P1351, DOI 10.4319/lo.1985.30.6.1351; Colman A. S., 2000, MARINE AUTHIGENESIS, P53, DOI DOI 10.2110/PEC.00.66; COLODNER D, 1995, EARTH PLANET SC LETT, V131, P1, DOI 10.1016/0012-821X(95)00010-A; DERRY LA, 1990, GEOCHIM COSMOCHIM AC, V54, P2965, DOI 10.1016/0016-7037(90)90114-Z; Eady RR, 1996, CHEM REV, V96, P3013, DOI 10.1021/cr950057h; EMERSON SR, 1991, MAR CHEM, V34, P177, DOI 10.1016/0304-4203(91)90002-E; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Filippelli GM, 1996, GEOCHIM COSMOCHIM AC, V60, P1479, DOI 10.1016/0016-7037(96)00042-7; Frausto da Silva J.J.R., 1991, BIOL CHEM ELEMENTS I; GANELS RM, 1971, EVOLUTION SEDIMENTAR, P119; Gilbert D, 1998, HYDROBIOLOGIA, V374, P111, DOI 10.1023/A:1017091926454; Habicht KS, 2001, GEOLOGY, V29, P555, DOI 10.1130/0091-7613(2001)029<0555:IFBSRN>2.0.CO;2; HAN TM, 1992, SCIENCE, V257, P232, DOI 10.1126/science.1631544; Hayes JM, 1999, CHEM GEOL, V161, P103, DOI 10.1016/S0009-2541(99)00083-2; Helz GR, 1996, GEOCHIM COSMOCHIM AC, V60, P3631, DOI 10.1016/0016-7037(96)00195-0; Herrero A, 2001, J BACTERIOL, V183, P411, DOI 10.1128/JB.183.2.411-425.2001; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; HOCH MP, 1994, GEOMICROBIOL J, V12, P113, DOI 10.1080/01490459409377977; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; HOLLAND HD, 1973, ECON GEOL, V68, P1169, DOI 10.2113/gsecongeo.68.7.1169; HOLLAND HD, 1990, AM J SCI, V290A, P1; Howard JB, 1996, CHEM REV, V96, P2965, DOI 10.1021/cr9500545; HURTGEN MT, IN PRESS EARTH PLANE; JACOBSEN SB, 1988, GEOPHYS RES LETT, V15, P393, DOI 10.1029/GL015i004p00393; Javaux EJ, 2001, NATURE, V412, P66, DOI 10.1038/35083562; JOERGER RD, 1988, CRIT REV MICROBIOL, V16, P1, DOI 10.3109/10408418809104465; Johnson MK, 1996, CHEM REV, V96, P2817, DOI 10.1021/cr950063d; Kah LC, 1999, CAN J EARTH SCI, V36, P313, DOI 10.1139/e98-100; Kah LC, 2001, PRECAMBRIAN RES, V111, P203, DOI 10.1016/S0301-9268(01)00161-9; Karhu JA, 1996, GEOLOGY, V24, P867, DOI 10.1130/0091-7613(1996)024<0867:CIATRO>2.3.CO;2; KAUFMAN AJ, 1995, PRECAMBRIAN RES, V73, P27, DOI 10.1016/0301-9268(94)00070-8; Kaufman AJ, 1997, P NATL ACAD SCI USA, V94, P6600, DOI 10.1073/pnas.94.13.6600; Kirschvink JL, 2000, P NATL ACAD SCI USA, V97, P1400, DOI 10.1073/pnas.97.4.1400; Knoll A. H, 1992, ORIGIN EARLY EVOLUTI, P53; KNOLL AH, 1995, AM J SCI, V295, P823, DOI 10.2475/ajs.295.7.823; KNOLL AH, 1986, NATURE, V321, P832, DOI 10.1038/321832a0; KNOLL AH, 1994, P NATL ACAD SCI USA, V91, P6743, DOI 10.1073/pnas.91.15.6743; Kroneck PMH, 2002, MET IONS BIOL SYST, V39, P369; KROOPNICK PM, 1985, DEEP-SEA RES, V32, P57, DOI 10.1016/0198-0149(85)90017-2; Lane TW, 2000, P NATL ACAD SCI USA, V97, P4627, DOI 10.1073/pnas.090091397; LEWIS BL, 1991, DEEP-SEA RES, V38, pS773, DOI 10.1016/S0198-0149(10)80009-3; LEWIS BL, 1992, MAR CHEM, V40, P105, DOI 10.1016/0304-4203(92)90050-K; Lindell D, 1998, J BACTERIOL, V180, P1878, DOI 10.1128/JB.180.7.1878-1886.1998; LINDELL D, 1995, LIMNOL OCEANOGR, V40, P1130, DOI 10.4319/lo.1995.40.6.1130; Luepke JJ, 2001, PRECAMBRIAN RES, V111, P79, DOI 10.1016/S0301-9268(01)00157-7; Lyons TW, 1997, GEOCHIM COSMOCHIM AC, V61, P3367, DOI 10.1016/S0016-7037(97)00174-9; Lyons TW, 2000, GEOCHIM COSMOCHIM AC, V64, P427, DOI 10.1016/S0016-7037(99)00323-3; LYONS TW, IN PRESS CHEM GEOL; Malone TC, 1980, PRIMARY PRODUCTIVITY, P301; MARAIS DJD, 1992, NATURE, V359, P605, DOI 10.1038/359605a0; MARTIN JH, 1988, NATURE, V331, P341, DOI 10.1038/331341a0; MILLER RW, 1988, BIOCHEM J, V256, P429, DOI 10.1042/bj2560429; Moores EM, 2002, GEOL SOC AM BULL, V114, P80, DOI 10.1130/0016-7606(2002)114<0080:PGPROT>2.0.CO;2; MOREL FMM, 1994, NATURE, V369, P740, DOI 10.1038/369740a0; Morford JL, 1999, GEOCHIM COSMOCHIM AC, V63, P1735, DOI 10.1016/S0016-7037(99)00126-X; OHMOTO H, 1993, SCIENCE, V262, P555, DOI 10.1126/science.11539502; OHMOTO H, 1987, NATURE, V328, P244, DOI 10.1038/328244a0; PETROV PY, 1995, STRATIGR GEO CORREL+, V3, P435; Porter SM, 2000, PALEOBIOLOGY, V26, P360, DOI 10.1666/0094-8373(2000)026<0360:TAITNE>2.0.CO;2; Raiswell R, 2001, J SEDIMENT RES, V71, P286, DOI 10.1306/070300710286; Rasmussen B, 1999, GEOLOGY, V27, P115, DOI 10.1130/0091-7613(1999)027<0115:RSOTAA>2.3.CO;2; Ribbe M, 1997, J BIOL CHEM, V272, P26627, DOI 10.1074/jbc.272.42.26627; RUNNEGAR B, 1982, ALCHERINGA, V6, P223, DOI 10.1080/03115518208565415; RUTTENBERG KC, 1993, CHEM GEOL, V107, P405, DOI 10.1016/0009-2541(93)90220-D; Shen YA, 2001, NATURE, V410, P77, DOI 10.1038/35065071; Shen YN, 2002, AM J SCI, V302, P81, DOI 10.2475/ajs.302.2.81; Smith KS, 2000, FEMS MICROBIOL REV, V24, P335, DOI 10.1016/S0168-6445(00)00030-9; STEIN JG, 1994, POLIT PSYCHOL, V15, P1, DOI 10.2307/3791436; Stiefel EI, 1998, PURE APPL CHEM, V70, P889, DOI 10.1351/pac199870040889; STRAUSS H, 1993, PRECAMBRIAN RES, V63, P225, DOI 10.1016/0301-9268(93)90035-Z; Strauss H, 1999, CHEM GEOL, V161, P89, DOI 10.1016/S0009-2541(99)00082-0; SUMMONS RE, 1990, AM J SCI, V290A, P212; VANCAPPELLEN P, 1994, PALEOCEANOGRAPHY, V9, P677, DOI 10.1029/94PA01455; VEIZER J, 1992, GEOCHIM COSMOCHIM AC, V56, P2487, DOI 10.1016/0016-7037(92)90204-V; VEIZER J, 1992, GEOCHIM COSMOCHIM AC, V56, P875, DOI 10.1016/0016-7037(92)90033-F; VELINSKY DJ, 1991, GEOPHYS RES LETT, V18, P649, DOI 10.1029/91GL00344; VIDAL G, 1990, AM J SCI, V290A, P170; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Wignall PB, 2001, SEDIMENT GEOL, V144, P335, DOI 10.1016/S0037-0738(01)00125-7; Williams RJP, 2002, BIOCHEM BIOPH RES CO, V292, P293, DOI 10.1006/bbrc.2002.6518; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759; Wu JF, 2001, SCIENCE, V293, P847, DOI 10.1126/science.1059251; Xiao SH, 1997, PRECAMBRIAN RES, V84, P197, DOI 10.1016/S0301-9268(97)00029-6; Xiao SH, 2002, J PALEONTOL, V76, P347, DOI 10.1666/0022-3360(2002)076<0347:MCCIAT>2.0.CO;2; Yuan XL, 1999, LETHAIA, V32, P143; YUNG YL, 1979, SCIENCE, V203, P1002, DOI 10.1126/science.203.4384.1002; Zahn JA, 1996, FEBS LETT, V397, P35, DOI 10.1016/S0014-5793(96)01116-7; ZANG WL, 1992, PRECAMBRIAN RES, V57, P243; Zehr JP, 2002, APPL ENVIRON MICROB, V68, P1015, DOI 10.1128/AEM.68.3.1015-1024.2002; Zehr JP, 2000, TRENDS MICROBIOL, V8, P68, DOI 10.1016/S0966-842X(99)01670-4; ZHANG Y, 1998, PALEONTOL SOC MEM, V50, P1; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	121	749	842	10	287	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2002	297	5584					1137	1142		10.1126/science.1069651	http://dx.doi.org/10.1126/science.1069651			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183619	Green Submitted			2022-12-28	WOS:000177447600036
J	Huizinga, EG; Tsuji, S; Romijn, RAP; Schiphorst, ME; de Groot, PG; Sixma, JJ; Gros, P				Huizinga, EG; Tsuji, S; Romijn, RAP; Schiphorst, ME; de Groot, PG; Sixma, JJ; Gros, P			Structures of glycoprotein Ib alpha and its complex with von Willebrand factor A1 domain	SCIENCE			English	Article							ALANINE SCANNING MUTAGENESIS; VONWILLEBRAND DISEASE; CRYSTAL-STRUCTURE; FACTOR-BINDING; MUTATIONS; RECOGNITION; IX	Transient interactions of platelet-receptor glycoprotein Ibalpha (GpIbalpha) and the plasma protein von Willebrand factor (VWF) reduce platelet velocity at sites of vascular damage and play a role in haemostasis and thrombosis. Here we present structures of the GpIbalpha amino-terminal domain and its complex with the VWF domain A1. In the complex, GpIbalpha wraps around one side of A1, providing two contact areas bridged by an area of solvated charge interaction. The structures explain the effects of gain-of-function mutations related to bleeding disorders and provide a model for shear-induced activation. These detailed insights into the initial interactions in platelet adhesion are relevant to the development of antithrombotic drugs.	Univ Utrecht, Bijvoet Ctr Biomol Res, Dept Crystal & Struct Chem, NL-3584 CH Utrecht, Netherlands; Univ Med Ctr Utrecht, Inst Biomembranes, Dept Haematol, Thrombosis & Haemostasis Lab, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center	Huizinga, EG (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, Dept Crystal & Struct Chem, Padualaan 8, NL-3584 CH Utrecht, Netherlands.		Gros, Piet/AAD-6452-2019; Gros, Piet/I-5569-2016	Gros, Piet/0000-0002-7782-2585; Gros, Piet/0000-0002-7782-2585				Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Berndt MC, 2001, THROMB HAEMOSTASIS, V86, P178; Blanco F, 1998, CURR OPIN STRUC BIOL, V8, P107, DOI 10.1016/S0959-440X(98)80017-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Celikel R, 2000, NAT STRUCT BIOL, V7, P881; Celikel R, 1998, NAT STRUCT BIOL, V5, P189, DOI 10.1038/nsb0398-189; Cruz MA, 2000, J BIOL CHEM, V275, P19098, DOI 10.1074/jbc.M002292200; Dong JF, 2000, J BIOL CHEM, V275, P27663; Dong JF, 2001, J BIOL CHEM, V276, P16690, DOI 10.1074/jbc.M101035200; Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; GINSBURG D, 1993, THROMB HAEMOSTASIS, V69, P177; Goto S, 2001, Clin Lab, V47, P327; GOTO S, 1995, J BIOL CHEM, V270, P23352, DOI 10.1074/jbc.270.40.23352; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Lankhof H, 1996, THROMB HAEMOSTASIS, V75, P950; Matsushita T, 2000, J BIOL CHEM, V275, P11044, DOI 10.1074/jbc.275.15.11044; MATSUSHITA T, 1995, J BIOL CHEM, V270, P13406, DOI 10.1074/jbc.270.22.13406; MILLER JL, 1991, P NATL ACAD SCI USA, V88, P4761, DOI 10.1073/pnas.88.11.4761; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RUSSELL SD, 1993, BLOOD, V81, P1787; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Tait AS, 2001, BLOOD, V98, P1812, DOI 10.1182/blood.V98.6.1812; Vasudevan S, 2000, J BIOL CHEM, V275, P12763, DOI 10.1074/jbc.275.17.12763	29	459	491	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2002	297	5584					1176	1179		10.1126/science.107355	http://dx.doi.org/10.1126/science.107355			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183630	Green Submitted			2022-12-28	WOS:000177447600049
J	Li, JX; Kinoshita, T; Pandey, S; Ng, CKY; Gygi, SP; Shimazaki, K; Assmann, SM				Li, JX; Kinoshita, T; Pandey, S; Ng, CKY; Gygi, SP; Shimazaki, K; Assmann, SM			Modulation of an RNA-binding protein by abscisic-acid-activated protein kinase	NATURE			English	Article							MESSENGER-RNA; GUARD-CELLS; ARABIDOPSIS; GENE; EXPRESSION; ENCODES; RESPONSES; PLANTS	Protein kinases are involved in stress signalling in both plant and animal systems. The hormone abscisic acid mediates the responses of plants to stresses such as drought, salinity and cold. Abscisic-acid-activated protein kinase (AAPK)-found in guard cells, which control stomatal pores-has been shown to regulate plasma membrane ion channels(1). Here we show that AAPK-interacting protein 1 (AKIP1), with sequence homology to heterogeneous nuclear RNA-binding protein A/B, is a substrate of AAPK. AAPK-dependent phosphorylation is required for the interaction of AKIP1 with messenger RNA that encodes dehydrin, a protein implicated in cell protection under stress conditions. AAPK and AKIP1 are present in the guard-cell nucleus, and in vivo treatment of such cells with abscisic acid enhances the partitioning of AKIP1 into subnuclear foci which are reminiscent of nuclear speckles. These results show that phosphorylation-regulated RNA target discrimination by heterogeneous nuclear RNA-binding proteins(2) may be a general phenomenon in eukaryotes, and implicate a plant hormone in the regulation of protein dynamics during rapid subnuclear reorganization.	Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA; Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8108560, Japan; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Kyushu University; Harvard University; Harvard Medical School	Li, JX (corresponding author), Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA.		Pandey, Sona/M-2847-2013; Ng, Carl K/B-4626-2013; Kinoshita, Toshinori/C-2891-2012	Pandey, Sona/0000-0002-5570-3120; Kinoshita, Toshinori/0000-0001-7621-1259; Ng, Carl/0000-0001-5832-3265				Assmann SM, 2001, CURR OPIN PLANT BIOL, V4, P421, DOI 10.1016/S1369-5266(00)00195-3; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Busk PK, 1998, PLANT MOL BIOL, V37, P425, DOI 10.1023/A:1006058700720; Dixon AK, 1998, NUCLEIC ACIDS RES, V26, P4426, DOI 10.1093/nar/26.19.4426; Dunn MA, 1996, PLANT MOL BIOL, V30, P947, DOI 10.1007/BF00020806; Freire MA, 1995, PLANT MOL BIOL, V29, P797, DOI 10.1007/BF00041169; GOMEZ J, 1988, NATURE, V334, P262, DOI 10.1038/334262a0; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hugouvieux V, 2001, CELL, V106, P477, DOI 10.1016/S0092-8674(01)00460-3; KHAN FA, 1991, FEBS LETT, V290, P159, DOI 10.1016/0014-5793(91)81249-8; Kinoshita T, 1999, EMBO J, V18, P5548, DOI 10.1093/emboj/18.20.5548; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Lambermon MHL, 2000, EMBO J, V19, P1638, DOI 10.1093/emboj/19.7.1638; Li JX, 1996, PLANT CELL, V8, P2359, DOI 10.1105/tpc.8.12.2359; Li JX, 2000, SCIENCE, V287, P300, DOI 10.1126/science.287.5451.300; Li JX, 1998, PLANT PHYSIOL, V116, P785, DOI 10.1104/pp.116.2.785; Lorkovic ZJ, 2000, TRENDS PLANT SCI, V5, P160, DOI 10.1016/S1360-1385(00)01595-8; Lorkovic ZJ, 2002, NUCLEIC ACIDS RES, V30, P623, DOI 10.1093/nar/30.3.623; Lu C, 2000, PLANT CELL, V12, P2351, DOI 10.1105/tpc.12.12.2351; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Melcak I, 2001, MOL BIOL CELL, V12, P393, DOI 10.1091/mbc.12.2.393; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Moriyama Y, 1997, ANGIOLOGY, V48, P839, DOI 10.1177/000331979704800912; Moz Y, 1999, J BIOL CHEM, V274, P25266, DOI 10.1074/jbc.274.36.25266; Ostrowski J, 2001, P NATL ACAD SCI USA, V98, P9044, DOI 10.1073/pnas.161284098; Schomburg FM, 2001, PLANT CELL, V13, P1427, DOI 10.1105/tpc.13.6.1427; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; SHEN LM, 1995, PHYSIOL PLANTARUM, V95, P99, DOI 10.1111/j.1399-3054.1995.tb00814.x; STONE JM, 1994, SCIENCE, V266, P793, DOI 10.1126/science.7973632; Xiong LM, 2001, DEV CELL, V1, P771, DOI 10.1016/S1534-5807(01)00087-9	30	136	141	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 15	2002	418	6899					793	797		10.1038/nature00936	http://dx.doi.org/10.1038/nature00936			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181571				2022-12-28	WOS:000177428000043
J	Ingolia, NT; Murray, AW				Ingolia, NT; Murray, AW			Signal transduction - History matters	SCIENCE			English	Editorial Material							NETWORKS		Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA	Harvard University; Harvard University	Ingolia, NT (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.							Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; BELCHETZ PE, 1978, SCIENCE, V202, P631, DOI 10.1126/science.100883; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7	8	18	18	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2002	297	5583					948	949		10.1126/science.1075222	http://dx.doi.org/10.1126/science.1075222			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169717				2022-12-28	WOS:000177325400026
J	Taggart, AKP; Teng, SC; Zakian, VA				Taggart, AKP; Teng, SC; Zakian, VA			Est1p as a cell cycle-regulated activator of telomere-bound telomerase	SCIENCE			English	Article							DNA-POLYMERASE-ALPHA; SACCHAROMYCES-CEREVISIAE; CHROMOSOME STABILITY; BINDING PROTEIN; IN-VIVO; YEAST; CDC13; REPLICATION; IDENTIFICATION; MAINTENANCE	In Saccharomyces cerevisiae, the telomerase components Est2p, TLC1 RNA, Est1p, and Est3p are thought to form a complex that acts late during chromosome replication ( S phase) upon recruitment by Cdc13p, a telomeric DNA binding protein. Consistent with this model, we show that Est1p, Est2p, and Cdc13p are telomere-associated at this time. However, Est2p, but not Est1p, also binds telomeres before late S phase. The cdc13-2 allele has been proposed to be defective in recruitment, yet Est1p and Est2p telomere association persists in cdc13-2 cells. These findings suggest a model in which Est1p binds telomeres late in S phase and interacts with Cdc13p to convert inactive, telomere-bound Est2p to an active form.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Zakian, VA (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.			TENG, SHU-CHUN/0000-0002-6492-2560	NCI NIH HHS [T32 CA09528-16] Funding Source: Medline; NIGMS NIH HHS [GM43265] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043265] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Bourns BD, 1998, MOL CELL BIOL, V18, P5600, DOI 10.1128/MCB.18.9.5600; Chandra A, 2001, GENE DEV, V15, P404, DOI 10.1101/gad.861001; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Hughes TR, 2000, P NATL ACAD SCI USA, V97, P6457, DOI 10.1073/pnas.97.12.6457; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Nugent CI, 1998, GENE DEV, V12, P1073, DOI 10.1101/gad.12.8.1073; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Prescott J, 1997, GENE DEV, V11, P2790, DOI 10.1101/gad.11.21.2790; Qi HY, 2000, GENE DEV, V14, P1777; SANDELL LL, 1994, P NATL ACAD SCI USA, V91, P12061, DOI 10.1073/pnas.91.25.12061; SIKORSKI RS, 1989, GENETICS, V122, P19; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; TAGGART AKP, UNPUB; Tsukamoto Y, 2001, CURR BIOL, V11, P1328, DOI 10.1016/S0960-9822(01)00372-4; Wellinger RJ, 1996, CELL, V85, P423, DOI 10.1016/S0092-8674(00)81120-4; WRIGHT JH, 1992, GENE DEV, V6, P197, DOI 10.1101/gad.6.2.197; ZAKIAN VA, 1995, SCIENCE, V270, P1601, DOI 10.1126/science.270.5242.1601	22	294	301	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2002	297	5583					1023	1026		10.1126/science.1074968	http://dx.doi.org/10.1126/science.1074968			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169735				2022-12-28	WOS:000177325400047
J	Sanchez, W; Loftus, EV				Sanchez, W; Loftus, EV			Fistulizing Crohn's disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA	Mayo Clinic	Sanchez, W (corresponding author), Mayo Clin & Mayo Fdn, 200 1st St SW, Rochester, MN 55905 USA.		Loftus, Edward V/E-8304-2011	Loftus, Edward V/0000-0001-7199-6851; Sanchez, William/0000-0002-0410-3934					0	0	0	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 8	2002	347	6					416	416		10.1056/NEJMicm010427	http://dx.doi.org/10.1056/NEJMicm010427			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587YR	12167684				2022-12-28	WOS:000177672400006
J	Brady, DW; Corbie-Smith, G; Branch, WT				Brady, DW; Corbie-Smith, G; Branch, WT			"What's important to you?": The use of narratives to promote self-reflection and to understand the experiences of medical residents	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							STUDENTS; CARE; PHYSICIAN; AWARENESS; EDUCATION		Emory Univ, Atlanta, GA 30303 USA	Emory University	Brady, DW (corresponding author), 69 Butler St SE, Atlanta, GA 30303 USA.			Corbie, Giselle/0000-0003-0737-6775				Baldwin DC, 1998, ACAD MED, V73, P1195, DOI 10.1097/00001888-199811000-00019; Beaudoin C, 1998, CAN MED ASSOC J, V159, P765; BOLTON G, 2001, REFLECTIVE PRACTICE, P51; Bolton G, 2001, REFLECTIVE PRACTICE, P117; BRANCH W, 1993, NEW ENGL J MED, V329, P1130, DOI 10.1056/NEJM199310073291518; BRANCH W, 1991, J GEN INTERN MED, V6, P573, DOI 10.1007/BF02598231; Branch W T Jr, 1998, Trans Am Clin Climatol Assoc, V109, P218; Branch WT, 1995, J GEN INTERN MED, V10, P691, DOI 10.1007/BF02602767; Branch WT, 2000, ACAD MED, V75, P127, DOI 10.1097/00001888-200002000-00006; Brookfield S., 1990, FOSTERING CRITICAL R, P177; DENZIN NK, 1999, HDB QUALITATIVE RES, P643; Glaser B.G., 1967, DISCOVERY GROUNDED T, P101; Hupert N., 1995, HARVARD STUDENT BMJ, V3, P99; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Mezirow J., 1990, FOSTERING CRITICAL R, P1; Miller SZ, 1999, ACAD MED, V74, P800, DOI 10.1097/00001888-199907000-00014; Novack DH, 1997, JAMA-J AM MED ASSOC, V278, P502, DOI 10.1001/jama.278.6.502; Novack DH, 1999, ACAD MED, V74, P516, DOI 10.1097/00001888-199905000-00017; REYNOLDS PP, 1991, ANN INTERN MED, V114, P91, DOI 10.7326/0003-4819-114-1-91; Schoen Donald, 1987, ED REFLECTIVE PRACTI; Smith CS, 1997, ACAD MED, V72, P32; Stobo J., 1995, PROJECT PROFESSIONAL; 1992, ANN INTERN MED, V117, P947	23	93	94	1	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 6	2002	137	3					220	223		10.7326/0003-4819-137-3-200208060-00025	http://dx.doi.org/10.7326/0003-4819-137-3-200208060-00025			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580XP	12160380				2022-12-28	WOS:000177262300019
J	Herbst, J; Heyne, K; Diller, R				Herbst, J; Heyne, K; Diller, R			Femtosecond infrared spectroscopy of bacteriorhodopsin chromophore isomerization	SCIENCE			English	Article							PROTONATED SCHIFF-BASE; RESONANCE RAMAN-SPECTRA; VIBRATIONAL ANALYSIS; QUANTUM YIELD; PHOTOCYCLE; PHOTOISOMERIZATION; INTERMEDIATE; RELAXATION; TRANSITION; DYNAMICS	The vibrational dynamics of the retinal chromophore all-trans-to-13-cis photoisomerization in bacteriorhodopsin has been studied with mid-infrared absorption spectroscopy at high time resolution ( about 200 femtoseconds). After photoexcitation of light-adapted bacteriorhodopsin, the transient infrared absorption was probed in a broad spectral region, including vibrations with dominant C-C, C=C and C=NH stretching mode amplitude. All photoproduct modes, especially those around 1190 reciprocal-centimeters that are indicative for a 13-cis configuration of the chromophore, rise with a time constant of similar to0.5 picosecond. The results presented give direct vibrational-spectroscopic evidence for the isomerization taking place within 0.5 picosecond, as has been suggested by previous optical femtosecond time-resolved experiments but questioned recently by picosecond time-resolved vibrational spectroscopy experiments.	Free Univ Berlin, Inst Expt Phys, D-14195 Berlin, Germany	Free University of Berlin	Diller, R (corresponding author), Free Univ Berlin, Inst Expt Phys, Arnimallee 14, D-14195 Berlin, Germany.	diller@physik.fu-berlin.de	Diller, Rolf/P-8470-2018	Diller, Rolf/0000-0002-3629-8334				Aharoni A, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1210, DOI 10.1023/A:1013175000873; Atkinson GH, 2000, J PHYS CHEM A, V104, P4130, DOI 10.1021/jp9918306; BRACK TL, 1991, J PHYS CHEM-US, V95, P2351, DOI 10.1021/j100159a043; BRAIMAN M, 1982, P NATL ACAD SCI-BIOL, V79, P403, DOI 10.1073/pnas.79.2.403; Curry B., 1985, ADV INFRARED RAMAN S, V12, P115; Diller R, 1998, CHEM PHYS LETT, V295, P47, DOI 10.1016/S0009-2614(98)00932-4; DILLER R, 1995, CHEM PHYS LETT, V241, P109, DOI 10.1016/0009-2614(95)00598-X; DOBLER J, 1988, CHEM PHYS LETT, V144, P215, DOI 10.1016/0009-2614(88)87120-3; DOIG SJ, 1991, J PHYS CHEM-US, V95, P6372, DOI 10.1021/j100169a054; Dziewior R, 1996, BER BUNSEN PHYS CHEM, V100, P2103, DOI 10.1002/bbpc.19961001231; Gai F, 1998, SCIENCE, V279, P1886, DOI 10.1126/science.279.5358.1886; Garavelli M, 1999, J AM CHEM SOC, V121, P1023, DOI 10.1021/ja981719y; Hamm P, 1996, CHEM PHYS LETT, V263, P613, DOI 10.1016/S0009-2614(96)01269-9; Hamm P, 1997, CHEM PHYS LETT, V268, P180, DOI 10.1016/S0009-2614(97)00142-5; HAMM P, 1995, CHEM PHYS, V200, P415, DOI 10.1016/0301-0104(95)00262-6; HERBST J, UNPUB; Kobayashi T, 2001, NATURE, V414, P531, DOI 10.1038/35107042; LOHRMANN R, 1991, J PHYS CHEM-US, V95, P1993, DOI 10.1021/j100158a020; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MATHIES RA, 1988, SCIENCE, V240, P777, DOI 10.1126/science.3363359; POLLAND HJ, 1986, BIOPHYS J, V49, P651, DOI 10.1016/S0006-3495(86)83692-X; RIMAI L, 1973, J AM CHEM SOC, V95, P4493, DOI 10.1021/ja00795a005; SCHNEIDER G, 1989, CHEM PHYS, V131, P17, DOI 10.1016/0301-0104(89)87078-8; SIEBERT F, 1999, BIOPHYS J, V76, P2687; SMITH SO, 1987, J PHYS CHEM-US, V91, P804, DOI 10.1021/j100288a011; SMITH SO, 1987, J AM CHEM SOC, V109, P3108, DOI 10.1021/ja00244a038; Song L, 1998, J AM CHEM SOC, V120, P8889, DOI 10.1021/ja980390d; TITTOR J, 1990, FEBS LETT, V263, P269, DOI 10.1016/0014-5793(90)81390-A; VANDENBERG R, 1990, BIOPHYS J, V58, P135, DOI 10.1016/S0006-3495(90)82359-6; Zinth W, 2001, SPRINGER SERIES CHEM, V66, P680; 1995, ISR J CHEM, V35	31	187	193	4	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2002	297	5582					822	825		10.1126/science.1072144	http://dx.doi.org/10.1126/science.1072144			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161649				2022-12-28	WOS:000177192800046
J	de Mul, E				de Mul, E			Coordination of humanitarian aid - a UN perspective	LANCET			English	Editorial Material																		2002, LANCET, V359, P2125	1	4	4	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 27	2002	360	9329					335	336		10.1016/S0140-6736(02)09574-0	http://dx.doi.org/10.1016/S0140-6736(02)09574-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578DT	12147392				2022-12-28	WOS:000177102700030
J	Swerdlow, AJ; Higgins, CD; Adlard, P; Preece, MA				Swerdlow, AJ; Higgins, CD; Adlard, P; Preece, MA			Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study	LANCET			English	Article							EPITHELIAL-CELL PROLIFERATION; IGF-BINDING-PROTEINS; FACTOR-I; FACTOR (IGF)-I; COLORECTAL NEOPLASIA; ACROMEGALIC PATIENTS; PREMATURE MORTALITY; LEUKEMIA; ADULTS; WOMEN	Background Growth hormone raises serum concentrations of insulin-like growth factor IGFI, which is mitogenic and antiapoptotic. There is evidence that raised endogenous levels of growth hormone and IGFI might be associated with increased risk of certain solid cancers, but there have been no data on long-term risks of solid cancers after growth hormone treatment. Methods We did a cohort study to investigate cancer incidence and mortality in 1848 patients in the UK who were treated during childhood and early adulthood with human pituitary growth hormone during the period from 1959 to 1985. Patients were followed up for cancer incidence to December, 1995 and for mortality to December, 2000. Risk of cancer in the cohort was compared with that in the general population, controlling for age, sex, and calendar period. Findings Patients treated with human pituitary growth hormone had significantly raised risks of mortality from cancer overall (standardised mortality ratio 2.8, 95% CI 1.3-5.1; ten cases), colorectal cancer (10.8, 1.3-38.8; two cases), and Hodgkin's disease (11.4, 1.4-41.3; two cases). Incidence of colorectal cancer was also greatly raised (7.9, 1.0-28.7). After exclusion of patients whose original diagnosis rendered them at high risk of cancer, the significance and size of the risks of colorectal cancer incidence and mortality, and of Hodgkin's disease mortality were increased. Interpretation Although based on small numbers, the risk of colorectal cancer is of some concern and further investigation in other cohorts is needed. We have no evidence as to whether growth hormone in modern dosage regimens is associated with an increased risk of colorectal cancer.	Inst Canc Res, Epidemiol Sect, Sutton SM2 5NG, Surrey, England; London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London, England; Inst Child Hlth, Biochem Endocrinol & Metab Unit, London, England	University of London; Institute of Cancer Research - UK; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Swerdlow, AJ (corresponding author), Inst Canc Res, Epidemiol Sect, Sutton SM2 5NG, Surrey, England.			Swerdlow, Anthony/0000-0001-5550-4159				Allen DB, 1997, J PEDIATR-US, V131, pS32, DOI 10.1016/S0022-3476(97)70008-8; Beentjes JAM, 2000, CLIN ENDOCRINOL, V52, P457, DOI 10.1046/j.1365-2265.2000.00993.x; Blethen SL, 1996, J CLIN ENDOCR METAB, V81, P1704, DOI 10.1210/jc.81.5.1704; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; BUCHANAN CR, 1991, BRIT MED J, V302, P824, DOI 10.1136/bmj.302.6780.824; Cats A, 1996, CANCER RES, V56, P523; Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; Christiansen JS, 2001, J CLIN ENDOCR METAB, V86, P1868; FRADKIN JE, 1993, JAMA-J AM MED ASSOC, V270, P2829, DOI 10.1001/jama.270.23.2829; Ghigo E, 1999, AM J PHYSIOL-ENDOC M, V276, pE1009, DOI 10.1152/ajpendo.1999.276.6.E1009; Giovannucci E, 2000, CANCER EPIDEM BIOMAR, V9, P345; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Jenkins PJ, 1997, CLIN ENDOCRINOL, V47, P17, DOI 10.1046/j.1365-2265.1997.1911029.x; JUUL A, 1994, CLIN ENDOCRINOL, V41, P85, DOI 10.1111/j.1365-2265.1994.tb03788.x; JUUL A, 1994, EUR J ENDOCRINOL, V131, P41, DOI 10.1530/eje.0.1310041; Kaaks R, 2000, JNCI-J NATL CANCER I, V92, P1592, DOI 10.1093/jnci/92.19.1592; LAHM H, 1994, INT J CANCER, V58, P452, DOI 10.1002/ijc.2910580325; Ma J, 1999, J NATL CANCER I, V91, P620, DOI 10.1093/jnci/91.7.620; Ng ST, 1997, NAT MED, V3, P1141, DOI 10.1038/nm1097-1141; Nishi Y, 1999, J CLIN ENDOCR METAB, V84, P1961, DOI 10.1210/jc.84.6.1961; OgilvyStuart AL, 1995, HORM RES, V44, P73, DOI 10.1159/000184677; Orme SM, 1998, J CLIN ENDOCR METAB, V83, P2730, DOI 10.1210/jc.83.8.2730; PINES A, 1985, AM J GASTROENTEROL, V80, P266; Probst-Hensch NM, 2001, BRIT J CANCER, V85, P1695, DOI 10.1054/bjoc.2001.2172; RABEN MS, 1958, J CLIN ENDOCR METAB, V18, P901, DOI 10.1210/jcem-18-8-901; Renehan AG, 2000, GUT, V46, P440, DOI 10.1136/gut.46.3.440; Renehan AG, 2001, BRIT J SURG, V88, P107, DOI 10.1046/j.1365-2168.2001.01645.x; RON E, 1991, CANCER, V68, P1673, DOI 10.1002/1097-0142(19911015)68:8<1673::AID-CNCR2820680802>3.0.CO;2-0; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; Swerdlow AJ, 2001, CANC INCIDENCE MORTA; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; TUFFLI GA, 1995, J CLIN ENDOCR METAB, V80, P1416, DOI 10.1210/jc.80.4.1416; WHO (World Health Organization), 1977, MAN INT STAT CLASS D	33	204	211	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 27	2002	360	9329					273	277		10.1016/S0140-6736(02)09519-3	http://dx.doi.org/10.1016/S0140-6736(02)09519-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578DT	12147369				2022-12-28	WOS:000177102700007
J	Walker, N; Schwartlander, B; Bryce, J				Walker, N; Schwartlander, B; Bryce, J			Meeting international goals in child survival and HIV/AIDS	LANCET			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PERINATAL HIV-1 TRANSMISSION; INFANT TRANSMISSION; ORAL ZIDOVUDINE; COTE-DIVOIRE; PREVENTION; INFECTION; MORTALITY; IMPACT; AIDS	Background After a decade of focused efforts to reduce under-5 mortality results have been mixed, with the HIV/AIDS epidemic often used to explain reversing trends. We investigated this assumption by estimating HIV-attributable under-5 mortality in 39 countries in sub-Saharan Africa and comparing it to total mortality in children younger than 5 years between 1990 and 1999. Methods Annual HIV-attributable under-5 mortality was estimated in a four-step process with previously obtained data from antenatal clinics in 39 countries based on HIV seroprevalence among pregnant women. This process produced estimates of: the number of children born to HIV-infected women; the number of children infected via mother-to-child-transmission of HIV; the number of HIV-infected children who died before age 5 years; and the number of HIV-infected children who died before age 5 years adjusted for competing causes of mortality. Findings An estimated 330 000 children younger than age 5 years died in sub-Saharan Africa in 1999 with HIV infection. When corrected for competing causes of mortality, HIV infection caused 7.7% of under-5 deaths in 1999, a significant rise from 2% in 1990. Five countries (Botswana, Namibia, Swaziland, Zambia, and Zimbabwe) have rates of HIN-attributable under-5 mortality of above 30 per 1000. An additional 16 countries have HIV-specific under-5 mortality rates between 10 and 25 per 1000. The remaining 18 countries have rates under 10 per 1000. Interpretation HIV/AIDS is an increasingly important cause of under-5 mortality in Africa. However, in many African countries, slowing or reversal of trends in child mortality cannot be explained by HIV alone. To meet international goals for reductions in child mortality, efforts must continue to focus on HIV/AIDS, but must also strengthen health systems that can deliver available interventions for the other major killer diseases of children in the developing world.	Joint UN Programme HIV AIDS, CH-1211 Geneva, Switzerland; WHO, CH-1211 Geneva, Switzerland	World Health Organization	Walker, N (corresponding author), Joint UN Programme HIV AIDS, 20 Ave Appia, CH-1211 Geneva, Switzerland.	walkern@unaids.org						Ahmad OB, 2000, B WORLD HEALTH ORGAN, V78, P1175; Bobat R, 1999, SAMJ, V89, P46; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Cooper ER, 2000, J ACQ IMMUN DEF SYND, V24, P45; Dabis F, 1999, LANCET, V353, P786, DOI 10.1016/S0140-6736(98)11046-2; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Gray RH, 1998, LANCET, V351, P98, DOI 10.1016/S0140-6736(97)09381-1; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Hill K, 1999, TRENDS CHILD MORTALI; KAMELANTANO Y, 2000, 13 INT AIDS C JUL 9; Kind C, 1998, AIDS, V12, P205, DOI 10.1097/00002030-199802000-00011; MANASEKIHOLLAND S, 2000, GLOBAL BREASTFEEDING; Mandelbrot L, 1998, JAMA-J AM MED ASSOC, V280, P55, DOI 10.1001/jama.280.1.55; NICOLL A, 1994, AIDS, V8, P995, DOI 10.1097/00002030-199407000-00019; OBERLE MW, 1980, INT J EPIDEMIOL, V9, P341, DOI 10.1093/ije/9.4.341; Ota MOC, 2000, AIDS, V14, P435, DOI 10.1097/00002030-200003100-00018; SAZAWAL S, 1992, LANCET, V340, P528, DOI 10.1016/0140-6736(92)91720-S; Schellenberg JRMA, 2001, LANCET, V357, P1241, DOI 10.1016/S0140-6736(00)04404-4; Schwartlander B, 2001, SCIENCE, V292, P2434, DOI 10.1126/science.1062876; Schwartlander B, 1999, AIDS, V13, P2445, DOI 10.1097/00002030-199912030-00017; Shaffer N, 1999, LANCET, V353, P773, DOI 10.1016/S0140-6736(98)10411-7; Spira R, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.5.e56; Taha T E, 2000, Pediatrics, V106, pE77, DOI 10.1542/peds.106.6.e77; *UN, WE CHILDR END DEC RE; *UN JOINT PROGR HI, 1998, REP GLOB HIV AIDS EP; *UN JOINT PROGR HI, 2000, REP GLOB HIV AIDS EP; *UN SECR DEP EC SO, 1999, DEM IMP HIV AIDS REP; *UN SECR DEP EC SO, 1999, AG PATT FERT 1995 20; Urassa M, 2001, AIDS, V15, P2017, DOI 10.1097/00002030-200110190-00015; *US BUR CENS, 2000, INT DAT BAS UNP TABL; *US BUR CENS, 2000, HIV AIDS SURV DAT BA; VANBALEN H, 1981, LANCET, V1, P764; Walker N, 2001, AIDS, V15, P1545, DOI 10.1097/00002030-200108170-00012; Wiktor SZ, 1999, LANCET, V353, P781, DOI 10.1016/S0140-6736(98)10412-9	34	94	95	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 27	2002	360	9329					284	289		10.1016/S0140-6736(02)09550-8	http://dx.doi.org/10.1016/S0140-6736(02)09550-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578DT	12147371				2022-12-28	WOS:000177102700009
J	Anderson, DM; Overpeck, JT; Gupta, AK				Anderson, DM; Overpeck, JT; Gupta, AK			Increase in the Asian southwest monsoon during the past four centuries	SCIENCE			English	Article							EURASIAN SNOW COVER; ARABIAN SEA; LATE QUATERNARY; INDIAN MONSOON; NORTH-ATLANTIC; SCALE EVENTS; CLIMATE; RECORD; DENITRIFICATION; RAINFALL	Climate reconstructions reveal unprecedented warming in the past century; however, little is known about trends in aspects such as the monsoon. We reconstructed the monsoon winds for the past 1000 years using fossil Globigerina bulloides abundance in box cores from the Arabian Sea and found that monsoon wind strength increased during the past four centuries as the Northern Hemisphere warmed. We infer that the observed link between Eurasian snow cover and the southwest monsoon persists on a centennial scale. Alternatively, the forcing implicated in the warming trend (volcanic aerosols, solar output, and greenhouse gases) may directly affect the monsoon. Either interpretation is consistent with the hypothesis that the southwest monsoon strength will increase during the coming century as greenhouse gas concentrations continue to rise and northern latitudes continue to warm.	NOAA, Paleoclimatol Program, Boulder, CO 80303 USA; Univ Colorado, Boulder, CO 80303 USA; Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA; Univ Arizona, Inst Study Planet Earth, Tucson, AZ 85721 USA; Indian Inst Technol, Kharagpur 721302, W Bengal, India	National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; University of Arizona; University of Arizona; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	Anderson, DM (corresponding author), NOAA, Paleoclimatol Program, Boulder, CO 80303 USA.	dma@ngdc.noaa.gov	anderson, david/E-6416-2011	Gupta, Anil/0000-0003-0536-3911				ALTABET MA, 1995, NATURE, V373, P506, DOI 10.1038/373506a0; Altabet MA, 2002, NATURE, V415, P159, DOI 10.1038/415159a; ANDERSON DM, 1993, PALEOCEANOGRAPHY, V8, P193, DOI 10.1029/93PA00256; Anderson DM, 2001, PALEOCEANOGRAPHY, V16, P352, DOI 10.1029/2000PA000530; ANDERSON DM, 1991, THESIS BROWN U; [Anonymous], CLIMATE HIST; BARNETT TP, 1989, J ATMOS SCI, V46, P661, DOI 10.1175/1520-0469(1989)046<0661:TEOESC>2.0.CO;2; Black DE, 1999, SCIENCE, V286, P1709, DOI 10.1126/science.286.5445.1709; Burroughs W. J., 1997, DOES WEATHER REALLY; CLEMENS S, 1991, NATURE, V353, P720, DOI 10.1038/353720a0; Clemens SC, 1996, SCIENCE, V274, P943, DOI 10.1126/science.274.5289.943; CURRY WB, 1992, UPWELLING SYSTEMS EV, P93; GOREAU TJ, 1980, NATURE, V287, P620, DOI 10.1038/287620a0; Guo ZT, 2002, NATURE, V416, P159, DOI 10.1038/416159a; Huang SP, 2000, NATURE, V403, P756, DOI 10.1038/35001556; Jacoby GC, 1996, SCIENCE, V273, P771, DOI 10.1126/science.273.5276.771; JONES PD, 1992, CLIMATE AD 1500, P649; KUTZBACH JE, 1988, SCIENCE, V241, P1043, DOI 10.1126/science.241.4869.1043; KUTZBACH JE, 1985, NATURE, V317, P130, DOI 10.1038/317130a0; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; MEEHL GA, 1994, SCIENCE, V266, P263, DOI 10.1126/science.266.5183.263; MORRILL C, UNPUB; Naidu PD, 1996, PALEOCEANOGRAPHY, V11, P129, DOI 10.1029/95PA03198; Overpeck J, 1996, CLIM DYNAM, V12, P213, DOI 10.1007/BF00211619; PARTHASARATHY B, 1994, THEOR APPL CLIMATOL, V49, P217, DOI 10.1007/BF00867461; PORTER SC, 1995, NATURE, V375, P305, DOI 10.1038/375305a0; Prell W.L., 1992, SYNTHESIS RESULTS SC, DOI [DOI 10.1029/GM070P0447, 10.1029/GM070p0447]; Prell W.L., 1984, CLIMATE PROCESSES CL, V29, P48; PRELL WL, 1984, MILANKOVITCH CLIMA 1, P48; Reichart GJ, 1998, PALEOCEANOGRAPHY, V13, P607, DOI 10.1029/98PA02203; Ren GY, 1998, GEOPHYS RES LETT, V25, P1931, DOI 10.1029/98GL01508; SankarRao M, 1996, INT J CLIMATOL, V16, P605, DOI 10.1002/(SICI)1097-0088(199606)16:6<605::AID-JOC41>3.0.CO;2-P; Sharma C., 2001, J PALAEONTOLOGICAL S, V46, P51; SIROCKO F, 1993, NATURE, V364, P322, DOI 10.1038/364322a0; Sirocko F, 1996, SCIENCE, V272, P526, DOI 10.1126/science.272.5261.526; Slutz R., 1985, COMPREHENSIVE OCEAN; STUIVER M, 1993, RADIOCARBON, V35, P1, DOI 10.1017/S0033822200013874; SUBBARAMAYYA I, 1992, INT J CLIMATOL, V12, P597, DOI 10.1002/joc.3370120606; Vinnikov KY, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014025; Wang LJ, 1999, GEOPHYS RES LETT, V26, P2889, DOI 10.1029/1999GL900443; Yadava MG, 1999, J SCI IND RES INDIA, V58, P339	41	275	295	2	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2002	297	5581					596	599		10.1126/science.1072881	http://dx.doi.org/10.1126/science.1072881			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142536				2022-12-28	WOS:000177054200049
J	Lauwereyns, J; Watanabe, K; Coe, B; Hikosaka, O				Lauwereyns, J; Watanabe, K; Coe, B; Hikosaka, O			A neural correlate of response bias in monkey caudate nucleus	NATURE			English	Article							SACCADIC EYE-MOVEMENTS; NEURONAL-ACTIVITY; FUNCTIONAL-PROPERTIES; BASAL GANGLIA; REWARD; EXPECTATION; CORTEX; SIGNALS; TARGET	Primates are equipped with neural circuits in the prefrontal cortex(1-6), the parietal cortex(7) and the basal ganglia(6,8-11) that predict the availability of reward during the performance of behavioural tasks. It is not known, however, how reward value is incorporated in the control of action. Here we identify neurons in the monkey caudate nucleus that create a spatially selective response bias depending on the expected gain. In behavioural tasks, the monkey had to make a visually guided eye movement in every trial, but was rewarded for a correct response in only half of the trials. Reward availability was predictable on the basis of the spatial position of the visual target. We found that caudate neurons change their discharge rate systematically, even before the appearance of the visual target, and usually fire more when the contralateral position is associated with reward. Strong anticipatory activity of neurons with a contralateral preference is associated with decreased latency for eye movements in the contralateral direction. We conclude that this neuronal mechanism creates an advance bias that favours a spatial response when it is associated with a high reward value.	NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA; Juntendo Univ, Dept Physiol, Bunkyo Ku, Tokyo 1130033, Japan	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Juntendo University	Hikosaka, O (corresponding author), NEI, Sensorimotor Res Lab, NIH, Bldg 49,Room 2A50, Bethesda, MD 20892 USA.			Watanabe, Katsumi/0000-0003-1282-9994; Lauwereyns, Jan/0000-0003-0551-2550; Coe, Brian/0000-0002-3985-0163	NATIONAL EYE INSTITUTE [ZIAEY000415, Z01EY000415] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amador N, 2000, J NEUROPHYSIOL, V84, P2166, DOI 10.1152/jn.2000.84.4.2166; APICELLA P, 1992, J NEUROPHYSIOL, V68, P945, DOI 10.1152/jn.1992.68.3.945; Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; BINDRA D, 1968, PSYCHOL REV, V75, P1, DOI 10.1037/h0025306; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Dorris MC, 1998, J NEUROSCI, V18, P7015; FISHER RS, 1986, BRAIN RES, V398, P148, DOI 10.1016/0006-8993(86)91260-6; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1268; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P780, DOI 10.1152/jn.1989.61.4.780; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; IKEDA T, 2001, SOC NEUR ABSTR, V27; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; KAWAGUCHI Y, 1990, J NEUROSCI, V10, P3421; Kobayashi S, 2002, J NEUROPHYSIOL, V87, P1488, DOI 10.1152/jn.00472.2001; Lauwereyns J, 2002, NEURON, V33, P463, DOI 10.1016/S0896-6273(02)00571-8; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; ROLLS ET, 1983, BEHAV BRAIN RES, V7, P179, DOI 10.1016/0166-4328(83)90191-2; ROLLS ET, 1999, BRAIN EMOTION; Sato M, 2002, J NEUROSCI, V22, P2363, DOI 10.1523/JNEUROSCI.22-06-02363.2002; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHULTZ W, 1992, J NEUROSCI, V12, P4595, DOI 10.1523/jneurosci.12-12-04595.1992; Takikawa Y, 2002, J NEUROPHYSIOL, V87, P508, DOI 10.1152/jn.00288.2001; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Watanabe M, 2001, EXP BRAIN RES, V140, P511, DOI 10.1007/s002210100856; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0	28	315	321	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2002	418	6896					413	417		10.1038/nature00892	http://dx.doi.org/10.1038/nature00892			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12140557				2022-12-28	WOS:000177009700037
J	Schrag, SJ; Zell, ER; Lynfield, R; Roome, A; Arnold, KE; Craig, AS; Harrison, LH; Reingold, A; Stefonek, K; Smith, G; Gamble, M; Schuchat, A				Schrag, SJ; Zell, ER; Lynfield, R; Roome, A; Arnold, KE; Craig, AS; Harrison, LH; Reingold, A; Stefonek, K; Smith, G; Gamble, M; Schuchat, A		Active Bacterial Core Surveillance	A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFECTION	Background Guidelines issued in 1996 in the United States recommend either screening of pregnant women for group B streptococcal colonization by means of cultures (screening approach) or assessing clinical risk factors (risk-based approach) to identify candidates for intrapartum antibiotic prophylaxis. Methods In a multistate retrospective cohort study, we compared the effectiveness of the screening and risk based approaches in preventing early-onset group B streptococcal disease (in infants less than seven days old). We studied a stratified random sample of the 629,912 live births in 1998 and 1999 in eight geographical areas where there was active surveillance for group B streptococcal infection, including all births in which the neonate had early-onset disease. Women with no documented culture for group B streptococcus were considered to have been cared for according to the risk-based approach. Results We studied 5144 births, including 312 in which the newborn had early-onset group B streptococcal disease. Antenatal screening was documented for 52 percent of the mothers. The risk of early-onset disease was significantly lower among the infants of screened women than among those in the risk-based group (adjusted relative risk, 0.46; 95 percent confidence interval, 0.36 to 0.60). Because women whose providers had no strategy for prophylaxis may have been misclassified in the risk based group, we excluded all women with risk factors and adequate time for prophylaxis who did not receive antibiotics. The adjusted relative risk of early-onset disease associated with the screening approach in this secondary analysis was similar - 0.48 (95 percent confidence interval, 0.37 to 0.63). Conclusions Routine screening, for group B streptococcus during pregnancy prevents more cases of early-onset disease than the risk-based approach. Recommendations that endorse both strategies as equivalent warrant reconsideration.	Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial & Mycot Dis, Atlanta, GA 30333 USA; Minnesota Dept Hlth, Minneapolis, MN USA; Connecticut Dept Publ Hlth, Hartford, CT USA; Georgia Dept Human Resources, Atlanta, GA USA; Tennessee Dept Hlth, Nashville, TN USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; Dept Human Sern, Hlth Serv, Portland, OR USA; New York State Dept Hlth, Albany, NY USA	Centers for Disease Control & Prevention - USA; Minnesota Department of Health (MHD); Tennessee Department Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Berkeley; State University of New York (SUNY) System	Schrag, SJ (corresponding author), Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial & Mycot Dis, MS-C23,1600 Clifton Rd, Atlanta, GA 30333 USA.	zha6@cdc.gov						ANCONA RJ, 1980, J MED MICROBIOL, V13, P273, DOI 10.1099/00222615-13-2-273; ARMITAGE P, 1994, STAT METHODS MED RES, P621; Boyer K M, 1985, Antibiot Chemother (1971), V35, P267; Centers for Disease Control and Prevention, 1996, MMWR-MORBID MORTAL W, V45, P679; Cochran W.G., 1963, SAMPLING TECHNIQUES, V2nd ed., P413; *COMM OBST PRACT, 1996, PREV EARL ONS GROUP; DILLON HC, 1987, J PEDIATR-US, V110, P31, DOI 10.1016/S0022-3476(87)80283-4; Factor SH, 1998, AM J OBSTET GYNECOL, V179, P1568, DOI 10.1016/S0002-9378(98)70026-2; Gilson G J, 2000, J Perinatol, V20, P491, DOI 10.1038/sj.jp.7200463; Hafner E, 1998, AM J OBSTET GYNECOL, V179, P677, DOI 10.1016/S0002-9378(98)70063-8; Halsey NA, 1997, PEDIATRICS, V99, P489, DOI 10.1542/peds.99.3.489; KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1414, DOI 10.2105/AJPH.84.9.1414; Levine E M, 1999, Infect Dis Obstet Gynecol, V7, P210; Lieu TA, 1998, OBSTET GYNECOL, V92, P21, DOI 10.1016/S0029-7844(98)00147-1; Lin FYC, 2001, AM J OBSTET GYNECOL, V184, P1204, DOI 10.1067/mob.2001.113875; Locksmith GJ, 1999, AM J OBSTET GYNECOL, V180, P416, DOI 10.1016/S0002-9378(99)70225-5; Lohr S.L., 1999, SAMPLING DESIGN ANAL; Main EK, 2000, AM J OBSTET GYNECOL, V182, P1344, DOI 10.1067/mob.2000.106245; Reisner DP, 2000, AM J OBSTET GYNECOL, V182, P1335, DOI 10.1067/mob.2000.106246; Rosenstein NE, 1997, OBSTET GYNECOL, V90, P901, DOI 10.1016/S0029-7844(97)00486-9; ROUSE DJ, 1994, OBSTET GYNECOL, V83, P483, DOI 10.1097/00006250-199404000-00001; Schrag SJ, 2000, NEW ENGL J MED, V342, P15, DOI 10.1056/NEJM200001063420103; SCHUCHAT A, 1990, J INFECT DIS, V162, P672, DOI 10.1093/infdis/162.3.672; Schuchat A, 2001, EMERG INFECT DIS, V7, P92, DOI 10.3201/eid0701.010114; Watt JP, 2001, OBSTET GYNECOL, V98, P7, DOI 10.1016/S0029-7844(01)01401-6; White K., 2000, Morbidity and Mortality Weekly Report, V49, P793; 1996, MMWR MORB MORTAL WKL, V45, P1	27	399	425	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 25	2002	347	4					233	239		10.1056/NEJMoa020205	http://dx.doi.org/10.1056/NEJMoa020205			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587WB	12140298				2022-12-28	WOS:000177665800002
J	Steere, AC; Burns, RB				Steere, AC; Burns, RB			A 58-year-old man with a diagnosis of chronic Lyme disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC-FATIGUE-SYNDROME; RANDOMIZED CONTROLLED TRIAL; COGNITIVE-BEHAVIOR THERAPY; POLYMERASE CHAIN-REACTION; BORRELIA-BURGDORFERI DNA; DOUBLE-BLIND; ERYTHEMA MIGRANS; NEUROLOGIC MANIFESTATIONS; FIBROMYALGIA SYNDROME; ANTIBIOTIC-TREATMENT		Massachusetts Gen Hosp, Comprehens Arthrit Ctr, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Steere, AC (corresponding author), Massachusetts Gen Hosp, Comprehens Arthrit Ctr, 149 13th St,Room 8301, Charlestown, MA 02129 USA.			Steere, Allen/0000-0002-5268-9853				[Anonymous], 1995, MMWR Recomm Rep, V44, P1; [Anonymous], 1990, MMWR Recomm Rep, V39, P1; Bennett RM, 1996, RHEUM DIS CLIN N AM, V22, P351, DOI 10.1016/S0889-857X(05)70276-3; Bennett RM, 1996, J RHEUMATOL, V23, P521; BERGER BW, 1992, J CLIN MICROBIOL, V30, P359, DOI 10.1128/JCM.30.2.359-361.1992; Bujak DI, 1996, J RHEUMATOL, V23, P1392; BURDGE DR, 1993, CLIN INFECT DIS, V16, P558, DOI 10.1093/clind/16.4.558; Cadavid D, 2000, LAB INVEST, V80, P1043, DOI 10.1038/labinvest.3780109; CARETTE S, 1994, ARTHRITIS RHEUM, V37, P32, DOI 10.1002/art.1780370106; Chen J, 1999, ARTHRITIS RHEUM, V42, P1813, DOI 10.1002/1529-0131(199909)42:9&lt;1813::AID-ANR4&gt;3.0.CO;2-0; Clark S R, 1994, Arthritis Care Res, V7, P221, DOI 10.1002/art.1790070410; COYLE PK, 1999, CONTINUUM LIFELONG L, V5; DATTWYLER RJ, 1988, NEW ENGL J MED, V319, P1441, DOI 10.1056/NEJM198812013192203; DATTWYLER RJ, 1990, LANCET, V336, P1404, DOI 10.1016/0140-6736(90)93103-V; Deale A, 1997, AM J PSYCHIAT, V154, P408; DINERMAN H, 1992, ANN INTERN MED, V117, P281, DOI 10.7326/0003-4819-117-4-281; DRESSLER F, 1993, J INFECT DIS, V167, P392, DOI 10.1093/infdis/167.2.392; DURAY PH, 1987, AM J SURG PATHOL, V11, P47, DOI 10.1097/00000478-198700111-00005; ENGSTROM SM, 1995, J CLIN MICROBIOL, V33, P419, DOI 10.1128/JCM.33.2.419-427.1995; ETTESTAD PJ, 1995, J INFECT DIS, V171, P356, DOI 10.1093/infdis/171.2.356; Gerber MA, 1996, NEW ENGL J MED, V335, P1270, DOI 10.1056/NEJM199610243351703; Goldenberg D, 1996, ARTHRITIS RHEUM, V39, P1852, DOI 10.1002/art.1780391111; GOLDENBERG DL, 1986, ARTHRITIS RHEUM, V29, P1371, DOI 10.1002/art.1780291110; GOLDENBERG DL, 1989, RHEUM DIS CLIN N AM, V15, P105; GOLDENBERG DL, 1990, ARTHRITIS RHEUM, V33, P381, DOI 10.1002/art.1780330311; Goldenberg DL, 1994, J MUSCULOSKELET PAIN, V2, P53, DOI [10.1300/J094v02n02_05, DOI 10.1300/J094V02N02_05]; Gross DM, 1998, SCIENCE, V281, P703, DOI 10.1126/science.281.5377.703; HALPERIN JJ, 1989, NEUROLOGY, V39, P753, DOI 10.1212/WNL.39.6.753; HALPERIN JJ, 1987, NEUROLOGY, V37, P1700, DOI 10.1212/WNL.37.11.1700; IMBODEN JB, 1961, ARCH INTERN MED, V108, P393, DOI 10.1001/archinte.1961.03620090065008; JOHNSON RC, 1984, INT J SYST BACTERIOL, V34, P496, DOI 10.1099/00207713-34-4-496; Kalish RA, 2001, CLIN INFECT DIS, V33, P780, DOI 10.1086/322669; Kalish RA, 2001, J INFECT DIS, V183, P453, DOI 10.1086/318082; KAPLAN RF, 1992, NEUROLOGY, V42, P1263, DOI 10.1212/WNL.42.7.1263; Kaplan RF, 1997, SEMIN NEUROL, V17, P31, DOI 10.1055/s-2008-1040910; Klempner MS, 2001, AM J MED, V110, P217, DOI 10.1016/S0002-9343(00)00701-4; Klempner MS, 2001, NEW ENGL J MED, V345, P85, DOI 10.1056/NEJM200107123450202; Komaroff AL, 1997, JAMA-J AM MED ASSOC, V278, P1179; KRUESI MJP, 1989, J CLIN PSYCHIAT, V50, P53; LASTAVICA CC, 1989, NEW ENGL J MED, V320, P133, DOI 10.1056/NEJM198901193200301; Leventhal LJ, 1999, ANN INTERN MED, V131, P850, DOI 10.7326/0003-4819-131-11-199912070-00009; LOGIGIAN EL, 1990, NEW ENGL J MED, V323, P1438, DOI 10.1056/NEJM199011223232102; Logigian EL, 1997, NEUROLOGY, V49, P1661, DOI 10.1212/WNL.49.6.1661; Logigian EL, 1999, J INFECT DIS, V180, P377, DOI 10.1086/314860; LOGIGIAN EL, 1992, NEUROLOGY, V42, P303, DOI 10.1212/WNL.42.2.303; MCCAIN GA, 1988, ARTHRITIS RHEUM, V31, P1135, DOI 10.1002/art.1780310908; Mursic VP, 1996, INFECTION, V24, P218, DOI 10.1007/BF01781096; Nadelman RB, 1996, AM J MED, V100, P502, DOI 10.1016/S0002-9343(95)99915-9; NADELMAN RB, 1992, ANN INTERN MED, V117, P273, DOI 10.7326/0003-4819-117-4-273; Nocton JJ, 1996, J INFECT DIS, V174, P623, DOI 10.1093/infdis/174.3.623; NOCTON JJ, 1994, NEW ENGL J MED, V330, P229, DOI 10.1056/NEJM199401273300401; Orloski K A, 2000, MMWR CDC Surveill Summ, V49, P1; PACHNER AR, 1985, NEUROLOGY, V35, P47, DOI 10.1212/WNL.35.1.47; Patel R, 2000, CLIN INFECT DIS, V31, P1107, DOI 10.1086/318138; PIESMAN J, 1993, J INFECT DIS, V167, P1082, DOI 10.1093/infdis/167.5.1082; PREACMURSIC V, 1989, INFECTION, V17, P355, DOI 10.1007/BF01645543; Reid MC, 1998, ANN INTERN MED, V128, P354, DOI 10.7326/0003-4819-128-5-199803010-00003; REIK L, 1979, MEDICINE, V58, P281, DOI 10.1097/00005792-197907000-00001; SCHLUEDERBERG A, 1992, ANN INTERN MED, V117, P325, DOI 10.7326/0003-4819-117-4-325; Seltzer EG, 2000, JAMA-J AM MED ASSOC, V283, P609, DOI 10.1001/jama.283.5.609; Shadick NA, 1999, ANN INTERN MED, V131, P919, DOI 10.7326/0003-4819-131-12-199912210-00003; Sharpe M, 1996, BRIT MED J, V312, P22, DOI 10.1136/bmj.312.7022.22; SIGAL LH, 1990, AM J MED, V88, P577, DOI 10.1016/0002-9343(90)90520-N; STEER AC, 1983, ANN INTERN MED, V99, P767, DOI 10.7326/0003-4819-99-6-767; STEERE AC, 1983, ANN INTERN MED, V99, P76, DOI 10.7326/0003-4819-99-1-76; STEERE AC, 1990, J INFECT DIS, V161, P1203, DOI 10.1093/infdis/161.6.1203; STEERE AC, 1993, JAMA-J AM MED ASSOC, V269, P1812, DOI 10.1001/jama.269.14.1812; STEERE AC, 1993, JAMA-J AM MED ASSOC, V270, P1369, DOI 10.1001/jama.270.11.1369b; STEERE AC, 1989, NEW ENGL J MED, V321, P586, DOI 10.1056/NEJM198908313210906; STEERE AC, 1986, J INFECT DIS, V154, P295, DOI 10.1093/infdis/154.2.295; Steere AC, 1998, NEW ENGL J MED, V339, P209, DOI 10.1056/NEJM199807233390401; STEERE AC, 1983, NEW ENGL J MED, V308, P733, DOI 10.1056/NEJM198303313081301; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; STEERE AC, 1987, ANN INTERN MED, V107, P725, DOI 10.7326/0003-4819-107-5-725; Vercoulen JHMM, 1996, LANCET, V347, P858, DOI 10.1016/S0140-6736(96)91345-8; Wearden AJ, 1998, BRIT J PSYCHIAT, V172, P485, DOI 10.1192/bjp.172.6.485; WHITE KP, 1995, J RHEUMATOL, V22, P717; Wormser GP, 2000, J CLIN MICROBIOL, V38, P1648, DOI 10.1128/JCM.38.4.1648-1650.2000; Wormser GP, 2000, CLIN INFECT DIS, V31, pS1, DOI 10.1086/314053	79	9	9	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2002	288	8					1002	1010		10.1001/jama.288.8.1002	http://dx.doi.org/10.1001/jama.288.8.1002			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587RM	12190371				2022-12-28	WOS:000177656400026
J	Poulet, JFA; Hedwig, B				Poulet, JFA; Hedwig, B			A corollary discharge maintains auditory sensitivity during sound production	NATURE			English	Article							ECHOLOCATING BATS; NEURAL ATTENUATION; CRICKET; RESPONSES; NEURONS; INHIBITION; SYSTEM; INPUT	Speaking and singing present the auditory system of the caller with two fundamental problems: discriminating between self-generated and external auditory signals and preventing desensitization. In humans(1) and many other vertebrates(2-7), auditory neurons in the brain are inhibited during vocalization but little is known about the nature of the inhibition. Here we show, using intracellular recordings of auditory neurons in the singing cricket, that presynaptic inhibition of auditory afferents and postsynaptic inhibition of an identified auditory interneuron occur in phase with the song pattern. Presynaptic and postsynaptic inhibition persist in a fictively singing, isolated cricket central nervous system and are therefore the result of a corollary discharge from the singing motor network. Mimicking inhibition in the interneuron by injecting hyperpolarizing current suppresses its spiking response to a 100-dB sound pressure level (SPL) acoustic stimulus and maintains its response to subsequent, quieter stimuli. Inhibition by the corollary discharge reduces the neural response to self-generated sound and protects the cricket's auditory pathway from self-induced desensitization.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Poulet, JFA (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.			Poulet, James/0000-0003-0296-5415				BELL CC, 1981, SCIENCE, V214, P450, DOI 10.1126/science.7291985; BELL CC, 1984, COMP PHYSL SENSORY S, P636; BORG E, 1989, SCI AM, V261, P62; Clarac F, 1996, EXP BRAIN RES, V112, P163; CREUTZFELDT O, 1989, EXP BRAIN RES, V77, P476, DOI 10.1007/BF00249601; Givois V, 2000, J EXP BIOL, V203, P2529; GUTHRIE BL, 1983, SCIENCE, V221, P1193, DOI 10.1126/science.6612334; Hardt M, 1999, J COMP NEUROL, V403, P281, DOI 10.1002/(SICI)1096-9861(19990118)403:3<281::AID-CNE1>3.0.CO;2-0; Hedwig B, 2000, J NEUROPHYSIOL, V83, P712, DOI 10.1152/jn.2000.83.2.712; HENNIG RM, 1994, J EXP BIOL, V187, P45; JONES MDR, 1973, J COMP PHYSIOL, V87, P89, DOI 10.1007/BF00699298; Knepper M, 1997, COMPUT METH PROG BIO, V52, P75, DOI 10.1016/S0169-2607(96)01781-6; MCCASLAND JS, 1981, P NATL ACAD SCI-BIOL, V78, P7815, DOI 10.1073/pnas.78.12.7815; METZNER W, 1989, NATURE, V341, P529, DOI 10.1038/341529a0; MICHEL K, 1974, Z MORPHOL TIERE, V77, P285, DOI 10.1007/BF00298805; MULLERPREUSS P, 1981, BRAIN RES, V215, P61, DOI 10.1016/0006-8993(81)90491-1; NARINS PM, 1992, J ACOUST SOC AM, V91, P3551, DOI 10.1121/1.402844; NOCKE H, 1972, J COMP PHYSIOL, V80, P141, DOI 10.1007/BF00696487; POLLACK GS, 1988, J NEUROSCI, V8, P2635; Poulet JFA, 2001, J EXP BIOL, V204, P1281; Schildberger K., 1989, P423; SCHULLER G, 1979, J COMP PHYSIOL, V132, P39, DOI 10.1007/BF00617730; SILLAR KT, 1988, NATURE, V331, P262, DOI 10.1038/331262a0; SOBEL EC, 1994, SCIENCE, V263, P823, DOI 10.1126/science.263.5148.823; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; SUGA N, 1972, SCIENCE, V177, P82, DOI 10.1126/science.177.4043.82; SUGA N, 1975, J EXP BIOL, V62, P277; SUGA N, 1974, SCIENCE, V183, P1211, DOI 10.1126/science.183.4130.1211; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; ZARETSKY M, 1979, NATURE, V280, P583, DOI 10.1038/280583a0	30	107	108	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2002	418	6900					872	876		10.1038/nature00919	http://dx.doi.org/10.1038/nature00919			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192409				2022-12-28	WOS:000177555600037
J	Owsley, C; McGwin, G; Sloane, M; Wells, J; Stalvey, BT; Gauthreaux, S				Owsley, C; McGwin, G; Sloane, M; Wells, J; Stalvey, BT; Gauthreaux, S			Impact of cataract surgery on motor vehicle crash involvement by older adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LENS OPACITIES; VISUAL-ACUITY; DISABILITY GLARE; RISK; EYE; CLASSIFICATION; POPULATION; PREVALENCE; DRIVERS; VISION	Context Motor vehicle crash risk in older drivers is elevated in those with cataract, a condition that impairs vision and is present in half of adults aged 65 years or older. Objective To determine the impact of cataract surgery on the crash risk for older adults in the years following surgery, compared with that of older adults who have cataract but who elect to not have surgery. Design, Setting, and Patients Prospective cohort study of 277 patients with cataract, aged 55 to 84 years at enrollment, who were recruited from 12 eye clinics in Alabama from October 1994 through March 1996, with 4 to 6 years of follow-up (to March 1999). Main Outcome Measure Police-reported motor vehicle crash occurrence involving patients who elected to have surgery compared with those who did not. Results Comparing the cataract surgery group (n=174) with the no surgery group (n=103), the rate ratio for crash involvement was 0.47 (95% confidence interval, 0.23-0.94), adjusting for race and baseline visual acuity and contrast sensitivity. The absolute rate reduction associated with cataract surgery was 4.74 crashes per million miles of travel. Conclusions In our sample, patients with cataract who underwent cataract surgery and intraocular lens implantation had half the rate of crash involvement during the follow-up period compared with cataract patients who did not undergo surgery. Cataract surgery thus may have a previously undocumented benefit for older driver safety, reducing subsequent crash rate.	Univ Alabama Birmingham, Sch Med, Dept Ophthalmol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol & Int Hlth, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Surg, Div Gen Surg, Sect Trauma Burns & Surg Crit Care, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Owsley, C (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Ophthalmol, 700 S 18th St,Suite 609, Birmingham, AL 35294 USA.	owsley@eyes.uab.edu			NIA NIH HHS [P50-AG11684] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P50AG011684] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		APPLEGATE WB, 1987, JAMA-J AM MED ASSOC, V257, P1064; BALL K, 1993, INVEST OPHTH VIS SCI, V34, P3110; Ball K., 1990, DEV ATTENTION RES TH, V69, P489, DOI DOI 10.1016/S0166-4115(08)60472-0; Ball K., 2000, MOBILITY TRANSPORTAT, P213; Barancik JI, 1986, AM J EPIDEMIOL, V74, P473; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; COOPER PJ, 1993, J SAFETY RES, V24, P9, DOI 10.1016/0022-4375(93)90047-Q; ELLIOTT DB, 1993, INVEST OPHTH VIS SCI, V34, P108; Elliott DB, 1997, BRIT J OPHTHALMOL, V81, P889, DOI 10.1136/bjo.81.10.889; EVANS L, 1988, J TRAUMA, V28, P368, DOI 10.1097/00005373-198803000-00013; FERRIS FL, 1982, AM J OPHTHALMOL, V94, P91, DOI 10.1016/0002-9394(82)90197-0; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; HOLLADAY JT, 1987, J CATARACT REFR SURG, V13, P67, DOI 10.1016/S0886-3350(87)80016-0; HU PS, 1999, FHWAPL00006 US DEP T; Janke M., 1994, TRANSPORT RES REC, V1438, P77; Jobe JB, 2001, CONTROL CLIN TRIALS, V22, P453, DOI 10.1016/S0197-2456(01)00139-8; KAHN HA, 1977, AM J EPIDEMIOL, V106, P17, DOI 10.1093/oxfordjournals.aje.a112428; Karusu T.B., 1976, GERIATRIC PSYCHIAT, P77; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P546; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; MANGIONE CM, 1994, ARCH OPHTHALMOL-CHIC, V112, P1419, DOI 10.1001/archopht.1994.01090230033017; MAROTTOLI RA, 1994, ANN INTERN MED, V121, P842, DOI 10.7326/0003-4819-121-11-199412010-00003; MCKNIGHT AJ, 1982, PUBLICATION DOT; Monestam E, 1997, BRIT J OPHTHALMOL, V81, P16, DOI 10.1136/bjo.81.1.16; Murakami E, 1997, COMP COMPUTER ASSIST; *NAT HIGHW TRAFF S, 1989, C RES DEV NEED IMPR; *NAT HIGHW TRAFF S, 1993, ADDR SAF ISS REL YOU; Owsley C, 1999, J GERONTOL A-BIOL, V54, pM203, DOI 10.1093/gerona/54.4.M203; OWSLEY C, 1991, PSYCHOL AGING, V6, P403, DOI 10.1037/0882-7974.6.3.403; Owsley C, 2001, ARCH OPHTHALMOL-CHIC, V119, P881; Owsley C, 1998, JAMA-J AM MED ASSOC, V279, P1083, DOI 10.1001/jama.279.14.1083; OWSLEY C, IN PRESS ACCIDENT AN; PELLI DG, 1988, CLIN VISION SCI, V2, P187; POWE NR, 1994, ARCH OPHTHALMOL-CHIC, V112, P239, DOI 10.1001/archopht.1994.01090140115033; RADLOFF L S, 1986, Clinical Gerontologist, V5, P119; Ray W A, 1993, Clin Geriatr Med, V9, P413; RUBIN GS, 1993, ARCH OPHTHALMOL-CHIC, V111, P56, DOI 10.1001/archopht.1993.01090010060027; STALVEY BT, IN PRESS HLTH PROMOT; STARK WJ, 1983, OPHTHALMOLOGY, V90, P311; STEINBERG EP, 1994, OPHTHALMOLOGY, V101, P1131; West SK, 1998, AM J EPIDEMIOL, V148, P1033; Willis S L, 1987, Annu Rev Gerontol Geriatr, V7, P159	43	165	166	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2002	288	7					841	849		10.1001/jama.288.7.841	http://dx.doi.org/10.1001/jama.288.7.841			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585FC	12186601	Bronze			2022-12-28	WOS:000177513100026
J	Broadhead, RL; Muula, AS				Broadhead, RL; Muula, AS			Creating a medical school for Malawi: problems and achievements	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Coll Med, Blantyre 3, Malawi	University of Malawi	Broadhead, RL (corresponding author), Coll Med, Private Bag 360, Blantyre 3, Malawi.	rlbroadhead@sdnp.org.mw	Muula, Adamson/AAF-1153-2020	Muula, Adamson/0000-0003-4412-9773				Broadhead RL, 1998, ANN TROP PAEDIATR, V18, pS27, DOI 10.1080/02724936.1998.11747977; DAHLENBURG GW, 1993, TROP DOCT, V23, P4, DOI 10.1177/004947559302300104; GRILLO TA, 1981, FEASIBILITY STUDY FD; *MIN HLTH PLANN UN, 1986, 1986 MIN HLTH PL; *MIN HLTH PLANN UN, 1986, A2 MIN HLTH PLANN UN; Sridhar M, 2000, BRIT MED J, V321, P307, DOI 10.1136/bmj.321.7256.307; WELSH C, 2001, BRIT MED J, V321, P353	7	25	26	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 17	2002	325	7360					384	387		10.1136/bmj.325.7360.384	http://dx.doi.org/10.1136/bmj.325.7360.384			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587DV	12183314	Green Published			2022-12-28	WOS:000177626000026
J	Hoffman, JE; McElroy, K; Lee, DH; Lang, KM; Eisaki, H; Uchida, S; Davis, JC				Hoffman, JE; McElroy, K; Lee, DH; Lang, KM; Eisaki, H; Uchida, S; Davis, JC			Imaging quasiparticle interference in Bi2Sr2CaCu2O8+delta	SCIENCE			English	Article							SCANNING TUNNELING SPECTROSCOPY; SUPERCONDUCTING GAP ANISOTROPY; FERMI CONTOUR; SURFACE; STATE; SCATTERING; ELECTRONS; DENSITY	Scanning tunneling spectroscopy of the high-T-c superconductor Bi2Sr2CaCu2O8+delta reveals weak, incommensurate, spatial modulations in the tunneling conductance. Images of these energy-dependent modulations are Fourier analyzed to yield the dispersion of their wavevectors. Comparison of the dispersions with photoemission spectroscopy data indicates that quasiparticle interference, due to elastic scattering between characteristic regions of momentum-space, provides a consistent explanation for the conductance modulations, without appeal to another order parameter. These results refocus attention on quasiparticle scattering processes as potential explanations for other incommensurate phenomena in the cuprates. The momentum-resolved tunneling spectroscopy demonstrated here also provides a new technique with which to study quasiparticles in correlated materials.	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Natl Inst Stand & Technol, Div Electromagnet Technol, Boulder, CO 80305 USA; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; Agcy Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; Univ Tokyo, Dept Superconduct, Tokyo 1138656, Japan; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; National Institute of Standards & Technology (NIST) - USA; Stanford University; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Davis, JC (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.		Eisaki, Hiroshi/F-6317-2018; mcelroy, kyle/D-1816-2013; Hoffman, Jennifer E/H-4334-2011	Eisaki, Hiroshi/0000-0002-8299-6416; Hoffman, Jennifer E/0000-0003-2752-5379; McElroy, Kyle/0000-0003-4799-2820				Brinckmann J, 1999, PHYS REV LETT, V82, P2915, DOI 10.1103/PhysRevLett.82.2915; Burgi L, 2000, J ELECTRON SPECTROSC, V109, P33, DOI 10.1016/S0368-2048(00)00105-5; BYERS JM, 1993, PHYS REV LETT, V71, P3363, DOI 10.1103/PhysRevLett.71.3363; Corson J, 2000, PHYS REV LETT, V85, P2569, DOI 10.1103/PhysRevLett.85.2569; Cren T, 2001, EUROPHYS LETT, V54, P84, DOI 10.1209/epl/i2001-00232-4; CROMMIE MF, 1993, NATURE, V363, P524, DOI 10.1038/363524a0; Derro DJ, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097002; DESSAU DS, 1993, PHYS REV LETT, V71, P2781, DOI 10.1103/PhysRevLett.71.2781; Ding H, 1996, PHYS REV B, V54, pR9678, DOI 10.1103/PhysRevB.54.R9678; Feng DL, 2000, SCIENCE, V289, P277, DOI 10.1126/science.289.5477.277; Fujita D, 1999, SURF SCI, V423, P160, DOI 10.1016/S0039-6028(98)00886-3; HASEGAWA Y, 1993, PHYS REV LETT, V71, P1071, DOI 10.1103/PhysRevLett.71.1071; Hoffman JE, 2002, SCIENCE, V295, P466, DOI 10.1126/science.1066974; Howald C, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.100504; HOWALD C, IN PRESS CONDENS MAT; Kanisawa K, 2001, PHYS REV LETT, V86, P3384, DOI 10.1103/PhysRevLett.86.3384; Lang KM, 2002, NATURE, V415, P412, DOI 10.1038/415412a; LITTLEWOOD PB, 1993, PHYS REV B, V48, P487, DOI 10.1103/PhysRevB.48.487; Mesot J, 1999, PHYS REV LETT, V83, P840, DOI 10.1103/PhysRevLett.83.840; Norman MR, 2000, PHYS REV B, V61, P14751, DOI 10.1103/PhysRevB.61.14751; Norman MR, 1998, NATURE, V392, P157, DOI 10.1038/32366; Pan SH, 2001, NATURE, V413, P282, DOI 10.1038/35095012; Petersen L, 2000, J ELECTRON SPECTROSC, V109, P97, DOI 10.1016/S0368-2048(00)00110-9; SHEN ZX, 1995, SCIENCE, V267, P5196; SI QM, 1993, PHYS REV B, V47, P9055, DOI 10.1103/PhysRevB.47.9055; Valla T, 1999, SCIENCE, V285, P2110, DOI 10.1126/science.285.5436.2110; WANG QH, IN PRESS CONDENS MAT; Wittneven C, 1998, PHYS REV LETT, V81, P5616, DOI 10.1103/PhysRevLett.81.5616; Yazdani A, 1997, SCIENCE, V275, P1767, DOI 10.1126/science.275.5307.1767	29	495	500	7	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2002	297	5584					1148	1151		10.1126/science.1072640	http://dx.doi.org/10.1126/science.1072640			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12142440	Green Submitted			2022-12-28	WOS:000177447600039
J	Lee, EY; Marcucci, M; Daniell, L; Pypaert, M; Weisz, OA; Ochoa, GC; Farsad, K; Wenk, MR; De Camilli, P				Lee, EY; Marcucci, M; Daniell, L; Pypaert, M; Weisz, OA; Ochoa, GC; Farsad, K; Wenk, MR; De Camilli, P			Amphiphysin 2 (Bin1) and T-tubule biogenesis in muscle	SCIENCE			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; CAVEOLIN-3; CLATHRIN; DYNAMIN; TISSUE; DIFFERENTIATION; IDENTIFICATION; CHOLESTEROL	In striated muscle, the plasma membrane forms tubular invaginations (transverse tubules or T-tubules) that function in depolarization-contraction coupling. Caveolin-3 and amphiphysin were implicated in their biogenesis. Amphiphysin isoforms have a putative role in membrane deformation at endocytic sites. An isoform of amphiphysin 2 concentrated at T-tubules induced tubular plasma membrane invaginations when expressed in nonmuscle cells. This property required exon 10, a phosphoinositide-binding module. In developing myotubes, amphiphysin 2 and caveolin-3 segregated in tubular and vesicular portions of the T-tubule system, respectively. These findings support a role of the bilayer-deforming properties of amphiphysin at T-tubules and, more generally, a physiological role of amphiphysin in membrane deformation.	Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Univ Pittsburgh, Renal Electrolyte Div, Pittsburgh, PA 15261 USA	Yale University; Howard Hughes Medical Institute; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	De Camilli, P (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 295 Congress Ave, New Haven, CT 06510 USA.		Wenk, Markus Rene/D-1441-2014		NATIONAL CANCER INSTITUTE [P01CA046128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036251, R01NS036251] Funding Source: NIH RePORTER; NCI NIH HHS [CA46128] Funding Source: Medline; NINDS NIH HHS [NS36251] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bird I M, 1998, Methods Mol Biol, V105, P1; Butler MH, 1997, J CELL BIOL, V137, P1355, DOI 10.1083/jcb.137.6.1355; Carozzi AJ, 2000, TRAFFIC, V1, P326, DOI 10.1034/j.1600-0854.2000.010406.x; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; Galbiati F, 2001, TRENDS MOL MED, V7, P435, DOI 10.1016/S1471-4914(01)02105-0; HILGEMANN DW, 2001, SCI STKE; ISHIKAWA H, 1968, J CELL BIOL, V38, P51, DOI 10.1083/jcb.38.1.51; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Lee E, UNPUB; Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231; McMahon HT, 1997, FEBS LETT, V413, P319, DOI 10.1016/S0014-5793(97)00928-9; McNally EM, 1998, HUM MOL GENET, V7, P871, DOI 10.1093/hmg/7.5.871; Neufeld EB, 1996, J BIOL CHEM, V271, P21604, DOI 10.1074/jbc.271.35.21604; Parton RG, 1997, J CELL BIOL, V136, P137, DOI 10.1083/jcb.136.1.137; Ramjaun AR, 1997, J BIOL CHEM, V272, P16700, DOI 10.1074/jbc.272.26.16700; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; SCHIAFFINO S, 1977, TISSUE CELL, V9, P437, DOI 10.1016/0040-8166(77)90004-0; SHARP AH, 1987, J BIOL CHEM, V262, P12309; Slepnev VI, 2000, J BIOL CHEM, V275, P17583, DOI 10.1074/jbc.M910430199; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Wechsler-Reya RJ, 1998, MOL CELL BIOL, V18, P566, DOI 10.1128/MCB.18.1.566; WechslerReya R, 1997, J BIOL CHEM, V272, P31453, DOI 10.1074/jbc.272.50.31453; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1	29	300	308	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2002	297	5584					1193	1196		10.1126/science.1071362	http://dx.doi.org/10.1126/science.1071362			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183633				2022-12-28	WOS:000177447600054
J	Fang, J; McCutchan, TF				Fang, J; McCutchan, TF			Malaria: Thermoregulation in a parasite's life cycle	NATURE			English	Article							SUBUNIT RIBOSOMAL-RNA; PLASMODIUM-FALCIPARUM; DISTINCT; GENES		NIAID, Growth & Dev Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fang, J (corresponding author), NIAID, Growth & Dev Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000208, ZIAAI000208] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		GUNDERSON JH, 1987, SCIENCE, V238, P933, DOI 10.1126/science.3672135; LI J, 1994, MOL BIOCHEM PARASIT, V65, P283, DOI 10.1016/0166-6851(94)90079-5; MCCUTCHAN TF, 1988, MOL BIOCHEM PARASIT, V28, P63, DOI 10.1016/0166-6851(88)90181-8; Noden BH, 1995, PARASITOLOGY, V111, P539, DOI 10.1017/S0031182000077003; Rogers MJ, 1996, RNA, V2, P134; ROSALINA ML, 1999, MOL BIOCHEM PARASIT, V99, P193; Velichutina IV, 1998, RNA, V4, P594, DOI 10.1017/S1355838298980049; Waters AP, 1997, J BIOL CHEM, V272, P3583, DOI 10.1074/jbc.272.6.3583; WATERS AP, 1988, NATURE, V333, P74	9	36	38	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 15	2002	418	6899					742	742		10.1038/418742a	http://dx.doi.org/10.1038/418742a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181557	Bronze			2022-12-28	WOS:000177428000029
J	van Zuilen, MA; Lepland, A; Arrhenius, G				van Zuilen, MA; Lepland, A; Arrhenius, G			Reassessing the evidence for the earliest traces of life	NATURE			English	Article							ISUA SUPRACRUSTAL BELT; WEST-GREENLAND; GREENSTONE-BELT; ISOTOPIC COMPOSITION; SEDIMENTARY-ROCKS; IRON-FORMATION; CARBON; ORIGIN; METAMORPHISM; EARTH	The isotopic composition of graphite is commonly used as a biomarker in the oldest (> 3.5 Gyr ago) highly metamorphosed terrestrial rocks. Earlier studies on isotopic characteristics of graphite occurring in rocks of the approximately 3.8-Gyr-old Isua supracrustal belt (ISB) in southern West Greenland have suggested the presence of a vast microbial ecosystem in the early Archean(1-4). This interpretation, however, has to be approached with extreme care(5). Here we show that graphite occurs abundantly in secondary carbonate veins in the ISB that are formed at depth in the crust by injection of hot fluids reacting with older crustal rocks (metasomatism). During these reactions, graphite forms from the disproportionation of Fe(II)-bearing carbonates at high temperature. These metasomatic rocks, which clearly lack biological relevance, were earlier thought to be of sedimentary origin and their graphite association provided the basis for inferences about early life(1-4). The new observations thus call for a reassessment of previously presented evidence for ancient traces of life in the highly metamorphosed Early Archaean rock record.	Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Geol Survey Norway, N-7491 Trondheim, Norway; Tallinn Univ Technol, Inst Geol, Tallinn, Estonia	University of California System; University of California San Diego; Scripps Institution of Oceanography; Geological Survey of Norway; Tallinn University of Technology	van Zuilen, MA (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	mvanzuil@ucsd.edu		Lepland, Aivo/0000-0002-0248-1405				ABED AM, 1990, GEOL SOC SPEC PUBL, V52, P193, DOI 10.1144/GSL.SP.1990.052.01.14; Appel PWU, 1998, TERRA NOVA, V10, P57; APPEL PWU, 1980, PRECAMBRIAN RES, V11, P73; BOAK JL, 1982, EARTH PLANET SC LETT, V59, P155, DOI 10.1016/0012-821X(82)90123-6; CHACKO T, 1991, GEOCHIM COSMOCHIM AC, V55, P2867, DOI 10.1016/0016-7037(91)90452-B; Dimroth E., 1982, SEDIMENT GEOL, P16; DYMEK RF, 1988, PRECAMBRIAN RES, V39, P247, DOI 10.1016/0301-9268(88)90022-8; Fedo CM, 2002, SCIENCE, V296, P1448, DOI 10.1126/science.1070336; Fedo CM, 2001, SEDIMENT GEOL, V141, P61, DOI 10.1016/S0037-0738(01)00068-9; FRENCH BM, 1971, AM J SCI, V271, P37, DOI 10.2475/ajs.271.1.37; Hayes J. M., 1983, EARTHS EARLIEST BIOS, P93; Hayes JM, 1996, NATURE, V384, P21, DOI 10.1038/384021a0; LEPLAND A, IN PRESS PRECAMBRIAN; Macpherson CG, 1999, GEOCHIM COSMOCHIM AC, V63, P1805, DOI 10.1016/S0016-7037(99)00124-6; Mojzsis SJ, 1996, NATURE, V384, P55, DOI 10.1038/384055a0; Myers JS, 2001, PRECAMBRIAN RES, V105, P129, DOI 10.1016/S0301-9268(00)00108-X; NAGY B, 1970, GEOCHIM COSMOCHIM AC, V34, P525, DOI 10.1016/0016-7037(70)90144-4; NUTMAN AP, 1984, PRECAMBRIAN RES, V25, P365, DOI 10.1016/0301-9268(84)90010-X; OEHLER DZ, 1977, PRECAMBRIAN RES, V5, P221, DOI 10.1016/0301-9268(77)90029-8; PERRY EC, 1977, EARTH PLANET SC LETT, V36, P280, DOI 10.1016/0012-821X(77)90210-2; Rose NM, 1996, AM J SCI, V296, P1004, DOI 10.2475/ajs.296.9.1004; Rosing MT, 1999, SCIENCE, V283, P674, DOI 10.1126/science.283.5402.674; Rosing MT, 1996, GEOLOGY, V24, P43, DOI 10.1130/0091-7613(1996)024<0043:EPOESS>2.3.CO;2; ROSING MT, 1993, CHEM GEOL, V108, P187, DOI 10.1016/0009-2541(93)90324-C; SCHIDLOWSKI M, 1979, GEOCHIM COSMOCHIM AC, V43, P189, DOI 10.1016/0016-7037(79)90238-2; Schidlowski M, 2001, PRECAMBRIAN RES, V106, P117, DOI 10.1016/S0301-9268(00)00128-5; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; Ueno Y, 2002, GEOCHIM COSMOCHIM AC, V66, P1257, DOI 10.1016/S0016-7037(01)00840-7; VANZUILEN MA, UNPUB PRECAMBR RES	29	226	235	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2002	418	6898					627	630		10.1038/nature00934	http://dx.doi.org/10.1038/nature00934			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167858				2022-12-28	WOS:000177305600039
J	Crews, JC				Crews, JC			Multimodal pain management strategies for office-based and ambulatory procedures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POSTOPERATIVE PAIN; ANTIINFLAMMATORY DRUGS; RHEUMATOID-ARTHRITIS; ANALGESIA; SURGERY; MORPHINE; CHOLECYSTECTOMY; OSTEOARTHRITIS; ANESTHESIA; CELECOXIB		Wake Forest Univ, Bowman Gray Sch Med, Dept Anesthesiol, Acute Pain Serv, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center	Crews, JC (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Anesthesiol, Acute Pain Serv, Med Ctr Blvd, Winston Salem, NC 27157 USA.	jcrews@wfubmc.edu						*AC PAIN MAN GUID, 1992, ACT PAIN MAN OP MED; *AM AC FAM PHYS, 2002, PAIN CONTR SURG PAIN; Brodner G, 2001, ANESTH ANALG, V92, P1594, DOI 10.1097/00000539-200106000-00049; Cheer SM, 2001, DRUGS, V61, P1133, DOI 10.2165/00003495-200161080-00010; Chung F, 1997, ANESTH ANALG, V85, P808, DOI 10.1097/00000539-199710000-00017; Clemett D, 2000, DRUGS, V59, P957, DOI 10.2165/00003495-200059040-00017; Corda DM, 2000, J CLIN ANESTH, V12, P595, DOI 10.1016/S0952-8180(00)00197-5; Covino B. G., 1998, NEURAL BLOCKADE CLIN, P97; DAHL JB, 1991, BRIT J ANAESTH, V66, P703, DOI 10.1093/bja/66.6.703; DAHL JB, 1993, BRIT J ANAESTH, V70, P434, DOI 10.1093/bja/70.4.434; DAHL JB, 1994, REGION ANESTH, V19, P199; Dahl V, 2000, ACTA ANAESTH SCAND, V44, P1191, DOI 10.1034/j.1399-6576.2000.441003.x; EJLERSEN E, 1992, ANESTH ANALG, V74, P495; ETCHES RC, 1995, ANESTH ANALG, V81, P1175, DOI 10.1097/00000539-199512000-00010; Fortier J, 1998, CAN J ANAESTH, V45, P612, DOI 10.1007/BF03012088; Grant GJ, 2001, REGION ANESTH PAIN M, V26, P61, DOI 10.1053/rapm.2001.19166; Grant SA, 2001, REGION ANESTH PAIN M, V26, P209, DOI 10.1053/rapm.2001.22256; Gupta SK, 1999, J PHARM SCI, V88, P835, DOI 10.1021/js980258b; Gutstein HB, 2001, GOODMAN GILMANS PHAR, P569; Hawkey CJ, 1999, LANCET, V353, P307, DOI 10.1016/S0140-6736(98)12154-2; Hrachovec JB, 2001, JAMA-J AM MED ASSOC, V286, P2398, DOI 10.1001/jama.286.19.2398; KATZ J, 1995, EUR J ANAESTH, V12, P8; Kehlet H, 1997, BRIT J ANAESTH, V78, P606, DOI 10.1093/bja/78.5.606; Korpela R, 1999, ANESTHESIOLOGY, V91, P442, DOI 10.1097/00000542-199908000-00019; Kotani N, 2001, ANESTHESIOLOGY, V95, P349, DOI 10.1097/00000542-200108000-00015; Laurito CE, 1998, J CLIN ANESTH, V10, P176; Markham A, 1996, DRUGS, V52, P429, DOI 10.2165/00003495-199652030-00012; Matheson AJ, 2001, DRUGS, V61, P833, DOI 10.2165/00003495-200161060-00019; McClellan KJ, 1998, DRUGS, V56, P355, DOI 10.2165/00003495-199856030-00005; Michaloliakou C, 1996, ANESTH ANALG, V82, P44, DOI 10.1097/00000539-199601000-00009; Nilsson U, 2001, ACTA ANAESTH SCAND, V45, P812, DOI 10.1034/j.1399-6576.2001.045007812.x; PEREZFLORES D, 2001, ANESTH ANALG, V92, P1473; Rawal N, 1998, ANESTH ANALG, V86, P86, DOI 10.1097/00000539-199801000-00017; Reuben SS, 1999, ANESTH ANALG, V88, P1286, DOI 10.1097/00000539-199906000-00016; Rosaeg OP, 2001, REGION ANESTH PAIN M, V26, P125, DOI 10.1053/rapm.2001.20982; VENTAFRIDDA V, 1987, CANCER, V59, P850, DOI 10.1002/1097-0142(19870215)59:4<850::AID-CNCR2820590432>3.0.CO;2-1; WHITE PF, 1997, AMBULATORY ANAESTHES; WOOLF CJ, 1993, ANESTH ANALG, V77, P362, DOI 10.1213/00000539-199377020-00026; Yaksh TL, 2001, J NEUROSCI, V21, P5847, DOI 10.1523/JNEUROSCI.21-16-05847.2001	39	24	30	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	2002	288	5					629	632		10.1001/jama.288.5.629	http://dx.doi.org/10.1001/jama.288.5.629			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	581FJ	12150675				2022-12-28	WOS:000177280200022
J	Little, P; Barnett, J; Barnsley, L; Marjoram, J; Fitzgerald-Barron, A; Mant, D				Little, P; Barnett, J; Barnsley, L; Marjoram, J; Fitzgerald-Barron, A; Mant, D			Comparison of acceptability of and preferences for different methods of measuring blood pressure in primary care	BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE; HYPERTENSION		Univ Southampton, Aldermoor Hlth Ctr, Fac Med Hlth & Biol Sci, Community Clin Sci Div,Primary Med Care Grp, Southampton SO16 5ST, Hants, England; Nightingale Surg, Romsey SO51 7QN, Hants, England; St Clements Surg, Winchester SO23 8AD, Hants, England	University of Southampton	Little, P (corresponding author), Univ Southampton, Aldermoor Hlth Ctr, Fac Med Hlth & Biol Sci, Community Clin Sci Div,Primary Med Care Grp, Southampton SO16 5ST, Hants, England.		Mant, David CA/C-7763-2009	Little, Paul/0000-0003-3664-1873				Aylett M, 1999, BRIT J GEN PRACT, V49, P725; Beltman FW, 1996, J HUM HYPERTENS, V10, pS39; COX JP, 1992, BRIT J GEN PRACT, V42, P402; O'Brien E, 2000, BMJ-BRIT MED J, V320, P1128, DOI 10.1136/bmj.320.7242.1128; WEBB DJ, 1992, BRIT MED J, V304, P1442, DOI 10.1136/bmj.304.6839.1442-a	5	107	111	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 3	2002	325	7358					258	259		10.1136/bmj.325.7358.258	http://dx.doi.org/10.1136/bmj.325.7358.258			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582FL	12153924	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000177339000021
J	Zuckerman, JN				Zuckerman, JN			Recent developments - Travel medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Review							VACCINATION; HEPATITIS; FEVER		UCL Royal Free & Univ Coll Med Sch, Acad Ctr Travel Med & Vaccines, London NW3 2PF, England	University of London; University College London; UCL Medical School	Zuckerman, JN (corresponding author), UCL Royal Free & Univ Coll Med Sch, Acad Ctr Travel Med & Vaccines, London NW3 2PF, England.	j.zuckerman@rfc.ucl.ac.uk						*ADV COMM IMM PRAC, 2002, MMWR-MORBID MORTAL W, V51, P190; [Anonymous], 2001, MMWR-MORBID MORTAL W, V51, P253; Bradley D J, 2001, Commun Dis Public Health, V4, P84; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Carballo M, 1998, TROP MED INT HEALTH, V3, P936, DOI 10.1046/j.1365-3156.1998.00337.x; Chan RC, 2001, LANCET, V358, P121, DOI 10.1016/S0140-6736(01)05341-7; Department of Health, 2002, GETT AH CURV STRAT C; Dowdall N, 2000, BRIT MED J, V321, P1336, DOI 10.1136/bmj.321.7272.1336; Geroulakos G, 2001, BRIT MED J, V322, P188, DOI 10.1136/bmj.322.7280.188; Heymann D L, 2001, Lancet Infect Dis, V1, P345, DOI 10.1016/S1473-3099(01)00148-7; *HOUS LORDS, 2000, 5 HOUS LORDS; *IPS RSL, 1999, TRAV OMM SURV; Lederberg J., 2001, EMERGING INFECT DIS; Mardh PA, 2002, J TRAVEL MED, V9, P34; MARTIMER P, 2002, BRIT MED J, V324, P439; Martin M, 2001, LANCET, V358, P98, DOI 10.1016/S0140-6736(01)05327-2; *MEN DIS SER, 2001, WER, V19, P141; Nosten F, 2000, LANCET, V356, P1864, DOI 10.1016/S0140-6736(00)03250-5; SCHLAGENHAUF P, 1994, J TROP MED HYG, V97, P151; Scurr JH, 2001, LANCET, V357, P1485, DOI 10.1016/S0140-6736(00)04645-6; STEFFEN R, 1999, MANUAL TRAVEL MED HL, P43; Stringer Claire, 2002, Nurs Stand, V16, P49; *UN HIGH COMM REG, 2002, STAT REP; *WHO, 2001, TUB AIR TRAV; *WHO, 2001, INT TRAV HLTH VACC R; *WHO, 1998, WORLD HLTH REP; *WHO STUD VEN THRO, 2002, WEEKLY EPIDEMIOLOGIC, V77, P197; *WORLD TOUR ORG, 2000, WORLD TOUR ORG STAT; *WORLD TOUR ORG, 1998, TOUR HIGHL; Zuckerman J, 2001, Lancet Infect Dis, V1, P296, DOI 10.1016/S1473-3099(01)00142-6; Zuckerman JN, 2000, J TRAVEL MED, V7, P170; ZUCKERMAN JN, 2001, PRINCIPLES PRACTICE, P165; ZUCKERMAN JN, 2000, 10 INT S VIR HEP LIV	33	20	20	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2002	325	7358					260	264		10.1136/bmj.325.7358.260	http://dx.doi.org/10.1136/bmj.325.7358.260			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582FL	12153925	Green Published			2022-12-28	WOS:000177339000024
J	Barker, S; Elderfield, H				Barker, S; Elderfield, H			Foraminiferal calcification response to glacial-interglacial changes in atmospheric CO2	SCIENCE			English	Article							CARBON-DIOXIDE; NORTH-ATLANTIC; TEMPERATURE; SEAWATER; PRECIPITATION; PALEOSALINITY; DELTA-O-18; CALCITE	A record of foraminiferal shell weight across glacial-interglacial Termination I shows a response related to seawater carbonate ion concentration and allows reconstruction of a record of carbon dioxide in surface seawater that matches the atmospheric record. The results support suggestions that higher atmospheric carbon dioxide directly affects marine calcification, an effect that may be of global importance to past and future changes in atmospheric CO2. The process provides negative feedback to the influence of marine calcification on atmospheric carbon dioxide and is of practical importance to the application of paleoceanographic proxies.	Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England	University of Cambridge	Barker, S (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.	sbar98@esc.cam.ac.uk	Stephen, Barker/C-2770-2009	Stephen, Barker/0000-0001-7870-6431				BERTRAM CJ, 1995, PALEOCEANOGRAPHY, V10, P563, DOI 10.1029/94PA03058; BIANCHI GG, 1999, THESIS U CAMBRIDGE; Bijma J., 1999, USE PROXIES PALEOCEA, DOI DOI 10.1007/978-3-642-58646-0_20; Broecker W, 2001, PALEOCEANOGRAPHY, V16, P531, DOI 10.1029/2000PA000600; Broecker W, 2001, GEOCHEM GEOPHY GEOSY, V2, part. no.; Broecker W.S., 1982, TRACERS SEA; Broecker WS, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000231; BROECKER WS, 1979, SCIENCE, V206, P409, DOI 10.1126/science.206.4417.409; BROECKER WS, COMMUNICATION; de Villiers S, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000169; Elderfield H, 2000, NATURE, V405, P442, DOI 10.1038/35013033; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Langdon C, 2000, GLOBAL BIOGEOCHEM CY, V14, P639, DOI 10.1029/1999GB001195; Lea DW, 1999, GEOCHIM COSMOCHIM AC, V63, P2369, DOI 10.1016/S0016-7037(99)00197-0; Levitus S., 1994, WORLD OCEAN ATLAS 19, V4; Lewis E., 1998, ORNLCDIAC105; Marubini F, 2001, MAR ECOL PROG SER, V220, P153, DOI 10.3354/meps220153; Mashiotta TA, 1999, EARTH PLANET SC LETT, V170, P417, DOI 10.1016/S0012-821X(99)00116-8; MILLERO FJ, 1995, GEOCHIM COSMOCHIM AC, V59, P661, DOI 10.1016/0016-7037(94)00354-O; OPPO DW, 1993, SCIENCE, V259, P1148, DOI 10.1126/science.259.5098.1148; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Rohling EJ, 1998, J GEOPHYS RES-OCEANS, V103, P1307, DOI 10.1029/97JC01047; Schmidt GA, 1999, PALEOCEANOGRAPHY, V14, P422, DOI 10.1029/1999PA900008; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Spero HJ, 1997, NATURE, V390, P497, DOI 10.1038/37333; Weaver PPE, 1999, PALEOCEANOGRAPHY, V14, P336, DOI 10.1029/1999PA900009; Wolf-Gladrow DA, 1999, TELLUS B, V51, P461, DOI 10.1034/j.1600-0889.1999.00023.x; Zeebe R.E., 2001, ELSEV OCEANOGR SERIE; ZHONG SJ, 1989, CHEM GEOL, V78, P283, DOI 10.1016/0009-2541(89)90064-8; Zondervan I, 2001, GLOBAL BIOGEOCHEM CY, V15, P507, DOI 10.1029/2000GB001321; Zuddas P, 1998, GEOCHIM COSMOCHIM AC, V62, P757, DOI 10.1016/S0016-7037(98)00026-X	31	272	284	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2002	297	5582					833	836		10.1126/science.1072815	http://dx.doi.org/10.1126/science.1072815			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161653				2022-12-28	WOS:000177192800050
J	Cox, CM; Chao, BF				Cox, CM; Chao, BF			Detection of a large-scale mass redistribution in the terrestrial system since 1998	SCIENCE			English	Article							SATELLITE ALTIMETRY; EARTH; FIELD; CIRCULATION; LAGEOS	Earth's dynamic oblateness (J(2)) had been undergoing a decrease, according to space geodetic observations over the past 25 years, until around 1998, when it switched quite suddenly to an increasing trend that has continued to the present. The secular decrease in J(2) resulted primarily from the postglacial rebound in the mantle. The present increase, whose geophysical cause(s) are uncertain, thus signifies a large change in global mass distribution with a J(2) effect that considerably overshadows that of mantle rebound.	NASA, Goddard Space Flight Ctr, Raytheon Informat Technol & Sci Serv, Greenbelt, MD 20771 USA; NASA, Goddard Space Flight Ctr, Space Geodesy Branch, Greenbelt, MD 20771 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Cox, CM (corresponding author), NASA, Goddard Space Flight Ctr, Raytheon Informat Technol & Sci Serv, Code 926, Greenbelt, MD 20771 USA.	ccox@stokes.gsfc.nasa.gov	Chao, Benjamin Fong/N-6156-2013					Alexandrescu M, 1996, J GEOPHYS RES-SOL EA, V101, P21975, DOI 10.1029/96JB01648; ALLEY R, 2001, ABRUPT CLIMATE CHANG; Arendt AA, 2002, SCIENCE, V297, P382, DOI 10.1126/science.1072497; Cabanes C, 2001, SCIENCE, V294, P840, DOI 10.1126/science.1063556; Cazenave A, 1999, EARTH PLANET SC LETT, V171, P549, DOI 10.1016/S0012-821X(99)00172-7; CHAO BF, 1991, J GEOPHYS RES-SOLID, V96, P6577, DOI 10.1029/91JB00041; CHAO BF, 1988, GEOPHYS J INT, V94, P263, DOI 10.1111/j.1365-246X.1988.tb05900.x; Chao BF, 1995, GEOPHYS RES LETT, V22, P3529, DOI 10.1029/95GL02664; Cheng MK, 1997, J GEOPHYS RES-SOL EA, V102, P22377, DOI 10.1029/97JB01740; Cox CM, 2002, IAG SYMP, V123, P355; Douglas B.C., 2001, SEA LEVEL RISE; Dyurgerov MB, 2000, P NATL ACAD SCI USA, V97, P1406, DOI 10.1073/pnas.97.4.1406; Fu LL, 1996, B AM METEOROL SOC, V77, P2625, DOI 10.1175/1520-0477(1996)077<2625:GOCFSA>2.0.CO;2; HAN DZ, 1995, GEOPHYS J INT, V120, P287, DOI 10.1111/j.1365-246X.1995.tb01819.x; James TS, 1997, J GEOPHYS RES-SOL EA, V102, P605, DOI 10.1029/96JB02855; Johnson TJ, 2001, J GEOPHYS RES-SOL EA, V106, P11315, DOI 10.1029/2000JB900438; Krabill W, 2000, SCIENCE, V289, P428, DOI 10.1126/science.289.5478.428; Kuang WJ, 1998, GEODYNAMICS, V28, P197; Lemoine F. G., 1998, NASA TECHNICAL PUBLI; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Mandea M, 2000, EARTH PLANET SC LETT, V183, P369, DOI 10.1016/S0012-821X(00)00284-3; MITROVICA JX, 1993, J GEOPHYS RES-SOL EA, V98, P4509, DOI 10.1029/92JB02700; Nerem RS, 2000, GEOPHYS RES LETT, V27, P1783, DOI 10.1029/1999GL008440; RUBINCAM DP, 1984, J GEOPHYS RES, V89, P1077, DOI 10.1029/JB089iB02p01077; Stammer D, 1996, J GEOPHYS RES-OCEANS, V101, P25779, DOI 10.1029/96JC01754; Wunsch C, 1998, ANNU REV EARTH PL SC, V26, P219, DOI 10.1146/annurev.earth.26.1.219; YODER CF, 1983, NATURE, V303, P757, DOI 10.1038/303757a0; ZWALLY J, 2001, ALTIMETRY EARTH SCI, P351	28	166	181	5	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2002	297	5582					831	833		10.1126/science.1072188	http://dx.doi.org/10.1126/science.1072188			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161652				2022-12-28	WOS:000177192800049
J	Trainor, P; Krumlauf, R				Trainor, P; Krumlauf, R			Development: Riding the crest of the Wnt signaling wave	SCIENCE			English	Editorial Material							NEURAL CREST; PLATE; ECTODERM; GENE; SLUG		Stowers Inst Med Res, Kansas City, MO 64110 USA	Stowers Institute for Medical Research	Trainor, P (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.		Krumlauf, Robb/AAH-5012-2019	Krumlauf, Robb/0000-0001-9102-7927; Trainor, Paul/0000-0003-2774-3624				DICKINSON ME, 1995, DEVELOPMENT, V121, P2099; Garcia-Castro MI, 2002, SCIENCE, V297, P848, DOI 10.1126/science.1070824; Hall BK, 1999, NEURAL CREST DEV EVO; Knecht AK, 2002, NAT REV GENET, V3, P453, DOI 10.1038/nrg819; LaBonne C, 1998, J NEUROBIOL, V36, P175, DOI 10.1002/(SICI)1097-4695(199808)36:2<175::AID-NEU6>3.0.CO;2-Z; Le Douarin NM, 1999, NEURAL CREST, V2; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Manzanares M, 2001, TRENDS GENET, V17, P178, DOI 10.1016/S0168-9525(01)02232-6; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Sefton M, 1998, DEVELOPMENT, V125, P3111; SELLECK MAJ, 1995, DEVELOPMENT, V121, P525; Stern CD, 2001, NAT REV NEUROSCI, V2, P92, DOI 10.1038/35053563; Vallin J, 2001, J BIOL CHEM, V276, P30350, DOI 10.1074/jbc.M103167200	14	19	19	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2002	297	5582					781	783		10.1126/science.1075454	http://dx.doi.org/10.1126/science.1075454			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161639				2022-12-28	WOS:000177192800032
J	House, A; Stark, D				House, A; Stark, D			ABC of psychological medicine - Anxiety in medical patients	BRITISH MEDICAL JOURNAL			English	Review									Univ Leeds, Sch Med, Acad Unit Psychiat & Behav Sci, Leeds LS2 9JT, W Yorkshire, England; St Jamess Univ Hosp, Acad Unit Oncol, Leeds, W Yorkshire, England	University of Leeds; Saint James's University Hospital; University of Leeds	House, A (corresponding author), Univ Leeds, Sch Med, Acad Unit Psychiat & Behav Sci, Leeds LS2 9JT, W Yorkshire, England.			House, Allan/0000-0001-8721-8026				COLON EA, 1996, TXB CONSULTATION LIA, P403; NOYES R, 1998, ANXIETY DISORDERS, P285; Westra HA, 1998, CLIN PSYCHOL REV, V18, P307, DOI 10.1016/S0272-7358(97)00084-6	3	37	38	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 27	2002	325	7357					207	209		10.1136/bmj.325.7357.207	http://dx.doi.org/10.1136/bmj.325.7357.207			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	580PX	12142312	Green Published			2022-12-28	WOS:000177243900025
J	Lambert, H; McKevitt, C				Lambert, H; McKevitt, C			Anthropology in health research: from qualitative methods to multidisciplinarity	BRITISH MEDICAL JOURNAL			English	Article							SERVICES RESEARCH; EPIDEMIOLOGY; TIME		Univ Bristol, Dept Social Med, Bristol BS8 2PY, Avon, England; Kings Coll London, Dept Publ Hlth Sci, London SE1 3QD, England	University of Bristol; University of London; King's College London	Lambert, H (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PY, Avon, England.	H.Lambert@bristol.ac.uk	mckevitt, christopher/AAN-7271-2021	MCKEVITT, CHRISTOPHER/0000-0002-5290-4613				Baer H A, 1993, Med Anthropol, V15, P299; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; CAAN W, 2001, BMJ; Davison C., 1992, PRIVATE RISKS PUBLIC, P95; DiGiacomo SM, 1999, MED ANTHROPOL Q, V13, P436, DOI 10.1525/maq.1999.13.4.436; Ellen R.F., 1984, ETHNOGRAPHIC RES GUI; GOOD MJD, 1994, SOC SCI MED, V38, P855, DOI 10.1016/0277-9536(94)90157-0; GORDON DR, 1990, CULT MED PSYCHIAT, V14, P275; Kaufert P., 1993, KNOWLEDGE POWER PRAC, P32; KRIEGER N, 1994, SOC SCI MED, V39, P887, DOI 10.1016/0277-9536(94)90202-X; Lambert H, 1998, TROP MED INT HEALTH, V3, P1002, DOI 10.1046/j.1365-3156.1998.00336.x; LAMBERT H, 1996, ENCY SOCIAL CULTURAL, P358; Mays N, 1996, QUALITATIVE RES HLTH; MCKEVITT C, 2002, QUAL AGEING, V3, P12; MITCHELL JC, 1983, SOCIOL REV, V31, P187, DOI 10.1111/j.1467-954X.1983.tb00387.x; MORSY S, 1990, MED ANTHR CONT THEOR, P26; Popay J, 1998, QUAL HEALTH RES, V8, P341, DOI 10.1177/104973239800800305; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; POWER R, 2001, BMJ; RAPP R, 1988, Medical Anthropology Quarterly, V2, P143, DOI 10.1525/maq.1988.2.2.02a00040; Savage J, 2000, BMJ-BRIT MED J, V321, P1400, DOI 10.1136/bmj.321.7273.1400; Singer M, 1992, Med Anthropol, V14, P1; Smith GD, 2001, INT J EPIDEMIOL, V30, P1, DOI 10.1093/ije/30.1.1; WILLIAMS B, 2001, BMJ	24	175	179	0	23	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 27	2002	325	7357					210	213		10.1136/bmj.325.7357.210	http://dx.doi.org/10.1136/bmj.325.7357.210			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	580PX	12142313	Green Published			2022-12-28	WOS:000177243900026
J	Abbamonte, P; Venema, L; Rusydi, A; Sawatzky, GA; Logvenov, G; Bozovic, I				Abbamonte, P; Venema, L; Rusydi, A; Sawatzky, GA; Logvenov, G; Bozovic, I			A structural probe of the doped holes in cuprate superconductors	SCIENCE			English	Article							OXIDES	An unresolved issue concerning cuprate superconductors is whether the distribution of carriers in the CuO2 plane is uniform or inhomogeneous. Because the carriers comprise a small fraction of the total charge density and may be rapidly fluctuating, modulations are difficult to detect directly. We demonstrate that in anomalous x-ray scattering at the oxygen K edge of the cuprates, the contribution of carriers to the scattering amplitude is selectively magnified 82 times. This enhances diffraction from the doped holes by more than 10(3), permitting direct structural analysis of the superconducting ground state. Scattering from thin films of La2CuO4+delta (superconducting transition temperature = 39 K) at temperature = 50 +/- 5 kelvin on the reciprocal space intervals (0,0,0.21) --> (0,0,1.21) and (0,0,0.6) --> (0.3,0,0.6) shows a rounding of the carrier density near the substrate suggestive of a depletion zone or similar effect. The structure factor for off-specular scattering was less than 3 x 10(-7) electrons, suggesting an absence of in-plane hole ordering in this material.	Univ Groningen, Ctr Mat Sci, NL-9747 AG Groningen, Netherlands; Brookhaven Natl Lab, Natl Synchrotron Light Source, Upton, NY 11973 USA; Oxxel GmbH, D-28359 Bremen, Germany	University of Groningen; State University of New York (SUNY) System; United States Department of Energy (DOE); Brookhaven National Laboratory	Abbamonte, P (corresponding author), Cornell Univ, Dept Phys, Ithaca, NY 14853 USA.		Sawatzky, George A/D-2997-2012; Rusydi, Andrivo/I-1849-2016	Rusydi, Andrivo/0000-0001-8054-3934				BLUME M, 1985, J APPL PHYS, V57, P3615, DOI 10.1063/1.335023; Bozovic I, 2001, IEEE T APPL SUPERCON, V11, P2686, DOI 10.1109/77.919617; CHEN CT, 1991, PHYS REV LETT, V66, P104, DOI 10.1103/PhysRevLett.66.104; CHEN CT, 1992, PHYS REV LETT, V68, P2543, DOI 10.1103/PhysRevLett.68.2543; Ealick SE, 2000, CURR OPIN CHEM BIOL, V4, P495, DOI 10.1016/S1367-5931(00)00122-8; ESKES H, 1991, PHYS REV LETT, V67, P1035, DOI 10.1103/PhysRevLett.67.1035; Hoffman JE, 2002, SCIENCE, V295, P466, DOI 10.1126/science.1066974; Howald C, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.100504; Jackson J.D., 1999, CLASSICAL ELECTRODYN; LOW U, 1994, PHYS REV LETT, V72, P1918, DOI 10.1103/PhysRevLett.72.1918; Pan SH, 2001, NATURE, V413, P282, DOI 10.1038/35095012; Tranquada JM, 1998, J PHYS CHEM SOLIDS, V59, P2150, DOI 10.1016/S0022-3697(98)00198-X; ZAANEN J, 1989, PHYS REV B, V40, P7391, DOI 10.1103/PhysRevB.40.7391; ZHANG FC, 1988, PHYS REV B, V37, P3759, DOI 10.1103/PhysRevB.37.3759	14	86	86	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2002	297	5581					581	584		10.1126/science.1070903	http://dx.doi.org/10.1126/science.1070903			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142531	Green Submitted			2022-12-28	WOS:000177054200044
J	Fisher, B; Jeong, JH; Anderson, S; Bryant, J; Fisher, ER; Wolmark, N				Fisher, B; Jeong, JH; Anderson, S; Bryant, J; Fisher, ER; Wolmark, N			Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRIMARY BREAST-CANCER; POSTOPERATIVE RADIOTHERAPY; ALTERNATIVE TREATMENTS; PREMENOPAUSAL WOMEN; DISSECTION	Background In women with breast cancer, the role of radical mastectomy, as compared with less extensive surgery, has been a matter of debate. We report 25-year findings of a randomized trial initiated in 1971 to determine whether less extensive surgery with or without radiation therapy was as effective as the Halsted radical mastectomy. Methods A total of 1079 women with clinically negative axillary nodes underwent radical mastectomy, total mastectomy without axillary dissection but with postoperative irradiation, or total mastectomy plus axillary dissection only if their nodes became positive. A total of 586 women with clinically positive axillary nodes either underwent radical mastectomy or underwent total mastectomy without axillary dissection but with postoperative irradiation. Kaplan-Meier and cumulative-incidence estimates of outcome were obtained. Results No significant differences were observed among the three groups of women with negative nodes or between the two groups of women with positive nodes with respect to disease-free survival, relapse-free survival, distant-disease-free survival, or overall survival. Among women with negative nodes, the hazard ratio for death among those who were treated with total mastectomy and radiation as compared with those who underwent radical mastectomy was 1.08 (95 percent confidence interval, 0.91 to 1.28; P = 0.38), and the hazard ratio for death among those who had total mastectomy without radiation as compared with those who underwent radical mastectomy was 1.03 (95 percent confidence interval, 0.87 to 1.23; P = 0.72). Among women with positive nodes, the hazard ratio for death among those who underwent total mastectomy and radiation as compared with those who underwent radical mastectomy was 1.06 (95 percent confidence interval, 0.89 to 1.27; P = 0.49). Conclusions The findings validate earlier results showing no advantage from radical mastectomy. Although differences of a few percentage points cannot be excluded, the findings fail to show a significant survival advantage from removing occult positive nodes at the time of initial surgery or from radiation therapy.	Natl Surg Adjuvant Breast & Bowel Project, Pittsburgh, PA 15212 USA; Univ Pittsburgh, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Surgical Adjuvant Breast & Bowel Project; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Fisher, B (corresponding author), Natl Surg Adjuvant Breast & Bowel Project, 4 Allegheny Ctr,Suite 602, Pittsburgh, PA 15212 USA.	bernard.fisher@nsabp.org		Jeong, Jong/0000-0003-0596-2201; Anderson, Stewart/0000-0001-8948-0650	NCI NIH HHS [U10-CA-12027, U10-CA-69974, U10-CA-37377, U10-CA-69651] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U10CA069974, U10CA037377, U10CA069651, U10CA012027] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BLOODGOOD JC, 1930, J KANSAS MED SOC, V31, P311; COX DR, 1972, J R STAT SOC B, V34, P187; Early Breast Canc Trialists Collaborat, 2000, LANCET, V355, P1757, DOI 10.1016/S0140-6736(00)02263-7; FISHER B, 1981, SURG GYNECOL OBSTET, V152, P765; FISHER B, 1978, SEMIN ONCOL, V5, P385; FISHER B, 1977, CANCER-AM CANCER SOC, V39, P2827, DOI 10.1002/1097-0142(197706)39:6<2827::AID-CNCR2820390671>3.0.CO;2-I; FISHER B, 1985, NEW ENGL J MED, V312, P674, DOI 10.1056/NEJM198503143121102; FISHER B, 1991, CA-CANCER J CLIN, V41, P97, DOI 10.3322/canjclin.41.2.97; FISHER B, 1980, CANCER, V46, P1, DOI 10.1002/1097-0142(19800701)46:1<1::AID-CNCR2820460102>3.0.CO;2-3; FISHER B, 1980, CANCER RES, V40, P3863; FISHER B, 1970, CURR PROB SURG   OCT, P3; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; HARRIS JR, 1985, BREAST CANCER RES TR, V5, P17, DOI 10.1007/BF01807645; HOUGHTON J, 1980, LANCET, V2, P55; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Moore Michael P., 1996, P245; Overgaard M, 1999, LANCET, V353, P1641, DOI 10.1016/S0140-6736(98)09201-0; Overgaard M, 1997, NEW ENGL J MED, V337, P949, DOI 10.1056/NEJM199710023371401; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; Port ER, 1998, ANN SURG ONCOL, V5, P23, DOI 10.1007/BF02303759; Ragaz J, 1997, NEW ENGL J MED, V337, P956, DOI 10.1056/NEJM199710023371402; RECHT A, 1995, CANCER, V76, P1491, DOI 10.1002/1097-0142(19951101)76:9<1491::AID-CNCR2820760902>3.0.CO;2-8; 1976, BR MED J, V1, P1035	24	301	333	1	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 22	2002	347	8					567	575		10.1056/NEJMoa020128	http://dx.doi.org/10.1056/NEJMoa020128			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587ZR	12192016				2022-12-28	WOS:000177675400005
J	Schwartz, M; Vissing, J				Schwartz, M; Vissing, J			Paternal inheritance of mitochondrial DNA	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CYTOCHROME-B GENE; RECURRENT MYOGLOBINURIA; EXERCISE INTOLERANCE; NONSENSE MUTATION; MOUSE OOCYTE; MTDNA; ELIMINATION; SEQUENCES; EMBRYO; CELLS		Copenhagen Univ Hosp, Dept Clin Genet, Rigshop 4062, DK-2100 Copenhagen, Denmark; Copenhagen Univ Hosp, Dept Neurol, Rigshop 4062, DK-2100 Copenhagen, Denmark; Copenhagen Univ Hosp, Copenhagen Muscle Res Ctr, Rigshop 4062, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Schwartz, M (corresponding author), Copenhagen Univ Hosp, Dept Clin Genet, Rigshop 4062, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.							ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andreu AL, 1999, ANN NEUROL, V45, P820, DOI 10.1002/1531-8249(199906)45:6<820::AID-ANA22>3.0.CO;2-W; Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221; Cummins JM, 1998, ZYGOTE, V6, P213, DOI 10.1017/S0967199498000148; Cummins JM, 1997, ZYGOTE, V5, P301, DOI 10.1017/S0967199400003889; DiMauro S, 1993, MOL GENETIC BASIS NE, P665; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; GYLLENSTEN U, 1991, NATURE, V352, P255, DOI 10.1038/352255a0; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; Houshmand M, 1997, J ASSIST REPROD GEN, V14, P223, DOI 10.1007/BF02766114; Jensen TD, 2002, NEUROLOGY, V58, P1533, DOI 10.1212/WNL.58.10.1533; Karadimas CL, 2000, NEUROLOGY, V55, P644, DOI 10.1212/WNL.55.5.644; Keightley JA, 1996, NAT GENET, V12, P410, DOI 10.1038/ng0496-410; Kleinle S, 1997, HUM GENET, V100, P643, DOI 10.1007/s004390050567; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Saillard J, 2000, HUM BIOL, V72, P1065; Shitara H, 2000, GENETICS, V156, P1277; Shitara H, 1998, GENETICS, V148, P851; St John J, 2000, LANCET, V355, P200, DOI 10.1016/S0140-6736(99)03842-8; Suomalainen A, 2000, MOL BIOTECHNOL, V15, P123, DOI 10.1385/MB:15:2:123; Wibrand F, 2001, ANN NEUROL, V50, P540, DOI 10.1002/ana.1224; YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164	26	393	415	1	44	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 22	2002	347	8					576	580		10.1056/NEJMoa020350	http://dx.doi.org/10.1056/NEJMoa020350			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587ZR	12192017				2022-12-28	WOS:000177675400006
J	Winnett, M				Winnett, M			Cries and whiskers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2002	288	7					806	806		10.1001/jama.288.7.806	http://dx.doi.org/10.1001/jama.288.7.806			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585FC	12186579				2022-12-28	WOS:000177513100001
J	Barr, RG; Nathan, DM; Meigs, JB; Singer, DE				Barr, RG; Nathan, DM; Meigs, JB; Singer, DE			Tests of glycemia for the diagnosis of type 2 diabetes mellitus	ANNALS OF INTERNAL MEDICINE			English	Review							IMPAIRED GLUCOSE-TOLERANCE; HEALTH-ORGANIZATION CRITERIA; FASTING PLASMA-GLUCOSE; CORONARY-HEART-DISEASE; GLYCOSYLATED HEMOGLOBIN; CARDIOVASCULAR-DISEASE; FOLLOW-UP; GLYCATED HEMOGLOBIN; RISK-FACTOR; INTRAINDIVIDUAL VARIATION	This paper discusses tests of glycemia for the diagnosis of type 2 diabetes mellitus, with particular reference to the 1997 diagnostic criteria of the American Diabetes Association. The potential benefits of the lower diagnostic threshold for fasting plasma glucose are not well defined. However, the change in the diagnostic cutoff for diabetes mellitus affects as many as 1.9 million persons in the United States; therefore, the medical and social costs of the lower threshold may be considerable. Type 2 diabetes mellitus is defined by a threshold imposed on the continuous distribution of glycemic levels, typically with respect to risk for microvascular complications. However, the burden of type 2 diabetes relates more to macrovascular than microvascular complications. Because no clear threshold exists for macrovascular complications, a formal balancing of direct and indirect costs with both microvascular and macrovascular complications may be appropriate to establish glycemic thresholds. Because fasting plasma glucose, hemoglobin A(1c), and the oral glucose tolerance test all predict diabetic complications yet test reliability is better for fasting plasma glucose and hemoglobin A,c than for the oral glucose tolerance test, we suggest an alternative diagnostic approach: If random plasma glucose is elevated (greater than or equal to11.1 mmol/L [200 mg/dL]) and the hemoglobin A,c level is more than 2 SDs above the laboratory mean, then diabetes mellitus should be diagnosed, and management should be based on the hemoglobin A,c level. If the result of only one of these tests is positive, then fasting plasma glucose should be tested to evaluate the patient for impaired fasting glucose and diabetes mellitus. The glycemic threshold for type 2 diabetes should be established by cost-effectiveness analysis. The clinical diagnosis of diabetes mellitus could be streamlined by incorporation of hemoglobin A,c into established criteria.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02115 USA; Columbia Univ, Coll Phys & Surg, New York, NY USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Columbia University	Barr, RG (corresponding author), Columbia Presbyterian Med Ctr, Div Gen Med, PH-9 E 105,622 W 168th St, New York, NY 10032 USA.	rgb9@columbia.edu	Meigs, James/P-3927-2019	Meigs, James/0000-0002-2439-2657	BHP HRSA HHS [PE-11001] Funding Source: Medline	BHP HRSA HHS		Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; ALSAYEGH H, 1979, LANCET, V2, P431; American Diabetes Association, 2001, Diabetes Care, V24, P775; American Diabetes Association, 2001, DIABETES CARE, V24, P80; [Anonymous], 1995, DIABETES, V44, P968; [Anonymous], 1985, PREV MED, V14, P312; [Anonymous], 1976, Br Med J, V2, P35; Balkau B, 1999, DIABETES CARE, V22, P696, DOI 10.2337/diacare.22.5.696; Balkau B, 1998, DIABETES CARE, V21, P360, DOI 10.2337/diacare.21.3.360; Barzilay JI, 1999, LANCET, V354, P622, DOI 10.1016/S0140-6736(98)12030-5; BEKS PJ, 1995, DIABETOLOGIA, V38, P86, DOI 10.1007/s001250050257; Bennett P H, 1976, Recent Prog Horm Res, V32, P333; Blanchard JF, 1996, DIABETES CARE, V19, P807, DOI 10.2337/diacare.19.8.807; Borch-Johnsen K, 1999, LANCET, V354, P617; BOUCHER BJ, 1981, DIABETOLOGIA, V21, P34, DOI 10.1007/BF03216220; CAMERINIDAVALOS RA, 1970, EARL DIAB; CEDERHOLM J, 1984, DIABETES METAB, V10, P224; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1014; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P664; COCKRAM CS, 1993, DIABETES RES CLIN PR, V21, P67, DOI 10.1016/0168-8227(93)90099-Q; *COLL AM PATH, 1999, BLYC SURV 1999; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Curb JD, 1996, JAMA-J AM MED ASSOC, V276, P1886, DOI 10.1001/jama.276.23.1886; Davidson MB, 1999, JAMA-J AM MED ASSOC, V281, P1203, DOI 10.1001/jama.281.13.1203; De Vegt F, 1998, DIABETES CARE, V21, P1686, DOI 10.2337/diacare.21.10.1686; de Vegt F, 2001, JAMA-J AM MED ASSOC, V285, P2109, DOI 10.1001/jama.285.16.2109; Dinneen SF, 1998, DIABETES CARE, V21, P1408, DOI 10.2337/diacare.21.9.1408; DONAHUE RP, 1987, DIABETES, V36, P689, DOI 10.2337/diabetes.36.6.689; Edelstein SL, 1997, DIABETES, V46, P701, DOI 10.2337/diabetes.46.4.701; Engelgau MM, 1997, DIABETES CARE, V20, P785, DOI 10.2337/diacare.20.5.785; FAJANS SS, 1959, ANN NY ACAD SCI, V82, P208, DOI 10.1111/j.1749-6632.1959.tb44901.x; FESKENS EJM, 1992, J CLIN EPIDEMIOL, V45, P1327, DOI 10.1016/0895-4356(92)90173-K; FESKENS EJM, 1991, J CLIN EPIDEMIOL, V44, P947, DOI 10.1016/0895-4356(91)90058-H; Ford ES, 1997, AM J EPIDEMIOL, V146, P214, DOI 10.1093/oxfordjournals.aje.a009256; FORREST RD, 1987, DIABETIC MED, V4, P254, DOI 10.1111/j.1464-5491.1987.tb00875.x; Gabir MM, 2000, DIABETES CARE, V23, P1108, DOI 10.2337/diacare.23.8.1108; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gillery P, 1998, DIABETES CARE, V21, P265, DOI 10.2337/diacare.21.2.265; Goldstein DE, 1998, DIABETES CARE, V21, P1215, DOI 10.2337/diacare.21.8.1215; Goldstein DE, 1982, DIABETES S3, V31, P70; Haffner SM, 1998, DIABETES CARE, V21, P160, DOI 10.2337/diacare.21.1.160; HARRIS M, 1979, DIABETES, V28, P1039; Harris MI, 1998, DIABETES CARE, V21, P331, DOI 10.2337/diacare.21.3.331; HARRIS MI, 1987, DIABETES, V36, P523, DOI 10.2337/diabetes.36.4.523; Harris MI, 1997, DIABETES CARE, V20, P1859, DOI 10.2337/diacare.20.12.1859; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Huang ES, 2001, AM J MED, V111, P633, DOI 10.1016/S0002-9343(01)00978-0; JACKSON CA, 1992, DIABETES RES CLIN PR, V17, P111, DOI 10.1016/0168-8227(92)90156-L; JARRETT RJ, 1976, LANCET, V2, P1009; JARRETT RJ, 1979, DIABETOLOGIA, V16, P25, DOI 10.1007/BF00423146; John H., 1922, J METAB RES, V1, P497; KEEN H, 1982, DIABETOLOGIA, V22, P73, DOI 10.1007/BF00254832; KEEN H, 1975, COMPLICATIONS DIABET; Kilpatrick ES, 1998, DIABETES CARE, V21, P261, DOI 10.2337/diacare.21.2.261; KING H, 1984, DIABETOLOGIA, V26, P39, DOI 10.1007/BF00252261; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; KLEIN R, 1988, JAMA-J AM MED ASSOC, V260, P2864, DOI 10.1001/jama.260.19.2864; KNOWLER WC, 1990, DIABETES METAB REV, V6, P1, DOI 10.1002/dmr.5610060101; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Ko GTC, 1998, ANN CLIN BIOCHEM, V35, P62, DOI 10.1177/000456329803500107; Leibson CL, 1997, AM J EPIDEMIOL, V146, P12, DOI 10.1093/oxfordjournals.aje.a009187; LEVRAN A, 1981, ARCH INTERN MED, V141, P747, DOI 10.1001/archinte.141.6.747; Little RR, 2000, DIABETES CARE, V23, P265, DOI 10.2337/diacare.23.3.265; Lu FH, 1998, DIABETIC MED, V15, P564, DOI 10.1002/(SICI)1096-9136(199807)15:7<564::AID-DIA615>3.0.CO;2-H; Mannucci E, 1998, DIABETES CARE, V21, P468, DOI 10.2337/diacare.21.3.468; MCCANCE DR, 1994, BRIT MED J, V308, P1323, DOI 10.1136/bmj.308.6940.1323; McCance DR, 1997, DIABETOLOGIA, V40, P247, DOI 10.1007/s001250050671; MCCARTNEY P, 1983, DIABETES METAB, V9, P303; MCDONALD GW, 1965, DIABETES, V14, P473, DOI 10.2337/diab.14.8.473; McIntyre S, 1997, AUST NZ J OBSTET GYN, V37, P286, DOI 10.1111/j.1479-828X.1997.tb02410.x; Meigs JB, 1998, ANN INTERN MED, V128, P524, DOI 10.7326/0003-4819-128-7-199804010-00002; MITSCHERLICH E, 1841, ANN CHEM PHARM, V39, P360; Mooy JM, 1996, DIABETOLOGIA, V39, P298, DOI 10.1007/BF00418345; MOSENTHAL HO, 1950, ANN INTERN MED, V33, P1175, DOI 10.7326/0003-4819-33-5-1175; Muggeo M, 1997, CIRCULATION, V96, P1750, DOI 10.1161/01.CIR.96.6.1750; *NAT DIAB DAT GROU, 1995, SER NIH PUBL, P47; *NAT RES COUNC, 1995, NUTR REQ LAB AN, P1; NATHAN DM, 1984, NEW ENGL J MED, V310, P341, DOI 10.1056/NEJM198402093100602; OLEFSKY JM, 1974, DIABETES, V23, P449, DOI 10.2337/diab.23.5.449; ORCHARD TJ, 1994, DIABETES CARE, V17, P326, DOI 10.2337/diacare.17.4.326; Peters AL, 1996, JAMA-J AM MED ASSOC, V276, P1246, DOI 10.1001/jama.276.15.1246; PETTITT DJ, 1980, LANCET, V2, P1050; PHILLIPOU G, 1993, CLIN CHEM, V39, P2305; PROSNITZ LR, 1967, AM J MED SCI, V253, P700, DOI 10.1097/00000441-196706000-00008; Pyorala K, 1997, DIABETES CARE, V20, P614, DOI 10.2337/diacare.20.4.614; Ray NF, 1998, DIABETES CARE, V21, P296; RUSHFORTH NB, 1979, DIABETOLOGIA, V16, P373, DOI 10.1007/BF01223157; Ruwaard D, 1996, DIABETES CARE, V19, P214, DOI 10.2337/diacare.19.3.214; SASAKI A, 1982, DIABETOLOGIA, V22, P154, DOI 10.1007/BF00283743; Schnedl WJ, 2000, DIABETES CARE, V23, P339, DOI 10.2337/diacare.23.3.339; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shaw JE, 1999, DIABETES CARE, V22, P762, DOI 10.2337/diacare.22.5.762; Shaw JE, 1999, DIABETOLOGIA, V42, P1050, DOI 10.1007/s001250051269; SINGER DE, 1992, DIABETES, V41, P202, DOI 10.2337/diabetes.41.2.202; Siperstein M D, 1975, Adv Intern Med, V20, P297; STOLK RP, 1995, DIABETES CARE, V18, P1045, DOI 10.2337/diacare.18.7.1045; SVENDSEN PA, 1982, DIABETOLOGIA, V23, P403; TAHARA Y, 1995, DIABETES CARE, V18, P440, DOI 10.2337/diacare.18.4.440; Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Unwin N, 1998, DIABETIC MED, V15, P554, DOI 10.1002/(SICI)1096-9136(199807)15:7<554::AID-DIA626>3.0.CO;2-E; Vilbergsson S, 1997, DIABETIC MED, V14, P491, DOI 10.1002/(SICI)1096-9136(199706)14:6<491::AID-DIA365>3.0.CO;2-1; Wahl PW, 1998, LANCET, V352, P1012, DOI 10.1016/S0140-6736(98)04055-0; *WHO STUD GROUP DI, 1985, WHO TECHN REP SER, V727; Yoshinaga H, 1996, DIABETES RES CLIN PR, V31, P71, DOI 10.1016/0168-8227(96)01195-3; YUDKIN JS, 1991, DIABETES RES CLIN PR, V13, P1, DOI 10.1016/0168-8227(91)90027-B; 2001, DIABETES CARE, V24, P73; 1997, ARCH INTERN MED, V157, P2413; 2001, DIABETES CARE S1, V24, P33; 1979, J CHRONIC DIS, V32, P829; 1970, BR MED J, V3, P301	112	136	142	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2002	137	4					263	272		10.7326/0003-4819-137-4-200208200-00011	http://dx.doi.org/10.7326/0003-4819-137-4-200208200-00011			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585BB	12186517				2022-12-28	WOS:000177502300007
J	Lee, PY; Matchar, DB; Clements, DA; Huber, J; Hamilton, JD; Peterson, ED				Lee, PY; Matchar, DB; Clements, DA; Huber, J; Hamilton, JD; Peterson, ED			Economic analysis of influenza vaccination and antiviral treatment for healthy working adults	ANNALS OF INTERNAL MEDICINE			English	Article							NEURAMINIDASE INHIBITOR OSELTAMIVIR; COST-BENEFIT; VIRUS; IMPACT; AMANTADINE; ZANAMIVIR; RIMANTADINE; PREVENTION; RESISTANCE; EFFICACY	Background: hysicians have several treatment options for influenza, including vaccination and various antiviral therapies. However, the optimal influenza prevention and treatment strategy is unknown. Objective: To compare the relative health values of contemporary treatment strategies for influenza in a healthy sample of working adults. Design: Cost-benefit analysis using a decision model. Data Sources: Previously published data. Target Population: Healthy employed adults 18 to 50 years of age. Time Horizon: A complete influenza season. Perspective: Societal. Interventions: Eight treatment options (yes or no) based on the possible combinations of vaccination and antiviral therapy (rimantadine, oseltamivir, or zanamivir or no treatment) should infection develop. Outcome Measures: Cost in U.S. dollars, including the value of symptom relief and medication side effects, which was assigned a monetary value through a conjoint analysis that used a "willingness-to-pay" approach. Results: In the base-case analysis, all strategies for influenza vaccination had a higher net benefit than the nonvaccination strategies. Vaccination and use of rimantadine, the most cost-beneficial strategy, was $30.97 more cost-beneficial than nonvaccination and no use of antiviral medication. The health benefits of most antiviral treatments equaled or exceeded their costs for most scenarios. The choice of the most cost-beneficial antiviral strategy was sensitive to the prevalence of influenza B and to the comparative workdays gained by each antiviral therapy. Conclusions: Vaccination is cost-beneficial in most influenza seasons in healthy working adults. Although the benefits of antiviral therapy for persons with influenza infection appear to justify its cost, head-to-head trials of the various antiviral therapies are needed to determine the optimal treatment strategy.	Duke Univ, Med Ctr, Durham, NC 27710 USA; Durham Vet Affairs Med Ctr, Durham, NC USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Peterson, ED (corresponding author), Duke Univ, Med Ctr, Box 3226, Durham, NC 27710 USA.	peter016@mc.duke.edu	Matchar, David/M-3951-2019; Peterson, Eric David/ABF-5033-2021	Matchar, David/0000-0003-3020-2108	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T35GM008679] Funding Source: NIH RePORTER; NIGMS NIH HHS [T35-GM08679] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		*ADV COMM IMM PRAC, 2000, MMWR-MORBID MORTAL W, V19, P1; BELSHE RB, 1989, J INFECT DIS, V159, P430, DOI 10.1093/infdis/159.3.430; Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; CARDINALE V, 1999, DRUG TOPICS RED BOOK; COUCH RB, 1993, ANN NY ACAD SCI, V685, P803, DOI 10.1111/j.1749-6632.1993.tb35946.x; Demicheli V, 2000, VACCINE, V18, P957, DOI 10.1016/S0264-410X(99)00332-1; DEMICHELI V, 2001, COCHRANE DB SYST REV; DOLIN R, 1982, NEW ENGL J MED, V307, P580, DOI 10.1056/NEJM198209023071002; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; HAMMOND ML, 1978, MED J AUSTRALIA, V1, P301, DOI 10.5694/j.1326-5377.1978.tb107862.x; Hayden FG, 1999, NEW ENGL J MED, V341, P1336, DOI 10.1056/NEJM199910283411802; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; Hayden FG, 1997, NEW ENGL J MED, V337, P874, DOI 10.1056/NEJM199709253371302; Jefferson T, 2006, Cochrane Database Syst Rev, pCD001169, DOI 10.1002/14651858.CD001265.pub2; Jefferson T., 2000, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001265; Kaiser L, 2000, ARCH INTERN MED, V160, P3234, DOI 10.1001/archinte.160.21.3234; Keech M, 1998, OCCUP MED-OXFORD, V48, P85, DOI 10.1093/occmed/48.2.85; KIRSCHNER CG, 2000, CURRENT PROCEDURAL T; Long JK, 2000, CLEV CLIN J MED, V67, P92; LUI KJ, 1987, AM J PUBLIC HEALTH, V77, P712, DOI 10.2105/AJPH.77.6.712; MONTO AS, 1992, CLIN INFECT DIS, V15, P362, DOI 10.1093/clinids/15.2.362; Monto AS, 1999, J INFECT DIS, V180, P254, DOI 10.1086/314904; NICHOL KL, 1995, NEW ENGL J MED, V333, P889, DOI 10.1056/NEJM199510053331401; Nichol KL, 2001, JAMA-J AM MED ASSOC, V285, P290, DOI 10.1001/jama.285.3.290; Nichol KL, 2001, ARCH INTERN MED, V161, P749, DOI 10.1001/archinte.161.5.749; NICHOL KL, 2001, JAMA-J AM MED ASSOC, V285, P292; *RES TRIANGL PARK, 2001, REL PACK INS; *ROCH LAB, 1999, RAM PACK INS; SCHOENBAUM SC, 1987, AM J MED, V82, P26, DOI 10.1016/0002-9343(87)90557-2; Silagy C, 1998, LANCET, V352, P1877, DOI 10.1016/S0140-6736(98)10190-3; Singh J, 1998, MED CARE, V36, pAS31, DOI 10.1097/00005650-199808001-00005; SMITH SL, 1999, MEDICARE RBRVS PHYSI; SULLIVAN KM, 1993, AM J PUBLIC HEALTH, V83, P1712, DOI 10.2105/AJPH.83.12.1712; *US BUR LAB STAT, 2001, CONS PRIC IND MED CA; *US BUR LAB STAT, 2001, AV ANN PAY STAT IND; Willman D., 2000, LOS ANGELES TIM 1220; 2000, ASS PRESS NEWSW 1217	37	94	95	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2002	137	4					225	231		10.7326/0003-4819-137-4-200208200-00005	http://dx.doi.org/10.7326/0003-4819-137-4-200208200-00005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585BB	12186512				2022-12-28	WOS:000177502300001
J	Chuck, AL; Turner, SM; Liss, PS				Chuck, AL; Turner, SM; Liss, PS			Direct evidence for a marine source of C-1 and C-2 alkyl nitrates	SCIENCE			English	Article							PACIFIC; TEMPERATURE; TROPOSPHERE; CHEMISTRY; NITROGEN; AIR	Alkyl nitrates are a significant component of the odd nitrogen reservoir and play an important role in regulating tropospheric ozone levels in remote marine regions. Measurements of methyl and ethyl nitrate in seawater and air samples along two Atlantic Ocean transects provide the first direct evidence for an oceanic source of these compounds. Equatorial surface waters were highly supersaturated (up to 800%) in both species, with the waters in the temperate regions generally being closer to equilibrium. A simple box model calculation suggests that the equatorial source could be a major component of the local atmospheric alkyl nitrate budget.	Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Chuck, AL (corresponding author), Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England.		LISS, Peter S./A-8219-2013					Aiken J, 2000, PROG OCEANOGR, V45, P257, DOI 10.1016/S0079-6611(00)00005-7; ATKINSON R, 1987, J ATMOS CHEM, V5, P91; ATLAS E, 1993, J GEOPHYS RES-ATMOS, V98, P16933, DOI 10.1029/93JD01005; ATLAS E, 1988, NATURE, V331, P426, DOI 10.1038/331426a0; Blake NJ, 1999, J GEOPHYS RES-ATMOS, V104, P21803, DOI 10.1029/1999JD900238; Clemitshaw KC, 1997, J PHOTOCH PHOTOBIO A, V102, P117, DOI 10.1016/S1010-6030(96)04458-9; DAY DA, 2002, J GEOPHYS RES, P107; Jones AE, 1999, J GEOPHYS RES-ATMOS, V104, P21355, DOI 10.1029/1999JD900362; KAMES J, 1992, J ATMOS CHEM, V15, P79, DOI 10.1007/BF00053611; Liss P.S., 1986, ROLE AIR SEA EXCHANG, P113, DOI [10.1007/978-94-009-4738-2_5, DOI 10.1007/978-94-009-4738-2_5]; LUTJEHARMS JRE, 1987, S AFR J MARINE SCI, V5, P35, DOI 10.2989/025776187784522612; MCAULLIF C, 1971, CHEM TECHNOL, P46; McIntyre H.P., 2001, THESIS U E ANGLIA NO; Nightingale PD, 2000, GLOBAL BIOGEOCHEM CY, V14, P373, DOI 10.1029/1999GB900091; ROBERTS JM, 1990, ATMOS ENVIRON A-GEN, V24, P243, DOI 10.1016/0960-1686(90)90108-Y; Schneider M, 1999, CHEMOSPHERE, V38, P233, DOI 10.1016/S0045-6535(98)00173-8; Singh H, 2001, NATURE, V410, P1078, DOI 10.1038/35074067; Talbot RW, 2000, J GEOPHYS RES-ATMOS, V105, P6681, DOI 10.1029/1999JD901114; TURBERG MP, 1990, J PHOTOCH PHOTOBIO A, V51, P281, DOI 10.1016/1010-6030(90)87063-H; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; Wayne, 1991, CHEM ATMOSPHERES INT; WILLIAMS J, 1994, THESIS U E ANGLIA NO	22	81	82	4	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2002	297	5584					1151	1154		10.1126/science.1073896	http://dx.doi.org/10.1126/science.1073896			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183621				2022-12-28	WOS:000177447600040
J	Breyton, C; Haase, W; Rapoport, TA; Kuhlbrandt, W; Collinson, I				Breyton, C; Haase, W; Rapoport, TA; Kuhlbrandt, W; Collinson, I			Three-dimensional structure of the bacterial protein-translocation complex SecYEG	NATURE			English	Article							ESCHERICHIA-COLI; PREPROTEIN TRANSLOCATION; MEMBRANE; SECA; CHANNEL; RECONSTITUTION; TOPOLOGY; SEC61P	Transport and membrane integration of polypeptides is carried out by specific protein complexes in the membranes of all living cells. The Sec transport path provides an essential and ubiquitous route for protein translocation(1). In the bacterial cytoplasmic membrane, the channel is formed by oligomers of a heterotrimeric membrane protein complex consisting of subunits SecY, SecE and SecG(2,3). In the endoplasmic reticulum membrane, the channel is formed from the related Sec61 complex(4). Here we report the structure of the Escherichia coli SecYEG assembly at an in-plane resolution of 8 Angstrom. The three-dimensional map, calculated from two-dimensional SecYEG crystals, reveals a sandwich of two membranes interacting through the extensive cytoplasmic domains. Each membrane is composed of dimers of SecYEG. The monomeric complex contains 15 transmembrane helices. In the centre of the dimer we observe a 16 x 25 Angstrom cavity closed on the periplasmic side by two highly tilted transmembrane helices. This may represent the closed state of the protein-conducting channel.	Max Planck Inst Biophys, Abt Strukturbiol, D-60528 Frankfurt, Germany; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; IBPC, CNRS, UMR 7099, F-75005 Paris, France	Max Planck Society; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Breyton, C (corresponding author), Max Planck Inst Biophys, Abt Strukturbiol, Hoffmann Str 7, D-60528 Frankfurt, Germany.	Cecile.Breyton@ibpc.fr; Ian.Collinson@mpibp-frankfurt.mpg.de		Collinson, Ian/0000-0002-3931-0503; Kuhlbrandt, Werner/0000-0002-2013-4810				AKIMARU J, 1991, P NATL ACAD SCI USA, V88, P6545, DOI 10.1073/pnas.88.15.6545; AKIYAMA Y, 1987, EMBO J, V6, P3465, DOI 10.1002/j.1460-2075.1987.tb02670.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Bessonneau P, 2002, EMBO J, V21, P995, DOI 10.1093/emboj/21.5.995; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; Collinson I, 2001, EMBO J, V20, P2462, DOI 10.1093/emboj/20.10.2462; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Duong F, 1997, EMBO J, V16, P2756, DOI 10.1093/emboj/16.10.2756; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Eichler J, 1997, EMBO J, V16, P2188, DOI 10.1093/emboj/16.9.2188; FLOWER AM, 1995, EMBO J, V14, P884, DOI 10.1002/j.1460-2075.1995.tb07070.x; Fujimoto K, 1997, HISTOCHEM CELL BIOL, V107, P87, DOI 10.1007/s004180050092; GORLICH D, 1992, CELL, V71, P489, DOI 10.1016/0092-8674(92)90517-G; Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328; Hanein D, 1996, CELL, V87, P721, DOI 10.1016/S0092-8674(00)81391-4; HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; KLEYMANN G, 1995, J HISTOCHEM CYTOCHEM, V43, P607, DOI 10.1177/43.6.7769231; Manting EH, 2000, EMBO J, V19, P852, DOI 10.1093/emboj/19.5.852; Matlack KES, 1998, CELL, V92, P381, DOI 10.1016/S0092-8674(00)80930-7; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; NISHIYAMA K, 1994, EMBO J, V13, P3272, DOI 10.1002/j.1460-2075.1994.tb06628.x; Nishiyama KI, 1996, CELL, V85, P71, DOI 10.1016/S0092-8674(00)81083-1; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Shilton B, 1998, FEBS LETT, V436, P277, DOI 10.1016/S0014-5793(98)01141-7; Unger VM, 2000, ACTA CRYSTALLOGR D, V56, P1259, DOI 10.1107/S0907444900011252; van der Wolk JPW, 1997, EMBO J, V16, P7297, DOI 10.1093/emboj/16.24.7297; Veenendaal AKJ, 2001, J BIOL CHEM, V276, P32559, DOI 10.1074/jbc.M103912200	30	207	210	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2002	418	6898					662	665		10.1038/nature00827	http://dx.doi.org/10.1038/nature00827			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167867				2022-12-28	WOS:000177305600048
J	Tilman, D; Cassman, KG; Matson, PA; Naylor, R; Polasky, S				Tilman, D; Cassman, KG; Matson, PA; Naylor, R; Polasky, S			Agricultural sustainability and intensive production practices	NATURE			English	Review							FRESH-WATER; WORLD FOOD; NITROGEN; DIVERSITY; SYSTEMS; SOIL; RICE; CONSEQUENCES; ENVIRONMENT; CHALLENGES	A doubling in global food demand projected for the next 50 years poses huge challenges for the sustainability both of food production and of terrestrial and aquatic ecosystems and the services they provide to society. Agriculturalists are the principal managers of global useable lands and will shape, perhaps irreversibly, the surface of the Earth in the coming decades. New incentives and policies for ensuring the sustainability of agriculture and ecosystem services will be crucial if we are to meet the demands of improving yields without compromising environmental integrity or public health.	Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA; Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68583 USA; Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA; Stanford Univ, Ctr Environm Sci & Policy, Stanford, CA 94305 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Nebraska System; University of Nebraska Lincoln; Stanford University; Stanford University	Tilman, D (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.		Cassman, Kenneth G/C-3646-2019; Polasky, Stephen/AAC-5341-2019; Tilman, David/ABD-5309-2021					Alexandratos N, 1999, P NATL ACAD SCI USA, V96, P5908, DOI 10.1073/pnas.96.11.5908; BARNETT V, 1995, AGR SUSTAINABILITY E; Byerlee D, 1996, WORLD DEV, V24, P697, DOI 10.1016/0305-750X(95)00162-6; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Cassman K. G., 1995, Geojournal, V35, P299, DOI 10.1007/BF00989137; Cassman K. G., 2001, Crop science: progress and prospects. Papers presented at the Third International Crop Science Congress, Hamburg, Germany, 17-22 August 2000, P33, DOI 10.1079/9780851995304.0033; CASSMAN KG, 1993, PLANT SOIL, V155, P359, DOI 10.1007/BF00025057; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; CASSMAN KG, IN PRESS AMBIO; CASSMAN KG, 2001, RICE RES PRODUCTION, P79; CHAMEIDES WL, 1994, SCIENCE, V264, P74, DOI 10.1126/science.264.5155.74; Charles D, 2001, SCIENCE, V294, P772, DOI 10.1126/science.294.5543.772; Cicerone RJ, 1988, GLOBAL BIOGEOCHEM CY, V2, P299, DOI 10.1029/GB002i004p00299; Cohen J. E., 1995, MANY PEOPLE CAN EART; Cohen JE, 1999, C PLANTS POP IS THER; Conway G., 1997, DOUBLY GREEN REVOLUT; Daily GC, 2000, SCIENCE, V289, P395, DOI 10.1126/science.289.5478.395; Daily GC, 1997, NATURES SERVICES SOC, DOI DOI 10.12987/9780300188479-039; Delmas R, 1997, NUTR CYCL AGROECOSYS, V48, P51, DOI 10.1023/A:1009793806086; DeVries J, 2001, SECURING HARVEST BIO; Dobermann A, 2002, FIELD CROP RES, V74, P37, DOI 10.1016/S0378-4290(01)00197-6; DOWNING JA, 1999, 134 COUNC AGR SCI TE; Drinkwater LE, 1998, NATURE, V396, P262, DOI 10.1038/24376; Duvick DN, 1999, CROP SCI, V39, P1622, DOI 10.2135/cropsci1999.3961622x; DYNESIUS M, 1994, SCIENCE, V266, P753, DOI 10.1126/science.266.5186.753; Ehhalt D, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P239; FALCON W, IN PRESS FOOD POLICY; *FOOD AGR ORG UN, 2001, FAO STAT DAT; Frink CR, 1999, P NATL ACAD SCI USA, V96, P1175, DOI 10.1073/pnas.96.4.1175; GALLOWAY JN, 1994, AMBIO, V23, P120; GLEICK PH, 1993, INT SECURITY, V18, P79, DOI 10.2307/2539033; Gorbach SL, 2001, NEW ENGL J MED, V345, P1202, DOI 10.1056/NEJM200110183451610; Hall SJ, 1996, ANNU REV ENERG ENV, V21, P311, DOI 10.1146/annurev.energy.21.1.311; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Howarth RW, 1996, BIOGEOCHEMISTRY, V35, P75, DOI 10.1007/BF02179825; Kates R. W., 1996, CONSEQUENCES, V2, P3; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Manning Richard, 2000, FOODS FRONTIER NEXT; MARTIN L, 2000, W HOG J, V24; Matson PA, 1998, SCIENCE, V280, P112, DOI 10.1126/science.280.5360.112; Matson PA, 1996, J GEOPHYS RES-ATMOS, V101, P18533, DOI 10.1029/96JD01536; National Research Council, 1999, NAT NUMB EXP NAT EC; Naylor RL, 1996, ANNU REV ENERG ENV, V21, P99, DOI 10.1146/annurev.energy.21.1.99; NYE PH, 1960, 51 COMM AGR BUR SOIL; OLDEMAN LR, 1994, SOIL RESILIENCE AND SUSTAINABLE LAND USE, P99; *ORG EC COOP DEV, 2000, AGR POL OECD COUNTR; Organisation for Economic Cooperation and Development, 2001, AGR POL OECD COUNTR; ORTIZ R, 1998, J BIOTECHNOL, V1, P1; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Pardey P. G., 2001, SLOW MAGIC AGR R D C; Peng S, 1996, FIELD CROP RES, V47, P243, DOI 10.1016/0378-4290(96)00018-4; Peng S, 1999, CROP SCI, V39, P1552, DOI 10.2135/cropsci1999.3961552x; PinstrupAndersen P, 1996, ENVIRON CONSERV, V23, P226, DOI 10.1017/S0376892900038844; PLUCKNETT DL, 1993, BIOSCIENCE, V43, P432, DOI 10.2307/1311902; Postel S., 1999, PILLAR SAND CAN IRRI; Postel S., 1992, LAST OASIS FACING WA; Postel SL, 1996, SCIENCE, V271, P785, DOI 10.1126/science.271.5250.785; POWER AG, 1999, DEV SUSTAINABILITY, V1, P185; Reynolds MP, 1999, CROP SCI, V39, P1611, DOI 10.2135/cropsci1999.3961611x; Robertson G. Philip, 1997, P347; RUTTAN VR, IN PRESS J EC PERSPE; Ruttan VW, 1999, P NATL ACAD SCI USA, V96, P5960, DOI 10.1073/pnas.96.11.5960; Seckler D., 1999, International Journal of Water Resources Development, V15, P29, DOI 10.1080/07900629948916; Sen A., 1983, POVERTY FAMINES ESSA; Smil V, 2000, ANNU REV ENERG ENV, V25, P53, DOI 10.1146/annurev.energy.25.1.53; Smil V, 1999, GLOBAL BIOGEOCHEM CY, V13, P647, DOI 10.1029/1999GB900015; Smith KE, 1999, NEW ENGL J MED, V340, P1525, DOI 10.1056/NEJM199905203402001; *STAT CAN, 2002, NUMB FARMS REP PIGS; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; *US GEN ACC OFF, 1995, GAORCED95200BR; VITOUSEK PM, 1993, BIOGEOCHEMISTRY OF GLOBAL CHANGE, P193; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; WAGGONER PE, 1995, TECHNOL SOC, V17, P17, DOI 10.1016/0160-791X(94)00024-8; Woomer P.L., 1994, BIOL MANAG TROP SOIL; World Health Organization (WHO), 1990, PUBL HLTH IMP PEST U; Young A, 1999, ENVIRON DEV SUSTAIN, V1, P3, DOI DOI 10.1023/A:1010055012699; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046	79	4359	4622	88	2766	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2002	418	6898					671	677		10.1038/nature01014	http://dx.doi.org/10.1038/nature01014			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167873				2022-12-28	WOS:000177305600053
J	Travis, DJ; Carleton, AM; Lauritsen, RG				Travis, DJ; Carleton, AM; Lauritsen, RG			Climatology: Contrails reduce daily temperature range - A brief interval when the skies were clear of jets unmasked an effect on climate.	NATURE			English	Article							TRENDS; CLOUD		Univ Wisconsin, Dept Geog & Geol, Whitewater, WI 53190 USA; Penn State Univ, Dept Geog, University Pk, PA 16801 USA	University of Wisconsin System; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Travis, DJ (corresponding author), Univ Wisconsin, Dept Geog & Geol, Whitewater, WI 53190 USA.							CHANGNON SA, 1981, J APPL METEOROL, V20, P496, DOI 10.1175/1520-0450(1981)020<0496:MCSATT>2.0.CO;2; DeGrand JQ, 2000, J APPL METEOROL, V39, P1434, DOI 10.1175/1520-0450(2000)039<1434:ASBCDO>2.0.CO;2; Duda DP, 2001, J GEOPHYS RES-ATMOS, V106, P4927, DOI 10.1029/2000JD900393; KARL TR, 1993, B AM METEOROL SOC, V74, P1007, DOI 10.1175/1520-0477(1993)074<1007:ANPORG>2.0.CO;2; Liebmann B, 1996, B AM METEOROL SOC, V77, P1275; Meerkotter R, 1999, ANN GEOPHYS-ATM HYDR, V17, P1080, DOI 10.1007/s00585-999-1080-7; Sassen K, 1997, B AM METEOROL SOC, V78, P1885, DOI 10.1175/1520-0477(1997)078<1885:CCATPF>2.0.CO;2; Travis D. J., 1997, J WEATHER MODIFICAT, V29, P74	8	97	101	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2002	418	6898					601	601		10.1038/418601a	http://dx.doi.org/10.1038/418601a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167846				2022-12-28	WOS:000177305600027
J	Berg, AO; Allan, JD; Frame, P; Homer, CJ; Johnson, MS; Klein, JD; Lieu, TA; Mulrow, CD; Orleans, TC; Peipert, JF; Pender, NJ; Siu, AL; Teutsch, SM; Westhoff, C; Woolf, SH				Berg, AO; Allan, JD; Frame, P; Homer, CJ; Johnson, MS; Klein, JD; Lieu, TA; Mulrow, CD; Orleans, TC; Peipert, JF; Pender, NJ; Siu, AL; Teutsch, SM; Westhoff, C; Woolf, SH		US Preventive Task Force	Behavioral Counseling in primary care to promote physical activity: Recommendation and rationale	ANNALS OF INTERNAL MEDICINE			English	Article								This statement summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on counseling by primary care physicians to promote physical activity and the supporting scientific evidence, and it updates the 1996 recommendations contained in the Guide to Clinical Preventive Services, second edition, The complete USPSTF recommendations and rationale statement on this topic, which includes a brief review of the supporting evidence, is available through the USPSTF Web site (www.preventiveservices.ahrq.gov), the National Guideline Clearinghouse (www.guideline.gov), and in print through the Agency for Healthcare Research and Quality Publications Clearinghouse (telephone, 800-358-9295; e-mail, ahrqpubs@ahrq.gov). The complete information on which this statement is based, including tables and references, is available in the accompanying article in this issue and in the summary of the evidence and systematic evidence review on the Web sites already mentioned.	Univ Washington, Seattle, WA 98195 USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX 78284 USA; Tri County Family Med, Cohocton, NY USA; Univ Rochester, Sch Med, Rochester, NY 14642 USA; Natl Initiat Childrens Hlthcare Qual, Boston, MA USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA; Harvard Pilgrim Hlth Care, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Robert Wood Johnson Fdn, Prince George, BC, Canada; Women & Infants Hosp Rhode Isl, Providence, RI 02908 USA; Univ Michigan, Ann Arbor, MI 48109 USA; Mt Sinai Sch Med, New York, NY USA; Merck & Co Inc, West Point, PA USA; Columbia Univ, New York, NY 10032 USA; Virginia Commonwealth Univ, Fairfax, VA USA	University of Washington; University of Washington Seattle; University of Texas System; University of Texas Health San Antonio; University of Rochester; Rutgers State University New Brunswick; Rutgers State University Medical Center; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Robert Wood Johnson Foundation (RWJF); Women & Infants Hospital Rhode Island; University of Michigan System; University of Michigan; Icahn School of Medicine at Mount Sinai; Merck & Company; Columbia University; Virginia Commonwealth University	Berg, AO (corresponding author), Univ Washington, Seattle, WA 98195 USA.							*AM COLL OBST GYN, 2000, PRIM PREV CAR PER AS; American Academy of Family Physicians, 2002, SUMM POL REC PER HLT; Beaulieu MD, 1994, CANADIAN GUIDE CLIN, P560; Fletcher GF, 1997, CIRCULATION, V96, P355; Patrick K, 2001, BRIGHT FUTURES PRACT; Simons-Morton DG, 2001, JAMA-J AM MED ASSOC, V286, P677; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; *US DEP HHS, 2000, HLTH PEOPL 2010 C; Washington RL, 2001, PEDIATRICS, V107, P1459; 2002, AM J PREV MED S, V22, P67	10	73	74	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 6	2002	137	3					205	207		10.7326/0003-4819-137-3-200208060-00014	http://dx.doi.org/10.7326/0003-4819-137-3-200208060-00014			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580XP	12160370				2022-12-28	WOS:000177262300009
J	Gaspar, PP				Gaspar, PP			Silicon chemistry: R3Si+ - Free at last	SCIENCE			English	Editorial Material							SILYLIUM CATIONS; ION; GENERATION		Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL)	Gaspar, PP (corresponding author), Washington Univ, Dept Chem, St Louis, MO 63130 USA.							Arshadi M, 1996, J AM CHEM SOC, V118, P5120, DOI 10.1021/ja9542956; BARTON TJ, 1976, J AM CHEM SOC, V98, P5695, DOI 10.1021/ja00434a048; COREY JY, 1975, J AM CHEM SOC, V97, P3237, DOI 10.1021/ja00844a063; CORRIU RJP, 1974, J ORGANOMET CHEM, V74, P1, DOI 10.1016/S0022-328X(00)83756-0; Gaspar PP, 1999, ORGANOMETALLICS, V18, P3921, DOI 10.1021/om990418+; Kim KC, 2002, SCIENCE, V297, P825, DOI 10.1126/science.1073540; LAMBERT JB, 1983, J AM CHEM SOC, V105, P1671, DOI 10.1021/ja00344a053; Lambert JB, 2001, J PHYS ORG CHEM, V14, P370, DOI 10.1002/poc.377; LAMBERT JB, 1993, SCIENCE, V260, P1917, DOI 10.1126/science.260.5116.1917; Lambert JB, 1997, ANGEW CHEM INT EDIT, V36, P400, DOI 10.1002/anie.199704001; LAMBERT JB, 1995, CHEM REV, V95, P1191, DOI 10.1021/cr00037a003; Maerker C, 1998, CHEM FUNCT, V2, P513, DOI 10.1002/0470857250.ch10; OLAH GA, 1992, J AM CHEM SOC, V114, P7737, DOI 10.1021/ja00046a020; PAULING L, 1994, SCIENCE, V263, P983, DOI 10.1126/science.263.5149.983; Reed CA, 1998, ACCOUNTS CHEM RES, V31, P325, DOI 10.1021/ar960132q; Schwarz H, 1989, CHEM ORGANIC SILICON, V1, P445	16	26	26	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2002	297	5582					785	786		10.1126/science.1075469	http://dx.doi.org/10.1126/science.1075469			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161642				2022-12-28	WOS:000177192800035
J	Shin, M; Ueki, K; Kurita, H; Kirino, T				Shin, M; Ueki, K; Kurita, H; Kirino, T			Malignant transformation of a vestibular schwannoma after gamma knife radiosurgery	LANCET			English	Article								Stereotactic radiosurgery is used to treat benign tumours, but its long-term effects are not fully understood. Here we describe a vestibular schwannoma that underwent malignant transformation 6 years after gamma knife radiosurgery applied to the tumour remnant after a primary resection. Histological specimens of the original specimen did not show any atypical features. Genotyping showed a TP53 mutation in the recurrent tumour, which did not exist in the original tumour. Our results suggest that radiosurgery induced the malignant transformation, and we propose a cautious application of this treatment for benign tumours.	Tokyo Univ Hosp, Dept Neurosurg, Tokyo 113, Japan	University of Tokyo	Shin, M (corresponding author), Tokyo Univ Hosp, Dept Neurosurg, Tokyo 113, Japan.							Hanabusa K, 2001, J NEUROSURG, V95, P518, DOI 10.3171/jns.2001.95.3.0518; Kobayashi T, 2001, SURG NEUROL, V55, P325, DOI 10.1016/S0090-3019(01)00467-0; Kondziolka D, 1998, NEW ENGL J MED, V339, P1426, DOI 10.1056/NEJM199811123392003; MCLEAN CA, 1990, J NEUROSURG, V73, P946, DOI 10.3171/jns.1990.73.6.0946; Yu JS, 2000, LANCET, V356, P1576, DOI 10.1016/S0140-6736(00)03134-2	5	168	171	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 27	2002	360	9329					309	310		10.1016/S0140-6736(02)09521-1	http://dx.doi.org/10.1016/S0140-6736(02)09521-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578DT	12147377				2022-12-28	WOS:000177102700015
J	Heisler, LK; Cowley, MA; Tecott, LH; Fan, W; Low, MJ; Smart, JL; Rubinstein, M; Tatro, JB; Marcus, JN; Holstege, H; Lee, CE; Cone, RD; Elmquist, JK				Heisler, LK; Cowley, MA; Tecott, LH; Fan, W; Low, MJ; Smart, JL; Rubinstein, M; Tatro, JB; Marcus, JN; Holstege, H; Lee, CE; Cone, RD; Elmquist, JK			Activation of central melanocortin pathways by fenfluramine	SCIENCE			English	Article							RECEPTOR SUBTYPE; ARCUATE NUCLEUS; POMC NEURONS; BODY-WEIGHT; RAT-BRAIN; OBESITY; LEPTIN; SEROTONIN; MOUSE; MICE	D-fenfluramine (d-FEN) was once widely prescribed and was among the most effective weight loss drugs, but was withdrawn from clinical use because of reports of cardiac complications in a subset of patients. Discerning the neurobiology underlying the anorexic action of d-FEN may facilitate the development of new drugs to prevent and treat obesity. Through a combination of functional neuroanatomy, feeding, and electrophysiology studies in rodents, we show that d-FEN induced anorexia requires activation of central nervous system melanocortin pathways. These results provide a mechanistic explanation of d-FEN's anorexic actions and indicate that drugs targeting these downstream melanocortin pathways may prove to be effective and more selective anti-obesity treatments.	Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02215 USA; Oregon Hlth & Sci Univ, Oregon natl Primate Res Ctr, Div Neurosci, Beaverton, OR 97006 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Univ San Francisco, Dept Psychiat, San Francisco, CA 94117 USA; Univ San Francisco, Ctr Neurobiol & Psychiat, San Francisco, CA 94117 USA; Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biol Sci, RA-1053 Buenos Aires, DF, Argentina; Univ Buenos Aires, Inst Invest Ingn Genet & Biol Mol, CONICET, RA-1053 Buenos Aires, DF, Argentina; Tufts Univ, Sch Med, Dept Neurosci & Pharmacol & Expt Therapeut, Boston, MA 02111 USA; Tufts Univ, Sch Med, Tufts New England Med Ctr, Div Endocrinol Diabet Metab & Mol Med, Boston, MA 02111 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; University of San Francisco; University of San Francisco; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Tufts University; Tufts Medical Center; Tufts University	Elmquist, JK (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.		Cowley, Michael A/B-9428-2008	Cowley, Michael A/0000-0001-7811-134X; Heisler, Lora/0000-0002-7731-1419; Holstege, Henne/0000-0002-7688-3087; Low, Malcolm/0000-0002-9900-3708	FOGARTY INTERNATIONAL CENTER [R03TW001233] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F31HG000201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK055819, P01DK056116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061624, R01MH044694, R01MH061583] Funding Source: NIH RePORTER; FIC NIH HHS [R03TW01233] Funding Source: Medline; NHGRI NIH HHS [F31HG00201] Funding Source: Medline; NIDDK NIH HHS [P01DK55819, P01DK056116] Funding Source: Medline; NIMH NIH HHS [R01MH061583, R01MH44694, R01MH61624] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Butler AA, 2000, ENDOCRINOLOGY, V141, P3518, DOI 10.1210/en.141.9.3518; Chen AS, 2000, NAT GENET, V26, P97, DOI 10.1038/79254; Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Elias CF, 1998, NEURON, V21, P1375, DOI 10.1016/S0896-6273(00)80656-X; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elias CF, 2000, J COMP NEUROL, V423, P261; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Fan T, 2000, ENDOCRINOLOGY, V141, P3072; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; GUYGRAND B, 1989, LANCET, V2, P1142; GuyGrand B, 1995, OBES RES, V3, pS491, DOI 10.1002/j.1550-8528.1995.tb00217.x; Heal DJ, 1998, BRIT J PHARMACOL, V125, P301, DOI 10.1038/sj.bjp.0702067; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; KISS J, 1984, NEUROSCI LETT, V44, P119, DOI 10.1016/0304-3940(84)90068-5; LI BH, 1993, BRAIN RES BULL, V31, P43, DOI 10.1016/0361-9230(93)90009-Z; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; MOLINEAUX SM, 1989, P NATL ACAD SCI USA, V86, P6793, DOI 10.1073/pnas.86.17.6793; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Scammell TE, 1996, J NEUROSCI, V16, P6246; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Vickers SP, 1999, PSYCHOPHARMACOLOGY, V143, P309, DOI 10.1007/s002130050952; WRIGHT DE, 1995, J COMP NEUROL, V351, P357, DOI 10.1002/cne.903510304; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404	27	381	399	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2002	297	5581					609	611		10.1126/science.1072327	http://dx.doi.org/10.1126/science.1072327			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142539				2022-12-28	WOS:000177054200053
J	Preitner, N; Damiola, F; Molina, LL; Zakany, J; Duboule, D; Albrecht, U; Schibler, U				Preitner, N; Damiola, F; Molina, LL; Zakany, J; Duboule, D; Albrecht, U; Schibler, U			The orphan nuclear receptor REV-ERB alpha controls circadian transcription within the positive limb of the mammalian circadian oscillator	CELL			English	Article							SUPRACHIASMATIC NUCLEUS; RHYTHMIC EXPRESSION; FEEDBACK LOOPS; MESSENGER-RNA; ROR-BETA; CLOCK; GENE; IDENTIFICATION; SUPERFAMILY; REPRESSION	Mammalian circadian rhythms are generated by a feedback loop in which BMAL1 and CLOCK, players of the positive limb, activate transcription of the cryptochrome and period genes, components of the negative limb. Bmal1 and Per transcription cycles display nearly opposite phases and are thus governed by different mechanisms. Here, we identify the orphan nuclear receptor REV-ERBalpha as the major regulator of cyclic Bmal1 transcription. Circadian Rev-erbalpha expression is controlled by components of the general feedback loop. Thus, REV-ERBalpha constitutes a molecular link through which components of the negative limb drive antiphasic expression of components of the positive limb. While REV-ERBalpha influences the period length and affects the phase-shifting properties of the clock, it is not required for circadian rhythm generation.	Univ Geneva, Dept Mol Biol Sci 2, CH-1211 Geneva 4, Switzerland; Univ Geneva, Dept Anim Biol Sci 3, CH-1211 Geneva 4, Switzerland; Univ Fribourg, Dept Med, Div Biochem, CH-1700 Fribourg, Switzerland	University of Geneva; University of Geneva; University of Fribourg	Schibler, U (corresponding author), Univ Geneva, Dept Mol Biol Sci 2, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	ueli.schibler@molbio.unige.ch	Albrecht, Urs/A-9831-2011	Albrecht, Urs/0000-0002-0663-8676; duboule, denis/0000-0001-9961-2960; Damiola, Francesca/0000-0002-0238-1252; Lopez-Molina, Luis/0000-0003-0463-1187				Adelmant G, 1996, P NATL ACAD SCI USA, V93, P3553, DOI 10.1073/pnas.93.8.3553; Albrecht U, 2002, J APPL PHYSIOL, V92, P1348, DOI 10.1152/japplphysiol.00759.2001; Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Cermakian N, 2000, P NATL ACAD SCI USA, V97, P4339, DOI 10.1073/pnas.97.8.4339; Chomez P, 2000, DEVELOPMENT, V127, P1489; Delaunay F, 2000, SCIENCE, V289, P297, DOI 10.1126/science.289.5477.297; DUMAS B, 1994, MOL ENDOCRINOL, V8, P996, DOI 10.1210/me.8.8.996; Fonjallaz P, 1996, EMBO J, V15, P351, DOI 10.1002/j.1460-2075.1996.tb00365.x; FORMAN BM, 1994, MOL ENDOCRINOL, V8, P1253, DOI 10.1210/me.8.9.1253; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; HARDING HP, 1993, MOL CELL BIOL, V13, P3113, DOI 10.1128/MCB.13.5.3113; HARDING HP, 1995, MOL CELL BIOL, V15, P4791; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Joyner AL, 1993, GENE TARGETING PRACT; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; LopezMolina L, 1997, EMBO J, V16, P6762, DOI 10.1093/emboj/16.22.6762; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Medvedev A, 1996, GENE, V181, P199, DOI 10.1016/S0378-1119(96)00504-5; MIYAJIMA N, 1989, CELL, V57, P31, DOI 10.1016/0092-8674(89)90169-4; Nef S, 1996, MECH DEVELOP, V55, P65, DOI 10.1016/0925-4773(95)00491-2; Park HT, 1996, NEUROSCI LETT, V217, P17, DOI 10.1016/S0304-3940(96)13060-3; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; RETNAKARAN R, 1994, MOL ENDOCRINOL, V8, P1234, DOI 10.1210/me.8.9.1234; Ripperger JA, 2000, GENE DEV, V14, P679; RUSAK B, 1979, PHYSIOL REV, V59, P449, DOI 10.1152/physrev.1979.59.3.449; Schaeren-Wiemers N, 1997, EUR J NEUROSCI, V9, P2687, DOI 10.1111/j.1460-9568.1997.tb01698.x; Schibler U, 1999, DEV GENETICS EPIGENE, P487; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Sumi Y, 2002, NEUROSCI LETT, V320, P13, DOI 10.1016/S0304-3940(02)00011-3; Whitmore D, 1998, NAT NEUROSCI, V1, P701, DOI 10.1038/3703; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yu WJ, 2002, BIOCHEM BIOPH RES CO, V290, P933, DOI 10.1006/bbrc.2001.6300; Zamir I, 1997, GENE DEV, V11, P835, DOI 10.1101/gad.11.7.835; Zamir I, 1996, MOL CELL BIOL, V16, P5458; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	45	1559	1631	5	128	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 26	2002	110	2					251	260		10.1016/S0092-8674(02)00825-5	http://dx.doi.org/10.1016/S0092-8674(02)00825-5			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	578EV	12150932	Bronze			2022-12-28	WOS:000177105200012
J	Giaever, G; Chu, AM; Ni, L; Connelly, C; Riles, L; Veronneau, S; Dow, S; Lucau-Danila, A; Anderson, K; Andre, B; Arkin, AP; Astromoff, A; El Bakkoury, M; Bangham, R; Benito, R; Brachat, S; Campanaro, S; Curtiss, M; Davis, K; Deutschbauer, A; Entian, KD; Flaherty, P; Foury, F; Garfinkel, DJ; Gerstein, M; Gotte, D; Guldener, U; Hegemann, JH; Hempel, S; Herman, Z; Jaramillo, DF; Kelly, DE; Kelly, SL; Kotter, P; LaBonte, D; Lamb, DC; Lan, N; Liang, H; Liao, H; Liu, L; Luo, CY; Lussier, M; Mao, R; Menard, P; Ooi, SL; Revuelta, JL; Roberts, CJ; Rose, M; Ross-Macdonald, P; Scherens, B; Schimmack, G; Shafer, B; Shoemaker, DD; Sookhai-Mahadeo, S; Storms, RK; Strathern, JN; Valle, G; Voet, M; Volckaert, G; Wang, CY; Ward, TR; Wilhelmy, J; Winzeler, EA; Yang, YH; Yen, G; Youngman, E; Yu, KX; Bussey, H; Boeke, JD; Snyder, M; Philippsen, P; Davis, RW; Johnston, M				Giaever, G; Chu, AM; Ni, L; Connelly, C; Riles, L; Veronneau, S; Dow, S; Lucau-Danila, A; Anderson, K; Andre, B; Arkin, AP; Astromoff, A; El Bakkoury, M; Bangham, R; Benito, R; Brachat, S; Campanaro, S; Curtiss, M; Davis, K; Deutschbauer, A; Entian, KD; Flaherty, P; Foury, F; Garfinkel, DJ; Gerstein, M; Gotte, D; Guldener, U; Hegemann, JH; Hempel, S; Herman, Z; Jaramillo, DF; Kelly, DE; Kelly, SL; Kotter, P; LaBonte, D; Lamb, DC; Lan, N; Liang, H; Liao, H; Liu, L; Luo, CY; Lussier, M; Mao, R; Menard, P; Ooi, SL; Revuelta, JL; Roberts, CJ; Rose, M; Ross-Macdonald, P; Scherens, B; Schimmack, G; Shafer, B; Shoemaker, DD; Sookhai-Mahadeo, S; Storms, RK; Strathern, JN; Valle, G; Voet, M; Volckaert, G; Wang, CY; Ward, TR; Wilhelmy, J; Winzeler, EA; Yang, YH; Yen, G; Youngman, E; Yu, KX; Bussey, H; Boeke, JD; Snyder, M; Philippsen, P; Davis, RW; Johnston, M			Functional profiling of the Saccharomyces cerevisiae genome	NATURE			English	Article							YEAST GENOME; EXPRESSION; DELETION; GENES	Determining the effect of gene deletion is a fundamental approach to understanding gene function. Conventional genetic screens exhibit biases, and genes contributing to a phenotype are often missed. We systematically constructed a nearly complete collection of gene-deletion mutants (96% of annotated open reading frames, or ORFs) of the yeast Saccharomyces cerevisiae. DNA sequences dubbed 'molecular bar codes' uniquely identify each strain, enabling their growth to be analysed in parallel and the fitness contribution of each gene to be quantitatively assessed by hybridization to high-density oligonucleotide arrays. We show that previously known and new genes are necessary for optimal growth under six well-studied conditions: high salt, sorbitol, galactose, pH 8, minimal medium and nystatin treatment. Less than 7% of genes that exhibit a significant increase in messenger RNA expression are also required for optimal growth in four of the tested conditions. Our results validate the yeast gene-deletion collection as a valuable resource for functional genomics.	Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; Rosetta Inpharmat Inc, Kirkland, WA 98034 USA; Catholic Univ Louvain, FYSA, B-1348 Louvain, Belgium; Free Univ Brussels, Lab Physiol Cellulaire, Gosselies, Belgium; Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Free Univ Brussels, IRMW, B-1070 Brussels, Belgium; Univ Salamanca, CSIC, Inst Microbiol & Bioquim, Dept Genet & Microbiol, E-37007 Salamanca, Spain; Univ Basel, Biozentrum, Dept Mol Microbiol, CH-4056 Basel, Switzerland; Univ Padua, Dept Biol, I-35121 Padua, Italy; Goethe Univ Frankfurt, Inst Microbiol, EUROSCARF, D-60439 Frankfurt, Germany; Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; NCI, Ctr Canc Res, Gene Regulat & Chromosome Biol Lab, Frederick, MD 21702 USA; Univ Dusseldorf, Inst Mikrobiol, D-40225 Dusseldorf, Germany; Univ Wales, Inst Biol Sci, Aberystwyth SY23 3DA, Dyfed, Wales; Concordia Univ, Dept Biol, Montreal, PQ H3G 1M8, Canada; Katholieke Univ Leuven, Lab Gene Technol, B-3001 Heverlee, Belgium	Stanford University; Stanford University; Yale University; Yale University; Johns Hopkins University; Washington University (WUSTL); McGill University; Universite Catholique Louvain; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; University of Basel; University of Padua; Goethe University Frankfurt; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Heinrich Heine University Dusseldorf; Aberystwyth University; Concordia University - Canada; KU Leuven	Davis, RW (corresponding author), Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA.	dbowe@cmgm.stanford.edu	Revuelta, Jose Luis/ABG-1502-2020; André, Bruno/D-1725-2010; Güldener, Ulrich/G-5227-2012; Arkin, Adam P/A-6751-2008; BENITO, ROCIO/B-4271-2017; Youngman, Elaine/O-7449-2019; Storms, Reginald/B-2405-2013; Winzeler, Elizabeth/AAP-6752-2020; Arkin, Adam/M-9941-2019; Lucau-Danila, Anca/AAE-7674-2021; Johnston, Mark/K-3543-2019; Revuelta, Jose L/C-2324-2012; Johnston, Mark/R-6156-2019; Entian, Karl-Dieter/D-3080-2011; Flaherty, Patrick/A-1720-2011; Campanaro, Stefano/I-5657-2019	Revuelta, Jose Luis/0000-0001-7838-5308; Güldener, Ulrich/0000-0001-5052-8610; Arkin, Adam P/0000-0002-4999-2931; BENITO, ROCIO/0000-0001-9781-4198; Winzeler, Elizabeth/0000-0002-4049-2113; Arkin, Adam/0000-0002-4999-2931; Johnston, Mark/0000-0002-4932-7229; Revuelta, Jose L/0000-0001-7838-5308; Snyder, Michael/0000-0003-0784-7987; Menard, Patrice/0000-0001-8844-3727; VALLE, GIORGIO/0000-0003-4377-5685; LUCAU-DANILA, Anca/0000-0002-9379-6241; CAMPANARO, STEFANO/0000-0002-9431-1648; Lemire-Brachat, Sophie/0000-0002-3398-8225; Boeke, Jef/0000-0001-5322-4946				BENZER S, 1961, P NATL ACAD SCI USA, V47, P403, DOI 10.1073/pnas.47.3.403; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; GUTHRIE C, 1991, GUIDE YEAST GENETICS, P12; Hamer L, 2001, P NATL ACAD SCI USA, V98, P5110, DOI 10.1073/pnas.091094198; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Jones E. W., 1982, MOL BIOL YEAST SACCH, P181; Liu LX, 1999, GENOME RES, V9, P859, DOI 10.1101/gr.9.9.859; Mewes HW, 2000, NUCLEIC ACIDS RES, V28, P37, DOI 10.1093/nar/28.1.37; Ni L, 2001, MOL BIOL CELL, V12, P2147, DOI 10.1091/mbc.12.7.2147; Piano F, 2000, CURR BIOL, V10, P1619, DOI 10.1016/S0960-9822(00)00869-1; Poon PP, 1996, P NATL ACAD SCI USA, V93, P10074, DOI 10.1073/pnas.93.19.10074; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Sherman F., 1986, METHODS YEAST GENETI, P145; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WACH A, 1996, EUROFAN; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yale J, 2001, J BIOL CHEM, V276, P15996, DOI 10.1074/jbc.M008209200; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423	22	3071	4284	7	330	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2002	418	6896					387	391		10.1038/nature00935	http://dx.doi.org/10.1038/nature00935			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12140549				2022-12-28	WOS:000177009700029
J	Lavrov, AN; Komiya, S; Ando, Y				Lavrov, AN; Komiya, S; Ando, Y			Antiferromagnets - Magnetic shape-memory effects in a crystal	NATURE			English	Article									Cent Res Inst Elect Power Ind, Tokyo 2018511, Japan	Central Research Institute of Electric Power Industry - Japan	Lavrov, AN (corresponding author), Cent Res Inst Elect Power Ind, Tokyo 2018511, Japan.		Lavrov, Alexander/AAU-5191-2021; Ando, Yoichi/B-8163-2013; Lavrov, Alexander/AAQ-8875-2020	Lavrov, Alexander/0000-0002-2436-017X; Ando, Yoichi/0000-0002-3553-3355; Ando, Yukio/0000-0001-7115-9105				Ando Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137005; Kastner MA, 1998, REV MOD PHYS, V70, P897, DOI 10.1103/RevModPhys.70.897; Lavrov AN, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.017007; OHANDLEY RC, 2000, J APPL PHYS, V87, P5774	4	103	106	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2002	418	6896					385	386		10.1038/418385a	http://dx.doi.org/10.1038/418385a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12140547	Green Submitted			2022-12-28	WOS:000177009700027
J	Marshall, JL; Telfer, SJ; Young, MA; Lindholm, EP; Minns, RA; Takiff, L				Marshall, JL; Telfer, SJ; Young, MA; Lindholm, EP; Minns, RA; Takiff, L			A silver-free, single-sheet imaging medium based on acid amplification	SCIENCE			English	Article							CATIONIC POLYMERIZATION; ELECTRON-TRANSFER; SALTS	We describe a photographic medium that uses acid-amplified imaging (AAI) rather than silver halide development to amplify a latent image. The latent image is captured when small amounts of superacid are generated by the photolysis of iodonium salts sensitized by cationic dyes. During thermal processing, the quantity of acid is multiplied in a process catalyzed by strong acid, resulting in a much larger amount of a weaker acid. Acid-sensitive indicator dyes that diffuse into regions where acid has been produced form a colored image. The AAI system is not sufficiently sensitive for direct use in cameras but is suitable for many printing applications.	Polaroid Corp, Instant Digital Printing, Waltham, MA 02451 USA		Marshall, JL (corresponding author), Polaroid Corp, Instant Digital Printing, 1265 Main St,Bldg W4, Waltham, MA 02451 USA.							Arimitsu K, 1998, J AM CHEM SOC, V120, P37, DOI 10.1021/ja972353c; BI Y, 1994, MACROMOLECULES, V27, P3684; Crivello J. V., 1976, J POLYM SCI S, V56, P383; CRIVELLO JV, 1978, J POLYM SCI POL CHEM, V16, P2441, DOI 10.1002/pol.1978.170161004; DEKTAR JL, 1990, J ORG CHEM, V55, P639, DOI 10.1021/jo00289a045; GOULD IR, 1990, J AM CHEM SOC, V112, P4290, DOI 10.1021/ja00167a027; KAMPMEIER JA, 1994, J ORG CHEM, V59, P1381, DOI 10.1021/jo00085a030; KARVANOS GJ, 1986, CHEM REV, V86, P401; Klosterboer D. H., 1989, IMAGING PROCESSES MA, P279; LEDWITH A, 1975, PURE APPL CHEM, V51, P159; MARSHALL J, 1997, P 11 SPE INT C PHOT, P245; MUTHYALA R, 1997, TOPICS APPL CHEM; PALAZZOTTO MC, 1989, J CHEM PHYS, V90, P3373, DOI 10.1063/1.455891; SAVEANT JM, 1988, J PHYS CHEM-US, V92, P1011, DOI 10.1021/j100316a003; WALLRAFF GM, 1992, J IMAGING SCI TECHN, V36, P468; WILLSON CG, 1986, J ELECTROCHEM SOC, V133, P181, DOI 10.1149/1.2108519	16	8	9	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 30	2002	297	5586					1516	1521		10.1126/science.1074583	http://dx.doi.org/10.1126/science.1074583			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588JA	12169657				2022-12-28	WOS:000177697300047
J	Koops, L; Lindley, RI				Koops, L; Lindley, RI			Thrombolysis for acute ischaemic stroke: consumer involvement in design of new randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							ACUTE ISCHEMIC STROKE; RECRUITMENT	Objectives To determine whether consumer involvement would help to solve some of the ethical problems associated with research into thrombolysis for acute ischaemic stroke, with its inherent risk of fatal intracranial haemorrhage. Design Quantitative and qualitative research. Setting and participants Consultation phase: three meetings were held to discuss the planned research, and participants completed a questionnaire. Qualitative work: focus group meetings explored the issues raised during the consultation phase. Design of information leaflets for patients and relatives: trial materials were drafted during the consultation phase and revised in the light of feedback from the focus group meetings and review by patients and caters on a stroke rehabilitation unit. Results 54 people attended the consultation meetings. Four (9%) participants considered the risks of thrombolysis too great, but most (89%) were prepared to accept the treatment in a clinical trial. Nearly all would accept treatment if it was shown to be effective. Most (85%) would give their consent to enter the planned trial. The focus group meetings and feedback from patients and carers led to significant changes in the information leaflets. The revised trial materials were considered ethical by a national multicentre research ethics committee. Conclusions Consumers generally supported a planned trial, and their involvement helped to refine trial consent procedures and led to an ethically acceptable trial design.	Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Lindley, RI (corresponding author), Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland.		Lindley, Richard/B-8148-2013	Lindley, Richard/0000-0002-0104-5679				APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; BAUM M, 1993, LANCET, V341, P812, DOI 10.1016/0140-6736(93)90573-Y; Entwistle VA, 1998, BRIT MED J, V316, P463, DOI 10.1136/bmj.316.7129.463; Gage BF, 1996, ARCH INTERN MED, V156, P1829, DOI 10.1001/archinte.156.16.1829; Hanley B, 2001, BRIT MED J, V322, P519, DOI 10.1136/bmj.322.7285.519; Lindley RI, 1998, BRIT MED J, V316, P1005, DOI 10.1136/bmj.316.7136.1005; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; SOLOMON NA, 1994, STROKE, V25, P1721, DOI 10.1161/01.STR.25.9.1721; THORNTON H, 1993, LANCET, V341, P795, DOI 10.1016/0140-6736(93)90568-2; Wardlaw JM, 1997, LANCET, V350, P607, DOI 10.1016/S0140-6736(97)03022-5; Wichman A, 1997, NEUROLOGY, V48, P1151, DOI 10.1212/WNL.48.5.1151	11	80	81	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 24	2002	325	7361					415	+		10.1136/bmj.325.7361.415	http://dx.doi.org/10.1136/bmj.325.7361.415			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588RY	12193356	Bronze, Green Published			2022-12-28	WOS:000177715500018
J	Zureik, M; Neukirch, C; Leynaert, B; Liard, R; Bousquet, L; Neukirch, F				Zureik, M; Neukirch, C; Leynaert, B; Liard, R; Bousquet, L; Neukirch, F		European Community Respiratory Hlt	Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SKIN-TEST REACTIVITY; YOUNG-ADULTS; RISK FACTOR; INDIVIDUAL ALLERGENS; LUNG-FUNCTION; CHILDREN; ASSOCIATION; SYMPTOMS; EXPOSURE; SENSITIZATION	Objective To assess whether the.. severity of asthma is associated with sensitisation to airborne moulds rather than to other seasonal or perennial allergens. Design Multicentre epidemiological survey in 30 centres. Setting European Community respiratory health survey. Participants 1132 adults. aged 20-44 years with current asthma and with skin prick test results. Main outcome measure Severity of asthma according to score based on forced expiratory volume in one second, number of asthma attacks, hospital admissions for breathing problems, and use of corticosteroids in past 12 months. Results The frequency of sensitisation to moulds (Alternaria alternata or Cladosporium herbarum, or both) increased significantly with increasing asthma severity (odds ratio 2.34 (95% confidence interval 1.56 to 3.52) for either for severe v mild asthma). This association existed in all of the study areas (gathered into regions), although there were differences in the frequency of sensitisation. There was no association between asthma severity and sensitisation to pollens or cats. Sensitisation to Dermatophagoides pteronyssinus was also positively associated with severity. In multivariable logistic regressions including sensitisation to moulds, pollens, D pteronyssinus, and cats simultaneously, the odds ratios for sensitisation to moulds were 1.48 (0.97 to 2.26) for moderate v mild asthma and 2.16 (1.37 to 3.35) for severe v mild asthma (P < 0.001 for trend)., Conclusions Sensitisation to moulds is a powerful risk factor for severe asthma in adults. This should be taken into account in primary prevention, management and patients' education.	Univ Paris 07, Natl Inst Hlth & Med Res, INSERM,U408, Unite Epidemiol, F-75870 Paris 18, France; Hop Arnaud Villeneuve, INSERM, U454, Natl Inst Hlth & Med Res, F-34295 Montpellier 05, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier	Zureik, M (corresponding author), Univ Paris 07, Natl Inst Hlth & Med Res, INSERM,U408, Unite Epidemiol, BP 416, F-75870 Paris 18, France.	zureik@vjf.inserrn.fr	Bucca, Caterina/C-9886-2009; Leynaert, Benedicte/N-5251-2018; Zureik, Mahmoud/F-7855-2018	Bucca, Caterina/0000-0002-9941-9236; Leynaert, Benedicte/0000-0001-5045-2492; Zureik, Mahmoud/0000-0002-8393-4217	NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR005521] Funding Source: NIH RePORTER; NCRR NIH HHS [2 S07 RR05521-28] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Wellcome Trust(Wellcome TrustEuropean Commission)		Black PN, 2000, ALLERGY, V55, P501, DOI 10.1034/j.1398-9995.2000.00293.x; Burney P, 1996, EUR RESPIR J, V9, P687; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; Chinn S, 1998, THORAX, V53, P662, DOI 10.1136/thx.53.8.662; Cockcroft DW, 1996, J ALLERGY CLIN IMMUN, V98, P1016, DOI 10.1016/S0091-6749(96)80185-0; Codina R, 1998, J ALLERGY CLIN IMMUN, V102, P318, DOI 10.1016/S0091-6749(98)70102-2; DesRoches A, 1997, J ALLERGY CLIN IMMUN, V99, P524, DOI 10.1016/S0091-6749(96)70085-4; *EUR COMM DIR GEN, 1993, PROT EUR COMM RESP H; Halonen M, 1997, AM J RESP CRIT CARE, V155, P1356, DOI 10.1164/ajrccm.155.4.9105079; HENDERSON FW, 1995, AM J RESP CRIT CARE, V151, P1786, DOI 10.1164/ajrccm.151.6.7767521; Hopkinson L., 1997, European Respiratory Journal Supplement, V10, p28S; INGRAM JM, 1995, J ALLERGY CLIN IMMUN, V96, P449, DOI 10.1016/S0091-6749(95)70286-5; Janson C, 1997, EUR RESPIR J, V10, P1795, DOI 10.1183/09031936.97.10081795; Janson C, 2001, EUR RESPIR J, V18, P598, DOI 10.1183/09031936.01.00205801; Jarvis D, 1998, EUR RESPIR J, V11, P651; Jarvis D, 1996, LANCET, V347, P426, DOI 10.1016/S0140-6736(96)90009-4; Liard R, 2000, EUR RESPIR J, V16, P615, DOI 10.1034/j.1399-3003.2000.16d08.x; *NAT HEART LUNG BL, 1995, NATL HEART LUNG BLOO; Neukirch C, 1999, J ALLERGY CLIN IMMUN, V103, P709, DOI 10.1016/S0091-6749(99)70247-2; Newson R, 1997, THORAX, V52, P680, DOI 10.1136/thx.52.8.680; OHOLLAREN MT, 1991, NEW ENGL J MED, V324, P359, DOI 10.1056/NEJM199102073240602; Peat JK, 1996, AM J RESP CRIT CARE, V153, P141, DOI 10.1164/ajrccm.153.1.8542107; POLLART SM, 1988, J ALLERGY CLIN IMMUN, V82, P224, DOI 10.1016/0091-6749(88)91003-2; Roca J, 1998, EUR RESPIR J, V11, P1354, DOI 10.1183/09031936.98.11061354; Ronchetti R, 1997, EUR RESPIR J, V10, P1248, DOI 10.1183/09031936.97.10061248; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Ross MA, 2000, ALLERGY, V55, P705, DOI 10.1034/j.1398-9995.2000.00551.x; SCHWARTZ J, 1995, AM J RESP CRIT CARE, V152, P2176, DOI 10.1164/ajrccm.152.6.8520794; SNELLER MR, 1981, ANN ALLERGY, V46, P30; SPORIK R, 1995, AM J RESP CRIT CARE, V151, P1388, DOI 10.1164/ajrccm.151.5.7735590; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; Sunyer J, 2000, INT J EPIDEMIOL, V29, P125, DOI 10.1093/ije/29.1.125; TARGONSKI PV, 1995, J ALLERGY CLIN IMMUN, V95, P955, DOI 10.1016/S0091-6749(95)70095-1	33	328	349	0	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 24	2002	325	7361					411	414		10.1136/bmj.325.7361.411	http://dx.doi.org/10.1136/bmj.325.7361.411			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588RY	12193354	Green Published, Bronze			2022-12-28	WOS:000177715500016
J	Dullmann, CE; Bruchle, W; Dressler, R; Eberhardt, K; Eichler, B; Eichler, R; Gaggeler, HW; Ginter, TN; Glaus, F; Gregorich, KE; Hoffman, DC; Jager, E; Jost, DT; Kirbach, UW; Lee, DM; Nitsche, H; Patin, JB; Pershina, V; Piguet, D; Qin, Z; Schadel, M; Schausten, B; Schimpf, E; Schott, HJ; Soverna, S; Sudowe, R; Thorle, P; Timokhin, SN; Trautmann, N; Turler, A; Vahle, A; Wirth, G; Yakushev, AB; Zielinski, PM				Dullmann, CE; Bruchle, W; Dressler, R; Eberhardt, K; Eichler, B; Eichler, R; Gaggeler, HW; Ginter, TN; Glaus, F; Gregorich, KE; Hoffman, DC; Jager, E; Jost, DT; Kirbach, UW; Lee, DM; Nitsche, H; Patin, JB; Pershina, V; Piguet, D; Qin, Z; Schadel, M; Schausten, B; Schimpf, E; Schott, HJ; Soverna, S; Sudowe, R; Thorle, P; Timokhin, SN; Trautmann, N; Turler, A; Vahle, A; Wirth, G; Yakushev, AB; Zielinski, PM			Chemical investigation of hassium (element 108)	NATURE			English	Article							ELECTRONIC-STRUCTURE; SEPARATION; DISCOVERY	The periodic table provides a classification of the chemical properties of the elements. But for the heaviest elements, the transactinides, this role of the periodic table reaches its limits because increasingly strong relativistic effects on the valence electron shells can induce deviations from known trends in chemical properties(1-4). In the case of the first two transactinides, elements 104 and 105, relativistic effects do indeed influence their chemical properties(5), whereas elements 106 and 107 both behave as expected from their position within the periodic table(6,7). Here we report the chemical separation and characterization of only seven detected atoms of element 108 (hassium, Hs), which were generated as isotopes (269)Hs (refs 8, 9) and (270)Hs (ref. 10) in the fusion reaction between Mg-26 and Cm-248. The hassium atoms are immediately oxidized to a highly volatile oxide, presumably HsO(4), for which we determine an enthalpy of adsorption on our detector surface that is comparable to the adsorption enthalpy determined under identical conditions for the osmium oxide OsO4. These results provide evidence that the chemical properties of hassium and its lighter homologue osmium are similar, thus confirming that hassium exhibits properties as expected from its position in group 8 of the periodic table.	Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland; Paul Scherrer Inst, Lab Radio & Umweltchem, CH-5232 Villigen, Switzerland; Gesell Schwerionenforsch mbH, D-64291 Darmstadt, Germany; Univ Mainz, Inst Kernchem, D-55128 Mainz, Germany; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Nucl Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Chinese Acad Sci, Inst Modern Phys, Lanzhou 730000, Peoples R China; Joint Inst Nucl Res, Flerov Lab Nucl React, Dubna 141980, Russia; Tech Univ Munich, Inst Radiochem, D-85748 Garching, Germany; Res Ctr Rossendorf eV, D-01314 Dresden, Germany	University of Bern; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; Johannes Gutenberg University of Mainz; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Chinese Academy of Sciences; Institute of Modern Physics, CAS; Joint Institute for Nuclear Research - Russia; Technical University of Munich	Gaggeler, HW (corresponding author), Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland.		Türler, Andreas/D-3913-2014; Düllmann, Christoph E/L-3401-2017; Eichler, Robert/G-5130-2011	Türler, Andreas/0000-0002-4274-1056; Düllmann, Christoph E/0000-0002-1194-0423; Eichler, Robert/0000-0002-6690-7284				Domanov V. P., 1984, RADIOKHIMIYA, V26, P770; DOMANOV VP, 1985, SOV RADIOCHEM, V26, P731; DOUGAN RJ, 1987, 1006287 UCAR, P4; Dullmann CE, 2002, NUCL INSTRUM METH A, V479, P631, DOI 10.1016/S0168-9002(01)00898-1; Dullmann CE, 2002, J PHYS CHEM B, V106, P6679, DOI 10.1021/jp0257146; Eichler R, 2000, NATURE, V407, P63, DOI 10.1038/35024044; FRICKE B, 1975, STRUCT BOND, V21, P90; HOFMANN S, 1995, Z PHYS A-HADRON NUCL, V350, P277, DOI 10.1007/BF01291181; Hofmann S, 2000, REV MOD PHYS, V72, P733, DOI 10.1103/RevModPhys.72.733; Hofmann S, 1996, Z PHYS A-HADRON NUCL, V354, P229, DOI 10.1007/s002180050036; Kirbach UW, 2002, NUCL INSTRUM METH A, V484, P587, DOI 10.1016/S0168-9002(01)01990-8; KRATZ JV, 1999, HEAVY ELEMENTS RELAT, P129; Malmbeck R, 2001, RADIOCHIM ACTA, V89, P543, DOI 10.1524/ract.2001.89.9.543; MUNZENBERG G, 1984, Z PHYS A-HADRON NUCL, V317, P235, DOI 10.1007/BF01421260; Pershina V, 2001, J CHEM PHYS, V115, P792, DOI 10.1063/1.1379579; Pershina VG, 1996, CHEM REV, V96, P1977, DOI 10.1021/cr941182g; PYYKKO P, 1979, ACCOUNTS CHEM RES, V12, P276, DOI 10.1021/ar50140a002; Schadel M, 1996, J RADIOAN NUCL CH AR, V203, P283, DOI 10.1007/BF02041512; Schadel M, 1997, NATURE, V388, P55, DOI 10.1038/40375; Schwerdtfeger P, 1998, ENCY COMPUTATIONAL C, V4, P2480; TURLER A, UNPUB EUR PHYS J A; ZHUIKOV BL, 1986, P786322 JOINT I NUCL, P26; ZUDE E, 1993, RADIOCHIM ACTA, V62, P61; ZVARA I, 1990, ISOTOPENPRAXIS, V26, P251, DOI 10.1080/10256019008624294; Zvara I., 1985, RADIOCHIM ACTA, V38, P95, DOI DOI 10.1524/RACT.1985.38.2.95	25	196	200	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2002	418	6900					859	862		10.1038/nature00980	http://dx.doi.org/10.1038/nature00980			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192405				2022-12-28	WOS:000177555600033
J	Moake, JL				Moake, JL			Mechanisms of disease - Thrombotic microangiopathies	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HEMOLYTIC-UREMIC SYNDROME; VON-WILLEBRAND-FACTOR; FACTOR-CLEAVING PROTEASE; FACTOR-H DEFICIENCY; INDUCED PLATELET-AGGREGATION; BONE-MARROW TRANSPLANTATION; INTESTINAL EPITHELIAL-CELLS; THROMBOCYTOPENIC PURPURA; ESCHERICHIA-COLI; SHIGA TOXIN-1		Baylor Coll Med, Houston, TX 77030 USA; Rice Univ, Houston, TX 77251 USA	Baylor College of Medicine; Rice University	Moake, JL (corresponding author), Methodist Hosp, Hematol Oncol Sect, MS 902,Main Bldg,6565 Fannin, Houston, TX 77030 USA.				NHLBI NIH HHS [1P50 HL 65967] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL065967] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adler S, 1998, KIDNEY BLOOD PRESS R, V21, P13, DOI 10.1159/000025838; ALEVRIADOU BR, 1993, BLOOD, V81, P1263; Allford SL, 2000, BRIT J HAEMATOL, V111, P1215, DOI 10.1046/j.1365-2141.2000.02503.x; AMOROSI EL, 1966, MEDICINE, V45, P139, DOI 10.1097/00005792-196603000-00003; Arya M, 2002, BLOOD, V99, P3971, DOI 10.1182/blood-2001-11-0060; ASADA Y, 1985, THROMB RES, V38, P469, DOI 10.1016/0049-3848(85)90180-X; Banatvala N, 2001, J INFECT DIS, V183, P1063, DOI 10.1086/319269; Barbot J, 2001, BRIT J HAEMATOL, V113, P649, DOI 10.1046/j.1365-2141.2001.02808.x; BELL WR, 1991, NEW ENGL J MED, V325, P398, DOI 10.1056/NEJM199108083250605; Bennett CL, 2000, NEW ENGL J MED, V342, P1773, DOI 10.1056/NEJM200006153422402; Bennett CL, 1998, ANN INTERN MED, V128, P541, DOI 10.7326/0003-4819-128-7-199804010-00004; BYRNES JJ, 1986, CLIN HAEMATOL, V15, P413; Byun Y, 2001, VACCINE, V19, P2061, DOI 10.1016/S0264-410X(00)00411-4; Caprioli J, 2001, J AM SOC NEPHROL, V12, P297, DOI 10.1681/ASN.V122297; Chandler WL, 2002, NEW ENGL J MED, V346, P715; Chandler WL, 2002, NEW ENGL J MED, V346, P23, DOI 10.1056/NEJMoa011033; Chow TW, 1998, AM J HEMATOL, V57, P293, DOI 10.1002/(SICI)1096-8652(199804)57:4<293::AID-AJH5>3.3.CO;2-R; CLEARY TG, 1988, PEDIATR CLIN N AM, V35, P485; Cohen JA, 1998, J CLIN APHERESIS, V13, P16, DOI 10.1002/(SICI)1098-1101(1998)13:1<16::AID-JCA3>3.0.CO;2-C; Crowther MA, 1996, ANN INTERN MED, V125, P294, DOI 10.7326/0003-4819-125-4-199608150-00006; Deschenes G, 1996, PEDIATR NEPHROL, V10, P203; Dong JF, 2001, BLOOD, V98, p752A; Eisenhauer PB, 2001, INFECT IMMUN, V69, P1889, DOI 10.1128/IAI.69.3.1889-1894.2001; FITZPATRICK MM, 1992, KIDNEY INT, V42, P951, DOI 10.1038/ki.1992.372; Foster GH, 2002, J LEUKOCYTE BIOL, V71, P107; FRANGOS JA, 1989, AM J PHYSIOL, V256, pH1635, DOI 10.1152/ajpheart.1989.256.6.H1635; Fujikawa K, 2001, BLOOD, V98, P1662, DOI 10.1182/blood.V98.6.1662; Furlan M, 1999, THROMB HAEMOSTASIS, V81, P8; Furlan M, 1997, BLOOD, V89, P3097, DOI 10.1182/blood.V89.9.3097; Furlan M, 1998, BLOOD, V91, P2839, DOI 10.1182/blood.V91.8.2839.2839_2839_2846; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; Furlan M, 2001, BEST PRACT RES CL HA, V14, P437, DOI 10.1053/beha.2001.0142; GASSER C, 1955, Schweiz Med Wochenschr, V85, P905; George JN, 2000, BLOOD, V96, P1223, DOI 10.1182/blood.V96.4.1223.h8001223_1223_1229; Gerritsen HE, 2001, BLOOD, V98, P1654, DOI 10.1182/blood.V98.6.1654; GOTTSCHALL JL, 1991, BLOOD, V77, P306; Grif K, 1998, EUR J CLIN MICROBIOL, V17, P761, DOI 10.1007/s100960050181; GUTTERMAN LA, 1982, JAMA-J AM MED ASSOC, V247, P1433, DOI 10.1001/jama.247.10.1433; HARKNESS DR, 1981, JAMA-J AM MED ASSOC, V246, P1931, DOI 10.1001/jama.246.17.1931; Hughes AK, 1998, KIDNEY INT, V54, P426, DOI 10.1046/j.1523-1755.1998.00015.x; Hughes AK, 2001, NEPHRON, V88, P14, DOI 10.1159/000045953; KAPLAN BS, 1987, SEMIN HEMATOL, V24, P148; KARMALI MA, 1985, J INFECT DIS, V151, P775, DOI 10.1093/infdis/151.5.775; Karpman D, 2001, BLOOD, V97, P3100, DOI 10.1182/blood.V97.10.3100; Kiyokawa N, 1998, J INFECT DIS, V178, P178, DOI 10.1086/515592; Kojouri K, 2001, ANN INTERN MED, V135, P1047, DOI 10.7326/0003-4819-135-12-200112180-00008; Konstantopoulos K, 1997, BIORHEOLOGY, V34, P57, DOI 10.1016/S0006-355X(97)00004-8; KOREC S, 1986, J CLIN ONCOL, V4, P210, DOI 10.1200/JCO.1986.4.2.210; Landau D, 2001, J PEDIATR-US, V138, P412, DOI 10.1067/mpd.2001.112649; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; LINDBERG AA, 1987, J BIOL CHEM, V262, P1779; Mannucci PM, 2001, BLOOD, V98, P2730, DOI 10.1182/blood.V98.9.2730; MILFORD D, 1989, LANCET, V2, P1153; MISIANI R, 1982, BRIT MED J, V285, P1304, DOI 10.1136/bmj.285.6351.1304; MOAKE J, 1994, BLOOD, V84, P490; Moake JL, 1996, HEMATOL ONCOL CLIN N, V10, P485, DOI 10.1016/S0889-8588(05)70348-8; MOAKE JL, 1994, LANCET, V343, P393, DOI 10.1016/S0140-6736(94)91227-0; MOAKE JL, 1982, NEW ENGL J MED, V307, P1432, DOI 10.1056/NEJM198212023072306; MOAKE JL, 1986, J CLIN INVEST, V78, P1456, DOI 10.1172/JCI112736; MOAKE JL, 1989, AM J MED, V87, P3; Moghal NE, 1998, J PEDIATR-US, V133, P220, DOI 10.1016/S0022-3476(98)70223-9; Morigi M, 2001, BLOOD, V98, P1828, DOI 10.1182/blood.V98.6.1828; Moschcowitz E., 1924, P NY PATHOL SOC, V24, P21; Muller T, 1998, CLIN NEPHROL, V49, P82; NEAME PB, 1980, SEMIN THROMB HEMOST, V6, P416, DOI 10.1055/s-2007-1005113; Noris M, 1999, J AM SOC NEPHROL, V10, P281; Obrig TG, 1992, HEMOLYTIC UREMIC SYN, P405; Ogborn MR, 1998, PEDIATR NEPHROL, V12, P485, DOI 10.1007/s004670050493; Ohali M, 1998, PEDIATR NEPHROL, V12, P619, DOI 10.1007/s004670050515; Oleksowicz L, 1999, CANCER RES, V59, P2244; Perez-Caballero D, 2001, AM J HUM GENET, V68, P478, DOI 10.1086/318201; Pruimboom-Brees IM, 2000, P NATL ACAD SCI USA, V97, P10325, DOI 10.1073/pnas.190329997; Ray PE, 2001, PEDIATR NEPHROL, V16, P823, DOI 10.1007/s004670100660; Richards A, 2001, AM J HUM GENET, V68, P485, DOI 10.1086/318203; ROCK GA, 1991, NEW ENGL J MED, V325, P393, DOI 10.1056/NEJM199108083250604; ROSOVE MH, 1982, ANN INTERN MED, V96, P27, DOI 10.7326/0003-4819-96-1-27; Rougier N, 1998, J AM SOC NEPHROL, V9, P2318; Ruggeri ZM, 2000, THROMB HAEMOSTASIS, V84, P147; Savasan S, 2001, J PEDIAT HEMATOL ONC, V23, P364, DOI 10.1097/00043426-200108000-00008; SHETH KJ, 1988, CHILD NEPHROL UROL, V89, P38; SHUMAK KH, 1995, ANN INTERN MED, V122, P569, DOI 10.7326/0003-4819-122-8-199504150-00002; Siegler RL, 2001, J AM SOC NEPHROL, V12, P1458, DOI 10.1681/ASN.V1271458; Siegler RL, 2001, AM J NEPHROL, V21, P420, DOI 10.1159/000046288; Simon M, 1998, KIDNEY INT, V54, P1117, DOI 10.1046/j.1523-1755.1998.00085.x; Singh N, 1996, TRANSPLANT INT, V9, P68, DOI 10.1007/BF00336815; TANDON NN, 1994, BRIT J HAEMATOL, V88, P816, DOI 10.1111/j.1365-2141.1994.tb05122.x; Taylor CM, 2001, SEMIN THROMB HEMOST, V27, P185, DOI 10.1055/s-2001-15247; THOMPSON CE, 1992, BLOOD, V80, P1890; Thorpe CM, 1999, INFECT IMMUN, V67, P5985, DOI 10.1128/IAI.67.11.5985-5993.1999; Thorpe CM, 2001, INFECT IMMUN, V69, P6140, DOI 10.1128/IAI.69.10.6140-6147.2001; Tsai HM, 2000, AM J HEMATOL, V65, P251, DOI 10.1002/1096-8652(200011)65:3<251::AID-AJH13>3.0.CO;2-2; Tsai HM, 2000, ANN INTERN MED, V132, P794, DOI 10.7326/0003-4819-132-10-200005160-00005; TSAI HM, 1994, BLOOD, V83, P2171; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Tsai HM, 1996, BLOOD, V87, P4235, DOI 10.1182/blood.V87.10.4235.bloodjournal87104235; Tsai HM, 2001, PEDIATR RES, V49, P653, DOI 10.1203/00006450-200105000-00008; Uchida H, 1999, PEDIATR RES, V45, P133, DOI 10.1203/00006450-199901000-00022; van der Plas RM, 1999, BLOOD, V93, P3798, DOI 10.1182/blood.V93.11.3798.411k07_3798_3802; Van Setten PA, 1998, PEDIATR RES, V43, P759, DOI 10.1203/00006450-199806000-00008; Veyradier A, 2001, BLOOD, V98, P1765, DOI 10.1182/blood.V98.6.1765; WALTERS MDS, 1989, PEDIATR NEPHROL, V3, P130, DOI 10.1007/BF00852893; Warwicker P, 1999, NEPHROL DIAL TRANSPL, V14, P1229, DOI 10.1093/ndt/14.5.1229; Warwicker P, 1998, KIDNEY INT, V53, P836, DOI 10.1111/j.1523-1755.1998.00824.x; Williams JM, 1999, TOXICOL LETT, V105, P47, DOI 10.1016/S0378-4274(98)00383-X; Xie LJ, 2001, J EXP MED, V193, P1341, DOI 10.1084/jem.193.12.1341; Zheng XL, 2001, J BIOL CHEM, V276, P41059, DOI 10.1074/jbc.C100515200; Zipfel PF, 2001, TRENDS IMMUNOL, V22, P345, DOI 10.1016/S1471-4906(01)01972-X	108	953	1027	1	27	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 22	2002	347	8					589	600		10.1056/NEJMra020528	http://dx.doi.org/10.1056/NEJMra020528			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587ZR	12192020				2022-12-28	WOS:000177675400009
J	Rannou, P; Hourdin, F; McKay, CP				Rannou, P; Hourdin, F; McKay, CP			A wind origin for Titan's haze structure	NATURE			English	Article							GENERAL-CIRCULATION; ATMOSPHERE; AEROSOLS; MODEL; OCCULTATION; SCATTERING; GROWTH	Titan, the largest moon of Saturn, is the only satellite in the Solar System with a dense atmosphere. Titan's atmosphere is mainly nitrogen with a surface pressure of 1.5 atmospheres and a temperature of 95 K (ref. 1). A seasonally varying(2) haze, which appears to be the main source of heating and cooling that drives atmospheric circulation(3,4), shrouds the moon. The haze has numerous features that have remained unexplained. There are several layers(5), including a 'polar hood'(6-8), and a pronounced hemispheric asymmetry(2). The upper atmosphere rotates much faster than the surface of the moon(9,10), and there is a significant latitudinal temperature asymmetry at the equinoxes(11,12). Here we describe a numerical simulation of Titan's atmosphere, which appears to explain the observed features of the haze. The critical new factor in our model is the coupling of haze formation with atmospheric dynamics, which includes a component of strong positive feedback between the haze and the winds.	Univ Paris 06 Univ Versailles St Quentin, Serv Aeron, F-75252 Paris, France; Univ Paris 06, Meteorol Dynam Lab, F-75252 Paris, France; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Rannou, P (corresponding author), Univ Paris 06 Univ Versailles St Quentin, Serv Aeron, B102,4 Pl Jussieu, F-75252 Paris, France.	pra@ccr.jussieu.fr	RANNOU, Pascal/I-9059-2012	RANNOU, pascal/0000-0003-0836-723X				ALLEN M, 1980, ASTROPHYS J, V242, pL125, DOI 10.1086/183416; CABANE M, 1993, PLANET SPACE SCI, V41, P257, DOI 10.1016/0032-0633(93)90021-S; CABANE M, 1992, ICARUS, V96, P176, DOI 10.1016/0019-1035(92)90071-E; COUSTENIS A, 1995, ICARUS, V115, P126, DOI 10.1006/icar.1995.1084; Coustenis A, 2001, ICARUS, V154, P501, DOI 10.1006/icar.2001.6643; DANIELSON RE, 1973, ICARUS, V20, P437, DOI 10.1016/0019-1035(73)90016-X; FLASAR FM, 1990, ICARUS, V85, P346, DOI 10.1016/0019-1035(90)90122-P; HOURDIN F, 1995, ICARUS, V117, P358, DOI 10.1006/icar.1995.1162; HUBBARD WB, 1993, ASTRON ASTROPHYS, V269, P541; HUTZELL WT, 1993, ICARUS, V105, P162, DOI 10.1006/icar.1993.1116; Hutzell WT, 1996, ICARUS, V119, P112, DOI 10.1006/icar.1996.0005; KHARE BN, 1984, ICARUS, V60, P127, DOI 10.1016/0019-1035(84)90142-8; Kostiuk T, 2001, GEOPHYS RES LETT, V28, P2361, DOI 10.1029/2000GL012617; KUNDE VG, 1981, NATURE, V292, P686, DOI 10.1038/292686a0; Lebonnois S, 2001, ICARUS, V152, P384, DOI 10.1006/icar.2001.6632; LELLOUCH E, 1989, ICARUS, V79, P328, DOI 10.1016/0019-1035(89)90081-X; MAGUIRE WC, 1981, NATURE, V292, P683, DOI 10.1038/292683a0; MCKAY CP, 1991, SCIENCE, V253, P1118, DOI 10.1126/science.11538492; MCKAY CP, 1989, ICARUS, V80, P23, DOI 10.1016/0019-1035(89)90160-7; POLLACK JB, 1980, GEOPHYS RES LETT, V7, P829, DOI 10.1029/GL007i010p00829; RAGES K, 1983, ICARUS, V55, P50, DOI 10.1016/0019-1035(83)90049-0; Rannou P, 1999, PLANET SPACE SCI, V47, P385, DOI 10.1016/S0032-0633(99)00007-0; RANNOU P, 1993, GEOPHYS RES LETT, V20, P967, DOI 10.1029/93GL00911; Samuelson RE, 1997, PLANET SPACE SCI, V45, P941, DOI 10.1016/S0032-0633(97)00088-3; SROMOVSKY LA, 1981, NATURE, V292, P698, DOI 10.1038/292698a0; Tokano T, 1999, PLANET SPACE SCI, V47, P493, DOI 10.1016/S0032-0633(99)00011-2; TOON OB, 1992, ICARUS, V95, P24, DOI 10.1016/0019-1035(92)90188-D; Young EF, 2002, ASTRON J, V123, P3473, DOI 10.1086/339826	28	96	96	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 22	2002	418	6900					853	856		10.1038/nature00961	http://dx.doi.org/10.1038/nature00961			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192403				2022-12-28	WOS:000177555600031
J	Steinbrook, R				Steinbrook, R			Beyond Barcelona - The global response to HIV	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	5	6	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 22	2002	347	8					553	554		10.1056/NEJMp020094	http://dx.doi.org/10.1056/NEJMp020094			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587ZR	12192013				2022-12-28	WOS:000177675400002
J	Forrest, CB; Majeed, A; Weiner, JP; Carroll, K; Bindman, AB				Forrest, CB; Majeed, A; Weiner, JP; Carroll, K; Bindman, AB			Comparison of specialty referral rates in the United Kingdom and the United States: retrospective cohort analysis	BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE		Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Johns Hopkins Med Inst, Dept Hlth Policy & Management,Hlth Serv Res & Dev, Baltimore, MD 21205 USA; UCL, Sch Publ Policy, London WC1H 9QU, England; Off Natl Stat, London SW1V 2QU, England; Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA 94143 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Medicine; University of London; University College London; University of California System; University of California San Francisco	Forrest, CB (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Johns Hopkins Med Inst, Dept Hlth Policy & Management,Hlth Serv Res & Dev, 624 N Broadway,Room 689, Baltimore, MD 21205 USA.	cforrest@jhsph.edu	Forrest, Christopher/CAF-1379-2022	Forrest, Christopher/0000-0003-1252-068X; Majeed, Azeem/0000-0002-2357-9858				Donelan K, 1999, HEALTH AFFAIR, V18, P206, DOI 10.1377/hlthaff.18.3.206; *J HOPK U, 2002, ACG CAS MIX SYST; Lawson DH, 1998, QJM-MON J ASSOC PHYS, V91, P445, DOI 10.1093/qjmed/91.6.445; MCCOLL E, 1994, BRIT J GEN PRACT, V44, P157; Stoddard J, 1998, HEALTH AFFAIR, V17, P252, DOI 10.1377/hlthaff.17.1.252	5	54	56	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 17	2002	325	7360					370	371		10.1136/bmj.325.7360.370	http://dx.doi.org/10.1136/bmj.325.7360.370			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587DV	12183310	Green Published, Bronze			2022-12-28	WOS:000177626000022
J	Fedoroff, N; Fontana, W				Fedoroff, N; Fontana, W			Genetic networks: Small numbers of big molecules	SCIENCE			English	Editorial Material							EVOLUTION; NOISE		Penn State Univ, University Pk, PA 16803 USA; Santa Fe Inst, Santa Fe, NM 87501 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; The Santa Fe Institute	Fedoroff, N (corresponding author), Penn State Univ, University Pk, PA 16803 USA.	nvf1@psu.edu; walter@santafe.edu						Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; BIRD A, 1995, PHILOS T ROY SOC B, V349, P249, DOI 10.1098/rstb.1995.0109; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fedoroff N, 2000, P NATL ACAD SCI USA, V97, P7002, DOI 10.1073/pnas.97.13.7002; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Palsson E, 1996, P NATL ACAD SCI USA, V93, P1151, DOI 10.1073/pnas.93.3.1151; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; VANPUTTE P, 1992, TRENDS GENET, V8, P457; Wagner A, 2000, NAT GENET, V24, P355, DOI 10.1038/74174; 2002, NY TIMES        0717, P1	13	111	114	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2002	297	5584					1129	1131		10.1126/science.1075988	http://dx.doi.org/10.1126/science.1075988			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183614				2022-12-28	WOS:000177447600031
J	Rockoff, A				Rockoff, A			Vanity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2002	288	6					677	677		10.1001/jama.288.6.677	http://dx.doi.org/10.1001/jama.288.6.677			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	583KY	12169046				2022-12-28	WOS:000177408100001
J	Wood, RA				Wood, RA			Pediatric asthma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INHALED BUDESONIDE; CHILDHOOD; INFECTIONS; PREVALENCE; CHILDREN; ALLERGY		Johns Hopkins Univ, Sch Med, Dept Pediat, Div Allergy & Immunol, Baltimore, MD 21205 USA	Johns Hopkins University	Wood, RA (corresponding author), Johns Hopkins Univ Hosp, CMSC 1102, 600 N Wolfe St, Baltimore, MD 21287 USA.	rwood@jhmi.edu						Agertoft L, 2000, NEW ENGL J MED, V343, P1064, DOI 10.1056/NEJM200010123431502; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Bodner C, 1998, THORAX, V53, P28, DOI 10.1136/thx.53.1.28; Bousquet J., 1998, Allergy (Copenhagen), V53, P1; *CHILDH ASTHM MAN, 2000, NEW ENGLAND J MED, V0343; Diaz-Sanchez D, 2000, IMMUNOLOGY, V101, P11, DOI 10.1046/j.1365-2567.2000.00108.x; HAAHTELA T, 1994, NEW ENGL J MED, V331, P700, DOI 10.1056/NEJM199409153311103; HAAHTELA T, 1991, NEW ENGL J MED, V325, P388, DOI 10.1056/NEJM199108083250603; *I MED, 2000, CLEAR AIR ASTHM IND, P223; Mannino D M, 1998, MMWR CDC Surveill Summ, V47, P1; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; MARTINEZ FD, 1995, AM J RESP CRIT CARE, V151, P1644, DOI 10.1164/ajrccm.151.5.7735627; MASSEY IT, 1989, DHHS PUBLICATION; *NAT CTR HLTH STAT, 1994, DHHS PUBL; *NAT CTR HLTH STAT, 1996, US VIT STAT; *NIH, 1997, NIH PUBL; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Platts-Mills TAE, 2000, J ALLERGY CLIN IMMUN, V105, pS503, DOI 10.1016/S0091-6749(00)90051-4; Sharek PJ, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.1.e8; SIMONS WR, 1997, DHEW PUBLICATION; Sly RM, 1999, ANN ALLERG ASTHMA IM, V82, P233, DOI 10.1016/S1081-1206(10)62603-8; Smith DH, 1997, AM J RESP CRIT CARE, V156, P787, DOI 10.1164/ajrccm.156.3.9611072; Strannegard O, 2001, ALLERGY, V56, P91, DOI 10.1034/j.1398-9995.2001.056002091.x; vonMutius E, 1996, THORAX, V51, pS3, DOI 10.1136/thx.51.Suppl_1.S3; Warner JO, 1998, PEDIATR PULM, V25, P1; WEISS KB, 1992, CHEST, V101, pS362, DOI 10.1378/chest.101.6_Supplement.362S	26	22	22	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2002	288	6					745	747		10.1001/jama.288.6.745	http://dx.doi.org/10.1001/jama.288.6.745			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	583KY	12169079				2022-12-28	WOS:000177408100036
J	Bass, C; May, S				Bass, C; May, S			ABC of psychological medicine - Chronic multiple functional somatic symptoms	BRITISH MEDICAL JOURNAL			English	Review									John Radcliffe Hosp, Dept Psychol Med, Oxford OX3 9DU, England; Stockwell Grp Practice, London, England	University of Oxford	Bass, C (corresponding author), John Radcliffe Hosp, Dept Psychol Med, Oxford OX3 9DU, England.							BASS C, 1996, PRESCRIBERS J, V36, P198; Dixon DM, 1999, BRIT J GEN PRACT, V49, P309; Fink P, 2002, PSYCHOSOMATICS, V43, P93, DOI 10.1176/appi.psy.43.2.93; Smith GR, 1995, TREATMENT OF FUNCTIONAL SOMATIC SYMPTOMS, P175; TATE P, 1994, DOCTORS COMMUNICATIO	5	25	25	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 10	2002	325	7359					323	326		10.1136/bmj.325.7359.323	http://dx.doi.org/10.1136/bmj.325.7359.323			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	584RQ	12169511	Green Published			2022-12-28	WOS:000177482500022
J	Morimoto, RI				Morimoto, RI			Dynamic remodeling of transcription complexes by molecular chaperones	CELL			English	Review							RECEPTOR; HSP90; P23; PROTEIN	The assembly and disassembly of macromolecular transcription complexes represents a key step in the regulation of gene expression. For inducible responses to hormones and stress, different combinations of molecular chaperones govern the activities of intracellular hormone receptors and heat shock transcription factor. Through their capacity to remodel the conformation of these activators, chaperones ensure tight control, dynamic range, and rapid reversible transcriptional response.	Northwestern Univ, Rice Inst Biomed Res, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Morimoto, RI (corresponding author), Northwestern Univ, Rice Inst Biomed Res, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA.				NIGMS NIH HHS [R37 GM038109] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAMSKY S, 1992, THEORET COMPUT SCI, V111, P3; Arbeitman MN, 2000, CELL, V101, P67, DOI 10.1016/S0092-8674(00)80624-8; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Davies TH, 2002, J BIOL CHEM, V277, P4597, DOI 10.1074/jbc.C100531200; Donze O, 2001, EMBO J, V20, P3771, DOI 10.1093/emboj/20.14.3771; Freeman BC, 2000, GENE DEV, V14, P422; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; Guo YL, 2001, J BIOL CHEM, V276, P45791, DOI 10.1074/jbc.M105931200; Hernandez MP, 2002, J BIOL CHEM, V277, P11873, DOI 10.1074/jbc.M111445200; Kosano H, 1998, J BIOL CHEM, V273, P32973, DOI 10.1074/jbc.273.49.32973; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morishima Y, 2000, J BIOL CHEM, V275, P18054, DOI 10.1074/jbc.M000434200; Nollen EAA, 2002, J CELL SCI, V115, P2809; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Song JW, 2001, NAT CELL BIOL, V3, P276, DOI 10.1038/35060068; Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930	20	147	165	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 9	2002	110	3					281	284		10.1016/S0092-8674(02)00860-7	http://dx.doi.org/10.1016/S0092-8674(02)00860-7			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	583MN	12176314	Bronze			2022-12-28	WOS:000177411800003
J	Storgaard, L; Bonde, JP; Ernst, E; Andersen, CY; Kyvik, KO; Olsen, J				Storgaard, L; Bonde, JP; Ernst, E; Andersen, CY; Kyvik, KO; Olsen, J			Effect of prenatal exposure to oestrogen on quality of semen: comparison of twins and singleton brothers	BRITISH MEDICAL JOURNAL			English	Article							ESTROGENS		Aarhus Univ Hosp, Dept Occupat Med, DK-8000 Aarhus, Denmark; Aarhus Univ, Inst Anat, Lab Reprod, DK-8000 Aarhus, Denmark; Aarhus Univ, Danish Epidemiol Sci Ctr, DK-8000 Aarhus, Denmark; Univ Copenhagen Hosp, Reprod Biol Lab, DK-2100 Copenhagen, Denmark; Danish Twin Registry, Inst Community Hlth, DK-5000 Odense, Denmark; Ctr Hlth & Social Policy, DK-5000 Odense, Denmark	Aarhus University; Aarhus University; Aarhus University; University of Copenhagen; University of Southern Denmark	Storgaard, L (corresponding author), Aarhus Univ Hosp, Dept Occupat Med, DK-8000 Aarhus, Denmark.		; Kyvik, Kirsten Ohm/K-5680-2016	Andersen, Claus Yding/0000-0001-7681-253X; Storgaard, Lone/0000-0002-9364-6497; Kyvik, Kirsten Ohm/0000-0003-2981-0245				Daston GP, 1997, REPROD TOXICOL, V11, P465, DOI 10.1016/S0890-6238(97)00014-2; GILL WB, 1979, J UROLOGY, V122, P36, DOI 10.1016/S0022-5347(17)56240-0; JOHNSON MR, 1993, HUM REPROD, V8, P1496, DOI 10.1093/oxfordjournals.humrep.a138286; KAPPEL B, 1985, ACTA GENET MED GEMEL, V34, P59, DOI 10.1017/S000156600000492X; SHARPE RM, 1993, LANCET, V341, P1392, DOI 10.1016/0140-6736(93)90953-E	5	12	12	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 3	2002	325	7358					252	253		10.1136/bmj.325.7358.252	http://dx.doi.org/10.1136/bmj.325.7358.252			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582FL	12153922	Green Published, Bronze			2022-12-28	WOS:000177339000019
J	DeSimone, JM				DeSimone, JM			Practical approaches to green solvents	SCIENCE			English	Article							SUPERCRITICAL CARBON-DIOXIDE; ORGANIC-COMPOUNDS; SEPARATION; WATER; HYDROFORMYLATION; POLYMERIZATIONS; FLUOROPOLYMERS; PRECIPITATION; HYDROGENATION; COMPLEXES	Solvents are widely used in commercial manufacturing and service industries. Despite abundant precaution, they inevitably contaminate our air, land, and water because they are difficult to contain and recycle. Researchers have therefore focused on reducing solvent use through the development of solvent-free processes and more efficient recycling protocols. However, these approaches have their limitations, necessitating a pollution prevention approach and the search for environmentally benign solvent alternatives. This report highlights opportunities for the practical implementation of such green solvents.	Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; N Carolina State Univ, Dept Chem Engn, Raleigh, NC 27695 USA; Micell Technol, Raleigh, NC 27613 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University	DeSimone, JM (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.							Abdul-Sada AK, 1995, World Pat., Patent No. [WO 95 21806, 9521806]; Anastas P. T., 1998, GREEN CHEM THEORY PR; ANASTAS PT, 1994, ACS SYM SER, V677, P2; BAGALA JM, 2001, Patent No. 6325846; Balbuena PB, 1998, J PHYS CHEM B, V102, P3806, DOI 10.1021/jp972870h; Balema VP, 2002, J AM CHEM SOC, V124, P6244, DOI 10.1021/ja017908p; Behles JA, 2001, PURE APPL CHEM, V73, P1281, DOI 10.1351/pac200173081281; BERNDT WR, 2000, Patent No. 6056789; Blanchard L. A., 1999, NATURE, V28, P399; Breslow R, 1998, GREEN CHEMISTRY, P225; Butler R, 2001, ADV MATER, V13, P1459, DOI 10.1002/1521-4095(200110)13:19<1459::AID-ADMA1459>3.0.CO;2-K; Carlson R.L., 1962, SILENT SPRING; Charpentier PA, 1999, MACROMOLECULES, V32, P5973, DOI 10.1021/ma990377t; CHAUVIN Y, 1996, ANGEW CHEM INT EDIT, V34, P2698; Curran DP, 2001, SYNLETT, P1488; Curran DP, 2000, PURE APPL CHEM, V72, P1649, DOI 10.1351/pac200072091649; Curran DP, 1998, ANGEW CHEM INT EDIT, V37, P1175, DOI 10.1002/(SICI)1521-3773(19980518)37:9<1174::AID-ANIE1174>3.0.CO;2-P; DESIMONE JM, 1992, SCIENCE, V257, P945, DOI 10.1126/science.257.5072.945; DESIMONE JM, 1999, Patent No. 5944996; DESIMONE JM, 2001, Patent No. 6001418; DeSimone L.D., 2000, ECOEFFICIENCY BUSINE; DeVito SC, 1996, ACS SYM SER, V640, P16; DIXON DJ, 1993, AICHE J, V39, P127, DOI 10.1002/aic.690390113; Dolman SJ, 2002, J AM CHEM SOC, V124, P6991, DOI 10.1021/ja012534l; *EPA MAN, 1996, RPA625R96004 US EPA; *EPA NAT EMM STAND, 1993, 1993 EC IMP AN HAL S; FOX DW, 1964, Patent No. 3153008; Hitzler MG, 1997, CHEM COMMUN, P1667, DOI 10.1039/a704371f; HORVATH IT, 1994, SCIENCE, V266, P72, DOI 10.1126/science.266.5182.72; Horvath IT, 1998, ACCOUNTS CHEM RES, V31, P641, DOI 10.1021/ar970342i; JESSOP PG, 1994, J AM CHEM SOC, V116, P8851, DOI 10.1021/ja00098a072; JESSOP PG, 1999, CHEM SYNTHESIS USING; Kendall JL, 1999, CHEM REV, V99, P543, DOI 10.1021/cr9700336; Krocher O, 1997, CHEM COMMUN, P453, DOI 10.1039/a608150i; LI CJ, 1993, CHEM REV, V93, P2023, DOI 10.1021/cr00022a004; Lo WJ, 2000, J BIOMED MATER RES, V50, P536, DOI 10.1002/(SICI)1097-4636(20000615)50:4<536::AID-JBM9>3.3.CO;2-L; Luo ZY, 2001, SCIENCE, V291, P1766, DOI 10.1126/science.1057567; MACHALABA D, 1999, WALL STREET J   0203; MCHUGH MA, 1996, SUPERCRITICAL FLUID; MEIXNER J, 2001, Patent No. 6232360; MOORE S, 1994, CHEM ENG-NEW YORK, V101, P32; Namatsu H, 2000, J VAC SCI TECHNOL B, V18, P780, DOI 10.1116/1.591276; NIELSEN KA, 1996, Patent No. 5509959; OSTERYOUNG RA, 1987, NATO ASI SER, V202, P329; PARKINSON G, 1999, CHEM ENG, V106, P17; Reichardt C., 1988, SOLVENTS SOLVENT EFF; ROBINSON J, 1979, J AM CHEM SOC, V101, P323, DOI 10.1021/ja00496a008; ROMACK TJ, 1995, MACROMOLECULES, V28, P8429, DOI 10.1021/ma00128a065; Salzer A, 2002, CHEM ENG NEWS, V80, P4; *SEIM IND ASS SIA, 1997, NAT TECHN ROADM SEM; *SEM IND ASS SIA, 1999, NAT TECHN ROADM SEM; STEINER R, 1993, CHEM ENG-NEW YORK, V100, P114; Subramaniam B, 1997, J PHARM SCI-US, V86, P885, DOI 10.1021/js9700661; TANAKA T, 1993, JPN J APPL PHYS, V12, P5831; TESTER JW, 1993, ACS SYM SER, V518, pCH3; THOMASON TB, 1984, HAZARD WASTE HAZARD, V1, P453, DOI 10.1089/hzw.1984.1.453; TSAI SP, 1995, Patent No. 5464760; VOSS D, 2002, TECHNOL REV      JAN, P27; Walsh KA, 1996, CHEM WEEK, V158, P38; Wells S.L, 2001, ANGEW CHEM INT EDIT, V40, P518, DOI [10.1002/1521-3773(20010202)40:33.0.CO;2-4, DOI 10.1002/1521-3773(20010202)40:33.0.CO;2-4]; WILKES JS, 1982, INORG CHEM, V21, P1263, DOI 10.1021/ic00133a078	61	829	851	7	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2002	297	5582					799	803		10.1126/science.1069622	http://dx.doi.org/10.1126/science.1069622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161645				2022-12-28	WOS:000177192800039
J	Sun, X; Mariani, FV; Martin, GR				Sun, X; Mariani, FV; Martin, GR			Functions of FGF signalling from the apical ectodermal ridge in limb development	NATURE			English	Article							CHICK LIMB; PATTERN-FORMATION; BUD DEVELOPMENT; CELL-MIGRATION; GROWTH; OUTGROWTH; AER; MORPHOGENESIS; INDUCTION; MUTANT	To determine the role of fibroblast growth factor (FGF) signalling from the apical ectodermal ridge (AER), we inactivated Fgf4 and Fgf8 in AER cells or their precursors at different stages of mouse limb development. We show that FGF4 and FGF8 regulate cell number in the nascent limb bud and are required for survival of cells located far from the AER. On the basis of the skeletal phenotypes observed, we conclude that these functions are essential to ensure that sufficient progenitor cells are available to form the normal complement of skeletal elements, and perhaps other limb tissues. In the complete absence of both FGF4 and FGF8 activities, limb development fails. We present a model to explain how the mutant phenotypes arise from FGF-mediated effects on limb bud size and cell survival.	Univ Calif San Francisco, Sch Med, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Program Dev Biol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Martin, GR (corresponding author), Univ Calif San Francisco, Sch Med, Dept Anat, San Francisco, CA 94143 USA.	gmartin@itsa.ucsf.edu		Mariani, Francesca/0000-0003-1619-8763	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD008696] Funding Source: NIH RePORTER; NICHD NIH HHS [F32 HD008696] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALBERCH P, 1983, J EMBRYOL EXP MORPH, V76, P177; BALDWIN HS, 1994, DEVELOPMENT, V120, P2539; BOBER E, 1994, DEVELOPMENT, V120, P603; Capdevila J, 1999, MOL CELL, V4, P839, DOI 10.1016/S1097-2765(00)80393-7; CARTER TC, 1954, J GENET, V52, P1, DOI 10.1007/BF02981488; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Dahn RD, 2000, SCIENCE, V289, P438, DOI 10.1126/science.289.5478.438; Dudley AT, 2002, NATURE, V418, P539, DOI 10.1038/nature00945; FALLON JF, 1994, SCIENCE, V264, P104, DOI 10.1126/science.7908145; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; GURLEY LR, 1978, EUR J BIOCHEM, V84, P1, DOI 10.1111/j.1432-1033.1978.tb12135.x; Hinchliffe J. R., 1980, DEV VERTEBRATE LIMB; HORNBRUCH A, 1970, NATURE, V226, P764, DOI 10.1038/226764a0; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; Kingsley D M, 2001, Novartis Found Symp, V232, P213; Kraus P, 2001, MECH DEVELOP, V100, P45, DOI 10.1016/S0925-4773(00)00492-5; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; Li SG, 1999, DEV BIOL, V211, P335, DOI 10.1006/dbio.1999.9317; MAINI PK, 1991, INT REV CYTOL, V129, P91; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; Mercader N, 2000, DEVELOPMENT, V127, P3961; Mercader N, 1999, NATURE, V402, P425, DOI 10.1038/46580; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Min Q, 1998, TEACH LEARN MED, V10, P12, DOI 10.1207/S15328015TLM1001_3; Moon AM, 2000, NAT GENET, V26, P455, DOI 10.1038/82601; Moon AM, 2000, DEVELOPMENT, V127, P989; MUNEOKA K, 1989, J EXP ZOOL, V249, P50, DOI 10.1002/jez.1402490110; NISWANDER L, 1993, CELL, V75, P579, DOI 10.1016/0092-8674(93)90391-3; Ornitz DM, 2001, GENOME BIOL, V2; PRAHLAD KV, 1979, J EXP ZOOL, V209, P427, DOI 10.1002/jez.1402090308; Revest JM, 2001, DEV BIOL, V231, P47, DOI 10.1006/dbio.2000.0144; ROWE DA, 1982, J EMBRYOL EXP MORPH, V68, P1; ROWE DA, 1982, DEV BIOL, V93, P83, DOI 10.1016/0012-1606(82)90241-X; RUBIN L, 1972, DEV BIOL, V28, P94, DOI 10.1016/0012-1606(72)90129-7; SAUNDERS JW, 1948, J EXP ZOOL, V108, P363, DOI 10.1002/jez.1401080304; Saxton TM, 2000, NAT GENET, V24, P420, DOI 10.1038/74279; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; STARK RJ, 1974, DEV BIOL, V38, P51, DOI 10.1016/0012-1606(74)90258-9; SUMMERBELL D, 1974, J EMBRYOL EXP MORPH, V32, P651; SUMMERBELL D, 1973, NATURE, V244, P492, DOI 10.1038/244492a0; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; Takahashi M, 1998, DEVELOPMENT, V125, P4417; Vargesson N, 1997, DEVELOPMENT, V124, P1909; WOLPERT L, 1979, J EMBRYOL EXP MORPH, V50, P175; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Xu JS, 2000, DEVELOPMENT, V127, P1833	48	423	437	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 1	2002	418	6897					501	508		10.1038/nature00902	http://dx.doi.org/10.1038/nature00902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152071				2022-12-28	WOS:000177162800032
J	Maris, RW				Maris, RW			Suicide	LANCET			English	Review								Suicide is a multidimensional concomitant of psychiatric diagnoses, especially mood disorders, and is complex in both its causation and in the treatment of those at risk. It has known risk and protective factors that tend to be fairly consistent worldwide, with some cultural variation. Even with standardised assessment and prediction scales (such as the Hamilton or Beck depression inventories), suicide prediction results in about 30% false positives. The most common biological marker of suicide is reduced concentrations of the serotonin metabolite 5-hydroxyindoleacetic acid in the CSF of suicide cases versus controls. Although suicide prevention is ideally primary, in fact most treatment is secondary or tertiary. Dependent on the individual characteristics present, suicide prevention usually includes a pharmacological cocktail (especially one of the selective serotonin reuptake inhibitors, to raise serotonin concentrations, perhaps combined with an anxiolytic, mood stabilising, or antipsychotic agent), supportive psychotherapy (often cognitive or behavioural therapy), and sometimes electroconvulsive therapy. Perceived danger to self can necessitate treatment in hospital.	Univ S Carolina, Ctr Study Suicide, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Maris, RW (corresponding author), Univ S Carolina, Ctr Study Suicide, 305 Sloan Bldg,911 Pickens St, Columbia, SC 29208 USA.	Maris@sc.edu						ADDY CL, 1992, ASSESSMENT PREDICTIO, P218; American Psychiatric Association, 2000, DSM 4 TR; ARANGO V, 1997, PSYCHIAT CLIN N AM S; ASBERG M, ARCH GEN PSYCHIAT, V136, P559; BECK AT, 2001, SUICIDE PREVENTION I, P10; BERMAN AL, 2000, COMPREHENSIVE TXB SU, P427; BREGIN PD, 1993, LISTENING PROZAC; Brent DA, 2001, ANN NY ACAD SCI, V932, P225; BROWN G, 2001, RISK FACTORS SUICIDE, P5; BROWN G, 1992, ASSESSMENT PREDICTIO, P589; BYERLY W, 2001, RISK FACTORS SUICIDE, P11; COMTOSI K, 2001, RISK FACTORS SUICIDE, P13; DECATANZARO D, 1992, ASSESSMENT PREDICTIO, P607; EGELAND J, JAMA, V254, P915; FAWCETT JA, J CLIN PSYCHIAT, V53, P217; Fernquist RM, 2001, SUICIDE LIFE-THREAT, V31, P333, DOI 10.1521/suli.31.3.333.24242; GOLDSTON D, 2001, RISK FACTORS SUICIDE, P5; Hammond WR, 2001, SUICIDE LIFE-THREAT, V32, P1, DOI 10.1521/suli.32.1.5.1.24213; Hughes D, 2001, SUICIDE LIFE-THREAT, V31, P48, DOI 10.1521/suli.31.1.5.48.24226; ISAACSON G, 1977, REV SUICIDOLOGY 1997; KETY SS, 2000, COMPREHENSIVE TXB SU, P381; KOVACS M, 1975, SUICIDE, V5, P98; Kreitman N., 1977, PARASUICIDE; Lester D, 2000, COMPREHENSIVE TEXTBOOK OF SUICIDOLOGY, P357; MALTSBERGER J. T., 1992, ASSESSMENT PREDICTIO, P25; Mancinelli I, 2002, SUICIDE LIFE-THREAT, V32, P91, DOI 10.1521/suli.32.1.91.22186; Maris R., 1981, PATHWAYS TO SUICIDE; MARIS R, 1986, BIOL SUICIDE; Maris R. W., 1992, ASSESSMENT PREDICTIO, P65; Maris RW, 2000, COMPREHENSIVE TEXTBOOK OF SUICIDOLOGY, P170; MARIS RW, 2000, COMPREHENSIVE TXB SU, P376; MARIS RW, 2000, COMPREHENSIVE TXB SU, P599; MARIS RW, 1997, ENCY HUMAN BIOL, V8, P255; MARIS RW, 2000, TREATMENT PREVENTION, P509; Maris RW, 2000, COMPREHENSIVE TXB SU, P71; MARIS RW, 1995, SUICIDE PREVENTION Y; MCINTOSH JL, 2001, US SUICIDE 1999 OFFI; Menninger K. A, 1938, MAN HIMSELF; MOSCICKI E, 2001, RISK FACTORS SUICIDE, P1; MURPHY GE, 1982, J NERV MENT DIS, V170, P86, DOI 10.1097/00005053-198202000-00004; MURPHY GE, 1992, SUICIDE ALCOHOLSM; OCarroll PW, 1996, SUICIDE LIFE-THREAT, V26, P237; Plutchik R, 2000, COMPREHENSIVE TEXTBOOK OF SUICIDOLOGY, P407; POKORNY AD, 1983, ARCH GEN PSYCHIAT, V40, P249; ROTHBERG JM, 1992, ASSESSMENT PREDICTIO, P202; ROY A, 1991, ARCH GEN PSYCHIAT, V48, P29; ROY A, 1986, BIOL SUICIDE, P244; SCHMIDTKE A, 1997, SUICIDE INDIVIDUAL C; SILVERMAN MM, 2000, COMPREHENSIVE TXB SU, P342; Tanney BL, 2000, COMPREHENSIVE TEXTBOOK OF SUICIDOLOGY, P311; World Health Organisation, 1993, ICD 10 CLASSIFICATIO; Yip PSF, 2001, SUICIDE LIFE-THREAT, V31, P62, DOI 10.1521/suli.31.1.62.21311; Yufit R. I., 1992, ASSESSMENT PREDICTIO, P553	53	235	249	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 27	2002	360	9329					319	326		10.1016/S0140-6736(02)09556-9	http://dx.doi.org/10.1016/S0140-6736(02)09556-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578DT	12147388				2022-12-28	WOS:000177102700026
J	Ye, H; Arron, JR; Lamothe, B; Cirilli, M; Kobayashi, T; Shevde, NK; Segal, D; Dzivenu, OK; Vologodskaia, M; Yim, M; Du, K; Singh, S; Pike, JW; Darnay, BG; Choi, Y; Wu, H				Ye, H; Arron, JR; Lamothe, B; Cirilli, M; Kobayashi, T; Shevde, NK; Segal, D; Dzivenu, OK; Vologodskaia, M; Yim, M; Du, K; Singh, S; Pike, JW; Darnay, BG; Choi, Y; Wu, H			Distinct molecular mechanism for initiating TRAF6 signalling	NATURE			English	Article							NF-KAPPA-B; DEFECTIVE INTERLEUKIN-1; STRUCTURAL BASIS; RECEPTOR; KINASE; ACTIVATION; CD40; RECOGNITION; FAMILY; IRAK	Tumour-necrosis factor (TNF) receptor-associated factor 6 (TRAF6) is the only TRAF family member that participates in signal transduction of both the TNF receptor (TNFR) superfamily and the interleukin-1 receptor (IL-1R)/Toll-like receptor (TLR) superfamily(1-5); it is important for adaptive immunity, innate immunity and bone homeostasis. Here we report crystal structures of TRAF6, alone and in complex with TRAF6-binding peptides from CD40 and TRANCE-R (also known as RANK), members of the TNFR superfamily, to gain insight into the mechanism by which TRAF6 mediates several signalling cascades. A 408 difference in the directions of the bound peptides in TRAF6 and TRAF2 shows that there are marked structural differences between receptor recognition by TRAF6 and other TRAFs. The structural determinant of the petide-TRAF6 interaction reveals a Pro-X-Glu-X-X-(aromatic/acidic residue) TRAF6-binding motif, which is present not only in CD40 and TRANCE-R but also in the three IRAK adapter kinases for IL-1R/TLR signalling. Cell-permeable peptides with the TRAF6-binding motif inhibit TRAF6 signalling, which indicates their potential as therapeutic modulators. Our studies identify a universal mechanism by which TRAF6 regulates several signalling cascades in adaptive immunity, innate immunity and bone homeostasis.	Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Rockefeller Univ, Tri Inst MD PhD Program, New York, NY 10021 USA; Rockefeller Univ, Immunol Lab, New York, NY 10021 USA; Univ Penn, Sch Med, Dept Pathol & Lab Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Texas, MD Anderson Canc Ctr, Dept Bioimmunotherapy, Houston, TX 77030 USA; CNR, Ist Strutturist Chim Giordano Giacomello, Monterotondo Staz, Italy; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Imgenex Corp, San Diego, CA 92121 USA	Cornell University; Rockefeller University; Rockefeller University; University of Pennsylvania; Pennsylvania Medicine; University of Texas System; UTMD Anderson Cancer Center; Consiglio Nazionale delle Ricerche (CNR); University of Wisconsin System; University of Wisconsin Madison	Wu, H (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA.			Arron, Joseph/0000-0001-7677-9979				Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Arron JR, 2000, NATURE, V408, P535, DOI 10.1038/35046196; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUNDEL DR, 1987, METHOD ENZYMOL, V247, P288; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Chung JY, 2002, J CELL SCI, V115, P679; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Haridas V, 1998, J IMMUNOL, V160, P3152; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Liu XY, 2000, J BIOL CHEM, V275, P16774; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; McWhirter SM, 1999, P NATL ACAD SCI USA, V96, P8408, DOI 10.1073/pnas.96.15.8408; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Pullen SS, 1999, J BIOL CHEM, V274, P14246, DOI 10.1074/jbc.274.20.14246; Pullen SS, 1998, BIOCHEMISTRY-US, V37, P11836, DOI 10.1021/bi981067q; Shevde NK, 2000, P NATL ACAD SCI USA, V97, P7829, DOI 10.1073/pnas.130200197; TONG L, 1993, J APPL CRYSTALLOGR, V26, P748, DOI 10.1107/S0021889893005631; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Zhang FX, 1999, J BIOL CHEM, V274, P7611, DOI 10.1074/jbc.274.12.7611	30	505	530	4	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2002	418	6896					443	447		10.1038/nature00888	http://dx.doi.org/10.1038/nature00888			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12140561				2022-12-28	WOS:000177009700044
J	Cope, GA; Suh, GSB; Aravind, L; Schwarz, SE; Zipursky, SL; Koonin, EV; Deshaies, RJ				Cope, GA; Suh, GSB; Aravind, L; Schwarz, SE; Zipursky, SL; Koonin, EV; Deshaies, RJ			Role of predicted metalloprotease motif of Jab1/Csn5 in cleavage of Nedd8 from Cul1	SCIENCE			English	Article							MODULATE AP-1 ACTIVITY; SCF UBIQUITIN-LIGASE; COP9 SIGNALOSOME; FISSION YEAST; COMPLEX; JAB1; ZINC; TRANSCRIPTION; PURIFICATION; P27(KIP1)	COP9 signalosome (CSN) cleaves the ubiquitin-like protein Nedd8 from the Cul1 subunit of SCF ubiquitin ligases. The Jab1/MPN domain metalloenzyme (JAMM) motif in the Jab1/Csn5 subunit was found to underlie CSN's Nedd8 isopeptidase activity. JAMM is found in proteins from archaea, bacteria, and eukaryotes, including the Rpn11 subunit of the 26 S proteasome. Metal chelators and point mutations within JAMM abolished CSN-dependent cleavage of Nedd8 from Cul1, yet had little effect on CSN complex assembly. Optimal SCF activity in yeast and both viability and proper photoreceptor cell ( R cell) development in Drosophila melanogaster required an intact Csn5 JAMM domain. We propose that JAMM isopeptidases play important roles in a variety of physiological pathways.	CALTECH, Dept Biol, Pasadena, CA 91125 USA; Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA	California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Deshaies, RJ (corresponding author), CALTECH, Dept Biol, Pasadena, CA 91125 USA.		Deshaies, Raymond/B-8354-2014	Deshaies, Raymond/0000-0002-3671-9354; Suh, Greg/0000-0003-4381-658X; Zipursky, Stephen/0000-0001-5630-7181; Aravind, L/0000-0003-0771-253X	NATIONAL LIBRARY OF MEDICINE [ZIALM000061, Z01LM000061] Funding Source: NIH RePORTER	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aravind L, 1998, PROTEIN SCI, V7, P1250, DOI 10.1002/pro.5560070521; Bianchi E, 2000, NATURE, V404, P617, DOI 10.1038/35007098; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; COPE G, UNPUB; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Freilich S, 1999, CURR BIOL, V9, P1187, DOI 10.1016/S0960-9822(00)80023-8; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GomezOrtiz M, 1997, FEBS LETT, V400, P336, DOI 10.1016/S0014-5793(96)01412-3; HOLLAND DR, 1995, PROTEIN SCI, V4, P1955, DOI 10.1002/pro.5560041001; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; LOEWY AG, 1993, J BIOL CHEM, V268, P9071; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Mundt KE, 1999, CURR BIOL, V9, P1427, DOI 10.1016/S0960-9822(00)80091-3; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; Ponting CP, 1999, J MOL BIOL, V289, P729, DOI 10.1006/jmbi.1999.2827; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Seeger M, 2001, CURR BIOL, V11, pR643, DOI 10.1016/S0960-9822(01)00382-7; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Suh GSB, 2002, NEURON, V33, P35, DOI 10.1016/S0896-6273(01)00576-1; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wei N, 1998, PHOTOCHEM PHOTOBIOL, V68, P237; Wei N, 1999, TRENDS GENET, V15, P98, DOI 10.1016/S0168-9525(98)01670-9; ZHOU C, 2001, BMC BIOCH	33	557	582	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 18	2002	298	5593					608	611		10.1126/science.1075901	http://dx.doi.org/10.1126/science.1075901			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604RL	12183637				2022-12-28	WOS:000178634800043
J	Lenhardt, R; Seybold, T; Kimberger, O; Stoiser, B; Sessler, DI				Lenhardt, R; Seybold, T; Kimberger, O; Stoiser, B; Sessler, DI			Local warming and insertion of peripheral venous cannulas: single blinded prospective randomised controlled trial and single blinded randomised crossover trial	BRITISH MEDICAL JOURNAL			English	Article							HYPOTHERMIA; OINTMENT; ACCESS	Objective To determine whether local warming of the lower arm and hand facilitates peripheral venous cannulation. Design Single blinded prospective randomised controlled trial and single blinded randomised crossover trial. Setting Neurosurgical unit and haematology ward of university hospital. Participants 100 neurosurgical patients and 40 patients with leukaemia who required chemotherapy. Interventions Neurosurgical patients' hands and forearms were covered for 15 minutes with a carbon fibre heating mitt. Patients were assigned randomly to active warming at 52degreesC or passive insulation (heater not activated). The same warming system was used for 10 minutes in patients with leukaemia. They were assigned randomly to active warming or passive insulation on day 1 and given alternative treatment during the subsequent visit. Main outcome measures Primary: success rate for insertion of 18 gauge cannula into vein on back of hand. Secondary: time required for successful cannulation. Results In neurosurgical patients, it took 36 seconds (95% confidence interval 31 to 40 seconds) to insert a cannula in the active warming group and 62 (50 to 74) seconds in the passive insulation group (P=0.002). Three (6%) first attempts failed in the active warming group compared with 14 (28%) in the passive insulation group (P=0.008). The crossover study in patients with leukaemia showed that insertion time was reduced by 20 seconds (8 to 32, P=0.013) with active warming and that failure rates at first attempt were 6% with warming and 30% with passive insulation (P <0.001). Conclusions Local warming facilitates the insertion of peripheral venous cannulas, reducing both time and number of attempts required. This may decrease the time staff spend inserting cannulas, reduce supply costs, and improve patient satisfaction.	Univ Louisville, Outcomes Res Inst, Louisville, KY 40202 USA; Univ Louisville, Dept Anaesthesiol, Louisville, KY 40202 USA; Univ Vienna, Dept Anaesthesiol, A-1090 Vienna, Austria; Univ Vienna, Dept Internal Med, A-1090 Vienna, Austria	University of Louisville; University of Louisville; University of Vienna; University of Vienna	Lenhardt, R (corresponding author), Univ Louisville, Outcomes Res Inst, Louisville, KY 40202 USA.		Sessler, Daniel/D-3504-2011	Sessler, Daniel/0000-0001-9932-3077; Kimberger, Oliver/0000-0002-9766-1360	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058273] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM58273] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cleary M, 1991, Aust Fam Physician, V20, P1285; CLEARY M, 1991, AUST FAM PHYSICIAN, V120, P1285; DATTA S, 1990, BRIT J HOSP MED, V43, P67; GENDRON FG, 1988, UNEXPLAINED PATIENT; Greif R, 2000, ANN EMERG MED, V35, P337, DOI 10.1016/S0196-0644(00)70051-5; JOHNSTONE FD, 1976, BRIT MED J, V1, P68, DOI 10.1136/bmj.1.6001.68; Kober A, 2001, MAYO CLIN PROC, V76, P369; Mbamalu D, 1999, POSTGRAD MED J, V75, P459, DOI 10.1136/pgmj.75.886.459; Michael A, 1996, ANAESTH INTENS CARE, V24, P360, DOI 10.1177/0310057X9602400310; MORRIS CC, 1985, INT J RADIAT BIOL, V47, P41, DOI 10.1080/09553008514550061; ROBERGE RJ, 1987, ANN EMERG MED, V16, P546, DOI 10.1016/S0196-0644(87)80682-0; Roberts G H, 1993, Radiol Technol, V65, P107	12	57	63	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 24	2002	325	7361					409	410A		10.1136/bmj.325.7361.409	http://dx.doi.org/10.1136/bmj.325.7361.409			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588RY	12193353	Bronze, Green Published			2022-12-28	WOS:000177715500015
J	Gregory, SG; Sekhon, M; Schein, J; Zhao, SY; Osoegawa, K; Scott, CE; Evans, RS; Burridge, PW; Cox, TV; Fox, CA; Hutton, RD; Mullenger, IR; Phillips, KJ; Smith, J; Stalker, J; Threadgold, GJ; Birney, E; Wylie, K; Chinwalla, A; Wallis, J; Hillier, L; Carter, J; Gaige, T; Jaeger, S; Kremitzki, C; Layman, D; Maas, J; McGrane, R; Mead, K; Walker, R; Jones, S; Smith, M; Asano, J; Bosdet, I; Chan, S; Chittaranjan, S; Chiu, R; Fjell, C; Fuhrmann, D; Girn, N; Gray, C; Guin, R; Hsiao, L; Krzywinski, M; Kutsche, R; Lee, SS; Mathewson, C; McLeavy, C; Messervier, S; Ness, S; Pandoh, P; Prabhu, AL; Saeedi, P; Smailus, D; Spence, L; Stott, J; Taylor, S; Terpstra, W; Tsai, M; Vardy, J; Wye, N; Yang, G; Shatsman, S; Ayodeji, B; Geer, K; Tsegaye, G; Shvartsbeyn, A; Gebregeorgis, E; Krol, M; Russell, D; Overton, L; Malek, JA; Holmes, M; Heaney, M; Shetty, J; Feldblyum, T; Nierman, WC; Catanese, JJ; Hubbard, T; Waterston, RH; Rogers, J; de Jong, PJ; Fraser, CM; Marra, M; McPherson, JD; Bentley, DR				Gregory, SG; Sekhon, M; Schein, J; Zhao, SY; Osoegawa, K; Scott, CE; Evans, RS; Burridge, PW; Cox, TV; Fox, CA; Hutton, RD; Mullenger, IR; Phillips, KJ; Smith, J; Stalker, J; Threadgold, GJ; Birney, E; Wylie, K; Chinwalla, A; Wallis, J; Hillier, L; Carter, J; Gaige, T; Jaeger, S; Kremitzki, C; Layman, D; Maas, J; McGrane, R; Mead, K; Walker, R; Jones, S; Smith, M; Asano, J; Bosdet, I; Chan, S; Chittaranjan, S; Chiu, R; Fjell, C; Fuhrmann, D; Girn, N; Gray, C; Guin, R; Hsiao, L; Krzywinski, M; Kutsche, R; Lee, SS; Mathewson, C; McLeavy, C; Messervier, S; Ness, S; Pandoh, P; Prabhu, AL; Saeedi, P; Smailus, D; Spence, L; Stott, J; Taylor, S; Terpstra, W; Tsai, M; Vardy, J; Wye, N; Yang, G; Shatsman, S; Ayodeji, B; Geer, K; Tsegaye, G; Shvartsbeyn, A; Gebregeorgis, E; Krol, M; Russell, D; Overton, L; Malek, JA; Holmes, M; Heaney, M; Shetty, J; Feldblyum, T; Nierman, WC; Catanese, JJ; Hubbard, T; Waterston, RH; Rogers, J; de Jong, PJ; Fraser, CM; Marra, M; McPherson, JD; Bentley, DR			A physical map of the mouse genome	NATURE			English	Article							HUMAN-CHROMOSOME 7Q11.23; WILLIAMS-SYNDROME; SEQUENCE-ANALYSIS; HUMAN-CHROMOSOME-19; EVOLUTION; REGIONS; DNA; CONSERVATION; SEGMENTS; CLONING	A physical map of a genome is an essential guide for navigation, allowing the location of any gene or other landmark in the chromosomal DNA. We have constructed a physical map of the mouse genome that contains 296 contigs of overlapping bacterial clones and 16,992 unique markers. The mouse contigs were aligned to the human genome sequence on the basis of 51,486 homology matches, thus enabling use of the conserved synteny (correspondence between chromosome blocks) of the two genomes to accelerate construction of the mouse map. The map provides a framework for assembly of whole-genome shotgun sequence data, and a tile path of clones for generation of the reference sequence. Definition of the human-mouse alignment at this level of resolution enables identification of a mouse clone that corresponds to almost any position in the human genome. The human sequence may be used to facilitate construction of other mammalian genome maps using the same strategy.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; Inst Genom Res, Rockville, MD 20850 USA; Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; EMBL European Bioinformat Inst, Cambridge CB10 1SD, England; Washington Univ, Dept Elect Engn, St Louis, MO 63130 USA	Wellcome Trust Sanger Institute; Washington University (WUSTL); British Columbia Cancer Agency; J. Craig Venter Institute; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; European Molecular Biology Laboratory (EMBL); Washington University (WUSTL)	Bentley, DR (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	drb@sanger.ac.uk	Burridge, Paul Wesley/AAI-2717-2021; Marra, Marco A/B-5987-2008; Sekhon, Mandeep/L-4665-2018; Hubbard, Tim J/C-2567-2008; McPherson, John D/D-2633-2017; MALEK, JALALUDDIN ABDUL/ABU-1982-2022; Jones, Steven J/C-3621-2009; Schein, Jacquie E/G-3674-2015; Hubbard, Tim J.P./AAT-4571-2020	Marra, Marco A/0000-0001-7146-7175; Sekhon, Mandeep/0000-0002-9993-6938; Hubbard, Tim J/0000-0002-1767-9318; McPherson, John D/0000-0001-8049-9347; Jones, Steven J/0000-0003-3394-2208; Hubbard, Tim J.P./0000-0002-1767-9318; Kremitzki, Colin/0000-0001-9175-3136; Birney, Ewan/0000-0001-8314-8497; Fraser, Claire/0000-0003-1462-2428; Chinwalla, Asif/0000-0001-7831-3996; Gregory, Simon/0000-0002-7805-1743; Smith, James/0000-0002-0445-8305	NHGRI NIH HHS [U01 HG002137, U01 HG002137-03] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG002137] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Altschul SF, 1996, METHOD ENZYMOL, V266, P460; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ASHWORTH LK, 1995, NAT GENET, V11, P422, DOI 10.1038/ng1295-422; Batzoglou S, 2000, GENOME RES, V10, P950, DOI 10.1101/gr.10.7.950; Bentley DR, 2001, NATURE, V409, P942, DOI 10.1038/35057165; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cai WW, 2001, NAT GENET, V29, P133, DOI 10.1038/ng716; Carver EA, 1997, GENOME RES, V7, P1123, DOI 10.1101/gr.7.12.1123; Churcher C, 1997, NATURE, V387, P84, DOI 10.1038/387s084; COLLINS J, 1978, P NATL ACAD SCI USA, V75, P4242, DOI 10.1073/pnas.75.9.4242; COPELAND NG, 1993, SCIENCE, V262, P57, DOI 10.1126/science.8211130; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; DeBry RW, 1996, GENOMICS, V33, P337, DOI 10.1006/geno.1996.0209; Dehal P, 2001, SCIENCE, V293, P104, DOI 10.1126/science.1060310; DeSilva U, 2002, GENOME RES, V12, P3, DOI 10.1101/gr.214802; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; EVANS EP, 1996, GENETIC VARIANTS STR, P1446; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Green ED, 2001, NAT REV GENET, V2, P573, DOI 10.1038/35084503; Hardison RC, 1997, GENOME RES, V7, P959, DOI 10.1101/gr.7.10.959; Hudson TJ, 2001, NAT GENET, V29, P201, DOI 10.1038/ng1001-201; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim J, 2001, GENOMICS, V74, P129, DOI 10.1006/geno.2001.6521; KOOP BF, 1994, GENOMICS, V19, P478, DOI 10.1006/geno.1994.1097; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Marra MA, 1997, GENOME RES, V7, P1072, DOI 10.1101/gr.7.11.1072; Martindale DW, 2000, MAMM GENOME, V11, P890, DOI 10.1007/s003350010166; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Nadeau JH, 1998, TRENDS GENET, V14, P495, DOI 10.1016/S0168-9525(98)01607-2; NADEAU JH, 1984, P NATL ACAD SCI-BIOL, V81, P814, DOI 10.1073/pnas.81.3.814; Nusbaum C, 1999, NAT GENET, V22, P388, DOI 10.1038/11967; Oeltjen JC, 1997, GENOME RES, V7, P315, DOI 10.1101/gr.7.4.315; OLSON MV, 1986, P NATL ACAD SCI USA, V83, P7826, DOI 10.1073/pnas.83.20.7826; Osoegawa K, 2000, GENOME RES, V10, P116; Pletcher MT, 2000, GENOME RES, V10, P1463, DOI 10.1101/gr.146600; Pletcher MT, 2001, GENOMICS, V74, P45, DOI 10.1006/geno.2001.6533; Puttagunta R, 2000, GENOME RES, V10, P1369, DOI 10.1101/gr.145200; Ross NP, 1999, ENVIRON ECOL STAT, V6, P5, DOI 10.1023/A:1009627431759; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; Soderlund C, 2000, GENOME RES, V10, P1772, DOI 10.1101/gr.GR-1375R; Stubbs L, 1996, GENOMICS, V35, P499, DOI 10.1006/geno.1996.0390; Thomas JW, 2000, GENOME RES, V10, P624, DOI 10.1101/gr.10.5.624; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waterston R, 1998, SCIENCE, V282, P53, DOI 10.1126/science.282.5386.53; WatkinsChow DE, 1997, GENOMICS, V40, P114, DOI 10.1006/geno.1996.4532; Zhao SY, 2001, GENOME RES, V11, P1736, DOI 10.1101/gr.179201; 1997, NATURE S, V387, P5	50	239	255	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2002	418	6899					743	U3		10.1038/nature00957	http://dx.doi.org/10.1038/nature00957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181558				2022-12-28	WOS:000177428000030
J	Lawlor, DA; Ebrahim, S; Smith, GD				Lawlor, DA; Ebrahim, S; Smith, GD			Role of endogenous oestrogen in aetiology of coronary heart disease: analysis of age related trends in coronary heart disease and breast cancer in England and Wales and Japan	BRITISH MEDICAL JOURNAL			English	Article							MENOPAUSE; PARADOX; MYTH		Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of Bristol	Lawlor, DA (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.		Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; Lawlor, Debbie A/0000-0002-6793-2262				Lawlor DA, 2001, BRIT MED J, V323, P541, DOI 10.1136/bmj.323.7312.541; Meilahn E, 1999, HEALTH AND DISEASE AMONG WOMEN: BIOLOGICAL AND ENVIRONMENTAL INFLUENCES, P155; TRACY RE, 1966, J CHRON DIS, V19, P1245, DOI 10.1016/0021-9681(66)90022-1; Tunstall-Pedoe H, 1998, LANCET, V351, P1425, DOI 10.1016/S0140-6736(97)11321-6; Witteman JCM, 1998, LANCET, V352, P407, DOI 10.1016/S0140-6736(05)60507-7	5	21	22	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 10	2002	325	7359					311	312		10.1136/bmj.325.7359.311	http://dx.doi.org/10.1136/bmj.325.7359.311			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	584RQ	12169507	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000177482500018
J	Assender, H; Bliznyuk, V; Porfyrakis, K				Assender, H; Bliznyuk, V; Porfyrakis, K			How surface topography relates to materials properties	SCIENCE			English	Review							POLYMER; FILMS; WAVES	The topography of a surface is known to substantially affect the bulk properties of a material. Despite the often nanoscale nature of the surface undulations, the influence they have may be observed by macroscopic measurements. This review explores many of the areas in which the effect of topography is macroscopically relevant, as well as introducing some recent developments in topographic analysis and control.	Univ Oxford, Dept Mat, Oxford OX1 3PH, England	University of Oxford	Bliznyuk, V (corresponding author), Univ Oxford, Dept Mat, Parks Rd, Oxford OX1 3PH, England.		Porfyrakis, Kyriakos/B-6118-2009; Bliznyuk, Valery/FQH-1836-2022; Porfyrakis, Kyriakos/AAH-2790-2019	Porfyrakis, Kyriakos/0000-0003-1364-0261				Affinito JD, 1996, THIN SOLID FILMS, V290, P63, DOI 10.1016/S0040-6090(96)09202-4; Awaja F, 2005, EUR POLYM J, V41, P1453, DOI 10.1016/j.eurpolymj.2005.02.005; Banerjee P, 2000, J BIOMED MATER RES, V50, P331, DOI 10.1002/(SICI)1097-4636(20000605)50:3<331::AID-JBM6>3.3.CO;2-K; Beckmann P., 1987, SCATTERING ELECTROMA; Bliznyuk V. N., 2000, POLYM PREPRINTS, V41, P1489; Bliznyuk VN, 2001, MACROMOL SYMP, V167, P89, DOI 10.1002/1521-3900(200103)167:1<89::AID-MASY89>3.0.CO;2-S; Bliznyuk VN, 1999, MACROMOLECULES, V32, P361, DOI 10.1021/ma9808979; Bucknall DG, 2002, MATER RES SOC SYMP P, V705, P151; Chan CM, 1996, SURF SCI REP, V24, P3; Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0; DAVIES H, 1954, P I ELECTR ENG, V101, P209, DOI 10.1049/pi-4.1954.0025; DeAro JA, 1997, CHEM PHYS LETT, V277, P532, DOI 10.1016/S0009-2614(97)00882-8; Dinelli F, 2000, POLYMER, V41, P4285, DOI 10.1016/S0032-3861(99)00500-5; Goldbeck-Wood G, 2002, MACROMOLECULES, V35, P5283, DOI 10.1021/ma0119777; Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2; Guinier, 1963, XRAY DIFFRACTION CRY, DOI DOI 10.1002/bip.10163; Heier J, 1999, MACROMOLECULES, V32, P9007, DOI 10.1021/ma990916u; Jiang XP, 2002, LANGMUIR, V18, P2607, DOI 10.1021/la011098d; Karim A, 1998, MACROMOLECULES, V31, P857, DOI 10.1021/ma970687g; Lawson AC, 1999, MATER RES SOC SYMP P, V550, P235; LISTON EM, 1993, J ADHES SCI TECHNOL, V7, P1091, DOI 10.1163/156856193X00600; Liu SJ, 2001, PLAST RUBBER COMPOS, V30, P170, DOI 10.1179/146580101101541598; McGloughlin TM, 2000, P I MECH ENG H, V214, P349, DOI 10.1243/0954411001535390; Mealdn P, 1998, FRACTALS SCALING GRO; MONASSE B, 2001, PLAST ELASTOMERS MAG, V53, P29; Nabetani Y, 2001, THIN SOLID FILMS, V393, P329, DOI 10.1016/S0040-6090(01)01108-7; Ogilvy J., 1991, THEORY WAVE SCATTERI; Oyanagi Y., 1997, INT POLYM SCI TECHN, V24, pT38; PORFYRAKIS K, UNPUB; Porter D., 1995, GROUP INTERACTION MO; Ranucci CS, 2001, J BIOMED MATER RES, V54, P149, DOI 10.1002/1097-4636(200102)54:2<149::AID-JBM1>3.0.CO;2-O; Rauwendaal C., 1985, POLYM EXTRUSION; Schaffer E, 2001, EUROPHYS LETT, V53, P518, DOI 10.1209/epl/i2001-00183-2; Sferrazza M, 1997, PHYS REV LETT, V78, P3693, DOI 10.1103/PhysRevLett.78.3693; Sun QC, 1998, TAPPI J, V81, P177; Thurn-Albrecht T, 2000, MACROMOLECULES, V33, P3250, DOI 10.1021/ma991896z; TONG WM, 1994, ANNU REV PHYS CHEM, V45, P401; Walheim S, 1999, SCIENCE, V283, P520, DOI 10.1126/science.283.5401.520; WHITEHOUSE DJ, 1993, P I MECH ENG B-J ENG, V207, P31, DOI 10.1243/PIME_PROC_1993_207_059_02; WILLMOUTH FM, 1986, OPTICAL PROPERTIES P; Zettsu N, 2001, ADV MATER, V13, P1693, DOI 10.1002/1521-4095(200111)13:22<1693::AID-ADMA1693>3.0.CO;2-2	41	203	213	3	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 9	2002	297	5583					973	976		10.1126/science.1074955	http://dx.doi.org/10.1126/science.1074955			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169724				2022-12-28	WOS:000177325400033
J	Gilbert, N; Lutz-Prigge, S; Moran, JV				Gilbert, N; Lutz-Prigge, S; Moran, JV			Genomic deletions created upon LINE-1 retrotransposition	CELL			English	Article							HUMAN L1 RETROTRANSPOSITION; HUMAN TRANSPOSABLE ELEMENT; REVERSE TRANSCRIPTION; ESCHERICHIA-COLI; GENE; RNA; CELLS; RECOMBINATION; ENDONUCLEASE; MECHANISM	LINE-1 (L1) retrotransposition continues to impact the human genome, yet little is known about how L1 integrates into DNA. Here, we developed a plasmid-based rescue system and have used it to recover 37 new Ll retrotransposition events from cultured human cells. Sequencing of the insertions revealed the usual Ll structural hallmarks; however, in four instances, retrotransposition generated large target site deletions. Remarkably, three of those resulted in the formation of chimeric Lls, containing the 5' end of an endogenous L1 fused precisely to our engineered L1. Thus, our data demonstrate multiple pathways for Ll integration in cultured cells, and show that L1 is not simply an insertional mutagen, but that its retrotransposition can result in significant deletions of genomic sequence.	Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gilbert, N (corresponding author), Univ Michigan, Sch Med, Dept Human Genet, 1241 E Catherine St, Ann Arbor, MI 48109 USA.	gilbertn@umich.edu; moranj@umich.edu	Gilbert, Nicolas/M-9568-2018	Gilbert, Nicolas/0000-0003-3311-7494; Lutz, Sheila/0000-0002-6729-4598	NIGMS NIH HHS [GM60518] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060518] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boeke JD, 1997, NAT GENET, V16, P6, DOI 10.1038/ng0597-6; Carroll ML, 2001, J MOL BIOL, V311, P17, DOI 10.1006/jmbi.2001.4847; Chaboissier MC, 2000, NUCLEIC ACIDS RES, V28, P2467, DOI 10.1093/nar/28.13.2467; Cost GJ, 1998, BIOCHEMISTRY-US, V37, P18081, DOI 10.1021/bi981858s; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Garvey SM, 2002, GENOMICS, V79, P146, DOI 10.1006/geno.2002.6685; Hayakawa T, 2001, P NATL ACAD SCI USA, V98, P11399, DOI 10.1073/pnas.191268198; Hayward BE, 1997, GENETICS, V146, P641; Hohjoh H, 1997, EMBO J, V16, P6034, DOI 10.1093/emboj/16.19.6034; Hohjoh H, 1996, EMBO J, V15, P630, DOI 10.1002/j.1460-2075.1996.tb00395.x; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; KASS DH, 1995, MOL CELL BIOL, V15, P19, DOI 10.1128/MCB.15.1.19; Kojima T, 2000, MOL BRAIN RES, V75, P121, DOI 10.1016/S0169-328X(99)00313-7; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liao DQ, 1998, J MOL EVOL, V46, P649, DOI 10.1007/PL00006345; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; LUAN DD, 1995, MOL CELL BIOL, V15, P3882; MARTIN SL, 1991, MOL CELL BIOL, V11, P4804, DOI 10.1128/MCB.11.9.4804; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; Moran J.V., 2002, MOBILE DNA, P836; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Ostertag EM, 2001, GENOME RES, V11, P2059, DOI 10.1101/gr.205701; Ovchinnikov I, 2001, GENOME RES, V11, P2050, DOI 10.1101/gr.194701; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; Saxton JA, 1998, J MOL BIOL, V280, P611, DOI 10.1006/jmbi.1998.1899; Segal Y, 1999, AM J HUM GENET, V64, P62, DOI 10.1086/302213; Sheen FM, 2000, GENOME RES, V10, P1496, DOI 10.1101/gr.149400; Su LK, 2000, HUM GENET, V106, P101, DOI 10.1007/s004390051016; SWERGOLD GD, 1990, MOL CELL BIOL, V10, P6718, DOI 10.1128/MCB.10.12.6718; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; TANG XR, 1994, NUCLEIC ACIDS RES, V22, P2857, DOI 10.1093/nar/22.14.2857; Wang T, 2001, GENE CHROMOSOME CANC, V31, P91, DOI 10.1002/gcc.1110; Wei W, 2000, ANAL BIOCHEM, V284, P435, DOI 10.1006/abio.2000.4675; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001	39	360	367	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 9	2002	110	3					315	325		10.1016/S0092-8674(02)00828-0	http://dx.doi.org/10.1016/S0092-8674(02)00828-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	583MN	12176319	Bronze			2022-12-28	WOS:000177411800008
J	Matheson, RR				Matheson, RR			20th-to 21st-century technological challenges in soft coatings	SCIENCE			English	Article								Coatings are among the most ancient technologies of humankind. Relatively soft coatings comprising organic materials such as blood, eggs, and extracts from plants were in use more than 20,000 years ago, and coating activity has been continuously practiced since then with gradually improving materials and application techniques. The fundamental purposes of protecting and/or decorating substrates have remained ubiquitous across all the centuries and cultures of civilization. This article attempts to extrapolate the long tale of change in soft coating technology from its current state by identifying some key problems that attract research and development efforts as our 21st century begins.	DuPont Performance Coatings, Troy, MI 48083 USA	DuPont	Matheson, RR (corresponding author), DuPont Performance Coatings, 950 Stephenson Highway, Troy, MI 48083 USA.							ADAMSONS K, 1997, P 23 INT C ORG COAT, P151; CHUNG K, 2002, NY TIMES        0305, P23; HOUSOTTEFILBERT C, 1997, Patent No. 5681877; NICHOLS M, 2001, RAD TECH REPORT  NOV; NYLEN P, 1965, MODERN SURFACE COATI, P1; OSTERHOLTZ FD, 1992, J ADHES SCI TECHNOL, V6, P127, DOI 10.1163/156856192X00106; PREUSS VP, 1970, PAINT ADDITIVES; VANKREVELEN DW, 1976, PROPERTIES POLYM, P275; WEBSTER OW, 1983, Patent No. 4417034	9	30	34	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2002	297	5583					976	979		10.1126/science.1075707	http://dx.doi.org/10.1126/science.1075707			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169725				2022-12-28	WOS:000177325400034
J	Miller, MB; Skorupski, K; Lenz, DH; Taylor, RK; Bassler, BL				Miller, MB; Skorupski, K; Lenz, DH; Taylor, RK; Bassler, BL			Parallel quorum sensing systems converge to regulate virulence in Vibrio cholerae	CELL			English	Article							ACYLHOMOSERINE LACTONE SYNTHASE; LOCUS CONTROLLING EXPRESSION; TOXIN-COREGULATED PILUS; GRAM-NEGATIVE BACTERIA; AUTOINDUCER SYNTHESIS; S-ADENOSYLMETHIONINE; NUCLEOTIDE-SEQUENCE; HOMOSERINE LACTONES; GENETIC-ANALYSIS; EL-TOR	The marine bacterium Vibrio harveyi possesses two quorum sensing systems (System I and System 2) that regulate bioluminescence. Although the Vibrio cholerae genome sequence reveals that a V. harveyi-like System 2 exists, it does not predict the existence of a V. harveyi-like System 1 or any obvious quorum sensing-controlled target genes. In this report we identify and characterize the genes encoding an additional V. cholerae autoinducer synthase and its cognate sensor. Analysis of double mutants indicates that a third as yet unidentified sensory circuit exists in V. cholerae. This quorum sensing apparatus is unusually complex, as it is composed of at least three parallel signaling channels. We show that in V. cholerae these communication systems converge to control virulence.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Dartmouth Coll Sch Med, Dept Microbiol & Immunol, Hanover, NH 03755 USA	Princeton University; Dartmouth College	Bassler, BL (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.			Bassler, Bonnie/0000-0002-0043-746X	NIAID NIH HHS [AI39654, AI41558] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041558, R29AI041558, R01AI039654] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; BASSLER BL, 1994, MOL MICROBIOL, V12, P403, DOI 10.1111/j.1365-2958.1994.tb01029.x; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; CAO JG, 1989, J BIOL CHEM, V264, P21670; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; de Kievit TR, 2000, INFECT IMMUN, V68, P4839, DOI 10.1128/IAI.68.9.4839-4849.2000; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; DERITA VJ, 1991, P NATL ACAD SCI USA, V88, P5403; ENGEBRECHT J, 1987, NUCLEIC ACIDS RES, V15, P10455, DOI 10.1093/nar/15.24.10455; ENGEBRECHT J, 1984, P NATL ACAD SCI-BIOL, V81, P4154, DOI 10.1073/pnas.81.13.4154; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Freeman JA, 1999, J BACTERIOL, V181, P899, DOI 10.1128/JB.181.3.899-906.1999; Freeman JA, 1999, MOL MICROBIOL, V31, P665, DOI 10.1046/j.1365-2958.1999.01208.x; Freeman JA, 2000, MOL MICROBIOL, V35, P139, DOI 10.1046/j.1365-2958.2000.01684.x; GARDEL CL, 1994, METHOD ENZYMOL, V235, P517; GILSON L, 1995, J BACTERIOL, V177, P6946, DOI 10.1128/jb.177.23.6946-6951.1995; Hanzelka BL, 1996, J BACTERIOL, V178, P5291, DOI 10.1128/jb.178.17.5291-5294.1996; Hanzelka BL, 1999, J BACTERIOL, V181, P5766, DOI 10.1128/JB.181.18.5766-5770.1999; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; IWANAGA M, 1986, MICROBIOL IMMUNOL, V30, P1075, DOI 10.1111/j.1348-0421.1986.tb03037.x; Jobling MG, 1997, MOL MICROBIOL, V26, P1023, DOI 10.1046/j.1365-2958.1997.6402011.x; Kalogeraki VS, 1997, GENE, V188, P69, DOI 10.1016/S0378-1119(96)00778-0; Kleerebezem M, 1997, MOL MICROBIOL, V24, P895, DOI 10.1046/j.1365-2958.1997.4251782.x; Klose KE, 1998, J BACTERIOL, V180, P5256, DOI 10.1128/JB.180.19.5256-5259.1998; Laue RE, 2000, MICROBIOL-UK, V146, P2469, DOI 10.1099/00221287-146-10-2469; Lazazzera BA, 1998, TRENDS MICROBIOL, V6, P288, DOI 10.1016/S0966-842X(98)01313-4; Lilley BN, 2000, MOL MICROBIOL, V36, P940, DOI 10.1046/j.1365-2958.2000.01913.x; Liu PC, 1996, CURR MICROBIOL, V33, P129, DOI 10.1007/s002849900087; Manefield M, 2000, APPL ENVIRON MICROB, V66, P2079, DOI 10.1128/AEM.66.5.2079-2084.2000; MARTIN M, 1989, J BACTERIOL, V171, P2406, DOI 10.1128/jb.171.5.2406-2414.1989; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; More MI, 1996, SCIENCE, V272, P1655, DOI 10.1126/science.272.5268.1655; PALMER LM, 1991, APPL ENVIRON MICROB, V57, P1286, DOI 10.1128/AEM.57.5.1286-1293.1991; Parsek MR, 1999, P NATL ACAD SCI USA, V96, P4360, DOI 10.1073/pnas.96.8.4360; PIPER KR, 1993, NATURE, V362, P448, DOI 10.1038/362448a0; Ravn L, 2001, J MICROBIOL METH, V44, P239, DOI 10.1016/S0167-7012(01)00217-2; Sambrook J., 2002, MOL CLONING LAB MANU; Schaefer AL, 2000, METHOD ENZYMOL, V305, P288; Schaefer AL, 2001, METHOD ENZYMOL, V336, P41, DOI 10.1016/S0076-6879(01)36576-X; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Schauder S, 2001, GENE DEV, V15, P1468, DOI 10.1101/gad.899601; Shaw PD, 1997, P NATL ACAD SCI USA, V94, P6036, DOI 10.1073/pnas.94.12.6036; SHOWALTER RE, 1990, J BACTERIOL, V172, P2946, DOI 10.1128/jb.172.6.2946-2954.1990; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; Skorupski K, 1997, MOL MICROBIOL, V25, P1003, DOI 10.1046/j.1365-2958.1997.5481909.x; SLAUCH JM, 1991, J BACTERIOL, V173, P4039, DOI 10.1128/jb.173.13.4039-4048.1991; SUN D, 1991, INFECT IMMUN, V59, P114, DOI 10.1128/IAI.59.1.114-118.1991; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Thelin KH, 1996, INFECT IMMUN, V64, P2853, DOI 10.1128/IAI.64.7.2853-2856.1996; Val DL, 1998, J BACTERIOL, V180, P2644, DOI 10.1128/JB.180.10.2644-2651.1998; ZHANG LH, 1993, NATURE, V362, P446, DOI 10.1038/362446a0; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	57	480	519	3	81	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 9	2002	110	3					303	314		10.1016/S0092-8674(02)00829-2	http://dx.doi.org/10.1016/S0092-8674(02)00829-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	583MN	12176318	Bronze			2022-12-28	WOS:000177411800007
J	Gallagher, GT; Lyle, S; Scully, RE; Durand, ML; Duncan, LM				Gallagher, GT; Lyle, S; Scully, RE; Durand, ML; Duncan, LM			A 48-year-old man with persistent erosive oral lesions - Lichen planus.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RECURRENT APHTHOUS STOMATITIS; HEPATITIS-C VIRUS; CLINICAL-FEATURES; HCV INFECTION; PEMPHIGUS; DISEASE; UPDATE; MANAGEMENT; ENTITY		Boston Univ, Goldman Sch Dent Med, Boston, MA 02215 USA	Boston University	Gallagher, GT (corresponding author), Boston Univ, Goldman Sch Dent Med, Boston, MA 02215 USA.							Albert M R, 1998, J Cutan Med Surg, V3, P109; Chorzelski TP, 1998, EUR J DERMATOL, V8, P261; Chuang TY, 1999, J AM ACAD DERMATOL, V41, P787, DOI 10.1016/S0190-9622(99)70025-3; Cohen DM, 1999, ORAL SURG ORAL MED O, V88, P196, DOI 10.1016/S1079-2104(99)70117-4; Dayan S, 1999, ORAL SURG ORAL MED O, V88, P424, DOI 10.1016/S1079-2104(99)70056-9; Edelson RL, 2000, NEW ENGL J MED, V343, P60, DOI 10.1056/NEJM200007063430111; Eisen D, 1999, ORAL SURG ORAL MED O, V88, P431, DOI 10.1016/S1079-2104(99)70057-0; Ingafou M, 1998, INT J ORAL MAX SURG, V27, P65, DOI 10.1016/S0901-5027(98)80101-X; Jonkman MF, 2000, ARCH DERMATOL, V136, P227, DOI 10.1001/archderm.136.2.227; Krause I, 1999, J ORAL PATHOL MED, V28, P193; LOZADANUR F, 1994, ORAL SURG ORAL MED O, V77, P598, DOI 10.1016/0030-4220(94)90318-2; Mignogna MD, 1998, INT J DERMATOL, V37, P575, DOI 10.1046/j.1365-4362.1998.00510.x; Mignogna MD, 2000, INT J DERMATOL, V39, P134, DOI 10.1046/j.1365-4362.2000.00903.x; Porter SR, 1998, CRIT REV ORAL BIOL M, V9, P306, DOI 10.1177/10454411980090030401; Roy K M, 2000, Clin Lab, V46, P251; Scully C, 1999, ORAL SURG ORAL MED O, V88, P56, DOI 10.1016/S1079-2104(99)70194-0; Scully C, 1999, BRIT J DERMATOL, V140, P84; Setterfield JF, 2000, CLIN EXP DERMATOL, V25, P176, DOI 10.1046/j.1365-2230.2000.00607.x; Ship JA, 1996, ORAL SURG ORAL MED O, V81, P141, DOI 10.1016/S1079-2104(96)80403-3; Silverman S, 1997, AM J DENT, V10, P259; Sklavounou A, 1998, ORAL ONCOL, V34, P437, DOI 10.1016/S1368-8375(98)00059-1; Takeuchi Yoshio, 2000, Journal of Dermatology (Tokyo), V27, P94; van der Meij EH, 2000, J ORAL PATHOL MED, V29, P255; Warren SJP, 2000, NEW ENGL J MED, V343, P23, DOI 10.1056/NEJM200007063430104; Yancey KB, 2000, JAMA-J AM MED ASSOC, V284, P350, DOI 10.1001/jama.284.3.350	25	0	0	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 8	2002	347	6					430	436		10.1056/NEJMcpc020107	http://dx.doi.org/10.1056/NEJMcpc020107			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587YR	12167686				2022-12-28	WOS:000177672400008
J	Pauly, D; Christensen, V; Guenette, S; Pitcher, TJ; Sumaila, UR; Walters, CJ; Watson, R; Zeller, D				Pauly, D; Christensen, V; Guenette, S; Pitcher, TJ; Sumaila, UR; Walters, CJ; Watson, R; Zeller, D			Towards sustainability in world fisheries	NATURE			English	Review							MARINE RESERVES; TROPHIC CASCADES; STOCK ASSESSMENT; NORTHERN COD; FISH STOCKS; MANAGEMENT; CONSERVATION; ECOSYSTEMS; RESOURCES; COLLAPSE	Fisheries have rarely been 'sustainable'. Rather, fishing has induced serial depletions, long masked by improved technology, geographic expansion and exploitation of previously spurned species lower in the food web. With global catches declining since the late 1980s, continuation of present trends will lead to supply shortfall, for which aquaculture cannot be expected to compensate, and may well exacerbate. Reducing fishing capacity to appropriate levels will require strong reductions of subsidies. Zoning the oceans into unfished marine reserves and areas with limited levels of fishing effort would allow sustainable fisheries, based on resources embedded in functional, diverse ecosystems.	Univ British Columbia, Fisheries Ctr, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Pauly, D (corresponding author), Univ British Columbia, Fisheries Ctr, 2204 Main Mall, Vancouver, BC V6T 1Z4, Canada.	d.pauly@fisheries.ubc.ca	Sumaila, U. Rashid/ABE-6475-2020; Watson, Reg A/F-4850-2012; Walters, Carl/D-5714-2012; Pauly, Daniel Marc/AAY-2316-2021; Christensen, Villy/C-3945-2009	Watson, Reg A/0000-0001-7201-8865; Christensen, Villy/0000-0003-0688-2633; Zeller, Dirk/0000-0001-7304-4125; Pauly, Daniel/0000-0003-3756-4793				Alverson DL, 1994, FISH TECHNOL, DOI DOI 10.3168/JDS.S0022-0302(94)77044-2; Beverton R.J.H., 1957, FISH INVEST SER, P19; BOHNSACK JA, 1990, NMFSSEFC261 NOAA; BOYD RT, 1990, HDB AM INDIANS NW CO, P135; BRAY K, 2000, IUU20006 FAO UN, P53; Caddy JF, 2000, OCEAN COAST MANAGE, V43, P615, DOI 10.1016/S0964-5691(00)00052-1; Casey JM, 1998, SCIENCE, V281, P690, DOI 10.1126/science.281.5377.690; Castillo S., 1987, PERUVIAN ANCHOVETA I, P109; Choat J. Howard, 2002, P57; CHRISTENSEN V, 2002, FISHERIES IMPACTS N, P1; Clark C.W., 1990, MATH BIOECONOMICS OP, V2nd; Clark WG, 1999, CAN J FISH AQUAT SCI, V56, P242, DOI 10.1139/cjfas-56-2-242; Cochrane KL, 2000, FISH FISH, V1, P3, DOI 10.1046/j.1467-2979.2000.00003.x; CUSHING DH, 1987, PROVIDENT SEA; Daskalov GM, 2002, MAR ECOL PROG SER, V225, P53, DOI 10.3354/meps225053; Dayton PK, 1998, SCIENCE, V279, P821, DOI 10.1126/science.279.5352.821; Edeson W.R., 1996, INT J MARINE COASTAL, V11, P233, DOI DOI 10.1163/157180896X00104; FEIGON L, 2000, J CONTEMP CHINA, V9, P323; FORREST R, 2001, FISHERIES IMPACTS N, P81; FROESE R, 2000, FISHBASE 2000 CONCEP; Garcia SM, 1997, AM FISH S S, V20, P3; Gislason H, 2000, ICES J MAR SCI, V57, P468, DOI 10.1006/jmsc.2000.0741; Gordon HS, 1954, J POLIT ECON, V62, P124, DOI 10.1086/257497; GRAINGER RJR, 1996, 359 FAO UN; Guenette S, 2000, B MAR SCI, V66, P831; HALL SJ, 1998, EFFECTS FISHERIES EC; Hardy A., 1956, OPEN SEA; Hutchings JA, 2000, MAR ECOL PROG SER, V208, P299; Hutchings JA, 2000, NATURE, V406, P882, DOI 10.1038/35022565; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kaczynski VM, 2002, MAR POLICY, V26, P75, DOI 10.1016/S0308-597X(01)00039-2; Koslow JA, 2000, ICES J MAR SCI, V57, P548, DOI 10.1006/jmsc.2000.0722; Law R, 2000, ICES J MAR SCI, V57, P659, DOI 10.1006/jmsc.2000.0731; LEWIS JB, 1977, BIOL REV, V52, P305, DOI 10.1111/j.1469-185X.1977.tb00836.x; Lindholm JB, 1999, MAR ECOL PROG SER, V180, P247, DOI 10.3354/meps180247; Lipcius RN, 2001, LOW WAKE FI, V17, P643; Longhurst A, 1998, FISH RES, V38, P101, DOI 10.1016/S0165-7836(98)00152-0; LUDWIG D, 1993, SCIENCE, V260, P17, DOI 10.1126/science.260.5104.17; Mace P. M., 1997, DEV SUSTAINING WORLD, P1; Mace PM, 2001, FISH FISH, V2, P2, DOI 10.1046/j.1467-2979.2001.00033.x; Milazzo, 1998, WORLD BANK TECHNICAL; Mills CE, 2001, HYDROBIOLOGIA, V451, P55, DOI 10.1023/A:1011888006302; Mosqueira I, 2000, ANIM CONSERV, V3, P321, DOI 10.1017/S1367943000001049; MUNRO GR, 1979, CAN J ECON, V12, P355, DOI 10.2307/134727; MUNRO GR, 2001, 9 U BRIT COL FISH CT, P10; Murawski SA, 2000, B MAR SCI, V66, P775; Myers RA, 1997, ECOL APPL, V7, P91, DOI 10.1890/1051-0761(1997)007[0091:WDFSCT]2.0.CO;2; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; Orensanz JML, 1998, REV FISH BIOL FISHER, V8, P117, DOI 10.1023/A:1008891412756; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; Parsons Timothy R., 1996, P352; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Pauly D., 2001, CONSERVATION BIOL PR, V2, P25; PAULY S, 1997, SMALL SCALE FISHERIE; Perry RI, 1999, REV FISH BIOL FISHER, V9, P125, DOI 10.1023/A:1008946522213; Pinnegar JK, 2000, ENVIRON CONSERV, V27, P179, DOI 10.1017/S0376892900000205; Pitcher TJ, 1998, REV FISH BIOL FISHER, V8, P367, DOI 10.1023/A:1008804029850; Pitcher TJ, 2001, ECOL APPL, V11, P601; PULLIN RSV, 1993, ENV AQUACULTURE DEV; Punt AE, 2000, POPUL ECOL, V42, P19, DOI 10.1007/s101440050005; Rawski TG, 2001, CHINA ECON REV, V12, P298, DOI 10.1016/S1043-951X(01)00074-8; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; ROSENBERG AA, 1993, SCIENCE, V262, P828, DOI 10.1126/science.262.5135.828; Russ G.R., 1991, P601; Russ Garry R., 2002, P421, DOI 10.1016/B978-012615185-5/50024-4; Sadovy Y, 2001, J FISH BIOL, V59, P90, DOI 10.1006/jfbi.2001.1760; Sadovy Yvonne J., 2002, P391, DOI 10.1016/B978-012615185-5/50023-2; Sainsbury KJ, 2000, ICES J MAR SCI, V57, P731, DOI 10.1006/jmsc.2000.0737; Schaefer MB., 1954, INT AM TROPICAL TUNA, V1, P23; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; SILVESTRE G, 1997, STATUS MANAGEMENT TR; Spalding M. D., 2001, WORLD ATLAS CORAL RE; Spalding MD, 1997, CORAL REEFS, V16, P225, DOI 10.1007/s003380050078; Steele JH, 1998, ECOL APPL, V8, pS33, DOI 10.1890/1051-0761(1998)8[S33:RSIME]2.0.CO;2; Stephens D.W., 1986, pi; Stergiou KI, 2002, FISH RES, V55, P1; Sumaila U. R., 1997, Environmental and Resource Economics, V10, P147, DOI 10.1023/A:1026459309123; Sumaila U.R., 2000, MICROBEHAVIOR MACROR, P7; SUMAILA UR, 1999, P EXP 98 C OC FOOD W, P87; SUMAILA UR, 2000, FISH ETHICS JUSTICE, P140; Thorpe A., 2001, Marine Resource Economics, V16, P143; Tupper MH, 2002, SCIENCE, V295, P1233; Turner SJ, 1999, FISHERIES MANAG ECOL, V6, P401, DOI 10.1046/j.1365-2400.1999.00167.x; ULANOWICZ R E, 1990, Coenoses, V5, P7; *UNCLOS, 1982, UN CONV LAW SEA; Van Dolah FM, 2001, HUM ECOL RISK ASSESS, V7, P1329; VITOUSEK PM, 1986, BIOSCIENCE, V36, P368, DOI 10.2307/1310258; Walters C, 1996, REV FISH BIOL FISHER, V6, P125; Walters C, 2001, CAN J FISH AQUAT SCI, V58, P39, DOI 10.1139/cjfas-58-1-39; Walters C, 2000, ECOSYSTEMS, V3, P70, DOI 10.1007/s100210000011; Watling L, 1998, CONSERV BIOL, V12, P1180, DOI 10.1046/j.1523-1739.1998.0120061180.x; Watson R, 2001, NATURE, V414, P534, DOI 10.1038/35107050; Wing ES, 2001, INT J OSTEOARCHAEOL, V11, P112, DOI 10.1002/oa.550; YELLEN JE, 1995, SCIENCE, V268, P553, DOI 10.1126/science.7725100; Zeller DC, 1997, MAR ECOL PROG SER, V154, P65, DOI 10.3354/meps154065; [No title captured]	100	1912	2011	17	1392	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2002	418	6898					689	695		10.1038/nature01017	http://dx.doi.org/10.1038/nature01017			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167876				2022-12-28	WOS:000177305600056
J	Hollifield, M; Warner, TD; Lian, N; Krakow, B; Jenkins, JH; Kesler, J; Stevenson, J; Westermeyer, J				Hollifield, M; Warner, TD; Lian, N; Krakow, B; Jenkins, JH; Kesler, J; Stevenson, J; Westermeyer, J			Measuring trauma and health status in refugees - A critical review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							POSTTRAUMATIC-STRESS-DISORDER; SOUTHEAST-ASIAN REFUGEES; TAMIL ASYLUM-SEEKERS; QUALITY-OF-LIFE; MENTAL-HEALTH; PSYCHOLOGICAL SEQUELAE; WAR TRAUMA; BOSNIAN REFUGEES; EVENT SCALE; PSYCHIATRIC-ILLNESS	Context Refugees experience multiple traumatic events and have significant associated health problems, but data about refugee trauma and health status are often conflicting and difficult to interpret. Objectives To assess the characteristics of the literature on refugee trauma and health, to identify and evaluate instruments used to measure refugee trauma and health status, and to recommend improvements. Data Sources MEDLINE, PsychInfo, Health and PsychoSocial Instruments, CINAHL, and Cochrane Systematic Reviews (searched through OVID from the inception of each database to October 2001), and the New Mexico Refugee Project database. Study Selection Key terms and combination operators were applied to identify English-language publications evaluating measurement of refugee trauma and/or health status. Data Extraction Information extracted for each article included author; year of publication; primary focus; type (empirical, review, or descriptive); and type/name and properties of instrument(s) included. Articles were excluded from further analyses if they were review or descriptive, were not primarily about refugee health status or trauma, or were only about infectious diseases. Instruments were then evaluated according to 5 criteria (purpose, construct definition, design, developmental process, reliability and validity) as described in the published literature. Data Synthesis Of 394 publications identified, 183 were included for further analyses of their characteristics; 91 (49.7%) included quantitative data but did not evaluate measurement properties of instruments used in refugee research, 78 (42.6%) reported on statistical relationships between measures (presuming validity), and 14 (7.7%) were only about statistical properties of instruments. In these 183 publications, 125 different instruments were used; of these, 12 were developed in refugee research. None of these instruments fully met all 5 evaluation criteria, 3 met 4 criteria, and 5 met only 1 of the criteria. Another 8 standard instruments were designed and developed in non-refugee populations but adapted for use in refugee research; of these, 2 met all 5 criteria and 6 met 4 criteria. Conclusions The majority of articles about refugee trauma or health are either descriptive or include quantitative data from instruments that have limited or untested validity and reliability in refugees. Primary limitations to accurate measurement in refugee research are the lack of theoretical bases to instruments and inattention to using and reporting sound measurement principles.	Univ New Mexico, Hlth Sci Ctr, Dept Psychiat, Albuquerque, NM 87131 USA; Univ New Mexico, Hlth Sci Ctr, Dept Family & Community Med, Albuquerque, NM 87131 USA; Sleep & Human Hlth Inst, Albuquerque, NM USA; Case Western Reserve Univ, Dept Anthropol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44106 USA; No Colorado Family Practice Ctr, Greeley, CO USA; Univ Minnesota, Minneapolis, MN USA; Minneapolis Vet Affairs Ctr, Minneapolis, MN USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; Case Western Reserve University; Case Western Reserve University; University of Minnesota System; University of Minnesota Twin Cities	Hollifield, M (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Psychiat, 2400 Tucker Ave NE, Albuquerque, NM 87131 USA.		Breakwell, Lauren/ABD-2739-2020; WARNER, TEDDY/AAI-6905-2020		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059574] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH 59574] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Achenbach TM, 1983, MANUAL CHILD BEHAV C; Allden K, 1996, AM J PUBLIC HEALTH, V86, P1561, DOI 10.2105/AJPH.86.11.1561; ALLODI F, 1982, CAN J PSYCHIAT, V27, P98, DOI 10.1177/070674378202700203; ALLODI FA, 1991, J NERV MENT DIS, V179, P4, DOI 10.1097/00005053-199101000-00002; Allotey P, 1998, WOMEN HEALTH, V28, P63; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; BASOGLU M, 1994, JAMA-J AM MED ASSOC, V272, P357, DOI 10.1001/jama.272.5.357; BASOGLU M, 1994, AM J PSYCHIAT, V151, P76; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BEISER M, 1986, PSYCHOL MED, V16, P627, DOI 10.1017/S0033291700010382; Bernard HR, 1994, RES METHODS ANTHR QU; Bolton P, 2001, J NERV MENT DIS, V189, P243, DOI 10.1097/00005053-200104000-00006; Bolton P, 2001, J NERV MENT DIS, V189, P238, DOI 10.1097/00005053-200104000-00005; BONNERJEA L, 1985, SHAMING WORLD NEEDS; BRETT EA, 1985, AM J PSYCHIAT, V142, P417; BRETT EA, 1988, AM J PSYCHIAT, V145, P1232; BRODMAN K, 1956, MANUAL CORNELL MED I; BROWN AC, 1962, J PSYCHOSOM RES, V6, P185, DOI 10.1016/0022-3999(62)90005-3; BROWN GW, 1972, J PSYCHOSOM RES, V16, P311, DOI 10.1016/0022-3999(72)90083-9; Brugha TS, 1999, PSYCHOL MED, V29, P1029, DOI 10.1017/S0033291799008892; BUTCHER JN, 1991, MENTAL HLTH SERVICES, P111; CARLSON EB, 1994, J TRAUMA STRESS, V7, P43, DOI 10.1007/BF02111911; Castillo R, 1995, Arch Fam Med, V4, P637, DOI 10.1001/archfami.4.7.637; CERVANTES RC, 1989, HOSP COMMUNITY PSYCH, V40, P615; CHESTER B, 1992, WESTERN J MED, V157, P301; Cheung P, 1994, Int J Soc Psychiatry, V40, P17, DOI 10.1177/002076409404000102; CHEUNG P, 1993, AUST NZ J PSYCHIAT, V27, P422, DOI 10.3109/00048679309075798; CHUNG RCY, 1995, J NERV MENT DIS, V183, P639, DOI 10.1097/00005053-199510000-00005; CHUNG RCY, 1993, SOC SCI MED, V36, P631, DOI 10.1016/0277-9536(93)90060-H; CLARKE G, 1993, J ABNORM CHILD PSYCH, V21, P65, DOI 10.1007/BF00910489; COHEN P, 1984, ARCH GEN PSYCHIAT, V41, P1178; COOK TD, 1979, QUASI EXPT DESIGN AN; Cunningham M, 1997, AUST NZ J PSYCHIAT, V31, P555, DOI 10.3109/00048679709065078; DEGIROLAMO G, 1996, ETHNOCULTURAL ASPECT; Derogatis L. R., 1974, MODERN PROBLEMS PHAR; DEROGATIS LR, 1977, J CLIN PSYCHOL, V33, P981, DOI 10.1002/1097-4679(197710)33:4<981::AID-JCLP2270330412>3.0.CO;2-0; DEVRIES J, 1994, INT J MENT HEALTH, V23, P57, DOI 10.1080/00207411.1994.11449287; Dyregrov A, 1996, SCAND J PSYCHOL, V37, P339, DOI 10.1111/j.1467-9450.1996.tb00667.x; EITINGER L, 1960, J MENT SCI, V106, P947, DOI 10.1192/bjp.106.444.947; Eitinger L., 1964, CONCENTRATION CAMP S; EKBLAD S, 1999, TRANSCULT PSYCHIATRY, V36, P329; Fawzi MCS, 1997, ACTA PSYCHIAT SCAND, V95, P87, DOI 10.1111/j.1600-0447.1997.tb00379.x; FOY DW, 1992, TREATING PTSD COGNIT; Friedman Matthew J., 1995, P507; Gavagan T, 1998, AM FAM PHYSICIAN, V57, P1061; GOLDFELD AE, 1988, JAMA-J AM MED ASSOC, V259, P2725, DOI 10.1001/jama.259.18.2725; GONGGUY E, 1987, 8576282A2 AS COMM ME; GREEN BL, 1985, J NERV MENT DIS, V173, P406, DOI 10.1097/00005053-198507000-00004; GREEN BL, 1996, INT REV PSYCHIATR, P177; HARRIS LE, 1993, AM J KIDNEY DIS, V21, P161, DOI 10.1016/S0272-6386(12)81087-0; HAUFF E, 1993, ACTA PSYCHIAT SCAND, V88, P162, DOI 10.1111/j.1600-0447.1993.tb03432.x; Helitzer-Allen D, 1994, REPROD HEALTH MATTER, V2, P75, DOI DOI 10.1016/0968-8080(94)90084-1; HERMAN JL, 1992, J TRAUMA STRESS, V5, P377, DOI 10.1007/BF00977235; Hollifield M, 1997, AM J PSYCHIAT, V154, P766; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; HOROWITZ MJ, 1980, ARCH GEN PSYCHIAT, V37, P85; HOUGEN HP, 1988, FORENSIC SCI INT, V36, P153, DOI 10.1016/0379-0738(88)90229-0; HOUGEN HP, 1988, FORENSIC SCI INT, V39, P5, DOI 10.1016/0379-0738(88)90113-2; JENKINS JH, 1996, CULTURE PSYCHIAT DIA; JULIUS M, 1989, AM J KIDNEY DIS, V13, P61, DOI 10.1016/S0272-6386(89)80118-0; KALUCY RS, 1988, MED J AUSTRALIA, V148, P321, DOI 10.5694/j.1326-5377.1988.tb133728.x; Keyes E F, 2000, Issues Ment Health Nurs, V21, P397, DOI 10.1080/016128400248013; KINZIE JD, 1987, HOSP COMMUNITY PSYCH, V38, P190; KINZIE JD, 1982, AM J PSYCHIAT, V139, P1276; Kleinman Arthur, 1998, RETHINKING PSYCHIAT; Krakow B, 2000, J TRAUMA STRESS, V13, P589, DOI 10.1023/A:1007854015481; Leighton D, 1963, CHARACTER DANGER; LIN KM, 1979, ARCH GEN PSYCHIAT, V36, P955; LIPMAN RS, 1979, J AFFECT DISORDERS, V1, P9, DOI 10.1016/0165-0327(79)90021-1; Litz BT, 1997, AM J PSYCHIAT, V154, P178; MCCLOSKEY LA, 1995, J COMMUNITY PSYCHOL, V23, P95, DOI 10.1002/1520-6629(199504)23:2<95::AID-JCOP2290230202>3.0.CO;2-A; MCDOWELL I, 1996, QUALITY WELL BEING S, P483; Mollica R., HARVARD TRAUMA QUEST; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; MOLLICA RF, 1987, AM J PSYCHIAT, V144, P497; MOLLICA RF, 1987, AM J PSYCHIAT, V144, P1567; Mollica RF, 1999, JAMA-J AM MED ASSOC, V282, P433, DOI 10.1001/jama.282.5.433; MOLLICA RF, 1990, AM J PSYCHIAT, V147, P83; MOLLICA RF, 1993, JAMA-J AM MED ASSOC, V270, P581, DOI 10.1001/jama.270.5.581; Mollica RF, 1991, PSYCHOL ASSESSMENT J, V3, P581, DOI DOI 10.1037/1040-3590.3.4; MOSSEY JM, 1982, AM J PUBLIC HEALTH, V72, P800, DOI 10.2105/AJPH.72.8.800; *NAT I MENT HLTH, 1998, MENT HLTH RES SURV T; NORBECK JS, 1981, NURS RES, V30, P264; Norris Fran H., 1997, P7; PARLOFF MB, 1954, AM J PSYCHIAT, V111, P343, DOI 10.1176/ajp.111.5.343; Paton Douglas, 1990, COUNS PSYCHOL, V3, P149; Pedersen S, 1949, PSYCHOANAL REV, V36, P344; PELTO PJ, 1984, ANTHR RES STRUCTURE; PETERSEN HD, 1994, FORENSIC SCI INT, V67, P9, DOI 10.1016/0379-0738(94)90406-5; Porter M, 2001, J TRAUMA STRESS, V14, P817, DOI 10.1023/A:1013054524810; PUNAMAKI RL, 1989, INT J MENT HEALTH, V17, P3; RASMUSSEN OV, 1977, EVIDENCE TORTURE; Roth S, 1997, J TRAUMA STRESS, V10, P539, DOI 10.1002/jts.2490100403; Sartorius N., 1996, MENTAL HLTH OUTCOME, P153; SCHNURR PP, 1996, PTSD RES Q, V7, P1; SCHWARZWALD J, 1987, J CONSULT CLIN PSYCH, V55, P251, DOI 10.1037/0022-006X.55.2.251; SEGAL J, 1976, INT SOC SCI J, V28, P593; SHISANA O, 1987, SOC SCI MED, V24, P145, DOI 10.1016/0277-9536(87)90247-4; Shrestha NM, 1998, JAMA-J AM MED ASSOC, V280, P443, DOI 10.1001/jama.280.5.443; Silove D, 1997, BRIT J PSYCHIAT, V170, P351, DOI 10.1192/bjp.170.4.351; Silove D, 1998, ACTA PSYCHIAT SCAND, V97, P175, DOI 10.1111/j.1600-0447.1998.tb09984.x; SINGER E, 1976, SOC SCI MED, V10, P517, DOI 10.1016/0037-7856(76)90019-6; SOLOMON Z, 1995, PSYCHOL MED, V25, P1289, DOI 10.1017/S0033291700033250; SOLOMON Z, 1988, J ABNORM PSYCHOL, V97, P302, DOI 10.1037/0021-843X.97.3.302; Spradley J. P., 1977, ETHNOGRAPHIC INTERVI; Steel Z, 1999, J TRAUMA STRESS, V12, P421, DOI 10.1023/A:1024710902534; Sullivan MD, 1997, AM J MED, V103, P348, DOI 10.1016/S0002-9343(97)00167-8; Summerfield D, 1991, Med War, V7, P84, DOI 10.1080/07488009108408972; TAN ES, 1986, STRESSES EXPERIENCED; THOMPSON M, 1995, AUST NZ J PSYCHIAT, V29, P84, DOI 10.3109/00048679509075896; Thulesius H, 1999, J TRAUMA STRESS, V12, P167, DOI 10.1023/A:1024758718971; TURNER S, 1990, BRIT J PSYCHIAT, V157, P475, DOI 10.1192/bjp.157.4.475; TURNER SW, 1989, LANCET, V1, P1319; Turner SW, 1993, INT HDB TRAUMATIC ST; URSANO RJ, 1981, AM J PSYCHIAT, V138, P310; US Committee for Refugees, 2002, WORLD REF SURV 2002; vanderKolk BA, 1996, AM J PSYCHIAT, V153, P83; VanVelsen C, 1996, J TRAUMA STRESS, V9, P181, DOI 10.1002/jts.2490090203; VANWILLIGEN LHM, 1995, TROP GEOGR MED, V47, P118; Weathers Frank W., 1997, P98; WEINE S, 1995, PSYCHIATRY, V58, P246, DOI 10.1080/00332747.1995.11024729; Weine SM, 2001, COMMUNITY MENT HLT J, V37, P261, DOI 10.1023/A:1017533214935; Weinstein HM, 1996, WESTERN J MED, V165, P112; Weiss, 1997, TRANSCULT PSYCHIATRY, V34, P235, DOI [DOI 10.1177/136346159703400204, 10.1177/136346159703400204]; WEISS MG, 1992, BRIT J PSYCHIAT, V160, P819, DOI 10.1192/bjp.160.6.819; WESTERMEYER J, 1989, J NERV MENT DIS, V177, P132, DOI 10.1097/00005053-198903000-00002; WESTERMEYER J, 1989, PSYCHOSOMATICS, V30, P34, DOI 10.1016/S0033-3182(89)72315-X; WESTERMEYER J, 1983, J OPER PSYCHIATR, V14, P36; Westermeyer J., 1997, TRANSCULT PSYCHIATRY, V34, P291, DOI [DOI 10.1177/136346159703400301, 10.1177/136346159703400301]; Wilson J. P., 1994, HDB POSTTRAUMATIC TH, P3; Wilson JP., 1997, ASSESSING PSYCHOL TR; WINOKUR A, 1984, BRIT J PSYCHIAT, V144, P395, DOI 10.1192/bjp.144.4.395; WYSHAK G, 1994, GEN HOSP PSYCHIAT, V16, P290, DOI 10.1016/0163-8343(94)90009-4; YEHUDA R, 1995, AM J PSYCHIAT, V152, P1705; ZOLA IK, 1966, AM SOCIOL REV, V31, P615, DOI 10.2307/2091854; [No title captured]	137	437	443	3	68	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	2002	288	5					611	621		10.1001/jama.288.5.611	http://dx.doi.org/10.1001/jama.288.5.611			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	581FJ	12150673				2022-12-28	WOS:000177280200020
J	Corma, A; Diaz-Cabanas, M; Martinez-Triguero, J; Rey, F; Rius, J				Corma, A; Diaz-Cabanas, M; Martinez-Triguero, J; Rey, F; Rius, J			A large-cavity zeolite with wide pore windows and potential as an oil refining catalyst	NATURE			English	Article							HIGH-SILICA; METHYLCYCLOHEXANE; CRACKING; ITQ-7; UNITS; BETA; GE	Crude oil is an important feedstock for the petrochemical industry and the dominant energy source driving the world economy, but known oil reserves will cover demand for no more than 50 years at the current rate of consumption(1). This situation calls for more efficient strategies for converting crude oil into fuel and petrochemical products. At present, more than 40% of oil conversion is achieved using catalysts based on faujasite; this zeolite requires extensive post-synthesis treatment to produce an ultrastable form 2,3, and has a large cavity accessible through four 0.74-nm-wide windows and thus limits the access of oil molecules to the catalytically active sites. The use of zeolites with better accessibility to their active sites should result in improved catalyst efficiency. To date, two zeolites with effective pore diameters exceeding that of faujasite have been reported(4,5), but their one-dimensional pore topology excludes use in oil refining. Similarly, zeolites with large pores and a three-dimensional pore topology have been reported(6-8), but in all these materials the pore openings are smaller than in faujasite. Here we report the synthesis of ITQ-21, a zeolite with a three-dimensional pore network containing 1.18-nm-wide cavities, each of which is accessible through six circular and 0.74-nm-wide windows. As expected for a zeolite with this structure, ITQ-21 exhibits high catalytic activity and selectivity for valuable products in preliminary oil refining tests.	Univ Politecn Valencia, CSIC, Inst Tecnol Quim, Valencia 46022, Spain; Inst Ciencia Mat Barcelona, CSIC, Bellaterra, Catalunya, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Tecnologia Quimica (ITQ); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Barcelona (ICMAB)	Corma, A (corresponding author), Univ Politecn Valencia, CSIC, Inst Tecnol Quim, Avda Naranjos S-N, Valencia 46022, Spain.	acorma@itq.upv.es	Rey, Fernando/C-6778-2011; Martinez-Triguero, Joaquin/H-4269-2015; CANOS, AVELINO CORMA/A-3040-2013	Rey, Fernando/0000-0003-3227-5669; Martinez-Triguero, Joaquin/0000-0003-4590-724X; CANOS, AVELINO CORMA/0000-0002-2232-3527; RIUS, JORDI/0000-0002-8376-8634				BAERLOCHER C, 2000, ATLAS ZEOLITE FRAMEW; BISWAS J, 1990, APPL CATAL, V63, P197, DOI 10.1016/S0166-9834(00)81716-9; Blasco T, 2002, J PHYS CHEM B, V106, P2634, DOI 10.1021/jp013302b; Camblor MA, 2001, MICROPOR MESOPOR MAT, V48, P11, DOI 10.1016/S1387-1811(01)00325-0; Cerqueira HS, 2001, IND ENG CHEM RES, V40, P1032, DOI 10.1021/ie000730f; Corma A, 2001, ANGEW CHEM INT EDIT, V40, P2277, DOI 10.1002/1521-3773(20010618)40:12<2277::AID-ANIE2277>3.0.CO;2-O; CORMA A, 1991, APPL CATAL, V67, P307; Corma A, 1997, J CATAL, V165, P102, DOI 10.1006/jcat.1997.1474; Corma A, 2001, CHEM COMMUN, P1486, DOI 10.1039/b104114m; Corma A, 2001, J CATAL, V197, P151, DOI 10.1006/jcat.2000.3065; Corma V, 2000, ANGEW CHEM INT EDIT, V39, P2346; Freyhardt CC, 1996, NATURE, V381, P295, DOI 10.1038/381295a0; KLINOWSKI J, 1984, PROG NUCL MAG RES SP, V16, P237, DOI 10.1016/0079-6565(84)80007-2; LACOMBE S, 2001, STUD SURF SCI CATAL, V135, P4272; MARCILLY C, 2001, STUD SURF SCI CATAL, V135, P37, DOI DOI 10.1016/S0167-2991(01)81185-X; MARTINO G, 2000, STUD SURF SCI CATAL, V130, P83; O'Keeffe M, 1999, CHEM-EUR J, V5, P2796, DOI 10.1002/(SICI)1521-3765(19991001)5:10<2796::AID-CHEM2796>3.3.CO;2-Y; Rius J, 1999, POWDER DIFFR, V14, P267, DOI 10.1017/S0885715600010654; RUIS J, 1999, PROGRAM LSP7 PROGRAM; TREACY MMJ, 1988, NATURE, V332, P249, DOI 10.1038/332249a0; Yoshikawa M, 1998, J PHYS CHEM B, V102, P7139, DOI 10.1021/jp982169t	21	450	474	7	341	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 1	2002	418	6897					514	517		10.1038/nature00924	http://dx.doi.org/10.1038/nature00924			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152074				2022-12-28	WOS:000177162800035
J	Roberts, G; Sherratt, TN				Roberts, G; Sherratt, TN			Behavioural evolution - Does similarity breed cooperation?	NATURE			English	Article							RECIPROCITY; ALTRUISM		Univ Newcastle Upon Tyne, Sch Biol Sci, Evolut & Behav Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England	Newcastle University - UK; Durham University	Roberts, G (corresponding author), Univ Newcastle Upon Tyne, Sch Biol Sci, Evolut & Behav Res Grp, Henry Wellcome Bldg Neuroecol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.							AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Dawkins Richard, 1976, SELFISH GENE; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Riolo RL, 2001, NATURE, V414, P441, DOI 10.1038/35106555; Roberts G, 1998, P ROY SOC B-BIOL SCI, V265, P427, DOI 10.1098/rspb.1998.0312; Sigmund K, 2001, NATURE, V414, P403, DOI 10.1038/35106672; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755	8	64	65	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2002	418	6897					499	500		10.1038/418499b	http://dx.doi.org/10.1038/418499b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152069				2022-12-28	WOS:000177162800030
J	Ford, N				Ford, N			Slow response to Angola's food crisis	LANCET			English	Editorial Material									Med Sans Frontieres, London EC1R 5DJ, England	Doctors Without Borders	Ford, N (corresponding author), Med Sans Frontieres, 124-32 Clerkenwell Rd, London EC1R 5DJ, England.							Ford N, 2001, LANCET, V358, P1543, DOI 10.1016/S0140-6736(01)06588-6; Stokes C, 2000, LANCET, V356, P2093, DOI 10.1016/S0140-6736(00)03415-2; 2002, LANCET, V359, P2125	3	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 27	2002	360	9329					334	334		10.1016/S0140-6736(02)09559-4	http://dx.doi.org/10.1016/S0140-6736(02)09559-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578DT	12147391				2022-12-28	WOS:000177102700029
J	Marshall, T; Rouse, A				Marshall, T; Rouse, A			Resource implications and health benefits of primary prevention strategies for cardiovascular disease in people aged 30 to 74: mathematical modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; RISK PROFILE; CHOLESTEROL; METAANALYSIS; STROKE; STATINS	Objective To develop a model to determine the resource costs and health benefits of implementing guidelines for the prevention of cardiovascular disease in primary care, Design Modelling of data from six strategies for prevention of cardiovascular disease. Strategies incorporated two ways of identifying patients for assessment: traditional (assessment of all adults) and novel (preselection of patients For assessment using a prior estimate of their risk of cardiovascular disease). Three treatment strategies were modelled in conjunction with each identification strategy. Setting England. Subjects Patients aged 30 to 74 eligible for primary prevention strategies for cardiovascular disease who were selected from a hypothetical population of 2000. Main outcome measures Resource costs of assessing eligible adults, providing treatment and follow up and number of cardiovascular events this should prevent. Results Novel strategies prevented more cardiovascular disease, at lower cost, than traditional strategies. Some treatment strategies prevent more cardiovascular disease with fewer resources than others. The findings were robust across a range of different assumptions about workload. Conclusion Preselecting patients for assessment makes better use of staff time than assessing all adults. Treating many patients with low cost drugs is more efficient than prescribing a few patients intensive antihypertensives and statins. Authors of guidelines should model workload implications and health benefits of following their recommendations.	Univ Birmingham, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Marshall, T (corresponding author), Univ Birmingham, Birmingham B15 2TT, W Midlands, England.	T.P.Marshall@bham.ac.uk		Marshall, Tom/0000-0001-9277-5214				ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Bakx JC, 1999, HUISARTS WETENSCHAP, V42, P53; Blauw GJ, 1997, STROKE, V28, P946, DOI 10.1161/01.STR.28.5.946; *BRIT MED ASS, 2000, BRIT NAT FORM; *BRIT MED ASS ROYA, 2000, BRIT NAT FORM; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; *DEP HLTH, 2002, DOH B; *DEP HLTH, 2000, PREV COR HEART DIS H, P2; *DEP HLTH, 2000, HLTH SURV ENGL 98; *DEP HLTH PRESCR P, DRUG TAR JAN 2002; Gueyffier F, 1997, ANN INTERN MED, V126, P761, DOI 10.7326/0003-4819-126-10-199705150-00002; Hebert PR, 1997, JAMA-J AM MED ASSOC, V278, P313, DOI 10.1001/jama.278.4.313; JACKSON R, 1993, BRIT MED J, V307, P107, DOI 10.1136/bmj.307.6896.107; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; *LOND SCH HYG TROP, LOC STAND COSTS PATH; *LOND SCH HYG TROP, UNPUB LOC STAND COST; MARCOVINA SM, 1994, CLIN CHEM, V40, P574; Marshall T, 2001, BRIT J GEN PRACT, V51, P571; *MED RES COUNC GEN, 1998, LANCET, V351, P23; Neal B, 2000, LANCET, V356, P1955; Netten A.P., 2000, UNIT COSTS HLTH SOCI; Pedersen TR, 1996, CIRCULATION, V93, P1796, DOI 10.1161/01.CIR.93.10.1796; RODERICK PJ, 1993, BRIT J CLIN PHARMACO, V35, P219, DOI 10.1111/j.1365-2125.1993.tb05689.x; Roncaglioni MC, 2001, LANCET, V357, P1706, DOI 10.1016/S0140-6736(00)04836-4; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Wood D, 1998, HEART S2, V80	27	40	40	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2002	325	7357					197	199		10.1136/bmj.325.7357.197	http://dx.doi.org/10.1136/bmj.325.7357.197			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580PX	12142309	Green Published, Bronze			2022-12-28	WOS:000177243900022
J	Watt, G				Watt, G			The inverse care law today	LANCET			English	Article									Univ Glasgow, Dept Gen Practice, Glasgow G12 0RR, Lanark, Scotland	University of Glasgow	Watt, G (corresponding author), Univ Glasgow, Dept Gen Practice, Glasgow G12 0RR, Lanark, Scotland.	gcmw1j@clinmed.gla.ac.uk						HART JT, 1991, BMJ-BRIT MED J, V302, P1509, DOI 10.1136/bmj.302.6791.1509; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Hart JT, 2001, BRIT MED J, V322, P1363; KAUL S, 1991, BRIT MED J, V303, P524, DOI 10.1136/bmj.303.6801.524-b; McKeown T., 1976, ROLE MED DREAM MIRAG; *SCOTT EX HLTH DEP, 1999, FAIR SHAR ALL REP NA; Starfield B, 2001, BRIT J GEN PRACT, V51, P303; Stirling AM, 2001, BRIT J GEN PRACT, V51, P456; TOYNBEE P, 2001, DID THINGS GET BETTE, P87; Tunstall-Pedoe H, 2000, LANCET, V355, P688, DOI 10.1016/S0140-6736(99)11181-4; Watt G, 1999, BRIT J GEN PRACT, V49, P503	11	183	187	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 20	2002	360	9328					252	254		10.1016/S0140-6736(02)09466-7	http://dx.doi.org/10.1016/S0140-6736(02)09466-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	576DX	12133675				2022-12-28	WOS:000176988500030
J	Verma, R; Aravind, L; Oania, R; McDonald, WH; Yates, JR; Koonin, EV; Deshaies, RJ				Verma, R; Aravind, L; Oania, R; McDonald, WH; Yates, JR; Koonin, EV; Deshaies, RJ			Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome	SCIENCE			English	Article							UBIQUITIN; YEAST; GENE; TRANSCRIPTION; RECOGNITION; ACTIVATION; INHIBITOR; CLEAVAGE; SUBUNIT; ENZYMES	The 26 S proteasome mediates degradation of ubiquitin-conjugated proteins. Although ubiquitin is recycled from proteasome substrates, the molecular basis of deubiquitination at the proteasome and its relation to substrate degradation remain unknown. The Rpn11 subunit of the proteasome lid subcomplex contains a highly conserved Jab1/MPN domain associated metalloisopeptidase (JAMM) motif EXnHXHX10D. Mutation of the predicted active-site histidines to alanine (rpn11AXA) was lethal and stabilized ubiquitin pathway substrates in yeast. Rpn11(AXA) mutant proteasomes assembled normally but failed to either deubiquitinate or degrade ubiquitinated Sic1 in vitro. Our findings reveal an unexpected coupling between substrate deubiquitination and degradation and suggest a unifying rationale for the presence of the lid in eukaryotic proteasomes.	CALTECH, Dept Biol, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; Scripps Res Inst, Dept Cell Biol, San Diego, CA 92037 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Scripps Research Institute	Deshaies, RJ (corresponding author), CALTECH, Dept Biol, Pasadena, CA 91125 USA.	deshaies@caltech.edu	McDonald, W. Hayes/B-4109-2016; Deshaies, Raymond/B-8354-2014	McDonald, W. Hayes/0000-0002-3510-426X; Deshaies, Raymond/0000-0002-3671-9354; Aravind, L/0000-0003-0771-253X	NCRR NIH HHS [RR11823-05-01] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AMON A, 1994, CELL, V77, P1037, DOI 10.1016/0092-8674(94)90443-X; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Chung CH, 1999, BIOCHEM BIOPH RES CO, V266, P633, DOI 10.1006/bbrc.1999.1880; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; EYTAN E, 1993, J BIOL CHEM, V268, P4668; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; JOHNSON ES, 1992, EMBO J, V11, P497, DOI 10.1002/j.1460-2075.1992.tb05080.x; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Ponting CP, 1999, J MOL BIOL, V289, P729, DOI 10.1006/jmbi.1999.2827; Rinaldi T, 1998, MOL BIOL CELL, V9, P2917, DOI 10.1091/mbc.9.10.2917; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; SEUFERT W, 1992, EMBO J, V11, P3077, DOI 10.1002/j.1460-2075.1992.tb05379.x; SHIMANUKI M, 1995, J CELL SCI, V108, P569; Smith CK, 1999, P NATL ACAD SCI USA, V96, P6678, DOI 10.1073/pnas.96.12.6678; Stitzel ML, 2001, GENE DEV, V15, P128, DOI 10.1101/gad.863801; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Verma R, 2000, CELL, V101, P341, DOI 10.1016/S0092-8674(00)80843-0; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Verma R, 2001, MOL CELL, V8, P439, DOI 10.1016/S1097-2765(01)00308-2; Verma R. P., UNPUB; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wilkinson KD, 1998, UBIQUITIN BIOL CELL, P99	31	775	811	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2002	298	5593					611	615		10.1126/science.1075898	http://dx.doi.org/10.1126/science.1075898			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604RL	12183636				2022-12-28	WOS:000178634800044
J	Hutvagner, G; Zamore, PD				Hutvagner, G; Zamore, PD			A microRNA in a multiple-turnover RNAi enzyme complex	SCIENCE			English	Article							C-ELEGANS; REGULATORY RNA; INTERFERENCE; GENE; EXPRESSION; RDE-1; TRANSCRIPTION; INITIATION; PATHWAY; LIN-14	In animals, the double-stranded RNA-specific endonuclease Dicer produces two classes of functionally distinct, tiny RNAs: microRNAs ( miRNAs) and small interfering RNAs (siRNAs). miRNAs regulate mRNA translation, whereas siRNAs direct RNA destruction via the RNA interference (RNAi) pathway. Here we show that, in human cell extracts, the miRNA let-7 naturally enters the RNAi pathway, which suggests that only the degree of complementarity between a miRNA and its RNA target determines its function. Human let-7 is a component of a previously identified, miRNA-containing ribonucleoprotein particle, which we show is an RNAi enzyme complex. Each let-7 containing complex directs multiple rounds of RNA cleavage, which explains the remarkable efficiency of the RNAi pathway in human cells.	Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Zamore, PD (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Lazare Res Bldg,Room 825,364 Plantat St, Worcester, MA 01605 USA.	phillip.zamore@umassmed.edu	Zamore, Phillip D/A-8941-2013	Zamore, Phillip/0000-0002-4505-9618; Hutvagner, Gyorgy/0000-0002-7231-9446	NIGMS NIH HHS [GM62862-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062862, R01GM062862] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Billy E, 2001, P NATL ACAD SCI USA, V98, P14428, DOI 10.1073/pnas.261562698; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Catalanotto C, 2002, GENE DEV, V16, P790, DOI 10.1101/gad.222402; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; HUTVAGNER G, UNPUB; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Plasterk RHA, 2002, SCIENCE, V296, P1263, DOI 10.1126/science.1072148; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; SCHWARZ D, IN PRESS MOL CELL; SCHWARZ D, UNPUB; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5	37	1537	1855	4	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2002	297	5589					2056	2060		10.1126/science.1073827	http://dx.doi.org/10.1126/science.1073827			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594XV	12154197				2022-12-28	WOS:000178078500048
J	Ownby, DR; Johnson, CC; Peterson, EL				Ownby, DR; Johnson, CC; Peterson, EL			Exposure to dogs and cats in the first year of life and risk of allergic sensitization at 6 to 7 years of age	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HOUSE-DUST ENDOTOXIN; CORD BLOOD-IGE; SERUM IGE; RESPIRATORY SYMPTOMS; BRONCHIAL RESPONSIVENESS; ASTHMATIC-CHILDREN; PARENTAL SMOKING; HAY-FEVER; POPULATION; PREVALENCE	Context Childhood asthma is strongly associated with allergic sensitization. Studies have suggested that animal exposure during infancy reduces subsequent allergic sensitization. Objective To evaluate the relationship between dog and cat exposure in the first year of life and allergic sensitization at 6 to 7 years of age. Design, Setting, and Subjects Prospective birth cohort study of healthy, fullterm infants enrolled in a health maintenance organization in suburban Detroit, Mich, who were born between April 15,1987, and August 31,1989, and followed up yearly to a mean age of 6.7 years. Of 835 children initially in the study at birth, 474 (57%) completed follow-up evaluations at age 6 to 7 years. Main Outcome Measures Atopy, defined as any skin prick test positivity to 6 common aeroallergens (dust mites [Dermatophagoides farinae, D pteronyssinus], dog, cat, short ragweed [Ambrosia artemisiifolia], and blue grass [Poa pratensis]); seroatopy, defined as any positive allergen-specific IgE test result for the same 6 allergens or for Alternaria species. Results The prevalence of any skin prick test positivity (atopy) at age 6 to 7 years was 33.6% with no dog or cat exposure in the first year of life, 34.3% with exposure to 1 dog or cat, and 15.4% with exposure to 2 or more dogs or cats (P = .005). The prevalence of any positive allergen-specific IgE test result (seroatopy) was 38.5% with no dog or cat exposure, 41.2% with exposure to 1 dog or cat, and 17.9% with exposure to 2 or more dogs or cats (P = .003). After adjustment for cord serum IgE concentration, sex, older siblings, parental smoking, parental asthma, bedroom dust mite allergen levels at 2 years, and current dog and cat ownership, exposure to 2 or more dogs or cats in the first year of life was associated with a significantly lower risk of atopy (adjusted odds ratio, 0.23; 95% confidence interval, 0.09-0.60) and seroatopy (adjusted odds ratio, 0.33; 95% confidence interval, 0.13-0.83). Conclusion Exposure to 2 or more dogs or cats in the first year of life may reduce subsequent risk of allergic sensitization to multiple allergens during childhood.	Med Coll Georgia, Dept Pediat, Sect Allergy & Immunol, Augusta, GA 30912 USA; Henry Ford Hlth Syst, Dept Biostat & Res Epidemiol, Detroit, MI USA; Wayne State Univ, Natl Inst Environm Hlth Sci Ctr Mol & Cellular To, Detroit, MI USA	University System of Georgia; Augusta University; Henry Ford Health System; Henry Ford Hospital; Wayne State University	Ownby, DR (corresponding author), Med Coll Georgia, Dept Pediat, Sect Allergy & Immunol, BG-1019, Augusta, GA 30912 USA.	downby@mail.mcg.edu		Johnson, Christine Cole/0000-0002-6864-6604	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006639] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Apelberg BJ, 2001, J ALLERGY CLIN IMMUN, V107, P455, DOI 10.1067/mai.2001.113240; AVITAL A, 1991, AM REV RESPIR DIS, V144, P36, DOI 10.1164/ajrccm/144.1.36; BACKER V, 1992, ALLERGY, V47, P484, DOI 10.1111/j.1398-9995.1992.tb00669.x; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Bergmann RL, 1997, CLIN EXP ALLERGY, V27, P752, DOI 10.1046/j.1365-2222.1997.310899.x; Braback Lennart, 1995, Archives of Disease in Childhood, V72, P487; Burr ML, 1997, CLIN EXP ALLERGY, V27, P1247; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Custovic A, 2001, J ALLERGY CLIN IMMUN, V108, P537, DOI 10.1067/mai.2001.118599; Ernst P, 2000, AM J RESP CRIT CARE, V161, P1563, DOI 10.1164/ajrccm.161.5.9908119; Everitt B.S., 1977, ANAL CONTINGENCY TAB; GALDESSEBALDT M, 1985, J PEDIATR-US, V107, P526, DOI 10.1016/S0022-3476(85)80009-3; Gereda JE, 2000, LANCET, V355, P1680, DOI 10.1016/S0140-6736(00)02239-X; Gold DR, 1999, AM J RESP CRIT CARE, V160, P227, DOI 10.1164/ajrccm.160.1.9807104; Hesselmar B, 1999, CLIN EXP ALLERGY, V29, P611; HORWOOD LJ, 1985, PEDIATRICS, V75, P859; HOSMER DW, 1989, APPL LOGISTIC REGRES; Johnson CC, 1998, AM J EPIDEMIOL, V147, P1145; Johnson CC, 1996, CLIN EXP ALLERGY, V26, P624, DOI 10.1111/j.1365-2222.1996.tb00588.x; Joseph CLM, 2000, CHEST, V117, P1336, DOI 10.1378/chest.117.5.1336; KJELLMAN NIM, 1984, ANN ALLERGY, V53, P167; Lindfors A, 1999, J ALLERGY CLIN IMMUN, V104, P755, DOI 10.1016/S0091-6749(99)70284-8; Litonjua AA, 1997, AM J RESP CRIT CARE, V156, P23, DOI 10.1164/ajrccm.156.1.9608072; MARTINEZ FD, 1988, AM REV RESPIR DIS, V138, P518, DOI 10.1164/ajrccm/138.3.518; Nafstad P, 2001, ALLERGY, V56, P307, DOI 10.1034/j.1398-9995.2001.00881.x; NETER J, 1990, APPL STAT MODELS REG; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Osborne ML, 1998, AM J RESP CRIT CARE, V157, P123, DOI 10.1164/ajrccm.157.1.9612063; OWNBY DR, 1991, J ALLERGY CLIN IMMUN, V88, P555, DOI 10.1016/0091-6749(91)90148-H; Ownby DR, 2000, AM J RESP CRIT CARE, V161, P1578, DOI 10.1164/ajrccm.161.5.9812156; Ownby DR, 1996, PEDIATR ALLERGY IMMU, V7, P125, DOI 10.1111/j.1399-3038.1996.tb00119.x; Ownby DR, 1996, ANN ALLERG ASTHMA IM, V77, P304, DOI 10.1016/S1081-1206(10)63325-X; Ownby DR, 2000, ARCH PEDIAT ADOL MED, V154, P1237, DOI 10.1001/archpedi.154.12.1237; Park JH, 2001, AM J RESP CRIT CARE, V163, P322, DOI 10.1164/ajrccm.163.2.2002088; PEAT JK, 1987, CLIN ALLERGY, V17, P291, DOI 10.1111/j.1365-2222.1987.tb02017.x; PEAT JK, 1989, CLIN EXP ALLERGY, V19, P299, DOI 10.1111/j.1365-2222.1989.tb02387.x; Peterson EL, 1999, J ALLERGY CLIN IMMUN, V104, P348, DOI 10.1016/S0091-6749(99)70378-7; Peterson EL, 1997, J CLIN EPIDEMIOL, V50, P917, DOI 10.1016/S0895-4356(97)00095-4; Platts-Mills T, 2001, LANCET, V357, P752, DOI 10.1016/S0140-6736(00)04168-4; Platts-Mills TAE, 1997, J ALLERGY CLIN IMMUN, V100, pS2, DOI 10.1016/S0091-6749(97)70292-6; POPP W, 1990, ALLERGY, V45, P75, DOI 10.1111/j.1398-9995.1990.tb01087.x; Reijonen TM, 2000, PEDIATRICS, V106, P1406, DOI 10.1542/peds.106.6.1406; Remes ST, 2001, J ALLERGY CLIN IMMUN, V108, P509, DOI 10.1067/mai.2001.117797; Riedler J, 2000, CLIN EXP ALLERGY, V30, P194, DOI 10.1046/j.1365-2222.2000.00799.x; Roost HP, 1999, J ALLERGY CLIN IMMUN, V104, P941, DOI 10.1016/S0091-6749(99)70072-2; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; SAS Institute Inc, 1999, SAS STAT US GUID; SEARS MR, 1993, CLIN EXP ALLERGY, V23, P941, DOI 10.1111/j.1365-2222.1993.tb00279.x; SKOBELOFF EM, 1992, JAMA-J AM MED ASSOC, V268, P3437, DOI 10.1001/jama.268.24.3437; SPORIK R, 1995, AM J RESP CRIT CARE, V151, P1388, DOI 10.1164/ajrccm.151.5.7735590; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; Steerenberg PA, 1999, CLIN EXP ALLERGY, V29, P1304, DOI 10.1046/j.1365-2222.1999.00658.x; STODDARD JJ, 1995, AM J EPIDEMIOL, V141, P96, DOI 10.1093/oxfordjournals.aje.a117418; SUONIEMI I, 1981, ALLERGY, V36, P263, DOI 10.1111/j.1398-9995.1981.tb01573.x; TAKEDA K, 1993, CLIN EXP ALLERGY, V23, P450, DOI 10.1111/j.1365-2222.1993.tb00353.x; VANTO T, 1983, ACTA PAEDIATR SCAND, V72, P571, DOI 10.1111/j.1651-2227.1983.tb09773.x; von Mutius E, 2000, J ALLERGY CLIN IMMUN, V105, P9, DOI 10.1016/S0091-6749(00)90171-4; Withers NJ, 1998, AM J RESP CRIT CARE, V158, P352, DOI 10.1164/ajrccm.158.2.9705079; WRIGHT AL, 1994, PEDIATRICS, V94, P895; YUNGINGER JW, 1992, AM REV RESPIR DIS, V146, P888, DOI 10.1164/ajrccm/146.4.888	60	512	529	1	44	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2002	288	8					963	972		10.1001/jama.288.8.963	http://dx.doi.org/10.1001/jama.288.8.963			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587RM	12190366	Bronze			2022-12-28	WOS:000177656400021
J	Kane, B				Kane, B			Chronic HIV infection: Can anyone afford a drug holiday?	ANNALS OF INTERNAL MEDICINE			English	News Item																		Lisziewicz J, 1999, NEW ENGL J MED, V340, P1683, DOI 10.1056/NEJM199905273402114; Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222; 2001, AIDS, V15, P2251; 2002, MMWR MORB MORTAL WKL, V17, P55; 2001, JAMA, V286, P2568; 2001, N ENGL J MED, V344, P472; 1997, AIDS, V11, P477	7	2	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2002	137	4					301	304		10.7326/0003-4819-137-4-200208200-00031	http://dx.doi.org/10.7326/0003-4819-137-4-200208200-00031			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585BB	12186535				2022-12-28	WOS:000177502300023
J	Oddie, S; Embleton, ND				Oddie, S; Embleton, ND		No Neonatal Network	Risk factors for early onset neonatal group B streptococcal sepsis: case-control study	BRITISH MEDICAL JOURNAL			English	Article							INTRAPARTUM AMPICILLIN; INFECTION; PROPHYLAXIS; PREVENTION; DISEASE	Objectives To quantify risk factors for and the prevalence of early onset group B streptococcal sepsis in neonates in a geographically defined population. Design Cases were collected prospectively for two years from April 1998 and compared with four controls each, matched for time and place of delivery. Setting The former Northern health region of the United Kingdom. Participants Infants infected with group B streptococcus in the first week of life. Results The prevalence of early onset group B streptococcal sepsis was 0.57 per 1000 live births. Premature infants comprised 38% of all cases and 83% of die deaths. Prematurity (odds ratio 10.4,95% confidence interval 3.9 to 27.6), rupture of the membranes more than 18 hours before delivery (25.8, 10.2 to 64.8), rupture of the membranes before the onset of labour (11.1, 4.8 to 25.9), and intrapartum fever (10.0, 2.4 to 40.8) were significant risk factors for infection. Had the interim recommendations on best practice issued by the Group B Streptococcus Working Group of the Public Health Laboratory Service been uniformly applied to the fetuses alive at the onset of labour, 29 of 37 (78%) might have been given antibiotic prophylaxis during labour. At least 23 of these 29 (79%) could have had antibiotics for four hours or more before delivery. To achieve this, 16% of all women would have been given antibiotics during labour. Conclusions Early onset group B streptococcal sepsis remains an important problem in the United Kingdom. Prevention based on risk factors might reduce the prevalence at the cost of treating many women with risk factors. Using rupture of the membranes before the onset of labour as a risk factor might be expected to improve the success of guidelines for prophylaxis.	Royal Victoria Infirm, Dept Child Hlth, Newcastle Neonatal Serv, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK	Oddie, S (corresponding author), Royal Victoria Infirm, Dept Child Hlth, Newcastle Neonatal Serv, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.		Embleton, Nicholas/D-4905-2011	Embleton, Nicholas/0000-0003-3750-5566				American College of Obstetrics and Gynecologists. ACOG Committee opinion, 1996, INT J GYNECOL OBSTET, V54, P197; BAKER CJ, 2001, INFECT DIS FETUS NEW, P1091; Beardsall K, 2000, ARCH DIS CHILD-FETAL, V82, pF205, DOI 10.1136/fn.82.3.F205; Benitz WE, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.6.e77; BENITZ WE, 1999, PEDIATRICS, V103, pE79; BIGNARDI GE, 1999, COMMUN DIS PUBLIC HL, V2, P264; DAGAPEYEFF K, 2001, ARCH DIS CHILD S, V84, pA30; De Cueto M, 1998, OBSTET GYNECOL, V91, P112, DOI 10.1016/S0029-7844(97)00587-5; Embleton N, 1999, ARCH DIS CHILD-FETAL, V80, pF139, DOI 10.1136/fn.80.2.F139; FEY R, 1999, ARCH DIS CHILD FE S1, V80, pG202; FEY RJ, 1999, ARCH DIS CHILD S, V80, pA70; Halsey NA, 1997, PEDIATRICS, V99, P489, DOI 10.1542/peds.99.3.489; HEATH PT, 2001, ARCH DIS CHILD S, V84, pA8; HEY EN, 1984, BRIT MED J, V288, P1717; Isaacs D, 1998, ARCH DIS CHILD-FETAL, V79, pF81, DOI 10.1136/fn.79.2.F81; Jeffery HE, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.1.e2; Joseph TA, 1998, ARCH PEDIAT ADOL MED, V152, P35; Kenyon SL, 2001, LANCET, V357, P979, DOI 10.1016/S0140-6736(00)04233-1; *MAT CHILD HLTH CO, 2000, 7 MAT CHILD HLTH CON; McCartney C, 2001, LANCET, V357, P395, DOI 10.1016/S0140-6736(05)71530-0; Moses LM, 1998, ARCH DIS CHILD-FETAL, V79, pF148, DOI 10.1136/fn.79.2.F148; *PHLS GROUP B STRE, 2000, INT BEST PRACT REC P; PYLIPOW M, 1994, PEDIATRICS, V93, P631; Schrag SJ, 2000, NEW ENGL J MED, V342, P15, DOI 10.1056/NEJM200001063420103; WEBBER S, 1990, ARCH DIS CHILD, V65, P207, DOI 10.1136/adc.65.2.207	25	100	110	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 10	2002	325	7359					308	311		10.1136/bmj.325.7359.308	http://dx.doi.org/10.1136/bmj.325.7359.308			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	584RQ	12169506	Bronze, Green Published			2022-12-28	WOS:000177482500017
J	Groman, JD; Meyer, ME; Wilmott, RW; Zeitlin, PL; Cutting, GR				Groman, JD; Meyer, ME; Wilmott, RW; Zeitlin, PL; Cutting, GR			Variant cystic fibrosis phenotypes in the absence of CFTR mutations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENE-MUTATIONS; 5T ALLELE; DISEASE; SWEAT; PANCREAS; MARKERS	Background Cystic fibrosis is a life-limiting autosomal recessive disorder with a highly variable clinical presentation. The classic form involves characteristic findings in the respiratory tract, gastrointestinal tract, male reproductive tract, and sweat glands and is caused by loss-of-function mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Nonclassic forms Of cystic fibrosis have been associated with mutations that reduce but do not eliminate the function of the CFTR protein. We assessed whether alteration in CFTR function is responsible for the entire spectrum of variant cystic fibrosis phenotypes. Methods Extensive genetic analysis of the CFTR gene was performed in 74 patients with nonclassic cystic fibrosis who had been referred by 34 medical centers. We evaluated two families that each included a proband without identified mutations and a sibling with nonclassic cystic fibrosis to determine whether there was linkage to the CFTR locus and to measure the extent of CFTR function in the sweat gland and nasal epithelium. Results Of the 74 patients studied, 29 had two mutations in the CFTR gene, 15 had one mutation, and 30 had no mutations. A final genotype of two mutations was more common among patients who had been referred after screening for common cystic fibrosis-causing mutations identified one mutation than among those who had been referred after screening had identified no such mutations (26 of 34 patients vs. 3 of 40 patients, P < 0.001). Comparison of clinical features and sweat chloride concentrations revealed no significant differences among patients with two, one, or no CFTR mutations. Haplotype analysis in the two families revealed no linkage to CFTR. Although each of the affected siblings had elevated sweat chloride concentrations, measurements of cyclic AMP-mediated ion and fluid transport in the sweat gland and nasal epithelium demonstrated the presence of functional CFTR. Conclusions Factors other than mutations in the CFTR gene can produce phenotypes clinically indistinguishable from nonclassic cystic fibrosis caused by CFTR dysfunction.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Cyst Fibrosis Fdn Genotyping Ctr, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Predoctoral Training Program Human Genet, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; St Louis Univ, Sch Med, Dept Pediat, St Louis, MO 63104 USA	Johns Hopkins University; Cystic Fibrosis Foundation; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Saint Louis University	Cutting, GR (corresponding author), Childrens Med Surg Ctr, 9-125,600 N Wolfe St, Baltimore, MD 21287 USA.	gcutting@jhmi.edu		Zeitlin, Pamela/0000-0002-2719-1834	NCRR NIH HHS [RR00052] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Andersen DH, 1938, AM J DIS CHILD, V56, P344, DOI 10.1001/archpedi.1938.01980140114013; Boehm CD, 1999, MOL GENET METAB, V66, P128, DOI 10.1006/mgme.1998.2779; Bronsveld I, 1999, THORAX, V54, P278, DOI 10.1136/thx.54.3.278; Callen A, 2000, J PEDIATR-US, V137, P849, DOI 10.1067/mpd.2000.109198; Choi JY, 2001, NATURE, V410, P94, DOI 10.1038/35065099; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002; CUTTING GR, 1997, EMERY RIMOINS PRINCI, V2, P2685; *CYST FIBR FDN, 2000, CYST FIBR FDN PAT RE; DISANTAGNESE PA, 1953, PEDIATRICS, V12, P549; Dreesen JCFM, 2000, MOL HUM REPROD, V6, P391, DOI 10.1093/molehr/6.5.391; GAN KH, 1995, NEW ENGL J MED, V333, P95, DOI 10.1056/NEJM199507133330204; GIBSON LE, 1959, PEDIATRICS, V23, P545; Guggino WB, 1999, CELL, V96, P607, DOI 10.1016/S0092-8674(00)80570-X; HIGHSMITH WE, 1994, NEW ENGL J MED, V331, P974, DOI 10.1056/NEJM199410133311503; *HOSP SICK CHILDR, 2001, CYST FIBR MUT DAT BA; KEREM BS, 1989, AM J HUM GENET, V44, P827; KNOWLES MR, 1995, HUM GENE THER, V6, P445, DOI 10.1089/hum.1995.6.4-445; KRISTIDIS P, 1992, AM J HUM GENET, V50, P1178; Mak V, 1999, JAMA-J AM MED ASSOC, V281, P2217, DOI 10.1001/jama.281.23.2217; Marchand E, 2001, CHEST, V119, P762, DOI 10.1378/chest.119.3.762; MCCONKIEROSELL A, 1989, ANN INTERN MED, V111, P797, DOI 10.7326/0003-4819-111-10-797; Mekus F, 1998, HUM GENET, V102, P582, DOI 10.1007/s004390050744; Miller PW, 1996, AM J HUM GENET, V59, P45; Noone PG, 2000, AM J RESP CRIT CARE, V162, P1919, DOI 10.1164/ajrccm.162.5.2003160; RIORDAN JR, 1989, SCIENCE, V245, P1437; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rubenstein RC, 1998, AM J RESP CRIT CARE, V157, P484, DOI 10.1164/ajrccm.157.2.9706088; TSUI LC, 1988, AM J HUM GENET, V42, P184; TSUI LC, 1985, SCIENCE, V230, P1054, DOI 10.1126/science.2997931; Wang XJ, 2000, JAMA-J AM MED ASSOC, V284, P1814, DOI 10.1001/jama.284.14.1814; Welsh MJ, 2001, METABOLIC MOL BASES, P5121; Wine JJ, 1999, J CLIN INVEST, V103, P309, DOI 10.1172/JCI6222; Zielenski J, 2000, RESPIRATION, V67, P117, DOI 10.1159/000029497	33	121	126	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 8	2002	347	6					401	407		10.1056/NEJMoa011899	http://dx.doi.org/10.1056/NEJMoa011899			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587YR	12167682	Bronze			2022-12-28	WOS:000177672400004
J	Lorenz, T; Hofmann, M; Gruninger, M; Freimurth, A; Uhrig, GS; Dumm, M; Dressel, M				Lorenz, T; Hofmann, M; Gruninger, M; Freimurth, A; Uhrig, GS; Dumm, M; Dressel, M			RETRACTED: Evidence for spin-charge separation in quasi-one-dimensional organic conductors (Retracted Article. See vol 440, pg 707, 2006)	NATURE			English	Article; Retracted Publication							THERMAL-CONDUCTIVITY; CHAIN	Interacting conduction electrons are usually described within Fermi-liquid theory(1), which states that, in spite of strong interactions, the low-energy excitations are electron-like quasiparticles with charge and spin. In recent years there has been tremendous interest in conducting systems that are not Fermi liquids, motivated by the observation of highly anomalous metallic states in various materials, most notably the copper oxide superconductors(2,3). Non-Fermi-liquid behaviour is generic to one-dimensional interacting electron systems, which are predicted to be Luttinger liquids(4,5). One of their key properties is spin-charge separation: instead of quasiparticles, collective excitations of charge (with no spin) and spin (with no charge) are formed, which move independently and at different velocities. However, experimental confirmation of spin-charge separation remains a challenge. Here we report experiments probing the charge and heat current in quasi-one-dimensional conductors-the organic Bechgaard salts(6-10). It was found that the charge and spin excitations have distinctly different thermal conductivities, which gives strong evidence for spin-charge separation. The spin excitations have a much larger thermal conductivity than the charge excitations, which indicates that the coupling of the charge excitations to the lattice is important.	Univ Cologne, Inst Phys 2, D-50937 Cologne, Germany; Univ Cologne, Inst Theoret Phys, D-50937 Cologne, Germany; Univ Stuttgart, Inst Phys 1, D-70550 Stuttgart, Germany	University of Cologne; University of Cologne; University of Stuttgart	Freimurth, A (corresponding author), Univ Cologne, Inst Phys 2, D-50937 Cologne, Germany.	freimuth@ph2.uni-koeln.de	Dumm, Michael/N-4362-2016; Lorenz, Thomas/J-2955-2017; Dressel, Martin/D-3244-2012; Lorenz, Thomas/AAC-3331-2020	Dumm, Michael/0000-0002-3502-8615; Lorenz, Thomas/0000-0003-4832-5157; Dressel, Martin/0000-0003-1907-052X; Lorenz, Thomas/0000-0003-4832-5157; Uhrig, Gotz/0000-0003-1961-0346				[Anonymous], 1979, SOLID STATE PHYS, DOI 10.1016/S0081-1947(08)60359-8; Berman R, 1976, THERMAL CONDUCTION S; Bockrath M, 1999, NATURE, V397, P598, DOI 10.1038/17569; Bourbonnais C, 1997, SYNTHETIC MET, V84, P19, DOI 10.1016/S0379-6779(97)80657-1; Bourbonnais C, 1998, PHYS WORLD, V11, P41; BOURBONNAIS C, 1999, ADV SYNTHETIC METALS, P206; CHOI MY, 1986, PHYS REV B, V34, P7727, DOI 10.1103/PhysRevB.34.7727; Claessen R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.096402; COULON C, 1982, J PHYS-PARIS, V43, P1059, DOI 10.1051/jphys:019820043070105900; DJUREK D, 1982, J PHYS C SOLID STATE, V15, pL669, DOI 10.1088/0022-3719/15/21/005; Dumm M, 2000, PHYS REV B, V61, P511, DOI 10.1103/PhysRevB.61.511; ENGELSBERG S, 1964, PHYS REV A-GEN PHYS, V136, P1582; Gogolin AO., 1998, BOSONIZATION STRONGL; HEEGER AJ, 1988, REV MOD PHYS, V60, P781, DOI 10.1103/RevModPhys.60.781; Ishiguro T., 1998, ORGANIC SUPERCONDUCT, V2nd; JEROME D, 1982, ADV PHYS, V31, P299, DOI 10.1080/00018738200101398; Klumper A, 1998, EUR PHYS J B, V5, P677, DOI 10.1007/s100510050491; Nozieres P., 1966, THEORY QUANTUM LIQUI; Orenstein J, 2000, SCIENCE, V288, P468, DOI 10.1126/science.288.5465.468; Schwartz A, 1998, PHYS REV B, V58, P1261, DOI 10.1103/PhysRevB.58.1261; Sologubenko AV, 2000, PHYS REV LETT, V84, P2714, DOI 10.1103/PhysRevLett.84.2714; Sologubenko AV, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.054412; VOIT J, 1995, REP PROG PHYS, V58, P977, DOI 10.1088/0034-4885/58/9/002; Yacoby A, 1997, SOLID STATE COMMUN, V101, P77, DOI 10.1016/S0038-1098(96)00377-8; Zeini B, 2001, EUR PHYS J B, V20, P189, DOI 10.1007/PL00011098	26	98	100	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2002	418	6898					614	617		10.1038/nature00913	http://dx.doi.org/10.1038/nature00913			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167854				2022-12-28	WOS:000177305600035
J	Toyoshima, C; Nomura, H				Toyoshima, C; Nomura, H			Structural changes in the calcium pump accompanying the dissociation of calcium	NATURE			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; CA2+ TRANSPORT ATPASE; ION-TRANSPORT; ALPHA-SUBUNIT; PHOSPHORYLATION; THAPSIGARGIN; STABILIZATION; DOMAINS; BINDING; ORGANIZATION	In skeletal muscle, calcium ions are transported (pumped) against a concentration gradient from the cytoplasm into the sarcoplasmic reticulum, an intracellular organelle. This causes muscle cells to relax after cytosolic calcium increases during excitation. The Ca2+ ATPase that carries out this pumping is a representative P-type ion-transporting ATPase. Here we describe the structure of this ion pump at 3.1 Angstrom resolution in a Ca2+-free (E2) state, and compare it with that determined previously for the Ca2+-bound (E1Ca(2+)) state. The structure of the enzyme stabilized by thapsigargin, a potent inhibitor, shows large conformation differences from that in E1Ca(2+). Three cytoplasmic domains gather to form a single headpiece, and six of the ten transmembrane helices exhibit large-scale rearrangements. These rearrangements ensure the release of calcium ions into the lumen of sarcoplasmic reticulum and, on the cytoplasmic side, create a pathway for entry of new calcium ions.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	University of Tokyo	Toyoshima, C (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.	ct@iam.u-tokyo.ac.jp	Toyoshima, Chikashi/R-4153-2019	Toyoshima, Chikashi/0000-0001-9640-0778				ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; ANDERSEN JP, 1994, J BIOL CHEM, V269, P15931; ANDERSEN JP, 1992, J BIOL CHEM, V267, P2767; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P46, DOI 10.1107/S0108767389009633; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHRISTENSEN SB, 1982, J ORG CHEM, V47, P649; Christensen SB, 1997, PROG CH ORG NAT PROD, V71, P129; COLL RJ, 1984, J BIOL CHEM, V259, P4249; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2001, FEBS LETT, V489, P277, DOI 10.1016/S0014-5793(01)02111-1; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; Gatto C, 1999, J BIOL CHEM, V274, P13737, DOI 10.1074/jbc.274.20.13737; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; Hayward S, 1999, PROTEINS, V36, P425, DOI 10.1002/(SICI)1097-0134(19990901)36:4<425::AID-PROT6>3.3.CO;2-J; Hua SM, 1997, BIOCHEMISTRY-US, V36, P11865, DOI 10.1021/bi970105n; JAMES P, 1989, NATURE, V342, P90, DOI 10.1038/342090a0; Johnson LN, 2001, CHEM REV, V101, P2209, DOI 10.1021/cr000225s; JORGENSEN PL, 1986, BIOCHIM BIOPHYS ACTA, V860, P570, DOI 10.1016/0005-2736(86)90555-9; Juul B, 2000, INT CONGR SER, V1207, P233; JUUL B, 1995, J BIOL CHEM, V270, P20123, DOI 10.1074/jbc.270.34.20123; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUTSCHABSKY L, 1986, CRYST RES TECHNOL, V21, P627, DOI 10.1002/crat.2170210513; Lee AG, 2001, BIOCHEM J, V356, P665, DOI 10.1042/0264-6021:3560665; LUTSENKO S, 1995, P NATL ACAD SCI USA, V92, P7936, DOI 10.1073/pnas.92.17.7936; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; MEDDA P, 1987, EUR J BIOCHEM, V165, P251, DOI 10.1111/j.1432-1033.1987.tb11435.x; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PIKULA S, 1988, J BIOL CHEM, V263, P5277; POST RL, 1972, J BIOL CHEM, V247, P6530; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; STOKES DL, 1990, BIOPHYS J, V57, P1, DOI 10.1016/S0006-3495(90)82501-7; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Xu C, 2002, J MOL BIOL, V316, P201, DOI 10.1006/jmbi.2001.5330; Yu MH, 1998, J BIOL CHEM, V273, P3542, DOI 10.1074/jbc.273.6.3542; YU X, 1993, BIOPHYS J, V64, P1232, DOI 10.1016/S0006-3495(93)81489-9; Zhang PJ, 1998, NATURE, V392, P835, DOI 10.1038/33959; ZHANG Z, 1995, J BIOL CHEM, V270, P16283; Zhang ZS, 2000, BIOCHEMISTRY-US, V39, P8758, DOI 10.1021/bi000185m; Zhang ZS, 2001, J BIOL CHEM, V276, P15232, DOI 10.1074/jbc.M010813200	44	765	791	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2002	418	6898					605	611		10.1038/nature00944	http://dx.doi.org/10.1038/nature00944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167852				2022-12-28	WOS:000177305600033
J	Amoore, J; Ingram, P				Amoore, J; Ingram, P			Quality improvement report - Learning from adverse incidents involving medical devices	BRITISH MEDICAL JOURNAL			English	Article							HUMAN ERROR; MANAGEMENT; SAFETY; RISK; UNIT	Problem ne NHS is perceived to have a poor record of learning from incidents. Despite efforts of the Medical Devices Agency, which issues safety warnings, adverse incidents with medical devices continue to occur, some of which result in serious injury or death through device failures, user errors, and organisational problems. Design Introduction of feedback notes on a supportive investigation that seeks to determine latent factors, immediate triggers, causes, and positive actions taken by staff that minimised adverse consequences. Background and setting Medical physics department providing equipment management services in a major NHS teaching trust. Key measures for improvement Reduction in repetitions of adverse incidents and improved staff competency in using devices. Strategy for change A feedback note was developed to describe the incident and generic details of the equipment, summarise the investigation (focusing on latent causes and immediate triggers), and describe lessons to be learnt and positive actions by staff. Effects of change Feedback notes have been used in teaching sessions and given to ward link nurses. Despite being new, the positive supportive approach has encouraged an open reporting culture. Lessons learnt Adverse incidents are typically caused by alignment of different factors, but good practice can prevent errors becoming incidents. Careful analysis of incidents reveals both the multifactorial causes and the good practices that can help minimise repetitions.	Royal Infirm Edinburgh NHS Trust, Dept Med Phys & Med Engn, Edinburgh EH3 9YW, Midlothian, Scotland; Royal Infirm Edinburgh NHS Trust, Dept Nursing, Edinburgh EH3 9YW, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Amoore, J (corresponding author), Royal Infirm Edinburgh NHS Trust, Dept Med Phys & Med Engn, Edinburgh EH3 9YW, Midlothian, Scotland.							Arnstein F, 1997, BRIT J ANAESTH, V79, P645, DOI 10.1093/bja/79.5.645; Barach P, 2000, BMJ-BRIT MED J, V320, P1683, DOI 10.1136/bmj.320.7251.1683; Cohen M R, 1994, Hosp Pharm, V29, P319; COHEN MR, 1994, HOSP PHARM, V29, P330; COHEN MR, 1994, HOSP PHARM, V29, P326; COOPER JB, 1984, ANESTHESIOLOGY, V60, P34, DOI 10.1097/00000542-198401000-00008; *DEP HLTH, 1998, B MDA DB, V9801; *DEP HLTH, 2000, EQ CAR SAF US MED DE; Department of Health, 2001, BUILD SAF NHS PAT; Donaldson L., 2005, ORG MEMORY REPORT EX; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Leape LL, 2000, BMJ-BRIT MED J, V320, P725, DOI 10.1136/bmj.320.7237.725; Reason J, 2000, BMJ-BRIT MED J, V320, P768, DOI 10.1136/bmj.320.7237.768; RUNCIMAN WB, 1993, ANAESTH INTENS CARE, V21, P506, DOI 10.1177/0310057X9302100506; *SCOTT OFF, 1995, MEL199574 SCOTT OFF; *SCOTT OFF, 1993, SAF ACT B, V937; *SCOTT OFF, 1994, HAZ B HC HAZ, V889; *SCOTT OFF, 1994, SAB B, V9426; Vincent C, 2000, BRIT MED J, V320, P777, DOI 10.1136/bmj.320.7237.777; Vincent C, 1998, BRIT MED J, V316, P1154, DOI 10.1136/bmj.316.7138.1154; WEBB RK, 1993, ANAESTH INTENS CARE, V21, P673, DOI 10.1177/0310057X9302100533; Williams C, 2000, Prof Nurse, V15, P382; WOLFF HSW, 2000, P I PHYS ENG MED 6 A; WRIGHT D, 1991, LANCET, V338, P676, DOI 10.1016/0140-6736(91)91243-N	24	45	47	0	12	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 3	2002	325	7358					272	275		10.1136/bmj.325.7358.272	http://dx.doi.org/10.1136/bmj.325.7358.272			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582FL	12153928	Green Published			2022-12-28	WOS:000177339000027
J	Briggs, SD; Xiao, TJ; Sun, ZW; Caldwell, JA; Shabanowitz, J; Hunt, DF; Allis, CD; Strahl, BD				Briggs, SD; Xiao, TJ; Sun, ZW; Caldwell, JA; Shabanowitz, J; Hunt, DF; Allis, CD; Strahl, BD			Gene silencing - Trans-histone regulatory pathway in chromatin	NATURE			English	Article									Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ Virginia, Dept Chem, Charlottesville, VA 22908 USA; Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia; University of North Carolina; University of North Carolina Chapel Hill; University of Virginia; University of Virginia	Briggs, SD (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.		Strahl, Brian/C-7601-2012; Hunt, Donald F/I-6936-2012	Strahl, Brian/0000-0002-4947-6259; Hunt, Donald F/0000-0003-2815-6368; Briggs, Scott D/0000-0003-2852-3594				Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2; Dlakic M, 2001, TRENDS BIOCHEM SCI, V26, P405, DOI 10.1016/S0968-0004(01)01856-4; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6	11	376	391	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2002	418	6897					498	498		10.1038/nature00970	http://dx.doi.org/10.1038/nature00970			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152067	Bronze			2022-12-28	WOS:000177162800028
J	Carter, R				Carter, R			Ombudsman's sixth report	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Carter, R (corresponding author), The Lancet, London NW1 7BY, England.							Carter R, 2001, LANCET, V358, P350, DOI 10.1016/S0140-6736(01)05588-X; Horton R, 1996, LANCET, V348, P6, DOI 10.1016/S0140-6736(05)64352-8	2	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 27	2002	360	9329					272	272		10.1016/S0140-6736(02)09564-8	http://dx.doi.org/10.1016/S0140-6736(02)09564-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578DT	12147368				2022-12-28	WOS:000177102700006
J	Richards, SCM; Scott, DL				Richards, SCM; Scott, DL			Prescribed exercise in people with fibromyalgia: parallel group randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHRONIC-FATIGUE-SYNDROME; EXAGGERATED PAIN PERCEPTION; CHRONIC WIDESPREAD PAIN; FEAR-AVOIDANCE MODEL; PHYSICAL-FITNESS; GENERAL-POPULATION; PROGRAM; QUESTIONNAIRE; RELAXATION; PREVALENCE	Objectives To evaluate cardiovascular fitness exercise in people with fibromyalgia. Design Randomised controlled trial, Setting Hospital rheumatology outpatients, Group based classes took place at a "healthy living centre." Participants 132 patients with fibromyalgia. Interventions Prescribed graded aerobic exercise (active treatment) and relaxation and flexibility (control treatment), Main outcome measures Participants' self assessment of improvement, tender point count, impact of condition measured by fibromyalgia impact questionnaire, and short form McGill pain questionnaire. Results Compared with relaxation exercise led to significantly more participants rating themselves as much or very much better at three months: 24/69 (35%) v 12/67 (18%), P=0.03, Benefits were maintained or improved at one year follow up when fewer participants in the exercise group fulfilled the criteria for fibromyalgia (31/69 v 44/67, P=0.01). People in the exercise group also had greater reductions in tender point counts (4.2 v 2.0, P=0.02) and in scores on the fibromyalgia impact questionnaire (4.0 v 0.6, P=0.07). Conclusions Prescribed graded aerobic exercise is a simple, cheap, effective, and potentially widely available treatment for fibromyalgia.	Poole Hosp NHS Trust, Poole BH15 2JB, Dorset, England; Kings Coll Hosp London, London SE22 8PT, England	King's College Hospital NHS Foundation Trust; King's College Hospital	Richards, SCM (corresponding author), Poole Hosp NHS Trust, Poole BH15 2JB, Dorset, England.	srichards@poole-tr.swest.nhs.uk						Bailey A, 1999, ARTHRIT CARE RES, V12, P336, DOI 10.1002/1529-0131(199910)12:5<336::AID-ART5>3.0.CO;2-E; Buckelew SP, 1998, ARTHRIT CARE RES, V11, P196, DOI 10.1002/art.1790110307; BURCKHARDT CS, 1991, J RHEUMATOL, V18, P728; BURCKHARDT CS, 1994, J RHEUMATOL, V21, P714; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; CROFT P, 1993, J RHEUMATOL, V20, P710; *DEP HLTH, 1997, HLTH LIV CTR; *DEP HLTH, 1997, 9783 MISC DEP HLTH; Fulcher KY, 1997, BRIT MED J, V314, P1647, DOI 10.1136/bmj.314.7095.1647; GARRATT AM, 1993, BMJ-BRIT MED J, V306, P1440, DOI 10.1136/bmj.306.6890.1440; Gowans SE, 1999, ARTHRIT CARE RES, V12, P120, DOI 10.1002/1529-0131(199904)12:2<120::AID-ART7>3.0.CO;2-4; Guy W, ECDEU ASSESSMENT MAN, P218; Guy W., 1976, ECDEU ASSESSMENT MAN, P218; Keel PJ, 1998, CLIN J PAIN, V14, P232, DOI 10.1097/00002508-199809000-00010; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; LEDINGHAM J, 1993, BRIT J RHEUMATOL, V32, P139; LETHEM J, 1983, BEHAV RES THER, V21, P401, DOI 10.1016/0005-7967(83)90009-8; Macfarlane GJ, 1999, J RHEUMATOL, V26, P413; Martin L, 1996, J RHEUMATOL, V23, P1050; MCCAIN GA, 1988, ARTHRITIS RHEUM, V31, P1135, DOI 10.1002/art.1780310908; MCCAIN GA, 1986, AM J MED, V81, P73, DOI 10.1016/0002-9343(86)90881-8; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; MENGSHOEL AM, 1992, CLIN EXP RHEUMATOL, V10, P345; OST LG, 1987, BEHAV RES THER, V25, P397, DOI 10.1016/0005-7967(87)90017-9; PHILIPS HC, 1987, BEHAV RES THER, V25, P273, DOI 10.1016/0005-7967(87)90005-2; Powell P, 2001, BRIT MED J, V322, P1; SLADE PD, 1983, BEHAV RES THER, V21, P409, DOI 10.1016/0005-7967(83)90010-4; SURAWY C, 1995, BEHAV RES THER, V33, P535, DOI 10.1016/0005-7967(94)00077-W; Verstappen FTJ, 1997, J MUSCULOSKELET PAIN, V5, P17, DOI 10.1300/J094v05n04_03; White KP, 2000, SCAND J RHEUMATOL, V29, P44; WHITE KP, 1995, J RHEUMATOL, V22, P717; Wigers SH, 1996, J PSYCHOSOM RES, V41, P235, DOI 10.1016/0022-3999(96)00070-0; Wigers SH, 1996, SCAND J RHEUMATOL, V25, P77, DOI 10.3109/03009749609069212; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 1997, ARTHRITIS RHEUM, V40, P1571, DOI 10.1002/art.1780400905	35	152	164	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2002	325	7357					185	187		10.1136/bmj.325.7357.185	http://dx.doi.org/10.1136/bmj.325.7357.185			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580PX	12142304	Bronze, Green Published			2022-12-28	WOS:000177243900015
J	Maser, RS; DePinho, RA				Maser, RS; DePinho, RA			Connecting chromosomes, crisis, and cancer	SCIENCE			English	Review							TELOMERASE-DEFICIENT MICE; MAMMARY EPITHELIAL-CELLS; IMMORTAL HUMAN-CELLS; HUMAN TUMOR-CELLS; TO-END FUSIONS; LIFE-SPAN; COLORECTAL CARCINOGENESIS; PREMALIGNANT LESIONS; CATALYTIC SUBUNIT; HUMAN FIBROBLASTS	Cancer is a disease of impaired genome stability. The molecular forces that maintain genome integrity and sense altered chromosome structure are invariably subverted in cancer cells. Here, we explore the contrasting contributions of telomeres in the initiation and suppression of cancer and review the evidence supporting a role for telomere dysfunction as a mechanism driving the radical chromosomal aberrations that typify cancer genomes. Recent work suggests that passage of cells through crisis in the setting of deactivated DNA damage checkpoints provides a mutational mechanism that can generate the diverse genetic alterations required for cancer initiation. A greater understanding of telomere-induced crisis and the cell's crisis management mechanisms should guide the rational development of new therapeutics for cancer and other disorders.	Harvard Univ, Sch Med, Dept Med, Dana Farber Canc Inst,Dept Adult Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Dana Farber Canc Inst,Dept Adult Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	DePinho, RA (corresponding author), Harvard Univ, Sch Med, Dept Med, Dana Farber Canc Inst,Dept Adult Oncol, 44 Binney St,M413, Boston, MA 02115 USA.		Maser, Richard/B-2970-2012	DePinho, Ronald/0000-0002-5625-577X				Akiyama M, 2002, CANCER LETT, V178, P187, DOI 10.1016/S0304-3835(01)00838-2; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Boveri T., 1914, FRAGE ENTSTEHUNG MAL; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; CHADENEAU C, 1995, CANCER RES, V55, P2533; Chen QJ, 2001, MOL CELL BIOL, V21, P1819, DOI 10.1128/MCB.21.5.1819-1827.2001; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; Corey DR, 2002, ONCOGENE, V21, P631, DOI 10.1038/sj.onc.1205063; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Damm K, 2001, EMBO J, V20, P6958, DOI 10.1093/emboj/20.24.6958; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; DELANGE T, 1995, TELOMERES, P265; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Dove WF, 1998, PHILOS T ROY SOC B, V353, P915, DOI 10.1098/rstb.1998.0256; Ducray C, 1999, ONCOGENE, V18, P4211, DOI 10.1038/sj.onc.1202797; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Engelhardt M, 1997, CLIN CANCER RES, V3, P1931; Gisselsson D, 2001, P NATL ACAD SCI USA, V98, P12683, DOI 10.1073/pnas.211357798; Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Gowan SM, 2002, MOL PHARMACOL, V61, P1154, DOI 10.1124/mol.61.5.1154; Gray JW, 2000, CARCINOGENESIS, V21, P443, DOI 10.1093/carcin/21.3.443; Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Harley CB, 1997, CANCER SURV, V29, P263; HARLEY CB, 1992, EXP GERONTOL, V27, P375, DOI 10.1016/0531-5565(92)90068-B; HASTIE ND, 1990, NATURE, V346, P86; Herbert BS, 1999, P NATL ACAD SCI USA, V96, P14276, DOI 10.1073/pnas.96.25.14276; HERMANN MT, 2001, MOL BIOL CELL, V12, P2023; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Jackson SP, 2001, BIOCHEM SOC T, V29, P655, DOI 10.1042/BST0290655; Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim S, 2002, ONCOGENE, V21, P503, DOI 10.1038/sj.onc.1205077; KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Kolquist KA, 1998, NAT GENET, V19, P182, DOI 10.1038/554; Le S, 1999, GENETICS, V152, P143; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lee KH, 2001, P NATL ACAD SCI USA, V98, P3381, DOI 10.1073/pnas.051629198; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Levitt NC, 2002, TRENDS MOL MED, V8, P179, DOI 10.1016/S1471-4914(02)02298-0; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; McClintock B, 1941, GENETICS, V26, P234; Miura N, 1997, CANCER GENET CYTOGEN, V93, P56, DOI 10.1016/S0165-4608(96)00329-9; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Muller H J, 1927, Science, V66, P84, DOI 10.1126/science.66.1699.84; Muller H.J., 1938, COLLECTING NET, V13, P181; MURNANE JP, 1994, EMBO J, V13, P4953, DOI 10.1002/j.1460-2075.1994.tb06822.x; Naasani I, 1999, CANCER RES, V59, P4004; OHAGAN RC, IN PRESS CANC CELL; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Pipiras E, 1998, EMBO J, V17, P325, DOI 10.1093/emboj/17.1.325; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; RUDOLPH KL, 2001, LIVER BIOL PATHOBIOL, P999; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Sharpless NE, 2001, MOL CELL, V8, P1187, DOI 10.1016/S1097-2765(01)00425-7; Shay JW, 2000, NAT BIOTECHNOL, V18, P22, DOI 10.1038/71872; Shiloh Y, 2001, ADV CANCER RES, V83, P209, DOI 10.1016/S0065-230X(01)83007-4; Stampfer MR, 2001, P NATL ACAD SCI USA, V98, P4498, DOI 10.1073/pnas.071483998; Stewart SA, 2002, ONCOGENE, V21, P627, DOI 10.1038/sj.onc.1205062; Tang RP, 1998, CANCER RES, V58, P4052; Teng SC, 1999, MOL CELL BIOL, V19, P8083; Thomas M, 2000, NAT BIOTECHNOL, V18, P39, DOI 10.1038/71894; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Vaziri H, 1999, MOL CELL BIOL, V19, P2373; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Vonderheide RH, 2002, ONCOGENE, V21, P674, DOI 10.1038/sj.onc.1205074; VONHANSEMANN D, 1890, ARCH PATHOL ANAT PHY, V119, P299; Wahl GM, 2001, NAT CELL BIOL, V3, pE277, DOI 10.1038/ncb1201-e277; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; White LK, 2001, TRENDS BIOTECHNOL, V19, P114, DOI 10.1016/S0167-7799(00)01541-9; WINDLE B, 1991, GENE DEV, V5, P160, DOI 10.1101/gad.5.2.160; WRIGHT WE, 1992, EXP GERONTOL, V27, P383, DOI 10.1016/0531-5565(92)90069-C; Yan P, 1999, J PATHOL, V189, P207, DOI 10.1002/(SICI)1096-9896(199910)189:2<207::AID-PATH424>3.0.CO;2-H; Yang JW, 2001, NAT BIOTECHNOL, V19, P219, DOI 10.1038/85655; Zhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	93	444	455	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2002	297	5581					565	569		10.1126/science.297.5581.565	http://dx.doi.org/10.1126/science.297.5581.565			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142527				2022-12-28	WOS:000177054200040
J	Moore, SA; Saito, F; Chen, JG; Michele, DE; Henry, MD; Messing, A; Cohn, RD; Ross-Barta, SE; Westra, S; Williamson, RA; Hoshi, T; Campbell, KP				Moore, SA; Saito, F; Chen, JG; Michele, DE; Henry, MD; Messing, A; Cohn, RD; Ross-Barta, SE; Westra, S; Williamson, RA; Hoshi, T; Campbell, KP			Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy	NATURE			English	Article							FUKUYAMA-TYPE; LAMININ; DISRUPTION; DEFICIENCY; MUTATIONS; INTEGRINS; MEMBRANE; COMPLEX; ROLES; MICE	Fukuyama congenital muscular dystrophy (FCMD), muscle-eye-brain disease (MEB), and Walker-Warburg syndrome are congenital muscular dystrophies (CMDs) with associated developmental brain defects(1-4). Mutations reported in genes of FCMD2 and MEB5 patients suggest that the genes may be involved in protein glycosylation. Dystroglycan is a highly glycosylated component of the muscle dystrophin-glycoprotein complex(6) that is also expressed in brain, where its function is unknown(7). Here we show that brain-selective deletion of dystroglycan in mice is sufficient to cause CMD-like brain malformations, including disarray of cerebral cortical layering, fusion of cerebral hemispheres and cerebellar folia, and aberrant migration of granule cells. Dystroglycan-null brain loses its high-affinity binding to the extracellular matrix protein laminin, and shows discontinuities in the pial surface basal lamina (glia limitans) that probably underlie the neuronal migration errors. Furthermore, mutant mice have severely blunted hippocampal long-term potentiation with electrophysiologic characterization indicating that dystroglycan might have a postsynaptic role in learning and memory. Our data strongly support the hypothesis that defects in dystroglycan are central to the pathogenesis of structural and functional brain abnormalities seen in CMD.	Univ Iowa, Howard Hughes Med Inst, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA; Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53705 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Campbell, KP (corresponding author), Univ Iowa, Howard Hughes Med Inst, Dept Physiol & Biophys, Iowa City, IA 52242 USA.	kevin-campbell@uiowa.edu	Cohn, Ronald/AAC-5835-2021	Henry, Michael/0000-0002-7871-245X; Moore, Steven/0000-0002-6353-7900; Campbell, Kevin/0000-0003-2066-5889				Aravind L, 1999, CURR BIOL, V9, pR836, DOI 10.1016/S0960-9822(00)80039-1; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; CHOI BH, 1994, MICROSC RES TECHNIQ, V28, P193, DOI 10.1002/jemt.1070280304; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T; Cormand B, 2001, NEUROLOGY, V56, P1059, DOI 10.1212/WNL.56.8.1059; De Arcangelis A, 1999, DEVELOPMENT, V126, P3957; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; FUKUYAMA Y, 1981, BRAIN DEV-JPN, V3, P1; Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; GREWAL PK, 1908, NAT GENET, V28, P151; Haltia M, 1997, ANN NEUROL, V41, P173, DOI 10.1002/ana.410410208; Hayashi YK, 2001, NEUROLOGY, V57, P115, DOI 10.1212/WNL.57.1.115; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Henry MD, 1999, CURR OPIN CELL BIOL, V11, P602, DOI 10.1016/S0955-0674(99)00024-1; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Ross ME, 2001, ANNU REV NEUROSCI, V24, P1041, DOI 10.1146/annurev.neuro.24.1.1041; SCHULZ PE, 1994, J NEUROSCI, V14, P5325; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Williamson RA, 1997, HUM MOL GENET, V6, P831, DOI 10.1093/hmg/6.6.831; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Zaccaria ML, 2001, NEUROSCIENCE, V104, P311, DOI 10.1016/S0306-4522(01)00092-6; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	30	439	446	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2002	418	6896					422	425		10.1038/nature00838	http://dx.doi.org/10.1038/nature00838			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12140559				2022-12-28	WOS:000177009700039
J	Bledsoe, RK; Montana, VG; Stanley, TB; Delves, CJ; Apolito, CJ; McKee, DD; Consler, TG; Parks, DJ; Stewart, EL; Willson, TM; Lambert, MH; Moore, JT; Pearce, KH; Xu, HE				Bledsoe, RK; Montana, VG; Stanley, TB; Delves, CJ; Apolito, CJ; McKee, DD; Consler, TG; Parks, DJ; Stewart, EL; Willson, TM; Lambert, MH; Moore, JT; Pearce, KH; Xu, HE			Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition	CELL			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; THYROID-HORMONE RECEPTOR; HEAT-SHOCK-PROTEIN; NUCLEAR RECEPTOR; STEROID-RECEPTOR; MOLECULAR-BASIS; ESTROGEN-RECEPTOR; ANDROGEN RECEPTOR; CO-REPRESSOR; HSP90	Transcriptional regulation by the glucocorticoid receptor (GR) is mediated by hormone binding, receptor dimerization, and coactivator recruitment. Here, we report the crystal structure of the human GR ligand binding domain (LBD) bound to dexamethasone and a coactivator motif derived from the transcriptional intermediary factor 2. Despite structural similarity to other steroid receptors, the GR LBD adopts a surprising dimer configuration involving formation of an intermolecular P sheet. Functional studies demonstrate that the novel dimer interface is important for GR-mediated activation. The structure also reveals an additional charge clamp that determines the binding selectivity of a coactivator and a distinct ligand binding pocket that explains its selectivity for endogenous steroid hormones. These results establish a framework for understanding the roles of protein-hormone and protein-protein interactions in GR signaling pathways.	GlaxoSmithKline, Computat Analyt & Strust Sci, Discovery Res, Res Triangle Pk, NC 27709 USA; GlaxoSmithKline, Nucl Receptor Syst Res, Discovery Res, Res Triangle Pk, NC 27709 USA; GlaxoSmithKline, High Throughput Chem, Discovery Res, Res Triangle Pk, NC 27709 USA; GlaxoSmithKline, High Throughput Biol, Discovery Res, Res Triangle Pk, NC 27709 USA; GlaxoSmithKline, Gene Express & Prot Biochem, Discovery Res, Stevenage SG1 2NY, Herts, England; GlaxoSmithKline, Gene Express & Prot Biochem, Discovery Res, Res Triangle Pk, NC 27709 USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Pearce, KH (corresponding author), Van Andel Res Inst, Lab Struct Sci, 333 Bostowick NE, Grand Rapids, MI 49503 USA.	kenneth.h.pearce@gsk.com; eric.xu@vai.org	Xu, H. Eric/ABD-7487-2021; feinstein, doug/M-9414-2019; ID, IMCACAT/D-5867-2014	Xu, H. Eric/0000-0002-6829-8144				Auwerx J, 1999, CELL, V97, P161; Barnes PJ, 1998, AM J RESP CRIT CARE, V157, pS1, DOI 10.1164/ajrccm.157.3.157315; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; BRESNICK EH, 1989, J BIOL CHEM, V264, P4992; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Caamano CA, 1998, J BIOL CHEM, V273, P20473, DOI 10.1074/jbc.273.32.20473; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Cohn E. J., 1943, PROTEINS AMINO ACIDS; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Ding XF, 1998, MOL ENDOCRINOL, V12, P302, DOI 10.1210/me.12.2.302; DURCHSCHLAG H, 1986, THERMODYNAMIC DATA B, P45; Escriva H, 2000, BIOESSAYS, V22, P717; Freeman BC, 2000, GENE DEV, V14, P422; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; GARABEDIAN MJ, 1992, MOL BIOL CELL, V3, P1245, DOI 10.1091/mbc.3.11.1245; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; LAMBERT MH, 1997, PRACTICAL APPL COMPU, P243; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; List HJ, 1999, EXP CELL RES, V250, P414, DOI 10.1006/excr.1999.4517; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; Matias PM, 2000, J BIOL CHEM, V275, P26164, DOI 10.1074/jbc.M004571200; McKay LI, 1999, ENDOCR REV, V20, P435, DOI 10.1210/er.20.4.435; Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200; Morishima Y, 2000, J BIOL CHEM, V275, P18054, DOI 10.1074/jbc.M000434200; NAVAZA J, 1992, MOL REPLACEMENT, P87; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; ONATE SA, 1995, SCIENCE, V270, P1354; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Ping DS, 1999, J IMMUNOL, V162, P727; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Reichardt HM, 2000, ADV PHARMACOL, V47, P1; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Sack JS, 2001, P NATL ACAD SCI USA, V98, P4904, DOI 10.1073/pnas.081565498; Savory JGA, 2001, MOL CELL BIOL, V21, P781, DOI 10.1128/MCB.21.3.781-793.2001; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Valentine JE, 2000, J BIOL CHEM, V275, P25322, DOI 10.1074/jbc.M002497200; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; WAGNER RL, 1995, NATURE, V378, P690, DOI 10.1038/378690a0; Werner S, 1996, STEROIDS, V61, P216, DOI 10.1016/0039-128X(96)00017-7; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775; Willson TM, 1996, J MED CHEM, V39, P665, DOI 10.1021/jm950395a; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Zhang SM, 1996, MOL ENDOCRINOL, V10, P24, DOI 10.1210/me.10.1.24	51	626	659	0	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 12	2002	110	1					93	105		10.1016/S0092-8674(02)00817-6	http://dx.doi.org/10.1016/S0092-8674(02)00817-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	573PU	12151000	Bronze			2022-12-28	WOS:000176840700010
J	Chen, CR; Kang, YB; Siegel, PM; Massague, J				Chen, CR; Kang, YB; Siegel, PM; Massague, J			E2F4/5 and p107 as Smad cofactors linking the TGF beta receptor to c-myc repression	CELL			English	Article							GROWTH-FACTOR-BETA; CELL-CYCLE ARREST; TRANSCRIPTION FACTORS; STRUCTURAL BASIS; DNA-BINDING; FUNCTIONAL INTERACTION; TARGETED DISRUPTION; MICE LACKING; CANCER CELLS; IN-VIVO	Smad3 is a direct mediator of transcriptional activation by the TGFbeta receptor. Its target genes in epithelial cells include cyclin-dependent kinase inhibitors that generate a cytostatic reponse. We defined how, in the same context, Smad3 can also mediate transcriptional repression of the growth-promoting gene c-myc. A complex containing Smad3, the transcription factors E2F4/5 and DP1, and the corepressor p107 preexists in the cytoplasm. In response to TGFbeta, this complex moves into the nucleus and associates with Smad4, recognizing a composite Smad-E2F site on c-myc for repression. Previously known as the ultimate recipients of cdk regulatory signals, E2F4/5 and p107 act here as transducers of TGFbeta receptor signals upstream of cdk. Smad proteins therefore mediate transcriptional activation or repression depending on their associated partners.	Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Cell Biol Program, New York, NY 10021 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Cell Biol Program, 1275 York Ave, New York, NY 10021 USA.			Massague, Joan/0000-0001-9324-8408; Kang, Yibin/0000-0002-1626-6730				ALEXANDROW MG, 1995, CANCER RES, V55, P1452; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Bai RY, 2002, NAT CELL BIOL, V4, P181, DOI 10.1038/ncb753; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Bottinger EP, 1997, KIDNEY INT, V51, P1355, DOI 10.1038/ki.1997.185; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BUCKLES R, 1995, J URBAN TECHNOL, V2, P31, DOI 10.1080/10630739508724497; Calonge MJ, 1999, J BIOL CHEM, V274, P33637, DOI 10.1074/jbc.274.47.33637; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; Claassen GF, 2000, P NATL ACAD SCI USA, V97, P9498, DOI 10.1073/pnas.150006697; Classon M, 2001, EXP CELL RES, V264, P135, DOI 10.1006/excr.2000.5135; Cobrinik D, 1996, GENE DEV, V10, P1633, DOI 10.1101/gad.10.13.1633; Depoortere F, 2000, MOL BIOL CELL, V11, P1061, DOI 10.1091/mbc.11.3.1061; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Gaubatz S, 2000, MOL CELL, V6, P729, DOI 10.1016/S1097-2765(00)00071-X; Germain S, 2000, GENE DEV, V14, P435; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Huse M, 2001, MOL CELL, V8, P671, DOI 10.1016/S1097-2765(01)00332-X; Iavarone A, 1999, MOL CELL BIOL, V19, P916; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Jayaraman L, 2000, J BIOL CHEM, V275, P40710, DOI 10.1074/jbc.M005799200; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; LeCouter JE, 1998, MOL CELL BIOL, V18, P7455, DOI 10.1128/MCB.18.12.7455; Lee MH, 1996, GENE DEV, V10, P1621, DOI 10.1101/gad.10.13.1621; LEES JA, 1993, MOL CELL BIOL, V13, P7813, DOI 10.1128/MCB.13.12.7813; Lo RS, 1998, EMBO J, V17, P996, DOI 10.1093/emboj/17.4.996; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Moberg K, 1996, MOL CELL BIOL, V16, P1436; Mulligan G, 1998, TRENDS GENET, V14, P223, DOI 10.1016/S0168-9525(98)01470-X; Pouponnot C, 1998, J BIOL CHEM, V273, P22865, DOI 10.1074/jbc.273.36.22865; Qin BY, 2001, MOL CELL, V8, P1303, DOI 10.1016/S1097-2765(01)00417-8; Randall RA, 2002, EMBO J, V21, P145, DOI 10.1093/emboj/21.1.145; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Reynisdottir I, 1997, GENE DEV, V11, P492, DOI 10.1101/gad.11.4.492; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; SANCHEZ A, 1995, J CELL PHYSIOL, V165, P398, DOI 10.1002/jcp.1041650221; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Shen X, 1998, MOL BIOL CELL, V9, P3309, DOI 10.1091/mbc.9.12.3309; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shi YG, 1997, NATURE, V388, P87, DOI 10.1038/40431; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; Takahashi Y, 2000, GENE DEV, V14, P804; Tommasi S, 1997, J BIOL CHEM, V272, P30483, DOI 10.1074/jbc.272.48.30483; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Truant R, 1999, J BIOL CHEM, V274, P32167, DOI 10.1074/jbc.274.45.32167; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; VAIRO G, 1995, GENE DEV, V9, P869, DOI 10.1101/gad.9.7.869; Warner BJ, 1999, MOL CELL BIOL, V19, P5913; Whitman M, 1998, GENE DEV, V12, P2445, DOI 10.1101/gad.12.16.2445; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; Wu G, 2000, SCIENCE, V287, P92, DOI 10.1126/science.287.5450.92; Wu JW, 2001, MOL CELL, V8, P1277, DOI 10.1016/S1097-2765(01)00421-X; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Yagi K, 2002, J BIOL CHEM, V277, P854, DOI 10.1074/jbc.M104170200; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; ZHANG YH, 1995, ONCOGENE, V10, P2085; Zheng N, 1999, GENE DEV, V13, P666, DOI 10.1101/gad.13.6.666; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4; Zwicker J, 1996, SCIENCE, V271, P1595, DOI 10.1126/science.271.5255.1595	73	358	382	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 12	2002	110	1					19	32		10.1016/S0092-8674(02)00801-2	http://dx.doi.org/10.1016/S0092-8674(02)00801-2			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	573PU	12150994	Bronze			2022-12-28	WOS:000176840700004
J	Butov, LV; Gossard, AC; Chemla, DS				Butov, LV; Gossard, AC; Chemla, DS			Macroscopically ordered state in an exciton system	NATURE			English	Article							COUPLED QUANTUM-WELLS; CONDENSATION; GAS	There is a rich variety of quantum liquids-such as superconductors, liquid helium and atom Bose-Einstein condensates-that exhibit macroscopic coherence in the form of ordered arrays of vortices(1-4). Experimental observation of a macroscopically ordered electronic state in semiconductors has, however, remained a challenging and relatively unexplored problem. A promising approach for the realization of such a state is to use excitons, bound pairs of electrons and holes that can form in semiconductor systems. At low densities, excitons are Bose-particles(5), and at low temperatures, of the order of a few kelvin, excitons can form a quantum liquid-that is, a statistically degenerate Bose gas or even a Bose-Einstein condensate(5-7). Here we report photoluminescence measurements of a quasi-two-dimensional exciton gas in GaAs/AlGaAs coupled quantum wells and the observation of a macroscopically ordered exciton state. Our spatially resolved measurements reveal fragmentation of the ring-shaped emission pattern into circular structures that form periodic arrays over lengths up to 1 mm.	Univ Calif Berkeley, EO Lawrence Berkeley Natl Lab, Div Sci Mat, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Russian Acad Sci, Inst Solid State Phys, Chernogolovka 142432, Russia; Univ Calif Santa Barbara, Dept Elect & Comp Engn, Santa Barbara, CA 93106 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Russian Academy of Sciences; Osipyan Institute of Solid State Physics RAS; University of California System; University of California Santa Barbara	Butov, LV (corresponding author), Univ Calif Berkeley, EO Lawrence Berkeley Natl Lab, Div Sci Mat, Berkeley, CA 94720 USA.							Abo-Shaeer JR, 2001, SCIENCE, V292, P476, DOI 10.1126/science.1060182; Butov LV, 1998, PHYS REV B, V58, P1980, DOI 10.1103/PhysRevB.58.1980; Butov LV, 2002, NATURE, V417, P47, DOI 10.1038/417047a; Butov LV, 2001, PHYS REV LETT, V86, P5608, DOI 10.1103/PhysRevLett.86.5608; Carr LD, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.063610; ESSMANN U, 1967, PHYS LETT A, VA 24, P526, DOI 10.1016/0375-9601(67)90819-5; FELDMANN J, 1987, PHYS REV LETT, V59, P2337, DOI 10.1103/PhysRevLett.59.2337; FUKUZAWA T, 1990, PHYS REV LETT, V64, P3066, DOI 10.1103/PhysRevLett.64.3066; KELDYSH LV, 1968, ZH EKSP TEOR FIZ, V27, P521; Kosterlitz JM, 1973, J PHYS C SOLID STATE, V6, P1181, DOI 10.1088/0022-3719/6/7/010; Larionov AV, 2002, JETP LETT+, V75, P200, DOI 10.1134/1.1475723; Leggett AJ, 2001, REV MOD PHYS, V73, P307, DOI 10.1103/RevModPhys.73.307; Lozovik YE., 1976, SOV PHYS JETP, V44, P389; Madison KW, 2000, PHYS REV LETT, V84, P806, DOI 10.1103/PhysRevLett.84.806; Perakis IE, 2002, NATURE, V417, P33, DOI 10.1038/417033a; Popov V. N., 1983, Functional integrals in quantum field theory and statistical physics, DOI 10.1007/BF01028373; Taylor GI, 1923, PHILOS T R SOC LOND, V223, P289, DOI 10.1098/rsta.1923.0008; Topinka MA, 2001, NATURE, V410, P183, DOI 10.1038/35065553; YARMCHUK EJ, 1979, PHYS REV LETT, V43, P214, DOI 10.1103/PhysRevLett.43.214; YOSHIOKA D, 1990, J PHYS SOC JPN, V59, P4211, DOI 10.1143/JPSJ.59.4211; ZHU XJ, 1995, PHYS REV LETT, V74, P1633, DOI 10.1103/PhysRevLett.74.1633	21	408	417	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 15	2002	418	6899					751	754		10.1038/nature00943	http://dx.doi.org/10.1038/nature00943			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181559	Green Submitted			2022-12-28	WOS:000177428000031
J	Demetri, GD; von Mehren, M; Blanke, CD; Van den Abbeele, AD; Eisenberg, B; Roberts, PJ; Heinrich, MC; Tuveson, DA; Singer, S; Janicek, M; Fletcher, JA; Silverman, SG; Silberman, SL; Capdeville, R; Kiese, B; Peng, B; Dimitrijevic, S; Druker, BJ; Corless, C; Fletcher, CDM; Joensuu, H				Demetri, GD; von Mehren, M; Blanke, CD; Van den Abbeele, AD; Eisenberg, B; Roberts, PJ; Heinrich, MC; Tuveson, DA; Singer, S; Janicek, M; Fletcher, JA; Silverman, SG; Silberman, SL; Capdeville, R; Kiese, B; Peng, B; Dimitrijevic, S; Druker, BJ; Corless, C; Fletcher, CDM; Joensuu, H			Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TYROSINE KINASE INHIBITOR; CHRONIC MYELOID-LEUKEMIA; C-KIT; STI-571; GROWTH; AMPLIFICATION; RESISTANCE; STI571; ST1571; CELLS	Background Constitutive activation of KIT receptor tyrosine kinase is critical in the pathogenesis of gastrointestinal stromal tumors. Imatinib mesylate, a selective tyrosine kinase inhibitor, has been shown in preclinical models and preliminary clinical studies to have activity against such tumors. Methods We conducted an open-label, randomized, multicenter trial to evaluate the activity of imatinib in patients with advanced gastrointestinal stromal tumor. We assessed antitumor response and the safety and tolerability of the drug. Pharmacokinetics were assessed in a subgroup of patients. Results A total of 147 patients were randomly assigned to receive 400 mg or 600 mg of imatinib daily. Overall, 79 patients (53.7 percent) had a partial response, 41 patients (27.9 percent) had stable disease, and for technical reasons, response could not be evaluated in 7 patients (4.8 percent). No patient had a complete response to the treatment. The median duration of response had not been reached after a median follow-up of 24 weeks after the onset of response. Early resistance to imatinib was noted in 20 patients (13.6 percent). Therapy was well tolerated, although mild-to-moderate edema, diarrhea, and fatigue were common. Gastrointestinal or intraabdominal hemorrhage occurred in approximately 5 percent of patients. There were no significant differences in toxic effects or response between the two doses. Imatinib was well absorbed, with pharmacokinetics similar to those reported in patients with chronic myeloid leukemia. Conclusions Imatinib induced a sustained objective response in more than half of patients with an advanced unresectable or metastatic gastrointestinal stromal tumor. Inhibition of the KIT signal-transduction pathway is a promising treatment for advanced gastrointestinal stromal tumors, which resist conventional chemotherapy.	Dana Farber Canc Inst, Ctr Sarcoma & Bone Oncol, Boston, MA 02115 USA; Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Oregon Hlth & Sci Univ, Portland, OR USA; Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Portland, OR 97201 USA; Univ Turku, Turku, Finland; Novartis Oncol, Basel, Switzerland; Univ Helsinki, Helsinki, Finland	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Fox Chase Cancer Center; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Turku; Novartis; University of Helsinki	Demetri, GD (corresponding author), Dana Farber Canc Inst, Ctr Sarcoma & Bone Oncol, SW 530,44 Binney St, Boston, MA 02115 USA.	gdemetri@partners.org	Heinrich, Michael/AAC-6745-2019; Van den Abbeele, Annick/AAK-9792-2020; ravegnini, gloria/K-1330-2016	ravegnini, gloria/0000-0002-7774-402X; Singer, Samuel/0000-0001-9713-8230; Janicek, Milos/0000-0003-4084-3339; Heinrich, Michael/0000-0003-3790-0478; Druker, Brian/0000-0001-8331-8206				Bakhtiar R, 2002, J CHROMATOGR B, V768, P325, DOI 10.1016/S1570-0232(01)00611-0; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; *CANC THER EV PROG, 1999, COMM TOX CRIT MAN CO; DeMatteo RP, 2000, ANN SURG, V231, P51, DOI 10.1097/00000658-200001000-00008; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Druker BJ, 2001, NEW ENGL J MED, V345, P232; Fletcher CDM, 2002, HUM PATHOL, V33, P459, DOI 10.1053/hupa.2002.123545; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; GOSS GA, 2000, PROG P AM SOC CLIN O, V19, pA599; GREEN S, 1992, INVEST NEW DRUG, V10, P239, DOI 10.1007/BF00944177; Heinrich MC, 2000, BLOOD, V96, P925, DOI 10.1182/blood.V96.3.925.015k50_925_932; Hornick JL, 2002, AM J CLIN PATHOL, V117, P188; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; le Coutre P, 2000, BLOOD, V95, P1758, DOI 10.1182/blood.V95.5.1758.005a41_1758_1766; Lux ML, 2000, AM J PATHOL, V156, P791, DOI 10.1016/S0002-9440(10)64946-2; Miettinen M, 1999, HUM PATHOL, V30, P1213, DOI 10.1016/S0046-8177(99)90040-0; Miettinen M, 2001, AM J SURG PATHOL, V25, P1121, DOI 10.1097/00000478-200109000-00002; PENG B, 2001, P AN M AM SOC CLIN, V20, pA71; Rubin BP, 2001, CANCER RES, V61, P8118; Rubin BP, 2000, INT J SURG PATHOL, V8, P5, DOI 10.1177/106689690000800105; Tuveson DA, 2001, ONCOGENE, V20, P5054, DOI 10.1038/sj.onc.1204704; van Oosterom AT, 2001, LANCET, V358, P1421, DOI 10.1016/S0140-6736(01)06535-7; Wang WL, 2000, ONCOGENE, V19, P3521, DOI 10.1038/sj.onc.1203698	25	3199	3412	3	218	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 15	2002	347	7					472	480		10.1056/NEJMoa020461	http://dx.doi.org/10.1056/NEJMoa020461			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587ZM	12181401	Green Published			2022-12-28	WOS:000177674400003
J	Flemons, WW				Flemons, WW			Obstructive sleep APNEA	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITIVE AIRWAY PRESSURE; APNEA/HYPOPNEA SYNDROME; ORAL APPLIANCE; OBESE PATIENTS; AUTO-CPAP; DIAGNOSIS; TRIAL; UVULOPALATOPHARYNGOPLASTY; AUTOSET(TM); CROSSOVER		Univ Calgary, Calgary, AB, Canada; Foothills Med Ctr, Calgary, AB, Canada	University of Calgary; University of Calgary	Flemons, WW (corresponding author), Foothills Prov Gen Hosp, 1403 29th St NW, Calgary, AB T2N 2T9, Canada.		Amedee, Ronald/A-5480-2011					BERRY RB, 1995, AM J RESP CRIT CARE, V151, P450, DOI 10.1164/ajrccm.151.2.7842205; Bridgman SA, 2000, COCHRANE DB SYST REV, V2; Chesson AL, 1997, SLEEP, V20, P406; d'Ortho MP, 2000, CHEST, V118, P1010, DOI 10.1378/chest.118.4.1010; Engleman HM, 1999, AM J RESP CRIT CARE, V159, P461, DOI 10.1164/ajrccm.159.2.9803121; Farre R, 1999, LANCET, V353, P1154, DOI 10.1016/S0140-6736(99)01056-9; Ferguson KA, 1996, CHEST, V109, P1269, DOI 10.1378/chest.109.5.1269; Ferguson KA, 1997, THORAX, V52, P362, DOI 10.1136/thx.52.4.362; Ficker JH, 1998, THORAX, V53, P643, DOI 10.1136/thx.53.8.643; Flemons WW, 2002, AM J RESP CRIT CARE, V165, P159, DOI 10.1164/ajrccm.165.2.2010008; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; FLEMONS WW, 1994, AM J RESP CRIT CARE, V150, P1279, DOI 10.1164/ajrccm.150.5.7952553; FLEMONS WW, 1997, SLEEP MED REV, V1, P19; Fleury B, 1996, SLEEP, V19, P502, DOI 10.1093/sleep/19.6.502; FLEURY B, 1996, SLEEP, V19, P601; George CFP, 2001, THORAX, V56, P508, DOI 10.1136/thorax.56.7.508; HE J, 1988, CHEST, V94, P9, DOI 10.1378/chest.94.1.9; Hoy CJ, 1999, AM J RESP CRIT CARE, V159, P1096, DOI 10.1164/ajrccm.159.4.9808008; Janson C, 1997, ARCH OTOLARYNGOL, V123, P257; Jenkinson C, 1999, LANCET, V353, P2100, DOI 10.1016/S0140-6736(98)10532-9; Littner M, 2001, SLEEP, V24, P603, DOI 10.1093/sleep/24.5.603; Mayer P, 1998, EUR RESPIR J, V12, P770, DOI 10.1183/09031936.98.12040770; McArdle N, 1999, AM J RESP CRIT CARE, V159, P1108, DOI 10.1164/ajrccm.159.4.9807111; Mehta A, 2001, AM J RESP CRIT CARE, V163, P1457, DOI 10.1164/ajrccm.163.6.2004213; Meurice JC, 1996, AM J RESP CRIT CARE, V153, P794, DOI 10.1164/ajrccm.153.2.8564134; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Newman AB, 2001, AM J EPIDEMIOL, V154, P50, DOI 10.1093/aje/154.1.50; Oksenberg A, 1997, CHEST, V112, P629, DOI 10.1378/chest.112.3.629; PARTINEN M, 1988, CHEST, V94, P1200, DOI 10.1378/chest.94.6.1200; Peppard PE, 2000, JAMA-J AM MED ASSOC, V284, P3015, DOI 10.1001/jama.284.23.3015; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; PILLAR G, 1994, CHEST, V106, P1702, DOI 10.1378/chest.106.6.1702; Ross SD, 2000, SLEEP, V23, P519; Scheuller M, 2001, OTOLARYNG HEAD NECK, V125, P299, DOI 10.1067/mhn.2001.119139; SERIES F, 1993, ANN INTERN MED, V119, P449, DOI 10.7326/0003-4819-119-6-199309150-00001; Series F, 2000, AM J RESP CRIT CARE, V162, P94, DOI 10.1164/ajrccm.162.1.9908023; Sher AE, 1996, SLEEP, V19, P156, DOI 10.1093/sleep/19.2.156; Shneerson J, 2001, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD002875; SMITH PL, 1985, ANN INTERN MED, V103, P850, DOI 10.7326/0003-4819-103-6-850; Stradling JR, 1997, THORAX, V52, P72, DOI 10.1136/thx.52.1.72; STROHL KP, 1994, AM J RESP CRIT CARE, V150, P1463; TAASAN VC, 1981, AM J MED, V71, P240; THORPY M, 1994, SLEEP, V17, P372; Vazquez JC, 2000, THORAX, V55, P302, DOI 10.1136/thorax.55.4.302; Wilhelmsson B, 1999, ACTA OTO-LARYNGOL, V119, P503; Wright J, 1997, BRIT MED J, V314, P851; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; 1995, AM J RESP CRIT CARE, V151, P578; 1999, ASDA NEWS, V6, P19; 1994, AM J RESP CRIT CARE, V151, P1738	50	236	260	0	8	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 15	2002	347	7					498	504		10.1056/NEJMcp012849	http://dx.doi.org/10.1056/NEJMcp012849			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587ZM	12181405				2022-12-28	WOS:000177674400007
J	Nyman, M; Bonhomme, F; Alam, TM; Rodriguez, MA; Cherry, BR; Krumhansl, JL; Nenoff, TM; Sattler, AM				Nyman, M; Bonhomme, F; Alam, TM; Rodriguez, MA; Cherry, BR; Krumhansl, JL; Nenoff, TM; Sattler, AM			A general synthetic procedure for heteropolyniobates	SCIENCE			English	Article							POLYOXOMETALATE-DIPHOSPHATE COMPLEXES	The heteropolyanions of W, Mo, and V, which have found numerous applications, are formed simply by acidification of solutions of their oxoanions. Under similar conditions, these oxoanion precursors are not available for Nb, and Nb-oxo chemistry is dominated by formation of the Lindquist ion [Nb6O19](8-) only. However, heteropolyniobate formation is favored in hydrothermal reactions of aqueous, alkaline precursor mixtures. Here we give two examples of heteropolyniobates formed by this general reaction type: K-12[Ti2O2] [SiNb12O40].16H(2)O [1], which contains chains of silicododecaniobate Keggin ions, and Na-14[H2Si4Nb16O56].45.5H(2)O [2], a new heteropolyanion structure type.	Sandia Natl Labs, Albuquerque, NM 87185 USA	United States Department of Energy (DOE); Sandia National Laboratories	Nyman, M (corresponding author), Sandia Natl Labs, POB 5800, Albuquerque, NM 87185 USA.	mdnyman@sandia.gov	Bonhomme, Francois/C-6290-2012	Bonhomme, Francois/0000-0002-8792-9239; Nyman, May/0000-0002-1787-0518				BRESE NE, 1991, ACTA CRYSTALLOGR B, V47, P192, DOI 10.1107/S0108768190011041; Casey WH, 2001, GEOCHIM COSMOCHIM AC, V65, P705, DOI 10.1016/S0016-7037(00)00611-6; Coronado E, 1998, CHEM REV, V98, P273, DOI 10.1021/cr970471c; Dale B.W., 1967, J CHEM SOC CHEM COMM, V67, P792; DALE BW, 1969, J CHEM SOC A, P301, DOI 10.1039/j19690000301; DAWSON B, 1953, ACTA CRYSTALLOGR, V6, P113, DOI 10.1107/S0365110X53000466; Dickman MH, 2001, INORG CHEM, V40, P2582, DOI 10.1021/ic001031y; FLYNN CM, 1969, INORG CHEM, V8, P335, DOI 10.1021/ic50072a030; GRAEBER EJ, 1977, ACTA CRYSTALLOGR B, V33, P2137, DOI 10.1107/S0567740877007900; Hartl H, 2001, Z ANORG ALLG CHEM, V627, P2630; Jeannin YP, 1998, CHEM REV, V98, P51, DOI 10.1021/cr960397i; Katsoulis DE, 1998, CHEM REV, V98, P359, DOI 10.1021/cr960398a; KATSOULIS DE, 1984, J AM CHEM SOC, V106, P2737, DOI 10.1021/ja00321a064; KORTZ U, 1994, INORG CHEM, V33, P5643, DOI 10.1021/ic00103a008; Kortz U, 2000, INORG CHEM, V39, P623, DOI 10.1021/ic9907258; Mizuno N, 1998, CHEM REV, V98, P199, DOI 10.1021/cr960401q; MULLER A, 1997, J CHEM SOC CHEM COMM, V97, P1715; Pope M. T., 1983, HETEROPOLY ISOPOLY O; Rhule JT, 1998, CHEM REV, V98, P327, DOI 10.1021/cr960396q; Rozantsev GM, 2000, RUSS J COORD CHEM+, V26, P247; Silva MFP, 2000, J COORD CHEM, V50, P145, DOI 10.1080/00958970008054933; WANG SH, 1994, CHEM MATER, V6, P2130, DOI 10.1021/cm00047a038	22	274	277	4	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 9	2002	297	5583					996	998		10.1126/science.1073979	http://dx.doi.org/10.1126/science.1073979			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169730				2022-12-28	WOS:000177325400040
J	Diamond, J				Diamond, J			Evolution, consequences and future of plant and animal domestication	NATURE			English	Review							GENETIC DIVERSITY; ORIGINS; AGRICULTURE; EPIDEMIC; MULTIPLE; CATTLE; GOATS; DOG	Domestication interests us as the most momentous change in Holocene human history. Why did it operate on so few wild species, in so few geographic areas? Why did people adopt it at all, why did they adopt it when they did, and how did it spread? The answers to these questions determined the remaking of the modern world, as farmers spread at the expense of hunter-gatherers and of other farmers.	Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Diamond, J (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.							AMMERMAN AJ, 1984, NEOLITHIC TRANSITION; Amos A.F., 1997, DIABETIC MED, V14, P81; [Anonymous], 1861, ORIGIN SPECIES MEANS; Arnold J.E., 2001, ORIGINS PACIFIC COAS; Bellwood Peter, 1997, PREHISTORY INDOMALAY; Binford L.R., 1968, NEW PERSPECTIVES ARC, P313; BONSALL C, 1990, MESOLITHIC EUROPE; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Clutton-Brock J., 1992, HORSE POWER; CLUTTONBROCK I, 1981, DOMESTICATED ANIMALS; COHEN MN, 1984, PALEOPATHOLOGY ORIGI; Crosby A., 1972, COLUMBIAN EXCHANGE B; Crosby A.W., 1986, ECOLOGICAL IMPERIALI, DOI DOI 10.1017/CBO9780511805554; DIAMOND I, 2002, GENETIC BASIS COMMON, P50; Diamond J, 1992, 3 CHIMPANZEE EVOLUTI; Diamond J., 2010, RUZHYA MIKROBY STALI; Diamond JM, 1996, NATURE, V382, P756, DOI 10.1038/382756a0; DOWSE GK, 1991, AM J EPIDEMIOL, V133, P1093, DOI 10.1093/oxfordjournals.aje.a115822; Ehret Christopher, 1998, AFRICAN CLASSICAL AG; Flannery K. V., 1969, The domestication and exploitation of plants and animals., P73; Giuffra E, 2000, GENETICS, V154, P1785; Hanotte O, 2002, SCIENCE, V296, P336, DOI 10.1126/science.1069878; Heun M, 1997, SCIENCE, V278, P1312, DOI 10.1126/science.278.5341.1312; Hiendleder S, 2002, P ROY SOC B-BIOL SCI, V269, P893, DOI 10.1098/rspb.2002.1975; HILLMAN GC, 1990, J WORLD PREHIST, V4, P157, DOI 10.1007/BF00974763; HUDSON M, 1999, RUINS IDENTITY; Kenneth F, 2000, CAMBRIDGE WORLD HIST; Klein R. G., 1999, HUMAN CAREER HUMAN B; Konner M, 1988, PALEOLITHIC PRESCRIP; Ladizinsky G, 1998, PLANT EVOLUTION DOME; Lau CH, 1998, ANIM GENET, V29, P253, DOI 10.1046/j.1365-2052.1998.00309.x; Lentz DL, 2001, ECON BOT, V55, P370, DOI 10.1007/BF02866560; Lev-Yadun S, 2000, SCIENCE, V288, P1602, DOI 10.1126/science.288.5471.1602; LOFTUS RT, 1994, P NATL ACAD SCI USA, V91, P2757, DOI 10.1073/pnas.91.7.2757; LOURANDOS, 1997, CONTINENT HUNTER GAT; Luikart G, 2001, P NATL ACAD SCI USA, V98, P5927, DOI 10.1073/pnas.091591198; MacHugh DE, 2001, P NATL ACAD SCI USA, V98, P5382, DOI 10.1073/pnas.111163198; MARCHETTI M, IN PRESS ENV BIOL FI; Marshall F., 2000, ORIGIN DEV AFRICAN L, P191; Martin PS, 1984, QUATERNARY EXTINCTIO; McNeill W.H., 1976, PLAGUES PEOPLES, V1st ed.; Piperno D.R., 1998, ORIGINS AGR LOWLAND; Piperno DR, 2000, NATURE, V407, P894, DOI 10.1038/35038055; Ramenofsky A, 1987, VECTORS DEATH; RENFREW C, 1987, ARCHAEOLOGY LANGUAGE; Richerson PJ, 2001, AM ANTIQUITY, V66, P387, DOI 10.2307/2694241; Rindos D., 1984, ORIGINS AGR EVOLUTIO; RUHLEN M, 1997, GUIDE WORLDS LANGUAG; Sanjur OI, 2002, P NATL ACAD SCI USA, V99, P535, DOI 10.1073/pnas.012577299; Smartt J., 1995, EVOLUTION CROP PLANT, V2nd; Smith B. D., 1998, EMERGENCE AGR; Smith BD, 2001, J ARCHAEOL RES, V9, P1, DOI 10.1023/A:1009436110049; Smith BD, 2001, P NATL ACAD SCI USA, V98, P1324, DOI 10.1073/pnas.98.4.1324; Smith BruceD., 1992, RIVERS CHANGE ESSAYS; SPINNAGE C, 1986, NATURAL HIST ANTELOP; Stiner MC, 2000, CURR ANTHROPOL, V41, P39, DOI 10.1086/300102; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; Vila C, 1999, J HERED, V90, P71, DOI 10.1093/jhered/90.1.71; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; VOGEL F, 1966, HUMANGENETIK, V3, P166, DOI 10.1007/BF00291297; Zilhao J, 2001, P NATL ACAD SCI USA, V98, P14180, DOI 10.1073/pnas.241522898; Zimmet P, 2000, J INTERN MED, V247, P301, DOI 10.1046/j.1365-2796.2000.00625.x; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a; Zohary D, 1999, GENET RESOUR CROP EV, V46, P133, DOI 10.1023/A:1008692912820; Zohary D, 1996, ORIGINS SPREAD AGR P, P142; Zohary D, 2000, DOMESTICATION PLANTS, DOI DOI 10.1006/ANBO.2001.1505	67	874	934	13	526	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2002	418	6898					700	707		10.1038/nature01019	http://dx.doi.org/10.1038/nature01019			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167878				2022-12-28	WOS:000177305600058
J	Hails, RS				Hails, RS			Assessing the risks associated with new agricultural practices	NATURE			English	Article							GENETICALLY-MODIFIED CROPS; FARMLAND BIRDS; GRANIVOROUS BIRDS; SURVIVAL RATES; BIODIVERSITY; ABUNDANCE; DIVERSITY; ECOLOGY; GREEN; INTENSIFICATION	One key challenge for the twenty-first century is how to produce the food we need, yet ensure the landscape we want. Genetically modified crops have focused our attention on how to answer this question for one part of agriculture. The same principles could be applied to assess environmental impacts of future land-use change in a much broader context.	NERC, Ctr Ecol & Hydrol, Oxford OX1 3SR, England	UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Hails, RS (corresponding author), NERC, Ctr Ecol & Hydrol, Mansfield Rd, Oxford OX1 3SR, England.	rha@ceh.ac.uk	Hails, Rosemary S/E-9478-2010	Hails, Rosemary S/0000-0002-6975-1318				*ADV COMM REL ENV, 2001, GUID ASS IMP WID BIO; Agricultural & Environmental Biotechnology Commission, 2001, CROPS TRIAL; Bakker JP, 1999, TRENDS ECOL EVOL, V14, P63, DOI 10.1016/S0169-5347(98)01544-4; Beringer J, 2001, OUTLOOK AGR, V30, P7, DOI 10.5367/000000001101293391; Bobbink R., 1996, MANUAL METHODOLOGIES, P71; Campbell L.H., 1997, 227 JNCC; Chamberlain DE, 2000, J APPL ECOL, V37, P771, DOI 10.1046/j.1365-2664.2000.00548.x; Chamberlain DE, 1999, J APPL ECOL, V36, P856, DOI 10.1046/j.1365-2664.1999.00453.x; Chamberlain DE, 2000, AGR ECOSYST ENVIRON, V78, P1, DOI 10.1016/S0167-8809(99)00105-X; Conway G, 1999, NATURE, V402, pC55, DOI [10.1038/35011545, 10.1038/990141]; COOPER JI, 1997, COMMERCIALISATION TR, P115; CRAWLEY MJ, 1993, NATURE, V363, P620, DOI 10.1038/363620a0; Crawley MJ, 1999, NATURE, V400, P501, DOI 10.1038/22869; Crawley MJ, 2001, NATURE, V409, P682, DOI 10.1038/35055621; Daily GC, 2000, SCIENCE, V289, P395, DOI 10.1126/science.289.5478.395; *DEP ENV FOOD RUR, DIG ENV STAT; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Falconer K, 2000, LAND USE POLICY, V17, P269, DOI 10.1016/S0264-8377(00)00036-3; Firbank Les, 2002, Aspects of Applied Biology, V67, P165; Firbank LG, 1999, NATURE, V399, P727, DOI 10.1038/21516; Firbank LG, 2000, SCIENCE, V289, P1481, DOI 10.1126/science.289.5484.1481; Gates S, 2000, J APPL ECOL, V37, P806, DOI 10.1046/j.1365-2664.2000.00549.x; Hails RS, 2000, TRENDS ECOL EVOL, V15, P14, DOI 10.1016/S0169-5347(99)01751-6; Haines-Young RH., 2000, ACCOUNTING NATURE AS; Hald AB, 1999, J APPL ECOL, V36, P24, DOI 10.1046/j.1365-2664.1999.00364.x; Kleijn D, 2001, NATURE, V413, P723, DOI 10.1038/35099540; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Lawton JH, 2000, EXCELLENCE ECOLOGY, V11; Marsh J., 2000, INTEGRATED FARM MANA; Peach WJ, 2001, BIOL CONSERV, V101, P361, DOI 10.1016/S0006-3207(01)00083-0; Perfecto I, 1996, BIOSCIENCE, V46, P598, DOI 10.2307/1312989; Phipps RH, 2002, J ANIM FEED SCI, V11, P1; Pidgeon JD, 2001, BCPC CONFERENCE - WEEDS 2001, VOLS 1 AND 2, P373; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Policy Commission on the Future of Farming and Food, 2002, FARM FOOD SUST FUT; Pretty JN, 2000, AGR SYST, V65, P113, DOI 10.1016/S0308-521X(00)00031-7; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Siriwardena GM, 1998, BIRD STUDY, V45, P276, DOI 10.1080/00063659809461099; Siriwardena GM, 1999, IBIS, V141, P621, DOI 10.1111/j.1474-919X.1999.tb07370.x; Smart SM, 2000, J APPL ECOL, V37, P398, DOI 10.1046/j.1365-2664.2000.00508.x; Sutherland WJ, 2002, TRENDS ECOL EVOL, V17, P148, DOI 10.1016/S0169-5347(01)02421-1; Tilman D, 1998, NATURE, V396, P211, DOI 10.1038/24254; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; TREWAVAS AJ, 2001, EMBO REP, V2, P1; VESTERBY M, 2001, ERS STAT B, V973; Watkinson AR, 2000, SCIENCE, V289, P1554, DOI 10.1126/science.289.5484.1554; Whitfield J, 2001, NATURE, V413, P659, DOI 10.1038/35099698; Wilson JD, 1999, AGR ECOSYST ENVIRON, V75, P13, DOI 10.1016/S0167-8809(99)00064-X; Wilson P. J., 1994, BR CROP PR, V58, P253	51	90	96	1	65	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 8	2002	418	6898					685	688		10.1038/nature01016	http://dx.doi.org/10.1038/nature01016			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167875				2022-12-28	WOS:000177305600055
J	Huang, JK; Pray, C; Rozelle, S				Huang, JK; Pray, C; Rozelle, S			Enhancing the crops to feed the poor	NATURE			English	Review							RESEARCH-AND-DEVELOPMENT; AGRICULTURAL-RESEARCH; PRODUCTIVITY GROWTH; PRIVATE-SECTOR; CHINA; SYSTEMS; ECONOMY	Solutions to the problem of how the developing world will meet its future food needs are broader than producing more food, although the successes of the 'Green Revolution' demonstrate the importance of technology in generating the growth in food output in the past. Despite these successes, the world still faces continuing vulnerability to food shortages. Given the necessary funding, it seems likely that conventional crop breeding, as well as emerging technologies based on molecular biology, genetic engineering and natural resource management, will continue to improve productivity in the coming decades.	Chinese Acad Sci, Inst Geog Sci & Nat Resource Res, Ctr Chinese Agr Policy, Beijing 100101, Peoples R China; Rutgers State Univ, Dept Agr Food & Resource Econ, New Brunswick, NJ 08901 USA; Univ Calif Davis, Dept Agr & Resource Econ, Davis, CA 95616 USA	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Rutgers State University New Brunswick; University of California System; University of California Davis	Huang, JK (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resource Res, Ctr Chinese Agr Policy, 917 Bldg,Anwai Datun Rd, Beijing 100101, Peoples R China.							ALI M, IN PRESS EC DEV CULT; Alston JM, 1998, WORLD DEV, V26, P1057, DOI 10.1016/S0305-750X(98)00029-1; Alston JM, 2000, AUST J AGR RESOUR EC, V44, P185, DOI 10.1111/1467-8489.00107; ANTLE JM, 1994, AM J AGR ECON, V76, P418, DOI 10.2307/1243654; Barker R., 1985, RICE EC ASIA; Byerlee D., 2000, FOOD NEEDS DEV WORLD, P207; Cassman K. G., 1995, Agricultural sustainability: economic, environmental and statistical considerations., P63; Cassman KG, 1998, FIELD CROP RES, V56, P7, DOI 10.1016/S0378-4290(97)00140-8; David C. C., 1994, MODERN RICE TECHNOLO; EKBOIR J, 2001, WORLD WHEAT OVERVIEW; El-Kholy M.K.T.A., 1992, WORLD ENV 1972 1992; Evenson R., 1996, RICE RES ASIA PROGR; EVENSON RE, 2001, COMPREHENSIVE ASSESS; Fan S., 1999, LINKAGES GOVT SPENDI; Fan SG., 2002, 125 INT FOOD POL RES; HUANG J, 1995, AM J AGR ECON, V77, P246; Huang JK, 1996, J DEV ECON, V49, P337, DOI 10.1016/0304-3878(95)00065-8; Huang JK, 1999, ECON DEV CULT CHANGE, V47, P737, DOI 10.1086/452430; Huang JK, 2002, SCIENCE, V295, P674, DOI 10.1126/science.1067226; HUANG JK, 2001, AGR BIOTECHNOLOGY DE; Huang Q., 2002, IRRIGATION YIELDS CH; Huffman W.E., 1993, SCI AGR LONG TERM PE; ISMAEL Y, 2001, R7946 DFID DEP INT D; JIN S, IN PRESS AM J AGR EC; Khush G. S., 1995, Geojournal, V35, P275, DOI 10.1007/BF00989135; Madhu Khanna, 1999, Review of Agricultural Economics, V21, P455, DOI 10.2307/1349891; MORRIS ML, 1998, AGR DEV 3 WORLD, P458; Murgai R, 2001, WORLD BANK RES OBSER, V16, P199, DOI 10.1093/wbro/16.2.199; Pachico D., 2000, FOOD POLICY, V25, P379; Pardey P. G., 2001, SLOW MAGIC AGR R D C; PINGALI PL, 1994, AGRICULTURAL TECHNOLOGY, P384; PINGALI PL, 1994, PUBLIC REGULATORY RO; PINGALI PL, 1997, ASIAN RICE BOWLS; PINSTRUPANDERSO.P, 1999, WORLD FOOD PROSPECTS; Pray CE, 2001, AM J AGR ECON, V83, P742, DOI 10.1111/0002-9092.00201; Pray CE, 1998, WORLD DEV, V26, P1127, DOI 10.1016/S0305-750X(98)00040-0; PRAY CE, 2001, ROLE BIOTECH S AFRIC; PRAY CE, 1998, GREEN REVOLUTION EXT; PRAY CE, 2002, INT C AGR BIOT RES R; QAIM M, 2002, INT C AGR BIOT RES R; Rosegrant MW, 1999, P NUTR SOC, V58, P219, DOI 10.1017/S0029665199000312; Seckler D., 1998, WATER SCARCITY 21 CE; SEN A, 1993, SCI AM, V5, P40; SERAGELDIN I, 2000, PROMETHIAN SCI AGR B; Traxler G, 2001, TRANSGENIC COTTON ME; VIRMANI SS, 1994, HYBRID RES DEV MAJOR, P61; World Bank, 2000, WORLD DEV REP 2000; YUAN L, 2000, BIOL ENG PROG, V20, P2	48	185	212	9	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2002	418	6898					678	684		10.1038/nature01015	http://dx.doi.org/10.1038/nature01015			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	581RA	12167874				2022-12-28	WOS:000177305600054
J	Sheehy, AM; Gaddis, NC; Choi, JD; Malim, MH				Sheehy, AM; Gaddis, NC; Choi, JD; Malim, MH			Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 VIF; DNA-SYNTHESIS; SOR GENE; RNA; CELLS; GAG; RESTRICTION; REPLICATION; EFFICIENT	Viruses have developed diverse non-immune strategies to counteract host-mediated mechanisms that confer resistance to infection. The Vif (virion infectivity factor) proteins are encoded by primate immunodeficiency viruses, most notably human immunodeficiency virus-1 (HIV-1). These proteins are potent regulators of virus infection and replication and are consequently essential for pathogenic infections in vivo(1-6). HIV-1 Vif seems to be required during the late stages of virus production(3,6) for the suppression of an innate antiviral phenotype that resides in human T lymphocytes(7,8). Thus, in the absence of Vif, expression of this phenotype renders progeny virions non-infectious. Here, we describe a unique cellular gene, CEM15, whose transient or stable expression in cells that do not normally express CEM15 recreates this phenotype, but whose antiviral action is overcome by the presence of Vif. Because the Vif: CEM15 regulatory circuit is critical for HIV-1 replication, perturbing the circuit may be a promising target for future HIV/AIDS therapies.	Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Human Genet, Philadelphia, PA 19104 USA; Kings Coll London, Guys Kings & St Thomas Sch Med, Dept Infect Dis, London SE1 9RT, England	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of London; King's College London	Malim, MH (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	michael.malim@kcl.ac.uk	Gaddis, Nathan/GXG-6447-2022; Gaddis, Nathan/GXG-6395-2022; Liu, FL/D-1795-2009	Gaddis, Nathan/0000-0001-5205-7138; Malim, Michael/0000-0002-7699-2064				BHATTACHARYA S, 1994, TRENDS BIOCHEM SCI, V19, P105, DOI 10.1016/0968-0004(94)90200-3; Camaur D, 1996, J VIROL, V70, P6106, DOI 10.1128/JVI.70.9.6106-6111.1996; COURCOUL M, 1995, J VIROL, V69, P2068, DOI 10.1128/JVI.69.4.2068-2074.1995; Desrosiers RC, 1998, J VIROL, V72, P1431, DOI 10.1128/JVI.72.2.1431-1437.1998; Dettenhofer M, 2000, J VIROL, V74, P8938, DOI 10.1128/JVI.74.19.8938-8945.2000; FISHER AG, 1987, SCIENCE, V237, P888, DOI 10.1126/science.3497453; FOLEY GE, 1965, CANCER RES, V25, P1254; Fouchier RAM, 1996, J VIROL, V70, P8263, DOI 10.1128/JVI.70.12.8263-8269.1996; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; Hassaine G, 2001, J BIOL CHEM, V276, P16885, DOI 10.1074/jbc.M009076200; Khan MA, 2001, J VIROL, V75, P7252, DOI 10.1128/JVI.75.16.7252-7265.2001; LIU HM, 1995, J VIROL, V69, P7630, DOI 10.1128/JVI.69.12.7630-7638.1995; MACGINNITIE AJ, 1995, J BIOL CHEM, V270, P14768, DOI 10.1074/jbc.270.24.14768; Madani N, 1998, J VIROL, V72, P10251, DOI 10.1128/JVI.72.12.10251-10255.1998; Madsen P, 1999, J INVEST DERMATOL, V113, P162, DOI 10.1046/j.1523-1747.1999.00682.x; NARA PL, 1988, NATURE, V332, P469, DOI 10.1038/332469a0; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; PRYCIAK PM, 1992, J VIROL, V66, P5959, DOI 10.1128/JVI.66.10.5959-5966.1992; Simon JHM, 1997, J VIROL, V71, P5259, DOI 10.1128/JVI.71.7.5259-5267.1997; Simon JHM, 1998, NAT MED, V4, P1397, DOI 10.1038/3987; Simon JHM, 1996, J VIROL, V70, P5297, DOI 10.1128/JVI.70.8.5297-5305.1996; Simon JHM, 1998, EMBO J, V17, P1259, DOI 10.1093/emboj/17.5.1259; SMITH AA, 1994, BIOCHEMISTRY-US, V33, P6468, DOI 10.1021/bi00187a012; SOVA P, 1993, J VIROL, V67, P6322, DOI 10.1128/JVI.67.10.6322-6326.1993; STREBEL K, 1987, NATURE, V328, P728, DOI 10.1038/328728a0; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Towers G, 2000, P NATL ACAD SCI USA, V97, P12295, DOI 10.1073/pnas.200286297; VONSCHWEDLER U, 1993, J VIROL, V67, P4945, DOI 10.1128/JVI.67.8.4945-4955.1993; Zhang H, 2000, J VIROL, V74, P8252, DOI 10.1128/JVI.74.18.8252-8261.2000	30	1839	1933	1	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2002	418	6898					646	650		10.1038/nature00939	http://dx.doi.org/10.1038/nature00939			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167863				2022-12-28	WOS:000177305600044
J	Tichelli, A; Socie, G; Marsh, J; Barge, R; Frickhofen, N; McCann, S; Bacigalupo, A; Hows, J; Marin, P; Nachbaur, D; Symeonidis, A; Passweg, J; Schrezenmeier, H				Tichelli, A; Socie, G; Marsh, J; Barge, R; Frickhofen, N; McCann, S; Bacigalupo, A; Hows, J; Marin, P; Nachbaur, D; Symeonidis, A; Passweg, J; Schrezenmeier, H		European Grp Blood Marrow Transpla	Outcome of pregnancy and disease course among women with aplastic anemia treated with immunosuppression	ANNALS OF INTERNAL MEDICINE			English	Article							BONE-MARROW-TRANSPLANTATION; SAA WORKING PARTY; RED-CELL APLASIA; PLATELET COUNT; ANTILYMPHOCYTE GLOBULIN; CYCLOSPORINE; RECIPIENTS; MANAGEMENT; DELIVERY; SMOKING	Background: Aplastic anemia may develop during pregnancy and sometimes improves spontaneously after delivery. The effects of pregnancy on aplastic anemia after immunosuppressive treatment and of aplastic anemia on the outcome of pregnancy have not been described. Objective: To determine the outcome of pregnancy and the disease course among women with aplastic anemia who received immunosuppressive therapy. Design: Retrospective multicenter study. Setting: Twelve centers participating in the European Group for Blood and Marrow Transplantation. Patients: 36 women who received immunosuppressive therapy to treat aplastic anemia. Measurements: Outcomes of pregnancy and aplastic anemia and blood counts before, during, and after delivery. Results: The 36 pregnancies resulted in 34 live births (one set of twins), 2 elective abortions, and 1 spontaneous abortion. Of the 36 pregnancies, 22 were uncomplicated and 14 involved medical complications. Seven pregnancies (19%) were complicated by relapse of aplastic anemia, and 5 patients without relapse (14%) needed transfusions during delivery. After delivery, 3 of the 7 patients who had relapse recovered spontaneously and 3 recovered after retreatment. One patient who did not respond to treatment died of aplastic anemia. A woman with aplastic anemia and paroxysmal nocturnal hemoglobinuria had a fatal cerebral thrombosis after delivery. Women with uneventful pregnancies had better prepregnancy remission status (8 complete and 11 partial remissions) and a higher median platelet count (146 x 10(9) cells/L) than did women with complicated pregnancies (2 complete remissions, 8 partial remissions, and 4 cases of paroxysmal nocturnal hemoglobinuria; median platelet count, 92 x 10(9) cells/L). Conclusions: Successful pregnancy with normal outcome is possible in women with aplastic anemia previously treated with immunosuppression. Complications appear to be more likely in patients with low platelet counts and paroxysmal nocturnal hemoglobinuria-associated aplastic anemia.			Tichelli, A (corresponding author), Univ Basel Hosp, Petersgraben 4, CH-4031 Basel, Switzerland.		Symeonidis, Argiris/K-2287-2019; passweg, jakob/AAG-3911-2020	Symeonidis, Argiris/0000-0002-3685-3473; Passweg, Jakob R/0000-0001-7092-3351				AITCHISON RGM, 1989, BRIT J HAEMATOL, V73, P541, DOI 10.1111/j.1365-2141.1989.tb00294.x; APPERLEY JF, 1995, BLOOD REV, V9, P93, DOI 10.1016/S0268-960X(95)90030-6; ARMENTI VT, 1994, TRANSPLANTATION, V57, P502; BACIGALUPO A, 1988, BRIT J HAEMATOL, V70, P177, DOI 10.1111/j.1365-2141.1988.tb02460.x; Boehlen F, 2000, OBSTET GYNECOL, V95, P29, DOI 10.1016/S0029-7844(99)00537-2; Bourantas K, 1997, J REPROD MED, V42, P672; BURROWS RF, 1990, AM J OBSTET GYNECOL, V162, P731, DOI 10.1016/0002-9378(90)90996-K; CAMITTA BM, 1976, BLOOD, V48, P63; COHEN E, 1993, ACTA HAEMATOL-BASEL, V89, P32; Di Paolo S, 2000, TRANSPLANTATION, V69, P2049, DOI 10.1097/00007890-200005270-00013; Doney K, 1997, ANN INTERN MED, V126, P107, DOI 10.7326/0003-4819-126-2-199701150-00003; Ehrlich P, 1888, CHARITE ANN, V13, P300; EVANS IL, 1968, BRIT MED J, V3, P166, DOI 10.1136/bmj.3.5611.166; FLEMING AF, 1973, BRIT MED J, V3, P166; FRICKHOFEN N, 1991, NEW ENGL J MED, V324, P1297, DOI 10.1056/NEJM199105093241901; GOLDSTEIN IM, 1975, ANN INTERN MED, V82, P537, DOI 10.7326/0003-4819-82-4-537_2; Huter O, 1996, J MATERN-FETAL INVES, V6, P175; Knispel J W, 1976, Obstet Gynecol Surv, V31, P523, DOI 10.1097/00006254-197607000-00001; Little MA, 2000, IRISH J MED SCI, V169, P19, DOI 10.1007/BF03170477; Lurie S, 1998, GYNECOL OBSTET INVES, V45, P229, DOI 10.1159/000009973; MARSH JCW, 1990, BLOOD, V76, P1748; MERCELINAROUMANS PEAM, 1995, EUR J CLIN CHEM CLIN, V33, P267; MERCELINAROUMANS PEAM, 1994, EUR J OBSTET GYN R B, V55, P169, DOI 10.1016/0028-2243(94)90033-7; MIYOSHI I, 1978, NEW ENGL J MED, V299, P777; NAJEAN Y, 1990, BLOOD, V76, P2222; NISSEN C, 1993, BRIT J HAEMATOL, V83, P319, DOI 10.1111/j.1365-2141.1993.tb08288.x; Oosterkamp HM, 1998, BRIT J HAEMATOL, V103, P315; PICOT C, 1984, NEW ENGL J MED, V311, P196; SCHREZENMEIER H, 1993, BRIT J HAEMATOL, V85, P371, DOI 10.1111/j.1365-2141.1993.tb03181.x; Stanley CW, 1999, TRANSPLANT P, V31, P241, DOI 10.1016/S0041-1345(98)01519-X; SUDA T, 1978, BLUT, V36, P285, DOI 10.1007/BF01880679; TICHELLI A, 1988, BRIT J HAEMATOL, V69, P413, DOI 10.1111/j.1365-2141.1988.tb02382.x; VANBESIEN K, 1991, EUR J HAEMATOL, V47, P253; Verdy E, 1997, THROMB HAEMOSTASIS, V77, P806	34	50	56	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 6	2002	137	3					164	172		10.7326/0003-4819-137-3-200208060-00008	http://dx.doi.org/10.7326/0003-4819-137-3-200208060-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580XP	12160364				2022-12-28	WOS:000177262300003
J	Linden, H				Linden, H			Circadian rhythms: A white collar protein senses blue light	SCIENCE			English	Editorial Material							NEUROSPORA-CRASSA; SIGNAL-TRANSDUCTION		Univ Konstanz, Lehrstuhl Physiol & Biochem Pflanzen, D-78434 Constance, Germany	University of Konstanz	Linden, H (corresponding author), Univ Konstanz, Lehrstuhl Physiol & Biochem Pflanzen, D-78434 Constance, Germany.							Ballario P, 1998, MOL MICROBIOL, V29, P719, DOI 10.1046/j.1365-2958.1998.00955.x; Ballario P, 1996, EMBO J, V15, P1650, DOI 10.1002/j.1460-2075.1996.tb00510.x; Briggs WR, 2001, PLANT PHYSIOL, V125, P85, DOI 10.1104/pp.125.1.85; Dragovic Z, 2002, EMBO J, V21, P3643, DOI 10.1093/emboj/cdf377; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; HARDING RW, 1980, ANNU REV PLANT PHYS, V31, P217, DOI 10.1146/annurev.pp.31.060180.001245; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Linden H, 1997, FUNGAL GENET BIOL, V22, P141, DOI 10.1006/fgbi.1997.1013; Linden H, 1997, EMBO J, V16, P98, DOI 10.1093/emboj/16.1.98; Talora C, 1999, EMBO J, V18, P4961, DOI 10.1093/emboj/18.18.4961	11	25	26	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2002	297	5582					777	778		10.1126/science.1075485	http://dx.doi.org/10.1126/science.1075485			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161636				2022-12-28	WOS:000177192800029
J	Rapin, I				Rapin, I			The autistic-spectrum disorders	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Yeshiva Univ Albert Einstein Coll Med, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Rapin, I (corresponding author), Yeshiva Univ Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.								0	50	52	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2002	347	5					302	303		10.1056/NEJMp020062	http://dx.doi.org/10.1056/NEJMp020062			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587WC	12151466				2022-12-28	WOS:000177665900001
J	Ueda, HR; Chen, WB; Adachi, A; Wakamatsu, H; Hayashi, S; Takasugi, T; Nagano, M; Nakahama, K; Suzuki, Y; Sugano, S; Iino, M; Shigeyoshi, Y; Hashimoto, S				Ueda, HR; Chen, WB; Adachi, A; Wakamatsu, H; Hayashi, S; Takasugi, T; Nagano, M; Nakahama, K; Suzuki, Y; Sugano, S; Iino, M; Shigeyoshi, Y; Hashimoto, S			A transcription factor response element for gene expression during circadian night	NATURE			English	Article							CLOCK; DROSOPHILA; MECHANISM; CLONING	Mammalian circadian clocks consist of complex integrated feedback loops(1-10) that cannot be elucidated without comprehensive measurement of system dynamics and determination of network structures(11). To dissect such a complicated system, we took a systems-biological approach based on genomic, molecular and cell biological techniques. We profiled suprachiasmatic nuclei and liver genome-wide expression patterns under light/dark cycles and constant darkness. We determined transcription start sites of human orthologues for newly identified cycling genes and then performed bioinformatical searches for relationships between time-of-day specific expression and transcription factor response elements around transcription start sites. Here we demonstrate the role of the Rev-ErbA/ROR response element in gene expression during circadian night, which is in phase with Bmal1 and in antiphase to Per2 oscillations. This role was verified using an in vitro validation system, in which cultured fibroblasts transiently transfected with clock-controlled reporter vectors exhibited robust circadian bioluminescence(12).	Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Mol Med Labs, Tsukuba, Ibaraki 3058585, Japan; Univ Tokyo, Grad Sch Med, Dept Pharmacol, Bunkyo Ku, Tokyo 1130033, Japan; Kinki Univ, Sch Med, Dept Anat & Neurobiol, Osakasayama, Osaka 5898511, Japan; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Minato Ku, Tokyo 1088639, Japan	Astellas Pharmaceuticals; University of Tokyo; Kindai University (Kinki University); University of Tokyo	Ueda, HR (corresponding author), Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Mol Med Labs, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.		Jansen, Heiko T./A-5770-2008; Ueda, Hiroki R/C-5037-2014; Wakamatsu, Hisanori/AAV-9782-2021	Jansen, Heiko T./0000-0003-0178-396X; Ueda, Hiroki R/0000-0001-8342-9176; 				Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; CHEN W, UNPUB CURR BIOL; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Clayton JD, 2001, NATURE, V409, P829, DOI 10.1038/35057006; Duffield GE, 2002, CURR BIOL, V12, P551, DOI 10.1016/S0960-9822(02)00765-0; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Grundschober C, 2001, J BIOL CHEM, V276, P46751, DOI 10.1074/jbc.M107499200; HARDING HP, 1993, MOL CELL BIOL, V13, P3113, DOI 10.1128/MCB.13.5.3113; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hida A, 2000, GENOMICS, V65, P224, DOI 10.1006/geno.2000.6166; Jetten AM, 2001, PROG NUCLEIC ACID RE, V69, P205, DOI 10.1016/S0079-6603(01)69048-2; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; MARUYAMA K, 1994, GENE, V138, P171; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Obrietan K, 1999, J BIOL CHEM, V274, P17748, DOI 10.1074/jbc.274.25.17748; PACAUCCARALERTK.S, 1994, TAX MOL CELL BIOL, V14, P456; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; UEDA HR, 2000, J BIOL CHEM, V277, P14018; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Yu WJ, 2002, BIOCHEM BIOPH RES CO, V290, P933, DOI 10.1006/bbrc.2001.6300; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	30	652	677	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2002	418	6897					534	539		10.1038/nature00906	http://dx.doi.org/10.1038/nature00906			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152080				2022-12-28	WOS:000177162800041
J	Ronchese, F; Prasad, S; Ritchie, DS				Ronchese, F; Prasad, S; Ritchie, DS			Tumour antigens on tap	LANCET			English	Editorial Material							EXOSOMES; VACCINE		Wellington Sch Med, Malaghan Inst Med Res, Wellington, New Zealand	Malaghan Institute; University of Otago; Victoria University Wellington	Ronchese, F (corresponding author), Wellington Sch Med, Malaghan Inst Med Res, Wellington, New Zealand.							RAPOSO G, 1996, J EXP MED, V183, P1; Wang RF, 1999, IMMUNOL REV, V170, P85, DOI 10.1111/j.1600-065X.1999.tb01331.x; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	4	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 27	2002	360	9329					268	268		10.1016/S0140-6736(02)09560-0	http://dx.doi.org/10.1016/S0140-6736(02)09560-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578DT	12147364				2022-12-28	WOS:000177102700002
J	Kim, DH; Feinbaum, R; Alloing, G; Emerson, FE; Garsin, DA; Inoue, H; Tanaka-Hino, M; Hisamoto, N; Matsumoto, K; Tan, MW; Ausubel, FM				Kim, DH; Feinbaum, R; Alloing, G; Emerson, FE; Garsin, DA; Inoue, H; Tanaka-Hino, M; Hisamoto, N; Matsumoto, K; Tan, MW; Ausubel, FM			A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate immunity	SCIENCE			English	Article							C-ELEGANS; MUTATIONS; RNA	A genetic screen for Caenorhabditis elegans mutants with enhanced susceptibility to killing by Pseudomonas aeruginosa led to the identification of two genes required for pathogen resistance: sek-1, which encodes a mitogen-activated protein (MAP) kinase kinase, and nsy-1, which encodes a MAP kinase kinase kinase. RNA interference assays and biochemical analysis established that a p38 ortholog, pmk-1, functions as the downstream MAP kinase required for pathogen defense. These data suggest that this MAP kinase signaling cassette represents an ancient feature of innate immune responses in evolutionarily diverse species.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Japan Sci & Technol Corp, CREST, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Nagoya, Aichi 4648602, Japan	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Japan Science & Technology Agency (JST); Nagoya University	Ausubel, FM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA.	ausubel@molbio.mgh.harvard.edu		Inoue, Hideki/0000-0002-4301-1936	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048707, R37GM048707] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM48707] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aballay A, 2001, P NATL ACAD SCI USA, V98, P2735, DOI 10.1073/pnas.041613098; ABALLAY A, UNPUB; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Berman Kevin, 2001, Molecular Cell Biology Research Communications, V4, P337, DOI 10.1006/mcbr.2001.0300; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Han ZQS, 1998, MOL CELL BIOL, V18, P3527, DOI 10.1128/MCB.18.6.3527; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Ihle JN, 2000, CELL, V102, P131, DOI 10.1016/S0092-8674(00)00017-9; KIM D, UNPUB; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Reiner DJ, 1999, NATURE, V402, P199, DOI 10.1038/46072; Sagasti A, 2001, CELL, V105, P221, DOI 10.1016/S0092-8674(01)00313-0; Sluss HK, 1996, GENE DEV, V10, P2745, DOI 10.1101/gad.10.21.2745; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tanaka-Hino M, 2002, EMBO REP, V3, P56, DOI 10.1093/embo-reports/kvf001; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Villanueva A, 2001, EMBO J, V20, P5114, DOI 10.1093/emboj/20.18.5114; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147	24	573	614	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2002	297	5581					623	626		10.1126/science.1073759	http://dx.doi.org/10.1126/science.1073759			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142542				2022-12-28	WOS:000177054200057
J	Rouse, J; Jackson, SP				Rouse, J; Jackson, SP			Interfaces between the detection, signaling, and repair of DNA damage	SCIENCE			English	Review							CHECKPOINT CONTROL; STRAND BREAKS; NUCLEAR FOCI; PROTEIN; PHOSPHORYLATION; RAD9; ATR; REPLICATION; MEC1; PATHWAY	Left unrepaired, the myriad types of damage that can occur in genomic DNA pose a serious threat to the faithful transmission of the correct complement of genetic material. Defects in DNA damage signaling and repair result in genomic instability, a hallmark of cancer, and often cause lethality, underlining the importance of these processes in the cell and whole organism. The past decade has seen huge advances in our understanding of how the signal transduction pathways triggered by DNA damage radically alter cell behavior. In contrast, it is still unclear how primary DNA damage is detected and how this interfaces with signal transduction and DNA repair proteins.	Univ Cambridge, Wellcome Trust Canc Res UK Inst Canc & Dev Biol, Cambridge CB2 1QR, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QR, England	University of Cambridge; University of Cambridge	Rouse, J (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Inst Canc & Dev Biol, Tennis Court Rd, Cambridge CB2 1QR, England.	jwr24@mole.bio.cam.ac.uk; spj13@mole.bio.cam.ac.uk	Dry, Kate/I-2328-2014; Jackson, Stephen Philip/R-4548-2019	Jackson, Stephen Philip/0000-0001-9317-7937				Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Bashkirov VI, 2000, MOL CELL BIOL, V20, P4393, DOI 10.1128/MCB.20.12.4393-4404.2000; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; de la Torre-Ruiz MA, 1998, EMBO J, V17, P2687, DOI 10.1093/emboj/17.9.2687; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Durocher D, 2000, COLD SPRING HARB SYM, V65, P423, DOI 10.1101/sqb.2000.65.423; Edwards RJ, 1999, NAT CELL BIOL, V1, P393, DOI 10.1038/15623; Essers J, 2002, EMBO J, V21, P2030, DOI 10.1093/emboj/21.8.2030; Featherstone C, 1999, CURR BIOL, V9, pR759, DOI 10.1016/S0960-9822(00)80005-6; Forsburg SL, 2002, MOL CELL, V9, P703, DOI 10.1016/S1097-2765(02)00508-7; Freire R, 1998, GENE DEV, V12, P2560, DOI 10.1101/gad.12.16.2560; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; GRIFFITHS DJF, 1995, EMBO J, V14, P5812, DOI 10.1002/j.1460-2075.1995.tb00269.x; Guillet M, 2002, EMBO J, V21, P2833, DOI 10.1093/emboj/21.11.2833; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Houtsmuller AB, 1999, SCIENCE, V284, P958, DOI 10.1126/science.284.5416.958; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Jiricny J, 1998, MUTAT RES-DNA REPAIR, V409, P107, DOI 10.1016/S0921-8777(98)00056-1; Kondo T, 2001, SCIENCE, V294, P867, DOI 10.1126/science.1063827; KUZMINOV A, 1995, MOL MICROBIOL, V16, P373, DOI 10.1111/j.1365-2958.1995.tb02403.x; Lakin ND, 1999, ONCOGENE, V18, P3989, DOI 10.1038/sj.onc.1202973; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Leroy C, 2001, EMBO J, V20, P2896, DOI 10.1093/emboj/20.11.2896; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; Lowndes NF, 2000, CURR OPIN GENET DEV, V10, P17, DOI 10.1016/S0959-437X(99)00050-7; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; Melo JA, 2001, GENE DEV, V15, P2809; MINZEROVA OK, 2001, MOL CELL BIOL, V21, P281; Morrison C, 2000, EMBO J, V19, P463, DOI 10.1093/emboj/19.3.463; Neecke H, 1999, EMBO J, V18, P4485, DOI 10.1093/emboj/18.16.4485; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; NELSON WG, 1994, MOL CELL BIOL, V14, P1815, DOI 10.1128/MCB.14.3.1815; Paciotti V, 2000, GENE DEV, V14, P2046; Paulovich AG, 1998, GENETICS, V150, P75; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; REAPER P, UNPUB; Rouse J, 2000, EMBO J, V19, P5801, DOI 10.1093/emboj/19.21.5801; Rouse J, 2002, MOL CELL, V9, P857, DOI 10.1016/S1097-2765(02)00507-5; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Smith GCM, 1999, P NATL ACAD SCI USA, V96, P11134, DOI 10.1073/pnas.96.20.11134; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Tan TLR, 1999, CURR BIOL, V9, P325, DOI 10.1016/S0960-9822(99)80142-0; Usui T, 2001, MOL CELL, V7, P1255, DOI 10.1016/S1097-2765(01)00270-2; Venclovas C, 2000, NUCLEIC ACIDS RES, V28, P2481, DOI 10.1093/nar/28.13.2481; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wakayama T, 2001, MOL CELL BIOL, V21, P755, DOI 10.1128/MCB.21.3.755-764.2001; Wang Y, 2000, GENE DEV, V14, P927; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302	54	542	567	3	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2002	297	5581					547	551		10.1126/science.1074740	http://dx.doi.org/10.1126/science.1074740			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142523				2022-12-28	WOS:000177054200036
J	Diegeler, A; Thiele, H; Falk, V; Hambrecht, R; Spyrantis, N; Sick, P; Diederich, KW; Mohr, FW; Schuler, G				Diegeler, A; Thiele, H; Falk, V; Hambrecht, R; Spyrantis, N; Sick, P; Diederich, KW; Mohr, FW; Schuler, G			Comparison of stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FOLLOW-UP; CARDIOPULMONARY BYPASS; BALLOON ANGIOPLASTY; MEDICAL THERAPY; OFF-PUMP; DISEASE; TRIAL; ANGIOGRAPHY; RESTENOSIS; PLACEMENT	Background Minimally invasive bypass surgery and coronary-artery stenting are both accepted treatments for isolated stenosis of the proximal left anterior descending coronary artery. We compared the clinical outcomes after these two procedures. Methods A total of 220 symptomatic patients with high-grade lesions in the proximal left anterior descending coronary artery were randomly assigned to treatment - 110 to surgery and 110 to stenting. The combined clinical end point was freedom from major adverse cardiac events, such as death from cardiac causes, myocardial infarction, and the need for repeated revascularization of the target lesion within six months. Results A major adverse cardiac event occurred in 31 percent of patients after stenting, as compared with 15 percent in the surgery group (P = 0.02). The difference was predominantly due to a higher rate of repeated revascularization of the target vessel for restenosis after stenting (29 percent vs. 8 percent, P = 0.003). The combined rates of death and myocardial infarction did not differ significantly between groups (3 percent in the stenting group and 6 percent in the surgery group, P = 0.50). Adverse events occurred more frequently after surgery. The percentage of patients free from angina after six months was 79 percent in the surgery group, as compared with 62 percent in the stenting group (P = 0.03). Conclusions In patients with isolated high-grade lesions of the proximal left anterior descending artery, both minimally invasive bypass surgery and stenting are effective. Stenting yields excellent short-term results with fewer periprocedural adverse events, but surgery is superior with regard to the need for repeated intervention in the target vessel and freedom from angina at six months of follow-up.	Univ Leipzig, Dept Internal Med & Cardiol, Ctr Heart, D-04289 Leipzig, Germany; Univ Leipzig, Dept Cardiac Surg, Ctr Heart, D-04289 Leipzig, Germany	Heart Center Leipzig GMBH; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heart Center Leipzig GMBH; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Schuler, G (corresponding author), Univ Leipzig, Dept Internal Med & Cardiol, Ctr Heart, Strumpellstr 39, D-04289 Leipzig, Germany.		Thiele, Holger/ABE-6792-2020	Thiele, Holger/0000-0002-0169-998X; Falk, Volkmar/0000-0002-7911-8620				Alderman EL, 1997, JAMA-J AM MED ASSOC, V277, P715; Calafiore AM, 1998, J THORAC CARDIOV SUR, V115, P763, DOI 10.1016/S0022-5223(98)70353-8; Calafiore AM, 1997, ANN THORAC SURG, V63, pS72, DOI 10.1016/S0003-4975(97)00426-8; Calafiore AM, 1996, ANN THORAC SURG, V61, P1658, DOI 10.1016/0003-4975(96)00187-7; CAMPEAU L, 1976, CIRCULATION, V54, P522, DOI 10.1161/circ.54.3.947585; CARROZZA JP, 1992, J AM COLL CARDIOL, V20, P328, DOI 10.1016/0735-1097(92)90098-8; Diegeler A, 2000, CIRCULATION, V102, P95; Diegeler A, 1998, ANN THORAC SURG, V66, P1022, DOI 10.1016/S0003-4975(98)00703-6; Diegeler A, 2000, ANN THORAC SURG, V69, P1162, DOI 10.1016/S0003-4975(99)01574-X; ELLIS SG, 1990, CIRCULATION, V82, P1193, DOI 10.1161/01.CIR.82.4.1193; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; FRIERSON JH, 1992, J AM COLL CARDIOL, V19, P745, DOI 10.1016/0735-1097(92)90512-L; Gill IS, 2000, ANN THORAC SURG, V69, P56, DOI 10.1016/S0003-4975(99)00861-9; GOY JJ, 1994, LANCET, V343, P1449, DOI 10.1016/S0140-6736(94)92579-8; Goy JJ, 1999, CIRCULATION, V99, P3255, DOI 10.1161/01.CIR.99.25.3255; Henderson RA, 1998, LANCET, V352, P1419, DOI 10.1016/S0140-6736(98)03358-3; HUEB WA, 1995, J AM COLL CARDIOL, V26, P1600, DOI 10.1016/0735-1097(95)00384-3; Kastrati A, 1999, CIRCULATION, V100, P1285, DOI 10.1161/01.CIR.100.12.1285; Kastrati A, 2001, CIRCULATION, V103, P2816; Kastrati A, 1997, J AM COLL CARDIOL, V30, P1428, DOI 10.1016/S0735-1097(97)00334-3; KLEIN LW, 1986, AM J CARDIOL, V58, P42, DOI 10.1016/0002-9149(86)90238-9; Mack MJ, 1999, ANN THORAC SURG, V68, P383, DOI 10.1016/S0003-4975(99)00648-7; PARISI AF, 1992, NEW ENGL J MED, V326, P10, DOI 10.1056/NEJM199201023260102; POCOCK SJ, 1995, LANCET, V346, P1184, DOI 10.1016/S0140-6736(95)92897-9; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; Sousa JE, 2001, CIRCULATION, V103, P192; Tcheng JE, 2000, LANCET, V356, P2037; Teirstein PS, 1997, NEW ENGL J MED, V336, P1697, DOI 10.1056/NEJM199706123362402; The ESPRIT Investigators, 2001, LANCET, V357, P1370; Topol EJ, 1997, NEW ENGL J MED, V336, P1689; VARNAUSKAS E, 1988, NEW ENGL J MED, V319, P332, DOI 10.1056/NEJM198808113190603; Versaci F, 1997, NEW ENGL J MED, V336, P817, DOI 10.1056/NEJM199703203361201	32	164	182	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 22	2002	347	8					561	566		10.1056/NEJMoa013563	http://dx.doi.org/10.1056/NEJMoa013563			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587ZR	12192015				2022-12-28	WOS:000177675400004
J	Burtis, KC				Burtis, KC			Development: Doublesex in the middle	SCIENCE			English	Editorial Material							DROSOPHILA; EVOLUTION; PROTEINS; WINGLESS; DISC		Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Burtis, KC (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.			Burtis, Kenneth/0000-0002-9644-3265				Ahmad SM, 2002, CELL, V109, P651, DOI 10.1016/S0092-8674(02)00744-4; BURTIS KC, 1991, EMBO J, V10, P2577, DOI 10.1002/j.1460-2075.1991.tb07798.x; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; ERDMAN SE, 1993, EMBO J, V12, P527, DOI 10.1002/j.1460-2075.1993.tb05684.x; Keisman EL, 2001, DEVELOPMENT, V128, P1643; Keisman EL, 2001, DEV CELL, V1, P215, DOI 10.1016/S1534-5807(01)00027-2; Kopp A, 2000, NATURE, V408, P553, DOI 10.1038/35046017; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Sanchez L, 2001, DEVELOPMENT, V128, P1033; Schutt C, 2000, DEVELOPMENT, V127, P667; Sefton L, 2000, NATURE, V405, P970, DOI 10.1038/35016119; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; Zhu LY, 2000, GENE DEV, V14, P1750	13	8	8	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2002	297	5584					1135	1136		10.1126/science.1074492	http://dx.doi.org/10.1126/science.1074492			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183618				2022-12-28	WOS:000177447600035
J	Sethi, S; Evans, N; Grant, BJB; Murphy, TF				Sethi, S; Evans, N; Grant, BJB; Murphy, TF			New strains of bacteria and exacerbations of chronic obstructive pulmonary disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; RESPIRATORY-TRACT COLONIZATION; CHRONIC-BRONCHITIS; BRANHAMELLA-CATARRHALIS; PSEUDOMONAS-AERUGINOSA; AIRWAY INFLAMMATION; IMMUNE-RESPONSE; INFECTION; ETIOLOGY	Background The role of bacterial pathogens in acute exacerbations of chronic obstructive pulmonary disease is controversial. In older studies, the rates of isolation of bacterial pathogens from sputum were the same during acute exacerbations and during stable disease. However, these studies did not differentiate among strains within a bacterial species and therefore could not detect changes in strains over time. We hypothesized that the acquisition of a new strain of a pathogenic bacterial species is associated with exacerbation of chronic obstructive pulmonary disease. Methods We conducted a prospective study in which clinical information and sputum samples for culture were collected monthly and during exacerbations from 81 outpatients with chronic obstructive pulmonary disease. Molecular typing of sputum isolates of nonencapsulated Haemophilus influenzae, Moraxella catarrhalis, Streptococcus pneumoniae, and Pseudomonas aeruginosa was performed. Results Over a period of 56 months, the 81 patients made a total of 1975 clinic visits, 374 of which were made during exacerbations (mean, 2.1 per patient per year). On the basis of molecular typing, an exacerbation was diagnosed at 33.0 percent of the clinic visits that involved isolation of a new strain of a bacterial pathogen, as compared with 15.4 percent of visits at which no new strain was isolated (P < 0.001; relative risk of an exacerbation, 2.15; 95 percent confidence interval, 1.83 to 2.53). Isolation of a new strain of H. influenzae, M. catarrhalis, or S. pneumoniae was associated with a significantly increased risk of an exacerbation. Conclusions The association between an exacerbation and the isolation of a new strain of a bacterial pathogen supports the causative role of bacteria in exacerbations of chronic obstructive pulmonary disease.	Vet Affairs Western New York Healthcare Syst 151, Buffalo, NY 14215 USA; SUNY Buffalo, Div Pulm & Crit Care Med, Dept Med, Buffalo, NY 14260 USA; SUNY Buffalo, Div Infect Dis, Dept Med, Buffalo, NY 14260 USA; SUNY Buffalo, Dept Microbiol, Buffalo, NY 14260 USA; SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA; SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Sethi, S (corresponding author), Vet Affairs Western New York Healthcare Syst 151, 3495 Bailey Ave, Buffalo, NY 14215 USA.	ssethi@buffalo.edu		Murphy, Timothy/0000-0002-3496-2641				Bresser P, 1997, EUR RESPIR J, V10, P2319, DOI 10.1183/09031936.97.10102319; BURROWS B, 1969, NEW ENGL J MED, V280, P397, DOI 10.1056/NEJM196902202800801; CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77; CHAPMAN AJ, 1985, J INFECT DIS, V151, P878, DOI 10.1093/infdis/151.5.878; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; Connors AF, 1997, AM J RESP CRIT CARE, V155, P386; DUIM B, 1994, MOL MICROBIOL, V11, P1181, DOI 10.1111/j.1365-2958.1994.tb00394.x; Eller J, 1998, CHEST, V113, P1542, DOI 10.1378/chest.113.6.1542; FADEN H, 1989, J INFECT DIS, V160, P999, DOI 10.1093/infdis/160.6.999; Fagon J Y, 1996, Semin Respir Infect, V11, P109; FAGON JY, 1990, AM REV RESPIR DIS, V142, P1004, DOI 10.1164/ajrccm/142.5.1004; GROTHUES D, 1988, J CLIN MICROBIOL, V26, P1973, DOI 10.1128/JCM.26.10.1973-1977.1988; GUMP DW, 1976, AM REV RESPIR DIS, V113, P465; Hill AT, 1999, AM J RESP CRIT CARE, V160, P1968, DOI 10.1164/ajrccm.160.6.9904097; Hirschmann JV, 2000, CHEST, V118, P193, DOI 10.1378/chest.118.1.193; KLINGMAN KL, 1995, AM J RESP CRIT CARE, V152, P1072, DOI 10.1164/ajrccm.152.3.7663786; LEFEVRE JC, 1993, J CLIN MICROBIOL, V31, P2724, DOI 10.1128/JCM.31.10.2724-2728.1993; MASLOW JN, 1993, CLIN INFECT DIS, V17, P153, DOI 10.1093/clinids/17.2.153; MCHARDY VU, 1980, BRIT J DIS CHEST, V74, P228, DOI 10.1016/0007-0971(80)90048-0; Miravitlles M, 1999, CHEST, V116, P40, DOI 10.1378/chest.116.1.40; MONSO E, 1995, AM J RESP CRIT CARE, V152, P1316, DOI 10.1164/ajrccm.152.4.7551388; Murphy TF, 2000, CHEST, V118, P204, DOI 10.1378/chest.118.1.204; MURPHY TF, 1992, AM REV RESPIR DIS, V146, P1067, DOI 10.1164/ajrccm/146.4.1067; MURPHY TF, 1983, J INFECT DIS, V147, P838, DOI 10.1093/infdis/147.5.838; Murphy TF, 1999, J INFECT DIS, V180, P404, DOI 10.1086/314870; Obaji A, 2001, DRUG AGING, V18, P1, DOI 10.2165/00002512-200118010-00001; Seemungal TAR, 2000, AM J RESP CRIT CARE, V161, P1608, DOI 10.1164/ajrccm.161.5.9908022; SENEFF MG, 1995, JAMA-J AM MED ASSOC, V274, P1852, DOI 10.1001/jama.274.23.1852; Sethi S, 2000, CHEST, V118, P1557, DOI 10.1378/chest.118.6.1557; Sethi S, 2000, CHEST, V117, p380S, DOI 10.1378/chest.117.5_suppl_2.380S; SMITH CB, 1976, J INFECT DIS, V134, P552, DOI 10.1093/infdis/134.6.552; Soler N, 1999, EUR RESPIR J, V14, P1015, DOI 10.1183/09031936.99.14510159; Speijer H, 1999, J CLIN MICROBIOL, V37, P3654, DOI 10.1128/JCM.37.11.3654-3661.1999; TAGER I, 1975, NEW ENGL J MED, V292, P563, DOI 10.1056/NEJM197503132921105; WACHOLDER S, 1986, AM J EPIDEMIOL, V123, P174, DOI 10.1093/oxfordjournals.aje.a114212; Yi KC, 1997, J INFECT DIS, V176, P1247, DOI 10.1086/514119; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	37	716	762	1	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 15	2002	347	7					465	471		10.1056/NEJMoa012561	http://dx.doi.org/10.1056/NEJMoa012561			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587ZM	12181400				2022-12-28	WOS:000177674400002
J	Burns, JA				Burns, JA			Solar system science - Two bodies are better than one	SCIENCE			English	Editorial Material							BINARY ASTEROIDS; COLLISIONS; DISCOVERY		Cornell Univ, Dept Theoret & Appl Mech, Ithaca, NY 14853 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA	Cornell University; Cornell University	Burns, JA (corresponding author), Cornell Univ, Dept Theoret & Appl Mech, Ithaca, NY 14853 USA.							ASPHAUG E, 1994, NATURE, V370, P120, DOI 10.1038/370120a0; BATTEN AH, 1973, BINARY MULTIPLE STAR; Bottke WF, 1996, ICARUS, V124, P372, DOI 10.1006/icar.1996.0215; Britt DT, 2000, ICARUS, V146, P213, DOI 10.1006/icar.2000.6374; Brown M. E., 2001, IAU CIRC, V7588, P1; CHAPMAN CR, 1995, NATURE, V374, P783, DOI 10.1038/374783a0; CHAUVINEAU B, 1991, ICARUS, V94, P299, DOI 10.1016/0019-1035(91)90229-M; HAMILTON DP, 1991, ICARUS, V92, P118, DOI 10.1016/0019-1035(91)90039-V; Margot JL, 2002, SCIENCE, V296, P1445, DOI 10.1126/science.1072094; Merline WJ, 1999, NATURE, V401, P565, DOI 10.1038/44089; MERLINE WJ, IN PRESS ASTEROIDS, V3; Michel P, 2001, SCIENCE, V294, P1696, DOI 10.1126/science.1065189; NOLAN M, COMMUNICATION; Pravec P, 2000, ICARUS, V148, P12, DOI 10.1006/icar.2000.6482; Pravec P, 2000, ICARUS, V146, P190, DOI 10.1006/icar.2000.6375; Richardson DC, 1998, ICARUS, V134, P47, DOI 10.1006/icar.1998.5954; SCHEERES DJ, 1994, ICARUS, V110, P225, DOI 10.1006/icar.1994.1118; STORRS A, 2001, IAU CIRC, V7599, P1; Veillet C, 2002, NATURE, V416, P711, DOI 10.1038/416711a; [No title captured]	20	6	6	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2002	297	5583					942	943		10.1126/science.1072078	http://dx.doi.org/10.1126/science.1072078			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169713				2022-12-28	WOS:000177325400022
J	Kohli, RM; Walsh, CT; Burkart, MD				Kohli, RM; Walsh, CT; Burkart, MD			Biomimetic synthesis and optimization of cyclic peptide antibiotics	NATURE			English	Article							THIOESTERASE; BIOSYNTHESIS; SYNTHETASES; BACTERIAL; DOMAINS	Molecules in nature are often brought to a bioactive conformation by ring formation (macrocyclization)(1). A recurrent theme in the enzymatic synthesis of macrocyclic compounds by non-ribosomal and polyketide synthetases is the tethering of activated linear intermediates through thioester linkages to carrier proteins, in a natural analogy to solid-phase synthesis(2). A terminal thioesterase domain of the synthetase catalyses release from the tether and cyclization(3,4). Here we show that an isolated thioesterase can catalyse the cyclization of linear peptides immobilized on a solid-phase support modified with a biomimetic linker, offering the possibility of merging natural-product biosynthesis with combinatorial solid-phase chemistry. Starting from the cyclic decapeptide antibiotic tyrocidine A, this chemo-enzymatic approach allows us to diversify the linear peptide both to probe the enzymology of the macrocyclizing enzyme, TycC thioesterase, and to create a library of cyclic peptide antibiotic products. We have used this method to reveal natural-product analogues of potential therapeutic utility; these compounds have an increased preference for bacterial over eukaryotic membranes and an improved spectrum of activity against some common bacterial pathogens.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Walsh, CT (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.			Kohli, Rahul/0000-0002-7689-5678				Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; HULL SE, 1978, NATURE, V275, P206, DOI 10.1038/275206a0; Izumiya N., 1979, SYNTHETIC ASPECTS BI; Keating TA, 2001, CHEMBIOCHEM, V2, P99, DOI 10.1002/1439-7633(20010202)2:2<99::AID-CBIC99>3.0.CO;2-3; Kohli RM, 2001, BIOCHEMISTRY-US, V40, P7099, DOI 10.1021/bi010036j; Kondejewski LH, 1999, J BIOL CHEM, V274, P13181, DOI 10.1074/jbc.274.19.13181; KUO MC, 1980, BIOPHYS J, V32, P807, DOI 10.1016/S0006-3495(80)85018-1; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Li J, 1996, BIOCHEMISTRY-US, V35, P9967, DOI 10.1021/bi9605292; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; OVCHINNIKOV YA, 1982, PROTEINS, V5, P391; RIZO J, 1992, ANNU REV BIOCHEM, V61, P387, DOI 10.1146/annurev.bi.61.070192.002131; Scott CP, 2001, CHEM BIOL, V8, P801, DOI 10.1016/S1074-5521(01)00052-7; STACHELHAUS T, 1995, SCIENCE, V269, P69, DOI 10.1126/science.7604280; Trauger JW, 2000, NATURE, V407, P215, DOI 10.1038/35025116; YOUNG JDE, 1986, ANAL BIOCHEM, V154, P649, DOI 10.1016/0003-2697(86)90042-4; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	20	242	261	0	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2002	418	6898					658	661		10.1038/nature00907	http://dx.doi.org/10.1038/nature00907			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167866				2022-12-28	WOS:000177305600047
J	Pandur, P; Lasche, M; Eisenberg, LM; Kuhl, M				Pandur, P; Lasche, M; Eisenberg, LM; Kuhl, M			Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis	NATURE			English	Article							CONVERGENT EXTENSION MOVEMENTS; PROTEIN-KINASE-C; XENOPUS-LAEVIS; TRANSCRIPTION FACTOR; CARDIAC DEVELOPMENT; SIGNALING PATHWAYS; FRIZZLED HOMOLOGS; WNT/BETA-CATENIN; EXPRESSION; MESODERM	Formation of the vertebrate heart requires a complex interplay of several temporally regulated signalling cascades(1). In Xenopus laevis, cardiac specification occurs during gastrulation and requires signals from the dorsal lip and underlying endoderm(2). Among known Xenopus Wnt genes, only Wnt-11 shows a spatiotemporal pattern of expression that correlates with cardiac specification, which indicates that Wnt-11 may be involved in heart development(3,4). Here we show, through loss- and gain-of-function experiments, that XWnt-11 is required for heart formation in Xenopus embryos and is sufficient to induce a contractile phenotype in embryonic explants. Treating the mouse embryonic carcinoma stem cell line P19 with murine Wnt-11 conditioned medium triggers cardiogenesis, which indicates that the function of Wnt-11 in heart development has been conserved in higher vertebrates. XWnt-11 mediates this effect by non-canonical Wnt signalling, which is independent of beta-catenin and involves protein kinase C and Jun amino-terminal kinase. Our results indicate that the cardiac developmental program requires non-canonical Wnt signal transduction.	Univ Gottingen, Abt Entwicklungsbiochem, Jr Grp SFB 271, D-37073 Gottingen, Germany; Univ Ulm, Biochem Abt, D-89081 Ulm, Germany; Med Univ S Carolina, Dept Cell Biol & Anat, Charleston, SC 29425 USA	University of Gottingen; Ulm University; Medical University of South Carolina	Kuhl, M (corresponding author), Univ Gottingen, Abt Entwicklungsbiochem, Jr Grp SFB 271, Humboldtallee 23, D-37073 Gottingen, Germany.	wnt_signaling@web.de						BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Boutros M, 1999, MECH DEVELOP, V83, P27, DOI 10.1016/S0925-4773(99)00046-5; De Windt LJ, 2000, J BIOL CHEM, V275, P13571, DOI 10.1074/jbc.275.18.13571; Djiane A, 2000, DEVELOPMENT, V127, P3091; DRYSDALE TA, 1994, DEV BIOL, V165, P432, DOI 10.1006/dbio.1994.1265; Eisenberg CA, 1999, DEV DYNAM, V216, P45, DOI 10.1002/(SICI)1097-0177(199909)216:1<45::AID-DVDY7>3.0.CO;2-L; Eisenberg CA, 1997, DEVELOPMENT, V124, P525; Grepin C, 1997, DEVELOPMENT, V124, P2387; GRUNZ H, 1983, ROUX ARCH DEV BIOL, V192, P130, DOI 10.1007/BF00848681; Kispert A, 1996, DEVELOPMENT, V122, P3627; KU M, 1993, DEVELOPMENT, V119, P1161; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Kuhl M, 2001, MECH DEVELOP, V106, P61, DOI 10.1016/S0925-4773(01)00416-6; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; NASCONE N, 1995, DEVELOPMENT, V121, P515; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Pera EM, 2000, MECH DEVELOP, V96, P183, DOI 10.1016/S0925-4773(00)00394-4; Runnicki M.A., 1987, TERATOCARCINOMAS EMB, P19; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Schroeder KE, 1999, DEV BIOL, V214, P288, DOI 10.1006/dbio.1999.9426; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Sucov HM, 1998, ANNU REV PHYSIOL, V60, P287, DOI 10.1146/annurev.physiol.60.1.287; Tada M, 2000, DEVELOPMENT, V127, P2227; TONISSEN KF, 1994, DEV BIOL, V162, P325, DOI 10.1006/dbio.1994.1089; Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008	29	422	448	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2002	418	6898					636	641		10.1038/nature00921	http://dx.doi.org/10.1038/nature00921			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167861				2022-12-28	WOS:000177305600042
J	Rappe, MS; Connon, SA; Vergin, KL; Giovannoni, SJ				Rappe, MS; Connon, SA; Vergin, KL; Giovannoni, SJ			Cultivation of the ubiquitous SAR11 marine bacterioplankton clade	NATURE			English	Article							PHYLOGENETIC DIVERSITY; BACTERIAL DIVERSITY; DILUTION CULTURE; IDENTIFICATION; PICOPLANKTON; PROKARYOTES; SEQUENCES; CLUSTER; ARCHAEA; PROBES	The alpha-proteobacterial lineage that contains SAR11 and related ribosomal RNA gene clones was among the first groups of organisms to be identified when cultivation-independent approaches based on rRNA gene cloning and sequencing were applied to survey microbial diversity in natural ecosystems(1). This group accounts for 26% of all ribosomal RNA genes that have been identified in sea water and has been found in nearly every pelagic marine bacterioplankton community studied by these methods(2). The SAR11 clade represents a pervasive problem in microbiology: despite its ubiquity, it has defied cultivation efforts. Genetic evidence suggests that diverse uncultivated microbial taxa dominate most natural ecosystems(3-5), which has prompted widespread efforts to elucidate the geochemical activities of these organisms without the benefit of cultures for study(6,7). Here we report the isolation of representatives of the SAR11 clade. Eighteen cultures were initially obtained by means of high-throughput procedures for isolating cell cultures through the dilution of natural microbial communities into very low nutrient media. Eleven of these cultures have been successfully passaged and cryopreserved for future study. The volume of these cells, about 0.01 mum(3), places them among the smallest free-living cells in culture.	Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA	Oregon State University	Giovannoni, SJ (corresponding author), Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA.		Connon, Stephanie A/K-1959-2012	VERGIN, KEVIN/0000-0002-8972-2813				AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; Bahr M, 1996, AQUAT MICROB ECOL, V11, P271, DOI 10.3354/ame011271; Bano N, 2002, APPL ENVIRON MICROB, V68, P505, DOI 10.1128/AEM.68.2.505-518.2002; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; BUTTON DK, 1993, APPL ENVIRON MICROB, V59, P881, DOI 10.1128/AEM.59.3.881-891.1993; Davis H. C., 1958, Fishery Bulletin United States, V58, P293; DELONG EF, 1993, LIMNOL OCEANOGR, V38, P924, DOI 10.4319/lo.1993.38.5.0924; Ducklow H., 2000, MICROBIAL ECOLOGY OC, P85, DOI DOI 10.1002/9780470281840; Fuhrman JA, 1997, MAR ECOL PROG SER, V150, P275, DOI 10.3354/meps150275; Garcia-Martinez J, 2000, MOL ECOL, V9, P935, DOI 10.1046/j.1365-294x.2000.00953.x; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; GIOVANNONI SJ, 1990, APPL ENVIRON MICROB, V56, P2572, DOI 10.1128/AEM.56.8.2572-2575.1990; GIOVANNONI SJ, 1988, J BACTERIOL, V170, P720, DOI 10.1128/jb.170.2.720-726.1988; Giovannoni SJ., 2000, MICROBIAL ECOLOGY OC, P47; Glockner FO, 1996, SYST APPL MICROBIOL, V19, P403; HICKS RE, 1992, APPL ENVIRON MICROB, V58, P2158, DOI 10.1128/AEM.58.7.2158-2163.1992; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Ludwig W, 1998, ELECTROPHORESIS, V19, P554, DOI 10.1002/elps.1150190416; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Rappe MS, 1997, LIMNOL OCEANOGR, V42, P811, DOI 10.4319/lo.1997.42.5.0811; Rochelle P. A., 1995, NUCL ACIDS ENV, P219, DOI DOI 10.1007/978-3-642-79050-8_11; SCHUT F, 1993, APPL ENVIRON MICROB, V59, P2150, DOI 10.1128/AEM.59.7.2150-2160.1993; Stein JL, 1996, J BACTERIOL, V178, P591, DOI 10.1128/jb.178.3.591-599.1996; SWOFFORD D, 2000, PAUL ASTERISQUE 4 0; WARD DM, 1992, ADV MICROB ECOL, V12, P219; Yager PL, 2001, LIMNOL OCEANOGR, V46, P790, DOI 10.4319/lo.2001.46.4.0790	27	662	714	14	196	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2002	418	6898					630	633		10.1038/nature00917	http://dx.doi.org/10.1038/nature00917			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167859				2022-12-28	WOS:000177305600040
J	Holt, VL; Kernic, MA; Lumley, T; Wolf, ME; Rivara, FP				Holt, VL; Kernic, MA; Lumley, T; Wolf, ME; Rivara, FP			Civil protection orders and risk of subsequent police-reported violence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTIMATE PARTNER VIOLENCE; HEALTH; WOMEN	Context Approximately 1.5 million US women experience intimate partner violence annually. Approximately 20% of these women obtain civil protection orders, but the effectiveness of such orders in preventing future violence is unclear. Objective To assess associations between obtaining a protection order and risk of subsequent police-reported intimate partner violence. Design, Setting, and Subjects Retrospective cohort study of 2691 adult female residents of Seattle, Wash, with an incident of male intimate partner violence reported to the Seattle Police Department between August 1, 1998, and December 31, 1999. Main Outcome Measure Relative risk (RR) of police-reported physical and psychological abuse in the 12 months following the index incident according to protection order status (temporary protection order, usually in effect for 2 weeks; permanent protection order, usually in effect for 12 months; or no protection order). Results Overall rates of police-reported physical and psychological abuse in the 12 months of follow-up were 13.5 per 100 person-years and 12.3 per 100 person-years, respectively. After controlling for cohabitation at time of index incident and index incident offense type, women with temporary protection orders in effect were more likely than women without protection orders to be psychologically abused (RR in the first 6 months after the index incident, 4.0; 95% confidence interval [0], 2.2-7.2; RR in the entire 12 months after the index incident, 4.9; 95% Cl, 2.8-8.6), while women with permanent protection orders in effect were less likely than those without orders to be physically abused (RR in the first 6 months, 0.4; 95% Cl, 0.1-1.1; RR in the entire 12 months, 0.2; 95% Cl, 0.1-0.8). Conclusions Permanent, but not temporary, protection orders are associated with a significant decrease in risk of police-reported violence against women by their male intimate partners.	Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; Harborview Injury Prevent & Res Ctr, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Holt, VL (corresponding author), Univ Washington, Dept Epidemiol, Box 358080 MP474, Seattle, WA 98195 USA.				NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011151] Funding Source: NIH RePORTER; NIDA NIH HHS [1 R01 DA11151] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Bachman R., 1995, BUREAU JUSTICE STAT; Campbell JC, 1997, PSYCHIAT CLIN N AM, V20, P353, DOI 10.1016/S0193-953X(05)70317-8; Carlson MJ, 1999, J FAM VIOLENCE, V14, P205, DOI 10.1023/A:1022032904116; Chaudhuri M., 1992, DOMESTIC VIOLENCE CH, P227; COX DR, 1972, J R STAT SOC B, V34, P187; Crowell N. A., 1996, UNDERSTANDING VIOLEN; FINN P, 1990, CIVIL PROTECTION ORD; GLICK B, 1999, OREGON DOMESTIC VIOL; GRAU J, 1985, CRIMINAL JUSTICE POL, P13; Harrell A.V., 1993, COURT PROCESSING EFF; Horton A., 1987, J FAMILY VIOLENCE, V2, P265; Kernic MA, 2000, AM J PUBLIC HEALTH, V90, P1416, DOI 10.2105/AJPH.90.9.1416; KLEIN AR, 1996, DO ARRESTS RESTRAINI, P192; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; McCauley J, 1998, J GEN INTERN MED, V13, P687, DOI 10.1046/j.1525-1497.1998.00205.x; Resnick HS, 1997, BEHAV MED, V23, P65, DOI 10.1080/08964289709596730; *STAT, 1999, STAT STAT SOFTW REL; TJADEN P, 2000, EXTENT NAUTRE CONSEQ; Tjaden P., 2000, FULL REPORT PREVALEN; Wolf ME, 2000, AM J PREV MED, V19, P286, DOI 10.1016/S0749-3797(00)00235-X; Wolf ME, 2000, AM J EPIDEMIOL, V151, pS53; 2000, MMWR MORB MORTAL WKL, V49, P485	22	115	115	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	2002	288	5					589	594		10.1001/jama.288.5.589	http://dx.doi.org/10.1001/jama.288.5.589			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	581FJ	12150670				2022-12-28	WOS:000177280200017
J	Eden, KB; Orleans, CT; Mulrow, CD; Pender, NJ; Teutsch, SM				Eden, KB; Orleans, CT; Mulrow, CD; Pender, NJ; Teutsch, SM			Does counseling by clinicians improve physical activity? A summary of the evidence for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CORONARY-HEART-DISEASE; PRIMARY-CARE; GENERAL-PRACTICE; ACTIVITY INTERVENTION; HEALTH BEHAVIORS; EXERCISE; ADVICE; RISK; RECOMMENDATIONS	Purpose: To determine whether counseling adults in primary care settings improves and maintains physical activity levels. Data Sources: The Cochrane Database of Systematic Reviews and Registry of Controlled Trials and the MEDLINE, HealthStar, and Best Evidence databases were searched for papers published from 1994 to March 2002. Study Selection: Controlled trials, case-control studies, and observational studies that examined counseling interventions aimed at increasing physical activity in general primary care populations were reviewed. The researchers included trials in which 1) a patient's primary care clinician performed some of the counseling intervention; 2) behavioral outcomes (physical activity) were reported; and 3) the study was of "good" or "fair" quality, according to criteria developed by the U.S. Preventive Services Task Force. Data Extraction: Data were abstracted on design and execution, quality, providers, patients, setting, counseling intervention, and self-reported physical activity at follow-up. Data Synthesis: Eight trials involving 9054 adults met the inclusion criteria. Among six controlled trials with a usual care control group, the effects of counseling on physical activity were mixed. Because most studies had at least one methodologic limitation, it was difficult to rigorously assess the efficacy of the interventions. More research is needed to clarify the effect, benefits, and potential harms of counseling patients in primary care settings to increase physical activity. Conclusion: Evidence is inconclusive that counseling adults in the primary care setting to increase physical activity is effective.	Robert Wood Johnson Fdn, Princeton, NJ 08540 USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA; Univ Michigan, Ann Arbor, MI 48109 USA; Merck & Co Inc, West Point, PA USA	Robert Wood Johnson Foundation (RWJF); Oregon Health & Science University; University of Texas System; University of Texas Health San Antonio; University of Michigan System; University of Michigan; Merck & Company					PHS HHS [290-97-0018] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; [Anonymous], 1994, BMJ, V308, P313; Bull FC, 1998, AM J PREV MED, V15, P85, DOI 10.1016/S0749-3797(98)00040-3; BURTON LC, 1995, PREV MED, V24, P492, DOI 10.1006/pmed.1995.1078; Calfas KJ, 1996, PREV MED, V25, P225, DOI 10.1006/pmed.1996.0050; Calfas KJ, 2002, PREV MED, V34, P153, DOI 10.1006/pmed.2001.0964; Centers for Disease Control and Prevention, 2001, MMWR-MORBID MORTAL W, V50, P166, DOI DOI 10.1001/JAMA.285.14.1835-JWR0411-3-1; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P74; COULTER A, 1994, BRIT MED J, V308, P308; Damush TM, 1999, J GERONTOL A-BIOL, V54, pM423, DOI 10.1093/gerona/54.8.M423; Eakin EG, 2000, J FAM PRACTICE, V49, P158; Eaton CB, 1998, BRIT J SPORT MED, V32, P11, DOI 10.1136/bjsm.32.1.11; Elder JP, 1995, AM J PREV MED, V11, P354, DOI 10.1016/S0749-3797(18)30412-4; FIORE MC, 2000, TREATING TOBACCO USE; Goldstein MG, 1999, ANN BEHAV MED, V21, P40, DOI 10.1007/BF02895032; GRAHAMCLARKE P, 1994, BEHAV CHANGE, V11, P132, DOI 10.1017/S0813483900005039; Green BB, 2002, AM J PREV MED, V22, P177, DOI 10.1016/S0749-3797(01)00428-7; Halbert JA, 2000, MED J AUSTRALIA, V173, P84, DOI 10.5694/j.1326-5377.2000.tb139250.x; Harland J, 1999, BRIT MED J, V319, P828, DOI 10.1136/bmj.319.7213.828; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Kerse NM, 1999, BRIT MED J, V319, P683, DOI 10.1136/bmj.319.7211.683; King AC, 1998, MED SCI SPORT EXER, V30, P1086, DOI 10.1097/00005768-199807000-00011; Kreuter MW, 2000, ARCH FAM MED, V9, P426, DOI 10.1001/archfami.9.5.426; Lee IM, 2001, MED SCI SPORT EXER, V33, pS459, DOI 10.1097/00005768-200106001-00016; Marcus BH, 1997, PREV MED, V26, P382, DOI 10.1006/pmed.1997.0158; Marcus BH, 2000, HEALTH PSYCHOL, V19, P32, DOI 10.1037/0278-6133.19.Suppl1.32; Norris SL, 2000, PREV MED, V30, P513, DOI 10.1006/pmed.2000.0673; Orleans CT, 2000, HEALTH PSYCHOL, V19, P76, DOI 10.1037/0278-6133.19.Suppl1.76; Simons-Morton DG, 2000, PREV MED, V31, P513, DOI 10.1006/pmed.2000.0733; Simons-Morton DG, 2001, JAMA-J AM MED ASSOC, V286, P677; Smith BJ, 2000, BRIT J SPORT MED, V34, P262, DOI 10.1136/bjsm.34.4.262; Steptoe A, 1999, BRIT MED J, V319, P943, DOI 10.1136/bmj.319.7215.943; Stevens W, 1998, BRIT J SPORT MED, V32, P236, DOI 10.1136/bjsm.32.3.236; Swinburn BA, 1998, AM J PUBLIC HEALTH, V88, P288, DOI 10.2105/AJPH.88.2.288; Taylor AH, 1998, J EPIDEMIOL COMMUN H, V52, P595, DOI 10.1136/jech.52.9.595; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; *US PREV SERV TASK, 1996, COUNS PROM PHYS ACT, P611; Whitlock EP, 2002, AM J PREV MED, V22, P267, DOI 10.1016/S0749-3797(02)00415-4	38	198	199	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 6	2002	137	3					208	215		10.7326/0003-4819-137-3-200208060-00015	http://dx.doi.org/10.7326/0003-4819-137-3-200208060-00015			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580XP	12160371				2022-12-28	WOS:000177262300010
J	Kjaergard, LL; Als-Nielsen, B				Kjaergard, LL; Als-Nielsen, B			Association between competing interests and authors' conclusions: epidemiological study of ramdomised clinical trials published in the BMJ	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED TRIALS; CONFLICT-OF-INTEREST; QUALITY; BIAS	Objective To assess the association between competing interests and authors' conclusions in randomised clinical trials. Design Epidemiological study of randomised clinical trials published in the BMJ from January 1997 to June 2001. Financial competing interests were defined as funding by for profit organisations and other competing interests as personal, academic, or political. Studies 159 trials from 12 medical specialties. Main outcome measures Authors' conclusions defined as interpretation of extent to which overall results favoured experimental intervention. Conclusions appraised on 6 point scale; higher scores favour experimental intervention. Results Authors' conclusions were significantly more positive towards the experimental intervention in trials funded by for profit organisations alone compared with trials without competing interests (mean difference 0.48 (SE 0.13), P=0.014), trials funded by both for profit and non-profit organisations (0.30 (SE 0.10), P=0.003), and trials with other competing interests (0.45 (SE 0.13), P=0.006). Other competing interests and funding from both for profit and non-profit organisations were not significantly associated with authors' conclusions. The association between financial competing interests and authors' conclusions was not explained by methodological quality, statistical power, type of experimental intervention (pharmacological or non-pharmacological), type of control intervention (for example, placebo or active drug), or medical specialty. Conclusions Authors' conclusions in randomised clinical trials significantly favoured experimental interventions if financial competing interests were declared. Other competing interests were not significantly associated with authors' conclusions.	Univ Copenhagen Hosp, Dept 7102,Rigshosp, Ctr Clin Intervent Res, Copenhagen Trial Unit,Cochrane Hepatobiliary Grp, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Kjaergard, LL (corresponding author), Univ Copenhagen Hosp, Dept 7102,Rigshosp, Ctr Clin Intervent Res, Copenhagen Trial Unit,Cochrane Hepatobiliary Grp, DK-2100 Copenhagen, Denmark.	Kjaergard@ctu.rh.dk	Gluud, Lise L/AAY-2120-2020	Gluud, Lise L/0000-0002-9462-4468				Altman DG, 1996, BRIT MED J, V312, P1472, DOI 10.1136/bmj.312.7044.1472; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Davidoff F, 2001, ANN INTERN MED, V135, P463, DOI 10.7326/0003-4819-135-6-200109180-00016; Dieppe P, 1999, LANCET, V353, P1626, DOI 10.1016/S0140-6736(05)75755-X; Djulbegovic B, 2000, LANCET, V356, P635, DOI 10.1016/S0140-6736(00)02605-2; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Egger M, 2001, BRIT MED J, V323, P1253, DOI 10.1136/bmj.323.7323.1253a; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Smith R, 1998, BMJ-BRIT MED J, V317, P291, DOI 10.1136/bmj.317.7154.291; Wahlbeck K, 1999, BRIT MED J, V318, P465	13	331	337	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2002	325	7358					249	252		10.1136/bmj.325.7358.249	http://dx.doi.org/10.1136/bmj.325.7358.249			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582FL	12153921	Bronze, Green Published			2022-12-28	WOS:000177339000018
J	Baughman, RH; Zakhidov, AA; de Heer, WA				Baughman, RH; Zakhidov, AA; de Heer, WA			Carbon nanotubes - the route toward applications	SCIENCE			English	Review							FIELD-EMISSION; HYDROGEN STORAGE; ELECTRONIC-PROPERTIES; ELECTRICAL-TRANSPORT; SINGLE; GROWTH; ROPES; SUPERCONDUCTIVITY; COMPOSITES; CIRCUITS	Many potential applications have been proposed for carbon nanotubes, including conductive and high-strength composites; energy storage and energy conversion devices; sensors; field emission displays and radiation sources; hydrogen storage media; and nanometer-sized semiconductor devices, probes, and interconnects. Some of these applications are now realized in products. Others are demonstrated in early to advanced devices, and one, hydrogen storage, is clouded by controversy. Nanotube cost, polydispersity in nanotube type, and limitations in processing and assembly methods are important barriers for some applications of single-walled nanotubes.	Univ Texas, Nanotech Inst, Richardson, TX 75083 USA; Univ Texas, Dept Chem, Richardson, TX 75083 USA; Univ Texas, Dept Phys, Richardson, TX 75083 USA; Georgia Inst Technol, Dept Phys, Atlanta, GA 30332 USA	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas; University System of Georgia; Georgia Institute of Technology	Baughman, RH (corresponding author), Univ Texas, Nanotech Inst, Richardson, TX 75083 USA.	ray.baughman@utdallas.edu	Baughman, Ray/A-8628-2018; Han, Jinhua/F-9464-2010	Baughman, Ray/0000-0001-5845-5137; Zakhidov, Anvar/0000-0003-3983-2229				An KH, 2001, ADV FUNCT MATER, V11, P387, DOI 10.1002/1616-3028(200110)11:5<387::AID-ADFM387>3.0.CO;2-G; Bachtold A, 2001, SCIENCE, V294, P1317, DOI 10.1126/science.1065824; Ball P, 2001, NATURE, V414, P142, DOI 10.1038/35102721; Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340; Baughman RH, 2000, SCIENCE, V290, P1310, DOI 10.1126/science.290.5495.1310; BAUGHMAN RH, UNPUB; Biercuk MJ, 2002, APPL PHYS LETT, V80, P2767, DOI 10.1063/1.1469696; Bonard JM, 1998, PHYS REV LETT, V81, P1441, DOI 10.1103/PhysRevLett.81.1441; Chen Y, 2001, APPL PHYS LETT, V78, P2128, DOI 10.1063/1.1341224; Collins PC, 2001, SCIENCE, V292, P706, DOI 10.1126/science.1058782; Collins PG, 2000, SCIENCE, V287, P1801, DOI 10.1126/science.287.5459.1801; Dai HJ, 1996, NATURE, V384, P147, DOI 10.1038/384147a0; DAVIS VA, UNPUB; DEHEER WA, 1995, SCIENCE, V270, P1179, DOI 10.1126/science.270.5239.1179; Dillon AC, 2001, APPL PHYS A-MATER, V72, P133, DOI 10.1007/s003390100788; Ding RG, 2001, J NANOSCI NANOTECHNO, V1, P7, DOI 10.1166/jnn.2001.012; DISMA F, 1997, SOLID STATE IONICS, V98, P145; Dresselhaus MS, 1999, MRS BULL, V24, P45, DOI 10.1557/S0883769400053458; Fan SS, 1999, SCIENCE, V283, P512, DOI 10.1126/science.283.5401.512; Frank S, 1998, SCIENCE, V280, P1744, DOI 10.1126/science.280.5370.1744; Franklin NR, 2001, APPL PHYS LETT, V79, P4571, DOI 10.1063/1.1429294; Fuhrer MS, 2000, SCIENCE, V288, P494, DOI 10.1126/science.288.5465.494; Gao B, 1999, CHEM PHYS LETT, V307, P153, DOI 10.1016/S0009-2614(99)00486-8; Gao GH, 1998, NANOTECHNOLOGY, V9, P184, DOI 10.1088/0957-4484/9/3/007; Hafner JH, 1999, NATURE, V398, P761, DOI 10.1038/19658; Haggenmueller R, 2000, CHEM PHYS LETT, V330, P219, DOI 10.1016/S0009-2614(00)01013-7; Hirscher M, 2002, J ALLOY COMPD, V330, P654, DOI 10.1016/S0925-8388(01)01643-7; Huang Y, 2001, SCIENCE, V291, P630, DOI 10.1126/science.291.5504.630; Kim P, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.215502; Kim P, 1999, SCIENCE, V286, P2148, DOI 10.1126/science.286.5447.2148; Kociak M, 2001, PHYS REV LETT, V86, P2416, DOI 10.1103/PhysRevLett.86.2416; Kong J, 2000, SCIENCE, V287, P622, DOI 10.1126/science.287.5453.622; Kwo JL, 2001, J VAC SCI TECHNOL B, V19, P23, DOI 10.1116/1.1340668; Lee NS, 2001, DIAM RELAT MATER, V10, P265, DOI 10.1016/S0925-9635(00)00478-7; Liang WJ, 2001, NATURE, V411, P665, DOI 10.1038/35079517; Louie SG, 2001, TOP APPL PHYS, V80, P113; Martel R, 1998, APPL PHYS LETT, V73, P2447, DOI 10.1063/1.122477; NIU C, 2000, P 39 POW SOURC C MAP, P314; Niu CM, 1997, APPL PHYS LETT, V70, P1480, DOI 10.1063/1.118568; Qian D, 2000, APPL PHYS LETT, V76, P2868, DOI 10.1063/1.126500; Ren ZF, 1998, SCIENCE, V282, P1105, DOI 10.1126/science.282.5391.1105; Rinzler AG, 1998, APPL PHYS A-MATER, V67, P29, DOI 10.1007/s003390050734; RINZLER AG, 1995, SCIENCE, V269, P1550, DOI 10.1126/science.269.5230.1550; Rosen R, 2000, APPL PHYS LETT, V76, P1668, DOI 10.1063/1.126130; Rueckes T, 2000, SCIENCE, V289, P94, DOI 10.1126/science.289.5476.94; Saito Y, 2000, CARBON, V38, P169, DOI 10.1016/S0008-6223(99)00139-6; Sohn JI, 2001, APPL PHYS LETT, V78, P901, DOI 10.1063/1.1335846; Sugie H, 2001, APPL PHYS LETT, V78, P2578, DOI 10.1063/1.1367278; Tang ZK, 2001, SCIENCE, V292, P2462, DOI 10.1126/science.1060470; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Tennent Howard G., 1987, U.S. Patent, Patent No. [US 4663230, 4663230, 4,663,230]; Thess A, 1996, SCIENCE, V273, P483, DOI 10.1126/science.273.5274.483; Tibbetts GG, 2001, CARBON, V39, P2291, DOI 10.1016/S0008-6223(01)00051-3; Vigolo B, 2000, SCIENCE, V290, P1331, DOI 10.1126/science.290.5495.1331; Walters DA, 1999, APPL PHYS LETT, V74, P3803, DOI 10.1063/1.124185; Wildoer JWG, 1998, NATURE, V391, P59, DOI 10.1038/34139; Wong EW, 1997, SCIENCE, V277, P1971, DOI 10.1126/science.277.5334.1971; Wong SS, 1998, NATURE, V394, P52, DOI 10.1038/27873; Yao Z, 2001, TOP APPL PHYS, V80, P147; Yao Z, 2000, PHYS REV LETT, V84, P2941, DOI 10.1103/PhysRevLett.84.2941; Yao Z, 1999, NATURE, V402, P273, DOI 10.1038/46241; Ye Y, 1999, APPL PHYS LETT, V74, P2307, DOI 10.1063/1.123833; Yu MF, 2000, PHYS REV LETT, V84, P5552, DOI 10.1103/PhysRevLett.84.5552; Zandonella C, 2001, NATURE, V410, P734, DOI 10.1038/35071183; ZHOU O, COMMUNICATION; Zhu W, 1999, APPL PHYS LETT, V75, P873, DOI 10.1063/1.124541; 2002, NY TIMES        0520, pC4; [No title captured]	68	8887	9223	171	6418	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2002	297	5582					787	792		10.1126/science.1060928	http://dx.doi.org/10.1126/science.1060928			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161643				2022-12-28	WOS:000177192800036
J	Kim, KC; Reed, CA; Elliott, DW; Mueller, LJ; Tham, F; Lin, LJ; Lambert, JB				Kim, KC; Reed, CA; Elliott, DW; Mueller, LJ; Tham, F; Lin, LJ; Lambert, JB			Crystallographic evidence for a free silylium ion	SCIENCE			English	Article							TRIMESITYLSILYLIUM CATION; TRICOORDINATE SILYL; CRYSTAL-STRUCTURE; CONDENSED-PHASE; SUPERACIDS; CHEMISTRY; ANIONS	Evidence for a three-coordinate silyl cation is provided by the crystal structure of [(Mes)(3)Si][H-CB11Me5Br6].C6H6 ( where Mes is 2,4,6-trimethylphenyl). Free (Mes)(3)Si+ cations are well separated from the carborane anions and benzene solvate molecules. Ortho-methyl groups of the mesityl substituents shield the silicon atom from the close approach of nucleophiles, while remaining innocent as significant ligands themselves. The silicon center is three-coordinate and planar. The down field Si-29 nuclear magnetic resonance chemical shift in the solid state (226.7 parts per million) is almost identical to that in benzene solution and in gas phase calculations, indicating that three-coordination can be preserved in all phases.	Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	University of California System; University of California Riverside; Northwestern University	Reed, CA (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.			Mueller, Leonard/0000-0002-2607-9875				HERZFELD J, 1980, J CHEM PHYS, V73, P6021, DOI 10.1063/1.440136; Kraka E, 1997, CHEM PHYS LETT, V279, P9, DOI 10.1016/S0009-2614(97)00944-5; Lambert JB, 2001, J ORG CHEM, V66, P8537, DOI 10.1021/jo010772t; Lambert JB, 2001, J PHYS ORG CHEM, V14, P370, DOI 10.1002/poc.377; LAMBERT JB, 1993, SCIENCE, V260, P1917, DOI 10.1126/science.260.5116.1917; Lambert JB, 1997, ANGEW CHEM INT EDIT, V36, P400, DOI 10.1002/anie.199704001; Lambert JB, 1999, J AM CHEM SOC, V121, P5001, DOI 10.1021/ja990389u; LAMBERT JB, 1995, CHEM REV, V95, P1191, DOI 10.1021/cr00037a003; Lambert JB, 1998, J ORGANOMET CHEM, V568, P21, DOI 10.1016/S0022-328X(98)00754-2; Lickiss P., 1998, CHEM ORGANIC SILICON; Maerker C, 1996, ORGANOSILICON CHEMISTRY II, P329; Muller T, 1998, ORGANOMETALLICS, V17, P278, DOI 10.1021/om971003w; Nishinaga T, 2000, J AM CHEM SOC, V122, P9312, DOI 10.1021/ja0014685; Olah GA, 2001, J ORG CHEM, V66, P5943, DOI 10.1021/jo010438x; Reed CA, 1998, ACCOUNTS CHEM RES, V31, P133, DOI 10.1021/ar970230r; Reed CA, 2000, SCIENCE, V289, P101, DOI 10.1126/science.289.5476.101; REED CA, 1993, SCIENCE, V262, P402, DOI 10.1126/science.262.5132.402; Reed CA, 1999, J AM CHEM SOC, V121, P6314, DOI 10.1021/ja981861z; Reed CA, 1998, ACCOUNTS CHEM RES, V31, P325, DOI 10.1021/ar960132q; Sekiguchi A, 2000, J AM CHEM SOC, V122, P11250, DOI 10.1021/ja002344v; Stasko D, 2002, J AM CHEM SOC, V124, P1148, DOI 10.1021/ja0118800; West R, 1997, J AM CHEM SOC, V119, P4972, DOI 10.1021/ja963921b; Zharov I, 2000, J AM CHEM SOC, V122, P10253, DOI 10.1021/ja001374v	23	246	248	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2002	297	5582					825	827		10.1126/science.1073540	http://dx.doi.org/10.1126/science.1073540			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161650	Green Published			2022-12-28	WOS:000177192800047
J	Gerrits, T; van den Berg, HAM; Hohlfeld, J; Bar, L; Rasing, T				Gerrits, T; van den Berg, HAM; Hohlfeld, J; Bar, L; Rasing, T			Ultrafast precessional magnetization reversal by picosecond magnetic field pulse shaping	NATURE			English	Article							DYNAMICS; GENERATION	Since the invention of the first magnetic memory disk in 1954, much effort has been put into enhancing the speed, bit density and reliability of magnetic memory devices. In the case of magnetic random access memory (MRAM) devices, fast coherent magnetization rotation by precession of the entire memory cell is desired(1-6), because reversal by domain-wall motion is much too slow. In principle, the fundamental limit of the switching speed via precession is given by half of the precession period. However, under-critically damped systems exhibit severe ringing(7,8) and simulations show that, as a consequence, undesired back-switching of magnetic elements of an MRAM can easily be initiated by subsequent write pulses, threatening data integrity. We present a method to reverse the magnetization in under-critically damped systems by coherent rotation of the magnetization while avoiding any ringing. This is achieved by applying specifically shaped magnetic field pulses that match the intrinsic properties of the magnetic elements. We demonstrate, by probing all three magnetization components(9,10), that reliable precessional reversal in lithographically structured micrometre-sized elliptical permalloy elements is possible at switching times of about 200 ps, which is ten times faster than the natural damping time constant.	Univ Nijmegen, Mat Res Labs, NL-6525 ED Nijmegen, Netherlands; Siemens AG, CTMF 1, D-91052 Erlangen, Germany	Radboud University Nijmegen; Siemens AG; Siemens Germany	Rasing, T (corresponding author), Univ Nijmegen, Mat Res Labs, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.	theoras@sci.kun.nl	Rasing, Theo/D-5207-2012	Rasing, Theo/0000-0002-6656-5528				Acremann Y, 2000, SCIENCE, V290, P492, DOI 10.1126/science.290.5491.492; Acremann Y, 2001, APPL PHYS LETT, V79, P2228, DOI 10.1063/1.1407299; Acremann Y, 2001, NATURE, V414, P51, DOI 10.1038/35102026; AUSTON DH, 1983, IEEE J QUANTUM ELECT, V19, P639, DOI 10.1109/JQE.1983.1071904; Back CH, 1998, PHYS REV LETT, V81, P3251, DOI 10.1103/PhysRevLett.81.3251; Bauer M, 2000, APPL PHYS LETT, V76, P2758, DOI 10.1063/1.126466; Choi BC, 2001, PHYS REV LETT, V86, P728, DOI 10.1103/PhysRevLett.86.728; Crawford TM, 2000, APPL PHYS LETT, V76, P2113, DOI 10.1063/1.126280; Crawford TM, 1999, APPL PHYS LETT, V74, P3386, DOI 10.1063/1.123353; FRANKEL MY, 1991, IEEE T MICROW THEORY, V39, P910, DOI 10.1109/22.81658; Gerrits T., 2001, Journal of the Magnetics Society of Japan, V25, P192, DOI 10.3379/jmsjmag.25.192; Gerrits T, 2002, J MAGN MAGN MATER, V240, P283, DOI 10.1016/S0304-8853(01)00779-X; Hiebert WK, 1997, PHYS REV LETT, V79, P1134, DOI 10.1103/PhysRevLett.79.1134; Hiebert WK, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.140404; Holzman JF, 2000, APPL PHYS LETT, V76, P134, DOI 10.1063/1.125679; Kaka S, 2002, APPL PHYS LETT, V80, P2958, DOI 10.1063/1.1470704; Keil UD, 1996, IEEE J QUANTUM ELECT, V32, P1664, DOI 10.1109/3.535372; KEIL UD, 1995, APPL PHYS LETT, V66, P1629, DOI 10.1063/1.113874; KEIL UD, 1992, IEEE J QUANTUM ELECT, V28, P2333, DOI 10.1109/3.159540; Landau LD., 1935, PHYS SOVIETUNION, V8, P153, DOI DOI 10.1016/B978-0-08-036364-6.50008-9; Rasing T, 1999, APPL PHYS B-LASERS O, V68, P477, DOI 10.1007/s003400050652; SCHUMACHER HW, 2002, PRECESSIONAL MAGNETI; Silva TJ, 2002, J APPL PHYS, V91, P1066, DOI 10.1063/1.1421040; Stamps RL, 1999, APPL PHYS LETT, V75, P1143, DOI 10.1063/1.124623; ZHU J, 2002, MAGNETIZATION REVERS	25	392	399	2	140	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 1	2002	418	6897					509	512		10.1038/nature00905	http://dx.doi.org/10.1038/nature00905			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152072				2022-12-28	WOS:000177162800033
J	Brittis, PA; Lu, Q; Flanagan, JG				Brittis, PA; Lu, Q; Flanagan, JG			Axonal protein synthesis provides a mechanism for localized regulation at an intermediate target	CELL			English	Article							ALKALINE-PHOSPHATASE FUSIONS; TYROSINE KINASE; ROBO RECEPTORS; MESSENGER-RNA; GROWTH CONES; GUIDANCE; MIDLINE; SLIT; EXPRESSION; TRANSLATION	As axons grow past intermediate targets, they change their responsiveness to guidance cues. Local upregulation of receptor expression is involved, but the mechanisms for this are not clear. Here protein synthesis is traced within individual axons by introducing RNAs encoding visualizable reporters. Individual severed axons and growth cones can translate proteins and also export them to the cell surface. As axons reach the spinal cord midline, EphA2 is among the receptors upregulated on at least some distal axon segments. Midline reporter upregulation is recapitulated by part of the EphA2 mRNA 3' untranslated region, which is highly conserved and includes known translational control sequences. These results show axons contain all the machinery for protein translation and cell surface expression, and they reveal a potentially general and flexible RNA-based mechanism for regulation localized within a subregion of the axon.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Flanagan, JG (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	flanagan@hms.harvard.edu	Flanagan, John/AAM-2995-2020					Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Alvarez J, 2000, PROG NEUROBIOL, V62, P1, DOI 10.1016/S0301-0082(99)00062-3; Bassell GJ, 1998, J NEUROSCI, V18, P251; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; Bergemann AD, 1998, ONCOGENE, V16, P471, DOI 10.1038/sj.onc.1201557; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; BRITTIS PA, 1995, EXP NEUROL, V134, P1, DOI 10.1006/exnr.1995.1031; BRITTIS PA, 1995, MOL CELL NEUROSCI, V6, P433, DOI 10.1006/mcne.1995.1032; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; Burstyn-Cohen T, 1999, NEURON, V23, P233, DOI 10.1016/S0896-6273(00)80776-X; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Eng H, 1999, J NEUROSCI, V19, P1; Flanagan JG, 1998, CELL, V92, P429, DOI 10.1016/S0092-8674(00)80935-6; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; GILARDIHEBENSTREIT P, 1992, ONCOGENE, V7, P2499; Imondi R, 2001, DEVELOPMENT, V128, P4859; Job C, 2001, NAT REV NEUROSCI, V2, P889, DOI 10.1038/35104069; Kaprielian Z, 2001, DEV DYNAM, V221, P154, DOI 10.1002/dvdy.1143; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; KOENIG E, 1967, J NEUROCHEM, V14, P437, DOI 10.1111/j.1471-4159.1967.tb09542.x; Koenig E, 2000, J NEUROSCI, V20, P8390, DOI 10.1523/JNEUROSCI.20-22-08390.2000; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; LINDBERG RA, 1990, MOL CELL BIOL, V10, P6316, DOI 10.1128/MCB.10.12.6316; Lodish H, 2000, MOL CELL BIOL; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Magal E, 1996, J NEUROSCI RES, V43, P735, DOI 10.1002/(SICI)1097-4547(19960315)43:6<735::AID-JNR10>3.0.CO;2-X; MANOIL C, 1990, J BACTERIOL, V172, P515, DOI 10.1128/jb.172.2.515-518.1990; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Richter JD, 1999, MICROBIOL MOL BIOL R, V63, P446, DOI 10.1128/MMBR.63.2.446-456.1999; SCHWARTZ JH, 2000, PRINCIPLES NEURAL SC, P88; SHAW G, 1977, EXP CELL RES, V104, P55, DOI 10.1016/0014-4827(77)90068-4; SILOSSANTIAGO I, 1992, J COMP NEUROL, V325, P514, DOI 10.1002/cne.903250405; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Spencer GE, 2000, J NEUROBIOL, V44, P72, DOI 10.1002/1097-4695(200007)44:1<72::AID-NEU7>3.0.CO;2-#; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; Terskikh A, 2000, SCIENCE, V290, P1585, DOI 10.1126/science.290.5496.1585; Teruel MN, 1999, J NEUROSCI METH, V93, P37, DOI 10.1016/S0165-0270(99)00112-0; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wells DG, 2000, CURR OPIN NEUROBIOL, V10, P132, DOI 10.1016/S0959-4388(99)00050-1; Wickens M, 2000, COLD SPRING HARBOR M, V39, P295; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	55	323	332	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 26	2002	110	2					223	235		10.1016/S0092-8674(02)00813-9	http://dx.doi.org/10.1016/S0092-8674(02)00813-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	578EV	12150930	Bronze			2022-12-28	WOS:000177105200010
J	Gagnon, E; Duclos, S; Rondeau, C; Chevet, E; Cameron, PH; Steele-Mortimer, O; Paiement, J; Bergeron, JJM; Desjardins, M				Gagnon, E; Duclos, S; Rondeau, C; Chevet, E; Cameron, PH; Steele-Mortimer, O; Paiement, J; Bergeron, JJM; Desjardins, M			Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages	CELL			English	Article							ISOLATED RAT HEPATOCYTES; LEGIONELLA-PNEUMOPHILA; PHOSPHATIDYLINOSITOL 3-KINASE; MATURING PHAGOSOMES; CONTAINING VACUOLES; IN-VITRO; MATURATION; FUSION; CALRETICULIN; CELLS	Phagocytosis is a key aspect of our innate ability to fight infectious diseases. In this study, we have found that fusion of the endoplasmic reticulum (ER) with the macrophage plasmalemma, underneath phagocytic cups, is a source of membrane for phagosome formation in macrophages. Successive waves of ER become associated with maturing phagosomes during phagolysosome biogenesis. Thus, the ER appears to possess unexpectedly pluripotent fusion properties. ER-mediated phagocytosis is regulated in part by phosphatidylinositol 3-kinase and used for the internalization of inert particles and intracellular pathogens, regardless of their final trafficking in the host. In neutrophils, where pathogens are rapidly killed, the ER is not used as a major source of membrane for phagocytosis. We propose that intracellular pathogens have evolved to adapt and exploit ER-mediated phagocytosis to avoid destruction in host cells.	Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ H3C 3J7, Canada; McGill Univ, Dept Surg, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2T5, Canada; NIAID, Rocky Mt Labs, Intracellular Parasites Lab, Hamilton, MT 59840 USA; Caprion Pharmaceut Inc, Montreal, PQ, Canada	Universite de Montreal; McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Desjardins, M (corresponding author), Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ H3C 3J7, Canada.		Bergeron, John/AAW-1893-2021; chevet, eric/E-4992-2016	chevet, eric/0000-0001-5855-4522; Desjardins, Michel/0000-0002-5684-5980	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000918] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; ANDERSON TD, 1986, AM J PATHOL, V124, P226; BIDANI A, 1995, J LEUKOCYTE BIOL, V57, P275, DOI 10.1002/jlb.57.2.275; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; CANNON GJ, 1992, J CELL SCI, V101, P907; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Cougoule C, 2002, INFECT IMMUN, V70, P1591, DOI 10.1128/IAI.70.3.1591-1598.2002; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200; Desjardins M, 1997, J CELL SCI, V110, P2303; DESJARDINS M, 1995, TRENDS CELL BIOL, V5, P183, DOI 10.1016/S0962-8924(00)88989-8; DESJARDINS M, 1994, J BIOL CHEM, V269, P32194; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Diakonova M, 2002, MOL BIOL CELL, V13, P402, DOI 10.1091/mbc.01-05-0273; Duclos S, 2000, J CELL SCI, V113, P3531; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Gold ES, 2000, IMMUNITY, V12, P285, DOI 10.1016/S1074-7613(00)80181-8; GRIFFITHS G, 1983, J CELL BIOL, V96, P835, DOI 10.1083/jcb.96.3.835; Hackam DJ, 1998, P NATL ACAD SCI USA, V95, P11691, DOI 10.1073/pnas.95.20.11691; HEINE JW, 1971, J CELL BIOL, V48, P703, DOI 10.1083/jcb.48.3.703; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; Jahraus A, 1998, J BIOL CHEM, V273, P30379, DOI 10.1074/jbc.273.46.30379; Johnson S, 2001, TRENDS CELL BIOL, V11, P122, DOI 10.1016/S0962-8924(01)01926-2; Kakimura J, 2001, BIOCHEM BIOPH RES CO, V281, P6, DOI 10.1006/bbrc.2001.4299; KATZ SM, 1982, LAB INVEST, V46, P24; Kleijmeer MJ, 2001, TRAFFIC, V2, P124, DOI 10.1034/j.1600-0854.2001.020207.x; Lafont F, 1999, P NATL ACAD SCI USA, V96, P3734, DOI 10.1073/pnas.96.7.3734; Laufs H, 2002, INFECT IMMUN, V70, P826, DOI 10.1128/IAI.70.2.826-835.2002; Lavoie C, 2000, P NATL ACAD SCI USA, V97, P13637, DOI 10.1073/pnas.240278097; Massol P, 1998, EMBO J, V17, P6219, DOI 10.1093/emboj/17.21.6219; May RC, 2001, J CELL SCI, V114, P1061; Meresse S, 1997, ELECTROPHORESIS, V18, P2682, DOI 10.1002/elps.1150181425; Meresse S, 1999, NAT CELL BIOL, V1, pE183, DOI 10.1038/15620; Merhi Y, 1999, ARTERIOSCL THROM VAS, V19, P372, DOI 10.1161/01.ATV.19.2.372; Muller-Taubenberger A, 2001, EMBO J, V20, P6772, DOI 10.1093/emboj/20.23.6772; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Okazaki Y, 2000, J BIOL CHEM, V275, P35751, DOI 10.1074/jbc.M007476200; OLAFSON RW, 1990, J BIOL CHEM, V265, P12240; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; PAIEMENT J, 1983, J CELL BIOL, V96, P1791, DOI 10.1083/jcb.96.6.1791; PAIEMENT J, 1988, J HISTOCHEM CYTOCHEM, V36, P441, DOI 10.1177/36.4.2450122; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; PITT A, 1992, J CLIN INVEST, V90, P1978, DOI 10.1172/JCI116077; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; ROKEACH LA, 1991, PROTEIN ENG, V4, P981, DOI 10.1093/protein/4.8.981; Scianimanico S, 1999, CELL MICROBIOL, V1, P19, DOI 10.1046/j.1462-5822.1999.00002.x; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Steele-Mortimer O, 1999, CELL MICROBIOL, V1, P33, DOI 10.1046/j.1462-5822.1999.00003.x; SWANSON MS, 1995, INFECT IMMUN, V63, P3609, DOI 10.1128/IAI.63.9.3609-3620.1995; TARDIEUX I, 1992, CELL, V71, P1117, DOI 10.1016/S0092-8674(05)80061-3; Tilney LG, 2001, J CELL SCI, V114, P4637; VICKER MG, 1977, EXP CELL RES, V109, P127, DOI 10.1016/0014-4827(77)90052-0; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Whatmore J, 1999, BIOCHEM J, V341, P435, DOI 10.1042/0264-6021:3410435; Zapun A, 1999, STRUCT FOLD DES, V7, pR173, DOI 10.1016/S0969-2126(99)80112-9	56	536	553	2	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 12	2002	110	1					119	131		10.1016/S0092-8674(02)00797-3	http://dx.doi.org/10.1016/S0092-8674(02)00797-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	573PU	12151002	Bronze			2022-12-28	WOS:000176840700012
J	Schnyder, G; Roffi, M; Flammer, Y; Pin, R; Hess, OM				Schnyder, G; Roffi, M; Flammer, Y; Pin, R; Hess, OM			Effect of homocysteine-lowering therapy with folic acid, vitamin B-12, and vitamin B-6 on clinical outcome after percutaneous coronary intervention - The Swiss heart study: A randomized controlled triala	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLASMA HOMOCYSTEINE; RISK-FACTOR; ENDOTHELIAL FUNCTION; VASCULAR-DISEASE; ARTERY-DISEASE; NITRIC-OXIDE; RESTENOSIS; ANGIOPLASTY; EXPRESSION; HYPERHOMOCYST(E)INEMIA	Context Plasma homocysteine level has been recognized as an important cardiovascular risk factor that predicts adverse cardiac events in patients with established coronary atherosclerosis and influences restenosis rate after percutaneous coronary intervention. Objective To evaluate the effect of homocysteine-lowering therapy on clinical outcome after percutaneous coronary intervention. Design, Setting, and Participants Randomized, double-blind placebo-controlled trial involving 553 patients referred to the University Hospital in Bern, Switzerland, from May 1998 to April 1999 and enrolled after successful angioplasty of at least 1 significant coronary stenosis (greater than or equal to50%). Intervention Participants were randomly assigned to receive a combination of folic acid (1 mg/d), vitamin B-12 (cyanocobalamin, 400 mug/d), and vitamin B-6 (pyridoxine hydrochloride, 10 mg/d) (n = 272) or placebo (n = 281) for 6 months. Main Outcome Measure Composite end point of major adverse events defined as death, nonfatal myocardial infarction, and need for repeat revascularization, evaluated at 6 months and 1 year. Results After a mean (SD) follow-up of 11 (3) months, the composite end point was significantly lower at 1 year in patients treated with homocysteine-lowering therapy (15.4% vs 22.8%; relative risk [RR], 0.68; 95% confidence interval [CI], 0.48-0.96; P = .03), primarily due to a reduced rate of target lesion revascularization (9.9% vs 16.0%; RR, 0.62; 95% CI, 0.40-0.97; P = .03). A nonsignificant trend was seen toward fewer deaths (1.5% vs 2.8%; RR, 0.54; 95% CI, 0.16-1.70; P = .27) and nonfatal myocardial infarctions (2.6% vs 4.3%; RR, 0.60;95% CI, 0.24-1.51; P = .27) with homocysteine-lowering therapy. These findings remained unchanged after adjustment for potential confounders. Conclusion Homocysteine-lowering therapy with folic acid, vitamin B-12, and vitamin B-6 significantly decreases the incidence of major adverse events after percutaneous coronary intervention.	Univ Calif San Diego, Med Ctr, Div Cardiol, San Diego, CA 92103 USA; Univ Hosp Bern, Swiss Cardiovasc Ctr Bern, Div Cardiol, CH-3010 Bern, Switzerland; Cleveland Clin Fdn, Dept Cardiovasc Med F25, Cleveland, OH 44195 USA	University of California System; University of California San Diego; University of Bern; University Hospital of Bern; Cleveland Clinic Foundation	Schnyder, G (corresponding author), Univ Calif San Diego, Med Ctr, Div Cardiol, 200 W Arbor Dr, San Diego, CA 92103 USA.	g.schnyder@lycos.com						BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Brattstrom L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894; CAMPBELL MJ, 1995, BRIT MED J, V311, P1145, DOI 10.1136/bmj.311.7013.1145; Cannon RO, 2002, NEW ENGL J MED, V346, P1182, DOI 10.1056/NEJM200204183461602; Chao CL, 1999, ATHEROSCLEROSIS, V147, P379, DOI 10.1016/S0021-9150(99)00208-7; CUSHING SD, 1990, P NATL ACAD SCI USA, V87, P5134, DOI 10.1073/pnas.87.13.5134; Doshi SN, 2001, ARTERIOSCL THROM VAS, V21, P1196, DOI 10.1161/hq0701.092000; ELLIS SG, 1990, CIRCULATION, V82, P1193, DOI 10.1161/01.CIR.82.4.1193; ELLIS SG, 1991, CIRCULATION, V83, P1905, DOI 10.1161/01.CIR.83.6.1905; Hackam DG, 2000, AM J HYPERTENS, V13, P105, DOI 10.1016/S0895-7061(99)00180-6; Hajjar KA, 1998, J BIOL CHEM, V273, P9987, DOI 10.1074/jbc.273.16.9987; HIRSHFELD JW, 1991, J AM COLL CARDIOL, V18, P647, DOI 10.1016/0735-1097(91)90783-6; Khajurla A, 2000, BLOOD, V96, P966, DOI 10.1182/blood.V96.3.966.015k12_966_972; KRISHNAMURTHI S, 1985, THROMB HAEMOSTASIS, V53, P337; KU G, 1988, AM J CARDIOL, V62, pB77, DOI 10.1016/S0002-9149(88)80057-2; Majors A, 1997, ARTERIOSCL THROM VAS, V17, P2074, DOI 10.1161/01.ATV.17.10.2074; Mangoni AA, 2002, AM J MED, V112, P556, DOI 10.1016/S0002-9343(02)01021-5; Morita H, 2000, THROMB HAEMOSTASIS, V84, P27; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; PASSAMANI E, 1985, NEW ENGL J MED, V312, P932; Poddar R, 2001, CIRCULATION, V103, P2717; Robinson K, 1998, CIRCULATION, V97, P437; RODGERS GM, 1986, J CLIN INVEST, V77, P1909, DOI 10.1172/JCI112519; RODGERS GM, 1990, BLOOD, V75, P895; Schnyder G, 2002, EUR HEART J, V23, P726, DOI 10.1053/euhj.2001.2962; Schnyder G, 2001, NEW ENGL J MED, V345, P1593, DOI 10.1056/NEJMoa011364; Schynder G, 2001, AM J CARDIOL, V88, P1027, DOI 10.1016/S0002-9149(01)01983-X; Seshadri N, 2000, MED CLIN N AM, V84, P215, DOI 10.1016/S0025-7125(05)70215-7; STARKEBAUM G, 1986, J CLIN INVEST, V77, P1370, DOI 10.1172/JCI112442; STIKORAHM A, 1992, ARTERIOSCLER THROMB, V12, P1099, DOI 10.1161/01.ATV.12.9.1099; Stubbs PJ, 2000, CIRCULATION, V102, P605, DOI 10.1161/01.CIR.102.6.605; Stuhlinger MC, 2001, CIRCULATION, V104, P2569, DOI 10.1161/hc4601.098514; Tang LL, 1998, ATHEROSCLEROSIS, V136, P169, DOI 10.1016/S0021-9150(97)00208-6; Tawakol A, 1997, CIRCULATION, V95, P1119; TAWAKOL A, 2000, CIRCULATION, V101, pE116; Title LM, 2000, J AM COLL CARDIOL, V36, P758, DOI 10.1016/S0735-1097(00)00809-3; TSAI JC, 1994, P NATL ACAD SCI USA, V91, P6369, DOI 10.1073/pnas.91.14.6369; UBBINK JB, 1991, J CHROMATOGR-BIOMED, V565, P441, DOI 10.1016/0378-4347(91)80407-4; Upchurch GR, 1997, J BIOL CHEM, V272, P17012, DOI 10.1074/jbc.272.27.17012; Verhaar MC, 1998, CIRCULATION, V97, P237, DOI 10.1161/01.CIR.97.3.237; Vermeulen EGJ, 2000, LANCET, V355, P517, DOI 10.1016/S0140-6736(99)07391-2; Voutilainen S, 1999, ARTERIOSCL THROM VAS, V19, P1263, DOI 10.1161/01.ATV.19.5.1263; Wang XL, 1999, ATHEROSCLEROSIS, V146, P133, DOI 10.1016/S0021-9150(99)00111-2; Woo KS, 1997, CIRCULATION, V96, P2542, DOI 10.1161/01.CIR.96.8.2542; Woo KS, 1999, J AM COLL CARDIOL, V34, P2002, DOI 10.1016/S0735-1097(99)00469-6	45	289	308	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2002	288	8					973	979		10.1001/jama.288.8.973	http://dx.doi.org/10.1001/jama.288.8.973			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587RM	12190367	Bronze			2022-12-28	WOS:000177656400022
J	Levin, V; Shapiro, N; Park, J; Ritzwoller, M				Levin, V; Shapiro, N; Park, J; Ritzwoller, M			Seismic evidence for catastrophic slab loss beneath Kamchatka	NATURE			English	Article							KLYUCHEVSKOY VOLCANO; LITHOSPHERE; SUBDUCTION; MANTLE; DEFORMATION; CONSTRAINTS; TOMOGRAPHY; DETACHMENT; MAGMATISM; PACIFIC	In the northwest Pacific Ocean, a sharp corner in the boundary between the Pacific plate and the North American plate joins a subduction zone running along the southern half of the Kamchatka peninsula(1) with a region of transcurrent motion along the western Aleutian arc(1,2). Here we present images of the seismic structure beneath the Aleutian-Kamchatka junction and the surrounding region, indicating that: the subducting Pacific lithosphere terminates at the Aleutian-Kamchatka junction; no relict slab underlies the extinct northern Kamchatka volcanic arc; and the upper mantle beneath northern Kamchatka has unusually slow shear wavespeeds. From the tectonic and volcanic evolution of Kamchatka over the past 10 Myr (refs 3-5) we infer that at least two episodes of catastrophic slab loss have occurred. About 5 to 10 Myr ago, catastrophic slab loss shut down island-arc volcanic activity north of the Aleutian-Kamchatka junction. A later episode of slab loss, since about 2 Myr ago, seems to be related to the activity of the world's most productive island-arc volcano, Klyuchevskoy(6). Removal of lithospheric mantle is commonly discussed in the context of a continental collision, but our findings imply that episodes of slab detachment and loss are also important agents in the evolution of oceanic convergent margins.	Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; Univ Colorado, Dept Phys, Boulder, CO 80309 USA	Yale University; University of Colorado System; University of Colorado Boulder	Levin, V (corresponding author), Yale Univ, Dept Geol & Geophys, Box 208109, New Haven, CT 06520 USA.	vadim.levin@yale.edu	Shapiro, Nikolai M/G-1049-2010	Shapiro, Nikolai M/0000-0002-0144-723X				BOYD TM, 1991, J GEOPHYS RES-SOLID, V96, P2267, DOI 10.1029/90JB01919; Braitseva OA, 1995, B VOLCANOL, V57, P383, DOI 10.1007/s004450050100; DAVIES JH, 1995, EARTH PLANET SC LETT, V129, P85, DOI 10.1016/0012-821X(94)00237-S; Ekstrom G, 1997, J GEOPHYS RES-SOL EA, V102, P8137, DOI 10.1029/96JB03729; Erlich E. N., 1979, B VOLCANOL, V42, P1; FEDOROV PI, 1998, GEOTECTONICS, V32, P122; GEIST EL, 1992, J GEOPHYS RES-SOL EA, V97, P4953, DOI 10.1029/91JB02992; Gorbatov A, 2000, GEOPHYS J INT, V142, P27, DOI 10.1046/j.1365-246x.2000.00122.x; Gorbatov A, 1997, J GEOPHYS RES-SOL EA, V102, P17883, DOI 10.1029/96JB03491; HONTHAAS C, 1995, CR ACAD SCI II, V320, P197; Kepezhinskas P, 1996, GEOCHIM COSMOCHIM AC, V60, P1217, DOI 10.1016/0016-7037(96)00001-4; Kepezhinskas P, 1997, GEOCHIM COSMOCHIM AC, V61, P577, DOI 10.1016/S0016-7037(96)00349-3; KERSTING AB, 1994, J PETROL, V35, P1; Kosarev G, 1999, SCIENCE, V283, P1306, DOI 10.1126/science.283.5406.1306; Lallemand S, 2001, TECTONOPHYSICS, V335, P229, DOI 10.1016/S0040-1951(01)00071-3; LEVIN V, IN PRESS TECTONOPHYS; Ozerov AY, 2000, J VOLCANOL GEOTH RES, V95, P65, DOI 10.1016/S0377-0273(99)00118-3; Park J., 2002, GEODYNAMICS, P295; Peyton V, 2001, GEOPHYS RES LETT, V28, P379, DOI 10.1029/2000GL012200; Ritzwoller MH, 1998, J GEOPHYS RES-SOL EA, V103, P4839, DOI 10.1029/97JB02622; RITZWOLLER MH, IN PRESS J GEOPHYS R; Seber D, 1996, NATURE, V379, P785, DOI 10.1038/379785a0; SHAPIRO NM, IN PRESS GEOPHYS J I; TRAMPERT J, 1995, GEOPHYS J INT, V122, P675, DOI 10.1111/j.1365-246X.1995.tb07019.x; Turner S, 1998, CONTRIB MINERAL PETR, V133, P217, DOI 10.1007/s004100050449; VANDERHILST R, 1991, NATURE, V353, P37, DOI 10.1038/353037a0; VOLYNETS ON, 1994, INT GEOL REV, V36, P373; Wortel MJR, 2000, SCIENCE, V290, P1910, DOI 10.1126/science.290.5498.1910; Yogodzinski GM, 2001, NATURE, V409, P500, DOI 10.1038/35054039; ZONENSHAIN LP, 1990, AGU GEODYNAMICS SERI, V21	30	145	158	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2002	418	6899					763	767		10.1038/nature00973	http://dx.doi.org/10.1038/nature00973			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181563				2022-12-28	WOS:000177428000035
J	Shao, ZZ; Vollrath, F				Shao, ZZ; Vollrath, F			Materials: Surprising strength of silkworm silk	NATURE			English	Article									Fudan Univ, Dept Macromol Sci, Shanghai 200433, Peoples R China; Fudan Univ, Key Lab Polymer Engn Educ Minist, Shanghai 200433, Peoples R China; Univ Oxford, Dept Zool, Oxford OX1 PX3, England	Fudan University; Fudan University; University of Oxford	Shao, ZZ (corresponding author), Fudan Univ, Dept Macromol Sci, Shanghai 200433, Peoples R China.			Vollrath, Fritz/0000-0003-3484-9005				Kaplan D.L., 1994, SILK POLYM MAT SCI B; Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780; Miura Mikihiko, 1998, Journal of Sericultural Science of Japan, V67, P51; Monti P, 1998, J RAMAN SPECTROSC, V29, P297, DOI 10.1002/(SICI)1097-4555(199804)29:4<297::AID-JRS240>3.0.CO;2-G; Perez-Rigueiro J, 2000, POLYMER, V41, P8433, DOI 10.1016/S0032-3861(00)00179-8; Perez-Rigueiro J, 2001, J APPL POLYM SCI, V82, P1928, DOI 10.1002/app.2038; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; VOLLRATH F, 2001, Z P R SOC LOND B, V268, P2339; Wiedbrauck J., 1955, Zeitschrift fuer Tierpsychologie Berlin, V12, P176; Wilding M.A., 1996, POLYM MAT ENCY, V11, P8307	10	725	769	31	548	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 15	2002	418	6899					741	741		10.1038/418741a	http://dx.doi.org/10.1038/418741a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181556				2022-12-28	WOS:000177428000028
J	Bernath, PF				Bernath, PF			Laser chemistry - Water vapor gets excited	SCIENCE			English	Editorial Material							DIPOLE-MOMENT; ABSORPTION; H2O		Univ Waterloo, Dept Chem, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Bernath, PF (corresponding author), Univ Waterloo, Dept Chem, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada.		Bernath, Peter F/B-6567-2012	Bernath, Peter F/0000-0002-1255-396X				Allard F, 2000, ASTROPHYS J, V540, P1005, DOI 10.1086/309366; Bernath PF, 2002, PHYS CHEM CHEM PHYS, V4, P1501, DOI 10.1039/b200372d; Callegari A, 2002, SCIENCE, V297, P993, DOI 10.1126/science.1073731; Carleer M, 1999, J CHEM PHYS, V111, P2444, DOI 10.1063/1.479859; Partridge H, 1997, J CHEM PHYS, V106, P4618, DOI 10.1063/1.473987; Polyansky OL, 1997, SCIENCE, V277, P346, DOI 10.1126/science.277.5324.346; Pyykko P, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.024502; Ramanathan V, 1997, AMBIO, V26, P38; Schwenke DW, 2000, J CHEM PHYS, V113, P6592, DOI 10.1063/1.1311392; SHOSTAK SL, 1991, J CHEM PHYS, V94, P5875, DOI 10.1063/1.460471; WATTSON RB, 1992, J QUANT SPECTROSC RA, V48, P763, DOI 10.1016/0022-4073(92)90140-Y; WAYNE RP, 2000, CHEM ATMOSPHERES, P50; Zhong WY, 2001, Q J ROY METEOR SOC, V127, P1615, DOI 10.1002/qj.49712757508	13	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2002	297	5583					943	+		10.1126/science.1075934	http://dx.doi.org/10.1126/science.1075934			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169714				2022-12-28	WOS:000177325400023
J	Williamson, R; Duncan, R				Williamson, R; Duncan, R			DNA testing for all - There are two fair possibilities for forensic DNA testing: everyone or no one.	NATURE			English	Editorial Material									Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Williamson, R (corresponding author), Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.			Duncan, Rony/0000-0002-1602-7174				*AUSTR LAW REF COM, 2001, PROT HUM GEN INF ISS; CONCAR D, 2001, NEW SCI         0505, P10; Kimmelman J, 2000, NAT BIOTECHNOL, V18, P695, DOI 10.1038/77173; Nowlan W, 2002, SCIENCE, V297, P195, DOI 10.1126/science.1070987; Reilly P, 2001, NAT REV GENET, V2, P313, DOI 10.1038/35066091; Rothenberg KH, 2002, SCIENCE, V297, P196, DOI 10.1126/science.1075221	6	18	19	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2002	418	6898					585	586		10.1038/418585a	http://dx.doi.org/10.1038/418585a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167832				2022-12-28	WOS:000177305600016
J	Kochel, TJ; Watts, DM; Halstead, SB; Hayes, CG; Espinoza, A; Felices, V; Caceda, R; Bautista, CT; Montoya, Y; Douglas, S; Russe, KL				Kochel, TJ; Watts, DM; Halstead, SB; Hayes, CG; Espinoza, A; Felices, V; Caceda, R; Bautista, CT; Montoya, Y; Douglas, S; Russe, KL			Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever	LANCET			English	Article							VIRUSES	In Iquitos, Peru, no cases of dengue haemorrhagic fever have been recorded in individuals infected with dengue-1 virus followed by American genotype dengue-2 (American dengue-2) virus. We assayed serum samples collected in Iquitos that tested positive for antibodies of monotype dengue-1 and monotype dengue-2 using a plaque reduction neutralisation test to determine their ability to neutralise the infectivity of two dengue-1 viruses, two American dengue-2 viruses, and two Asian dengue-2 viruses. Sera positive for the dengue-1 antibody neutralised dengue-1 viruses and American dengue-2 viruses much more effectively than Asian dengue-2 viruses. Neutralisation of American dengue-2 virus by sera positive for dengue-1 antibodies may account for the absence of dengue haemorrhagic fever in individuals infected with dengue-1 in 1990-91 followed by American dengue-2 virus in 1995 in Iquitos, Peru.	Naval Med Res Ctr Detachment, Dept Virol, Lima, Peru; Naval Med Res Ctr, Silver Spring, MD USA; Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; Peruvian Natl Inst Hlth, Lima, Peru	Naval Medical Research Center (NMRC); Uniformed Services University of the Health Sciences - USA; Instituto Nacional de Salud - Peru	Kochel, TJ (corresponding author), Amer Embassy Peru, NMRCD, Unit 3800, APO, AA 34031 USA.		Felices, Vidal/AAL-1717-2020; Bautista, Christian/B-2812-2011	Felices, Vidal/0000-0001-5336-7293; Bautista, Christian/0000-0002-1228-0754				LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999; MORENS DM, 1985, J CLIN MICROBIOL, V22, P250, DOI 10.1128/JCM.22.2.250-254.1985; VORNDAM V, 1994, J VIROL METHODS, V48, P237, DOI 10.1016/0166-0934(94)90122-8; Watts DM, 1999, LANCET, V354, P1431, DOI 10.1016/S0140-6736(99)04015-5	5	118	128	1	17	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 27	2002	360	9329					310	312		10.1016/S0140-6736(02)09522-3	http://dx.doi.org/10.1016/S0140-6736(02)09522-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578DT	12147378				2022-12-28	WOS:000177102700016
J	McDowell, N				McDowell, N			Lords blast red tape in animal experiments	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2002	418	6896					358	358		10.1038/418358a	http://dx.doi.org/10.1038/418358a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12140524	Bronze			2022-12-28	WOS:000177009700007
J	Rosenfeld, D; Lahav, R; Khain, A; Pinsky, M				Rosenfeld, D; Lahav, R; Khain, A; Pinsky, M			The role of sea spray in cleansing air pollution over ocean via cloud processes	SCIENCE			English	Article							CONDENSATION NUCLEI; CONVECTIVE CLOUDS; AEROSOL; PRECIPITATION; RAIN; MICROPHYSICS; ATMOSPHERE; SULFATE	Particulate air pollution has been shown to strongly suppress precipitation from convective clouds over land. New observations show that precipitation from similar polluted clouds over oceans is much less affected, because large sea salt nuclei override the precipitation suppression effect of the large number of small pollution nuclei. Raindrops initiated by the sea salt grow by collecting small cloud droplets that form on the pollution particles, thereby cleansing the air. Therefore, sea salt helps cleanse the atmosphere of the air pollution via cloud processes. This implies that over oceans, the climatic aerosol indirect effects are significantly smaller than current estimates.	Hebrew Univ Jerusalem, Inst Earth Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Rosenfeld, D (corresponding author), Hebrew Univ Jerusalem, Inst Earth Sci, IL-91904 Jerusalem, Israel.		Rosenfeld, Daniel/F-6077-2016; Rosenfeld, Daniel/AAJ-4617-2021	Rosenfeld, Daniel/0000-0002-0784-7656; Rosenfeld, Daniel/0000-0002-0784-7656				ACKERMAN AS, 1993, SCIENCE, V262, P226, DOI 10.1126/science.262.5131.226; ALBRECHT BA, 1989, SCIENCE, V245, P1227, DOI 10.1126/science.245.4923.1227; Breon FM, 2002, SCIENCE, V295, P834, DOI 10.1126/science.1066434; Cooper WA, 1997, J APPL METEOROL, V36, P1449, DOI 10.1175/1520-0450(1997)036<1449:CPTHSW>2.0.CO;2; Feingold G, 1999, J ATMOS SCI, V56, P4100, DOI 10.1175/1520-0469(1999)056<4100:TIOGCC>2.0.CO;2; Hegg DA, 1998, J GEOPHYS RES-ATMOS, V103, P5671, DOI 10.1029/97JD03652; Heymsfield AJ, 2001, J GEOPHYS RES-ATMOS, V106, P28653, DOI 10.1029/2000JD900776; Khain A, 2000, ATMOS RES, V55, P159, DOI 10.1016/S0169-8095(00)00064-8; Khain AP, 2001, GEOPHYS RES LETT, V28, P3887, DOI 10.1029/2000GL012662; Lelieveld J, 2001, SCIENCE, V291, P1031, DOI 10.1126/science.1057103; Levin Z, 1996, J APPL METEOROL, V35, P1511, DOI 10.1175/1520-0450(1996)035<1511:TEODPC>2.0.CO;2; LUCAS C, 1994, J ATMOS SCI, V51, P3183, DOI 10.1175/1520-0469(1994)051<3183:VVIOCO>2.0.CO;2; O'Dowd CD, 1999, Q J ROY METEOR SOC, V125, P1295, DOI 10.1256/smsqj.55609; Ramanathan V, 2001, SCIENCE, V294, P2119, DOI 10.1126/science.1064034; Rosenfeld D, 1999, GEOPHYS RES LETT, V26, P3105, DOI 10.1029/1999GL006066; Rosenfeld D, 1998, B AM METEOROL SOC, V79, P2457, DOI 10.1175/1520-0477(1998)079<2457:SBIIPF>2.0.CO;2; Rosenfeld D, 2000, SCIENCE, V287, P1793, DOI 10.1126/science.287.5459.1793; Rosenfeld D, 2001, P NATL ACAD SCI USA, V98, P5975, DOI 10.1073/pnas.101122798; ROSENFELD D, IN PRESS METEOROL MO; Rosenfeld D, 1994, ATMOS RES, V34, P259, DOI 10.1016/0169-8095(94)90096-5; RUDICH Y, IN PRESS NATURE; Satheesh SK, 2000, NATURE, V405, P60, DOI 10.1038/35011039; Sugimoto N, 2000, J MAR METEOROL SOC, V76, P93; TWOMEY S, 1977, J ATMOS SCI, V34, P1149, DOI 10.1175/1520-0469(1977)034<1149:TIOPOT>2.0.CO;2; WOODCOCK AH, 1953, J METEOROL, V10, P362, DOI 10.1175/1520-0469(1953)010<0366:SNIMAA>2.0.CO;2; Yin Y, 2000, ATMOS RES, V53, P91, DOI 10.1016/S0169-8095(99)00046-0; ZIPSER EJ, 1980, J ATMOS SCI, V37, P2458, DOI 10.1175/1520-0469(1980)037<2458:CVVEIG>2.0.CO;2	27	152	166	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2002	297	5587					1667	1670		10.1126/science.1073869	http://dx.doi.org/10.1126/science.1073869			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590JE	12183635				2022-12-28	WOS:000177819100039
J	Bernards, R; Weinberg, RA				Bernards, R; Weinberg, RA			Metastasis genes: A progression puzzle	NATURE			English	Editorial Material									Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, Amsterdam, Netherlands; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Netherlands Cancer Institute; Netherlands Cancer Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Bernards, R (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Plesmanlaan 121, Amsterdam, Netherlands.			Bernards, Rene/0000-0001-8677-3423				Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; POZZATTI R, 1986, SCIENCE, V232, P223, DOI 10.1126/science.3456644; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Yokota J, 2000, CARCINOGENESIS, V21, P497, DOI 10.1093/carcin/21.3.497	4	651	682	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2002	418	6900					823	823		10.1038/418823a	http://dx.doi.org/10.1038/418823a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192390	Green Submitted, Bronze			2022-12-28	WOS:000177555600018
J	Shi, JY; Krishnamoorthy, G; Yang, YW; Hu, L; Chaturvedi, N; Harilal, D; Qin, J; Cui, JM				Shi, JY; Krishnamoorthy, G; Yang, YW; Hu, L; Chaturvedi, N; Harilal, D; Qin, J; Cui, JM			Mechanism of magnesium activation of calcium-activated potassium channels	NATURE			English	Article							CA2+-ACTIVATED K+ CHANNELS; BK CHANNEL; CA2+-DEPENDENT ACTIVATION; PROTEINS; VOLTAGE; DOMAIN; CONDUCTANCE; SENSITIVITY; SUBUNIT; MSLO	Large-conductance (BK type) Ca2+-dependent K+ channels are essential for modulating muscle contraction and neuronal activities such as synaptic transmission and hearing(1-5). BK channels are activated by membrane depolarization and intracellular Ca2+ and Mg2+ (refs 6-10). The energy provided by voltage, Ca2+ and Mg2+ binding are additive in activating the channel, suggesting that these signals open the activation gate through independent pathways(9,11). Here we report a molecular investigation of a Mg2+ dependent activation mechanism. Using a combined site-directed mutagenesis and structural analysis, we demonstrate that a structurally new Mg2+-binding site in the RCK/Rossman fold domain-an intracellular structural motif that immediately follows the activation gate S6 helix(12-15)-is responsible for Mg2+ dependent activation. Mutations that impair or abolish Mg2+ sensitivity do not affect Ca2+ sensitivity, and vice versa. These results indicate distinct structural pathways for Mg2+ - and Ca2+ dependent activation and suggest a possible mechanism for the coupling between Mg2+ binding and channel opening.	Case Western Reserve Univ, Cardiac Bioelect Res & Training Ctr, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; Cleveland Clin Fdn, Lerner Res Inst, Struct Biol Program, Cleveland, OH 44195 USA	Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation	Cui, JM (corresponding author), Case Western Reserve Univ, Cardiac Bioelect Res & Training Ctr, Cleveland, OH 44106 USA.		Hu, Lei/B-1455-2009	Natarajan, Gayathri/0000-0001-7654-5013; Qin, Jun/0000-0002-2647-9270; Krishnamoorthy, Gayathri/0000-0002-2208-3244	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070393] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL070393] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; Bian S, 2001, P NATL ACAD SCI USA, V98, P4776, DOI 10.1073/pnas.081072398; BRANDEN CI, 1980, Q REV BIOPHYS, V13, P317, DOI 10.1017/S0033583500001712; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; Cui JM, 2000, BIOCHEMISTRY-US, V39, P15612, DOI 10.1021/bi001509+; Fettiplace R, 1999, ANNU REV PHYSIOL, V61, P809, DOI 10.1146/annurev.physiol.61.1.809; FLATMAN PW, 1991, ANNU REV PHYSIOL, V53, P259, DOI 10.1146/annurev.ph.53.030191.001355; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; Isaacson JS, 2001, NEURON, V31, P1027, DOI 10.1016/S0896-6273(01)00428-7; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Johnson JP, 2001, NATURE, V412, P917, DOI 10.1038/35091089; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; MILKMAN R, 1994, P NATL ACAD SCI USA, V91, P3510, DOI 10.1073/pnas.91.9.3510; NEEDHAM JV, 1993, BIOCHEMISTRY-US, V32, P3363, DOI 10.1021/bi00064a020; PALLOTTA BS, 1981, NATURE, V293, P471, DOI 10.1038/293471a0; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; Rosenblatt KP, 1997, NEURON, V19, P1061, DOI 10.1016/S0896-6273(00)80397-9; Schreiber M, 1999, NAT NEUROSCI, V2, P416, DOI 10.1038/8077; Schreiber M, 1998, J BIOL CHEM, V273, P3509, DOI 10.1074/jbc.273.6.3509; Shi JY, 2001, J GEN PHYSIOL, V118, P589, DOI 10.1085/jgp.118.5.589; STOCK JB, 1992, J BIOL CHEM, V267, P19753; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Zhang X, 2001, J GEN PHYSIOL, V118, P607, DOI 10.1085/jgp.118.5.607	29	168	175	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2002	418	6900					876	880		10.1038/nature00941	http://dx.doi.org/10.1038/nature00941			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192410				2022-12-28	WOS:000177555600038
J	Ryan, ET; Wilson, ME; Kain, KC				Ryan, ET; Wilson, ME; Kain, KC			Current concepts - Illness after international travel	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CLINICAL PRESENTATION; NONENDEMIC POPULATIONS; PERSISTENT DIARRHEA; IMPORTED MALARIA; HEALTH-PROBLEMS; UNITED-STATES; FEVER; RISK; DIAGNOSIS; LEPTOSPIROSIS		Massachusetts Gen Hosp, Trop & Geog Med Ctr, Div Infect Dis, Boston, MA 02114 USA; Massachusetts Gen Hosp, Travelers Advice & Immunizat Ctr, Div Infect Dis, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Mt Auburn Hosp, Travel Resource Ctr, Div Infect Dis, Cambridge, MA 02238 USA; Univ Toronto, Toronto Gen Hosp, Div Infect Dis, Ctr Travel & Trop Med, Toronto, ON M5G 1L7, Canada	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Mount Auburn Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Ryan, ET (corresponding author), Massachusetts Gen Hosp, Trop & Geog Med Ctr, Div Infect Dis, Jackson 504,55 Fruit St, Boston, MA 02114 USA.	etryan@partners.org		Kain, Kevin/0000-0001-6068-1272	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD039165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040725] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI040725, AI-40725] Funding Source: Medline; NICHD NIH HHS [U01 HD039165, HD-39165] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AFZALPURKAR RG, 1992, NEW ENGL J MED, V327, P1849, DOI 10.1056/NEJM199212243272605; Basgoz N, 1998, NEW ENGL J MED, V339, P105, DOI 10.1056/NEJM199807093390208; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bloor M, 1998, LANCET, V352, P1664, DOI 10.1016/S0140-6736(98)09414-8; Castelli F, 2001, J TRAVEL MED, V8, pS26, DOI 10.1111/j.1708-8305.2001.tb00543.x; CAUMES E, 1995, CLIN INFECT DIS, V20, P542, DOI 10.1093/clinids/20.3.542; Caumes E, 2001, J TRAVEL MED, V8, P293, DOI 10.2310/7060.2001.22378; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P281; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P21; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P475; Cobelens FGJ, 2000, LANCET, V356, P461, DOI 10.1016/S0140-6736(00)02554-X; DOHERTY JF, 1995, QJM-INT J MED, V88, P277; Doherty JF, 1996, BRIT MED J, V313, P1071, DOI 10.1136/bmj.313.7064.1071; DONOWITZ M, 1995, NEW ENGL J MED, V332, P725, DOI 10.1056/NEJM199503163321107; Dorsey G, 2000, ARCH INTERN MED, V160, P2505, DOI 10.1001/archinte.160.16.2505; DuPont HL, 1996, CLIN INFECT DIS, V22, P124, DOI 10.1093/clinids/22.1.124; Ericsson CD, 1998, INFECT DIS CLIN N AM, V12, P285, DOI 10.1016/S0891-5520(05)70006-4; FREUDENTHAL AR, 1993, NEW ENGL J MED, V329, P542, DOI 10.1056/NEJM199308193290805; Habib N A, 2000, Curr Opin Pulm Med, V6, P246, DOI 10.1097/00063198-200005000-00014; HARRIES AD, 1986, T ROY SOC TROP MED H, V80, P327, DOI 10.1016/0035-9203(86)90049-0; HERWALDT BL, 1993, ANN INTERN MED, V118, P779, DOI 10.7326/0003-4819-118-10-199305150-00004; HERWALDT BL, 1993, ANN INTERN MED, V119, P173, DOI 10.7326/0003-4819-119-2-199307150-00031; Hill DR, 2000, J TRAVEL MED, V7, P259, DOI 10.2310/7060.2000.00075; Holtz T H, 2001, MMWR CDC Surveill Summ, V50, P1; Isaacson M, 2001, CLIN INFECT DIS, V33, P1707, DOI 10.1086/322620; Jelinek T, 2002, EMERG INFECT DIS, V8, P634, DOI 10.3201/eid0806.010432; Jelinek T, 2000, CLIN INFECT DIS, V31, P144, DOI 10.1086/313889; Kain KC, 1998, CLIN INFECT DIS, V27, P142, DOI 10.1086/514616; Kain KC, 1999, MED CLIN N AM, V83, P1077; Katz AR, 2001, CLIN INFECT DIS, V33, P1834, DOI 10.1086/324084; KLION AD, 1991, J INFECT DIS, V163, P1318, DOI 10.1093/infdis/163.6.1318; LIBMAN MD, 1993, CLIN INFECT DIS, V17, P353, DOI 10.1093/clinids/17.3.353; MACLEAN JD, 1994, TRAVEL MED ADVISOR, V5; Matteelli A, 2001, CLIN INFECT DIS, V32, P1063, DOI 10.1086/319607; MCCARTHY JS, 1994, J INFECT DIS, V170, P736, DOI 10.1093/infdis/170.3.736; Memish ZA, 2002, CLIN INFECT DIS, V34, P84, DOI 10.1086/323403; Mermin JH, 1998, ARCH INTERN MED, V158, P633, DOI 10.1001/archinte.158.6.633; Moore AC, 2002, NEW ENGL J MED, V346, P2069, DOI 10.1056/NEJMcpc010056; Newman Robert D, 2002, MMWR Surveill Summ, V51, P15; Okhuysen PC, 2001, CLIN INFECT DIS, V33, P110, DOI 10.1086/320894; Raoult D, 2001, NEW ENGL J MED, V344, P1504, DOI 10.1056/NEJM200105173442003; REES JH, 1995, NEW ENGL J MED, V333, P1374, DOI 10.1056/NEJM199511233332102; Ryan ET, 2000, NEW ENGL J MED, V342, P1716, DOI 10.1056/NEJM200006083422306; Schulte C, 2002, CLIN INFECT DIS, V34, P407, DOI 10.1086/338026; SENAY H, 1989, CAN MED ASSOC J, V140, P1329; Slom TJ, 2002, NEW ENGL J MED, V346, P668, DOI 10.1056/NEJMoa012462; STEFFEN R, 1987, J INFECT DIS, V156, P84, DOI 10.1093/infdis/156.1.84; STRICKER M, 1990, MUNCHEN MED WOCHEN, V132, P175; SVENSON JE, 1995, ARCH INTERN MED, V155, P861, DOI 10.1001/archinte.155.8.861; Thielman NM, 1998, INFECT DIS CLIN N AM, V12, P489, DOI 10.1016/S0891-5520(05)70015-5; VANCREVEL R, 1994, CLIN INFECT DIS, V19, P132, DOI 10.1093/clinids/19.1.132; von Sonnenburg F, 2000, LANCET, V356, P133, DOI 10.1016/S0140-6736(00)02451-X; Wilson ME, 1998, INFECT DIS CLIN N AM, V12, P471, DOI 10.1016/S0891-5520(05)70014-3; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601; 2000, MMWR MORB MORTAL WKL, V49, P1004; 2002, MMWR MORB MORTAL WKL, V51, P324; 2002, HDB ANTIMICROBIAL TH, P120; 2001, MMWR MORB MORTAL WKL, V50, P261; 2000, MMWR MORB MORTAL WKL, V49, P303; 2002, WKLY EPIDEMIOL REC, V77, P41	60	180	184	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 15	2002	347	7					505	516		10.1056/NEJMra020118	http://dx.doi.org/10.1056/NEJMra020118			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587ZM	12181406				2022-12-28	WOS:000177674400008
J	Graat, JM; Schouten, EG; Kok, FJ				Graat, JM; Schouten, EG; Kok, FJ			Effect of daily vitamin E and multivitamin-mineral supplementation on acute respiratory tract infections in elderly persons - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNE-RESPONSE; NUTRITION; COMMUNITY; TOCOPHEROLS; ANTIOXIDANT; LYCOPENE; RETINOL; DISEASE; ILLNESS; PLASMA	Context Immune response in elderly individuals has been reported to improve after micronutrient supplementation. However, efficacy trials evaluating infectious diseases as outcomes are scarce and inconclusive. Objective To investigate the effect of daily multivitamin-mineral and vitamin E supplementation on incidence and severity of acute respiratory tract infections in elderly individuals. Design A randomized, double blind, placebo-controlled, 2 X 2 factorial trial. Setting and Participants A total of 652 noninstitutionalized individuals aged 60 years or older enrolled from 2 community-based sampling strategies in the Wageningen area of the Netherlands, conducted from 1998 to 2000. At baseline, 6% of participants had suboptimal ascorbic acid and 1.3% had suboptimal alpha-tocopherol plasma concentration. Intervention Physiological doses of multivitamin-minerals, 200 mg of vitamin E, both, or placebo. Main Outcome Measures Incidence and severity of self-reported acute respiratory tract infections at 15 months, as assessed by a nurse (telephone contact), home visits, and microbiological and serological testing in subsets of patients. Results During a median observation period of 441 days, 443 (68%) of 652 participants recorded 1024 respiratory tract infection episodes. The incidence rate ratio of acute respiratory tract infection for multivitamin-mineral supplementation was 0.95 (95% confidence interval, 0.75-1.15; P=.58) and for vitamin E supplementation, 1.12 (95% confidence interval, 0.88-1.25; P=.21). Severity of infections was not influenced by multivitamin-mineral supplementation. For vitamin E vs no vitamin E, severity was worse: median (interquartile range) for illness-duration was 19 (9-37) vs 14 (6-29) days, P=.02; number of symptoms, 6 (3-8) vs 4 (3-8), P=.03; presence of fever, 36.7% vs 25.2%, P=.009; and restriction of activity, 52.3% vs 41.1 %, P=.02. Conclusions Neither daily multivitamin-mineral supplementation at physiological dose nor 200 mg of vitamin E showed a favorable effect on incidence and severity of acute respiratory tract infections in well-nourished noninstitutionalized elderly individuals. Instead we observed adverse effects of vitamin E on illness severity.	Univ Wageningen & Res Ctr, Div Human Nutr & Epidemiol, NL-6700 EV Wageningen, Netherlands	Wageningen University & Research	Schouten, EG (corresponding author), Univ Wageningen & Res Ctr, Div Human Nutr & Epidemiol, POB 8129, NL-6700 EV Wageningen, Netherlands.	Evert.Schouten@staff.nutepi.wau.nl						Aebischer CP, 1999, METHOD ENZYMOL, V299, P348; Andeweg AC, 1999, J CLIN MICROBIOL, V37, P524, DOI 10.1128/JCM.37.3.524-530.1999; Azzi A, 2000, PROG LIPID RES, V39, P231, DOI 10.1016/S0163-7827(00)00006-0; BOWRY VW, 1992, BIOCHEM J, V288, P341, DOI 10.1042/bj2880341; CHANDRA RK, 1992, LANCET, V340, P1124, DOI 10.1016/0140-6736(92)93151-C; CHAVANCE M, 1993, INT J VITAM NUTR RES, V63, P11; deGroot CPGM, 1996, EUR J CLIN NUTR, V50, pS32; DeWaart FG, 1997, BRIT J NUTR, V78, P761, DOI 10.1079/BJN19970193; Dorigo-Zetsma JW, 1999, J CLIN MICROBIOL, V37, P14, DOI 10.1128/JCM.37.1.14-17.1999; FALSEY AR, 1995, J AM GERIATR SOC, V43, P30, DOI 10.1111/j.1532-5415.1995.tb06238.x; Girodon F, 1997, ANN NUTR METAB, V41, P98, DOI 10.1159/000177984; Girodon F, 1999, ARCH INTERN MED, V159, P748, DOI 10.1001/archinte.159.7.748; HARMAN D, 1986, AGE, V9, P21, DOI 10.1007/BF02431896; HESS D, 1991, INT J VITAM NUTR RES, V61, P232; Lesourd B, 1999, P NUTR SOC, V58, P685, DOI 10.1017/S0029665199000907; LOWIK MRH, 1992, J AM COLL NUTR, V11, P673; McKenzie J, 2001, CAN J PUBLIC HEALTH, V92, P286, DOI 10.1007/BF03404962; Meydani SN, 1997, JAMA-J AM MED ASSOC, V277, P1380, DOI 10.1001/jama.277.17.1380; Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70; MONTO A S, 1971, American Journal of Epidemiology, V94, P269; MONTO AS, 1993, EPIDEMIOL INFECT, V110, P145, DOI 10.1017/S0950268800050779; MYINT S, 1994, MOL CELL PROBE, V8, P357, DOI 10.1006/mcpr.1994.1052; NICHOLSON KG, 1990, EPIDEMIOL INFECT, V105, P609, DOI 10.1017/S0950268800048251; Nicholson KG, 1997, BRIT MED J, V315, P1060, DOI 10.1136/bmj.315.7115.1060; Pallast EG, 1999, AM J CLIN NUTR, V69, P1273; PAYETTE H, 1990, AM J CLIN NUTR, V52, P927, DOI 10.1093/ajcn/52.5.927; RICHMOND W, 1973, CLIN CHEM, V19, P1350; Serafini M, 2000, INT J DEV NEUROSCI, V18, P401, DOI 10.1016/S0736-5748(00)00016-2; van Haaften RIM, 2001, BIOCHEM BIOPH RES CO, V280, P631, DOI 10.1006/bbrc.2000.4174; Vitolins MZ, 2000, J GERONTOL A-BIOL, V55, pM613, DOI 10.1093/gerona/55.10.M613; VUILLEUMIER JP, 1989, J MICRONUTR ANAL, V5, P25	31	163	169	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2002	288	6					715	721		10.1001/jama.288.6.715	http://dx.doi.org/10.1001/jama.288.6.715			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	583KY	12169075				2022-12-28	WOS:000177408100032
J	Weir, AAS; Chappell, J; Kacelnik, A				Weir, AAS; Chappell, J; Kacelnik, A			Shaping of hooks in new Caledonian crows	SCIENCE			English	Article							CEBUS-APELLA; TOOL-USE; MANUFACTURE		Dept Zool, Oxford OX1 3PS, England		Kacelnik, A (corresponding author), Dept Zool, S Parks Rd, Oxford OX1 3PS, England.		Chappell, Jackie/W-6772-2019; Weir, Alex/B-4664-2008	Chappell, Jackie/0000-0001-7338-9449; 				ANDERSON JR, 1994, MAMMALIA, V58, P351, DOI 10.1515/mamm.1994.58.3.351; Chappell J, 2002, ANIM COGN, V5, P71, DOI 10.1007/s10071-002-0130-2; CHEVALIERSKOLNIKOFF S, 1989, BEHAV BRAIN SCI, V12, P561, DOI 10.1017/S0140525X00057678; Hunt GR, 2000, P ROY SOC B-BIOL SCI, V267, P403, DOI 10.1098/rspb.2000.1015; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; Pepperberg IM., 1999, ALEX STUDIES COGNITI; POVINELLI DJ, 2000, FOLK PHYSICS APES; Tomasello M, 1997, PRIMATE COGNITION; Visalberghi E, 1997, INT J PRIMATOL, V18, P811, DOI 10.1023/A:1026399930727	9	381	394	3	199	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2002	297	5583					981	981		10.1126/science.1073433	http://dx.doi.org/10.1126/science.1073433			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169726				2022-12-28	WOS:000177325400035
J	Gosden, TB; Torgerson, D				Gosden, TB; Torgerson, D			Economics notes - Converting international cost effectiveness data to UK prices	BRITISH MEDICAL JOURNAL			English	Article							HORMONE REPLACEMENT THERAPY; HEALTH-CARE; OSTEOPOROSIS; MENOPAUSE; BENEFITS; RISKS; WOMEN		Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England; Univ York, Ctr Hlth Econ, Natl Primary Care Res & Dev Ctr, York YO1 5DD, N Yorkshire, England	University of Manchester; University of York - UK	Gosden, TB (corresponding author), Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England.		Torgerson, David/L-4566-2019	Torgerson, David/0000-0002-1667-4275				CHEUNG AP, 1992, MED J AUSTRALIA, V156, P312, DOI 10.5694/j.1326-5377.1992.tb139784.x; DALY E, 1992, BRIT MED BULL, V48, P368, DOI 10.1093/oxfordjournals.bmb.a072552; *DEP HLTH EC OP RE, 1994, REG COST EFF STUD; GEELHOED E, 1994, AUST J PUBLIC HEALTH, V18, P153; GERDTHAM UG, 1991, J HEALTH ECON, V10, P227, DOI 10.1016/0167-6296(91)90005-8; Jefferson T, 1996, HEALTH ECON, V5, P155, DOI 10.1002/(SICI)1099-1050(199603)5:2<155::AID-HEC194>3.3.CO;2-F; *NHS MAN EX, 1992, HOSP COMM HLTH SERV; *OECD, 1993, OECD HLTH SYST, V2; *OECD, 1993, OECD HLTH SYST, V1; PARKIN D, 1987, J HEALTH ECON, V6, P109, DOI 10.1016/0167-6296(87)90002-6; Torgerson DJ, 1997, PHARMACOECONOMICS, V11, P126, DOI 10.2165/00019053-199711020-00003; TOSTESON ANA, 1991, BAILLIERE CLIN OB GY, V5, P943, DOI 10.1016/S0950-3552(05)80298-6; TOSTESON ANA, 1990, ANN INTERN MED, V113, P594, DOI 10.7326/0003-4819-113-8-594; WEINSTEIN M, 1990, ANN NY ACAD SCI, V92, P162; Weinstein M C, 1983, Obstet Gynecol Surv, V38, P445, DOI 10.1097/00006254-198308000-00001; WEINSTEIN MC, 1980, NEW ENGL J MED, V303, P308, DOI 10.1056/NEJM198008073030604	16	19	19	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 3	2002	325	7358					275	276		10.1136/bmj.325.7358.275	http://dx.doi.org/10.1136/bmj.325.7358.275			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	582FL	12153929	Green Published			2022-12-28	WOS:000177339000028
J	Dudley, AT; Ros, MA; Tabin, CJ				Dudley, AT; Ros, MA; Tabin, CJ			A re-examination of proximodistal patterning during vertebrate limb development	NATURE			English	Article							APICAL ECTODERMAL RIDGE; CELL-DIVISION; MORPHOGENESIS; GROWTH; BUD; MISEXPRESSION; EXPRESSION; MESODERM; GENES; DEATH	The 'progress zone' model provides a framework for understanding progressive development of the vertebrate limb(1). This model holds that undifferentiated cells in a zone of fixed size at the distal tip of the limb bud (the progress zone) undergo a progressive change in positional information such that their specification is altered from more proximal to more distal fates. This positional change is thought to be driven by an internal clock that is kept active as long as the cells remain in the progress zone. However, owing to cell division, the most proximal of these cells are continually pushed outside the confines of the zone. As they exit, clock function ceases and cells become fixed with the positional value last attained while within the zone. In contrast to this model, our data suggest that the various limb segments are 'specified' early in limb development as distinct domains, with subsequent development involving expansion of these progenitor populations before differentiation. We also find, however, that the distal limb mesenchyme becomes progressively 'determined', that is, irreversibly fixed, to a progressively limited range of potential proximodistal fates.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Cantabria, Fac Med, Dept Anat & Biol Celular, Santander 39011, Spain	Harvard University; Harvard Medical School; Universidad de Cantabria	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, 200 Longwood Ave, Boston, MA 02115 USA.	tabin@rascal.med.harvard.edu	Ros, Maria A./K-8160-2014	Ros, Maria A./0000-0002-1224-7671				Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; CROSBY GM, 1975, DEV BIOL, V46, P28, DOI 10.1016/0012-1606(75)90084-6; FALLON JF, 1994, SCIENCE, V264, P104, DOI 10.1126/science.7908145; FREDERICK JM, 1982, J EMBRYOL EXP MORPH, V67, P13; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GibsonBrown JJ, 1996, MECH DEVELOP, V56, P93, DOI 10.1016/0925-4773(96)00514-X; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hardy A, 1995, DEVELOPMENT, V121, P4329; HORNBRUCH A, 1970, NATURE, V226, P764, DOI 10.1038/226764a0; KIENY M, 1977, ROUX ARCH DEV BIOL, V183, P177, DOI 10.1007/BF00867319; LEWIS JH, 1975, J EMBRYOL EXP MORPH, V33, P419; Logan M, 1998, METHODS, V14, P407, DOI 10.1006/meth.1998.0595; NISWANDER L, 1993, CELL; Piedra ME, 2000, MECH DEVELOP, V90, P167, DOI 10.1016/S0925-4773(99)00247-6; ROS MA, 1994, DEV BIOL, V166, P59, DOI 10.1006/dbio.1994.1296; ROWE DA, 1982, DEV BIOL, V93, P83, DOI 10.1016/0012-1606(82)90241-X; RUBIN L, 1972, DEV BIOL, V28, P94, DOI 10.1016/0012-1606(72)90129-7; SAUNDERS JW, 1948, J EXP ZOOL, V108, P363, DOI 10.1002/jez.1401080304; SUMMERBELL D, 1974, J EMBRYOL EXP MORPH, V32, P651; SUMMERBELL D, 1973, NATURE, V244, P492, DOI 10.1038/244492a0; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Vargesson N, 1997, DEVELOPMENT, V124, P1909; WADA N, 1993, DEV GROWTH DIFFER, V35, P421; WOLPERT L, 1979, J EMBRYOL EXP MORPH, V50, P175; YOKOUCHI Y, 1995, GENE DEV, V9, P2509, DOI 10.1101/gad.9.20.2509	25	218	222	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 1	2002	418	6897					539	544		10.1038/nature00945	http://dx.doi.org/10.1038/nature00945			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152081				2022-12-28	WOS:000177162800042
J	Kenchaiah, S; Evans, JC; Levy, D; Wilson, PWF; Benjamin, EJ; Larson, MG; Kannel, WB; Vasan, RS				Kenchaiah, S; Evans, JC; Levy, D; Wilson, PWF; Benjamin, EJ; Larson, MG; Kannel, WB; Vasan, RS			Obesity and the risk of heart failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEFT-VENTRICULAR MASS; ARTERIAL-HYPERTENSION; GENERAL-POPULATION; WEIGHT-GAIN; FRAMINGHAM; DISEASE; MEN; PROGNOSIS; WOMEN	Background Extreme obesity is recognized to be a risk factor for heart failure. It is unclear whether overweight and lesser degrees of obesity also pose a risk. Methods We investigated the relation between the body-mass index (the weight in kilograms divided by the square of the height in meters) and the incidence of heart failure among 5881 participants in the Framingham Heart Study (mean age, 55 years; 54 percent women). With the use of Cox proportional-hazards models, the body-mass index was evaluated both as a continuous variable and as a categorical variable (normal, 18.5 to 24.9; overweight, 25.0 to 29.9; and obese, 30.0 or more). Results During follow-up (mean, 14 years), heart failure developed in 496 subjects (258 women and 238 men). After adjustment for established risk factors, there was an increase in the risk of heart failure of 5 percent for men and 7 percent for women for each increment of 1 in body-mass index. As compared with subjects with a normal body-mass index, obese subjects had a doubling of the risk of heart failure. For women, the hazard ratio was 2.12 (95 percent confidence interval, 1.51 to 2.97); for men, the hazard ratio was 1.90 (95 percent confidence interval, 1.30 to 2.79). A graded increase in the risk of heart failure was observed across categories of body-mass index. The hazard ratios per increase in category were 1.46 in women (95 percent confidence interval, 1.23 to 1.72) and 1.37 in men (95 percent confidence interval, 1.13 to 1.67). Conclusions In our large, community-based sample, increased body-mass index was associated with an increased risk of heart failure. Given the high prevalence of obesity in the United States, strategies to promote optimal body weight may reduce the population burden of heart failure.	Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; Boston Univ, Sch Med, Sect Prevent Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Cardiol Sect, Boston, MA 02118 USA; Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; NHLBI, Bethesda, MD 20892 USA	Framingham Heart Study; Boston University; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Vasan, RS (corresponding author), Framingham Heart Dis Epidemiol Study, 73 Mt Wayte Ave,Suite 2, Framingham, MA 01702 USA.		Levy, Daniel/ABF-6873-2021; Kenchaiah, Satish/A-1519-2016; Wilson, Peter W.F./J-2455-2016; Ramachandran, Vasan/Y-2527-2019; Levy, Daniel/ABB-2752-2021; Benjamin, Emelia/E-7103-2011	Levy, Daniel/0000-0003-1843-8724; Kenchaiah, Satish/0000-0002-8731-8702; Ramachandran, Vasan/0000-0001-7357-5970; Larson, Martin/0000-0002-9631-1254; Benjamin, Emelia/0000-0003-4076-2336	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004334] Funding Source: NIH RePORTER; NHLBI NIH HHS [1K24 HL04334, N01-HC-25195] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALEXANDER J K, 1962, Cardiovasc Res Cent Bull, V1, P39; ALPERT MA, 1995, AM HEART J, V130, P1068, DOI 10.1016/0002-8703(95)90210-4; Alpert MA, 2001, AM J MED SCI, V321, P225, DOI 10.1097/00000441-200104000-00003; *AM HEART ASS, 2001, 2002 HEART STROK STA; Anker SD, 1999, CURR OPIN CARDIOL, V14, P211, DOI 10.1097/00001573-199905000-00004; [Anonymous], 2000, WHO TECH REP SER, V894, P1; Caruana L, 2000, BRIT MED J, V321, P215, DOI 10.1136/bmj.321.7255.215; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; Chen YT, 1999, AM J MED, V106, P605, DOI 10.1016/S0002-9343(99)00126-6; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; COX DR, 1972, J R STAT SOC B, V34, P187; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Engeli S, 2001, J MOL MED, V79, P21, DOI 10.1007/s001090000144; Gardin JM, 2001, AM J CARDIOL, V87, P1051, DOI 10.1016/S0002-9149(01)01460-6; HAMMOND IW, 1988, J AM COLL CARDIOL, V12, P996, DOI 10.1016/0735-1097(88)90467-6; He J, 2001, ARCH INTERN MED, V161, P996, DOI 10.1001/archinte.161.7.996; Hunt SA, 2001, J AM COLL CARDIOL, V38, P2101, DOI 10.1016/S0735-1097(01)01683-7; Kannel W B, 1979, Diabetes Care, V2, P120, DOI 10.2337/diacare.2.2.120; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; KANNEL WB, 1987, NIH PUBLICATION NAT; Kannell WB, 1999, ARCH INTERN MED, V159, P1197, DOI 10.1001/archinte.159.11.1197; LAUER MS, 1991, JAMA-J AM MED ASSOC, V266, P231, DOI 10.1001/jama.266.2.231; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; MANSON JAE, 1990, NEW ENGL J MED, V322, P882, DOI 10.1056/NEJM199003293221303; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; MESSERLI FH, 1983, ANN INTERN MED, V99, P757, DOI 10.7326/0003-4819-99-6-757; MESSERLI FH, 1983, AM J MED, V74, P808, DOI 10.1016/0002-9343(83)91071-9; Mosterd A, 2001, EUR HEART J, V22, P1318, DOI 10.1053/euhj.2000.2533; *NAT HEART LUNG BL, 1998, NIH PUBL NAT HEART L; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; *SAS I INC, 1997, SAS STAT SOFTW CHANG, P871; Stamler J, 1991, Ann Epidemiol, V1, P347, DOI 10.1016/1047-2797(91)90045-E; Vasan RS, 1997, NEW ENGL J MED, V336, P1350, DOI 10.1056/NEJM199705083361903; Vasan RS, 2000, CIRCULATION, V101, P2118, DOI 10.1161/01.CIR.101.17.2118; Vincent HK, 1999, INT J OBESITY, V23, P67, DOI 10.1038/sj.ijo.0800761; Wilhelmsen L, 2001, J INTERN MED, V249, P253, DOI 10.1046/j.1365-2796.2001.00801.x; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	37	1888	1979	1	55	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2002	347	5					305	313		10.1056/NEJMoa020245	http://dx.doi.org/10.1056/NEJMoa020245			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587WC	12151467				2022-12-28	WOS:000177665900002
J	Selvachandran, SN; Hodder, RJ; Ballal, MS; Jones, P; Cade, D				Selvachandran, SN; Hodder, RJ; Ballal, MS; Jones, P; Cade, D			Prediction of colorectal cancer by a patient consultation questionnaire and scoring system: a prospective study	LANCET			English	Article							DIAGNOSIS; SYMPTOMS; DURATION; DELAY; CARCINOMA	Background Current NHS guidelines for referral of patients with colorectal symptoms classify many as high risk but fail to identify a significant number of cancers in the low-risk group. We describe a practical scoring method to predict colorectal cancers. Methods From October, 1999, 2268 patients with distal colonic symptoms, referred by general practitioners, completed a patient consultation questionnaire linked to a computerised record. Referrals Were prioritised with a malignancy risk score by a senior colorectal surgeon separately from the general practitioner's letter and from the questionnaire. A weighted numerical score was derived from weighting of primary symptoms and symptom complexes and was calculated automatically when the questionnaire data were entered into the computer program. Analysis by receiver-operating characteristics assessed the scoring systems. Sensitivities and specificities of scoring systems were compared with McNemar's test. Findings Of the 2268 patients, 95 had colorectal cancer. The average weighted numerical score was significantly higher for patients with cancer than for non-cancer patients (mean 76.5 [95% CI 72.2-80.9] vs 44.5 [43.6-45.4]; p<0.0001). At similar cancer detection rates, the malignancy risk score derived from the patient consultation questionnaire and the weighted numerical score graded lower proportions of referrals as urgent than did the current NHS guidelines (43.1% and 39.8% vs 49.8%; p<0.0001). Interpretation The patient consultation questionnaire depends on history alone and is easily reproducible. In conjunction with the weighted numerical score, which removes operator bias, it can be used as an accurate system for prediction of symptomatic colorectal cancer.	Leighton Hosp, Mid Cheshire Hosp Trust, Dept Surg, Crewe CW1 4QJ, Cheshire, England; Keele Univ, Dept Math, Keele, Staffs, England	Keele University	Cade, D (corresponding author), Leighton Hosp, Mid Cheshire Hosp Trust, Dept Surg, Middlewich Rd, Crewe CW1 4QJ, Cheshire, England.							COHEN JR, 1983, AUST NZ J SURG, V53, P113, DOI 10.1111/j.1445-2197.1983.tb02409.x; CONI L, 2001, COLORECT DIS S1, V3, P33; Copeland G P, 1991, Br J Surg, V78, P355, DOI 10.1002/bjs.1800780327; *DEP HLTH, 2000, NHS EX GUID URG REF; DIXON AR, 1990, BRIT MED J, V301, P152, DOI 10.1136/bmj.301.6744.152; Dodds S, 1999, GUT, V44, pA99; ECCERSLEY AJP, 2001, COLORECT DIS S1, V3, P34; FIJTEN GH, 1995, FAM PRACT, V12, P279, DOI 10.1093/fampra/12.3.279; FLASHMAN K, 2001, COLORECT DIS S1, V3; GOODMAN D, 1993, BRIT J SURG, V80, P1327, DOI 10.1002/bjs.1800801037; HAGGER R, 2001, COLORECT DIS S1, V3; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HARINATH G, 2001, COLORECT DIS, V3; HERIOT AG, 2001, COLORECT DIS S1, V3; HOLLIDAY HW, 1979, LANCET, V1, P309; HURST NG, 2001, COLORECT DIS S1, V3; Jones R, 2001, BRIT MED J, V322, P1555, DOI 10.1136/bmj.322.7302.1555; KEDDIE N, 1968, LANCET, V2, P749; KELLY MJ, 2001, COLORECT DIS S1, V3, P33; KEMPPAINEN M, 1993, AGE AGEING, V22, P260, DOI 10.1093/ageing/22.4.260; KYLE SM, 1991, AUST NZ J SURG, V61, P137, DOI 10.1111/j.1445-2197.1991.tb00190.x; LYDEARD S, 1991, FAM PRACT, V8, P84, DOI 10.1093/fampra/8.1.84; Majumdar SR, 1999, AM J GASTROENTEROL, V94, P3039, DOI 10.1111/j.1572-0241.1999.01454.x; MIHSSIN N, 2001, COLORECT DIS S1, V3, P33; *NHS EX, 1997, IMPR OUTC COL CANC; ROBINSON E, 1986, EUR J CANCER CLIN ON, V22, P157, DOI 10.1016/0277-5379(86)90025-8; ROWEJONES DC, 1965, LANCET, V2, P973, DOI 10.1016/S0140-6736(65)92839-4; Royal College of Physicians of London, 1996, GUID MAN COL CANC, P3; SHEKOUH AR, 2001, COLORECT DIS S1, V3; STUBBS RS, 1986, EUR J SURG ONCOL, V12, P127	30	114	117	1	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 27	2002	360	9329					278	283		10.1016/S0140-6736(02)09549-1	http://dx.doi.org/10.1016/S0140-6736(02)09549-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578DT	12147370				2022-12-28	WOS:000177102700008
J	Tse, E; Yeung, CK; Trendell-Smith, N; Kwong, YL				Tse, E; Yeung, CK; Trendell-Smith, N; Kwong, YL			A cutaneous sore with black eschar in a cowhide worker	LANCET			English	Editorial Material									Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Kwong, YL (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China.		Tse, Eric/ABB-4021-2020; Yeung, Chi Keung/L-4795-2013; Yeung, Keung Chi/M-8132-2014; Kwong, Yok Lam/C-4296-2009	Tse, Eric/0000-0002-8351-4722; 				CHAN JKC, 2001, PATHOLOGY GENETICS T; CHRISTIE AB, 1996, OXFORD TXB MED; Jessup M, 2001, NEW ENGL J MED, V345, P1490, DOI 10.1056/NEJMed010109; Kwong YL, 1997, BRIT J HAEMATOL, V97, P821, DOI 10.1046/j.1365-2141.1997.1462962.x	4	2	2	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 27	2002	360	9329					306	306		10.1016/S0140-6736(02)09554-5	http://dx.doi.org/10.1016/S0140-6736(02)09554-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578DT	12147375				2022-12-28	WOS:000177102700013
J	Geiger, B; Bershadsky, A				Geiger, B; Bershadsky, A			Exploring the neighborhood: Adhesion-coupled cell mechanosensors	CELL			English	Review							FOCAL CONTACTS; CYTOSKELETON; ACTIVATION; KINASE; STRETCH; FORCE	Here we discuss recent studies addressing adhesion-coupled mechanosensory processes and consider their molecular nature. Are cells using stretch-activated ion channels to explore the extracellular environment surrounding them, or do they use for that purpose the submembrane protein network that interconnects integrin receptors with the actin cytoskeleton?	Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Geiger, B (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.			Bershadsky, Alexander/0000-0002-9571-7375				Aikawa R, 2002, HYPERTENSION, V39, P233, DOI 10.1161/hy0202.102699; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; DAVIES PF, 1994, J CLIN INVEST, V93, P2031, DOI 10.1172/JCI117197; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Koo LY, 2002, J CELL SCI, V115, P1423; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455; MacKenna DA, 1998, J CLIN INVEST, V101, P301, DOI 10.1172/JCI1026; Martin P, 2001, P NATL ACAD SCI USA, V98, P14386, DOI 10.1073/pnas.251530498; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Sawada Y, 2002, J CELL BIOL, V156, P609, DOI 10.1083/jcb.200110068; Tsuruta D, 2002, FASEB J, V16, P866, DOI 10.1096/fj.01-0878fje; Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161	20	318	330	0	35	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 26	2002	110	2					139	142		10.1016/S0092-8674(02)00831-0	http://dx.doi.org/10.1016/S0092-8674(02)00831-0			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	578EV	12150922	Bronze			2022-12-28	WOS:000177105200002
J	Li, J; Wen, JQ; Lease, KA; Doke, JT; Tax, FE; Walker, JC				Li, J; Wen, JQ; Lease, KA; Doke, JT; Tax, FE; Walker, JC			BAK1, an Arabidopsis LRR receptor-like protein kinase, interacts with BRI1 and modulates brassinosteroid signaling	CELL			English	Article							LEUCINE-RICH REPEAT; THALIANA; GENE; BIOSYNTHESIS; GROWTH; TRANSDUCTION; ENCODES; EMBRYOS; MUTANT; FORM	Brassinosteroids regulate plant growth and development through a protein complex that includes the leucine-rich repeat receptor-like protein kinase (LRR-RLK) brassinosteroid-insensitive 1 (BRI1). Activation tagging was used to identify a dominant genetic suppressor of bri1, bak1-1D (bri1-associated receptor kinase 1-1Dominant), which encodes an LRR-RLK, distinct from BRI1. Overexpression of BAK1 results in elongated organ phenotypes, while a null allele of BAK1 displays a semidwarfed phenotype and has reduced sensitivity to brassinosteroids (BRs). BAK1 is a serine/threonine protein kinase, and BRI1 and BAK1 interact in vitro and in vivo. Expression of a dominant-negative mutant allele of BAK1 causes a severe dwarf phenotype, resembling the phenotype of null bri1 alleles. These results indicate BAK1 is a component of BR signaling.	Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	University of Missouri System; University of Missouri Columbia; University of Arizona	Walker, JC (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	walkerj@missouri.edu		Tax, Frans/0000-0002-1386-3310; Wen, Jiangqi/0000-0001-5113-7750; Walker, John/0000-0002-2050-1641				Asami T, 2000, PLANT PHYSIOL, V123, P93, DOI 10.1104/pp.123.1.93; BECKER D, 1992, PLANT MOL BIOL, V20, P1195, DOI 10.1007/BF00028908; Braun DM, 1997, PLANT J, V12, P83, DOI 10.1046/j.1365-313X.1997.12010083.x; Choe S, 2001, PLANT J, V26, P573, DOI 10.1046/j.1365-313x.2001.01055.x; Choe SW, 1998, PLANT CELL, V10, P231, DOI 10.1105/tpc.10.2.231; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Clouse SD, 1996, PLANT PHYSIOL, V111, P671, DOI 10.1104/pp.111.3.671; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Fujioka S, 1997, PLANT CELL, V9, P1951, DOI 10.1105/tpc.9.11.1951; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; HORN MA, 1994, BBA-PROTEIN STRUCT M, V1208, P65, DOI 10.1016/0167-4838(94)90160-0; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kauschmann A, 1996, PLANT J, V9, P701, DOI 10.1046/j.1365-313X.1996.9050701.x; Li J, 2001, P NATL ACAD SCI USA, V98, P5916, DOI 10.1073/pnas.091065998; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 2002, SCIENCE, V295, P1299; Li JM, 2001, PLANT PHYSIOL, V127, P14, DOI 10.1104/pp.127.1.14; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Noguchi T, 1999, PLANT PHYSIOL, V121, P743, DOI 10.1104/pp.121.3.743; Perez-Perez JM, 2002, DEV BIOL, V242, P161, DOI 10.1006/dbio.2001.0543; Schmidt EDL, 1997, DEVELOPMENT, V124, P2049; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3	30	968	1056	15	220	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 26	2002	110	2					213	222		10.1016/S0092-8674(02)00812-7	http://dx.doi.org/10.1016/S0092-8674(02)00812-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	578EV	12150929	Bronze			2022-12-28	WOS:000177105200009
J	Thaler, JP; Lee, SK; Jurata, LW; Gill, GN; Pfaff, SL				Thaler, JP; Lee, SK; Jurata, LW; Gill, GN; Pfaff, SL			LIM factor Lhx3 contributes to the specification of motor neuron and interneuron identity through cell-type-specific protein-protein interactions	CELL			English	Article							ACTIVITY IN-VIVO; HOMEODOMAIN PROTEINS; HOMEOBOX GENES; TRANSCRIPTION FACTORS; SPINAL-CORD; EXPRESSION; CHIP; DROSOPHILA; FATE; CODE	LIM homeodomain codes regulate the development of many cell types, though it is poorly understood how these factors control gene expression in a cell-specific manner. Lhx3 is involved in the generation of two adjacent, but distinct, cell types for locomotion, motor neurons and V2 interneurons. Using in vivo function and protein interaction assays, we found that Lhx3 binds directly to the LIM cofactor NLI to trigger V2 interneuron differentiation. In motor neurons, however, IsI1 is available to compete for binding to NLI, displacing Lhx3 to a high-affinity binding site on the C-terminal region of IsI1 and thereby transforming Lhx3 from an interneuron-promoting factor to a motor neuron-promoting factor. This switching mechanism enables specific LIM complexes to form in each cell type and ensures that neuronal fates are tightly segregated.	Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego	Pfaff, SL (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK013149, R01DK013149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037116] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK13149] Funding Source: Medline; NINDS NIH HHS [R01NS37116] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Appel B, 1995, DEVELOPMENT, V121, P4117; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Dasen JS, 1999, CURR OPIN GENET DEV, V9, P566, DOI 10.1016/S0959-437X(99)00015-5; Dawid IB, 1998, TRENDS GENET, V14, P156, DOI 10.1016/S0168-9525(98)01424-3; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Howard PW, 2000, J BIOL CHEM, V275, P13336, DOI 10.1074/jbc.275.18.13336; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Johnson JD, 1997, MOL CELL BIOL, V17, P3488, DOI 10.1128/MCB.17.7.3488; Jurata LW, 2000, CURR OPIN NEUROBIOL, V10, P72, DOI 10.1016/S0959-4388(99)00053-7; Jurata LW, 1998, J BIOL CHEM, V273, P3152, DOI 10.1074/jbc.273.6.3152; Jurata LW, 1996, P NATL ACAD SCI USA, V93, P11693, DOI 10.1073/pnas.93.21.11693; Jurata LW, 1997, MOL CELL BIOL, V17, P5688, DOI 10.1128/MCB.17.10.5688; Kenny DA, 1998, P NATL ACAD SCI USA, V95, P11257, DOI 10.1073/pnas.95.19.11257; Kessaris N, 2001, NEURON, V31, P677, DOI 10.1016/S0896-6273(01)00430-5; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; Marin O, 2000, J NEUROSCI, V20, P6063; Marquardt T, 2001, CELL, V106, P651, DOI 10.1016/S0092-8674(01)00499-8; Milan M, 1999, MOL CELL, V4, P267, DOI 10.1016/S1097-2765(00)80374-3; Milan M, 1998, GENE DEV, V12, P2912, DOI 10.1101/gad.12.18.2912; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Morcillo P, 1997, GENE DEV, V11, P2729, DOI 10.1101/gad.11.20.2729; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Nakagawa Y, 2001, J NEUROSCI, V21, P2711, DOI 10.1523/JNEUROSCI.21-08-02711.2001; Nakamura H, 2001, METHODS, V24, P43, DOI 10.1006/meth.2001.1155; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Ramain P, 2000, MOL CELL, V6, P781, DOI 10.1016/S1097-2765(05)00079-1; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; Sharma K, 2000, NATURE, V406, P515, DOI 10.1038/35020078; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Sheng HZ, 1996, SCIENCE, V272, P1004, DOI 10.1126/science.272.5264.1004; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Torigoi E, 2000, P NATL ACAD SCI USA, V97, P2686, DOI 10.1073/pnas.050586397; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; van Meyel DJ, 2000, DEVELOPMENT, V127, P1823; van Meyel DJ, 1999, MOL CELL, V4, P259, DOI 10.1016/S1097-2765(00)80373-1; VarelaEchavarria A, 1996, MOL CELL NEUROSCI, V8, P242, DOI 10.1006/mcne.1996.0061	47	273	282	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 26	2002	110	2					237	249		10.1016/S0092-8674(02)00823-1	http://dx.doi.org/10.1016/S0092-8674(02)00823-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	578EV	12150931	Bronze			2022-12-28	WOS:000177105200011
J	Gleick, PH				Gleick, PH			Water management - Soft water paths	NATURE			English	Editorial Material									Pacific Inst Studies Dev Environm & Secur, Oakland, CA 94612 USA		Gleick, PH (corresponding author), Pacific Inst Studies Dev Environm & Secur, 654 13th St, Oakland, CA 94612 USA.		Gleick, Peter H/E-5528-2015	Gleick, Peter H/0000-0001-7232-9284				GLEICK P, 2002, WORLDS WATER, V3; GLEICK P, 1998, WORLDS WATER, V1; GLEICK P, 2000, WORLDS WATER, V2; Gleick PH, 2000, WATER INT, V25, P127, DOI 10.1080/02508060008686804; OWENSVIANI L, 1999, SUSTAINABLE USE WATE; Vickers A., 2001, HDB WATER USE CONSER	6	127	130	3	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2002	418	6896					373	373		10.1038/418373a	http://dx.doi.org/10.1038/418373a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12140538	Bronze			2022-12-28	WOS:000177009700019
J	Salvarani, C; Cantini, F; Boiardi, L; Hunder, GG				Salvarani, C; Cantini, F; Boiardi, L; Hunder, GG			Medical progress - Polymyalgia rheumatica and giant-cell arteritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ERYTHROCYTE SEDIMENTATION-RATE; PROSPECTIVE FOLLOW-UP; SERONEGATIVE SYMMETRICAL SYNOVITIS; TEMPORAL ARTERITIS; CORTICOSTEROID TREATMENT; PITTING EDEMA; MUSCULOSKELETAL MANIFESTATIONS; CLASSIFICATION CRITERIA; HLA-DRB1 ALLELES; OLMSTED COUNTY		Arcispedale S Maria Nuova, Rheumatol Serv, Reggio Emilia, Italy; Osped Prato, Rheumatol Unit, Div Med, Prato, Italy; Mayo Clin, Rochester, MN USA	IRCCS Arcispedale S. Maria Nuova; Prato Hospital; Mayo Clinic	Salvarani, C (corresponding author), Viale Umberto 1 N50, I-42100 Reggio Emilia, Italy.		Salvarani, Carlo/K-2431-2018	Salvarani, Carlo/0000-0001-5426-5133				ACHKAR AA, 1994, ANN INTERN MED, V120, P987, DOI 10.7326/0003-4819-120-12-199406150-00003; AIELLO PD, 1993, OPHTHALMOLOGY, V100, P550; ANDERSSON R, 1986, ACTA MED SCAND, V220, P465; AYOUB WT, 1985, AM J MED, V79, P309, DOI 10.1016/0002-9343(85)90309-2; BAGRATUNI L, 1963, Br Med J, V1, P513; BARBER HS, 1957, ANN RHEUM DIS, V16, P230, DOI 10.1136/ard.16.2.230; Blockmans D, 1999, RHEUMATOLOGY, V38, P444, DOI 10.1093/rheumatology/38.5.444; Bruce W, 1888, Br Med J, V2, P811; CALAMIA KT, 1980, CLIN RHEUM DIS, V6, P389; CALAMIA KT, 1981, ARTHRITIS RHEUM, V24, P1414, DOI 10.1002/art.1780241113; Cantini F, 2000, SEMIN ARTHRITIS RHEU, V30, P17, DOI 10.1053/sarh.2000.8366; Cantini F, 1999, ANN RHEUM DIS, V58, P230, DOI 10.1136/ard.58.4.230; Cantini F, 2001, ARTHRITIS RHEUM, V44, P2933, DOI 10.1002/1529-0131(200112)44:12<2933::AID-ART482>3.0.CO;2-Y; Cantini F, 2001, ARTHRITIS RHEUM, V44, P1155, DOI 10.1002/1529-0131(200105)44:5<1155::AID-ANR198>3.0.CO;2-N; Cantini F, 2001, J RHEUMATOL, V28, P1049; CASELLI RJ, 1988, NEUROLOGY, V38, P352, DOI 10.1212/WNL.38.3.352; CASELLI RJ, 1988, NEUROLOGY, V38, P685, DOI 10.1212/WNL.38.5.685; CHUANG TY, 1982, ANN INTERN MED, V97, P672, DOI 10.7326/0003-4819-97-5-672; CID MC, 1989, ARTHRITIS RHEUM, V32, P884; Duhaut P, 1999, J RHEUMATOL, V26, P361; Elling P, 1996, J RHEUMATOL, V23, P112; Esteban MJ, 2001, ARTHRITIS RHEUM-US, V44, P1387, DOI 10.1002/1529-0131(200106)44:6<1387::AID-ART232>3.0.CO;2-B; EVANS JM, 1995, ANN INTERN MED, V122, P502, DOI 10.7326/0003-4819-122-7-199504010-00004; FRANZEN P, 1992, J RHEUMATOL, V19, P273; Gabriel SE, 1997, ARTHRITIS RHEUM, V40, P1873, DOI 10.1002/art.1780401022; GABRIEL SE, 1995, J RHEUMATOL, V22, P93; Gabriel SE, 1999, ARTHRITIS RHEUM, V42, P1255, DOI 10.1002/1529-0131(199906)42:6<1255::AID-ANR23>3.0.CO;2-P; Gonzalez-Gay MA, 2000, J RHEUMATOL, V27, P2179; Gonzalez-Gay MA, 1998, ARTHRITIS RHEUM, V41, P1497, DOI 10.1002/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z; GONZALEZGAY MA, 1992, J RHEUMATOL, V19, P277; Haworth S, 1996, BRIT J RHEUMATOL, V35, P632; Hayreh SS, 1997, AM J OPHTHALMOL, V123, P285, DOI 10.1016/S0002-9394(14)70123-0; HEALEY LA, 1984, SEMIN ARTHRITIS RHEU, V13, P322, DOI 10.1016/0049-0172(84)90012-X; HOPKINSON ND, 1991, ANN RHEUM DIS, V50, P321, DOI 10.1136/ard.50.5.321; Horton BM., 1932, PROC STAFF MEET MAYO, V7, P700; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122; HUNDER GG, 1975, ANN INTERN MED, V82, P613, DOI 10.7326/0003-4819-82-5-613; HUSTON KA, 1978, ANN INTERN MED, V88, P162, DOI 10.7326/0003-4819-88-2-162; Hutchinson J., 1890, ARCH SURG-CHICAGO, V1, P323; HUTTON CW, 1986, ANN RHEUM DIS, V45, P641, DOI 10.1136/ard.45.8.641; Jover JA, 2001, ANN INTERN MED, V134, P106, DOI 10.7326/0003-4819-134-2-200101160-00010; KLEIN RG, 1975, ANN INTERN MED, V83, P806, DOI 10.7326/0003-4819-83-6-806; LARSON TS, 1984, ANN INTERN MED, V101, P594, DOI 10.7326/0003-4819-101-5-594; LIE JT, 1990, ARTHRITIS RHEUM-US, V33, P1074; MCCARTY DJ, 1985, JAMA-J AM MED ASSOC, V254, P2763, DOI 10.1001/jama.254.19.2763; Meliconi R, 1996, ARTHRITIS RHEUM-US, V39, P1199, DOI 10.1002/art.1780390719; Narvaez J, 2000, J RHEUMATOL, V27, P953; NESHER G, 1994, J RHEUMATOL, V21, P1283; Nesher G, 2001, J RHEUMATOL, V28, P2046; NOLTORP S, 1991, CLIN EXP RHEUMATOL, V9, P351; ODUFFY JD, 1976, MAYO CLIN PROC, V51, P519; Olivieri I, 1997, J RHEUMATOL, V24, P249; Ostberg G, 1973, ACTA PATHOL MICROB S, V237, P1; PAULLEY JW, 1960, BRIT MED J, V2, P1562, DOI 10.1136/bmj.2.5212.1562; Rao JK, 1998, ANN INTERN MED, V129, P345, DOI 10.7326/0003-4819-129-5-199809010-00001; Saag KG, 1998, NEW ENGL J MED, V339, P292, DOI 10.1056/NEJM199807303390502; SALVARANI C, 1994, ARTHRITIS RHEUM, V37, P1621, DOI 10.1002/art.1780371111; SALVARANI C, 1995, ARTHRITIS RHEUM, V38, P369, DOI 10.1002/art.1780380311; SALVARANI C, 1987, CLIN EXP RHEUMATOL, V5, P205; Salvarani C, 1997, ANN INTERN MED, V127, P27, DOI 10.7326/0003-4819-127-1-199707010-00005; Salvarani C, 1999, ARTHRITIS RHEUM-US, V42, P1259, DOI 10.1002/1529-0131(199906)42:6<1259::AID-ANR24>3.0.CO;2-I; Salvarani C, 1997, LANCET, V350, P43, DOI 10.1016/S0140-6736(97)05001-0; Salvarani C, 1998, ARTHRITIS RHEUM, V41, P1221, DOI 10.1002/1529-0131(199807)41:7<1221::AID-ART12>3.0.CO;2-W; Salvarani C, 1999, J RHEUMATOL, V26, P517; Salvarani C, 1996, ARTHRITIS RHEUM, V39, P73, DOI 10.1002/art.1780390110; SALVARANI C, 1995, ANN INTERN MED, V123, P192, DOI 10.7326/0003-4819-123-3-199508010-00006; SALVARANI C, 1991, ARTHRITIS RHEUM, V34, P351, DOI 10.1002/art.1780340313; Salvarani C, 2001, ARTHRIT RHEUM-ARTHR, V45, P140, DOI 10.1002/1529-0131(200104)45:2<140::AID-ANR166>3.0.CO;2-2; Salvarani C, 1999, ANN RHEUM DIS, V58, P303, DOI 10.1136/ard.58.5.303; SALVARANI C, IN PRESS ANN INTERN; Schmidt WA, 1997, NEW ENGL J MED, V337, P1336, DOI 10.1056/NEJM199711063371902; Stanson AW, 2000, CLIN EXP RHEUMATOL, V18, pS43; van der Veen MJ, 1996, ANN RHEUM DIS, V55, P563; vanderVeen MJ, 1996, ANN RHEUM DIS, V55, P218, DOI 10.1136/ard.55.4.218; Weyand CM, 1999, ARCH INTERN MED, V159, P577, DOI 10.1001/archinte.159.6.577; WEYAND CM, 1994, ANN INTERN MED, V121, P484, DOI 10.7326/0003-4819-121-7-199410010-00003; Weyand CM, 1999, ARTHRITIS RHEUM-US, V42, P844, DOI 10.1002/1529-0131(199905)42:5<844::AID-ANR2>3.0.CO;2-M; WEYAND CM, 1994, ARTHRITIS RHEUM, V37, P514, DOI 10.1002/art.1780370411	78	673	701	0	20	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 25	2002	347	4					261	271		10.1056/NEJMra011913	http://dx.doi.org/10.1056/NEJMra011913			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587WB	12140303				2022-12-28	WOS:000177665800007
J	Stoll, BJ; Hansen, N; Fanaroff, AA; Wright, LL; Carlo, WA; Ehrenkranz, RA; Lemons, JA; Donovan, EF; Stark, AR; Tyson, JE; Oh, W; Bauer, CR; Korones, SB; Shankaran, S; Laptook, AR; Stevenson, DK; Papile, LA; Poole, WK				Stoll, BJ; Hansen, N; Fanaroff, AA; Wright, LL; Carlo, WA; Ehrenkranz, RA; Lemons, JA; Donovan, EF; Stark, AR; Tyson, JE; Oh, W; Bauer, CR; Korones, SB; Shankaran, S; Laptook, AR; Stevenson, DK; Papile, LA; Poole, WK			Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEONATAL SEPSIS; ESCHERICHIA-COLI; INFECTION; AMPICILLIN; DISEASE; CONSEQUENCES; ANTIBIOTICS; RESISTANCE; PREVENTION; HOSPITALS	Background It is uncertain whether the rates and causes of early-onset sepsis (that occurring within 72 hours after birth) among very-low-birth-weight infants have changed in recent years, since antibiotics have begun to be used more widely during labor and delivery. Methods We studied 5447 very-low-birth-weight infants (those weighing between 401 and 1500 g) born at centers of the Neonatal Research Network of the National Institute of Child Health and Human Development between 1998 and 2000 who had at least one blood culture in the first three days of life and compared them with 7606 very-low-birth-weight infants born at centers in the network between 1991 and 1993. Results Early-onset sepsis (as confirmed by positive blood cultures) was present in 84 infants in the more recent birth cohort (1.5 percent). As compared with the earlier birth cohort, there was a marked reduction in group B streptococcal sepsis (from 5.9 to 1.7 per 1000 live births of infants weighing 401 to 1500 g, P < 0.001) and an increase in Escherichia coli sepsis (from 3.2 to 6.8 per 1000 live births, P = 0.004); the overall rate of early-onset sepsis was not significantly changed. Most E. coli isolates from the recent birth cohort (85 percent) were resistant to ampicillin, and mothers of infants with ampicillin-resistant E. coli infections were more likely to have received intrapartum ampicillin than were those with ampicillin-sensitive strains (26 of 28 with sensitivity data vs. 1 of 5, P = 0.01). Infants with early-onset sepsis were more likely to die than uninfected infants (37 percent vs. 13 percent, P < 0.001), especially if they were infected with gram-negative organisms. Conclusions Early-onset sepsis remains an uncommon but potentially lethal problem among very-low-birth-weight infants. The; change in pathogens over time from predominantly gram-positive to predominantly gram-negative requires confirmation by ongoing surveillance.	Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; Res Triangle Inst, Res Triangle Pk, NC 27709 USA; Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; NICHHD, Bethesda, MD 20892 USA; Univ Alabama, Dept Pediat, Birmingham, AL USA; Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; Brigham & Womens Hosp, Dept Newborn Med, Boston, MA 02115 USA; Univ Texas, Houston, TX USA; Brown Univ, Women & Infants Hosp, Providence, RI USA; Univ Miami, Dept Pediat, Miami, FL 33152 USA; Univ Tennessee, Newborn Ctr, Memphis, TN USA; Wayne State Univ, Div Neonatol & Perinatal Med, Detroit, MI USA; Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX USA; Stanford Univ, Div Neonatol, Med Ctr, Palo Alto, CA 94304 USA; Univ New Mexico, Sch Med, Dept Pediat, Albuquerque, NM 87131 USA	Emory University; Research Triangle Institute; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Alabama System; University of Alabama Birmingham; Yale University; Indiana University System; Indiana University-Purdue University Indianapolis; University System of Ohio; University of Cincinnati; Harvard University; Brigham & Women's Hospital; University of Texas System; Brown University; Women & Infants Hospital Rhode Island; University of Miami; University of Tennessee System; University of Tennessee Health Science Center; Wayne State University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Stanford University; University of New Mexico	Stoll, BJ (corresponding author), Emory Univ, Sch Med, Dept Pediat, 2040 Ridgewood Dr NE, Atlanta, GA 30322 USA.			Hansen, Nellie/0000-0003-4794-9646; Stark, Ann/0000-0002-6051-1190	NICHD NIH HHS [U10 HD27856, U10 HD21397, U10 HD21385, U10 HD21373, U10 HD34216, U10 HD21415, U10 HD27851, U10 HD40689, U10 HD27853, U10 HD27880, U10 HD27871, U01 HD36790, U10 HD21364, U10 HD27881, U10 HD27904, U10 HD34167] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD027880, U10HD027871, U10HD040689, U10HD027904, U10HD027856, U10HD034216, U10HD021373, U10HD021385, U10HD027851, U10HD027853, U10HD021364] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD021415, U10HD027881, U10HD021397, U01HD036790, U10HD034167] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ACOG, 1998, INT J GYNECOL OBSTET, V63, P75; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Benitz WE, 1999, PEDIATRICS, V103, P1275; Berger A, 1998, ACTA PAEDIATR, V87, P1066, DOI 10.1080/080352598750031392; Centers for Disease Control and Prevention, 1996, MMWR-MORBID MORTAL W, V45, P679; FREEDMAN RM, 1981, AM J DIS CHILD, V135, P140, DOI 10.1001/archpedi.1981.02130260032010; Friedman S, 2000, ACTA PAEDIATR, V89, P686, DOI 10.1080/080352500750044007; GIBBS RS, 1992, AM J OBSTET GYNECOL, V166, P1515, DOI 10.1016/0002-9378(92)91628-N; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldmann DA, 1996, JAMA-J AM MED ASSOC, V275, P234, DOI 10.1001/jama.275.3.234; Goldmann DA, 1997, CLIN INFECT DIS, V24, pS139, DOI 10.1093/clinids/24.Supplement_1.S139; HACK M, 1991, PEDIATRICS, V87, P587; Hager WD, 2000, OBSTET GYNECOL, V96, P141, DOI 10.1016/S0029-7844(00)00848-6; ISAACS D, 1995, MED J AUSTRALIA, V162, P198, DOI 10.5694/j.1326-5377.1995.tb126024.x; Isaacs D, 1999, PEDIATR INFECT DIS J, V18, P524, DOI 10.1097/00006454-199906000-00009; Joseph TA, 1998, ARCH PEDIAT ADOL MED, V152, P35; Klein O.J., 2001, INFECT DIS FETUS NEW, P943; Mercer BM, 1997, JAMA-J AM MED ASSOC, V278, P989, DOI 10.1001/jama.278.12.989; Mercer BM, 1999, AM J OBSTET GYNECOL, V181, P816, DOI 10.1016/S0002-9378(99)70307-8; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; PHILIP AGS, 1994, PEDIATR INFECT DIS J, V13, P1098, DOI 10.1097/00006454-199412000-00005; POURCYROUS M, 1993, PEDIATRICS, V92, P431; *RES TRIANGL I, 2000, SUDAAN US MAN REL 8; ROMERO R, 1989, AM J OBSTET GYNECOL, V161, P817, DOI 10.1016/0002-9378(89)90409-2; SAS Institute, 1999, SAS STAT US GUID VER; Schrag SJ, 2000, NEW ENGL J MED, V342, P15, DOI 10.1056/NEJM200001063420103; Schuchat A, 2000, PEDIATRICS, V105, P21, DOI 10.1542/peds.105.1.21; Stoll BJ, 1996, J PEDIATR-US, V129, P72, DOI 10.1016/S0022-3476(96)70192-0; Stoll BJ, 2001, INFECT DIS FETUS NEW, P139; Terrone DA, 1999, AM J OBSTET GYNECOL, V180, P1345, DOI 10.1016/S0002-9378(99)70017-7; Towers CV, 1998, AM J OBSTET GYNECOL, V179, P879, DOI 10.1016/S0002-9378(98)70182-6; Waterer GW, 2001, CRIT CARE MED, V29, pN75, DOI 10.1097/00003246-200104001-00004; Weinstein RA, 2001, EMERG INFECT DIS, V7, P188, DOI 10.3201/eid0702.010206; 1996, MMWR MORB MORTAL WKL, V45, P1	34	515	543	0	16	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 25	2002	347	4					240	247		10.1056/NEJMoa012657	http://dx.doi.org/10.1056/NEJMoa012657			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587WB	12140299	Bronze			2022-12-28	WOS:000177665800003
J	Tonello, F; Seveso, M; Marin, O; Mock, M; Montecucco, C				Tonello, F; Seveso, M; Marin, O; Mock, M; Montecucco, C			Pharmacology - Screening inhibitors of anthrax lethal factor	NATURE			English	Article							KINASE-KINASE; MACROPHAGES		Univ Padua, CNR, Ist Neurosci, Dipartimento Sci Biomed, I-35121 Padua, Italy; Univ Padua, Ist Veneto Med Mol, I-35121 Padua, Italy; Univ Padua, Dipartimento Chim Biol, I-35121 Padua, Italy; Univ Padua, CRIBI, I-35121 Padua, Italy; Inst Pasteur, Lab Genet Mol Toxines, CNRS, URA 557, F-75724 Paris 15, France	Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Padua; Veneto Institute Molecular Medicine; University of Padua; University of Padua; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Tonello, F (corresponding author), Univ Padua, CNR, Ist Neurosci, Dipartimento Sci Biomed, Via G Colombo 3, I-35121 Padua, Italy.		Tonello, Fiorella/AAM-6737-2021; Tonello, Fiorella/G-8957-2013	Tonello, Fiorella/0000-0001-8935-8938; Tonello, Fiorella/0000-0001-8935-8938				Chaudry GJ, 2002, TRENDS MICROBIOL, V10, P58, DOI 10.1016/S0966-842X(01)02294-6; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; Friedlander AM, 2001, NATURE, V414, P160, DOI 10.1038/35102660; Hanna P, 1998, CURR TOP MICROBIOL, V225, P13; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Roques BP, 2000, TRENDS PHARMACOL SCI, V21, P475, DOI 10.1016/S0165-6147(00)01571-6; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739	11	102	106	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2002	418	6896					386	386		10.1038/418386a	http://dx.doi.org/10.1038/418386a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12140548	Green Submitted, Bronze			2022-12-28	WOS:000177009700028
J	Hobbs, R				Hobbs, R			Checks and balances	LANCET			English	Editorial Material									Univ Birmingham, Dept Gen Practice, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Hobbs, R (corresponding author), Univ Birmingham, Dept Gen Practice, Birmingham B15 2TT, W Midlands, England.			hobbs, richard/0000-0001-7976-7172					0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 20	2002	360	9328					254	254		10.1016/S0140-6736(02)09467-9	http://dx.doi.org/10.1016/S0140-6736(02)09467-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	576DX	12133676				2022-12-28	WOS:000176988500031
J	Cho, HS; Leahy, DJ				Cho, HS; Leahy, DJ			Structure of the extracellular region of HER3 reveals an interdomain tether	SCIENCE			English	Article							EPIDERMAL GROWTH-FACTOR; LIGAND-BINDING SPECIFICITY; FACTOR RECEPTOR; EGF RECEPTOR; PROTEIN STRUCTURES; SIGNALING NETWORK; DOMAIN; EXPRESSION; AFFINITY; MODEL	We have determined the 2.6 angstrom crystal structure of the entire extracellular region of human HER3 ( ErbB3), a member of the epidermal growth factor receptor ( EGFR) family. The structure consists of four domains with structural homology to domains found in the type I insulin-like growth factor receptor. The HER3 structure reveals contact between domains II and IV that constrains the relative orientations of ligand-binding domains and provides structural basis for understanding both multiple-affinity forms of EGFRs and conformational changes induced in the receptor by ligand binding during signaling. These results also suggest new therapeutic approaches to modulating the behavior of members of the EGFR family.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Leahy, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Biophys & Biophys Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.							BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BROWN PM, 1994, EUR J BIOCHEM, V225, P223, DOI 10.1111/j.1432-1033.1994.00223.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1997, RIBBONS, V277; COHEN S, 1987, IN VITRO CELL DEV B, V23, P239; Domagala T, 2000, GROWTH FACTORS, V18, P11, DOI 10.3109/08977190009003231; Elleman TC, 2001, BIOCHEMISTRY-US, V40, P8930, DOI 10.1021/bi010037b; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; GADELLA TWJ, 1995, J CELL BIOL, V129, P1543, DOI 10.1083/jcb.129.6.1543; Garrett TPJ, 1998, NATURE, V394, P395, DOI 10.1038/28668; GRASBERGER B, 1986, P NATL ACAD SCI USA, V83, P6258, DOI 10.1073/pnas.83.17.6258; GREENFIELD C, 1989, EMBO J, V8, P4115, DOI 10.1002/j.1460-2075.1989.tb08596.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KOHDA D, 1993, J BIOL CHEM, V268, P1976; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRAUS MH, 1989, P NATL ACAD SCI USA, V86, P9193, DOI 10.1073/pnas.86.23.9193; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LAX I, 1991, CELL REGUL, V2, P337, DOI 10.1091/mbc.2.5.337; LAX I, 1991, J BIOL CHEM, V266, P13828; Leahy DJ, 2000, PROTEIN EXPRES PURIF, V20, P500, DOI 10.1006/prep.2000.1331; Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; MONTELIONE GT, 1992, BIOCHEMISTRY-US, V31, P236, DOI 10.1021/bi00116a033; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; PLOWMAN GD, 1990, P NATL ACAD SCI USA, V87, P4905, DOI 10.1073/pnas.87.13.4905; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; SCHECHTER Y, 1979, NATURE, V278, P835, DOI 10.1038/278835a0; SCHLESSINGER J, 1983, CRC CR REV BIOCH MOL, V14, P93, DOI 10.3109/10409238309102791; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shak S, 1999, SEMIN ONCOL, V26, P71; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; STANLEY P, 1975, CELL, V6, P121, DOI 10.1016/0092-8674(75)90002-1; Tang CK, 1998, HORMONES SIGNALING, P113; Tanner KG, 1999, J BIOL CHEM, V274, P35985, DOI 10.1074/jbc.274.50.35985; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; WOLTJER RL, 1992, P NATL ACAD SCI USA, V89, P7801, DOI 10.1073/pnas.89.16.7801; WU DG, 1990, P NATL ACAD SCI USA, V87, P3151, DOI 10.1073/pnas.87.8.3151; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; ZHANG KYJ, 1990, ACTA CRYSTALLOGR A, V46, P377, DOI 10.1107/S0108767389012158	43	329	371	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2002	297	5585					1330	1333		10.1126/science.1074611	http://dx.doi.org/10.1126/science.1074611			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FL	12154198				2022-12-28	WOS:000177573900042
J	Grumbach, K; Bodenheimer, T				Grumbach, K; Bodenheimer, T			A primary care home for Americans - Putting the house in order	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICIAN-PATIENT RELATIONSHIPS; EDUCATION-PROGRAM; MEDICAL OUTCOMES; HEALTH-CARE; SATISFACTION; HYPERTENSION; SPECIALTIES; PERFORMANCE; SERVICES; SYSTEMS	This article-the first in a series on primary care outlines the daunting challenges facing primary care today. Most people in the United States desire a primary care "home" to provide for and coordinate their health care needs. Yet primary care is endangered by physician stress, inadequate performance in managing chronic illness, and inability to provide prompt access and reliable continuity of care. Fundamental redesign is needed to improve access to and quality of care while easing physicians' workload without causing major increases in health care costs.	Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bodenheimer, T (corresponding author), San Francisco Gen Hosp, Ward 83,1001 Potrero Ave, San Francisco, CA 94110 USA.		Grumbach, Kevin/L-9222-2016					*AM AC FAM PHYS, 2002 MATCH INF SHEET; BENSON P, 1984, AM J DIS CHILD, V138, P74, DOI 10.1001/archpedi.1984.02140390062019; Bindman AB, 1996, J GEN INTERN MED, V11, P269, DOI 10.1007/BF02598266; Black HR, 1997, ARCH INTERN MED, V157, P2413; Brotherton SE, 2001, JAMA-J AM MED ASSOC, V286, P1056, DOI 10.1001/jama.286.9.1056; Burdi MD, 1999, HEALTH AFFAIR, V18, P134, DOI 10.1377/hlthaff.18.4.134; Campion EW, 2001, NEW ENGL J MED, V344, P223, DOI 10.1056/NEJM200101183440311; CAREY TS, 1995, NEW ENGL J MED, V333, P913, DOI 10.1056/NEJM199510053331406; Clark CM, 2000, JAMA-J AM MED ASSOC, V284, P363, DOI 10.1001/jama.284.3.363; Cunningham PJ, 1995, MED CARE RES REV, V52, P453, DOI 10.1177/107755879505200402; Green LA, 2001, NEW ENGL J MED, V344, P2021, DOI 10.1056/NEJM200106283442611; GREEN LA, 2001, FUT PRIM CAR C OCT 4; GREENFIELD S, 1995, JAMA-J AM MED ASSOC, V274, P1436; GREENFIELD S, 1992, JAMA-J AM MED ASSOC, V267, P1624, DOI 10.1001/jama.267.12.1624; GRUMBACH K, 1995, JAMA-J AM MED ASSOC, V274, P1282, DOI 10.1001/jama.274.16.1282; Grumbach K, 1999, JAMA-J AM MED ASSOC, V282, P261, DOI 10.1001/jama.282.3.261; Hadley J, 1999, HEALTH SERV RES, V34, P307; Harrold LR, 1999, J GEN INTERN MED, V14, P499, DOI 10.1046/j.1525-1497.1999.08168.x; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 1996, PRIM CAR AM HLTH NEW; *KAIS FAM FDN, NAT SURV CONS EXP AT; LIPPMAN H, 2000, HIPPOCRATES      JAN, P38; McBride P, 1998, ARCH INTERN MED, V158, P1238, DOI 10.1001/archinte.158.11.1238; Mechanic D, 2001, NEW ENGL J MED, V344, P198, DOI 10.1056/NEJM200101183440307; Morrison I, 2000, BRIT MED J, V321, P1541, DOI 10.1136/bmj.321.7276.1541; MULLAN F, 2000, NATL AREA HLTH ED CT, V17, P6; Murphy J, 2001, J FAM PRACTICE, V50, P123; Murray A, 2000, ARCH FAM MED, V9, P327, DOI 10.1001/archfami.9.4.327; Perez-Stable EJ, 1998, WESTERN J MED, V169, P23; Pugno PA, 2001, FAM MED, V33, P594; Rosenblatt RA, 1998, JAMA-J AM MED ASSOC, V279, P1364, DOI 10.1001/jama.279.17.1364; Safran DG, 1998, MED CARE, V36, P728, DOI 10.1097/00005650-199805000-00012; SHEA S, 1992, NEW ENGL J MED, V327, P776, DOI 10.1056/NEJM199209103271107; SHI LY, 1994, INT J HEALTH SERV, V24, P431, DOI 10.2190/BDUU-J0JD-BVEX-N90B; Sommers LS, 2001, WESTERN J MED, V174, P175, DOI 10.1136/ewjm.174.3.175; SPIEGEL JS, 1983, NEW ENGL J MED, V308, P1208, DOI 10.1056/NEJM198305193082007; STARFIELD B, 1998, PRIMARY CARE; *US HLTH RES SERV, 2000, PHARM WORKSF STUD SU; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; WASSON JH, 1984, JAMA-J AM MED ASSOC, V252, P2413; Weiss LJ, 1996, AM J PUBLIC HEALTH, V86, P1742, DOI 10.2105/AJPH.86.12.1742	41	188	189	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2002	288	7					889	893		10.1001/jama.288.7.889	http://dx.doi.org/10.1001/jama.288.7.889			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585FC	12186609				2022-12-28	WOS:000177513100034
J	White, CA; Macleod, U				White, CA; Macleod, U			ABC of psychological medicine - Cancer	BRITISH MEDICAL JOURNAL			English	Review									Univ Glasgow, Dept Psychol Med, Glasgow G12 8QQ, Lanark, Scotland; Univ Glasgow, Dept Gen Practice, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Glasgow	White, CA (corresponding author), Univ Glasgow, Dept Psychol Med, Glasgow G12 8QQ, Lanark, Scotland.			White, Craig/0000-0001-8695-8014				BARRACLOUGH J, 1998, CANC EMOTION PRACTIC; BURTON M, 1998, COUNSELLING PATIENTS; FAULKENER A, 1994, TALKING CANC PATIENT; Holland J., 1998, ENSIGN, V28; LEWIS S, 2000, HUMAN SIDE CANC LIVI; SCOTT JT, 2001, RECORDINGS SUMMARIES	6	17	18	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 17	2002	325	7360					377	380		10.1136/bmj.325.7360.377	http://dx.doi.org/10.1136/bmj.325.7360.377			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587DV	12183312	Green Published			2022-12-28	WOS:000177626000024
J	Meldrum, DR; Holl, MR				Meldrum, DR; Holl, MR			Microscale bioanalytical systems	SCIENCE			English	Editorial Material							CAPILLARY-ELECTROPHORESIS; MICROFLUIDICS; MOLECULES; CHANNEL; DEVICE		Univ Washington, Dept Elect Engn, Genomat Lab, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Meldrum, DR (corresponding author), Univ Washington, Dept Elect Engn, Genomat Lab, Seattle, WA 98195 USA.							Auroux PA, 2002, ANAL CHEM, V74, P2637, DOI 10.1021/ac020239t; Boone T, 2002, ANAL CHEM, V74, p78A, DOI 10.1021/ac021943c; Chiem N, 1997, ANAL CHEM, V69, P373, DOI 10.1021/ac9606620; Chiu DT, 2001, CURR OPIN CHEM BIOL, V5, P609, DOI 10.1016/S1367-5931(00)00242-8; Farinas J, 2001, ANAL BIOCHEM, V295, P138, DOI 10.1006/abio.2001.5202; Fluri K, 1996, ANAL CHEM, V68, P4285, DOI 10.1021/ac9604090; Foquet M, 2002, ANAL CHEM, V74, P1415, DOI 10.1021/ac011076w; Fu AY, 1999, NAT BIOTECHNOL, V17, P1109, DOI 10.1038/15095; Gascoyne P, 2002, LAB CHIP, V2, P70, DOI [10.1039/b110990c, 10.1039/b110090c]; Hu S, 2002, ANAL CHEM, V74, P2833, DOI 10.1021/ac0202379; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Kopp MU, 1998, SCIENCE, V280, P1046, DOI 10.1126/science.280.5366.1046; Lagally ET, 2001, LAB CHIP, V1, P102, DOI 10.1039/b109031n; Li J, 2001, NATURE, V412, P166, DOI 10.1038/35084037; Meller A, 2001, PHYS REV LETT, V86, P3435, DOI 10.1103/PhysRevLett.86.3435; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Reyes DR, 2002, ANAL CHEM, V74, P2623, DOI 10.1021/ac0202435; Schwarz MA, 2001, LAB CHIP, V1, P1, DOI 10.1039/b103795c; SENDER AJ, 2002, GENOME TECHNOL, V21, P60; Tudos AJ, 2001, LAB CHIP, V1, P83, DOI 10.1039/b106958f; Vercoutere W, 2001, NAT BIOTECHNOL, V19, P248, DOI 10.1038/85696; Verpoorte E, 2002, ELECTROPHORESIS, V23, P677, DOI 10.1002/1522-2683(200203)23:5<677::AID-ELPS677>3.0.CO;2-8; Vogel S., 1988, LIFES DEVICES PHYS W, DOI [10.2307/j.ctvx8b6qj, DOI 10.2307/J.CTVX8B6QJ]; Wang J, 2002, ELECTROPHORESIS, V23, P713, DOI 10.1002/1522-2683(200203)23:5<713::AID-ELPS713>3.0.CO;2-7; Webster JR, 2001, ANAL CHEM, V73, P1622, DOI 10.1021/ac0004512; Whitesides GM, 2001, PHYS TODAY, V54, P42, DOI 10.1063/1.1387591	26	134	139	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2002	297	5584					1197	1198		10.1126/science.297.5584.1197	http://dx.doi.org/10.1126/science.297.5584.1197			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183634				2022-12-28	WOS:000177447600055
J	McGowan, K; Muse, VV; Mark, EJ; Heller, HM				McGowan, K; Muse, VV; Mark, EJ; Heller, HM			A 46-year-old woman with extensive pulmonary infiltrates - Cryptococcal sepsis, with pneumonia and meningitis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							STRONGYLOIDES-STERCORALIS; HISTOPLASMOSIS; INFECTIONS		Faulkner Hosp, Infect Dis Serv, Boston, MA 02130 USA; Lemuel Shattuck Hosp, Infect Dis Serv, Boston, MA USA; Tufts Univ, Sch Med, Boston, MA 02111 USA	Tufts University	McGowan, K (corresponding author), Faulkner Hosp, Infect Dis Serv, Boston, MA 02130 USA.							Aberg JA, 1999, CHEST, V115, P734, DOI 10.1378/chest.115.3.734; BAKER RD, 1976, AM J CLIN PATHOL, V65, P83; BARRETTCONNOR E, 1982, AM REV RESPIR DIS, V126, P558; Bethlem E P, 1997, Curr Opin Pulm Med, V3, P361, DOI 10.1097/00063198-199709000-00008; CAMERON ML, 1991, REV INFECT DIS, V13, P64; COX SK, 1981, MO MED, V78, P70; DEVAULT GA, 1990, REV INFECT DIS, V12, P653; ELLNER JJ, 1976, MEDICINE, V55, P341, DOI 10.1097/00005792-197609000-00001; FRASER RS, 1999, DIAGNOSIS DIS CHEST, V2, P890; GOODWIN RA, 1980, MEDICINE, V59, P1, DOI 10.1097/00005792-198001000-00001; GOODWIN RA, 1981, MEDICINE, V60, P231, DOI 10.1097/00005792-198107000-00001; GRAHAM BS, 1983, MEDICINE, V62, P384, DOI 10.1097/00005792-198311000-00004; KAPLAN MH, 1977, CANCER, V39, P2265, DOI 10.1002/1097-0142(197705)39:5&lt;2265::AID-CNCR2820390546&gt;3.0.CO;2-X; KAUFFMAN CA, 1978, AM J MED, V64, P923, DOI 10.1016/0002-9343(78)90445-X; KERKERING TM, 1981, ANN INTERN MED, V94, P611, DOI 10.7326/0003-4819-94-5-611; KHOURY MB, 1984, AM J ROENTGENOL, V142, P893, DOI 10.2214/ajr.142.5.893; LAZCANO O, 1993, MODERN PATHOL, V6, P80; LEEDOM JM, 1980, CURRENT CLIN TOPICS, V1, P304; LESSNAU KD, 1993, CHEST, V104, P119, DOI 10.1378/chest.104.1.119; Murakawa GJ, 1996, ARCH DERMATOL, V132, P545, DOI 10.1001/archderm.132.5.545; NANA A, 1991, SEMIN RESPIR MED, V12, P46, DOI 10.1055/s-2007-1006224; NELSON S, 1995, ALCOHOL CLIN EXP RES, V19, P17, DOI 10.1111/j.1530-0277.1995.tb01467.x; Pearson RD, 1996, CLIN INFECT DIS, V22, P1, DOI 10.1093/clinids/22.1.1; PERLA EN, 1985, NEW YORK STATE J MED, V85, P704; PLOUFFE JF, 1979, J INFECT DIS, V139, P152, DOI 10.1093/infdis/139.2.152; ROZENBAUM R, 1994, CLIN INFECT DIS, V18, P369, DOI 10.1093/clinids/18.3.369; SPEED B, 1995, CLIN INFECT DIS, V21, P28, DOI 10.1093/clinids/21.1.28; SPOSTO MR, 1993, ORAL SURG ORAL MED O, V75, P461, DOI 10.1016/0030-4220(93)90171-Y; STEAD WW, 1967, AM REV RESPIR DIS, V95, P729; WHEAT LJ, 1990, MEDICINE, V69, P361, DOI 10.1097/00005792-199011000-00004; Winn R E, 1988, Infect Dis Clin North Am, V2, P899; WOODRING JH, 1986, AM J ROENTGENOL, V146, P497, DOI 10.2214/ajr.146.3.497; WOODRING JH, 1994, AM J ROENTGENOL, V162, P537, DOI 10.2214/ajr.162.3.8109492	33	6	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 15	2002	347	7					517	524		10.1056/NEJMcpc020108	http://dx.doi.org/10.1056/NEJMcpc020108			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587ZM	12181407				2022-12-28	WOS:000177674400009
J	Reddy, DM; Fleming, R; Swain, C				Reddy, DM; Fleming, R; Swain, C			Effect of mandatory parental notification on adolescent girls' use of sexual health care services	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context Mandatory parental notification for adolescents to obtain prescribed contraceptives is a controversial issue. Recently, legislation that would prohibit prescribed contraceptives for adolescents without parental involvement was introduced in 10 states and the US Congress. Objective To determine the effect of mandatory parental notification for prescribed contraceptives on use of sexual health care services by adolescent girls. Design, Setting, and Participants Girls younger than 18 years and seeking services at all 33 Planned Parenthood family planning clinics in Wisconsin (n=1118) were surveyed during the spring of 1999. A response rate of 85% was achieved, yielding a sample of 950 girls. Main Outcome Measures Percentages of girls who reported that they would stop using all sexual health care services, delay testing or treatment for human immunodeficiency virus (HIV) or other sexually transmitted diseases (STDs), or discontinue using specific (but not all) services because of parental notification. Results Fifty-nine percent (n=556) indicated they would stop using all sexual health care services, delay testing or treatment for HIV or other STDs, or discontinue use of specific (but not all) sexual health care services if their parents were informed that they were seeking prescribed contraceptives. Eleven percent indicated they would discontinue or delay STD tests or treatment, even though the survey made it clear that mandatory parental notification would occur only for prescribed contraceptives. Analyses comparing girls of different ages and races and from urban vs rural clinics showed that, although the 17-year-olds and African American girls were significantly less likely to stop using sexual health care services with mandatory parental notification, roughly half of the 17-year-olds (56%) and African American girls (49%) indicated that they would stop using all sexual health care services, delay testing or treatment for HIV or other STDs, or discontinue use of specific (but not all) services with mandatory parental notification. Conclusion Mandatory parental notification for prescribed contraceptives would impede girls' use of sexual health care services, potentially increasing teen pregnancies and the spread of STDs.	Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA; Planned Parenthood Wisconsin Inc, Milwaukee, WI USA	University of Wisconsin System; University of Wisconsin Milwaukee	Reddy, DM (corresponding author), Univ Wisconsin, Dept Psychol, POB 413, Milwaukee, WI 53201 USA.							*AM COLL OBST GYN, 1988, ACOG STAT POL CONF A; *AM MED ASS, 1990, AMA POL COMP; [Anonymous], 1978, MAIL TELEPHONE SURVE; Bulcroft RA, 1996, J MARRIAGE FAM, V58, P866, DOI 10.2307/353976; Clinton WJ., 2000, OFF PRES FED REGIST, V65, P67249; COBLE YD, 1993, JAMA-J AM MED ASSOC, V269, P1420, DOI 10.1001/jama.1993.03500110088042; GANS JE, 1993, POLICY COMPENDIUM CO; MARKS A, 1983, J PEDIATR-US, V102, P456, DOI 10.1016/S0022-3476(83)80677-5; Raffaelli M, 1998, J FAM ISSUES, V19, P315, DOI 10.1177/019251398019003005; TORRES A, 1978, FAM PLANN PERSPECT, V10, P280, DOI 10.2307/2134380; TORRES A, 1980, FAM PLANN PERSPECT, V12, P284, DOI 10.2307/2134659	11	181	188	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2002	288	6					710	714		10.1001/jama.288.6.710	http://dx.doi.org/10.1001/jama.288.6.710			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	583KY	12169074				2022-12-28	WOS:000177408100031
J	Quinn, J; Cummings, S; Callaham, M; Sellers, K				Quinn, J; Cummings, S; Callaham, M; Sellers, K			Suturing versus conservative management of lacerations of the hand: randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							CLINICAL WOUND EVALUATION; SCALES	Objective To assess the difference in clinical outcome between lacerations of the hand closed with sutures and those treated conservatively. Design Randomised controlled trial. Setting Emergency department in a tertiary hospital. Participants Consecutive patients presenting between 16 February and 30 November 2000 with uncomplicated lacerations of the hand (full thickness < 2 cm; without tendon, joint, fracture, or nerve complications) who would normally require sutures. 154 patients were eligible, 58 refused, and 5 were missed; 91 patients with 95 lacerations were enrolled. Intervention Participants were randomised to suturing or conservative treatment. Main outcome measures Primary outcome was cosmetic appearance after three months, rated on a previously validated visual analogue scale. Duration of treatment, pain during treatment, patients' assessment of their outcome, and the time for patients to resume normal activities were also measured. Results Participants treated with sutures and those treated conservatively did not differ significantly in the assessment of cosmetic appearance by independent blinded doctors after three months: 83 min v 80 mm, (mean difference 3 (95% confidence interval - 1 to 8) min) on the visual analogue scale. The mean time to resume normal activities was the same in both groups (3.4 days). Patients treated conservatively had less pain (difference 18 (12 to 24) min) and treatment time was 14 (10 to 18) min shorter. Conclusion Similar cosmetic and functional outcomes result from either conservative treatment or suturing of small uncomplicated lacerations of the hand, but conservative treatment is faster and less painful.	Univ Calif San Francisco, Div Emergency Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94118 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Quinn, J (corresponding author), Univ Calif San Francisco, Div Emergency Med, 505 Parnassus Ave, San Francisco, CA 94143 USA.			Callaham, Michael/0000-0003-2284-256X; Quinn, James/0000-0002-3694-2118	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR002137] Funding Source: NIH RePORTER; NIAMS NIH HHS [K23 AR02137-02, K23 AR002137] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		CARRICO TJ, 1984, SURG CLIN N AM, V64, P721; HOLLANDER JE, 1995, ANN EMERG MED, V25, P675, DOI 10.1016/S0196-0644(95)70183-4; Huskisson E., 1983, PAIN MEASUREMENT ASS, P33; Lehmann L, 1977, Handchirurgie, V9, P7; Quinn JV, 1998, ACAD EMERG MED, V5, P583, DOI 10.1111/j.1553-2712.1998.tb02465.x; QUINN JV, 1995, AM J EMERG MED, V13, P229, DOI 10.1016/0735-6757(95)90100-0; Quinn JV, 1996, ACAD EMERG MED, V3, P298, DOI 10.1111/j.1553-2712.1996.tb03440.x; Singer AJ, 1997, NEW ENGL J MED, V337, P1142, DOI 10.1056/NEJM199710163371607; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Storrow A B, 1994, Acad Emerg Med, V1, P454	10	20	20	1	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 10	2002	325	7359					299	300A		10.1136/bmj.325.7359.299	http://dx.doi.org/10.1136/bmj.325.7359.299			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	584RQ	12169503	Green Published, Bronze			2022-12-28	WOS:000177482500014
J	Symer, DE; Connelly, C; Szak, ST; Caputo, EM; Cost, GJ; Parmigiani, G; Boeke, JD				Symer, DE; Connelly, C; Szak, ST; Caputo, EM; Cost, GJ; Parmigiani, G; Boeke, JD			Human L1 retrotransposition is associated with genetic instability in vivo	CELL			English	Article							HUMAN TRANSPOSABLE ELEMENT; LINE-1 RETROTRANSPOSITION; MAMMALIAN-CELLS; DNA; ENDONUCLEASE; REARRANGEMENTS; RECOMBINATION; INTEGRATION; MECHANISM; EVOLUTION	Retrotransposons have shaped eukaryotic genomes for millions of years. To analyze the consequences of human Ll retrotransposition, we developed a genetic system to recover many new L1 insertions in somatic cells. Forty-two de novo integrants were recovered that faithfully mimic many aspects of L1s that accumulated since the primate radiation. Their structures experimentally demonstrate an association between Ll retrotransposition and various forms of genetic instability. Numerous L1 element inversions, extra nucleotide insertions, exon deletions, a chromosomal inversion, and flanking sequence comobilization (called 5' transduction) were identified. In a striking number of integrants, short identical sequences were shared between the donor and the target site's 3' end, suggesting a mechanistic model that helps explain the structure of Ll insertions.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Johns Hoipkins, Sidney Kimmel Comprehens Canc Ctr, Dept Med Oncol, Baltimore, MD 21231 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Boeke, JD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, 725 N Wolfe St, Baltimore, MD 21205 USA.	jboeke@jhmi.edu	Symer, David E./E-4173-2011	Cost, Gregory/0000-0002-8509-4653; Boeke, Jef/0000-0001-5322-4946	NATIONAL CANCER INSTITUTE [P01CA016519] Funding Source: NIH RePORTER; NCI NIH HHS [CA16519] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Boissinot S, 2000, MOL BIOL EVOL, V17, P915, DOI 10.1093/oxfordjournals.molbev.a026372; Boissinot S, 2001, MOL BIOL EVOL, V18, P926, DOI 10.1093/oxfordjournals.molbev.a003893; Cost GJ, 1998, BIOCHEMISTRY-US, V37, P18081, DOI 10.1021/bi981858s; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hughes JF, 2001, NAT GENET, V29, P487, DOI 10.1038/ng775; JENSEN S, 1995, BIOCHEM BIOPH RES CO, V15, P111; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; Moore JK, 1996, NATURE, V383, P644, DOI 10.1038/383644a0; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; NEVERS P, 1977, NATURE, V268, P109, DOI 10.1038/268109a0; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Ostertag EM, 2001, GENOME RES, V11, P2059, DOI 10.1101/gr.205701; Ovchinnikov I, 2001, GENOME RES, V11, P2050, DOI 10.1101/gr.194701; REVIE D, 1988, NUCLEIC ACIDS RES, V16, P10301, DOI 10.1093/nar/16.21.10301; ROTH DB, 1985, MOL CELL BIOL, V5, P2599, DOI 10.1128/MCB.5.10.2599; Santos FR, 2000, HUM MOL GENET, V9, P421, DOI 10.1093/hmg/9.3.421; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; Saxton JA, 1998, J MOL BIOL, V280, P611, DOI 10.1006/jmbi.1998.1899; SMIT AF, 2001, REPEATMASKER; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; SZAK ST, 2002, IN PRESS GENOME BIOL; Teng SC, 1996, NATURE, V383, P641, DOI 10.1038/383641a0; Wei W, 2000, ANAL BIOCHEM, V284, P435, DOI 10.1006/abio.2000.4675; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001	35	341	349	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 9	2002	110	3					327	338		10.1016/S0092-8674(02)00839-5	http://dx.doi.org/10.1016/S0092-8674(02)00839-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	583MN	12176320	Bronze			2022-12-28	WOS:000177411800009
J	Wichterle, H; Lieberam, I; Porter, JA; Jessell, TM				Wichterle, H; Lieberam, I; Porter, JA; Jessell, TM			Directed differentiation of embryonic stem cells into motor neurons	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; VENTRAL NEURAL-TUBE; LIM HOMEOBOX GENES; CHICK-EMBRYO; IN-VITRO; HOMEODOMAIN PROTEIN; INDUCTIVE SIGNALS; SPINAL-CORD; ES CELLS; SPECIFICATION	Inductive signals and transcription factors involved in motor neuron generation have been identified, raising the question of whether these developmental insights can be used to direct stem cells to a motor neuron fate. We show that developmentally relevant signaling factors can induce mouse embryonic stem (ES) cells to differentiate into spinal progenitor cells, and subsequently into motor neurons, through a pathway recapitulating that used in vivo. ES cell-derived motor neurons can populate the embryonic spinal cord, extend axons, and form synapses with target muscles. Thus, inductive signals involved in normal pathways of neurogenesis can direct ES cells to form specific classes of CNS neurons.	Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Curis Inc, Cambridge, MA 02138 USA	Columbia University; Howard Hughes Medical Institute	Jessell, TM (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA.		Lieberam, Ivo/C-5324-2009	Lieberam, Ivo/0000-0003-3539-3054				ABBONDANZO SJ, 1993, METHOD ENZYMOL, V225, P803; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Belting HG, 1998, J EXP ZOOL, V282, P196, DOI 10.1002/(SICI)1097-010X(199809/10)282:1/2&lt;196::AID-JEZ22&gt;3.0.CO;2-R; BLOCHGALLEGO E, 1991, DEVELOPMENT, V111, P221; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Byrd N, 2002, DEVELOPMENT, V129, P361; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; CHOI T, 1991, MOL CELL BIOL, V11, P3070, DOI 10.1128/MCB.11.6.3070; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; Durston AJ, 1998, CURR TOP DEV BIOL, V40, P111, DOI 10.1016/S0070-2153(08)60366-X; Dyer MA, 2001, DEVELOPMENT, V128, P1717; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gratsch TE, 2002, DEV BIOL, V245, P83, DOI 10.1006/dbio.2002.0629; HOLLYDAY M, 1977, BRAIN RES, V132, P197, DOI 10.1016/0006-8993(77)90416-4; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; Li M, 1998, CURR BIOL, V8, P971, DOI 10.1016/S0960-9822(98)70399-9; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Mallamaci A, 1996, MECH DEVELOP, V58, P165, DOI 10.1016/S0925-4773(96)00571-0; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Muhr J, 1999, NEURON, V23, P689, DOI 10.1016/S0896-6273(01)80028-3; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; OBRIEN MK, 1990, J NEUROBIOL, V21, P313, DOI 10.1002/neu.480210207; Pattyn A, 2000, DEVELOPMENT, V127, P1349; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Rathjen J, 2002, DEVELOPMENT, V129, P2649; Renoncourt Y, 1998, MECH DEVELOP, V79, P185, DOI 10.1016/S0925-4773(98)00189-0; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; Sharma K, 2000, NATURE, V406, P515, DOI 10.1038/35020078; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; Wilson SI, 2000, CURR BIOL, V10, P421, DOI 10.1016/S0960-9822(00)00431-0; Wilson SI, 2001, NAT NEUROSCI, V4, P1161, DOI 10.1038/nn747; Wilson SI, 2001, NATURE, V411, P325, DOI 10.1038/35077115; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	61	1294	1402	2	123	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 9	2002	110	3					385	397		10.1016/S0092-8674(02)00835-8	http://dx.doi.org/10.1016/S0092-8674(02)00835-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	583MN	12176325	Bronze			2022-12-28	WOS:000177411800014
J	Gross, RA; Kalra, B				Gross, RA; Kalra, B			Biodegradable polymers for the environment	SCIENCE			English	Article							BLEND MISCIBILITY; CELLULOSE-ACETATE	Biodegradable polymers are designed to degrade upon disposal by the action of living organisms. Extraordinary progress has been made in the development of practical processes and products from polymers such as starch, cellulose, and lactic acid. The need to create alternative biodegradable water-soluble polymers for down-the-drain products such as detergents and cosmetics has taken on increasing importance. Consumers have, however, thus far attached little or no added value to the property of biodegradability, forcing industry to compete head-to-head on a cost-performance basis with existing familiar products. In addition, no suitable infrastructure for the disposal of biodegradable materials exists as yet.	Polytech Univ, Natl Sci Fdn, Ctr Biocatalysis & Bioproc Macromol, Brooklyn, NY 11201 USA	National Science Foundation (NSF); New York University; Polytechnic University Puerto Rico	Gross, RA (corresponding author), Polytech Univ, Natl Sci Fdn, Ctr Biocatalysis & Bioproc Macromol, 6 Metrotech Ctr, Brooklyn, NY 11201 USA.							[Anonymous], 1971, LACTIC ACID PROPERTI; Bastioli C, 1998, MACROMOL SYMP, V135, P193, DOI 10.1002/masy.19981350122; Bastioli C, 1998, POLYM DEGRAD STABIL, V59, P263, DOI 10.1016/S0141-3910(97)00156-0; BASTOLI C, 2001, ACT C BIRM UK 29 30; Buchanan CM, 1997, J ENVIRON POLYM DEGR, V5, P209; Buchanan CM, 1996, J ENVIRON POLYM DEGR, V4, P179, DOI 10.1007/BF02067452; COOK WJ, 1981, J POLYM SCI POL LETT, V19, P159, DOI 10.1002/pol.1981.130190402; DOI Y, 1994, P 3 INT SCI WORKSH B; Doi Y., 1990, MICROBIAL POLYESTERS; Grigat E, 1998, POLYM DEGRAD STABIL, V59, P223, DOI 10.1016/S0141-3910(97)00174-2; GROSS RA, 1995, J MACROMOL SCI PURE, VA32, P613, DOI 10.1080/10601329508010275; Guillet J., 1973, POLYM SCI TECHNOL, V3, P61; Kaplan D. L., 1993, BIODEGRADABLE POLYM, P1; Lowe C. E., 1954, [No title captured], Patent No. [2,668,162, 2668162, US2668162A]; Lunt J, 1998, POLYM DEGRAD STABIL, V59, P145, DOI 10.1016/S0141-3910(97)00148-1; Moore GF, 1997, ADV BIODEGRADABLE PO, V9; Steinbuchel A., 1991, BIOMATERIALS, P123, DOI DOI 10.1007/978-1-349-11167-1_3; TOKIWA Y, 1976, J FERMENT TECHNOL, V54, P603; WOODINGS C, 2001, NF NEW FIBRES; 2001, FRANKFURTER ALLGEMEI, P19	20	1340	1425	24	703	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2002	297	5582					803	807		10.1126/science.297.5582.803	http://dx.doi.org/10.1126/science.297.5582.803			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161646	Green Submitted			2022-12-28	WOS:000177192800040
J	Robinson, P; Harrison, RJ; McEnroe, SA; Hargraves, RB				Robinson, P; Harrison, RJ; McEnroe, SA; Hargraves, RB			Lamellar magnetism in the haematite-ilmenite series as an explanation for strong remanent magnetization	NATURE			English	Article							AEROMAGNETIC ANOMALIES; CUMULATE ROCKS; SOKNDAL REGION; SOUTH ROGALAND; HEMO-ILMENITE; NORWAY	Magnetic anomalies associated with slowly cooled igneous and metamorphic rocks are commonly attributed to the presence of the mineral magnetite. Although the intermediate members of the ilmenite-haematite mineral series can also carry a strong ferrimagnetic remanence(1), it is preserved only in rapidly cooled volcanic rocks, where formation of intergrowths of weakly magnetic haematite and paramagnetic ilmenite is suppressed. But the occurrence of unusually large and stable magnetic remanence in rocks containing such intergrowths has been known for decades(2-5), and has recently been the subject of intense investigation(6-10). These unmixed oxide phases have been shown to contain pervasive exsolution lamellae with thickness from 100 mum down to about 1 nm (one unit cell). These rocks, many of which contain only a few per cent of such oxides, show natural remanent magnetizations up to 30 A m(-1)-too strong to be explained even by pure haematite in an unsaturated state(11,12). Here we propose a new ferrimagnetic substructure created by ferrous-ferric 'contact layers' that reduce charge imbalance along lamellar contacts between antiferromagnetic haematite and paramagnetic ilmenite. We estimate that such a lamellar magnetic material can have a saturation magnetization up to 55 kA m(-1)-22 times stronger than pure haematite-while retaining the high coercivity and thermal properties of single-domain haematite.	Geol Survey Norway, N-7491 Trondheim, Norway; Univ Massachusetts, Dept Geosci, Amherst, MA 01003 USA; Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	Geological Survey of Norway; University of Massachusetts System; University of Massachusetts Amherst; University of Cambridge; Princeton University	Robinson, P (corresponding author), Geol Survey Norway, N-7491 Trondheim, Norway.		Harrison, Richard/R-8802-2019; Harrison, Richard J/B-3609-2010	Harrison, Richard/0000-0003-3469-762X; Harrison, Richard J/0000-0003-3469-762X; mcenroe, suzanne/0000-0002-0011-6156				Balsley J.R., 1958, ECON GEOL, V53, P777; BANERJEE SK, 1991, REV MINERAL, V25, P107; BURTON BP, 1991, REV MINERAL, V25, P303; CARMICHAEL C, 1961, PROC R SOC LON SER-A, V263, P508, DOI 10.1098/rspa.1961.0177; Dunlop D. J., 1997, ROCK MAGNETISM FUNDA; HARGRAVES RB, 1959, J GEOPHYS RES, V64, P1565, DOI 10.1029/JZ064i010p01565; Harrison RJ, 2000, REV MINERAL GEOCHEM, V39, P175; HARRISON RJ, 2001, SOLID SOLUTIONS SILI, V3, P349; ISHIKAWA Y, 1958, J PHYS SOC JPN, V13, P1298, DOI 10.1143/JPSJ.13.1298; Kletetschka G, 2002, TECTONOPHYSICS, V347, P167, DOI 10.1016/S0040-1951(01)00243-8; McEnroe SA, 2000, J GEOPHYS RES-SOL EA, V105, P16437, DOI 10.1029/2000JB900051; McEnroe SA, 2001, J GEOPHYS RES-SOL EA, V106, P30523, DOI 10.1029/2001JB000180; McEnroe SA, 2001, AM MINERAL, V86, P1447; McEnroe SA., 2000, NGU B, V436, P49; MCENROE SA, 1998, EOS, V79, pS362; MERRILL RT, 1969, J GEOPHYS RES, V74, P2014, DOI 10.1029/JB074i008p02014; MERRILL RT, 1968, J GEOMAGN GEOELECTR, V20, P181, DOI 10.5636/jgg.20.181; Robinson P, 2001, AM MINERAL, V86, P1469	18	193	197	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2002	418	6897					517	520		10.1038/nature00942	http://dx.doi.org/10.1038/nature00942			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152075				2022-12-28	WOS:000177162800036
J	O'Connell, MJ; Bachilo, SM; Huffman, CB; Moore, VC; Strano, MS; Haroz, EH; Rialon, KL; Boul, PJ; Noon, WH; Kittrell, C; Ma, JP; Hauge, RH; Weisman, RB; Smalley, RE				O'Connell, MJ; Bachilo, SM; Huffman, CB; Moore, VC; Strano, MS; Haroz, EH; Rialon, KL; Boul, PJ; Noon, WH; Kittrell, C; Ma, JP; Hauge, RH; Weisman, RB; Smalley, RE			Band gap fluorescence from individual single-walled carbon nanotubes	SCIENCE			English	Article							MOLECULAR-DYNAMICS; POLYMER; PHOTOLUMINESCENCE; ROPES; WATER	Fluorescence has been observed directly across the band gap of semiconducting carbon nanotubes. We obtained individual nanotubes, each encased in a cylindrical micelle, by ultrasonically agitating an aqueous dispersion of raw single-walled carbon nanotubes in sodium dodecyl sulfate and then centrifuging to remove tube bundles, ropes, and residual catalyst. Aggregation of nanotubes into bundles otherwise quenches the fluorescence through interactions with metallic tubes and substantially broadens the absorption spectra. At pH less than 5, the absorption and emission spectra of individual nanotubes show evidence of band gap selective protonation of the side walls of the tube. This protonation is readily reversed by treatment with base or ultraviolet light.	Rice Univ, Dept Chem, Rice Quantum Inst, Houston, TX 77005 USA; Rice Univ, Ctr Nanoscale Sci & Technol, Houston, TX 77005 USA; Rice Univ, Dept Phys, Houston, TX 77005 USA; Rice Univ, Dept Bioengn, Houston, TX 77005 USA; Baylor Coll Med, Grad Program Sturct & Computat Biol & Mol Biophys, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Rice University; Rice University; Rice University; Rice University; Baylor College of Medicine	Smalley, RE (corresponding author), Rice Univ, Dept Chem, Rice Quantum Inst, 6100 Main St, Houston, TX 77005 USA.		Bachilo, Sergei/ABC-4606-2020; Hauge, Robert H/A-7008-2011	Bachilo, Sergei/0000-0001-5236-1383; Hauge, Robert H/0000-0002-3656-0152; Weisman, R. Bruce/0000-0001-8546-9980				Ando T, 1997, J PHYS SOC JPN, V66, P1066, DOI 10.1143/JPSJ.66.1066; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; Bandow S, 1997, J PHYS CHEM B, V101, P8839, DOI 10.1021/jp972026r; Bandyopadhyay S, 1998, MOL PHYS, V95, P377, DOI 10.1080/00268979809483170; Bandyopadhyaya R, 2002, NANO LETT, V2, P25, DOI 10.1021/nl010065f; Brennan ME, 2001, SYNTHETIC MET, V119, P641, DOI 10.1016/S0379-6779(00)01416-8; Bronikowski MJ, 2001, J VAC SCI TECHNOL A, V19, P1800, DOI 10.1116/1.1380721; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chen J, 1998, SCIENCE, V282, P95, DOI 10.1126/science.282.5386.95; Chen RJ, 2001, APPL PHYS LETT, V79, P2258, DOI 10.1063/1.1408274; Dalton AB, 2000, J PHYS CHEM B, V104, P10012, DOI 10.1021/jp002857o; Dalton AB, 2001, SYNTHETIC MET, V121, P1217, DOI 10.1016/S0379-6779(00)00861-4; Dickey EC, 2001, APPL PHYS LETT, V79, P4022, DOI 10.1063/1.1419238; Dresselhaus M.S., 2001, CARBON NANOTUBES SYN, V80; Dresselhaus M.S., 1996, SCI FULLERENES CARBO; Duesberg GS, 1998, APPL PHYS A-MATER, V67, P117, DOI 10.1007/s003390050747; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Girifalco LA, 2000, PHYS REV B, V62, P13104, DOI 10.1103/PhysRevB.62.13104; JORGENSEN WL, 1981, J AM CHEM SOC, V103, P335, DOI 10.1021/ja00392a016; KARAULIS P, 1991, J APPL CRYSTALLOGR, V24, P946; Liu J, 1998, SCIENCE, V280, P1253, DOI 10.1126/science.280.5367.1253; O'Connell MJ, 2001, CHEM PHYS LETT, V342, P265, DOI 10.1016/S0009-2614(01)00490-0; Odom TW, 1998, NATURE, V391, P62, DOI 10.1038/34145; Reich S, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.155411; Riggs JE, 2000, J AM CHEM SOC, V122, P5879, DOI 10.1021/ja9942282; Saito R, 2000, PHYS REV B, V61, P2981, DOI 10.1103/PhysRevB.61.2981; Saito R., 1998, PHYS PROPERTIES CARB; Sun Y, 2001, J AM CHEM SOC, V123, P5348, DOI 10.1021/ja0041730; Sun YP, 2002, CHEM PHYS LETT, V351, P349, DOI 10.1016/S0009-2614(01)01404-X; Thess A, 1996, SCIENCE, V273, P483, DOI 10.1126/science.273.5274.483; Wildoer JWG, 1998, NATURE, V391, P59, DOI 10.1038/34139; Zhou W, 2001, CHEM PHYS LETT, V350, P6, DOI 10.1016/S0009-2614(01)01237-4	32	3274	3404	23	1182	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2002	297	5581					593	596		10.1126/science.1072631	http://dx.doi.org/10.1126/science.1072631			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142535				2022-12-28	WOS:000177054200048
J	Yang, XY; Zhang, FX; Kudlow, JE				Yang, XY; Zhang, FX; Kudlow, JE			Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: Coupling protein O-GlcNAcylation to transcriptional repression	CELL			English	Article							PROTEASOME-DEPENDENT DEGRADATION; HISTONE DEACETYLASE ACTIVITY; RNA-POLYMERASE-II; TETRATRICOPEPTIDE REPEATS; TERMINAL DOMAIN; N-COR; ORDERED RECRUITMENT; MEDIATED REPRESSION; IN-VITRO; CHROMATIN	Transcription factors and RNA polymerase II can be modified by O-linked N-acetylglucosamine (O-GlcNAc) monosaccharides at serine or threonine residues, yet the precise functional roles of this modification are largely unknown. Here, we show that O-GlcNAc transferase (OGT), the enzyme that catalyzes this post-translational modification, interacts with a histone deacetylase complex by binding to the corepressor mSin3A. Functionally, OGT and mSin3A cooperatively repress transcription in parallel with histone deacetylation. We propose that mSin3A targets OGT to promoters to inactivate transcription factors and RNA polymerase II by O-GlcNAc modification, which acts in concert with histone deacetylation to promote gene silencing in an efficient and specific manner.	Univ Alabama, Dept Med, Div Endocrinol & Metab, Dept Cell Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Kudlow, JE (corresponding author), Univ Alabama, Dept Med, Div Endocrinol & Metab, Dept Cell Biol, Birmingham, AL 35294 USA.							Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; Berger SL, 2001, SCIENCE, V292, P64; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Burke LJ, 2000, FASEB J, V14, P1876, DOI 10.1096/fj.99-0943rev; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Chen HW, 2001, CURR OPIN CELL BIOL, V13, P218, DOI 10.1016/S0955-0674(00)00200-3; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Glass CK, 2000, GENE DEV, V14, P121; Gregory PD, 2001, EXP CELL RES, V265, P195, DOI 10.1006/excr.2001.5187; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HERSCHBACH BM, 1994, NATURE, V370, P309, DOI 10.1038/370309a0; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kadosh D, 1998, GENE DEV, V12, P797, DOI 10.1101/gad.12.6.797; Kao HY, 2002, J BIOL CHEM, V277, P187, DOI 10.1074/jbc.M108931200; Kao HY, 2000, GENE DEV, V14, P55; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; KELLY WG, 1989, CELL, V57, P243, DOI 10.1016/0092-8674(89)90962-8; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Kouzarides T, 1999, CURR OPIN GENET DEV, V9, P40, DOI 10.1016/S0959-437X(99)80006-9; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Kuchin S, 1998, MOL CELL BIOL, V18, P1163, DOI 10.1128/MCB.18.3.1163; Kuzmichev A, 2001, CURR TOP MICROBIOL, V254, P35; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Laherty CD, 1998, MOL CELL, V2, P33, DOI 10.1016/S1097-2765(00)80111-2; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Moazed D, 2001, CURR OPIN CELL BIOL, V13, P232, DOI 10.1016/S0955-0674(00)00202-7; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Muller C, 2001, CURR OPIN GENET DEV, V11, P167, DOI 10.1016/S0959-437X(00)00175-1; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Pham AD, 2000, SCIENCE, V289, P2357, DOI 10.1126/science.289.5488.2357; Redd MJ, 1996, MOL CELL BIOL, V16, P2865; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Roos MD, 1997, MOL CELL BIOL, V17, P6472, DOI 10.1128/MCB.17.11.6472; Roose J, 2000, NAT IMMUNOL, V1, P275, DOI 10.1038/79713; Sekinger EA, 2001, CELL, V105, P403, DOI 10.1016/S0092-8674(01)00329-4; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Su KH, 1999, J BIOL CHEM, V274, P15194, DOI 10.1074/jbc.274.21.15194; Su KH, 2000, BIOCHEM J, V348, P281, DOI 10.1042/0264-6021:3480281; TZAMARIAS D, 1995, GENE DEV, V9, P821, DOI 10.1101/gad.9.7.821; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Watson AD, 2000, GENE DEV, V14, P2737, DOI 10.1101/gad.829100; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Wolffe AP, 2000, BIOCHEM SOC T, V28, P379, DOI 10.1042/0300-5127:0280379; Wong CW, 1998, MOL CELL BIOL, V18, P5500, DOI 10.1128/MCB.18.9.5500; Wu JS, 2001, MOL CELL, V7, P117, DOI 10.1016/S1097-2765(01)00160-5; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0	69	319	332	1	32	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 12	2002	110	1					69	80		10.1016/S0092-8674(02)00810-3	http://dx.doi.org/10.1016/S0092-8674(02)00810-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	573PU	12150998	Bronze			2022-12-28	WOS:000176840700008
J	MacGillivray, TE; Vlahakes, GJ				MacGillivray, TE; Vlahakes, GJ			Perspective - Angioplasty versus minimally invasive bypass surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	MacGillivray, TE (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.								0	2	2	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 22	2002	347	8					551	552		10.1056/NEJMp020078	http://dx.doi.org/10.1056/NEJMp020078			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587ZR	12192012				2022-12-28	WOS:000177675400001
J	Xia, XM; Zeng, XH; Lingle, CJ				Xia, XM; Zeng, XH; Lingle, CJ			Multiple regulatory sites in large-conductance calcium-activated potassium channels	NATURE			English	Article							CA2+-ACTIVATED K+ CHANNEL; BK CHANNELS; SKELETAL-MUSCLE; CA2+-DEPENDENT ACTIVATION; GATING KINETICS; RAT MUSCLE; VOLTAGE; CA2+; DOMAIN; SENSITIVITY	Large conductance, Ca2+- and voltage-activated K+ channels (BK) respond to two distinct physiological signals-membrane voltage and cytosolic Ca2+ (refs 1, 2). Channel opening is regulated by changes in Ca2+ concentration spanning 0.5 muM to 50 mM (refs 2-5), a range of Ca2+ sensitivity unusual among Ca2+ -regulated proteins. Although voltage regulation arises from mechanisms shared with other voltage-gated channels(6-8), the mechanisms of Ca2+ regulation remain largely unknown. One potential Ca2+-regulatory site, termed the 'Ca2+ bowl', has been located to the large cytosolic carboxy terminus(9-11). Here we show that a second region of the C terminus, the RCK domain (regulator of conductance for K+ (ref. 12)), contains residues that define two additional regulatory effects of divalent cations. One site, together with the Ca2+ bowl, accounts for all physiological regulation of BK channels by Ca2+; the other site contributes to effects of millimolar divalent cations that may mediate physiological regulation by cytosolic Mg2+ (refs 5, 13). Independent regulation by multiple sites explains the large concentration range over which BK channels are regulated by Ca2+. This allows BK channels to serve a variety of physiological roles contingent on the Ca2+ concentration to which the channels are exposed(14,15).	Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Lingle, CJ (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, Box 8054, St Louis, MO 63110 USA.			Lingle, Christopher/0000-0002-9916-3795				ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; BARRETT JN, 1982, J PHYSIOL-LONDON, V331, P211, DOI 10.1113/jphysiol.1982.sp014370; Bellamacina CR, 1996, FASEB J, V10, P1257, DOI 10.1096/fasebj.10.11.8836039; Bian S, 2001, P NATL ACAD SCI USA, V98, P4776, DOI 10.1073/pnas.081072398; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Cox DH, 2000, J GEN PHYSIOL, V116, P411, DOI 10.1085/jgp.116.3.411; Cox DH, 1997, J GEN PHYSIOL, V110, P257, DOI 10.1085/jgp.110.3.257; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; Cui JM, 2000, BIOCHEMISTRY-US, V39, P15612, DOI 10.1021/bi001509+; FERGUSON WB, 1991, J GEN PHYSIOL, V98, P163, DOI 10.1085/jgp.98.1.163; GOLOWASCH J, 1986, J EXP BIOL, V124, P5; Horrigan FT, 1999, J GEN PHYSIOL, V114, P277, DOI 10.1085/jgp.114.2.277; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Jones EMC, 1999, J PHYSIOL-LONDON, V518, P653, DOI 10.1111/j.1469-7793.1999.0653p.x; Lingle CJ, 2001, J GEN PHYSIOL, V117, P583, DOI 10.1085/jgp.117.6.583; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; MOCZYDLOWSKI E, 1983, J GEN PHYSIOL, V82, P511, DOI 10.1085/jgp.82.4.511; Moss BL, 2001, J GEN PHYSIOL, V118, P711, DOI 10.1085/jgp.118.6.711; OBERHAUSER A, 1988, J GEN PHYSIOL, V92, P67, DOI 10.1085/jgp.92.1.67; Rothberg BS, 1999, J GEN PHYSIOL, V114, P93, DOI 10.1085/jgp.114.1.93; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Schreiber M, 1999, NAT NEUROSCI, V2, P416, DOI 10.1038/8077; Schreiber M, 1998, J BIOL CHEM, V273, P3509, DOI 10.1074/jbc.273.6.3509; Shao LR, 1999, J PHYSIOL-LONDON, V521, P135, DOI 10.1111/j.1469-7793.1999.00135.x; SHEN KZ, 1994, PFLUG ARCH EUR J PHY, V426, P440, DOI 10.1007/BF00388308; Shi JY, 2001, J GEN PHYSIOL, V118, P589, DOI 10.1085/jgp.118.5.589; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; Xia XM, 1999, J NEUROSCI, V19, P5255, DOI 10.1523/jneurosci.19-13-05255.1999; Zhang X, 2001, J GEN PHYSIOL, V118, P607, DOI 10.1085/jgp.118.5.607	30	286	299	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2002	418	6900					880	884		10.1038/nature00956	http://dx.doi.org/10.1038/nature00956			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192411				2022-12-28	WOS:000177555600039
J	Humphrey, LL; Chan, BKS; Sox, HC				Humphrey, LL; Chan, BKS; Sox, HC			Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; ACUTE MYOCARDIAL-INFARCTION; SERVICES-TASK-FORCE; ESTROGEN-REPLACEMENT; FOLLOW-UP; SECONDARY PREVENTION; RISK-FACTORS; VENOUS THROMBOEMBOLISM; TREATMENT ADHERENCE; CIGARETTE-SMOKING	Purpose: To evaluate the value of hormone replacement therapy (HRT) in the primary prevention of cardiovascular disease (CVD) and coronary artery disease (CAD). Data Sources: MEDLINE and Cochrane databases were searched for all primary prevention studies reporting CVD or CAD incidence, mortality, or both in association with HRT; reference lists, letters, editorials, and reviews were also reviewed. Data Extraction: All studies were reviewed, abstracted, and rated for quality. Study Selection: Only studies of good or fair quality, according to U.S. Preventive Services Task Force (USPSTF) criteria, were included in the detailed review and meta-analysis. Data Synthesis: The summary relative risk with any HRT use was 0.75 (95% credible interval [Crl], 0.42 to 1.23) for CVD mortality and 0.74 (Crl, 0.36 to 1.45) for CAD mortality. The summary relative risk with any use was 1.28 (Crl, 0.86 to 2.00) for CVD incidence and 0.87 (Crl, 0.62 to 1.21) for CAD incidence. Further analysis of studies adjusting for socioeconomic status, as well as other major CAD risk factors, showed a summary relative risk of 1.07 (Crl, 0.79 to 1.48) for CAD incidence associated with any HRT use. Similar results were found when the analysis was stratified by studies adjusting for alcohol consumption, exercise, or both, in addition to other major risk factors, suggesting confounding by these factors. Conclusions: This meta-analysis differs from previous meta-analyses by evaluating potential explanatory variables of the relationship between HRT, CVD, and CAD. The adjusted meta-analysis is consistent with recent randomized trials that have shown no benefit in the secondary or primary prevention of CVD events. A valid answer to the role of HRT in the primary prevention of CVD will best come from randomized, controlled trials.	Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Amer Coll Physicians, Amer Soc Internal Med, Philadelphia, PA USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Oregon Health & Science University; American College of Physicians	Humphrey, LL (corresponding author), Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Portland, OR 97201 USA.				PHS HHS [290-97-0018] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ADAM S, 1981, BRIT MED J, V282, P1277, DOI 10.1136/bmj.282.6272.1277; Alexander KP, 2001, J AM COLL CARDIOL, V38, P1, DOI 10.1016/S0735-1097(01)01329-8; [Anonymous], 1994, Circulation, V89, P1333; Barrett-Connor E, 1998, ANNU REV PUBL HEALTH, V19, P55, DOI 10.1146/annurev.publhealth.19.1.55; BARRETTCONNOR E, 1991, ANN INTERN MED, V115, P455, DOI 10.7326/0003-4819-115-6-455; BEARD CM, 1989, MAYO CLIN PROC, V64, P1471, DOI 10.1016/S0025-6196(12)65702-4; BUSH TL, 1987, CIRCULATION, V75, P1102, DOI 10.1161/01.CIR.75.6.1102; Bush TL, 1996, EUR HEART J, V17, P9, DOI 10.1093/eurheartj/17.suppl_D.9; BYRD BF, 1977, ANN SURG, V185, P574, DOI 10.1097/00000658-197705000-00010; Cauley JA, 1997, ARCH INTERN MED, V157, P2181, DOI 10.1001/archinte.157.19.2181; CRIQUI MH, 1988, AM J EPIDEMIOL, V128, P606, DOI 10.1093/oxfordjournals.aje.a115008; CROFT P, 1989, BRIT MED J, V298, P165, DOI 10.1136/bmj.298.6667.165; Cushman M, 1999, CIRCULATION, V100, P717, DOI 10.1161/01.CIR.100.7.717; DERBY CA, 1995, AM J OBSTET GYNECOL, V173, P544, DOI 10.1016/0002-9378(95)90280-5; Eaker E, 1994, Heart Dis Stroke, V3, P114; Ettinger B, 1996, OBSTET GYNECOL, V87, P6, DOI 10.1016/0029-7844(95)00358-4; FALKEBORN M, 1992, BRIT J OBSTET GYNAEC, V99, P821, DOI 10.1111/j.1471-0528.1992.tb14414.x; FOLSOM AR, 1995, AM J PUBLIC HEALTH, V85, P1128, DOI 10.2105/AJPH.85.8_Pt_1.1128; GALLAGHER EJ, 1993, JAMA-J AM MED ASSOC, V270, P742, DOI 10.1001/jama.270.6.742; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; Grady D, 1998, CONTROL CLIN TRIALS, V19, P314, DOI 10.1016/S0197-2456(98)00010-5; Grodstein F, 1996, NEW ENGL J MED, V335, P453, DOI 10.1056/NEJM199608153350701; Grodstein F, 2001, ANN INTERN MED, V135, P1, DOI 10.7326/0003-4819-135-1-200107030-00003; Grodstein F, 1997, NEW ENGL J MED, V336, P1769, DOI 10.1056/NEJM199706193362501; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; HAMMOND CB, 1979, AM J OBSTET GYNECOL, V133, P525, DOI 10.1016/0002-9378(79)90288-6; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Heckbert SR, 2001, ARCH INTERN MED, V161, P1709, DOI 10.1001/archinte.161.14.1709; Heckbert SR, 1997, ARCH INTERN MED, V157, P1330, DOI 10.1001/archinte.157.12.1330; Hemminki E, 1997, BRIT MED J, V315, P149, DOI 10.1136/bmj.315.7101.149; HENDERSON BE, 1986, AM J OBSTET GYNECOL, V154, P1181, DOI 10.1016/0002-9378(86)90696-4; HENDERSON BE, 1991, ARCH INTERN MED, V151, P75, DOI 10.1001/archinte.151.1.75; HERNANDEZ AM, 1990, EPIDEMIOLOGY, V1, P128; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; HORWITZ RI, 1990, LANCET, V336, P542, DOI 10.1016/0140-6736(90)92095-Y; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; HUMPHREY LL, IN PRESS SYSTEMATIC; HUNT K, 1990, BRIT J OBSTET GYNAEC, V97, P1080, DOI 10.1111/j.1471-0528.1990.tb02494.x; JICK H, 1978, JAMA-J AM MED ASSOC, V239, P1407, DOI 10.1001/jama.239.14.1407; LAFFERTY FW, 1994, AM J MED, V97, P66, DOI 10.1016/0002-9343(94)90050-7; LAVECCHIA C, 1987, AM J EPIDEMIOL, V125, P832, DOI 10.1093/oxfordjournals.aje.a114599; LENFANT C, 2000, NHLBI DIRECTOR PRELI; Lowe G, 2000, THROMB HAEMOSTASIS, V83, P530; MANN RD, 1994, J CLIN EPIDEMIOL, V47, P307, DOI 10.1016/0895-4356(94)90014-0; Matthews KA, 1996, AM J EPIDEMIOL, V143, P971; MCMAHON B, 1978, CORONARY HEART DIS Y; Miller J, 2002, ANN INTERN MED, V136, P680, DOI 10.7326/0003-4819-136-9-200205070-00011; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; NACHTIGALL LE, 1979, OBSTET GYNECOL, V54, P74, DOI 10.1097/00006250-197907000-00017; *NIH, 2001, HRT UPD; Persson I, 1997, J CLIN EPIDEMIOL, V50, P611, DOI 10.1016/S0895-4356(97)00004-8; Petitti DB, 1998, JAMA-J AM MED ASSOC, V280, P650, DOI 10.1001/jama.280.7.650; PETITTI DB, 1987, OBSTET GYNECOL, V70, P289; PFEFFER RI, 1978, AM J EPIDEMIOL, V107, P479, DOI 10.1093/oxfordjournals.aje.a112567; Price DT, 1997, ANN INTERN MED, V127, P895, DOI 10.7326/0003-4819-127-10-199711150-00007; PSATY BM, 1994, ARCH INTERN MED, V154, P1333, DOI 10.1001/archinte.154.12.1333; Psaty BM, 2001, JAMA-J AM MED ASSOC, V285, P906, DOI 10.1001/jama.285.7.906; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; ROSE G, 1981, BRIT HEART J, V45, P13, DOI 10.1136/hrt.45.1.13; ROSENBERG L, 1993, AM J EPIDEMIOL, V137, P54, DOI 10.1093/oxfordjournals.aje.a116602; ROSS RK, 1981, LANCET, V1, P858; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schairer C, 1997, EPIDEMIOLOGY, V8, P59, DOI 10.1097/00001648-199701000-00010; Shlipak MG, 2000, JAMA-J AM MED ASSOC, V283, P1845, DOI 10.1001/jama.283.14.1845; Sidney S, 1997, ANN INTERN MED, V127, P501, DOI 10.7326/0003-4819-127-7-199710010-00001; Sourander L, 1998, LANCET, V352, P1965, DOI 10.1016/S0140-6736(98)05066-1; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102; STAMPFER MJ, 1991, PREV MED, V20, P47, DOI 10.1016/0091-7435(91)90006-P; STAMPFER MJ, 1985, NEW ENGL J MED, V313, P1044, DOI 10.1056/NEJM198510243131703; STURGEON SR, 1995, EPIDEMIOLOGY, V6, P227, DOI 10.1097/00001648-199505000-00006; SUTTON AJ, 2000, METHODS META ANALYSI; SZKLO M, 1984, PREV MED, V13, P510, DOI 10.1016/0091-7435(84)90019-7; TAKANO L, 2001, J GEN INTERN MED S1, V16, P177; TALBOTT E, 1977, AM J CARDIOL, V39, P858, DOI 10.1016/S0002-9149(77)80040-4; THOMPSON SG, 1989, J EPIDEMIOL COMMUN H, V43, P173, DOI 10.1136/jech.43.2.173; VANDENBROUCKE JP, 1995, EPIDEMIOLOGY, V6, P207; Varas-Lorenzo C, 2000, CIRCULATION, V101, P2572, DOI 10.1161/01.CIR.101.22.2572; Viscoli CM, 2001, NEW ENGL J MED, V345, P1243, DOI 10.1056/NEJMoa010534; Wenger NK, 2000, JAMA-J AM MED ASSOC, V284, P41, DOI 10.1001/jama.284.1.41-a; WILSON PWF, 1985, NEW ENGL J MED, V313, P1038, DOI 10.1056/NEJM198510243131702; WOLF PH, 1991, AM J OBSTET GYNECOL, V164, P489, DOI 10.1016/S0002-9378(11)80006-2	81	210	212	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2002	137	4					273	284		10.7326/0003-4819-137-4-200208200-00012	http://dx.doi.org/10.7326/0003-4819-137-4-200208200-00012			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585BB	12186518				2022-12-28	WOS:000177502300008
J	Elowitz, MB; Levine, AJ; Siggia, ED; Swain, PS				Elowitz, MB; Levine, AJ; Siggia, ED; Swain, PS			Stochastic gene expression in a single cell	SCIENCE			English	Article							ESCHERICHIA-COLI; BACTERIOPHAGE-LAMBDA; CHEMOTAXIS; PROMOTERS; NETWORKS; SYSTEM; NOISE	Clonal populations of cells exhibit substantial phenotypic variation. Such heterogeneity can be essential for many biological processes and is conjectured to arise from stochasticity, or noise, in gene expression. We constructed strains of Escherichia coli that enable detection of noise and discrimination between the two mechanisms by which it is generated. Both stochasticity inherent in the biochemical process of gene expression (intrinsic noise) and fluctuations in other cellular components (extrinsic noise) contribute substantially to overall variation. Transcription rate, regulatory dynamics, and genetic factors control the amplitude of noise. These results establish a quantitative foundation for modeling noise in genetic networks and reveal how low intracellular copy numbers of molecules can fundamentally limit the precision of gene regulation.	Rockefeller Univ, Canc Biol Lab, New York, NY 10021 USA; Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Elowitz, MB (corresponding author), Rockefeller Univ, Canc Biol Lab, 1230 York Ave, New York, NY 10021 USA.		Swain, Peter S/AAW-3265-2020	Swain, Peter/0000-0001-7489-8587	NIGMS NIH HHS [GM59018] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059018] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Boyd D, 2000, J BACTERIOL, V182, P842, DOI 10.1128/JB.182.3.842-847.2000; Capaldo F N, 1975, Basic Life Sci, V5A, P405; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; DEUSCHLE U, 1986, EMBO J, V5, P2987, DOI 10.1002/j.1460-2075.1986.tb04596.x; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fiering S, 2000, BIOESSAYS, V22, P381, DOI 10.1002/(SICI)1521-1878(200004)22:4<381::AID-BIES8>3.0.CO;2-E; GUPTASARMA P, 1995, BIOESSAYS, V17, P987, DOI 10.1002/bies.950171112; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; KO MSH, 1992, BIOESSAYS, V14, P341, DOI 10.1002/bies.950140510; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; MALONEY PC, 1973, J MOL BIOL, V73, P77, DOI 10.1016/0022-2836(73)90160-5; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; MEYER BJ, 1980, J MOL BIOL, V139, P163, DOI 10.1016/0022-2836(80)90303-4; Miller J.H., 1992, SHORT COURSE BACTERI, P150; PARKINSON JS, 1982, J BACTERIOL, V151, P106, DOI 10.1128/JB.151.1.106-113.1982; Paulsson J, 2001, Q REV BIOPHYS, V34, P1, DOI 10.1017/S0033583501003663; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; SWAIN PS, IN PRESS P NATL ACAD; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	24	3580	3664	14	545	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2002	297	5584					1183	1186		10.1126/science.1070919	http://dx.doi.org/10.1126/science.1070919			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183631				2022-12-28	WOS:000177447600051
J	Marsh, JL; Hutton, JL; Binks, K				Marsh, JL; Hutton, JL; Binks, K			Removal of radiation dose response effects: an example of over-matching	BRITISH MEDICAL JOURNAL			English	Article							BRITISH-NUCLEAR-FUELS; SELLAFIELD PLANT; CANCER MORTALITY; WORKERS; MORBIDITY		Westlakes Sci Consulting, Occupat Hlth & Med Stat, Moor Row CA24 3LN, Cumbria, England; Univ Newcastle Upon Tyne, Dept Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Marsh, JL (corresponding author), Univ Warwick, Dept Stat, Coventry CV4 7AL, W Midlands, England.							BRESLOW NE, 1980, IARC SCI PUBL, V1, P94; *COMM BIOL EFF ION, 1990, HLTH EFF EXP LOW LEV; DOUGLAS AJ, 1994, BRIT J CANCER, V70, P1232, DOI 10.1038/bjc.1994.479; Omar RZ, 1999, BRIT J CANCER, V79, P1288, DOI 10.1038/sj.bjc.6690207; *SAS I, 2000, SAS STAT US GUID VER, P2569; SMITH PG, 1986, BRIT MED J, V293, P845, DOI 10.1136/bmj.293.6551.845	6	23	24	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 10	2002	325	7359					327	330		10.1136/bmj.325.7359.327	http://dx.doi.org/10.1136/bmj.325.7359.327			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	584RQ	12169512	Green Published			2022-12-28	WOS:000177482500023
J	Brashear, A; Gordon, MF; Elovic, E; Kassicieh, VD; Marciniak, C; Lee, CH; Jenkins, S; Turkel, C				Brashear, A; Gordon, MF; Elovic, E; Kassicieh, VD; Marciniak, C; Lee, CH; Jenkins, S; Turkel, C		Botox Post Stroke Spasticity Study	Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLACEBO-CONTROLLED TRIAL; UPPER-LIMB SPASTICITY; DOUBLE-BLIND; MANAGEMENT; BURDEN; INJURY; ARM	Background Spasticity is a disabling complication of stroke, and it is uncertain whether intramuscular injections of botulinum toxin type A reduce disability in persons with spasticity of the wrist and fingers after a stroke. Methods We performed a randomized, double-blind, placebo-controlled, multicenter trial to assess the efficacy and safety of one-lime injections of botulinum toxin A (200 to 240 units) in 126 subjects with increased flexor tone in the wrist and fingers after a stroke. The primary outcome measure was self-reported disability in four areas: personal hygiene, dressing, pain, and limb position (on a four-point scale ranging from no disability to severe disability) at six weeks; at base line, each subject selected one of these areas in which there was moderate-to-severe disability as the principal target of treatment. Results Subjects who received botulinum toxin A had greater improvement in flexor tone in the wrist and fingers at all follow-up visits through 12 weeks than did subjects who received placebo (P < 0.001 for all comparisons). Subjects treated with botulinum toxin A had greater improvement in the principal target of treatment at weeks 4, 6, 8, and 12 (P < 0.001, P < 0.001, P = 0.03, and P = 0.02, respectively); at week 6, 40 of the 64 subjects in the botulinum-toxin group (62 percent), as compared with 17 of the 62 in the placebo group (27 percent), reported improvement of at least one point on the Disability Assessment Scale in the principal target of treatment (P < 0.001). There were no major adverse events associated with injection of botulinum toxin A. Conclusions Intramuscular injections of botulinum toxin A reduce spasticity of the wrist and finger muscles and associated disability in patients who have had a stroke.	Indiana Univ, Sch Med, Dept Neurol, Indianapolis, IN 46202 USA; Long Isl Jewish Med Ctr, Dept Neurol & Psychiat, New Hyde Pk, NY 11042 USA; Kessler Med Rehabil Res Educ Corp, Traumat Brain Injury Res Lab, W Orange, NJ USA; Neurol Res Inst, Sarasota, FL USA; Rehabil Inst Chicago, Chicago, IL 60611 USA; Allergan, Irvine, CA USA	Indiana University System; Indiana University-Purdue University Indianapolis; Northwell Health; Kessler Institute for Rehabilitation; Shirley Ryan AbilityLab; AbbVie; Allergan	Brashear, A (corresponding author), Indiana Univ Hosp, Dept Neurol, 550 N Univ Blvd,Rm 6620, Indianapolis, IN 46202 USA.	abrashea@iupui.edu	Brashear, Allison/G-3853-2015	Marciniak, Christina/0000-0003-3300-0050				ALBRIGHT AL, 1993, JAMA-J AM MED ASSOC, V270, P2475, DOI 10.1001/jama.270.20.2475; ASHWORTH B, 1964, PRACTITIONER, V192, P540; Bakheit A, 1996, CRITICAL REV PHYSICA, V8, P235, DOI 10.1615/critrevphysreha-bilmed.v8.i3.50; Bakheit AMO, 2000, STROKE, V31, P2402, DOI 10.1161/01.STR.31.10.2402; Bhakta BB, 2000, J NEUROL NEUROSUR PS, V69, P217, DOI 10.1136/jnnp.69.2.217; BRASHEAR A, IN PRESS ARCH PHYS M; Brin M F, 1997, Muscle Nerve Suppl, V6, pS208; Childers MK, 1999, NEUROLOGY, V52, pA295; Gordon MF, 2002, NEUROLOGY, V58, pA221; Gormley ME, 1997, MUSCLE NERVE, pS14; Hatheway C, 1994, THERAPY BOTULINUM TO, P93; KLAINMAN MD, 1997, TRAUMA, V39, P33; KURTZKE JF, 1982, NEUROLOGY, V32, P1207, DOI 10.1212/WNL.32.11.1207; Lagalla G, 2000, AM J PHYS MED REHAB, V79, P377, DOI 10.1097/00002060-200007000-00010; LANDAU WM, 1974, ARCH NEUROL-CHICAGO, V31, P217; MAYER NH, 1997, MUSCLE NERVE       S, V6, P21; Naumann M, 2002, J NEUROL, V249, P57, DOI 10.1007/PL00007848; Richardson D, 2000, J NEUROL NEUROSUR PS, V69, P499, DOI 10.1136/jnnp.69.4.499; Sampaio C, 1997, CLIN REHABIL, V11, P3, DOI 10.1177/026921559701100102; Simpson DM, 1996, NEUROLOGY, V46, P1306, DOI 10.1212/WNL.46.5.1306; Smith SJ, 2000, CLIN REHABIL, V14, P5, DOI 10.1191/026921500666642221; Wissel J, 2000, J PAIN SYMPTOM MANAG, V20, P44, DOI 10.1016/S0885-3924(00)00146-9; YOUNG RR, 1994, NEUROLOGY, V44, P12	23	415	443	1	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 8	2002	347	6					395	400		10.1056/NEJMoa011892	http://dx.doi.org/10.1056/NEJMoa011892			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587YR	12167681				2022-12-28	WOS:000177672400003
J	Spitzer, D				Spitzer, D			Uphill falling	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	2002	288	5					548	548		10.1001/jama.288.5.548	http://dx.doi.org/10.1001/jama.288.5.548			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	581FJ	12150653				2022-12-28	WOS:000177280200001
J	Birrer, M; Baumgartner, I				Birrer, M; Baumgartner, I			Work-related vascular injuries of the hand - Hypothenar hammer syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Spital Bern, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern	Birrer, M (corresponding author), Univ Spital Bern, CH-3010 Bern, Switzerland.								0	7	7	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2002	347	5					339	339		10.1056/NEJMicm010297	http://dx.doi.org/10.1056/NEJMicm010297			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587WC	12151471				2022-12-28	WOS:000177665900006
J	Marsicano, G; Wotjak, CT; Azad, SC; Bisogno, T; Rammes, G; Cascio, MG; Hermann, H; Tang, JR; Hofmann, C; Zieglgansberger, W; Di Marzo, V; Lutz, B				Marsicano, G; Wotjak, CT; Azad, SC; Bisogno, T; Rammes, G; Cascio, MG; Hermann, H; Tang, JR; Hofmann, C; Zieglgansberger, W; Di Marzo, V; Lutz, B			The endogenous cannabinoid system controls extinction of aversive memories	NATURE			English	Article							BASOLATERAL AMYGDALA; PREFRONTAL CORTEX; MOUSE-BRAIN; RECEPTOR; MICE; FEAR; CB1; TRANSMISSION; ENHANCEMENT; ANTAGONIST	Acquisition and storage of aversive memories is one of the basic principles of central nervous systems throughout the animal kingdom(1). In the absence of reinforcement, the resulting behavioural response will gradually diminish to be finally extinct. Despite the importance of extinction(2), its cellular mechanisms are largely unknown. The cannabinoid receptor 1 (CB1)(3) and endocannabinoids(4) are present in memory-related brain areas(5,6) and modulate memory(7,8). Here we show that the endogenous cannabinoid system has a central function in extinction of aversive memories. CB1-deficient mice showed strongly impaired short-term and long-term extinction in auditory fear-conditioning tests, with unaffected memory acquisition and consolidation. Treatment of wild-type mice with the CB1 antagonist SR141716A mimicked the phenotype of CB1-deficient mice, revealing that CB1 is required at the moment of memory extinction. Consistently, tone presentation during extinction trials resulted in elevated levels of endocannabinoids in the basolateral amygdala complex,a region known to control extinction of aversive memories(9). In the basolateral amygdala, endocannabinoids and CB1 were crucially involved in long-term depression of GABA (gamma-aminobutyric acid)-mediated inhibitory currents. We propose that endocannabinoids facilitate extinction of aversive memories through their selective inhibitory effects on local inhibitory networks in the amygdala.	Max Planck Inst Psychiat, Mol Genet Behav Grp, D-80804 Munich, Germany; Max Planck Inst Psychiat, Neuronal Plast Mouse Behav Grp, D-80804 Munich, Germany; Max Planck Inst Psychiat, Neuropharmacol Grp, D-80804 Munich, Germany; Univ Munich, Klinikum Grosshadern, Clin Anaesthesiol, D-81377 Munich, Germany; CNR, Inst Biomol Chem, Endocannabinoid Res Grp, I-80078 Naples, Italy; GSF, Natl Res Ctr Environm & Hlth, Inst Mammalian Genet, D-85764 Neuherberg, Germany	Max Planck Society; Max Planck Society; Max Planck Society; University of Munich; Consiglio Nazionale delle Ricerche (CNR); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Lutz, B (corresponding author), Max Planck Inst Psychiat, Mol Genet Behav Grp, Kraepelinstr 2-10, D-80804 Munich, Germany.		Lutz, Beat/AFK-6229-2022; Wotjak, Carsten T./S-3200-2019; Bisogno, Tiziana/B-7891-2015; Lutz, Beat/AAG-4538-2022; Di Marzo, Vincenzo/AAD-7742-2019	Di Marzo, Vincenzo/0000-0002-1490-3070; Marsicano, Giovanni/0000-0003-3804-1951				Collins DR, 1999, J NEUROSCI, V19, P836; Davis M., 2000, CONT ISSUES MODELING, P113, DOI [DOI 10.1007/978-1-4757-4860-4_8, 10.1007/978-1-4757-4860-4_8]; de Fonseca FR, 1998, NEUROBIOL DIS, V5, P483, DOI 10.1006/nbdi.1998.0217; Di Marzo V, 2000, J NEUROCHEM, V75, P2434, DOI 10.1046/j.1471-4159.2000.0752434.x; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; El-Ghundi M, 2001, BRAIN RES, V892, P86, DOI 10.1016/S0006-8993(00)03234-0; FALLS WA, 1992, J NEUROSCI, V12, P854; FRANKLIN KBJ, 1997, MOUSE BRAIN; Hampson RE, 1998, NEUROBIOL DIS, V5, P474, DOI 10.1006/nbdi.1998.0223; Harris JA, 1998, PSYCHOPHARMACOLOGY, V140, P105, DOI 10.1007/s002130050745; Katona I, 2001, J NEUROSCI, V21, P9506, DOI 10.1523/JNEUROSCI.21-23-09506.2001; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lu KT, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0005.2001; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; MCGAUGH JL, 1990, BEHAV NEUROSCI, V104, P264, DOI 10.1037/0735-7044.104.2.264; Medina JF, 2002, NAT REV NEUROSCI, V3, P122, DOI 10.1038/nrn728; MORGAN MA, 1993, NEUROSCI LETT, V163, P109, DOI 10.1016/0304-3940(93)90241-C; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Pertwee RG, 2001, PROG NEUROBIOL, V63, P569, DOI 10.1016/S0301-0082(00)00031-9; Petitet F, 1999, EUR J PHARMACOL, V374, P417, DOI 10.1016/S0014-2999(99)00189-2; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; Rammes G, 2000, EUR J NEUROSCI, V12, P2534, DOI 10.1046/j.1460-9568.2000.00108.x; Rammes G, 2001, NEUROSCIENCE, V107, P85, DOI 10.1016/S0306-4522(01)00336-0; Reibaud M, 1999, EUR J PHARMACOL, V379, pR1, DOI 10.1016/S0014-2999(99)00496-3; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Royer S, 1999, J NEUROSCI, V19, P10575; Santini E, 2001, J NEUROSCI, V21, P9009, DOI 10.1523/JNEUROSCI.21-22-09009.2001; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076	30	1302	1338	1	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2002	418	6897					530	534		10.1038/nature00839	http://dx.doi.org/10.1038/nature00839			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152079				2022-12-28	WOS:000177162800040
J	White, IR; Altmann, DR; Nanchahal, K				White, IR; Altmann, DR; Nanchahal, K			Alcohol consumption and mortality: modelling risks for men and women at different ages	BRITISH MEDICAL JOURNAL			English	Article							ALL-CAUSE MORTALITY; CORONARY HEART-DISEASE; CARDIOVASCULAR-DISEASE; DRINKING PATTERNS; METAANALYSIS; CONSEQUENCES; INFARCTION; HEALTH	Objective To estimate the relation between alcohol consumption and risk of death, the level of alcohol consumption at which risk is least, and how these vary with age and sex, Design Analysis using published systematic reviews and population data, Setting England and Wales in 1997. Main outcome measures Death from any of the following causes: cancer of lip, oral cavity, pharynx, oesophagus, colon, rectum, liver, larynx, and breast, essential hypertension, coronary heart disease, stroke, cirrhosis, non-cirrhotic chronic liver disease, chronic pancreatitis, and injuries. Results A direct dose-response relation exists between alcohol consumption and risk of death in women aged 16-54 and in men aged 16-34. At older ages the relation is U shaped. The level at which the risk is lowest increases with age, reaching 3 units a week in women aged over 65 and 8 units a week in men aged over 65. The level at which die risk is increased by 51% above this minimum is 8 units a week in women aged 16-24 and 5 units a week in men aged 16-24, increasing to 20 and 34 units a week in women and men aged over 65, respectively. Conclusions Substantially increased risks of all cause mortality can occur even in people drinking lower than recommended limits, and especially among younger people.	Univ London London Sch Hyg & Trop Med, Med Stat Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	White, IR (corresponding author), Inst Publ Hlth, Biostat Unit, MRC, Cambridge CB2 2SR, England.			Nanchahal, Kiran/0000-0001-8812-7628; White, Ian/0000-0002-6718-7661				ANDERSON P, 1993, ADDICTION, V88, P1493, DOI 10.1111/j.1360-0443.1993.tb03135.x; ANDREASSON S, 1991, BRIT J ADDICT, V86, P877; BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P16, DOI 10.1136/jnnp.53.1.16; Beaglehole R, 1992, Drug Alcohol Rev, V11, P275, DOI 10.1080/09595239200185811; Bondy SJ, 1996, ADDICTION, V91, P1663; Britton A, 2001, J EPIDEMIOL COMMUN H, V55, P383, DOI 10.1136/jech.55.6.383; Chick J, 1998, ALCOHOL ALCOHOLISM, V33, P576, DOI 10.1093/alcalc/33.6.576; Corrao G, 2000, ADDICTION, V95, P1505, DOI 10.1046/j.1360-0443.2000.951015056.x; Corrao G, 1999, ADDICTION, V94, P1551, DOI 10.1046/j.1360-0443.1999.9410155111.x; Davison AC, 1997, BOOTSTRAP METHODS TH; Dawson DA, 1998, ADDICTION, V93, P965; DOLL R, 1994, BRIT MED J, V309, P911, DOI 10.1136/bmj.309.6959.911; English D.R., 1995, QUANTIFICATION DRUG; FUCHS CS, 1995, NEW ENGL J MED, V332, P1245, DOI 10.1056/NEJM199505113321901; GROBBEE DE, 1999, HLTH ISSUES RELATED, P126; Holman CDJ, 1996, MED J AUSTRALIA, V164, P141, DOI 10.5694/j.1326-5377.1996.tb122011.x; HOLMAN CDJ, 1992, MED J AUSTRALIA, V157, P560, DOI 10.5694/j.1326-5377.1992.tb137360.x; HOLMAN CDJ, 1988, QUANTIFICATION DRUG; *INT WORK GROUP, 1995, SENS DRINK; KLATSKY AL, 1994, ALCOHOL CLIN EXP RES, V18, P88, DOI 10.1111/j.1530-0277.1994.tb00886.x; MACLURE M, 1993, EPIDEMIOL REV, V15, P328, DOI 10.1093/oxfordjournals.epirev.a036124; MARMOT M, 1991, BMJ-BRIT MED J, V303, P565, DOI 10.1136/bmj.303.6802.565; MCPHERSON K, 1999, HLTH ISSUES RELATED, P215; Murray J.L., 1996, GLOBAL BURDEN DIS CO; *OFF NAT STAT, 1997, 20 CENT MORT 95 YEAR; *OFF NAT STAT SOC, 1998, GEN HOUS SURV 1996 1; PERNANEN K, 1974, RES ADV ALCOHOL DRUG, V1; POIKOLAINEN K, 1995, J CLIN EPIDEMIOL, V48, P455, DOI 10.1016/0895-4356(94)00174-O; Puddey IB, 1999, ADDICTION, V94, P649, DOI 10.1046/j.1360-0443.1999.9456493.x; REHM J, 1995, ADDICTION, V90, P471, DOI 10.1046/j.1360-0443.1995.9044712.x; Rehm J, 1996, ADDICTION, V91, P1615; Rehm J, 2000, ADDICTION, V95, P989, DOI 10.1046/j.1360-0443.2000.9579891.x; REHM J, 1998, ALCOHOL CARDIOVASCUL; REHM J, 1998, NOV FDN S; Royal Colleges of Physicians Psychiatrists and General Practitioners, 1995, ALC HEART PERSP SENS; VANGIJN J, 1993, HLTH ISSUES RELATED, P43; White IR, 1999, J CLIN EPIDEMIOL, V52, P967, DOI 10.1016/S0895-4356(99)00076-1; WHITE IR, 2000, OPTIMAL LEVELS ALCOH; WHITE IR, 1997, NUMBER DEATHS PERSON	39	147	153	0	12	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 27	2002	325	7357					191	194		10.1136/bmj.325.7357.191	http://dx.doi.org/10.1136/bmj.325.7357.191			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	580PX	12142306	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000177243900017
J	Bakker, HJ; Nienhuys, HK				Bakker, HJ; Nienhuys, HK			Delocalization of protons in liquid water	SCIENCE			English	Article							MOLECULAR-DYNAMICS SIMULATION; VIBRATIONAL-ENERGY; RELAXATION; SOLVATION; TRANSPORT; MODEL; IONS; BOND	We find that the vibrational potential of the O-H stretch vibrations of liquid water shows extreme anharmonicity that arises from the O-H...hydrogen bond interaction. We observe that already in the second excited state of the O-H stretch vibration, the hydrogen atom becomes delocalized between the oxygen atoms of two neighboring water molecules. The energy required for this delocalization is unexpectedly low and corresponds to less than 20% of the dissociation energy of the O-H bond of the water molecule in the gas phase.	FOM, Inst Atom & Mol Phys, NL-1098 SJ Amsterdam, Netherlands	AMOLF	Bakker, HJ (corresponding author), FOM, Inst Atom & Mol Phys, Kruislaan 407, NL-1098 SJ Amsterdam, Netherlands.	bakker@amolf.nl						Atkins P., 1998, PHYS CHEM, P834; Dahlquist G., 1974, NUMERICAL METHODS; de Grotthuss CJT, 2006, BBA-BIOENERGETICS, V1757, P871, DOI 10.1016/j.bbabio.2006.07.004; Deak JC, 2000, J PHYS CHEM A, V104, P4866, DOI 10.1021/jp99442h; Franks F., 1972, WATER COMPREHENSIVE; Gale GM, 1999, PHYS REV LETT, V82, P1068, DOI 10.1103/PhysRevLett.82.1068; Geissler PL, 2001, SCIENCE, V291, P2121, DOI 10.1126/science.1056991; GRAENER H, 1993, J CHEM PHYS, V98, P36, DOI 10.1063/1.464629; KUBO R, 1995, STAT PHYSICS, V2; Laenen R, 1998, PHYS REV LETT, V80, P2622, DOI 10.1103/PhysRevLett.80.2622; LIPPINCOTT ER, 1955, J CHEM PHYS, V23, P1099, DOI 10.1063/1.1742196; Lock AJ, 2001, J PHYS CHEM A, V105, P1238, DOI 10.1021/jp003158e; LUCK WAP, 1991, CAN J CHEM, V69, P1819, DOI 10.1139/v91-266; Marx D, 1999, NATURE, V397, P601, DOI 10.1038/17579; MIKENDA W, 1986, J MOL STRUCT, V147, P1, DOI 10.1016/0022-2860(86)87054-5; NATZLE WC, 1985, J PHYS CHEM-US, V89, P2605, DOI 10.1021/j100258a035; Novak, 1974, STRUCT BOND, P177, DOI [10.1007/BFb0116438, DOI 10.1007/BFB0116438]; Stenger J, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.027401; TUCKERMAN M, 1995, J CHEM PHYS, V103, P150, DOI 10.1063/1.469654; TUCKERMAN M, 1995, J PHYS CHEM-US, V99, P5749, DOI 10.1021/j100016a003; Woutersen S, 1998, PHYS REV LETT, V81, P1106, DOI 10.1103/PhysRevLett.81.1106; Woutersen S, 1999, NATURE, V402, P507, DOI 10.1038/990058; Woutersen S, 1999, PHYS REV LETT, V83, P2077, DOI 10.1103/PhysRevLett.83.2077; Woutersen S, 1997, SCIENCE, V278, P658, DOI 10.1126/science.278.5338.658	24	117	119	5	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2002	297	5581					587	590		10.1126/science.1073298	http://dx.doi.org/10.1126/science.1073298			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142533				2022-12-28	WOS:000177054200046
J	Taddio, A; Shah, V; Gilbert-MacLeod, C; Katz, J				Taddio, A; Shah, V; Gilbert-MacLeod, C; Katz, J			Conditioning and hyperalgesia in newborns exposed to repeated heel lances	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEONATAL CIRCUMCISION; PAIN; INFANTS; DETERMINANTS; CRY; VACCINATION; REACTIVITY; CHILDREN	Context Hospitalized infants undergo repeated invasive procedures. It is unknown whether cumulative experiences with pain lead to anticipatory pain behaviors and hyperalgesia. Objectives To determine whether newborns who are born to mothers with diabetes and undergo repeated pain learn to anticipate pain and exhibit more pain during a painful procedure than normal infants. Design, Setting, and Participants Prospective cohort study of 21 full-term newborns born to mothers with diabetes and 21 born to mothers with uneventful pregnancies, at a university teaching hospital between August 1999 and October 2000. Infants of diabetic mothers underwent repeated heel lances in the first 24 to 36 hours of life for monitoring of blood glucose concentrations. Pain responses of all infants undergoing a venipuncture on the dorsum of the hand to obtain blood for the newborn screening test after the first day of life were compared. In addition, from September through November 2001, 12 infants of diabetic mothers and 12 normal infants were compared for pain reactions to intramuscular vitamin K injection after birth. Main Outcome Measures Percentages of time observed grimacing and crying and visual analog scale WAS) scores. Results Raters were blinded to exposure group. Median baseline scores for grimacing, crying time, and VAS did not differ significantly between groups (P=.27, P=.32, and P=.32, respectively). Median scores (interquartile range) for grimacing during skin cleansing were higher in infants of diabetic mothers (22.2% [77.5%] vs 0% [15%]; P=.03). The VAS scores for both groups were zero, but the distribution of the scores was significantly different (86% of normal infants vs 52% of infants of diabetic mothers had scores of zero) (P=.04). During venipuncture, infants of diabetic mothers had higher median scores for grimacing (81.7% [32.5%] vs 40% [73.4%]; P=.01), VAS (69% [27.5%] vs 5% [60.5%]; P=.002), and crying (40.2% [77%] vs 0% [54.8%]; P=.03) compared with normal infants. There were no differences between groups on any pain measure in response to intramuscular injection. Conclusions Newborns who had diabetic mothers and were exposed to repeated heel lances in the first 24 to 36 hours of life learned to anticipate pain and exhibited more intense pain responses during venipuncture than normal infants.	Univ Toronto, Hosp Sick Children, Dept Pharm, Grad Dept Pharmaceut Sci, Toronto, ON M5G 1X8, Canada; Mt Sinai Hosp, Dept Paediat, Toronto, ON M5G 1X5, Canada; Univ Toronto, Toronto Gen Hosp, Dept Anesthesia & Pain Management, Toronto, ON, Canada; Univ Toronto, Mt Sinai Hosp, Dept Publ Hlth Sci, Toronto, ON, Canada; Univ Toronto, Mt Sinai Hosp, Dept Anesthesia, Toronto, ON, Canada; IWK Grace Hlth Ctr, Halifax, NS, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Dalhousie University	Taddio, A (corresponding author), Univ Toronto, Hosp Sick Children, Dept Pharm, Grad Dept Pharmaceut Sci, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	anna.taddio@sickkids.on.ca	Katz, Joel/HDO-1635-2022; Shah, Vibhuti/P-5853-2015; Katz, Joel/J-7015-2014	Katz, Joel/0000-0002-8686-447X				Abu-Saad HH, 1998, SEMIN PERINATOL, V22, P402, DOI 10.1016/S0146-0005(98)80056-6; CRAIG KD, 1988, CAN J BEHAV SCI, V20, P442, DOI 10.1037/h0079934; FITZGERALD M, 1989, PAIN, V39, P31, DOI 10.1016/0304-3959(89)90172-3; Franck LS, 2000, PEDIATR CLIN N AM, V47, P487, DOI 10.1016/S0031-3955(05)70222-4; Grunau RE, 2000, CLIN J PAIN, V16, P37, DOI 10.1097/00002508-200003000-00007; Grunau RE, 2001, PEDIATRICS, V107, P105, DOI 10.1542/peds.107.1.105; GRUNAU RVE, 1987, PAIN, V28, P395, DOI 10.1016/0304-3959(87)90073-X; GUNNAR MR, 1992, PEDIATRICS, V90, P491; HADJISTAVROPOULOS HD, 1994, J PEDIATR PSYCHOL, V19, P485, DOI 10.1093/jpepsy/19.4.485; Health Canada, 2000, PER HLTH IND CAN RES; Hepper PG, 1996, ACTA PAEDIATR, V85, P16, DOI 10.1111/j.1651-2227.1996.tb14272.x; Oberlander TF, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.1.e6; OWENS ME, 1984, PAIN, V20, P77, DOI 10.1016/0304-3959(84)90813-3; PORTER FL, PEDIATRICS; Shah V, 1998, ARCH DIS CHILD-FETAL, V79, pF209, DOI 10.1136/fn.79.3.F209; Shah VS, 1997, ARCH DIS CHILD-FETAL, V77, pF143, DOI 10.1136/fn.77.2.F143; Stevens B, 1996, CLIN J PAIN, V12, P13, DOI 10.1097/00002508-199603000-00004; Stevens B, 1997, ACTA PAEDIATR, V86, P837, DOI 10.1111/j.1651-2227.1997.tb08607.x; TADDIO A, 1995, LANCET, V345, P291, DOI 10.1016/S0140-6736(95)90278-3; Taddio A, 1997, LANCET, V349, P599, DOI 10.1016/S0140-6736(96)10316-0; Taddio A, 1999, PROG PAIN RES MANAG, V13, P57; Williams AF, 1997, B WORLD HEALTH ORGAN, V75, P261	22	233	239	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2002	288	7					857	861		10.1001/jama.288.7.857	http://dx.doi.org/10.1001/jama.288.7.857			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585FC	12186603	Bronze, Green Submitted			2022-12-28	WOS:000177513100028
J	Kirk, O; Reiss, P; Uberti-Foppa, C; Bickel, M; Gerstoft, J; Pradier, C; Wit, FW; Ledergerber, B; Lundgren, JD; Furrer, H; Seven European HIV Cohorts				Kirk, O; Reiss, P; Uberti-Foppa, C; Bickel, M; Gerstoft, J; Pradier, C; Wit, FW; Ledergerber, B; Lundgren, JD; Furrer, H; Seven European HIV Cohorts			Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy	ANNALS OF INTERNAL MEDICINE			English	Article							PNEUMOCYSTIS-CARINII-PNEUMONIA; PLACEBO-CONTROLLED TRIAL; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; AVIUM COMPLEX BACTEREMIA; MYCOBACTERIUM-AVIUM; CYTOMEGALOVIRUS RETINITIS; PRIMARY PROPHYLAXIS; SECONDARY PROPHYLAXIS; HIV-1-INFECTED PATIENTS; TOXOPLASMA ENCEPHALITIS	Background: The safety of interrupting maintenance therapy for previous opportunistic infections other than Pneumocystis carinii pneumonia among patients with HIV infection who respond to potent antiretroviral therapy has not been well documented. Objective: To assess the safety of interrupting maintenance therapy for cytomegalovirus (CMV) end-organ disease, disseminated Mycobacterium avium complex (MAC) infection, cerebral toxoplasmosis, and extrapulmonary cryptococcosis in patients receiving antiretroviral therapy. Design: Observational study. Setting: Seven European HIV cohorts. Patients: 358 patients taking potent antiretroviral therapy (greater than or equal to3 drugs) who interrupted maintenance therapy at a CD4 lymphocyte count greater than 50 x 10(6) cells/L. Measurements: Recurrence of opportunistic infection after interruption of maintenance therapy. Results: 379 interruptions of maintenance therapy were identified: 162 for CMV disease, 103 for MAC infection, 75 for toxoplasmosis, and 39 for cryptococcosis. During 781 person-years of follow-up, five patients had relapse. Two relapses (one of CMV disease and one of MAC infection) were diagnosed after maintenance therapy was interrupted when the CD4 lymphocyte count was less than 100 x 106 cells/L or when only one recent measurement exceeded this value. Two relapses (one of CMV disease and one of MAC infection) were diagnosed after maintenance therapy was interrupted once CD4 counts were greater than 100 x 106 cells/L for 10 and 8 months, respectively. One relapse (toxoplasmosis) was diagnosed after maintenance therapy interruption at a CD4 lymphocyte count greater than 200 x 106 cells/L for 15 months. The overall incidences of recurrent CMV disease, MAC infection, toxoplasmosis, and cryptococcosis were 0.54 per 100 person-years (95% Cl, 0.07 to 1.95 per 100 person-years), 0.90 per 100 person-years (Cl, 0.11 to 3.25 per 100 person-years), 0.84 per 100 person-years (Cl, 0.02 to 4.68 per 100 person-years), and 0.00 per 100 person-years (Cl, 0.00 to 5.27 per 100 person-years), respectively. Conclusion: Maintenance therapy against previous infection with CMV, MAC, Toxoplasma gondii, or Cryptococcus neoformans in patients with HIV infection can be interrupted after sustained CD4 count increases to greater than 200 (or possibly 100 to 200) x 106 cells/L for at least 6 months after the start of potent antiretroviral therapy.	Univ Copenhagen, Hvidovre Hosp, Coordinating Ctr EuroSIDA, Dept Infect Dis, DK-2650 Hvidovre, Denmark; Rigshosp, DK-2100 Copenhagen, Denmark; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; Hosp San Raffaele, I-20132 Milan, Italy; JW Goethe Univ Clin, Frankfurt, Germany; Hop Archet, Nice, France; Univ Zurich Hosp, CH-8091 Zurich, Switzerland; Univ Hosp Bern, CH-3010 Bern, Switzerland	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Amsterdam; Academic Medical Center Amsterdam; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Goethe University Frankfurt; Goethe University Frankfurt Hospital; CHU Nice; University of Zurich; University Zurich Hospital; University of Bern; University Hospital of Bern	Kirk, O (corresponding author), Univ Copenhagen, Hvidovre Hosp, Coordinating Ctr EuroSIDA, Dept Infect Dis, Kettegaard Alle, DK-2650 Hvidovre, Denmark.	oki@cphiv.dk	VALLET, Yannick/F-9979-2011; Foppa, Caterina Uberti/ABH-3089-2020; Pradier, Christian/AAE-9669-2022; Furrer, Hansjakob/G-6768-2013; Wit, Ferdinand/AAC-3803-2019; Pradier, Christian/AFE-8255-2022; kirk, ole/ABB-4746-2021; Lundgren, Jens/AAE-6876-2019; Ledergerber, Bruno/B-5656-2009	Foppa, Caterina Uberti/0000-0001-5271-9138; Furrer, Hansjakob/0000-0002-1375-3146; Ledergerber, Bruno/0000-0002-6881-4401; Lundgren, Jens/0000-0001-8901-7850				*1999 USPHS IDSA, 1999, MMWR-MORBID MORTAL W, V48, P1; *2001 USPHS IDSA, 2001, UIG PREV OPP INF PER; Aberg JA, 1998, J INFECT DIS, V178, P1446, DOI 10.1086/314469; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; BOZZETTE SA, 1991, NEW ENGL J MED, V324, P580, DOI 10.1056/NEJM199102283240902; Brodt HR, 1997, AIDS, V11, P1731, DOI 10.1097/00002030-199714000-00010; Carr A, 1998, LANCET, V351, P256, DOI 10.1016/S0140-6736(97)07529-6; Curi ALL, 2001, BRIT J OPHTHALMOL, V85, P471, DOI 10.1136/bjo.85.4.471; Currier JS, 2000, ANN INTERN MED, V133, P493, DOI 10.7326/0003-4819-133-7-200010030-00008; de Quiros JCLB, 2001, NEW ENGL J MED, V344, P159, DOI 10.1056/NEJM200101183440301; Dube MP, 1997, J INFECT DIS, V176, P1225, DOI 10.1086/514116; El-Sadr WM, 2000, NEW ENGL J MED, V342, P1085, DOI 10.1056/NEJM200004133421503; FEINSTEIN A, 1984, STAT MED, V3, P341, DOI 10.1002/sim.4780030409; Foudraine NA, 1998, AIDS, V12, P35, DOI 10.1097/00002030-199801000-00005; Furrer H, 2000, LANCET, V355, P2217, DOI 10.1016/S0140-6736(00)02407-7; Furrer H, 1999, NEW ENGL J MED, V340, P1301, DOI 10.1056/NEJM199904293401701; Furrer H, 2001, AIDS, V15, P501, DOI 10.1097/00002030-200103090-00009; Furrer H, 2000, AIDS, V14, P1409, DOI 10.1097/00002030-200007070-00014; Hadad DJ, 1998, CLIN INFECT DIS, V26, P758, DOI 10.1086/514577; HAVERKOS HW, 1987, AM J MED, V82, P907, DOI 10.1016/0002-9343(87)90151-3; JACOBSON MA, 1993, J INFECT DIS, V168, P112, DOI 10.1093/infdis/168.1.112; JACOBSON MA, 1988, J MED VIROL, V25, P339, DOI 10.1002/jmv.1890250311; Jouan M, 2001, AIDS, V15, P23, DOI 10.1097/00002030-200101050-00006; Katlama C, 1996, CLIN INFECT DIS, V22, P268, DOI 10.1093/clinids/22.2.268; Kirk O, 1999, AIDS, V13, P1647, DOI 10.1097/00002030-199909100-00007; Komanduri KV, 2001, J INFECT DIS, V183, P1285, DOI 10.1086/319683; Komanduri KV, 1998, NAT MED, V4, P953, DOI 10.1038/nm0898-953; Ledergerber B, 2001, NEW ENGL J MED, V344, P168, DOI 10.1056/NEJM200101183440302; Li TS, 1998, LANCET, V351, P1682, DOI 10.1016/S0140-6736(97)10291-4; Lundgren JD, 1997, J ACQ IMMUN DEF SYND, V16, P153, DOI 10.1097/00042560-199711010-00003; Macdonald JC, 1998, J INFECT DIS, V177, P1182, DOI 10.1086/515281; Martinez E, 2000, AIDS, V14, P2615, DOI 10.1097/00002030-200011100-00029; Martinez E, 1999, AIDS, V13, P147; Murphy M, 1997, AIDS, V11, P261; Mussini C, 2000, J INFECT DIS, V181, P1635, DOI 10.1086/315471; Nieuwkerk PT, 2001, ARCH INTERN MED, V161, P1962, DOI 10.1001/archinte.161.16.1962; Nwokolo NC, 2001, AIDS, V15, P1438, DOI 10.1097/00002030-200107270-00015; PALESTINE AG, 1991, ANN INTERN MED, V115, P665, DOI 10.7326/0003-4819-115-9-665; Pocock SJ, 2000, NEW ENGL J MED, V342, P1907, DOI 10.1056/NEJM200006223422511; Pradier C, 1997, AIDS, V11, P832; RENOLD C, 1992, MEDICINE, V71, P224, DOI 10.1097/00005792-199207000-00005; Rizzardi GP, 1996, J INFECTION, V32, P123, DOI 10.1016/S0163-4453(96)91312-2; Schneider MME, 1999, LANCET, V353, P201, DOI 10.1016/S0140-6736(98)07204-3; Soriano V, 2000, AIDS, V14, P383, DOI 10.1097/00002030-200003100-00011; Sudre P, 2000, SCHWEIZ MED WSCHR, V130, P1493; Tural C, 1998, J INFECT DIS, V177, P1080, DOI 10.1086/517399; Vrabec TR, 1998, OPHTHALMOLOGY, V105, P1259, DOI 10.1016/S0161-6420(98)97031-2; Weverling GJ, 1999, LANCET, V353, P1293, DOI 10.1016/S0140-6736(99)03287-0; Whitcup SM, 1999, JAMA-J AM MED ASSOC, V282, P1633, DOI 10.1001/jama.282.17.1633; Whitcup SM, 1997, JAMA-J AM MED ASSOC, V277, P1519, DOI 10.1001/jama.277.19.1519; Yangco BG, 2000, ANN INTERN MED, V132, P201, DOI 10.7326/0003-4819-132-3-200002010-00005	51	93	98	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2002	137	4					239	250		10.7326/0003-4819-137-4-200208200-00008	http://dx.doi.org/10.7326/0003-4819-137-4-200208200-00008			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585BB	12186514				2022-12-28	WOS:000177502300004
J	Janka, HT				Janka, HT			Astronomy: The secrets behind supernovae	SCIENCE			English	Editorial Material							BOLTZMANN NEUTRINO TRANSPORT; CORE-COLLAPSE; POSTBOUNCE EVOLUTION; SIMULATION; STAR		Max Planck Inst Astrophys, D-85741 Garching, Germany	Max Planck Society	Janka, HT (corresponding author), Max Planck Inst Astrophys, Karl Schwarzschild Str 1, D-85741 Garching, Germany.	thj@mpa-garching.mpg.de						BETHE HA, 1985, ASTROPHYS J, V295, P14, DOI 10.1086/163343; BURROWS A, 1995, ASTROPHYS J, V450, P830, DOI 10.1086/176188; COLGATE SA, 1966, ASTROPHYS J, V143, P626, DOI 10.1086/148549; Cordes JM, 1998, ASTROPHYS J, V505, P315, DOI 10.1086/306138; Fryer CL, 2000, ASTROPHYS J, V541, P1033, DOI 10.1086/309446; Fryer CL, 1999, ASTROPHYS J, V522, P413, DOI 10.1086/307647; Fryer CL, 2002, ASTROPHYS J, V574, pL65, DOI 10.1086/342258; HERANT M, 1994, ASTROPHYS J, V435, P339, DOI 10.1086/174817; Horowitz CJ, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.043001; Janka HT, 1996, ASTRON ASTROPHYS, V306, P167; Kifonidis K, 2000, ASTROPHYS J, V531, pL123, DOI 10.1086/312541; Liebendorfer M, 2001, PHYS REV D, V63, DOI 10.1103/PhysRevD.63.103004; MAYLE RW, 1993, ASTROPHYS J, V418, P398, DOI 10.1086/173400; Mezzacappa A, 2001, PHYS REV LETT, V86, P1935, DOI 10.1103/PhysRevLett.86.1935; Muller E, 1997, ASTRON ASTROPHYS, V317, P140; Rampp M, 2000, ASTROPHYS J, V539, pL33, DOI 10.1086/312837; WILSON JR, 1993, PHYS REP, V227, P97, DOI 10.1016/0370-1573(93)90059-M	17	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2002	297	5584					1134	1135		10.1126/science.1075935	http://dx.doi.org/10.1126/science.1075935			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183617				2022-12-28	WOS:000177447600034
J	Dohlman, HG				Dohlman, HG			Desensitization: Diminishing returns	NATURE			English	Editorial Material							PROTEIN		Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Dohlman, HG (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Campus Box 7260, Chapel Hill, NC 27599 USA.			Dohlman, Henrik/0000-0003-2443-0729				Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Wang YQ, 2002, J BIOL CHEM, V277, P15766, DOI 10.1074/jbc.M111733200	4	10	10	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2002	418	6898					591	591		10.1038/418591a	http://dx.doi.org/10.1038/418591a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167838	Bronze			2022-12-28	WOS:000177305600020
J	Schlenger, WE; Caddell, JM; Ebert, L; Jordan, BK; Rourke, KM; Wilson, D; Thalji, L; Dennis, JM; Fairbank, JA; Kulka, RA				Schlenger, WE; Caddell, JM; Ebert, L; Jordan, BK; Rourke, KM; Wilson, D; Thalji, L; Dennis, JM; Fairbank, JA; Kulka, RA			Psychological reactions to terrorist attacks - Findings from the national study of Americans' reactions to September 11	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTTRAUMATIC-STRESS-DISORDER; PTSD CHECKLIST; DIAGNOSIS; SURVIVORS; CANCER	Context The terrorist attacks of September 11, 2001, represent an unprecedented exposure to trauma in the United States. Objectives To assess psychological symptom levels in the United States following the events of September 11 and to examine the association between postattack symptoms and a variety of indices of exposure to the events. Design Web-based epidemiological survey of a nationally representative cross-sectional sample using the Posttraumatic Stress Disorder (PTSD) Checklist and the Brief Symptom Inventory, administered 1 to 2-months following the attacks. Setting and Participants Sample of 2273 adults, including oversamples of the New York, NY, and Washington, DC, metropolitan areas. Main Outcome Measures Self-reports of the symptoms of PTSD and of clinically significant nonspecific psychological distress; adult reports of symptoms of distress among children living in their households. Results The prevalence of probable PTSD was significantly higher in the New York City metropolitan area (11.2%) than in Washington, DC (2.7%), other major metropolitan areas (3.6%), and the rest of the country (4.0%). A broader measure of clinically significant psychological distress suggests that overall distress levels across the country, however, were within expected ranges for a general community sample. In multivariate models, sex, age, direct exposure to the attacks, and the amount of time spent viewing TV coverage of the attacks on September 11 and the few days afterward were associated with PTSD symptom levels; sex, the number of hours of television coverage viewed, and an index of the content of. that coverage were associated with the broader distress measure. More than 60% of adults in New York City households with children reported that 1, or more children were upset by the attacks. Conclusions One to 2 months following the events of September 11, probable PTSD was associated with direct exposure to the terrorist attacks among adults, and the prevalence in the New York City metropolitan area was substantially higher than elsewhere in the country. However, overall distress levels in the country were within normal ranges. Further research should document the course of symptoms and recovery among adults following exposure to the events of September 11 and further specify the types and severity of distress in children.	Res Triangle Inst, Ctr Risk Behav & Mental Hlth Res, Res Triangle Pk, NC 27709 USA; Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; Knowledge Networks, Menlo Pk, CA USA	Research Triangle Institute; Duke University	Schlenger, WE (corresponding author), Res Triangle Inst, Ctr Risk Behav & Mental Hlth Res, POB 12194, Res Triangle Pk, NC 27709 USA.	bs@rti.org	Fairbank, John/F-8972-2013	Fairbank, John/0000-0003-2604-7256; Wilson, David/0000-0002-5198-7509				American Association of Public Opinion Research, 2001, STAND DEF FIN DISP C; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Andrykowski MA, 1998, J CONSULT CLIN PSYCH, V66, P586, DOI 10.1037/0022-006X.66.3.586; [Anonymous], BRIEF SYMPTOM INVENT; [Anonymous], RANGE MAGNITUDE DURA; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P1062; Classen C, 1998, AM J PSYCHIAT, V155, P620, DOI 10.1176/ajp.155.5.620; Couper MP, 2000, PUBLIC OPIN QUART, V64, P464, DOI 10.1086/318641; Derogatis L.R., 1994, SYMPTOM CHECKLIST 90; Derogatis L.R., 1993, BRIEF SYMPTOM INVENT, V18; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Harvey AG, 1998, J CONSULT CLIN PSYCH, V66, P507, DOI 10.1037/0022-006X.66.3.507; Manne SL, 1998, J PEDIATR PSYCHOL, V23, P357, DOI 10.1093/jpepsy/23.6.357; North CS, 1999, JAMA-J AM MED ASSOC, V282, P755, DOI 10.1001/jama.282.8.755; Pfefferbaum B, 2001, PSYCHIATRY, V64, P202, DOI 10.1521/psyc.64.3.202.18462; Pfefferbaum B, 1999, AM J PSYCHIAT, V156, P1069; Pfefferbaum B, 2000, PSYCHIATRY, V63, P358, DOI 10.1080/00332747.2000.11024929; Research Triangle Institute, 2001, SUDAAN US MAN REL 8; Schuster MA, 2001, NEW ENGL J MED, V345, P1507, DOI 10.1056/NEJM200111153452024; Smith D W, 1999, J Okla State Med Assoc, V92, P193; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; *US BUR CENS, 2002, URR POP SURV; Weathers F, 1993, ANN CONVENTION INT S; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941	28	758	765	2	47	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	2002	288	5					581	588		10.1001/jama.288.5.581	http://dx.doi.org/10.1001/jama.288.5.581			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	581FJ	12150669				2022-12-28	WOS:000177280200016
J	Kreiss, K; Gomaa, A; Kullman, G; Fedan, K; Simoes, EJ; Enright, PL				Kreiss, K; Gomaa, A; Kullman, G; Fedan, K; Simoes, EJ; Enright, PL			Clinical bronchiolitis obliterans in workers at a microwave-popcorn plant	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VALUES; SAMPLE	Background In May 2000, eight persons who had formerly worked at a microwave-popcorn production plant were reported to have severe bronchiolitis obliterans. No recognized cause was identified in the plant. Therefore, we medically evaluated current employees and assessed their occupational exposures. Methods Questionnaire responses and spirometric findings in participating workers were compared with data from the third National Health and Nutrition Examination Survey, after adjustment for age and smoking status. We evaluated the relation between exposures and health-related outcomes by analyzing the rates of symptoms and abnormalities according to current and cumulative exposure to diacetyl, the predominant ketone in artificial butter flavoring and in the air at the plant. Results Of the 135 current workers at the plant, 117 (87 percent) completed the questionnaire. These 117 workers had 2.6 times the expected rates of chronic cough and shortness of breath, according to comparisons with the national data, and twice the expected rates of physician-diagnosed asthma and chronic bronchitis. Overall, the workers had 3.3 times the expected rate of airway obstruction; those who had never smoked had 10.8 times the expected rate. Workers directly involved in the production of microwave popcorn had higher rates of shortness of breath on exertion and skin problems that had developed since they started work than workers in other parts of the plant. There was a strong relation between the quartile of estimated cumulative exposure to diacetyl and the frequency and extent of airway obstruction. Conclusions The excess rates of lung disease and lung-function abnormalities and the relation between exposure and outcomes in this working population indicate that they probably had occupational bronchiolitis obliterans caused by the inhalation of volatile butter-flavoring ingredients.	NIOSH, Div Resp Dis Studies, Morgantown, WV 26505 USA; Missouri Dept Hlth & Senior Serv, Off Epidemiol, Jefferson City, MO USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Kreiss, K (corresponding author), NIOSH, Div Resp Dis Studies, H2800,1095 Willowdale Rd, Morgantown, WV 26505 USA.	kkreiss@cdc.gov	Simoes, Eduardo J/H-4546-2018	Simoes, Eduardo J/0000-0003-4371-4305				AKPINARELCI M, 2002, AM J RESP CRIT CARE, V165, pA526; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P2185; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P345; Eller P., 1994, DHHS NIOSH PUBLICATI, V94-113; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; HUBBS AF, 2002, TOXICOL SCI S, V66, P194; *INT BAK SERV INC, 1986, DHHS NIOSH PUBL; *INT LAB OFF, 1980, OCC SAF HLTH SER, V22; King T. E., 1998, FISHMANS PULMONARY D, P825; Lockey J., 2002, AM J RESP CRIT CARE, V165, pA461; MILLER A, 1983, AM REV RESPIR DIS, V127, P270; MONSON RR, 1990, OCCUPATIONAL EPIDEMI, P114; MORGAN RH, 1979, AM J ROENTGENOL, V132, P803, DOI 10.2214/ajr.132.5.803; National Center for Health Statistics, 1996, 3 NAT HLTH NUTR EX S; Parmet AJ, 2002, J OCCUP ENVIRON MED, V44, P216, DOI 10.1097/00043764-200203000-00002; SAS Institute, 1990, SAS STAT US GUID VER	19	316	323	1	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2002	347	5					330	338		10.1056/NEJMoa020300	http://dx.doi.org/10.1056/NEJMoa020300			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587WC	12151470	Bronze			2022-12-28	WOS:000177665900005
J	Edgar, M				Edgar, M			A new classification of adolescent idiopathic scoliosis	LANCET			English	Editorial Material							FUSION LEVELS		Middlesex Hosp, Dept Orthopaed Surg, London W1N 8AA, England; Univ Coll Hosp Trust, London W1N 8AA, England	University of London; University College London	Edgar, M (corresponding author), Middlesex Hosp, Dept Orthopaed Surg, London W1N 8AA, England.							BURSTEIN AH, 1993, J BONE JOINT SURG AM, V75A, P1743, DOI 10.2106/00004623-199312000-00001; Cummings RJ, 1998, J BONE JOINT SURG AM, V80A, P1107; D'Andrea LP, 2000, SPINE, V25, P1795, DOI 10.1097/00007632-200007150-00010; KING HA, 1983, J BONE JOINT SURG AM, V65, P1302, DOI 10.2106/00004623-198365090-00012; Lenke LG, 2001, J BONE JOINT SURG AM, V83A, P1169, DOI 10.2106/00004623-200108000-00006; Lenke LG, 2001, SPINE, V26, P2347, DOI 10.1097/00007632-200111010-00011; McCance SE, 1998, SPINE, V23, P2063, DOI 10.1097/00007632-199810010-00005; NASH CL, 1969, J BONE JOINT SURG AM, VA 51, P223, DOI 10.2106/00004623-196951020-00002; Poncet P, 2001, SPINE, V26, P2235, DOI 10.1097/00007632-200110150-00015; PONSETI IV, 1950, J BONE JOINT SURG AM, V32-A, P381, DOI 10.2106/00004623-195032020-00017	10	2	2	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 27	2002	360	9329					270	271		10.1016/S0140-6736(02)09562-4	http://dx.doi.org/10.1016/S0140-6736(02)09562-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578DT	12147366				2022-12-28	WOS:000177102700004
J	Stich, A; Abel, PM; Krishna, S				Stich, A; Abel, PM; Krishna, S			Human African trypanosomiasis	BRITISH MEDICAL JOURNAL			English	Review							SLEEPING SICKNESS; MELARSOPROL; DIAGNOSIS; GAMBIENSE; TRIAL		Med Mission Inst, Dept Trop Med & Epidem Control, D-97074 Wurzburg, Germany; Angotrip Project, Caritas Luanda, Angola; St George Hosp, Sch Med, Dept Infect Dis, London SW17 0RE, England	St Georges University London	Stich, A (corresponding author), Med Mission Inst, Dept Trop Med & Epidem Control, D-97074 Wurzburg, Germany.			Krishna, Sanjeev/0000-0003-0066-0634				[Anonymous], 1998, WHO TECHN REP SER, V881; BAILEY JW, 1992, T ROY SOC TROP MED H, V86, P630, DOI 10.1016/0035-9203(92)90160-E; Brun R, 2001, TROP MED INT HEALTH, V6, P906, DOI 10.1046/j.1365-3156.2001.00775.x; Burri C, 2000, LANCET, V355, P1419, DOI 10.1016/S0140-6736(00)02141-3; Dumas M, 2000, B WORLD HEALTH ORGAN, V78, P1474; Dumas M, 1999, PROGR HUMAN AFRICAN; GREENWOOD BM, 1980, T ROY SOC TROP MED H, V74, P716, DOI 10.1016/0035-9203(80)90184-4; Keiser J, 2001, TRENDS PARASITOL, V17, P42, DOI 10.1016/S1471-4922(00)01829-8; PEPIN J, 1989, LANCET, V1, P1246, DOI 10.1016/S0140-6736(89)92340-4; Ripamonti D, 2002, CLIN INFECT DIS, V34, pE18, DOI 10.1086/338157; Smith DH, 1998, BRIT MED BULL, V54, P341, DOI 10.1093/oxfordjournals.bmb.a011692; TRUC P, 1994, T ROY SOC TROP MED H, V88, P419, DOI 10.1016/0035-9203(94)90410-3; VANNIEUWENHOVE S, 1999, PROGR HUMAN AFRICAN; VICKERMAN K, 1969, NATURE, V224, P1125, DOI 10.1038/2241125a0; VICKERMAN K, 1997, TRYPANOSOMIASIS LEIS; *WHO, 2002, WHO REP GLOB SURV EP	16	74	76	0	15	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 27	2002	325	7357					203	206		10.1136/bmj.325.7357.203	http://dx.doi.org/10.1136/bmj.325.7357.203			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580PX	12142311	Green Published			2022-12-28	WOS:000177243900024
J	Sogo, JM; Lopes, M; Foiani, M				Sogo, JM; Lopes, M; Foiani, M			Fork reversal and ssDNA accumulation at stalled replication forks owing to checkpoint defects	SCIENCE			English	Article							DNA-REPLICATION; DAMAGE; PHOSPHORYLATION; ACTIVATION; ORIGINS; KINASE; MEC1	Checkpoint-mediated control of replicating chromosomes is essential for preventing cancer. In yeast, Rad53 kinase protects stalled replication forks from pathological rearrangements. To characterize the mechanisms controlling fork integrity, we analyzed replication intermediates formed in response to replication blocks using electron microscopy. At the forks, wild-type cells accumulate short single-stranded regions, which likely causes checkpoint activation, whereas rad53 mutants exhibit extensive single-stranded gaps and hemi-replicated intermediates, consistent with a lagging-strand synthesis defect. Further, rad53 cells accumulate Holliday junctions through fork reversal. We speculate that, in checkpoint mutants, abnormal replication intermediates begin to form because of uncoordinated replication and are further processed by unscheduled recombination pathways, causing genome instability.	Ist FIRC Oncol Mol, I-20141 Milan, Italy; ETH Honggerberg, Inst Cell Biol, CH-8093 Zurich, Switzerland; Univ Milan, Dipartimento Genet & Biol Microrganismi, I-20133 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Milan	Foiani, M (corresponding author), Ist FIRC Oncol Mol, Via Adamello 16, I-20141 Milan, Italy.	foiani@ifom-firc.it	Lopes, Massimo/G-4300-2013; Foiani, Marco/M-8234-2014	Foiani, Marco/0000-0003-4795-834X				Allers T, 2000, Nucleic Acids Res, V28, pe6, DOI 10.1093/nar/28.2.e6; Bashkirov VI, 2000, MOL CELL BIOL, V20, P4393, DOI 10.1128/MCB.20.12.4393-4404.2000; Boddy MN, 2001, CURR BIOL, V11, pR953, DOI 10.1016/S0960-9822(01)00572-3; Brush GS, 1996, P NATL ACAD SCI USA, V93, P15075, DOI 10.1073/pnas.93.26.15075; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Gasser R, 1996, J MOL BIOL, V258, P224, DOI 10.1006/jmbi.1996.0245; Gruber M, 2000, MOL CELL BIOL, V20, P5777, DOI 10.1128/MCB.20.15.5777-5787.2000; Haber JE, 2001, CELL, V107, P551, DOI 10.1016/S0092-8674(01)00593-1; INMAN RB, 1984, BIOCHIM BIOPHYS ACTA, V783, P205, DOI 10.1016/0167-4781(84)90030-7; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Liberi G, 2000, EMBO J, V19, P5027, DOI 10.1093/emboj/19.18.5027; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lowndes NF, 2000, CURR OPIN GENET DEV, V10, P17, DOI 10.1016/S0959-437X(99)00050-7; LUCCHINI R, 1995, NATURE, V374, P276, DOI 10.1038/374276a0; Marini F, 1997, EMBO J, V16, P639, DOI 10.1093/emboj/16.3.639; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; VAZE MB, UNPUB; Weinert T, 1997, CANCER SURV, V29, P109	27	653	666	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2002	297	5581					599	602		10.1126/science.1074023	http://dx.doi.org/10.1126/science.1074023			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142537				2022-12-28	WOS:000177054200050
J	Aderem, A				Aderem, A			How to eat something bigger than your head	CELL			English	Review							ENDOPLASMIC-RETICULUM; PHAGOCYTOSIS; CALRETICULIN; PHAGOSOME; CELLS; PHOSPHATIDYLINOSITOL	Macrophage phagocytosis, the engulfment of large particles, is important for host defense against infection and for the removal of dead cells. These phagocytes can internalize particles larger than themselves, obtaining membrane from internal pools including recycling endosomes. Desjardins and coworkers report in this issue of Cell (Gagnon et al., 2002) that the endoplasmic reticulum is a major reservoir of membrane for phagocytosis, an observation that may shed light on a number of conundrums in immunology.	Inst Syst Biol, Seattle, WA 98103 USA	Institute for Systems Biology (ISB)	Aderem, A (corresponding author), Inst Syst Biol, 1441 N 34th St, Seattle, WA 98103 USA.							Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Hackstadt T, 2000, TRAFFIC, V1, P93, DOI 10.1034/j.1600-0854.2000.010201.x; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; Johnson S, 2001, TRENDS CELL BIOL, V11, P122, DOI 10.1016/S0962-8924(01)01926-2; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Morrissette NS, 1999, J CELL SCI, V112, P4705; Muller-Taubenberger A, 2001, EMBO J, V20, P6772, DOI 10.1093/emboj/20.23.6772; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; STEINMAN RM, 1994, J EXP MED, V179, P1, DOI 10.1084/jem.179.1.1; TARDIEUX I, 1992, CELL, V71, P1117, DOI 10.1016/S0092-8674(05)80061-3; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Whatmore J, 1999, BIOCHEM J, V341, P435, DOI 10.1042/0264-6021:3410435	19	60	60	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 12	2002	110	1					5	8		10.1016/S0092-8674(02)00819-X	http://dx.doi.org/10.1016/S0092-8674(02)00819-X			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	573PU	12150991	Bronze			2022-12-28	WOS:000176840700002
J	Berger, A				Berger, A			Science commentary: Skin prick testing	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	15	17	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 24	2002	325	7361					414	414		10.1136/bmj.325.7361.414	http://dx.doi.org/10.1136/bmj.325.7361.414			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588RY	12193355	Bronze, Green Published			2022-12-28	WOS:000177715500017
J	Lawlor, DA; Smith, GD; Ebrahim, S				Lawlor, DA; Smith, GD; Ebrahim, S			Birth weight of offspring and insulin resistance in late adulthood: cross sectional survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEART-DISEASE; FETAL GROWTH; MORTALITY; RISK; OUTCOMES; GLUCOSE	Objective To investigate the association between birth weight of offspring and mothers' insulin resistance in late adulthood. Design Cross sectional survey. Setting General practitioner's surgeries in 23 towns in Great Britain. Participants 4286 women aged 60-79 years. Main outcome measures Maternal insulin resistance. Results Birth weight of offspring was inversely related to maternal insulin resistance in late adulthood. For each 1 kg higher birth weight of offspring, women had a 15% reduction in the odds of being in the fourth with highest insulin resistance, compared to other fourths (odds ratio 0.85; 95% confidence interval 0.71 to 1.00). This increased to 27% (0.73; 0.60 to 0.90) after adjusting data for potential confounders. A U shaped relation between birth weight of offspring and diabetes in older age was found; women with the lightest and heaviest offspring had the highest prevalence of diabetes. Conclusions Birth weight of offspring is inversely related to the mother's insulin resistance in late adulthood, despite the association of glucose intolerance during pregnancy with heavier offspring at birth. Common genetic factors probably contribute to the relation between birth weight and risk of cardiovascular disease and diabetes in adults.	Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of Bristol	Lawlor, DA (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.	d.a.lawlor@bristol.ac.uk	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; Lawlor, Debbie A/0000-0002-6793-2262				Barker DJP, 1998, MOTHERS BABIES HLTH; BUTLER N, 1969, 2 1958 BRIT PER MORT; Casteels K, 1999, LANCET, V353, P1499, DOI 10.1016/S0140-6736(98)05817-6; Dornhorst A, 1998, DIABETES CARE, V21, pB43; ERENS B, 1999, HLTH SURVEY ENGLAND; Hattersley AT, 1998, NAT GENET, V19, P268, DOI 10.1038/953; Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1; LAWLOR DA, IN PRESS J EPIDEMIOL; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; NESS RB, 1994, EPIDEMIOL REV, V16, P298, DOI 10.1093/oxfordjournals.epirev.a036155; O'Sullivan JJ, 2000, ARCH DIS CHILD, V82, P202, DOI 10.1136/adc.82.3.202; Pennison EH, 2001, AM J OBSTET GYNECOL, V184, P1118, DOI 10.1067/mob.2001.114918; Rasmussen F, 2001, AM J EPIDEMIOL, V153, pS98; Scholl TO, 2001, AM J EPIDEMIOL, V154, P514, DOI 10.1093/aje/154.6.514; SERMER M, 1995, AM J OBSTET GYNECOL, V173, P146, DOI 10.1016/0002-9378(95)90183-3; SHAPER AG, 1981, BRIT MED J, V283, P179, DOI 10.1136/bmj.283.6285.179; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; Smith GD, 1997, BRIT MED J, V315, P1189, DOI 10.1136/bmj.315.7117.1189; Smith GD, 2000, BRIT MED J, V320, P839, DOI 10.1136/bmj.320.7238.839; Smith GD, 2000, LANCET, V356, P2066, DOI 10.1016/S0140-6736(00)03406-1; Stoltenberg C, 2001, AM J EPIDEMIOL, V153, pS98; Tynelius P, 2001, AM J EPIDEMIOL, V153, pS47	22	62	64	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 17	2002	325	7360					359	362		10.1136/bmj.325.7360.359	http://dx.doi.org/10.1136/bmj.325.7360.359			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587DV	12183306	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000177626000017
J	Tsai, HH; Frost, E; To, V; Robinson, S; ffrench-Constant, C; Geertman, R; Ransohoff, RM; Miller, RH				Tsai, HH; Frost, E; To, V; Robinson, S; ffrench-Constant, C; Geertman, R; Ransohoff, RM; Miller, RH			The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR; LINEAGE; CELL; INTERLEUKIN-8; ORIGIN; GENE; DIFFERENTIATION; PROLIFERATION; EXPRESSION	Spinal cord oligodendrocytes originate in the ventricular zone and subsequently migrate to white matter, stop, proliferate, and differentiate. Here we demonstrate a role for the chemokine CXCL1 and its receptor CXCR2 in patterning the developing spinal cord. Signaling through CXCR2, CXCL1 inhibited oligodendrocyte precursor migration. The migrational arrest was rapid, reversible, concentration dependent, and reflected enhanced cell/substrate interactions. White matter expression of CXCL1 was temporo-spatially regulated. Developing CXCR2 null spinal cords contained reduced oligodendrocytes, abnormally concentrated at the periphery. In slice preparations, CXCL1 inhibited embryonic oligodendrocyte precursor migration, and widespread dispersal of postnatal precursors occurred in the absence of CXCR2 signaling. These data suggest that population of presumptive white matter by oligodendrocyte precursors is dependent on localized expression of CXCL1.	Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; Uniformed Serv Univ Hlth Sci, Dept Anat & Cell Biol, Bethesda, MD 20814 USA; Univ Hosp Cleveland, Res Inst, Dept Neurosurg, Cleveland, OH 44106 USA; Cambridge Ctr Brain Repair, Cambridge CB2 2PY, England; Cleveland Clin Fdn, Lerner Res Inst, Dept Neurol & Neurosci, Cleveland, OH 44195 USA	Case Western Reserve University; Uniformed Services University of the Health Sciences - USA; University Hospitals of Cleveland; University of Cambridge; Cleveland Clinic Foundation	Miller, RH (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA.		Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036674, R37NS036674] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 36674] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANISOWICZ A, 1987, P NATL ACAD SCI USA, V84, P7188, DOI 10.1073/pnas.84.20.7188; ARMSTRONG GR, 1991, CYTOPATHOLOGY, V2, P52; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; BAGGIOLINI M, 1992, INT ARCH ALLERGY IMM, V99, P196, DOI 10.1159/000236247; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BARRES BA, 1994, NATURE, V367, P371, DOI 10.1038/367371a0; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BUNGE RP, 1968, PHYSIOL REV, V48, P197, DOI 10.1152/physrev.1968.48.1.197; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Chisholm A, 1999, CURR OPIN NEUROBIOL, V9, P603, DOI 10.1016/S0959-4388(99)00021-5; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; Dreyfus CF, 1999, J NEUROSCI RES, V56, P1, DOI 10.1002/(SICI)1097-4547(19990401)56:1<1::AID-JNR1>3.0.CO;2-3; Frost E, 1996, DEV NEUROSCI-BASEL, V18, P266, DOI 10.1159/000111416; Frost EE, 2000, METH MOL B, V139, P265; Glabinski AR, 1997, AM J PATHOL, V150, P617; HUBER AR, 1991, SCIENCE, V254, P99, DOI 10.1126/science.1718038; HUO Y, 2001, J CLIN INVEST, V108, P1269; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Martins-Green M., 1997, Cytokine and Growth Factor Reviews, V8, P221, DOI 10.1016/S1359-6101(97)00016-6; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Miller RH, 1997, J NEUROSCI RES, V50, P157; MILNER R, 1994, DEVELOPMENT, V120, P3497; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; NOLL E, 1993, DEVELOPMENT, V118, P563; ONO K, 1995, DEVELOPMENT, V121, P1743; OQUENDO P, 1989, J BIOL CHEM, V264, P4133; Orentas DM, 1996, DEV BIOL, V177, P43, DOI 10.1006/dbio.1996.0143; Pringle NP, 1996, DEV BIOL, V177, P30, DOI 10.1006/dbio.1996.0142; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; RICHMOND A, 1988, J CELL BIOCHEM, V36, P185, DOI 10.1002/jcb.240360209; Robinson S, 1998, J NEUROSCI, V18, P10457; TANI M, 1994, BRAIN PATHOL, V4, P135, DOI 10.1111/j.1750-3639.1994.tb00824.x; TSAI HH, 2001, SOC NEUR ABSTR, V897, P11; WARF BC, 1991, J NEUROSCI, V11, P2477; WARRINGTON AE, 1993, J NEUROSCI RES, V34, P1, DOI 10.1002/jnr.490340102; Weber KSC, 1999, EUR J IMMUNOL, V29, P700, DOI 10.1002/(SICI)1521-4141(199902)29:02<700::AID-IMMU700>3.0.CO;2-1; Wu Q, 2000, J NEUROSCI, V20, P2609; Zhang H, 1996, J NEUROSCI, V16, P6886; ZHOU L, 1995, J NEUROSCI RES, V42, P504, DOI 10.1002/jnr.490420409; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	45	275	287	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 9	2002	110	3					373	383		10.1016/S0092-8674(02)00838-3	http://dx.doi.org/10.1016/S0092-8674(02)00838-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	583MN	12176324	Bronze			2022-12-28	WOS:000177411800013
J	Batterham, RL; Cowley, MA; Small, CJ; Herzog, H; Cohen, MA; Dakin, CL; Wren, AM; Brynes, AE; Low, MJ; Ghatei, MA; Cone, RD; Bloom, SR				Batterham, RL; Cowley, MA; Small, CJ; Herzog, H; Cohen, MA; Dakin, CL; Wren, AM; Brynes, AE; Low, MJ; Ghatei, MA; Cone, RD; Bloom, SR			Gut hormone PYY3-36 physiologically inhibits food intake	NATURE			English	Article							NEUROPEPTIDE-Y RECEPTOR; PEPTIDE-YY; ARCUATE NUCLEUS; BODY-WEIGHT; NEURONS; SYSTEM; RELEASE; LEPTIN; ANALOG; RAT	Food intake is regulated by the hypothalamus, including the melanocortin and neuropeptide Y (NPY) systems in the arcuate nucleus(1). The NPY Y2 receptor (Y2R), a putative inhibitory presynaptic receptor, is highly expressed on NPY neurons(2) in the arcuate nucleus, which is accessible to peripheral hormones(3). Peptide YY3-36 (PYY3-36), a Y2R agonist(4), is released from the gastrointestinal tract postprandially in proportion to the calorie content of a meal(5-7). Here we show that peripheral injection of PYY3-36 in rats inhibits food intake and reduces weight gain. PYY3-36 also inhibits food intake in mice but not in Y2r-null mice, which suggests that the anorectic effect requires the Y2R. Peripheral administration of PYY3-36 increases c-Fos immunoreactivity in the arcuate nucleus and decreases hypothalamic Npy messenger RNA. Intra-arcuate injection of PYY3-36 inhibits food intake. PYY3-36 also inhibits electrical activity of NPY nerve terminals, thus activating adjacent pro-opiomelanocortin (POMC) neurons(8). In humans, infusion of normal postprandial concentrations of PYY3-36 significantly decreases appetite and reduces food intake by 33% over 24 h. Thus, postprandial elevation of PYY3-36 may act through the arcuate nucleus Y2R to inhibit feeding in a gut-hypothalamic pathway.	Imperial Coll Fac Med, London W12 0NN, England; Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Garvan Inst Med Res, Neurobiol Program, Sydney, NSW 2010, Australia	Imperial College London; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Garvan Institute of Medical Research	Bloom, SR (corresponding author), Imperial Coll Fac Med, Hammersmith Campus,Du Cane Rd, London W12 0NN, England.		Herzog, Herbert/B-8294-2008; Cowley, Michael A/B-9428-2008	Cowley, Michael A/0000-0001-7811-134X; Batterham, Rachel/0000-0002-5477-8585; Low, Malcolm/0000-0002-9900-3708				ADRIAN TE, 1985, GASTROENTEROLOGY, V89, P1070, DOI 10.1016/0016-5085(85)90211-2; Barrachina MD, 1997, AM J PHYSIOL-REG I, V272, pR1007, DOI 10.1152/ajpregu.1997.272.3.R1007; Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519; Broberger C, 1997, NEUROENDOCRINOLOGY, V66, P393, DOI 10.1159/000127265; Butler AA, 2001, NAT NEUROSCI, V4, P605, DOI 10.1038/88423; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Edwards CMB, 2001, AM J PHYSIOL-ENDOC M, V281, pE155, DOI 10.1152/ajpendo.2001.281.1.E155; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; GRANDT D, 1994, REGUL PEPTIDES, V51, P151, DOI 10.1016/0167-0115(94)90204-6; Grove KL, 2000, NEUROSCIENCE, V100, P731, DOI 10.1016/S0306-4522(00)00308-0; HOFFMAN GE, 1993, FRONT NEUROENDOCRIN, V14, P173, DOI 10.1006/frne.1993.1006; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; Keire DA, 2000, AM J PHYSIOL-GASTR L, V279, pG126, DOI 10.1152/ajpgi.2000.279.1.G126; Kim MS, 2000, DIABETES, V49, P177, DOI 10.2337/diabetes.49.2.177; Kim MS, 2000, J CLIN INVEST, V105, P1005, DOI 10.1172/JCI8857; Moran TH, 2000, NUTRITION, V16, P858, DOI 10.1016/S0899-9007(00)00419-6; PedersenBjergaard U, 1996, SCAND J CLIN LAB INV, V56, P497, DOI 10.3109/00365519609088805; POTTER EK, 1994, EUR J PHARM-MOLEC PH, V267, P253, DOI 10.1016/0922-4106(94)90148-1; RABEN A, 1995, BRIT J NUTR, V73, P517, DOI 10.1079/BJN19950056; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Small CJ, 1997, P NATL ACAD SCI USA, V94, P11686, DOI 10.1073/pnas.94.21.11686; Soderberg C, 2000, J NEUROCHEM, V75, P908, DOI 10.1046/j.1471-4159.2000.0750908.x; Tarling MM, 1997, INTENS CARE MED, V23, P256, DOI 10.1007/s001340050325	23	1654	1800	5	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2002	418	6898					650	654		10.1038/nature00887	http://dx.doi.org/10.1038/nature00887			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167864				2022-12-28	WOS:000177305600045
J	Bickford, D				Bickford, D			Animal behaviour - Male parenting of New Guinea froglets	NATURE			English	Article							CARE		Univ Miami, Coral Gables, FL 33124 USA; Wildlife Conservat Soc, Papua New Guinea Program, Goroka, Papua N Guinea	University of Miami	Bickford, D (corresponding author), Univ Miami, POB 249118, Coral Gables, FL 33124 USA.		Bickford, David P/A-5306-2011	Bickford, David P/0000-0003-1478-3387				BICKFORD DP, 2001, THESIS U MIAMI; Clutton-Brock T. H., 1991, EVOLUTION PARENTAL C; COGGER HG, 1996, REPTILES AMPHIBIANS, P159; Crump Martha L., 1996, Advances in the Study of Behavior, V25, P109; DIESEL R, 1995, COPEIA, P354; SIMON MP, 1983, BEHAV ECOL SOCIOBIOL, V14, P61, DOI 10.1007/BF00366657; Wright DD, 1997, BIOTROPICA, V29, P250, DOI 10.1111/j.1744-7429.1997.tb00426.x; Zweifel R.G., 1972, Bulletin Am Mus nat Hist, V148, P411	8	22	24	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2002	418	6898					601	602		10.1038/418601b	http://dx.doi.org/10.1038/418601b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167847				2022-12-28	WOS:000177305600028
J	Bisson, LF; Waterhouse, AL; Ebeler, SE; Walker, MA; Lapsley, JT				Bisson, LF; Waterhouse, AL; Ebeler, SE; Walker, MA; Lapsley, JT			The present and future of the international wine industry	NATURE			English	Article							CHARACTER IMPACT ODORANTS; XYLELLA-FASTIDIOSA; ALCOHOL; IDENTIFICATION; MECHANISMS; MORTALITY; DISEASE	Wine production is both art and science, a blend of individual creativity and innovative technology. But wine production is also business, with economic factors driving manufacturing practices. To be successful in the modern marketplace, a winemaker must integrate the artistic and economic aspects of wine production, and possess a solid understanding of the intrinsic and extrinsic factors that underlie purchase motivation.	Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA; Univ Calif Davis, UC Davis Extens, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Bisson, LF (corresponding author), Univ Calif Davis, Dept Viticulture & Enol, 1 Shields Ave, Davis, CA 95616 USA.		Waterhouse, Andrew/F-6719-2011	Waterhouse, Andrew/0000-0002-5088-7442; Ebeler, Susan/0000-0002-8394-6736				Acree TE, 1997, ANAL CHEM, V69, pA170, DOI 10.1021/ac971560s; Aigrain P., 2001, Bulletin de l'OIV, V74, P209; [Anonymous], 1998, CHEM WINE FLAVOR; Brand G, 2001, NEUROSCI BIOBEHAV R, V25, P159, DOI 10.1016/S0149-7634(01)00005-7; de Lorimier AA, 2000, AM J SURG, V180, P357, DOI 10.1016/S0002-9610(00)00486-4; Donald TM, 2002, THEOR APPL GENET, V104, P610, DOI 10.1007/s00122-001-0768-1; Dufour C, 1999, J AGR FOOD CHEM, V47, P678, DOI 10.1021/jf980314u; Ebeler SE, 1999, FLAVOR CHEMISTRY, P409; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; GERMAN BG, 1997, WINE NUTR THERAPEUTI, P196; Granett J, 2001, ANNU REV ENTOMOL, V46, P387, DOI 10.1146/annurev.ento.46.1.387; Gronbaek M, 2000, ANN INTERN MED, V133, P411, DOI 10.7326/0003-4819-133-6-200009190-00008; Guth H, 1997, J AGR FOOD CHEM, V45, P3022, DOI 10.1021/jf9608433; Guth H, 1997, J AGR FOOD CHEM, V45, P3027, DOI 10.1021/jf970280a; GUTH H, 1998, CHEM WINE FLAVOR, P39; HOPKINS DL, 1989, ANNU REV PHYTOPATHOL, V27, P271, DOI 10.1146/annurev.py.27.090189.001415; Ishibashi Tokuo, 1999, Japanese Journal of Alcohol Studies and Drug Dependence, V34, P117; Jung DM, 2000, J AGR FOOD CHEM, V48, P407, DOI 10.1021/jf9906883; KINSELLA JE, 1993, FOOD TECHNOL-CHICAGO, V47, P85; LAVILLE P, 1990, B OIV, V217, P709; LODHI MA, 1995, GENOME, V38, P786, DOI 10.1139/g95-100; Lucia SP, 1963, HIST WINE THERAPY; MARMOT MG, 1981, LANCET, V1, P580; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; NOBLE AC, 1980, J AGR FOOD CHEM, V28, P346, DOI 10.1021/jf60228a030; Ohmart C. P., 2000, LODI WINEGROWERS WOR; Pauquet J, 2001, THEOR APPL GENET, V103, P1201, DOI 10.1007/s001220100664; PROTIN R, 1971, B OIV, V44, P110; Purcell AH, 1999, PLANT DIS, V83, P825, DOI 10.1094/PDIS.1999.83.9.825; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Rouquier S, 2000, P NATL ACAD SCI USA, V97, P2870, DOI 10.1073/pnas.040580197; Sosinsky A, 2000, GENOMICS, V70, P49, DOI 10.1006/geno.2000.6363; STEINBERG D, 1993, J INTERN MED, V233, P227, DOI 10.1111/j.1365-2796.1993.tb00980.x; STEVENSON RL, 1923, AMATEUR EMIGRANT SIL; YEGGE J, 2000, P ASEV 50 ANN ANN M; 2000, B OIV S, P20	36	152	168	4	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2002	418	6898					696	699		10.1038/nature01018	http://dx.doi.org/10.1038/nature01018			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167877				2022-12-28	WOS:000177305600057
J	Abu-Omar, Y; Taggart, DP				Abu-Omar, Y; Taggart, DP			Off-pump coronary artery bypass grafting	LANCET			English	Review							CARDIOPULMONARY BYPASS; CARDIAC-SURGERY; NEUROCOGNITIVE FUNCTION; ON-PUMP; REVASCULARIZATION; DYSFUNCTION; OPERATIONS		John Radcliffe Hosp, Oxford Heart Ctr, Dept Cardiac Surg, Oxford OX3 9DU, England	University of Oxford	Taggart, DP (corresponding author), John Radcliffe Hosp, Oxford Heart Ctr, Dept Cardiac Surg, Oxford OX3 9DU, England.							Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8; Arom KV, 2000, ANN THORAC SURG, V69, P704, DOI 10.1016/S0003-4975(99)01510-6; Arom KV, 1999, ANN THORAC SURG, V68, P1562, DOI 10.1016/S0003-4975(99)00962-5; Ascione R, 2000, ANN THORAC SURG, V69, P1198, DOI 10.1016/S0003-4975(00)01152-8; Ascione R, 1999, ANN THORAC SURG, V68, P493, DOI 10.1016/S0003-4975(99)00566-4; Ascione R, 1999, EUR J CARDIO-THORAC, V15, P685, DOI 10.1016/S1010-7940(99)00072-X; Ascione R, 1999, ANN THORAC SURG, V68, P2237, DOI 10.1016/S0003-4975(99)01123-6; Ascione R, 2001, ANN THORAC SURG, V72, P2020, DOI 10.1016/S0003-4975(01)03250-7; Bowles BJ, 2001, CHEST, V119, P25, DOI 10.1378/chest.119.1.25; Calafiore AM, 1999, ANN THORAC SURG, V67, P450, DOI 10.1016/S0003-4975(98)01194-1; Califf RM, 1998, J AM COLL CARDIOL, V31, P241, DOI 10.1016/S0735-1097(97)00506-8; Caputo M, 2001, ANN THORAC SURG, V71, P1215, DOI 10.1016/S0003-4975(00)02686-2; Costa MA, 2001, CIRCULATION, V104, P2689, DOI 10.1161/hc4701.099789; Cox CM, 2000, ANN THORAC SURG, V69, P140, DOI 10.1016/S0003-4975(99)01196-0; Edmunds LH, 1998, ANN THORAC SURG, V66, pS12, DOI 10.1016/S0003-4975(98)00967-9; Fortescue EB, 2000, KIDNEY INT, V57, P2594, DOI 10.1046/j.1523-1755.2000.00119.x; Gundry SR, 1998, J THORAC CARDIOV SUR, V115, P1273, DOI 10.1016/S0022-5223(98)70209-0; Jansen EWL, 1998, J THORAC CARDIOV SUR, V116, P60, DOI 10.1016/S0022-5223(98)70243-0; Kshettry VR, 2000, ANN THORAC SURG, V69, P1725, DOI 10.1016/S0003-4975(00)01419-3; Magee MJ, 2002, ANN THORAC SURG, V73, P1196, DOI 10.1016/S0003-4975(01)03587-1; Newman MF, 2001, STROKE, V32, P2874, DOI 10.1161/hs1201.099803; Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601; Puskas JD, 2001, ANN THORAC SURG, V71, P1477, DOI 10.1016/S0003-4975(01)02473-0; Shennib H, 2001, ANN THORAC SURG, V72, pS993, DOI 10.1016/S0003-4975(01)02948-4; Taggart DP, 2000, J THORAC CARDIOV SUR, V120, P651, DOI 10.1067/mtc.2000.106325; Taggart DP, 2000, EUR J CARDIO-THORAC, V18, P31, DOI 10.1016/S1010-7940(00)00438-3; Taggart DP, 1999, J THORAC CARDIOV SUR, V118, P414, DOI 10.1016/S0022-5223(99)70177-7; Taggart DP, 2001, CURR OPIN CARDIOL, V16, P271, DOI 10.1097/00001573-200109000-00003; van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036; Van Dijk D, 2002, JAMA-J AM MED ASSOC, V287, P1405, DOI 10.1001/jama.287.11.1405; van Dijk D, 2000, J THORAC CARDIOV SUR, V120, P632, DOI 10.1067/mtc.2000.108901	31	39	41	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 27	2002	360	9329					327	329		10.1016/S0140-6736(02)09557-0	http://dx.doi.org/10.1016/S0140-6736(02)09557-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578DT	12147389				2022-12-28	WOS:000177102700027
J	Otto, S; Furlan, RLE; Sanders, JKM				Otto, S; Furlan, RLE; Sanders, JKM			Selection and amplification of hosts from dynamic combinatorial libraries of macrocyclic disulfides	SCIENCE			English	Article							MOLECULAR AMPLIFICATION; AQUEOUS-MEDIA; RECEPTOR; RECOGNITION; GENERATION; DIVERSITY; EVOLUTION; BINDING; SYSTEM; MODEL	We have discovered two receptors for two different guests from a single dynamic combinatorial library. Each of the two guests amplifies the formation of a tightly binding host at the expense of unfit library members. Small differences in host-guest binding translate into useful differences in amplification. The selected hosts could be readily synthesized using biased dynamic libraries that contain only the right ratio of those building blocks that were selected by the guests. These results establish dynamic combinatorial chemistry as a practical method not only for the discovery but also for the synthesis of new receptors.	Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge	Otto, S (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	so230@cam.ac.uk	Otto, Sijbren/E-9568-2014; Furlan, Ricardo/AGU-7634-2022	Otto, Sijbren/0000-0003-0259-5637; Furlan, Ricardo/0000-0001-6136-0980; Sanders, Jeremy Keith Morris/0000-0002-5143-5210				Berl V, 1999, EUR J ORG CHEM, V1999, P3089; BOLDT P, 1967, CHEM BER-RECL, V100, P1270, DOI 10.1002/cber.19671000428; Brady PA, 1996, CHEM COMMUN, P319, DOI 10.1039/cc9960000319; Calama MC, 2000, ANGEW CHEM INT EDIT, V39, P755, DOI 10.1002/(SICI)1521-3773(20000218)39:4<755::AID-ANIE755>3.0.CO;2-6; Cousins GRL, 2001, ANGEW CHEM INT EDIT, V40, P423, DOI 10.1002/1521-3773(20010119)40:2<423::AID-ANIE423>3.0.CO;2-6; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; FIELD L, 1970, J ORG CHEM, V35, P3647, DOI 10.1021/jo00836a012; Furlan RLE, 2002, TETRAHEDRON, V58, P771, DOI 10.1016/S0040-4020(01)01102-4; Furlan RLE, 2001, J AM CHEM SOC, V123, P8876, DOI 10.1021/ja0160703; Furlan RLE, 2000, CHEM COMMUN, P1761, DOI 10.1039/b006149m; Hioki H, 1998, J ORG CHEM, V63, P904, DOI 10.1021/jo971782q; Huc I, 1999, EUR J INORG CHEM, P1415; Huc I, 1997, P NATL ACAD SCI USA, V94, P2106, DOI 10.1073/pnas.94.6.2106; KEARNEY PC, 1993, J AM CHEM SOC, V115, P9907, DOI 10.1021/ja00075a006; Klekota B, 1999, TRENDS BIOTECHNOL, V17, P205, DOI 10.1016/S0167-7799(99)01305-0; Lehn JM, 2001, SCIENCE, V291, P2331, DOI 10.1126/science.1060066; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Moore JS, 2000, ORG LETT, V2, P915, DOI 10.1021/ol0055723; Ngola SM, 1999, J AM CHEM SOC, V121, P1192, DOI 10.1021/ja982499r; Otto S, 2002, DRUG DISCOV TODAY, V7, P117, DOI 10.1016/S1359-6446(01)02086-4; Otto S, 2000, J AM CHEM SOC, V122, P12063, DOI 10.1021/ja005507o; PETTI MA, 1988, J AM CHEM SOC, V110, P6825, DOI 10.1021/ja00228a036; Ramstrom O, 2000, CHEMBIOCHEM, V1, P41, DOI 10.1002/1439-7633(20000703)1:1<41::AID-CBIC41>3.0.CO;2-L; Rowan SJ, 2002, ANGEW CHEM INT EDIT, V41, P898, DOI 10.1002/1521-3773(20020315)41:6<898::AID-ANIE898>3.0.CO;2-E; Sakai S, 1999, B CHEM SOC JPN, V72, P1313, DOI 10.1246/bcsj.72.1313; STAAB HA, 1979, LIEBIGS ANN CHEM, P886; STAUFFER DA, 1990, J ORG CHEM, V55, P2762, DOI 10.1021/jo00296a038; Stulz E, 2002, CHEM COMMUN, P524, DOI 10.1039/b111019p	28	319	326	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2002	297	5581					590	593		10.1126/science.1072361	http://dx.doi.org/10.1126/science.1072361			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142534				2022-12-28	WOS:000177054200047
J	Nathan, R; Katul, GG; Horn, HS; Thomas, SM; Oren, R; Avissar, R; Pacala, SW; Levin, SA				Nathan, R; Katul, GG; Horn, HS; Thomas, SM; Oren, R; Avissar, R; Pacala, SW; Levin, SA			Mechanisms of long-distance dispersal of seeds by wind	NATURE			English	Article							PLANT MIGRATION; TURBULENCE; MODEL	Long-distance dispersal (LDD) is central to species expansion following climate change, re-colonization of disturbed areas and control of pests(1-8). The current paradigm is that the frequency and spatial extent of LDD events are extremely difficult to predict(9-12). Here we show that mechanistic models coupling seed release and aerodynamics with turbulent transport processes provide accurate probabilistic descriptions of LDD of seeds by wind. The proposed model reliably predicts the vertical distribution of dispersed seeds of five tree species observed along a 45-m high tower in an eastern US deciduous forest. Simulations show that uplifting above the forest canopy is necessary and sufficient for LDD, hence, they provide the means to define LDD quantitatively rather than arbitrarily. Seed uplifting probability thus sets an upper bound on the probability of long-distance colonization. Uplifted yellow poplar seeds are on average lighter than seeds at the forest floor, but also include the heaviest seeds. Because uplifting probabilities are appreciable (as much as 15%), and tree seed crops are commonly massive, some LDD events will establish individuals that can critically affect plant dynamics on large scales.	Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Duke Univ, Dept Civil & Environm Engn, Durham, NC 27708 USA	Ben Gurion University; Duke University; Princeton University; Duke University	Nathan, R (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	rnathan@bgumail.bgu.ac.il	Levin, Simon A/J-1218-2014; Katul, Gabriel G/A-7210-2008; Oren, Ram/AAC-5326-2019; Nathan, Ran/A-9380-2008	Levin, Simon A/0000-0002-8216-5639; Katul, Gabriel G/0000-0001-9768-3693; Oren, Ram/0000-0002-5654-1733; Nathan, Ran/0000-0002-5733-6715				Bullock JM, 2000, OECOLOGIA, V124, P506, DOI 10.1007/PL00008876; Burns R.M., 1990, AGR HDB USDA, V654; Cain ML, 2000, AM J BOT, V87, P1217, DOI 10.2307/2656714; Clark JS, 1998, BIOSCIENCE, V48, P13, DOI 10.2307/1313224; Clark JS, 1998, ECOL MONOGR, V68, P213, DOI 10.1890/0012-9615(1998)068[0213:SASSOR]2.0.CO;2; Clark JS, 2001, AM NAT, V157, P537, DOI 10.1086/319934; DESTEVEN D, 1991, ECOLOGY, V72, P1076, DOI 10.2307/1940607; Finnigan J, 2000, ANNU REV FLUID MECH, V32, P519, DOI 10.1146/annurev.fluid.32.1.519; GREENE DF, 1995, CAN J BOT, V73, P1036, DOI 10.1139/b95-113; Gregory PH, 1973, MICROBIOLOGY ATMOSPH; Higgins SI, 1999, AM NAT, V153, P464, DOI 10.1086/303193; HIGGINS SI, UNPUB ECOLOGY; Horn HS, 2001, ECOL RES, V16, P877, DOI 10.1046/j.1440-1703.2001.00456.x; Hsieh CI, 1997, WATER RESOUR RES, V33, P427, DOI 10.1029/96WR03136; Katul GG, 1998, BOUND-LAY METEOROL, V89, P47, DOI 10.1023/A:1001509106381; Katul GG, 1998, J APPL METEOROL, V37, P1533, DOI 10.1175/1520-0450(1998)037<1533:ATASTN>2.0.CO;2; Leonard KJ, 1986, PLANT DIS EPIDEMIOLO; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; MONIN AS, 1971, STAT FLUID MECH, V1, P209; Nathan R, 2001, ECOLOGY, V82, P374, DOI 10.1890/0012-9658(2001)082[0374:FVASAO]2.0.CO;2; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; NATHAN R, 2001, ENCY BIODIVERSITY, V2, P127; Nathan Ran, 2001, Trends in Ecology and Evolution, V16, P481, DOI 10.1016/S0169-5347(01)02272-8; OKUBO A, 1989, ECOLOGY, V70, P329, DOI 10.2307/1937537; Pasquill F., 1983, ATMOSPHERIC DIFFUSIO, V3rd; Ridley H., 1930, J ECOL, DOI DOI 10.2307/2255951; Ridley HN, 1905, ANN BOT-LONDON, V19, P351, DOI 10.1093/oxfordjournals.aob.a089006; Van der Pijl L, 1982, PRINCIPLES DISPERSAL, V214; Webber M. L., 1934, MALAYAN FORESTER, V3, P18; WILLSON MF, 1993, VEGETATIO, V108, P261	30	466	492	1	188	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2002	418	6896					409	413		10.1038/nature00844	http://dx.doi.org/10.1038/nature00844			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12140556				2022-12-28	WOS:000177009700036
J	Schuch, R; Nelson, D; Fischetti, VA				Schuch, R; Nelson, D; Fischetti, VA			A bacteriolytic agent that detects and kills Bacillus anthracis	NATURE			English	Article							CEREUS SPORES; LYTIC ENZYME; THURINGIENSIS; EXPRESSION; INFECTIONS; GENES	The dormant and durable spore form of Bacillus anthracis is an ideal biological weapon of mass destruction(1,2). Once inhaled, spores are transported by alveolar macrophages to lymph nodes surrounding the lungs, where they germinate; subsequent vegetative expansion causes an overwhelming flood of bacteria and toxins into the blood, killing up to 99% of untreated victims. Natural and genetically engineered antibiotic- resistant bacilli amplify the threat of spores being used as weapons, and heighten the need for improved treatments and spore-detection methods after an intentional release. We exploited the inherent binding specificity and lytic action of bacteriophage enzymes called lysins for the rapid detection and killing of B. anthracis. Here we show that the PlyG lysin, isolated from the gamma phage of B. anthracis, specifically kills B. anthracis isolates and other members of the B. anthracis 'cluster' of bacilli in vitro and in vivo. Both vegetative cells and germinating spores are susceptible. The lytic specificity of PlyG was also exploited as part of a rapid method for the identification of B. anthracis. We conclude that PlyG is a tool for the treatment and detection of B. anthracis.	Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, New York, NY 10021 USA	Rockefeller University	Fischetti, VA (corresponding author), Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, 1230 York Ave, New York, NY 10021 USA.		Nelson, Daniel C./I-2198-2012	Nelson, Daniel C./0000-0003-3248-4831				BROWN ER, 1955, J INFECT DIS, V96, P34, DOI 10.1093/infdis/96.1.34; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; BURDON KL, 1967, J INFECT DIS, V117, P307, DOI 10.1093/infdis/117.4.307; CORRAN J, 1968, MOL GEN GENET, V103, P42, DOI 10.1007/BF00271156; Fischetti VA, 2001, NAT BIOTECHNOL, V19, P734, DOI 10.1038/90777; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Helgason E, 2000, J CLIN MICROBIOL, V38, P1615, DOI 10.1128/JCM.38.4.1615-1622.2000; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Henriques AO, 2000, METHODS, V20, P95, DOI 10.1006/meth.1999.0909; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Jackson PJ, 1997, APPL ENVIRON MICROB, V63, P1400, DOI 10.1128/AEM.63.4.1400-1405.1997; JENKINSON HF, 1980, J BACTERIOL, V141, P793, DOI 10.1128/JB.141.2.793-805.1980; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; LAMANNA C, 1963, J BACTERIOL, V85, P532, DOI 10.1128/JB.85.3.532-535.1963; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Loessner MJ, 2002, MOL MICROBIOL, V44, P335, DOI 10.1046/j.1365-2958.2002.02889.x; LOESSNER MJ, 1995, MOL MICROBIOL, V16, P1231, DOI 10.1111/j.1365-2958.1995.tb02345.x; Lopez R, 1997, MICROB DRUG RESIST, V3, P199, DOI 10.1089/mdr.1997.3.199; MAKINO S, 1994, MICROBIOL-SGM, V140, P1403, DOI 10.1099/00221287-140-6-1403; Mazas M, 1999, INT J FOOD MICROBIOL, V53, P61, DOI 10.1016/S0168-1605(99)00145-2; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Nelson D, 2001, P NATL ACAD SCI USA, V98, P4107, DOI 10.1073/pnas.061038398; Pannucci J, 2002, J BACTERIOL, V184, P134, DOI 10.1128/JB.184.1.134-141.2002; Redmond C., 1996, SALISBURY MED B SP S, V87, P60; SANTO LY, 1974, J BACTERIOL, V120, P475, DOI 10.1128/JB.120.1.475-481.1974; Schmitt CK, 2001, INFECT IMMUN, V69, P5619, DOI 10.1128/IAI.69.9.5619-5625.2001; Stopa PJ, 1999, FIELD ANAL CHEM TECH, V3, P283, DOI 10.1002/(SICI)1520-6521(1999)3:4/5<283::AID-FACT7>3.0.CO;2-9; Ticknor LO, 2001, APPL ENVIRON MICROB, V67, P4863, DOI 10.1128/AEM.67.10.4863-4873.2001; Turnbull PCB, 1999, J APPL MICROBIOL, V87, P237, DOI 10.1046/j.1365-2672.1999.00876.x; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799	30	469	547	3	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2002	418	6900					884	889		10.1038/nature01026	http://dx.doi.org/10.1038/nature01026			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192412				2022-12-28	WOS:000177555600040
J	Taipale, J; Cooper, MK; Maiti, T; Beachy, PA				Taipale, J; Cooper, MK; Maiti, T; Beachy, PA			Patched acts catalytically to suppress the activity of Smoothened	NATURE			English	Article							STEROL-SENSING DOMAIN; BASAL-CELL CARCINOMAS; PICK C1 PROTEIN; SONIC HEDGEHOG; SUBCELLULAR-LOCALIZATION; VESICULAR TRAFFICKING; MUTATIONS; GENE; IDENTIFICATION; PATHWAY	Mutations affecting the transmembrane proteins Patched (Ptc) or Smoothened (Smo) that trigger ligand-independent activity of the Hedgehog (Hh) signalling pathway are associated with human tumours such as basal cell carcinoma (BCC) and medulloblastoma(1-3). Despite extensive genetic studies demonstrating the importance of these receptor components in embryonic patterning and cancer, the mechanism by which Ptc regulates Smo is not understood(4). Here we report that Ptc and Smo are not significantly associated within Hh-responsive cells. Furthermore, we show that free Ptc (unbound by Hh) acts sub-stoichiometrically to suppress Smo activity and thus is critical in specifying the level of pathway activity. Patched is a twelve-transmembrane protein with homology to bacterial proton-driven transmembrane molecular transporters; we demonstrate that the function of Ptc is impaired by alterations of residues that are conserved in and required for function of these bacterial transporters. These results suggest that the Ptc tumour suppressor functions normally as a transmembrane molecular transporter, which acts indirectly to inhibit Smo activity, possibly through changes in distribution or concentration of a small molecule.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Beachy, PA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA.							Alcedo J, 2000, MOL CELL, V6, P457, DOI 10.1016/S1097-2765(00)00044-7; Aszterbaum M, 1998, J INVEST DERMATOL, V110, P885, DOI 10.1046/j.1523-1747.1998.00222.x; Bale AE, 2001, HUM MOL GENET, V10, P757, DOI 10.1093/hmg/10.7.757; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; CAPDEVILA J, 1994, DEVELOPMENT, V120, P987; Chidambaram A, 1996, CANCER RES, V56, P4599; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Davies JP, 2000, SCIENCE, V290, P2295, DOI 10.1126/science.290.5500.2295; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Goldberg M, 1999, J BIOL CHEM, V274, P26065, DOI 10.1074/jbc.274.37.26065; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Guan L, 2001, J BACTERIOL, V183, P1734, DOI 10.1128/JB.183.5.1734-1739.2001; Ingham PW, 2000, CURR BIOL, V10, P1315, DOI 10.1016/S0960-9822(00)00755-7; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; INGHAM PW, 1991, NATURE, V353, P184, DOI 10.1038/353184a0; Kalderon D, 2000, CELL, V103, P371, DOI 10.1016/S0092-8674(00)00129-X; Ko DC, 2001, MOL BIOL CELL, V12, P601, DOI 10.1091/mbc.12.3.601; Martin V, 2001, CURR BIOL, V11, P601, DOI 10.1016/S0960-9822(01)00178-6; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Strutt H, 2001, CURR BIOL, V11, P608, DOI 10.1016/S0960-9822(01)00179-8; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wicking C, 1997, AM J HUM GENET, V60, P21; Williams KP, 1999, J CELL SCI, V112, P4405; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648	30	599	631	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2002	418	6900					892	897		10.1038/nature00989	http://dx.doi.org/10.1038/nature00989			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192414				2022-12-28	WOS:000177555600042
J	Crowther, MA; Douketis, JD; Schnurr, T; Steidl, L; Mera, V; Ultori, C; Venco, A; Ageno, W				Crowther, MA; Douketis, JD; Schnurr, T; Steidl, L; Mera, V; Ultori, C; Venco, A; Ageno, W			Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy - A randomized, controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							EXCESSIVE ANTICOAGULATION; PHYTONADIONE; REVERSAL; TIME	Background: Excessive anticoagulation due to warfarin use is associated with hemorrhage. Subcutaneously administered vitamin K has not been evaluated for the treatment of warfarin-associated coagulopathy, yet it is widely used. Objective: To show that oral vitamin K is more effective than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. Design: Randomized, controlled trial. Setting: Two teaching hospitals. Patients: Patients with an international normalized ratio (INR) between 4.5 and 10.0. Intervention: Warfarin therapy was withheld, and 1 mg of vitamin K was given orally or subcutaneously. Measurements: The primary outcome measure was the INR on the day after administration of vitamin K. Secondary outcome measures were hemorrhage and thrombosis during a 1-month follow-up period. Results: 15 of 26 patients receiving oral vitamin K and 6 of 25 patients receiving subcutaneous vitamin K had therapeutic INRs on the day after study drug administration (P = 0.015; odds ratio, 4.32 [95% Cl, 1.13 to 17.441). Conclusion: Oral vitamin K lowers INR more rapidly than subcutaneous vitamin K in asymptomatic patients who have supra-therapeutic INR values while receiving warfarin.	St Josephs Hosp, Hamilton, ON L8N 4A6, Canada; Osped Circolo Varese, Varese, Italy	McGill University; McMaster University	Crowther, MA (corresponding author), St Josephs Hosp, Room L208,50 Charlton Ave E, Hamilton, ON L8N 4A6, Canada.	crowthrm@mcmaster.ca	Douketis, James/AAO-5659-2021	ageno, walter/0000-0002-1922-8879				Crowther MA, 1998, THROMB HAEMOSTASIS, V79, P1116; Crowther MA, 2000, LANCET, V356, P1551, DOI 10.1016/S0140-6736(00)03125-1; GLOVER JJ, 1995, CHEST, V108, P987, DOI 10.1378/chest.108.4.987; Hylck EM, 2000, ARCH INTERN MED, V160, P1612, DOI 10.1001/archinte.160.11.1612; LANDEFELD CS, 1989, AM J MED, V87, P153; Lousberg TR, 1998, ARCH INTERN MED, V158, P528, DOI 10.1001/archinte.158.5.528; Nee R, 1999, AM J CARDIOL, V83, P286, DOI 10.1016/S0002-9149(98)00842-X; Patel RJ, 2000, PHARMACOTHERAPY, V20, P1159, DOI 10.1592/phco.20.15.1159.34585; PENGO V, 1993, BLOOD COAGUL FIBRIN, V4, P739, DOI 10.1097/00001721-199304050-00010; Raj G, 1999, ARCH INTERN MED, V159, P2721, DOI 10.1001/archinte.159.22.2721; Wilson SE, 2001, CHEST, V120, P1972, DOI 10.1378/chest.120.6.1972	11	114	117	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2002	137	4					251	254		10.7326/0003-4819-137-4-200208200-00009	http://dx.doi.org/10.7326/0003-4819-137-4-200208200-00009			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585BB	12186515				2022-12-28	WOS:000177502300005
J	Lewenstein, M				Lewenstein, M			Physics: Resolving physical processes on the attosecond time scale	SCIENCE			English	Editorial Material							HIGH-HARMONIC-GENERATION; LASER-PULSES		Univ Hannover, Inst Theoret Phys, D-30167 Hannover, Germany	Leibniz University Hannover	Lewenstein, M (corresponding author), Univ Hannover, Inst Theoret Phys, D-30167 Hannover, Germany.		Lewenstein, Maciej/I-1337-2014	Lewenstein, Maciej/0000-0002-0210-7800				Antoine P, 1996, PHYS REV LETT, V77, P1234, DOI 10.1103/PhysRevLett.77.1234; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; Joachain CJ, 2000, ADV ATOM MOL OPT PHY, V42, P225, DOI 10.1016/S1049-250X(08)60188-3; KIENBERGER, SCIENCE, P1144; KROLL NM, 1973, PHYS REV A, V8, P804, DOI 10.1103/PhysRevA.8.804; LEWENSTEIN M, 1994, PHYS REV A, V49, P2117, DOI 10.1103/PhysRevA.49.2117; Papadogiannis NA, 1999, PHYS REV LETT, V83, P4289, DOI 10.1103/PhysRevLett.83.4289; Paul PM, 2001, SCIENCE, V292, P1689, DOI 10.1126/science.1059413; Paulus GG, 2001, NATURE, V414, P182, DOI 10.1038/35102520; Rzazewski, 1993, SUPER INTENSE LASER; Salieres P, 2001, SCIENCE, V292, P902, DOI 10.1126/science.108836; Spielmann C, 1997, SCIENCE, V278, P661, DOI 10.1126/science.278.5338.661; 2002, SCIENCE         0711	15	19	20	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2002	297	5584					1131	1132		10.1126/science.1075873	http://dx.doi.org/10.1126/science.1075873			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183615				2022-12-28	WOS:000177447600032
J	Shamasunder, B; Bero, L				Shamasunder, B; Bero, L			Financial ties and conflicts of interest between pharmaceutical and tobacco companies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INDUSTRY	Corporate diversification allows for well-hidden financial ties between pharmaceutical and tobacco companies, which can cause a conflict of interest in the development and marketing of pharmaceutical products. In our investigation of tobacco company documents released and posted on the Internet as a result of the Master Settlement Agreement, we have found that these financial ties have fostered both competition and collaboration between the tobacco and pharmaceutical industries. We present 3 case studies. One shows how tobacco companies pressured pharmaceutical companies to scale back their smoking cessation educational materials that accompanied Nicorette. The second shows how they restricted to whom the pharmaceutical company could market its transdermal nicotine patch. In the third case, we show how subsidiary tobacco and pharmaceutical companies of a parent company collaborated in the production of a nicotine-release gum. Thus, because tobacco cessation product marketing has been altered as a result of these financial conflicts, disclosure would serve the interest of public health.	Univ Calif San Francisco, Inst Hlth Policy Studies, Dept Clin Pharm, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bero, L (corresponding author), 3333 Calif St,Suite 265, San Francisco, CA 94143 USA.							BALLIN SD, 1989, TOB US AM C REP DALL; BLUM A, 1985, NY STATE J MED, P328; BUDICH KM, 1991, Q A TOBACCO REGULATI; CHARLES JL, 1982, CGA41065 CIBA GEIG P; *CIBA, 1943, CIBA S TOB, V4, P1426; *COAL SMOK OR HLTH, 1993, HIST OV CIG NIC REG; COTIGNOLA F, 1992, NICOTINE PATCH IND V; ELLIOT D, 1992, COMMUNICATION   0311; *FDC, 1992, FDC REP, V54, P8; FREUDENHEIM M, 1992, NY TIMES        0819; Garner B. A, 1999, BLACKS LAW DICT; JENKINS RW, 1980, COMMUNICATION   0116; JENKINS RW, 1977, COMMUNICATION   1122; Joossens L, 1996, Tob Control, V5, P177, DOI 10.1136/tc.5.3.177; KANIPE RW, 1987, MASTERPIECE TOBACS C; KAY A, 1984, COMMUNICATION   1217; Krantz A, 1998, NAT BIOTECHNOL, V16, P1294, DOI 10.1038/4243; Landman A, 2000, TOB CONTROL, V9, P339, DOI 10.1136/tc.9.3.339; LATSHAW RD, 1985, COMMUNICATION   0122; LATSHAW RD, 1984, COMMUNICATION   0507; LATSHAW RD, 1982, M DOW PHARM M JUL 13; LATSHAW RD, 1984, COMMUNICATION   1023; LATSHAW RD, 1985, COMMUNICATION   0118; LATSHAW RD, 1985, DOW ICORETTE SITUAT; LINDSAY D, 1982, 1170 TD CIBA GEIG RI; LUDOLF A, 1993, NICOTINE PATCH SUMMA; *M DOW PHARM, 1984, IF YOU WANT QUIT GOO; Markides CC, 1997, HARVARD BUS REV, V75, P93; MCDONALD CE, 1991, WORLDWIDE PRODUCERS; *MM DOW PHARM INC, 1981, SMOK CESS NEWSL; Muggli ME, 2001, AM J PUBLIC HEALTH, V91, P1419, DOI 10.2105/AJPH.91.9.1419; OSDENE TS, 1979, M CIBA GEIG PERS; OSDENE TS, 1982, COMMUNICATION   0104; *P MORR, 1991, SMOK CESS NIC DEL DE; *P MORR, 1993, RIS FALL RIS NIC PAT; *P MORR, 1992, PATCH ADV; *P MORR, SMOK CESS NIC DEL DE; *P MORR, 1992, NIC PATCH QUAL RES I; *P MORR, 1992, NIC PATCH ADV WEEKL; *P MORR, 1992, NIC PATCH CONS RES; PADOAN A, 1992, NICOTINE SKIN PATCH; RESNIK F, 1985, COMMUNICATION   0920; REUTER B, 2001, COMPETITIVE ANAL; RYAN N, 1992, NICOTINE PATCH ADV; SEIDENSTICKER R, 1991, COMMUNICATION   0523; Stern D, 1992, NICOTINE PATCH TRACK; SYKES L, 1992, COMMUNICATION   0313; SYKES L, 1992, COMMUNICATION   0128; TAYLOR JM, 1987, MASTERPIECE TOBACS; TIGHE L, 1992, COMMUNICATION   0722	50	25	25	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2002	288	6					738	744		10.1001/jama.288.6.738	http://dx.doi.org/10.1001/jama.288.6.738			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	583KY	12169078				2022-12-28	WOS:000177408100035
J	Jefferis, BJMH; Power, C; Hertzman, C				Jefferis, BJMH; Power, C; Hertzman, C			Birth weight, childhood socioeconomic environment, and cognitive development in the 1958 British birth cohort study	BRITISH MEDICAL JOURNAL			English	Article							FOR-GESTATIONAL-AGE; ADULT LIFE; FOLLOW-UP; HEALTH; BORN	Objectives To examine the combined effect of social class and weight at birth on cognitive trajectories during school age and the associations between birth weight and educational outcomes through to 33 years. Design Longitudinal, population based, birth cohort study. Participants 10 845 males and females born during 3-9 March 1958 with information on birth weight, social class, and cognitive tests. Main outcome measures Reading, maths, draw a man, copying designs, verbal and non-verbal ability tests at ages 7, 11, and 16, highest qualifications achieved by 33, and trajectories of maths standardised scores at 7-16 years. Results The outcome of all childhood cognitive tests and educational achievements improved significantly with increasing birth weight. Analysis of maths scores at 7 and of highest qualifications achieved by 33 showed that the relations were robust to adjustment for potential confounding factors. For each kilogram increase in birth weight, maths z score increased by 0.17 (adjusted estimate 0.15, 95% confidence interval 0.10 to 0.21) for males and 0.21 (0.20,0.14 to 0.25) for females. Trajectories of maths z scores between 7 and 16 years diverged for different social class groups: participants from classes I and II increased their relative position on the score with increasing age, whereas classes IV and V showed a relative decline with increasing age. Birth weight explained much less of the variation in cognition than did social class (range 0.5-1.5% v 2.9-12.5%). Conclusions The postnatal environment has an overwhelming influence on cognitive function through to early adulthood, but these strong effects do not explain the weaker but independent association with birth weight.	Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England; Univ British Columbia, Fac Med, Dept Hlth Care & Epidemiol, Vancouver, BC V6T 1Z3, Canada	University of London; University College London; University of British Columbia	Power, C (corresponding author), Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, 30 Guilford St, London WC1N 1EH, England.		Jefferis, Barbara/AAE-5186-2020; Jefferis, Barbara JMH/C-1786-2008	Jefferis, Barbara/0000-0002-0850-3177; Jefferis, Barbara JMH/0000-0002-0850-3177				Butler NR, 1969, 2 REPORT BRIT PERINA; DAVIE R, 1972, BIRTH 7 FULL STAT AP; Douglas James W.B, 1964, HOME SCH; DRILLIEN CM, 1969, ARCH DIS CHILD, V44, P562, DOI 10.1136/adc.44.237.562; FERRI E, 1993, LIFE 33 5 FOLLOW UP; FOGELMAN K, 1978, EDUC STUD, V4, P121, DOI 10.1080/0305569780040205; GOLDSTEIN H, 1976, BIOL HUMAN FETAL GRO, P81; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; GOLDSTEIN H, 1983, GROWING UP GREAT BRI, P9; Goodenough FL., 1926, MEASUREMENT INTELLIG; Kaplan GA, 2001, INT J EPIDEMIOL, V30, P256, DOI 10.1093/ije/30.2.256; Martyn CN, 1996, BRIT MED J, V312, P1393; Matte TD, 2001, BRIT MED J, V323, P310, DOI 10.1136/bmj.323.7308.310; OUNSTED MK, 1983, EARLY HUM DEV, V8, P243, DOI 10.1016/0378-3782(83)90007-5; PHAROAH POD, 1994, ARCH DIS CHILD, V70, P264, DOI 10.1136/adc.70.4.264; Power C, 1997, LANCET, V350, P1584, DOI 10.1016/S0140-6736(97)07474-6; Power C, 2000, BRIT MED J, V320, P840, DOI 10.1136/bmj.320.7238.840; Richards M, 2001, BRIT MED J, V322, P199, DOI 10.1136/bmj.322.7280.199; SEIDMAN DS, 1992, OBSTET GYNECOL, V79, P543; Shenkin SD, 2001, ARCH DIS CHILD, V85, P189, DOI 10.1136/adc.85.3.189; Sommerfelt K, 2000, ARCH DIS CHILD, V83, P25, DOI 10.1136/adc.83.1.25; Sorensen HT, 1997, BRIT MED J, V315, P401, DOI 10.1136/bmj.315.7105.401; Southgate V, 1962, SOUTHGATE GROUP READ; Strauss RS, 2000, JAMA-J AM MED ASSOC, V283, P625, DOI 10.1001/jama.283.5.625; WEIR W, 1992, ARCH DIS CHILD, V67, P675; WERNER EE, 1986, RISK INTELLECTUAL PS	26	182	191	0	21	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 10	2002	325	7359					305	308		10.1136/bmj.325.7359.305	http://dx.doi.org/10.1136/bmj.325.7359.305			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	584RQ	12169505	Bronze, Green Published			2022-12-28	WOS:000177482500016
J	Balmford, A; Bruner, A; Cooper, P; Costanza, R; Farber, S; Green, RE; Jenkins, M; Jefferiss, P; Jessamy, V; Madden, J; Munro, K; Myers, N; Naeem, S; Paavola, J; Rayment, M; Rosendo, S; Roughgarden, J; Trumper, K; Turner, RK				Balmford, A; Bruner, A; Cooper, P; Costanza, R; Farber, S; Green, RE; Jenkins, M; Jefferiss, P; Jessamy, V; Madden, J; Munro, K; Myers, N; Naeem, S; Paavola, J; Rayment, M; Rosendo, S; Roughgarden, J; Trumper, K; Turner, RK			Ecology - Economic reasons for conserving wild nature	SCIENCE			English	Review							WORLDS ECOSYSTEM SERVICES	On the eve of the World Summit on Sustainable Development, it is timely to assess progress over the 10 years since its predecessor in Rio de Janeiro. Loss and degradation of remaining natural habitats has continued largely unabated. However, evidence has been accumulating that such systems generate marked economic benefits, which the available data suggest exceed those obtained from continued habitat conversion. We estimate that the overall benefit:cost ratio of an effective global program for the conservation of remaining wild nature is at least 100:1.	Univ Cambridge, Dept Zool, Conservat Biol Grp, Cambridge CB2 3EJ, England; Conservat Int, Ctr Appl Biodivers Sci, Washington, DC 20036 USA; Univ E Anglia, Sch Environm Sci, Ctr Social & Econ Res Global Environm, Norwich NR4 7TJ, Norfolk, England; Univ Maryland, Ctr Environm Sci, Dept Biol, Solomons, MD 20688 USA; Univ Maryland, Inst Ecol Econ, Solomons, MD 20688 USA; Univ Pittsburgh, Grad Sch Publ & Int Affairs, Pittsburgh, PA 15260 USA; Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; UNEP, WCMC, Cambridge CB3 ODL, England; Univ Oxford Green Coll, Oxford OX2 6HG, England; Univ Washington, Dept Zool, Seattle, WA 98195 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	University of Cambridge; Conservation International; University of East Anglia; University System of Maryland; University of Maryland Center for Environmental Science; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Royal Society for Protection of Birds; University of Oxford; University of Washington; University of Washington Seattle; Stanford University	Balmford, A (corresponding author), Univ Cambridge, Dept Zool, Conservat Biol Grp, Downing St, Cambridge CB2 3EJ, England.	a.balmford@zoo.cam.ac.uk	Costanza, Robert/A-4912-2008; Wrbka, Thomas/A-5699-2010; Costanza, Robert/AAJ-3546-2021; Rosendo, Sergio/J-3904-2013; Paavola, Jouni/A-5413-2010	Costanza, Robert/0000-0001-6348-8734; Wrbka, Thomas/0000-0002-1451-9108; Paavola, Jouni/0000-0001-5720-466X; Balmford, Andrew/0000-0002-0144-3589; Rosendo, Sergio/0000-0002-3095-9824				*CA DEP FISH GAM N, 2001, REC MAR PROT AR CHAN; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Daily GC, 2000, SCIENCE, V289, P395, DOI 10.1126/science.289.5478.395; Daily GC, 1997, NATURES SERVICES SOC, DOI DOI 10.12987/9780300188479-039; Dasgupta P., 2001, HUMAN WELL BEING NAT; EHRENFELD D, 1988, BIODIVERSITY; FAO, 2001, GLOB FOR RES ASS 200; FAO (The U.N. Food and Agriculture Organization, 2000, STAT WORLD FISH AQ; Hardner J, 2002, SCI AM, V286, P88; *INT MON FUND, 2001, INT FIN STAT; *INT UN CONS NAT N, 1998, 1997 UN LIST PROT AR; *IUCN, 1993, 4 WORLD C NAT PARKS; James A, 2001, BIOSCIENCE, V51, P43, DOI 10.1641/0006-3568(2001)051[0043:CWATCB]2.0.CO;2; James A. N., 1999, GLOBAL REV PROTECTED; James AN, 1999, NATURE, V401, P323, DOI 10.1038/43774; KUMARI K, 1994, THESIS U E ANGLIA NO; LOH J, 2000, WWF LIVING PLANET RE; Myers N, 2001, PERVERSE SUBSIDIES; Norton B., 1992, ENVIRON VALUE, V1, P97, DOI [10.3197/096327192776680133, DOI 10.3197/096327192776680133, 10.1017/cbo9780511613821.015]; Nunes PALD, 2001, ECOL ECON, V39, P203, DOI 10.1016/S0921-8009(01)00233-6; Pimm SL, 2001, SCIENCE, V293, P2207, DOI 10.1126/science.1061626; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Roughgarden J, 2001, ECOLOGY: ACHIEVEMENT AND CHALLENGE, P337; SATHIRATHAI S, 1998, UNPUB EC VALUATION M; SCHERR S, 2002, POLICY BRIEF MAKING; Soule ME, 1998, SCIENCE, V279, P2060, DOI 10.1126/science.279.5359.2060; Taylor P.W., 1981, ENVIRON ETHICS, V3, P197, DOI [10.5840/enviroethics19813321, DOI 10.5840/ENVIROETHICS19813321]; Toman M, 1998, ECOL ECON, V25, P57, DOI 10.1016/S0921-8009(98)00017-2; Turner RK, 1998, ECOL ECON, V25, P61, DOI 10.1016/S0921-8009(98)00018-4; Turner RK, 2000, ECOL ECON, V35, P7, DOI 10.1016/S0921-8009(00)00164-6; TURNER RK, 1991, WETLANDS MARKET INTE; *UN DEV PROGR, 2001, HUM DEV REP 2001; *UN POP DIV, 2001, WORLD POP PROSP 2000; VANBEERS CP, 1999, ADDICTED SUBSIDIES G; VANVUUREN W, 1993, ECOL ECON, V8, P289, DOI 10.1016/0921-8009(93)90063-C; Wells S., 1995, GLOBAL REPRESENTATIV; White AT, 2000, MAR POLLUT BULL, V40, P598, DOI 10.1016/S0025-326X(00)00022-9; Yaron G., 2001, Journal of Environmental Planning and Management, V44, P85, DOI 10.1080/09640560123194	38	892	948	10	744	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 9	2002	297	5583					950	953		10.1126/science.1073947	http://dx.doi.org/10.1126/science.1073947			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	581ZN	12169718				2022-12-28	WOS:000177325400027
J	Davis, MM				Davis, MM			A new trigger for T cells	CELL			English	Review							RECEPTOR; ACTIVATION; BINDING	Understanding the early events in T cell activation and signaling is an active area of research. A recent study (Gil et al, 2002) has described a new trigger for T cell activation, involving a TCR-ligand-induced conformational change in CD3epsilon that permits binding of the adaptor protein Nck.	Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Davis, MM (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.			Davis, Mark/0000-0001-6868-657X				Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Fernandez-Miguel G, 1999, P NATL ACAD SCI USA, V96, P1547, DOI 10.1073/pnas.96.4.1547; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; He XL, 2001, SCIENCE, V293, P1657, DOI 10.1126/science.1062246; Lin J, 2001, J CELL SCI, V114, P243; Mowbray SL, 1999, J MOL BIOL, V294, P487, DOI 10.1006/jmbi.1999.3271; Ottemann KM, 1999, SCIENCE, V285, P1751, DOI 10.1126/science.285.5434.1751; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; TERHORST C, 1996, MOL IMMUNOL, P132; van der Merwe PA, 2001, IMMUNITY, V14, P665, DOI 10.1016/S1074-7613(01)00155-8; WEISS A, 1999, FUNDAMENTAL IMMUNOLO, P411; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920	16	42	49	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 9	2002	110	3					285	287		10.1016/S0092-8674(02)00865-6	http://dx.doi.org/10.1016/S0092-8674(02)00865-6			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	583MN	12176315	Bronze			2022-12-28	WOS:000177411800004
J	Russell, TP				Russell, TP			Surface-responsive materials	SCIENCE			English	Article							DIBLOCK COPOLYMERS; PROCESSING AID; POLYMER; METHACRYLATE); POLYETHYLENE; RESISTANT; BLENDS		Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Russell, TP (corresponding author), Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA.		Russell, Thomas Paul/ADL-3689-2022	Russell, Thomas Paul/0000-0001-6384-5826				ANASTASIADIS SH, 1990, J CHEM PHYS, V92, P5677, DOI 10.1063/1.458499; Banerjee P, 2000, J BIOMED MATER RES, V50, P331, DOI 10.1002/(SICI)1097-4636(20000605)50:3<331::AID-JBM6>3.3.CO;2-K; CHAUDHURY MK, 1992, SCIENCE, V256, P1539, DOI 10.1126/science.256.5063.1539; COULON G, 1989, MACROMOLECULES, V22, P2581, DOI 10.1021/ma00196a006; Crevoisier GB, 1999, SCIENCE, V285, P1246, DOI 10.1126/science.285.5431.1246; Falsafi A, 2000, LANGMUIR, V16, P1816, DOI 10.1021/la990345z; Genzer J, 2000, SCIENCE, V290, P2130, DOI 10.1126/science.290.5499.2130; HENKEE CS, 1988, J MATER SCI, V23, P1685, DOI 10.1007/BF01115708; Hester JF, 1999, MACROMOLECULES, V32, P1643, DOI 10.1021/ma980707u; Hong Y, 1999, J RHEOL, V43, P781, DOI 10.1122/1.550999; Hong Y, 2000, POLYMER, V41, P7705, DOI 10.1016/S0032-3861(00)00130-0; Ichimura K, 2000, SCIENCE, V288, P1624, DOI 10.1126/science.288.5471.1624; Irvine DJ, 2001, BIOMACROMOLECULES, V2, P545, DOI 10.1021/bm015510f; Khongtong S, 2002, J AM CHEM SOC, V124, P7254, DOI 10.1021/ja017396e; MORI H, 1994, MACROMOLECULES, V27, P4093, DOI 10.1021/ma00093a010; PENELLE JP, 2002, MACROMOLECULES, V35, P329; Pollard M, 1998, MACROMOLECULES, V31, P6493, DOI 10.1021/ma980316f; RUSSELL TP, 1994, NATURE, V368, P729, DOI 10.1038/368729a0; RUZETTE AV, 1990, J CHEM PHYS, V41, P525; Ruzette AVG, 1998, MACROMOLECULES, V31, P8509, DOI 10.1021/ma981055c; Senshu K, 1999, LANGMUIR, V15, P1754, DOI 10.1021/la980815+; Thanawala SK, 2000, LANGMUIR, V16, P1256, DOI 10.1021/la9906626; THEODOROU DN, 1988, MACROMOLECULES, V21, P1422, DOI 10.1021/ma00183a038; Vaidya A, 2002, J COLLOID INTERF SCI, V249, P235, DOI 10.1006/jcis.2002.8262; Walton DG, 1997, MACROMOLECULES, V30, P6947, DOI 10.1021/ma970698+	25	446	460	7	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 9	2002	297	5583					964	967		10.1126/science.1075997	http://dx.doi.org/10.1126/science.1075997			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169722				2022-12-28	WOS:000177325400031
J	Wells, M; Sturdee, DW; Barlow, DH; Ulrich, LG; O'Brien, K; Campbell, MJ; Vessey, MP; Bragg, A				Wells, M; Sturdee, DW; Barlow, DH; Ulrich, LG; O'Brien, K; Campbell, MJ; Vessey, MP; Bragg, A		UK Continuous Combined Hormone Re	Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POSTMENOPAUSAL WOMEN; ESTRADIOL; RISK; ACETATE; CANCER; REGIMEN	Objective To determine effects of five years of treatment with an oral continuous combined regimen of 2 mg 17beta-oestradiol and 1 mg norethisterone acetate on endometrial histology in postmenopausal women. Design Follow up study in postmenopausal women. Setting 31 menopause clinics in the United Kingdom. Participants 534 postmenopausal women, all with an intact uterus, who had completed nine months of treatment with oral continuous combined 2 mg 17beta-oestradiol and 1 mg norethisterone acetate agreed to take part in a long term follow up study. Women were assigned to different groups on the basis of the treatment status immediately before entering the original study: 360 women had taken sequential oestrogen-progestogen hormone replacement therapy, 164 had taken no hormone replacement therapy, and 10 had taken unopposed oestrogen therapy. Methods Endometrial aspiration specimens were taken before the women started the continuous combined regimen, after 9 and 24-36 months, and at the end of the five year treatment period or on withdrawal from the study. Main outcome measure Results of endometrial histology. Results The duration of treatment with continuous combined hormone replacement therapy was 4.4 (range 1.1-5.9) years. Data on endometrial specimens were available for 526 women after nine months of treatment, 465 women after 24-36 months of treatment, and 398 women who completed the five years treatment (345 women) or were withdrawn between the two latter visits for biopsies (53 women). No cases of endometrial hyperplasia or malignancy were detected at biopsy; 69% of women had an endometrium classified as atrophic or unassessable on completion of the study or withdrawal from it. Before the continuous combined therapy was started, complex hyperplasia was detected in 21 women who had taken sequential hormone replacement therapy before the study and in one who had taken unopposed oestrogen. All of these women had normal results on histological examination of endometrial tissue after nine months of treatment with continuous combined hormone replacement therapy, and hyperplasia did not recur after up to five years of treatment. Conclusions Long term treatment (for up to five years) with continuous combined hormone replacement therapy containing oestradiol 2 mg and norethisterone 1 mg daily was associated with neither endometrial hyperplasia nor malignancy. In women who had complex hyperplasia during previous sequential or unopposed regimens, the endometrium returned to normal during treatment with continuous combined hormone replacement therapy. These findings provide reassurance about the long term safety of this continuous combined regimen in terms of the endometrium.	Univ Sheffield, Sch Med, Div Genom Med, Sect Oncol & Pathol,Acad Unit Pathol, Sheffield S10 2RX, S Yorkshire, England; Solihull Hosp, Dept Obstet & Gynaecol, Solihull B91 2JL, W Midlands, England; Univ Oxford, John Radcliffe Hosp, Oxford OX3 9DU, England; Copenhagen Cty Hosp Gentofte, Dept Obstet & Gynaecol, DK-2900 Hellerup, Denmark; Novo Nordisk AS, Dept Med, Crawley RH11 9RT, W Sussex, England; No Gen Hosp, Community Sci Ctr, Sch Hlth Related Res, Sheffield S5 7AU, S Yorkshire, England; Inst Hlth Sci, Dept Publ Hlth, Oxford OX3 7LF, England	University of Sheffield; Heart of England NHS Foundation Trust; University of Oxford; Novo Nordisk; Northern General Hospital; University of Oxford	Wells, M (corresponding author), Univ Sheffield, Sch Med, Div Genom Med, Sect Oncol & Pathol,Acad Unit Pathol, Sheffield S10 2RX, S Yorkshire, England.	m.wells@sheffield.ac.uk	Campbell, Michael J/I-4253-2014; Barlow, David/F-8738-2011; Sturdee, David/ABF-9792-2020	Campbell, Michael J/0000-0003-3529-2739; 				AinMelk Y, 1996, FERTIL STERIL, V66, P962, DOI 10.1016/S0015-0282(16)58690-7; ARCHER DF, 1991, AM J OBSTET GYNECOL, V165, P317, DOI 10.1016/0002-9378(91)90084-5; Beresford SAA, 1997, LANCET, V349, P458, DOI 10.1016/S0140-6736(96)07365-5; Comerci JT, 1997, GYNECOL ONCOL, V64, P425, DOI 10.1006/gyno.1996.4559; CORNIER E, 1984, AM J OBSTET GYNECOL, V148, P109, DOI 10.1016/S0002-9378(84)80043-5; HAWTHORN RJS, 1991, BRIT J OBSTET GYNAEC, V98, P939, DOI 10.1111/j.1471-0528.1991.tb13519.x; Hill DA, 2000, AM J OBSTET GYNECOL, V183, P1456, DOI 10.1067/mob.2000.108081; Judd HL, 1996, JAMA-J AM MED ASSOC, V275, P370, DOI 10.1001/jama.1996.03530290040035; Kurman RJ, 2000, OBSTET GYNECOL, V96, P373, DOI 10.1016/S0029-7844(00)00944-3; LEATHER AT, 1991, OBSTET GYNECOL, V78, P1008; MATTSSON LA, 1982, MATURITAS, V4, P95, DOI 10.1016/0378-5122(82)90035-4; MCGONIGLE KF, 1994, GYNECOL ONCOL, V55, P126, DOI 10.1006/gyno.1994.1261; Nand SL, 1998, OBSTET GYNECOL, V91, P678, DOI 10.1016/S0029-7844(98)00038-6; OBEL EB, 1993, MATURITAS, V16, P13, DOI 10.1016/0378-5122(93)90129-6; Perry W, 1998, GYNECOL ENDOCRINOL, V12, P109, DOI 10.3109/09513599809024959; Piegsa K, 1997, EUR J OBSTET GYN R B, V72, P175, DOI 10.1016/S0301-2115(96)02670-X; Pike MC, 1997, J NATL CANCER I, V89, P1110, DOI 10.1093/jnci/89.15.1110; RAVNIKAR VA, 1996, EUR MENOPAUSE J S, V3, P90; REES M, 1994, LANCET, V343, P250, DOI 10.1016/S0140-6736(94)91108-8; SPORRONG T, 1988, BRIT J OBSTET GYNAEC, V95, P1042, DOI 10.1111/j.1471-0528.1988.tb06511.x; SPOWART KJM, 1992, GYNAECOL ENDOSC, V1, P33; Stadberg E, 1996, MATURITAS, V23, P31, DOI 10.1016/0378-5122(95)00949-3; STALAND B, 1981, MATURITAS, V3, P145, DOI 10.1016/0378-5122(81)90006-2; STALAND B, 1985, ACTA OBSTET GYN SCAN, P29; STURDEE DW, 1994, LANCET, V344, P979, DOI 10.1016/S0140-6736(94)91640-3; Sturdee DW, 2000, BRIT J OBSTET GYNAEC, V107, P1392, DOI 10.1111/j.1471-0528.2000.tb11654.x; UDOFF L, 1995, OBSTET GYNECOL, V86, P306, DOI 10.1016/0029-7844(95)00115-8; Weiderpass E, 1999, J NATL CANCER I, V91, P1131, DOI 10.1093/jnci/91.13.1131; WEINSTEIN L, 1990, AM J OBSTET GYNECOL, V162, P1534, DOI 10.1016/0002-9378(90)90917-V; WOODRUFF JD, 1994, AM J OBSTET GYNECOL, V170, P1213	30	45	46	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2002	325	7358					239	242A		10.1136/bmj.325.7358.239	http://dx.doi.org/10.1136/bmj.325.7358.239			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582FL	12153918	Green Published, Bronze			2022-12-28	WOS:000177339000015
J	Johnson, K				Johnson, K			Astronomy: Infant globular clusters	SCIENCE			English	Editorial Material									Univ Wisconsin, Dept Astron, Madison, WI 53706 USA; Natl Radio Astron Observ, Socorro, NM 87801 USA	University of Wisconsin System; University of Wisconsin Madison; National Radio Astronomy Observatory (NRAO)	Johnson, K (corresponding author), Univ Wisconsin, Dept Astron, Madison, WI 53706 USA.	kjohnson@astro.wisc.edu						Elmegreen BG, 1997, ASTROPHYS J, V480, P235, DOI 10.1086/303966; ELMEGREEN BG, 1994, ASTROPHYS J, V435, pL121, DOI 10.1086/187609; Gorjian V, 2001, ASTROPHYS J, V554, pL29, DOI 10.1086/320923; Johnson KE, 2001, ASTROPHYS J, V559, P864, DOI 10.1086/322335; Johnson KE, 2000, ASTRON J, V120, P1273, DOI 10.1086/301541; JOHNSON KE, 2002, ASP C P SER, V267, P307; Kobulnicky HA, 1999, ASTROPHYS J, V527, P154, DOI 10.1086/308075; PEEBLES PJE, 1968, ASTROPHYS J, V154, P891, DOI 10.1086/149811; Turner JL, 1998, ASTRON J, V116, P1212, DOI 10.1086/300485; Vacca WD, 2002, ASTRON J, V123, P772, DOI 10.1086/338644; WHITMORE BC, 2002, DECADE HUBBLE SPACE, P153	11	6	6	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2002	297	5582					776	777		10.1126/science.1075224	http://dx.doi.org/10.1126/science.1075224			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161635				2022-12-28	WOS:000177192800028
J	Nanchahal, K; Duncan, JR; Durrington, PN; Jackson, RT				Nanchahal, K; Duncan, JR; Durrington, PN; Jackson, RT			Analysis of predicted coronary heart disease risk in England based on Framingham study risk appraisal models published in 1991 and 2000	BRITISH MEDICAL JOURNAL			English	Article									Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Promot Res Unit, London WC1E 7HT, England; GlaxoSmithKline, Harlow CM19 5AW, Essex, England; Univ Manchester, Manchester Royal Infirm, Med Unit, Clin Res Div 2, Manchester M13 9WL, Lancs, England; Univ Auckland, Fac Med & Hlth Sci, Auckland 1, New Zealand	University of London; London School of Hygiene & Tropical Medicine; GlaxoSmithKline; University of Manchester; University of Auckland	Nanchahal, K (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Promot Res Unit, London WC1E 7HT, England.			Nanchahal, Kiran/0000-0001-8812-7628; Jackson, Rod/0000-0001-5914-6934				ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; D'Agostino RB, 2000, AM HEART J, V139, P272, DOI 10.1016/S0002-8703(00)90236-9; Erens B., 2000, HLTH SURVEY ENGLAND; Ramsay LE, 1999, BMJ-BRIT MED J, V319, P630, DOI 10.1136/bmj.319.7210.630; Taggart DP, 1998, HEART, V80, P1	5	5	5	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 27	2002	325	7357					194	195		10.1136/bmj.325.7357.194	http://dx.doi.org/10.1136/bmj.325.7357.194			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580PX	12142307	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000177243900018
J	Newman, P; Peile, E				Newman, P; Peile, E			Valuing learners' experience and supporting further growth: educational models to help experienced adult learners in medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Article							UNITED-KINGDOM; DOCTORS		Wendover Hlth Ctr, Wendover, Bucks, England; Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England	University of Oxford	Newman, P (corresponding author), Wendover Hlth Ctr, Wendover, Bucks, England.	pennynewm@aol.com						Allen, 1988, DOCTORS THEIR CAREER; BAHRAMI J, 1995, ED GEN PRACT, V4, P342; BERNE E, 1966, TRANSACTIONAL ANAL P; *BRIT FURTH ED COU, 1981, EXP REFL LEARN; Brookfield S., 1986, UNDERSTANDING FACILI; Brookfield S., 1995, INT ENCY ED; Charon R, 2001, JAMA-J AM MED ASSOC, V286, P1897, DOI 10.1001/jama.286.15.1897; Cohen N. H., 1995, MENTORING ADULT LEAR; Coulter A, 1999, BRIT MED J, V319, P719, DOI 10.1136/bmj.319.7212.719; Department of Health, 2000, NHS PLAN PLAN INV PL; Ebrahim S, 1999, BRIT MED J, V319, P1358, DOI 10.1136/bmj.319.7221.1358; Elwyn G, 1999, BRIT MED J, V319, P753, DOI 10.1136/bmj.319.7212.753; ENGESTROM Y, 1996, DEV BREAKING AWAY OP; GROW GO, 1991, ADULT EDUC QUART, V41, P125, DOI 10.1177/0001848191041003001; HUTCHINSON L, 2002, BRIT MED J, V324, P28; Jonassen D.H., 1993, HDB INDIVIDUAL DIFFE; KNOWLES S, 1998, ADULT LEARNER DEFINI; Lambert TW, 2000, MED EDUC, V34, P348, DOI 10.1046/j.1365-2923.2000.00573.x; LANGFORD F, 1987, ANN M AM ASS AD CONT; Peile EB, 2001, MED TEACH, V23, P205, DOI 10.1080/01421590020031138; Spencer JA, 1999, BRIT MED J, V318, P1280; Welsh C, 2000, BRIT MED J, V321, P253, DOI 10.1136/bmj.321.7256.253; WOODALL A, 1997, BMJ-BRIT MED J, V315, P2	23	66	68	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2002	325	7357					200	202		10.1136/bmj.325.7357.200	http://dx.doi.org/10.1136/bmj.325.7357.200			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580PX	12142310	Bronze, Green Published			2022-12-28	WOS:000177243900023
J	Clement, CM				Clement, CM			Astronomy - Of clusters and galaxies	SCIENCE			English	Editorial Material							GLOBULAR-CLUSTERS		Univ Toronto, Dept Astron & Astrophys, Toronto, ON M5S 3H8, Canada	University of Toronto	Clement, CM (corresponding author), Univ Toronto, Dept Astron & Astrophys, Toronto, ON M5S 3H8, Canada.							Chaboyer B, 2001, ASTR SOC P, V245, P162; EGGEN OJ, 1962, ASTROPHYS J, V136, P748, DOI 10.1086/147433; Ibata R, 2001, ASTROPHYS J, V547, pL133, DOI 10.1086/318894; IBATA RA, 1994, NATURE, V370, P194, DOI 10.1038/370194a0; LEE YW, 1994, ASTROPHYS J, V423, P248, DOI 10.1086/173803; LIN DNC, 1992, ASTROPHYS J, V388, pL57, DOI 10.1086/186329; MORRISON HL, 2000, B AM ASTRON SOC, V32, P1513; Oosterhoff P. T., 1939, OBSERVATORY, V62, P104; SEARLE L, 1978, ASTROPHYS J, V225, P357, DOI 10.1086/156499; SMITH HA, 1995, RR LYRAE STARS, P13; VANDENBERG DA, 1990, ASTRON J, V100, P445, DOI 10.1086/115529; Yoon SJ, 2002, SCIENCE, V297, P578, DOI 10.1126/science.1073090	12	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2002	297	5581					532	533		10.1126/science.1074922	http://dx.doi.org/10.1126/science.1074922			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142519				2022-12-28	WOS:000177054200031
J	Safdar, N; Said, A; Gangnon, RE; Maki, DG				Safdar, N; Said, A; Gangnon, RE; Maki, DG			Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157 : H7 enteritis - A meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							TRIMETHOPRIM-SULFAMETHOXAZOLE; SUBINHIBITORY CONCENTRATIONS; ANTIMICROBIAL AGENTS; HEMORRHAGIC COLITIS; NURSING-HOME; MOUSE MODEL; INFECTION; OUTBREAK; TOXIN; DIARRHEA	Context The use of antibiotics for treatment of Escherichia coli O157:H7 infection has become controversial since a recent small study found that it may increase the risk of hemolytic uremic syndrome (HUS). However, other larger studies have reported a protective effect or no association. Objective To determine whether antibiotic therapy for E coli O157:H7 enteritis increases the risk of HUS. Data Sources PubMed and MEDLINE computer searches were performed for studies published from January 1983 to February 2001 using the key words hemolytic uremic syndrome, risk factor, antibiotics, and Escherichia coli O157:H7. Reference lists of relevant publications were reviewed, and 12 experts in the field were contacted to identify additional reports. No language restrictions were applied to the search. Study Selection Studies were included if they reported a series of patients with documented E coli O157:H7 enteritis, some of whom developed HUS; had clear definitions of HUS; and had adequate data delineating the relationship between antibiotic therapy and the occurrence of HUS. Nine of the 26 identified studies fulfilled these criteria. Data Extraction Two authors (N.S. and A.S.) independently reviewed each report identified by the searches and recorded predetermined information relevant to the inclusion criteria. A pooled odds ratio was calculated using a fixed-effects model, with assessment of heterogeneity among the studies. Data Synthesis The pooled odds ratio was 1.15 (95% confidence interval, 0.79-1.68), indicating that there does not appear to be an increased risk of HUS with antibiotic treatment of E coli O57:H7 enteritis. Incomplete reporting of data in individual studies precluded adjustment for severity of illness. Conclusion Our meta-analysis did not show a higher risk of HUS associated with antibiotic administration. A randomized trial of adequate power, with multiple distinct strains of E coli O157:H7 represented, is needed to conclusively determine whether antibiotic treatment of E coli O157:H7 enteritis increases the risk of HUS.	Univ Wisconsin Hosp & Clin, Madison, WI 53792 USA; Univ Wisconsin, Sch Med, Dept Med, Infect Dis Sect, Madison, WI USA; Univ Wisconsin, Sch Med, Gastroenterol Sect, Madison, WI USA; Univ Wisconsin, Sch Med, Dept Biostat & Med Informat, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Maki, DG (corresponding author), Univ Wisconsin Hosp & Clin, 600 Highland Ave,H4-574, Madison, WI 53792 USA.							Andreoli SP, 1999, CURR OPIN NEPHROL HY, V8, P459, DOI 10.1097/00041552-199907000-00010; Bell BP, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.1.e12; BESSER RE, 1993, JAMA-J AM MED ASSOC, V269, P2217, DOI 10.1001/jama.269.17.2217; BOYCE TG, 1995, NEW ENGL J MED, V333, P364, DOI 10.1056/NEJM199508103330608; BRESLOW NE, 1980, STATISTICAL METHODS, V1, P142; Buteau C, 2000, PEDIATR INFECT DIS J, V19, P642, DOI 10.1097/00006454-200007000-00012; CARTER AO, 1987, NEW ENGL J MED, V317, P1496, DOI 10.1056/NEJM198712103172403; CIMOLAI N, 1990, J PEDIATR-US, V116, P589, DOI 10.1016/S0022-3476(05)81609-9; CIMOLAI N, 1994, CLIN NEPHROL, V42, P85; Dundas S, 1999, LANCET, V354, P1327, DOI 10.1016/S0140-6736(99)01251-9; Dundas S, 2001, CLIN INFECT DIS, V33, P923, DOI 10.1086/322598; DUPONT HL, 1983, GASTROENTEROLOGY, V84, P75; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elliott MA, 2001, MAYO CLIN PROC, V76, P1154, DOI 10.4065/76.11.1154; Friedman MS, 1999, CLIN INFECT DIS, V29, P298, DOI 10.1086/520204; Fukushima H, 1999, PEDIATR INT, V41, P213, DOI 10.1046/j.1442-200X.1999.4121041.x; Grif K, 1998, EUR J CLIN MICROBIOL, V17, P761, DOI 10.1007/s100960050181; GRIFFIN PM, 1988, ANN INTERN MED, V109, P705, DOI 10.7326/0003-4819-109-9-705; HALTALIN KC, 1967, J PEDIATR-US, V70, P970, DOI 10.1016/S0022-3476(67)80275-0; Higami S, 1998, Kansenshogaku Zasshi, V72, P266; Ikeda K, 1999, CLIN NEPHROL, V52, P357; Isogai E, 2000, MICROBIOL IMMUNOL, V44, P89, DOI 10.1111/j.1348-0421.2000.tb01251.x; Izumikawa K, 1998, J ANTIMICROB CHEMOTH, V42, P341, DOI 10.1093/jac/42.3.341; KARCH H, 1986, FEMS MICROBIOL LETT, V35, P141, DOI 10.1016/0378-1097(86)90080-7; KARMALI MA, 1985, J INFECT DIS, V151, P775, DOI 10.1093/infdis/151.5.775; KARMALI MA, 1983, LANCET, V1, P619, DOI 10.1016/s0140-6736(83)91795-6; Kawamura N, 1999, PEDIATR INT, V41, P218, DOI 10.1046/j.1442-200X.1999.4121040.x; Kohsaka T, 1997, Nihon Rinsho, V55, P706; Kurioka T, 1999, EUR J CLIN MICROBIOL, V18, P561, DOI 10.1007/s100960050348; LOPEZ EL, 1995, J PEDIATR-US, V127, P364, DOI 10.1016/S0022-3476(95)70064-1; MANTEL N, 1959, J NATL CANCER I, V22, P719; MARTIN DL, 1990, NEW ENGL J MED, V323, P1161, DOI 10.1056/NEJM199010253231703; Murakami J, 2000, INT J ANTIMICROB AG, V15, P103, DOI 10.1016/S0924-8579(00)00126-6; Oshima Toshio, 1997, Japanese Journal of Antibiotics, V50, P855; OSTROFF SM, 1989, JAMA-J AM MED ASSOC, V262, P355, DOI 10.1001/jama.262.3.355; PAVIA AT, 1990, J PEDIATR-US, V116, P544, DOI 10.1016/S0022-3476(05)81600-2; Proulx F, 1999, EUR J CLIN MICROBIOL, V18, P533, DOI 10.1007/s100960050343; PROULX F, 1992, J PEDIATR-US, V121, P299, DOI 10.1016/S0022-3476(05)81209-0; Rowe PC, 1998, J PEDIATR-US, V132, P777, DOI 10.1016/S0022-3476(98)70303-8; RYAN CA, 1986, J INFECT DIS, V154, P631, DOI 10.1093/infdis/154.4.631; SALAZARLINDO E, 1986, J PEDIATR-US, V109, P355, DOI 10.1016/S0022-3476(86)80404-8; Sawamura S, 1999, Kansenshogaku Zasshi, V73, P1054; Shiomi M, 1999, PEDIATR INT, V41, P228, DOI 10.1046/j.1442-200X.1999.4121038.x; Siegler RL, 1995, PEDIATR CLIN N AM, V42, P1505; SIEGLER RL, 1994, PEDIATRICS, V94, P35; Slutsker L, 1998, J INFECT DIS, V177, P962, DOI 10.1086/515258; SPIKA JS, 1986, J PEDIATR-US, V109, P287, DOI 10.1016/S0022-3476(86)80386-9; TAKEDA T, 1999, ESCHERICHIA COLI O15, P385; WALTERSPIEL JN, 1992, INFECTION, V20, P25, DOI 10.1007/BF01704889; WOLF LE, 1997, 3 INT S WORKSH SHIG; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601; Yoh M, 1997, FEMS IMMUNOL MED MIC, V19, P57, DOI 10.1111/j.1574-695X.1997.tb01072.x; Yoshimura K, 1999, FEMS IMMUNOL MED MIC, V26, P101, DOI 10.1016/S0928-8244(99)00119-4; Zimmerhackl LB, 2000, NEW ENGL J MED, V342, P1990, DOI 10.1056/NEJM200006293422611	54	167	179	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2002	288	8					996	1001		10.1001/jama.288.8.996	http://dx.doi.org/10.1001/jama.288.8.996			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587RM	12190370				2022-12-28	WOS:000177656400025
J	Allen, JF				Allen, JF			Photosynthesis of ATP - Electrons, proton pumps, rotors, and poise	CELL			English	Review							SYNTHASE; MOTOR	Light-driven electron transport is coupled to ATP synthesis in chloroplasts. While the nature of the coupling and the structures of key components are now known, there has long been disagreement over pathways of electron transport. Recent results now put an old idea back on the agenda -cyclic electron transport around photosystem 1.	Lund Univ, Ctr Chem & Chem Engn, Dept Plant Biochem, SE-22100 Lund, Sweden	Lund University	Allen, JF (corresponding author), Lund Univ, Ctr Chem & Chem Engn, Dept Plant Biochem, Box 124, SE-22100 Lund, Sweden.		Allen, John/K-6309-2019	Allen, John/0000-0002-0950-0429				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Albertsson PA, 2001, TRENDS PLANT SCI, V6, P349, DOI 10.1016/S1360-1385(01)02021-0; Allen JF, 2001, TRENDS PLANT SCI, V6, P317, DOI 10.1016/S1360-1385(01)02010-6; [Anonymous], 2002, PHOTOSYNTHETICA; ARNON DI, 1957, NATURE, V180, P182, DOI 10.1038/180182a0; ARNON DI, 1954, NATURE, V174, P394, DOI 10.1038/174394a0; Finazzi G, 2002, EMBO REP, V3, P280, DOI 10.1093/embo-reports/kvf047; Gupta R, 2002, NATURE, V417, P567, DOI 10.1038/417567a; Heathcote P, 2002, TRENDS BIOCHEM SCI, V27, P79, DOI 10.1016/S0968-0004(01)02034-5; HEBER U, 1992, PLANT PHYSIOL, V100, P1621, DOI 10.1104/pp.100.4.1621; HILL R, 1960, NATURE, V186, P136, DOI 10.1038/186136a0; Junge W, 1999, P NATL ACAD SCI USA, V96, P4735, DOI 10.1073/pnas.96.9.4735; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; McCarty RE, 2000, ANNU REV PLANT PHYS, V51, P83, DOI 10.1146/annurev.arplant.51.1.83; Munekage Y, 2002, CELL, V110, P361, DOI 10.1016/S0092-8674(02)00867-X; Pfannschmidt T, 1999, NATURE, V397, P625, DOI 10.1038/17624; Seelert H, 2000, NATURE, V405, P418, DOI 10.1038/35013148; Whatley FR, 1995, PHOTOSYNTH RES, V46, P17, DOI 10.1007/BF00020411; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623; Zhang HM, 2001, J BIOL CHEM, V276, P38159	20	191	195	3	60	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 9	2002	110	3					273	276		10.1016/S0092-8674(02)00870-X	http://dx.doi.org/10.1016/S0092-8674(02)00870-X			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	583MN	12176312	Bronze			2022-12-28	WOS:000177411800001
J	D'Amore, PA; Ng, YS				D'Amore, PA; Ng, YS			Won't you be my neighbor? Local induction of arteriogenesis	CELL			English	Review							ENDOTHELIAL GROWTH-FACTOR; SONIC HEDGEHOG; EXPRESSION; DIFFERENTIATION; RECEPTOR; CELLS	Two recent papers in Cell and Developmental Cell provide evidence that VEGF directs arterial differentiation. Evidence that sensory nerves direct arteriogenesis (Mukouyama et al., 2002) and that the membrane-spanning Notch signaling system is downstream of VEGF (Lawson et al., 2002) emphasize the paracrine regulation of vessel formation.	Schepens Eye Res Inst, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Schepens Eye Research Institute; Harvard University; Harvard Medical School	D'Amore, PA (corresponding author), Schepens Eye Res Inst, Boston, MA 02114 USA.		Ng, Wing Yin/HHN-1743-2022; D'Amore, Patricia A/G-5660-2017	D'Amore, Patricia A/0000-0001-9652-8974; Ng, Yin Shan/0000-0002-4982-1999				Brown LA, 2000, MECH DEVELOP, V90, P237, DOI 10.1016/S0925-4773(99)00256-7; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; Gridley T, 2001, P NATL ACAD SCI USA, V98, P5377, DOI 10.1073/pnas.101138098; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; Marti E, 2002, TRENDS NEUROSCI, V25, P89, DOI 10.1016/S0166-2236(02)02062-3; Moyon D, 2001, DEVELOPMENT, V128, P3359; Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2; Neufeld G, 2002, TRENDS CARDIOVAS MED, V12, P13, DOI 10.1016/S1050-1738(01)00140-2; Ng YS, 2001, DEV DYNAM, V220, P112, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1093>3.0.CO;2-D; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; Shima DT, 2000, CURR OPIN GENET DEV, V10, P536, DOI 10.1016/S0959-437X(00)00124-6; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599	19	36	38	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 9	2002	110	3					289	292		10.1016/S0092-8674(02)00869-3	http://dx.doi.org/10.1016/S0092-8674(02)00869-3			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	583MN	12176316	Bronze			2022-12-28	WOS:000177411800005
J	Herbrecht, R; Denning, DW; Patterson, TF; Bennett, JE; Greene, RE; Oestmann, JW; Kern, WV; Marr, KA; Ribaud, P; Lortholary, O; Sylvester, R; Rubin, RH; Wingard, JR; Stark, P; Durand, C; Caillot, D; Thiel, E; Chandrasekar, PH; Hodges, MR; Schlamm, HT; Troke, PF; de Pauw, B				Herbrecht, R; Denning, DW; Patterson, TF; Bennett, JE; Greene, RE; Oestmann, JW; Kern, WV; Marr, KA; Ribaud, P; Lortholary, O; Sylvester, R; Rubin, RH; Wingard, JR; Stark, P; Durand, C; Caillot, D; Thiel, E; Chandrasekar, PH; Hodges, MR; Schlamm, HT; Troke, PF; de Pauw, B		Invasive Fungal Infect Grp Europea	Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Background Voriconazole is a broad-spectrum triazole that is active against aspergillus species. We conducted a randomized trial to compare voriconazole with amphotericin B for primary therapy of invasive aspergillosis. Methods In this randomized, unblinded trial, patients received either intravenous voriconazole (two doses of 6 mg per kilogram of body weight on day 1, then 4 mg per kilogram twice daily for at least seven days) followed by 200 mg orally twice daily or intravenous amphotericin B deoxycholate (1 to 1.5 mg per kilogram per day). Other licensed antifungal treatments were allowed if the initial therapy failed or if the patient had an intolerance to the first drug used. A complete or partial response was considered to be a successful outcome. Results A total of 144 patients in the voriconazole group and 133 patients in the amphotericin B group with definite or probable aspergillosis received at least one dose of treatment. In most of the patients, the underlying condition was allogeneic hematopoietic-cell transplantation, acute leukemia, or other hematologic diseases. At week 12, there were successful outcomes in 52.8 percent of the patients in the voriconazole group (complete responses in 20.8 percent and partial responses in 31.9 percent) and 31.6 percent of those in the amphotericin B group (complete responses in 16.5 percent and partial responses in 15.0 percent; absolute difference, 21.2 percentage points; 95 percent confidence interval, 10.4 to 32.9). The survival rate at 12 weeks was 70.8 percent in the voriconazole group and 57.9 percent in the amphotericin B group (hazard ratio, 0.59; 95 percent confidence interval, 0.40 to 0.88). Voriconazole-treated patients had significantly fewer severe drug-related adverse events, but transient visual disturbances were common with voriconazole (occurring in 44.8 percent of patients). Conclusions In patients with invasive aspergillosis, initial therapy with voriconazole led to better responses and improved survival and resulted in fewer severe side effects than the standard approach of initial therapy with amphotericin B.	Hop Hautepierre, Dept Hematol & Oncol, Ave Moliere, F-67098 Strasbourg, France; Univ Manchester, Manchester, Lancs, England; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA; NIAID, Bethesda, MD 20892 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Campus Virchow Klinikum, Charite, Berlin, Germany; Med Univ Klin, Freiburg, Germany; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Inst Pasteur, Paris, France; European Org Res Treatment Canc, Brussels, Belgium; Brigham & Womens Hosp, Boston, MA 02115 USA; Univ Florida, Coll Med, Gainesville, FL USA; Univ Calif San Diego, San Diego, CA 92103 USA; Hop Bocage, Dijon, France; Univ Hosp Benjamin Franklin, Berlin, Germany; Wayne State Univ, Sch Med, Detroit, MI USA; Pfizer, Global Res & Dev, New York, NY USA; Pfizer, Global Res & Dev, Sandwich, Kent, England; Univ Nijmegen, Med Ctr, Nijmegen, Netherlands; Hop St Louis, Paris, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Manchester; University of Texas System; University of Texas Health San Antonio; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Massachusetts General Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Fred Hutchinson Cancer Center; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; European Organisation for Research & Treatment of Cancer; Harvard University; Brigham & Women's Hospital; State University System of Florida; University of Florida; University of California System; University of California San Diego; CHU Dijon Bourgogne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Wayne State University; Pfizer; Pfizer; Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Herbrecht, R (corresponding author), Hop Hautepierre, Dept Hematol & Oncol, Ave Moliere, F-67098 Strasbourg, France.	raoul.herbrecht@chru-strasbourg.fr	Denning, David/AAC-6931-2019; Herbrecht, Raoul/D-3471-2013; Herbrecht, Raoul/GVU-1333-2022; Herbrecht, Raoul/AAT-1763-2021	Denning, David/0000-0001-5626-2251; Herbrecht, Raoul/0000-0002-9381-4876; Wingard, John/0000-0001-7478-5398; oestmann, joerg-wilhelm/0000-0003-1468-4485	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000654, Z01AI000654] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bates DW, 2001, CLIN INFECT DIS, V32, P686, DOI 10.1086/319211; Denning DW, 2002, CLIN INFECT DIS, V34, P563, DOI 10.1086/324620; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Ellis M, 1998, CLIN INFECT DIS, V27, P1406, DOI 10.1086/515033; Espinel-Ingroff A, 2001, J CLIN MICROBIOL, V39, P954, DOI 10.1128/JCM.39.3.954-958.2001; FREEDMAN LS, 1976, BIOMETRICS, V32, P691, DOI 10.2307/2529759; KUHLMAN JE, 1985, RADIOLOGY, V157, P611, DOI 10.1148/radiology.157.3.3864189; Patterson TF, 2000, MEDICINE, V79, P250, DOI 10.1097/00005792-200007000-00006; Stevens DA, 2000, CLIN INFECT DIS, V30, P696, DOI 10.1086/313756; Tiphine M, 1999, Transpl Infect Dis, V1, P273; Walsh TJ, 2002, NEW ENGL J MED, V346, P225, DOI 10.1056/NEJM200201243460403; White MH, 1997, CLIN INFECT DIS, V24, P635; Wingard JR, 1999, CLIN INFECT DIS, V29, P1402, DOI 10.1086/313498	13	2275	2425	3	97	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 8	2002	347	6					408	415		10.1056/NEJMoa020191	http://dx.doi.org/10.1056/NEJMoa020191			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587YR	12167683	Green Published			2022-12-28	WOS:000177672400005
J	Garattini, S; Bertele', V				Garattini, S; Bertele', V			Efficacy, safety, and cost of new anticancer drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Mario Negri Inst Pharmacol Res, Regulatory Policy Lab, I-20157 Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Garattini, S (corresponding author), Mario Negri Inst Pharmacol Res, Regulatory Policy Lab, Via Eritrea 62, I-20157 Milan, Italy.	sgarattini@marionegri.it	Bertele, Vittorio/AAA-6461-2020; Garattini, Silvio/AAA-6390-2020	Bertele, Vittorio/0000-0002-0032-7033; Garattini, Silvio/0000-0003-0647-9297				Abe O, 1998, LANCET, V352, P930; Bailar JC, 1997, NEW ENGL J MED, V336, P1569, DOI 10.1056/NEJM199705293362206; Batchelor T, 2000, LANCET, V355, P1115, DOI 10.1016/S0140-6736(00)02055-9; Berrino F, 1998, EUR J CANCER, V34, P2139, DOI 10.1016/S0959-8049(98)00334-7; Clarke M, 1998, LANCET, V351, P1451; Coleman M P, 1999, Breast Cancer Res, V1, P22, DOI 10.1186/bcr8; Findlay B P, 1998, Cancer Prev Control, V2, P140; Friedberg M, 1999, JAMA-J AM MED ASSOC, V282, P1453, DOI 10.1001/jama.282.15.1453; Garattini S, 2001, LANCET, V358, P64, DOI 10.1016/S0140-6736(00)05258-2; HORTOBAGYI GN, 1997, DRUGS S4, V54, pS1; Levi F, 2000, EUR J CANCER, V36, P1965, DOI 10.1016/S0959-8049(00)00283-5; QUINN MJ, 2001, STUDIES MED POPULATI, V66, P206; White CA, 2001, ANNU REV MED, V52, P125, DOI 10.1146/annurev.med.52.1.125	13	73	75	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2002	325	7358					269	271		10.1136/bmj.325.7358.269	http://dx.doi.org/10.1136/bmj.325.7358.269			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582FL	12153927	Green Published			2022-12-28	WOS:000177339000026
J	Cazenave, A; Nerem, RS				Cazenave, A; Nerem, RS			Geophysics: Redistributing Earth's mass	SCIENCE			English	Editorial Material							SOLID-EARTH; SATELLITE; LEVEL; SEA		Ctr Natl Etud Spatiales, GRGS, LEGOS, F-31400 Toulouse, France; Univ Colorado, Colorado Ctr Astrodynam Res, Boulder, CO 80309 USA	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Laboratoire d'Etudes en Geophysique et oceanographie spatiales; University of Colorado System; University of Colorado Boulder	Cazenave, A (corresponding author), Ctr Natl Etud Spatiales, GRGS, LEGOS, F-31400 Toulouse, France.							Cabanes C, 2001, SCIENCE, V294, P840, DOI 10.1126/science.1063556; Cazenave A, 1999, EARTH PLANET SC LETT, V171, P549, DOI 10.1016/S0012-821X(99)00172-7; Church JA, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P639; Cox CM, 2002, SCIENCE, V297, P831, DOI 10.1126/science.1072188; Dickey J O, 1997, SATELLITE GRAVITY GE; Lambeck K., 1988, GEOPHYSICAL GEODESY; Mandea M, 2000, EARTH PLANET SC LETT, V183, P369, DOI 10.1016/S0012-821X(00)00284-3; MANDEA M, COMMUNICATION; McPhaden MJ, 2002, NATURE, V415, P603, DOI 10.1038/415603a; Nerem RS, 2000, GEOPHYS RES LETT, V27, P1783, DOI 10.1029/1999GL008440; NEREM RS, 2001, INT GEOPHYSICS SERIE, V69, P329; Peltier WR, 1998, REV GEOPHYS, V36, P603, DOI 10.1029/98RG02638; YODER CF, 1983, NATURE, V303, P757, DOI 10.1038/303757a0	13	27	36	2	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2002	297	5582					783	784		10.1126/science.1074593	http://dx.doi.org/10.1126/science.1074593			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161640				2022-12-28	WOS:000177192800033
J	Dudovich, N; Oron, D; Silberberg, Y				Dudovich, N; Oron, D; Silberberg, Y			Single-pulse coherently controlled nonlinear Raman spectroscopy and microscopy	NATURE			English	Article							3RD-HARMONIC GENERATION; SCATTERING	Molecular vibrations have oscillation periods that reflect the molecular structure, and are hence being used as a spectroscopic fingerprint for detection and identification. At present, all nonlinear spectroscopy schemes use two or more laser beams to measure such vibrations(1). The availability of ultrashort (femtosecond) optical pulses with durations shorter than typical molecular vibration periods has enabled the coherent excitation of molecular vibrations using a single pulse(2). Here we perform single-pulse vibrational spectroscopy on several molecules in the liquid phase, where both the excitation and the readout processes are performed by the same pulse. The main difficulty with single-pulse spectroscopy is that all vibrational levels with energies within the pulse bandwidth are excited. We achieve high spectral resolution, nearly two orders of magnitude better than the pulse bandwidth, by using quantum coherent control techniques. By appropriately modulating the spectral phase of the pulse we are able to exploit the quantum interference between multiple paths to selectively populate a given vibrational level, and to probe this population using the same pulse. This scheme, using a single broadband laser source, is particularly attractive for nonlinear microscopy applications, as we demonstrate by constructing a coherent anti-Stokes Raman (CARS) microscope operating with a single laser beam.	Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Silberberg, Y (corresponding author), Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel.		SILBERBERG, YARON/K-1564-2012; Oron, Dan/W-1947-2019	Oron, Dan/0000-0003-1582-8532				Assion A, 1998, SCIENCE, V282, P919, DOI 10.1126/science.282.5390.919; Barad Y, 1997, APPL PHYS LETT, V70, P922, DOI 10.1063/1.118442; Bartels R, 2000, NATURE, V406, P164, DOI 10.1038/35018029; Cheng JX, 2001, J PHYS CHEM B, V105, P1277, DOI 10.1021/jp003774a; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; JUDSON RS, 1992, PHYS REV LETT, V68, P1500, DOI 10.1103/PhysRevLett.68.1500; KIEFER W, 1995, INFRARED RAMAN SPECT, P162; LEONHARDT R, 1987, CHEM PHYS LETT, V133, P373, DOI 10.1016/0009-2614(87)87085-9; Levenson M.D., 1982, INTRO NONLINEAR LASE, pxiv, 256p; Meshulach D, 1998, NATURE, V396, P239, DOI 10.1038/24329; Muller M, 2000, J MICROSC-OXFORD, V197, P150, DOI 10.1046/j.1365-2818.2000.00648.x; Muller M, 1998, J MICROSC-OXFORD, V191, P266, DOI 10.1046/j.1365-2818.1998.00399.x; Oron D, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.043408; Oron D, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.063004; Potma EO, 2001, P NATL ACAD SCI USA, V98, P1577, DOI 10.1073/pnas.031575698; SHAPIRO M, 1986, J CHEM PHYS, V84, P4103, DOI 10.1063/1.450074; TANNOR DJ, 1985, J CHEM PHYS, V83, P5013, DOI 10.1063/1.449767; WARREN WS, 1993, SCIENCE, V259, P1581, DOI 10.1126/science.259.5101.1581; Weinacht TC, 1999, NATURE, V397, P233, DOI 10.1038/16654; Weiner AM, 2000, REV SCI INSTRUM, V71, P1929, DOI 10.1063/1.1150614; WEINER AM, 1990, SCIENCE, V247, P1317, DOI 10.1126/science.247.4948.1317; YAN YX, 1988, ADV SPECTROSCOPY SER, V16, P299; Zumbusch A, 1999, PHYS REV LETT, V82, P4142, DOI 10.1103/PhysRevLett.82.4142	23	619	651	4	162	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2002	418	6897					512	514		10.1038/nature00933	http://dx.doi.org/10.1038/nature00933			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152073				2022-12-28	WOS:000177162800034
J	Haskell, JP; Ritchie, ME; Olff, H				Haskell, JP; Ritchie, ME; Olff, H			Fractal geometry predicts varying body size scaling relationships for mammal and bird home ranges	NATURE			English	Article							ECOLOGY; SCALES; LAWS	Scaling laws that describe complex interactions between organisms and their environment as a function of body size offer exciting potential for synthesis in biology(1-4). Home range size, or the area used by individual organisms, is a critical ecological variable that integrates behaviour, physiology and population density and strongly depends on organism size(5-7). Here we present a new model of home range-body size scaling based on fractal resource distributions, in which resource encounter rates are a function of body size. The model predicts no universally constant scaling exponent for home range, but defines a possible range of values set by geometric limits to resource density and distribution. The model unifies apparently conflicting earlier results and explains differences in scaling exponents among herbivorous and carnivorous mammals and birds(5-18). We apply the model to predict that home range increases with habitat fragmentation, and that the home ranges of larger species should be much more sensitive to habitat fragmentation than those of smaller species.	Utah State Univ, Coll Nat Resources, Logan, UT 84322 USA; Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA; Univ Wageningen & Res Ctr, Trop Natl Conservat & Vertebrate Ecol Grp, NL-6708 PD Wageningen, Netherlands	Utah System of Higher Education; Utah State University; Syracuse University; Wageningen University & Research	Haskell, JP (corresponding author), Utah State Univ, Coll Nat Resources, Logan, UT 84322 USA.	jhaskell@cc.usu.edu	Olff, Han/A-8516-2008	Olff, Han/0000-0003-2154-3576				ARMSTRONG JT, 1965, ECOLOGY, V46, P619, DOI 10.2307/1935001; BELOVSKY GE, 1987, VIABLE POPULATIONS C; Brown James H., 1998, P71; Calder WAI., 1996, SIZE FUNCTION LIFE H; DAMUTH J, 1981, BIOL J LINN SOC, V15, P185, DOI 10.1111/j.1095-8312.1981.tb00758.x; Dunning J.B., 2007, CRC HDB AVIAN BODY M, V2nd ed., DOI [10.1201/9781420064452, DOI 10.1201/9781420064452]; GOMPPER ME, 1991, OECOLOGIA, V87, P343, DOI 10.1007/BF00634589; HARESTAD AS, 1979, ECOLOGY, V60, P389, DOI 10.2307/1937667; HOLLING CS, 1992, ECOL MONOGR, V62, P447, DOI 10.2307/2937313; Kelt DA, 1999, ECOLOGY, V80, P337; KOTLIAR NB, 1990, OIKOS, V59, P253, DOI 10.2307/3545542; Kunin WE, 1998, SCIENCE, V281, P1513, DOI 10.1126/science.281.5382.1513; Lawler GF, 2001, MATH RES LETT, V8, P13; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; LINDSTEDT SL, 1986, ECOLOGY, V67, P413, DOI 10.2307/1938584; Mandelbrot B.B., 1982, FRACTAL GEOMETRY NAT, P480; MCNAB BK, 1963, AM NAT, V97, P133, DOI 10.1086/282264; MILNE BT, 1992, AM NAT, V139, P32, DOI 10.1086/285312; Milne BT, 1997, WILDLIFE AND LANDSCAPE ECOLOGY, P32; OLFF H, 2001, LANDSCAPE URBAN PLAN, V858, P1; Owen-Smith R.N., 1992, MEGAHERBIVORES INFLU; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; POOLE A, 1996, BIRDS N AM; REISS M, 1988, TRENDS ECOL EVOL, V3, P85, DOI 10.1016/0169-5347(88)90025-0; Ritchie ME, 1999, NATURE, V400, P557, DOI 10.1038/23010; Ritchie ME, 1998, EVOL ECOL, V12, P309, DOI 10.1023/A:1006552200746; SCHOENER TW, 1968, ECOLOGY, V49, P123, DOI 10.2307/1933567; SWIHART RK, 1988, ECOLOGY, V69, P393, DOI 10.2307/1940437; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; WITTING L, 1995, J THEOR BIOL, V177, P129, DOI 10.1006/jtbi.1995.0231	30	231	238	3	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 1	2002	418	6897					527	530		10.1038/nature00840	http://dx.doi.org/10.1038/nature00840			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152078	Green Published			2022-12-28	WOS:000177162800039
J	Dzik-Jurasz, A; Domenig, C; George, M; Wolber, J; Padhani, A; Brown, G; Doran, S				Dzik-Jurasz, A; Domenig, C; George, M; Wolber, J; Padhani, A; Brown, G; Doran, S			Diffusion MRI for prediction of response of rectal cancer to chemoradiation	LANCET			English	Article								Prediction of tumour response before onset of treatment could have considerable clinical benefit. Since the apparent diffusion coefficient (ADC) of a tumour's water content can show the extent of necrosis, we looked for a possible correlation of ADC with response to treatment. We measured mean tumour water ADC before and after chemotherapy and chemoradiation in 14 patients, with locally advanced rectal cancer, with a quantitative magnetic resonance diffusion imaging sequence. We found a strong negative correlation between mean pretreatment tumour water ADC and percentage size change of tumours after chemotherapy (r=-0.67, p=0.01) and chemoradiation (r=-0.83, p=0.001). Persistence of low ADC in responders after chemotherapy could represent loss of a nonviable fraction of the treated tumour.	Royal Marsden NHS Trust, Inst Canc Res, UK Canc Res Clin Magnet Resonance Res Grp, Sutton SM2 5PT, Surrey, England; Univ Surrey, Dept Phys, Guildford GU2 5XH, Surrey, England; Mayday Univ Hosp, Dept Surg, Thornton Heath, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Surrey; Croydon University Hospital	Dzik-Jurasz, A (corresponding author), Royal Marsden NHS Trust, Inst Canc Res, UK Canc Res Clin Magnet Resonance Res Grp, Downs Rd, Sutton SM2 5PT, Surrey, England.	andrzej@icr.ac.uk	BROWN, GINA/F-8081-2012; Woelber, Johan/AFX-4559-2022	Brown, Gina/0000-0002-2336-622X; Padhani, Anwar/0000-0002-5830-5777				Chenevert TL, 2000, JNCI-J NATL CANCER I, V92, P2029, DOI 10.1093/jnci/92.24.2029; George ML, 2001, BRIT J SURG, V88, P1628, DOI 10.1046/j.0007-1323.2001.01947.x; Lemaire L, 1999, MAGN RESON MATER PHY, V8, P20; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Wheeler-Kingshott CA, 2000, MAGN RESON MED, V44, P737, DOI 10.1002/1522-2594(200011)44:5<737::AID-MRM12>3.0.CO;2-T	5	370	393	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 27	2002	360	9329					307	308		10.1016/S0140-6736(02)09520-X	http://dx.doi.org/10.1016/S0140-6736(02)09520-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578DT	12147376				2022-12-28	WOS:000177102700014
J	Lomvardas, S; Thanos, D				Lomvardas, S; Thanos, D			Modifying gene expression programs by altering core promoter chromatin architecture	CELL			English	Article							INTERFERON-BETA ENHANCEOSOME; TRANSCRIPTION FACTORS; IN-VITRO; BINDING; ACETYLATION; YEAST; HYPERACETYLATION; RECRUITMENT; NUCLEOSOMES; MECHANISM	Transcriptional activation of the IFN-beta gene in response to virus infection requires the assembly of an enhanceosome, which instructs a recruitment program of chromatin modifiers/remodelers and general transcription factors to the promoter. This program culminates with sliding of a nucleosome blocking the core promoter to a downstream position, a prerequisite for transcriptional activation. We show that delivery of this nucleosome to the same downstream position to create an accessible IFN-beta core promoter prior to enhanceosome assembly results in major changes in the gene expression program with regard to the temporal pattern and the signal specificity of the transcriptional response. Thus, the identity of a gene expression program is achieved and maintained by the dynamic interplay between specific enhanceosomes and specific local chromatin structure.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University	Thanos, D (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.		Thanos, Dimitris/AAE-5720-2019	Lomvardas, Stavros/0000-0002-7668-3026	NIGMS NIH HHS [GM54605] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054605] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; DAVIDSON EH, 2001, GENOME REGULATORY SY; Deckert J, 2001, MOL CELL BIOL, V21, P2726, DOI 10.1128/MCB.21.8.2726-2735.2001; Falvo JV, 2000, MOL CELL BIOL, V20, P4814, DOI 10.1128/MCB.20.13.4814-4825.2000; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Kim TK, 1998, P NATL ACAD SCI USA, V95, P12191, DOI 10.1073/pnas.95.21.12191; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; Lomvardas S, 2001, CELL, V106, P685, DOI 10.1016/S0092-8674(01)00490-1; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Munshi N, 2001, SCIENCE, V293, P1133, DOI 10.1126/science.293.5532.1133; Parekh BS, 1999, MOL CELL, V3, P125, DOI 10.1016/S1097-2765(00)80181-1; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; PTASHNE M, 2002, GENES SIGNALS; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; SHRADER TE, 1989, P NATL ACAD SCI USA, V86, P7418, DOI 10.1073/pnas.86.19.7418; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; STRAKA C, 1991, EMBO J, V10, P361, DOI 10.1002/j.1460-2075.1991.tb07957.x; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Struhl K, 2001, SCIENCE, V293, P1054, DOI 10.1126/science.1064050; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; VanLint C, 1996, GENE EXPRESSION, V5, P245; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Yie JM, 1999, P NATL ACAD SCI USA, V96, P13108, DOI 10.1073/pnas.96.23.13108	35	150	153	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 26	2002	110	2					261	271		10.1016/S0092-8674(02)00822-X	http://dx.doi.org/10.1016/S0092-8674(02)00822-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	578EV	12150933	Bronze			2022-12-28	WOS:000177105200013
J	Didenko, YT; Suslick, KS				Didenko, YT; Suslick, KS			The energy efficiency of formation of photons, radicals and ions during single-bubble cavitation	NATURE			English	Article							AQUEOUS-SOLUTIONS; SONOLUMINESCENCE; ULTRASOUND; OH; TEREPHTHALATE; EMISSIONS; DOSIMETER; SPECTRA; LIGHT; WATER	It is extremely difficult to perform a quantitative analysis of the chemistry(1,2) associated with multibubble cavitation: unknown parameters include the number of active bubbles, the acoustic pressure acting on each bubble and the bubble size distribution. Single-bubble sonoluminescence(3-7) (characterized by the emission of picosecond flashes of light) results from nonlinear pulsations of an isolated vapour-gas bubble in an acoustic field. Although the latter offers a much simpler environment in which to study the chemical activity of cavitation, quantitative measurements have been hindered by the tiny amount of reacting gas within a single bubble (typically <10(-13) mol). Here we demonstrate the existence of chemical reactions within a single cavitating bubble, and quantify the sources of energy dissipation during bubble collapse. We measure the yields of nitrite ions, hydroxyl radicals and photons. The energy efficiency of hydroxyl radical formation is comparable to that in multibubble cavitation, but the energy efficiency of light emission is much higher. The observed rate of nitrite formation is in good agreement with the calculated diffusion rate of nitrogen into the bubble. We note that the temperatures attained in single-bubble cavitation in liquids with significant vapour pressures will be substantially limited by the endothermic chemical reactions of the polyatomic species inside the collapsing bubble.	Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Suslick, KS (corresponding author), Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA.	ksuslick@uiuc.edu	Suslick, Kenneth S/A-1841-2010	Suslick, Kenneth S/0000-0001-5422-0701				Barber BP, 1997, PHYS REP, V281, P65, DOI 10.1016/S0370-1573(96)00050-6; Brenner MP, 2002, REV MOD PHYS, V74, P425, DOI 10.1103/RevModPhys.74.425; DAMIANI P, 1986, TALANTA, V33, P649, DOI 10.1016/0039-9140(86)80151-5; Didenko YT, 2000, NATURE, V407, P877, DOI 10.1038/35038020; Fang XW, 1996, ULTRASON SONOCHEM, V3, P57, DOI 10.1016/1350-4177(95)00032-1; FIELD L, 1970, J ORG CHEM, V35, P3647, DOI 10.1021/jo00836a012; GAITAN DF, 1992, J ACOUST SOC AM, V91, P3166, DOI 10.1121/1.402855; Gompf B, 1997, PHYS REV LETT, V79, P1405, DOI 10.1103/PhysRevLett.79.1405; Hilgenfeldt S, 1999, NATURE, V398, P402, DOI 10.1038/18842; Hiller RA, 1998, PHYS REV LETT, V80, P1090, DOI 10.1103/PhysRevLett.80.1090; Lepoint T, 1999, NATO ADV SCI I C-MAT, V524, P285; Levi BG, 2002, PHYS TODAY, V55, P16, DOI 10.1063/1.1480768; Lohse D, 1997, J CHEM PHYS, V107, P6986, DOI 10.1063/1.474939; MAKINO K, 1982, J AM CHEM SOC, V104, P3537, DOI 10.1021/ja00376a064; MARGULIS MA, 1976, ZH FIZ KHIM+, V50, P1; Mark G, 1998, ULTRASON SONOCHEM, V5, P41, DOI 10.1016/S1350-4177(98)00012-1; Matula TJ, 1998, J ACOUST SOC AM, V103, P1377, DOI 10.1121/1.421279; MCLEAN JR, 1988, ULTRASOUND MED BIOL, V14, P59, DOI 10.1016/0301-5629(88)90164-0; MEAD EL, 1976, CAN J CHEM, V54, P1114, DOI 10.1139/v76-159; Moss WC, 1997, SCIENCE, V276, P1398, DOI 10.1126/science.276.5317.1398; Moss WC, 1996, PHYS LETT A, V211, P69, DOI 10.1016/0375-9601(95)00934-5; Putterman SJ, 2000, ANNU REV FLUID MECH, V32, P445, DOI 10.1146/annurev.fluid.32.1.445; Storey BD, 2000, P ROY SOC A-MATH PHY, V456, P1685, DOI 10.1098/rspa.2000.0582; Suslick K. S., 1988, ULTRASOUND ITS CHEM; Suslick K. S., 1998, KIRK OTHMER ENCY CHE, V26, P516, DOI DOI 10.1002/0471238961.herbduke.a01.pub2; Taleyarkhan RP, 2002, SCIENCE, V295, P1868, DOI 10.1126/science.1067589; Tian Y, 1996, J ACOUST SOC AM, V100, P3976, DOI 10.1121/1.417339; Toegel R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevB.88.034301; Vazquez G, 2001, OPT LETT, V26, P575, DOI 10.1364/OL.26.000575; Verraes T, 2000, J ACOUST SOC AM, V108, P117, DOI 10.1121/1.429449; Zeldovich Y.B., 1967, PHYS SHOCK WAVES HIG, V2, DOI 10.1063/1.3021982	31	273	298	8	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2002	418	6896					394	397		10.1038/nature00895	http://dx.doi.org/10.1038/nature00895			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12140551				2022-12-28	WOS:000177009700031
J	Zhou, ZH; Zhang, FC				Zhou, ZH; Zhang, FC			A long-tailed, seed-eating bird from the Early Cretaceous of China	NATURE			English	Article							EVOLUTION; ORIGIN	The lacustrine deposits of the Yixian and Jiufotang Formations in the Early Cretaceous Jehol Group in the western Liaoning area of northeast China are well known for preserving feathered dinosaurs, primitive birds and mammals(1-3). Here we report a large basal bird, Jeholornis prima gen. et sp. nov., from the Jiufotang Formation. This bird is distinctively different from other known birds of the Early Cretaceous period in retaining a long skeletal tail with unexpected elongated prezygopophyses and chevrons, resembling that of dromaeosaurids(4-6), providing a further link between birds and non-avian theropods(7-8). Despite its basal position in early avian evolution, the advanced features of the pectoral girdle and the carpal trochlea of the carpometacarpus of Jeholornis indicate the capability of powerful flight. The dozens of beautifully preserved ovules of unknown plant taxa in the stomach represents direct evidence for seed-eating adaptation in birds of the Mesozoic era.	Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Zhou, ZH (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.	zhonghe@yeah.net						Chiappe LM, 1999, B AM MUS NAT HIST, P3; Elzanowski A, 2001, ACTA PALAEONTOL POL, V46, P519; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Hopson JA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P211; HOU LH, 1995, NATURE, V377, P616, DOI 10.1038/377616a0; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Martin LD, 1998, NATURWISSENSCHAFTEN, V85, P286, DOI 10.1007/s001140050501; MCGOWAN C, 1984, NATURE, V315, P159; Norell M, 2002, NATURE, V416, P36, DOI 10.1038/416036a; Norell MA, 2001, NATURE, V409, P181, DOI 10.1038/35051563; Norell Mark A., 1997, American Museum Novitates, V3215, P1; Novas FE, 1997, NATURE, V387, P390, DOI 10.1038/387390a0; Ostrom J. H., 1969, Bulletin of the Peabody Museum of Natural History, VNo. 30, P1; Padian K, 1998, BIOL REV, V73, P1, DOI 10.1111/j.1469-185X.1997.tb00024.x; Sanz Jose L., 1995, American Museum Novitates, V3133, P1; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Sun G, 2001, EARLY ANGIOSPERMS TH; Wang YQ, 2001, SCIENCE, V294, P357, DOI 10.1126/science.1063830; Wellnhofer Peter, 1993, Archaeopteryx, V11, P1; Wellnhofer Peter, 1992, Natural History Museum of Los Angeles County Science Series, V36, P3; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; Xu X, 2001, CAN J EARTH SCI, V38, P1739, DOI 10.1139/e01-082; Zhang FC, 2000, SCIENCE, V290, P1955, DOI 10.1126/science.290.5498.1955; Zhang FC, 2001, CHINESE SCI BULL, V46, P945, DOI 10.1007/BF02900473; Zhou ZH, 2001, CHINESE SCI BULL, V46, P1258, DOI 10.1007/BF03184320; Zhou ZH, 2002, NATURWISSENSCHAFTEN, V89, P34, DOI 10.1007/s00114-001-0276-9; Zhou ZH, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P237	28	190	226	4	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2002	418	6896					405	409		10.1038/nature00930	http://dx.doi.org/10.1038/nature00930			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12140555				2022-12-28	WOS:000177009700035
J	Mott, JA; Wolfe, MI; Alverson, CJ; Macdonald, SC; Bailey, CR; Ball, LB; Moorman, JE; Somers, JH; Mannino, DM; Redd, SC				Mott, JA; Wolfe, MI; Alverson, CJ; Macdonald, SC; Bailey, CR; Ball, LB; Moorman, JE; Somers, JH; Mannino, DM; Redd, SC			National vehicle emissions policies and practices and declining US carbon monoxide-related mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; EXHAUST; DEATHS	Context Carbon monoxide (CO) has been reported to contribute to more than 2000 poisoning deaths per year in the United States. Objectives To evaluate the influence of national vehicle emissions policies and practices on CO-related mortality and to describe 31 years (1968-1998) of CO-related deaths in the United States. Design and Setting Longitudinal trend analysis using computerized death data from the Centers for Disease Control and Prevention, US Census Bureau population data, and annual CO emissions estimates for light-duty vehicles provided by the US Environmental Protection Agency. Main Outcome Measure All deaths in the US for which non-fire-related CO poisoning was an underlying or contributing condition, classified by intent and mechanism of death. Negative binomial regression was used to incorporate every year of data into estimated percentage changes in CO emissions and mortality rates over time. Results During 1968-1998, CO-related mortality rates in the United States declined from 20.2 deaths to 8.8 deaths per 1 million person-years (an estimated decline of 57.8%; 95% confidence interval [CI], -62.4% to -52.6%). Following the introduction of the catalytic converter to automobiles in 1975, CO emissions from automobiles decreased by an estimated 76.3% of 1975 levels (95% Cl, -82.0% to -70.4%) and unintentional motor vehicle-related CO death rates declined from 4.0 to 0.9 deaths per 1 million person-years (an estimated decline of 81.3%; 95% Cl, -84.8% to -77.0%). Rates of motor vehicle-related CO suicides declined from 10.0 to 4.9 deaths per 1 million person-years (an estimated decline of 43.3%; 95% Cl, -57.5% to -24.3%). During 1975-1996, an annual decrease of 10 g/mile of estimated CO emissions from automobiles was associated with a 21.3% decrease (95% Cl, -24.2% to -18.4%) in the annual unintentional motor vehicle-related CO death rate and a 5.9% decrease (95% CI, -10.0% to -1.8%) in the annual rate of motor vehicle-related CO suicides. Conclusions If rates of unintentional CO-related deaths had remained at pre-1975 levels, an estimated additional 11700 motor vehicle-related CO poisoning deaths might have occurred by 1998. This decline in death rates appears to be a public health benefit associated with the enforcement of standards set by the 1970 Clean Air Act.	Ctr Dis Control & Prevent, Air Pollut & Resp Hlth Branch, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA; Washington State Dept Hlth, Off Epidemiol, Olympia, WA USA; US EPA, Off Transportat & Air Qual, Ann Arbor, MI USA; Ctr Dis Control & Prevent, Parasit Dis Epidemiol Branch, Natl Ctr Infect Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; United States Environmental Protection Agency; Centers for Disease Control & Prevention - USA	Mott, JA (corresponding author), Ctr Dis Control & Prevent, Air Pollut & Resp Hlth Branch, Natl Ctr Environm Hlth, 1600 Clifton Rd NE,MS E-17, Atlanta, GA 30333 USA.	zud9@cdc.gov		Mannino, David/0000-0003-3646-7828				*AM AUT MAN ASS, 1985, MOT VEH FACTS FIG 19; *AM AUT MAN ASS, 1998, MOT VEH FACTS FIG 19; Amos T, 2001, PSYCHOL MED, V31, P935, DOI 10.1017/S0033291701003920; COBB N, 1991, JAMA-J AM MED ASSOC, V266, P659, DOI 10.1001/jama.266.5.659; Cummings P, 1999, JAMA-J AM MED ASSOC, V281, P2198, DOI 10.1001/jama.281.23.2198; Easley RB, 2000, SOUTH MED J, V93, P430, DOI 10.1097/00007611-200004000-00016; *FED HIGHW ADM, 1999, C P FED HIGHW ADM; HAMPSON NB, 2000, CARBON MONOXIDE TOXI, P193; Krenzelok EP, 1996, AM J EMERG MED, V14, P484, DOI 10.1016/S0735-6757(96)90159-X; Kwor R., 2000, CARBON MONOXIDE TOXI, P61; LANDERS D, 1981, WESTERN J MED, V135, P360; LESTER D, 1989, ACCIDENT ANAL PREV, V21, P191, DOI 10.1016/0001-4575(89)90086-9; MAH JC, 2002, NONFIRE CARBON MONOX; Marr LC, 1998, J AIR WASTE MANAGE, V48, P899, DOI 10.1080/10473289.1998.10463745; MATHIEUNOLF M, 2000, CARBON MONOXIDE TOXI, P291; *NAT CTR HLTH STAT, 1982, PUBL US DAT FIL DOC; National Center for Health Statistics, 1996, PUBL US DAT FIL DOC; PIRKLE JL, 1994, JAMA-J AM MED ASSOC, V272, P284, DOI 10.1001/jama.272.4.284; Raub, 2000, CARBON MONOXIDE TOXI, P83; Riveros HG, 1998, J AIR WASTE MANAGE, V48, P459, DOI 10.1080/10473289.1998.10463696; Routley VH, 1998, MED J AUSTRALIA, V168, P65, DOI 10.5694/j.1326-5377.1998.tb126713.x; SHELEF M, 1994, SCI TOTAL ENVIRON, V147, P93, DOI 10.1016/0048-9697(94)90224-0; Shepherd G, 1998, ARCH PEDIAT ADOL MED, V152, P1181; *US CONS PROD SAF, 1993, WHAT YOU SHOULD KNOW; *US EPA, 1999, 420P99015 US EPA; *US EPA, 1998, OMS12EPA400F92014 OF; *WHO, 1967, MAN INT STAT CLASS D; WHO (World Health Organization), 1977, MAN INT STAT CLASS D; 2000, MMWR MORB MORTAL WKL, V49, P105	29	107	110	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2002	288	8					988	995		10.1001/jama.288.8.988	http://dx.doi.org/10.1001/jama.288.8.988			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587RM	12190369	Bronze			2022-12-28	WOS:000177656400024
J	Euler, T; Detwiler, PB; Denk, W				Euler, T; Detwiler, PB; Denk, W			Directionally selective calcium signals in dendrites of starburst amacrine cells	NATURE			English	Article							RETINAL GANGLION-CELLS; RABBIT RETINA; CHOLINERGIC NEURONS; ACETYLCHOLINE; GABA; RECEPTORS; MICROSCOPY; RELEASE; IMMUNOREACTIVITY; IDENTIFICATION	The detection of image motion is fundamental to vision. In many species, unique classes of retinal ganglion cells selectively respond to visual stimuli that move in specific directions. It is not known which retinal cell first performs the neural computations that give rise to directional selectivity in the ganglion cell. A prominent candidate has been an interneuron called the 'starburst amacrine cell'. Using two-photon optical recordings of intracellular calcium concentration, here we find that individual dendritic branches of starburst cells act as independent computation modules. Dendritic calcium signals, but not somatic membrane voltage, are directionally selective for stimuli that move centrifugally from the cell soma. This demonstrates that direction selectivity is computed locally in dendritic branches at a stage before ganglion cells.	Max Planck Inst Med Res, D-69120 Heidelberg, Germany; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	Max Planck Society; University of Washington; University of Washington Seattle	Euler, T (corresponding author), Max Planck Inst Med Res, Jahnstr 29, D-69120 Heidelberg, Germany.		denk, winfried/I-6627-2012	Detwiler, Peter/0000-0003-3910-2023; Euler, Thomas/0000-0002-4567-6966				ARIEL M, 1982, J PHYSIOL-LONDON, V324, P161, DOI 10.1113/jphysiol.1982.sp014105; BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; BLOOMFIELD SA, 1992, J NEUROPHYSIOL, V68, P711, DOI 10.1152/jn.1992.68.3.711; Borg-Graham L.J., 1992, SINGLE NEURON COMPUT, P347; Borg-Graham LJ, 2001, NAT NEUROSCI, V4, P176, DOI 10.1038/84007; BORST A, 1990, P NATL ACAD SCI USA, V87, P9363, DOI 10.1073/pnas.87.23.9363; BRANDON C, 1987, BRAIN RES, V426, P119, DOI 10.1016/0006-8993(87)90431-8; BRECHA N, 1988, P NATL ACAD SCI USA, V85, P6187, DOI 10.1073/pnas.85.16.6187; Denk W, 1999, P NATL ACAD SCI USA, V96, P7035, DOI 10.1073/pnas.96.12.7035; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; EHINGER B, 1994, GLIA, V10, P40, DOI 10.1002/glia.440100106; Euler T, 2001, CURR OPIN NEUROBIOL, V11, P415, DOI 10.1016/S0959-4388(00)00228-2; FAMIGLIETTI EV, 1991, J COMP NEUROL, V309, P40, DOI 10.1002/cne.903090105; Grzywacz NM, 1997, VISUAL NEUROSCI, V14, P39, DOI 10.1017/S0952523800008749; Grzywacz NM, 1998, VISUAL NEUROSCI, V15, P1119, DOI 10.1017/S0952523898156109; He SG, 1997, NATURE, V389, P378, DOI 10.1038/38723; Keyser KT, 2000, VISUAL NEUROSCI, V17, P743, DOI 10.1017/S095252380017508X; Kittila CA, 1997, J NEUROPHYSIOL, V77, P675, DOI 10.1152/jn.1997.77.2.675; LINN DM, 1992, VISUAL NEUROSCI, V8, P97, DOI 10.1017/S0952523800009263; MASLAND RH, 1984, PROC R SOC SER B-BIO, V223, P121, DOI 10.1098/rspb.1984.0086; MASLAND RH, 1979, J CELL BIOL, V83, P159, DOI 10.1083/jcb.83.1.159; MASLAND RH, 1984, PROC R SOC SER B-BIO, V223, P79, DOI 10.1098/rspb.1984.0084; Massey SC, 1997, VISUAL NEUROSCI, V14, P939, DOI 10.1017/S0952523800011652; MILLER RF, 1983, P NATL ACAD SCI-BIOL, V80, P3069, DOI 10.1073/pnas.80.10.3069; Miller RF, 2001, J COMP NEUROL, V437, P129, DOI 10.1002/cne.1275; OMALLEY DM, 1992, J NEUROSCI, V12, P1394; PAN ZH, 1995, J NEUROSCI, V15, P2668; Peters BN, 1996, J NEUROPHYSIOL, V75, P469, DOI 10.1152/jn.1996.75.1.469; POZNANSKI RR, 1992, B MATH BIOL, V54, P905; REICHARDT W, 1961, SENS COMMUN, P377; SCHWARTZ EA, 1987, SCIENCE, V238, P350, DOI 10.1126/science.2443977; TAUCHI M, 1984, PROC R SOC SER B-BIO, V223, P101, DOI 10.1098/rspb.1984.0085; Taylor WR, 2000, SCIENCE, V289, P2347, DOI 10.1126/science.289.5488.2347; TAYLOR WR, 1995, EUR J NEUROSCI, V7, P2308, DOI 10.1111/j.1460-9568.1995.tb00652.x; TAYLOR WR, 1995, EUR J NEUROSCI, V7, P2300; Vaney D.I., 2001, MOTION VISION COMPUT; VANEY DI, 1988, BRAIN RES, V438, P369, DOI 10.1016/0006-8993(88)91366-2; VANEY DI, 1989, NEUROBIOLOGY INNER R, P157; Velte TJ, 1997, VISUAL NEUROSCI, V14, P1073, DOI 10.1017/S0952523800011780; Wassle H, 1998, VISION RES, V38, P1411, DOI 10.1016/s0042-6989(97)00300-3; WYATT HJ, 1976, SCIENCE, V191, P204, DOI 10.1126/science.1857; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; ZHOU ZJ, 1995, J NEUROSCI, V15, P5334	45	402	408	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2002	418	6900					845	852		10.1038/nature00931	http://dx.doi.org/10.1038/nature00931			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192402				2022-12-28	WOS:000177555600030
J	Ganzini, L; Harvath, TA; Jackson, A; Goy, ER; Miller, LL; Delorit, MA				Ganzini, L; Harvath, TA; Jackson, A; Goy, ER; Miller, LL; Delorit, MA			Experiences of Oregon nurses and social workers with hospice patients who requested assistance with suicide	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TERMINALLY ILL PATIENTS; DEATH; EUTHANASIA; DESIRE; ATTITUDES	Background Oregon's 1997 Death with Dignity Act legalizes physician-assisted suicide. To date, information about patients who have requested this option has come from surveys of physicians. Although 78 percent of the 91 Oregonians who have died by assisted suicide were enrolled in hospice programs, there is little information about the experiences of hospice practitioners with these patients. Methods In 2001, we mailed a questionnaire to all hospice nurses and social workers in Oregon. Results Of 545 eligible hospice nurses and social workers, 397 (73 percent) returned the survey, including 71 percent of nurses and 78 percent of social workers. Since November 1997,179 of the respondents (45 percent) had cared for a patient who requested assistance with suicide. Hospice nurses reported on 82 patients who had received prescriptions for lethal medication. Ninety-eight percent of the nurses had discussed the request with a coworker, and 77 percent of the requests had been presented at a hospice interdisciplinary conference on patient care. A very important reason for the request was to control the circumstances of death. The least important reasons included depression, lack of social support, and fear of being a financial drain on family members. Although the patients were concerned about burdening others, only 11 percent of hospice nurses rated their family caregivers as more burdened than family caregivers for other hospice patients. Conclusions Since assisted suicide was legalized in Oregon, many hospice nurses and social workers have provided care for a patient who requested assistance with suicide. They rated desire for control as a very important reason for these requests.	Vet Affairs Med Ctr, Div Mental Hlth, Portland, OR 97207 USA; Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR USA; Oregon Hlth & Sci Univ, Sch Nursing, Portland, OR USA; Oregon Hospice Assoc, Portland, OR USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Oregon Health & Science University; Oregon Health & Science University	Ganzini, L (corresponding author), Vet Affairs Med Ctr, Div Mental Hlth, P3MHDC,POB 1034, Portland, OR 97207 USA.		Harvath, Theresa/L-1115-2019					Breitbart W, 1996, AM J PSYCHIAT, V153, P238; Breitbart W, 2000, JAMA-J AM MED ASSOC, V284, P2907, DOI 10.1001/jama.284.22.2907; BROWN JH, 1986, AM J PSYCHIAT, V143, P208; Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; DANIEL WW, 1999, BIOSTATISTICS FDN AN; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V284, P2460, DOI 10.1001/jama.284.19.2460; Foley K, 1999, HASTINGS CENT REP, V29, P37, DOI 10.2307/3528194; Ganzini L, 2000, NEW ENGL J MED, V342, P1538; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; Hamilton NG, 2000, HASTINGS CENT REP, V30, P4; Hedberg K, 2002, NEW ENGL J MED, V346, P450, DOI 10.1056/NEJM200202073460614; Miller FG, 1997, CAMB Q HEALTHC ETHIC, V6, P78, DOI 10.1017/S0963180100007635; Rosenfeld B, 2000, NEW ENGL J MED, V343, P151; SACHS GA, 1995, J AM GERIATR SOC, V43, P553, DOI 10.1111/j.1532-5415.1995.tb06106.x; Sullivan AD, 2000, NEW ENGL J MED, V342, P598, DOI 10.1056/NEJM200002243420822; Sullivan AD, 2001, NEW ENGL J MED, V344, P605, DOI 10.1056/NEJM200102223440811; Wilson KG, 2000, ARCH INTERN MED, V160, P2454, DOI 10.1001/archinte.160.16.2454	18	113	114	0	8	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 22	2002	347	8					582	588		10.1056/NEJMsa020562	http://dx.doi.org/10.1056/NEJMsa020562			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	587ZR	12192019				2022-12-28	WOS:000177675400008
J	Ward, DJ; MacKay, DJC				Ward, DJ; MacKay, DJC			Artificial intelligence - Fast hands-free writing by gaze direction	NATURE			English	Article									Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England	University of Cambridge	Ward, DJ (corresponding author), Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England.	mackay@nrao.cam.ac.uk						BORGES JL, 1941, LIB BABEL; CLEARY JG, 1984, IEEE T COMMUN, V32, P396, DOI 10.1109/TCOM.1984.1096090; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Teahan W. J., 1995, P NZ COMP SCI RES ST; Ward D. J., 2000, UIST. Proceedings of the 13th Annual ACM Symposium on User Interface Software and Technology, P129, DOI 10.1145/354401.354427; WITTEN IH, 1987, COMMUN ACM, V30, P520, DOI 10.1145/214762.214771	7	122	125	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 22	2002	418	6900					838	838		10.1038/418838a	http://dx.doi.org/10.1038/418838a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192400	Bronze, Green Submitted			2022-12-28	WOS:000177555600028
J	Elphick, HE; Tan, A; Ashby, D; Smyth, RL				Elphick, HE; Tan, A; Ashby, D; Smyth, RL			Systematic reviews and lifelong diseases	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CYSTIC-FIBROSIS; CONTROLLED TRIALS; BETA-LACTAM; AMINOGLYCOSIDE; TOBRAMYCIN; GENTAMICIN		Univ Liverpool, Inst Child Hlth, Alder Hey Childrens Hosp, Liverpool L12 2AP, Merseyside, England; Univ London, Barts & London Queen Marys Sch Med & Dent, Wolfson Inst Prevent Med, London EC1M 6B9, England	Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Liverpool; University of London; Queen Mary University London	Smyth, RL (corresponding author), Univ Liverpool, Inst Child Hlth, Alder Hey Childrens Hosp, Liverpool L12 2AP, Merseyside, England.	r.l.smyth@liv.ac.uk						Akbar A, 1999, ACTA PAEDIATR, V88, P783; Black N, 1996, BRIT MED J, V312, P1215; Cheng K, 1996, LANCET, V348, P639, DOI 10.1016/S0140-6736(96)05169-0; Cheng K, 2000, PEDIATR PULM, V29, P1; ELPHICK HE, 2001, COCHRANE LIB; Ernst E, 2001, BRIT MED J, V323, P546, DOI 10.1136/bmj.323.7312.546; Frederiksen B, 1996, PEDIATR PULM, V21, P153, DOI 10.1002/(SICI)1099-0496(199603)21:3<153::AID-PPUL1>3.0.CO;2-R; GODSON C, 1988, SCAND J GASTROENTERO, V23, P70, DOI 10.3109/00365528809090220; GOTSCHE PC, 2001, COCHRANE LIB; Katbamna B, 1999, EAR HEARING, V20, P393, DOI 10.1097/00003446-199910000-00002; Leibovici L, 1999, BRIT MED J, V318, P1614, DOI 10.1136/bmj.318.7198.1614; MCLAUGHLIN FJ, 1983, J INFECT DIS, V147, P559, DOI 10.1093/infdis/147.3.559; Mehta A, 2001, LANCET, V358, P1546, DOI 10.1016/S0140-6736(01)06593-X; Mulheran M, 1997, BRIT J AUDIOL, V31, P5, DOI 10.3109/03005364000000004; MULHERIN D, 1991, IRISH J MED SCI, V160, P173, DOI 10.1007/BF02961666; PADOAN R, 1987, PEDIATR INFECT DIS J, V6, P648, DOI 10.1097/00006454-198707000-00006; PO ALW, 2001, 8 COCHR C CAP TOWN S; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Scott CS, 2001, PEDIATR PULM, V31, P314, DOI 10.1002/ppul.1047; SHAREK PJ, 2001, COCHRANE LIB; Smith AL, 1999, J PEDIATR-US, V134, P413, DOI 10.1016/S0022-3476(99)70197-6; TAYLOR RFH, 1993, RESP MED, V87, P535, DOI 10.1016/0954-6111(93)90010-W; *UK CYST FIBR TRUS, 2000, ANT TREATM CYST FIBR	23	22	22	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 17	2002	325	7360					381	384		10.1136/bmj.325.7360.381	http://dx.doi.org/10.1136/bmj.325.7360.381			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587DV	12183313	Green Published			2022-12-28	WOS:000177626000025
J	Flottorp, S; Oxman, AD; Havelsrud, K; Treweek, S; Herrin, J				Flottorp, S; Oxman, AD; Havelsrud, K; Treweek, S; Herrin, J			Cluster randomised controlled trial of tailored interventions to improve the management of urinary tract infections in women and sore throat	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; GUIDELINE; EDUCATION	Objective To assess the effectiveness of tailored interventions to implement guidelines for urinary tract infections in women and sore throat. Design Unblinded, cluster randomised pretest-post-test trial. Setting 142 general practices in Norway. Participants 72 practices received interventions to implement guidelines for urinary tract infection and 70 practices received interventions to implement guidelines for sore throats serving as controls for each other. 59 practices in the urinary tract infection group and 61 practices in the sore throat group completed the study. Outcomes were measured in 16 939 consultations for sore throat and 9887 consultations for urinary tract infection. Interventions Interventions were developed to overcome identified barriers to implementing the guidelines. The main components of the tailored interventions were patient educational material, computer based decision support and reminders, an increase in the fee for telephone consultations, and interactive courses for general practitioners and practice assistants. Main outcome measures Changes in rates of use of antibiotics, laboratory tests, and telephone consultations. Results Patients in the sore throat group were 3% less likely to receive antibiotics after the intervention. Women with symptoms of urinary tract infection in the intervention group were 5% less likely to have a laboratory test ordered. No significant differences were found between the groups for the other outcomes. Large variation was found across the included practices in the rates of antibiotic prescription, use of laboratory tests and telephone consultations, and in the extent of change for all three outcome measures. Conclusions Passively delivered, complex interventions targeted at identified barriers to change had little effect in changing practice.	Norwegian Directorate Hlth & Social Welf, Dept Hlth Serv Res, N-0031 Oslo, Norway; Flying Buttress Associates, Charlottesville, VA 22902 USA		Flottorp, S (corresponding author), Norwegian Directorate Hlth & Social Welf, Dept Hlth Serv Res, POB 8054 Dep, N-0031 Oslo, Norway.	signe.flottorp@shdir.no	Oxman, Andrew/Y-3004-2019; Treweek, Shaun/AAE-8006-2019	Oxman, Andrew/0000-0002-5608-5061; Treweek, Shaun/0000-0002-7239-7241; Flottorp, Signe/0000-0003-2961-7461				Baker R, 2001, BRIT J GEN PRACT, V51, P737; Bryk A. S., 1992, HIERARCHICAL LINEAR; CHEATER F, 2001, COCHRANE LIB; Cranney M, 1999, BRIT J GEN PRACT, V49, P522; Donner A, 1996, J CLIN EPIDEMIOL, V49, P435, DOI 10.1016/0895-4356(95)00511-0; Flottorp S, 2000, Tidsskr Nor Laegeforen, V120, P1754; Flottorp S, 2000, Tidsskr Nor Laegeforen, V120, P1748; Grimshaw JM, 2001, MED CARE, V39, pII2; Grol R, 1997, BRIT MED J, V315, P418, DOI 10.1136/bmj.315.7105.418; Hux JE, 1999, CAN MED ASSOC J, V161, P388; LAMBERTS H, 1993, INT CLASSIFICATION P; Lundborg CS, 1999, J CLIN EPIDEMIOL, V52, P801, DOI 10.1016/S0895-4356(99)00036-0; McIsaac WJ, 1998, MED DECIS MAKING, V18, P220, DOI 10.1177/0272989X9801800211; Murray DM, 1998, DESIGN ANAL GROUP RA; Omar RZ, 2000, STAT MED, V19, P2675, DOI 10.1002/1097-0258(20001015)19:19<2675::AID-SIM556>3.3.CO;2-1; OXMAN AD, 2001, EVIDENCE BASED PRACT, P101; POSES RM, 1995, MED DECIS MAKING, V15, P65, DOI 10.1177/0272989X9501500110; Saint S, 1999, AM J MED, V106, P636, DOI 10.1016/S0002-9343(99)00122-9; Santoso B, 1996, SOC SCI MED, V42, P1163, DOI 10.1016/0277-9536(95)00390-8; *SCI SOFTW INT, 2000, HIER LIN NONL MOD; Soumerai SB, 1998, JAMA-J AM MED ASSOC, V279, P1358, DOI 10.1001/jama.279.17.1358; TREWEEK S, 2001, HLTH INF J, V7, P96; Van der Weijden T, 1999, INT J QUAL HEALTH C, V11, P131, DOI 10.1093/intqhc/11.2.131; *WHO COLL CTR DRUG, 1999, ATC IND DDDS	24	98	99	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 17	2002	325	7360					367	370		10.1136/bmj.325.7360.367	http://dx.doi.org/10.1136/bmj.325.7360.367			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587DV	12183309	Bronze, Green Published			2022-12-28	WOS:000177626000021
J	Boyer, D; Tamarat, P; Maali, A; Lounis, B; Orrit, M				Boyer, D; Tamarat, P; Maali, A; Lounis, B; Orrit, M			Photothermal imaging of nanometer-sized metal particles among scatterers	SCIENCE			English	Article							COLLOIDAL GOLD; MICROSCOPY; NANOPARTICLES; NANOCRYSTALS; MOVEMENTS; MOLECULES	Ambient optical detection of labeled molecules is limited for fluorescent dyes by photobleaching and for semiconducting nanoparticles by blinking effects. Because nanometer-sized metal particles do not optically bleach, they may be useful optical labels if suitable detection signals can be found. We demonstrate far-field optical detection of gold colloids down to diameters of 2.5 nanometers with a photothermal method that combines high-frequency modulation and polarization interference contrast. The photothermal image is immune to the effects of scattering background, which limits particle imaging through Rayleigh scattering to diameters larger than 40 nanometers.	CNRS, F-33405 Talence, France; Univ Bordeaux 1, F-33405 Talence, France; Leiden Univ, Huygens Lab, NL-2300 RA Leiden, Netherlands	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Leiden University; Leiden University - Excl LUMC	Lounis, B (corresponding author), CNRS, 351 Cours Liberat, F-33405 Talence, France.		Lounis, Brahim/I-7862-2016; ORRIT, Michel/I-2426-2013; ORRIT, Michel/ABC-1795-2020	Lounis, Brahim/0000-0001-7501-0236; ORRIT, Michel/0000-0002-3607-3426; MAALI, Abdelhamid/0000-0002-9459-6081				BASCHONG W, 1985, HISTOCHEMISTRY, V83, P409, DOI 10.1007/BF00509201; Bohren C., 2008, ABSORPTION SCATTERIN; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Carslaw H., 1986, CONDUCTION HEAT SOLI; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; CLEYZES P, 1997, OPT LETT, V22, P1529; Frey PA, 1999, J STRUCT BIOL, V127, P94, DOI 10.1006/jsbi.1999.4150; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; Hainfeld JF, 2000, J HISTOCHEM CYTOCHEM, V48, P471, DOI 10.1177/002215540004800404; Klar T, 1998, PHYS REV LETT, V80, P4249, DOI 10.1103/PhysRevLett.80.4249; Moerner WE, 1999, SCIENCE, V283, P1670, DOI 10.1126/science.283.5408.1670; Nirmal M, 1996, NATURE, V383, P802, DOI 10.1038/383802a0; Robinson JM, 2000, J MICROSC-OXFORD, V199, P163, DOI 10.1046/j.1365-2818.2000.00734.x; Schultz S, 2000, P NATL ACAD SCI USA, V97, P996, DOI 10.1073/pnas.97.3.996; SHEETZ MP, 1989, NATURE, V340, P284, DOI 10.1038/340284a0; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; Sonnichsen C, 2000, APPL PHYS LETT, V77, P2949, DOI 10.1063/1.1323553; Tokeshi M, 2001, ANAL CHEM, V73, P2112, DOI 10.1021/ac001479g	18	793	837	11	347	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2002	297	5584					1160	1163		10.1126/science.1073765	http://dx.doi.org/10.1126/science.1073765			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183624				2022-12-28	WOS:000177447600043
J	Liu, W; Christenson, SD; Standage, S; Shen, B				Liu, W; Christenson, SD; Standage, S; Shen, B			Biosynthesis of the enediyne antitumor antibiotic C-1027	SCIENCE			English	Article							ADENYLATION DOMAINS; CHROMOPHORE; STREPTOMYCES; PROTEINS; PATHWAY; CODE; GENE	C-1027 is a potent antitumor agent with a previously undescribed molecular architecture and mode of action. Cloning and characterization of the 85-kilobase C-1027 biosynthesis gene cluster from Streptomyces globisporus revealed (i) an iterative type I polyketide synthase that is distinct from any bacterial polyketide synthases known to date, (ii) a general polyketide pathway for the biosynthesis of both the 9- and 10-membered enediyne antibiotics, and (iii) a convergent biosynthetic strategy for the C-1027 chromophore from four building blocks. Manipulation of genes governing C-1027 biosynthesis allowed us to produce an enediyne compound in a predicted manner.	Univ Wisconsin, Div Pharmaceut Sci, Madison, WI 53705 USA; Univ Wisconsin, Dept Chem, Madison, WI 53705 USA; Univ Calif Davis, Biochem & Mol Biol Grad Grp, Davis, CA 95616 USA; Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Davis; University of California System; University of California Davis	Shen, B (corresponding author), Univ Wisconsin, Div Pharmaceut Sci, Madison, WI 53705 USA.				NCI NIH HHS [CA78747] Funding Source: Medline; NIAID NIH HHS [AI51689] Funding Source: Medline; NIGMS NIH HHS [T32 GM07377] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI051689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007377] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahlert J, 2002, SCIENCE, V297, P1173, DOI 10.1126/science.1072105; BIBB MJ, 1994, MOL MICROBIOL, V14, P533, DOI 10.1111/j.1365-2958.1994.tb02187.x; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Brukner I., 2000, CURR OPIN ONCOL ENDO, V2, P344; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Chen H, 2002, CHEM BIOL, V9, P103, DOI 10.1016/S1074-5521(02)00090-X; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Du L, 2001, Curr Opin Drug Discov Devel, V4, P215; Funa N, 1999, NATURE, V400, P897, DOI 10.1038/23748; HENSENS OD, 1989, J AM CHEM SOC, V111, P3295, DOI 10.1021/ja00191a028; Iida K, 1996, TETRAHEDRON LETT, V37, P4997, DOI 10.1016/0040-4039(96)00993-8; Kennedy J, 1999, SCIENCE, V284, P1368, DOI 10.1126/science.284.5418.1368; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; LAM KS, 1993, J AM CHEM SOC, V115, P12340, DOI 10.1021/ja00079a014; Lee M, 1998, SCIENCE, V280, P915, DOI 10.1126/science.280.5365.915; Liu W, 2000, ANTIMICROB AGENTS CH, V44, P382, DOI 10.1128/AAC.44.2.382-392.2000; Maeda Hiroshi, 1997, NEOCARZINOSTATIN PAS, P227; Metz JG, 2001, SCIENCE, V293, P290, DOI 10.1126/science.1059593; MINAMI Y, 1993, TETRAHEDRON LETT, V34, P2633, DOI 10.1016/S0040-4039(00)77643-X; Moore BS, 2001, CHEMBIOCHEM, V2, P35, DOI 10.1002/1439-7633(20010105)2:1<35::AID-CBIC35>3.3.CO;2-T; NICOLAOU KC, 1991, ANGEW CHEM INT EDIT, V30, P1387, DOI 10.1002/anie.199113873; OTANI T, 1988, J ANTIBIOT, V41, P1580, DOI 10.7164/antibiotics.41.1580; Shen B, 2000, TOP CURR CHEM, V209, P1; Sievers EL, 1999, BLOOD, V93, P3678, DOI 10.1182/blood.V93.11.3678; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Thorson JS, 2000, CURR PHARM DESIGN, V6, P1841, DOI 10.2174/1381612003398564; TOKIWA Y, 1992, J AM CHEM SOC, V114, P4107, DOI 10.1021/ja00037a011; Xi Z., 1999, COMPREHENSIVE NATURA, V7, P553; YOSHIDA K, 1993, TETRAHEDRON LETT, V34, P2637	31	242	267	6	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2002	297	5584					1170	1173		10.1126/science.1072110	http://dx.doi.org/10.1126/science.1072110			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183628				2022-12-28	WOS:000177447600047
J	Crawford, LM				Crawford, LM			Revision of grant program	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Crawford, LM (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2002	288	6					688	688		10.1001/jama.288.6.688	http://dx.doi.org/10.1001/jama.288.6.688			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	583KY	12169049				2022-12-28	WOS:000177408100006
J	Ramsay, J; Richardson, J; Carter, YH; Davidson, LL; Feder, G				Ramsay, J; Richardson, J; Carter, YH; Davidson, LL; Feder, G			Should health professionals screen women for domestic violence? Systematic review	BRITISH MEDICAL JOURNAL			English	Review							ABUSED WOMEN; EMERGENCY; CARE; INTERVENTION; PROTOCOL; PROGRAM; EXPERIENCES; ATTITUDES; NURSES	Objective To assess the evidence for the acceptability and effectiveness of screening women for domestic violence in healthcare settings. Design Systematic review of published quantitative studies. Search strategy Three electronic databases (Medline, Embase, and CINAHL) were searched for articles published in the English language up to February 2001. Included studies Surveys that elicited the attitudes of women and health professionals on the screening of women in health settings; comparative studies conducted in healthcare settings that measured rates of identification of domestic violence in the presence and absence of screening; studies measuring outcomes of interventions for women identified in health settings who experience abuse from a male partner or ex-partner compared with abused women not receiving an intervention. Results 20 papers met the inclusion criteria. In four surveys, 43-85% of women respondents found screening in healthcare settings acceptable. Two surveys of health professionals' views found that two thirds of physicians and almost half of emergency department nurses were not in favour of screening. In nine studies of screening compared with no screening, most detected a greater proportion of abused women identified by healthcare professionals. Six studies of interventions used weak study designs and gave inconsistent results. Other than increased referral to outside agencies, little evidence exists for changes in important outcomes such as decreased exposure to violence. No studies measured quality of life, mental health outcomes, or potential harm to women from screening programmes. Conclusion Although domestic violence is a corm-non problem with major health consequences for women, implementation of screening programmes in healthcare settings cannot be justified. Evidence of the benefit of specific interventions and lack of harm from screening is needed.	Queen Marys Sch Med & Dent, Barts & London, Dept Gen Practice & Primary Care, London E1 4NS, England; Inst Hlth Sci, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England	University of London; Queen Mary University London; University of Oxford	Feder, G (corresponding author), Queen Marys Sch Med & Dent, Barts & London, Dept Gen Practice & Primary Care, London E1 4NS, England.			Feder, Gene/0000-0002-7890-3926				Abbott P, 1999, J GENDER STUD, V8, P83, DOI 10.1080/095892399102841; BEWLEY S, 1997, VIOLENCE WOMEN; *BRIT MED ASS, 1998, DOM VIOL HLTH CAR IS; Caralis PV, 1997, SOUTH MED J, V90, P1075, DOI 10.1097/00007611-199711000-00003; Cole TB, 2000, JAMA-J AM MED ASSOC, V284, P551, DOI 10.1001/jama.284.5.551; *COMM PRACT HLTH V, 1998, DOM VIOL ROL COMM NU; Covington D L, 1997, Matern Child Health J, V1, P129, DOI 10.1023/A:1026278508610; Davidson LL, 2001, J WOMEN HEALTH GEN-B, V10, P953, DOI 10.1089/152460901317193530; *DEP HLTH, 2000, DOM VIOL RES MAN HLT; Easteal P W, 1992, Violence Vict, V7, P217; Eisenstat SA, 1999, NEW ENGL J MED, V341, P886, DOI 10.1056/NEJM199909163411206; Ellis AJ, 1999, INT J ARTIF ORGANS, V22, P27, DOI 10.1177/039139889902200107; Fanslow JL, 1999, AUST NZ J PUBL HEAL, V23, P418, DOI 10.1111/j.1467-842X.1999.tb01286.x; Fanslow JL, 1998, AUST NZ J PUBL HEAL, V22, P598, DOI 10.1111/j.1467-842X.1998.tb01445.x; Fitzpatrick M., 2001, TYRANNY HLTH; Freund KM, 1996, J GEN INTERN MED, V11, P44, DOI 10.1007/BF02603485; FRIEDMAN LS, 1992, ARCH INTERN MED, V152, P1186, DOI 10.1001/archinte.152.6.1186; Gielen AC, 2000, AM J PREV MED, V19, P279, DOI 10.1016/S0749-3797(00)00234-8; Harwell TS, 1998, AM J PREV MED, V15, P235, DOI 10.1016/S0749-3797(98)00070-1; HEATH I, 1998, DOMESTIC VIOLENCE GE; HENDERSON S, 1997, SERVICE PROVISION WO; Humphreys J., 1993, NURSING CARE SURVIVO; McFarlane J, 1997, PUBLIC HEALTH NURS, V14, P244, DOI 10.1111/j.1525-1446.1997.tb00297.x; McFarlane J, 1998, J Obstet Gynecol Neonatal Nurs, V27, P64, DOI 10.1111/j.1552-6909.1998.tb02592.x; McNutt L A, 1999, J Am Med Womens Assoc (1972), V54, P85; Morrison LJ, 2000, J EMERG MED, V19, P117, DOI 10.1016/S0736-4679(00)00204-3; Muelleman RL, 1999, ANN EMERG MED, V33, P62, DOI 10.1016/S0196-0644(99)70418-X; Olson L, 1996, ANN EMERG MED, V27, P741, DOI 10.1016/S0196-0644(96)70193-2; Parker B, 1999, RES NURS HEALTH, V22, P59; RAMSAY J, 2001, APPRAISAL EVIDENCE S; Richardson J, 2001, BRIT J GEN PRACT, V51, P468; Roberts GL, 1997, GEN HOSP PSYCHIAT, V19, P12, DOI 10.1016/S0163-8343(96)00121-1; *ROYAL COLL MIDW, 1997, 19 ROYAL COLL MIDW R; *ROYAL COLL NURS, 2000, DOM VIOL GUID NURS; Shepard MF, 1999, PUBLIC HEALTH NURS, V16, P359, DOI 10.1046/j.1525-1446.1999.00359.x; Sleutel M R, 1998, Issues Ment Health Nurs, V19, P525, DOI 10.1080/016128498248827; Thompson RS, 2000, AM J PREV MED, V19, P253, DOI 10.1016/S0749-3797(00)00231-2; Waalen J, 2000, AM J PREV MED, V19, P230, DOI 10.1016/S0749-3797(00)00229-4; *WHO, 1998, VIOLENCE WOMEN INFOR; *WHO, 1998, VIOL WOM INF PACK PR; Wiist WH, 1999, AM J PUBLIC HEALTH, V89, P1217, DOI 10.2105/AJPH.89.8.1217	41	317	319	0	30	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 10	2002	325	7359					314	318B		10.1136/bmj.325.7359.314	http://dx.doi.org/10.1136/bmj.325.7359.314			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	584RQ	12169509	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000177482500020
J	Kazazian, HH; Goodier, JL				Kazazian, HH; Goodier, JL			LINE drive: Retrotransposition and genome instability	CELL			English	Review							L1 RETROTRANSPOSITION; GENE	The LINE-1 (L1) retrotransposon, the most important human mobile element, shapes the genome in many ways. Now two groups provide evidence that Ll retrotransposition is associated with large genomic deletions and inversions in transformed cells. If these events occur at a similar frequency in vivo, they have had a substantial effect on human genome evolution.	Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19105 USA	University of Pennsylvania	Kazazian, HH (corresponding author), Univ Penn, Sch Med, Dept Genet, 475 Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19105 USA.							Boissinot SP, 2001, MOL BIOL EVOL, V18, P2186, DOI 10.1093/oxfordjournals.molbev.a003765; Cummings CJ, 2000, HUM MOL GENET, V9, P909, DOI 10.1093/hmg/9.6.909; CURCIO MJ, 1991, P NATL ACAD SCI USA, V88, P936, DOI 10.1073/pnas.88.3.936; Dennis JJ, 1998, APPL ENVIRON MICROB, V64, P2710; Emanuel BS, 2001, NAT REV GENET, V2, P791, DOI 10.1038/35093500; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Garvey SM, 2002, GENOMICS, V79, P146, DOI 10.1006/geno.2002.6685; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Kojima T, 2000, MOL BRAIN RES, V75, P121, DOI 10.1016/S0169-328X(99)00313-7; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; MIKI Y, 1992, CANCER RES, V52, P643; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Myers JS, 2002, AM J HUM GENET, V71, P312, DOI 10.1086/341718; Nigumann P, 2002, GENOMICS, V79, P628, DOI 10.1006/geno.2002.6758; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Teng SC, 1996, NATURE, V383, P641, DOI 10.1038/383641a0; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001	20	157	165	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 9	2002	110	3					277	280		10.1016/S0092-8674(02)00868-1	http://dx.doi.org/10.1016/S0092-8674(02)00868-1			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	583MN	12176313	Bronze			2022-12-28	WOS:000177411800002
J	Petersen, LR; Marfin, AA				Petersen, LR; Marfin, AA			West Nile virus: A primer for the clinician	ANNALS OF INTERNAL MEDICINE			English	Review							NEW-YORK-CITY; UNITED-STATES; FEVER OUTBREAK; ENCEPHALITIS; INFECTION; ISRAEL; EPIDEMIC	This paper provides the clinician with an understanding of the epidemiologic and biological characteristics of West Nile virus in North America, as well as useful information on the diagnosis, reporting, and management of patients with suspected West Nile virus infection and on advising patients about prevention. Information was gathered from the medical literature and from national surveillance data through May 2002. Since the identification of West Nile virus in New York City in 1999, enzootic activity has been documented in 27 states and the District of Columbia. Continued geographic expansion is likely. Overall, one in 150 infections results in severe neurologic illness. Advanced age is by far the most important risk factor for neurologic disease and, once disease develops, for worse clinical outcome. Surveillance has identified 149 persons with West Nile virus-related illness in 10 states. Encephalitis is more commonly reported than meningitis, and concomitant muscle weakness and flaccid paralysis may provide a clinical clue to the presence of West Nile virus infection. Peak incidence occurs in late summer, although onset has occurred from July through December. Immunoglobulin M antibody testing of serum specimens and cerebrospinal fluid is the most efficient method of diagnosis, although cross-reactions are possible in patients recently vaccinated against or recently infected with related flaviviruses. Testing can be arranged through local, state, or provincial (in Canada) health departments. Prevention rests on elimination of mosquito breeding sites; judicious use of pesticides; and avoidance of mosquito bites, including mosquito repellent use.	Ctr Dis Control & Prevent, US Natl Ctr Infect Dis, Div Vector Borne Infect Dis, Ft Collins, CO 80522 USA	Centers for Disease Control & Prevention - USA	Petersen, LR (corresponding author), Ctr Dis Control & Prevent, US Natl Ctr Infect Dis, Div Vector Borne Infect Dis, Ft Collins, CO 80522 USA.							Ahmed S, 2000, NEUROLOGY, V55, P144, DOI 10.1212/WNL.55.1.144; Anderson JF, 2002, EMERG INFECT DIS, V8, P107, DOI 10.3201/eid0801.010252; Asnis DS, 2000, CLIN INFECT DIS, V30, P413, DOI 10.1086/313737; Asnis DS, 2001, ANN NY ACAD SCI, V951, P161; Chowers MY, 2001, EMERG INFECT DIS, V7, P675; Eidson M, 2001, EMERG INFECT DIS, V7, P662, DOI 10.3201/eid0704.010411; Ford-Jones EL, 2002, CAN MED ASSOC J, V166, P29; Fradin MS, 1998, ANN INTERN MED, V128, P931, DOI 10.7326/0003-4819-128-11-199806010-00013; Giladi M, 2001, EMERG INFECT DIS, V7, P659; Hayes CG, 2001, ANN NY ACAD SCI, V951, P25; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; Hubalek Z, 2001, LANCET, V358, P254, DOI 10.1016/S0140-6736(01)05491-5; Jupp PG, 2001, ANN NY ACAD SCI, V951, P143, DOI 10.1111/j.1749-6632.2001.tb02692.x; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Martin DA, 2002, CLIN DIAGN LAB IMMUN, V9, P544, DOI 10.1128/CDLI.9.3.544-549.2002; Monath TP, 2001, ANN NY ACAD SCI, V951, P1; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Murgue B, 2001, ANN NY ACAD SCI, V951, P117; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; *NEW YORK DEP HLTH, 2001, W NIL VIR SURV CONTR, P20; Petersen LR, 2001, EMERG INFECT DIS, V7, P611; Platonov AE, 2001, EMERG INFECT DIS, V7, P128, DOI 10.3201/eid0701.010118; Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP), 1997, MMWR MORB MORTAL WKL, V46, P12; Sampson BA, 2001, ANN NY ACAD SCI, V951, P172; SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471; SOUTHAM CM, 1954, AM J TROP MED HYG, V3, P19, DOI 10.4269/ajtmh.1954.3.19; SPIGLAND L, 1958, HAREFUAH, V54, P275; Swayne DE, 2001, EMERG INFECT DIS, V7, P751; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; Turell MJ, 2001, ANN NY ACAD SCI, V951, P317; Weinberger M, 2001, EMERG INFECT DIS, V7, P686, DOI 10.3201/eid0704.010416; Weiss D, 2001, EMERG INFECT DIS, V7, P654, DOI 10.3201/eid0704.010409; 1997, MMWR MORB MORTAL WKL, V46, P43; 2001, MMWR MORB MORTAL WKL, V50, P37; 2002, MMWR MORB MORTAL WKL, V51, P497; 2001, MMWR MORB MORTAL WKL, V50, P761	36	413	430	1	28	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 6	2002	137	3					173	179		10.7326/0003-4819-137-3-200208060-00009	http://dx.doi.org/10.7326/0003-4819-137-3-200208060-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580XP	12160365				2022-12-28	WOS:000177262300004
J	Hellmann, H; Estelle, M				Hellmann, H; Estelle, M			Plant development: Regulation by protein degradation	SCIENCE			English	Review							F-BOX PROTEIN; ARABIDOPSIS CULLIN ATCUL1; UBIQUITIN LIGASE ACTIVITY; COP9 SIGNALOSOME; AUX/IAA PROTEINS; AUXIN-RESPONSE; GENE-EXPRESSION; LIGHT CONTROL; POLYUBIQUITIN CHAIN; POSITIVE REGULATOR	Many aspects of eukaryotic development depend on regulated protein degradation by the ubiquitin-proteasome pathway. This highly conserved pathway promotes covalent attachment of ubiquitin to protein substrates through the sequential action of three enzymes called a ubiquitin-activating enzyme (E1), a ubiquitin-conjugating enzyme (E2), and a ubiquitin-protein ligase (E3). Most ubiquitinated proteins are then targeted for degradation by the 26 S proteasome. Recent studies have also shown that the ubiquitin-related protein RUB/Nedd8 and the proteasome-related COP9 signalosome complex cooperate with the ubiquitin-proteasome pathway to promote protein degradation. Most of these components are conserved in all three eukaryotic kingdoms. However, the known targets of the pathway in plants, and the developmental processes they regulate, are specific to the plant kingdom.	Univ Texas, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Estelle, M (corresponding author), Indiana Univ, Myers Hall,915 E 3rd St, Bloomington, IN 47405 USA.	mestelle@bio.indiana.edu	Estelle, Mark/ABD-6742-2021		NIGMS NIH HHS [GM43644] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABEL S, 1994, P NATL ACAD SCI USA, V91, P326, DOI 10.1073/pnas.91.1.326; Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; Bates PW, 1999, PLANT J, V20, P183, DOI 10.1046/j.1365-313x.1999.00590.x; Bech-Otschir D, 2002, J CELL SCI, V115, P467; Callis J, 2000, CURR OPIN PLANT BIOL, V3, P381, DOI 10.1016/S1369-5266(00)00100-X; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Chamovitz DA, 1996, CELL, V86, P115, DOI 10.1016/S0092-8674(00)80082-3; Chattopadhyay S, 1998, PLANT CELL, V10, P673, DOI 10.1105/tpc.10.5.673; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Colon-Carmona A, 2000, PLANT PHYSIOL, V124, P1728, DOI 10.1104/pp.124.4.1728; del Pozo JC, 1999, P NATL ACAD SCI USA, V96, P15342, DOI 10.1073/pnas.96.26.15342; del Pozo JC, 2002, PLANT CELL, V14, P421, DOI 10.1105/tpc.010282; del Pozo JC, 1998, SCIENCE, V280, P1760, DOI 10.1126/science.280.5370.1760; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; DHARMASIRI M, UNPUB; Dieterle M, 2001, GENE DEV, V15, P939, DOI 10.1101/gad.197201; Dill A, 2001, P NATL ACAD SCI USA, V98, P14162, DOI 10.1073/pnas.251534098; Freed E, 1999, GENE DEV, V13, P2242, DOI 10.1101/gad.13.17.2242; GAGNE JM, IN PRESS P NATL ACAD; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Hardtke CS, 2000, EMBO J, V19, P4997, DOI 10.1093/emboj/19.18.4997; Hardtke CS, 2002, PLANT J, V30, P385, DOI 10.1046/j.1365-313X.2002.01298.x; He JX, 2002, P NATL ACAD SCI USA, V99, P10185, DOI 10.1073/pnas.152342599; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Holm M, 2002, GENE DEV, V16, P1247, DOI 10.1101/gad.969702; Hori T, 1999, ONCOGENE, V18, P6829, DOI 10.1038/sj.onc.1203093; Ingram GC, 1997, EMBO J, V16, P6521, DOI 10.1093/emboj/16.21.6521; Itoh H, 2002, PLANT CELL, V14, P57, DOI 10.1105/tpc.010319; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jackson PK, 2001, GENE DEV, V15, P3053, DOI 10.1101/gad.955501; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; Kurz T, 2002, SCIENCE, V295, P1294, DOI 10.1126/science.1067765; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Lee HJ, 2001, GENE DEV, V15, P912, DOI 10.1101/gad.866801; Li JM, 2001, PLANT PHYSIOL, V127, P14, DOI 10.1104/pp.127.1.14; Liakopoulos D, 1999, P NATL ACAD SCI USA, V96, P5510, DOI 10.1073/pnas.96.10.5510; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Morimoto M, 2000, BIOCHEM BIOPH RES CO, V270, P1093, DOI 10.1006/bbrc.2000.2576; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Mundt KE, 2002, MOL BIOL CELL, V13, P493, DOI 10.1091/mbc.01-10-0521; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Ouellet F, 2001, PLANT CELL, V13, P829, DOI 10.1105/tpc.13.4.829; Oyama T, 1997, GENE DEV, V11, P2983, DOI 10.1101/gad.11.22.2983; Peng ZH, 2001, DEVELOPMENT, V128, P4277; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Reed JW, 2001, TRENDS PLANT SCI, V6, P420, DOI 10.1016/S1360-1385(01)02042-8; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Samach A, 1999, PLANT J, V20, P433, DOI 10.1046/j.1365-313x.1999.00617.x; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Schwechheimer C, 2001, TRENDS CELL BIOL, V11, P420, DOI 10.1016/S0962-8924(01)02091-8; Silverstone AL, 1997, GENETICS, V146, P1087; Smalle J, 2002, PLANT CELL, V14, P17, DOI 10.1105/tpc.010381; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Stirnberg P, 2002, DEVELOPMENT, V129, P1131; Suzuki G, 2002, GENE DEV, V16, P554, DOI 10.1101/gad.964602; Tateishi K, 2001, J CELL BIOL, V155, P571, DOI 10.1083/jcb.200104035; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Ulmasov T, 1997, SCIENCE, V276, P1865, DOI 10.1126/science.276.5320.1865; VIERSTRA R, COMMUNICATION; Vierstra RD, 1999, PLANT MOL BIOL, V41, P435, DOI 10.1023/A:1006323317890; VONARNIM AG, 1994, CELL, V79, P1035, DOI 10.1016/0092-8674(94)90034-5; Wang HY, 2001, SCIENCE, V294, P154, DOI 10.1126/science.1063630; Wang XP, 2002, MOL BIOL CELL, V13, P646, DOI 10.1091/mbc.01-08-0427; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Wei N, 1999, TRENDS GENET, V15, P98, DOI 10.1016/S0168-9525(98)01670-9; Woo HR, 2001, PLANT CELL, V13, P1779, DOI 10.1105/tpc.13.8.1779; Worley CK, 2000, PLANT J, V21, P553, DOI 10.1046/j.1365-313x.2000.00703.x; Wu K, 2002, J BIOL CHEM, V277, P516, DOI 10.1074/jbc.M108008200; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Yamamoto YY, 1998, PLANT CELL, V10, P1083, DOI 10.1105/tpc.10.7.1083; Yamamoto YY, 2001, PLANT CELL, V13, P399, DOI 10.1105/tpc.13.2.399; Yang HQ, 2001, PLANT CELL, V13, P2573, DOI 10.1105/tpc.13.12.2573; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7; Yang M, 1999, P NATL ACAD SCI USA, V96, P11416, DOI 10.1073/pnas.96.20.11416; Yang X., UNPUB; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3; Zenser N, 2001, P NATL ACAD SCI USA, V98, P11795, DOI 10.1073/pnas.211312798; Zhao DH, 1999, DEV GENET, V25, P209, DOI 10.1002/(SICI)1520-6408(1999)25:3&lt;209::AID-DVG4&gt;3.0.CO;2-O; Zhou CS, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-7	92	268	304	3	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2002	297	5582					793	797		10.1126/science.1072831	http://dx.doi.org/10.1126/science.1072831			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161644				2022-12-28	WOS:000177192800037
J	Brown, JKM; Hovmoller, MS				Brown, JKM; Hovmoller, MS			Epidemiology - Aerial dispersal of pathogens on the global and continental scales and its impact on plant disease	SCIENCE			English	Review							STRIIFORMIS F.SP TRITICI; F-SP TRITICI; CHESTNUT BLIGHT FUNGUS; PHYTOPHTHORA-INFESTANS; POPULATION; RUST; MANAGEMENT; SPREAD; EXPANSION; DYNAMICS		John Innes Ctr Plant Sci Res, Dept Dis & Stress Biol, Norwich NR4 7UH, Norfolk, England; Danish Inst Agr Sci, Dept Plant Protect, DK-4200 Slagelse, Denmark	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Aarhus University	Brown, JKM (corresponding author), John Innes Ctr Plant Sci Res, Dept Dis & Stress Biol, Norwich NR4 7UH, Norfolk, England.	james.brown@bbsrc.ac.uk; mogens.hovmoller@agrsci.dk	Hovmoller, Mogens S/E-8374-2016	Hovmoller, Mogens S/0000-0002-4432-8898				Aylor DE, 1999, AGR FOREST METEOROL, V97, P275, DOI 10.1016/S0168-1923(99)00072-6; BECKERRATERINK S, 1982, Z PFLANZENK PFLANZEN, V89, P619; BOURKE PMA, 1964, NATURE, V203, P805, DOI 10.1038/203805a0; BOWDEN J, 1971, NATURE, V229, P500, DOI 10.1038/229500b0; BROWN JKM, 1991, P ROY SOC B-BIOL SCI, V246, P83, DOI 10.1098/rspb.1991.0128; Brown JKM, 2002, DISPERSAL ECOLOGY, P395; BROWN JKM, 1995, ADV PLANT P, V11, P75; Brown James K. M., 1994, Trends in Microbiology, V2, P470, DOI 10.1016/0966-842X(94)90124-4; Cain ML, 2000, AM J BOT, V87, P1217, DOI 10.2307/2656714; Carlier J, 1996, MOL ECOL, V5, P499, DOI 10.1111/j.1365-294X.1996.tb00342.x; Chen W.Q., 1999, RES PROGR PLANT PROT, P276; Donaldson AI, 2001, VET REC, V148, P602, DOI 10.1136/vr.148.19.602; DRENTH A, 1994, EUR J PLANT PATHOL, V100, P97, DOI 10.1007/BF01876244; FERRANDINO FJ, 1993, PHYTOPATHOLOGY, V83, P795, DOI 10.1094/Phyto-83-795; Fisher MC, 2001, P NATL ACAD SCI USA, V98, P4558, DOI 10.1073/pnas.071406098; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; FRY WE, 1993, PLANT DIS, V77, P653, DOI 10.1094/PD-77-0653; Gage SH, 1999, AGR FOREST METEOROL, V97, P249, DOI 10.1016/S0168-1923(99)00070-2; HAMILTON LM, 1967, PHYTOPATHOLOGY, V57, P609; Hermansen J. E., 1978, Grana, V17, P41, DOI 10.1080/00173137809428851; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; *HOM GROWN CER AUT, 1994, CER STAT; Hovmoller MS, 2000, AGRONOMIE, V20, P729, DOI 10.1051/agro:2000172; Hovmoller MS, 2002, PLANT PATHOL, V51, P24, DOI 10.1046/j.1365-3059.2002.00652.x; Hovmoller MS, 2001, PLANT PATHOL, V50, P181, DOI 10.1046/j.1365-3059.2001.00525.x; Ibrahim KM, 1996, HEREDITY, V77, P282, DOI 10.1038/hdy.1996.142; Jeger MJ, 1999, AGR FOREST METEOROL, V97, P331, DOI 10.1016/S0168-1923(99)00076-3; Justesen AF, 2002, PLANT PATHOL, V51, P13, DOI 10.1046/j.0032-0862.2001.00651.x; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Knowles NJ, 2001, VET REC, V148, P258; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; LUIG NH, 1985, CAN J PLANT PATHOL, V7, P173, DOI 10.1080/07060668509501497; MILGROOM MG, 1995, PHYTOPATHOLOGY, V85, P155, DOI 10.1094/Phyto-85-155; Milgroom MG, 1996, MYCOLOGIA, V88, P179, DOI 10.2307/3760921; MONACO LC, 1977, ANN NY ACAD SCI, V287, P57, DOI 10.1111/j.1749-6632.1977.tb34231.x; Mourichon X., 1990, Fruits (Paris), V45, P213; NAGARAJAN S, 1990, ANNU REV PHYTOPATHOL, V28, P139, DOI 10.1146/annurev.py.28.090190.001035; Niederhauser J.S., 1991, PHYTOPHTHORA, P25; PURDY LH, 1985, PLANT DIS, V69, P689, DOI 10.1094/PD-69-689; ROTEM J, 1985, PHYTOPATHOLOGY, V75, P510, DOI 10.1094/Phyto-75-510; Scherm H, 1996, ECOL MODEL, V87, P217, DOI 10.1016/0304-3800(95)00030-5; Shan WX, 1998, CAN J BOT, V76, P587, DOI 10.1139/cjb-76-4-587; SHAW MW, 1994, ANNU REV PHYTOPATHOL, V32, P523, DOI 10.1146/annurev.py.32.090194.002515; Skotnicki ML, 2001, ANTARCT SCI, V13, P280, DOI 10.1017/S0954102001000396; STOCKMARR A, IN PRESS J MATH BIOL; Stover RH, 1987, BANANAS, P486; van den Bosch F, 1999, PHYTOPATHOLOGY, V89, P495, DOI 10.1094/PHYTO.1999.89.6.495; Wan A.-M., 2000, P 1 AS C PLANT PATH, P98; Watson I. A., 1983, Proceedings of the Linnean Society of New South Wales, V106, P311; WELLINGS CR, 1987, PLANT PATHOL, V36, P239, DOI 10.1111/j.1365-3059.1987.tb02230.x; WELLINGS CR, 1990, PLANT PATHOL, V39, P316, DOI 10.1111/j.1365-3059.1990.tb02509.x; WOLFE MS, 1992, EUPHYTICA, V63, P125, DOI 10.1007/BF00023918; Xie S. X., 1988, Acta Phytophylactica Sinica, V15, P85; Xie S. X., 1993, Acta Phytopathologica Sinica, V23, P203; Xie ShuiXian, 1997, Acta Phytophylacica Sinica, V24, P29; ZADOKS JC, 1994, ANNU REV PHYTOPATHOL, V32, P503, DOI 10.1146/annurev.py.32.090194.002443	56	777	841	9	277	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2002	297	5581					537	541		10.1126/science.1072678	http://dx.doi.org/10.1126/science.1072678			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142520				2022-12-28	WOS:000177054200033
J	Kim, DH; Sarbassov, DD; Ali, SM; King, JE; Latek, RR; Erdjument-Bromage, H; Tempst, P; Sabatini, DM				Kim, DH; Sarbassov, DD; Ali, SM; King, JE; Latek, RR; Erdjument-Bromage, H; Tempst, P; Sabatini, DM			MTOR interacts with Raptor to form a nutrient-sensitive complex that signals to the cell growth machinery	CELL			English	Article							P70 S6 KINASE; MAMMALIAN TARGET; TRANSLATION INITIATION; EIF-4E BP1; RAPAMYCIN; PROTEIN; TOR; YEAST; PHOSPHORYLATION; HOMOLOG	mTOR/RAFT1/FRAP is the target of the immunosuppressive drug rapamycin and the central component of a nutrient- and hormone-sensitive signaling pathway that regulates cell growth. We report that mTOR forms a stoichiometric complex with raptor, an evolutionarily conserved protein with at least two roles in the mTOR pathway. Raptor has a positive role in nutrient-stimulated signaling to the downstream effector S6K1, maintenance of cell size, and mTOR protein expression. The association of raptor with mTOR also negatively regulates the mTOR kinase activity. Conditions that repress the pathway, such as nutrient deprivation and mitochondrial uncoupling, stabilize the mTOR-raptor association and inhibit mTOR kinase activity. We propose that raptor is a missing component of the mTOR pathway that through its association with mTOR regulates cell size in response to nutrient levels.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Memorial Sloan Kettering Cancer Center	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Sarbassov, Dos/AAS-4950-2020; Ali, Siraj/AAE-2958-2019	Kim, Do-Hyung/0000-0002-2924-4370; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Tempst, Paul/0000-0002-6680-3987; /0000-0002-1446-7256; Sarbassov, Dos/0000-0002-6848-1133	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047389] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI47389] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; BAILEY TL, 1994, ISMB, V2, P28; BERNARD PA, 1979, BIOCHIM BIOPHYS ACTA, V548, P173, DOI 10.1016/0005-2728(79)90127-0; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Dixon, 1998, Curr Opin Plant Biol, V1, P1, DOI 10.1016/S1369-5266(98)80118-0; Dudkin L, 2001, CLIN CANCER RES, V7, P1758; Efstratiadis A, 1998, INT J DEV BIOL, V42, P955; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Erdjument-Bromage H, 1998, J CHROMATOGR A, V826, P167, DOI 10.1016/S0021-9673(98)00705-5; Fox HL, 1998, AM J PHYSIOL-CELL PH, V274, pC206, DOI 10.1152/ajpcell.1998.274.1.C206; Geromanos S, 2000, ANAL CHEM, V72, P777, DOI 10.1021/ac991071n; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hidalgo M, 2000, ONCOGENE, V19, P6680, DOI 10.1038/sj.onc.1204091; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Johnston LA, 2002, BIOESSAYS, V24, P54, DOI 10.1002/bies.10021; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kozma SC, 2002, BIOESSAYS, V24, P65, DOI 10.1002/bies.10031; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Lawrence J C Jr, 2001, Prog Mol Subcell Biol, V26, P1; Lynch CJ, 2000, J CELL BIOCHEM, V77, P234, DOI 10.1002/(SICI)1097-4644(20000501)77:2<234::AID-JCB7>3.0.CO;2-I; Majumder PK, 2001, CELL GROWTH DIFFER, V12, P465; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Parrott LA, 1999, J BIOL CHEM, V274, P24731, DOI 10.1074/jbc.274.35.24731; Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sabatini DM, 1999, SCIENCE, V284, P1161, DOI 10.1126/science.284.5417.1161; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Saunders RN, 2001, KIDNEY INT, V59, P3, DOI 10.1046/j.1523-1755.2001.00460.x; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Shinozaki-Yabana S, 2000, MOL CELL BIOL, V20, P1234, DOI 10.1128/MCB.20.4.1234-1242.2000; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Sousa JE, 2001, CIRCULATION, V104, P2007, DOI 10.1161/hc4201.098056; Taha C, 1999, J MEMBRANE BIOL, V169, P1, DOI 10.1007/PL00005896; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WOLVETANG EJ, 1994, FEBS LETT, V339, P40, DOI 10.1016/0014-5793(94)80380-3; Xu G, 2001, DIABETES, V50, P353, DOI 10.2337/diabetes.50.2.353; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; ZHENG XF, 1995, CELL, V82, P121, DOI 10.1016/0092-8674(95)90058-6	50	2234	2314	12	189	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 26	2002	110	2					163	175		10.1016/S0092-8674(02)00808-5	http://dx.doi.org/10.1016/S0092-8674(02)00808-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	578EV	12150925	Bronze			2022-12-28	WOS:000177105200005
J	Kobayashi, K; Hernandez, LD; Galan, JE; Janeway, CA; Medzhitov, R; Flavell, RA				Kobayashi, K; Hernandez, LD; Galan, JE; Janeway, CA; Medzhitov, R; Flavell, RA			IRAK-M is a negative regulator of toll-like receptor signaling	CELL			English	Article							FACTOR-KAPPA-B; MONOPHOSPHORYL LIPID-A; IL-1 RECEPTOR; SALMONELLA-TYPHIMURIUM; INTERLEUKIN-1 RECEPTOR; ENDOTOXIN TOLERANCE; GENE-EXPRESSION; INNATE IMMUNITY; CUTTING EDGE; KINASE	Toll-like receptors (TLRs) detect microorganisms and protect multicellular organisms from infection. TLRs transduce their signals through MyD88 and the serine/ threonine kinase IRAK. The IRAK family consists of two active kinases, IRAK and IRAK-4, and two inactive kinases, IRAK-2 and IRAK-M. IRAK-M expression is restricted to monocytes/macrophages, whereas other IRAKs are ubiquitous. We show here that IRAK-M is induced upon TLR stimulation and negatively regulates TLR signaling. IRAK-M prevented dissociation of IRAK and IRAK-4 from MyD88 and formation of IRAK-TRAF6 complexes. IRAK-M I cells exhibited increased cytokine production upon TLR/IL-1 stimulation and bacterial challenge, and IRAK-M-/- mice showed increased inflammatory responses to bacterial infection. Endotoxin tolerance, a protection mechanism against endotoxin shock, was significantly reduced in IRAK-M-/- cells. Thus, IRAK-M regulates TLR signaling and innate immune homeostasis.	Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06510 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA	Howard Hughes Medical Institute; Yale University; Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06510 USA.		Eckhardt, Erik/G-1567-2010	Kobayashi, Koichi/0000-0003-2930-0114				Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; BEESON PB, 1947, J EXP MED, V86, P29, DOI 10.1084/jem.86.1.29; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Chen LM, 1996, MOL MICROBIOL, V21, P1101, DOI 10.1046/j.1365-2958.1996.471410.x; CROSS A, 1995, J CLIN INVEST, V96, P676, DOI 10.1172/JCI118110; DANNER RL, 1991, CHEST, V99, P169, DOI 10.1378/chest.99.1.169; EDEN CS, 1988, J IMMUNOL, V140, P3180; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Goldring CE, 1998, EUR J IMMUNOL, V28, P2960, DOI 10.1002/(SICI)1521-4141(199809)28:09<2960::AID-IMMU2960>3.0.CO;2-B; GREISMAN SE, 1966, J EXP MED, V124, P983, DOI 10.1084/jem.124.5.983; Gustafson G L, 1995, Prog Clin Biol Res, V392, P567; HAGBERG L, 1984, INFECT IMMUN, V46, P839, DOI 10.1128/IAI.46.3.839-844.1984; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; HENRICSON BE, 1990, INFECT IMMUN, V58, P2429, DOI 10.1128/IAI.58.8.2429-2437.1990; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kanakaraj P, 1998, J EXP MED, V187, P2073, DOI 10.1084/jem.187.12.2073; KANIGA K, 1994, MOL MICROBIOL, V13, P555, DOI 10.1111/j.1365-2958.1994.tb00450.x; Kastenbauer S, 1999, INFECT IMMUN, V67, P1553; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Knop J, 1999, FEBS LETT, V448, P81, DOI 10.1016/S0014-5793(99)00322-1; Kobayashi K, 1999, P NATL ACAD SCI USA, V96, P1457, DOI 10.1073/pnas.96.4.1457; Kojima H, 1998, BIOCHEM BIOPH RES CO, V244, P183, DOI 10.1006/bbrc.1998.8236; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li XX, 1999, MOL CELL BIOL, V19, P4643; Maschera B, 1999, BIOCHEM J, V339, P227, DOI 10.1042/0264-6021:3390227; MCMAHAN CJ, 1991, EMBO J, V10, P2821, DOI 10.1002/j.1460-2075.1991.tb07831.x; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; Penheiter KL, 1997, MOL MICROBIOL, V24, P697, DOI 10.1046/j.1365-2958.1997.3741745.x; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Salkowski CA, 1998, INFECT IMMUN, V66, P3569, DOI 10.1128/IAI.66.8.3569-3578.1998; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; SHAHIN RD, 1987, J IMMUNOL, V138, P3475; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Swantek JL, 2000, J IMMUNOL, V164, P4301, DOI 10.4049/jimmunol.164.8.4301; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Thomas JA, 1999, J IMMUNOL, V163, P978; van Heel DA, 2001, LANCET, V357, P1902, DOI 10.1016/S0140-6736(00)05091-1; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540; Zhang FX, 1999, J BIOL CHEM, V274, P7611, DOI 10.1074/jbc.274.12.7611; ZIEGLERHEITBROCK HWL, 1995, J INFLAMM, V45, P13; ZIEGLERHEITBROCK HWL, 1994, J BIOL CHEM, V269, P17001	55	1089	1149	1	59	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 26	2002	110	2					191	202		10.1016/S0092-8674(02)00827-9	http://dx.doi.org/10.1016/S0092-8674(02)00827-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	578EV	12150927	Bronze			2022-12-28	WOS:000177105200007
J	Whistler, JL; Enquist, J; Marley, A; Fong, J; Gladher, F; Tsuruda, P; Murray, SR; von Zastro, M				Whistler, JL; Enquist, J; Marley, A; Fong, J; Gladher, F; Tsuruda, P; Murray, SR; von Zastro, M			Modulation of postendocytic sorting of G-protein coupled receptors	SCIENCE			English	Article							INDUCED DOWN-REGULATION; DELTA-OPIOID RECEPTORS; BETA(2)-ADRENERGIC RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; ENDOCYTOSIS; MU; INTERNALIZATION; RESENSITIZATION; UBIQUITINATION; PROTEASOME	Recycling of the mu opioid receptor to the plasma membrane after endocytosis promotes rapid resensitization of signal transduction, whereas targeting of the delta opioid receptor (DOR) to lysosomes causes proteolytic down-regulation. We identified a protein that binds preferentially to the cytoplasmic tail of the DOR as a candidate heterotrimeric GTP-binding protein (G protein)-coupled receptor-associated sorting protein (GASP). Disruption of the DOR-GASP interaction through receptor mutation or overexpression of a dominant negative fragment of GASP inhibited receptor trafficking to lysosomes and promoted recycling. The GASP family of proteins may modulate lysosomal sorting and functional down-regulation of a variety of G protein-coupled receptors.	Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, Oakland, CA 94608 USA; Lund Univ, Program Mol Med, S-22100 Lund, Sweden; Univ Calif San Francisco, Dept Psychiat, Cell Biol Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; Lund University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Whistler, JL (corresponding author), Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, Oakland, CA 94608 USA.							Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Chaturvedi K, 2001, J BIOL CHEM, V276, P12345, DOI 10.1074/jbc.M008054200; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Cong M, 2001, J BIOL CHEM, V276, P45145, DOI 10.1074/jbc.M106087200; EVANS CJ, 1992, SCIENCE, V258, P1952, DOI 10.1126/science.1335167; Finn AK, 2001, NEURON, V32, P829, DOI 10.1016/S0896-6273(01)00517-7; Gage RM, 2001, J BIOL CHEM, V276, P44712, DOI 10.1074/jbc.M107417200; Gagnon AW, 1998, J BIOL CHEM, V273, P6976, DOI 10.1074/jbc.273.12.6976; Goodman O B Jr, 1998, Adv Pharmacol, V42, P429; Heck DA, 1997, J PHARMACOL EXP THER, V282, P1219; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Innamorati G, 1998, P NATL ACAD SCI USA, V95, P2222, DOI 10.1073/pnas.95.5.2222; KAUFMAN DL, 1995, J BIOL CHEM, V270, P15877, DOI 10.1074/jbc.270.26.15877; Klein U, 1997, J BIOL CHEM, V272, P19099, DOI 10.1074/jbc.272.31.19099; Koch T, 1998, J BIOL CHEM, V273, P13652, DOI 10.1074/jbc.273.22.13652; Law PY, 1999, J PHARMACOL EXP THER, V289, P607; Lefkowitz R J, 1998, Adv Pharmacol, V42, P416; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; PETERSON MG, 1990, SCIENCE, V248, P1625, DOI 10.1126/science.2363050; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Suyama M, 1999, NUCLEIC ACIDS RES, V27, P338, DOI 10.1093/nar/27.1.338; Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; VONZASTROW M, 1992, J BIOL CHEM, V267, P3530; Whistler JL, 2001, J BIOL CHEM, V276, P34331, DOI 10.1074/jbc.M104627200; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157; ZHANG J, 1999, J REC SIG T RES, V19, P1	29	260	277	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2002	297	5581					615	620		10.1126/science.1073308	http://dx.doi.org/10.1126/science.1073308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142540				2022-12-28	WOS:000177054200055
J	Yoon, SJ; Lee, YW				Yoon, SJ; Lee, YW			An aligned stream of low-metallicity clusters in the halo of the Milky Way	SCIENCE			English	Article							HORIZONTAL-BRANCH STARS; YOUNG GLOBULAR-CLUSTERS; MAGELLANIC CLOUDS; GALAXY; LMC; SPECTROSCOPY; VELOCITIES; ORBITS; SYSTEM; ORIGIN	One of the long-standing problems in modern astronomy is the curious division of Galactic globular clusters, the "Oosterhoff dichotomy", according to the properties of their RR Lyrae stars. Here, we find that most of the lowest metallicity ([Fe/H] < -2.0) clusters, which are essential to an understanding of this phenomenon, display a planar alignment in the outer halo. This alignment, combined with evidence from kinematics and stellar population, indicates a captured origin from a satellite galaxy. We show that, together with the horizontal-branch evolutionary effect, the factor producing the dichotomy could be a small time gap between the cluster-formation epochs in the Milky Way and the satellite. The results oppose the traditional view that the metal-poorest clusters represent the indigenous and oldest population of the Galaxy.	Yonsei Univ, Ctr Space Astrophys, Seoul 120749, South Korea	Yonsei University	Yoon, SJ (corresponding author), Yonsei Univ, Ctr Space Astrophys, Seoul 120749, South Korea.			Lee, Young-Wook/0000-0002-2210-1238				ARP HC, 1955, ASTRON J, V60, P317, DOI 10.1086/107232; Clement CM, 2001, ASTRON J, V122, P2587, DOI 10.1086/323719; Demarque P, 2000, ASTRON J, V119, P1398, DOI 10.1086/301261; Dinescu DI, 1999, ASTRON J, V117, P1792, DOI 10.1086/300807; EGGEN OJ, 1962, ASTROPHYS J, V136, P748, DOI 10.1086/147433; GARDINER LT, 1994, MON NOT R ASTRON SOC, V266, P567, DOI 10.1093/mnras/266.3.567; Ibata R, 2001, NATURE, V412, P49, DOI 10.1038/35083506; Johnson JA, 1999, ASTROPHYS J, V527, P199, DOI 10.1086/308066; KUNKEL WE, 1979, ASTROPHYS J, V228, P718, DOI 10.1086/156897; KUNKEL WE, 1977, ASTROPHYS J, V214, P21, DOI 10.1086/155226; LEE YW, 1990, ASTROPHYS J, V350, P155, DOI 10.1086/168370; LIN DNC, 1992, ASTROPHYS J, V388, pL57, DOI 10.1086/186329; LIN DNC, 1995, ASTROPHYS J, V439, P652, DOI 10.1086/175205; LYNDENBELL D, 1976, MON NOT R ASTRON SOC, V174, P695, DOI 10.1093/mnras/174.3.695; Olsen KAG, 1998, MON NOT R ASTRON SOC, V300, P665, DOI 10.1046/j.1365-8711.1998.01860.x; Oosterhoff P. T., 1939, OBSERVATORY, V62, P104; Palma C, 2002, ASTROPHYS J, V564, P736, DOI 10.1086/324137; PECCI FF, 1995, ASTRON J, V110, P1664, DOI 10.1086/117639; REE CH, 2002, ASP C SER, V265, P101; Renzini A., 1983, MEM SOC ASTRON ITAL, V54, P335; Rey SC, 2001, ASTRON J, V122, P3219, DOI 10.1086/324104; SUNTZEFF NB, 1992, ASTRON J, V104, P1743, DOI 10.1086/116356; VANDENBERG DA, 1990, ASTRON J, V100, P445, DOI 10.1086/115529; VANDENBERGH S, 1993, MON NOT R ASTRON SOC, V262, P588, DOI 10.1093/mnras/262.3.588; VANDENBERGH S, 1999, IAU S, V192, P3; WALKER AR, 1992, ASTRON J, V104, P1395, DOI 10.1086/116328; Yi SY, 1997, ASTROPHYS J, V482, P677, DOI 10.1086/304192; ZINN R, 1993, ASTR SOC P, V48, P38	30	40	40	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2002	297	5581					578	581		10.1126/science.1073090	http://dx.doi.org/10.1126/science.1073090			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142530				2022-12-28	WOS:000177054200043
J	Michele, DE; Barresi, R; Kanagawa, M; Saito, F; Cohn, RD; Satz, JS; Dollar, J; Nishino, I; Kelley, RI; Somer, H; Straub, V; Mathews, KD; Moore, SA; Campbell, KP				Michele, DE; Barresi, R; Kanagawa, M; Saito, F; Cohn, RD; Satz, JS; Dollar, J; Nishino, I; Kelley, RI; Somer, H; Straub, V; Mathews, KD; Moore, SA; Campbell, KP			Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies	NATURE			English	Article							ALPHA-DYSTROGLYCAN; GLYCOPROTEIN COMPLEX; DELTA-SARCOGLYCAN; LAMININ; MEMBRANE; LOCALIZATION; MUTATIONS; RECEPTOR; BRAIN; GENE	Muscle-eye-brain disease (MEB) and Fukuyama congenital muscular dystrophy (FCMD) are congenital muscular dystrophies with associated, similar brain malformations(1,2). The FCMD gene, fukutin, shares some homology with fringe-like glycosyltransferases, and the MEB gene, POMGnT1, seems to be a new glycosyltransferase(3,4). Here we show, in both MEB and FCMD patients, that alpha-dystroglycan is expressed at the muscle membrane, but similar hypoglycosylation in the diseases directly abolishes binding activity of dystroglycan for the ligands laminin, neurexin and agrin. We show that this post-translational biochemical and functional disruption of alpha-dystroglycan is recapitulated in the muscle and central nervous system of mutant myodystrophy (myd) mice. We demonstrate that myd mice have abnormal neuronal migration in cerebral cortex, cerebellum and hippocampus, and show disruption of the basal lamina. In addition, myd mice reveal that dystroglycan targets proteins to functional sites in brain through its interactions with extracellular matrix proteins. These results suggest that at least three distinct mammalian genes function within a convergent post-translational processing pathway during the biosynthesis of dystroglycan, and that abnormal dystroglycan-ligand interactions underlie the pathogenic mechanism of muscular dystrophy with brain abnormalities.	Univ Iowa, Howard Hughes Med Inst, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; Albany Med Coll, Dept Pathol, Albany, NY 12208 USA; Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo 1878502, Japan; Johns Hopkins Univ, Kennedy Krieger Inst, Baltimore, MD 21205 USA; Univ Helsinki Hosp, Dept Neurol, Helsinki 00029, Finland	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Albany Medical College; National Center for Neurology & Psychiatry - Japan; Johns Hopkins University; Kennedy Krieger Institute; University of Helsinki; Helsinki University Central Hospital	Campbell, KP (corresponding author), Univ Iowa, Howard Hughes Med Inst, Dept Physiol & Biophys, Iowa City, IA 52242 USA.		Barresi, Rita/AAB-9569-2022; Cohn, Ronald/AAC-5835-2021; Nishino, Ichizo/G-2676-2010	Barresi, Rita/0000-0001-7351-959X; Nishino, Ichizo/0000-0001-9452-112X; Kanagawa, Motoi/0000-0003-0984-6398; Moore, Steven/0000-0002-6353-7900; mathews, katherine/0000-0003-4160-0435; Straub, Volker/0000-0001-9046-3540; Campbell, Kevin/0000-0003-2066-5889				Allamand V, 1997, HUM MOL GENET, V6, P747, DOI 10.1093/hmg/6.5.747; Barton LL, 2001, CLIN INFECT DIS, V33, P370, DOI 10.1086/321897; CAMPANELLI JT, 1994, CELL, V77, P663, DOI 10.1016/0092-8674(94)90051-5; Chiba A, 1997, J BIOL CHEM, V272, P2156; Dubowitz T, 2000, ANN NEUROL, V47, P143, DOI 10.1002/1531-8249(200002)47:2<143::AID-ANA2>3.0.CO;2-Y; DUBOWITZ V, 2000, ANN NEUROL, V47, P554; ENGVALL E, 1986, J CELL BIOL, V103, P2457, DOI 10.1083/jcb.103.6.2457; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; Haltia M, 1997, ANN NEUROL, V41, P173, DOI 10.1002/ana.410410208; Henry MD, 1998, CELL, V95, P859, DOI 10.1016/S0092-8674(00)81708-0; Henry MD, 1999, CURR OPIN CELL BIOL, V11, P602, DOI 10.1016/S0955-0674(99)00024-1; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; IBRAGHIMOVBESKROVNAYA O, 1993, HUM MOL GENET, V2, P1651, DOI 10.1093/hmg/2.10.1651; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Jung D, 1996, J BIOL CHEM, V271, P32321, DOI 10.1074/jbc.271.50.32321; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Kunz S, 2001, J CELL BIOL, V155, P301, DOI 10.1083/jcb.200104103; LIM LE, 1995, NAT GENET, V11, P257, DOI 10.1038/ng1195-257; MATSUMURA K, 1992, NATURE, V359, P320, DOI 10.1038/359320a0; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Nigro V, 1996, NAT GENET, V14, P195, DOI 10.1038/ng1096-195; NOGUCHI S, 1995, SCIENCE, V270, P819, DOI 10.1126/science.270.5237.819; ROBERDS SL, 1994, CELL, V78, P625, DOI 10.1016/0092-8674(94)90527-4; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Toda T, 2000, NEUROMUSCULAR DISORD, V10, P153, DOI 10.1016/S0960-8966(99)00109-1; Williamson RA, 1997, HUM MOL GENET, V6, P831, DOI 10.1093/hmg/6.6.831; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3	30	622	641	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2002	418	6896					417	422		10.1038/nature00837	http://dx.doi.org/10.1038/nature00837			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12140558				2022-12-28	WOS:000177009700038
J	Yoshida, Y; Chiba, T; Tokunaga, F; Kawasaki, H; Iwai, K; Suzuki, T; Ito, Y; Matsuoka, K; Yoshida, M; Tanaka, K; Tai, T				Yoshida, Y; Chiba, T; Tokunaga, F; Kawasaki, H; Iwai, K; Suzuki, T; Ito, Y; Matsuoka, K; Yoshida, M; Tanaka, K; Tai, T			E3 ubiquitin ligase that recognizes sugar chains	NATURE			English	Article							HIF-ALPHA; PROTEIN; DEGRADATION; PROTEASOME; HYDROXYLATION; PRECURSOR; RECEPTOR; PATHWAY; CFTR; SCF	N-glycosylation of proteins in the endoplasmic reticulum (ER) has a central role in protein quality control(1-3). Here we report that N-glycan serves as a signal for degradation by the Skp1-Cullin1-Fbx2-Roc1 (SCFFbx2) ubiquitin ligase complex. The F-box protein Fbx2 (ref. 4) binds specifically to proteins attached to N-linked high-mannose oligosaccharides and subsequently contributes to ubiquitination of N-glycosylated proteins. Pre-integrin beta1 is a target of Fbx2; these two proteins interact in the cytosol after inhibition of the proteasome. In addition, expression of the mutant Fbx2DeltaF, which lacks the F-box domain that is essential for forming the SCF complex, appreciably blocks degradation of typical substrates of the ER-associated degradation pathway(5,6). Our results indicate that SCFFbx2 ubiquitinates N-glycosylated proteins that are translocated from the ER to the cytosol by the quality control mechanism.	Tokyo Metropolitan Inst Med Sci, Dept Tumor Immunol, Bunkyo Ku, Tokyo 1138613, Japan; Tokyo Metropolitan Inst Med Sci, Dept Mol Oncol, Bunkyo Ku, Tokyo 1138613, Japan; JST, CREST, Wako, Saitama 3320012, Japan; Osaka City Univ, Grad Sch Med, Dept Mol Cell Biol, Osaka 5458585, Japan; Yokohama City Univ, Grad Sch Integrated Sci, Kihara Inst Biol Res, Kanagawa 2440813, Japan; RIKEN, Synthet Cellular Chem Lab, Wako, Saitama 3510198, Japan; RIKEN, Chem Genet Lab, Wako, Saitama 3510198, Japan; Saitama Univ, Dept Funct Mat Sci, Saitama, Saitama 3388570, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST); Osaka Metropolitan University; Yokohama City University; RIKEN; RIKEN; Saitama University	Tai, T (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Tumor Immunol, Bunkyo Ku, Tokyo 1138613, Japan.	tanakak@rinshoken.or.jp	Yoshida, Minoru/C-8049-2014; IWAI, KAZUHIRO/GSN-7385-2022; Ito, Yukishige/ACL-6203-2022; Kawasaki, Hiroshi/C-3048-2011; Ito, Yukishige/M-5119-2014; Yoshida, Yukiko/ABB-7218-2020; Matsuoka, Koji/A-9463-2008	Yoshida, Minoru/0000-0002-4376-5674; Ito, Yukishige/0000-0001-6251-7249; Kawasaki, Hiroshi/0000-0002-2517-159X; Ito, Yukishige/0000-0001-6251-7249; Yoshida, Yukiko/0000-0002-0629-0219; Matsuoka, Koji/0000-0002-8987-2715; Suzuki, Toshiaki/0000-0002-0650-6251; Tokunaga, Fuminori/0000-0003-3626-9119; Iwai, Kazuhiro/0000-0001-5620-5951				AKIYAMA SK, 1989, J BIOL CHEM, V264, P18011; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Erhardt JA, 1998, J BIOL CHEM, V273, P35222, DOI 10.1074/jbc.273.52.35222; HEINO J, 1989, J BIOL CHEM, V264, P380; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; KOIVISTO L, 1994, BIOCHEM J, V300, P771, DOI 10.1042/bj3000771; LENTER M, 1994, J BIOL CHEM, V269, P12263; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; RICE KG, 1990, ANAL BIOCHEM, V184, P249, DOI 10.1016/0003-2697(90)90676-Z; TOKUNAGA F, 1995, BIOCHEMISTRY-US, V34, P1163, DOI 10.1021/bi00004a009; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800	24	291	303	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2002	418	6896					438	442		10.1038/nature00890	http://dx.doi.org/10.1038/nature00890			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12140560				2022-12-28	WOS:000177009700043
J	Fyodorov, DV; Kadonaga, JT				Fyodorov, DV; Kadonaga, JT			Dynamics of ATP-dependent chromatin assembly by ACF	NATURE			English	Article							DNA HELICASE; REMODELING COMPLEXES; HISTONE OCTAMER; ISWI; TRANSCRIPTION; MECHANISMS; PROTEINS; MOTORS; CHRAC	The assembly of DNA into chromatin is a critical step in the replication and repair of the eukaryotic genome(1-8). It has been known for nearly 20 years that chromatin assembly is an ATP-dependent process(9). ATP-dependent chromatin-assembly factor (ACF) uses the energy of ATP hydrolysis for the deposition of histones into periodic nucleosome arrays, and the ISWI subunit of ACF is an ATPase that is related to helicases(10,11). Here we show that ACF becomes committed to the DNA template upon initiation of chromatin assembly. We also observed that ACF assembles nucleosomes in localized arrays, rather than randomly distributing them. By using a purified ACF-dependent system for chromatin assembly, we found that ACF hydrolyses about 2-4 molecules of ATP per base pair in the assembly of nucleosomes. This level of ATP hydrolysis is similar to that used by DNA helicases for the unwinding of DNA(12). These results suggest that a tracking mechanism exists in which ACF assembles chromatin as an ATP-driven DNA-translocating motor. Moreover, this proposed mechanism for ACF may be relevant to the function of other chromatin-remodelling factors that contain ISWI subunits.	Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kadonaga, JT (corresponding author), Univ Calif San Diego, Mol Biol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.							Adams CR, 1999, CURR OPIN GENET DEV, V9, P185, DOI 10.1016/S0959-437X(99)80028-8; Cairns BR, 1998, TRENDS BIOCHEM SCI, V23, P20, DOI 10.1016/S0968-0004(97)01160-2; Eberharter A, 2001, EMBO J, V20, P3781, DOI 10.1093/emboj/20.14.3781; EGGLESTON AK, 1995, J BIOL CHEM, V270, P2024, DOI 10.1074/jbc.270.5.2024; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Flaus A, 2001, CURR OPIN GENET DEV, V11, P148, DOI 10.1016/S0959-437X(00)00172-6; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; Fyodorov DV, 2001, CELL, V106, P523, DOI 10.1016/S0092-8674(01)00478-0; GLIKIN GC, 1984, CELL, V37, P33, DOI 10.1016/0092-8674(84)90298-8; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; Havas K, 2000, CELL, V103, P1133, DOI 10.1016/S0092-8674(00)00215-4; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; KORNBERG RD, 1995, CURR OPIN CELL BIOL, V7, P371, DOI 10.1016/0955-0674(95)80092-1; Kornberg RD, 1999, CURR OPIN GENET DEV, V9, P148, DOI 10.1016/S0959-437X(99)80022-7; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Mello JA, 2001, CURR OPIN GENET DEV, V11, P136, DOI 10.1016/S0959-437X(00)00170-2; Pazin MJ, 1997, CELL, V88, P737, DOI 10.1016/S0092-8674(00)81918-2; RAMSPERGER U, 1995, EMBO J, V14, P3215, DOI 10.1002/j.1460-2075.1995.tb07324.x; STUDITSKY VM, 1995, CELL, V83, P19, DOI 10.1016/0092-8674(95)90230-9; Tsukiyama T, 1997, CURR OPIN GENET DEV, V7, P182, DOI 10.1016/S0959-437X(97)80127-X; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Verreault A, 2000, GENE DEV, V14, P1430; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506	28	71	71	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2002	418	6900					897	900		10.1038/nature00929	http://dx.doi.org/10.1038/nature00929			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192415				2022-12-28	WOS:000177555600043
J	Honaramooz, A; Snedaker, A; Boiani, M; Scholer, H; Dobrinski, I; Schlatt, S				Honaramooz, A; Snedaker, A; Boiani, M; Scholer, H; Dobrinski, I; Schlatt, S			Sperm from neonatal mammalian testes grafted in mice	NATURE			English	Article							GERM-CELL TRANSPLANTATION; MOUSE TESTES; ESTROGEN-RECEPTOR; SPERMATOGENESIS; RAT; SPERMATOZOA; OOCYTES; HOST	Spermatogenesis is a productive and highly organized process that generates virtually unlimited numbers of sperm during adulthood. Continuous proliferation and differentiation of germ cells occur in a delicate balance with other testicular compartments, especially the supporting Sertoli cells(1). Many complex aspects of testis function in humans and large animals have remained elusive because of a lack of suitable in vitro or in vivo models. Germ cell transplantation has produced complete donor-derived spermatogenesis in rodents(2-6) but not in other mammalian species(7-9). Production of sperm in grafted tissue from immature mammalian testes and across species has not yet been accomplished. Here we report the establishment of complete spermatogenesis by grafting testis tissue from newborn mice, pigs or goats into mouse hosts. This approach maintains structural integrity and provides the accessibility that is essential for studying and manipulating the function of testes and for preserving the male germ line. Our results indicate that this approach is applicable to diverse mammalian species.	Univ Penn, Sch Vet Med, New Bolton Ctr,Male Germ Cell Biol Grp, Ctr Anim Transgenesis & Germ Cell Res, Kennett Sq, PA 19348 USA; Univ Penn, Sch Vet Med, New Bolton Ctr,Germline Dev Grp, Ctr Anim Transgenesis & Germ Cell Res, Kennett Sq, PA 19348 USA; Univ Munster, Inst Reprod Med, D-48149 Munster, Germany	University of Pennsylvania; University of Pennsylvania; University of Munster	Dobrinski, I (corresponding author), Univ Penn, Sch Vet Med, New Bolton Ctr,Male Germ Cell Biol Grp, Ctr Anim Transgenesis & Germ Cell Res, Kennett Sq, PA 19348 USA.		Boiani, Michele/M-3519-2015; Dobrinski, Ina/A-1095-2007; , HS/AAB-4434-2019	Boiani, Michele/0000-0003-2765-2781; , HS/0000-0003-2643-5136; Schlatt, Stefan/0000-0002-7571-5313				Amann RP., 1970, TESTIS, V1, P433, DOI DOI 10.1016/B978-0-12-386601-1.50013-5; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; CHANDOLIA RK, 1991, ACTA ENDOCRINOL-COP, V125, P547, DOI 10.1530/acta.0.1250547; CHATOT CL, 1990, BIOL REPROD, V42, P432, DOI 10.1095/biolreprod42.3.432; Clouthier DE, 1996, NATURE, V381, P418, DOI 10.1038/381418a0; DEANESLY R, 1954, J ENDOCRINOL, V11, P201, DOI 10.1677/joe.0.0110201; Dobrinski I, 1999, BIOL REPROD, V61, P1331, DOI 10.1095/biolreprod61.5.1331; Dobrinski I, 2000, MOL REPROD DEV, V57, P270, DOI 10.1002/1098-2795(200011)57:3&lt;270::AID-MRD9&gt;3.0.CO;2-Z; Eddy EM, 1996, ENDOCRINOLOGY, V137, P4796, DOI 10.1210/en.137.11.4796; FRASER LR, 1975, BIOL REPROD, V13, P513, DOI 10.1095/biolreprod13.5.513; Goud PT, 1998, HUM REPROD, V13, P1336, DOI 10.1093/humrep/13.5.1336; Jiang FX, 1995, INT J ANDROL, V18, P326, DOI 10.1111/j.1365-2605.1995.tb00570.x; Johnson L, 1996, BIOL REPROD, V54, P948, DOI 10.1095/biolreprod54.5.948; KUOPIO T, 1989, J ANDROL, V10, P335; Lee KH, 2000, BIOL REPROD, V63, P1873, DOI 10.1095/biolreprod63.6.1873; McCarrey J, 1993, CELL MOL BIOL TESTIS, P58; Nagano M, 2001, BIOL REPROD, V64, P1409, DOI 10.1095/biolreprod64.5.1409; Ogawa T, 2000, NAT MED, V6, P29, DOI 10.1038/71496; Ogawa T, 1999, BIOL REPROD, V60, P515, DOI 10.1095/biolreprod60.2.515; Orth JM., 1993, CELL MOL BIOL TESTIS, P3; Russell LD, 1990, HISTOLOGICAL HISTOPA, P1; Schlatt S, 1999, HUM REPROD, V14, P144, DOI 10.1093/humrep/14.1.144; SCHLATT S, 2000, BR MED B, V56, P577; SWIERSTRA EE, 1968, J REPROD FERTIL, V17, P459, DOI 10.1530/jrf.0.0170459; SWIERSTRA EE, 1971, J REPROD FERTIL, V27, P91, DOI 10.1530/jrf.0.0270091; Wakayama T, 1998, J REPROD FERTIL, V112, P11, DOI 10.1530/jrf.0.1120011	27	312	351	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 15	2002	418	6899					778	781		10.1038/nature00918	http://dx.doi.org/10.1038/nature00918			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181567				2022-12-28	WOS:000177428000039
J	Michaelis, W; Seifert, R; Nauhaus, K; Treude, T; Thiel, V; Blumenberg, M; Knittel, K; Gieseke, A; Peterknecht, K; Pape, T; Boetius, A; Amann, R; Jorgensen, BB; Widdel, F; Peckmann, J; Pimenov, NV; Gulin, MB				Michaelis, W; Seifert, R; Nauhaus, K; Treude, T; Thiel, V; Blumenberg, M; Knittel, K; Gieseke, A; Peterknecht, K; Pape, T; Boetius, A; Amann, R; Jorgensen, BB; Widdel, F; Peckmann, J; Pimenov, NV; Gulin, MB			Microbial reefs in the Black Sea fueled by anaerobic oxidation of methane	SCIENCE			English	Article							SULFATE-REDUCING BACTERIA; WATER COLUMN; ARCHAEA; SEDIMENTS; COMMUNITIES; CONSORTIUM; CARBONATES; REDUCTION; DIETHERS; SEEPS	Massive microbial mats covering up to 4-meter-high carbonate buildups prosper at methane seeps in anoxic waters of the northwestern Black Sea shelf. Strong C-13 depletions indicate an incorporation of methane carbon into carbonates, bulk biomass, and specific lipids. The mats mainly consist of densely aggregated archaea ( phylogenetic ANME-1 cluster) and sulfate-reducing bacteria (Desulfosarcina/Desulfococcus group). If incubated in vitro, these mats perform anaerobic oxidation of methane coupled to sulfate reduction. Obviously, anaerobic microbial consortia can generate both carbonate precipitation and substantial biomass accumulation, which has implications for our understanding of carbon cycling during earlier periods of Earth's history.	Univ Hamburg, Inst Biogeochem & Marine Chem, D-20146 Hamburg, Germany; Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany; Int Univ Bremen, D-28725 Bremen, Germany; Univ Gottingen, Geowissensch Zentrum, D-37077 Gottingen, Germany; Russian Acad Sci, Inst Microbiol, Moscow 117811, Russia; Natl Acad Sci Ukraine, Inst Biol So Seas, Sevastopol, Ukraine	University of Hamburg; Max Planck Society; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Jacobs University; University of Gottingen; Research Center of Biotechnology RAS; Russian Academy of Sciences; National Academy of Sciences Ukraine; Russian Academy of Sciences; AO Kovalevsky Institute of Biology of the Southern Seas of RAS (IBSS)	Michaelis, W (corresponding author), Univ Hamburg, Inst Biogeochem & Marine Chem, Bundesstr 55, D-20146 Hamburg, Germany.	michaelis@geowiss.uni-hamburg.de	Treude, Tina/AAD-5817-2020; Pape, Thomas/A-8138-2018; Jorgensen, Bo B/C-2214-2013; Boetius, Antje/D-5459-2013; Gulin, Maksim/E-1233-2016; Amann, Rudolf I/C-6534-2014	Pape, Thomas/0000-0002-6872-2144; Jorgensen, Bo B/0000-0001-9398-8027; Boetius, Antje/0000-0003-2117-4176; Gulin, Maksim/0000-0002-3644-4362; Amann, Rudolf I/0000-0002-0846-7372; Treude, Tina/0000-0001-6366-286X; Peckmann, Jorn/0000-0002-8572-0060; Blumenberg, Martin/0000-0002-9791-8568; Pimenov, Nikolai/0000-0001-9757-0867; Thiel, Volker/0000-0003-4758-2784				Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Boetius A, 2000, DEEP-SEA RES PT II, V47, P2835, DOI 10.1016/S0967-0645(00)00051-5; Boetius A., 2002, OCEAN MARGIN SYSTEMS, P457, DOI [DOI 10.1007/978-3-662-05127-6_28, 10.1007/978-3-662-05127-6_28]; Elvert M, 1999, NATURWISSENSCHAFTEN, V86, P295, DOI 10.1007/s001140050619; Elvert M, 2000, ORG GEOCHEM, V31, P1175, DOI 10.1016/S0146-6380(00)00111-X; Elvert M., 2001, NATURAL GAS HYDRATES, P115, DOI [10.1029/GM124p0115, DOI 10.1029/GM124P0115]; FRY B, 1991, DEEP SEA RES S2, V38, P1013; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Hayes JM, 1994, NOBEL S, P220; Hinrichs KU, 2000, GEOCHEM GEOPHY GEOSY, V1; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; Hinrichs KU, 2000, ORG GEOCHEM, V31, P1685, DOI 10.1016/S0146-6380(00)00106-6; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; IVANOV MV, 1991, DOKL AKAD NAUK SSSR+, V320, P1235; IVERSEN N, 1981, APPL ENVIRON MICROB, V41, P1295, DOI 10.1128/AEM.41.6.1295-1300.1981; Jahnke LL, 2001, APPL ENVIRON MICROB, V67, P5179, DOI 10.1128/AEM.67.11.5179-5189.2001; King LL, 1998, ORG GEOCHEM, V28, P677, DOI 10.1016/S0146-6380(98)00037-0; Laniece P, 1998, J NEUROSCI METH, V86, P1, DOI 10.1016/S0165-0270(98)00128-9; LIEN AY, 2002, MICROBIOLOGY, V70, P78; Mojzsis SJ, 1996, NATURE, V384, P55, DOI 10.1038/384055a0; Nauhaus K, 2002, ENVIRON MICROBIOL, V4, P296, DOI 10.1046/j.1462-2920.2002.00299.x; ORPHAN V, 2002, P NATL ACAD SCI USA; Orphan VJ, 2002, P NATL ACAD SCI USA, V99, P7663, DOI 10.1073/pnas.072210299; Orphan VJ, 2001, SCIENCE, V293, P484, DOI 10.1126/science.1061338; Orphan VJ, 2001, APPL ENVIRON MICROB, V67, P1922, DOI 10.1128/AEM.67.4.1922-1934.2001; Pancost RD, 2000, APPL ENVIRON MICROB, V66, P1126, DOI 10.1128/AEM.66.3.1126-1132.2000; Pancost RD, 2001, ORG GEOCHEM, V32, P695, DOI 10.1016/S0146-6380(01)00015-8; Peckmann J, 2001, MAR GEOL, V177, P129, DOI 10.1016/S0025-3227(01)00128-1; Pimenov NV, 1997, MICROBIOLOGY+, V66, P354; Rutters H, 2001, ARCH MICROBIOL, V176, P435, DOI 10.1007/s002030100343; SCHOPF JW, 1993, SCIENCE, V260, P640, DOI 10.1126/science.260.5108.640; Schouten S, 1997, ORG GEOCHEM, V26, P409, DOI 10.1016/S0146-6380(97)00011-9; Schramm A, 1996, APPL ENVIRON MICROB, V62, P4641, DOI 10.1128/AEM.62.12.4641-4647.1996; Seifert R, 1999, BIOGEOCHEMISTRY, V44, P73, DOI 10.1007/BF00992999; Shen YA, 2001, NATURE, V410, P77, DOI 10.1038/35065071; SINNINGHE JS, 2000, CHEM COMMUN, V2000, P1683; Snaidr J, 1997, APPL ENVIRON MICROB, V63, P2884, DOI 10.1128/AEM.63.7.2884-2896.1997; TEIXIDOR P, 1992, J CHROMATOGR, V607, P253, DOI 10.1016/0021-9673(92)87083-K; Thiel V, 2001, ORG GEOCHEM, V32, P1019, DOI 10.1016/S0146-6380(01)00075-4; Thiel V, 1999, GEOCHIM COSMOCHIM AC, V63, P3959, DOI 10.1016/S0016-7037(99)00177-5; Thiel V, 2001, MAR CHEM, V73, P97, DOI 10.1016/S0304-4203(00)00099-2; Valentine DL, 2000, ENVIRON MICROBIOL, V2, P477, DOI 10.1046/j.1462-2920.2000.00135.x	42	531	590	5	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 9	2002	297	5583					1013	1015		10.1126/science.1072502	http://dx.doi.org/10.1126/science.1072502			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169733				2022-12-28	WOS:000177325400044
J	Davies, PCW; Davis, TM; Lineweaver, CH				Davies, PCW; Davis, TM; Lineweaver, CH			Cosmology - Black holes constrain varying constants	NATURE			English	Article							FINE-STRUCTURE CONSTANT		Macquarie Univ, Australian Ctr Astrobiol, Sydney, NSW 2109, Australia; Univ New S Wales, Dept Astrophys, Sydney, NSW 2052, Australia	Macquarie University; University of New South Wales Sydney	Davies, PCW (corresponding author), Macquarie Univ, Australian Ctr Astrobiol, Sydney, NSW 2109, Australia.	pdavies@els.mq.edu.au	Davis, Tamara/A-4280-2008	Davis, Tamara/0000-0002-4213-8783; Lineweaver, Charles/0000-0003-2047-1558				Barrow JD, 1999, PHYS REV D, V59, DOI 10.1103/PhysRevD.59.043515; Barrow JD, 1998, PHYS LETT B, V443, P104, DOI 10.1016/S0370-2693(98)01294-5; BEKENSTEIN JD, 1982, PHYS REV D, V25, P1527, DOI 10.1103/PhysRevD.25.1527; HAWKING SW, 1976, PHYS REV D, V13, P191, DOI 10.1103/PhysRevD.13.191; Magueijo J, 2001, PHYS REV D, V63, DOI 10.1103/PhysRevD.63.043502; Magueijo J, 2000, PHYS REV D, V62, DOI 10.1103/PhysRevD.62.103521; Murphy MT, 2001, MON NOT R ASTRON SOC, V327, P1208, DOI 10.1046/j.1365-8711.2001.04840.x; Penrose R., 1969, Rivista del Nuovo Cimento, V1, P252, DOI 10.1023/A:1016578408204; Sandvik HB, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.031302; Songaila A, 1999, NATURE, V398, P667, DOI 10.1038/19426; Webb JK, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.091301; Webb JK, 1999, PHYS REV LETT, V82, P884, DOI 10.1103/PhysRevLett.82.884	13	50	53	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2002	418	6898					602	603		10.1038/418602a	http://dx.doi.org/10.1038/418602a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167848				2022-12-28	WOS:000177305600029
J	Rowland, LP				Rowland, LP			Stroke, spasticity, and botulinum toxin	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Columbia Presbyterian Med Ctr, New York, NY 10032 USA	Columbia University; NewYork-Presbyterian Hospital	Rowland, LP (corresponding author), Columbia Presbyterian Med Ctr, New York, NY 10032 USA.		Taylor, Graham/A-4027-2012						0	17	20	1	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 8	2002	347	6					382	383		10.1056/NEJMp020071	http://dx.doi.org/10.1056/NEJMp020071			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587YR	12167679				2022-12-28	WOS:000177672400001
J	Hynes, M; Sheik, M; Wilson, HG; Spiegel, P				Hynes, M; Sheik, M; Wilson, HG; Spiegel, P			Reproductive health indicators and outcomes among refugee and internally displaced persons in postemergency phase camps	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NUTRITIONAL-STATUS; PUBLIC-HEALTH; MORTALITY; CONFLICT; INTERVENTIONS; POPULATIONS; CHILDHOOD; GUINEA	Context Despite increasing awareness of the importance of reproductive health programs and services for refugee and internally displaced populations, there is a paucity of basic epidemiological data on reproductive health outcomes. Objectives To collect data on reproductive health outcomes among refugees and internally displaced persons in postemergency phase camps and compare these outcomes with those of host country and country-of-origin populations. To determine programmatic factors that may affect reproductive health outcomes. Design, Setting, and Participants Retrospective study of data collected from August 1998 through March 2000 of 688766 persons living in 52 postemergency phase camps in 7 countries. Reproductive health outcomes of refugee and internally displaced populations were compared with available data of reference populations within their respective host country and country of origin. Main Outcome Measures Crude birth rate (CBR), neonatal mortality rate (NNMR), maternal mortality ratio (MMR), percentage of newborns with low birth weight (LBW), and incidence of complications of unsafe or spontaneous abortions. Results Six of 11 groups had lower CBRs than their country of origin and 5 of 9 groups had lower CBRs than their host country. Four of 5 had lower NNMRs than their country of origin and 6 of 9 had lower NNMRs than the host country. Four of 6 had lower MMRs than their country of origin, and 5 of 6 had lower MMRs than their host country. Seven of 9 had lower percentages of LBWs than in the country of origin and 5 of 9 had lower percentages of LBWs than the host country. Higher CBRs were associated with more recently established camps and higher numbers of local health staff per 1000 persons; and higher percentages of LBW newborns were associated with rainy season, more recently established camps, lower numbers of community health workers per 1000 persons, and camps without supplementary feeding-programs. Conclusions Refugees and internally displaced persons inmost postemergency phase camps had better reproductive health outcomes than their respective host country and country-of-origin populations.	Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis, Atlanta, GA 30341 USA; Ctr Dis Control & Prevent, Int Emergency & Refugee Hlth Branch, Div Emergency & Environm Hlth Serv, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA; Johns Hopkins Sch Publ Hlth, Ctr Refugee & Disaster Studies, Baltimore, MD USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Hynes, M (corresponding author), Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis, Mailstop K-22,2900 Woodcock Blvd, Atlanta, GA 30341 USA.	mhynes@cdc.gov	Spiegel, Paul/AAL-3238-2021	Spiegel, Paul/0000-0002-6158-6661; Hynes, Michelle/0000-0002-2204-6531				Aaby P, 1999, BRIT MED J, V319, P878, DOI 10.1136/bmj.319.7214.878; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Banatvala N, 2000, BMJ-BRIT MED J, V321, P101, DOI 10.1136/bmj.321.7253.101; Becker S, 1998, INT J EPIDEMIOL, V27, P814, DOI 10.1093/ije/27.5.814; BOSS LP, 1987, INT J EPIDEMIOL, V16, P556, DOI 10.1093/ije/16.4.556; CANTRELLE P, 1971, POP STUD-J DEMOG, V25, P505, DOI 10.1080/00324728.1971.10405821; Ceesay SM, 1997, BMJ-BRIT MED J, V315, P786, DOI 10.1136/bmj.315.7111.786; Dorman EK, 2002, ULTRASOUND OBST GYN, V19, P165, DOI 10.1046/j.0960-7692.2001.00545.x; ELIAS CJ, 1990, AM J PUBLIC HEALTH, V80, P824, DOI 10.2105/AJPH.80.7.824; GUYATT H, 1995, T R SOC TROP MED HYG, V6, P569; Hoa DP, 1996, ANN TROP PAEDIATR, V16, P327, DOI 10.1080/02724936.1996.11747845; *MACR INT INC, 1997, TANZ DEM HLTH SURV; *MACR INT INC, 1997, MAT HLTH CAR; *MACR INT INC, 1996, UG DEM HLTH SURV 199; *MACR INT INC, 1994, ENQ DEM SANT RWAND; MAINE D, 1999, SAFE MOTHERHOOD INIT; McGinn T, 2000, INT FAM PLAN PERSPEC, V26, P174, DOI 10.2307/2648255; MCGINN T, 1998, EFFECT MAT CALORIE S; MERCER A, 1992, DISASTERS, V16, P28, DOI 10.1111/j.1467-7717.1992.tb00373.x; Palmer CA, 1999, SOC SCI MED, V49, P1689, DOI 10.1016/S0277-9536(99)00253-1; Pitt MarkM., 1998, SEASONALITY WEATHER; PRADHAN A, 1996, NEPAL FAMILY HLTH SU; Sachs L, 1997, Afr Health, V19, P24; SPIEGEL P, IN PRESS LANCET; SPIEGEL P, 2000, REFUGE, V18, P1; Spiegel PB, 2001, DISASTERS, V25, P172, DOI 10.1111/1467-7717.00169; *STEER COMM HUM RE, 1998, SPHER HUM CHART MIN; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; TOOLE MJ, 1990, JAMA-J AM MED ASSOC, V263, P3296, DOI 10.1001/jama.263.24.3296; *UN CHILDR FUND, 2000, STAT WORLDS CHILDR; *UN HIGH COMM REF, 1999, REPR HLTH REF SIT IN; *UN HIGH COMM REF, 1998, REPR HLTH REF SIT RE; UN. High Commission for Refugees, 1999, HDB EM; US Committee for Refugees, 2002, WORLD REF SURV 2002; *US STAT DIV, 2000, IND HLTH; Van Damme W, 1998, LANCET, V351, P1609, DOI 10.1016/S0140-6736(97)10348-8; Waldman R, 1999, AM J PUBLIC HEALTH, V89, P1483, DOI 10.2105/AJPH.89.10.1483; *WHO, 2000, BAS HLTH IND COUNTR; *WHO, 1998, SAF MOTH INF KIT; WHO, 2000, MAN NUTR MAJ EM, V2nd, P236; WHO UNICEF UNFPA, 1997, GUID MON AV US OBST; Wulf D, 1994, REFUGEE WOMEN REPROD	42	64	64	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	2002	288	5					595	603		10.1001/jama.288.5.595	http://dx.doi.org/10.1001/jama.288.5.595			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	581FJ	12150671	Bronze			2022-12-28	WOS:000177280200018
J	Little, P; Barnett, J; Barnsley, L; Marjoram, J; Fitzgerald-Barron, A; Mant, D				Little, P; Barnett, J; Barnsley, L; Marjoram, J; Fitzgerald-Barron, A; Mant, D			Comparison of agreement between different measures of blood pressure in primary care and daytime ambulatory blood pressure	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WHITE-COAT HYPERTENSION; MANAGEMENT; NURSE; HOME	Objective To assess alternatives to measuring ambulatory pressure, which best predicts response to treatment and adverse outcome. Setting Three general practices in England. Design Validation study. Participants Patients with newly diagnosed high or borderline high blood pressure; patients receiving treatment for hypertension but with poor control. Main outcome measures Overall agreement with ambulatory pressure; prediction of high ambulatory pressure (> 135/85 mm Hg) and treatment thresholds. Results Readings made by doctors were much higher than ambulatory systolic pressure (difference 18.9 mm Hg, 95% confidence interval 16.1 to 21.7), as were recent readings made in the clinic outside research settings (19.9 mm Hg,17.6 to 22.1). This applied equally to treated patients with poor control (doctor v ambulatory 21.4 mm Hg, 17.3 to 25.4). Doctors' and recent clinic readings ranked systolic pressure poorly compared with ambulatory pressure and other measurements (doctor r=0.46; clinic 0.47; repeated readings by nurse 0.60; repeated self measurement 0.73; home readings 0.75) and were not specific at predicting high blood pressure (doctor 26%; recent clinic 15%; nurse 72%; patient in surgery 81%; home 60%), with poor likelihood ratios for a positive test (doctor 1.2; clinic 1.1; nurse 2.1, patient in surgery 4.7; home 2.2). Nor were doctor or recent clinic measures specific in predicting treatment thresholds. Conclusion The "white coat" effect is important in diagnosing and assessing control of hypertension in primary care and is not a research artefact. If ambulatory or home measurements are not available, repeated measurements by the nurse or patient should result in considerably less unnecessary monitoring, initiation, or changing of treatment. It is time to stop using high blood pressure readings documented by general practitioners to make treatment decisions.	Univ Southampton, Aldermoor Hlth Ctr, Fac Med Hlth & Biol Sci, Community Clin Sci Div,Primary Med Care Grp, Southampton SO16 5ST, Hants, England; Nightingale Surg, Romsey SO51 7QN, Hants, England; St Clements Surg, Winchester SO23 8AD, Hants, England	University of Southampton	Little, P (corresponding author), Univ Southampton, Aldermoor Hlth Ctr, Fac Med Hlth & Biol Sci, Community Clin Sci Div,Primary Med Care Grp, Southampton SO16 5ST, Hants, England.	psl3@soton.ac.uk	Mant, David CA/C-7763-2009	Little, Paul/0000-0003-3664-1873				[Anonymous], 1981, LANCET, V2, P539; Aylett M, 1999, BRIT J GEN PRACT, V49, P725; AYLETT MJ, 1994, FAM PRACT, V11, P197, DOI 10.1093/fampra/11.2.197; Brueren MM, 1998, BRIT J GEN PRACT, V48, P1585; COX JP, 1992, BRIT J GEN PRACT, V42, P402; FAGARD R, 1995, AM J HYPERTENS, V8, P533, DOI 10.1016/0895-7061(95)00043-O; FINNERTY FA, 1981, JAMA-J AM MED ASSOC, V246, P2593, DOI 10.1001/jama.246.22.2593; IMAI Y, 1992, AM J HYPERTENS, V5, P719, DOI 10.1093/ajh/5.10.719; JAMES GD, 1988, HYPERTENSION, V11, P545, DOI 10.1161/01.HYP.11.6.545; JAMIESON MJ, 1990, J HYPERTENS, V8, P377, DOI 10.1097/00004872-199004000-00012; MARTEAU TM, 1990, BRIT MED J, V301, P26, DOI 10.1136/bmj.301.6742.26; McGrath BP, 1996, LANCET, V348, P630, DOI 10.1016/S0140-6736(05)65069-6; Muscholl MW, 1998, BMJ-BRIT MED J, V317, P565, DOI 10.1136/bmj.317.7158.565; O'Brien, 1996, Blood Press Monit, V1, P55; O'Brien E, 2000, BMJ-BRIT MED J, V320, P1128, DOI 10.1136/bmj.320.7242.1128; O'Rorke JE, 2001, BRIT MED J, V322, P1229, DOI 10.1136/bmj.322.7296.1229; Pickering T G, 1999, Blood Press Monit, V4 Suppl 2, pS3; Pickering T G, 2000, Curr Hypertens Rep, V2, P558, DOI 10.1007/s11906-996-0041-8; PICKERING TG, 1994, LANCET, V344, P31; Prasad N, 1996, BRIT MED J, V313, P1535, DOI 10.1136/bmj.313.7071.1535; Ramsay LE, 1999, J HUM HYPERTENS, V13, P569, DOI 10.1038/sj.jhh.1000917; Staessen JA, 1997, JAMA-J AM MED ASSOC, V278, P1065, DOI 10.1001/jama.278.13.1065; VEERMAN DP, 1993, J HYPERTENS, V11, P287, DOI 10.1097/00004872-199303000-00009; Veerman DP, 1996, J HUM HYPERTENS, V10, P9	24	121	123	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2002	325	7358					254	257		10.1136/bmj.325.7358.254	http://dx.doi.org/10.1136/bmj.325.7358.254			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582FL	12153923	Green Published, Bronze			2022-12-28	WOS:000177339000020
J	Kohler, E; Keysers, C; Umilta, MA; Fogassi, L; Gallese, V; Rizzolatti, G				Kohler, E; Keysers, C; Umilta, MA; Fogassi, L; Gallese, V; Rizzolatti, G			Hearing sounds, understanding actions: Action representation in mirror neurons	SCIENCE			English	Article							PREMOTOR CORTEX; PERIARCUATE NEURONS; AFFERENT PROPERTIES; MACAQUE MONKEYS; AREA; RECOGNITION; MOVEMENTS; RESPONSES; SPACE	Many object-related actions can be recognized by their sound. We found neurons in monkey premotor cortex that discharge when the animal performs a specific action and when it hears the related sound. Most of the neurons also discharge when the monkey observes the same action. These audiovisual mirror neurons code actions independently of whether these actions are performed, heard, or seen. This discovery in the monkey homolog of Broca's area might shed light on the origin of language: audiovisual mirror neurons code abstract contents - the meaning of actions - and have the auditory access typical of human language to these contents.	Univ Parma, Ist Fisiol Umana, I-43100 Parma, Italy; Univ Parma, Dipartimento Psicol, I-43100 Parma, Italy	University of Parma; University of Parma	Rizzolatti, G (corresponding author), Univ Parma, Ist Fisiol Umana, I-43100 Parma, Italy.		Keysers, Christian/H-6251-2013; Gallese, Vittorio/ABD-5097-2021; Galantucci, Bruno/E-5770-2010; FOGASSI, Leonardo/K-3541-2018	Keysers, Christian/0000-0002-2845-5467; Gallese, Vittorio/0000-0003-4815-3607; FOGASSI, Leonardo/0000-0003-3348-039X; Umilta', Maria Alessandra/0000-0003-0180-6818				BACH M, 1983, J NEUROSCI METH, V9, P9, DOI 10.1016/0165-0270(83)90103-6; BAYLIS GC, 1987, J NEUROSCI, V7, P330; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; Cantalupo C, 2001, NATURE, V414, P505, DOI 10.1038/35107134; Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; Fogassi L, 2001, BRAIN, V124, P571, DOI 10.1093/brain/124.3.571; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; GENTILUCCI M, 1988, EXP BRAIN RES, V71, P475, DOI 10.1007/BF00248741; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; MISTLIN AJ, 1990, EXP BRAIN RES, V82, P437; Petrides M., 1994, HDB NEUROPSYCHOLOGY, V9, P17; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P147, DOI 10.1016/0166-4328(81)90053-X; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P125, DOI 10.1016/0166-4328(81)90052-8; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G., 1988, NEUROBIOLOGY NEOCORT, P269; Stein BE, 2001, PROG BRAIN RES, V134, P143; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3	20	1150	1195	4	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2002	297	5582					846	848		10.1126/science.1070311	http://dx.doi.org/10.1126/science.1070311			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161656				2022-12-28	WOS:000177192800054
J	Wasch, R; Cross, FR				Wasch, R; Cross, FR			APC-dependent proteolysis of the mitotic cyclin Clb2 is essential for mitotic exit	NATURE			English	Article							ANAPHASE-PROMOTING COMPLEX; S-PHASE; SACCHAROMYCES-CEREVISIAE; MEDIATED PROTEOLYSIS; PHOSPHATASE CDC14; BUDDING YEAST; HCT1; PHOSPHORYLATION; MITOSIS; FIZZY	Cyclin degradation is central to regulation of the cell cycle. Mitotic exit was proposed to require degradation of the S phase cyclin Clb5 by the anaphase-promoting complex 1,2 activated by Cdc20 (APC(Cdc20))(3). Furthermore, Clb5 degradation was thought to be necessary for effective dephosphorylation and activation of the APC regulatory subunit Cdh1 (also known as Hct1) and the cyclin-dependent kinase inhibitor Sic1 by the phosphatase Cdc14, allowing mitotic kinase inactivation and mitotic exit(3-7). Here we show, however, that spindle disassembly and cell division occur without significant APC Cdc20-mediated Clb5 degradation, as well as in the absence of both Cdh1 and Sic1. We find instead that destruction-box-dependent degradation of the mitotic cyclin Clb2 is essential for mitotic exit. APC Cdc20 may be required for an essential early phase of Clb2 degradation, and this phase may be sufficient for most aspects of mitotic exit. Cdh1 and Sic1 may be required for further inactivation of Clb2-Cdk1, regulating cell size and the length of G1.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Cross, FR (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.		Waesch, Ralph/F-6282-2019					Calzada A, 2001, NATURE, V412, P355, DOI 10.1038/35085610; Cross FR, 1999, MOL CELL, V4, P11, DOI 10.1016/S1097-2765(00)80183-5; Gieffers C, 1999, P NATL ACAD SCI USA, V96, P11317, DOI 10.1073/pnas.96.20.11317; HOGAN E, 1992, P NATL ACAD SCI USA, V89, P3098, DOI 10.1073/pnas.89.7.3098; Huang JN, 2001, J CELL BIOL, V154, P85, DOI 10.1083/jcb.200102007; Jacobson MD, 2000, MOL CELL BIOL, V20, P4483, DOI 10.1128/MCB.20.13.4483-4493.2000; Jaspersen SL, 2000, CURR BIOL, V10, P615, DOI 10.1016/S0960-9822(00)00491-7; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Lim HH, 1998, CURR BIOL, V8, P231, DOI 10.1016/S0960-9822(98)70088-0; Lorca T, 1998, EMBO J, V17, P3565, DOI 10.1093/emboj/17.13.3565; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; Noton E, 2000, MOL CELL, V5, P85, DOI 10.1016/S1097-2765(00)80405-0; Oehlen LJWM, 1996, MOL CELL BIOL, V16, P2830; Pfleger CM, 2000, GENE DEV, V14, P655; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Sigrist SJ, 1997, CELL, V90, P671, DOI 10.1016/S0092-8674(00)80528-0; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Yamaguchi S, 2000, EMBO J, V19, P3968, DOI 10.1093/emboj/19.15.3968; Yeong FM, 2000, MOL CELL, V5, P501, DOI 10.1016/S1097-2765(00)80444-X; Yeong FM, 2001, MOL CELL BIOL, V21, P5071, DOI 10.1128/MCB.21.15.5071-5081.2001; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721	30	185	186	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2002	418	6897					556	562		10.1038/nature00856	http://dx.doi.org/10.1038/nature00856			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152084				2022-12-28	WOS:000177162800046
J	Bland-Hawthorn, J; Harwit, A; Harwit, M				Bland-Hawthorn, J; Harwit, A; Harwit, M			Astronomy - Laser telemetry from space	SCIENCE			English	Editorial Material									Anglo Australian Observ, Epping, NSW 2121, Australia; Transparent Networks, Milpitas, CA 95035 USA; Cornell Univ, Ithaca, NY USA	Cornell University	Harwit, M (corresponding author), 511 H St SW, Washington, DC 20024 USA.		bland-hawthorn, joss/ABE-7646-2020	bland-hawthorn, joss/0000-0001-7516-4016				BECKER PC, 1999, ERBIUM DOPED FIBER A; KARTALOPOULOS SV, 2000, FAULT DETECTABILITY; MECHERLE GS, 2001, P SPIE, V4272; *NAT RES COUNC, 2001, ASTR ASTR NEW MILL, P46; Starck JL, 1999, ASTRON ASTROPHYS SUP, V138, P365, DOI 10.1051/aas:1999281	5	9	9	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2002	297	5581					523	523		10.1126/science.1074113	http://dx.doi.org/10.1126/science.1074113			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142515				2022-12-28	WOS:000177054200025
J	Blumberg, G; Littlewood, P; Gozar, A; Dennis, BS; Motoyama, N; Eisaki, H; Uchida, S				Blumberg, G; Littlewood, P; Gozar, A; Dennis, BS; Motoyama, N; Eisaki, H; Uchida, S			Sliding density wave in Sr14Cu24O41 ladder compounds	SCIENCE			English	Article							DIELECTRIC RESPONSE; SUPERCONDUCTIVITY; SPIN; HOLE; SR14-XCAXCU24O41; SPECTROSCOPY; CONDUCTIVITY; TRANSPORT; K0.3MOO3; DYNAMICS	We used transport and Raman scattering measurements to identify the insulating state of self-doped spin 1/2 two-leg ladders of Sr14Cu24O41 as a weakly pinned, sliding density wave with nonlinear conductivity and a giant dielectric response that persists to remarkably high temperatures.	Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA; Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; Univ Tokyo, Bunkyo Ku, Tokyo 113, Japan; Stanford Univ, Stanford, CA 94305 USA	Alcatel-Lucent; Lucent Technologies; AT&T; University of Cambridge; University of Tokyo; Stanford University	Blumberg, G (corresponding author), Bell Labs, Lucent Technol, 600 Mt Ave, Murray Hill, NJ 07974 USA.		Eisaki, Hiroshi/F-6317-2018; Littlewood, Peter/M-4960-2019; Littlewood, Peter B/B-7746-2008	Eisaki, Hiroshi/0000-0002-8299-6416; Blumberg, Girsh/0000-0003-0388-8327				ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; CAVA RJ, 1986, PHYS REV B, V33, P2439, DOI 10.1103/PhysRevB.33.2439; CAVA RJ, 1984, PHYS REV B, V30, P3228, DOI 10.1103/PhysRevB.30.3228; DAGOTTO E, 1992, PHYS REV B, V45, P5744, DOI 10.1103/PhysRevB.45.5744; Dagotto E, 1996, SCIENCE, V271, P618, DOI 10.1126/science.271.5249.618; DEGIORGI L, 1991, PHYS REV B, V44, P7808, DOI 10.1103/PhysRevB.44.7808; Eisaki H, 2000, PHYSICA C, V341, P363, DOI 10.1016/S0921-4534(00)00512-8; FROHLICH H, 1954, PROC R SOC LON SER-A, V223, P296, DOI 10.1098/rspa.1954.0116; Gozar A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.197202; GRUNER G, 1980, PHYS REV LETT, V45, P935, DOI 10.1103/PhysRevLett.45.935; Gruner G., 1994, DENSITY WAVES SOLIDS; Havriliak S, 1966, J POLYMER SCI      C, V14, P99, DOI DOI 10.1002/POLC.5070140111; Kitano H, 2001, EUROPHYS LETT, V56, P434, DOI 10.1209/epl/i2001-00537-2; LITTLEWOOD PB, 1988, SOLID STATE COMMUN, V65, P1347, DOI 10.1016/0038-1098(88)90090-7; LITTLEWOOD PB, 1987, PHYS REV B, V36, P3108, DOI 10.1103/PhysRevB.36.3108; MCCARRON EM, 1988, MATER RES BULL, V23, P1355, DOI 10.1016/0025-5408(88)90124-9; MCELFRESH MW, 1989, PHYS REV B, V40, P825, DOI 10.1103/PhysRevB.40.825; Motoyama N, 1997, PHYS REV B, V55, pR3386, DOI 10.1103/PhysRevB.55.R3386; Osafune T, 1997, PHYS REV LETT, V78, P1980, DOI 10.1103/PhysRevLett.78.1980; Sachdev S, 2000, SCIENCE, V288, P475, DOI 10.1126/science.288.5465.475; SIEGRIST T, 1988, MATER RES BULL, V23, P1429, DOI 10.1016/0025-5408(88)90268-1; SIGRIST M, 1994, PHYS REV B, V49, P12058, DOI 10.1103/PhysRevB.49.12058; Takigawa M, 1998, PHYS REV B, V57, P1124, DOI 10.1103/PhysRevB.57.1124; Troyer M, 1996, PHYS REV B, V53, P251, DOI 10.1103/PhysRevB.53.251; Uehara M, 1996, J PHYS SOC JPN, V65, P2764, DOI 10.1143/JPSJ.65.2764; White SR, 1997, PHYS REV B, V55, P6504, DOI 10.1103/PhysRevB.55.6504; WU W, 1984, PHYS REV LETT, V52, P2382, DOI 10.1103/PhysRevLett.52.2382; ZETTL A, 1982, PHYS REV B, V26, P5760, DOI 10.1103/PhysRevB.26.5760	29	100	104	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2002	297	5581					584	587		10.1126/science.1070481	http://dx.doi.org/10.1126/science.1070481			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142532	Green Submitted			2022-12-28	WOS:000177054200045
J	Boube, M; Joulia, L; Cribbs, DL; Bourbon, HM				Boube, M; Joulia, L; Cribbs, DL; Bourbon, HM			Evidence for a mediator of RNA polymerase II transcriptional regulation conserved from yeast to man	CELL			English	Review							TATA-BINDING PROTEIN; DROSOPHILA HOMOLOGS; COMPLEX SUBUNITS; GENE; ACTIVATOR; EXPRESSION; HOLOENZYME; CELL; ORGANIZATION; REQUIREMENT	Mediator complexes (MED) link transcriptional regulators to RNA polymerase II. Here, we summarize the latest advances on the functional organization of yeast Mediator. We argue for the existence of a "universal" Mediator structurally conserved from yeast to man, based on an extensive analysis of sequence databases. Finally, we examine the implications of these observations for the physiological roles of metazoan MED subunits.	Univ Toulouse 3, Ctr Dev Biol, F-31062 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Bourbon, HM (corresponding author), Univ Toulouse 3, Ctr Dev Biol, F-31062 Toulouse, France.	bourbon@cict.fr						Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; BARBERIS A, 1995, CELL, V81, P359, DOI 10.1016/0092-8674(95)90389-5; Bhoite LT, 2001, GENE DEV, V15, P2457, DOI 10.1101/gad.921601; Bjorklund S, 2001, MOL CELLS, V11, P129; Boube M, 2000, GENE DEV, V14, P2906, DOI 10.1101/gad.17900; Boyer TG, 1999, NATURE, V399, P276, DOI 10.1038/20466; Carlson M, 1997, ANNU REV CELL DEV BI, V13, P1, DOI 10.1146/annurev.cellbio.13.1.1; CROWLEY TE, 1993, NATURE, V361, P557, DOI 10.1038/361557a0; Dotson MR, 2000, P NATL ACAD SCI USA, V97, P14307, DOI 10.1073/pnas.260489497; FLANAGAN PM, 1991, NATURE, V350, P436, DOI 10.1038/350436a0; GARSON K, 1995, GENOMICS, V30, P163, DOI 10.1006/geno.1995.9889; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; Gim BS, 2001, MOL CELL BIOL, V21, P5242, DOI 10.1128/MCB.21.15.5242-5255.2001; Gu JY, 2002, J BIOL CHEM, V277, P27154, DOI 10.1074/jbc.M204144200; Gustafsson CM, 2001, MOL MICROBIOL, V41, P1, DOI 10.1046/j.1365-2958.2001.02481.x; Han SJ, 1999, MOL CELL BIOL, V19, P979; Han SJ, 2001, J BIOL CHEM, V276, P37020, DOI 10.1074/jbc.M105596200; Hengartner CJ, 1998, MOL CELL, V2, P43, DOI 10.1016/S1097-2765(00)80112-4; HENGARTNER CJ, 1995, GENE DEV, V9, P897, DOI 10.1101/gad.9.8.897; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Ito M, 2000, MOL CELL, V5, P683, DOI 10.1016/S1097-2765(00)80247-6; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kang JS, 2001, J BIOL CHEM, V276, P42003, DOI 10.1074/jbc.M105961200; KELLEHER RJ, 1990, CELL, V61, P1209, DOI 10.1016/0092-8674(90)90685-8; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; KOLESKE AJ, 1994, NATURE, V368, P466, DOI 10.1038/368466a0; Kon T, 2000, GENES CELLS, V5, P43, DOI 10.1046/j.1365-2443.2000.00305.x; Kornberg Roger D., 1999, Trends in Cell Biology, V9, pM46, DOI 10.1016/S0962-8924(99)01679-7; Kwon JY, 1999, P NATL ACAD SCI USA, V96, P14990, DOI 10.1073/pnas.96.26.14990; Kwon JY, 2001, DEVELOPMENT, V128, P3095; Kwon JY, 2001, FEBS LETT, V508, P305, DOI 10.1016/S0014-5793(01)03072-1; Lee DH, 2000, DATA KNOWL ENG, V34, P77, DOI 10.1016/S0169-023X(00)00009-4; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; LI Y, 1995, P NATL ACAD SCI USA, V92, P10864, DOI 10.1073/pnas.92.24.10864; Malik S, 2000, MOL CELL, V5, P753, DOI 10.1016/S1097-2765(00)80254-3; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Mittler G, 2001, EMBO REP, V2, P808, DOI 10.1093/embo-reports/kve186; Myers LC, 1999, P NATL ACAD SCI USA, V96, P67, DOI 10.1073/pnas.96.1.67; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; Naar AM, 2002, GENE DEV, V16, P1339, DOI 10.1101/gad.987602; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Park JM, 2001, MOL CELL BIOL, V21, P2312, DOI 10.1128/MCB.21.7.2312-2323.2001; Rachez C, 2001, CURR OPIN CELL BIOL, V13, P274, DOI 10.1016/S0955-0674(00)00209-X; Sakurai H, 2000, J BIOL CHEM, V275, P37251, DOI 10.1074/jbc.M004364200; SINGH N, 1995, GENE DEV, V9, P2251, DOI 10.1101/gad.9.18.2251; Spahr H, 2000, J BIOL CHEM, V275, P1351, DOI 10.1074/jbc.275.2.1351; Spahr H, 2001, P NATL ACAD SCI USA, V98, P11985, DOI 10.1073/pnas.211253898; Stevens JL, 2002, SCIENCE, V296, P755, DOI 10.1126/science.1068943; Taatjes DJ, 2002, SCIENCE, V295, P1058, DOI 10.1126/science.1065249; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; Treisman JE, 2001, DEVELOPMENT, V128, P603; Tudor M, 1999, GENE DEV, V13, P2365, DOI 10.1101/gad.13.18.2365; Wang G, 2001, MOL CELL BIOL, V21, P4604, DOI 10.1128/MCB.21.14.4604-4613.2001; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3; Zhang H, 2000, GENE DEV, V14, P2161, DOI 10.1101/gad.814700; Zhang H, 2001, DEVELOPMENT, V128, P767	58	201	211	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 26	2002	110	2					143	151		10.1016/S0092-8674(02)00830-9	http://dx.doi.org/10.1016/S0092-8674(02)00830-9			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	578EV	12150923	Bronze			2022-12-28	WOS:000177105200003
J	Nasmyth, K				Nasmyth, K			Segregating sister genomes: The molecular biology of chromosome separation	SCIENCE			English	Review							COHESIN SUBUNIT SCC1; CHROMATID SEPARATION; BUDDING YEAST; FISSION YEAST; MEIOSIS-I; PRECOCIOUS SEPARATION; PROTEIN COMPLEXES; XENOPUS OOCYTES; 13S CONDENSIN; HUMAN-CELLS	During cell division, each daughter cell inherits one copy of every chromosome. Accurate transmission of chromosomes requires that the sister DNA molecules created during DNA replication are disentangled and then pulled to opposite poles of the cell before division. Defects in chromosome segregation produce cells that are aneuploid ( containing an abnormal number of chromosomes)-a situation that can have dire consequences. Aneuploidy is a leading cause of spontaneous miscarriages in humans and is also a hallmark of many human cancer cells. Recent work with yeast, Xenopus, and other model systems has provided new information about the proteins that control chromosome segregation during cell division and how the activities of these proteins are coordinated with the cell cycle.	Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Nasmyth, K (corresponding author), Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.			Nasmyth, Kim/0000-0001-7030-4403				Alexandru G, 1999, EMBO J, V18, P2707, DOI 10.1093/emboj/18.10.2707; Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Allshire R, 2001, CURR BIOL, V11, pR454, DOI 10.1016/S0960-9822(01)00278-0; [Anonymous], 1163, COMMUNICATION; Aravind L, 2002, PROTEINS, V46, P355, DOI 10.1002/prot.10060; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Bhalla N, 2002, MOL BIOL CELL, V13, P632, DOI 10.1091/mbc.01-05-0264; Bhat MA, 1996, CELL, V87, P1103, DOI 10.1016/S0092-8674(00)81804-8; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; BIRKENBIHL RP, 1995, J BIOL CHEM, V270, P7703, DOI 10.1074/jbc.270.13.7703; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; FLEMMING W, 1879, ARCH MIKROSK ANAT, V18, P151; Fraschini R, 2001, EMBO J, V20, P6648, DOI 10.1093/emboj/20.23.6648; Funabiki H, 1996, EMBO J, V15, P6617, DOI 10.1002/j.1460-2075.1996.tb01052.x; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; GRUBER S, UNPUB; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hagstrom KA, 2002, GENE DEV, V16, P729, DOI 10.1101/gad.968302; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; Hiraga S, 2000, ANNU REV GENET, V34, P21, DOI 10.1146/annurev.genet.34.1.21; Hirano M, 2001, EMBO J, V20, P3238, DOI 10.1093/emboj/20.12.3238; Hirano T, 2000, ANNU REV BIOCHEM, V69, P115, DOI 10.1146/annurev.biochem.69.1.115; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; Holmes VF, 2000, P NATL ACAD SCI USA, V97, P1322, DOI 10.1073/pnas.040576797; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hoque MT, 2001, J BIOL CHEM, V276, P5059, DOI 10.1074/jbc.M007809200; HORNIG NCD, IN PRESS CURR BIOL; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; JANSSENS FA, 1909, CELLULE, V25, P387; Kaitna S, 2002, CURR BIOL, V12, P798, DOI 10.1016/S0960-9822(02)00820-5; Kimura K, 1999, CELL, V98, P239, DOI 10.1016/S0092-8674(00)81018-1; Kimura K, 1998, SCIENCE, V282, P487, DOI 10.1126/science.282.5388.487; Lavoie BD, 2002, J CELL BIOL, V156, P805, DOI 10.1083/jcb.200109056; LEHNE CF, COMMUNICATION; Lemon KP, 2001, GENE DEV, V15, P2031, DOI 10.1101/gad.913301; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Losada A, 2000, Curr Biol, V10, pR615, DOI 10.1016/S0960-9822(00)00670-9; Losada A, 2001, CURR BIOL, V11, P268, DOI 10.1016/S0960-9822(01)00066-5; Mei JJ, 2001, CURR BIOL, V11, P1197, DOI 10.1016/S0960-9822(01)00325-6; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Peter M, 2001, NAT CELL BIOL, V3, P83, DOI 10.1038/35050607; Pidoux AL, 2000, J CELL SCI, V113, P4177; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Rogers E, 2002, J CELL BIOL, V157, P219, DOI 10.1083/jcb.200110045; SAKA Y, 1994, EMBO J, V13, P4938, DOI 10.1002/j.1460-2075.1994.tb06821.x; Siomos MF, 2001, CURR BIOL, V11, P1825, DOI 10.1016/S0960-9822(01)00588-7; Sonoda E, 2001, DEV CELL, V1, P759, DOI 10.1016/S1534-5807(01)00088-0; Steffensen S, 2001, CURR BIOL, V11, P295, DOI 10.1016/S0960-9822(01)00096-3; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Stern BM, 2002, CURR BIOL, V12, pR316, DOI 10.1016/S0960-9822(02)00828-X; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Taieb FE, 2001, CURR BIOL, V11, P508, DOI 10.1016/S0960-9822(01)00145-2; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; WAIZENEGGER I, COMMUNICATION; Wang ZY, 2001, MOL ENDOCRINOL, V15, P1870, DOI 10.1210/me.15.11.1870; Warren WD, 2000, CURR BIOL, V10, P1463, DOI 10.1016/S0960-9822(00)00806-X; Wassmann K, 2001, CURR OPIN GENET DEV, V11, P83, DOI 10.1016/S0959-437X(00)00161-1; Whitehouse H. L. K., 1973, UNDERSTANDING MECH H; Yamamoto A, 1996, J CELL BIOL, V133, P99, DOI 10.1083/jcb.133.1.99; Yamazoe M, 1999, EMBO J, V18, P5873, DOI 10.1093/emboj/18.21.5873; [No title captured]	77	435	449	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2002	297	5581					559	565		10.1126/science.1074757	http://dx.doi.org/10.1126/science.1074757			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142526				2022-12-28	WOS:000177054200039
J	Schoenberg, R; Kamber, BS; Collerson, KD; Moorbath, S				Schoenberg, R; Kamber, BS; Collerson, KD; Moorbath, S			Tungsten isotope evidence from similar to 3.8-Gyr metamorphosed sediments for early meteorite bombardment of the Earth	NATURE			English	Article							EARLY SOLAR-SYSTEM; WEST GREENLAND; CHONDRITES; ACCRETION; DIFFERENTIATION; CARBON	The 'Late Heavy Bombardment' was a phase in the impact history of the Moon that occurred 3.8-4.0 Gyr ago, when the lunar basins with known dates were formed(1,2). But no record of this event has yet been reported from the few surviving rocks of this age on the Earth. Here we report tungsten isotope anomalies, based on the Hf-182-W-182 system (half-life of 9 Myr), in metamorphosed sedimentary rocks from the 3.7-3.8-Gyr-old Isua greenstone belt of West Greenland and closely related rocks from northern Labrador, Canada. As it is difficult to conceive of a mechanism by which tungsten isotope heterogeneities could have been preserved in the Earth's dynamic crust-mantle environment from a time when short-lived Hf-182 was still present, we conclude that the metamorphosed sediments contain a component derived from meteorites.	Univ Queensland, Queensland Univ res Excellence ACQUIRE, Adv Ctr, St Lucia, Qld 4072, Australia; Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England	University of Queensland; University of Oxford	Schoenberg, R (corresponding author), Univ Queensland, Queensland Univ res Excellence ACQUIRE, Adv Ctr, St Lucia, Qld 4072, Australia.		Kamber, Balz S/A-1823-2008	Kamber, Balz S/0000-0002-8720-0608				Anbar AD, 2001, J GEOPHYS RES-PLANET, V106, P3219, DOI 10.1029/2000JE001272; Appel P W, 1999, Eos (Washington DC), V80, P264, DOI 10.1029/99EO00189; Cohen BA, 2000, SCIENCE, V290, P1754, DOI 10.1126/science.290.5497.1754; Horan MF, 1998, GEOCHIM COSMOCHIM AC, V62, P545, DOI 10.1016/S0016-7037(97)00368-2; KOEBERL C, 1999, IMPACTS EARLY EARTH, P73; KRING DA, 2002, J GEOPHYS RES E, V107; Lee DC, 1997, SCIENCE, V278, P1098, DOI 10.1126/science.278.5340.1098; Lee DC, 2000, SCIENCE, V288, P1629, DOI 10.1126/science.288.5471.1629; Lee DC, 2000, CHEM GEOL, V169, P35, DOI 10.1016/S0009-2541(99)00193-X; Lee DC, 1996, SCIENCE, V274, P1876, DOI 10.1126/science.274.5294.1876; Mason B., 1971, HDB ELEMENTAL ABUNDA; Meier R, 1999, SPACE SCI REV, V90, P33, DOI 10.1023/A:1005269208310; NUTMAN AP, 1991, GEOLOGY, V19, P791, DOI 10.1130/0091-7613(1991)019<0791:VEACAC>2.3.CO;2; Nutman AP, 1999, CONTRIB MINERAL PETR, V137, P364, DOI 10.1007/s004100050556; Quitte G, 2000, EARTH PLANET SC LETT, V184, P83, DOI 10.1016/S0012-821X(00)00303-4; Rosing MT, 1999, SCIENCE, V283, P674, DOI 10.1126/science.283.5402.674; Ryder G., 1990, EOS, V71, P322; SCHOENBERG R, IN PRESS GEOCHIM COS; Shukolyukov A, 1998, SCIENCE, V282, P927, DOI 10.1126/science.282.5390.927; WASSON JT, 1988, PHILOS T R SOC A, V325, P535, DOI 10.1098/rsta.1988.0066; YIN QZ, 2002, LUNAR PLANET SCI, V33, pA1700	22	90	96	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2002	418	6896					403	405		10.1038/nature00923	http://dx.doi.org/10.1038/nature00923			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12140554				2022-12-28	WOS:000177009700034
J	Smith, A				Smith, A			Screening for drug discovery: The leading question	NATURE			English	Article																			0	84	89	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2002	418	6896					453	+		10.1038/418453a	http://dx.doi.org/10.1038/418453a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12140563	Bronze			2022-12-28	WOS:000177009700046
J	Weber, M; Dindo, D; Demartines, N; Ambuhl, PM; Clavien, PA				Weber, M; Dindo, D; Demartines, N; Ambuhl, PM; Clavien, PA			Kidney transplantation from donors without a heartbeat	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DELAYED GRAFT FUNCTION; RENAL-TRANSPLANTATION; BEATING DONORS; ACUTE REJECTION; ALLOGRAFTS; EXPERIENCE; SURVIVAL	Background The dramatic shortage of kidney donors has triggered interest in other sources of organs, such as donors without a heartbeat. Accumulating evidence suggests that the short-term survival of cadaveric kidneys from such donors is similar to that of cadaveric kidneys from donors with a heartbeat. However, no data from large, matched studies with long-term follow-up are available. We conducted a matched, single-center study of kidney transplants obtained from donors without a heartbeat and those from donors with a heartbeat, with a 15-year follow-up period. Methods Between 1985 and 2000,122 kidney transplantations involving donors without a heartbeat were performed at the University of Zurich, in Switzerland. Outcomes of these procedures were compared with those of 122 transplantations of kidneys from donors with a heartbeat. The recipients were matched according to age, sex, number of transplantations, and calendar period of transplantation. Results The characteristics of the recipients did not differ significantly between the two groups. We observed a significantly higher incidence of delayed graft function among the patients who received kidneys from donors without a heartbeat (48.4 percent) than among the patients who received kidneys from donors with a heartbeat (23.8 percent) (P < 0.001). However, the long-term rate of graft survival was similar in the two groups (P = 0.98): at 10 years, the rate of graft survival was 78.7 percent for kidneys from donors without a heartbeat and 76.7 percent for kidneys from donors with a heartbeat. Conclusions Although the incidence of delayed graft function is significantly higher with kidneys from donors without a heartbeat than with kidneys from donors with a heartbeat, there is no difference in long-term outcome between the two types of graft.	Univ Zurich Hosp, Dept Visceral Surg & Transplantat, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Clavien, PA (corresponding author), Univ Zurich Hosp, Dept Surg, Ramistr 100, CH-8091 Zurich, Switzerland.	clavien@chir.unizh.ch		Demartines, Nicolas/0000-0002-1530-3114				Agha IA, 2002, TRANSPLANTATION, V73, P473, DOI 10.1097/00007890-200202150-00025; Balupuri S, 2000, TRANSPLANTATION, V69, P842; CASAVILLA A, 1995, TRANSPLANTATION, V59, P197, DOI 10.1097/00007890-199501270-00008; Cho YW, 1998, NEW ENGL J MED, V338, P221, DOI 10.1056/NEJM199801223380403; D'Alessandro AM, 2000, SURGERY, V128, P579, DOI 10.1067/msy.2000.108421; de Mattos AM, 2000, AM J KIDNEY DIS, V35, P333, DOI 10.1016/S0272-6386(00)70348-9; Gaber LW, 1996, CLIN TRANSPLANT, V10, P629; HARPER AM, 1997, CLIN TRANSPLANTS 199, P69; Jain S, 2000, Transpl Int, V13 Suppl 1, pS52, DOI 10.1111/j.1432-2277.2000.tb02094.x; KAHAN BD, 2000, PRINCIPLES PRACTICE, P149; KOOTSTRA G, 1995, TRANSPLANT P, V27, P2965; Localio AR, 2001, ANN INTERN MED, V135, P112, DOI 10.7326/0003-4819-135-2-200107170-00012; LYNN J, 1981, JAMA-J AM MED ASSOC, V246, P2184; Metcalfe MS, 2001, TRANSPLANTATION, V71, P1556, DOI 10.1097/00007890-200106150-00012; Nicholson ML, 1996, BRIT J SURG, V83, P147, DOI 10.1002/bjs.1800830203; Nicholson ML, 2001, TRANSPLANT P, V33, P3756, DOI 10.1016/S0041-1345(01)02590-8; NOVICK AC, 1986, TRANSPLANTATION, V42, P154, DOI 10.1097/00007890-198608000-00010; Ojo AO, 1997, TRANSPLANTATION, V63, P968, DOI 10.1097/00007890-199704150-00011; ORLOFF MS, 1994, ANN SURG, V220, P578; Pacholczyk M J, 1996, Transpl Int, V9 Suppl 1, pS81, DOI 10.1111/j.1432-2277.1996.tb01693.x; Sanchez-Fructuoso AI, 2000, J AM SOC NEPHROL, V11, P350, DOI 10.1681/ASN.V112350; SANFILIPPO F, 1984, TRANSPLANTATION, V38, P643, DOI 10.1097/00007890-198412000-00019; Schnuelle P, 1998, J AM SOC NEPHROL, V9, P2135; SEGURA CG, 1995, TRANSPLANT P, V27, P2948; Shoskes DA, 1998, TRANSPLANTATION, V66, P1697, DOI 10.1097/00007890-199812270-00022; SOLEZ K, 1993, KIDNEY INT, V44, P411, DOI 10.1038/ki.1993.259; TROPPMANN C, 1995, TRANSPLANTATION, V59, P962, DOI 10.1097/00007890-199504150-00007; Vanrenterghem Y, 2000, LANCET, V356, P528, DOI 10.1016/S0140-6736(00)02575-7; WIJNEN RMH, 1995, LANCET, V345, P1067, DOI 10.1016/S0140-6736(95)90815-3	29	272	278	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 25	2002	347	4					248	255		10.1056/NEJMoa020274	http://dx.doi.org/10.1056/NEJMoa020274			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587WB	12140300				2022-12-28	WOS:000177665800004
J	Chowdhury, PS; Ramos, RG				Chowdhury, PS; Ramos, RG			Coronary-stent fracture	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									William Beaumont Hosp, Royal Oak, MI 48073 USA	Beaumont Health	Chowdhury, PS (corresponding author), William Beaumont Hosp, Royal Oak, MI 48073 USA.								0	56	61	0	6	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 22	2002	347	8					581	581		10.1056/NEJMicm020259	http://dx.doi.org/10.1056/NEJMicm020259			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587ZR	12192018				2022-12-28	WOS:000177675400007
J	Lee, SH; Broholm, C; Ratcliff, W; Gasparovic, G; Huang, Q; Kim, TH; Cheong, SW				Lee, SH; Broholm, C; Ratcliff, W; Gasparovic, G; Huang, Q; Kim, TH; Cheong, SW			Emergent excitations in a geometrically frustrated magnet	NATURE			English	Article							KAGOME LATTICE; PYROCHLORE ANTIFERROMAGNET; SPIN LIQUID; FLUCTUATIONS; TRANSITION; GLASS	Frustrated systems are ubiquitous(1-3), and they are interesting because their behaviour is difficult to predict; frustration can lead to macroscopic degeneracies and qualitatively new states of matter. Magnetic systems offer good examples in the form of spin lattices, where all interactions between spins cannot be simultaneously satisfied(4). Here we report how unusual composite spin degrees of freedom can emerge from frustrated magnetic interactions in the cubic spinel ZnCr2O4. Upon cooling, groups of six spins self-organize into weakly interacting antiferromagnetic loops, whose directors-the unique direction along which the spins are aligned, parallel or antiparallel-govern all low-temperature dynamics. The experimental evidence comes from a measurement of the magnetic form factor by inelastic neutron scattering; the data show that neutrons scatter from hexagonal spin clusters rather than individual spins. The hexagon directors are, to a first approximation, decoupled from each other, and hence their reorientations embody the long-sought local zero energy modes for the pyrochlore lattice.	Natl Inst Stand & Technol, NIST Ctr Neutron Res, Gaithersburg, MD 20899 USA; Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA	National Institute of Standards & Technology (NIST) - USA; Johns Hopkins University; Rutgers State University New Brunswick	Lee, SH (corresponding author), Natl Inst Stand & Technol, NIST Ctr Neutron Res, Gaithersburg, MD 20899 USA.		Broholm, Collin Leslie/E-8228-2011	Broholm, Collin Leslie/0000-0002-1569-9892; Ratcliff, William/0000-0001-8956-3851				Birgeneau RJ, 1999, PHYS REV B, V59, P13788, DOI 10.1103/PhysRevB.59.13788; Bramwell ST, 2001, SCIENCE, V294, P1495, DOI 10.1126/science.1064761; BROHOLM C, 1990, PHYS REV LETT, V65, P3173, DOI 10.1103/PhysRevLett.65.3173; Canals B, 1998, PHYS REV LETT, V80, P2933, DOI 10.1103/PhysRevLett.80.2933; Debenedetti PG, 2001, NATURE, V410, P259, DOI 10.1038/35065704; Garcia-Adeva AJ, 2001, CAN J PHYS, V79, P1359, DOI 10.1139/cjp-79-11/12-1359; Laughlin RB, 2000, P NATL ACAD SCI USA, V97, P28, DOI 10.1073/pnas.97.1.28; Lee SH, 2000, PHYS REV LETT, V84, P3718, DOI 10.1103/PhysRevLett.84.3718; Lee SH, 1996, EUROPHYS LETT, V35, P127, DOI 10.1209/epl/i1996-00543-x; LOVESEY SM, 1984, THEORY THERMAL NEUTR; Mekata M, 2001, CAN J PHYS, V79, P1421, DOI 10.1139/cjp-79-11/12-1421; Moessner R, 1998, PHYS REV B, V58, P12049, DOI 10.1103/PhysRevB.58.12049; Moessner R, 1999, PHYS REV LETT, V83, P3293, DOI 10.1103/PhysRevLett.83.3293; Moessner R, 1998, PHYS REV LETT, V80, P2929, DOI 10.1103/PhysRevLett.80.2929; Pande VS, 2000, REV MOD PHYS, V72, P259, DOI 10.1103/RevModPhys.72.259; RAMIREZ AP, 1992, PHYS REV B, V45, P2505, DOI 10.1103/PhysRevB.45.2505; Ramirez AP., 2001, HDB MAGNETIC MAT, Vvol 13, P423, DOI DOI 10.1016/S1567-2719(01)13008-8; Stormer HL, 1999, REV MOD PHYS, V71, pS298, DOI 10.1103/RevModPhys.71.S298; UEMURA YJ, 1994, PHYS REV LETT, V73, P3306, DOI 10.1103/PhysRevLett.73.3306; Wolynes PG, 1999, PHYS WORLD, V12, P39	20	411	413	8	172	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2002	418	6900					856	858		10.1038/nature00964	http://dx.doi.org/10.1038/nature00964			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192404	Green Submitted			2022-12-28	WOS:000177555600032
J	Kuehnle, I; Goodell, MA				Kuehnle, I; Goodell, MA			The therapeutic potential of stem cells from adults	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BONE-MARROW-CELLS; CARDIAC-MUSCLE; SKELETAL; BRAIN; DIFFERENTIATE; REGENERATION; HEPATOCYTES; EXPRESSION; NEURONS; BLOOD		Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA	Baylor College of Medicine	Goodell, MA (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.	goodell@bcm.umc.edu		Goodell, Margaret A./0000-0003-1111-2932				Bittner RE, 1999, ANAT EMBRYOL, V199, P391, DOI 10.1007/s004290050237; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Galli R, 2000, NAT NEUROSCI, V3, P986, DOI 10.1038/79924; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Kawada H, 2001, BLOOD, V98, P2008, DOI 10.1182/blood.V98.7.2008; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Lagasse E, 2001, IMMUNITY, V14, P425, DOI 10.1016/S1074-7613(01)00123-6; Lopez-Lozano JJ, 2000, REV NEUROLOGIA, V30, P1077, DOI 10.33588/rn.3011.99664; McKinney-Freeman SL, 2002, P NATL ACAD SCI USA, V99, P1341, DOI 10.1073/pnas.032438799; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pang WX, 2000, BLOOD, V95, P1106, DOI 10.1182/blood.V95.3.1106; PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124; Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	33	65	75	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 17	2002	325	7360					372	376		10.1136/bmj.325.7360.372	http://dx.doi.org/10.1136/bmj.325.7360.372			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587DV	12183311	Green Published			2022-12-28	WOS:000177626000023
J	Bhutta, AT; Cleves, MA; Casey, PH; Cradock, MM; Anand, KJS				Bhutta, AT; Cleves, MA; Casey, PH; Cradock, MM; Anand, KJS			Cognitive and behavioral outcomes of school-aged children who were born preterm - A meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							LOW-BIRTH-WEIGHT; LOW-BIRTHWEIGHT CHILDREN; PREMATURE-INFANTS; FOLLOW-UP; ENVIRONMENTAL RISK; EARLY INTERVENTION; PARENTING STRESS; ABILITIES; HEALTH; INTELLIGENCE	Context The cognitive and behavioral outcomes of school-aged children who were born preterm have been reported extensively. Many of these studies have methodological flaws that preclude an accurate estimate of the long-term outcomes of prematurity. Objective To estimate the effect of preterm birth on cognition and behavior in school-aged children. Data Sources MEDLINE search (1980 to November 2001) for English-language articles, supplemented by a manual search of personal files maintained by 2 of the authors. Study Selection We included case-control studies reporting cognitive and/or behavioral data of children who were born preterm and who were evaluated after their fifth birthday if the attrition rate was less than 30%. From the 227 reviewed studies, cognitive data from 15 studies and behavioral data from 16 studies were selected. Data Extraction Data on population demographics, study characteristics, and cognitive and behavioral outcomes were extracted from each study, entered in a customized database, and reviewed twice to minimize error. Differences between the mean cognitive scores of cases and controls were pooled. Homogeneity across studies was formally tested using a general variance-based method and graphically using Galbraith plots. Linear meta-analysis regression models were fitted to explore the impact of birth weight and gestational age on cognitive outcomes. Study-specific relative risks (RRs) were calculated for the incidence of attention-deficit/hyperactivity disorder (ADHD) and pooled. Quality assessment of the studies was performed based on a 10-point scale. Publication bias was examined using Begg modified funnel plots and formally teste using the Egger weighted-linear regression method. Data Synthesis Among 1556 cases and 1720 controls, controls had significantly higher cognitive scores compared with children who were born preterm (weighted mean difference, 10.9; 95% confidence interval [CI], 9.2-12.5). The mean cognitive scores of preterm-born cases and term-born controls were directly proportional to their birth weight (R-2=0.51; P<.001) and gestational age (R-2=0.49; P<.001). Age at evaluation had no significant correlation with mean difference in cognitive scores (R-2=0.12; P=.20). Preterm-born children showed increases in externalizing and internalizing behaviors in 81% of studies and had more than twice the RR for developing ADHD (pooled RR, 2.64; 95% Cl, 1.85-3.78). No differences were noted in cognition and behaviors based on the quality of the study. Conclusions Children who were born preterm are at risk for reduced cognitive test scores and their immaturity at birth is directly proportional to the mean cognitive scores at school age. Preterm-born children also show an increased incidence of ADHD and other behaviors.	Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Dept Biostat, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Dept Anesthesiol, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Dept Pharmacol, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Dept Neurobiol, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Arkansas Ctr Birth Defects Res & Prevent, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Anand, KJS (corresponding author), Arkansas Childrens Hosp, 800 Marshall St,S-431, Little Rock, AR 72202 USA.	anandsunny@exchange.uams.edu	Fahimifar, Sepideh/M-5303-2019; Bhutta, Adnan/AAN-8551-2021; Bhutta, Adnan T/ADN-9072-2022; Anand, Kanwaljeet/B-3287-2014	Bhutta, Adnan/0000-0003-3362-5835; Anand, Kanwaljeet/0000-0001-6498-1483	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036484] Funding Source: NIH RePORTER; NICHD NIH HHS [HD36484-02] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AVERY M, 1998, AVERYS DIS NEWBORN, P1; AYLWARD GP, 1989, J PEDIATR-US, V115, P515, DOI 10.1016/S0022-3476(89)80273-2; AYLWARD GP, 1992, J DEV BEHAV PEDIATR, V13, P222; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bhutta AT, 2001, TRENDS NEUROSCI, V24, P129, DOI 10.1016/S0166-2236(00)01747-1; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Botting N, 1998, DEV MED CHILD NEUROL, V40, P652; Botting N, 1997, J CHILD PSYCHOL PSYC, V38, P931, DOI 10.1111/j.1469-7610.1997.tb01612.x; Breslau N, 2000, BIOL PSYCHIAT, V47, P71, DOI 10.1016/S0006-3223(99)00131-6; BROOKSGUNN J, 1994, JAMA-J AM MED ASSOC, V272, P1257, DOI 10.1001/jama.272.16.1257; Burguet A, 2000, ARCH PEDIATRIE, V7, P357, DOI 10.1016/S0929-693X(00)88830-2; CHAIKIND S, 1991, J HEALTH ECON, V10, P291, DOI 10.1016/0167-6296(91)90031-H; DRILLIEN CM, 1980, DEV MED CHILD NEUROL, V22, P26, DOI 10.1111/j.1469-8749.1980.tb04303.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ESCALONA SK, 1982, PEDIATRICS, V70, P670; ESCOBAR GJ, 1991, ARCH DIS CHILD, V66, P204, DOI 10.1136/adc.66.2.204; Evers-Embden B, 1983, Tijdschr Kindergeneeskd, V51, P85; Finnstrom O, 2000, Lakartidningen, V97, P3492; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Gardner J. M., 1983, INFANTS BORN RISK PH, P69; GLADMAN G, 1990, ARCH DIS CHILD-FETAL, V65, P1063, DOI 10.1136/adc.65.10_Spec_No.1063; Grantham-McGregor SM, 1998, J PEDIATR-US, V132, P661, DOI 10.1016/S0022-3476(98)70357-9; GREENLAND S, 1998, MODERN EPIDEMIOLOGY, P643; GREGOIRE G, 1995, J CLIN EPIDEMIOL, V48, P159, DOI 10.1016/0895-4356(94)00098-B; Gross SJ, 2001, J PEDIATR-US, V138, P169, DOI 10.1067/mpd.2001.111945; Guyer B, 1999, PEDIATRICS, V104, P1229, DOI 10.1542/peds.104.6.1229; HACK M, 1992, J DEV BEHAV PEDIATR, V13, P412; HACK M, 1995, FUTURE CHILD, V5, P176, DOI 10.2307/1602514; HACK M, 1994, NEW ENGL J MED, V331, P753, DOI 10.1056/NEJM199409223311201; Hall A, 1995, DEV MED CHILD NEUROL, V37, P1037; Horwood LJ, 1998, ARCH DIS CHILD-FETAL, V79, pF12, DOI 10.1136/fn.79.1.F12; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; KLEBANOV PK, 1994, PEDIATRICS, V94, P700; Laird N M, 1990, Int J Technol Assess Health Care, V6, P5; Langkamp DL, 1999, J PEDIATR-US, V135, P756, DOI 10.1016/S0022-3476(99)70097-1; LEVYSHIFF R, 1994, J PEDIATR PSYCHOL, V19, P63, DOI 10.1093/jpepsy/19.1.63; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; LLOYD BW, 1988, DEV MED CHILD NEUROL, V30, P36, DOI 10.1111/j.1469-8749.1988.tb04724.x; Lubetzky O, 1999, Harefuah, V137, P380; McCarton CM, 1997, JAMA-J AM MED ASSOC, V277, P126, DOI 10.1001/jama.277.2.126; MCDONALD MA, 1989, J DEV BEHAV PEDIATR, V10, P86; Mitani A, 1998, J NEUROSCI, V18, P7941; ORNSTEIN M, 1991, ACTA PAEDIATR SCAND, V80, P741, DOI 10.1111/j.1651-2227.1991.tb11943.x; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; PORTNOY S, 1988, DEV MED CHILD NEUROL, V30, P590; Rabinowicz T, 1996, J NEUROPATH EXP NEUR, V55, P320, DOI 10.1097/00005072-199603000-00007; Rasco L, 2000, Sleep Res Online, V3, P97; Resnick MB, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.6.e74; Rickards AL, 2001, J DEV BEHAV PEDIATR, V22, P11, DOI 10.1097/00004703-200102000-00002; Robson AL, 1997, J PEDIATR PSYCHOL, V22, P297, DOI 10.1093/jpepsy/22.3.297; ROSS G, 1991, PEDIATRICS, V88, P1125; ROUSSOUNIS SH, 1993, CHILD CARE HLTH DEV, V19, P45, DOI 10.1111/j.1365-2214.1993.tb00712.x; SAIGAL S, 1991, J PEDIATR-US, V118, P751, DOI 10.1016/S0022-3476(05)80043-5; Saigal S, 2000, PEDIATRICS, V105, P325, DOI 10.1542/peds.105.2.325; SAMEROFF AJ, 1987, PEDIATRICS, V79, P343; Singer LT, 1999, JAMA-J AM MED ASSOC, V281, P799, DOI 10.1001/jama.281.9.799; SMITH AEA, 1990, DEV MED CHILD NEUROL, V32, P590; SOMMERFELT K, 1995, ARCH DIS CHILD-FETAL, V73, pF135, DOI 10.1136/fn.73.3.F135; SOMMERFELT K, 1993, ACTA PAEDIATR, V82, P723, DOI 10.1111/j.1651-2227.1993.tb12546.x; Stevenson CJ, 1999, ARCH DIS CHILD-FETAL, V81, pF5, DOI 10.1136/fn.81.1.F5; Stewart AL, 1999, LANCET, V353, P1653, DOI 10.1016/S0140-6736(98)07130-X; Stjernqvist K, 1999, ACTA PAEDIATR, V88, P557, DOI 10.1080/08035259950169594; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; SZATMARI P, 1990, DEV MED CHILD NEUROL, V32, P954; Taylor HG, 2000, CHILD DEV, V71, P1495, DOI 10.1111/1467-8624.00242; TEPLIN SW, 1991, J PEDIATR-US, V118, P768, DOI 10.1016/S0022-3476(05)80045-9; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; VERLOOVEVANHORICK SP, 1994, PEDIATRICS, V93, P576; Whitfield MF, 1997, ARCH DIS CHILD-FETAL, V77, pF85, DOI 10.1136/fn.77.2.F85; Wolke D, 1999, DEV MED CHILD NEUROL, V41, P94, DOI 10.1017/S0012162299000201; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601	71	1676	1715	2	341	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2002	288	6					728	737		10.1001/jama.288.6.728	http://dx.doi.org/10.1001/jama.288.6.728			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	583KY	12169077				2022-12-28	WOS:000177408100034
J	Snooks, H; Williams, S; Crouch, R; Foster, T; Hartley-Sharpe, C; Dale, J				Snooks, H; Williams, S; Crouch, R; Foster, T; Hartley-Sharpe, C; Dale, J			NHS emergency response to 999 calls: alternatives for cases that are neither life threatening nor serious	BRITISH MEDICAL JOURNAL			English	Article							CARE		Univ Wales, Swansea Clin Sch, Ctr Postgrad Studies, Swansea SA2 8PP, W Glam, Wales; Univ Southampton, Sch Nursing & Midwifery, Southampton SO17 1BJ, Hants, England; London Ambulance Serv NHS Trust, London SE1 8SD, England; Univ Warwick, Ctr Primary Hlth Care Studies, Coventry CV4 7AL, W Midlands, England	University of Southampton; University of Warwick	Snooks, H (corresponding author), Univ Wales, Swansea Clin Sch, Ctr Postgrad Studies, Swansea SA2 8PP, W Glam, Wales.		Crouch, Robert/AAT-9842-2021; Snooks, Helen A/N-2165-2014	Crouch, Robert/0000-0003-3901-084X; Snooks, Helen A/0000-0003-0173-8843; Dale, Jeremy/0000-0001-9256-3553				Billittier AJ, 1996, ACAD EMERG MED, V3, P1046; CONE DC, 1995, PREHOSP DISASTER MED, V10, P22; COOKE MW, 1999, PREHOSPITAL IMMEDIAT, V3, P191; CULLEY LL, 1994, ANN EMERG MED, V24, P867, DOI 10.1016/S0196-0644(54)00223-5; DALE J, 2000, CLIN ORG COST CONSEQ; *DEP HLTH, 1999, AMB SERV ENGL 1998 9; Department of Health, 2000, NAT SERV FRAM COR AR; Department of Health, 2000, NHS PLAN PLAN INV PL; Department of Health, 2001, REF EM CAR 1 STEPS N; GOLDBERG RJ, 1990, ANN EMERG MED, V19, P557, DOI 10.1016/S0196-0644(05)82189-4; HALLAM L, 1994, BRIT MED J, V308, P249, DOI 10.1136/bmj.308.6923.249; HALTER M, 2002, EMERG MED J, V19, P167; Lattimer V, 1998, BMJ-BRIT MED J, V317, P1054; Munro J, 2000, BRIT MED J, V321, P150, DOI 10.1136/bmj.321.7254.150; *NAT ASS EM MED SE, 1994, PREHOSP DISASTER MED, V9, P133; *NHS EX STEER GROU, 1996, REV AMB PERF STAND; Nicholl J, 1999, PREHOSP IMMED CARE, V3, P71; PLORDE ML, 2001, APPROPRIATE DESTINAT; Schmidt T, 2000, ACAD EMERG MED, V7, P663, DOI 10.1111/j.1553-2712.2000.tb02041.x; SELDEN BS, 1991, PREHOSP DISASTER MED, V6, P135, DOI DOI 10.1017/S1049023X00028259; Smith W R, 2001, Prehosp Emerg Care, V5, P174, DOI 10.1080/10903120190940092; Snooks H, 1998, J ACCID EMERG MED, V15, P212; SNOOKS H, 2001, DEV IMPACT EMERGENCY; SNOOKS H, IN PRESS EMERG MED J; SNOOKS H, 2000, PREHOSPITAL IMMEDIAT, V4, P180; STARK G, 1990, AM J EMERG MED, V8, P509, DOI 10.1016/0735-6757(90)90152-P; THOMPSON RH, 1991, PREHOSP DISAS MED, V8, P53; Zachariah BS, 1992, PREHOSP DISASTER MED, V7, P359	28	54	56	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 10	2002	325	7359					330	333		10.1136/bmj.325.7359.330	http://dx.doi.org/10.1136/bmj.325.7359.330			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	584RQ	12169513	Green Published			2022-12-28	WOS:000177482500024
J	Wang, CP; Liu, XJ; Ohnuma, I; Kainuma, R; Ishida, K				Wang, CP; Liu, XJ; Ohnuma, I; Kainuma, R; Ishida, K			Formation of immiscible alloy powders with egg-type microstructure	SCIENCE			English	Article							FE-CU	The egg-type core microstructure where one alloy encases another has previously been obtained during experiments in space. Working with copper-iron base alloys prepared by conventional gas atomization, we were able to obtain this microstructure under gravity conditions. The minor liquid phase always formed the core of the egg, and it sometimes also formed a shell layer. The origin of the formation of this core microstructure can be explained by Marangoni motion on the basis of the temperature dependence of the interfacial energy, which shows that this type of powder can be formed even if the cooling rate is very high.	Tohoku Univ, Grad Sch Engn, Dept Mat Sci, Sendai, Miyagi 9808579, Japan	Tohoku University	Kainuma, R (corresponding author), Tohoku Univ, Grad Sch Engn, Dept Mat Sci, Aobayama 02, Sendai, Miyagi 9808579, Japan.	kainuma@material.tohoku.ac.jp	Liu, XJ/G-4152-2010; OHNUMA, Ikuo/J-4253-2015; Kainuma, Ryosuke/I-6482-2013; Wang, CP/G-4151-2010					Ahlborn H, 1979, 17 AER SCI M AM I AE, P3; Becker R, 1938, ANN PHYS-BERLIN, V32, P128; Bradley E, 1996, IEEE T COMPON PACK B, V19, P320, DOI 10.1109/96.496035; CHEN Q, 1995, METALL MATER TRANS A, V26, P417, DOI 10.1007/BF02664678; JAMIL SJ, 1985, POWDER METALL, V28, P65, DOI 10.1179/pom.1985.28.2.65; KIYONO S, 1999, JPN J ELECT PACKAGIN, V2, P298; MARANGONI CGM, 1871, ANN PHYS, V143, P337, DOI DOI 10.1002/ANDP.18712190702; Nishizawa T, 2001, J PHASE EQUILIB, V22, P269, DOI 10.1361/105497101770338761; Ohnuma I, 1999, J ELECTRON MATER, V28, P1164, DOI 10.1007/s11664-999-0152-5; Predel B, 1997, THERMODYMANICS OF ALLOY FORMATION, P1; PREDEL B, 1987, FLUID SCI MAT SCI SP, P517; PRINZ B, 1995, J MATER SCI, V30, P4715, DOI 10.1007/BF01153083; RATKE L, 1995, MAT SCI ENG R, V15, P263, DOI 10.1016/0927-796X(95)00180-8; RATKE L, 2002, GROWTH COARSENING, P239; SEETHARAMAN S, 1994, METALL MATER TRANS B, V25, P589, DOI 10.1007/BF02650079; Wang CP, 2002, J PHASE EQUILIB, V23, P236, DOI 10.1361/105497102770331712; YOUNG NO, 1959, J FLUID MECH, V6, P350, DOI 10.1017/S0022112059000684	17	268	285	15	210	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 9	2002	297	5583					990	993		10.1126/science.1073050	http://dx.doi.org/10.1126/science.1073050			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169728				2022-12-28	WOS:000177325400038
J	Cumming, BG				Cumming, BG			An unexpected specialization for horizontal disparity in primate primary visual cortex	NATURE			English	Article							CORTICAL AREA V1; BINOCULAR DISPARITY; DEPTH DISCRIMINATION; STRIATE CORTEX; COMPLEX CELLS; NEURONS; MACAQUE; MECHANISMS; PERCEPTION; RESPONSES	The horizontal separation of the eyes means that objects nearer or farther than the fixation point project to different locations on the two retinae, differing principally in their horizontal coordinates (horizontal binocular disparity). Disparity-selective neurons have generally been studied with disparities applied in only one direction 1 (often horizontal), which cannot determine whether the encoding is specialized for processing disparities along the horizontal axis. It is therefore unclear if disparity selectivity represents a specialization for naturally occurring disparities. I used random dot stereograms to study disparity-selective neurons from the primary visual cortex (V1) of awake fixating monkeys. Many combinations of vertical and horizontal disparity were used, characterizing the surface of responses as a function of two-dimensional disparity. Here I report that the response surface usually showed elongation along the horizontal disparity axis, despite the isotropic stimulus. Thus these neurons modulated their firing rate over a wider range of horizontal disparity than vertical disparity. This demonstrates that disparity-selective cells are specialized for processing horizontal disparity, and that existing models(2,3) of disparity selectivity require substantial revision.	NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20982 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Cumming, BG (corresponding author), NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20982 USA.				NATIONAL EYE INSTITUTE [Z01EY000404, ZIAEY000404] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Anzai A, 1999, J NEUROPHYSIOL, V82, P909, DOI 10.1152/jn.1999.82.2.909; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; Cumming BG, 1997, NATURE, V389, P280, DOI 10.1038/38487; Cumming BG, 2000, J NEUROSCI, V20, P4758, DOI 10.1523/JNEUROSCI.20-12-04758.2000; Cumming BG, 1999, J NEUROSCI, V19, P5602; Cumming BG, 2001, ANNU REV NEUROSCI, V24, P203, DOI 10.1146/annurev.neuro.24.1.203; DEANGELIS GC, 1991, NATURE, V352, P156, DOI 10.1038/352156a0; Howard IP, 1995, BINOCULAR VISION STE; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; JOSHUA DE, 1970, EXP BRAIN RES, V10, P389, DOI 10.1007/BF02324766; Livingstone MS, 1999, NAT NEUROSCI, V2, P825, DOI 10.1038/12199; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1148, DOI 10.1152/jn.1983.49.5.1148; MAYHEW JEW, 1982, NATURE, V297, P376, DOI 10.1038/297376a0; Nieder A, 2001, VISUAL NEUROSCI, V18, P541, DOI 10.1017/S095252380118404X; Ohzawa I, 1998, CURR OPIN NEUROBIOL, V8, P509, DOI 10.1016/S0959-4388(98)80039-1; Ohzawa I, 1997, J NEUROPHYSIOL, V77, P2879, DOI 10.1152/jn.1997.77.6.2879; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; Prince SJD, 2000, J NEUROSCI, V20, P3387, DOI 10.1523/JNEUROSCI.20-09-03387.2000; Prince SJD, 2002, J NEUROPHYSIOL, V87, P209, DOI 10.1152/jn.00466.2000; VANDERHEYDT R, 1978, EXP BRAIN RES, V31, P523	20	89	91	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2002	418	6898					633	636		10.1038/nature00909	http://dx.doi.org/10.1038/nature00909			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167860				2022-12-28	WOS:000177305600041
J	Socha, JJ				Socha, JJ			Kinematics - Gliding flight in the paradise tree snake	NATURE			English	Article									Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	University of Chicago	Socha, JJ (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57th St, Chicago, IL 60637 USA.							DALY M, 1899, BOMBAY NAT HIST J, V12, P589; EMERSON SB, 1990, EVOLUTION, V44, P1931, DOI 10.1111/j.1558-5646.1990.tb04300.x; FLOWER SS, 1899, P ZOOL SOC LOND 16 M; HEYER W R, 1970, Herpetologica, V26, P317; MCGUIRE JA, 1998, THESIS U TEXAS AUSTI; PENDLEBURY H. M., 1931, BULL RAFFLES MUS, V5, P75; Scholey K., 1986, Biona Report, V5, P187; VAUGHNARBUCKLE KH, 1959, J BOMBAY NAT HIST SO, V56, P640; Wall F., 1908, Journal of the Bombay Natural History Society, V18	9	58	59	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2002	418	6898					603	604		10.1038/418603a	http://dx.doi.org/10.1038/418603a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167849				2022-12-28	WOS:000177305600030
J	Caspi, A; McClay, J; Moffitt, TE; Mill, J; Martin, J; Craig, IW; Taylor, A; Poulton, R				Caspi, A; McClay, J; Moffitt, TE; Mill, J; Martin, J; Craig, IW; Taylor, A; Poulton, R			Role of genotype in the cycle of violence in maltreated children	SCIENCE			English	Article							MONOAMINE-OXIDASE-A; FUNCTIONAL POLYMORPHISM; AGGRESSIVE-BEHAVIOR; ANTISOCIAL-BEHAVIOR; GENE PROMOTER; ASSOCIATION; PERSONALITY; STRESS; BRAIN; RISK	We studied a large sample of male children from birth to adulthood to determine why some children who are maltreated grow up to develop antisocial behavior, whereas others do not. A functional polymorphism in the gene encoding the neurotransmitter-metabolizing enzyme monoamine oxidase A (MAOA) was found to moderate the effect of maltreatment. Maltreated children with a genotype conferring high levels of MAOA expression were less likely to develop antisocial problems. These findings may partly explain why not all victims of maltreatment grow up to victimize others, and they provide epidemiological evidence that genotypes can moderate children's sensitivity to environmental insults.	Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Res Ctr, MRC, London SE5 8AF, England; Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; Univ Otago, Dunedin Sch Med, Dunedin, New Zealand	University of London; King's College London; University of Wisconsin System; University of Wisconsin Madison; University of Otago	Moffitt, TE (corresponding author), Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Res Ctr, MRC, London SE5 8AF, England.	t.moffitt@iop.kcl.ac.uk	Mill, Jonathan S/B-3276-2010; caspi, avshalom/D-5294-2011; McClay, Joseph/C-9931-2009; Kennedy, Kristen M/B-4699-2008; caspi, avshalom/AAJ-5874-2020; Craig, Ian/AAF-9167-2019; Mill, Jonathan/B-5678-2014; Moffitt, Terrie E/D-5295-2011	Mill, Jonathan S/0000-0003-1115-3224; caspi, avshalom/0000-0003-0082-4600; McClay, Joseph/0000-0002-3628-2447; Kennedy, Kristen M/0000-0001-5373-9026; caspi, avshalom/0000-0003-0082-4600; Mill, Jonathan/0000-0003-1115-3224; Moffitt, Terrie E/0000-0002-8589-6760; Craig, Ian/0000-0002-4063-1005	NIMH NIH HHS [MH45070, MH49414] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045070, R29MH049414, R01MH049414] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AIKEN LS, 1991, MULTIPLE REGRESS TES; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Bennett AJ, 2002, MOL PSYCHIATR, V7, P118, DOI 10.1038/sj/mp/4000949; BERMAN ME, 1997, HDB ANTISOCIAL BEHAV; BOWTELL DDL, 1987, ANAL BIOCHEM, V162, P463, DOI 10.1016/0003-2697(87)90421-0; Bremner JD, 2001, DEV PSYCHOPATHOL, V13, P473, DOI 10.1017/S0954579401003042; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; Cicchetti D, 2001, DEV PSYCHOPATHOL, V13, P783, DOI 10.1017/S0954579401004035; COHEN P, 1984, ARCH GEN PSYCHIAT, V41, P1178; De Bellis MD, 2001, DEV PSYCHOPATHOL, V13, P539, DOI 10.1017/S0954579401003078; Denney RM, 1999, HUM GENET, V105, P542, DOI 10.1007/s004390051143; DODGE KA, 1990, SCIENCE, V250, P1678, DOI 10.1126/science.2270481; FERGUSSON DM, 1992, J CHILD PSYCHOL PSYC, V33, P1059, DOI 10.1111/j.1469-7610.1992.tb00925.x; Francis DD, 1999, CURR OPIN NEUROBIOL, V9, P128, DOI 10.1016/S0959-4388(99)80016-6; Freeman B, 1997, BEHAV GENET, V27, P251, DOI 10.1023/A:1025614231190; Glaser D, 2000, J CHILD PSYCHOL PSYC, V41, P97, DOI 10.1111/1469-7610.00551; Grundy SM, 1999, J AM COLL CARDIOL, V34, P1348, DOI 10.1016/S0735-1097(99)00387-3; Hill AVS, 1999, BRIT MED BULL, V55, P401, DOI 10.1258/0007142991902457; Jaffee SR, 2002, ARCH GEN PSYCHIAT, V59, P215, DOI 10.1001/archpsyc.59.3.215; JEANPIERRE M, 1987, NUCLEIC ACIDS RES, V15, P9611, DOI 10.1093/nar/15.22.9611; Johnson JG, 1999, ARCH GEN PSYCHIAT, V56, P600, DOI 10.1001/archpsyc.56.7.600; Jorm AF, 2000, PSYCHIATR GENET, V10, P87, DOI 10.1097/00041444-200010020-00006; Jorm AF, 2000, SOC PSYCH PSYCH EPID, V35, P1, DOI 10.1007/s001270050001; Keiley ML, 2001, DEV PSYCHOPATHOL, V13, P891, DOI 10.1017/S0954579401004084; Kendler KS, 2001, ARCH GEN PSYCHIAT, V58, P1005, DOI 10.1001/archpsyc.58.11.1005; KRAEMER GW, 1989, NEUROPSYCHOPHARMACOL, V2, P175, DOI 10.1016/0893-133X(89)90021-3; Krueger RF, 2000, J PERS, V68, P967, DOI 10.1111/1467-6494.00123; LEVY ER, 1989, GENOMICS, V5, P368, DOI 10.1016/0888-7543(89)90072-4; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; LYNAM D, 1993, J ABNORM PSYCHOL, V102, P187, DOI 10.1037/0021-843X.102.2.187; Manuck SB, 2000, PSYCHIAT RES, V95, P9, DOI 10.1016/S0165-1781(00)00162-1; Moffitt T. E., 2001, SEX DIFFERENCES ANTI; Moffitt TE, 2002, DEV PSYCHOPATHOL, V14, P179, DOI 10.1017/S0954579402001104; MORELL V, 1993, SCIENCE, V260, P1722, DOI 10.1126/science.8511575; MUTHEN LK, 1999, M PLUS; Parsian A, 2001, PSYCHIAT GENET, V11, P89, DOI 10.1097/00041444-200106000-00006; Pine DS, 1997, ARCH GEN PSYCHIAT, V54, P839; Pollak SD, 1997, CHILD DEV, V68, P773, DOI 10.1111/j.1467-8624.1997.tb01961.x; POULTON R, IN PRESS LANCET; RAINE A, 1994, ARCH GEN PSYCHIAT, V51, P984; ROBINS LN, 1978, PSYCHOL MED, V8, P611, DOI 10.1017/S0033291700018821; ROWE DC, 2001, BIOL CRIME; Rutter M, 2002, ANNU REV PSYCHOL, V53, P463, DOI 10.1146/annurev.psych.53.100901.135223; Rutter M., 1998, ANTISOCIAL BEHAV YOU; Sabol SZ, 1998, HUM GENET, V103, P273, DOI 10.1007/s004390050816; Samochowiec J, 1999, PSYCHIAT RES, V86, P67, DOI 10.1016/S0165-1781(99)00020-7; Satten GA, 2001, AM J HUM GENET, V68, P466, DOI 10.1086/318195; Shih JC, 1999, AM J HUM GENET, V65, P593, DOI 10.1086/302562; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; Silva P., 1996, CHILD ADULT DUNEDIN; Straus MA, 1997, ARCH PEDIAT ADOL MED, V151, P761, DOI 10.1001/archpedi.1997.02170450011002; SUOMI SJ, IN PRESS HDB DEV PSY; Ward HE, 1998, PHARMACOL BIOCHEM BE, V60, P209, DOI 10.1016/S0091-3057(97)00580-7; *WHO, IN PRESS COMP QUANT; Widom C.S., 1997, HDB ANTISOCIAL BEHAV; WIDOM CS, 1989, SCIENCE, V244, P160, DOI 10.1126/science.2704995	57	2829	2923	13	682	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2002	297	5582					851	854		10.1126/science.1072290	http://dx.doi.org/10.1126/science.1072290			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	579RZ	12161658				2022-12-28	WOS:000177192800056
J	Gold, BS; Dart, RC; Barish, RA				Gold, BS; Dart, RC; Barish, RA			Bites of venomous snakes	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							EXPOSURE SURVEILLANCE SYSTEM; UNITED-STATES; RATTLESNAKE BITES; ENVENOMATION; ANTIVENOM; FAB; MANAGEMENT		Univ Maryland, Sch Med, Div Emergency Med, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Off Dean, Baltimore, MD 21201 USA; Rocky Mt Poison Ctr, Denver, CO USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Barish, RA (corresponding author), Univ Maryland, Sch Med, Div Emergency Med, 655 W Baltimore St,Rm 14-011, Baltimore, MD 21201 USA.			Dart, Richard/0000-0001-5989-9354				CONSROE P, 1995, AM J TROP MED HYG, V53, P507, DOI 10.4269/ajtmh.1995.53.507; Dart R.C., 1992, BIOL PITVIPERS, P395; Dart RC, 1997, ANN EMERG MED, V30, P33, DOI 10.1016/S0196-0644(97)70107-0; Dart RC, 2001, ARCH INTERN MED, V161, P2030, DOI 10.1001/archinte.161.16.2030; DART RC, 1991, ANN EMERG MED, V20, P659, DOI 10.1016/S0196-0644(05)82389-3; Dart RC, 1996, ANN EMERG MED, V27, P321, DOI 10.1016/S0196-0644(96)70267-6; Dart RC, 2001, ANN EMERG MED, V37, P181, DOI 10.1067/mem.2001.113372; DOWNEY DJ, 1991, J TRAUMA, V31, P1380, DOI 10.1097/00005373-199110000-00011; GARFIN SR, 1985, TOXICON, V23, P677, DOI 10.1016/0041-0101(85)90372-1; GOLD B S, 1992, Emergency Medicine Clinics of North America, V10, P249; GOLD BS, 1994, SOUTHERN MED J, V87, P579, DOI 10.1097/00007611-199406000-00001; GRACE TG, 1980, J HAND SURG-AM, V5, P168, DOI 10.1016/S0363-5023(80)80149-3; Hall EL, 2001, ANN EMERG MED, V37, P175, DOI 10.1067/mem.2001.113373; JURKOVICH GJ, 1988, J TRAUMA, V28, P1032, DOI 10.1097/00005373-198807000-00020; KITCHENS CS, 1987, JAMA-J AM MED ASSOC, V258, P1615, DOI 10.1001/jama.258.12.1615; Langley RL, 1997, WILD ENVIRON MED, V8, P8, DOI 10.1580/1080-6032(1997)008[0008:DRFAAI]2.3.CO;2; Litovitz TL, 1999, AM J EMERG MED, V17, P435, DOI 10.1016/S0735-6757(99)90254-1; Litovitz TL, 2001, AM J EMERG MED, V19, P337, DOI 10.1053/ajem.2001.25272; Litovitz TL, 2000, AM J EMERG MED, V18, P517, DOI 10.1053/ajem.2000.9261; McCoLLOUGH N. C., 1963, Journal of the Florida Medical Association., V49, P959; MEIER J, 1995, HDB CLIN TOXICOLOGY, P477; Minton SA, 1996, WILD ENVIRON MED, V7, P297, DOI 10.1580/1080-6032(1996)007[0297:BBNNVS]2.3.CO;2; Ownby C. L, 1982, RATTLESNAKE VENOMS T, P163; PARRISH HM, 1966, PUBLIC HEALTH REP, V81, P269, DOI 10.2307/4592691; ROWLAND SA, 1999, GREENS OPERATIVE HAN, V1, P689; Ruha A. M., 2001, Journal of Toxicology Clinical Toxicology, V39, P546; Russel F, 1990, EMERGEN MED, V22, P33; Russell F. E., 1990, EMERGEN MED, V22, P43; RUSSELL FE, 1980, ANNU REV MED, V31, P247, DOI 10.1146/annurev.me.31.020180.001335; Russell FE, 1990, EMERGEN MED, V22, P37; Russell FE, 1990, EMERGEN MED, V22, P20; RUSSELL FE, 1983, SNAKE VENOM POSONING, P163; RUSSELL FINDLAY E., 1964, TOXICON, V2, P81, DOI 10.1016/0041-0101(64)90033-9; Steinberg E, 1978, TOXIN ANIMAL PLANT M, P489; Stocker K., 1990, P33; Tagwireyi D D, 2001, BMC Clin Pharmacol, V1, P4, DOI 10.1186/1472-6904-1-4; THEAKSTON RDG, 1991, TOXICON, V29, P1419, DOI 10.1016/0041-0101(91)90002-9; TRESTRAIL JH, 1982, VET HUM TOXICOL, V24, P144; WHITE RR, 1991, ANN SURG, V213, P466, DOI 10.1097/00000658-199105000-00012; WINGERT WA, 1988, WESTERN J MED, V148, P37	40	274	292	2	41	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2002	347	5					347	356		10.1056/NEJMra013477	http://dx.doi.org/10.1056/NEJMra013477			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587WC	12151473				2022-12-28	WOS:000177665900009
J	Leu, KM; Kalemkerian, GP				Leu, KM; Kalemkerian, GP			Osteoporosis circumscripta	NEW ENGLAND JOURNAL OF MEDICINE			English	Article																			0	0	0	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2002	347	5					E2	E2		10.1056/ENEJMicm020146	http://dx.doi.org/10.1056/ENEJMicm020146			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587WC	12151465				2022-12-28	WOS:000177665900007
J	Wright, KP; Czeisler, CA				Wright, KP; Czeisler, CA			Absence of circadian phase resetting in response to bright light behind the knees	SCIENCE			English	Article							EXTRAOCULAR LIGHT; NO EVIDENCE; HUMANS; MELATONIN; EXPOSURE; RHYTHMS; PHOTOTRANSDUCTION; ENTRAINMENT		Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Sleep Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Wright, KP (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Sleep Med, 221 Longwood Ave,Suite 438, Boston, MA 02115 USA.				NCRR NIH HHS [M01-RR02635] Funding Source: Medline; NIDDK NIH HHS [T32-DK07529] Funding Source: Medline; NIMH NIH HHS [NIH R01-MH45130] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045130] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ADLER K, 1969, SCIENCE, V164, P1290, DOI 10.1126/science.164.3885.1290; Atkinson G, 2001, CHRONOBIOL INT, V18, P1041, DOI 10.1081/CBI-100107977; Campbell SS, 1998, SCIENCE, V279, P396, DOI 10.1126/science.279.5349.396; CAMPBELL SS, 2000, Patent No. 63135117; CAMPBELL SS, 2000, SLEEP, V23, pA23; CZEISLER CA, 1999, REGULATION SLEEP CIR; Eastman CI, 2000, CHRONOBIOL INT, V17, P807, DOI 10.1081/CBI-100102116; ERMAN MK, 1999, SLEEP S, V22, P96; Foster RG, 1998, NEURON, V20, P829, DOI 10.1016/S0896-6273(00)80464-X; Hebert M, 1999, NEUROSCI LETT, V274, P127, DOI 10.1016/S0304-3940(99)00685-0; Jagota A, 1999, BRAIN RES, V825, P95, DOI 10.1016/S0006-8993(99)01226-3; Jean-Louis G, 2000, J BIOL RHYTHM, V15, P265, DOI 10.1177/074873040001500307; Koorengevel KM, 2001, BIOL PSYCHIAT, V50, P691, DOI 10.1016/S0006-3223(01)01182-9; Lindblom N, 2000, BIOL PSYCHIAT, V48, P1098, DOI 10.1016/S0006-3223(00)00905-7; Lindblom N, 2000, NEUROREPORT, V11, P713, DOI 10.1097/00001756-200003200-00012; Lockley SW, 1998, J CLIN ENDOCR METAB, V83, P3369, DOI 10.1210/jc.83.9.3369; Murphy PJ, 2001, AM J PHYSIOL-REG I, V280, pR1606, DOI 10.1152/ajpregu.2001.280.6.R1606; *NEWS ED STAFF, 1998, SCIENCE, V282, P2157; Oren DA, 1996, NEUROSCIENTIST, V2, P207, DOI 10.1177/107385849600200408; SEKI HS, 2000, Patent No. 6164787; UNDERWOOD H, 1982, EXPERIENTIA, V38, P1013, DOI 10.1007/BF01955345; Wright KP, 2001, P NATL ACAD SCI USA, V98, P14027, DOI 10.1073/pnas.201530198; Yamazaki S, 1999, J BIOL RHYTHM, V14, P197, DOI 10.1177/074873099129000605; Zeitzer JM, 1997, NEUROSCI LETT, V232, P135, DOI 10.1016/S0304-3940(97)00599-5	24	65	71	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2002	297	5581					571	571		10.1126/science.1071697	http://dx.doi.org/10.1126/science.1071697			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142528				2022-12-28	WOS:000177054200041
J	Halpern, SD; Ubel, PA; Caplan, AL				Halpern, SD; Ubel, PA; Caplan, AL			Solid-organ transplantation in HIV-infected patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; LIVER-TRANSPLANTATION; DIABETES-MELLITUS; RECIPIENTS; RETRANSPLANTATION; CYCLOSPORINE; PROGRESSION; SURVIVAL; DISEASE; SURGERY		Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI 48109 USA	University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Halpern, SD (corresponding author), Univ Penn, Sch Med, Philadelphia, PA 19104 USA.							*AM COLL SURG, 1991, B AM COLL SURG, V76, P28; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; [Anonymous], 1988, JAMA-J AM MED ASSOC, V259, P1360; Astermark T, 1998, BRIT J HAEMATOL, V103, P10, DOI 10.1046/j.1365-2141.1998.00961.x; BAYER R, 1988, B NEW YORK ACAD MED, V64, P498; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; BOUSCARAT F, 1994, CLIN INFECT DIS, V19, P854, DOI 10.1093/clinids/19.5.854; CLARKE OW, 1995, ARCH INTERN MED, V155, P29, DOI 10.1001/archinte.1995.00430010033005; Corley M C, 1995, Medsurg Nurs, V4, P211; DEIN JR, 1989, ANN THORAC SURG, V48, P350, DOI 10.1016/S0003-4975(10)62855-X; DUMMER JS, 1989, TRANSPLANTATION, V47, P134, DOI 10.1097/00007890-198901000-00030; ERICE A, 1991, REV INFECT DIS, V13, P537; Forman LM, 2002, GASTROENTEROLOGY, V122, P889, DOI 10.1053/gast.2002.32418; Goldberg D, 2000, J HOSP INFECT, V44, P99, DOI 10.1053/jhin.1999.0672; Gow PJ, 2001, AIDS, V15, P291, DOI 10.1097/00002030-200101260-00029; HALEVY A, 1994, AM J MED, V96, P282, DOI 10.1016/0002-9343(94)90154-6; Halevy A, 2000, ARCH SURG-CHICAGO, V135, P51, DOI 10.1001/archsurg.135.1.51; HARIHARAN S, 1993, CLIN TRANSPLANT, V7, P235; Henderson DK, 1999, JAMA-J AM MED ASSOC, V281, P931, DOI 10.1001/jama.281.10.931; Isaacs RB, 1999, AM J KIDNEY DIS, V34, P706, DOI 10.1016/S0272-6386(99)70397-5; John PR, 2001, HEPATOLOGY, V34, P889, DOI 10.1053/jhep.2001.29134; Kaplan JE, 2000, CLIN INFECT DIS, V30, pS5, DOI 10.1086/313843; Kappes U, 2001, AM J NEPHROL, V21, P259, DOI 10.1159/000046259; KASISKE BL, 1991, NEW ENGL J MED, V324, P302, DOI 10.1056/NEJM199101313240505; Kuo PC, 2001, AM J TRANSPLANT, V1, P13, DOI 10.1034/j.1600-6143.2001.010104.x; Kuo PC, 2001, TRANSPLANTATION, V71, P1689, DOI 10.1097/00007890-200106150-00033; LEMMA M, 1992, THORAC CARDIOV SURG, V40, P279, DOI 10.1055/s-2007-1022720; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mocroft A, 2000, LANCET, V356, P291, DOI 10.1016/S0140-6736(00)02504-6; Mullen MA, 1996, CAN MED ASSOC J, V154, P337; Nair S, 2002, LANCET, V359, P287, DOI 10.1016/S0140-6736(02)07494-9; OBrien WA, 1997, ANN INTERN MED, V126, P939, DOI 10.7326/0003-4819-126-12-199706150-00002; Ojo AO, 2000, AM J KIDNEY DIS, V36, P153, DOI 10.1053/ajkd.2000.8288; Ojo AO, 2001, J AM SOC NEPHROL, V12, P589, DOI 10.1681/ASN.V123589; *ORG TRANSPL ASS, 2001, HIV TRANSPL; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; POLI F, 1989, TRANSPLANTATION, V47, P725; Prachalias AA, 2001, TRANSPLANTATION, V72, P1684, DOI 10.1097/00007890-200111270-00020; Ragni MV, 1999, BLOOD, V93, P1113, DOI 10.1182/blood.V93.3.1113.403a38e_1113_1115; Revanur VK, 2001, CLIN TRANSPLANT, V15, P89, DOI 10.1034/j.1399-0012.2001.150202.x; RUBIN RH, 1987, TRANSPLANTATION, V44, P1, DOI 10.1097/00007890-198707000-00001; Schvarcz R, 2000, TRANSPLANTATION, V69, P2194, DOI 10.1097/00007890-200005270-00041; SCHWARZ A, 1993, TRANSPLANTATION, V55, P95, DOI 10.1097/00007890-199301000-00019; SCHWARZ A, 1987, TRANSPLANTATION, V44, P21, DOI 10.1097/00007890-198707000-00006; Sewell CA, 2001, J REPROD MED, V46, P199; SHAW BW, 1985, TRANSPLANT P, V17, P264; Sheikh AM, 1999, TRANSPLANTATION, V68, P307, DOI 10.1097/00007890-199907270-00027; SMITH S, 2002, BOSTON GLOBE    0313, pB3; Spital A, 1998, TRANSPLANTATION, V65, P1187, DOI 10.1097/00007890-199805150-00008; STRYKER J, 2001, NY TIMES        1211, pF6; TZAKIS AG, 1990, TRANSPLANTATION, V49, P354, DOI 10.1097/00007890-199002000-00025; Ubel P A, 1997, Liver Transpl Surg, V3, P343; Ubel PA, 1998, NEW ENGL J MED, V339, P1322, DOI 10.1056/NEJM199810293391811; UBEL PA, 1995, HEALTH POLICY, V34, P145, DOI 10.1016/0168-8510(95)00714-4; Ubel PA, 1996, SOC SCI MED, V42, P1049, DOI 10.1016/0277-9536(95)00216-2; UBEL PA, 1993, JAMA-J AM MED ASSOC, V270, P2469, DOI 10.1001/jama.270.20.2469; Ubel PA, 2001, LIVER TRANSPLANT, V7, P600, DOI 10.1053/jlts.2001.25361; *UN NETW ORG SHAR, 2001, POL BYL; Valente JF, 1997, CLIN TRANSPLANT, V11, P231; WHITE LJ, 1988, ANN INTERN MED, V108, P460, DOI 10.7326/0003-4819-108-3-460	60	106	107	3	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 25	2002	347	4					284	287		10.1056/NEJMsb020632	http://dx.doi.org/10.1056/NEJMsb020632			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587WB	12140307	Green Published			2022-12-28	WOS:000177665800011
J	Workowski, KA; Levine, WC; Wasserheit, JN				Workowski, KA; Levine, WC; Wasserheit, JN			US centers for disease control and prevention guidelines for the treatment of sexually transmitted diseases: An opportunity to unify clinical and public health practice	ANNALS OF INTERNAL MEDICINE			English	Article							HERPES-SIMPLEX-VIRUS; SQUAMOUS INTRAEPITHELIAL LESIONS; PELVIC-INFLAMMATORY-DISEASE; BACTERIAL VAGINOSIS; CHLAMYDIAL INFECTION; HUMAN-PAPILLOMAVIRUS; COST-EFFECTIVENESS; PRETERM DELIVERY; AZITHROMYCIN; PREVALENCE	Sexually transmitted diseases (STDs) constitute an epidemic of tremendous magnitude, with an estimated 15 million persons in the United States acquiring a new STD each year. Effective clinical management of STDs is a strategic common element in efforts to prevent HIV infection and to improve reproductive and sexual health. Sexually transmitted diseases may result in severe, longterm, costly complications, including facilitation of HIV infection, tubal infertility, adverse outcomes of pregnancy, and cervical and other types of anogenital cancer. The publication of national guidelines for the management of STDs, by the U.S. Centers for Disease Control and Prevention (CDC), has been a key component of federal initiatives to improve the health of the U.S. population by preventing and controlling STDs and their sequelae. This paper presents new recommendations from the 2002 CDC Guidelines for the Treatment of Sexually Transmitted Diseases in the context of current disease trends and public health.	Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	Centers for Disease Control & Prevention - USA; Fred Hutchinson Cancer Center	Workowski, KA (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,Mailstop E02, Atlanta, GA 30333 USA.	kgw2@cdc.gov						AMSTEY M S, 1976, Journal of the American Venereal Disease Association, V3, P14; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; AUGENBRAUN MH, 2001, IN PRESS CLIN INFECT; Berg AO, 2001, AM J PREV MED, V20, P90, DOI 10.1016/S0749-3797(01)00254-9; Berg AO, 2001, AM J PREV MED, V20, P59, DOI 10.1016/S0749-3797(01)00257-4; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; BROWN ZA, 1991, NEW ENGL J MED, V324, P1247, DOI 10.1056/NEJM199105023241804; Brown ZA, 1997, NEW ENGL J MED, V337, P509, DOI 10.1056/NEJM199708213370801; Cates W, 1999, SEX TRANSM DIS, V26, pS2, DOI 10.1097/00007435-199904001-00002; *CDCP, 2001, JAMA-J AM MED ASSOC, V286, P40; Chesson HW, 1999, AIDS, V13, P1387, DOI 10.1097/00002030-199907300-00017; Cohen DA, 1998, PEDIATRICS, V101, part. no., DOI 10.1542/peds.101.1.e1; *COMM PREV CONTR S, 1997, HIDD EP CONFR SEX TA, P1; COTCH MF, 1991, OBSTET GYNECOL, V78, P1087; *DEP HHS, 2001, SEX TRANSM DIS SURV; DiCarlo RP, 1997, CLIN INFECT DIS, V25, P292, DOI 10.1086/514548; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Fleming DT, 1997, NEW ENGL J MED, V337, P1105, DOI 10.1056/NEJM199710163371601; Fox K K, 1999, Curr Opin Urol, V9, P65, DOI 10.1097/00042307-199901000-00011; Goldenberg RL, 1997, CLIN PERINATOL, V24, P23, DOI 10.1016/S0095-5108(18)30182-9; Goldie SJ, 1999, JAMA-J AM MED ASSOC, V281, P1822, DOI 10.1001/jama.281.19.1822; Hauth JC, 1995, NEW ENGL J MED, V333, P1732, DOI 10.1056/NEJM199512283332603; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Hook EW, 1999, ANN INTERN MED, V131, P434, DOI 10.7326/0003-4819-131-6-199909210-00007; HOOK EW, 1988, J INFECT DIS, V158, P881, DOI 10.1093/infdis/158.4.881; Knapp JS, 1997, EMERG INFECT DIS, V3, P33, DOI 10.3201/eid0301.970104; Koutsky LA, 2000, J NATL CANCER I, V92, P397, DOI 10.1093/jnci/92.5.397; Langenberg AGM, 1999, NEW ENGL J MED, V341, P1432, DOI 10.1056/NEJM199911043411904; Magid D, 1996, ANN INTERN MED, V124, P389, DOI 10.7326/0003-4819-124-4-199602150-00002; Mayer KH, 2001, SEX TRANSM DIS, V28, P464, DOI 10.1097/00007435-200108000-00008; Mertz KJ, 1998, J INFECT DIS, V178, P1795, DOI 10.1086/314502; MORALES WJ, 1994, AM J OBSTET GYNECOL, V171, P345, DOI 10.1016/S0002-9378(94)70033-8; National Committee for Quality Assurance (NCQA), 1999, HEDIS 2000 TECHN SPE, p[68, 285]; NUGENT RP, 1992, SEX TRANSM DIS, V19, P198, DOI 10.1097/00007435-199207000-00003; Palefsky JM, 1998, AIDS, V12, P495, DOI 10.1097/00002030-199805000-00011; PALEFSKY JM, 1991, CANCER RES, V51, P1014; Rolfs RT, 1997, NEW ENGL J MED, V337, P307, DOI 10.1056/NEJM199707313370504; Scholes D, 1996, NEW ENGL J MED, V334, P1362, DOI 10.1056/NEJM199605233342103; Sobel JD, 1997, NEW ENGL J MED, V337, P1896, DOI 10.1056/NEJM199712253372607; Solomon D, 2001, J NATL CANCER I, V93, P293, DOI 10.1093/jnci/93.4.293; SURAWICZ CM, 1995, AM J GASTROENTEROL, V90, P1776; *US DEP HHS, 1999, NAT PLAN EL SYPH US, P1; VERDON MS, 1994, CLIN INFECT DIS, V19, P486, DOI 10.1093/clinids/19.3.486; Wald A, 1999, CLIN INFECT DIS, V28, pS4, DOI 10.1086/514723; Wald A, 1996, ANN INTERN MED, V124, P8, DOI 10.7326/0003-4819-124-1_Part_1-199601010-00002; WESTROM L, 1975, AM J OBSTET GYNECOL, V121, P707, DOI 10.1016/0002-9378(75)90477-9; 2002, MMWR MORB MORTAL WKL, V51, P1; 2002, MMWR MORB MORTAL WKL, V49, pR4	48	38	38	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2002	137	4					255	262		10.7326/0003-4819-137-4-200208200-00010	http://dx.doi.org/10.7326/0003-4819-137-4-200208200-00010			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585BB	12186516				2022-12-28	WOS:000177502300006
J	Fischer, TP; Hilton, DR; Zimmer, MM; Shaw, AM; Sharp, ZD; Walker, JA				Fischer, TP; Hilton, DR; Zimmer, MM; Shaw, AM; Sharp, ZD; Walker, JA			Subduction and recycling of nitrogen along the central American margin	SCIENCE			English	Article							ORGANIC-MATTER; ISOTOPIC COMPOSITION; CONVERGENT MARGIN; SEDIMENT INPUT; COSTA-RICA; ARC LAVAS; MANTLE; HELIUM; CARBON; VOLATILES	We report N and He isotopic and relative abundance characteristics of volatiles emitted from two segments of the Central American volcanic arc. In Guatemala, delta(15)N values are positive (i.e., greater than air) and N-2/He ratios are high (up to 25,000). In contrast, Costa Rican N-2/He ratios are low ( maximum 1483) and delta(15)N values are negative ( minimum -3.0 per mil). The results identify shallow hemipelagic sediments, subducted into the Guatemalan mantle, as the transport medium for the heavy N. Mass balance arguments indicate that the subducted N is efficiently cycled to the atmosphere by arc volcanism. Therefore, the subduction zone acts as a barrier to input of sedimentary N to the deeper mantle.	Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; Univ Calif San Diego, Scripps Inst Oceanog, Geosci Res Div, Fluids & Volatiles Lab, La Jolla, CA 92093 USA; No Illinois Univ, Dept Geol & Environm Sci, De Kalb, IL 60115 USA	University of New Mexico; University of California System; University of California San Diego; Scripps Institution of Oceanography; Northern Illinois University	Fischer, TP (corresponding author), Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA.		Hilton, David/B-7611-2008	Zimmer, Mindy/0000-0003-1866-1889				AUBOUIN J, 1982, INITIAL REP DEEP SEA, V67, P79; BEBOUT GE, 1996, GEOPHYS MONOGR, V98, P179; BOYD SR, 1994, CHEM GEOL, V116, P43, DOI 10.1016/0009-2541(94)90157-0; CARR MJ, 1984, J VOLCANOL GEOTH RES, V20, P231, DOI 10.1016/0377-0273(84)90041-6; CARR MJ, 1990, CONTRIB MINERAL PETR, V105, P369, DOI 10.1007/BF00286825; Cartigny P, 1998, SCIENCE, V280, P1421, DOI 10.1126/science.280.5368.1421; Cartigny P, 1997, TERRA NOVA, V9, P175, DOI 10.1046/j.1365-3121.1997.d01-26.x; CLINE J D, 1975, Marine Chemistry, V3, P271, DOI 10.1016/0304-4203(75)90009-2; Dauphas N, 1998, METEORIT PLANET SCI, V33, pA38; Dauphas N, 1999, SCIENCE, V286, P2488, DOI 10.1126/science.286.5449.2488; EPPLEY RW, 1979, NATURE, V282, P677, DOI 10.1038/282677a0; Farley KA, 1998, ANNU REV EARTH PL SC, V26, P189, DOI 10.1146/annurev.earth.26.1.189; Fischer TP, 1998, EARTH PLANET SC LETT, V160, P81, DOI 10.1016/S0012-821X(98)00086-7; GASPARON M, 1994, EARTH PLANET SC LETT, V126, P15, DOI 10.1016/0012-821X(94)90239-9; Giggenbach W.F., 1996, MONITORING MITIGATIO, P221, DOI [10.1007/978-3-642-80087-0_7, DOI 10.1007/978-3-642-80087-0_7]; Giggenbach W. F, 1975, B VOLCANOL, V39, P132, DOI [DOI 10.1007/BF02596953, 10.1007/BF02596953]; GIGGENBACH WF, 1995, J VOLCANOL GEOTH RES, V68, P89, DOI 10.1016/0377-0273(95)00009-J; Gulec N, 2002, CHEM GEOL, V187, P129, DOI 10.1016/S0009-2541(02)00015-3; Hilton DR, 1996, CHEM GEOL, V127, P269, DOI 10.1016/0009-2541(95)00134-4; HILTON DR, 1993, EARTH PLANET SC LETT, V120, P265, DOI 10.1016/0012-821X(93)90244-4; HILTON DR, 2002, NOBLE GASES COSMOCHE, pCH9; HILTON DR, 2001, EOS, V82, P1275; JAMBON A, 1986, GEOCHIM COSMOCHIM AC, V50, P401, DOI 10.1016/0016-7037(86)90193-6; JAVOY M, 1986, CHEM GEOL, V57, P41, DOI 10.1016/0009-2541(86)90093-8; Javoy M, 1997, GEOPHYS RES LETT, V24, P177, DOI 10.1029/96GL03931; Javoy M, 1998, CHEM GEOL, V147, P11, DOI 10.1016/S0009-2541(97)00169-1; Kienast M, 2000, PALEOCEANOGRAPHY, V15, P244, DOI 10.1029/1999PA000407; KIRUMA G, 1997, P OCEAN DRIL PROGR I, V170, P45; Marty B, 1999, GEOCHIM COSMOCHIM AC, V63, P3619, DOI 10.1016/S0016-7037(99)00169-6; Marty B, 1997, EARTH PLANET SC LETT, V152, P101, DOI 10.1016/S0012-821X(97)00153-2; MIYAZAKI A, 1995, AIP CONF P, V341, P276; Moritz E, 2000, EARTH PLANET SC LETT, V174, P301, DOI 10.1016/S0012-821X(99)00270-8; MORRIS JD, 1990, NATURE, V344, P31, DOI 10.1038/344031a0; Ozima M., 2022, NOBLE GAS GEOCHEMIST; Patino LC, 2000, CONTRIB MINERAL PETR, V138, P265, DOI 10.1007/s004100050562; PETERS KE, 1978, LIMNOL OCEANOGR, V23, P598, DOI 10.4319/lo.1978.23.4.0598; Plank T, 1998, CHEM GEOL, V145, P325, DOI 10.1016/S0009-2541(97)00150-2; PLANK T, 1993, NATURE, V362, P739, DOI 10.1038/362739a0; POREDA R, 1989, NATURE, V338, P473, DOI 10.1038/338473a0; Sano Y, 1996, GEOPHYS RES LETT, V23, P2749, DOI 10.1029/96GL02260; SANO Y, 1985, J GEOPHYS RES-SOLID, V90, P8729, DOI 10.1029/JB090iB10p08729; Sano Y, 2001, CHEM GEOL, V171, P263, DOI 10.1016/S0009-2541(00)00252-7; Sano Y, 1998, GEOPHYS RES LETT, V25, P2289, DOI 10.1029/98GL01687; SHAW A, UNPUB; SHAW AM, 2001, EOS, V82, P1303; SHINOHARA H, 1993, GEOCHEM J, V27, P271, DOI 10.2343/geochemj.27.271; Snyder G, 2001, GEOCHEM GEOPHY GEOSY, V2; STAUDACHER T, 1988, EARTH PLANET SC LETT, V89, P173, DOI 10.1016/0012-821X(88)90170-7; Tolstikhin IN, 1998, CHEM GEOL, V147, P27, DOI 10.1016/S0009-2541(97)00170-8; VALENTINE RB, 1997, EOS, V78, pF673; von Huene R, 2000, TECTONICS, V19, P314, DOI 10.1029/1999TC001143; WADA E, 1975, Geochemical Journal, V9, P139	52	147	149	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2002	297	5584					1154	1157		10.1126/science.1073995	http://dx.doi.org/10.1126/science.1073995			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183622				2022-12-28	WOS:000177447600041
J	Crawford, LM				Crawford, LM			Limited approval for Lotronex	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Crawford, LM (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2002	288	6					688	688		10.1001/jama.288.6.688	http://dx.doi.org/10.1001/jama.288.6.688			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	583KY	12169049				2022-12-28	WOS:000177408100005
J	Honest, H; Bachmann, LM; Gupta, JK; Kleijnen, J; Khan, KS				Honest, H; Bachmann, LM; Gupta, JK; Kleijnen, J; Khan, KS			Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							VAGINAL SECRETIONS; DIAGNOSTIC-TEST; BACTERIAL VAGINOSIS; PREMATURE DELIVERY; CERVICAL LENGTH; SCREENING-TEST; LABOR; METAANALYSIS; INTERLEUKIN-6; GESTATION	Objective To determine the accuracy with which a cervicovaginal fetal fibronectin test predicts spontaneous preterm birth in women with or without symptoms of preterm labour. Design Systematic quantitative review of studies of test accuracy. Data sources Medline, Embase, PASCAL, Biosis, Cochrane Library, Medion, National Research Register, SCISEARCH, conference papers, manual searching of bibliographies of known primary and review articles, and contact with experts and manufacturer. Study selection Two reviewers independently selected and extracted data on study characteristics, quality, and accuracy. Data extraction Accuracy data were used to form 2x2 contingency tables with spontaneous preterm birth before 34 and 37 weeks' gestation and birth within 7-10 days of testing (for symptomatic pregnant women) as reference standards. Data were pooled to produce summary receiver operating characteristic curves and summary likelihood ratios for positive and negative test results. Data synthesis 64 primary articles were identified, consisting of 28 studies in asymptomatic women and 40 in symptomatic women, with a total of 26 876 women. Among asymptomatic women the best summary likelihood ratio for positive results was 4.01 (95% confidence interval 2.93 to 5.49) for predicting birth before 34 weeks' gestation, with corresponding summary likelihood ratio for negative results of 0.78 (0.72 to 0.84). Among symptomatic women the best summary likelihood ratio for positive results was 5.42 (4.36 to 6.74) for predicting birth within 7-10 days of testing, with corresponding ratio for negative results of 0.25 (0.20 to 0.31). Conclusion Cervicovaginal fetal fibronectin test is most accurate in predicting spontaneous preterm birth within 7-10 days of testing among women with symptoms of threatened preterm birth before advanced cervical dilatation.	Birmingham Womens Hosp, Acad Dept Obstet & Gynaecol, Birmingham B15 2TG, W Midlands, England; Univ Zurich, Horten Ctr, CH-8091 Zurich, Switzerland; Univ York, NHS Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England	Birmingham Women's Hospital; University of Zurich; University of York - UK	Honest, H (corresponding author), Birmingham Womens Hosp, Acad Dept Obstet & Gynaecol, Birmingham B15 2TG, W Midlands, England.	h.honest@bham.ac.uk	Khan, Khalid S/AAT-8824-2020; Bachmann, Lucas M/C-9686-2011	Khan, Khalid S/0000-0001-5084-7312; 				Arinami Y, 1999, J Matern Fetal Med, V8, P70; Ascarelli M H, 1997, Obstet Gynecol Surv, V52, pS1, DOI 10.1097/00006254-199704000-00024; Bartnicki J, 1996, AM J OBSTET GYNECOL, V174, P971, DOI 10.1016/S0002-9378(96)70335-6; Benattar C, 1997, EUR J OBSTET GYN R B, V72, P131, DOI 10.1016/S0301-2115(96)02673-5; Bittar RE, 1996, AM J OBSTET GYNECOL, V175, P178, DOI 10.1016/S0002-9378(96)70271-5; BON C, 2000, IMMUNO-ANAL BIOL SPE, V15, P96; BRUBAKER DB, 1992, AM J OBSTET GYNECOL, V166, P526, DOI 10.1016/0002-9378(92)91663-U; BURRUS DR, 1995, AM J OBSTET GYNECOL, V173, P1258, DOI 10.1016/0002-9378(95)91366-1; Calda P, 1995, Ceska Gynekol, V60, P293; Chang T. C., 1997, Annals Academy of Medicine Singapore, V26, P776; Chien PFW, 1997, BRIT J OBSTET GYNAEC, V104, P436, DOI 10.1111/j.1471-0528.1997.tb11495.x; Chuileannain FN, 1998, AUST NZ J OBSTET GYN, V38, P399, DOI 10.1111/j.1479-828X.1998.tb03096.x; *COCHR METH GROUP, 1996, COCHR METH GROUP SYS; Coleman MAG, 1998, AM J OBSTET GYNECOL, V179, P1553, DOI 10.1016/S0002-9378(98)70023-7; Coleman MAG, 2001, EUR J OBSTET GYN R B, V95, P154, DOI 10.1016/S0301-2115(00)00450-4; Cox S., 1996, American Journal of Obstetrics and Gynecology, V174, P306; Crane JMG, 1999, OBSTET GYNECOL, V93, P517, DOI 10.1016/S0029-7844(98)00470-0; Crowley P, 2007, COCHRANE DB SYST REV, V18, DOI [10.1002/14651858.CD000065, DOI 10.1002/14651858.CD000065, 10.1002/14651858.CD000065.pub2, DOI 10.1002/14651858.CD000065.PUB2]; Daskalakis G J, 2000, J Obstet Gynaecol, V20, P347; *DEP HLTH, 1997, NHS MAT STAT ENGL 19; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; deVries SO, 1996, ACAD RADIOL, V3, P361, DOI 10.1016/S1076-6332(96)80257-1; Di Stefano L., 1999, Clinical and Experimental Obstetrics and Gynecology, V26, P187; Faron G, 1997, BRIT J OBSTET GYNAEC, V104, P697, DOI 10.1111/j.1471-0528.1997.tb11980.x; Faron G, 1998, OBSTET GYNECOL, V92, P153, DOI 10.1016/S0029-7844(98)00067-2; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Garcia Alonso A, 1999, Ginecol Obstet Mex, V67, P23; GEBHARDT S, 1995, S AFR MED J, V85, P188; Giles W, 2000, AM J OBSTET GYNECOL, V182, P439, DOI 10.1016/S0002-9378(00)70236-5; Goffeng AR, 1997, ACTA OBSTET GYN SCAN, V76, P521, DOI 10.3109/00016349709024576; Goldenberg RL, 1996, OBSTET GYNECOL, V87, P643, DOI 10.1016/0029-7844(96)00035-X; Goldenberg RL, 1996, AM J OBSTET GYNECOL, V175, P1047, DOI 10.1016/S0002-9378(96)80051-2; Goldenberg RL, 1997, AM J OBSTET GYNECOL, V177, P8, DOI 10.1016/S0002-9378(97)70430-7; Goldenberg RL, 2000, AM J OBSTET GYNECOL, V183, P469, DOI 10.1067/mob.2000.106073; GRANDI C, 1996, REV HOSP MAT INF RAM, V15, P127; Greenhagen JB, 1996, AM J OBSTET GYNECOL, V175, P1054, DOI 10.1016/S0002-9378(96)80052-4; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; HAMPL M, 1994, GEBURTSH FRAUENHEILK, V54, P685, DOI 10.1055/s-2007-1023624; HAMPL M, 1994, GEBURTSH FRAUENHEILK, V685, P54; Heath VCF, 2000, BRIT J OBSTET GYNAEC, V107, P1276, DOI 10.1111/j.1471-0528.2000.tb11620.x; HELLEMANS P, 1995, BRIT J OBSTET GYNAEC, V102, P207, DOI 10.1111/j.1471-0528.1995.tb09095.x; HONEST H, IN PRESS EUR J OBSTE; HUX CH, 1995, J MATERN FETAL MED, V4, P100; IAMS JD, 1995, AM J OBSTET GYNECOL, V173, P141, DOI 10.1016/0002-9378(95)90182-5; INGLIS SR, 1994, AM J OBSTET GYNECOL, V171, P5, DOI 10.1016/S0002-9378(94)70069-9; Irion O., 1995, Journal de Gynecologie Obstetrique et Biologie de la Reproduction, V24, P624; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Khan K. S., 2001, 4 CRD U YORK; Khan KS, 2001, EUR J OBSTET GYN R B, V95, P6, DOI 10.1016/S0301-2115(00)00463-2; Khan KS, 1997, BRIT J OBSTET GYNAEC, V104, P1173, DOI 10.1111/j.1471-0528.1997.tb10942.x; Krems J., 1995, American Journal of Obstetrics and Gynecology, V172, P406; Langer B, 1997, ACTA OBSTET GYN SCAN, V76, P218, DOI 10.1111/j.1600-0412.1997.tb07848.x; LaShay N, 2000, J Matern Fetal Med, V9, P336; Leeson SC, 1996, BRIT J OBSTET GYNAEC, V103, P48, DOI 10.1111/j.1471-0528.1996.tb09514.x; Leitich H, 1999, AM J OBSTET GYNECOL, V180, P1169, DOI 10.1016/S0002-9378(99)70612-5; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; LOCKWOOD CJ, 1993, AM J OBSTET GYNECOL, V169, P798, DOI 10.1016/0002-9378(93)90008-7; LOCKWOOD CJ, 1991, NEW ENGL J MED, V325, P669, DOI 10.1056/NEJM199109053251001; Lopez RL, 2000, AM J OBSTET GYNECOL, V182, P1103, DOI 10.1067/mob.2000.105411; Lukes AS, 1997, AM J OBSTET GYNECOL, V176, P639, DOI 10.1016/S0002-9378(97)70561-1; Luo L, 1997, Zhonghua Fu Chan Ke Za Zhi, V32, P25; MALAGRIDA L, 1995, IMMUNOANAL BIOL SPEC, V10, P355; Malak TM, 1996, BRIT J OBSTET GYNAEC, V103, P648, DOI 10.1111/j.1471-0528.1996.tb09832.x; Mansouri A, 1997, Contracept Fertil Sex, V25, P380; *MAT CHILD HLTH CO, 1999, 6 MAT CHILD HLTH CON; *MAT CHILD HLTH CO, 1999, CONF ENQ STILLB DEAT; MATSUURA H, 1988, J BIOL CHEM, V263, P3314; McKenna MDS, 1999, J REPROD MED, V44, P796; MORRISON JC, 1993, AM J OBSTET GYNECOL, V168, P538, DOI 10.1016/0002-9378(93)90488-5; Morrison JC, 1996, OBSTET GYNECOL, V87, P649, DOI 10.1016/0029-7844(96)00041-5; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; NAGEOTTE M P, 1992, American Journal of Obstetrics and Gynecology, V166, P274; NAGEOTTE MP, 1994, AM J OBSTET GYNECOL, V170, P20; Oliveira T, 1998, INT J GYNECOL OBSTET, V62, P135, DOI 10.1016/S0020-7292(98)00076-9; Oliveira T A, 1999, Sao Paulo Med J, V117, P121; PARKER J, 1995, AUST NZ J OBSTET GYN, V35, P257, DOI 10.1111/j.1479-828X.1995.tb01976.x; Patricot MC, 1997, IMMUNOANAL BIOL SPEC, V12, P81; Peaceman AM, 1997, AM J OBSTET GYNECOL, V177, P13, DOI 10.1016/S0002-9378(97)70431-9; Peters K D, 1998, Natl Vital Stat Rep, V47, P1; Revah A, 1998, AM J PERINAT, V15, P613, DOI 10.1055/s-2007-994079; Rizzo G, 1996, AM J OBSTET GYNECOL, V175, P1146, DOI 10.1016/S0002-9378(96)70020-0; Rizzo G, 1997, J PERINAT MED, V25, P461, DOI 10.1515/jpme.1997.25.6.461; Roubille M, 1999, ANN BIOL CLIN-PARIS, V57, P93; Rozenberg P, 1997, AM J OBSTET GYNECOL, V176, P196, DOI 10.1016/S0002-9378(97)80035-X; Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942; SADOVSKY Y, 1992, NEW ENGL J MED, V326, P709; SCORZA FCZ, 2000, REV OBST GINECOL VEN, V60, P15; Senden I. P. M., 1996, Clinical and Experimental Obstetrics and Gynecology, V23, P5; Shimoya K, 1998, AM J OBSTET GYNECOL, V179, P255, DOI 10.1016/S0002-9378(98)70280-7; SINCLAIR JC, 1995, AM J OBSTET GYNECOL, V173, P335, DOI 10.1016/0002-9378(95)90223-6; Song FJ, 2001, EVAL HEALTH PROF, V24, P126, DOI 10.1177/01632780122034849; Song FJ, 2002, INT J EPIDEMIOL, V31, P88, DOI 10.1093/ije/31.1.88; Stewart AL, 1999, LANCET, V353, P1653, DOI 10.1016/S0140-6736(98)07130-X; Surbek D, 1997, Z GEBURTSH NEONATOL, V201, P15; Sutton A J, 1998, Health Technol Assess, V2, P1; Tolino A, 1996, INT J GYNECOL OBSTET, V52, P3, DOI 10.1016/0020-7292(95)02529-4; USHER RH, 1971, AM J OBSTET GYNECOL, V111, P826, DOI 10.1016/0002-9378(71)90495-9; VERCOUSTRE L, 1996, GYNECOL OBSTET, V4, P23; Vetr Miroslav, 1996, Acta Universitatis Palackianae Olomucensis Facultatis Medicae, V140, P55; Wennerholm UB, 1997, BRIT J OBSTET GYNAEC, V104, P1398, DOI 10.1111/j.1471-0528.1997.tb11010.x; Wolke D, 1999, DEV MED CHILD NEUROL, V41, P94, DOI 10.1017/S0012162299000201	101	196	200	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 10	2002	325	7359					301	304C		10.1136/bmj.325.7359.301	http://dx.doi.org/10.1136/bmj.325.7359.301			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	584RQ	12169504	Bronze, Green Published			2022-12-28	WOS:000177482500015
J	Achard, F; Eva, HD; Stibig, HJ; Mayaux, P; Gallego, J; Richards, T; Malingreau, JP				Achard, F; Eva, HD; Stibig, HJ; Mayaux, P; Gallego, J; Richards, T; Malingreau, JP			Determination of deforestation rates of the world's humid tropical forests	SCIENCE			English	Article							SATELLITE IMAGERY; CARBON; COVER; ECOSYSTEMS; EMISSIONS; AMAZON	A recently completed research program (TREES) employing the global imaging capabilities of Earth-observing satellites provides updated information on the status of the world's humid tropical forest cover. Between 1990 and 1997, 5.8 +/- 1.4 million hectares of humid tropical forest were lost each year, with a further 2.3 +/- 0.7 million hectares of forest visibly degraded. These figures indicate that the global net rate of change in forest cover for the humid tropics is 23% lower than the generally accepted rate. This result affects the calculation of carbon fluxes in the global budget and means that the terrestrial sink is smaller than previously inferred.	Joint Res Ctr, Global Vegetat Monitoring Unit, I-21020 Ispra, Italy; Joint Res Ctr, Land Use Land Cover Unit, I-21020 Ispra, Italy; Conservat Technol Ltd, Tarnwell BS18 4EA, Somerset, England; European Commiss, Joint Res Ctr, Sci Strategy Directorate, B-1049 Brussels, Belgium	European Commission Joint Research Centre; EC JRC ISPRA Site; European Commission Joint Research Centre; EC JRC ISPRA Site; European Commission Joint Research Centre	Achard, F (corresponding author), Joint Res Ctr, Global Vegetat Monitoring Unit, TP 440, I-21020 Ispra, Italy.		Wrbka, Thomas/A-5699-2010; EVA, Hugh D/F-8412-2011	Wrbka, Thomas/0000-0002-1451-9108; 				Achard F, 1995, REMOTE SENS ENVIRON, V54, P198, DOI 10.1016/0034-4257(95)00153-0; Achard F., 1998, IDENTIFICATION DEFOR; [Anonymous], EOS; Brown S, 1997, ESTIMATING BIOMASS B; Cochran W.G., 2007, SAMPLING TECHNIQUES; CZAPLEWSKI RI, 2002, SAMPLING ESTIMATING; DEVILLE JC, 1992, J AM STAT ASSOC, V87, P376, DOI 10.2307/2290268; EVA HD, 1999, VEGETATION MAP S AME; *FAO, 1993, FOR RES ASS 1990 TRO; *FAO, 2001, STAT WORLDS FOR 2001; *FAO, 2001, GLOB FOR RES ASS 200; Fearnside PM, 1997, CLIMATIC CHANGE, V35, P321, DOI 10.1023/A:1005336724350; Geist HJ, 2001, LUCC REP SER, P136; Harcourt C. S., 1996, CONSERVATION ATLAS T; Houghton RA, 2000, NATURE, V403, P301, DOI 10.1038/35002062; *I NAC PESQ ESP I, 1997, DEF 1995 1997 AM; MATTHEWS E, 2001, UNDERSTANDING FRA 20; Mayaux P, 1999, J BIOGEOGR, V26, P353, DOI 10.1046/j.1365-2699.1999.00270.x; Mayaux P, 1997, REMOTE SENS ENVIRON, V59, P29, DOI 10.1016/S0034-4257(96)00077-6; Mayaux P, 1998, ENVIRON CONSERV, V25, P37, DOI 10.1017/S0376892998000083; Richards T, 2000, INT J REMOTE SENS, V21, P1473, DOI 10.1080/014311600210272; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; SCHOLES RJ, 1993, SCIENCE, V294, P1012; Siegert F, 2001, NATURE, V414, P437, DOI 10.1038/35106547; SKOLE D, 1993, SCIENCE, V260, P1905, DOI 10.1126/science.260.5116.1905; Stibig HJ, 2001, INT J REMOTE SENS, V22, P503, DOI 10.1080/01431160010013531; Watson RT, 2000, LAND USE LAND USE CH; Zhang Q, 2001, AMBIO, V30, P351, DOI 10.1639/0044-7447(2001)030[0351:CEASPO]2.0.CO;2	28	1258	1338	9	548	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2002	297	5583					999	1002		10.1126/science.1070656	http://dx.doi.org/10.1126/science.1070656			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169731				2022-12-28	WOS:000177325400041
J	Batson, PE; Dellby, N; Krivanek, OL				Batson, PE; Dellby, N; Krivanek, OL			Sub-angstrom resolution using aberration corrected electron optics	NATURE			English	Article							MICROSCOPY; STEM	Following the invention of electron optics during the 1930s, lens aberrations have limited the achievable spatial resolution to about 50 times the wavelength of the imaging electrons(1). This situation is similar to that faced by Leeuwenhoek in the seventeenth century, whose work to improve the quality of glass lenses led directly to his discovery of the ubiquitous "animalcules" in canal water, the first hints of the cellular basis of life. The electron optical aberration problem was well understood from the start, but more than 60 years elapsed before a practical correction scheme for electron microscopy was demonstrated 2, and even then the remaining chromatic aberrations still limited the resolution. We report here the implementation of a computer-controlled aberration correction system in a scanning transmission electron microscope(3), which is less sensitive to chromatic aberration. Using this approach, we achieve an electron probe smaller than 1 Angstrom. This performance, about 20 times the electron wavelength at 120 keV energy, allows dynamic imaging of single atoms, clusters of a few atoms, and single atomic layer 'rafts' of atoms coexisting with Au islands on a carbon substrate. This technique should also allow atomic column imaging of semiconductors, for detection of single dopant atoms, using an electron beam with energy below the damage threshold for silicon.	IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA; Nion R&D, Kirkland, WA 98033 USA	International Business Machines (IBM)	Batson, PE (corresponding author), IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA.		Batson, Philip E/C-3107-2012					BATSON PE, 1993, PHYS REV LETT, V70, P1822, DOI 10.1103/PhysRevLett.70.1822; BATSON PE, 1993, NATURE, V366, P727, DOI 10.1038/366727a0; Batson PE, 2000, PHYS REV B, V61, P16633, DOI 10.1103/PhysRevB.61.16633; BROWNING ND, 1993, NATURE, V366, P143, DOI 10.1038/366143a0; CREWE AV, 1970, SCIENCE, V168, P1338, DOI 10.1126/science.168.3937.1338; CREWE AV, 1969, REV SCI INSTRUM, V40, P241, DOI 10.1063/1.1683910; CREWE AV, 1971, REV SCI INSTRUM, V42, P411, DOI 10.1063/1.1685116; Dellby N, 2001, J ELECTRON MICROSC, V50, P177, DOI 10.1093/jmicro/50.3.177; Haider M, 1998, NATURE, V392, P768, DOI 10.1038/33823; Kawasaki T, 2000, J ELECTRON MICROSC, V49, P711, DOI 10.1093/oxfordjournals.jmicro.a023863; Kirkland E. J., 2020, ADV COMPUTING ELECT, V3, DOI 10.1007/978-1-4419-6533-2#; MULLER DA, 1993, NATURE, V366, P725, DOI 10.1038/366725a0; O'Keefe MA, 2001, ULTRAMICROSCOPY, V89, P215, DOI 10.1016/S0304-3991(01)00094-8; PENNYCOOK SJ, 1988, NATURE, V336, P565, DOI 10.1038/336565a0; RONCHI V, 1964, APPL OPTICS, V3, P437, DOI 10.1364/AO.3.000437; SCHERZER O, 1949, J APPL PHYS, V20, P20, DOI 10.1063/1.1698233; Voyles PM, 2002, NATURE, V416, P826, DOI 10.1038/416826a; XU PR, 1990, ULTRAMICROSCOPY, V32, P93, DOI 10.1016/0304-3991(90)90027-J; Zhang ZY, 1997, SCIENCE, V276, P377, DOI 10.1126/science.276.5311.377; Zuo JM, 1999, NATURE, V401, P49, DOI 10.1038/43403	20	675	685	5	267	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2002	418	6898					617	620		10.1038/nature00972	http://dx.doi.org/10.1038/nature00972			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167855				2022-12-28	WOS:000177305600036
J	Koro, CE; Fedder, DO; L'Italien, GJ; Weiss, SS; Magder, LS; Kreyenbuhl, J; Revicki, DA; Buchanan, RW				Koro, CE; Fedder, DO; L'Italien, GJ; Weiss, SS; Magder, LS; Kreyenbuhl, J; Revicki, DA; Buchanan, RW			Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INDUCED WEIGHT-GAIN; ANTIPSYCHOTIC-DRUGS; PHARMACOVIGILANCE; HYPERGLYCEMIA; INSULIN	Objective To quantify the association between olanzapine and diabetes. Design Population based nested case-control study. Setting United Kingdom based General Practice Research Database comprising 3.5 million patients followed between 1987 and 2000. Participants 19 637 patients who had been diagnosed as having and treated for schizophrenia. 451 incident cases of diabetes were matched with 2696 controls. Main-outcome measures Diagnosis and treatment of diabetes. Results Patients taking olanzapine had a significantly increased risk of developing diabetes than non-users of antipsychotics (odds ratio 5.8, 95% confidence interval 2.0 to 16.7) and those taking conventional antipsychotics (4.2, 1.5 to 12.2). Patients taking risperidone had a non-significant increased risk of developing diabetes than non-users of antipsychotics (2.2,0.9 to 5.2) and those taking conventional antipsychotics (1.6, 0.7 to 3.8). Conclusion Olanzapine is associated with a clinically important and significant increased risk of diabetes.	Univ Maryland, Sch Pharm, Pharmaceut Hlth Serv Res Dept, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Baltimore, MD 21201 USA; Univ Maryland, Mental Illness Res Educ & Clin Ctr, VA Capital Network, Baltimore, MD 21201 USA; Univ Maryland, Maryland Psychiat Res Ctr, Baltimore, MD 21201 USA; Bristol Myers Squibb Co, Pharmaceut Res Inst, Decis Sci Outcomes Res, Wallingford, CT 06492 USA; MEDTAP Int, Ctr Hlth Outcomes, Bethesda, MD 20814 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Bristol-Myers Squibb	Koro, CE (corresponding author), Univ Maryland, Sch Pharm, Pharmaceut Hlth Serv Res Dept, Baltimore, MD 21201 USA.	ckoro001@umaryland.edu	Kreyenbuhl, Julie/GXM-4729-2022	Kreyenbuhl, Julie/0000-0003-3605-3123				Allison DB, 1999, AM J PSYCHIAT, V156, P1686; BERNSTEIN JG, 1988, CLIN NEUROPHARMACOL, V11, pS194; Bettinger TL, 2000, ANN PHARMACOTHER, V34, P865, DOI 10.1345/aph.19327; Biswas PN, 2001, J PSYCHOPHARMACOL, V15, P265, DOI 10.1177/026988110101500405; CARO J, 2000, VALUE HLTH, V3, pMH2; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; Coulter DM, 2001, BMJ-BRIT MED J, V322, P1207, DOI 10.1136/bmj.322.7296.1207; ELLIS S, 1965, PHARMACOL REV, V8, P485; Fertig MK, 1998, J CLIN PSYCHIAT, V59, P687, DOI 10.4088/JCP.v59n1208c; GOODALL E, 1988, BRIT J PSYCHIAT, V153, P208, DOI 10.1192/bjp.153.2.208; HOLBROOK TL, 1989, INT J OBESITY, V13, P723; HOWARTH PH, 1984, BRIT J CLIN PHARMACO, V18, P1; Isojarvi JIT, 1998, ANN NEUROL, V43, P446, DOI 10.1002/ana.410430406; Kane JM, 1999, BIOL PSYCHIAT, V46, P1396, DOI 10.1016/S0006-3223(99)00059-1; KLEINBAUM GG, 1994, LOGISTIC REGRESSION; Lawson DH, 1998, QJM-MON J ASSOC PHYS, V91, P445, DOI 10.1093/qjmed/91.6.445; Lieberman JA, 2000, PSYCHIAT SERV, V51, P1254, DOI 10.1176/appi.ps.51.10.1254; Lindenmayer JP, 1999, AM J PSYCHIAT, V156, P1471; Melkersson KI, 2000, J CLIN PSYCHIAT, V61, P742, DOI 10.4088/JCP.v61n1006; Melkersson KI, 1999, J CLIN PSYCHIAT, V60, P783, DOI 10.4088/JCP.v60n1112; Meyer JM, 2001, BIOL PSYCHIAT, V49, P536; NAZARETH I, 1993, BRIT MED J, V307, P32, DOI 10.1136/bmj.307.6895.32; Ober SK, 1999, AM J PSYCHIAT, V156, P970, DOI 10.1176/ajp.156.6.970; Rigalleau V, 2000, DIABETIC MED, V17, P484, DOI 10.1046/j.1464-5491.2000.00296.x; THONNARDNEUMANN E, 1968, AM J PSYCHIAT, V124, P978, DOI 10.1176/ajp.124.7.978; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; Wirshing DA, 1998, BIOL PSYCHIAT, V44, P778, DOI 10.1016/S0006-3223(98)00100-0; WYNN V, 1982, AM J OBSTET GYNECOL, V142, P739	28	306	315	1	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2002	325	7358					243	245		10.1136/bmj.325.7358.243	http://dx.doi.org/10.1136/bmj.325.7358.243			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582FL	12153919	Green Published, Bronze			2022-12-28	WOS:000177339000016
J	Giovannucci, E; Pollak, M				Giovannucci, E; Pollak, M			Risk of cancer after growth-hormone treatment	LANCET			English	Editorial Material							FACTOR-I; COLORECTAL NEOPLASIA; BINDING PROTEIN-3; PROSTATE-CANCER; FACTOR (IGF)-I; BREAST-CANCER; MORTALITY; COHORT; WOMEN; MEN		Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; McGill Univ, Jewish Gen Hosp, Dept Med, Canc Prevent Res Unit, Montreal, PQ H3T 1E2, Canada; McGill Univ, Jewish Gen Hosp, Dept Oncol, Montreal, PQ H3T 1E2, Canada; McGill Univ, Montreal, PQ, Canada	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; McGill University; McGill University; McGill University	Giovannucci, E (corresponding author), Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02115 USA.		Pollak, Michael/G-9094-2011	Pollak, Michael/0000-0003-3047-0604				Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; Christiansen JS, 2001, J CLIN ENDOCR METAB, V86, P1868; Giovannucci E, 2000, CANCER EPIDEM BIOMAR, V9, P345; Gunnell D, 2001, EPIDEMIOL REV, V23, P313, DOI 10.1093/oxfordjournals.epirev.a000809; Gunnell DJ, 1998, BRIT MED J, V317, P1350, DOI 10.1136/bmj.317.7169.1350; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Jenkins PJ, 2000, J CLIN ENDOCR METAB, V85, P3218, DOI 10.1210/jc.85.9.3218; Kaaks R, 2000, JNCI-J NATL CANCER I, V92, P1592, DOI 10.1093/jnci/92.19.1592; Le Marchand L, 2002, JNCI-J NATL CANCER I, V94, P454, DOI 10.1093/jnci/94.6.454; Lee KW, 2001, HORM RES, V56, P29, DOI 10.1159/000048131; Ma J, 1999, J NATL CANCER I, V91, P620, DOI 10.1093/jnci/91.7.620; MILLER AB, 1989, NEW ENGL J MED, V321, P1285, DOI 10.1056/NEJM198911093211902; Orme SM, 1998, J CLIN ENDOCR METAB, V83, P2730, DOI 10.1210/jc.83.8.2730; Pollak M, 2001, EPIDEMIOL REV, V23, P59, DOI 10.1093/oxfordjournals.epirev.a000796; Pollak MN, 1998, P SOC EXP BIOL MED, V217, P143; RUDMAN D, 1990, NEW ENGL J MED, V323, P1, DOI 10.1056/NEJM199007053230101; van der Lely AJ, 2001, LANCET, V358, P1754, DOI 10.1016/S0140-6736(01)06844-1; Wetterau L, 2000, J PEDIATR ENDOCR MET, V13, P1371	18	19	20	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 27	2002	360	9329					268	269		10.1016/S0140-6736(02)09561-2	http://dx.doi.org/10.1016/S0140-6736(02)09561-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578DT	12147365	Green Submitted			2022-12-28	WOS:000177102700003
J	Black, DE				Black, DE			Climate variability - The rains may be a-coming	SCIENCE			English	Editorial Material							TEMPERATURES; MILLENNIUM; CENTURIES		Univ Akron, Dept Geol, Akron, OH 44325 USA	University of Akron	Black, DE (corresponding author), Univ Akron, Dept Geol, Akron, OH 44325 USA.							ALTABET MA, 1995, NATURE, V373, P506, DOI 10.1038/373506a0; Anderson DM, 2002, SCIENCE, V297, P596, DOI 10.1126/science.1072881; Bradley R. S., 1995, CLIMATE AD 1500; Clemens SC, 1996, SCIENCE, V274, P943, DOI 10.1126/science.274.5289.943; Clement AC, 2000, PALEOCEANOGRAPHY, V15, P731, DOI 10.1029/1999PA000466; Cole JE, 2000, SCIENCE, V287, P617, DOI 10.1126/science.287.5453.617; EDDY JA, 1976, SCIENCE, V192, P1189, DOI 10.1126/science.192.4245.1189; HODELL DA, 1995, NATURE, V375, P391, DOI 10.1038/375391a0; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Jones PD, 2001, SCIENCE, V292, P662, DOI 10.1126/science.1059126; Liu KB, 1998, GEOLOGY, V26, P135, DOI 10.1130/0091-7613(1998)026<0135:APROHC>2.3.CO;2; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; Overpeck J, 1997, SCIENCE, V278, P1251, DOI 10.1126/science.278.5341.1251; Prell W.L., 1992, SYNTHESIS RESULTS SC, DOI [DOI 10.1029/GM070P0447, 10.1029/GM070p0447]; RAMAGE CS, 1971, INT GEOPHYSICAL SERI, V15; Sirocko F, 1996, SCIENCE, V272, P526, DOI 10.1126/science.272.5261.526	16	10	13	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2002	297	5581					528	529		10.1126/science.1074379	http://dx.doi.org/10.1126/science.1074379			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577GY	12142516				2022-12-28	WOS:000177054200028
J	Hara, K; Maruki, Y; Long, XM; Yoshino, K; Oshiro, N; Hidayat, S; Tokunaga, C; Avruch, J; Yonezawa, K				Hara, K; Maruki, Y; Long, XM; Yoshino, K; Oshiro, N; Hidayat, S; Tokunaga, C; Avruch, J; Yonezawa, K			Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action	CELL			English	Article							P70 S6 KINASE; MESSENGER-RNA TRANSLATION; MAMMALIAN TARGET; AMINO-ACID; PHAS-I; EIF-4E BP1; WD-REPEAT; YEAST TOR; PROTEIN; PHOSPHORYLATION	mTOR controls cell growth, in part by regulating p70 S6 kinase alpha (p70alpha) and eukaryotic initiation factor 4E binding protein 1 (4EBP1). Raptor is a 150 kDa mTOR binding protein that also binds 4EBP1 and p70alpha. The binding of raptor to mTOR is necessary for the mTOR-catalyzed phosphorylation of 4EBP1 in vitro, and it strongly enhances the mTOR kinase activity toward p70alpha. Rapamycin or amino acid withdrawal increases, whereas insulin strongly inhibits, the recovery of 4EBP1 and raptor on 7-methyl-GTP Sepharose. Partial inhibition of raptor expression by RNA interference (RNAi) reduces mTOR-catalyzed 4EBP1 phosphorylation in vitro. RNAi of C. elegans raptor yields an array of phenotypes that closely resemble those produced by inactivation of Ce-TOR. Thus, raptor is an essential scaffold for the mTOR-catalyzed phosphorylation of 4EBP1 and mediates TOR action in vivo.	Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan; Harvard Univ, Sch Med, Dept Med, Massachusetts Gen Hosp,Dept Mol Biol, Boston, MA 02114 USA	Kobe University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Hara, K (corresponding author), Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan.	harak@kobe-u.ac.jp; yonezawa@kobe-u.ac.jp	Long, Samuel/AAR-8118-2021	Long, Samuel/0000-0001-7559-3232	NCI NIH HHS [R01 CA73818B 06] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA073818] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Avruch J, 2001, Prog Mol Subcell Biol, V26, P115; Barbe E., 1996, MEDITERR POLIT, V1, P25; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; BRENNER S, 1974, GENETICS, V77, P71; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fox HL, 1998, AM J PHYSIOL-CELL PH, V274, pC206, DOI 10.1152/ajpcell.1998.274.1.C206; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Gout I, 1998, J BIOL CHEM, V273, P30061, DOI 10.1074/jbc.273.46.30061; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; Koh H, 1999, ONCOGENE, V18, P5115, DOI 10.1038/sj.onc.1202895; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Lawrence JC, 1997, TRENDS BIOCHEM SCI, V22, P345, DOI 10.1016/S0968-0004(97)01101-8; Lee-Fruman KK, 1999, ONCOGENE, V18, P5108, DOI 10.1038/sj.onc.1202894; LONG X, 2002, IN PRESS CURR BIOL, V12; Minami T, 2001, GENES CELLS, V6, P1003, DOI 10.1046/j.1365-2443.2001.00479.x; Mothe-Satney I, 2000, J BIOL CHEM, V275, P33836, DOI 10.1074/jbc.M006005200; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Nanahoshi M, 1999, FEBS LETT, V446, P108, DOI 10.1016/S0014-5793(99)00189-1; Nishiuma T, 1998, BIOCHEM BIOPH RES CO, V252, P440, DOI 10.1006/bbrc.1998.9671; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Saitoh M, 1998, BIOCHEM BIOPH RES CO, V253, P470, DOI 10.1006/bbrc.1998.9784; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Shigemitsu K, 1999, J BIOL CHEM, V274, P1058, DOI 10.1074/jbc.274.2.1058; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Shinozaki-Yabana S, 2000, MOL CELL BIOL, V20, P1234, DOI 10.1128/MCB.20.4.1234-1242.2000; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Sonenberg N, 1996, TRANSLATIONAL CONTRO, P245; Takahashi T, 2000, GENES CELLS, V5, P765, DOI 10.1046/j.1365-2443.2000.00365.x; Tang H, 2001, MOL CELL BIOL, V21, P8671, DOI 10.1128/MCB.21.24.8671-8683.2001; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Wang XM, 1998, BIOCHEM J, V334, P261, DOI 10.1042/bj3340261; Weisman R, 2001, J BIOL CHEM, V276, P7027, DOI 10.1074/jbc.M010446200; Xu G, 1998, J BIOL CHEM, V273, P28178, DOI 10.1074/jbc.273.43.28178; ZAKIAN VA, 1995, CELL, V82, P685, DOI 10.1016/0092-8674(95)90463-8; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000	57	1365	1437	4	121	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 26	2002	110	2					177	189		10.1016/S0092-8674(02)00833-4	http://dx.doi.org/10.1016/S0092-8674(02)00833-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	578EV	12150926	Bronze			2022-12-28	WOS:000177105200006
J	Christianson, AL; Canton, N				Christianson, AL; Canton, N			More stories	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		Scheetz A, 2000, JAMA-J AM MED ASSOC, V283, P1934, DOI 10.1001/jama.283.15.1934	1	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2002	288	8					931	931		10.1001/jama.288.8.931	http://dx.doi.org/10.1001/jama.288.8.931			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587RM	12190350				2022-12-28	WOS:000177656400001
J	Enard, W; Przeworski, M; Fisher, SE; Lai, CSL; Wiebe, V; Kitano, T; Monaco, AP; Paabo, S				Enard, W; Przeworski, M; Fisher, SE; Lai, CSL; Wiebe, V; Kitano, T; Monaco, AP; Paabo, S			Molecular evolution of FOXP2, a gene involved in speech and language	NATURE			English	Article							DNA POLYMORPHISM; POPULATION-SIZE; DISORDER; LIKELIHOOD; SELECTION; SEQUENCES; PROGRAM; TESTS	Language is a uniquely human trait likely to have been a prerequisite for the development of human culture. The ability to develop articulate speech relies on capabilities, such as fine control of the larynx and mouth(1), that are absent in chimpanzees and other great apes. FOXP2 is the first gene relevant to the human ability to develop language(2). A point mutation in FOXP2 co-segregates with a disorder in a family in which half of the members have severe articulation difficulties accompanied by linguistic and grammatical impairment(3). This gene is disrupted by translocation in an unrelated individual who has a similar disorder. Thus, two functional copies of FOXP2 seem to be required for acquisition of normal spoken language. We sequenced the complementary DNAs that encode the FOXP2 protein in the chimpanzee, gorilla, orang-utan, rhesus macaque and mouse, and compared them with the human cDNA. We also investigated intraspecific variation of the human FOXP2 gene. Here we show that human FOXP2 contains changes in amino-acid coding and a pattern of nucleotide polymorphism, which strongly suggest that this gene has been the target of selection during recent human evolution.	Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	Max Planck Society; University of Oxford; Wellcome Centre for Human Genetics	Paabo, S (corresponding author), Max Planck Inst Evolutionary Anthropol, Inselstr 22, D-04103 Leipzig, Germany.		Enard, Wolfgang/K-3483-2014; Fisher, Simon E./E-9130-2012; Monaco, Anthony P/A-4495-2010	Fisher, Simon E./0000-0002-3132-1996; Monaco, Anthony P/0000-0001-7480-3197				Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P217, DOI 10.1093/nar/25.1.217; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Eizirik E, 2001, J HERED, V92, P212, DOI 10.1093/jhered/92.2.212; Fay JC, 2000, GENETICS, V155, P1405; Fisher SE, 1998, NAT GENET, V18, P168, DOI 10.1038/ng0298-168; GOPNIK M, 1991, COGNITION, V39, P1, DOI 10.1016/0010-0277(91)90058-C; Harpending H, 2000, ANNU REV GENOM HUM G, V1, P361, DOI 10.1146/annurev.genom.1.1.361; Jensen MA, 2002, GENETICS, V160, P493; KLEIN G, 1989, HUMAN CAREER HUMAN B; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Liebermann P, 1984, BIOL EVOLUTION LANGU; Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407; Newbury DF, 2002, AM J HUM GENET, V70, P1318, DOI 10.1086/339931; Przeworski M, 2002, GENETICS, V160, P1179; Rost B, 1996, METHOD ENZYMOL, V266, P525; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; SIMONSEN KL, 1995, GENETICS, V141, P413; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VARGHAKHADEM F, 1995, P NATL ACAD SCI USA, V92, P930, DOI 10.1073/pnas.92.3.930; Wall JD, 2000, GENETICS, V155, P1865; Watkins KE, 2002, BRAIN, V125, P452, DOI 10.1093/brain/awf058; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957	30	944	990	12	415	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2002	418	6900					869	872		10.1038/nature01025	http://dx.doi.org/10.1038/nature01025			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192408	Green Published			2022-12-28	WOS:000177555600036
J	Howell, CJ; Dean, T; Lucking, L; Dziedzic, K; Jones, PW; Johanson, RB				Howell, CJ; Dean, T; Lucking, L; Dziedzic, K; Jones, PW; Johanson, RB			Randomised study of long term outcome after epidural versus non-epidural analgesia during labour	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOW-BACK-PAIN; ANESTHESIA	Objective To determine whether epidural analgesia during labour is associated with long term backache. Design Follow up after randomised controlled trial. Analysis by intention to treat. Setting Department of obstetrics and gynaecology at one NHS trust. Participants 369 women: 184 randomised to epidural group (treatment as allocated received by 123) and 185 randomised to non-epidural group (treatment as allocated received by 133). In the follow up study 151 women were from the epidural group and 155 from the non-epidural group. Main outcome measures Self reported low back pain, disability, and limitation of movement assessed through one to one interviews with physiotherapist, questionnaire on back pain and disability, physical measurements of spinal mobility. Results There were no significant differences between groups in demographic details or other key characteristics. The mean time interval from delivery to interview was 26 months. There were no significant differences in the onset or duration of low back pain, with nearly a third of women in each group reporting pain in the week before interview. There were no differences in self reported measures of disability in activities of daily living and no significant differences in measurements of spinal mobility. Conclusions After childbirth there are no differences in the incidence of long term low back pain, disability, or movement restriction between women who receive epidural pain relief and women who receive other forms of pain relief.	N Staffordshire Hosp NHS Trust, Acad Dept Obstet & Gynaecol, Stoke On Trent ST4 6QG, Staffs, England; Haywood Hosp, Staffordshire Rheumatol Ctr, Physiotherapy Dept, Stoke On Trent ST6 7AG, Staffs, England; Univ Keele, Dept Physiotherapy Studies, Keele ST5 5BG, Staffs, England; Univ Keele, Primary Care Sci Res Ctr, Keele ST5 5BG, Staffs, England; Univ Keele, Dept Math, Keele ST5 5BG, Staffs, England	University Hospital of North Staffordshire NHS Trust; Keele University; Keele University; Keele University	Howell, CJ (corresponding author), N Staffordshire Hosp NHS Trust, Acad Dept Obstet & Gynaecol, Stoke On Trent ST4 6QG, Staffs, England.	charlotte@kogs.freeserve.co.uk						BREEN TW, 1994, ANESTHESIOLOGY, V81, P29, DOI 10.1097/00000542-199407000-00006; Chamberlain G, 1993, PAIN ITS RELIEF CHIL; GAUVIN MG, 1990, PHYS THER, V70, P443, DOI 10.1093/ptj/70.7.443; Howell C.J, 2000, COCHRANE DB SYST REV; Howell CJ, 2001, BRIT J OBSTET GYNAEC, V108, P27, DOI 10.1016/S0306-5456(00)00012-7; MACARTHUR A, 1995, BRIT MED J, V311, P1336, DOI 10.1136/bmj.311.7016.1336; Macarthur AJ, 1997, ANESTH ANALG, V85, P1066, DOI 10.1097/00000539-199711000-00019; MACARTHUR C, 1993, BRIT MED J, V307, P64, DOI 10.1136/bmj.307.6895.64; MACARTHUR C, 1990, BRIT MED J, V301, P9, DOI 10.1136/bmj.301.6742.9; MacLeod J, 1995, Int J Obstet Anesth, V4, P21, DOI 10.1016/0959-289X(95)82164-6; MACRAE IF, 1969, ANN RHEUM DIS, V28, P584, DOI 10.1136/ard.28.6.584; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; ORVIETO R, 1994, ACTA OBSTET GYN SCAN, V73, P209, DOI 10.3109/00016349409023441; OSTGAARD HC, 1992, SPINE, V17, P53, DOI 10.1097/00007632-199201000-00008; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; RUSSELL R, 1993, BRIT MED J, V306, P1299, DOI 10.1136/bmj.306.6888.1299; SCOTT DB, 1990, BRIT J ANAESTH, V64, P537, DOI 10.1093/bja/64.5.537; SVENSSON HO, 1990, SPINE, V15, P371, DOI 10.1097/00007632-199005000-00006; WADDELL G, 1992, SPINE, V17, P617, DOI 10.1097/00007632-199206000-00001; WADDELL G, 1991, CLIN EVALUATION DISA, P155	20	54	58	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 17	2002	325	7360					357	359		10.1136/bmj.325.7360.357	http://dx.doi.org/10.1136/bmj.325.7360.357			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587DV	12183305	Green Published, Bronze			2022-12-28	WOS:000177626000016
J	Ballschmiter, K				Ballschmiter, K			Atmospheric chemistry: A marine source for alkyl nitrates	SCIENCE			English	Editorial Material							METHYL NITRATE; AIR		Univ Ulm, Dept Analyt & Environm Chem, D-89081 Ulm, Germany	Ulm University	Ballschmiter, K (corresponding author), Univ Ulm, Dept Analyt & Environm Chem, D-89081 Ulm, Germany.							ATLAS E, 1988, NATURE, V331, P426, DOI 10.1038/331426a0; ATLAS E, 1997, EOS S, V78, P46; Blake NJ, 1999, J GEOPHYS RES-ATMOS, V104, P21803, DOI 10.1029/1999JD900238; Chuck AL, 2002, SCIENCE, V297, P1151, DOI 10.1126/science.1073896; FAN SM, 1994, J GEOPHYS RES-ATMOS, V99, P16867, DOI 10.1029/94JD01122; Fischer R, 2002, CHEMOSPHERE, V48, P981, DOI 10.1016/S0045-6535(02)00110-8; Fischer RG, 2000, J GEOPHYS RES-ATMOS, V105, P14473, DOI 10.1029/1999JD900780; Flocke F, 1998, J GEOPHYS RES-ATMOS, V103, P5729, DOI 10.1029/97JD03461; Flocke F, 1998, GEOPHYS RES LETT, V25, P1891, DOI 10.1029/98GL01417; Jones AE, 1999, J GEOPHYS RES-ATMOS, V104, P21355, DOI 10.1029/1999JD900362; ORLANDO JJ, 1992, ATMOS ENVIRON A-GEN, V26, P3111, DOI 10.1016/0960-1686(92)90468-Z; Schneider M, 1998, ENVIRON SCI TECHNOL, V32, P3055, DOI 10.1021/es980132g; Urhahn T, 1998, CHEMOSPHERE, V37, P1017, DOI 10.1016/S0045-6535(98)00100-3; Werner G, 1999, ANGEW CHEM INT EDIT, V38, P1634, DOI 10.1002/(SICI)1521-3773(19990601)38:11<1634::AID-ANIE1634>3.0.CO;2-C	14	16	16	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2002	297	5584					1127	1128		10.1126/science.1075470	http://dx.doi.org/10.1126/science.1075470			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183612				2022-12-28	WOS:000177447600029
J	Doligez, B; Danchin, E; Clobert, J				Doligez, B; Danchin, E; Clobert, J			Public information and breeding habitat selection in a wild bird population	SCIENCE			English	Article							CONSPECIFIC REPRODUCTIVE SUCCESS; FLYCATCHER FICEDULA-ALBICOLLIS; PHALACROCORAX-CARBO SINENSIS; IDEAL FREE DISTRIBUTION; COLLARED FLYCATCHER; GREAT CORMORANT; TITS; COLONIALITY; RECRUITMENT; SURVIVAL	According to the public information hypothesis, some animal species may monitor the current reproductive success of conspecifics to assess local habitat quality and to choose their own subsequent breeding site. To test this hypothesis experimentally, we manipulated two components of public information, the mean number of offspring raised locally ( quantity) and their condition ( quality), in the collared flycatcher Ficedula albicollis. Immigration rate decreased with local offspring quantity but did not depend on local offspring quality, suggesting that immigrants are deprived of information regarding local quality. Conversely, emigration rate increased both when local offspring quantity or quality decreased, suggesting that residents can use both components of public information.	Univ Paris 06, Ecol Lab, CNRS, UMR 7625, F-75252 Paris 05, France; Uppsala Univ, Dept Anim Ecol, Ctr Evolutionary Biol, S-75236 Uppsala, Sweden	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Uppsala University	Doligez, B (corresponding author), Univ Bern, Inst Zool, Dept Evolutionary Ecol, Baltzerstr 6, CH-3012 Bern, Switzerland.		Doligez, Blandine/ABB-5977-2020; Danchin, Etienne/A-2299-2009; Danchin, Etienne/AAB-2091-2021	Doligez, Blandine/0000-0003-3015-5022; Danchin, Etienne/0000-0002-5013-9612				Boulinier T, 1996, J AVIAN BIOL, V27, P252, DOI 10.2307/3677230; Boulinier T, 1997, EVOL ECOL, V11, P505, DOI 10.1007/s10682-997-1507-0; Boulinier T, 2002, J APPL STAT, V29, P509, DOI 10.1080/02664760120108566; Brown CR, 2000, J ANIM ECOL, V69, P133, DOI 10.1046/j.1365-2656.2000.00382.x; Caro T, 1999, TRENDS ECOL EVOL, V14, P366, DOI 10.1016/S0169-5347(99)01663-8; Clobert J, 1995, J APPL STAT, V22, P989, DOI 10.1080/02664769524757; Colbert J, 2001, DISPERSAL; Danchin E, 1998, ECOLOGY, V79, P2415, DOI 10.2307/176832; Danchin E, 1997, TRENDS ECOL EVOL, V12, P342, DOI 10.1016/S0169-5347(97)01124-5; Danchin E, 2000, SCIENCE, V287, P804; Danchin Etienne, 2001, P243; Doligez B, 1999, J ANIM ECOL, V68, P1193, DOI 10.1046/j.1365-2656.1999.00362.x; DOLIGEZ B, UNPUB; Frederiksen M, 2001, P ROY SOC B-BIOL SCI, V268, P1519, DOI 10.1098/rspb.2001.1701; Giraldeau Luc-Alain, 1997, P42; GRAY RD, 1994, ANIM BEHAV, V47, P469, DOI 10.1006/anbe.1994.1064; GUSTAFSSON L, 1988, NATURE, V335, P813, DOI 10.1038/335813a0; Gustafsson L., 1989, P75; Houston AI, 1998, ANIM BEHAV, V56, P243, DOI 10.1006/anbe.1998.0773; Johnstone RA, 1999, BEHAV ECOL SOCIOBIOL, V45, P277, DOI 10.1007/s002650050562; Lahti K, 1998, BEHAV ECOL, V9, P122, DOI 10.1093/beheco/9.2.122; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; LINDEN M, 1992, ECOLOGY, V73, P336, DOI 10.2307/1938745; Naef-Daenzer B, 2001, J ANIM ECOL, V70, P730, DOI 10.1046/j.0021-8790.2001.00533.x; PART T, 1994, ANIM BEHAV, V48, P401, DOI 10.1006/anbe.1994.1254; PART T, 1989, J ANIM ECOL, V58, P305, DOI 10.2307/5002; Pettifor RA, 2001, J ANIM ECOL, V70, P62, DOI 10.1046/j.1365-2656.2001.00465.x; Reed J. Michael, 1999, Current Ornithology, V15, P189; Schjorring S, 1999, ANIM BEHAV, V57, P647, DOI 10.1006/anbe.1998.0993; SLAGSVOLD T, 1990, POPULATION BIOL PASS, P441; Sutherland WJ, 1998, ANIM BEHAV, V56, P801, DOI 10.1006/anbe.1998.0896; VALONE TJ, 1993, ANIM BEHAV, V45, P721, DOI 10.1006/anbe.1993.1086	32	372	380	1	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2002	297	5584					1168	1170		10.1126/science.1072838	http://dx.doi.org/10.1126/science.1072838			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183627				2022-12-28	WOS:000177447600046
J	Linnartz, H; Verdes, D; Maier, JP				Linnartz, H; Verdes, D; Maier, JP			Rotationally resolved infrared spectrum of the charge transfer complex [Ar-N-2](+)	SCIENCE			English	Article							IONIC CLUSTERS; SPECTROSCOPY; PHOTODISSOCIATION; DYNAMICS; RADICALS; N-4(+); ARGON	Difficulties in preparing cluster ions for spectroscopic studies have limited our understanding of intermolecular forces in charged complexes that are typical of many reactive intermediates. Here, the infrared spectrum of the charge transfer complex [Ar-N-2](+), recorded in a supersonic planar plasma with a tunable diode laser spectrometer, is presented. More than 70 adjacent rovibrational transitions were measured near 2272 wave numbers and assigned to the molecular nitrogen stretching fundamental in the (2)Sigma(+) ground state of [Ar-N-2](+). The accurate structural parameters that were determined confirm a linear structure and show that the major part of the charge is located at the argon atom. The latter result is surprising and implies a charge switch of the cationic center upon complexation.	Dept Chem, CH-4056 Basel, Switzerland		Linnartz, H (corresponding author), Dept Chem, Klingelbergstr 80, CH-4056 Basel, Switzerland.							Bieske EJ, 2000, CHEM REV, V100, P3963, DOI 10.1021/cr990064w; Candori R, 2001, J CHEM PHYS, V115, P8888, DOI 10.1063/1.1413980; CLARY DC, 1989, J CHEM PHYS, V90, P1686, DOI 10.1063/1.456061; Davis S, 1997, J CHEM PHYS, V107, P5661, DOI 10.1063/1.474259; FRECER V, 1991, J PHYS CHEM-US, V95, P9263, DOI 10.1021/j100176a043; Herzberg G., 1989, MOL SPECTRA MOL STRU, V2nd, P660; HIRAOKA K, 1992, CHEM PHYS LETT, V189, P7, DOI 10.1016/0009-2614(92)85144-Y; KIM HS, 1990, J CHEM PHYS, V93, P1158, DOI 10.1063/1.459179; Langenberg JH, 1997, CHEM PHYS, V221, P225, DOI 10.1016/S0301-0104(97)00143-2; LIAS SG, 1988, J PHYS CHEM REF DATA, V17, P1; Linnartz H, 2000, J CHEM PHYS, V113, P895, DOI 10.1063/1.481868; Linnartz H, 2000, REV SCI INSTRUM, V71, P1811, DOI 10.1063/1.1150541; MAGNERA TF, 1992, CHEM PHYS LETT, V192, P99, DOI 10.1016/0009-2614(92)85435-D; MAHNERT J, 1995, J CHEM PHYS, V102, P180, DOI 10.1063/1.469389; Motylewski T, 1999, REV SCI INSTRUM, V70, P1305, DOI 10.1063/1.1149589; Ruchti T, 1996, J CHEM PHYS, V105, P2591, DOI 10.1063/1.472124; SCHULTZ RH, 1991, CHEM PHYS LETT, V179, P429, DOI 10.1016/0009-2614(91)87081-L; SONNENFROH DM, 1989, J CHEM PHYS, V90, P1677, DOI 10.1063/1.456673; Verdes D, 1999, J CHEM PHYS, V111, P8400, DOI 10.1063/1.480181; VIGGIANO AA, 1993, J CHEM PHYS, V99, P3527; Weitzel KM, 2002, INT J MASS SPECTROM, V214, P175, DOI 10.1016/S1387-3806(02)00522-5; Wormer PES, 2000, CHEM REV, V100, P4109, DOI 10.1021/cr990046e	22	26	26	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2002	297	5584					1166	1167		10.1126/science.1074201	http://dx.doi.org/10.1126/science.1074201			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183626				2022-12-28	WOS:000177447600045
J	Schwartz, R				Schwartz, R			Perspective - A molecular star in the wars against cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	8	9	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 15	2002	347	7					462	463		10.1056/NEJMp020079	http://dx.doi.org/10.1056/NEJMp020079			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587ZM	12181399				2022-12-28	WOS:000177674400001
J	Glassman, AH; O'Connor, CM; Califf, RM; Swedberg, K; Schwartz, P; Bigger, JT; Krishnan, KRR; van Zyl, LT; Swenson, JR; Finkel, MS; Landau, C; Shapiro, PA; Pepine, CJ; Mardekian, J; Harrison, WM				Glassman, AH; O'Connor, CM; Califf, RM; Swedberg, K; Schwartz, P; Bigger, JT; Krishnan, KRR; van Zyl, LT; Swenson, JR; Finkel, MS; Landau, C; Shapiro, PA; Pepine, CJ; Mardekian, J; Harrison, WM		SADHART Grp	Sertraline treatment of major depression in patients with acute MI or unstable angina	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-HEART-DISEASE; SEROTONIN REUPTAKE INHIBITORS; DOUBLE-BLIND; RISK; MORTALITY; PROGNOSIS; SYMPTOMS; EFFICACY; TRIAL	Context Major depressive disorder (MDD) occurs in 15% to 23% of patients with acute coronary syndromes and constitutes an independent risk factor for morbidity and mortality. However,no published evidence exists that antidepressant drugs are safe or efficacious in patients with unstable ischemic heart disease. Objective To evaluate the safety and efficacy of sertraline treatment of MDD in patients hospitalized for acute myocardial infarction (MI) or unstable angina and free of other life-threatening medical conditions. Design and Setting Randomized, double-blind, placebo-controlled trial conducted in 40 outpatient cardiology centers and psychiatry clinics in the United States, Europe, Canada, and Australia. Enrollment began in April 1997 and follow-up ended in April 2001. Patients A total of 369 patients with MDD (64% male; mean age, 57.1 years; mean 17-item Hamilton Depression [HAM-D] score, 19.6; MI, 74%; unstable angina, 26%). Intervention After a 2-week single-blind placebo run-in, patients were randomly assigned to receive sertraline in flexible dosages of 50 to 200 mg/d (n = 186) or placebo (n = 183) for 24 weeks. Main Outcome Measures The primary (safety) outcome measure was change from baseline in left ventricular ejection fraction (LVEF); secondary measures included surrogate cardiac measures and cardiovascular adverse events, as well as scores on the HAM-D scale and Clinical Global Impression Improvement scale (CGI-1) in the total randomized sample, in a group with any prior history of MDD, and I n a more severe MDD subgroup defined a priori by a HAM-D score of at least 18 and history of 2 or more prior episodes of MDD. Results Sertraline had no significant effect on mean (SD) LVEF (sertraline: baseline, 54% [10%]; week 16,54% [11%]; placebo: baseline, 52% [13%]; week 16,53% [13%]), treatment-emergent increase in ventricular premature complex (VPC) runs (sertraline: 13.1 %; placebo: 12.9%), QTc interval greater than 450 milliseconds at end point (Sertraline: 12%; placebo: 13%), or other cardiac measures. All comparisons were statistically nonsignificant (P greater than or equal to.05). The incidence of severe cardiovascular adverse events was 14.5% with sertraline and 22.4% with placebo. In the total randomized sample, the CGI-I (P=.049), but not the HAM-D (P=.14), favored sertraline. The CGI-1 responder rates for sertraline were significantly higher than for placebo in the total sample (67% vs 53%; P=.01), in the group with at least 1 prior episode of depression (72% vs 51 %; P=.003), and in the more severe MDD group (78% vs 45%; P=.001). In the latter 2 groups, both CGI-I and HAM-D measures were significantly better in those assigned to sertraline. Conclusion Our results suggest that sertraline is a safe and effective treatment for, recurrent depression in patients with recent MI or unstable angina and without other life-threatening medical conditions.	New York State Psychiat Inst & Hosp, Dept Clin Psychopharmacol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Duke Univ, Med Ctr, Dept Cardiol, Durham, NC USA; Duke Univ, Med Ctr, Dept Psychiat, Durham, NC USA; Univ Gothenburg, Dept Med, Gothenburg, Sweden; IRCCS Policlin San Mateo, Dept Cardiol, Pavia, Italy; Univ Pavia, I-27100 Pavia, Italy; Queens Univ, Dept Psychiat, Kingston, ON K7L 3N6, Canada; Univ Ottawa, Ottawa Heart Inst, Ottawa, ON, Canada; Univ Ottawa, Dept Psychiat, Ottawa, ON K1N 6N5, Canada; W Virginia Univ, Sch Med, Dept Med, Morgantown, WV 26506 USA; Cardiac Associates So Connecticut, Bridgeport, CT USA; Univ Florida, Div Cardiovasc Med, Gainesville, FL USA; Pfizer Inc, New York, NY USA	New York State Psychiatry Institute; Columbia University; Columbia University; Duke University; Duke University; University of Gothenburg; IRCCS Fondazione San Matteo; University of Pavia; Queens University - Canada; University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; West Virginia University; State University System of Florida; University of Florida; Pfizer	Glassman, AH (corresponding author), New York State Psychiat Inst & Hosp, Dept Clin Psychopharmacol, 1051 Riverside Dr,Unit 116, New York, NY 10032 USA.	ahg1@columbia.edu	Schwartz, Peter J/J-4267-2016; Swedberg, Karl/B-2475-2008; Tang, Anthony S/E-6203-2014	Schwartz, Peter J/0000-0003-0367-1048; 				Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; ANDA R, 1993, EPIDEMIOLOGY, V4, P285, DOI 10.1097/00001648-199307000-00003; [Anonymous], 1989, NEW ENGL J MED, V321, P406; Ariyo AA, 2000, CIRCULATION, V102, P1773; AROMAA A, 1994, ACTA PSYCHIAT SCAND, V89, P77, DOI 10.1111/j.1600-0447.1994.tb05807.x; Barefoot JC, 1996, CIRCULATION, V93, P1976, DOI 10.1161/01.CIR.93.11.1976; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Bush DE, 2001, AM J CARDIOL, V88, P337, DOI 10.1016/S0002-9149(01)01675-7; Camm AJ, 1996, CIRCULATION, V93, P1043; Cannon CP, 1997, AM J CARDIOL, V80, P696, DOI 10.1016/S0002-9149(97)00497-9; Carney RM, 1997, CLIN CARDIOL, V20, P196, DOI 10.1002/clc.4960200304; CARNEY RM, 1988, PSYCHOSOM MED, V50, P627, DOI 10.1097/00006842-198811000-00009; CARNEY RM, 1995, HEALTH PSYCHOL, V14, P88, DOI 10.1037/0278-6133.14.1.88; Cohen HW, 2000, AM J MED, V108, P2, DOI 10.1016/S0002-9343(99)00301-0; DOOGAN DP, 1992, BRIT J PSYCHIAT, V160, P217, DOI 10.1192/bjp.160.2.217; Everson SA, 1996, PSYCHOSOM MED, V58, P113, DOI 10.1097/00006842-199603000-00003; FABRE LF, 1995, BIOL PSYCHIAT, V38, P592, DOI 10.1016/0006-3223(95)00178-8; Ferketich AK, 2000, ARCH INTERN MED, V160, P1261, DOI 10.1001/archinte.160.9.1261; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ford DE, 1998, ARCH INTERN MED, V158, P1422, DOI 10.1001/archinte.158.13.1422; FRASURESMITH N, 1993, JAMA-J AM MED ASSOC, V270, P1819, DOI 10.1001/jama.270.15.1819; FRASURESMITH N, 1995, CIRCULATION, V91, P999, DOI 10.1161/01.CIR.91.4.999; GLASSMAN AH, 1993, JAMA-J AM MED ASSOC, V269, P2673, DOI 10.1001/jama.269.20.2673; Glassman AH, 1998, AM J PSYCHIAT, V155, P4, DOI 10.1176/ajp.155.1.4; Guy W., 1976, DHEW PUBL; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hance M, 1996, GEN HOSP PSYCHIAT, V18, P61, DOI 10.1016/0163-8343(95)00100-X; Jiang W, 2001, ARCH INTERN MED, V161, P1849, DOI 10.1001/archinte.161.15.1849; Keller MB, 1998, JAMA-J AM MED ASSOC, V280, P1665, DOI 10.1001/jama.280.19.1665; Koenig HG, 1998, GEN HOSP PSYCHIAT, V20, P29, DOI 10.1016/S0163-8343(98)80001-7; LADWIG KH, 1991, EUR HEART J, V12, P959; Lesperance F, 1996, PSYCHOSOM MED, V58, P99, DOI 10.1097/00006842-199603000-00001; Lesperance F, 2000, ARCH INTERN MED, V160, P1354, DOI 10.1001/archinte.160.9.1354; Lydiard RB, 1997, J CLIN PSYCHIAT, V58, P484, DOI 10.4088/JCP.v58n1104; Meier CR, 2001, BRIT J CLIN PHARMACO, V52, P179, DOI 10.1046/j.0306-5251.2001.01426.x; Peterson JG, 2001, AM J CARDIOL, V87, P532, DOI 10.1016/S0002-9149(00)01426-0; Posternak MA, 2002, AM J PSYCHIAT, V159, P191, DOI 10.1176/appi.ajp.159.2.191; Ravindran AV, 2000, J CLIN PSYCHIAT, V61, P821, DOI 10.4088/JCP.v61n1103; REIMHERR FW, 1990, J CLIN PSYCHIAT, V51, P18; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; Sauer WH, 2001, CIRCULATION, V104, P1894, DOI 10.1161/hc4101.097519; SCHLEIFER SJ, 1989, ARCH INTERN MED, V149, P1785, DOI 10.1001/archinte.149.8.1785; Schulz R, 2000, ARCH INTERN MED, V160, P1761, DOI 10.1001/archinte.160.12.1761; Shapiro PA, 1999, AM HEART J, V137, P1100, DOI 10.1016/S0002-8703(99)70369-8; STERN MJ, 1977, ARCH INTERN MED, V137, P1680, DOI 10.1001/archinte.137.12.1680; Thase ME, 1996, ARCH GEN PSYCHIAT, V53, P777; TRAVELLA JI, 1994, INT J PSYCHIAT MED, V24, P357, DOI 10.2190/U8R0-A61Y-AKRP-T24V; Welin C, 2000, J INTERN MED, V247, P629, DOI 10.1046/j.1365-2796.2000.00694.x; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Ziegelstein R C, 2001, Cardiol Rev, V9, P45, DOI 10.1097/00045415-200101000-00009; Ziegelstein RC, 2000, ARCH INTERN MED, V160, P1818, DOI 10.1001/archinte.160.12.1818	52	998	1035	1	57	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2002	288	6					701	709		10.1001/jama.288.6.701	http://dx.doi.org/10.1001/jama.288.6.701			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	583KY	12169073	Bronze			2022-12-28	WOS:000177408100030
J	Fabian, AC; Miller, JM				Fabian, AC; Miller, JM			Astronomy - Black holes reveal their innermost secrets	SCIENCE			English	Editorial Material							DISK; MCG-6-30-15; LINE		Inst Astron, Cambridge CB3 0HA, England; MIT, Cambridge, MA 02139 USA	University of Cambridge; Massachusetts Institute of Technology (MIT)	Fabian, AC (corresponding author), Inst Astron, Cambridge CB3 0HA, England.							BLANDFORD RD, 1977, MON NOT R ASTRON SOC, V179, P433, DOI 10.1093/mnras/179.3.433; FABIAN AC, 1989, MON NOT R ASTRON SOC, V238, P729, DOI 10.1093/mnras/238.3.729; FABIAN AC, IN PRESS MON NOT R A; Iwasawa K, 1999, MON NOT R ASTRON SOC, V306, pL19, DOI 10.1046/j.1365-8711.1999.02671.x; LAOR A, 1991, ASTROPHYS J, V376, P90, DOI 10.1086/170257; Martocchia A, 2002, ASTRON ASTROPHYS, V387, P215, DOI 10.1051/0004-6361:20020359; MILLER JA, UNPUB; Miller JM, 2002, ASTROPHYS J, V570, pL69, DOI 10.1086/341099; MILLER JM, IN PRESS ASTROPHYS J; TANAKA Y, 1995, NATURE, V375, P659, DOI 10.1038/375659a0; Wilms J, 2001, MON NOT R ASTRON SOC, V328, pL27, DOI 10.1046/j.1365-8711.2001.05066.x; [No title captured]	13	3	3	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2002	297	5583					947	948		10.1126/science.1074957	http://dx.doi.org/10.1126/science.1074957			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169716				2022-12-28	WOS:000177325400025
J	Gostin, LO; Sapsin, JW; Teret, SP; Burris, S; Mair, JS; Hodge, JG; Vernick, JS				Gostin, LO; Sapsin, JW; Teret, SP; Burris, S; Mair, JS; Hodge, JG; Vernick, JS			The Model State Emergency Health Powers Act - Planning for and response to bioterrorism and naturally occurring infectious diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PUBLIC-HEALTH; BIOLOGICAL TERRORISM; ANTHRAX; LAW; WEAPON; THREAT; LIMITS	The Center for Law and the Public's Health at Georgetown and Johns Hopkins Universities drafted the Model State Emergency Health Powers Act (MSEHPA or Model Act) at the request of the Centers for Disease Control and Prevention. The Model Act provides state actors with the powers they need to detect and contain bioterrorism or a naturally occurring disease outbreak. Legislative bills based on the MSEHPA have been introduced in 34 states. Problems of obsolescence, inconsistency, and inadequacy may render current state laws ineffective or even counterproductive. State laws often date back to the early 20th century and have been built up in layers over the years. They frequently predate the vast changes in the public health sciences and constitutional law. The Model Act is structured to reflect 5 basic public health functions to be facilitated by law: (1) preparedness, comprehensive planning for a public health emergency; (2) surveillance, measures to detect and track public health emergencies; (3) management of property, ensuring adequate availability of vaccines, pharmaceuticals, and hospitals, as well as providing power to abate hazards to the public's health; (4) protection of persons, powers to compel vaccination, testing, treatment, isolation, and quarantine when clearly necessary; and (5) communication, providing clear and authoritative information to the public. The Model Act also contains a modernized, extensive set of principles and requirements to safeguard personal rights. Law can be a tool to improve public health preparedness. A constitutional democracy must balance the common good with respect for personal dignity, toleration of groups, and adherence to principles of justice.	Georgetown Univ, Ctr Law & Publ Hlth, Washington, DC 20001 USA; Johns Hopkins Univ, Baltimore, MD USA	Georgetown University; Johns Hopkins University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Burris, Scott/0000-0002-6013-5842	ODCDC CDC HHS [U50/CCU319118-02] Funding Source: Medline	ODCDC CDC HHS		ANDERSON R M, 1991; ANDERSON RN, 2001, NATL VITAL STAT REPO, V49; Annas GJ, 2002, NEW ENGL J MED, V346, P1337, DOI 10.1056/NEJM200204253461722; [Anonymous], 1988, FUT PUBL HLTH; Barbera J, 2001, JAMA-J AM MED ASSOC, V286, P2711, DOI 10.1001/jama.286.21.2711; Bush LM, 2001, NEW ENGL J MED, V345, P1607, DOI 10.1056/NEJMoa012948; *CDCP, 2002, PUBL HLTH ASS POT BI; *CDCP, 2002, PUBL HLTH INFR STAT; Cole LA, 1996, SCI AM, V275, P60, DOI 10.1038/scientificamerican1296-60; COTTRELL R, 2001, FINANCIAL TIMES 1123; Diamond J, 1999, GUNS GERMS STEEL; DOEBBELING B, 1998, MAXCY ROSENAU LST PU, P107; Fidler DP, 2002, J LAW MED ETHICS, V30, P150, DOI 10.1111/j.1748-720X.2002.tb00382.x; Fox Daniel M., 1995, HIVES SICKNESS PUBLI, P197; GILLIS J, 2001, WASHINTON POST  1119, pA1; Gostin Lawrence O., 2002, PUBLIC HLTH LAW ETHI; Gostin LO, 1999, COLUMBIA LAW REV, V99, P59, DOI 10.2307/1123597; Gostin LO, 1996, JAMA-J AM MED ASSOC, V275, P1921, DOI 10.1001/jama.275.24.1921; Gostin LO, 2001, AM J PUBLIC HEALTH, V91, P1365, DOI 10.2105/AJPH.91.9.1365; Gostin LO, 2000, PUBLIC HLTH LAW POWE; Henderson DA, 1999, SCIENCE, V283, P1279, DOI 10.1126/science.283.5406.1279; Horton HH, 2002, J LAW MED ETHICS, V30, P262, DOI 10.1111/j.1748-720X.2002.tb00392.x; Hughes JM, 1999, EMERG INFECT DIS, V5, P494, DOI 10.3201/eid0504.990403; *I MED, 2000, END NEGL EL TURB US; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Inglesby TV, 2001, CLIN INFECT DIS, V32, P436; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; Inglesby TV, 2000, CLIN INFECT DIS, V30, P926, DOI 10.1086/313794; JERIGAN JA, 2001, EMERG INFECT DIS, V7, P933; Kaiser J, 2001, SCIENCE, V294, P2070, DOI 10.1126/science.294.5549.2070; Lane HC, 2001, JAMA-J AM MED ASSOC, V286, P2595, DOI 10.1001/jama.286.20.2595; Loff B, 2001, LANCET, V358, P146, DOI 10.1016/S0140-6736(01)05325-9; LUECK S, 2002, WALL STREET J   0107, pA26; *NAT INT COUNC, 2000, NAT INTELLIGENCE COU; Novak William J., 1996, PEOPLES WELFARE LAW; O'Toole T, 2002, CLIN INFECT DIS, V34, P972, DOI 10.1086/339909; OSTERHOLM MT, 2001, WHAT AM NEEDS KNOW S; Parker-Pope T, 2001, WALL STREET J, pB1; POWELL JH, 1949, BRINT OUT YOUR DEAD; Rosenberg Charles E., 1987, CHOLERA YEARS US 183; Shah Nayan, 2001, CONTAGIOUS DIVIDES E; The Center for Law and the Public's Health, 2001, MOD STAT EM HLTH POW; *US COMM NAT SEC 2, 1999, NEW WORLD COMM AM SE; 2002, PROTECTING HOMELAND; 2001, CANTIGNY C SERIES	45	127	129	2	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	2002	288	5					622	628		10.1001/jama.288.5.622	http://dx.doi.org/10.1001/jama.288.5.622			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	581FJ	12150674				2022-12-28	WOS:000177280200021
J	Grimes, DA; Raymond, EG				Grimes, DA; Raymond, EG			Emergency contraception	ANNALS OF INTERNAL MEDICINE			English	Review							POST-COITAL CONTRACEPTION; YUZPE REGIMEN; ETHINYLESTRADIOL COMBINATION; DL-NORGESTREL; POSTCOITAL CONTRACEPTION; ETHINYL ESTRADIOL; VAGINAL BROMOCRIPTINE; OVARIAN-FUNCTION; LEVONORGESTREL; PILLS	Emergency contraception is used to prevent pregnancy after a coital act not adequately protected by a regular method of contraception. In contrast to early medical abortion, emergency contraception prevents a pregnancy from starting and does not disrupt an established pregnancy. The most commonly used approaches consist of two oral doses of contraceptive steroids. The levonorgestrel-only regimen (levonorgestrel, 0.75 mg, repeated in 12 hours) appears to be more effective and better tolerated than the Yuzpe regimen (ethinyl estradiol, 100 mug, and levonorgestrel, 0.5 mg, repeated in 12 hours). In the largest randomized, controlled trial to date, levonorgestrel prevented about 85% of pregnancies that would have occurred without its use. Hormonal emergency contraception has no known medical contraindications, although it is not indicated for suspected or confirmed pregnancy. However, if hormonal emergency contraception is inadvertently taken in early pregnancy, neither the woman nor the fetus will be harmed. Nausea and vomiting associated with the Yuzpe regimen can be reduced by prophylactic use of meclizine. A strong medical and legal case exists for making hormonal emergency contraception available over the counter, as has happened in countries other than the United States, Easier access to and wider use of emergency contraception could dramatically lower the high rates of unintended pregnancy and induced abortion in the United States.	Family Hlth Int, Res Triangle Pk, NC 27709 USA		Grimes, DA (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.	dgrimes@fhi.org						ALVAREZ F, 1983, FERTIL STERIL, V40, P120; *AM COLL OBST GYN, 2001, ACOG PRACT PATT EM O, P4; BACK DJ, 1987, CONTRACEPTION, V36, P471, DOI 10.1016/0010-7824(87)90095-3; BRACKEN MB, 1990, OBSTET GYNECOL, V76, P552; BURTON R, 1990, BR J FAM PLANN, V15, P119; CARDY GC, 1995, BRIT J FAM PLAN, V21, P112; *CONS EM CONTR, 2000, EXP GLOB ACC EM CONT, P9; Croxatto HB, 2001, CONTRACEPTION, V63, P111, DOI 10.1016/S0010-7824(01)00184-6; *CTR REPR LAW POL, 2000, EM CONTR PILLS COMM, P9; Delbanco SF, 1997, OBSTET GYNECOL, V89, P1006, DOI 10.1016/S0029-7844(97)00142-7; DIXON GW, 1980, JAMA-J AM MED ASSOC, V244, P1336, DOI 10.1001/jama.244.12.1336; Edwards J, 1997, AM J OBSTET GYNECOL, V176, P1101, DOI 10.1016/S0002-9378(97)70410-1; Ellertson C, 2000, CONTRACEPTION, V61, P145, DOI 10.1016/S0010-7824(00)00091-3; Ellertson C, 2001, SEMIN REPROD MED, V19, P323, DOI 10.1055/s-2001-18640; Ellertson C, 1996, FAM PLANN PERSPECT, V28, P44, DOI 10.2307/2136122; Ellison J, 2000, BRIT MED J, V321, P1382, DOI 10.1136/bmj.321.7273.1382; FASOLI M, 1989, CONTRACEPTION, V39, P459, DOI 10.1016/0010-7824(89)90123-6; GLASIER A, 1992, NEW ENGL J MED, V327, P1041, DOI 10.1056/NEJM199210083271501; Glasier A, 1998, NEW ENGL J MED, V339, P1, DOI 10.1056/NEJM199807023390101; Graham A, 1996, BRIT MED J, V312, P1567, DOI 10.1136/bmj.312.7046.1567; Grimes D, 1998, LANCET, V352, P428; Grimes DA, 1997, NEW ENGL J MED, V337, P1078, DOI 10.1056/NEJM199710093371510; Grimes DA, 2001, OBSTET GYNECOL, V98, P151, DOI 10.1016/S0029-7844(01)01412-0; Grimes DA, 1999, OBSTET GYNECOL, V94, P471, DOI 10.1016/S0029-7844(99)80049-0; Grimes DA, 2000, LANCET, V356, P1013, DOI 10.1016/S0140-6736(00)02699-4; GROU F, 1994, AM J OBSTET GYNECOL, V171, P1529, DOI 10.1016/0002-9378(94)90396-4; GUERTS TB, 1993, SUMMARY DRUG INTERAC, P49; Hapangama D, 2001, CONTRACEPTION, V63, P123, DOI 10.1016/S0010-7824(01)00186-X; HO PC, 1993, HUM REPROD, V8, P389, DOI 10.1093/oxfordjournals.humrep.a138057; HUGHES EC, 1972, OBSTETRIC GYNECOLOGI, P327; Jones B S, 1998, J Am Med Womens Assoc (1972), V53, P233; JOSHI JV, 1980, CONTRACEPTION, V22, P643, DOI 10.1016/0010-7824(80)90089-X; KESSERU E, 1975, FERTIL STERIL, V26, P57; KESSERU E, 1974, CONTRACEPTION, V10, P411, DOI 10.1016/0010-7824(74)90041-9; KLETZKY OA, 1989, FERTIL STERIL, V51, P269; KUBBA AA, 1986, FERTIL STERIL, V45, P512; Lake SR, 1999, BRIT J OPHTHALMOL, V83, P630; LANDGREN BM, 1989, CONTRACEPTION, V39, P275, DOI 10.1016/0010-7824(89)90060-7; Lee S. W. H., 1999, Hong Kong Medical Journal, V5, P349; LING WY, 1983, FERTIL STERIL, V39, P292; LING WY, 1979, FERTIL STERIL, V32, P297; LING WY, 1983, FERTIL STERIL, V40, P631; Lovvorn A, 2000, CONTRACEPTION, V61, P287, DOI 10.1016/S0010-7824(00)00107-4; NEELY JL, 1991, OBSTET GYNECOL, V77, P416; Nielsen CL, 2000, CONTRACEPTION, V62, P275, DOI 10.1016/S0010-7824(00)00178-5; Obach RS, 2000, J PHARMACOL EXP THER, V294, P88; PERCIVALSMITH RKL, 1987, CONTRACEPTION, V36, P287, DOI 10.1016/0010-7824(87)90098-9; Piaggio G, 1999, LANCET, V353, P721, DOI 10.1016/S0140-6736(98)05718-3; Piaggio G, 1999, LANCET, V353, P697; Pymar Helen C., 2000, American Journal of Obstetrics and Gynecology, V183, pS54; Raine T, 2000, OBSTET GYNECOL, V96, P1, DOI 10.1016/S0029-7844(00)00830-9; RAJAWATANA D, 1972, Journal of the Medical Association of Thailand, V55, P533; RAMANWILMS L, 1995, OBSTET GYNECOL, V85, P141, DOI 10.1016/0029-7844(94)00341-A; Raymond EG, 2000, HUM REPROD, V15, P2351, DOI 10.1093/humrep/15.11.2351; Raymond EG, 2000, OBSTET GYNECOL, V95, P271, DOI 10.1016/S0029-7844(99)00550-5; READER FC, 1991, BRIT MED J, V302, P801, DOI 10.1136/bmj.302.6780.801; Rodrigues I, 2001, AM J OBSTET GYNECOL, V184, P531, DOI 10.1067/mob.2001.111102; ROWLANDS S, 1986, CONTRACEPTION, V33, P539, DOI 10.1016/0010-7824(86)90042-9; Schaff EA, 2000, JAMA-J AM MED ASSOC, V284, P1948, DOI 10.1001/jama.284.15.1948; SIMPSON J L, 1990, Advances in Contraception, V6, P141, DOI 10.1007/BF01849490; SPONA J, 1975, CONTRACEPTION, V11, P31, DOI 10.1016/0010-7824(75)90048-7; Stewart FH, 2001, JAMA-J AM MED ASSOC, V285, P2232, DOI 10.1001/jama.285.17.2232; Stratton P, 2000, HUM REPROD, V15, P1092, DOI 10.1093/humrep/15.5.1092; Swahn ML, 1996, ACTA OBSTET GYN SCAN, V75, P738, DOI 10.3109/00016349609065738; TASKIN O, 1994, FERTIL STERIL, V61, P850; Trussell J, 1999, CONTRACEPTION, V59, P147, DOI 10.1016/S0010-7824(99)00018-9; TRUSSELL J, 1992, FAM PLANN PERSPECT, V24, P269, DOI 10.2307/2135857; Trussell J, 1998, J Am Med Womens Assoc (1972), V53, P247; Trussell J, 1999, OBSTET GYNECOL, V93, P872, DOI 10.1016/S0029-7844(98)00380-9; Trussell J, 1998, CONTRACEPTION, V57, P363, DOI 10.1016/S0010-7824(98)00042-0; Trussell J, 1996, OBSTET GYNECOL, V88, P150, DOI 10.1016/0029-7844(96)00036-1; TRUSSELL J, 1995, FERTILITY CONTROL RE, V4, P8; *US DEP HHS, 1996, VIT STAT US 1992 A, V2, P206; VANLOOK PFA, 1998, CONTRACEPTIVE TECHNO, P277; VERMESH M, 1988, OBSTET GYNECOL, V72, P693; von Hertzen H, 2000, CONTRACEPTION, V61, P303, DOI 10.1016/S0010-7824(00)00116-5; Webb A., 1993, Advances in Contraception, V9, P75, DOI 10.1007/BF02115904; WEBB AMC, 1992, BMJ-BRIT MED J, V305, P927, DOI 10.1136/bmj.305.6859.927; WELLS E, 1997, EMERGENCY CONTRACEPT, P15; *WHO, 2000, GEN REPR HLTH RES; WILCOX AJ, 1995, NEW ENGL J MED, V333, P1517, DOI 10.1056/NEJM199512073332301; YOUNG DC, 1994, OBSTET GYNECOL, V84, P266; YUZPE AA, 1977, FERTIL STERIL, V28, P932; YUZPE AA, 1974, J REPROD MED, V13, P53; Zieman M, 1997, OBSTET GYNECOL, V90, P88, DOI 10.1016/S0029-7844(97)00111-7; ZULIANI G, 1990, EUR J OBSTET GYN R B, V37, P253, DOI 10.1016/0028-2243(90)90032-V	86	57	58	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 6	2002	137	3					180	189		10.7326/0003-4819-137-3-200208060-00010	http://dx.doi.org/10.7326/0003-4819-137-3-200208060-00010			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580XP	12160366				2022-12-28	WOS:000177262300005
J	Gomes, CP; Selman, B				Gomes, CP; Selman, B			Computer science: Satisfied with physics	SCIENCE			English	Editorial Material							SATISFIABILITY		Cornell Univ, Dept Comp Sci, Ithaca, NY 14853 USA	Cornell University	Gomes, CP (corresponding author), Cornell Univ, Dept Comp Sci, Ithaca, NY 14853 USA.	gomes@cs.cornell.edu; selman@cs.cornell.edu						Achlioptas D., 2001, P 33 ANN ACM S THEOR, P337, DOI 10.1145/380752.380820; Bollobas B, 2001, RANDOM STRUCT ALGOR, V18, P201, DOI 10.1002/rsa.1006; Friedgut E, 1999, J AM MATH SOC, V12, P1017, DOI 10.1090/S0894-0347-99-00305-7; GENT IP, 2000, J AUTOM REAS, V24; Gomes CP, 2000, J AUTOM REASONING, V24, P67, DOI 10.1023/A:1006314320276; HOGG T, 1996, ARTIF INTELL, V81; Mezard M, 2002, SCIENCE, V297, P812, DOI 10.1126/science.1073287; MITCHELL D, 1992, AAAI-92 PROCEEDINGS : TENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, P459; Selman B, 1996, DIMACS SERIES DISCRE, P521, DOI [10.1090/dimacs/026/25, DOI 10.1090/DIMACS/026/25, DOI 10.1090/DIMACS/026]	10	13	13	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2002	297	5582					784	785		10.1126/science.1074599	http://dx.doi.org/10.1126/science.1074599			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161641				2022-12-28	WOS:000177192800034
J	Wu, LC; Tuot, DS; Lyons, DS; Garcia, KC; Davis, MM				Wu, LC; Tuot, DS; Lyons, DS; Garcia, KC; Davis, MM			Two-step binding mechanism for T-cell receptor recognition of peptide-MHC	NATURE			English	Article							ANTIGEN RECOGNITION; HOT-SPOT; LIGANDS; COMPLEX; REQUIREMENTS; REACTIVITY; REPERTOIRE; INTERFACE; RESIDUES; ENERGY	T cells probe a diverse milieu of peptides presented by molecules of the major histocompatibility complex (MHC) by using the T-cell receptor (TCR) to scan these ligands with high sensitivity and specificity(1). Here we describe a physical basis for this scanning process by studying the residues involved in both the initial association and the stable binding of TCR to peptide-MHC, using the well-characterized TCR and peptide-MHC pair of 2B4 and MCC-IEk (moth cytochrome c, residues 88-103)(2). We show that MHC contacts dictate the initial association, guiding TCR docking in a way that is mainly independent of the peptide. Subsequently, MCC-IEk peptide contacts dominate stabilization, imparting specificity and influencing T-cell activation by modulating the duration of binding. This functional subdivision of the peptide-MHC ligand suggests that a two-step process for TCR recognition facilitates the efficient scanning of diverse peptide-MHC complexes on the surface of cells and also makes TCRs inherently crossreactive towards different peptides bound by the same MHC.	Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Davis, MM (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, B221 Beckman Ctr, Stanford, CA 94305 USA.			Davis, Mark/0000-0001-6868-657X				Baker BM, 2001, J EXP MED, V193, P551, DOI 10.1084/jem.193.5.551; Baker BM, 1999, COLD SPRING HARB SYM, V64, P235, DOI 10.1101/sqb.1999.64.235; BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Davis SJ, 1998, P NATL ACAD SCI USA, V95, P5490, DOI 10.1073/pnas.95.10.5490; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; EHRICH EW, 1993, J EXP MED, V178, P713, DOI 10.1084/jem.178.2.713; Fersht AR, 1997, CURR OPIN STRUC BIOL, V7, P3, DOI 10.1016/S0959-440X(97)80002-4; Fremont DH, 2002, J EXP MED, V195, P1043, DOI 10.1084/jem.20011971; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; Hare BJ, 1999, NAT STRUCT BIOL, V6, P574; Hennecke J, 2002, J EXP MED, V195, P571, DOI 10.1084/jem.20011194; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lee PUY, 2000, J EXP MED, V191, P1355, DOI 10.1084/jem.191.8.1355; Luz JG, 2002, J EXP MED, V195, P1175, DOI 10.1084/jem.20011644; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; REAY PA, 1994, J IMMUNOL, V152, P3946; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; Savage PA, 2001, IMMUNITY, V14, P243, DOI 10.1016/S1074-7613(01)00106-6; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4; ZINKERNAGEL RM, 1978, J EXP MED, V147, P882, DOI 10.1084/jem.147.3.882	30	224	229	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2002	418	6897					552	556		10.1038/nature00920	http://dx.doi.org/10.1038/nature00920			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152083				2022-12-28	WOS:000177162800045
J	Fichtenberg, CM; Glantz, SA				Fichtenberg, CM; Glantz, SA			Effect of smoke-free workplaces on smoking behaviour: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							INDOOR-AIR LAWS; TOBACCO CONTROL PROGRAM; SHORT-TERM IMPACT; EMPLOYEE SMOKING; CIGARETTE CONSUMPTION; WORKSITE SMOKING; PASSIVE SMOKING; PUBLIC PLACES; UNITED-STATES; POLICY	Objective To quantify, the effects of smoke-free workplaces on smoking in employees and compare these effects to those achieved through tax increases. Design Systematic review with a random effects meta-analysis. Study selection 26 studies on the effects of smoke-free workplaces. Setting Workplaces in the United States. Australia, Canada, and Germany. Participants Employees in unrestricted and totally smoke-free workplaces. Main outcome measures Daily cigarette consumption (per smoker mid pet, employee) and smoking prevalence, Results Totally smoke-free workplaces are associated with reductions in prevalence of smoking of 3.8% (95%, confidence interval 2.8% to 4.7%) and 3.1 (2.4 to 3.8) fewer cigarettes smoked per day pet, continuing smoker. Combination of the effects of reduced prevalence and lower consumption per continuing smoker yields a mean reduction of 1.3 cigarettes per day per employee, which corresponds to a relative reduction of 29%. To achieve similar reductions the tax on it pack of cigarettes would have to increase from $0.76 to $3.05 (E0.78 to E3.14) in the United States and from pound3.44 to pound6.59 (5.32 to E10.20) in the United Kingdom, If all workplaces became smoke-free, consumption per capita in die entire population would drop 4.5% in the United States and 7.6%, in the United Kingdom, costing die tobacco industry S1.7 billion and 0 10 million annually in lost sales. To achieve similar reductions tax per pack would have to increase to $1.11 and pound4.26. Conclusions Smoke-free workplaces not only protect non-smokers from the clangers of passive smoking, they also encourage smokers to quit or to reduce consumption.	Univ Calif San Francisco, Cardiovasc Res Inst, Inst Hlth Policy Studies, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Glantz, SA (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, Inst Hlth Policy Studies, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA.	glantz@medicine.ucsf.edu			NCI NIH HHS [CA-61021, R01 CA061021] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA061021] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abernathy T, 1998, CAN J PUBLIC HEALTH, V89, P33, DOI 10.1007/BF03405791; Abrams KR, 2000, METHODS METAANALYSIS; ANDREWS JL, 1983, CHEST, V84, P206, DOI 10.1378/chest.84.2.206; BAILE WF, 1991, ADDICT BEHAV, V16, P419, DOI 10.1016/0306-4603(91)90050-R; BAL DG, 1990, JAMA-J AM MED ASSOC, V264, P1570, DOI 10.1001/jama.264.12.1570; BATLLE E, 1991, BRIT J ADDICT, V86, P709; BECKER DM, 1989, JAMA-J AM MED ASSOC, V262, P799, DOI 10.1001/jama.262.6.799; Biener L, 1999, J OCCUP ENVIRON MED, V41, P1121, DOI 10.1097/00043764-199912000-00017; BORLAND R, 1990, AM J PUBLIC HEALTH, V80, P178, DOI 10.2105/AJPH.80.2.178; BORLAND R, 1991, AUST J PUBLIC HEALTH, V15, P130; BRENNER H, 1994, PREV MED, V23, P230, DOI 10.1006/pmed.1994.1031; BRENNER H, 1992, PREV MED, V21, P252, DOI 10.1016/0091-7435(92)90023-B; BRIGHAM J, 1994, AM J PUBLIC HEALTH, V84, P773, DOI 10.2105/AJPH.84.5.773; BRODER I, 1993, CAN J PUBLIC HEALTH, V84, P254; *CDC, 2001, PERC AD WHO CURR FOR; *CDCP, 1990, MMWR-MORBID MORTAL W, V39, P673; *CDCP, 1999, BEST PRACT COMPR TOB; CHALOUPKA F, 1992, APPL ECON, V24, P193, DOI 10.1080/00036849200000118; Chaloupka F.J., 1996, 5740 NAT BUR EC RES; Chaloupka FJ, 1999, TOB CONTROL, V8, P373, DOI 10.1136/tc.8.4.373; Chaloupka FJ, 1997, J HEALTH ECON, V16, P359, DOI 10.1016/S0167-6296(96)00530-9; CHALOUPKA FJ, 1992, CONTEMP POLICY ISSUE, V10, P72, DOI 10.1111/j.1465-7287.1992.tb00227.x; Chapman S, 1999, AM J PUBLIC HEALTH, V89, P1018, DOI 10.2105/AJPH.89.7.1018; CHILCOTE S, 1985, PUBLIC SMOKING PROBL; Cooreman J, 1997, SEM HOP PARIS, V73, P317; DAUGHTON DM, 1992, PREV MED, V21, P670, DOI 10.1016/0091-7435(92)90073-Q; Eisner MD, 1998, JAMA-J AM MED ASSOC, V280, P1909, DOI 10.1001/jama.280.22.1909; EMONT SL, 1995, AM J HEALTH PROMOT, V9, P456, DOI 10.4278/0890-1171-9.6.456; Emont SL., 1993, TOB CONTROL, V2, P13, DOI [10.1136/tc.2.1.13, DOI 10.1136/TC.2.1.13]; ENGSTROM P, 1990, RELATIONSHIP WORKSIT; Etter JF, 1999, J EPIDEMIOL COMMUN H, V53, P710, DOI 10.1136/jech.53.11.710; EVANS W, 1996, 5567 NAT BUR EC RES; Farkas AJ, 2000, JAMA-J AM MED ASSOC, V284, P717, DOI 10.1001/jama.284.6.717; Farkas AJ, 1999, TOB CONTROL, V8, P261, DOI 10.1136/tc.8.3.261; Farrelly MC, 1999, TOB CONTROL, V8, P272, DOI 10.1136/tc.8.3.272; Fichtenberg CM, 2000, NEW ENGL J MED, V343, P1772, DOI 10.1056/NEJM200012143432406; Fichtenberg CM, 2002, PEDIATRICS, V109, P1088, DOI 10.1542/peds.109.6.1088; Gerlach K K, 1997, Tob Control, V6, P199; Glantz S., 1993, TOB CONTROL, V2, P311, DOI DOI 10.1136/TC.2.4.311; GLANTZ SA, 1991, CIRCULATION, V83, P1, DOI 10.1161/01.CIR.83.1.1; Glantz SA, 2000, PEDIATRICS, V106, part. no., DOI 10.1542/peds.106.6.e82; Glantz SA, 2000, TOBACCO WAR INSIDE C; Glasgow R E, 1997, Tob Control, V6 Suppl 2, pS44, DOI 10.1136/tc.6.suppl_2.S44; GOLDSTEIN AO, 1992, J FAM PRACTICE, V34, P729; GOMEL M, 1993, PSYCHOL HEALTH, V8, P223, DOI 10.1080/08870449308401917; GOTTLIEB NH, 1990, J OCCUP ENVIRON MED, V32, P16, DOI 10.1097/00043764-199001000-00008; Gruber J, 2000, YOUTH SMOKING US PRI; HEIRONIMUS J, 1992, COMMUNICATION   0121; Heloma A, 2001, AM J PUBLIC HEALTH, V91, P1416, DOI 10.2105/AJPH.91.9.1416; Hopkins DP, 2001, AM J PREV MED, V20, P16, DOI 10.1016/S0749-3797(00)00297-X; HUDZINSKI LG, 1994, SOUTHERN MED J, V87, P322, DOI 10.1097/00007611-199403000-00004; HUDZINSKI LG, 1990, CHEST, V97, P1198, DOI 10.1378/chest.97.5.1198; Hymowitz N, 1997, Tob Control, V6 Suppl 2, pS57, DOI 10.1136/tc.6.suppl_2.S57; JEFFERY RW, 1994, PREV MED, V23, P78, DOI 10.1006/pmed.1994.1011; Kessler KM, 2001, NEW ENGL J MED, V344, P1798; KINNE S, 1993, AM J PUBLIC HEALTH, V83, P1031, DOI 10.2105/AJPH.83.7.1031; LADER D, 2000, SMOKING RELATED BEHA; Lewit E M, 1997, Tob Control, V6 Suppl 2, pS17, DOI 10.1136/tc.6.suppl_2.S17; Longo DR, 1996, JAMA-J AM MED ASSOC, V275, P1252, DOI 10.1001/jama.275.16.1252; Longo DR, 2001, TOB CONTROL, V10, P267, DOI 10.1136/tc.10.3.267; Magzamen S, 2001, AM J PUBLIC HEALTH, V91, P245, DOI 10.2105/AJPH.91.2.245; Mangurian CV, 2000, AM J PUBLIC HEALTH, V90, P1926, DOI 10.2105/AJPH.90.12.1926; MILLAR WJ, 1988, CAN J PUBLIC HEALTH, V79, P379; MORRIS P, 1987, COMMUNICATION   0624; Moskowitz JM, 2000, AM J PUBLIC HEALTH, V90, P757, DOI 10.2105/AJPH.90.5.757; MULLOOLY JP, 1990, PUBLIC HEALTH REP, V105, P623; *NAT ASS ATT GEN, 2001, MULT SETTL TOB IND; *NAT CANC I, 1993, SMOK TOB CONTR MON U, V3; *NAT CANC POL BOAR, 2000, STAT PROGR CAN RED T; *NCI, 1999, SMOK LTH MON NCI, V10; *NCI, 1999, SMOK HLTH MON NCI, V10; *NCI, 1993, SMOK TOB CONTR MON U, V3; *NCI, 2000, SMOK TOB CONTR MON N, V12; *OFF NAT STAT, 2001, MID 2000 UK POP EST; OFFORD KP, 1992, CHEST, V102, P1531, DOI 10.1378/chest.102.5.1531; Olive KE, 1996, SOUTHERN MED J, V89, P699, DOI 10.1097/00007611-199607000-00010; ORZECHOWSKI W, 2000, TAX BURDEN TOBACCO; Owen N, 1997, Tob Control, V6, P131; PATTEN CA, 1995, TOB CONTROL, V4, P36; PAULOZZI LJ, 1992, PUBLIC HEALTH REP, V107, P724; PEDERSON LL, 1993, AM J PUBLIC HEALTH, V83, P1342, DOI 10.2105/AJPH.83.9.1342; PETERSEN LR, 1988, PUBLIC HEALTH REP, V103, P115; Petitti DB., 2000, META ANAL DECISION A; Pierce JP, 1998, JAMA-J AM MED ASSOC, V280, P893, DOI 10.1001/jama.280.10.893; Pierce JP, 1994, TOBACCO USE CALIFORN; Pierce JP., 1998, TOBACCO CONTROL CALI; REPACE JL, 1980, SCIENCE, V208, P464, DOI 10.1126/science.7367873; RIGOTTI NA, 1991, JAMA-J AM MED ASSOC, V266, P3162; ROSENSTOCK IM, 1986, AM J PUBLIC HEALTH, V76, P1014, DOI 10.2105/AJPH.76.8.1014; SAMUELS B, 1991, JAMA-J AM MED ASSOC, V266, P2110, DOI 10.1001/jama.266.15.2110; Scott C J, 1989, AAOHN J, V37, P265; Shirres G, 1996, Collegian, V3, P30, DOI 10.1016/S1322-7696(08)60191-2; Shopland DR, 2001, J OCCUP ENVIRON MED, V43, P680, DOI 10.1097/00043764-200108000-00005; Siegel M, 2000, AM J PUBLIC HEALTH, V90, P372, DOI 10.2105/AJPH.90.3.372; SORENSEN G, 1991, AM J PUBLIC HEALTH, V81, P202; STAVE GM, 1991, J OCCUP ENVIRON MED, V33, P884, DOI 10.1097/00043764-199108000-00014; Stephens T, 1997, AM J PUBLIC HEALTH, V87, P1519, DOI 10.2105/AJPH.87.9.1519; STILLMAN FA, 1990, JAMA-J AM MED ASSOC, V264, P1565, DOI 10.1001/jama.264.12.1565; TAURAS JA, 1999, PRICE CLEAN INDOOR A; Traynor MP, 1996, J HEALTH POLIT POLIC, V21, P543, DOI 10.1215/03616878-21-3-543; TRAYNOR MP, 1993, JAMA-J AM MED ASSOC, V270, P479, DOI 10.1001/jama.270.4.479; TSUSHIMA WT, 1991, INT J ADDICT, V26, P23, DOI 10.3109/10826089109056236; *US BUR CENS, 2001, RES POP US AG SEX; *US BUR LAB STAT, 2001, NAT EMPL WAG EST; *US DEP HHS, 1989, RED HLTH CONS SMOK 2; US Department of Health and Human Services, 2000, RED TOB US REP SURG; USDHHS (Department of Health and Human Services), 1986, HLTH CONS INV SMOK R; Wakefield MA, 2000, BRIT MED J, V321, P333, DOI 10.1136/bmj.321.7257.333; WAKEFIELD MA, 1992, J OCCUP ENVIRON MED, V34, P693; WASSERMAN J, 1991, J HEALTH ECON, V10, P43, DOI 10.1016/0167-6296(91)90016-G; WOODRUFF TJ, 1993, ARCH INTERN MED, V153, P1485, DOI 10.1001/archinte.153.12.1485; Yurekli AA, 2000, HEALTH ECON, V9, P159, DOI 10.1002/(SICI)1099-1050(200003)9:2<159::AID-HEC499>3.0.CO;2-T	112	771	790	0	75	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2002	325	7357					188	191		10.1136/bmj.325.7357.188	http://dx.doi.org/10.1136/bmj.325.7357.188			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	580PX	12142305	Bronze, Green Published			2022-12-28	WOS:000177243900016
J	Mitchell, J; Hussaini, H; McGovern, D; Farrow, R; Maskell, G; Dalton, H				Mitchell, J; Hussaini, H; McGovern, D; Farrow, R; Maskell, G; Dalton, H			Quality improvement report - The "jaundice hotline" for the rapid assessment of patients with jaundice	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Problem Patients with jaundice require rapid diagnosis and treatment, yet such patients are often subject to delay. Design An open referral, rapid access jaundice dinic was established by reorganisation of existing services and without the need for significant extra resources. Background and setting A large general hospital in a largely rural and geographically isolated area, Key measures for improvement Waiting times for, referral, consultation, diagnosis, and treatment, length of stay in hospital, and general practitioners' and patients' satisfaction with the service. Strategies for change Referrals were made through a 24 hour telephone answering machine and fax line. Initial assessment of patients was Carried out by junior staff as part of their working week. Dedicated ultrasonography appointments were made available. Effects of change Of 107 patients seen in the first year of the service, 62 had biliary obstruction. The mean time between referral and consultation was 2.5 days. Patients who went on to endoscopic retrograde cholangiopancreatography waited 5,7 clays on average. The mean length of stay in hospital in the 69 patients who were admitted was 6.1 days, compared with 11,5 days in 1996, as shown by audit data, Nearly all the 36 general practices (95%) and the 30 consecutive patients (97%) that were surveyed rated the service as above average or excellent. Lessons learnt An open referral, rapid access service for patients with jaundice can shorten time to diagnosis and treatment mid length of stay in hospital. These improvements can occur through die reorganisation of existing services and with minimal extra cost.	Royal Cornwall Hosp, Gastrointestinal Unit, Truro, NS TR1 3LJ, Canada		Mitchell, J (corresponding author), Kings Coll Hosp London, Inst Liver Studies, Denmark Hill, London SE5 9RS, England.	jonmitch@clara.net						*CORN ISL SCILL HL, 1998, BID HLTH ACT ZON STA; *DEP HLTH, 1998, POL FRAM COMM CANC S; Mitchell J, 2001, CLIN RADIOL, V56, P64, DOI 10.1053/crad.2000.0637; Sherlock, 1997, DIS LIVER BILIARY SY, V30, P61	4	18	19	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2002	325	7357					213	215		10.1136/bmj.325.7357.213	http://dx.doi.org/10.1136/bmj.325.7357.213			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580PX	12142314	Green Published			2022-12-28	WOS:000177243900027
J	Sandercock, P				Sandercock, P			Uses of error - A fainting mechanic	LANCET			English	Editorial Material									Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH2 4XU, Midlothian, Scotland	University of Edinburgh	Sandercock, P (corresponding author), Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH2 4XU, Midlothian, Scotland.		sandercock, peter/GQI-3167-2022	sandercock, peter/0000-0001-8484-0135					0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 27	2002	360	9329					305	305		10.1016/S0140-6736(02)09553-3	http://dx.doi.org/10.1016/S0140-6736(02)09553-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578DT	12147374				2022-12-28	WOS:000177102700012
J	Bouarab, K; Melton, R; Peart, J; Baulcombe, D; Osbourn, A				Bouarab, K; Melton, R; Peart, J; Baulcombe, D; Osbourn, A			A saponin-detoxifying enzyme mediates suppression of plant defences	NATURE			English	Article							ALLENE OXIDE SYNTHASE; ALPHA-TOMATINE; SEPTORIA-LYCOPERSICI; DISEASE RESISTANCE; GENE; BETA(2)-TOMATINASE; PURIFICATION; DEGRADATION; SENSITIVITY; EXPRESSION	Plant disease resistance can be conferred by constitutive features such as structural barriers or preformed antimicrobial secondary metabolites. Additional defence mechanisms are activated in response to pathogen attack and include localized cell death (the hypersensitive response)(1,2). Pathogens use different strategies to counter constitutive and induced plant defences, including degradation of preformed antimicrobial compounds(3) and the production of molecules that suppress induced plant defences(4-6). Here we present evidence for a two-component process in which a fungal pathogen subverts the preformed antimicrobial compounds of its host and uses them to interfere with induced defence responses. Antimicrobial saponins are first hydrolysed by a fungal saponin-detoxifying enzyme. The degradation product of this hydrolysis then suppresses induced defence responses by interfering with fundamental signal transduction processes leading to disease resistance.	John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Osbourn, A (corresponding author), John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England.	annie.osbourn@sainsbury-laboratory.ac.uk		Baulcombe, David/0000-0003-0780-6878; MELTON, RACHEL/0000-0002-8439-8153				ARNESON PA, 1968, PLANT PHYSIOL, V43, P683, DOI 10.1104/pp.43.5.683; ARNESON PA, 1967, PHYTOPATHOLOGY, V57, P1358; ARNESON PA, 1968, PHYTOPATHOLOGY, V58, P536; Austin MJ, 2002, SCIENCE, V295, P2077, DOI 10.1126/science.1067747; Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; Baulcombe DC, 1999, CURR OPIN PLANT BIOL, V2, P109, DOI 10.1016/S1369-5266(99)80022-3; Doke N, 1998, DEV PLANT PATHOL, V13, P331; DURBIN RD, 1969, BIOCHIM BIOPHYS ACTA, V191, P176, DOI 10.1016/0005-2744(69)90331-3; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Froehlich JE, 2001, PLANT PHYSIOL, V125, P306, DOI 10.1104/pp.125.1.306; GRUNWELLER S, 1990, PHYTOCHEMISTRY, V29, P2485, DOI 10.1016/0031-9422(90)85171-B; HAMMONDKOSACK K, 2001, BIOCH MOL BIOL PLANT, P1102; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; Martin-Hernandez AM, 2000, MOL PLANT MICROBE IN, V13, P1301, DOI 10.1094/MPMI.2000.13.12.1301; Morrissey JP, 1999, MICROBIOL MOL BIOL R, V63, P708, DOI 10.1128/MMBR.63.3.708-724.1999; Osbourn A, 1995, MOL PLANT MICROBE IN, V8, P971, DOI 10.1094/MPMI-8-0971; PEART J, 2002, P NATL ACAD SCI 0715, DOI DOI 10.1073/PNAS.152330599; RODDICK JG, 1974, PHYTOCHEMISTRY, V13, P9, DOI 10.1016/S0031-9422(00)91261-5; ROMMENS CMT, 1995, PLANT CELL, V7, P1537, DOI 10.1105/tpc.7.10.1537; Sandrock RW, 1995, MOL PLANT MICROBE IN, V8, P960, DOI 10.1094/MPMI-8-0960; Sandrock RW, 1998, PHYTOPATHOLOGY, V88, P137, DOI 10.1094/PHYTO.1998.88.2.137; Sandrock RW, 2001, PHYSIOL MOL PLANT P, V58, P159, DOI 10.1006/pmpp.2001.0324; Scofield SR, 1996, SCIENCE, V274, P2063, DOI 10.1126/science.274.5295.2063; Shiraishi T, 1998, DEV PLANT PATHOL, V13, P343; SINGH S, 1974, PHYTOCHEMISTRY, V13, P2020, DOI 10.1016/0031-9422(74)85157-5; Tronchet M, 2001, PLANT J, V27, P115, DOI 10.1046/j.1365-313x.2001.01072.x; Voinnet O, 1997, NATURE, V389, P553, DOI 10.1038/39215; Yoshioka K, 2001, PLANT J, V26, P447, DOI 10.1046/j.1365-313X.2001.2641039.x; Ziegler J, 2001, PHYTOCHEMISTRY, V58, P729, DOI 10.1016/S0031-9422(01)00284-9	30	179	194	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2002	418	6900					889	892		10.1038/nature00950	http://dx.doi.org/10.1038/nature00950			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192413				2022-12-28	WOS:000177555600041
J	Schneider, ME; Belyantseva, IA; Azevedo, RB; Kachar, B				Schneider, ME; Belyantseva, IA; Azevedo, RB; Kachar, B			Structural cell biology: Rapid renewal of auditory hair bundles - The recovery time after noise-induced hearing loss is in step with a molecular treadmill.	NATURE			English	Article							STEREOCILIA; RECEPTORS; COCHLEA		Natl Inst Deafness & Other Commun Disorders, Sect Struct Cell Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Schneider, ME (corresponding author), Natl Inst Deafness & Other Commun Disorders, Sect Struct Cell Biol, NIH, Bethesda, MD 20892 USA.		Azevedo, Ricardo/D-6273-2012	Azevedo, Ricardo/0000-0002-2137-9588	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000002] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Dumont RA, 2001, J NEUROSCI, V21, P5066, DOI 10.1523/JNEUROSCI.21-14-05066.2001; He DZZ, 2001, HEARING RES, V162, P113, DOI 10.1016/S0378-5955(01)00376-8; Hofer D, 1997, J CELL SCI, V110, P765; KALTENBACH JA, 1994, J COMP NEUROL, V350, P187, DOI 10.1002/cne.903500204; MILLER JS, 1989, MOL CRYST LIQ CRYST, V176, P1; Nguyen-Legros J, 2000, INT REV CYTOL, V196, P245; Pickles JO, 1996, HEARING RES, V101, P45, DOI 10.1016/S0378-5955(96)00129-3; Sobkowicz HM, 1997, INT J DEV NEUROSCI, V15, P463, DOI 10.1016/S0736-5748(96)00104-9; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cb.08.110192.001353; Zine A, 1996, BRAIN RES, V721, P49, DOI 10.1016/0006-8993(96)00147-3	10	145	156	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2002	418	6900					837	838		10.1038/418837a	http://dx.doi.org/10.1038/418837a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192399				2022-12-28	WOS:000177555600027
J	Salvarani, C; Silingardi, M; Ghirarduzzi, A; Lo Scocco, G; Macchioni, P; Bajocchi, G; Vinceti, M; Cantini, F; Iori, I; Boiardi, L				Salvarani, C; Silingardi, M; Ghirarduzzi, A; Lo Scocco, G; Macchioni, P; Bajocchi, G; Vinceti, M; Cantini, F; Iori, I; Boiardi, L			Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis?	ANNALS OF INTERNAL MEDICINE			English	Article							POLYMYALGIA-RHEUMATICA; CLASSIFICATION; CRITERIA; BIOPSY	Background: Evidence of a dark halo on ultrasonography has been considered a specific sign of giant-cell arteritis and may replace temporal artery biopsy for the diagnosis of giant-cell arteritis in patients with typical clinical manifestations. Objective: To assess the usefulness of temporal artery duplex Ultrasonography and to compare this mode of ultrasonography with physical examination of temporal arteries for the diagnosis of giant-cell arteritis in patients with suspected giant-cell arteritis or polymyalgia rheumatica. Design: Diagnostic test study. Setting: Several divisions of Reggio Emilia Hospital, Reggio Emilia, Italy. Patients: 86 consecutive patients with a suspected diagnosis of giant-cell arteritis or polymyalgia rheumatica identified over a 22-month period. Measurements: The temporal arteries were examined in all 86 patients. Duplex ultrasonography of the temporal arteries was then performed by two ultrasonographers who were unaware of the clinical diagnosis. Before corticosteroid therapy was started; temporal artery biopsies were performed in all patients at the site targeted by the ultrasonographer. Results: A hypoechoic halo around the lumen of the temporal arteries had a sensitivity of only 40% (95% Cl, 16% to 68%) and a specificity of 79% (Cl, 68% to 88%) for the diagnosis of biopsy-proven giant-cell arteritis. The negative likelihood ratio was 0.8 (Cl, 0.5 to 1.2), and the positive likelihood ratio was 1.9 (Cl, 0.9 to 4.1). When the thickness of the halo was at least 1 mm, specificity increased to 93% (Cl, 84% to 98%) and the positive likelihood ratio increased to 5.7 (Cl, 2.0 to 16.2); however, sensitivity remained low at 40% (Cl, 16% to 68%). On physical examination, temporal artery abnormalities had a higher sensitivity of 67% (Cl, 38% to 88%), a higher specificity of 99% (Cl, 92% to 100%), and a higher positive likelihood ratio of 47.3 (Cl, 6.5 to 342.4) than did ultrasonographic findings. None of the patients with giant-cell arteritis had a normal temporal artery inspection and a hypoechoic halo on ultrasonography. Conclusion: Evidence on ultrasonography of a halo around temporal arteries, either any halo or a halo 1 mm or greater in thickness, only modestly increased the probability of biopsy-proven giant-cell arteritis but did not improve the diagnostic accuracy of a careful physical examination.	Arcispedale S Maria Nuova, Serv Reumatol, I-42100 Reggio Emilia, Italy; Univ Modena & Reggio Emilia, Modena, Italy; Osped Prato, Prato, Italy	IRCCS Arcispedale S. Maria Nuova; Universita di Modena e Reggio Emilia; Prato Hospital	Salvarani, C (corresponding author), Arcispedale S Maria Nuova, Serv Reumatol, Viale Umberto 1 50, I-42100 Reggio Emilia, Italy.	salvarani.carlo@asmn.re.it	Salvarani, Carlo/K-2431-2018; Vinceti, Marco/O-2509-2015	Vinceti, Marco/0000-0002-0551-2473; Silingardi, Mauro/0000-0002-9518-8725; Salvarani, Carlo/0000-0001-5426-5133; bajocchi, gianluigi/0000-0002-6430-800X				ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; GABRIEL SE, 1995, J RHEUMATOL, V22, P93; HALL S, 1983, LANCET, V2, P1217; HEALEY LA, 1984, SEMIN ARTHRITIS RHEU, V13, P322, DOI 10.1016/0049-0172(84)90012-X; Hunder GG, 1997, NEW ENGL J MED, V337, P1385, DOI 10.1056/NEJM199711063371910; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122; Rao JK, 1998, ANN INTERN MED, V129, P345, DOI 10.7326/0003-4819-129-5-199809010-00001; RodriguezValverde V, 1997, AM J MED, V102, P331, DOI 10.1016/S0002-9343(97)00117-4; SALVARANI C, 1987, CLIN EXP RHEUMATOL, V5, P205; SALVARANI C, 1991, ARTHRITIS RHEUM, V34, P351, DOI 10.1002/art.1780340313; Schmidt WA, 1997, NEW ENGL J MED, V337, P1336, DOI 10.1056/NEJM199711063371902; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V	12	146	148	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2002	137	4					232	238		10.7326/0003-4819-137-4-200208200-00006	http://dx.doi.org/10.7326/0003-4819-137-4-200208200-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585BB	12186513				2022-12-28	WOS:000177502300002
J	Woolf, CJ; Bloechlinger, S				Woolf, CJ; Bloechlinger, S			Neuroscience: It takes more than two to Nogo	SCIENCE			English	Editorial Material							NEURITE GROWTH-INHIBITORS; SPINAL-CORD INJURY; AXON REGENERATION; RECOVERY; PROTEIN; CNS		Massachusetts Gen Hosp, Dept Anesthesia, Neural Plast Res Grp, Boston, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Woolf, CJ (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia, Neural Plast Res Grp, Boston, MA 02129 USA.		Woolf, Clifford/A-9784-2010					Bartsch U, 1995, NEURON, V15, P1375, DOI 10.1016/0896-6273(95)90015-2; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; OURNIER AE, 2001, NATURE, V409, P341; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; Vyas AA, 2002, P NATL ACAD SCI USA, V99, P8412, DOI 10.1073/pnas.072211699; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010	17	51	80	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2002	297	5584					1132	1134		10.1126/science.1076247	http://dx.doi.org/10.1126/science.1076247			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	584BP	12183616				2022-12-28	WOS:000177447600033
J	Apperley, JF; Gardembas, M; Melo, JV; Russell-Jones, R; Bain, BJ; Baxter, J; Chase, A; Chessells, JM; Colombat, M; Dearden, CE; Dimitrijevic, S; Mahon, FX; Marin, D; Nikolova, Z; Olavarria, E; Silberman, S; Schultheis, B; Cross, NCP; Goldman, JM				Apperley, JF; Gardembas, M; Melo, JV; Russell-Jones, R; Bain, BJ; Baxter, J; Chase, A; Chessells, JM; Colombat, M; Dearden, CE; Dimitrijevic, S; Mahon, FX; Marin, D; Nikolova, Z; Olavarria, E; Silberman, S; Schultheis, B; Cross, NCP; Goldman, JM			Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TYROSINE KINASE INHIBITOR; CHRONIC MYELOMONOCYTIC LEUKEMIA; PROTEASE-ACTIVATED LIGAND; CHRONIC MYELOID-LEUKEMIA; BCR-ABL; FUSION; CELLS; GENE; MICE; TEL	Background A small proportion of patients with chronic myeloproliferative diseases have constitutive activation of the gene for platelet-derived growth factor receptor beta (PDGFRB), which encodes a receptor tyrosine kinase. The gene is located on chromosome 5q33, and the activation is usually caused by a t(5;12)(q33;p13) translocation associated with an ETV6-PDGFRB fusion gene. The tyrosine kinase inhibitor imatinib mesylate specifically inhibits ABL, PDGFR, and KIT kinases and has impressive clinical efficacy in BCR-ABL-positive chronic myeloid leukemia. Methods We treated four patients who had chronic myeloproliferative diseases and chromosomal translocations involving 5q33 with imatinib mesylate (400 mg daily). Three of the four patients presented with leukocytosis and eosinophilia; their leukemia cells carried the ETV6-PDGFRB fusion gene. The fourth patient had leukocytosis, eosinophilia, and a t(5;12) translocation involving PDGFRB and an unknown partner gene; he also had extensive raised, ulcerated skin lesions that had been present for a long time. Results In all four patients, a normal blood count was achieved within four weeks after treatment began. In the patient with skin disease, the lesions began to resolve shortly after treatment began. The t(5;12) translocation was undetectable by 12 weeks in three patients and by 36 weeks in the fourth patient. In the three patients with the ETV6-PDGFRB fusion gene, the transcript level decreased, and in one patient, it became undetectable by 36 weeks. All responses were durable at 9 to 12 months of follow-up. Conclusions Imatinib mesylate induces durable responses in patients with chronic myeloproliferative diseases associated with activation of PDGFRB.	Ctr Hosp Univ Angers, Dept Hematol, Angers, France; St Thomas Hosp, Skin Tumour Unit, St Johns Inst Dermatol, London, England; Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury, Wilts, England; Great Ormond St Hosp Children, Dept Haematol, London WC1N 3JH, England; Ctr Hosp Univ Bordeaux, Dept Hematol, Pessac, France; Univ London St Georges Hosp, Dept Haematol, London SW17 0RE, England; Novartis Oncol, Basel, Switzerland; Univ London Imperial Coll Sci Technol & Med, Dept Haematol, Fac Med, London, England	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Salisbury District Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; CHU Bordeaux; St Georges University London; Novartis; Imperial College London	Apperley, JF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Haematol, Fac Med, Hammersmith Hosp, Du Cane Rd, London W12 0NN, England.		Schultheis, Beate/M-5889-2017; Cross, Nicholas/B-4817-2009	Cross, Nicholas/0000-0001-5481-2555; Baxter, Elizabeth Joanna/0000-0002-5946-5238; Chase, Andrew/0000-0001-6617-9953				Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; Carroll M, 1997, BLOOD, V90, P4947, DOI 10.1182/blood.V90.12.4947.4947_4947_4952; CLAESSONWELSH L, 1994, J BIOL CHEM, V269, P32023; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Druker BJ, 2001, NEW ENGL J MED, V345, P232; Gleich GJ, 2002, LANCET, V359, P1577, DOI 10.1016/S0140-6736(02)08505-7; GOLUB TR, 1994, CELL, V77, P307, DOI 10.1016/0092-8674(94)90322-0; Heldin CH, 1998, BIOCHIM BIOPHYS ACTA, V1378, P79; Irusta PM, 1998, EMBO J, V17, P6912, DOI 10.1093/emboj/17.23.6912; JANI K, 1994, BRIT J HAEMATOL, V87, P57, DOI 10.1111/j.1365-2141.1994.tb04870.x; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; KEENE P, 1987, BRIT J HAEMATOL, V67, P25, DOI 10.1111/j.1365-2141.1987.tb02291.x; Kulkarni S, 2000, CANCER RES, V60, P3592; LaRochelle WJ, 2001, NAT CELL BIOL, V3, P517, DOI 10.1038/35074593; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Magnusson MK, 2001, BLOOD, V98, P2518, DOI 10.1182/blood.V98.8.2518; Magnusson MK, 2001, BLOOD, V98, p631A; Reilly JT, 2002, BRIT J HAEMATOL, V116, P744, DOI 10.1046/j.0007-1048.2001.03294.x; Rioux JD, 1998, AM J HUM GENET, V63, P1086, DOI 10.1086/302053; Ritchie KA, 1999, LEUKEMIA, V13, P1790, DOI 10.1038/sj.leu.2401494; Ross TS, 1998, BLOOD, V91, P4419, DOI 10.1182/blood.V91.12.4419.412k43_4419_4426; Steer EJ, 2002, ACTA HAEMATOL-BASEL, V107, P113, DOI 10.1159/000046641; Tomasson MH, 1999, BLOOD, V93, P1707, DOI 10.1182/blood.V93.5.1707.405k24_1707_1714; Tomasson MH, 2000, J CLIN INVEST, V105, P423, DOI 10.1172/JCI8902	27	502	525	1	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 15	2002	347	7					481	487		10.1056/NEJMoa020150	http://dx.doi.org/10.1056/NEJMoa020150			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587ZM	12181402				2022-12-28	WOS:000177674400004
J	Campbell, G				Campbell, G			Distalization of the Drosophila leg by graded EGF-receptor activity	NATURE			English	Article							HOMEOBOX GENES; WINGLESS; PROTEIN; ROLES; KINASE; AXIS; EYE; SPECIFICATION; ARISTALESS; ACTIVATION	Arthropods and higher vertebrates both possess appendages, but these are morphologically distinct and the molecular mechanisms regulating patterning along their proximodistal axis (base to tip) are thought to be quite different. In Drosophila, gene expression along this axis is thought to be controlled primarily by a combination of transforming growth factor-beta (TGF-beta) and Wnt signalling from sources of ligands, Decapentaplegic (Dpp) and Wingless (Wg), in dorsal and ventral stripes, respectively(1-3). In vertebrates, however, proximodistal patterning is regulated by receptor tyrosine kinase (RTK) activity from a source of ligands, fibroblast growth factors (FGFs), at the tip of the limb bud(4). Here I revise our understanding of limb development in flies and show that the distal region is actually patterned by a distal-to-proximal gradient of RTK activity, established by a source of epidermal growth factor (EGF)-related ligands at the presumptive tip. This similarity between proximodistal patterning in vertebrates and flies supports previous suggestions(5,6) of an evolutionary relationship between appendages/body-wall outgrowths in animals.	Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Campbell, G (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.			Campbell, Gerard/0000-0002-7631-4394				Bang AG, 2000, GENE DEV, V14, P177; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; Campbell G, 1998, DEVELOPMENT, V125, P4483; CAMPBELL G, 1993, CELL, V74, P1113, DOI 10.1016/0092-8674(93)90732-6; CAMPBELL G, 1995, DEVELOPMENT, V121, P619; Casares F, 2001, SCIENCE, V293, P1477, DOI 10.1126/science.1062542; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; CLIFFORD RJ, 1989, GENETICS, V123, P771; Couso JP, 1998, INT J DEV BIOL, V42, P345; DIAZBENJUMEA FJ, 1994, NATURE, V372, P175, DOI 10.1038/372175a0; Halfar K, 2001, DEVELOPMENT, V128, P1687; Irvine KD, 1999, CURR OPIN GENET DEV, V9, P434, DOI 10.1016/S0959-437X(99)80066-5; Kojima T, 2000, DEVELOPMENT, V127, P769; Kramer S, 1999, DEVELOPMENT, V126, P2515; Kumar JP, 1998, DEVELOPMENT, V125, P3875; Lecuit T, 1997, NATURE, V388, P139, DOI 10.1038/40563; MARDON G, 1994, DEVELOPMENT, V120, P3473; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; NELLEN D, 1994, CELL, V78, P225, DOI 10.1016/0092-8674(94)90293-3; Panganiban G, 1997, P NATL ACAD SCI USA, V94, P5162, DOI 10.1073/pnas.94.10.5162; PENTON A, 1994, CELL, V78, P239, DOI 10.1016/0092-8674(94)90294-1; Queenan AM, 1997, DEVELOPMENT, V124, P3871; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Wasserman JD, 2000, GENE DEV, V14, P1651; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110	27	109	110	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 15	2002	418	6899					781	785		10.1038/nature00971	http://dx.doi.org/10.1038/nature00971			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583UF	12181568				2022-12-28	WOS:000177428000040
J	Crawford, LM				Crawford, LM			Xenotransplantation advisory	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Crawford, LM (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2002	288	6					688	688		10.1001/jama.288.6.688	http://dx.doi.org/10.1001/jama.288.6.688			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	583KY	12169049				2022-12-28	WOS:000177408100004
J	Gabellini, D; Green, MR; Tupler, R				Gabellini, D; Green, MR; Tupler, R			Inappropriate gene activation in FSHD: A repressor complex binds a chromosomal repeat deleted in dystrophic muscle	CELL			English	Article							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; TRANSCRIPTION FACTOR YY1; MINISATELLITE LOCUS; DNA REARRANGEMENTS; 4Q35; IDENTIFICATION; EXPRESSION; PROTEIN; REGION; ASSOCIATION	Facioscapulolhumeral muscular dystrophy (FSHD), a common myopathy, is an autosomal dominant disease of unknown molecular mechanism. Almost all FSHD patients carry deletions of an integral number of tandem 3.3 kilobase repeats, termed D4Z4, located on chromosome 4q35. Here, we find that in FSHD muscle, 4q35 genes located upstream of D4Z4 are inappropriately overexpressed. We show that an element within D4Z4 specifically binds a multiprotein complex consisting of YY1, a known transcriptional repressor, HMGB2, an architectural protein, and nucleolin. We demonstrate that this multiprotein complex binds D4Z4 in vitro and in vivo and mediates transcriptional repression of 4q35 genes. Based upon these results, we propose that deletion of D4Z4 leads to the inappropriate transcriptional derepression of 4q35 genes resulting in disease.	Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express,Program Mol Med, Worcester, MA 01605 USA; Univ Pavia, I-27100 Pavia, Italy	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Pavia	Tupler, R (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express,Program Mol Med, Worcester, MA 01605 USA.		Tupler, Rossella/C-9500-2015; Gabellini, Davide/I-4551-2018	Tupler, Rossella/0000-0002-3797-1789; Gabellini, Davide/0000-0002-3811-4121	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS043973] Funding Source: NIH RePORTER; NINDS NIH HHS [R21 NS43973] Funding Source: Medline; Telethon [GP0284Y01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon)		AUSUBEL FM, 2001, CURRENT PROTOCOLS MO; Bauer MKA, 1999, J CELL BIOL, V147, P1493, DOI 10.1083/jcb.147.7.1493; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; BLAIR IP, 2002, IN PRESS MOL PSYCHIA; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; Clark LN, 1996, CHROMOSOMA, V105, P180, DOI 10.1007/BF02509499; Dorner R, 2000, HERZ, V25, P176, DOI 10.1007/s000590050004; Dunger DB, 1998, NAT GENET, V19, P98, DOI 10.1038/ng0598-98; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fisher J, 1997, NEUROMUSCULAR DISORD, V7, P55, DOI 10.1016/S0960-8966(96)00400-2; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; GOTO K, 1995, NEUROMUSCULAR DISORD, V5, P201, DOI 10.1016/0960-8966(94)00055-E; Hanakahi LA, 1997, P NATL ACAD SCI USA, V94, P3605, DOI 10.1073/pnas.94.8.3605; HEWITT JE, 1994, HUM MOL GENET, V3, P1287, DOI 10.1093/hmg/3.8.1287; Hsu YD, 1997, J NEUROL SCI, V149, P73, DOI 10.1016/S0022-510X(97)05394-X; Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782; KENNEDY GC, 1995, NAT GENET, V9, P293, DOI 10.1038/ng0395-293; KRONTIRIS TG, 1993, NEW ENGL J MED, V329, P517, DOI 10.1056/NEJM199308193290801; Lehming N, 1998, P NATL ACAD SCI USA, V95, P7322, DOI 10.1073/pnas.95.13.7322; Lunt P W, 1998, Neuromuscul Disord, V8, P126, DOI 10.1016/S0960-8966(98)00012-1; LUNT PW, 1995, HUM MOL GENET, V4, P951, DOI 10.1093/hmg/4.5.951; Lustig AJ, 1998, CURR OPIN GENET DEV, V8, P233, DOI 10.1016/S0959-437X(98)80146-9; LYLE R, 1995, GENOMICS, V28, P389, DOI 10.1006/geno.1995.1166; Morcos PA, 2001, GENESIS, V30, P94, DOI 10.1002/gene.1039; Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295; ORLANDO V, 1993, CELL, V75, P1187, DOI 10.1016/0092-8674(93)90328-N; Padberg GW, 1982, THESIS LEIDEN U LEID; Pryde FE, 1999, EMBO J, V18, P2538, DOI 10.1093/emboj/18.9.2538; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; Ricci E, 1999, ANN NEUROL, V45, P751, DOI 10.1002/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M; Sandri M, 2001, J NEUROPATH EXP NEUR, V60, P302, DOI 10.1093/jnen/60.3.302; SARFARAZI M, 1992, AM J HUM GENET, V51, P396; Schulz M, 2001, BIOCHEM BIOPH RES CO, V280, P476, DOI 10.1006/bbrc.2000.4141; Tawil R, 1996, ANN NEUROL, V39, P744, DOI 10.1002/ana.410390610; Tews DS, 1997, NEUROPATH APPL NEURO, V23, P331, DOI 10.1046/j.1365-2990.1997.5998059.x; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Tupler R, 1999, P NATL ACAD SCI USA, V96, P12650, DOI 10.1073/pnas.96.22.12650; Tupler R, 1996, J MED GENET, V33, P366, DOI 10.1136/jmg.33.5.366; van Geel M, 1999, GENOMICS, V61, P55, DOI 10.1006/geno.1999.5942; van Geel M, 2000, CYTOGENET CELL GENET, V88, P316, DOI 10.1159/000015518; vanDeutekom JCT, 1996, HUM MOL GENET, V5, P581, DOI 10.1093/hmg/5.5.581; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Winokur ST, 1994, CHROMOSOME RES, V2, P225, DOI 10.1007/BF01553323; Xie JP, 1998, J CELL BIOCHEM, V70, P489, DOI 10.1002/(SICI)1097-4644(19980915)70:4<489::AID-JCB6>3.0.CO;2-F; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353; Ying GG, 2000, J BIOL CHEM, V275, P4152, DOI 10.1074/jbc.275.6.4152; ZATZ M, 1995, AM J HUM GENET, V56, P99	49	297	308	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 9	2002	110	3					339	348		10.1016/S0092-8674(02)00826-7	http://dx.doi.org/10.1016/S0092-8674(02)00826-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	583MN	12176321	Bronze			2022-12-28	WOS:000177411800010
J	Munekage, Y; Hojo, M; Meurer, J; Endo, T; Tasaka, M; Shikanai, T				Munekage, Y; Hojo, M; Meurer, J; Endo, T; Tasaka, M; Shikanai, T			PGR5 is involved in cyclic electron flow around photosystem I and is essential for photoprotection in Arabidopsis	CELL			English	Article							NDHB GENE; PHOTOACOUSTIC MEASUREMENTS; CHLOROPHYLL-FLUORESCENCE; DEHYDROGENASE COMPLEX; NAD(P)H DEHYDROGENASE; INTACT CHLOROPLASTS; NADH-DEHYDROGENASE; TRANSPORT; TOBACCO; ENERGY	During photosynthesis, plants must control the utilization of light energy in order to avoid photoinhibition. We isolated an Arabidopsis mutant, pgr5 (proton gradient regulation), in which downregulation of photosystem 11 photochemistry in response to intense light was impaired. PGR5 encodes a novel thylakoid membrane protein that is involved in the transfer of electrons from ferredoxin to plastoquinone. This alternative electron transfer pathway, whose molecular identity has long been unclear, is known to function in vivo in cyclic electron flow around photosystern 1. We propose that the PGR5 pathway contributes to the generation of a DeltapH that induces thermal dissipation when Calvin cycle activity is reduced. Under these conditions, the PGR5 pathway also functions to limit the overreduction of the acceptor side of photosystem 1, thus preventing photosystern I photoinhibition.	Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan; Univ Munich, Inst Bot, D-80638 Munich, Germany; Kyoto Univ, Grad Sch Biostudies, Sakyou Ku, Kyoto 6068502, Japan	Nara Institute of Science & Technology; University of Munich; Kyoto University	Shikanai, T (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan.	shikanai@bs.aist-nara.ac.jp	Shikanai, Toshiharu/AAK-9112-2020; Meurer, Jörg/F-8479-2010	Meurer, Jörg/0000-0003-2973-9514				ARNON DI, 1975, P NATL ACAD SCI USA, V72, P4961, DOI 10.1073/pnas.72.12.4961; ARNON DI, 1954, NATURE, V174, P394, DOI 10.1038/174394a0; ARNON DI, 1959, NATURE, V184, P10; ARNON DI, 1967, NATURE, V214, P562, DOI 10.1038/214562a0; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; ASADA K, 1993, PLANT CELL PHYSIOL, V34, P39; BELL CJ, 1994, GENOMICS, V19, P137, DOI 10.1006/geno.1994.1023; BENDALL DS, 1995, BBA-BIOENERGETICS, V1229, P23, DOI 10.1016/0005-2728(94)00195-B; Burrows PA, 1998, EMBO J, V17, P868, DOI 10.1093/emboj/17.4.868; Cornic G, 2000, PLANTA, V210, P468, DOI 10.1007/PL00008154; Endo T, 1999, FEBS LETT, V457, P5, DOI 10.1016/S0014-5793(99)00989-8; Endo T, 1998, PLANT CELL PHYSIOL, V39, P1226, DOI 10.1093/oxfordjournals.pcp.a029324; Felder S, 2001, PLANT CELL, V13, P2127, DOI 10.1105/tpc.13.9.2127; Finazzi G, 2002, EMBO REP, V3, P280, DOI 10.1093/embo-reports/kvf047; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Golbeck J., 1991, CURR TOP BIOENERG, P83; HEBER U, 1992, PLANT PHYSIOL, V100, P1621, DOI 10.1104/pp.100.4.1621; HEBER U, 1978, PLANTA, V143, P41, DOI 10.1007/BF00389050; HERBERT SK, 1990, PLANT PHYSIOL, V94, P926, DOI 10.1104/pp.94.3.926; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Horvath EM, 2000, PLANT PHYSIOL, V123, P1337, DOI 10.1104/pp.123.4.1337; Joet T, 2001, PLANT PHYSIOL, V125, P1919, DOI 10.1104/pp.125.4.1919; Kofer W, 1998, MOL GEN GENET, V258, P166, DOI 10.1007/s004380050719; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Kozaki A, 1996, NATURE, V384, P557, DOI 10.1038/384557a0; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; MAKINO A, 2002, IN PRESS PLANT CELL; MATSUBAYASHI T, 1987, MOL GEN GENET, V210, P385, DOI 10.1007/BF00327187; Meurer J, 1996, PLANTA, V198, P385, DOI 10.1007/BF00620055; MI HL, 1995, PLANT CELL PHYSIOL, V36, P661; MILLS JD, 1978, BIOCHIM BIOPHYS ACTA, V504, P298, DOI 10.1016/0005-2728(78)90178-0; MILLS JD, 1979, BIOCHIM BIOPHYS ACTA, V547, P127, DOI 10.1016/0005-2728(79)90101-4; MIYAKE C, 1994, PLANT CELL PHYSIOL, V35, P539, DOI 10.1093/oxfordjournals.pcp.a078628; MOSS DA, 1984, BIOCHIM BIOPHYS ACTA, V767, P389, DOI 10.1016/0005-2728(84)90036-7; Munekage Y, 2001, PLANT J, V28, P351, DOI 10.1046/j.1365-313X.2001.01178.x; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Peltier G, 2002, ANNU REV PLANT BIOL, V53, P523, DOI 10.1146/annurev.arplant.53.100301.135242; RAVENEL J, 1994, PLANTA, V193, P251; SCHREIBER U, 1988, Z NATURFORSCH C, V43, P686; Shikanai T, 1998, P NATL ACAD SCI USA, V95, P9705, DOI 10.1073/pnas.95.16.9705; Shikanai T, 1999, PLANT CELL PHYSIOL, V40, P1134, DOI 10.1093/oxfordjournals.pcp.a029498; Sonoike K, 1996, PLANT CELL PHYSIOL, V37, P239, DOI 10.1093/oxfordjournals.pcp.a028938; SONOIKE K, 1994, PLANTA, V194, P287, DOI 10.1007/BF01101690; TAGAWA K, 1963, P NATL ACAD SCI USA, V49, P567, DOI 10.1073/pnas.49.4.567; Zhang HM, 2001, J BIOL CHEM, V276, P38159	47	723	757	6	147	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 9	2002	110	3					361	371		10.1016/S0092-8674(02)00867-X	http://dx.doi.org/10.1016/S0092-8674(02)00867-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	583MN	12176323	Bronze			2022-12-28	WOS:000177411800012
J	Addiscott, T; Brookes, P				Addiscott, T; Brookes, P			Nitrogen cycle - What governs nitrogen loss from forest soils?	NATURE			English	Article									Rothamsted Expt, Harpenden AL5 2JQ, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Addiscott, T (corresponding author), Rothamsted Expt, Harpenden AL5 2JQ, Herts, England.	tom.addiscott@bbsrc.ac.uk						ANDERSON O. E., 1960, SOIL SCI SOC AMER PROC, V24, P286; CLARKSON DT, 1979, PLANT PHYSIOL, V64, P557, DOI 10.1104/pp.64.4.557; HERBERT BE, 1995, CARBON FORMS AND FUNCTIONS IN FOREST SOILS, P63; PEARCE F, 2002, NEW SCI, P11; Perakis SS, 2002, NATURE, V415, P416, DOI 10.1038/415416a; Persson J, 2001, ECOL LETT, V4, P434, DOI 10.1046/j.1461-0248.2001.00260.x; TYLER K. B., 1959, SOIL SCI, V87, P123, DOI 10.1097/00010694-195903000-00001; van Breemen N, 2002, NATURE, V415, P381, DOI 10.1038/415381a; Williams LE, 2001, ANNU REV PLANT PHYS, V52, P659, DOI 10.1146/annurev.arplant.52.1.659	9	1	1	4	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2002	418	6898					604	604		10.1038/418604a	http://dx.doi.org/10.1038/418604a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167851	Green Published			2022-12-28	WOS:000177305600031
J	Isley, WL				Isley, WL			Growth hormone therapy for adults: Not ready for prime time?	ANNALS OF INTERNAL MEDICINE			English	Article							CARDIOVASCULAR RISK-FACTORS; CORONARY-HEART-DISEASE; GH-DEFICIENT ADULTS; REPLACEMENT THERAPY; BODY-COMPOSITION; HYPOPITUITARY ADULTS; GLUCOCORTICOID REPLACEMENT; PREMATURE MORTALITY; INSULIN SENSITIVITY; CARDIAC-PERFORMANCE	Human growth hormone is now readily available and approved for treatment of the growth hormone deficiency syndrome in adults. However, physicians have been slow to adopt this therapeutic modality. Reasons for skepticism about the use of growth hormone for the growth hormone deficiency syndrome include doubts about whether growth hormone deficiency causes increased morbidity and mortality in patients with hypopituitarism; availability of highly efficacious, easier to use, and less expensive agents for certain aspects of the growth hormone deficiency syndrome, especially cardiovascular disease; and concerns about possible toxicity in adults. Long-term studies in patients receiving appropriate comprehensive management for other hormonal deficiencies and for concomitant abnormalities will be required to convince physicians of the utility and safety of growth hormone replacement therapy.	Univ Missouri, Sch Med, Kansas City, MO 64108 USA	University of Missouri System; University of Missouri Kansas City	Isley, WL (corresponding author), St Lukes Lipid & Diabet Res Ctr, Plaza 1,Suite 128,4320 Wornall Rd, Kansas City, MO 64111 USA.	wisley@saint-lukes.org						AlShoumer KAS, 1997, J CLIN ENDOCR METAB, V82, P2653, DOI 10.1210/jc.82.8.2653; Attanasio AF, 1997, J CLIN ENDOCR METAB, V82, P82, DOI 10.1210/jc.82.1.82; Barkan AL, 2000, TRENDS ENDOCRIN MET, V11, P238, DOI 10.1016/S1043-2760(00)00267-8; Bates AS, 1999, CLIN ENDOCRINOL, V50, P315, DOI 10.1046/j.1365-2265.1999.00650.x; Bates AS, 1996, J CLIN ENDOCR METAB, V81, P1169, DOI 10.1210/jc.81.3.1169; Baum HBA, 1996, ANN INTERN MED, V125, P883, DOI 10.7326/0003-4819-125-11-199612010-00003; BENGTSSON BA, 1993, J CLIN ENDOCR METAB, V76, P309, DOI 10.1210/jc.76.2.309; BESHYAH SA, 1995, J CLIN ENDOCR METAB, V80, P356, DOI 10.1210/jc.80.2.356; BESHYAH SA, 1995, CLIN ENDOCRINOL, V42, P73, DOI 10.1111/j.1365-2265.1995.tb02601.x; Bhasin S, 1997, J CLIN ENDOCR METAB, V82, P3, DOI 10.1210/jc.82.1.3; Black DM, 2000, J CLIN ENDOCR METAB, V85, P4118, DOI 10.1210/jc.85.11.4118; BOWEN J, 1992, STROKE, V23, P908, DOI 10.1161/01.STR.23.6.908; Bulow B, 1997, CLIN ENDOCRINOL, V46, P75, DOI 10.1046/j.1365-2265.1997.d01-1749.x; Bulow B, 2000, J CLIN ENDOCR METAB, V85, P574, DOI 10.1210/jc.85.2.574; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Carroll PV, 2000, TRENDS ENDOCRIN MET, V11, P231, DOI 10.1016/S1043-2760(00)00268-X; Chrisoulidou A, 2000, J CLIN ENDOCR METAB, V85, P3762, DOI 10.1210/jc.85.10.3762; Christiansen JS, 2001, J CLIN ENDOCR METAB, V86, P1868; Christopher M, 1998, J CLIN ENDOCR METAB, V83, P1668, DOI 10.1210/jc.83.5.1668; Colao A, 1999, J CLIN ENDOCR METAB, V84, P3950, DOI 10.1210/jc.84.11.3950; Colao A, 2001, J CLIN ENDOCR METAB, V86, P1874, DOI 10.1210/jc.86.5.1874; CUNEO RC, 1991, J APPL PHYSIOL, V70, P695, DOI 10.1152/jappl.1991.70.2.695; CUNEO RC, 1993, METABOLISM, V42, P1519, DOI 10.1016/0026-0495(93)90145-E; CUNEO RC, 1992, CLIN ENDOCRINOL, V37, P387, DOI 10.1111/j.1365-2265.1992.tb02347.x; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; DUNNE FP, 1995, CLIN ENDOCRINOL, V43, P623, DOI 10.1111/j.1365-2265.1995.tb02928.x; EDEN S, 1993, ARTERIOSCLER THROMB, V13, P296, DOI 10.1161/01.ATV.13.2.296; Evans LM, 1999, CLIN ENDOCRINOL, V50, P457; Gotherstrom G, 2001, J CLIN ENDOCR METAB, V86, P4657, DOI 10.1210/jc.86.10.4657; Greenspan SL, 1999, ANN INTERN MED, V130, P750, DOI 10.7326/0003-4819-130-9-199905040-00016; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; Hansen TB, 1995, CLIN ENDOCRINOL, V43, P689, DOI 10.1111/j.1365-2265.1995.tb00536.x; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hew FL, 1996, J CLIN ENDOCR METAB, V81, P555, DOI 10.1210/jc.81.2.555; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Johannsson G, 1996, J CLIN ENDOCR METAB, V81, P1575, DOI 10.1210/jc.81.4.1575; Johansson AG, 1999, J CLIN ENDOCR METAB, V84, P2002, DOI 10.1210/jc.84.6.2002; JORGENSEN JOL, 1989, LANCET, V1, P1221; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; MARKUSSIS V, 1992, LANCET, V340, P1188, DOI 10.1016/0140-6736(92)92892-J; MARTIN JB, 1992, PROG BRAIN RES, V93, P31; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; McConnell EM, 2001, CLIN ENDOCRINOL, V54, P593, DOI 10.1046/j.1365-2265.2001.01269.x; *MED EC, 2001, 2001 DRUG TOP RED BO; Meier C, 2001, J CLIN ENDOCR METAB, V86, P4860, DOI 10.1210/jc.86.10.4860; Mendelsohn ME, 2001, CIRCULATION, V104, P2256, DOI 10.1161/circ.104.19.2256; Miller KK, 2001, J CLIN ENDOCR METAB, V86, P561, DOI 10.1210/jc.86.2.561; MURROS KE, 1989, ARCH NEUROL-CHICAGO, V46, P449, DOI 10.1001/archneur.1989.00520400109029; NASS R, 1995, J CLIN ENDOCR METAB, V80, P552, DOI 10.1210/jc.80.2.552; OLIVECRONA H, 1993, BRIT MED J, V306, P1726, DOI 10.1136/bmj.306.6894.1726-a; ONeal D, 1996, J CLIN ENDOCR METAB, V81, P2448, DOI 10.1210/jc.81.7.2448; Peacey SR, 1997, CLIN ENDOCRINOL, V46, P255, DOI 10.1046/j.1365-2265.1997.780907.x; PEDERSEN TR, 1994, LANCET, V344, P1383; Ridker PM, 1999, CIRCULATION, V100, P230, DOI 10.1161/01.CIR.100.3.230; Ridker PM, 2001, JAMA-J AM MED ASSOC, V285, P2481, DOI 10.1001/jama.285.19.2481; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; Rosenfalck AM, 2000, J CLIN ENDOCR METAB, V85, P4173, DOI 10.1210/jc.85.11.4173; SALOMON F, 1989, NEW ENGL J MED, V321, P1797, DOI 10.1056/NEJM198912283212605; SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901; Schnitzer T, 2000, AGING CLIN EXP RES, V12, P1; Sesmilo G, 2000, ANN INTERN MED, V133, P111, DOI 10.7326/0003-4819-133-2-200007180-00010; SHAHI M, 1992, BRIT HEART J, V67, P92; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Stavrou S, 2001, ENDOCRIN METAB CLIN, V30, P545, DOI 10.1016/S0889-8529(05)70201-2; Thomas AM, 2001, J CLIN ENDOCR METAB, V86, P1871, DOI 10.1210/jc.86.5.1871; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; TOOGOOD AA, 1994, CLIN ENDOCRINOL, V41, P511, DOI 10.1111/j.1365-2265.1994.tb02583.x; Vance ML, 1999, NEW ENGL J MED, V341, P1206, DOI 10.1056/NEJM199910143411607; Villareal DT, 2000, CLIN ENDOCRINOL, V53, P561, DOI 10.1046/j.1365-2265.2000.01131.x; Wang C, 2000, J CLIN ENDOCR METAB, V85, P2839, DOI 10.1210/jc.85.8.2839; WEAVER JU, 1994, CLIN ENDOCRINOL, V41, P639, DOI 10.1111/j.1365-2265.1994.tb01830.x; WEAVER JU, 1995, J CLIN ENDOCR METAB, V80, P153, DOI 10.1210/jc.80.1.153; WHITEHEAD HM, 1992, CLIN ENDOCRINOL, V36, P45, DOI 10.1111/j.1365-2265.1992.tb02901.x; Wichers M, 1999, CLIN ENDOCRINOL, V50, P759, DOI 10.1046/j.1365-2265.1999.00723.x; Wuster C, 2001, J BONE MINER RES, V16, P398, DOI 10.1359/jbmr.2001.16.2.398; Yusuf S, 2000, NEW ENGL J MED, V342, P145	77	14	15	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 6	2002	137	3					190	196		10.7326/0003-4819-137-3-200208060-00011	http://dx.doi.org/10.7326/0003-4819-137-3-200208060-00011			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580XP	12160367				2022-12-28	WOS:000177262300006
J	Sanchez, V; Spector, DH				Sanchez, V; Spector, DH			Virology: CMV makes a timely exit	SCIENCE			English	Editorial Material							HERPES-SIMPLEX VIRUS-1; NUCLEAR-MEMBRANE; PSEUDORABIES VIRUS; GENE-PRODUCT; ENVELOPMENT; PROTEIN; REQUIRES; U(L)31; CELLS; UL31		Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Sanchez, V (corresponding author), Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA.			Spector, Deborah/0000-0002-7605-6348				Chang YE, 1997, J VIROL, V71, P8307, DOI 10.1128/JVI.71.11.8307-8315.1997; Dal Monte P, 2002, J GEN VIROL, V83, P1005, DOI 10.1099/0022-1317-83-5-1005; Fuchs W, 2002, J VIROL, V76, P364, DOI 10.1128/JVI.76.1.364-378.2002; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Klupp BG, 2000, J VIROL, V74, P10063, DOI 10.1128/JVI.74.21.10063-10073.2000; Mettenleiter TC, 2002, J VIROL, V76, P1537, DOI 10.1128/JVI.76.4.1537-1547.2002; Muranyi W, 2002, SCIENCE, V297, P854, DOI 10.1126/science.1071506; Reynolds AE, 2001, J VIROL, V75, P8803, DOI 10.1128/JVI.75.18.8803-8817.2001; Roller RJ, 2000, J VIROL, V74, P117, DOI 10.1128/JVI.74.1.117-129.2000; Scott ES, 2001, J VIROL, V75, P8818, DOI 10.1128/JVI.75.18.8818-8830.2001; Yamauchi Y, 2001, J GEN VIROL, V82, P1423, DOI 10.1099/0022-1317-82-6-1423; Ye GJ, 2000, J VIROL, V74, P1355, DOI 10.1128/JVI.74.3.1355-1363.2000	12	17	18	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2002	297	5582					778	779		10.1126/science.1075102	http://dx.doi.org/10.1126/science.1075102			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161637				2022-12-28	WOS:000177192800030
J	Schultz, PG; Lerner, RA				Schultz, PG; Lerner, RA			Antibody catalysis: Completing the circle	NATURE			English	Article									Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Schultz, PG (corresponding author), Scripps Res Inst, Dept Chem, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.							Haldane JBS, 1930, ENZYMES; SCHULTZ P, IN PRESS ANGEW CHEM	2	19	20	2	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2002	418	6897					485	485		10.1038/418485a	http://dx.doi.org/10.1038/418485a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152057	Bronze			2022-12-28	WOS:000177162800019
J	Andre, F; Schartz, NEC; Movassagh, M; Flament, C; Pautier, P; Morice, P; Pomel, C; Lhomme, C; Escudier, B; Le Chevalier, T; Tursz, T; Amigorena, S; Raposo, G; Angevin, E; Zitvogel, L				Andre, F; Schartz, NEC; Movassagh, M; Flament, C; Pautier, P; Morice, P; Pomel, C; Lhomme, C; Escudier, B; Le Chevalier, T; Tursz, T; Amigorena, S; Raposo, G; Angevin, E; Zitvogel, L			Malignant effusions and immunogenic tumour-derived exosomes	LANCET			English	Article							AUTOLOGOUS DENDRITIC CELLS; CYTOTOXIC T-LYMPHOCYTES; HEAT-SHOCK-PROTEIN; INFILTRATING LYMPHOCYTES; OVARIAN-CANCER; ADOPTIVE IMMUNOTHERAPY; ANTIGEN; VACCINATION; INDUCTION; CARCINOMA	Background Exosomes derived from tumours are small vesicles released in vitro by tumour cell lines in culture supernatants. To assess the role of these exosomes in vivo, we examined malignant effusions for their presence. We also investigated whether these exosomes could induce production of tumour-specific T cells when pulsed with dendritic cells. Methods We isolated exosomes by ultracentrifugation on sucrose and D2O gradients of 11 malignant effusions. We characterised exosomes with Western blot analyses, immunoelectron microscopy, and in-vitro stimulations of autologous T lymphocytes. Findings Malignant effusions accumulate high numbers of membrane vesicles that have a mean diameter of 80 nm (SD 30). These vesicles have antigen-presenting molecules (MHC class-I heat-shock proteins), tetraspanins (CD81), and tumour antigens (Her2/Neu, Mart1, TRP, gp100). These criteria, including their morphological characteristics, indicate the similarities between these vesicles and exosomes. Exosomes from patients with melanoma deliver Mart1 tumour antigens to dendritic cells derived from monocytes (MD-DCs) for cross presentation to clones of cytotoxic T lymphocytes specific to Mart1. In seven of nine patients with cancer, lymphocytes specific to the tumour could be efficiently expanded from peripheral blood cells by pulsing autologous MD-DCs with autologous ascitis exosomes. In one patient tested, we successfully expanded a restricted T-cell repertoire, which could not be recovered carcinomatosis nodules. Interpretation Exosomes derived from tumours accumulate in ascites from patients with cancer. Ascitis exosomes are a natural and new source of tumour-rejection antigens, opening up new avenues for immunisation against cancers.	Inst Gustave Roussy, Dept Biol Clin, Unite Immunol, F-94805 Villejuif, France; Inst Gustave Roussy, Dept Med Oncol, Villejuif, France; Inst Gustave Roussy, Dept Surg Oncol, Villejuif, France; Hop St Louis, INSERM, U520, Paris, France; Inst Curie, CNRS, UMR 144, F-75231 Paris, France	UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Zitvogel, L (corresponding author), Inst Gustave Roussy, Dept Biol Clin, Unite Immunol, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.		ANDRE, Fabrice/AAL-2683-2020; Morice, Philippe/ABC-3179-2021; Pomel, Christophe/E-6833-2013	ANDRE, Fabrice/0000-0001-5795-8357; Pomel, Christophe/0000-0003-3903-7321; Morice, Philippe/0000-0003-0579-9993; Amigorena, Sebastian/0000-0001-8583-8416; ZITVOGEL, laurence/0000-0003-1596-0998; ANGEVIN, Eric/0000-0001-6249-7209				Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; AOKI Y, 1991, CANCER RES, V51, P1934; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Denzer K, 2000, J IMMUNOL, V165, P1259, DOI 10.4049/jimmunol.165.3.1259; Dufour E, 1997, J IMMUNOL, V158, P3787; Farace F, 1997, INT J CANCER, V71, P972, DOI 10.1002/(SICI)1097-0215(19970611)71:6<972::AID-IJC11>3.3.CO;2-8; FREEDMAN RS, 1994, J IMMUNOTHER, V16, P198, DOI 10.1097/00002371-199410000-00004; Gong JL, 2000, J IMMUNOL, V165, P1705, DOI 10.4049/jimmunol.165.3.1705; Henry F, 1999, CANCER RES, V59, P3329; HSU D, 2002, P AM ASSOC CANC RES, V21, pA3362; Hsu FJ, 1996, NAT MED, V2, P52, DOI 10.1038/nm0196-52; Kugler A, 2000, NAT MED, V6, P332, DOI 10.1038/73193; Murphy GP, 1999, PROSTATE, V39, P54, DOI 10.1002/(SICI)1097-0045(19990401)39:1<54::AID-PROS9>3.0.CO;2-U; Nair SK, 2000, NAT MED, V6, P1011, DOI 10.1038/79519; Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328; PEOPLES GE, 1993, J IMMUNOL, V151, P5472; PEOPLES GE, 1994, J IMMUNOL, V152, P4993; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Santin AD, 2000, AM J OBSTET GYNECOL, V183, P601, DOI 10.1067/mob.2000.107097; Santin AD, 2000, OBSTET GYNECOL, V96, P422, DOI 10.1016/S0029-7844(00)00916-9; Singh-Jasuja H, 2000, J EXP MED, V191, P1965, DOI 10.1084/jem.191.11.1965; Soda H, 1999, J SURG ONCOL, V72, P211, DOI 10.1002/(SICI)1096-9098(199912)72:4<211::AID-JSO6>3.3.CO;2-1; Srivastava PK, 1997, METHODS, V12, P165, DOI 10.1006/meth.1997.0464; STEIS RG, 1990, J CLIN ONCOL, V8, P1618, DOI 10.1200/JCO.1990.8.10.1618; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; VANPEL A, 1983, J EXP MED, V157, P1992, DOI 10.1084/jem.157.6.1992; Vermorken JB, 1999, LANCET, V353, P345, DOI 10.1016/S0140-6736(98)07186-4; Wolfe K, 2000, NAT REV GENET, V1, P7, DOI 10.1038/35049607; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	30	707	769	2	67	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 27	2002	360	9329					295	305		10.1016/S0140-6736(02)09552-1	http://dx.doi.org/10.1016/S0140-6736(02)09552-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578DT	12147373				2022-12-28	WOS:000177102700011
J	Hamadani, JD; Fuchs, GJ; Osendarp, SJM; Huda, SN; Grantham-McGregor, SM				Hamadani, JD; Fuchs, GJ; Osendarp, SJM; Huda, SN; Grantham-McGregor, SM			Zinc supplementation during pregnancy and effects on mental development and behaviour of infants: a follow-up study	LANCET			English	Article							PLACEBO-CONTROLLED TRIAL; CHILD-DEVELOPMENT; DEFICIENCY; IRON	Background Zinc deficiency is widely prevalent in developing countries. Zinc supplements given to Bangladeshi pregnant women have been shown to reduce infants' infectious disease morbidity. We assessed these infants at age 13 months to establish the effect of antenatal zinc supplementation on infant development and behaviour. Methods The study originally consisted of 559 pregnant women who were randomly allocated to zinc (30 mg daily) or placebo (cellulose) from 4 months' gestation to delivery. The effect of zinc supplementation on pregnancy outcome and on infant growth and morbidity in the first 6 months was assessed. We then randomly selected a sulosample of 168 infants from 383 who completed the study at 6 months. When babies in this subsample reached age 13 months, we assessed mental development with Bayley scales of infant development-II, rated behaviour on a modified version of Wolke's scales, and measured weight and height. Findings When we controlled for differences between tested and non-tested participants, infants in the placebo group had higher scores on mental development index (regression coefficient=3.3, SE 1.6, 95% CI 0.2-6.5, p=0.04) and psychomotor development index (5.1, 2.4, 0.2-9.9, p=0.04) than those in the zinc-supplemented group. Zinc supplementation had no significant effect on behaviour or growth. The children's nutritional status was poor, and weight-for-age at testing was strongly related to developmental levels, which accounted for some of the treatment effect. Interpretation Prenatal supplementation with zinc alone in poor women from Bangladesh does not seem to confer benefit on infants' mental development. Such treatment should be considered with caution.	UCL, Inst Child Hlth, Ctr Int Child Hlth, London WC1N 1EH, England; Int Ctr Diarrhoeal Dis Res, Ctr Hlth & Populat Res, Dhaka, Bangladesh; Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; Univ Wageningen & Res Ctr, Div Human Nutr & Epidemiol, NL-6700 HB Wageningen, Netherlands; Univ Dhaka, Inst Nutr & Food Sci, Dhaka, Bangladesh	University of London; University College London; International Centre for Diarrhoeal Disease Research (ICDDR); University of Arkansas System; University of Arkansas Medical Sciences; Wageningen University & Research; University of Dhaka	Grantham-McGregor, SM (corresponding author), UCL, Inst Child Hlth, Ctr Int Child Hlth, London WC1N 1EH, England.	s.mcgregor@ich.ucl.ac.uk	Fuchs, George/GLV-1285-2022; Hamadani, Jena/Z-1429-2018	Fuchs, George/0000-0002-8679-8265; Hamadani, Jena/0000-0003-0733-6829				Bayley N, 1993, BAYLEY SCALES INFANT; Beshgetoor D, 1998, AM J CLIN NUTR, V67, p1017S, DOI 10.1093/ajcn/67.5.1017S; Bhutta ZA, 1999, J PEDIATR-US, V135, P689, DOI 10.1016/S0022-3476(99)70086-7; Black MM, 1998, AM J CLIN NUTR, V68, p464S, DOI 10.1093/ajcn/68.2.464S; Brown KH, 1998, BIBL NUTR DIET, P76; CALDWELL BM, 1967, PEDIATRICS, V40, P46; Caulfield LE, 1998, AM J CLIN NUTR, V68, p499S, DOI 10.1093/ajcn/68.2.499S; FESTA MD, 1985, AM J CLIN NUTR, V41, P285, DOI 10.1093/ajcn/41.2.285; GOLUB MS, 1995, J NUTR, V125, pS2263, DOI 10.1093/jn/125.suppl_8.2263S; GRANTHAMMCGREGOR S, 1995, J NUTR, V125, pS2233; HALAS ES, 1983, PHYSIOL BEHAV, V30, P371, DOI 10.1016/0031-9384(83)90140-3; Hamadani JD, 2001, AM J CLIN NUTR, V74, P381; Hamill PV, 1977, VITAL HLTH STAT 11, V11, P1; JOOS SK, 1983, CHILD DEV, V54, P669; Kilbride J, 1999, INT J EPIDEMIOL, V28, P461, DOI 10.1093/ije/28.3.461; KIRKSEY A, 1994, AM J CLIN NUTR, V60, P782, DOI 10.1093/ajcn/60.5.782; KIRKSEY A, 1991, AM J CLIN NUTR, V54, P657, DOI 10.1093/ajcn/54.4.657; LOZOFF B, 1998, SCI PUBLICATION, V566, P162; Martorell R, 1989, ANTHROPOMETRIC STAND; Merialdi M, 1999, AM J OBSTET GYNECOL, V180, P483, DOI 10.1016/S0002-9378(99)70236-X; Monroe R. L, 1980, HDB CROSS CULTURAL H, P181; O'Brien KO, 1999, AM J CLIN NUTR, V69, P509; Osendarp SJM, 2000, AM J CLIN NUTR, V71, P114; Osendarp SJM, 2001, LANCET, V357, P1080, DOI 10.1016/S0140-6736(00)04260-4; Sandstead HH, 1996, J NUTR, V126, pS2410, DOI 10.1093/jn/126.suppl_9.2410S; Shah D, 2001, BRIT J NUTR, V85, pS101, DOI 10.1079/BJN2000301; SWANSON CA, 1987, AM J CLIN NUTR, V46, P763, DOI 10.1093/ajcn/46.5.763; Tamura T, 2000, AM J CLIN NUTR, V71, P109; *WHO, 1996, TRAC EL HUM NUTR HLT, P72; WOLKE D, 1990, J PEDIATR PSYCHOL, V15, P237, DOI 10.1093/jpepsy/15.2.237	30	101	103	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 27	2002	360	9329					290	294		10.1016/S0140-6736(02)09551-X	http://dx.doi.org/10.1016/S0140-6736(02)09551-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578DT	12147372				2022-12-28	WOS:000177102700010
J	Abers, GA; Ferris, A; Craig, M; Davies, H; Lerner-Lam, AL; Mutter, JC; Taylor, B				Abers, GA; Ferris, A; Craig, M; Davies, H; Lerner-Lam, AL; Mutter, JC; Taylor, B			Mantle compensation of active metamorphic core complexes at Woodlark rift in Papua New Guinea	NATURE			English	Article							LOWER-CRUST; DENTRECASTEAUX ISLANDS; SEISMIC EVIDENCE; BENEATH; ORIGIN; REGION; TOMOGRAPHY; EVOLUTION; EXTENSION; FLOW	In many highly extended rifts on the Earth, tectonic removal of the upper crust exhumes mid-crustal rocks, producing metamorphic core complexes. These structures allow the upper continental crust to accommodate tens of kilometres of extension(1), but it is not clear how the lower crust and underlying mantle respond. Also, despite removal of the upper crust, such core complexes remain both topographically high and in isostatic equilibrium. Because many core complexes in the western United States are underlain by a flat Moho discontinuity(2,3), it has been widely assumed that their elevation is supported by flow in the lower crust(4-6) or by magmatic underplating(7). These processes should decouple upper-crust extension from that in the mantle. In contrast, here we present seismic observations of metamorphic core complexes of the western Woodlark rift that show the overall crust to be thinned beneath regions of greatest surface extension. These core complexes are actively being exhumed(8) at a rate of 5-10 km Myr(-1), and the thinning of the underlying crust appears to be compensated by mantle rocks of anomalously low density, as indicated by low seismic velocities. We conclude that, at least in this case, the development of metamorphic core complexes and the accommodation of high extension is not purely a crustal phenomenon, but must involve mantle extension.	Boston Univ, Dept Earth Sci, Boston, MA 02215 USA; Univ Papua New Guinea, Dept Geol, Port Moresby, Papua N Guinea; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Univ Hawaii Manoa, Honolulu, HI 96822 USA	Boston University; University of Papua New Guinea; Columbia University; University of Hawaii System; University of Hawaii Manoa	Abers, GA (corresponding author), Boston Univ, Dept Earth Sci, Boston, MA 02215 USA.	abers@bu.edu						Abers GA, 2001, GEOL SOC SPEC PUBL, V187, P305, DOI 10.1144/GSL.SP.2001.187.01.15; ACHAUER U, 1994, TECTONOPHYSICS, V236, P305, DOI 10.1016/0040-1951(94)90182-1; BALDWIN SL, 1993, TECTONICS, V12, P611, DOI 10.1029/93TC00235; BLOCK L, 1990, TECTONICS, V9, P557, DOI 10.1029/TC009i004p00557; BUCK WR, 1989, GEOPHYS RES LETT, V16, P641, DOI 10.1029/GL016i007p00641; DAVIES HL, 1988, TECTONICS, V7, P1, DOI 10.1029/TC007i001p00001; HACKER BR, IN PRESS J GEOPHYS R; HILL EJ, 1993, J METAMORPH GEOL, V11, P261, DOI 10.1111/j.1525-1314.1993.tb00146.x; HILL EJ, 1995, J GEOPHYS RES-SOL EA, V100, P10441, DOI 10.1029/94JB03329; KARATO S, 1993, GEOPHYS RES LETT, V20, P1623, DOI 10.1029/93GL01767; KLEMPERER SL, 1986, GEOL SOC AM BULL, V97, P603, DOI 10.1130/0016-7606(1986)97<603:TMITNB>2.0.CO;2; KRUSE S, 1991, J GEOPHYS RES-SOLID, V96, P4435, DOI 10.1029/90JB02621; LISTER GS, 1993, GEOLOGY, V21, P607, DOI 10.1130/0091-7613(1993)021<0607:PATOOM>2.3.CO;2; LISTER GS, 1989, J STRUCT GEOL, V11, P65, DOI 10.1016/0191-8141(89)90036-9; Martinez F, 2001, NATURE, V411, P930, DOI 10.1038/35082042; MCCARTHY J, 1991, J GEOPHYS RES-SOLID, V96, P12259, DOI 10.1029/91JB01004; MCKENZIE D, 1988, J PETROL, V29, P625, DOI 10.1093/petrology/29.3.625; MCKENZIE D, 1978, EARTH PLANET SC LETT, V40, P25, DOI 10.1016/0012-821X(78)90071-7; McKenzie D, 2000, J GEOPHYS RES-SOL EA, V105, P11029, DOI 10.1029/1999JB900446; Nyblade AA, 2000, GEOLOGY, V28, P599; OLLIER CD, 1980, J GEOL SOC AUST, V27, P33, DOI DOI 10.1080/00167618008729116; OWENS TJ, 1984, J GEOPHYS RES, V89, P7783, DOI 10.1029/JB089iB09p07783; Pinchin J., 1985, BUR MIN RESOUR AUST, V32, P31; Roecker S.W., 1993, SEISMIC TOMOGRAPHY T, P534; Ruppel C, 1995, J GEOPHYS RES-SOL EA, V100, P24187, DOI 10.1029/95JB02955; SHEEHAN AF, 1995, J GEOPHYS RES-SOL EA, V100, P20391, DOI 10.1029/95JB01966; SMITH IEM, 1976, VOLCANISM AUSTRALASI, P275; Taylor B, 1999, J GEOPHYS RES-SOL EA, V104, P7497, DOI 10.1029/1998JB900115; Toomey DR, 1998, SCIENCE, V280, P1224, DOI 10.1126/science.280.5367.1224; WEISSEL JK, 1982, TECTONOPHYSICS, V87, P253, DOI 10.1016/0040-1951(82)90229-3	30	65	66	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 22	2002	418	6900					862	865		10.1038/nature00990	http://dx.doi.org/10.1038/nature00990			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192406				2022-12-28	WOS:000177555600034
J	Deane, GB; Stokes, MD				Deane, GB; Stokes, MD			Scale dependence of bubble creation mechanisms in breaking waves	NATURE			English	Article							AIR ENTRAINMENT; SIZE DISTRIBUTIONS; DISSIPATION; GENERATION; AMBIENT; CLOUDS	Breaking ocean waves entrain air bubbles that enhance air-sea gas flux, produce aerosols, generate ambient noise and scavenge biological surfactants. The size distribution of the entrained bubbles is the most important factor in controlling these processes, but little is known about bubble properties and formation mechanisms inside whitecaps. We have measured bubble size distributions inside breaking waves in the laboratory and in the open ocean, and provide a quantitative description of bubble formation mechanisms in the laboratory. We find two distinct mechanisms controlling the size distribution, depending on bubble size. For bubbles larger than about 1 mm, turbulent fragmentation determines bubble size distribution, resulting in a bubble density proportional to the bubble radius to the power of -10/3. Smaller bubbles are created by jet and drop impact on the wave face, with a -3/2 power-law scaling. The length scale separating these processes is the scale where turbulent fragmentation ceases, also known as the Hinze scale. Our results will have important implications for the study of air-sea gas transfer.	Univ Calif San Diego, Scripps Inst Oceanog, Marine Phys Lab, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Deane, GB (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Marine Phys Lab, La Jolla, CA 92093 USA.	grant@mpl.ucsd.edu	Deane, Grant/B-1967-2010					BALDY S, 1993, J GEOPHYS RES-OCEANS, V98, P18277, DOI 10.1029/93JC01627; BEZZABOTNOV VS, 1986, IZV AS USSR ATMOS OC, V22, P922; BONETTO F, 1993, INT J MULTIPHAS FLOW, V19, P281, DOI 10.1016/0301-9322(93)90003-D; BONMARIN P, 1989, J FLUID MECH, V209, P405, DOI 10.1017/S0022112089003162; CLAY PH, 1940, P ROY ACAD SCI AMST, V43, P979; de Leeuw G, 2002, GEOPH MONOG SERIES, V127, P271; Deane GB, 1997, J ACOUST SOC AM, V102, P2671, DOI 10.1121/1.420321; Deane GB, 1999, J PHYS OCEANOGR, V29, P1393, DOI 10.1175/1520-0485(1999)029<1393:AEPABS>2.0.CO;2; Fan L.S., 1990, BUTTER WORTH HEINEMA; FARMER D, 1995, J PHYS OCEANOGR, V25, P1426, DOI 10.1175/1520-0485(1995)025<1426:POBCOB>2.0.CO;2; FARMER DM, 1993, NATURE, V361, P620, DOI 10.1038/361620a0; Garrett C, 2000, J PHYS OCEANOGR, V30, P2163, DOI 10.1175/1520-0485(2000)030<2163:TCBBSS>2.0.CO;2; HINZE JO, 1955, AICHE J, V1, P289, DOI 10.1002/aic.690010303; HWANG PA, 1990, J PHYS OCEANOGR, V20, P19, DOI 10.1175/1520-0485(1990)020<0019:ABPBBW>2.0.CO;2; KOGA M, 1982, TELLUS, V34, P481, DOI 10.1111/j.2153-3490.1982.tb01836.x; KOLMOGOROV AN, 1949, DOKL AKAD NAUK SSSR+, V66, P825; LAMARRE E, 1991, NATURE, V351, P469, DOI 10.1038/351469a0; Leighton T.G., 1994, ACOUSTIC BUBBLE, DOI DOI 10.1121/1.410082; LEWIS DA, 1982, T I CHEM ENG-LOND, V60, P283; Loewen MR, 1996, J GEOPHYS RES-OCEANS, V101, P20759, DOI 10.1029/96JC01919; LOEWEN MR, 1994, J ACOUST SOC AM, V95, P1329, DOI 10.1121/1.408573; LOEWEN MR, 1991, J FLUID MECH, V224, P601, DOI 10.1017/S0022112091001891; LOEWEN MR, 1995, 3 INT S AIR WAT GAS, P337; LONGUETHIGGINS MS, 1992, P ROY SOC LOND A MAT, V439, P611, DOI 10.1098/rspa.1992.0171; Martinez-Bazan C, 1999, J FLUID MECH, V401, P157, DOI 10.1017/S0022112099006680; MEDWIN H, 1989, J GEOPHYS RES-OCEANS, V94, P12751, DOI 10.1029/JC094iC09p12751; Melville WK, 1996, ANNU REV FLUID MECH, V28, P279, DOI 10.1146/annurev.fl.28.010196.001431; Minnaert M, 1933, PHILOS MAG, V16, P235; MONAHAN EC, 1990, IEEE J OCEANIC ENG, V15, P340, DOI 10.1109/48.103530; PUMPHREY HC, 1990, J FLUID MECH, V220, P539, DOI 10.1017/S0022112090003378; Stokes D, 2002, GEOPH MONOG SERIES, V127, P279; Stokes MD, 1999, IEEE J OCEANIC ENG, V24, P300, DOI 10.1109/48.775292; THORPE SA, 1984, J FLUID MECH, V142, P151, DOI 10.1017/S0022112084001038; THORPE SA, 1992, Q J ROY METEOR SOC, V118, P1, DOI 10.1002/qj.49711850302; THORPE SA, 1992, J PHYS OCEANOGR, V22, P382, DOI 10.1175/1520-0485(1992)022<0382:SFATSD>2.0.CO;2; VANDESANDE E, 1976, CHEM ENG SCI, V31, P219, DOI 10.1016/0009-2509(76)85060-9; WALLACE DWR, 1992, NATURE, V356, P694, DOI 10.1038/356694a0	37	383	394	9	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 22	2002	418	6900					839	844		10.1038/nature00967	http://dx.doi.org/10.1038/nature00967			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	585YR	12192401				2022-12-28	WOS:000177555600029
J	Solomon, PR; Adams, F; Silver, A; Zimmer, J; DeVeaux, R				Solomon, PR; Adams, F; Silver, A; Zimmer, J; DeVeaux, R			Ginkgo for memory enhancement - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BILOBA EXTRACT; DOUBLE-BLIND; VOLUNTEERS; DRUG	Context Several over-the-counter treatments are marketed as having the ability to improve memory, attention, and related cognitive functions in as little as 4 weeks. These claims, however, are generally not supported by well-controlled clinical studies. Objective To evaluate whether ginkgo, an over-the-counter agent marketed as enhancing memory, improves memory in elderly adults as measured by objective neuropsychological tests and subjective ratings. Design Six-week randomized, double-blind, placebo-controlled, parallel-group trial. Setting and Participants Community-dwelling volunteer men (n=98) and women (n=132) older than 60 years with Mini-Mental State Examination scores greater than 26 and in generally good health were recruited by a US academic center via newspaper advertisements and enrolled over a 26-month period from July 1996 to September 1998. Intervention Participants were randomly assigned to receive ginkgo, 40 mg 3 times per day (n=115), or matching placebo (n=115). Main Outcome Measures Standardized neuropsychological tests of verbal and nonverbal learning and memory, attention and concentration, naming and expressive language, participant self-report on a memory questionnaire, and caregiver clinical global impression of change as completed by a companion. Results Two hundred three participants (88%) completed the protocol. Analysis of the modified intent-to-treat population (all 219 participants returning for evaluation) indicated that there were no significant differences between treatment groups on any outcome measure. Analysis of the fully evaluable population (the 203 who complied with treatment and returned for evaluation) also indicated no significant differences for any outcome measure. Conclusions The results of this 6-week study indicate that ginkgo did not facilitate performance on standard neuropsychological tests of learning, memory, attention, and concentration or naming and verbal fluency in elderly adults without cognitive impairment. The ginkgo group also did not differ from the control group in terms of self-reported memory function or global rating by spouses, friends, and relatives. These data suggest that when taken following the manufacturer's instructions, ginkgo provides no measurable benefit in memory or related cognitive function to adults with healthy cognitive function.	Williams Coll, Bronfman Sci Ctr, Dept Psychol, Williamstown, MA 01267 USA; Williams Coll, Program Neurosci, Williamstown, MA 01267 USA; Williams Coll, Dept Math & Stat, Williamstown, MA 01267 USA; SW Vermont Med Ctr, Memory Clin, Bennington, VT USA	Williams College; Williams College; Williams College	Solomon, PR (corresponding author), Williams Coll, Bronfman Sci Ctr, Dept Psychol, 33 Hoxsey St, Williamstown, MA 01267 USA.			Karcioglu, Amanda Silver/0000-0002-1358-774X	NIA NIH HHS [AGO-5134-08S2] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALLAIN H, 1993, CLIN THER, V15, P549; Baddeley A., 1982, YOUR MEMORY USERS GU; Barrett B, 1999, ALTERN THER HEALTH M, V5, P40; Blumenthal M., 1998, COMPLETE GERMAN COMM, P136; *BOEHR ING PHARM P, 1997, GINK PACK INS; CANEDY D, 1998, NY TIMES        0723, pC1; Cupp MJ, 1999, AM FAM PHYSICIAN, V59, P1239; DELIS D, 1987, CALIFORNIA VERBAL LE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GAMES PA, 1967, ELEMENTARY STAT BEHA; Goodglass H., 1983, BOSTON NAMING TEST; HINDMARCH I, 1986, PRESSE MED, V15, P1592; KNAPP MJ, 1994, JAMA-J AM MED ASSOC, V271, P985, DOI 10.1001/jama.271.13.985; LeBars PL, 1997, JAMA-J AM MED ASSOC, V278, P1327, DOI 10.1001/jama.278.16.1327; O'Hara M, 1998, ARCH FAM MED, V7, P523, DOI 10.1001/archfami.7.6.523; RAI GS, 1991, CURR MED RES OPIN, V12, P350, DOI 10.1185/03007999109111504; Rigney U, 1999, PHYTOTHER RES, V13, P408, DOI 10.1002/(SICI)1099-1573(199908/09)13:5&lt;408::AID-PTR530&gt;3.0.CO;2-C; SHUAHAIM JR, 1997, CLIN GERIATR MED, V5, P50; Spreen O, 1998, COMPENDIUM NEUROPSYC; TAILLANDIER J, 1986, PRESSE MED, V15, P1583; WAROT D, 1991, THERAPIE, V46, P33; Wechsler D., 1945, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL, P257; Wesnes K., 1987, HUMAN PSYCHOPHARMACO, V2, P159, DOI [10.1002/hup.470020305, DOI 10.1002/HUP.470020305]; WINOCUR MZ, 1999, PSYCHIAT PHARM, V39, P308	25	184	197	1	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2002	288	7					835	840		10.1001/jama.288.7.835	http://dx.doi.org/10.1001/jama.288.7.835			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585FC	12186600	Bronze			2022-12-28	WOS:000177513100025
J	Bhalla, US; Ram, PT; Iyengar, R				Bhalla, US; Ram, PT; Iyengar, R			MAP kinase phosphatase as a locus of flexibility in a mitogen-activated protein kinase signaling network	SCIENCE			English	Article							PHOSPHORYLATION; RAF-1; GENE; ACID; 2A	Intracellular signaling networks receive and process information to control cellular machines. The mitogen-activated protein kinase (MAPK) 1,2/protein kinase C (PKC) system is one such network that regulates many cellular machines, including the cell cycle machinery and autocrine/paracrine factor synthesizing machinery. We used a combination of computational analysis and experiments in mouse NIH-3T3 fibroblasts to understand the design principles of this controller network. We find that the growth factor stimulated signaling network containing MAPK 1,2/PKC can operate with one (monostable) or two (bistable) stable states. At low concentrations of MAPK phosphatase, the system exhibits bistable behavior, such that brief stimulus results in sustained MAPK activation. The MAPK-induced increase in the amounts of MAPK phosphatase eliminates the prolonged response capability and moves the network to a monostable state, in which it behaves as a proportional response system responding acutely to stimulus. Thus, the MAPK 1,2/PKC controller network is flexibly designed, and MAPK phosphatase may be critical for this flexible response.	Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India; Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Icahn School of Medicine at Mount Sinai	Bhalla, US (corresponding author), Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India.			Ram, Prahlad/0000-0003-4739-3166	NCI NIH HHS [CA-81050, CA-79134] Funding Source: Medline; NIGMS NIH HHS [GM-54508] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA079134, R01CA081050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054508] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALESSI DR, 1995, CURR BIOL, V5, P283, DOI 10.1016/S0960-9822(95)00059-5; Baharians Z, 1998, J BIOL CHEM, V273, P19019, DOI 10.1074/jbc.273.30.19019; Bhalla US, 2001, CHAOS, V11, P221, DOI 10.1063/1.1350440; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; BHALLA US, 1998, BOOK GENESIS EXPLORI, pCH10; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DENT P, 1995, SCIENCE, V268, P1902, DOI 10.1126/science.7604263; Dorfman K, 1996, ONCOGENE, V13, P925; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; NEMENOFF RA, 1993, J BIOL CHEM, V268, P1960; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; SHEARMAN MS, 1989, FEBS LETT, V243, P177, DOI 10.1016/0014-5793(89)80125-5; SHINOMURA T, 1991, P NATL ACAD SCI USA, V88, P5149, DOI 10.1073/pnas.88.12.5149; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O	24	483	496	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2002	297	5583					1018	1023		10.1126/science.1068873	http://dx.doi.org/10.1126/science.1068873			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169734				2022-12-28	WOS:000177325400046
J	Nykypanchuk, D; Strey, HH; Hoagland, DA				Nykypanchuk, D; Strey, HH; Hoagland, DA			Brownian motion of DNA confined within a two-dimensional array	SCIENCE			English	Article							POLYMER-CHAIN; DIFFUSION; ELECTROPHORESIS; MACROMOLECULES; REPTATION; DYNAMICS; GELS; MEMBRANES; MOLECULES; VOIDS	Linear DNA molecules are visualized while undergoing Brownian motion inside media patterned with molecular-sized spatial constraints. The media, prepared by colloidal templating, trap the macromolecules within a two-dimensional array of spherical cavities interconnected by circular holes. Across a broad DNA size range, diffusion does not proceed by the familiar mechanisms of reptation or sieving. Rather, because of their inherent flexibility, DNA molecules strongly localize in cavities and only sporadically jump through holes. Jumping closely follows Poisson statistics. By reducing DNA's configurational freedom, the holes act as molecular weight dependent entropic barriers. Sterically constrained macromolecular diffusion underlies many separation methods and assumes an important role in intracellular and extracellular transport.	Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Strey, HH (corresponding author), Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA.	strey@mail.pse.umass.edu; dah@neurotica.pse.umass.edu	Strey, Helmut/B-5456-2009	Strey, Helmut/0000-0002-6554-5322				Akerman B, 1996, PHYS REV E, V54, P6685, DOI 10.1103/PhysRevE.54.6685; Chou CF, 1999, P NATL ACAD SCI USA, V96, P13762, DOI 10.1073/pnas.96.24.13762; DEGENNES PG, 1971, J CHEM PHYS, V55, P572, DOI 10.1063/1.1675789; DEGENNES PG, 1979, SCALING CONCEPTS PO, P193; DOI M, 1978, J CHEM SOC FARAD T 2, V74, P1789, DOI 10.1039/f29787401789; Einstein A, 1908, Z ELKTROCHEM ANGEW P, V14, P235, DOI 10.1002/bbpc.19080141703; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; GUILLOT G, 1985, MACROMOLECULES, V18, P2531, DOI 10.1021/ma00154a030; Han J, 1999, PHYS REV LETT, V83, P1688, DOI 10.1103/PhysRevLett.83.1688; HAUS JW, 1987, PHYS REP, V150, P263, DOI 10.1016/0370-1573(87)90005-6; HOUSEAL TW, 1989, BIOPHYS J, V56, P507, DOI 10.1016/S0006-3495(89)82697-9; Jiang P, 1999, J AM CHEM SOC, V121, P11630, DOI 10.1021/ja9903476; KAS J, 1994, NATURE, V368, P226, DOI 10.1038/368226a0; Liu L, 1999, NATURE, V397, P141, DOI 10.1038/16426; LODGE TP, 1990, ADV CHEM PHYS, V79, P1; Masaro L, 1999, PROG POLYM SCI, V24, P731, DOI 10.1016/S0079-6700(99)00016-7; MATSUMOTO M, 1992, J POLYM SCI POL PHYS, V30, P779, DOI 10.1002/polb.1992.090300716; Meistermann L, 2000, PHYS REV E, V62, P4014, DOI 10.1103/PhysRevE.62.4014; MUTHUKUMAR M, 1989, MACROMOLECULES, V22, P1941, DOI 10.1021/ma00194a071; MUTHUKUMAR M, 1989, MACROMOLECULES, V22, P1937, DOI 10.1021/ma00194a070; OGSTON AG, 1958, T FARADAY SOC, V54, P1754, DOI 10.1039/tf9585401754; Park SH, 1998, CHEM MATER, V10, P1745, DOI 10.1021/cm9801993; PERKINS TT, 1994, SCIENCE, V264, P819, DOI 10.1126/science.8171335; Slater GW, 1996, METHOD ENZYMOL, V270, P272; SMISEK DL, 1990, SCIENCE, V248, P1221, DOI 10.1126/science.2349481; Smith DE, 1996, MACROMOLECULES, V29, P1372, DOI 10.1021/ma951455p; Turner SWP, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.128103; Velikov KP, 2002, SCIENCE, V296, P106, DOI 10.1126/science.1067141; VOLKMUTH WD, 1992, NATURE, V358, P600, DOI 10.1038/358600a0; ZIMM BH, 1993, MACROMOLECULES, V26, P226, DOI 10.1021/ma00053a035	30	120	126	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 9	2002	297	5583					987	990		10.1126/science.1073277	http://dx.doi.org/10.1126/science.1073277			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581ZN	12169727				2022-12-28	WOS:000177325400037
J	Kato, Y; Habas, R; Katsuyama, Y; Naar, AM; He, X				Kato, Y; Habas, R; Katsuyama, Y; Naar, AM; He, X			A component of the ARC/mediator complex required for TGF beta/Nodal signalling	NATURE			English	Article							TRANSCRIPTIONAL REGULATION; DROSOPHILA HOMOLOGS; MEDIATOR COMPLEX; COFACTOR COMPLEX; BETA SIGNALS; COACTIVATOR; PROTEIN; INDUCTION; SMADS; GENE	The transforming growth factor beta (TGFbeta) family of cytokines, including Nodal, Activin and bone morphogenetic protein (BMP), have essential roles in development and tumorigenesis(1,2). TGFbeta molecules activate the Smad family of signal transducers, which form complexes with specific DNA-binding proteins to regulate gene expression(1,2). Two discrete Smad-dependent signalling pathways have been identified: TGFbeta, Activin and Nodal signal via the Smad2 (or Smad3)-Smad4 complex, whereas BMP signals via the Smad1-Smad4 complex(1,2). How distinct Smad complexes regulate specific gene expression is not fully understood. Here we show that ARC105, a component of the activator-recruited co-factor (ARC)(3) complex or the metazoan Mediator complex, is essential for TGFbeta/Activin/Nodal/Smad2/3 signal transduction. Expression of ARC105 stimulates Activin/Nodal/Smad2 signalling in Xenopus laevis embryos, inducing axis duplication and mesendoderm differentiation, and enhances TGFbeta response in human cells. Depletion of ARC105 inhibits TGFbeta/Activin/Nodal/Smad2/3 signalling and Xenopus axis formation, but not BMP/Smad1 signalling. ARC105 protein binds to Smad2/3-Smad4 in response to TGFbeta and is recruited to Activin/Nodal-responsive promoters in chromatin in a Smad2-dependent fashion. Thus ARC105 is a specific and key ARC/Mediator component linking TGFbeta/Activin/Nodal/Smad2/3 signalling to transcriptional activation.	Harvard Univ, Sch Med, Childrens Hosp, Dept Neurol,Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Canc Ctr,Dept Cell Biol, Charlestown, MA 02129 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital	He, X (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Dept Neurol,Div Neurosci, Boston, MA 02115 USA.							Abraham S, 2000, GENE, V255, P389, DOI 10.1016/S0378-1119(00)00292-4; Bai RY, 2002, NAT CELL BIOL, V4, P181, DOI 10.1038/ncb753; Berti L, 2001, GENOMICS, V74, P320, DOI 10.1006/geno.2001.6566; Boube M, 2000, GENE DEV, V14, P2906, DOI 10.1101/gad.17900; Boyer TG, 1999, NATURE, V399, P276, DOI 10.1038/20466; Candia AF, 1997, DEVELOPMENT, V124, P4467; CHEN WH, 1989, COMPUT MECH, V4, P1; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; HEMMATIBRIVANLOU A, 1992, NATURE, V359, P609, DOI 10.1038/359609a0; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Jiang YW, 1998, P NATL ACAD SCI USA, V95, P8538, DOI 10.1073/pnas.95.15.8538; Kato Y, 1999, J NEUROSCI, V19, P9364; Malik S, 2000, MOL CELL, V5, P753, DOI 10.1016/S1097-2765(00)80254-3; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Rachez C, 2001, CURR OPIN CELL BIOL, V13, P274, DOI 10.1016/S0955-0674(00)00209-X; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Sachs LM, 2000, P NATL ACAD SCI USA, V97, P13138, DOI 10.1073/pnas.260141297; Shimizu K, 2001, MOL CELL BIOL, V21, P3901, DOI 10.1128/MCB.21.12.3901-3912.2001; SINGH N, 1995, GENE DEV, V9, P2251, DOI 10.1101/gad.9.18.2251; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Treisman JE, 2001, DEVELOPMENT, V128, P603; Whitman M, 1998, GENE DEV, V12, P2445, DOI 10.1101/gad.12.16.2445; Yeo CY, 1999, J BIOL CHEM, V274, P26584, DOI 10.1074/jbc.274.37.26584; Zhang H, 2000, GENE DEV, V14, P2161, DOI 10.1101/gad.814700	30	128	140	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2002	418	6898					641	646		10.1038/nature00969	http://dx.doi.org/10.1038/nature00969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	581RA	12167862				2022-12-28	WOS:000177305600043
J	Mayou, R; Farmer, A				Mayou, R; Farmer, A			ABC of psychological medicine - Functional somatic symptoms and syndromes	BRITISH MEDICAL JOURNAL			English	Review									Univ Oxford, Warneford Hosp, Oxford OX1 2JD, England; Univ Oxford, Dept Publ Hlth & Primary Care, Oxford OX1 2JD, England	University of Oxford; University of Oxford	Mayou, R (corresponding author), Univ Oxford, Warneford Hosp, Oxford OX1 2JD, England.							Clark DM, 1998, BRIT J PSYCHIAT, V173, P218, DOI 10.1192/bjp.173.3.218; Kisely S, 1997, PSYCHOL MED, V27, P1011, DOI 10.1017/S0033291797005485; KROENKE K, 1989, AM J MED, V86, P262, DOI 10.1016/0002-9343(89)90293-3; Mayou R, 1995, TREATMENT FUNCTIONAL; Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2	5	106	106	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 3	2002	325	7358					265	268		10.1136/bmj.325.7358.265	http://dx.doi.org/10.1136/bmj.325.7358.265			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582FL	12153926	Green Published			2022-12-28	WOS:000177339000025
J	Bachman, ES; Dhillon, H; Zhang, CY; Cinti, S; Bianco, AC; Kobilka, BK; Lowell, BB				Bachman, ES; Dhillon, H; Zhang, CY; Cinti, S; Bianco, AC; Kobilka, BK; Lowell, BB			beta AR signaling required for diet-induced thermogenesis and obesity resistance	SCIENCE			English	Article							BROWN ADIPOSE-TISSUE; TYPE-2 IODOTHYRONINE DEIODINASE; MICE LACKING; ADAPTIVE THERMOGENESIS; NEONATAL SYMPATHECTOMY; UNCOUPLING PROTEIN; BODY-COMPOSITION; SUSCEPTIBILITY; NORADRENALINE; DISRUPTION	Excessive caloric intake is thought to be sensed by the brain, which then activates thermogenesis as a means of preventing obesity. The sympathetic nervous system, through beta-adrenergic receptor (betaAR) action on target tissues, is likely the efferent arm of this homeostatic mechanism. To test this hypothesis, we created mice that lack the three known betaARs (beta-less mice). beta-less mice on a Chow diet had a reduced metabolic rate and were slightly obese. On a high-fat diet, beta-less mice, in contrast to wild-type mice, developed massive obesity that was due entirely to a failure of diet-induced thermogenesis. These findings establish that betaARs are necessary for diet-induced thermogenesis and that this efferent pathway plays a critical role in the body's defense against diet-induced obesity.	Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Univ Ancona, Fac Med, Inst Normal Human Morphol, I-60020 Ancona, Italy; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Thyroid Div, Boston, MA 02215 USA; Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Howard Hughes Med Inst, Stanford, CA 94305 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Marche Polytechnic University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Stanford University	Lowell, BB (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol, 99 Brookline Ave, Boston, MA 02215 USA.		Bianco, Antonio/AAK-6336-2020; Bianco, Antonio C/A-4965-2008	Bianco, Antonio/0000-0001-7737-6813; Bianco, Antonio C/0000-0001-7737-6813; Kobilka, Brian/0000-0001-5958-3990; CINTI, Saverio/0000-0003-0362-5017				BACHMAN ES, UNPUB; Bronnikov G, 1999, ENDOCRINOLOGY, V140, P4185, DOI 10.1210/en.140.9.4185; CARRVALHO SD, 1996, ENDOCRINOLOGY, V137, P5519; Cinti S, 1997, ENDOCRINOLOGY, V138, P797, DOI 10.1210/en.138.2.797; Collins S, 2001, RECENT PROG HORM RES, V56, P309, DOI 10.1210/rp.56.1.309; Curcio C, 2001, J BIOL CHEM, V276, P30183, DOI 10.1074/jbc.C100325200; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; DESAUTELS M, 1991, CAN J PHYSIOL PHARM, V69, P1868, DOI 10.1139/y91-276; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Hamann A, 1996, ENDOCRINOLOGY, V137, P21, DOI 10.1210/en.137.1.21; HIMMSHAGEN J, 1990, FASEB J, V4, P2890, DOI 10.1096/fasebj.4.11.2199286; LANDSBERG L, 1984, AM J PHYSIOL, V247, pE181, DOI 10.1152/ajpendo.1984.247.2.E181; LEVIN BE, 1984, AM J PHYSIOL, V247, pR979, DOI 10.1152/ajpregu.1984.247.6.R979; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Revelli JP, 1997, J CLIN INVEST, V100, P1098, DOI 10.1172/JCI119620; Rohrer DK, 1999, J BIOL CHEM, V274, P16701, DOI 10.1074/jbc.274.24.16701; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; ROTHWELL NJ, 1984, J PHYSIOL-LONDON, V355, P457, DOI 10.1113/jphysiol.1984.sp015431; Schoeller DA, 2001, AM J CLIN NUTR, V73, P511; SUSULIC VS, 1995, J BIOL CHEM, V270, P29483, DOI 10.1074/jbc.270.49.29483; Thomas SA, 1997, NATURE, V387, P94, DOI 10.1038/387094a0; TORDOFF MG, 1985, PHYSIOL BEHAV, V35, P455, DOI 10.1016/0031-9384(85)90323-3; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	25	587	603	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2002	297	5582					843	845		10.1126/science.1073160	http://dx.doi.org/10.1126/science.1073160			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579RZ	12161655				2022-12-28	WOS:000177192800053
J	Stewart, SA; Allen, PJ				Stewart, SA; Allen, PJ			A 20-km-diameter multi-ringed impact structure in the North Sea	NATURE			English	Article							BASINS	Most craters found on Earth are highly eroded, poorly preserved and only exposed on land(1,2). Here we describe a multi-ringed impact structure discovered in the North Sea from the analysis of three-dimensional seismic reflection data. The structure is 20 km in diameter, and has at least ten distinctive concentric rings located between 2 and 10 km from the crater centre. The structure affects Cretaceous chalk and Jurassic shales, and is well preserved below several hundred metres of post-impact Tertiary strata, which constrains its age to be 60-65 Myr old. The formation of concentric ringed impact structures at this relatively small scale had not previously been thought possible, especially on the terrestrial planets(1,3,4). We have mapped the ring structures at a resolution of tens of metres both laterally and in depth, and show that the rings are fault-bounded graben structures, similar to fault arrays formed in low-strain-rate detachment tectonic settings(5). Strata deeper than 500 m palaeodepth appear unfaulted, and we infer that the concentric ring structures may have accommodated post-impact extension towards the excavated crater, through detachment on weak layers within the chalk(6,7).	BP Plc, Aberdeen AB21 7PB, Scotland; Prod Geosci Ltd, Banchory AB31 5YR, Kincardine, Scotland	BP	Stewart, SA (corresponding author), BP Plc, Burnside Rd, Aberdeen AB21 7PB, Scotland.							Allemand P, 1999, J GEOPHYS RES-PLANET, V104, P16501, DOI 10.1029/1999JE900008; Cameron T. D. J., 1992, UK OFFSHORE REGIONAL; FRENCH BM, 1990, EOS, V71, P411; Greeley R, 2000, PLANET SPACE SCI, V48, P829, DOI 10.1016/S0032-0633(00)00050-7; GRIEVE RAF, 1992, TECTONOPHYSICS, V216, P1, DOI 10.1016/0040-1951(92)90152-V; Grieve RAF, 1998, GEOL SOC SPEC PUBL, V140, P105, DOI 10.1144/GSL.SP.1998.140.01.10; Melosh H.J., 1989, OXFORD MONOGRAPHS GE; MELOSH HJ, 1978, GEOPHYS RES LETT, V5, P985, DOI 10.1029/GL005i011p00985; Moore JM, 1998, ICARUS, V135, P127, DOI 10.1006/icar.1998.5973; O'Keefe JD, 2001, INT J IMPACT ENG, V26, P543, DOI 10.1016/S0734-743X(01)00112-9; Schultz-Ela DD, 2002, J STRUCT GEOL, V24, P247, DOI 10.1016/S0191-8141(01)00066-9; SPUDIS PD, 1994, SCIENCE, V266, P1848, DOI 10.1126/science.266.5192.1848; Tsikalas F, 1998, GEOL SOC AM BULL, V110, P537, DOI 10.1130/0016-7606(1998)110<0537:CIAPDA>2.3.CO;2; Wray DS, 1998, P YORKS GEOL SOC, V52, P95, DOI 10.1144/pygs.52.1.95	14	60	61	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2002	418	6897					520	523		10.1038/nature00914	http://dx.doi.org/10.1038/nature00914			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579EE	12152076				2022-12-28	WOS:000177162800037
J	Wagemaker, M; Kentgens, APM; Mulder, FM				Wagemaker, M; Kentgens, APM; Mulder, FM			Equilibrium lithium transport between nanocrystalline phases in intercalated TiO2 anatase	NATURE			English	Article							TITANIUM-DIOXIDE; DIFFUSION; NMR; DYNAMICS; FILMS	Microcrystalline TiO2 with an anatase crystal structure is used as an anode material for lithium rechargeable batteries(1,2), and also as a material for electrochromic(3-6) and solar-cell devices(7,8). When intercalated with lithium, as required for battery applications, TiO2 anatase undergoes spontaneous phase separation into lithium-poor (Li0.01TiO2) and lithium-rich (Li0.6TiO2) domains on a scale of several tens of nanometres(9). During discharge, batteries need to maintain a constant electrical potential between their electrodes over a range of lithium concentrations. The two-phase equilibrium system in the electrodes provides such a plateau in potential, as only the relative phase fractions vary on charging (or discharging) of the lithium. Just as the equilibrium between a liquid and a vapour is maintained by a continuous exchange of particles between the two phases, a similar exchange is required to maintain equilibrium in the solid state. But the time and length scales over which this exchange takes place are unclear. Here we report the direct observation by solid-state nuclear magnetic resonance of the continuous lithium-ion exchange between the intermixed crystallographic phases of lithium-intercalated TiO2. We find that, at room temperature, the continuous flux of lithium ions across the phase boundaries is as high as 1.2x10(20) s(-1) m(-2).	Delft Univ Technol, Interfac Reactor Inst, NL-2629 JB Delft, Netherlands; Univ Nijmegen, Dept Phys Chem Solid State NMR, NSR Ctr Mol Design Synth & Struct, NL-6525 ED Nijmegen, Netherlands	Delft University of Technology; Radboud University Nijmegen	Mulder, FM (corresponding author), Delft Univ Technol, Interfac Reactor Inst, Mekelweg 15, NL-2629 JB Delft, Netherlands.	mulder@iri.tudelft.nl	Mulder, Fokko M/E-7113-2013; Kentgens, Arno P.M./D-8170-2012	Mulder, Fokko M/0000-0003-0526-7081; Kentgens, Arno P.M./0000-0001-5893-4488				Bechinger C, 1996, NATURE, V383, P608, DOI 10.1038/383608a0; CANTAO MP, 1995, THIN SOLID FILMS, V259, P70, DOI 10.1016/0040-6090(94)06401-6; CLAUSS J, 1993, ACTA POLYM, V44, P1, DOI 10.1002/actp.1993.010440101; Ernst R.R., 1994, PRINCIPLES NUCL MAGN; HAGFELDT A, 1995, CHEM REV, V95, P49, DOI 10.1021/cr00033a003; HUANG SY, 1995, J ELECTROCHEM SOC, V142, P142; Kavan L, 1996, J AM CHEM SOC, V118, P6716, DOI 10.1021/ja954172l; Koudriachova MV, 2001, PHYS REV LETT, V86, P1275, DOI 10.1103/PhysRevLett.86.1275; Lunell S, 1997, J AM CHEM SOC, V119, P7374, DOI 10.1021/ja9708629; OHZUKU T, 1982, ELECTROCHIM ACTA, V27, P1263; OHZUKU T, 1985, J POWER SOURCES, V14, P153, DOI 10.1016/0378-7753(85)88026-5; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; OTTAVIANI M, 1986, SOLID STATE IONICS, V20, P197, DOI 10.1016/0167-2738(86)90214-6; Verhoeven VWJ, 2001, PHYS REV LETT, V86, P4314, DOI 10.1103/PhysRevLett.86.4314; Wagemaker M, 2001, J AM CHEM SOC, V123, P11454, DOI 10.1021/ja0161148; XU Z, 1995, SCIENCE, V270, P1332, DOI 10.1126/science.270.5240.1332	17	427	431	12	412	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2002	418	6896					397	399		10.1038/nature00901	http://dx.doi.org/10.1038/nature00901			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	576MU	12140552				2022-12-28	WOS:000177009700032
J	Gnann, JW; Whitley, RJ				Gnann, JW; Whitley, RJ			Herpes zoster	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RELIEVES POSTHERPETIC NEURALGIA; HUMAN-IMMUNODEFICIENCY-VIRUS; PLACEBO-CONTROLLED TRIAL; CONTROLLED CLINICAL-TRIAL; VARICELLA-ZOSTER; ORAL ACYCLOVIR; RANDOMIZED TRIAL; NATURAL-HISTORY; DOUBLE-BLIND; PAIN		Univ Alabama Birmingham, Div Infect Dis, Dept Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA; Vet Affairs Med Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Gnann, JW (corresponding author), Univ Alabama Birmingham, Div Infect Dis, Dept Med, 845 S 19th St,BBRB 220, Birmingham, AL 35294 USA.				Intramural NIH HHS [Z01 AI000430-23] Funding Source: Medline; NCRR NIH HHS [RR-032] Funding Source: Medline; NIAID NIH HHS [N01-AI-15113, N01-AI-62554, N01-AI-12667] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alper BS, 2000, J FAM PRACTICE, V49, P255; BERNSTEIN JE, 1989, J AM ACAD DERMATOL, V21, P265, DOI 10.1016/S0190-9622(89)70171-7; BEUTNER KR, 1995, ANTIMICROB AGENTS CH, V39, P1546, DOI 10.1128/AAC.39.7.1546; Bowsher D, 1997, J PAIN SYMPTOM MANAG, V13, P327, DOI 10.1016/S0885-3924(97)00077-8; BUCHBINDER SP, 1992, J INFECT DIS, V166, P1153, DOI 10.1093/infdis/166.5.1153; Choo PW, 1997, ARCH INTERN MED, V157, P1217, DOI 10.1001/archinte.157.11.1217; CHOO PW, 1995, J INFECT DIS, V172, P706, DOI 10.1093/infdis/172.3.706; COBO LM, 1986, OPHTHALMOLOGY, V93, P763; COBO M, 1987, CURR EYE RES, V6, P195, DOI 10.3109/02713688709020090; Cohen JI, 1999, ANN INTERN MED, V130, P922, DOI 10.7326/0003-4819-130-11-199906010-00017; Colin J, 2000, OPHTHALMOLOGY, V107, P1507, DOI 10.1016/S0161-6420(00)00222-0; Dahl H, 1997, J CLIN MICROBIOL, V35, P347, DOI 10.1128/JCM.35.2.347-349.1997; Decroix J, 2000, J EUR ACAD DERMATOL, V14, P23, DOI 10.1046/j.1468-3083.2000.00020.x; DEMORAGAS JM, 1957, ARCH DERMATOL, V75, P193, DOI 10.1001/archderm.1957.01550140037006; DONAHUE JG, 1995, ARCH INTERN MED, V155, P1605, DOI 10.1001/archinte.155.15.1605; Dworkin RH, 1996, PAIN, V67, P241, DOI 10.1016/0304-3959(96)03122-3; Dworkin RH, 2000, CLIN J PAIN, V16, pS90, DOI 10.1097/00002508-200006001-00016; Galer BS, 1999, PAIN, V80, P533, DOI 10.1016/S0304-3959(98)00244-9; Gilden DH, 2000, NEW ENGL J MED, V342, P635, DOI 10.1056/NEJM200003023420906; GLESBY MJ, 1995, CLIN INFECT DIS, V21, P370, DOI 10.1093/clinids/21.2.370; Gnann JW, 1998, ANTIMICROB AGENTS CH, V42, P1139, DOI 10.1128/AAC.42.5.1139; GNANN JW, 1991, J HOSP INFECT, V18, P317, DOI 10.1016/0195-6701(91)90038-A; Harrison RA, 1999, J PAIN SYMPTOM MANAG, V17, P410, DOI 10.1016/S0885-3924(99)00013-5; HUFF JC, 1988, AM J MED, V85, P84; Jackson JL, 1997, ARCH INTERN MED, V157, P909, DOI 10.1001/archinte.157.8.909; Kanazi GE, 2000, DRUGS, V59, P1113, DOI 10.2165/00003495-200059050-00007; KISHOREKUMAR R, 1990, CLIN PHARMACOL THER, V47, P305, DOI 10.1038/clpt.1990.33; Kost RG, 1996, NEW ENGL J MED, V335, P32, DOI 10.1056/NEJM199607043350107; Kotani N, 2000, NEW ENGL J MED, V343, P1514, DOI 10.1056/NEJM200011233432102; Levin MJ, 1998, J INFECT DIS, V178, pS109, DOI 10.1086/514264; Liesegang TJ, 1999, MAYO CLIN PROC, V74, P983; MAX MB, 1988, NEUROLOGY, V38, P1427, DOI 10.1212/WNL.38.9.1427; MCKENDRICK MW, 1986, BRIT MED J, V293, P1529, DOI 10.1136/bmj.293.6561.1529; MCKENDRICK MW, 1989, BRIT MED J, V298, P431, DOI 10.1136/bmj.298.6671.431; MORTON P, 1989, NEW ZEAL MED J, V102, P93; Ormerod LD, 1998, CLIN INFECT DIS, V26, P34, DOI 10.1086/516285; Oxman MN, 1995, NEUROLOGY, V45, pS41, DOI 10.1212/WNL.45.12_Suppl_8.S41; RAGOZZINO MW, 1982, NEW ENGL J MED, V307, P393, DOI 10.1056/NEJM198208123070701; RAGOZZINO MW, 1982, MEDICINE, V61, P310, DOI 10.1097/00005792-198209000-00003; Rowbotham M, 1998, JAMA-J AM MED ASSOC, V280, P1837, DOI 10.1001/jama.280.21.1837; SAFRIN S, 1991, ANN INTERN MED, V115, P19, DOI 10.7326/0003-4819-115-1-19; THANH HX, 1992, OPHTHALMOLOGY, V99, P1062; TYRING S, 1995, ANN INTERN MED, V123, P89, DOI 10.7326/0003-4819-123-2-199507150-00002; Tyring S, 2001, BRIT J OPHTHALMOL, V85, P576, DOI 10.1136/bjo.85.5.576; Tyring SK, 2000, ARCH FAM MED, V9, P863, DOI 10.1001/archfami.9.9.863; Volmink J, 1996, FAM PRACT, V13, P84, DOI 10.1093/fampra/13.1.84; Watson CPN, 1998, NEUROLOGY, V50, P1837; Whitley RJ, 1999, J INFECT DIS, V179, P9, DOI 10.1086/314562; Whitley RJ, 1996, ANN INTERN MED, V125, P376, DOI 10.7326/0003-4819-125-5-199609010-00004; Wood MJ, 1998, J INFECT DIS, V178, pS81, DOI 10.1086/514271; WOOD MJ, 1994, NEW ENGL J MED, V330, P896, DOI 10.1056/NEJM199403313301304; Wood MJ, 1996, CLIN INFECT DIS, V22, P341, DOI 10.1093/clinids/22.2.341; Wu CL, 2000, PAIN, V87, P121, DOI 10.1016/S0304-3959(00)00230-X	53	812	850	5	66	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2002	347	5					340	346		10.1056/NEJMcp013211	http://dx.doi.org/10.1056/NEJMcp013211			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587WC	12151472				2022-12-28	WOS:000177665900008
J	Podolsky, DK				Podolsky, DK			Inflammatory bowel disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACTIVE CROHNS-DISEASE; DISTAL ULCERATIVE-COLITIS; NECROSIS-FACTOR-ALPHA; RECOMBINANT HUMAN INTERLEUKIN-10; PLACEBO-CONTROLLED TRIAL; GENOME-WIDE SEARCH; DOUBLE-BLIND; LONG-TERM; MONOCLONAL-ANTIBODY; MAINTENANCE TREATMENT		Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Podolsky, DK (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA.				NCRR NIH HHS [UL1 RR024139] Funding Source: Medline; NIDDK NIH HHS [P30 DK43351] Funding Source: Medline; NIDDK NIH HHS [R01 DK077905-01A2, R01 DK077905, DK P30-34989, U01 DK62429, R01 DK072373, R01DK077905, RC1 DK086800, U01 DK062429, U01 DK062422, R01DK072373, U01 DK062429-03, U01 DK062422-10] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahmad T, 2002, GASTROENTEROLOGY, V122, P854, DOI 10.1053/gast.2002.32413; Andersson RE, 2001, NEW ENGL J MED, V344, P808, DOI 10.1056/NEJM200103153441104; Bauditz J, 2002, GUT, V50, P196, DOI 10.1136/gut.50.2.196; Belluzzi A, 1996, NEW ENGL J MED, V334, P1557, DOI 10.1056/NEJM199606133342401; Bouhnik Y, 1996, LANCET, V347, P215, DOI 10.1016/S0140-6736(96)90402-X; Brant SR, 1998, GASTROENTEROLOGY, V115, P1056, DOI 10.1016/S0016-5085(98)70073-3; Cariappa A, 1998, GUT, V43, P210, DOI 10.1136/gut.43.2.210; Cohen RD, 2000, AM J GASTROENTEROL, V95, P3469; Colombel JF, 2000, GASTROENTEROLOGY, V118, P1025, DOI 10.1016/S0016-5085(00)70354-4; Corominas H, 2000, AM J GASTROENTEROL, V95, P2313; Cosnes J, 2001, GASTROENTEROLOGY, V120, P1093, DOI 10.1053/gast.2001.23231; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; D'Haens G, 2001, GASTROENTEROLOGY, V120, P1323, DOI 10.1053/gast.2001.23983; DANIELSSON A, 1992, SCAND J GASTROENTERO, V27, P9, DOI 10.3109/00365529209011158; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Dubinsky MC, 2000, GASTROENTEROLOGY, V118, P705, DOI 10.1016/S0016-5085(00)70140-5; Ehrenpreis ED, 1999, GASTROENTEROLOGY, V117, P1271, DOI 10.1016/S0016-5085(99)70276-3; ELSON CO, 1999, MUCOSAL IMMUNOLOGY, P1007; Evans JMM, 1997, GUT, V40, P619, DOI 10.1136/gut.40.5.619; Farrell RJ, 2000, GUT, V47, P514, DOI 10.1136/gut.47.4.514; Faubion WA, 2001, GASTROENTEROLOGY, V121, P255, DOI 10.1053/gast.2001.26279; Feagan BG, 2000, GASTROENTEROLOGY, V118, pA874, DOI 10.1016/S0016-5085(00)85637-1; Feagan BG, 2000, NEW ENGL J MED, V342, P1627, DOI 10.1056/NEJM200006013422202; FEAGAN BG, 1995, NEW ENGL J MED, V332, P292, DOI 10.1056/NEJM199502023320503; Fedorak RN, 2000, GASTROENTEROLOGY, V119, P1473, DOI 10.1053/gast.2000.20229; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Gionchetti P, 2000, GASTROENTEROLOGY, V119, P305, DOI 10.1053/gast.2000.9370; Gordon FH, 2001, GASTROENTEROLOGY, V121, P268, DOI 10.1053/gast.2001.26260; Green JRB, 1998, GASTROENTEROLOGY, V114, P15, DOI 10.1016/S0016-5085(98)70627-4; Greenberg GR, 1996, GASTROENTEROLOGY, V110, P45, DOI 10.1053/gast.1996.v110.pm8536887; GRIFFITHS AM, 1995, GASTROENTEROLOGY, V108, P1056, DOI 10.1016/0016-5085(95)90203-1; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Hanauer SB, 1998, GASTROENTEROLOGY, V115, P525, DOI 10.1016/S0016-5085(98)70131-3; HANAUER SB, 1993, AM J GASTROENTEROL, V88, P1343; Hommes D, 2002, GASTROENTEROLOGY, V122, P7, DOI 10.1053/gast.2002.30770; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; KOIZUMI M, 1992, GASTROENTEROLOGY, V103, P840, DOI 10.1016/0016-5085(92)90015-Q; Kornbluth A, 1997, AM J GASTROENTEROL, V92, P1424; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Lewis JD, 2001, AM J GASTROENTEROL, V96, P3323; Lewis JD, 2000, GASTROENTEROLOGY, V118, P1018, DOI 10.1016/S0016-5085(00)70353-2; Lewis JD, 2001, GASTROENTEROLOGY, V121, P1080, DOI 10.1053/gast.2001.28703; LICHTIGER S, 1994, NEW ENGL J MED, V330, P1841, DOI 10.1056/NEJM199406303302601; LINDBERG E, 1988, GUT, V29, P352, DOI 10.1136/gut.29.3.352; Loftus EV, 2001, GASTROENTEROLOGY, V121, P1239; Lopez-Cubero SO, 1998, GASTROENTEROLOGY, V114, P433, DOI 10.1016/S0016-5085(98)70525-6; Lugering A, 2001, GASTROENTEROLOGY, V121, P1145, DOI 10.1053/gast.2001.28702; Ma YH, 1999, INFLAMM BOWEL DIS, V5, P271, DOI 10.1097/00054725-199911000-00005; Mahmud N, 2001, GUT, V49, P552, DOI 10.1136/gut.49.4.552; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; Negoro K, 1999, GASTROENTEROLOGY, V117, P1062, DOI 10.1016/S0016-5085(99)70390-2; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Oren R, 1996, GASTROENTEROLOGY, V110, P1416, DOI 10.1053/gast.1996.v110.pm8613046; ORHOLM M, 1991, NEW ENGL J MED, V324, P84, DOI 10.1056/NEJM199101103240203; Peeters M, 2001, AM J GASTROENTEROL, V96, P730, DOI 10.1111/j.1572-0241.2001.03613.x; Prantera C, 1999, GASTROENTEROLOGY, V116, P521, DOI 10.1016/S0016-5085(99)70172-1; PRESENT DH, 1980, NEW ENGL J MED, V302, P981, DOI 10.1056/NEJM198005013021801; Present DH, 1999, NEW ENGL J MED, V340, P1398, DOI 10.1056/NEJM199905063401804; Rath HC, 2001, INFECT IMMUN, V69, P2277, DOI 10.1128/IAI.69.4.2277-2285.2001; Rembacken BJ, 1999, LANCET, V354, P635, DOI 10.1016/S0140-6736(98)06343-0; Ricart E, 2001, AM J GASTROENTEROL, V96, P722, DOI 10.1111/j.1572-0241.2001.03612.x; RIGAUD D, 1991, GUT, V32, P1492, DOI 10.1136/gut.32.12.1492; Rioux JD, 1998, GASTROENTEROLOGY, V115, P1062, DOI 10.1016/S0016-5085(98)70074-5; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Rutgeerts P, 1999, GASTROENTEROLOGY, V117, P761, DOI 10.1016/S0016-5085(99)70332-X; Sandborn WJ, 2001, GASTROENTEROLOGY, V120, P1330, DOI 10.1053/gast.2001.24042; Sandborn WJ, 2001, GASTROENTEROLOGY, V121, P1088, DOI 10.1053/gast.2001.28674; Sandborn WJ, 1997, ANN INTERN MED, V126, P364, DOI 10.7326/0003-4819-126-5-199703010-00004; Sands BE, 1999, GASTROENTEROLOGY, V117, P58, DOI 10.1016/S0016-5085(99)70550-0; Sans M, 2001, GASTROENTEROLOGY, V120, P1162, DOI 10.1053/gast.2001.23252; Satsangi J, 1996, LANCET, V347, P1212, DOI 10.1016/S0140-6736(96)90734-5; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; SAXON A, 1990, J ALLERGY CLIN IMMUN, V86, P202, DOI 10.1016/S0091-6749(05)80067-3; Schmitz H, 1999, GASTROENTEROLOGY, V116, P301, DOI 10.1016/S0016-5085(99)70126-5; Schreiber S, 2000, GASTROENTEROLOGY, V119, P1461, DOI 10.1053/gast.2000.20196; Slonim AE, 2000, NEW ENGL J MED, V342, P1633, DOI 10.1056/NEJM200006013422203; Stack WA, 1997, LANCET, V349, P521, DOI 10.1016/S0140-6736(97)80083-9; STANGE EF, 1995, GASTROENTEROLOGY, V109, P774, DOI 10.1016/0016-5085(95)90384-4; SUTHERLAND L, 1991, GUT, V32, P1071, DOI 10.1136/gut.32.9.1071; SUTHERLAND LR, 1987, GASTROENTEROLOGY, V92, P1894, DOI 10.1016/0016-5085(87)90621-4; Sutherland LR, 1997, INFLAMM BOWEL DIS, V3, P65, DOI 10.1002/ibd.3780030202; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; ten Hove T, 2002, GUT, V50, P206, DOI 10.1136/gut.50.2.206; Thomsen OO, 1998, NEW ENGL J MED, V339, P370, DOI 10.1056/NEJM199808063390603; THOMSEN OO, 2001, NEW ENGL J MED, V345, P1652; Toms C, 2001, MICROBES INFECT, V3, P929, DOI 10.1016/S1286-4579(01)01454-X; Turunen UM, 1998, GASTROENTEROLOGY, V115, P1072, DOI 10.1016/S0016-5085(98)70076-9; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; vanDeventer SJH, 1997, GASTROENTEROLOGY, V113, P383, DOI 10.1053/gast.1997.v113.pm9247454; VANDULLEMEN HM, 1995, GASTROENTEROLOGY, V109, P129, DOI 10.1016/0016-5085(95)90277-5; Vasiliauskas EA, 1999, GASTROENTEROLOGY, V117, P1278, DOI 10.1016/S0016-5085(99)70277-5; Vermeire S, 2001, GASTROENTEROLOGY, V120, P827, DOI 10.1053/gast.2001.22546	95	3184	3360	31	535	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 8	2002	347	6					417	429		10.1056/NEJMra020831	http://dx.doi.org/10.1056/NEJMra020831			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587YR	19923578				2022-12-28	WOS:000177672400007
